<SEC-DOCUMENT>0001564590-21-011240.txt : 20210305
<SEC-HEADER>0001564590-21-011240.hdr.sgml : 20210305
<ACCEPTANCE-DATETIME>20210305154605
ACCESSION NUMBER:		0001564590-21-011240
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		101
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210305
DATE AS OF CHANGE:		20210305

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DURECT CORP
		CENTRAL INDEX KEY:			0001082038
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				943297098
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-31615
		FILM NUMBER:		21718336

	BUSINESS ADDRESS:	
		STREET 1:		10260 BUBB RD
		CITY:			CUPERTINO
		STATE:			CA
		ZIP:			95014
		BUSINESS PHONE:		4087771417

	MAIL ADDRESS:	
		STREET 1:		10260 BUBB ROAD
		CITY:			CUPERTINO
		STATE:			CA
		ZIP:			95014
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>drrx-10k_20201231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-03-05T18:49:31.9815354+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : 68f21b77591e4eada77a5e64a41cc482 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:drrx="http://www.durect.com/20201231" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2020-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
drrx-10k_20201231.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0001082038_20200101_20201231">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:DocumentFiscalPeriodFocus" contextRef="C_0001082038_20200101_20201231">FY</ix:nonNumeric>
			<ix:nonNumeric id="F_000007" name="dei:EntityCentralIndexKey" contextRef="C_0001082038_20200101_20201231">0001082038</ix:nonNumeric>
			<ix:nonNumeric id="F_000008" name="dei:CurrentFiscalYearEndDate" contextRef="C_0001082038_20200101_20201231">--12-31</ix:nonNumeric>
			<ix:nonNumeric id="F_000718" name="drrx:EmployeesStockPurchasePlanExtendedTermPeriod" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20200101_20201231">P10Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000723" name="drrx:EmployeesStockPurchasePlanExtendedTermPeriod" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20190601_20190630">P10Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000740" name="drrx:EmployeesStockPurchasePlanExtendedTermPeriod" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20100401_20100430">P10Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000744" name="drrx:EmployeesStockPurchasePlanExtendedTermPeriod" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20150301_20150331">P10Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000725" name="drrx:EmployeeStockPurchasePlanExpirationDate" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20200101_20201231">2029-06-30</ix:nonNumeric>
			<ix:nonNumeric id="F_000728" name="drrx:StockOptionsVestingPeriod" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20130401_20130430">P10Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000730" name="drrx:ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors" contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20130401_20130430">P2Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000745" name="drrx:EmployeeStockPurchasePlanExpirationDate" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231">2030-06-30</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000996" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" contextRef="C_0001082038_20200101_20201231" decimals="INF">0</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000997" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" contextRef="C_0001082038_20190101_20191231" decimals="INF">0</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000998" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" contextRef="C_0001082038_20180101_20181231" decimals="INF">0</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000084" name="us-gaap:CommitmentsAndContingencies" contextRef="C_0001082038_20201231" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000085" name="us-gaap:CommitmentsAndContingencies" contextRef="C_0001082038_20191231" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000086" name="us-gaap:PreferredStockValue" contextRef="C_0001082038_20201231" xsi:nil="true"></ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD" id="F_000087" name="us-gaap:PreferredStockValue" contextRef="C_0001082038_20191231" xsi:nil="true"></ix:nonFraction>
			<ix:nonNumeric id="F_000130" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" contextRef="C_0001082038_20200101_20201231">us-gaap:ProductMember</ix:nonNumeric>
			<ix:nonNumeric id="F_000131" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" contextRef="C_0001082038_20190101_20191231">us-gaap:ProductMember</ix:nonNumeric>
			<ix:nonNumeric id="F_000132" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" contextRef="C_0001082038_20180101_20181231">us-gaap:ProductMember</ix:nonNumeric>
			<ix:nonNumeric id="F_000769" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_0001082038_20190101_20191231">P5Y2M1D</ix:nonNumeric>
			<ix:nonNumeric id="F_000770" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" contextRef="C_0001082038_20200101_20201231">P4Y11M23D</ix:nonNumeric>
			<ix:nonNumeric id="F_000771" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" contextRef="C_0001082038_20200101_20201231">P4Y5M8D</ix:nonNumeric>
			<ix:nonNumeric id="F_000772" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" contextRef="C_0001082038_20200101_20201231">P4Y11M23D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000803" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231" decimals="INF">0.014</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000804" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231" decimals="INF">0.027</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000805" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231" decimals="INF">0.031</ix:nonFraction>
			<ix:nonNumeric id="F_000806" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231">P7Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000807" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231">P7Y6M</ix:nonNumeric>
			<ix:nonNumeric id="F_000808" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231">P7Y</ix:nonNumeric>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000812" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231" decimals="INF">0.84</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000813" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231" decimals="INF">0.79</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000814" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231" decimals="INF">0.78</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000800" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231" decimals="INF">0.005</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000801" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231" decimals="INF">0.015</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000802" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231" decimals="INF">0.027</ix:nonFraction>
			<ix:nonNumeric id="F_000809" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231">P7Y3M18D</ix:nonNumeric>
			<ix:nonNumeric id="F_000810" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231">P10Y</ix:nonNumeric>
			<ix:nonNumeric id="F_000811" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231">P10Y</ix:nonNumeric>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000815" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231" decimals="INF">0.87</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000816" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231" decimals="INF">0.83</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000817" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231" decimals="INF">0.86</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000824" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20190101_20191231" decimals="INF">0.025</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000825" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20180101_20181231" decimals="INF">0.025</ix:nonFraction>
			<ix:nonNumeric id="F_000826" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20201231">P6M</ix:nonNumeric>
			<ix:nonNumeric id="F_000827" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20190101_20191231">P6M</ix:nonNumeric>
			<ix:nonNumeric id="F_000828" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20180101_20181231">P6M</ix:nonNumeric>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000829" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20201231" decimals="INF">0.78</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000830" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20190101_20191231" decimals="INF">0.60</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000831" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20180101_20181231" decimals="INF">0.60</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000821" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20201231" decimals="INF">0.001</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000822" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20190101_20191231" decimals="INF">0.016</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000823" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20180101_20181231" decimals="INF">0.013</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000832" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20201231" decimals="INF">1.24</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000833" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20190101_20191231" decimals="INF">1.03</ix:nonFraction>
			<ix:nonFraction unitRef="U_xbrlipure" id="F_000834" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20180101_20181231" decimals="INF">1.46</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000843" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20200101_20201231" decimals="INF">0.51</ix:nonFraction>
			<ix:nonNumeric id="F_000876" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20200101_20201231">P8Y1M13D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000844" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTwoMember_20200101_20201231" decimals="INF">0.58</ix:nonFraction>
			<ix:nonNumeric id="F_000877" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTwoMember_20200101_20201231">P7Y9M14D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000845" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeThreeMember_20200101_20201231" decimals="INF">0.58</ix:nonFraction>
			<ix:nonNumeric id="F_000878" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeThreeMember_20200101_20201231">P3Y7M24D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000846" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFourMember_20200101_20201231" decimals="INF">0.93</ix:nonFraction>
			<ix:nonNumeric id="F_000879" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFourMember_20200101_20201231">P4Y11M1D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000847" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFiveMember_20200101_20201231" decimals="INF">1.21</ix:nonFraction>
			<ix:nonNumeric id="F_000880" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFiveMember_20200101_20201231">P2Y1M17D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000848" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSixMember_20200101_20201231" decimals="INF">1.24</ix:nonFraction>
			<ix:nonNumeric id="F_000881" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSixMember_20200101_20201231">P6Y10M2D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000849" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSevenMember_20200101_20201231" decimals="INF">1.26</ix:nonFraction>
			<ix:nonNumeric id="F_000882" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSevenMember_20200101_20201231">P5Y3M10D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000850" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeEightMember_20200101_20201231" decimals="INF">1.31</ix:nonFraction>
			<ix:nonNumeric id="F_000883" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeEightMember_20200101_20201231">P5Y7M13D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000851" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeNineMember_20200101_20201231" decimals="INF">1.33</ix:nonFraction>
			<ix:nonNumeric id="F_000884" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeNineMember_20200101_20201231">P4Y4M6D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000852" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTenMember_20200101_20201231" decimals="INF">2.10</ix:nonFraction>
			<ix:nonNumeric id="F_000885" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTenMember_20200101_20201231">P4Y11M12D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000853" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeElevenMember_20200101_20201231" decimals="INF">0.51</ix:nonFraction>
			<ix:nonNumeric id="F_000886" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeElevenMember_20200101_20201231">P4Y11M23D</ix:nonNumeric>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000854" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20200101_20201231" decimals="INF">0.57</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000855" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTwoMember_20200101_20201231" decimals="INF">0.58</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000856" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeThreeMember_20200101_20201231" decimals="INF">0.88</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000857" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFourMember_20200101_20201231" decimals="INF">1.20</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000858" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFiveMember_20200101_20201231" decimals="INF">1.21</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000859" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSixMember_20200101_20201231" decimals="INF">1.24</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000860" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSevenMember_20200101_20201231" decimals="INF">1.26</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000861" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeEightMember_20200101_20201231" decimals="INF">1.31</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000862" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeNineMember_20200101_20201231" decimals="INF">2.09</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000863" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTenMember_20200101_20201231" decimals="INF">3.61</ix:nonFraction>
			<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000864" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeElevenMember_20200101_20201231" decimals="INF">3.61</ix:nonFraction>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="drrx-20201231.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0001082038_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_xbrlishares">
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001082038_20210301">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-03-01</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_iso4217USD">
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001082038_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-06-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_iso4217USD_xbrlishares">
				<xbrli:divide>
					<xbrli:unitNumerator>
						<xbrli:measure>iso4217:USD</xbrli:measure>
					</xbrli:unitNumerator>
					<xbrli:unitDenominator>
						<xbrli:measure>xbrli:shares</xbrli:measure>
					</xbrli:unitDenominator>
				</xbrli:divide>
			</xbrli:unit>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20171231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2017-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20171231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2017-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20171231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2017-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20171231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2017-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_20171231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2017-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtRestatementAxis_srtRevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtRestatementAxis_srtRevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapBalanceSheetLocationAxis_drrxLongTermRestrictedInvestmentsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">drrx:LongTermRestrictedInvestmentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapBalanceSheetLocationAxis_drrxLongTermRestrictedInvestmentsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">drrx:LongTermRestrictedInvestmentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapBalanceSheetLocationAxis_drrxLongTermRestrictedInvestmentsMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">drrx:LongTermRestrictedInvestmentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtRangeAxis_srtMinimumMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtRangeAxis_srtMaximumMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_drrxLactelProductLineMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:LactelProductLineMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210131">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-01-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_xbrlipure">
				<xbrli:measure>xbrli:pure</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_drrxAlzetProductLineMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapProductConcentrationRiskMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:AlzetProductLineMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_drrxAlzetProductLineMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapProductConcentrationRiskMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:AlzetProductLineMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_drrxAlzetProductLineMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapProductConcentrationRiskMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:AlzetProductLineMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtMajorCustomersAxis_drrxGileadMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">drrx:GileadMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtMajorCustomersAxis_drrxGileadMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">drrx:GileadMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtMajorCustomersAxis_drrxGileadMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">drrx:GileadMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtMajorCustomersAxis_drrxIndiviorMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:MajorCustomersAxis">drrx:IndiviorMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_countryUS_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_countryUS_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_countryUS_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_srtEuropeMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_srtEuropeMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_srtEuropeMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_countryJP_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_countryJP_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_countryJP_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_drrxOtherForeignCountriesMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:OtherForeignCountriesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_drrxOtherForeignCountriesMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:OtherForeignCountriesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_drrxOtherForeignCountriesMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:OtherForeignCountriesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_drrxSegment">
				<xbrli:measure>drrx:Segment</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001082038_us-gaapRelatedPartyTransactionAxis_drrxLACTELMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">drrx:LACTELMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtRestatementAxis_srtRevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember_20180101">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-01-01</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithGileadMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithGileadMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithGileadMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementsWithOtherCollaboratorsOrCounterpartiesMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementsWithOtherCollaboratorsOrCounterpartiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementsWithOtherCollaboratorsOrCounterpartiesMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementsWithOtherCollaboratorsOrCounterpartiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementsWithOtherCollaboratorsOrCounterpartiesMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementsWithOtherCollaboratorsOrCounterpartiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithGileadMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithGileadMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithGileadMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_us-gaapLicenseMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithGileadMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxDevelopmentBasedMilestonesMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210227_20210301">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:DevelopmentBasedMilestonesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-02-27</xbrli:startDate>
					<xbrli:endDate>2021-03-01</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxSalesBasedMilestonesMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210227_20210301">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:SalesBasedMilestonesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-02-27</xbrli:startDate>
					<xbrli:endDate>2021-03-01</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapChangeInAccountingEstimateByTypeAxis_drrxEarlyStageClinicalTestingMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210301">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">drrx:EarlyStageClinicalTestingMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-03-01</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapChangeInAccountingEstimateByTypeAxis_drrxLateStageClinicalTestingMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210301">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">drrx:LateStageClinicalTestingMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-03-01</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapChangeInAccountingEstimateByTypeAxis_us-gaapRegulatoryReviewsOfFilingsMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210301">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">us-gaap:RegulatoryReviewsOfFilingsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-03-01</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapChangeInAccountingEstimateByTypeAxis_drrxRegulatoryApprovalsMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210301">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">drrx:RegulatoryApprovalsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-03-01</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20190717_20190719">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithGileadMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-07-17</xbrli:startDate>
					<xbrli:endDate>2019-07-19</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20191001_20191031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithGileadMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-10-01</xbrli:startDate>
					<xbrli:endDate>2019-10-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxUpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">drrx:AdditionsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">drrx:DeletionsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_20200101">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-01-01</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">drrx:AdditionsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">drrx:DeletionsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20170925_20170926">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:PatentPurchaseAgreementWithIndiviorMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2017-09-25</xbrli:startDate>
					<xbrli:endDate>2017-09-26</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxRegulatoryBasedMilestoneMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20170926">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:PatentPurchaseAgreementWithIndiviorMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:RegulatoryBasedMilestoneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2017-09-26</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_us-gaapRoyaltyMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20170901_20170930">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:PatentPurchaseAgreementWithIndiviorMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2017-09-01</xbrli:startDate>
					<xbrli:endDate>2017-09-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_us-gaapRoyaltyMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20170101_20171231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:PatentPurchaseAgreementWithIndiviorMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2017-01-01</xbrli:startDate>
					<xbrli:endDate>2017-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxRegulatoryBasedMilestoneMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20180831">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:PatentPurchaseAgreementWithIndiviorMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:RegulatoryBasedMilestoneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-08-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxRegulatoryBasedMilestoneMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:PatentPurchaseAgreementWithIndiviorMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:RegulatoryBasedMilestoneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtProductOrServiceAxis_us-gaapLicenseMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20141210_20141211">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithSantenPharmaceuticalCoLtdMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2014-12-10</xbrli:startDate>
					<xbrli:endDate>2014-12-11</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20141211">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithSantenPharmaceuticalCoLtdMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2014-12-11</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxDevelopmentBasedMilestonesMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20141211">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:DevelopmentBasedMilestonesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithSantenPharmaceuticalCoLtdMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2014-12-11</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxCommercializationBasedMilestonesMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20141211">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:CommercializationBasedMilestonesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithSantenPharmaceuticalCoLtdMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2014-12-11</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxCommercializationBasedMilestonesMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:CommercializationBasedMilestonesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithSantenPharmaceuticalCoLtdMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithSantenPharmaceuticalCoLtdMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithSandozAGMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithSandozAGMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCertificatesOfDepositMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMunicipalBondsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCertificatesOfDepositMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCommercialPaperMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMunicipalBondsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCertificatesOfDepositMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCertificatesOfDepositMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCommercialPaperMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCertificatesOfDepositMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCashAndCashEquivalentsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapOtherLongTermInvestmentsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapInvestmentTypeAxis_drrxLongTermRestrictedInvestmentsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">drrx:LongTermRestrictedInvestmentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCertificatesOfDepositMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCashAndCashEquivalentsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_countryCA_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_countryCA_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:unit id="U_utrsqft">
				<xbrli:measure>utr:sqft</xbrli:measure>
			</xbrli:unit>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapLeaseContractualTermAxis_drrxLeaseAmendmentMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeLaboratoryAndManufacturingMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:CupertinoCAMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">drrx:OfficeLaboratoryAndManufacturingMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">drrx:LeaseAmendmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapLeaseContractualTermAxis_drrxLeaseAmendmentMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeAndLaboratoryMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:CupertinoCAMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">drrx:OfficeAndLaboratoryMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">drrx:LeaseAmendmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_drrxVacavilleCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapManufacturingFacilityMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:VacavilleCAMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapLeaseContractualTermAxis_drrxLeaseAmendmentMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeLaboratoryAndManufacturingMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:CupertinoCAMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">drrx:OfficeLaboratoryAndManufacturingMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">drrx:LeaseAmendmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapLeaseContractualTermAxis_drrxLeaseAmendmentMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeAndLaboratoryMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:CupertinoCAMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">drrx:OfficeAndLaboratoryMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">drrx:LeaseAmendmentMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_drrxVacavilleCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapManufacturingFacilityMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:VacavilleCAMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeLaboratoryAndManufacturingMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:CupertinoCAMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">drrx:OfficeLaboratoryAndManufacturingMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeLaboratoryAndManufacturingMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:CupertinoCAMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">drrx:OfficeLaboratoryAndManufacturingMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeAndLaboratoryMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:CupertinoCAMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">drrx:OfficeAndLaboratoryMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeAndLaboratoryMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:CupertinoCAMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">drrx:OfficeAndLaboratoryMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160731">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">drrx:OxfordFinanceLlcTermLoanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2016-07-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">drrx:OxfordFinanceLlcTermLoanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2016-07-01</xbrli:startDate>
					<xbrli:endDate>2016-07-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">drrx:OxfordFinanceLlcTermLoanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">drrx:OxfordFinanceLlcTermLoanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2016-07-01</xbrli:startDate>
					<xbrli:endDate>2016-07-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">drrx:OxfordFinanceLlcTermLoanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2016-07-01</xbrli:startDate>
					<xbrli:endDate>2016-07-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20180201_20180228">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">drrx:OxfordFinanceLlcTermLoanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-02-01</xbrli:startDate>
					<xbrli:endDate>2018-02-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20181101_20181130">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">drrx:OxfordFinanceLlcTermLoanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-11-01</xbrli:startDate>
					<xbrli:endDate>2018-11-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_20191201_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-12-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtRangeAxis_srtMaximumMember_20151130">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2015-11-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtRangeAxis_srtMaximumMember_20181031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-10-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_drrxControlledEquityOfferingProgramMember_20151130">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">drrx:CantorFitzgeraldCoMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:ControlledEquityOfferingProgramMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2015-11-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_drrxControlledEquityOfferingProgramMember_20181031">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">drrx:CantorFitzgeraldCoMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:ControlledEquityOfferingProgramMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-10-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapTypeOfArrangementAxis_drrxControlledEquityOfferingProgramMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:ControlledEquityOfferingProgramMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">drrx:CantorFitzgeraldCoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:OctoberTwoThousandEighteenRegistrationStatementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:OctoberTwoThousandEighteenRegistrationStatementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_20190620_20190620">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-06-20</xbrli:startDate>
					<xbrli:endDate>2019-06-20</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_20190620">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-06-20</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210201_20210228">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">drrx:CantorFitzgeraldCoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-02-01</xbrli:startDate>
					<xbrli:endDate>2021-02-28</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">drrx:CantorFitzgeraldCoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2021-02-28</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20210321_20210321">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:OctoberTwoThousandEighteenRegistrationStatementMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-03-21</xbrli:startDate>
					<xbrli:endDate>2021-03-21</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20110601_20110630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2011-06-01</xbrli:startDate>
					<xbrli:endDate>2011-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20140601_20140630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2014-06-01</xbrli:startDate>
					<xbrli:endDate>2014-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20160601_20160630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2016-06-01</xbrli:startDate>
					<xbrli:endDate>2016-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20180601_20180630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-06-01</xbrli:startDate>
					<xbrli:endDate>2018-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20190601_20190630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-06-01</xbrli:startDate>
					<xbrli:endDate>2019-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtTitleOfIndividualAxis_drrxNonEmployeeDirectorMember_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20000101_20000331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">drrx:NonEmployeeDirectorMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2000-01-01</xbrli:startDate>
					<xbrli:endDate>2000-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20130401_20130430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2013-04-01</xbrli:startDate>
					<xbrli:endDate>2013-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20130401_20130430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2013-04-01</xbrli:startDate>
					<xbrli:endDate>2013-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20130401_20130430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2013-04-01</xbrli:startDate>
					<xbrli:endDate>2013-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20100401_20100430">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2010-04-01</xbrli:startDate>
					<xbrli:endDate>2010-04-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20150301_20150331">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2015-03-01</xbrli:startDate>
					<xbrli:endDate>2015-03-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20170601_20170630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2017-06-01</xbrli:startDate>
					<xbrli:endDate>2017-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200601_20200630">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-06-01</xbrli:startDate>
					<xbrli:endDate>2020-06-30</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTwoMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeThreeMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFourMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeFourMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFiveMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSixMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeSixMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSevenMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeEightMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeEightMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeNineMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeNineMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTenMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeTenMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeElevenMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeElevenMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeOneMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTwoMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeThreeMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFourMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeFourMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFiveMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSixMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeSixMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSevenMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeEightMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeEightMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeNineMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeNineMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTenMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeTenMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeElevenMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeElevenMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapOtherNonoperatingIncomeExpenseMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapOtherNonoperatingIncomeExpenseMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapOtherNonoperatingIncomeExpenseMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_20181230">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-30</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_drrxEvonikCorporationMember_20201230_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">drrx:EvonikCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-12-30</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_drrxEvonikCorporationMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">drrx:EvonikCorporationMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20210101_20210301">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:OctoberTwoThousandEighteenRegistrationStatementMember</xbrldi:explicitMember>
						<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">drrx:CantorFitzgeraldCoMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-01</xbrli:startDate>
					<xbrli:endDate>2021-03-01</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2019-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2018-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20171231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2017-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20200101_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2020-01-01</xbrli:startDate>
					<xbrli:endDate>2020-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20190101_20191231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-01-01</xbrli:startDate>
					<xbrli:endDate>2019-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20180101_20181231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2018-01-01</xbrli:startDate>
					<xbrli:endDate>2018-12-31</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
			<xbrli:context id="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20201231">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001082038</xbrli:identifier>
					<xbrli:segment>
						<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
					</xbrli:segment>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:instant>2020-12-31</xbrli:instant>
				</xbrli:period>
			</xbrli:context>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000001" fromRefs="F_000342"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000003" fromRefs="F_000474 F_000475 F_000476"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000004" fromRefs="F_000818 F_000819 F_000820"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000002" fromRefs="F_000471 F_000472 F_000473"></ix:relationship>
			<ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_000000" fromRefs="F_000330 F_000331 F_000332 F_000333"></ix:relationship>
		</ix:resources>
	</ix:header>
</div>

<p style="border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;">&#160;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:9.5pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549</p>
<p style="margin-bottom:3pt;text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:38.46%;margin-right:38.46%;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">Form <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0001082038_20200101_20201231">10-K</ix:nonNumeric></p>
<p style="margin-bottom:3pt;text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:38.46%;margin-right:38.46%;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">(Mark One)</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Segoe UI Symbol;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000031" name="dei:DocumentAnnualReport" contextRef="C_0001082038_20200101_20201231" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the fiscal year ended <ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0001082038_20200101_20201231" format="ixt:datemonthdayyearen">December 31, <ix:nonNumeric id="F_000003" name="dei:DocumentFiscalYearFocus" contextRef="C_0001082038_20200101_20201231">2020</ix:nonNumeric></ix:nonNumeric></p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">OR</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Segoe UI Symbol;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000032" name="dei:DocumentTransitionReport" contextRef="C_0001082038_20200101_20201231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Commission file number: <ix:nonNumeric id="F_000022" name="dei:EntityFileNumber" contextRef="C_0001082038_20200101_20201231">000-31615</ix:nonNumeric></p>
<p style="margin-bottom:3pt;text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:38.46%;margin-right:38.46%;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:13pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityRegistrantName" contextRef="C_0001082038_20200101_20201231">DURECT CORP</ix:nonNumeric>ORATION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:8.5pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter)</p>
<p style="margin-bottom:3pt;text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:38.46%;margin-right:38.46%;text-indent:0%;font-size:3pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:33.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000023" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0001082038_20200101_20201231" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="top" style="width:33.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="width:33.32%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000024" name="dei:EntityTaxIdentificationNumber" contextRef="C_0001082038_20200101_20201231">94-3297098</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top" style="width:33.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">incorporation or organization)</p></td>
<td valign="top" style="width:33.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:7.5pt;">&#160;</p></td>
<td valign="top" style="width:33.32%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(I.R.S. Employer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification No.)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000025" name="dei:EntityAddressAddressLine1" contextRef="C_0001082038_20200101_20201231">10260 Bubb Road</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000026" name="dei:EntityAddressCityOrTown" contextRef="C_0001082038_20200101_20201231">Cupertino</ix:nonNumeric>, <ix:nonNumeric id="F_000027" name="dei:EntityAddressStateOrProvince" contextRef="C_0001082038_20200101_20201231">CA</ix:nonNumeric> <ix:nonNumeric id="F_000028" name="dei:EntityAddressPostalZipCode" contextRef="C_0001082038_20200101_20201231">95014</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman Bold;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices, including zip code)</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric id="F_000029" name="dei:CityAreaCode" contextRef="C_0001082038_20200101_20201231">408</ix:nonNumeric>)&#160;<ix:nonNumeric id="F_000030" name="dei:LocalPhoneNumber" contextRef="C_0001082038_20200101_20201231">777-1417</ix:nonNumeric></p>
<p style="margin-bottom:0pt;text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:38.46%;margin-right:38.46%;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(b) of the Act:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:33.3%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Title of Each Class</span></p></td>
<td valign="top" style="width:33.36%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Trading Symbol(s)</span></p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:33.36%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Name of Each Exchange on Which Registered</span></p></td>
</tr>
<tr>
<td valign="top" style="width:33.3%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:Security12bTitle" contextRef="C_0001082038_20200101_20201231">Common Stock $0.0001 par value per share</ix:nonNumeric></p></td>
<td valign="top" style="width:33.36%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000005" name="dei:TradingSymbol" contextRef="C_0001082038_20200101_20201231">DRRX</ix:nonNumeric></p></td>
<td valign="top" style="width:33.36%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">The&#160;<ix:nonNumeric id="F_000021" name="dei:SecurityExchangeName" contextRef="C_0001082038_20200101_20201231">NASDAQ</ix:nonNumeric>&#160;Capital&#160;Market LLC</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(g) of the Act:</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">None</p>
<p style="margin-bottom:0pt;text-align:center;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:38.46%;margin-right:38.46%;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:5.24%;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;">Yes</span>&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span>&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;"><ix:nonNumeric id="F_000009" name="dei:EntityWellKnownSeasonedIssuer" contextRef="C_0001082038_20200101_20201231">No</ix:nonNumeric></span>&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span></p>
<p style="margin-top:4pt;margin-bottom:0pt;text-indent:5.24%;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15 of the Act.&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;">Yes</span>&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span>&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;"><ix:nonNumeric id="F_000011" name="dei:EntityVoluntaryFilers" contextRef="C_0001082038_20200101_20201231">No</ix:nonNumeric></span>&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span></p>
<p style="margin-top:4pt;margin-bottom:0pt;text-indent:5.24%;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period than the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;"><ix:nonNumeric id="F_000010" name="dei:EntityCurrentReportingStatus" contextRef="C_0001082038_20200101_20201231">Yes</ix:nonNumeric></span>&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span>&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;">No</span>&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-top:4pt;margin-bottom:0pt;text-indent:5.24%;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;"><ix:nonNumeric id="F_000019" name="dei:EntityInteractiveDataCurrent" contextRef="C_0001082038_20200101_20201231">Yes</ix:nonNumeric></span>&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span>&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;">No</span>&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-top:4pt;margin-bottom:0pt;text-indent:5.24%;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:19.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Large&#160;accelerated&#160;filer</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:57.7%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:19.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accelerated&#160;filer</p></td>
<td valign="top" style="width:2.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:19.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000012" name="dei:EntityFilerCategory" contextRef="C_0001082038_20200101_20201231" format="ixt-sec:entityfilercategoryen">Non-accelerated&#160;filer</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:57.7%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9746;<span style="font-family:Times New Roman;">&#160;&#160;</span></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:19.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Smaller&#160;reporting&#160;company</p></td>
<td valign="top" style="width:2.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000014" name="dei:EntitySmallBusiness" contextRef="C_0001082038_20200101_20201231" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:19.24%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:57.7%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000015" name="dei:EntityEmergingGrowthCompany" contextRef="C_0001082038_20200101_20201231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:19.24%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;">&#160;</p></td>
<td valign="top" style="width:2.56%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:7pt;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> &#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160;&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000016" name="dei:IcfrAuditorAttestationFlag" contextRef="C_0001082038_20200101_20201231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;">Yes</span>&#160;&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000013" name="dei:EntityShellCompany" contextRef="C_0001082038_20200101_20201231" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;">No</span>&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9746;</span></p>
<p style="margin-top:4pt;margin-bottom:0pt;text-indent:5.24%;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aggregate market value of the voting stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000018" name="dei:EntityPublicFloat" contextRef="C_0001082038_20200630" decimals="0" format="ixt:numdotdecimal">169,632,305</ix:nonFraction> as of June&#160;30, 2020 based upon the closing sale price on The Nasdaq Global Market reported for such date. Shares of Common Stock held by each officer and director and by each person who may be deemed to be an affiliate have been excluded. This determination of affiliate status is not necessarily a conclusive determination for other purposes.</p>
<p style="margin-top:4pt;margin-bottom:0pt;text-indent:5.24%;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were <ix:nonFraction unitRef="U_xbrlishares" id="F_000017" name="dei:EntityCommonStockSharesOutstanding" contextRef="C_0001082038_20210301" decimals="INF" format="ixt:numdotdecimal">227,201,863</ix:nonFraction> shares of the registrant&#8217;s Common Stock issued and outstanding as of March 1, 2021.</p>
<p style="text-align:center;margin-top:4pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">DOCUMENTS INCORPORATED BY REFERENCE</p>
<p style="margin-top:4pt;margin-bottom:0pt;text-indent:5.24%;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000033" name="dei:DocumentsIncorporatedByReferenceTextBlock" contextRef="C_0001082038_20200101_20201231">Part III incorporates information by reference from the definitive Proxy Statement for the 2020 annual meeting of stockholders, which is expected to be filed not later than 120 days after the Registrant&#8217;s fiscal year ended December 31, 2020.</ix:nonNumeric></p>
<p style="border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="border-bottom:none 0pt;padding-bottom:0pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:2pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">DURECT CORPORATION</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">ANNUAL REPORT ON FORM 10-K</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">FOR THE FISCAL YEAR ENDED DECEMBER 31, 2020</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">TABLE OF CONTENTS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr style="height:1pt;">
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Page</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PART_I"><span style="text-decoration:none;">PART I</span></a></p></td>
<td valign="top" style="width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;1.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1_BUSINESS"><span style="text-decoration:none;">Business</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:-12pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:-12pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;1A.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1A_RISK_FACTORS"><span style="text-decoration:none;">Risk Factors</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;1B.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_1B_UNRESOLVED_STAFF_COMMENTS"><span style="text-decoration:none;">Unresolved Staff Comments</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;2.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_2_PROPERTIES"><span style="text-decoration:none;">Properties</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;3.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_3_LEGAL_PROCEEDINGS"><span style="text-decoration:none;">Legal Proceedings</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;4.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_4_MINE_SAFETY_DISCLOSURES"><span style="text-decoration:none;">Mine Safety Disclosures</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PART_II"><span style="text-decoration:none;">PART II</span></a></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;5.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_5_MARKET_FOR_REGISTRANTS_COMMON_EQU"><span style="text-decoration:none;">Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;7.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_7_MANAGEMENTS_DISCUSSION_ANALYSIS_F"><span style="text-decoration:none;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;7A.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_7A_QUANTITATIVE_QUALITATIVE_DISCLOS"><span style="text-decoration:none;">Quantitative and Qualitative Disclosures About Market Risk</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;8.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_8_FINANCIAL_STATEMENT_SUPPLEMENTAR"><span style="text-decoration:none;">Financial Statements and Supplementary Data</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;9.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9_CHANGES_IN_DISAGREEMENTS_WITH_ACC"><span style="text-decoration:none;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">112</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;9A.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9A_CONTROLS_PROCEDURES"><span style="text-decoration:none;">Controls and Procedures</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">112</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;9B.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_9B_OR_INFORMATION"><span style="text-decoration:none;">Other Information</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PART_III"><span style="text-decoration:none;">PART III</span></a></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;10.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_10___DIRECTORS_EXECUTIVE_FICERS_COR"><span style="text-decoration:none;">Directors, Executive Officers and Corporate Governance</span></a><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;11.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_11___EXECUTIVE_COMPENSATION"><span style="text-decoration:none;">Executive Compensation</span></a><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;12.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12.25pt;;text-indent:-12.25pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_12___SECURITY_OWNERSHIP_CERTAIN_BEN"><span style="text-decoration:none;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;13.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_13____CERTAIN_RELATIONSHIPS_RELATED"><span style="text-decoration:none;">Certain Relationships and Related Transactions, and Director Independence</span></a><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;14.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_14____PRINCIPAL_ACCOUNTANT_FEES_SER"><span style="text-decoration:none;">Principal Accountant Fees and Services</span></a><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PART_IV"><span style="text-decoration:none;">PART IV</span></a></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;15.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_15_EXHIBITS_FINANCIAL_STATEMENT_SCH"><span style="text-decoration:none;">Exhibits, and Financial Statement Schedules</span></a><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">114</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:94.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#EXHIBIT_INDEX"><span style="text-decoration:none;">Exhibit Index</span></a><span style="text-decoration:none;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ITEM&#160;16.</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ITEM_16____FORM_10K_SUMMARY"><span style="text-decoration:none;">Form 10-K Summary</span></a><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120</p></td>
</tr>
<tr style="height:1pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:9.62%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:84.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:1pt;">
<td colspan="3" valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:94.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#SIGNATURES"><span style="text-decoration:none;">Signatures</span></a><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1.08%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:-18.9pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:4.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">121</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;" id="PART_I">PART I</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;" id="ITEM_1_BUSINESS">Item&#160;1.<span style="margin-left:36pt;"></span>Business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Overview</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a biopharmaceutical company <span style="Background-color:#FFFFFF;letter-spacing:0.4pt;">advancing novel and potentially lifesaving investigational therapies derived from our Epigenetic Regulator Program.</span>&#160;&#160;DUR&#8209;928, a new chemical entity in clinical development, is the lead candidate in our Epigenetic Regulator Program.&#160;&#160;An endogenous, orally bioavailable small molecule, DUR-928 has been shown in preclinical studies to play an important regulatory role in lipid homeostasis, inflammation, and cell survival.&#160;&#160;Alcohol-associated hepatitis (AH) is a life-threatening acute liver condition with no approved therapeutics and a 28-day historical mortality rate of 26%.&#160;&#160;After completing a Phase 2a trial where 100% of AH patients treated with DUR-928 survived the 28-day study period, we are now conducting a double-blind, placebo-controlled Phase 2b clinical trial called AHFIRM, in which we are evaluating DUR-928&#8217;s life saving potential compared to the current standard of care in patients with severe AH. If the AHFIRM trial is successful, it may support an NDA filing, and we may decide to develop our own commercial, sales and marketing organization.  DUR-928 is also being investigated in patients with nonalcoholic steatohepatitis (NASH).</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to our Epigenetic Regulator Program, we developed a novel and proprietary post-surgical pain product called POSIMIR<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> that utilizes our innovative SABER<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> platform technology to enable continuous sustained delivery of bupivacaine, a non-opioid local analgesic, over 3 days in adults. In February 2021, we announced that the U.S. Food and Drug Administration (FDA) approved POSIMIR for infiltration use in adults for administration into the subacromial space under direct arthroscopic visualization to produce post-surgical analgesia for up to 72 hours following arthroscopic subacromial decompression. The approval was based on positive data from a randomized, multicenter, assessor-blinded, placebo&#8209;controlled clinical trial in patients undergoing arthroscopic subacromial decompression surgery with an intact rotator cuff. The primary outcome measures were mean pain intensity and total opioid rescue analgesia administered, both evaluated over the first 72 hours after surgery versus placebo. POSIMIR demonstrated a statistically significant improvement in both primary outcome measures: a 1.3 point, or 20%, reduction in mean pain intensity on a 0-10 point pain scale (p&#61;0.01), and a 67% reduction in intravenous morphine-equivalent rescue opioid use, from a median of 12 mg in the placebo group to 4 mg in the POSIMIR group (p&#61;0.01).&#160;&#160;We are in discussions with potential licensees regarding commercialization rights to POSIMIR, for which we hold worldwide rights.&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result of the assignment of certain patent rights, DURECT also receives single digit sales-based earn-out payments from U.S. net sales of Indivior&#8217;s PERSERIS<sup style="font-size:85%;line-height:120%;vertical-align:top">&#8482;</sup> (risperidone) drug for schizophrenia, which was launched commercially in the U.S. February 2019.&#160;&#160;In addition, in September 2020, our licensee, Orient Pharma informed us that it had launched Methydur Sustained Release Capsules (Methydur) for the treatment of attention deficit hyperactivity disorder (ADHD) in Taiwan.&#160;&#160;<span style="letter-spacing:0.2pt;">We receive a single digit royalty on sales of </span>Methydur by Orient Pharma.<span style="letter-spacing:0.2pt;"> &#160;We also</span> manufacture and sell ALZET osmotic pumps used in laboratory research and have several early-stage development programs with corporate collaborators on terms which typically call for our collaborator to fund all or a substantial portion of future development costs of the program and make milestone payments to us based on specific development or commercial achievements and royalty payments on product sales. </p>
<p style="border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:81.2%;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">NOTE: POSIMIR<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup>, SABER<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup>, CLOUD<sup style="font-size:85%;line-height:120%;vertical-align:top">TM</sup>, ORADUR<sup style="font-size:85%;line-height:120%;vertical-align:top">&#8482; </sup>and ALZET<sup style="font-size:85%;line-height:120%;vertical-align:top"> &#174;</sup> are trademarks of DURECT Corporation. Other trademarks referred to belong to their respective owners. Full prescribing information for POSIMIR, including BOXED WARNING and Medication Guide can be found at <span style="text-decoration:none;">www.posimir.com</span>. Full prescribing information for PERSERIS, including BOXED WARNING and Medication Guide can be found at www.perseris.com.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Epigenetic Regulator Program and New Chemical Entities</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Epigenetic regulation involves biochemical modification of either DNA itself or proteins that are intimately associated with DNA.&#160;&#160;These modifications lead to changes in gene expression that facilitate downstream biological effects.&#160;&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DURECT&#8217;s Epigenetic Regulator Program involves a multi-year collaborative effort with the Department of Internal Medicine at Virginia Commonwealth University (VCU), the VCU Medical Center and the McGuire VA Medical Center. The knowledge base supporting this program is a result of more than 30 years of lipid research by Shunlin Ren, M.D., Ph.D., Professor of Internal Medicine at the VCU Medical Center. The lead compound from this program, DUR-928, is an endogenous, orally bioavailable small molecule that modulates the gene expression of various nuclear receptors that play important regulatory roles in lipid homeostasis, inflammation, and cell survival. Under a license with VCU, we hold the exclusive royalty-bearing worldwide right to develop and commercialize DUR-928 and related molecules discovered in the program.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The biological activity of DUR-928 has been demonstrated in over a dozen different animal disease models involving three animal species. Some of these models represent acute organ injuries (e.g., endotoxin shock, acute oxidative stress, ischemic-reperfusion injury in the kidney and brain) and several represent chronic metabolic disorders involving hepatic lipid accumulation and dysfunction (e.g., NASH and NAFLD).</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our major product research and development efforts for DUR-928 are in the following table: </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gguopuizh44n000001.jpg" title="" alt="" style="width:618px;height:258px;" /></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In pharmacokinetic (PK) and toxicology studies conducted in mice, hamsters, rats, rabbits, dogs, minipigs and monkeys, DUR-928 has been found to be tolerable and safe by all routes of administration tested to date. These results support the use of DUR-928 in completed, ongoing and planned human safety, PK, proof-of-concept, and efficacy trials. The chronic toxicity of DUR-928 was further assessed in a 6-month oral study in rats and in a 9-month oral study in dogs. These studies were completed successfully and support long duration human clinical trials of DUR-928. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-size:11pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Acute Organ Injury Program with Injectable DUR-928 </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Market Opportunity.<span style="font-style:normal;">&#160;&#160;&#160;&#160;Alcohol-associated hepatitis (also called alcoholic hepatitis or AH), an acute form of alcohol-associated liver disease (ALD), is associated with long-term heavy intake of alcohol and often occurs after a recent period of increased alcohol consumption. AH is typically characterized by recent onset jaundice and hepatic failure.&#160;&#160;An analysis of 77 studies published between 1971 and 2016, which included data from a total of 8,184 patients, showed the overall mortality from AH was 26% at 28 days and 29% at 90 days. According to the most recent data provided by the Agency for Healthcare Research and Quality (AHRQ), a part of the US Department of Health and Human Services (HHS), there were 122,000 hospitalizations for patients with AH in 2017. From a recent publication analyzing the mortality and costs associated with AH, the cost per patient is estimated at over $50,000 in the first year</span>.<span style="font-style:normal;"> ALD is one of the leading causes of liver transplants in the US, each of which cost over $875,000. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Clinical Program.<span style="font-style:normal;">&#160;&#160;&#160;&#160;In 2019, we completed a Phase 2a clinical trial evaluating intravenously infused DUR-928 in patients with moderate and severe AH.&#160;&#160;This was an open label, dose escalation (30, 90 and 150 mg), multi-center U.S. study, originally designed to be conducted in two sequential parts.&#160;&#160;Part A included patients with moderate AH and Part B included patients with severe AH.&#160;&#160;Severity of AH was determined by the Model of End-Stage Liver Disease (MELD) scores, a common scoring system to assess the severity and prognosis of AH patients&#59; moderate was defined as MELD 11-20 and severe as MELD 21-30.&#160;&#160;</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In this Phase 2a trial, dose escalation was permitted following review of safety and pharmacokinetic (PK) results of the prior dose level by a Dose Escalation Committee. The target number of patients for the study was 4 per dose group. Final enrollment included 19 patients with moderate and severe AH, who were administered DUR-928 intravenously at three different doses.&#160;&#160;Eight patients (four moderate and four severe) were dosed at 30mg, seven patients (three moderate and four severe) were dosed at 90mg and four patients (all severe) were dosed at 150mg.&#160;&#160;After being discharged on day two, one patient did not return for the scheduled day seven and day 28 follow-up visits&#59; therefore Lille, bilirubin and MELD data reported below are based on 18 patients. The objectives of this study included assessment of safety, PK and pharmacodynamic (PD) signals, including liver biochemistry, biomarkers, and prognostic scores, including the Lille score, following DUR-928 treatment.&#160;&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2019, the results from this Phase 2a clinical trial of DUR-928 in alcoholic hepatitis (AH) were presented as a late-breaking oral presentation at The Liver Meeting<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup>.&#160;&#160;The study results were also selected for inclusion in the &#8216;Best of The Liver Meeting&#8217; summary slide presentation in the alcohol-related liver disease category.&#160;&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All 19 patients treated with DUR-928 in this trial survived the 28-day follow-up period and there were no drug-related serious adverse events.&#160;&#160;Using an alternative measure of AH severity to MELD, Maddrey&#8217;s Discrimination Function (DF), 15 of the 19 patients had DF scores of 32 or greater, indicating that they had severe AH. Patients treated with DUR-928 had a statistically significant reduction from baseline in bilirubin at day 7 and 28 and MELD at day 28.&#160;&#160;Lille scores, described below, were also statistically significantly lower than those from a well-matched group of patients in a contemporary ongoing trial as well as several published historical controls.&#160;&#160;74% of all DUR-928 treated patients and 67% of those with severe AH were discharged from the hospital within four days of receiving a single dose of DUR-928.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-size:11pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Lille</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lille scores are used in clinical practice to help determine the prognosis and response of AH patients after seven days of treatment.&#160;&#160;The lower the Lille score, the better the prognosis.&#160;&#160;Patients with a Lille score below 0.45 have a six-month survival rate of 85% compared to those with Lille scores above 0.45, who have only a 25% six-month survival rate.&#160;&#160;The chart below shows the Lille scores for individual AH patients treated with DUR-928 plotted as a function of their baseline MELD scores.&#160;&#160;In our study, the median Lille score for patients treated with DUR-928 was 0.10.&#160;&#160;The median Lille score among a cohort of 15 patients treated with standard of care at the University of Louisville (UL)<sup style="font-size:85%;line-height:120%;vertical-align:top"> </sup>was 0.41 (shown as historical control).</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The chart below shows individual patient Lille scores plotted as a function of their baseline MELD scores.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gguopuizh44n000002.jpg" title="" alt="" style="width:624px;height:277px;" /></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:italic;color:#auto;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:italic;text-decoration:none;Background-color:#auto;color:#auto;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-style:normal;color:#000000;"></span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;">Our advisor, Dr. Craig McClain from the University of Louisville (UL), shared anonymized data from his study, in which 15 AH patients with initial MELD scores ranging from 15-30 received either supportive care alone (n&#61;8 moderate AH patients) or supportive care with corticosteroids (n&#61;7 severe AH patients). Two of the UL control patients died by day 28.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:italic;color:#auto;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:italic;text-decoration:none;Background-color:#auto;color:#auto;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-style:normal;color:#000000;"></span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;">One patient in the DUR-928 group did not return for the day 7 or 28 visit. All 19 patients, including this one, treated with DUR-928 in this trial survived the 28-day follow-up period.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:italic;color:#auto;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:italic;text-decoration:none;Background-color:#auto;color:#auto;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-style:normal;color:#000000;"></span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;">Lille scores in the DUR-928 group were significantly lower than that of the UL patients (p&#61;0.01&#59; Wilcoxon's Rank Sum Test).</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As shown below, 100% of patients in the 30 mg and 90 mg DUR-928 dosing groups were treatment responders based on their Lille scores.&#160;&#160;89% of the overall DUR-928 patient population were treatment responders based on Lille.&#160;&#160;Patients with severe AH, as defined by Maddrey&#8217;s Discriminant Function (DF) <span style="font-style:italic;">&#8805;</span>32 or MELD 21-30, and baseline serum bilirubin above 8 mg/dL, had similarly high response rates to DUR-928 treatment.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:7.69%;width:84.81%;">
<tr>
<td style="width:30%;"></td>
<td style="width:7.69%;"></td>
<td style="width:7.69%;"></td>
<td style="width:16.35%;"></td>
<td style="width:23.08%;"></td>
</tr>
<tr style="height:30.55pt;">
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">AH Patient Category</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:10pt;">&#160;</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">n<sup style="font-size:85%;line-height:120%;vertical-align:top">1</sup></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Responders</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Lille&#60;0.45)</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Lille</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Median (Quartile)</p></td>
</tr>
<tr style="height:17.95pt;">
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All Patients<sup style="font-size:85%;line-height:120%;vertical-align:top">2</sup></p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30 or 90 mg DUR-928<sup style="font-size:85%;line-height:120%;vertical-align:top">3</sup></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89%</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100%</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.10 (0.04, 0.20)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.05 (0.04, 0.19)</p></td>
</tr>
<tr style="height:16.15pt;">
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DF<span style="font-style:italic;">&#8805;</span>32 (SAH)<sup style="font-size:85%;line-height:120%;vertical-align:top">2, 4</sup></p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30 or 90 mg DUR-928<sup style="font-size:85%;line-height:120%;vertical-align:top">3</sup></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87%</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100%</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.19 (0.05, 0.22)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.12 (0.05, 0.19)</p></td>
</tr>
<tr style="height:9.85pt;">
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MELD 21-30<sup style="font-size:85%;line-height:120%;vertical-align:top">2</sup></p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30 or 90 mg DUR-928<sup style="font-size:85%;line-height:120%;vertical-align:top">3</sup></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83%</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100%</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.19 (0.11, 0.25)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.19 (0.10, 0.19)</p></td>
</tr>
<tr>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Baseline bilirubin &#62;8mg/dl<sup style="font-size:85%;line-height:120%;vertical-align:top">2</sup></p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30 or 90 mg DUR-928<sup style="font-size:85%;line-height:120%;vertical-align:top">3</sup></p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82%</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100%</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.10 (0.05, 0.20)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.10 (0.05, 0.19)</p></td>
</tr>
</table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:italic;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:italic;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-style:normal;color:#000000;"></span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;">One patient did not return for Day 7 and 28 visits&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:italic;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:italic;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">2)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-style:normal;color:#000000;"></span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;">Including patients receiving 30, 90 and 150 mg of DUR-928&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:italic;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:italic;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">3)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-style:normal;color:#000000;"></span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;">Excluding patients receiving 150 mg of DUR-928.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:italic;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:italic;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">4)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:italic;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:12pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-style:normal;color:#000000;"></span><span style="font-size:11pt;font-family:Times New Roman;color:#000000;">Maddrey&#8217;s Discriminant Function (MDF or DF) is calculated using the patient&#8217;s prothrombin time and serum bilirubin level. DF was introduced in 1978 as a predictor of significant mortality risk for AH patients. A DF&#8805;32 identified AH patients with a 30-day mortality rate of &#8805;50%.</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Lille scores of patients treated with DUR-928 in this trial were also significantly lower than several selected published historical studies <span style="font-style:italic;">(Hepatology 2007, 45:1348-1354&#59; Gut 2011, 60:255-260)</span>, in which patients had similar baseline bilirubin, albumin, creatinine, prothrombin time and DF scores, and were treated with standard of care with or without corticosteroids.&#160;&#160;Of course, due to the historical nature of these studies, such comparisons should be taken cautiously.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A sub-group analysis was conducted to compare severe AH patients in the 30 mg and 90 mg dosing groups (n&#61;8) with well-matched severe AH patients (n&#61;13) who received corticosteroids for 28 days in a contemporaneous study at the University of Louisville (UL).&#160;&#160;Patients shown below in the UL steroid group had a mean baseline MELD of 24.46 and mean baseline Maddrey&#8217;s DF score of 62.98. The 8 patients in the DUR-928 group had baseline mean MELD of 24.50 and mean baseline Maddrey&#8217;s DF score of 61.25.&#160;&#160;All patients treated with DUR-928 survived the 28-day follow up period, while 3 of the 13 patients (23%) in the UL steroid group died within the first 28 days.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gguopuizh44n000003.jpg" title="" alt="" style="width:318px;height:235px;" /></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-size:11pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">The steroid group in the above graph includes the 7 severe AH patients treated with steroids from the UL group shown in the MELD vs Lille graph above plus an additional 6 severe AH patients subsequently treated in the UL study. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-size:11pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Bilirubin</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Bilirubin is formed by the breakdown of red blood cells in the body.&#160;&#160;The level of total bilirubin in the blood is an indication of how the liver is functioning.&#160;&#160;High bilirubin levels are associated with liver dysfunction and disease.&#160;&#160;In this trial, patients treated with DUR-928 had a significant early reduction from baseline in bilirubin by day 7.&#160;&#160;Patients with more elevated bilirubin at baseline (serum bilirubin &#62;8 mg/dL) had a median reduction from baseline of 25% by day 7 and 48% by day 28. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gguopuizh44n000004.jpg" title="" alt="" style="width:378px;height:264px;" /></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-size:11pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">*p&#60;0.05 compared to baseline (Wilcoxon's Signed Rank Test)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">MELD is another common scoring system used to assess the severity and prognosis of AH patients.&#160;&#160;Patients with MELD scores of 11-20 are classified as having moderate AH and patients with MELD scores of 21-30 are classified as having severe AH.&#160;&#160;As with Lille scores, the lower the MELD score, the better the prognosis for the AH patient. In this study (shown in the chart below), the median reduction from baseline in MELD among all DUR-928 treated patients was &#62;2 points and among those with baseline bilirubin levels &#62;8 mg/dL was 5 points by day 28.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gguopuizh44n000005.jpg" title="" alt="" style="width:388px;height:306px;" /></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:11pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">*p&#60;0.05 compared to baseline (Wilcoxon's Signed Rank Test)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:11pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">MELD is calculated based on (a) bilirubin, (b) serum creatinine (sCr), and (c) International Normalized Ratio (INR), which is a measure of prothrombin time.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-size:11pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Safety and Pharmacokinetics</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the Phase 2a study of DUR-928 in AH, DUR-928 was well tolerated at all doses tested.&#160;&#160;There were no drug-related serious adverse events and only three adverse events designated as possibly or probably related to DUR-928: one occurrence of moderate generalized pruritus, one mild rash and one grade two alkaline phosphatase elevation.&#160;&#160;There were no discontinuations, early withdrawals or termination of study drug or study participation due to adverse events.&#160;&#160;All patients treated with DUR-928 survived through the 28-day follow-up period. Drug exposures were dose proportional and were not affected by the severity of the disease.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2020, we announced that the FDA had granted DUR-928 Fast Track Designation for the treatment of AH.&#160;&#160;The FDA grants Fast Track Designation to facilitate development and expedite the review of therapies with the potential to treat a serious condition where there is an unmet medical need. A therapeutic that receives Fast Track Designation can benefit from early and frequent communication with the agency in addition to a rolling submission of the marketing application, with the objective of getting important new therapies to patients more quickly.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January 2021, we announced the dosing of the first patient in our <span style="color:#000000;">Phase 2b study in subjects with </span><span style="text-decoration:underline;color:#000000;">AH</span><span style="color:#000000;"> to evaluate sa</span><span style="text-decoration:underline;color:#000000;">F</span><span style="color:#000000;">ety and eff</span><span style="text-decoration:underline;color:#000000;">I</span><span style="color:#000000;">cacy of DU</span><span style="text-decoration:underline;color:#000000;">R</span><span style="color:#000000;">-928 treat</span><span style="text-decoration:underline;color:#000000;">M</span><span style="color:#000000;">ent (AHFIRM)</span>.&#160;&#160;AHFIRM is a randomized, double-blind, placebo-controlled, international, <span style="color:#000000;">multi-center Phase 2b study to evaluate the safety and efficacy of DUR-928 in approximately 300 patients with severe AH. The study is comprised of three arms targeting approximately 100 patients each: (1) Placebo plus standard of care (SOC, which may include the use of methylprednisolone, a corticosteroid, at the discretion of the treating physician)&#59; (2) DUR-928 (30 mg)&#59; and (3) DUR-928 (90 mg). Patients receive an intravenous (IV) dose of DUR-928 or placebo (sterile water) on day 1 and a second IV dose on day 4 if they are still hospitalized.&#160;&#160;The primary outcome measure will be the 90-day survival rate for patients treated with DUR-928 compared to those treated with placebo plus SOC.&#160;&#160;Secondary endpoints include 28-day survival, the rate of adverse events, Lille and MELD (prognostic scores), and time in the intensive care unit</span>. We are targeting 40-50 clinical trial sites in the United States, Europe and Australia.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Phase 1 trials of DUR-928 administered through injection have supported the development of DUR-928 in AH. The initial Phase 1 trial in healthy subjects was a single-site, randomized, double-blinded, placebo-controlled, single-ascending-dose study that evaluated the safety, tolerability and PK of intramuscular (IM) injected DUR-928. The 24-subject study (16 healthy volunteers on the drug and 8 on </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">placebo) of four escalating dose levels resulted in dose proportional systemic exposure of DUR-928 with peak plasma concentrations greater than 1000-fold higher than endogenous levels. DUR-928 was well-tolerated at all dose levels, with no serious treatment-related adverse events reported. We also conducted a multiple-dose study involving 10 healthy subjects, in which participants received IM-injected DUR-928 for 5 consecutive days (8 subjects on the drug, 2 on placebo) using the next to highest dose from the single dose study. No serious treatment related adverse events were reported, no subjects withdrew from the study, no accumulation in plasma concentrations were observed with repeat dosing, and the pain scores and injection site reactions were minimal. We also conducted a single-ascending dose intravenous (IV) infusion study with 16 healthy subjects and observed no treatment-related serious adverse events. The systemic exposure following IV infusion was dose proportional. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A Phase 1 drug-drug interaction study conducted in healthy subjects demonstrated that neither orally administered nor intravenously injected DUR-928 at doses tested affected the safety and PK of midazolam, a drug metabolized by CYP3A4, which is one of the important enzymes associated with clinically relevant drug-drug interactions.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have also conducted a Phase 1b study with injected DUR-928 in patients with impaired kidney function (stage 3 and 4 chronic kidney disease (CKD)) and matched control subjects (MCS), matched by age, body mass and gender with normal kidney function. This study was a single-site, open-label, single-ascending-dose study in two successive cohorts (first a low dose of 30 mg and then a high dose of 120 mg) evaluating safety and PK of intramuscular injected DUR-928. The low dose cohort consisted of 6 patients with CKD and 3 MCS&#59; the high dose cohort consisted of 5 CKD patients and 3 MCS.&#160;&#160;In this trial, DUR-928 was well tolerated among all subjects and the PK parameters between the kidney function impaired patients and the MCS were comparable. The results of this Phase 1b trial were presented at Kidney Week 2018 in San Diego.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">COVID-19 Program with Intravenous DUR-928</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:9pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since we initiated our clinical trial of DUR-928 in patients with COVID-19, several vaccines and therapeutics for COVID-19 have been approved and are being deployed worldwide.&#160;&#160;Treatment regimens for patients with COVID-19 have also evolved, the disease landscape has changed and additional therapies have entered clinical trials. Consequently, there have been a limited number of patients eligible or willing to enroll in our trial, and we have elected to discontinue the trial. </p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Chronic Liver Disease Program with Orally Administered DUR-928</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Market Opportunity.<span style="font-style:normal;">&#160;&#160;&#160;&#160;Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease in both children and adults.&#160;&#160; It is estimated that NAFLD affects approximately 30% to 40% of adults and 10% of children in the United States. Non-alcoholic steatohepatitis (NASH), a more severe and progressive form of NAFLD, is one of the most common chronic liver diseases worldwide, with an estimated prevalence of 3-5% globally. No drug is currently approved for treatment of NAFLD or NASH.&#160;&#160;Moreover, alcoholic fatty liver disease (AFLD), including its more advanced stage, alcoholic steatohepatitis (ASH), develops in approximately 90% of individuals who drink more than 60 grams/day of alcohol, but may occur in individuals who drink less, and is a major contributor to the global burden of liver cirrhosis.&#160;&#160;In addition to these liver diseases, there are a number of orphan liver diseases for which we may seek to develop DUR-928.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Clinical Program.<span style="font-style:normal;">&#160;&#160;&#160;&#160;In 2020, we completed a Phase 1b randomized, multi-center, and open-label clinical study in the United States to evaluate safety, PK and signals of biological activity of DUR-928 in NASH patients with stage 1-3 fibrosis. DUR-928 (at doses of 50 mg QD, 150 mg QD and 300 mg BID) was administered orally for 28 days with 20 patients or more per dose group for a total of 65 patients in the trial as shown below. Key endpoints included safety and PK, clinical chemistry and biomarkers (e.g., ALT, AST, GGT, triglycerides, Non-HDL-C, CK-18s, inflammatory cytokines) as well as liver fat content and liver stiffness by imaging (e.g., MRI-PDFF and FibroScan<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup>). </span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:9pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gguopuizh44n000006.jpg" title="" alt="" style="width:624px;height:152px;" /></p>
<p style="margin-bottom:9pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:9pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2020, we reported positive topline results from this Phase 1b clinical study of orally administered DUR-928 in NASH patients. In November 2020, we presented additional safety data and efficacy signals at the The AASLD Liver Meeting Digital Experience&#8482; (TLMdX).</p>
<p style="margin-bottom:9pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A total of 65 patients completed the study, in which DUR-928 was orally administered daily for 4 weeks at 50 mg (n&#61;23), 150 mg (n&#61;21), or 600 mg (300 mg BID (n&#61;21)) and followed up for an additional 4 weeks. Both the 50 mg and 600 mg dose groups showed a statistically significant median reduction at day 28 from baseline of serum alanine aminotransferase (ALT) levels at -16% and -17%, respectively. The 600 mg dose group also showed statistically significant median reductions at day 28 from baseline of serum aspartate aminotransferase (AST) (-18%) and gamma-glutamyl transferase (GGT) (-8%), and the 50 mg dose group had a statistically significant reduction at day 28 from baseline in liver stiffness as measured by Fibroscan (-10%). </p>
<p style="margin-bottom:9pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Patients in the 50 mg or 150 mg dose groups also had statistically significant median reduction at day 28 from baseline of serum triglycerides (-13% in the 50 mg group) or LDL-C (-11% in the 150mg group). Patients with elevated baseline triglycerides (&#8805;200 mg/dL&#59; n&#61;16) across all dose groups had a median reduction at day 28 from baseline of -24% (p &#60;0.01).&#160; </p>
<p style="margin-bottom:9pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At day 28, 43% of patients in all three dose groups showed &#8805; 10% liver fat reduction from baseline as measured by magnetic resonance&#160;imaging - proton density fat fraction (MRI-PDFF). In this subgroup, there was a significant reduction from baseline in median liver fat content (-18%, -19%, and -23%, in the 50 mg, 150 mg and 600 mg groups respectively). The reduction of liver fat content was accompanied by a significant median reduction from baseline of serum ALT (-21%, -19%, and -32%, in the 50 mg, 150 mg and 600 mg groups respectively), as well as both CK-18, M30 and M65 in the 50 mg and 600 mg groups. We may report additional efficacy signals of this trial at a future medical conference<span style="font-weight:bold;">.</span></p>
<p style="margin-bottom:9pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DUR-928 was well tolerated at all three doses evaluated. There were no serious adverse events reported during the study, and no discontinuations, early withdrawals or termination of study drug or study participation due to adverse events. PK parameters after repeat dosing were comparable to those after a single dose (from a prior study), indicating no accumulation of the drug after repeat dosing.&#160;&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:9pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:3pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Topline Data Summary (Day 28 vs Baseline) </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:auto;">
<tr>
<td style="width:10.84%;"></td>
<td style="width:15.67%;"></td>
<td style="width:12.63%;"></td>
<td style="width:12.63%;"></td>
<td style="width:12.64%;"></td>
<td style="width:12.63%;"></td>
<td style="width:12.63%;"></td>
<td style="width:12.64%;"></td>
</tr>
<tr style="height:27.25pt;">
<td rowspan="2" colspan="2" valign="middle" style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Median at Day 28</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">* p &#60; 0.05</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">** p &#60; 0.01</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">*** p &#60; 0.001</p></td>
<td colspan="3" valign="middle" style="padding-left:7.2pt;padding-Right:7.2pt;padding-Top:3.6pt;padding-Bottom:3.6pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">All Subjects</p></td>
<td colspan="3" valign="middle" style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Patients with &#8805; 10% Reduction in</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">MRI-PDFF</p></td>
</tr>
<tr style="height:36.6pt;">
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">50 mg QD</span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">(n&#61;21-23)</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">150 mg QD</span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">(n&#61;20-21)</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">300 mg BID</span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">(n&#61;20-21)</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">50 mg QD</span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">(n&#61;9)</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">150 mg QD</span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">(n&#61;8)</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">300 mg BID</span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">(n&#61;9)</p></td>
</tr>
<tr style="height:24.15pt;">
<td rowspan="3" valign="middle" style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Liver Enzymes</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ALT</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-16%*</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-10%</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-17%***</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-21%**</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-19%*</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-32%***</p></td>
</tr>
<tr style="height:24.15pt;">
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">AST</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-14%</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-9%</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-18%**</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-24%**</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-21%</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-39%***</p></td>
</tr>
<tr style="height:24.15pt;">
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">GGT</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-6%</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-1%</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-8%*</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-13%***</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-16%*</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-14%</p></td>
</tr>
<tr style="height:24.15pt;">
<td rowspan="2" valign="middle" style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Imaging</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">MRI-PDFF</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-7%</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-7%</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-4%</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-18%***</p></td>
<td valign="bottom" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-19%***</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-23%***</p></td>
</tr>
<tr style="height:24.15pt;">
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FibroScan</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-10%**</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-9%</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-1%</p></td>
<td valign="bottom" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-7%</p></td>
<td valign="bottom" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-9%**</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-9%</p></td>
</tr>
<tr style="height:24.15pt;">
<td rowspan="3" valign="middle" style="padding-left:5.4pt;padding-Right:5.4pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Serum Lipids</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">LDL-C</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-6%</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-11%*</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-7%</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-7%</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-11%</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-8%*</p></td>
</tr>
<tr style="height:24.15pt;">
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Non-HDL-C</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-8%</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-5%</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-1%</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-10%</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-8%*</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-12%*</p></td>
</tr>
<tr style="height:24.15pt;">
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Triglycerides</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-13%*</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-3%</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-2%</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-9%</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-8%</p></td>
</tr>
<tr style="height:29.75pt;">
<td rowspan="2" valign="middle" style=" border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.65pt;;margin-right:1.07%;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Biomarkers</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CK-18, M30</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-14.6%</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-8.6%</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-16.1%</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-22.8%***</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-3.8%</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-42.1%*</p></td>
</tr>
<tr style="height:34.7pt;">
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CK-18, M65</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-18.1%</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-9.9%</p></td>
<td valign="middle" style="padding-left:4.5pt;padding-Right:4.5pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-35.0%</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-28.1%***</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-8.7%</p></td>
<td valign="middle" style="padding-left:4.45pt;padding-Right:4.45pt;padding-Top:0.75pt;padding-Bottom:0pt; border-top:solid 1pt #000000; border-bottom:solid 1pt #000000; border-left:solid 1pt #000000; border-right:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-55.8%*</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">ALT<span style="font-weight:normal;"> (</span><span style="Background-color:#FFFFFF;font-weight:normal;">alanine aminotransferase)&#59; </span><span style="Background-color:#FFFFFF;">AST </span><span style="Background-color:#FFFFFF;font-weight:normal;">(aspartate aminotransferase)&#59; </span><span style="Background-color:#FFFFFF;">GGT</span><span style="Background-color:#FFFFFF;font-weight:normal;"> (gamma-glutamyl transferase)&#59;</span><span style="Background-color:#FFFFFF;color:#222222;"> MRI-PDFF&#160;</span><span style="Background-color:#FFFFFF;color:#222222;font-weight:normal;">(Magnetic Resonance&#160;Imaging - Proton Density Fat Fraction) is a non-invasive measure of the proportion of liver tissue which is composed of fat</span><span style="Background-color:#FFFFFF;color:#222222;">&#59; FibroScan</span><span style="Background-color:#FFFFFF;color:#222222;font-weight:normal;">&#160;is a specialized ultrasound machine that measures the stiffness of liver tissue. </span><span style="Background-color:#FFFFFF;">LDL-C</span><span style="Background-color:#FFFFFF;font-weight:normal;"> ( Low-Density Lipoprotein &#8211; Cholesterol)&#59; </span><span style="Background-color:#FFFFFF;">Non-HDL-C</span><span style="Background-color:#FFFFFF;font-weight:normal;"> (Total cholesterol excluding High-Density Lipoprotein-Cholesterol)&#59; </span><span style="Background-color:#FFFFFF;">QD</span><span style="Background-color:#FFFFFF;font-weight:normal;"> (once a day)&#59; </span><span style="Background-color:#FFFFFF;">BID</span><span style="Background-color:#FFFFFF;font-weight:normal;"> (twice a day)&#59; </span><span style="Background-color:#FFFFFF;">CK-18</span><span style="Background-color:#FFFFFF;font-weight:normal;"> (cytokeritin 18)</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have completed multiple Phase I trials in healthy subjects with orally administered DUR-928. These included single-ascending-dose and multiple-ascending-dose studies as well as a food effect study. In all of these studies DUR-928 was well-tolerated at all dose levels, with no serious treatment-related adverse events reported. Dose related increases in plasma concentrations were observed and no accumulation in plasma concentrations or food effects were observed with repeat dosing.&#160;&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also conducted a Phase 1b trial in cirrhotic and non-cirrhotic NASH patients and matched control subjects (MCS) (matched by age, body mass index and gender with normal liver function) utilizing orally administered DUR-928. This was an open-label, single-ascending-dose safety and PK study conducted in Australia in two successive dose cohorts (first a low dose of 50 mg and then a high dose of 200 mg). Both cohorts consisted of 10 NASH patients and 6 MCS. Data from this study was presented at the International Liver Congress&#8482; 2017 organized by the European Association for the Study of the Liver (EASL) in Amsterdam in April 2017. All patients and MCS in this study tolerated DUR-928 well.&#160;&#160;One patient (with a prior history of arrhythmia and an ongoing viral infection) in the high dose cohort experienced a serious adverse event (shortness of breath), which occurred without unusual </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">biochemical changes and resolved without intervention but was considered possibly treatment related by the physician due to its temporal association with dosing.&#160;&#160;In both low and high dose cohorts, the PK parameters were comparable between the NASH patients and the MCS.&#160;&#160;In addition, the systemic exposure following the low and high doses of DUR-928 was dose dependent.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While this study was not designed to assess efficacy, we observed statistically significant reductions from baseline of several biomarkers after both doses of DUR-928.&#160;&#160; A single oral dose of DUR-928 significantly reduced the levels of both full-length (M65) and cleaved (M30) cytokeratin-18 (CK-18), bilirubin, hsCRP, and IL-18 in these subjects.&#160;&#160;The mean decrease of full-length CK-18 (a generalized cell death marker) at the measured time point of greatest effect (12 hours after dosing) was 33% in the low dose cohort and 41% in the high dose cohort.&#160;&#160;The mean decrease of cleaved CK-18 (a cell apoptosis marker) at the measured time point of greatest effect (12 hours after dosing) was 37% in the low dose cohort and 47% in the high dose cohort.&#160;&#160;The mean reduction of total bilirubin (a liver function marker) at the measured time point of greatest effect (12 hours after dosing) was 27% in the low dose cohort and 31% in the high dose cohort.&#160;&#160;The mean decrease of high sensitivity C-Reactive Protein (hsCRP) (a marker of inflammation) at the measured time point of greatest effect (24 hours after dosing) was 8% in the low dose cohort and 13% in the high dose cohort.&#160;&#160; The mean decrease of IL-18 (an inflammatory mediator) at the measured time point of greatest effect (8 hours after dosing) was 4% in the low dose cohort and 8% in the high dose cohort.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Collectively, the biological signals observed in NASH patients plus results from our animal and cell culture studies suggest potential therapeutic activity of DUR-928 for patients with liver diseases.&#160;&#160;However, additional studies are required to evaluate the safety and efficacy of DUR-928, and there is no assurance that these biomarker, clinical chemistry and liver imaging effects will be associated with clinically relevant benefits, or that DUR-928 will demonstrate safety or efficacy in treating liver diseases in our ongoing or future trials.&#160;&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have also conducted a Phase 1b safety and PK study in subjects with moderate and severe hepatic function impairment (Child-Pugh Class B (n&#61;10) and C (n&#61;7) and matched control subjects (n&#61;10)) following a single oral dose of DUR-928 to support potential inclusion of patients with advanced fibrosis (f4) and cirrhosis in future clinical trials. DUR-928 was well tolerated by these subjects with no drug-related serious adverse events reported in this trial. We plan to report results of this trial at a future medical conference<span style="font-weight:bold;">.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Approved and Commercial Pharmaceutical Products</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><img src="gguopuizh44n000007.jpg" title="" alt="" style="width:624px;height:285px;" /></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">POSIMIR<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> (bupivacaine solution)</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">POSIMIR (bupivacaine solution) for infiltration<span style="font-style:italic;"> </span>use is a novel and proprietary product that combines the strength of 660 mg of bupivacaine base with the innovative SABER&#174; platform technology, enabling continuous sustained delivery of a non-opioid local analgesic over 3 days in adults, which we believe coincides with the time period of the greatest need for post-surgical pain control in most patients. POSIMIR contains more bupivacaine than any other approved single-dose sustained-release bupivacaine product.&#160;&#160;At the end of surgery, POSIMIR is administered into the subacromial space under direct arthroscopic visualization, where it continuously releases bupivacaine for 72 hours or more. We are in discussions with potential licensees regarding commercialization rights to POSIMIR, for which we hold worldwide rights. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2021, the U.S. Food and Drug Administration (FDA) approved POSIMIR for infiltration use in adults for administration into the subacromial space under direct arthroscopic visualization to produce post-surgical analgesia for up to 72 hours following arthroscopic subacromial decompression. The approval was based on positive data from a randomized, multicenter, assessor-blinded, placebo&#8209;controlled clinical trial in patients undergoing arthroscopic subacromial decompression surgery with an intact rotator cuff. The primary outcome measures were mean pain intensity and total opioid rescue analgesia administered, both evaluated over the first 72 hours after surgery versus placebo. POSIMIR demonstrated a statistically significant improvement in both primary outcome measures: a 1.3 point, or 20%, reduction in mean pain intensity on a 0-10 point pain scale (p&#61;0.01), and a 67% reduction in I.V. morphine-equivalent rescue opioid use, from a median of 12 mg in the placebo group to 4 mg in the POSIMIR group (p&#61;0.01). In connection with this approval, we or our licensee, will be required to conduct two postmarketing non-clinical studies. Full Prescribing Information, including the Boxed Warning, is available at <span style="text-decoration:none;">www.POSIMIR.com</span>. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:11pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Market Opportunity.<span style="font-style:normal;">&#160;&#160;&#160;&#160;</span>Arthroscopic Subacromial Decompression (ASD) Shoulder Surgery</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subacromial decompression is a type of shoulder surgery used to treat impingement syndrome, a common repetitive-use injury that causes pain when the arm is raised over the head. The procedure is typically performed arthroscopically, meaning that several small incisions are made in the skin and muscle of the shoulder through which a camera lens (arthroscope) and surgical instruments are inserted during surgery. Arthroscopic subacromial decompression is generally considered outpatient surgery, and most patients go home within a few hours of surgery. The recovery period may extend from weeks to months, but the most intense pain typically occurs during the first 3 days after surgery and is often managed with oral opioids. There are over 600,000 surgeries involving arthroscopic subacromial decompression performed each year in the U.S.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While ASD is the first approved indication for POSIMIR, there may be opportunities to expand the indication and addressable patient population based on existing data or data generated from additional POSIMIR trials.&#160;&#160;According to data published by the Center for Disease Control and Prevention, there are approximately 72&#160;million ambulatory and inpatient surgical procedures performed annually in the U.S. Insufficient postoperative pain control remains a significant problem, with studies indicating that roughly 65% of patients experience moderate-to-extreme pain after surgery. The current standard of care for post-surgical pain includes a variety of opiate and non-opiate analgesics and muscle relaxants. While systemic opioids can effectively reduce post-surgical pain, they commonly cause side effects including drowsiness, constipation, nausea and vomiting, and cognitive impairment, and have the potential for addiction and abuse. Post-surgical pain also can be treated effectively with local anesthetics&#59; however, their usefulness often is limited by their short duration of action<span style="font-weight:bold;">.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">PERSERIS<sup style="font-size:85%;line-height:120%;vertical-align:top">&#8482;</sup>(risperidone)</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September 2017, we entered into an agreement with Indivior, under which we assigned to Indivior certain patents that may provide further intellectual property protection for PERSERIS, Indivior&#8217;s extended-release injectable suspension for the treatment of schizophrenia in adults.&#160;&#160;In consideration for such assignment, Indivior has made non-refundable upfront and milestone payments to DURECT of $17.5 million.&#160;&#160;Under the terms of the agreement with Indivior, DURECT receives quarterly earn-out payments that are based on a single digit percentage of U.S. net sales of PERSERIS into 2026.&#160;&#160; Indivior commercially launched PERSERIS in the U.S. in February 2019. </p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">ORADUR-ADHD Program</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In collaboration with Orient Pharma (OP), we developed a drug candidate based on our ORADUR technology for the treatment of ADHD. This drug candidate is intended to provide once-a-day dosing. In August 2009, we entered into a development and license agreement, as amended, with OP, a diversified multinational pharmaceutical, healthcare and consumer products company with headquarters in Taiwan, under which we granted to OP development and commercialization rights in certain defined Asian and South Pacific countries to ORADUR-Methylphenidate ER. We retain rights to North America, Europe and all other countries not specifically licensed to OP. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">OP has informed us that they launched Methydur commercially in Taiwan in September 2020.  Methydur is indicated for the treatment of ADHD and is available in three strengths (22 mg, 33 mg and 44 mg) in Taiwan. They may seek a partner in China and pursue regulatory approvals in selected other countries in Southeast Asia where OP has commercialization rights and a commercialization presence. We receive a single digit royalty on sales of Methydur by OP and retain rights to this product in markets not specifically licensed to OP.&#160;&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Drug Delivery Technologies and Programs</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our drug delivery technologies are designed to deliver the right drug to the right place, in the right amount and at the right time to treat a variety of chronic, acute and episodic diseases and conditions. We aim to improve therapy for a given disease or patient population by controlling the rate and duration of drug administration. In addition, if advantageous for the therapy, our technologies can target the delivery of the drug to its intended site of action.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our technologies are suitable for providing long-term drug therapy because they can often store highly concentrated, stabilized drugs in a small volume and protect the drug from degradation by the body. This, in combination with the ability to continuously deliver desired doses of a drug, can extend the therapeutic value of a wide variety of drugs, including, in some cases, those which would otherwise be ineffective, too unstable, too potent or cause adverse side effects. In some cases, delivering the drug directly to the intended site of action can improve efficacy while minimizing unwanted side effects elsewhere in the body, which often limit the long-term use of many drugs. Our technologies may thus provide better therapy for chronic diseases or conditions, or for certain acute conditions where longer drug dosing is required or advantageous, by replacing multiple injection therapy or oral dosing, improving drug efficacy, reducing side effects and ensuring dosing compliance. Our technology may thereby improve patients&#8217; quality of life by eliminating more repetitive treatments, reducing dependence on caregivers and allowing patients to lead more independent lives.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We currently have several active drug delivery technology platforms:</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">The SABER and CLOUD Bioerodible Injectable Depot Systems</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our bioerodible injectable depot systems include our SABER and CLOUD platform technologies. SABER uses a high viscosity base component, such as sucrose acetate isobutyrate (SAIB), to provide controlled release of a drug. When the high viscosity SAIB is formulated with drug, biocompatible excipients and other additives, the resulting formulation is easily injectable with standard syringes and needles. After injection of a SABER formulation, the excipients diffuse away over time, leaving a viscous depot which provides controlled sustained release of drug. CLOUD is a class of bioerodible injectable depot technology which generally does not contain SAIB but includes various other release rate modifying excipients and/or bioerodible polymers to achieve the delivery of drugs for periods of days to months from a single injection.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The SABER technology is the basis of POSIMIR (described above). The SABER technology is also utilized in our ophthalmic program with Santen Pharmaceutical Co., Ltd. (Santen), as well as in feasibility programs. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The SABER technology is also the basis for SucroMate<sup style="font-size:85%;line-height:120%;vertical-align:top">&#8482;</sup> Equine, an injectable animal health drug utilizing our SABER technology to deliver the peptide deslorelin. This was the first FDA approved SABER injectable product when it was launched in 2011 by CreoSalus, Inc.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Sustained Release Gel Cap Technology</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe that our ORADUR sustained release technology can transform short-acting oral capsule dosage forms into sustained release oral products. Products based on our ORADUR technology can take the form of an easy to swallow capsule that uses a high-viscosity base component such as sucrose acetate isobutyrate (SAIB) to provide controlled release of active ingredients for an extended period of time. Oral dosage forms based on the ORADUR gel-cap may also have the added benefit of being less prone to abuse (e.g., by crushing and then snorting, smoking, injecting or extracting by mixing with alcohol or water). These properties have the potential to make ORADUR-based products an attractive option for pharmaceutical companies that seek to develop abuse-deterrent oral products.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The ORADUR technology is the basis of our ORADUR-Methylphenidate ER program (described above).</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">DURECT Strategy</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our objective is to develop multiple pharmaceutical products that address significant unmet medical needs and improve patients&#8217; quality of life. To achieve this objective, our strategy includes the following key elements:</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Focus on Areas with the Potential for Significant Value Creation.&#160;&#160;<span style="font-style:normal;">We view patients, physicians, the healthcare system, payers, and strategic partners, as all being important stakeholders in our company.&#160;&#160;We believe that developing the products in our pipeline, which may address significant unmet medical needs and may create value for our stakeholders, also has the potential to create value for our shareholders.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Apply our Drug Development Expertise to New Chemical Entities Derived from our Epigenetic Regulator Program<span style="font-style:normal;">.&#160;&#160;&#160;&#160;We have assembled a core team of employees with considerable experience in drug development, and it is our intent to leverage their capabilities by developing pharmaceuticals derived from our Epigenetic Regulator Program. We believe that these new chemical entities may have utility in acute organ injuries such as AH, in various orphan diseases, and for several metabolic diseases such as NASH.&#160;&#160;We believe that these product candidates may be of interest to other pharmaceutical companies and that it may be possible to license the rights to certain products, formulations, indications or territories from this program while retaining the rights to other product candidates, formulations, indications or territories for either our own development and commercialization or for licensing at a later stage of development. The sale of the LACTEL product line to Evonik in the fourth quarter of 2020 has streamlined the company and sharpened our focus on developing DUR-928, the lead product candidate in our Epigenetic Regulator Program.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Focus on Certain Acute Indications, Chronic Debilitating Medical Conditions and Certain Local Pain Conditions<span style="font-style:normal;">.&#160;&#160;&#160;&#160;Many of the diseases and disorders that present great challenges to medicine include acute organ injury, metabolic disorders, pain management, CNS disorders, cardiovascular disease, ophthalmic conditions and other acute and chronic conditions. Our current efforts focus on exploiting our Epigenetic Regulator Program through which we have identified new chemical entities that may have utility in conditions such as acute organ injuries and chronic metabolic/lipid disorders and on using our versatile drug delivery platform technologies to develop products that improve current treatment options.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Diversify Risk by Pursuing Multiple Programs in Development<span style="font-style:normal;">.&#160;&#160;&#160;&#160;In order to reduce the risks inherent in pharmaceutical product development, we have diversified our product pipeline such that, we are pursuing multiple indications with our lead epigenetic regulator, DUR-928, and we have several early-stage programs being developed in collaboration with partners.&#160;&#160;Between our own programs and those where we have collaborated, we have multiple programs with the potential to generate significant value. We believe that having multiple indications and programs in development helps mitigate the negative consequences to us of any setbacks or delays in any one of our indications or programs.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Enable Product Development Through Strategic Agreements<span style="font-style:normal;">.&#160;&#160;&#160;&#160;We believe that entering into selective strategic collaborations and other arrangements with respect to our product development programs and technology can enhance the success of our product development and commercialization, leverage and exploiting the value of our intellectual property portfolio, mitigate our risk and enable us to better manage our operating costs. Additionally, such collaborations and arrangements enable us to leverage investment by third parties and reduce our net cash burn, while retaining significant economic rights.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Build Our Own Commercial Organization<span style="font-style:normal;">.&#160;&#160;&#160;&#160;In the future, we may elect to build our own commercial, sales and marketing capability in order to capture more of the economic value of certain products that we may develop. If we choose to enter into third-party collaborations to commercialize our pharmaceutical product candidates, we may in the future enter into these alliances under circumstances that allow us to participate in the sales and marketing of these products.</span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Strategic Agreements</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have entered into the following strategic collaboration and other key agreements:</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Virginia Commonwealth University Intellectual Property Foundation<span style="font-style:normal;">. We have entered into an exclusive in-license and research and development agreement with the Virginia Commonwealth University Intellectual Property Foundation regarding certain new chemical entities under development through our Epigenetic Regulator Program, including DUR-928. Under this licensing arrangement, we have agreed to undertake certain efforts to bring licensed products to market, pay for prosecution of related patents and report on progress to VCU. In addition, we are obligated to pay low single-digit percentage patent royalties on net sales of licensed products, subject to annual minimum payments and additional milestone payments. This license includes rights to nine patent families. We may terminate this agreement at any time by written notice, and VCU may terminate this agreement by written notice if there is an uncured material breach.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Indivior UK Ltd<span style="font-style:normal;">.&#160;&#160;In September 2017, we entered into a patent purchase agreement (the &#8220;Indivior Agreement&#8221;) with Indivior.&#160; Pursuant to the Indivior Agreement, we assigned to Indivior certain patents that may provide further intellectual property protection for PERSERIS, Indivior&#8217;s once-monthly injectable risperidone product for the treatment of schizophrenia.&#160; In consideration for such assignment, Indivior made an upfront and milestone non-refundable payment to us of $12.5 million, and also agreed to make an additional $5 million payment to us contingent upon FDA approval of PERSERIS, as well as quarterly earn-out payments based on a single digit percentage of U.S. net sales for certain products covered by the assigned patent rights, including PERSERIS. The assigned patent rights include granted patents extending into at least 2026.&#160; We also receive a non-exclusive right under the assigned patents to develop and commercialize certain risperidone-containing products and products that do not contain risperidone or buprenorphine.&#160; The agreement contains customary representations, warranties and indemnities of the parties. We received the non-refundable payment of $12.5 million from Indivior in September 2017 and recognized this amount as revenue from sale of intellectual property rights in the year ended December 31, 2017 as we did not have any continuing obligations under the purchase agreement.&#160;&#160;In July 2018, Indivior announced that the FDA had approved the NDA for PERSERIS thereby triggering the $5.0 million payment, which was received by DURECT in August 2018.&#160;&#160;Indivior launched PERSERIS in the U.S. in February 2019.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Santen Pharmaceutical Co., Ltd<span style="font-style:normal;">.&#160;&#160;&#160;&#160;In December&#160;2014, we and Santen entered into a definitive agreement (the &#8220;Santen Agreement&#8221;). Pursuant to the Santen Agreement, we have granted Santen an exclusive worldwide license to our proprietary SABER formulation platform and other intellectual property to develop and commercialize a sustained release product utilizing our SABER technology to deliver an ophthalmology drug. Santen controls and funds the development and commercialization program, and the parties have established a joint management committee to oversee, review and coordinate the development activities of the parties under the Agreement.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the license agreement, Santen paid us a non-refundable upfront fee of $2.0 million in cash and agreed to make contingent cash payments to us of up to $76.0 million upon the achievement of certain milestones, of which $13.0 million are development-based milestones (none of which has been achieved as of December 31, 2020), and $63.0 million are commercialization-based milestones including milestones requiring the achievement of certain product sales targets (none of which has been achieved as of December 31, 2020). Santen will also pay for certain of our costs incurred in the development of the licensed product. If the product is commercialized, we would also receive a tiered royalty on annual net product sales ranging from single-digit to the low double digits, determined on a country-by-country basis. Santen may terminate the Agreement without cause at any time upon prior written notice, and either party may terminate the Agreement upon certain circumstances including a material uncured breach. As of December 31, 2020, the cumulative aggregate payments received by us under this agreement were $3.3 million. In January 2018, we were notified by Santen that due to a shift in priorities, Santen has elected to reallocate research and development resources and put our program on pause until further notice. While the main program is on pause, the parties are working together on a limited set of research and development activities funded by Santen.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Commercial Product Lines</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">ALZET</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The ALZET product line consists of miniature, implantable osmotic pumps and accessories used for research in mice, rats and other laboratory animals. These pumps are neither approved nor intended for human use. ALZET pumps continuously deliver drugs, hormones and other test agents at controlled rates from one day to six weeks without the need for external connections, frequent handling or repeated dosing. In laboratory research, these infusion pumps can be used for systemic administration when implanted under the skin or in the body. They can be attached to a catheter for intravenous, intracerebral, or intra-arterial infusion or for targeted delivery, where the effects of a drug or test agent are localized in a particular tissue or organ. The wide use and applications of the ALZET product line is evidenced by the more than 20,000 scientific references that now exist. </p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">LACTEL<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> Absorbable Polymers</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 31, 2020, we closed an Asset Purchase Agreement with Evonik Corporation (Evonik), pursuant to which Evonik purchased certain assets related to our LACTEL Absorbable Polymers product line. Under the terms of the Asset Purchase Agreement, Evonik paid us approximately $15&#160;million subject to certain adjustments, and also agreed to assume certain liabilities with respect to the transferred assets and assembled workforce.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Marketing and Sales</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Historically, we have established strategic distribution and marketing alliances for our product candidates to leverage the established sales organizations that certain pharmaceutical companies have in markets we are targeting. In the future, we may elect to build our own commercial, sales and marketing capability in order to capture more of the economic value of certain products that we may develop. If we choose to enter into third-party collaborations to commercialize our pharmaceutical product candidates, we may in the future enter into these alliances under circumstances that allow us to participate in the sales and marketing of these products. We will continue to pursue strategic alliances and collaborators from time to time consistent with our strategy to leverage the established sales organizations of third-party collaborators. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We market and sell our ALZET product line through a direct sales force in the U.S. and through a network of distributors outside of the U.S.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Suppliers</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We purchase the DUR-928 drug substance from a third-party manufacturer and DUR-928 clinical trial materials from another third party manufacturer. As needed, we purchase sucrose acetate isobutyrate, a raw material for our ORADUR and SABER-based pharmaceutical systems, including Methydur, POSIMIR, and SucroMate, from Eastman Chemical Company. We expect that we will continue to be able to obtain sufficient supply of these raw materials to meet our needs for the foreseeable future. We do not have in place long term supply agreements with respect to all of the components of any of our pharmaceutical product candidates, however, and are subject to the risk that we may not be able to procure all required components in adequate quantities with acceptable quality, within acceptable time frames or at reasonable cost.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Customers</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our product revenues principally are derived from sales of the ALZET product line to academic and pharmaceutical industry researchers, and from the sale of certain key excipients that are included in Methydur Sustained Release Capsules, SucroMate and other products. Until such time that we are able to bring our pharmaceutical product candidates to market, if at all, we expect these to be our principal sources of product revenue. We also receive revenue from collaborative research and development arrangements with our third-party collaborators. In 2020, 2019, and 2018, Gilead accounted for 76%, 68% and 33% or our total revenues, respectively, pursuant to an agreement that has been terminated, and in 2018, Indivior accounted for 17% of our total revenues.&#160;&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The process for manufacturing our pharmaceutical product candidates is technically complex, requires special skills, and must be performed in qualified facilities. We have entered into development and commercial manufacturing agreements with third parties for the manufacture of DUR-928 and POSIMIR. In addition, we have a small multi-discipline manufacturing facility in California that we have used to manufacture research and clinical supplies of several of our pharmaceutical product candidates under GMP, including DUR-928 dosage forms and POSIMIR. In the future, we may develop additional manufacturing capabilities for our pharmaceutical product candidates and components to meet our demands and those of our third-party collaborators by contracting with third party manufacturers and by potentially constructing additional manufacturing space at our current facilities in California. We manufacture our ALZET product line and certain key components for POSIMIR and Methydur at one of our California facilities<span style="font-weight:bold;">.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Patents and Proprietary Rights</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our success depends in part on our ability to obtain patents, to protect trade secrets, to operate without infringing upon the proprietary rights of others and to prevent others from infringing on our proprietary rights. Our policy is to seek to protect our proprietary position by, among other methods, filing U.S. and foreign patent applications related to our proprietary molecules and technology, inventions and improvements that are important to the development of our business. As of March 1, 2021, we owned or exclusively in-licensed over 35 unexpired issued U.S. patents and over 145 unexpired issued foreign patents (which include granted European patent rights that have been validated in various EU member states).&#160;In addition, we have over 55 pending U.S. patent applications and over 145 foreign applications pending in Europe, Australia, Japan, Canada and other countries.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The patent status of our most advanced drug candidates is as follows:</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Epigenetic Regulator Program includes nine in-licensed patent families and four patent families solely owned by us.&#160;Three patent families each include at least one granted patent that could provide protection until 2026, 2032, and 2034, respectively.&#160;The other patent families include pending patent applications, which if granted, could result in patents expiring in 2033, 2035, 2037, 2037, 2037, 2040, 2040, 2041, 2041 and 2041, respectively.&#160;&#160;Patent terms are potentially subject to terminal disclaimers as well as patent term adjustments and extensions.&#160;Of the thirteen patent families covering DUR-928 and/or other molecules in the Epigenetic Regulator Program, two were only filed in the United States, and the other eleven have been filed or likely will be filed both in the U.S. and internationally.&#160;Since DUR-928 is an endogenous molecule, patent claims directed to DUR-928 compositions of matter may be more difficult to maintain or enforce in the United States under Myriad Genetics and other recent court decisions.&#160;One of the U.S. patents issued before Myriad Genetics, and seven of the DUR-928 U.S. patents issued after Myriad Genetics.&#160;The granted claims in the U.S. include both composition of matter and method of treatment claims.&#160;There can be no assurance that the pending patent applications will be granted.&#160;Further, there can be no assurance that VCU will not attempt to terminate their license to us, which termination could result in the loss of our rights to these patent families.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the United States, POSIMIR is covered by four patent families. One patent family includes granted patents that could provide protection until 2025. The other three patent families include pending patent applications, which if granted, could result in patents expiring in 2026, 2041, and 2042, respectively. In Europe, POSIMIR is covered by four granted patents with two that could expire in 2025 and two that could expire in 2026.&#160;&#160;The families that could provide protection until at least 2041 and 2042, respectively, will likely be filed in Europe.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the United States, our ORADUR-Methylphenidate ER patent portfolio includes four patent families. Two patent families include granted patents that could provide protection until at least 2023 and 2029, respectively. The other patent families include pending patent applications, which if granted, could provide protection until 2026 and 2037, respectively. There can be no assurance that the pending patent applications will be granted.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proprietary rights relating to our planned and potential products will be protected from unauthorized use by third parties only to the extent that they are covered by valid and enforceable patents or are </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">effectively maintained as trade secrets. Patents owned by or licensed to us may not afford protection against competitors, and our pending patent applications now or hereafter filed by or licensed to us may not result in patents being issued. In addition, the laws of certain foreign countries may not protect our intellectual property rights to the same extent as do the laws of the U.S.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The patent positions of biopharmaceutical companies involve complex legal and factual questions and, therefore, their enforceability cannot be predicted with certainty. Our patents or patent applications, or those licensed to us, if issued, may be challenged, invalidated or circumvented, and the rights granted thereunder may not provide proprietary protection or competitive advantages to us against competitors with similar technology. Furthermore, our competitors may independently develop similar technologies or duplicate any technology developed by us. Because of the extensive time required for development, testing and regulatory review of a potential product, it is possible that, before any of our products can be commercialized, any related patent may expire or remain in existence for only a short period following commercialization, thus reducing any advantage of the patent, which could adversely affect our ability to protect future product development and, consequently, our operating results and financial position.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because patent applications in the U.S. are typically maintained in secrecy for at least 18 months after filing and since publication of discoveries in the scientific or patent literature often lag behind actual discoveries, we cannot be certain that we were the first to make the inventions covered by each of our issued or pending patent applications or that we were the first to file for protection of inventions set forth in such patent applications.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our planned or potential products may be covered by third-party patents or other intellectual property rights, in which case we would need to obtain a license to continue developing or marketing these products. Any required licenses may not be available to us on acceptable terms, if at all. If we do not obtain any required licenses, we could encounter delays in product introductions while we attempt to design around these patents, or could find that the development, manufacture or sale of products requiring such licenses is foreclosed. Litigation may be necessary to defend against or assert such claims of infringement, to enforce patents issued to us, to protect trade secrets or know-how owned by us, or to determine the scope and validity of the proprietary rights of others. In addition, interference, derivation, post-grant oppositions, and similar proceedings may be necessary to determine rights to inventions in our patents and patent applications. Litigation or similar proceedings could result in substantial costs to and diversion of effort by us, and could have a material adverse effect on our business, financial condition and results of operations. These efforts by us may not be successful.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may rely, in certain circumstances, on trade secrets to protect our technology. However, trade secrets are difficult to protect. We seek to protect our proprietary technology and processes, in part, by confidentiality agreements with our employees and certain contractors. There can be no assurance that these agreements will not be breached, that we will have adequate remedies for any breach, or that our trade secrets will not otherwise become known or be independently discovered by competitors. To the extent that our employees, consultants or contractors use intellectual property owned by others in their work for us, disputes may also arise as to the rights in related or resulting know-how and inventions.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Government Regulation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">The Food and Drug Administration.&#160;&#160;&#160;&#160;<span style="font-style:normal;">The FDA and comparable regulatory agencies in state and local jurisdictions and in foreign countries impose substantial requirements upon the development, manufacture and marketing of pharmaceutical products. These agencies and other federal, state and local entities regulate research and development activities and the testing, manufacture, quality control, safety, effectiveness, labeling, storage, distribution, record keeping, approval, advertising and promotion of our products. We believe that our products in development will be regulated as drugs by the FDA rather than as biologics or devices.</span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The process required by the FDA under the new drug provisions of the Federal Food, Drug and Cosmetics Act (the Act) before our products in development may be marketed in the U.S. generally involves the following:</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">preclinical laboratory and animal tests&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">submission of an Investigational New Drug (IND) application which must become effective before clinical trials may begin&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">adequate and well-controlled human clinical trials to establish the safety and efficacy of the proposed pharmaceutical products candidates in their intended uses&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">FDA approval of a new drug application.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Section&#160;505 of the Act describes three types of new drug applications: (1)&#160;an application that contains full reports of investigations of safety and effectiveness (section 505(b)(1))&#59; (2)&#160;an application that contains full reports of investigations of safety and effectiveness but where at least some of the information required for approval comes from studies not conducted by or for the applicant and for which the applicant has not obtained a right of reference (section 505(b)(2))&#59; and (3)&#160;an application that contains information to show that the proposed product is identical in active ingredient, dosage form, strength, route of administration, labeling, quality, performance characteristics and intended use, among other things, to a previously approved product (section 505(j)). We expect that our drug candidates deriving from our Epigenetic Regulator Program will be evaluated for approval after submission of a new drug application under section 505(b)(1).</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The testing and approval process require substantial time, effort, and financial resources, and we cannot be certain that any approval will be granted on a timely basis, if at all. Even though several of our pharmaceutical products candidates utilize active drug ingredients that are commercially marketed in the United States in other dosage forms, we need to establish safety and effectiveness of those active ingredients in the formulation and dosage forms that we are developing.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preclinical tests include laboratory evaluation of the product, its chemistry, formulation and stability, as well as animal studies to assess the potential safety and efficacy of the pharmaceutical product candidate. We then submit the results of the preclinical tests, together with manufacturing information and analytical data, to the FDA as part of an IND, which must become effective before we may begin human clinical trials. Each subsequent new clinical protocol must also be submitted to the FDA under the IND. An IND automatically becomes effective 30 days after receipt by the FDA, unless the FDA, within the 30-day time period, raises concerns or questions about the conduct of the trials as outlined in the IND and imposes a clinical hold. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before clinical trials can begin. Our submission of an IND may not result in FDA authorization to commence clinical trials. Further, an independent Institutional Review Board at each medical center proposing to conduct the clinical trials must review and approve any clinical study as well as the related informed consent forms and authorization forms that permit us to use individually identifiable health information of study participants.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Human clinical trials are typically conducted in three sequential phases which may overlap:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Phase 1:&#160;&#160;&#160;&#160;The drug is initially introduced into healthy human subjects or patients and tested for safety, dosage tolerance, absorption, metabolism, distribution and excretion.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Phase 2:&#160;&#160;&#160;&#160;Involves clinical trials in a limited patient population to identify possible adverse effects and safety risks, to determine the efficacy of the product for specific targeted diseases and to determine dosage tolerance and optimal dosage.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Phase 3:&#160;&#160;&#160;&#160;When Phase 2 clinical trials demonstrate that a dosage range of the product is effective and has an acceptable safety profile, Phase 3 clinical trials are undertaken to further evaluate dosage, clinical efficacy and to further test for safety in an expanded patient population, at multiple, geographically dispersed clinical study sites.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the case of products for severe diseases, such as chronic pain, or life-threatening diseases such as cancer, the initial human testing is often conducted in patients with disease rather than in healthy </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">volunteers. Since these patients already have the target disease or condition, these studies may provide initial evidence of efficacy traditionally obtained in Phase 2 trials, and thus these trials are frequently referred to as Phase 1/2 clinical trials or Phase 1b trials. We cannot be certain that we will successfully complete Phase 1, Phase 2 or Phase 3 clinical trials of our pharmaceutical products in development within any specific time period, if at all. Furthermore, the FDA or the Institutional Review Board or the sponsor may suspend clinical trials at any time on various grounds, including a finding that the subjects or patients are being exposed to an unacceptable health risk. During the clinical development of products, sponsors frequently meet and consult with the FDA in order to ensure that the design of their studies will likely provide data both sufficient and relevant for later regulatory review&#59; however, no assurance of approvability can be given by the FDA.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The results of product development, preclinical studies and clinical studies are submitted to the FDA as part of a new drug application, or NDA, for approval of the marketing and commercial shipment of the product. Submission of an NDA may require the payment of a substantial user fee to the FDA, and although the agency has defined user fee goals for the time in which to respond to sponsor applications, there can be no assurance that the FDA will act in any particular timeframe. The FDA may deny a new drug application if the applicable regulatory criteria are not satisfied or may require additional clinical trials be conducted. Even if such data is submitted, the FDA may ultimately decide that the new drug application does not satisfy the criteria for approval. Once issued, the FDA may withdraw product approval if compliance with regulatory standards is not maintained or if safety problems occur after the product reaches the market. Requirements for additional Phase 4 studies (post approval marketing studies) to confirm safety and effectiveness in a broader commercial use population may be imposed as a condition of marketing approval. In addition, the FDA requires surveillance programs to monitor approved products which have been commercialized, and the agency has the power to require changes in labeling or to prevent further marketing of a product based on the results of these post-marketing programs. Any comparative claims comparing a product to other dosage forms or competitive products typically need to be supported by two adequate and well-controlled head-to-head clinical trials.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Satisfaction of FDA requirements or similar requirements of state, local and foreign regulatory agencies typically takes several years and the actual time required may vary substantially, based upon the type, complexity and novelty of the pharmaceutical product. Government regulation may delay or prevent marketing of potential products for a considerable period of time and impose costly procedures upon our activities. We cannot be certain that the FDA or any other regulatory agency will grant approval for any of our pharmaceutical products under development on a timely basis, if at all. Success in preclinical or early stage clinical trials does not assure success in later stage clinical trials. Data obtained from preclinical and clinical activities is not always conclusive and may be susceptible to varying interpretations which could delay, limit or prevent regulatory approval. Evolving safety concerns can result in the imposition of new requirements for expensive and time-consuming tests, such as for QT interval cardiotoxicity testing. Even if a product receives regulatory approval, the approval may be significantly limited to specific indications. Further, even after regulatory approval is obtained, any problems associated with a product may result in restrictions on the product or even complete withdrawal of the product from the market. Any pharmaceutical products that we may develop and obtain approval for would also be subject to adverse findings of the active drug ingredients being marketed in different dosage forms and formulations. Delays in obtaining, or failures to obtain regulatory approvals would have a material adverse effect on our business. Marketing our pharmaceutical products abroad will require similar regulatory approvals and is subject to similar risks. In addition, we cannot predict what adverse governmental regulations may arise from future U.S. or foreign governmental action.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are several FDA programs intended to help facilitate the development of new drugs that meet certain criteria. Specifically, new drugs are eligible for Fast Track designation if they are intended to treat a serious or life- threatening condition and demonstrate the potential to address unmet medical needs for the condition. Fast Track designation applies to the combination of the product and the specific indication for which it is being studied. The sponsor of a new drug may request the FDA to designate the drug as a Fast Track product at any time during the clinical development of the product. Under a Fast Track designation, the FDA may consider for review sections of the marketing application on a rolling basis before the complete application is submitted, if the sponsor provides a schedule for the submission of the sections of the application, the FDA agrees to accept sections of the application and determines that the </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">schedule is acceptable, and the sponsor pays any required user fees upon submission of the first section of the application.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A product is eligible for priority review if it has the potential to provide safe and effective therapy where no satisfactory alternative therapy exists or a significant improvement in the treatment, diagnosis or prevention of a disease compared to marketed products. The FDA will attempt to direct additional resources to the evaluation of an application for a new drug or biological product designated for priority review to facilitate the review.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A product that is being studied for safety and effectiveness in treating serious or life-threatening illnesses and provides meaningful therapeutic benefit over existing treatments may receive accelerated approval, which means that it may be approved on the basis of adequate and well-controlled clinical trials establishing that the product has an effect on a surrogate endpoint that is reasonably likely to predict a clinical benefit, or on the basis of an effect on a clinical endpoint other than survival or irreversible morbidity. As a condition of approval, the FDA may require that a sponsor of a drug receiving accelerated approval perform adequate and well-controlled post-marketing clinical trials. In addition, the FDA currently requires pre-approval of promotional materials as a condition for accelerated approval, which could adversely impact the timing of the commercial launch of the product.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the Orphan Drug Act, the FDA may grant orphan drug designation to drugs intended to treat a rare disease or condition, which is generally a disease or condition that affects fewer than 200,000 individuals in the United States. Orphan drug designation must be requested before submitting an NDA. After the FDA grants orphan drug designation, the identity of the therapeutic agent and its potential orphan use are disclosed publicly by the FDA. Orphan drug designation does not convey any advantage in or shorten the duration of the regulatory review and approval process. If a product that has orphan drug designation subsequently receives FDA approval for the disease for which it has such designation, the product is entitled to orphan product exclusivity, which means that the FDA may not approve any other applications to market the same drug for the same disease, except in limited circumstances, for seven years. These circumstances are an inability to supply the drug in sufficient quantities or a situation in which a new formulation of the drug has shown superior safety or efficacy or a major contribution to patient care. This exclusivity, however, could also block the approval of our products for seven years if a competitor obtains earlier approval of the same drug for the same indication.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A product may also be eligible for receipt of a Breakthrough Therapy designation. The Breakthrough Therapy designation is intended to expedite the FDA&#8217;s review of a potential new drug for serious or life-threatening diseases where &#8220;preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development.&#8221; The designation of a drug as a Breakthrough Therapy provides the same benefits as are available under the Fast Track program, as well as intensive FDA guidance on the product&#8217;s development program. Fast Track designation, priority review, accelerated approval and Breakthrough Therapy designation do not change the standards for approval, but they may expedite the development or approval process.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any pharmaceutical products manufactured or distributed by us pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including record-keeping requirements and reporting of adverse experiences with the product or the active pharmaceutical ingredient or other components of the product. The FDA may also require post-approval clinical or non-clinical trials.&#160;&#160;Drug manufacturers and their subcontractors are required to register their establishments with the FDA and state agencies, and are subject to periodic unannounced inspections by the FDA and state agencies for compliance with good manufacturing practices, which impose procedural and documentation requirements upon us and our third party manufacturers. We cannot be certain that we or our present or future suppliers will be able to comply with the GMP regulations and other FDA regulatory requirements.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Federal Food, Drug, and Cosmetic Act strictly regulates drug product marketing, prohibits manufacturers from marketing drug products for off-label use and regulates the distribution of drug samples. The FDA has actively enforced regulations prohibiting the marketing of products for unapproved uses, and federal and state authorities are also actively litigating against sponsors who promote their drugs for unapproved uses under various fraud and abuse and false claims act statutes. We and our products are also subject to a variety of state laws and regulations in those states or localities where our products are or will be marketed. Any applicable state or local regulations may hinder our ability to market our products in those states or localities. We are also subject to numerous federal, state and local laws relating to such matters as safe working conditions, manufacturing practices, environmental protection, fire hazard control, and disposal of hazardous or potentially hazardous substances. We may incur significant costs to comply with such laws and regulations now or in the future.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA&#8217;s policies may change and additional government regulations may be enacted which could prevent or delay regulatory approval of our product candidates. Moreover, increased attention to the containment of health care costs in the U.S. and in foreign markets could result in new government regulations that could have a material adverse effect on our business. We cannot predict the likelihood, nature or extent of adverse governmental regulation that might arise from future legislative or administrative action, either in the U.S. or abroad.&#160;&#160;<span style="font-style:italic;">The Drug Enforcement Administration.&#160;&#160;&#160;&#160;</span>The Drug Enforcement Administration (DEA) regulates chemical compounds as Schedule I, II, III, IV or V substances, with Schedule I substances considered to present the highest risk of substance abuse and Schedule V substances the lowest risk. Certain active ingredients in ORADUR-Methylphenidate are listed by the DEA as Schedule II under the Controlled Substances Act of 1970. Consequently, their manufacture, research, shipment, storage, sale and use are subject to a high degree of oversight and regulation. For example, all Schedule II drug prescriptions must be signed by a physician, physically presented to a pharmacist and may not be refilled without a new prescription. Furthermore, the amount of Schedule II substances we can obtain for clinical trials and commercial distribution is limited by the DEA and our quota may not be sufficient to complete clinical trials or meet commercial demand. There is a risk that DEA regulations may interfere with the supply of the drugs used in our clinical trials, and, in the future, our ability to produce and distribute our products in the volume needed to meet commercial demand, which could negatively impact us and our collaborators.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other Healthcare Laws.&#160;&#160;In addition to FDA and DEA restrictions on the marketing of pharmaceutical products, other foreign, federal and state healthcare regulatory laws restrict business practices in the pharmaceutical industry. These laws include, but are not limited to, federal and state anti&#8209;kickback, false claims, data privacy and security, and physician payment and drug pricing transparency laws.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The U.S. federal Anti&#8209;Kickback Statute prohibits, among other things, any person or entity from knowingly and willfully offering, paying, soliciting, receiving or providing any remuneration, directly or indirectly, overtly or covertly, to induce or in return for purchasing, leasing, ordering, or arranging for or recommending the purchase, lease, or order of any good, facility, item or service reimbursable, in whole or in part, under Medicare, Medicaid or other federal healthcare programs. The term &#8220;remuneration&#8221; has been broadly interpreted to include anything of value. The Anti&#8209;Kickback Statute has been interpreted to apply to arrangements between pharmaceutical and medical device manufacturers on the one hand and prescribers, purchasers, formulary managers and beneficiaries on the other hand. Although there are a number of statutory exceptions and regulatory safe harbors protecting some common activities from prosecution, the exceptions and safe harbors are drawn narrowly. Practices that involve remuneration that may be alleged to be intended to induce prescribing, purchases, or recommendations may be subject to scrutiny if they do not meet the requirements of a statutory or regulatory exception or safe harbor. Failure to meet all of the requirements of a particular applicable statutory exception or regulatory safe harbor does not make the conduct per se illegal under the U.S. federal Anti&#8209;Kickback Statute. Instead, the legality of the arrangement will be evaluated on a case&#8209;by&#8209;case basis based on a cumulative review of all its facts and circumstances. Several courts have interpreted the statute&#8217;s intent requirement to mean that if any one purpose of an arrangement involving remuneration is to induce referrals of federal healthcare covered business, the statute has been violated. In addition, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. Moreover, a claim including items or services resulting from a violation of the U.S. federal Anti&#8209;Kickback Statute </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act. The majority of states also have anti&#8209;kickback laws, which establish similar prohibitions and in some cases may apply to items or services reimbursed by any third&#8209;party payor, including commercial insurers.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, there has been a recent trend of increased federal and state regulation of payments made to physicians and certain other healthcare providers. The Affordable Care Act imposed, among other things, new annual reporting requirements through the Physician Payments Sunshine Act for covered manufacturers for certain payments and &#8220;transfers of value&#8221; provided to physicians and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Failure to submit timely, accurately and completely the required information for all payments, transfers of value and ownership or investment interests may result in civil monetary penalties. Covered manufacturers must submit reports by the 90th day of each subsequent calendar year and the reported information is publicly made available on a searchable website. In addition, certain states require implementation of compliance programs and compliance with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government, impose restrictions on marketing practices and/or require the tracking and reporting of marketing expenditures and pricing information as well as gifts, compensation and other remuneration or items of value provided to physicians and other healthcare professionals and entities.&#160;&#160;Finally, the Physician Self-Referral (Stark) Law prohibits physicians from referring Medicare or Medicaid patients to providers of &#8220;designated health services&#8221; with whom the physician or a member of the physician&#8217;s immediate family has an ownership interest or compensation arrangement, unless a statutory or regulatory exception applies.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Competition</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may face competition from other companies in numerous industries including pharmaceuticals, medical devices and drug delivery. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Competition for DUR-928, if approved, will depend on the specific indications for which DUR-928 is approved. 89Bio, AbbVie, Afimmune, Akero Therapeutics, Ascletis, AstraZeneca, BMS, Cirius Therapeutics, CytoDyn, Dr. Falk Pharma, Eli Lilly, Enanta, ENYO Pharma, Galectin, Galmed, Genentech, Genfit, Gilead, Hanmi, HighTide Biopharma, Intercept, Inventiva Pharma, Ionis Pharmaceuticals, Inc., Isotechnika, Kowa, LifeMax, Lipidio, Lipocine, Madrigal, MediciNova, MedImmune, Mitsubishi Tanabe, NGM Biopharmaceuticals, Nimbus, NorthSea Therapeutics, Novartis, Novo Nordisk, Pfizer, PharmaKing, Poxel, Promethera Biosciences, Seal Rock Therapeutics, Terns Pharmaceutical, Thera Technologies, Viking, and others have development plans for products to treat NAFLD/NASH, AH or other liver diseases. Some of these competitors may be addressing the same therapeutic areas or indications as we are. Our current and potential competitors may succeed in obtaining patent protection or commercializing products before us. Many of these entities have significantly greater research and development capabilities than we do, as well as substantially more marketing, manufacturing, financial and managerial resources. These entities represent significant competition for us. Acquisitions of, or investments in, competing pharmaceutical or biotechnology companies by large corporations could increase such competitors&#8217; financial, marketing, manufacturing and other resources.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">POSIMIR will compete with currently marketed oral opioids, transdermal opioids, injectable local anesthetics, implantable materials containing local anesthetics, local anesthetic patches, implantable and external infusion pumps which can be used for infusion of opioids and local anesthetics. Products of these types are marketed by Pacira, Purdue Pharma, AbbVie, Janssen, Actavis, Medtronic, Endo, AstraZeneca, Pernix Therapeutics, Tricumed, Halyard Health, Cumberland Pharmaceuticals, Acorda Therapeutics, Mallinckrodt, Inspirion Delivery Technologies, Mylan, Shire, Johnson&#160;&#38; Johnson, Eli Lilly, Pfizer, Novartis, Zyla Life Sciences, Teva Pharmaceuticals, Collegium Pharmaceutical and others. Additional competition for POSIMIR may come from Heron Therapeutics if their product candidate, HTX-011, is approved, or from Innocoll if their recently approved product candidate, XARACOLL<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> is commercially launched. PERSERIS competes with currently marketed or approved products by Johnson &#38; Johnson, Eli Lilly, Otsuka, Alkermes, Merck, Allergan, Novartis, and others.&#160;&#160;Methydur competes with currently marketed or approved products by Shire, Johnson&#160;&#38; Johnson, UCB, Novartis, Noven, Eli Lilly, Pfizer and others. Many of these entities have significantly greater research and development capabilities than we </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">do, as well as substantially more marketing, manufacturing, financial and managerial resources. These entities represent significant competition for us.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Competition for our ALZET product line primarily consists of customers choosing to utilize delivery methods for their research projects other than an osmotic pump.&#160;&#160;We also face competition for our ALZET product line from other companies including low cost foreign competitors.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any pharmaceutical products we develop will compete in highly competitive markets. Many of our potential competitors in these markets have greater development, financial, manufacturing, marketing, and sales resources than we do and we cannot be certain that they will not succeed in developing products or technologies which will render our technologies and products obsolete or noncompetitive. In addition, many of those potential competitors have significantly greater experience than we do in their respective fields.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Corporate History, Headquarters and Website Information</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We were incorporated in Delaware in February 1998. Our principal executive offices are located at 10260 Bubb Road, Cupertino, California 95014. Our telephone number is (408)&#160;777-1417, and our website address is www.durect.com. We make our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to these reports available free of charge on our website as soon as reasonably practicable after we file these reports with the Securities and Exchange Commission (SEC). The SEC maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. The SEC&#8217;s website to access all of this information is <span style="text-decoration:none;">www.sec.gov</span>. Our Code of Ethics can be found on our website.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Human Capital Resources </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We consider our ability to recruit, retain and motivate our employees to be critical to our success. We are an equal opportunity employer and we are fundamentally committed to creating and maintaining a work environment in which employees are treated with respect and dignity. All&#160;&#160;human resources policies, practices and actions related to hiring, promotion, compensation, benefits and termination are administered in accordance with the principal of equal employment opportunity, meaning that they are made on the basis of individual skills, knowledge, abilities, job performance and other legitimate criteria and without regard to race, color, religion, sex, sexual orientation, gender expression or identity, ethnicity, national origin, ancestry, age, mental or physical disability, genetic information, any veteran status, any military status or application for military service, or membership in any other category protected under applicable law.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March 1, 2021, we had 81 employees, including 46 in research and development, 10 in manufacturing and 25 in selling, general and administrative. At least 41 of our employees have advanced degrees of some sort (e.g., MD, PhD, DVM, JD, MBA).&#160;&#160;Of our employees, 40% are male and 60% are female.&#160;&#160;From time to time, we also employ independent contractors to support our research, development and administrative organizations. None of our employees are represented by a collective bargaining unit, and we have never experienced a work stoppage. We consider our relations with our employees to be good.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Executive Officers of the Registrant</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our executive officers and their ages as of March 1, 2021 are as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name</p></td>
<td valign="top" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Age</p></td>
<td valign="top" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:60%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Position</p></td>
</tr>
<tr>
<td valign="top" style="width:28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">James E. Brown, D.V.M.</p></td>
<td valign="top" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.05pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:60%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">President, Chief Executive Officer and Director</p></td>
</tr>
<tr>
<td valign="top" style="width:28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Michael H. Arenberg, J.D., M.B.A.</p></td>
<td valign="top" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.05pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:60%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p></td>
</tr>
<tr>
<td valign="top" style="width:28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Norman L. Sussman, M.D.</p></td>
<td valign="top" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.05pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:60%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Medical Officer</p></td>
</tr>
<tr>
<td valign="top" style="width:28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:-12pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Judy R. Joice</p></td>
<td valign="top" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.05pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:60%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior Vice President, Operations and Corporate Quality Assurance</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">James E. Brown, D.V.M. co-founded DURECT in February 1998 and has served as our President, Chief Executive Officer and a Director since June 1998. He previously worked at ALZA Corporation as Vice President of Biopharmaceutical and Implant Research and Development from June 1995 to June 1998. Prior to that, Dr.&#160;Brown held various positions at Syntex Corporation, a pharmaceutical company, including Director of Business Development from May 1994 to May 1995, Director of Joint Ventures for Discovery Research from April 1992 to May 1995, and held a number of positions including Program Director for Syntex Research and Development from October 1985 to March 1992. Dr.&#160;Brown holds a B.A. from San Jose State University and a D.V.M. (Doctor of Veterinary Medicine) from the University of California, Davis where he also conducted post-graduate work in pharmacology and toxicology.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Michael H. Arenberg was appointed Chief Financial Officer effective October 2018.&#160; Mr. Arenberg has been with DURECT since 1999, most recently serving as Senior Vice President, Corporate and Business Development, where he negotiated and closed over 50 collaborations, including several important in-licensing transactions.&#160; Mr. Arenberg earned his undergraduate degree from the University of Colorado, his law degree from the University of Denver, his MBA from the Leavy School of Business at Santa Clara University. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Norman L. Sussman, M.D., FAASLD, joined DURECT as Chief Medical Officer in November 2020. He has extensive clinical experience and expertise in the field of liver disease and brings over 30 years of clinical research and development experience in academia and industry. Prior to joining DURECT he was an Associate Professor of Medicine and Surgery at Baylor College of Medicine and a faculty member of Baylor College of Medicine intermittently since 1985. During that time, he served as a Principal Investigator for research focused on the assessment and management of acute liver failure and artificial liver support. Dr. Sussman gained leadership experience in industry as the founder and Vice President of both Amphioxus Cell Technologies from 1995 to 2003 and Hepatix, Inc from 1993 to 1995. Most recently, he has also served in senior leadership roles as a member of the Baylor Faculty Senate and as Director of the telehealth program, Project ECHO&#174;, at Baylor St. Luke&#8217;s Medical Center. Dr. Sussman received his MBBCh from the University of the Witwatersrand in Johannesburg, South Africa. He then completed his residency at St. Louis University Hospital and his post-doctoral fellowship at Washington University. He is Board Certified in Internal Medicine, Gastroenterology, and Transplant Hepatology. Dr. Sussman is also a Fellow of the American Association of the Study of Liver Disease, which is a designation that recognizes his superior level of professional achievement in the field of hepatology.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Judy R. Joice has served as our Senior Vice President, Operations and Corporate Quality Assurance since March 2014 and as our Vice President, Operations and Corporate Quality Assurance since April 2011. Previously, Ms.&#160;Joice served as our Vice President, Corporate Quality Assurance since July 2008 and as our Executive Director, Quality Assurance from July 2007 to July 2008. She has over 30 years&#8217; experience in the pharmaceutical industry with such companies as Nektar Therapeutics, Oread, Roche Pharmaceuticals, and Syntex Research. During her career, Ms.&#160;Joice has gained broad experience in CMC development activities including novel excipients, new chemical entities, devices, and combination products. She has developed, implemented and managed all aspects of company-wide quality systems and compliance functions, ranging from drug development through commercial manufacturing. Ms.&#160;Joice has a B.S. in Chemistry from California State University, Hayward.</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:10.47%;text-indent:-10.47%;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:10.47%;text-indent:-10.47%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item&#160; 1A.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_1A_RISK_FACTORS">Risk Factors.</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the other information in this Form 10-K, a number of factors may affect our business and prospects. These factors include but are not limited to the following, which you should consider carefully in evaluating our business and prospects. If any of the following risks actually occur, our business, financial condition, results of operations and growth prospects may be materially and adversely affected.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Summary </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">We are dependent on the success of DUR-928 and we cannot be certain that it</span><span style="font-family:Times New Roman;color:#000000;"> </span><span style="font-family:Times New Roman;color:#000000;">will ever receive regulatory approval or be successfully commercialized</span><span style="font-family:Times New Roman;color:#000000;"> and the path to regulatory approval is uncertain</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;">Fast Track Designation for DUR-928 in AH may not actually lead to faster FDA review or an approval </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Indications of activity from completed DUR-928 clinical trials may not predict efficacy in future trials</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Open-label design of completed trials of DUR-928 have inherent limitations</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Ongoing and planned clinical trials for DUR-928 may not demonstrate efficacy or safety</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Clinical trial delays could increase expenses, delay clinical data and delay or prevent approvals</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;">The COVID-19 outbreak has and will adversely impact our business, including posing challenges to conducting clinical trials. </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;">We are in discussion with potential commercialization partners for POSIMIR and may be unable to enter an agreement </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;">The approved indication for POSIMIR may limit its market, and we or a commercialization partner may not be able to expand the label to include additional indications</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;">In connection with the approval of POSIMIR, we are required to conduct two postmarketing non-clinical studies. If the results from either of these studies are unfavorable, the FDA may require additional studies, or may take actions that are adverse to the regulatory status, commercial prospects and market acceptability of POSIMIR</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">We have a significant amount of debt. Compliance with repayment obligations and other covenants may be difficult&#59; failure to fulfill our obligations may cause the repayment obligations to accelerate</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">We will require and may have difficulty raising needed capital in the future</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">For certain of our product candidates, we depend on third-party collaborators, and we have limited or no control over their development, regulatory strategy or potential commercialization </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Cancellation of collaborations may adversely affect potential economic benefits</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;">Our revenues may decrease and losses may increase due to the sale of the LACTEL product line</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Our business strategy includes entering into additional collaborative agreements to support development, clinical trials, manufacturing and commercialization of product candidates. We may not be able to successfully negotiate or enter into acceptable collaboration agreements</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">We and our third-party collaborators may not be able to manufacture sufficient quantities of our product candidates and components at an acceptable cost or in compliance with applicable government regulations, and we have limited manufacturing experience</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Failure to comply with governmental regulations could materially harm our business</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">We have a history of operating losses, expect to continue to have losses and may never achieve profitability&#59; and we may not successfully manage our company through varying business cycles</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">We may develop our own sales force and commercial group to market future products but we have limited sales and marketing experience and may not be able to do so effectively</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Key product candidate components are provided by limited numbers of suppliers, and supply shortages or loss of these suppliers could result in interruptions in supply or increased costs</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Write-offs related to impairment of goodwill, long-lived assets, inventories and other non-cash charges may adversely impact profitability and cause cash flows to differ from reported revenues </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Global credit and financial market conditions could negatively impact the value of our investments </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">We depend upon key personnel who may terminate their employment with us at any time, and we may not be able to attract and retain sufficient qualified personnel</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Cyber-attacks or other failures in telecommunications or information technology systems could result in information theft, data corruption and significant disruption of our business operations</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Our corporate headquarters, certain manufacturing facilities and personnel are located in a seismically active area near wildfire zones&#59; Our business also involves environmental risks and risks related to handling regulated substances</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">As a non-accelerated filer, we are not required to comply with auditor attestation requirements of the Sarbanes-Oxley Act and, consequently, investors may find our common stock less attractive </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">If we are unable to protect, maintain or enforce our IP rights or secure rights to third-party </span><span style="font-family:Times New Roman;color:#000000;">IP</span><span style="font-family:Times New Roman;color:#000000;">, we may lose valuable assets, lose market share or incur costly litigation or our third-party collaborators may choose to terminate their agreements with us, which may depend on our IP</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">We may be sued by third parties claiming that our product candidates infringe on their IP rights, particularly because there is substantial uncertainty about the validity and breadth of medical patents</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Competitive products or technologies could impair our ability to maintain or grow our business</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">We could be exposed to significant product liability claims and we are subject to healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, contractual damages and reputational harm </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Healthcare reform measures could hinder or prevent our product candidates&#8217; commercial success</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Market acceptance of our product candidates is uncertain, and failure to achieve market acceptance or adequate reimbursement from third-party payers will harm our future revenues and profitability</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Inability to train physicians to use our products may prevent market acceptance of our products</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Risks related to actions on trade by the U.S. and foreign governments, new accounting pronouncements and legislative actions could adversely affect the Company's results of operations and financial condition</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Our operating history makes evaluating our stock difficult, the price of our stock may be volatile </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Investors may experience substantial dilution of their investment </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Our ability to use net operating losses and other tax attributes is uncertain and may be limited</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">We have broad discretion over the use of our cash and investments, which may not always yield a favorable return</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Our certificate of incorporation, bylaws and Delaware law could discourage an acquisition of us </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Having Delaware as the exclusive forum for substantially all disputes between us and our stockholders could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes</span></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Related To Our Business</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">We are dependent on the success of DUR-928 and we cannot be certain that it will receive regulatory approval or be commercialized</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our business depends substantially on the successful development of DUR-928, which has completed a Phase 1b clinical trial in NASH and a Phase 2a clinical trial in AH, and is currently recruiting patients for a Phase 2b clinical trial (AHFIRM) in patients with severe AH.&#160;&#160;Ongoing and future clinical trials will need to establish clinically and statistically significant proof of efficacy, and/or sufficient evidence of safety to support filing for regulatory approval and/or additional clinical trials and ultimately regulatory approval. DUR-928 will require additional development, including more clinical trials as well as further preclinical studies, including those designed to evaluate its dosage, dosing regimen, toxicology, carcinogenicity, pharmacokinetics and other non-clinical parameters, as well as regulatory clearances before it can be commercialized. Positive results obtained during early development do not necessarily mean later development will succeed or that regulatory clearances will be obtained. Our drug development efforts may not lead to commercial drugs, for several reasons such as if DUR-928 fails to be shown to be safe and effective or if we do not have adequate financial or other resources to advance DUR-928 through the pre-clinical and clinical development and approval processes. We consider DUR-928 to be our lead and most important asset. If DUR-928 fails to demonstrate safety or efficacy at any time or during any phase of development, we would experience potentially significant delays in, or be required to abandon, development of DUR-928, any of which would materially harm our business. Even if the Phase 2b AHFIRM trial successfully demonstrates a survival benefit over placebo, (1) additional clinical trial(s) may be required to support an NDA filing and ultimately to support approval by FDA and/or other regulatory bodies&#59; and (2) accelerated regulatory pathways (such as an FDA priority review designation) may not be available. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not anticipate that DUR-928 will be eligible to receive regulatory approval from the FDA or comparable foreign authorities and begin commercialization for a number of years, if ever. Even if we ultimately receive regulatory approval for DUR-928, we or our potential future partners, if any, may be unable to commercialize it successfully for a variety of reasons. These include, for example, the availability of alternative, potentially superior or less expensive treatments or vaccines, lack of cost-effectiveness, the lack of favorable access and/or commercial pricing, the cost or technical challenges of manufacturing the product on a commercial scale and competition with other drugs or vaccines. The success of DUR-928 may also be limited by the prevalence and severity of any adverse side effects, including mortality. If we fail to commercialize DUR-928, we may be unable to generate sufficient revenues to attain or maintain profitability, and our financial condition and stock price may decline.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Fast Track designation of&#160;DUR-928&#160;by the FDA may not actually lead to a faster development or regulatory review or approval process</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA grants Fast Track designation to therapies that are considered capable of addressing unmet medical needs and possess the potential to treat serious or life-threatening disease conditions in order to facilitate its development and expedite the review procedure. Even though&#160;DUR-928&#160;has received Fast Track designation for the treatment of alcoholic hepatitis, we may not experience a faster development process, review or approval, or receive FDA approval at all, in that indication or any other compared to conventional FDA procedures. A Fast Track designation does not change the standards for approval. The FDA may also withdraw Fast Track designation if it believes that the designation is no longer supported by data from our clinical development program.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Early indications of activity from Phase 1 and 2 clinical trials of DUR-928 may not predict therapeutic efficacy</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Although Phase 1 and Phase 2 clinical trials of DUR-928 have shown positive initial data in AH patients, including reductions in bilirubin and MELD scores from baseline and promising Lille scores, and demonstrated that DUR-928 can lead to the reduction from baseline in liver enzymes, liver stiffness and serum lipids as well as certain biomarkers, such initial results, indications of activity and biomarker </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">changes may ultimately not be correlated with treatment or improvement in the associated disease, and there is a risk that DUR-928 may not demonstrate therapeutic efficacy in larger controlled trials, despite encouraging initial data and improvements in biomarker levels in smaller, early trials.&#160;The failure of DUR-928 to show efficacy in one indication may negatively affect its perceived value in other indications, </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the emergence of safety signals in ongoing or future clinical trials would significantly harm our business.&#160;&#160;</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Open-label trials of DUR-928 in NASH and AH have inherent limitations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The most recently completed NASH and AH trials of DUR-928 are open-label trials with no control groups. Open label trials have inherent risk of bias given that the patients and physicians know that they received active study drug, which can lead to placebo effects. Trials without control groups have an inherent risk in that the comparisons used to determine the study drug&#8217;s effect and side effect profile are based on comparisons with baseline (pre-treatment) levels (for blood chemistry and biomarker endpoints) and/or with historical controls, which may not have been conducted under similar enough conditions to make accurate comparisons and/or draw accurate conclusions from those comparisons.&#160;&#160;Any initial data collected from these open-label trials also cannot be meaningfully analyzed or relied upon until after the completion of the trials due to the limited number of patients involved, open-label nature and lack of control groups. Additionally, larger controlled clinical trials will be required to evaluate the safety and efficacy of DUR-928 to treat any indication, including AH and NASH. There can be no assurance that ongoing or future studies will demonstrate the safety or efficacy of DUR-928 in a statistically significant or clinically meaningful manner.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">The COVID-19 outbreak has impacted and will adversely impact our business</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The global&#160;COVID-19&#160;pandemic has disrupted our operations and delayed our clinical trials. In particular, the&#160;COVID-19&#160;pandemic delayed the initiation of our AHFIRM Phase 2b clinical trial to evaluate the safety and efficacy of&#160;DUR-928&#160;in severe alcohol-associated hepatitis (AH) patients, and it may delay the pace of enrollment in this trial and other clinical trials. As a result of the&#160;COVID-19&#160;pandemic, there are also supply shortages of components needed for commercialization supplies of POSIMIR, which has delayed and may further delay availability of commercial supplies of POSIMIR and may adversely affect the timing for the commercial launch of POSIMIR, and there has been reduced demand for our ALZET products, which are used in scientific and&#160;pre-clinical&#160;research. In addition,&#160;COVID-19&#160;may have an adverse impact on the economies and financial markets of many countries, resulting in a severe and prolonged global economic downturn that could continue to affect demand for our ALZET product lines and POSIMIR and impact our operating results. We also need to raise additional capital to provide sufficient funding to continue our product development efforts, including clinical trials.&#160;COVID-19&#160;initially had an adverse impact on the capital markets and could again, which would make it more difficult for companies such as ours to access capital. The extent to which the coronavirus impacts our operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration and severity of the outbreak, and the actions that may be required to contain the coronavirus or treat its impact. As a result of the&#160;COVID-19&#160;pandemic, we may continue to experience disruptions that could severely impact our business, preclinical studies and clinical trials including:</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">delays or difficulties in enrolling patients in our clinical trials&#59;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">delays or difficulties in clinical site initiation, including difficulties in recruiting clinical site investigators and clinical site staff&#59;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">diversion of healthcare resources away from the conduct of clinical trials, including the diversion of hospitals serving as our clinical trial sites and hospital staff supporting the conduct of our clinical trials&#59;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">interruption of key clinical trial activities, such as clinical trial site data monitoring, due to limitations on travel imposed or recommended by federal or state governments, employers and others or interruption of clinical trial subject visits and study procedures, which may impact the integrity of subject data and clinical study endpoints, the ability to collect, ship and analyze biological samples from clinical trial patients due to concerns about potential contamination of samples and/or exposure of clinical staff to patients with the&#160;COVID-19&#59;</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">interruption or delays in the operations of the FDA or other regulatory authorities, which may impact review and approval timelines&#59;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">disruption or delays in manufacturing of clinical and commercial supplies due to issues experienced by our contract manufacturing organizations and/or shortages and delays in obtaining raw materials and supplies required in the manufacturing processes&#59;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">interruption of, or delays in receiving, supplies of our product candidates from our contract manufacturing organizations due to staffing shortages, production slowdowns or stoppages, prioritization of pandemic-related activities over ours&#160;&#160;and disruptions in delivery systems&#59;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">interruptions in preclinical studies due to restricted or limited operations at laboratory facilities&#59;</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="width:5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">limitations on employee resources that would otherwise be focused on the conduct of our preclinical studies and clinical trials, including because of sickness of employees or their families or the desire of employees to avoid contact with large groups of people&#59; and</p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="width:4.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8226;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">material delays and complications with respect to our research and development programs.</p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">We may not successfully manage our company through varying business cycles, including the COVID-19 pandemic</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our success will depend on properly sizing our company through growth and contraction cycles caused in part by changing business conditions, which places a significant strain on our management and on our administrative, operational and financial resources. For example, in connection with the COVID-19 pandemic, we asked most of our personnel, including all of our administrative employees,&#160;to&#160;work remotely, restricted on-site staff to only those personnel who must perform activities that must be completed on-site, implemented social distancing on-site, and closed certain of our offices temporarily. &#160;Our increased reliance on personnel working from home may negatively impact productivity, or disrupt, delay, or otherwise adversely impact our business.&#160; In addition, this could increase our cyber security risk, create data accessibility concerns, and make us more susceptible to communication disruptions, any of which could adversely impact our business operations or delay necessary interactions with the FDA<span style="color:#000000;">,</span> manufacturing sites, research or clinical trial sites.&#160;To manage through such cycles, we may expand or contract our facilities, our operational, financial and management systems and our personnel. If we were unable to manage growth and contractions effectively our business would be harmed.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Ongoing and planned clinical trials for DUR-928 in AH may be delayed and may not demonstrate efficacy or safety in the indications tested</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Phase 2b AHFIRM trial of DUR-928 in patients with AH is subject to potential delays resulting from COVID-19 as well as timing of entering contracts with clinical sites and contract research organizations, obtaining institutional review board approvals and delays in other activities that need to be put in place prior to clinical trial initiation at each clinical trial site.&#160; Given uncertainty of COVID-19-related impacts on clinical trial sites, the timing of availability of top-line data from this trial cannot be predicted with certainty. There can be no assurance that the trial will enroll as anticipated if at all, and delays in enrollment could add to the costs and expenses of this trial and harm our business.&#160;&#160;There can also be no assurance that biological activity demonstrated in previous animal disease models or earlier clinical trials of DUR-928 will also be seen in ongoing trials or future clinical trials, or that any clinically relevant biological activity will be observed, or that enrollment rates will be favorable or that these additional trials will not identify safety issues.&#160;&#160;Failure of the AHFIRM trial to achieve desired results in its anticipated timeframe would negatively impact our business and ability to raise additional capital.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">The path to regulatory approval of DUR-928 is uncertain</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DUR-928 is in clinical development for the potential treatment of AH&#59; NASH is also being explored. We are currently developing DUR-928 in several indications, including AH and NASH. In AH and NASH, there are no currently approved drugs. Accordingly, as the treatment landscape changes, we will have to interact with the FDA and other regulatory agencies regarding important aspects of the clinical development program, potentially including the size of clinical trials, the specific primary and secondary endpoints for the clinical trials, inclusion and exclusion criteria, stopping rules, duration of follow up, size of the safety databases, statistical analysis plans and other matters.&#160;&#160;This uncertainty may make it difficult to predict the timing or expense required to obtain regulatory approval for DUR-928.&#160;&#160;We also may need to revise our clinical development plans after trials have commenced or been completed, which could add to the time and expense associated with the clinical development of DUR-928.&#160;&#160;If we are unable to reach agreement with the FDA or other regulatory agencies regarding clinical development plans for DUR-928, we may curtail or limit our development activities for this product candidate.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">We are in discussions with potential commercialization partners for POSIMIR and may be unable to enter an agreement</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are in discussions to license POSIMIR to a third party for commercialization. There can be no assurance that we will be able to enter into an agreement with a third party for the commercialization of POSIMIR at all, or that any agreement we enter into will result in material payments to us. If we are not able to enter into such an agreement we may not commercially launch POSIMIR, or if such agreement does not result in material payments to us, our financial prospects may be harmed.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">The approved indication for POSIMIR may limit its market, and we or a commercialization partner may not be able to expand the label to include additional indications</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA approval for POSIMIR is limited to use in arthroscopic subacromial decompression surgery and contains a Boxed Warning about risks of intravenous administration.&#160;&#160;We or a commercialization partner<span style="font-weight:bold;font-style:italic;"> </span>cannot currently promote POSIMIR for use in other indications, and the Boxed Warning may deter physicians from using it, which may limit the market opportunity for POSIMIR.&#160;&#160;While we intend to seek approval from FDA for POSIMIR in additional indications, there is no assurance that we or a commercialization partner will be able to do so, in which case sales of POSIMIR may be limited.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">In connection with the approval of POSIMIR, the Company is required to conduct two postmarketing non-clinical studies. If the results from either of these studies are unfavorable, the FDA may require additional studies, or may take actions that are adverse to the regulatory status, commercial prospects and market acceptability of POSIMIR</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the approval of POSIMIR, we are required to conduct two postmarketing non-clinical studies to determine the ultimate impact of the drug product and fate of the vehicle if it is inadvertently administered into the intravascular space and to assess the potential serious risk of POSIMIR-induced Local Anesthetic Systemic Toxicity (LAST) following inadvertent intravenous route of administration and the ability of lipid infusions to treat the clinical manifestations of LAST.&#160;&#160;We will need to reach agreement with the FDA on the appropriate protocols for these non-clinical studies, complete them and submit final reports to the FDA by September 2023.  </p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FDA may require us to update POSIMIR&#8217;s labeling with the results from these studies, including any positive or negative results, which could have adverse impact on POSIMIR&#8217;s commercial prospects and market acceptability. We may be unable to complete our postmarketing studies in accordance with the required timeline, if at all. For example, it may not be feasible to assess the risk of LAST following inadvertent intravenous route of administration and the ability of lipid infusions to treat the clinical manifestations of LAST. If the FDA determines the study cannot be completed as designed, but the study objectives remain important, the FDA may require one or more new postmarketing studies with new commitments and schedules. The FDA may also amend the labeling or take other actions that are adverse to POSIMIR&#8217;s regulatory status.  If there are delays in completing the postmarketing studies, </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p>
<hr style="page-break-after:always" />
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the </span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">FDA </span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">may </span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">post information about the </span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">delayed </span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">status </span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on </span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">its website. </span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any of the above FDA actions </span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">could adversely affect </span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">us</span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or POSIMIR&#8217;s commercial prospects, or have other collateral effects</span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">such as making it more difficult for us to find a third-party licensee to commercialize POSIMIR</span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In POSIMIR clinical studies, no inadvertent intravascular injections were observed.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">If we experience delays or difficulties in the enrollment of subjects in clinical trials, our product development expenses may increase, clinical trial data could be delayed and receipt of necessary regulatory approvals could be delayed or prevented</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Successful and timely completion of clinical trials will require that we enroll a sufficient number of subjects and/or patients. Enrollment, a significant factor in the timing of clinical trials, is affected by many factors including the size and nature of the patient population, our ability to recruit clinical sites and the ability of clinical sites to successfully recruit subjects to participate in clinical trials. Initiation of and enrollment in many clinical trials is being adversely affected by COVID-19, which has caused many institutions to stop enrolling patients, has created a large number of clinical trial proposals for potential clinical trial sites to review and consider, and has caused many individuals to avoid contact with hospitals or other healthcare providers.&#160;&#160;Additionally, some of the patients in our clinical trials, including AH patients, are hospitalized and concerns about exposure to COVID-19 limit clinical trial staff&#8217;s access to patients, the frequency of interactions between patients and staff, the ability to obtain blood draws and other biological sample collection, and may limit the ability to ship samples to outside laboratories for analysis. In areas heavily impacted by COVID-19, there may be limited hospital staff available for clinical trial activities due to staff becoming infected or due to deprioritization of clinical trial activities. Trials may be subject to delays as a result of patient enrollment taking longer than anticipated or patient withdrawal. We may not be able to initiate or continue clinical trials for DUR-928 if we are unable to sign sufficient clinical sites, locate and enroll a sufficient number of eligible patients to participate in these trials as required by the FDA or similar regulatory authorities outside the United States or if we are unable to collect and analyze biological samples required for trial endpoints. It is possible that the inclusion and exclusion criteria for patients to be included in these trials or COVID-19-related issues may make the trials more difficult to conduct or may significantly extend the time required for enrollment and the cost of these trials.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We cannot predict how successful we will be at enrolling patients in our clinical trials. Enrollment is affected by other factors including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the eligibility criteria for the trial in question&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the prevalence and incidence of the conditions being studied in the clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">COVID-19-related challenges with patient access, hospital prioritization, clinical trial staff availability, ability to collect, ship and analyze patients&#8217; biological samples, availability of personal protective equipment (PPE), swabs, reagents and other materials and supplies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the perceived risks and benefits of our product candidates&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">clinicians&#8217; and patients&#8217; perceptions as to the potential advantages of the product candidate being studied in relation to other available therapies, including any new drugs or therapeutic biologics that may be approved for the indications we are investigating&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the efforts to facilitate timely enrollment in clinical trials&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">competition for clinical sites and patients from other clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the willingness of potential clinical trial patients to provide informed consent to participate in the trial&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the patient referral practices of physicians&#59; </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the ability to monitor patients adequately during and after treatment&#59; and </span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the proximity and availability of clinical trial sites for prospective patients. </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our inability to sign up sufficient clinical trial sites and/or enroll a sufficient number of patients for clinical trials would result in significant delays and could require us to abandon one or more clinical trials altogether. Enrollment delays in these clinical trials may result in increased development costs for our drug candidates or delays in regulatory filings and progression, which would cause the value of our company to decline and limit our ability to obtain additional financing. </p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">The FDA may require more information or clinical studies for all of our product candidates, and our product candidates may never be approved</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The failure to adequately demonstrate the safety and effectiveness of a pharmaceutical product candidate under development to the satisfaction of FDA and other regulatory agencies will result in delays to the regulatory approval or non-approvability of our product candidates, and could materially harm our business. Clinical trials may not demonstrate the sufficient levels of safety and efficacy necessary to obtain the requisite regulatory approvals for our product candidates, or may require such significant numbers of patients or additional costs to make it impractical to satisfy the FDA&#8217;s requirements, and thus our product candidates may not be approved for marketing. During the review process, the FDA may request more information regarding the safety of our product candidates, as they did in their Complete Response Letter for POSIMIR, and answering such questions could require significant additional work and expense, and take a significant amount of time, resulting in a material delay of approval or the failure to obtain approval or lead the company to abandon the development of that product candidate. During the review process, the FDA may also request more information regarding the chemistry, manufacturing or controls related to our product candidates, and answering such questions could require significant additional work and expense, and take a significant amount of time, resulting in a material delay of approval or the failure to obtain approval or abandonment of the product candidate. Additionally, even if our product candidates receive FDA approval, the FDA may require that we conduct additional clinical or non-clinical studies after such approval, place limitations on the use of our products in applicable labels, require marketing under a REMS program, include commercially unattractive language in the approved product label, delay approval to market our products or limit the indicated use of our products, which may harm our business and results of operations.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">We currently have a significant amount of debt. Compliance with repayment obligations and other covenants may be difficult, and failure by us to fulfill our obligations under the applicable loan agreements may cause the repayment obligations to accelerate</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July 2016, we entered into a Loan and Security Agreement (the Loan Agreement) with Oxford Finance LLC (Oxford Finance), pursuant to which Oxford Finance provided a $20 million secured single-draw term loan to us with an initial maturity date of August&#160;1, 2020. The term loan was fully drawn at close and the proceeds may be used for working capital and general business requirements. The term loan repayment schedule provided initially for interest only payments for the first 18 months, followed by consecutive monthly payments of principal and interest in arrears starting on March&#160;1, 2018 and continuing through the maturity date of August&#160;1, 2020. Following three amendments, we make interest only payments under the amended Loan Agreement until December 1, 2021 and the final maturity date of the loan is May 1, 2024.&#160;&#160;The Loan Agreement provides for a floating interest rate (7.95% initially and 7.95% as of December 31, 2020) based on an index rate plus a spread and an additional payment equal to 10% of the principal amount of the term loan, which is due when the term loan becomes due or upon the prepayment of the facility. If we elect to prepay the loan, there is also a prepayment fee between 0.75% and 2.5% of the principal amount of the term loan depending on the timing of prepayment.&#160;&#160; Our debt repayment obligations under the Loan Agreement, as amended, may prove a burden to the Company as they become due, particularly following the expiration of the interest-only period.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Loan Agreement contains customary events of default, including, among other things, our failure to fulfill certain of our obligations under the Loan Agreement and the occurrence of a material adverse change in our business, operations or condition (financial or otherwise), a material impairment of the prospect of repayment of any portion of the loan, the failure to deliver an unqualified audit report and board approved financial projections within time periods set forth in the Loan Agreement, or a material impairment in the perfection or priority of lender&#8217;s lien in the collateral or in the value of such collateral. In the event of default by us under the Loan Agreement, the lender would be entitled to exercise its remedies thereunder, including the right to accelerate the debt, upon which we may be required to repay all amounts then outstanding under the Loan Agreement, which could harm our business, operations and financial condition.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, the term loan is secured by substantially all of our assets, except that the collateral does not include any equity interests in the Company, any intellectual property (including all licensing, collaboration and similar agreements relating thereto), and certain other excluded assets. The Loan Agreement contains customary representations, warranties and covenants by us, which covenants limit our ability to convey, sell, lease, transfer, assign or otherwise dispose of certain of our assets&#59; engage in any business other than the businesses currently engaged in by us or reasonably related thereto&#59; liquidate or dissolve&#59; make certain management changes&#59; undergo certain change of control events&#59; create, incur, assume, or be liable with respect to certain indebtedness&#59; grant certain liens&#59; pay dividends and make certain other restricted payments&#59; make certain investments&#59; make payments on any subordinated debt&#59; and enter into transactions with any of our affiliates outside of the ordinary course of business or permit our subsidiaries to do the same. Complying with these covenants may make it more difficult for us to successfully execute our business strategy.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">We will require and may have difficulty raising needed capital in the future</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our business currently does not generate sufficient revenues to meet our capital requirements and we do not expect that it will do so in the near future. We have expended and will continue to expend substantial funds to complete the research, development and clinical testing of our product candidates. We will require additional funds for these purposes, to establish additional clinical- and commercial-scale manufacturing arrangements and facilities, and to provide for the marketing and distribution of our product candidates. Additional funds may not be available on acceptable terms, if at all, and such availability will depend on a number of factors, some of which are outside of our control, including general capital markets conditions and investors&#8217; view of our prospects and valuation. If adequate funds are unavailable from operations or additional sources of financing, we may have to delay, reduce the scope of or eliminate one or more of our research or development programs which would materially harm our business, financial condition and results of operations.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe that our cash, cash equivalents and investments and anticipated revenues will be adequate to satisfy our capital needs for at least the next 12 months from the date the financial statements are filed. However, our independent auditors may not agree with this assessment, and our actual capital requirements will depend on many factors, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">success in entering into collaboration agreements and achieving milestones under such agreements&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the continuation of our collaborative agreements that provide financial funding for our activities&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">regulatory actions with respect to our and our collaborators&#8217; product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">continued progress and cost of our research and development programs&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">progress with preclinical studies and clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the time and costs involved in obtaining regulatory clearance&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing patent claims&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">costs of developing sales, marketing and distribution channels and our ability and that of our collaborators to sell our products, products we have a financial interest in and eventually, product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">costs involved in establishing manufacturing capabilities for pre-clinical, non-clinical, clinical and commercial quantities of our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">competing technological and market developments&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">market acceptance of our products, products we have a financial interest in and, eventually, product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">any failure to comply with the covenants in our debt instruments that results in acceleration of repayment obligations&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">impacts of the COVID-19 crisis&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">costs for recruiting and retaining employees and consultants&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">unexpected legal, accounting and other costs and liabilities related to our business.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may consume available resources more rapidly than currently anticipated, resulting in the need for additional funding. We may seek to raise additional funds through equity or debt financings, convertible debt financings, collaborative arrangements with corporate collaborators or other sources, which may be dilutive to existing stockholders and may cause the price of our common stock to decline. In addition, in the event that additional funds are obtained through arrangements with collaborators or other sources, we may have to relinquish rights to some of our technologies or pharmaceutical product candidates that we would otherwise seek to develop or commercialize ourselves. If adequate funds are not available, we may be required to significantly reduce or refocus our product development efforts, resulting in delays in generating future product revenue.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">We do not control the commercialization of PERSERIS or Methydur</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We rely on Indivior for the commercialization of PERSERIS.&#160;&#160;Indivior has stated that it launched PERSERIS in February 2019 in the United States. There can be no assurance that Indivior will obtain market acceptance and meaningful sales.&#160;&#160;If Indivior does not successfully commercialize PERSERIS, the earn-out payments we receive under our agreement with them may be limited. We rely on Orient Pharma for the commercialization of Methydur in the territories licensed to Orient Pharma. If Orient Pharma does not successfully commercialize Methydur throughout their territory, the royalty payments we receive under our agreement with them may be limited. The sales of both of these products may be negatively impacted by the COVID-19 pandemic.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Development of our pharmaceutical product candidates is not complete, and we cannot be certain that our product candidates will be able to be commercialized</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To be profitable, we or our third-party collaborators must successfully research, develop, obtain regulatory approval for, manufacture, introduce, market and distribute our pharmaceutical product candidates under development. For each product candidate that we or our third-party collaborators intend to commercialize, we must successfully meet a number of critical developmental milestones for each disease or medical condition targeted, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">with respect to each product candidate based on a new chemical entity, determining appropriate indication(s)&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">with respect to our Proprietary Pharmaceutical Programs based on our drug delivery technologies, selecting and developing a drug delivery technology to deliver the proper dose of drug over the desired period of time&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">determining the appropriate route of administration and drug dosage for each product candidate in each indication&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">developing product candidates that will be tolerated, safe and effective&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">demonstrating each product candidate will be chemically and physically stable for commercially reasonable time periods&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">demonstrating through clinical trials that each product candidate is safe and effective in patients for the intended indication at an achievable dose and that the product candidate&#8217;s benefits outweigh its risks&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">completing the manufacturing development and scale-up to permit manufacture of the product candidate in commercial quantities and at acceptable cost.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The time frame necessary to achieve these developmental milestones for any individual product candidate is long and uncertain, and we may not successfully complete these milestones for any of our product candidates in development.&#160;&#160;Except for marketing authorization for POSIMIR in the U.S. for post-surgical pain reduction for up to 72 hours following arthroscopic subacromial decompression (ASD), PERSERIS by Indivior in the U.S. and for Orient Pharma&#8217;s approval of Methydur in Taiwan, development is incomplete for all product candidates in our development programs, including DUR-928. We may not be able to finalize the design or formulation of any of our product candidates. In addition, we may select components, solvents, excipients or other ingredients to include in our product candidates that have not been previously approved for use in pharmaceutical products, which may require us or our collaborators to perform additional studies and may delay clinical testing and regulatory approval of our product candidates. Even after we complete the design of a product candidate, the product candidate must still complete required clinical trials and additional safety testing in animals before approval for commercialization. We are continuing testing and development of our product candidates and may explore possible design or formulation changes to address issues of safety, manufacturing efficiency, stability and performance. We or our collaborators may not be able to complete development of any product candidates that will be safe and effective and that will have a commercially reasonable treatment and storage period. If we or our third-party collaborators are unable to complete development of DUR-928 or other product candidates, we will not be able to earn revenue from them, which would materially harm our business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">For certain of our product candidates, we depend to a large extent on third-party collaborators, and we have limited or no control over the development, sales, distribution and disclosure for those product candidates which are the subject of third-party collaborative or license agreements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our performance for certain of our product candidates depends to a large extent on the ability of our third-party collaborators to successfully develop and obtain approvals for certain of our pharmaceutical product candidates. We have entered into agreements with Indivior, Santen and Orient Pharma under which we granted such third parties the right to develop, apply for regulatory approval for, market, promote or distribute certain product candidates, subject to payments to us in the form of product royalties, earn-out and other payments. We have limited or no control over the expertise or resources that any collaborator may devote to the development, clinical trial strategy, regulatory approval, marketing or sale of these product candidates, or the timing of their activities. Any of our present or future collaborators may not perform their obligations as expected. These collaborators may breach or terminate their agreement with us or otherwise fail to conduct their collaborative activities successfully and in a timely manner. Enforcing any of these agreements in the event of a breach by the other party could require the expenditure of significant resources and consume a significant amount of management time and attention. Our collaborators may also conduct their activities in a manner that is different from the manner we would recommend or would have chosen, had we been developing such product candidates ourselves. Further, our collaborators may elect not to develop or commercialize product candidates arising out of our collaborative arrangements or not devote sufficient resources to the development, clinical trials, regulatory approval, manufacture, marketing or sale of these product candidates. If any of these events occur, we may not recognize revenue from the commercialization of our product candidates based on such collaborations. In addition, these third parties may have similar or competitive products to the ones which are the subject of their collaborations with us, or relationships with our competitors, which may reduce their interest in developing or selling our product candidates. We may not be able to control public disclosures made by some of our third-party collaborators, which could negatively impact our stock price.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Cancellation of collaborations regarding our product candidates may adversely affect potential economic benefits </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Third-party collaboration agreements typically allow the third party to terminate the agreement (or a specific program within an agreement) at will by providing notice. Termination can result from failure of the collaboration to achieve anticipated milestones, for changes in strategy of the other party or for other reasons. In these cases, the product rights revert to us or certain rights of the partner to use our proprietary technology are terminated. If there have been payments under such agreements that are being recognized over time, termination of such agreements (or programs) can lead to a near-term increase in our reported revenues resulting from the immediate recognition of the balance of such payments. Termination deprives us of potential future economic benefits under such agreements, and may make it more difficult or impossible to enter into agreements with other third parties for use of the assets and/or technologies that were subject to the terminated agreement. For example, termination of our agreements with Santen or Orient Pharma could have negative effects on the Company.&#160;&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">A significant component of our revenues resulted from collaboration agreements with other companies that have terminated </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our revenues have been based to a significant extent on collaborative arrangements with third parties, pursuant to which we receive payments based on our performance of research and development activities set forth in these agreements. For example, approximately 58% of our total revenues were derived from our collaboration agreement with Gilead in 2019.&#160;&#160;In June 2020, Gilead notified us that they were terminating this collaboration.&#160;&#160;In addition, we have seen periodic fluctuations in revenues associated with our other collaboration agreements, which reflect the current development stage of the product candidates subject to those agreements, and our collaborator&#8217;s needs for our services. Long-term growth of our collaboration revenues requires us to enter into new collaboration agreements, and there can be no assurance that we will do so. Even if we enter into new collaboration agreements, we may not be able to fulfill our obligations or attain milestones set forth in any specific agreement, which could cause our revenues and/or cash flows to fluctuate or be less than anticipated and may expose us to liability for contractual breach. In addition, these agreements may require us to devote significant time and resources to communicating with and managing our relationships with such collaborators and resolving possible issues of contractual interpretation which may detract from time our management would otherwise devote to managing our operations. Such agreements are generally complex and contain provisions that could give rise to legal disputes, including potential disputes concerning ownership of intellectual property under collaborations. Such disputes can delay or prevent the development of potential new product candidates, or can lead to lengthy, expensive litigation or arbitration. In general, our collaboration agreements, including our agreements with Orient Pharma with respect to Methydur and Santen with respect to an investigational ophthalmic product may be terminated by the other party at will or upon specified conditions including, for example, if we fail to satisfy specified performance milestones or if we breach the terms of the agreement. Acquisitions of our collaborators or strategic changes or re-organizations or re-prioritizations of our collaborators can lead to turnover of program staff, a review of development programs and strategies by the acquirer, and other events that can disrupt a program, resulting in program delays or discontinuations.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we do not enter into new collaboration agreements, our anticipated revenues and/or cash flows will be reduced relative to periods of increased R&#38;D revenues, such as occurred in 2020.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Our cash flows are likely to differ from our reported revenues </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our revenues will likely differ from our cash flows from revenue-generating activities. Upfront payments received upon execution of collaborative agreements are recorded as deferred revenue and generally recognized over the period of our performance obligations with the third-party collaborator pursuant to the applicable agreement. The period of performance obligations may also be revised on a prospective basis. As of December 31, 2020, we had $812,000 of deferred revenue which will be recognized in future periods and may cause our reported revenues to be greater than cash flows from our ongoing revenue-generating activities. Assumptions related to revenue recognition of deferred revenue are reviewed in each accounting period and changes are recorded in the current period. In certain circumstances, changes in assumptions related to the timing and amount of work required to complete a performance obligation tied to deferred revenue can result in negative revenue for an accounting period or the accelerated recognition of non-cash revenue.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Our revenues may decrease and our losses may increase compared to prior years as a result of the sale of the LACTEL&#174;&#160;polymer product line</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2020 we completed the sale of our LACTEL polymer product line to Evonik for approximately $15&#160;million <span style="color:#000000;">subject to certain adjustments</span>. Sales of LACTEL polymers contributed to our product revenues and earnings, and the loss of these revenues and earnings will decrease our future period product related revenues and operating results.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Our business strategy includes the entry into additional collaborative agreements. We may not be able to enter into additional collaborative agreements or may not be able to negotiate commercially acceptable terms for these agreements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our current business strategy includes the entry into additional collaborative agreements for the development and commercialization of our product candidates, including, but not limited to POSIMIR, DUR-928 and others. The negotiation and consummation of these types of agreements typically involve simultaneous discussions with multiple potential collaborators and require significant time and resources from our officers, business development, legal, and research and development staff. In addition, in attracting the attention of pharmaceutical and biotechnology company collaborators, we compete with numerous other third parties with product opportunities as well as the collaborators&#8217; own internal product opportunities. We may not be able to consummate additional collaborative agreements, or we may not be able to negotiate commercially acceptable terms for these agreements. If we do not consummate additional collaborative agreements, we may have to consume money more rapidly on our product development efforts, defer development activities or forgo the exploitation of certain opportunities, abandon development of certain product candidates or indications for certain product candidates, any of which could have a material adverse effect on our business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">We and our third-party collaborators may not be able to manufacture sufficient quantities of our pharmaceutical product candidates and components to support the non-clinical, clinical and commercial requirements of our collaborators and ourselves at an acceptable cost or in compliance with applicable government regulations, and we have limited manufacturing experience</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We or our third-party collaborators to whom we have assigned such responsibility must manufacture our product candidates, and components (including active ingredients and excipients) in non-clinical (e.g., toxicology), clinical and commercial quantities, either directly or through third parties, in compliance with regulatory requirements and at an acceptable cost. The manufacturing processes associated with our product candidates are complex. We and our third-party collaborators, where relevant, have not yet completed development of the manufacturing process for any of our product candidates or components that are in pre-clinical or clinical development, including DUR-928.&#160;&#160;If we and our third-party collaborators, where relevant, fail to timely complete the development of the manufacturing process for our product candidates, we and our third-party collaborators, where relevant, will not be able to timely produce supplies for non-clinical, clinical trials and commercialization of our product candidates. We have also committed to manufacture and supply product candidates or components under a number of our collaborative agreements with third-party companies. We have limited experience manufacturing pharmaceutical products, and we may not be able to timely accomplish these tasks. If we and our third-</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">party collaborators, where relevant, fail to develop manufacturing processes to permit us to manufacture a product candidate or component at an acceptable quality and cost, then we and our third-party collaborators may not be able to develop or commercialize that product candidate or we may be in breach of our supply obligations to our third-party collaborators.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our manufacturing facility in Cupertino is a multi-disciplinary site that we have used to manufacture only research and clinical trial supplies of several of our product candidates, including DUR-928 and POSIMIR. If we experience delays or technical difficulties in developing acceptable manufacturing processes or scaling up the manufacturing of our product candidates, it could result in delays or added cost in our development programs. We have not manufactured commercial quantities of any of our product candidates at our Cupertino facility. In the future, we may develop additional manufacturing capabilities for our product candidates and components to meet our demands and those of our third-party collaborators by contracting with third-party manufacturers and/or by potentially constructing additional manufacturing space at our facilities in California or elsewhere. We have limited experience building and validating manufacturing facilities, and we may not be able to accomplish these tasks in a timely or cost-effective manner.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we and our third-party collaborators, where relevant, are unable to manufacture our product candidates or components in a timely manner or at an acceptable cost, quality or performance level, and are unable to attain and maintain compliance with applicable regulations, the non-clinical and clinical trials and the commercial sale of our product candidates and those of our third-party collaborators could be delayed or never occur. Additionally, we may need to alter our facility design or manufacturing processes, install additional equipment or do additional construction or testing in order to meet regulatory requirements, optimize the production process, increase efficiencies or production capacity or for other reasons, which may result in additional cost to us or delay production of product needed for the non-clinical trials, clinical trials, chemistry, manufacturing and controls (CMC) and commercial launch of our product candidates and those of our third-party collaborators.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If we or our third-party collaborators cannot manufacture our pharmaceutical product candidates or components in time to meet the clinical or commercial requirements of our collaborators or ourselves or at an acceptable cost, our operating results will be harmed.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Failure to comply with ongoing governmental regulations for our pharmaceutical product candidates could materially harm our business in the future</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Developing, manufacturing, marketing or promoting a drug is subject to very strict regulations and controls. Furthermore, clearance or approval may entail ongoing requirements for post-marketing studies. The manufacture and marketing of drugs are subject to continuing FDA and foreign regulatory review and requirements that we update our regulatory filings. Later discovery of previously unknown problems with a product, manufacturer or facility, or our failure to update regulatory files, may result in restrictions, including withdrawal of the product from the market. Any of the following or other similar events, if they were to occur, could delay or preclude us from further developing, marketing or realizing full commercial use of our product candidates, which in turn would materially harm our business, financial condition and results of operations:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">failure to obtain or maintain requisite governmental approvals&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">failure to meet GMP, GLP and/or other governmental requirements for drug development&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">failure to obtain approvals for clinically intended uses of our pharmaceutical product candidates under development&#59; or</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">FDA required product withdrawals or warnings arising from identification of serious adverse side effects in our product candidates.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturers of drugs must comply with the applicable FDA good manufacturing practice (GMP) regulations, which include production design controls, testing, quality control and quality assurance requirements as well as the corresponding maintenance of records and documentation. Compliance with current GMP regulations is difficult and costly. Manufacturing facilities are subject to ongoing periodic inspection by the FDA and corresponding state and in some cases, foreign agencies, including unannounced inspections, and must be licensed before they can be used for the commercial manufacture </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of our product candidates. We and/or our present or future suppliers and distributors may be unable to comply with the applicable GMP regulations and other FDA and/or foreign regulatory requirements. If we, our third-party collaborators or our respective suppliers do not achieve compliance for our product candidates we or they manufacture, the FDA or foreign equivalents may refuse or withdraw marketing clearance, put our or our partner&#8217;s clinical trial on hold, withdraw or reject an investigational new drug (IND) application or require product recall, which may cause interruptions or delays in the development, manufacture and sale of our product candidates.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">We have a history of operating losses, expect to continue to have losses in the future and may never achieve or maintain profitability</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have incurred significant operating losses since our inception in 1998 and, as of December 31, 2020, had an accumulated deficit of approximately $489.8 million. We expect to continue to incur significant operating losses over the next several years as we continue to incur significant costs for research and development, clinical trials, manufacturing, sales, and general and administrative functions. Our ability to achieve profitability depends upon our ability, alone or with others, to successfully complete the development of our proposed product candidates, obtain the required regulatory clearances, and manufacture and market our proposed product candidates. Development of pharmaceutical product candidates is costly and requires significant investment. In addition, we may choose to license from third parties either additional drug delivery platform technology or rights to particular drugs or other appropriate technology and/or intellectual property rights for use in our product candidates. The license fees for these technologies or rights would increase the costs of our product candidates.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To date, we have not generated significant revenue from the commercial sale of our pharmaceutical product candidates and do not expect to do so in the near future. Our current revenues are from the ALZET product line, from certain excipient sales, from earn-out payments from Indivior related to sales of PERSERIS, from royalty payments from Orient Pharma related to sales of Methydur in Taiwan, and from payments under collaborative research and development agreements with third parties. We do not expect our product revenues to increase significantly in the near future, and we do not expect that collaborative research and development revenues will exceed our actual operating expenses in the near future. We do not anticipate meaningful revenues to derive from the commercialization and marketing of our product candidates in development in the near future, and therefore do not expect to generate sufficient revenues to cover expenses or achieve profitability in the near future.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">We may develop our own sales force and commercial group to market future products but we have limited sales and marketing experience with respect to pharmaceuticals and may not be able to do so effectively</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have a small sales and marketing group focused on our ALZET product line. We may choose to develop our own sales force and commercial group to market products that we have developed or may develop in the future, including POSIMIR and/or DUR-928, if approved. Developing a sales force and commercial group would require substantial expenditures and the hiring of qualified personnel. We have limited sales and marketing experience, and may not be able to effectively recruit, train or retain sales and marketing personnel. If we are not able to put in place an appropriate sales force and commercial group for our products in development, we may not be able to effectively launch these products. We may not be able to effectively sell our product candidates, if approved, and our failure to do so could limit or materially harm our business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">We and our third-party collaborators may not sell our product candidates effectively</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We and our third-party collaborators compete with many other companies that currently have extensive and well-funded marketing and sales operations. Our marketing and sales efforts and those of our third-party collaborators may be unable to compete successfully against these other companies. We and our third-party collaborators, if relevant, may be unable to establish a sufficient sales and marketing organization on a timely basis, if at all. We and our third-party collaborators, if relevant, may be unable to engage qualified distributors. Even if engaged, these collaborators and distributors may:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">fail to satisfy financial or contractual obligations to us&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">fail to adequately market our product candidates&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">cease operations with little or no notice to us&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">offer, design, manufacture or promote competing product lines&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">fail to maintain adequate inventory and thereby restrict use of our product candidates&#59; or</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">build up inventory in excess of demand thereby limiting future purchases of our product candidates resulting in significant quarter-to-quarter variability in our sales.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The failure of us or our third-party collaborators to effectively develop, gain regulatory approval for, sell, manufacture and market our product candidates will hurt our business, prospects, financial results and may impact our access to capital.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">We rely heavily on third parties to support development, clinical testing and manufacturing of our product candidates</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We rely on third-party contract research organizations, consultants, service providers and suppliers to provide critical services to support development, clinical testing, and manufacturing of our product candidates. For example, we currently depend on third-party vendors to manage and monitor most of our clinical trials. We rely on third-parties to manufacture or perform manufacturing steps relating to our product candidates or components. We anticipate that we will continue to rely on these and other third-party contractors to support development, clinical testing, and manufacturing of our product candidates. These third parties may not execute their responsibilities and tasks competently in compliance with applicable laws and regulations or in a timely or cost-effective fashion. Failure of these contractors to provide the required services in a competent or timely manner or on reasonable commercial terms could materially delay the development and approval of our product candidates, increase our expenses and materially harm our business, financial condition, results of operations and access to capital.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Key components of our product candidates are provided by limited numbers of suppliers, and supply shortages or loss of these suppliers could result in interruptions in supply or increased costs</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain components and drug substances used in our and our collaborators&#8217; products and product candidates, including DUR-928, POSIMIR, Methydur, and PERSERIS, are currently purchased from a single or a limited number of outside sources. In particular, Eastman Chemical is the sole supplier of our requirements of sucrose acetate isobutyrate, a necessary component of POSIMIR and certain other pharmaceutical product candidates we have under development. A third-party manufacturer is our sole supplier for future commercial supplies of POSIMIR. Another third- party manufacturer is our sole supplier for future non-clinical, clinical and commercial supplies of DUR-928. The reliance on a sole or limited number of suppliers could result in:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">delays associated with redesigning a pharmaceutical product candidate due to a failure to obtain a single source component&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">delays associated with finding and contracting with a new supplier (if we can find one capable of replacing the old supplier and negotiate commercially reasonable terms) and then transferring the technology required to perform the services to the new supplier&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">an inability to obtain an adequate supply of required product candidate, active pharmaceutical ingredient or excipients or other components&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">reduced control over pricing, quality and delivery time.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While we have entered into contract manufacturing agreements with multiple vendors for DUR-928, we currently have a third-party sole supplier for GMP supplies of DUR-928. This third party is our sole source for the drug product required for development and commercialization of this drug candidate. There can be no assurance that we will receive sufficient quantities of DUR-928 to commence and conduct the non-clinical trials, clinical trials and CMC activities we are planning, and delays in supply could delay development of DUR-928. In addition, certain of our third-party manufacturers and suppliers may be experiencing delays as a result of the&#160;COVID-19 coronavirus&#160;pandemic or have otherwise encountered delays in providing their services. As a result, we may not be able to manufacture our product candidates for our clinical trials and conduct other research and development operations and maintain current clinical and pre-clinical timelines. In addition, if additional third parties in our supply chain are adversely impacted by restrictions resulting from the&#160;coronavirus&#160;pandemic, including staffing shortages, raw material shortages, production slowdowns and disruptions in delivery systems, our supply chain may be disrupted in other ways, further limiting our ability to manufacture our product candidates for our clinical trials and conduct our research and development operations.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have entered into a commercial manufacturing and packaging agreement with a third-party manufacturer for future supply of POSIMIR. This third party is our sole source for the drug product required for commercialization of this drug candidate. There may be technical risks associated with establishing an alternative commercial manufacturer that could entail delays in supply, quality issues or delays in the possible regulatory approval of POSIMIR. Furthermore, we and our contract manufacturer may also need or choose to subcontract with additional third-party contractors to perform manufacturing steps of POSIMIR or supply required components for POSIMIR. Where third party contractors perform manufacturing services for us, we will be subject to the schedule, expertise and performance of third parties as well as incur significant additional costs. Failure of third parties to perform their obligations could adversely affect our operations, development timeline and financial results. If we proceed with the commercialization of POSIMIR, we expect to put in place in the future second source supply arrangements, which may be costly and time consuming. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have supply agreements in place for certain components of our pharmaceutical product candidates, but do not have in place long term supply agreements with respect to all of the components of any of our products or product candidates. Therefore, the supply of a particular component could be terminated at any time without penalty to the supplier. In addition, we may not be able to procure required components or drugs from third-party suppliers at a quantity, quality, cost and timing acceptable to us. In addition, certain of our suppliers may be experiencing delays as a result of the&#160;COVID-19 coronavirus&#160;pandemic or have otherwise encountered delays in providing their services. Any interruption in the supply of single source components (including active pharmaceutical ingredients, excipients, or components like vials, stoppers, filters and the like) or product candidates, could cause us to seek alternative sources of supply or manufacture these items internally if feasible. Furthermore, in some cases, we are relying on our third-party collaborators to procure supply of necessary components. If the supply of any components for our product candidates is interrupted, components from alternative suppliers may not be available in sufficient volumes or at acceptable quality levels within required timeframes, if at all, to meet our needs or those of our third-party collaborators. This could delay our ability to complete development and obtain approval for commercialization and marketing of our product candidates, causing us to lose sales, incur additional costs, delay new product introductions and could harm our reputation and make access to capital more difficult, expensive or impossible. The spread of COVID-19 has and is likely to continue to affect the manufacturing and shipment of goods globally. Many countries have imposed or are imposing certain restrictions on the movement of people and goods and may continue to lift and reimpose such restrictions as needed. Any delay in production or delivery of the components and drug substances used in our product candidates due to an extended closure of our suppliers&#8217; plants as a result of efforts to limit the spread of COVID-19 could adversely impact our business and hinder our growth.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Write-offs related to the impairment of our goodwill, long-lived assets, inventories and other non-cash charges, as well as stock-based compensation expenses may adversely impact or delay our profitability</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may incur significant non-cash charges related to impairment write-downs of our long-lived assets, including goodwill. We are required to perform periodic impairment reviews of our goodwill at least annually. The carrying value of goodwill on our balance sheet was $6.2 million at December 31, 2020. To the extent these reviews conclude that the expected future cash flows generated from our business activities are not sufficient to recover the cost of our long-lived assets, we will be required to measure and record an impairment charge to write-down these assets to their realizable values. We completed our last review during the fourth quarter of 2020 and determined that goodwill was not impaired as of December 31, 2020. However, there can be no assurance that upon completion of subsequent reviews a material impairment charge will not be recorded. If future periodic reviews determine that our assets are impaired and a write-down is required, it will adversely impact or delay our profitability.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories, in part, include certain excipients that are sold to customers and included in product candidates in development. These inventories are capitalized based on management&#8217;s judgment of probable sale prior to their expiration date which in turn is primarily based on management&#8217;s internal estimates. The valuation of inventory requires us to estimate the value of inventory that may become expired prior to use. We may be required to expense previously capitalized inventory costs upon a change in our judgment, due to, among other potential factors, a denial or delay of approval of a product by the necessary regulatory bodies, changes in product development timelines, or other information that suggests that the inventory will not be saleable.&#160;&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Global credit and financial market conditions could negatively impact the value of our current portfolio of cash equivalents, short-term investments or long-term investments and our ability to meet our financing objectives</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our cash and cash equivalents are maintained in highly liquid investments with remaining maturities of 90 days or less at the time of purchase. Our short-term investments consist primarily of readily marketable debt securities with original maturities of greater than 90 days from the date of purchase but remaining maturities of less than one year from the balance sheet date. Our long-term investments consist primarily of readily marketable debt securities with maturities in one year or beyond from the balance sheet date. While, as of the date of this filing, we are not aware of any downgrades, material losses, or other significant deterioration in the fair value of our cash equivalents, short-term investments or long-term investments since December 31, 2020, no assurance can be given that deterioration in conditions of the global credit and financial markets would not negatively impact our current portfolio of cash equivalents, short-term investments or long-term investments or our ability to meet our financing objectives.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">We depend upon key personnel who may terminate their employment with us at any time, and we may need to hire additional qualified personnel</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our success will depend to a significant degree upon the continued services of key management, technical and scientific personnel. In addition, our success will depend on our ability to attract and retain other highly skilled personnel, particularly as we develop and expand our Epigenetic Regulator Program. Competition for qualified personnel is intense, and the process of hiring and integrating such qualified personnel is often lengthy. We may be unable to recruit such personnel on a timely basis, if at all. Our management and other employees may voluntarily terminate their employment with us at any time. The loss of the services of key personnel, or the inability to attract and retain additional qualified personnel, could result in delays to product development or approval, loss of sales and diversion of management resources as well as difficulties or inability to raise sufficient capital to fund the Company&#8217;s operations.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Our business involves environmental risks and risks related to handling regulated substances</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with our research and development activities and our manufacture of materials and product candidates, we are subject to federal, state and local laws, rules, regulations and policies governing the use, generation, manufacture, storage, air emission, effluent discharge, handling and disposal of certain materials, biological specimens and wastes. Although we believe that we have complied with the applicable laws, regulations and policies in all material respects and have not been required to correct any material noncompliance, we may be required to incur significant costs to comply with environmental and health and safety regulations in the future. Our research and development involves the use, generation and disposal of hazardous materials, including but not limited to certain hazardous chemicals, solvents, agents and biohazardous materials. The extent of our use, generation and disposal of such substances has increased substantially when we started manufacturing and selling biodegradable polymers. Although we believe that our safety procedures for storing, handling and disposing of such materials comply with the standards prescribed by state and federal regulations, we cannot completely eliminate the risk of accidental contamination or injury from these materials. We currently contract with third parties to dispose of these substances generated by us, and we rely on these third parties to properly dispose of these substances in compliance with applicable laws and regulations. If these third parties do not properly dispose of these substances in compliance with applicable laws and regulations, we may be subject to legal action by governmental agencies or private parties for improper disposal of these substances. The costs of defending such actions and the potential liability resulting from such actions are often very large. In the event we are subject to such legal action or we otherwise fail to comply with applicable laws and regulations governing the use, generation and disposal of hazardous materials and chemicals, we could be held liable for any damages that result, and any such liability could exceed our resources.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Cyber-attacks or other failures in telecommunications or information technology systems could result in information theft, data corruption and significant disruption of our business operations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We utilize information technology, systems and networks to process, transmit and store electronic information in connection with our business activities. As use of digital technologies has increased, cyber incidents, including deliberate attacks and attempts to gain unauthorized access to computer systems and networks, have increased in frequency and sophistication. These threats pose a risk to the security of our systems and networks and the confidentiality, availability and integrity of our data, and may cause a disruption in our operations, harm our reputation, cause us to pay to retrieve our data if it becomes infected or otherwise subject to ransomware and increase our stock trading risk. There can be no assurance that we will be successful in preventing cyber-attacks or successfully mitigating their effects. Similarly, there can be no assurance that our third-party collaborators, distributors and other contractors and consultants will be successful in protecting our clinical and other data that is stored on their systems. Any cyber-attack or destruction or loss of data could have a material adverse effect on our business and prospects. In addition, we may suffer reputational harm or face litigation or adverse regulatory action as a result of cyber-attacks or other data security breaches and may incur significant additional expense to implement further data protection measures.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Our corporate headquarters, certain manufacturing facilities and personnel are located in a geographical area that is seismically active and near wildfire zones</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our corporate headquarters, certain manufacturing facilities and personnel are located in a geographical area that is known to be seismically active and prone to earthquakes, as well as wildfires and related power outages or power shortages. Should such a natural disaster occur or power outage or power shortage, our ability to conduct our business could be severely restricted, and our business and assets, including the results of our research, development and manufacturing efforts, could be harmed or destroyed.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">As a non-accelerated filer, we are not required to comply with the auditor attestation requirements of the Sarbanes-Oxley Act and, consequently, some investors may find our common stock less attractive </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a non-accelerated filer as defined by Rule 12b-2 of the Exchange Act, and as such, are not required to provide an auditor attestation of management&#8217;s assessment of internal control over financial reporting, which is generally required for SEC reporting companies under Section 404(b) of the Sarbanes-Oxley Act. Therefore, our internal controls over financial reporting will not receive the level of review provided by the process relating to the auditor attestation included in annual reports of issuers that are subject to the auditor attestation requirements. Because we are not required to have our auditors provide an attestation of our management&#8217;s assessment of internal control over financial reporting, a material weakness in internal control may remain undetected for a longer period. In addition, we cannot predict if investors will find our common stock less attractive because we are not required to comply with the auditor attestation requirements. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and the trading price for our common stock may be negatively affected.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Related to Our Intellectual Property</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">If we are unable to adequately protect, maintain or enforce our intellectual property rights or secure rights to third-party patents, we may lose valuable assets, experience reduced market share or incur costly litigation to protect our rights or our third-party collaborators may choose to terminate their agreements with us</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our ability to commercially exploit our products will depend significantly on our ability to obtain and maintain patents, maintain trade secret protection and operate without infringing the proprietary rights of others.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March 1, 2021, we owned or exclusively in-licensed over 35 unexpired issued U.S. patents and over 145 unexpired issued foreign patents (which include granted European patent rights that have been validated in various EU member states). In addition, we have over 55 pending U.S. patent applications and over 145 foreign applications pending in Europe, Australia, Japan, Canada and other countries.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There can be no assurance that the pending patent applications will be granted.&#160;Further, there can be no assurance that VCU will not attempt to terminate their license to us, which termination could result in the loss of our rights to these patent families</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The patent positions of pharmaceutical companies, including ours, are uncertain and involve complex legal and factual questions. In addition, the coverage claimed in a patent application can be significantly reduced before the patent is issued. Consequently, our patent applications or those that are licensed to us may not issue into patents, and any issued patents may not provide protection against competitive technologies or may be held invalid if challenged. Our competitors may also independently develop products similar to ours or design around or otherwise circumvent patents issued to us or licensed by us. In addition, the laws of some foreign countries may not protect our proprietary rights to the same extent as U.S. law.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also rely upon trade secrets, technical know-how and continuing technological innovation to develop and maintain our competitive position. We require our employees, consultants, advisors and collaborators to execute appropriate confidentiality and assignment-of-inventions agreements with us. These agreements typically provide that all materials and confidential information developed or made known to the individual during the course of the individual&#8217;s relationship with us is to be kept confidential and not disclosed to third parties except in specific circumstances, and that all inventions arising out of the individual&#8217;s relationship with us will be our exclusive property. These agreements may be breached, and in some instances, we may not have an appropriate remedy available for breach of the agreements. Furthermore, our competitors may independently develop substantially equivalent proprietary information and techniques, reverse engineer our information and techniques, or otherwise gain access to our proprietary technology.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may be unable to meaningfully protect our rights in trade secrets, technical know-how and other non-patented technology. We may have to resort to litigation or arbitration to protect our intellectual property rights, or to determine their scope, validity or enforceability. In addition, interference, derivation, post-grant oppositions, and similar proceedings may be necessary to determine rights to inventions in our patents and patent applications. Enforcing or defending our proprietary rights is expensive, could cause diversion of our resources and may be unsuccessful. Any failure to enforce or protect our rights could cause us to lose the ability to exclude others from using our technology to develop or sell competing products.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Our collaboration agreements may depend on our intellectual property</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are party to collaborative agreements with Orient Pharma and Santen among others. Our third-party collaborators have entered into these agreements based on the exclusivity that our intellectual property rights confer on the products being developed. The loss or diminution of our intellectual property rights could result in a decision by our third-party collaborators to terminate their agreements with us. In addition, these agreements are generally complex and contain provisions that could give rise to legal disputes, including potential disputes concerning ownership of intellectual property and data under collaborations. Such disputes can lead to lengthy, expensive litigation or arbitration requiring us to devote management time and resources to such dispute which we would otherwise spend on our business. </p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">We may be sued by third parties claiming that our product candidates infringe on their intellectual property rights, particularly because there is substantial uncertainty about the validity and breadth of medical patents</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We or our collaborators may be exposed to future litigation by third parties based on claims that our product candidates or activities infringe the intellectual property rights of others or that we or our collaborators have misappropriated the trade secrets of others. This risk is exacerbated by the fact that the validity and breadth of claims covered in medical technology, pharmaceutical and biotechnology patents and the breadth and scope of trade secret protection involve complex legal and factual questions for which important legal principles are unresolved. Any litigation or claims against us or our collaborators, whether or not valid, could result in substantial costs, could place a significant strain on our financial resources and could harm our reputation. We also may not have sufficient funds to litigate against parties with substantially greater resources. In addition, pursuant to our collaborative agreements, we have provided our collaborators with the right, under specified circumstances, to defend against any claims of infringement of the third-party intellectual property rights, and such collaborators may not defend against such claims adequately or in the manner that we would do ourselves. Intellectual property litigation or claims could force us or our collaborators to do one or more of the following, any of which could harm our business or financial results:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">cease selling, incorporating or using any of our product candidates that incorporate the challenged intellectual property, which would adversely affect our revenue&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">obtain a license from the holder of the infringed intellectual property right, which license may be costly or may not be available on reasonable terms, if at all&#59; or</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">redesign our product candidates, which would be costly and time-consuming.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Related To Our Industry</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">The markets for our pharmaceutical product candidates and for our ALZET product line are rapidly changing and competitive, and new products or technologies developed by others could impair our ability to maintain or grow our business and remain competitive</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The pharmaceutical industry is subject to rapid and substantial technological change. Developments by others may render our product candidates under development or technologies noncompetitive or obsolete, or we may be unable to keep pace with technological developments or other market factors. Technological competition in the industry from pharmaceutical and biotechnology companies, universities, governmental entities and others diversifying into the field is intense and is expected to increase.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We may face competition from other companies in numerous industries including pharmaceuticals, biotechnology, medical devices and drug delivery. Competition for DUR-928, if approved, will depend on the specific indications for which DUR-928 is approved. </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89Bio, AbbVie, Afimmune, Akero Therapeutics, Ascletis, AstraZeneca, BMS, Cirius Therapeutics, CytoDyn, Dr. Falk Pharma, Eli Lilly, Enanta, ENYO Pharma, Galectin, Galmed, Genentech, Genfit, Gilead, Hanmi, HighTide Biopharma, Intercept, Inventiva Pharma, Ionis Pharmaceuticals, Inc., Isotechnika, Kowa, LifeMax, Lipidio, Lipocine, Madrigal, MediciNova, MedImmune, Mitsubishi Tanabe, NGM Biopharmaceuticals, Nimbus, NorthSea Therapeutics, Novartis, Novo Nordisk, Pfizer, </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">PharmaKing</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Poxel</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Promethera</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Biosciences,</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Seal Rock Therapeutics,</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Terns Pharmaceutical, Thera Technologies, Viking, and others have development plans for products to treat NAFLD/NASH, AH or other liver diseases</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">POSIMIR, if commercially launched, will compete with currently marketed oral opioids, transdermal opioids, local anesthetic patches, implantable and external infusion pumps which can be used for infusion of opioids and local anesthetics. Products of these types are marketed by Pacira, Purdue Pharma, AbbVie, Janssen, Actavis, Medtronic, Endo, AstraZeneca, Pernix Therapeutics, Tricumed, Halyard Health, Cumberland Pharmaceuticals, Acorda Therapeutics, Mallinckrodt, Inspirion Delivery Technologies, Mylan, Shire, Johnson&#160;&#38; Johnson, Eli Lilly, Pfizer, Novartis, Zyla Life Sciences, Teva Pharmaceuticals, Collegium Pharmaceutical and others. Additional competition for POSIMIR may come from Heron Therapeutics if their product candidate, HTX-011, is approved or from Innocoll if their recently approved product candidate, XARACOLL<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> is commercially launched. PERSERIS competes with currently marketed or approved products by Johnson &#38; Johnson, Eli Lilly, Otsuka, Alkermes, Merck, Allergan, Novartis, and others.&#160;&#160;Orient Pharma&#8217;s Methydur competes with multiple ADHD products in Taiwan. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerous companies are applying significant resources and expertise to the problems of drug delivery and several of these are focusing or may focus on delivery of drugs to the intended site of action, including Pacira, Heron Therapeutics, Alkermes, Immune Pharmaceuticals, Innocoll, Nektar, Acorda Therapeutics, Flamel, Alexza, Mallinckrodt, Pfizer, Cumberland Pharmaceuticals, Zyla Life Sciences, Acura, Elite Pharmaceuticals, Phosphagenics, Intellipharmaceutics, Collegium Pharmaceutical, Charleston Laboratories, Daiichi Sankyo and others. Some of these competitors may be addressing the same therapeutic areas or indications as we are. Our current and potential competitors may succeed in obtaining patent protection or commercializing products before us. Many of these entities have significantly greater research and development capabilities than we do, as well as substantially more marketing, manufacturing, financial and managerial resources. These entities represent significant competition for us. Acquisitions of, or investments in, competing pharmaceutical or biotechnology companies by large corporations could increase such competitors&#8217; financial, marketing, manufacturing and other resources.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Competition for our ALZET product line primarily consists of customers choosing to utilize delivery methods for their research projects other than an osmotic pump. We may also face competition for our ALZET product line from other companies including low cost foreign competitors.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are engaged in the development of novel therapeutic technologies. Our resources are limited and we may experience technical challenges inherent in such novel technologies. Competitors have developed or are in the process of developing technologies that are, or in the future may be, the basis for competitive products. Some of these products may have an entirely different approach or means of accomplishing similar therapeutic effects than our product candidates. Our competitors may develop products that are safer, more effective or less costly than our product candidates and, therefore, present a serious competitive threat to our product offerings.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The widespread acceptance of therapies that are alternatives to ours may limit market acceptance of our product candidates even if commercialized. Post-operative pain is currently being treated by oral medication, transdermal drug delivery systems, such as drug patches, injectable products and implantable drug delivery devices which will be competitive with our product candidates. Many of these treatments are widely accepted in the medical community and have a long history of use. The established use of these competitive products may limit the potential for our product candidates to receive widespread acceptance if commercialized.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Our relationships with customers and third-party payers will be subject to applicable anti-kickback, fraud and abuse and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, contractual damages, reputational harm and diminished profits and future earnings</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Healthcare providers, physicians and third-party payers will play a primary role in the recommendation and prescription of POSIMIR and any additional product candidates for which we obtain marketing approval. Our future arrangements with third-party payers and customers may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations that may constrain the business or financial arrangements and relationships through which we may market, sell and distribute our products. As a pharmaceutical company, even though we do not and may not control referrals of healthcare services or bill directly to Medicare, Medicaid or other third-party payers, federal and state healthcare laws and regulations pertaining to fraud and abuse and patients&#8217; rights are and will be applicable to our business. These regulations include:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the Federal Healthcare Anti-Kickback Statute, which prohibits, among other things, persons from knowingly and willfully soliciting, offering, receiving or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made under a federal healthcare program such as Medicare and Medicaid, and which will constrain our marketing practices and the marketing practices of our licensees, educational programs, pricing policies, and relationships with healthcare providers or other entities&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the federal physician self-referral prohibition, commonly known as the Stark Law, which prohibits physicians from referring Medicare or Medicaid patients to providers of &#8220;designated health services&#8221; with whom the physician or a member of the physician&#8217;s immediate family has an ownership interest or compensation arrangement, unless a statutory or regulatory exception applies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">federal false claims laws that prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, claims for payment from Medicare, Medicaid, or other government reimbursement programs that are false or fraudulent, and which may expose entities that provide coding and billing advice to customers to potential criminal and civil penalties, including through civil whistleblower or qui tam actions, and including as a result of claims presented in violation of the Federal Healthcare Anti-Kickback Statute, the Stark Law or other healthcare-related laws, including laws enforced by the FDA&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which imposes criminal and civil liability for executing a scheme to defraud any healthcare benefit program and also created federal criminal laws that prohibit knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statements in connection with the delivery of or payment for healthcare benefits, items or services, and which as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, also imposes obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually identifiable health information&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">federal physician sunshine requirements under the Affordable Care Act, which requires manufacturers of drugs, devices, biologics and medical supplies to report annually to HHS </span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="font-family:Times New Roman;color:#000000;">information related to payments and other transfers of value to physicians, other healthcare providers, and teaching hospitals, and ownership and investment interests held by physicians and other healthcare providers and their immediate family members and applicable group purchasing organizations&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the Federal Food, Drug, and Cosmetic Act, which, among other things, strictly regulates drug product marketing, prohibits manufacturers from marketing drug products for off-label use and regulates the distribution of drug samples&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">state and foreign law equivalents of each of the above federal laws, such as anti-kickback and false claims laws, which may apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by non- governmental third-party payers, including private insurers, state laws requiring pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government and which may require drug manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures, and state and foreign laws governing the privacy and security of health information in specified circumstances, many of which differ from each other in significant ways and often are not preempted by federal laws such as HIPAA, thus complicating compliance efforts.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. It is possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, fines, imprisonment, exclusion from government funded healthcare programs, such as Medicare and Medicaid, and the curtailment or restructuring of our operations. If any physicians or other healthcare providers or entities with whom we expect to do business are found to not be in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Healthcare reform measures could hinder or prevent our product candidates&#8217; commercial success</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the United States and some non-U.S. jurisdictions, there have been, and we expect there will continue to be, a number of legislative and regulatory changes to the healthcare system that could prevent or delay marketing approval of our product candidates, restrict or regulate post-approval activities, affect our ability to profitably sell any product candidates for which we obtain marketing and otherwise affect our future revenue and profitability and the future revenue and profitability of our collaborators or potential collaborators. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For example, in March 2010, the Affordable Care Act was enacted in the United States to broaden access to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against fraud and abuse, add new transparency requirements for healthcare and health insurance industries, impose new taxes and fees on the health industry and impose additional health policy reforms. The law appears likely to continue the downward pressure on the pricing of medical items and services, especially under the Medicare program, and increased the industry&#8217;s regulatory burdens and operating costs. </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The previous U.S. presidential administration signed two Executive Orders designed to delay the implementation of certain provisions of the Affordable Care Act or otherwise circumvent some of the requirements for health insurance mandated by the Affordable Care Act. Concurrently, Congress has considered legislation that would repeal or repeal and replace all or part of the Affordable Care Act. While Congress has not passed comprehensive repeal legislation, two bills affecting the implementation of certain taxes under the Affordable Care Act have been signed into law. The Tax Cuts and Jobs Act of 2017 includes a provision repealing, effective January 1, 2019, the tax-based shared responsibility payment imposed by the Affordable Care Act on certain individuals who fail to maintain qualifying health coverage for all or part of a year that is commonly referred to as the &#8220;individual mandate.&#8221; As legislative and regulatory developments are ongoing, we cannot predict the ultimate content, timing or effect of healthcare reform legislation or the impact of potential legislation on our business.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, other legislative changes have been proposed and adopted since the Affordable Care Act was enacted. These changes include reductions to Medicare payments to providers of up to 2% per fiscal year that will remain in effect through 2027&#59; the American Taxpayer Relief Act of 2012, which, among other things, further reduced Medicare payments to several types of providers and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. More recently, there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which has resulted in several Congressional inquiries and proposed bills designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for pharmaceutical products.&#160;&#160;For example, the marketing, pricing and sale of the Company&#8217;s products are subject to regulation, investigations and legal actions including under the Medicaid Drug Rebate Program under the Affordable Care Act, which has increased the statutory minimum rebates a manufacturer must pay under the program as well as a new methodology by which rebates are owed for drugs that are inhaled, infused, instilled, implanted or injected.&#160;&#160;We are also subject to federal and state false claims acts, as well as federal and state antitrust and consumer protection laws. Increased scrutiny of health care industry business practices in recent years by government agencies and state attorneys general in the U.S., and any resulting investigations and prosecutions, carry risk of significant civil and criminal penalties including, but not limited to, debarment from participation in such government healthcare programs.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Individual states in the United States have also become increasingly aggressive in passing legislation and implementing regulations designed to control pharmaceutical product and medical device pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. For example, in October 2017, California passed a new law, effective in January 2019, which requires transparency from biopharmaceutical companies regarding price increases for prescription drugs. In addition, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and medical devices to purchase and which suppliers will be included in their prescription drug and other healthcare programs. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect that the Affordable Care Act, as well as other healthcare reform measures that may be adopted in the future, may result in more rigorous coverage criteria, new payment methodologies and in additional downward pressure on the price that we receive for any approved or cleared product. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the United States or abroad. If we are slow or unable to adapt to new requirements or policies, or if we are not able to maintain regulatory compliance, our products and product candidates may lose any regulatory approval that may have been obtained and we may not achieve or sustain profitability, or be able to enter attractive collaboration agreements, which would adversely affect our business.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">We could be exposed to significant product liability claims which could be time consuming and costly to defend, divert management attention and adversely impact our ability to obtain and maintain insurance coverage</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The testing, clinical development, manufacture, marketing and sale of our product candidates involve an inherent risk that product liability claims will be asserted against us. Although we are insured against such risks up to an annual aggregate limit in connection with clinical trials and commercial sales of our product candidates, our present product liability insurance may be inadequate and may not fully cover the costs of any claim or any ultimate damages we might be required to pay. Product liability </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">claims or other claims related to our product candidates, regardless of their outcome, could require us to spend significant time and money in litigation or to pay significant damages. Any successful product liability claim may prevent us from obtaining adequate product liability insurance in the future on commercially desirable or reasonable terms. In addition, product liability coverage may cease to be available in sufficient amounts or at an acceptable cost. An inability to obtain sufficient insurance coverage at an acceptable cost or otherwise to protect against potential product liability claims could prevent or inhibit the commercialization of our product candidates. A product liability claim could also significantly harm our reputation and delay market acceptance of our product candidates.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Acceptance of our pharmaceutical product candidates in the marketplace is uncertain, and failure to achieve market acceptance will delay our ability to generate or grow revenues</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our future financial performance will depend upon the successful introduction and customer acceptance of our product candidates in research and development, including DUR-928, and our FDA approved product, POSIMIR, if commercially launched, and including Indivior&#8217;s PERSERIS and Orient Pharma&#8217;s Methydur. Even if approved for marketing, these products and product candidates may not achieve market acceptance. The degree of market acceptance will depend upon a number of factors, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the receipt of regulatory clearance of marketing claims for the uses that we are developing&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the approved product labeling&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">pricing, reimbursement and formulary access&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the establishment and demonstration in the medical community of the safety and clinical efficacy of our products and their potential advantages over existing therapies&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">pricing and reimbursement policies of government and third-party payors such as insurance companies, health maintenance organizations, hospital formularies and other health plan administrators.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Physicians, patients, payers or the medical community in general may be unwilling to accept, utilize or recommend any of our products. If we are unable to obtain regulatory approval, commercialize and market our current and future products when planned and achieve market acceptance, we will not achieve meaningful revenues.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">If users of our products are unable to obtain adequate reimbursement from third-party payers, or if new restrictive legislation is adopted, market acceptance of our products may be limited and we may not achieve meaningful revenues</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The continuing efforts of government and insurance companies, health maintenance organizations and other payers of healthcare costs to contain or reduce costs of health care may affect our future revenues and profitability, and the future revenues and profitability of our potential customers, suppliers and third-party collaborators and the availability of capital. For example, in certain foreign markets, pricing or profitability of prescription pharmaceuticals is subject to government control. In the United States, recent federal and state government initiatives have been directed at lowering the total cost of health care, and the U.S. Congress and state legislatures will likely continue to focus on health care reform, the cost of prescription pharmaceuticals and on the reform of the Medicare and Medicaid systems. While we cannot predict whether any such legislative or regulatory proposals will be adopted, the announcement or adoption of such proposals could materially harm our business, financial condition and results of operations.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The successful commercialization of our product candidates will depend in part on the extent to which appropriate reimbursement levels for the cost of our product candidates and related treatment are obtained from governmental authorities, private health insurers and other organizations, such as HMOs. Third-party payers often limit payments or reimbursement for medical products and services. Also, the trend toward managed health care in the United States and the concurrent growth of organizations such as HMOs, which could control or significantly influence the purchase of health care services and products, as well as legislative proposals to reform health care or reduce government insurance programs, may limit reimbursement or payment for our products. The cost containment measures that health care payers and providers are instituting and the effect of any health care reform could materially harm our ability to operate profitably and access capital.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">If we or our third-party collaborators are unable to train physicians to use our pharmaceutical product candidates to treat patients&#8217; diseases or medical conditions, we may incur delays in market acceptance of our products</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Broad use of certain of our product candidates, such as POSIMIR, will require extensive training of numerous physicians on their proper and safe use. The time required to begin and complete training of physicians could delay introduction of our products and adversely affect market acceptance of our products. We or third parties selling our product candidates may be unable to rapidly train physicians in numbers sufficient to generate adequate demand for our product candidates. Any delay in training would materially delay the demand for our product candidates and harm our business and financial results. In addition, we may expend significant funds towards such training before any orders are placed for our products, which would increase our expenses and harm our financial results.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Potential new accounting pronouncements and legislative actions are likely to impact our future financial position or results of operations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future changes in financial accounting standards may cause adverse, unexpected fluctuations in the timing of the recognition of revenues or expenses and may affect our financial position or results of operations. New pronouncements and varying interpretations of pronouncements have occurred with frequency and may occur in the future and we may make changes in our accounting policies in the future. Compliance with changing regulation of corporate governance and public disclosure may result in additional expenses. Changing laws, regulations and standards relating to corporate governance and public disclosure, including the Sarbanes-Oxley Act of 2002, new SEC regulations, PCAOB pronouncements and NASDAQ rules, are creating uncertainty for companies such as ours and insurance, accounting and auditing costs are high as a result of this uncertainty and other factors. Compliance with evolving corporate governance and public disclosure standards may result in increased general and administrative expenses and a diversion of management time and attention from value-creating activities to compliance activities.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Risks related to actions on trade by the U.S. and foreign governments could adversely affect the Company's results of operations and financial condition</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The U.S. government under the previous administration indicated its intent to adopt a new approach to trade policy and in some cases to renegotiate, or potentially terminate, certain existing bilateral or multilateral trade agreements.&#160;&#160; It also initiated the imposition of tariffs on certain foreign products. Changes in U.S. trade policy have resulted in, and could continue to result in, one or more U.S. trading partners adopting responsive trade policy making it more difficult or costly for us to export our products to those countries. These measures could also result in increased costs for goods imported into the United States. This in turn could require us to increase prices to our customers which may reduce demand, or, if we are unable to increase prices, result in lowering our margin on products sold.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There is also a concern that the imposition of additional tariffs by the United States could result in the adoption of tariffs by other countries. A potential resulting trade war could have a significant adverse effect on world trade and the world economy.&#160;&#160;We cannot predict future trade policy or the terms of any renegotiated trade agreements and their impact on our business. The adoption and expansion of trade restrictions, the occurrence of a trade war, or other governmental action related to tariffs or trade agreements or policies has the potential to adversely impact demand for our products, our costs, our customers, our suppliers, and the U.S. economy, which in turn could adversely impact our business, financial condition and results of operations.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Risks Related To Our Common Stock</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Our operating history makes evaluating our stock difficult</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our quarterly and annual results of operations have historically fluctuated and we expect will continue to fluctuate for the foreseeable future. We believe that period-to-period comparisons of our operating results should not be relied upon as predictive of future performance. Our prospects must be considered in light of the risks, expenses and difficulties encountered by companies with a limited number of approved pharmaceutical products, particularly companies in new and rapidly evolving markets such as </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">pharmaceuticals and biotechnology. To address these risks, we must, among other things, obtain regulatory approval for and commercialize our product candidates, which may not occur. We may not be successful in addressing these risks and difficulties. We may require additional funds to complete the development of our product candidates and to fund operating losses to be incurred in the next several years.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Investors may experience substantial dilution of their investment</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In order to raise capital and for other purposes, we may in the future offer and issue additional shares of our common stock or other securities convertible into or exchangeable for our common stock, and the price per share at which we sell additional shares of our common stock or other securities convertible into or exchangeable for our common stock in future transactions may be higher or lower than the price per share at which investors in our common stock bought their shares. In August 2018, we filed a shelf registration statement on Form S-3 with the SEC that allows us to offer up to $175 million of securities from time to time in one or more public offerings, inclusive of up to $75.0 million of additional shares of common stock which the Company may sell, subject to certain limitations, under the 2015 Sales Agreement through Cantor Fitzgerald, acting as agent. Through several financings between 2019 and March 1, 2021, and through our 2015 Sales Agreement with Cantor Fitzgerald during this period, we have raised an aggregate of $79.4 million, so that we may sell an additional $95.6 million under our existing shelf registration statement. We may also file a new shelf registration statement on Form S-3 for the potential sale of additional securities.&#160;&#160;Any additional sales in the public market of our common stock, under our 2015 Sales Agreement with Cantor Fitzgerald, in other offerings under the shelf registration statement or otherwise, could adversely affect prevailing market prices for our common stock. In addition, as of December 31, 2020, 27,274,439 shares of our common stock were issuable upon exercise of stock options outstanding under our stock option plans at a weighted average exercise price of $1.45 per share, 7,599,531 additional shares of common stock were reserved for potential future issuance under our stock option plan, and an aggregate of 497,270 shares of common stock were reserved for potential future issuance under our 2000 Employee Stock Purchase Plan. Investors will incur dilution from the sale of any additional shares or upon the issuance of any shares pursuant to such plans, or upon exercise of any outstanding options. </p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Our stock price has in the past and may in the future not meet the minimum bid price for continued listing on Nasdaq. Our ability to continue operations or to publicly or privately sell equity securities and the liquidity of our common stock could be adversely affected if we are delisted from Nasdaq</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In several instances in the past, including as recently as December 2018, we received written notification from Nasdaq informing us that because the closing bid price of our common stock was below $1.00 for 30 consecutive trading days, our shares no longer complied with the minimum closing bid price requirement for continued listing on Nasdaq under Nasdaq Marketplace Rules. Each time, we were given a period of 180 days from the date of the notification and in one case an extra 180-day period to regain compliance with Nasdaq&#8217;s listing requirements by having the closing bid price of our common stock listed on Nasdaq be at least $1.00 for at least 10 consecutive trading days.  </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">While we have regained compliance within the applicable time periods in the past, if our shares again no longer comply with the minimum closing bid price requirement for continued listing on the Nasdaq Capital Market under Nasdaq Marketplace Rule 5550(a)(2) and we do not regain compliance within the applicable 180-day time period, Nasdaq will notify us that our securities will be subject to delisting. One strategy to regain compliance in such circumstances would be to implement a reverse stock split. The Company may appeal Nasdaq&#8217;s determination to delist its securities to a Hearings Panel. During any appeal process, shares of our common stock would continue to trade on the Nasdaq Capital Market.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There can be no assurance that we will maintain compliance with the requirements for listing our common stock on the Nasdaq Capital Market. Delisting from Nasdaq would constitute an event of default under our loan facility with Oxford, entitling Oxford to accelerate our obligations under such facility, among other actions. Under such circumstances, we could be required to renegotiate the repayment terms of our loan facility, on terms which would not be as favorable to the Company as our current terms, or we could be required to take other actions, such as discontinuing some or all of our operations, selling assets, or other action. Delisting could also adversely affect our ability to raise additional financing through the </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">public or private sale of equity securities, would significantly affect the ability of investors to trade our securities and would negatively affect the value and liquidity of our common stock. Delisting could also have other negative results, including the potential loss of confidence by employees, the loss of institutional investor interest and fewer business development opportunities.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Our ability to use net operating losses and certain other tax attributes is uncertain and may be limited</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our ability to use our federal and state net operating losses to offset potential future taxable income and related income taxes that would otherwise be due is dependent upon our generation of future taxable income before the expiration dates of the net operating losses, and we cannot predict with certainty when, or whether, we will generate sufficient taxable income to use all of our net operating losses. In addition, utilization of net operating losses to offset potential future taxable income and related income taxes that would otherwise be due is subject to annual limitations under the &#8220;ownership change&#8221; provisions of Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (Internal Revenue Code) and similar state provisions, which may result in the expiration of net operating losses before future utilization. In general, under the Code, if a corporation undergoes an &#8220;ownership change,&#8221; generally defined as a greater than 50% change (by value) in its equity ownership over a three-year period, the corporation&#8217;s ability to use its pre-change net operating losses and other pre-change tax attributes (such as research and development credit carryforwards) to offset its post-change taxable income or taxes may be limited. Our equity offerings and other changes in our stock ownership, some of which are outside of our control, may have resulted or could in the future result in an ownership change. If an ownership change limitation were to apply, utilization of our domestic net operating losses and tax credit carryforwards could be limited in future periods and a portion of the carryforwards could expire before being available to reduce future income tax liabilities.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">The price of our common stock may be volatile</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The stock markets in general, and the markets for pharmaceutical stocks in particular, have experienced extreme volatility that has often been unrelated to the operating performance of particular companies. These broad market fluctuations may adversely affect the trading price of our common stock.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Price declines in our common stock could result from general market and economic conditions and a variety of other factors, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">adverse results (including adverse events or failure to demonstrate safety or efficacy) or delays in our clinical and non-clinical trials of DUR-928 or other product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">announcements of FDA non-approval of our product candidates, approvals with commercially limiting labels, or delays in the FDA or other foreign regulatory agency review process&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">adverse actions taken by regulatory agencies or law enforcement agencies with respect to our product candidates, clinical trials, manufacturing processes, accounting practices or sales and marketing activities, or those of our third-party collaborators&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">announcements of technological innovations, patents, product approvals or new products by our competitors&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">failure of third-party collaborators to continue development or commercialization of the respective product candidates they are developing or commercializing&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">regulatory, judicial and patent developments in the United States and foreign countries&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">any lawsuit or arbitration involving us or our product candidates including intellectual property infringement or product liability suits&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">announcements concerning our competitors, or the biotechnology or pharmaceutical industries in general&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">developments concerning our strategic alliances or acquisitions or termination of such alliances&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">actual or anticipated variations in our operating results&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">changes in recommendations by securities analysts, misstatements or mischaracterizations in analyst reports or dropping or lack of analyst coverage&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">negative press coverage or online misinformation about the Company or its partners or their respective products or personnel&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">deviations in our operating results from the estimates of analysts&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">sales of our common stock by our executive officers or directors or sales of substantial amounts of common stock by us or others&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">potential failure to meet continuing listing standards from The Nasdaq Capital Market&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">loss or disruption of facilities due to natural disasters&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">acceleration of our debt obligations due to a determination by our lender that a material adverse change has occurred&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">changes in accounting principles&#59; or</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">loss of any of our key scientific or management personnel.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The market price of our common stock may fluctuate significantly in response to factors which are beyond our control. The stock market in general has recently experienced extreme price and volume fluctuations. For example, the outbreak of the COVID-19 coronavirus, oil price volatility and other factors have caused broad stock market and industry fluctuations. In addition, the market prices of securities of technology and pharmaceutical companies have also been extremely volatile, and have experienced fluctuations that often have been unrelated or disproportionate to the operating performance of these companies. These broad market fluctuations could result in extreme fluctuations in the price of our common stock, which could cause a decline in the value of our common stock.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the past, following periods of volatility in the market price of a particular company&#8217;s securities, litigation has often been brought against that company. If litigation of this type is brought against us, it could be extremely expensive, particularly if we were to lose the lawsuit and have to pay damages, and divert management&#8217;s attention and our company&#8217;s resources.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">We have broad discretion over the use of our cash and investments, and their investment may not always yield a favorable return</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our management has broad discretion over how our cash and investments are used and may from time to time invest in ways with which our stockholders may not agree and that do not yield favorable returns.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Our certificate of incorporation, our bylaws and Delaware law contain provisions that could discourage another company from acquiring us</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provisions of Delaware law, our certificate of incorporation and bylaws may discourage, delay or prevent a merger or acquisition that stockholders may consider favorable, including transactions in which you might otherwise receive a premium for your shares. These provisions include:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">authorizing the issuance of &#8220;blank check&#8221; preferred stock without any need for action by stockholders&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">providing for a classified board of directors with staggered terms&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">requiring supermajority stockholder voting to effect certain amendments to our certificate of incorporation and bylaws&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">eliminating the ability of stockholders to call special meetings of stockholders&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">prohibiting stockholder action by written consent&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">establishing advance notice requirements for nominations for election to the board of directors or for proposing matters that can be acted on by stockholders at stockholder meetings.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Our bylaws provide that the Court of Chancery of the State of Delaware is the exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our bylaws provide that the Court of Chancery of the State of Delaware is the exclusive forum for any derivative action or proceeding brought on behalf of the Company, any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Company, any action asserting a claim arising pursuant to any provision of the General Corporation Law of Delaware or our Certificate of Incorporation or bylaws or any action asserting a claim governed by the internal affairs doctrine. The choice of forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors, officers and other employees. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Alternatively, if a court were to find the choice of forum provision contained in our certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could adversely affect our business and financial condition.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <span style="font-weight:bold;"> </span> </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:10.47%;text-indent:-10.47%;font-weight:bold;;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;1B.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_1B_UNRESOLVED_STAFF_COMMENTS">Unresolved Staff Comments.</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;2.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_2_PROPERTIES">Properties.</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following chart indicates the facilities that we lease, the location and size of each such facility and their designated use.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:16.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Location</p></td>
<td valign="top" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Approximate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Square Feet<span style="font-weight:normal;"> </span></p></td>
<td valign="top" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.65pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:20%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operation</p></td>
<td valign="top" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.65pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:45%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Expiration</p></td>
</tr>
<tr>
<td valign="top" style="width:16.98%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cupertino,&#160;CA</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,149 sq. ft.</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:20%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Office,&#160;Laboratory and&#160;Manufacturing</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:45%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease expires 2024 (with an option to renew for an additional five years)</p></td>
</tr>
<tr style="height:3.75pt;">
<td valign="middle" style="width:16.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:15%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:20%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:16.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cupertino, CA</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,100 sq. ft.</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:20%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Office and Laboratory</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease expires 2024 (with an option to renew for an additional five years)</p></td>
</tr>
<tr style="height:3.75pt;">
<td valign="middle" style="width:16.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:15%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:20%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:16.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vacaville, CA</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,634 sq. ft.</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:20%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease expires 2023 (with an option to renew for an additional five years)</p></td>
</tr>
<tr style="height:3.75pt;">
<td valign="middle" style="width:16.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:15%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:20%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe that our existing facilities are adequate to meet our current and foreseeable requirements or that suitable additional or substitute space will be available as needed.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;3.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_3_LEGAL_PROCEEDINGS">Legal Proceedings.</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are not a party to any material legal proceedings.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;4.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_4_MINE_SAFETY_DISCLOSURES">Mine Safety Disclosures.</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;" id="PART_II">PART II</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-top:10pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;5.</span></p></td>
<td valign="top">
<p style="margin-top:10pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_5_MARKET_FOR_REGISTRANTS_COMMON_EQU">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. </p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our common stock is traded on the NASDAQ Capital Market under the symbol &#8220;DRRX&#8221;.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March 1, 2021, there were approximately 101 holders of record of the common stock. This does not include the number of persons whose stock is in nominee or &#8220;street name&#8221; accounts through brokers. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Dividend Policy</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have never paid cash dividends on our common stock. We currently intend to retain any future earnings to fund the development and growth of our business. Therefore, we do not currently anticipate paying any cash dividends in the foreseeable future.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">STOCK PERFORMANCE GRAPH</p>
<p style="margin-top:10pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following graph compares the cumulative total stockholder return data for our stock with the cumulative return of (i)&#160;The NASDAQ Stock Market (U.S.) Index and (ii)&#160;the NASDAQ Biotechnology Index since December&#160;31, 2015. The graph assumes that $100 was invested on December&#160;31, 2015. The stock price performance on the following graph is not necessarily indicative of future stock price performance.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gguopuizh44n000008.jpg" title="" alt="" style="width:624px;height:504px;" /></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:4pt;">&#160;</p>
<p style="border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:61.54%;text-indent:0%;font-family:Times New Roman;font-size:5pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</span></p></td>
<td valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">$100 Invested on 12/31/15 in stock or index&#8212;including reinvestment of dividends. Fiscal year ending December&#160;31.</p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-top:17pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">DURECT CORPORATION</span></p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12/31/15</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12/31/16</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12/31/17</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12/31/18</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12/31/2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">12/31/2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DURECT CORPORATION</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100.00</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.63</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41.63</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.72</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">171.95</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93.67</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NASDAQ STOCK MARKET (U.S.)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100.00</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">107.50</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">137.86</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">132.51</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">179.19</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">257.38</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NASDAQ BIOTECHNOLOGY</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100.00</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78.32</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94.81</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85.97</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106.95</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">134.42</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</p>
<p style="margin-top:5pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;</span><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">6</span><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_6_SELECTED_FINANCIAL_DATA">Selected Financial Data.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:-5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Information under this item is omitted in compliance with recently adopted rules of the Securities and Exchange Commission.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</p>
<hr style="page-break-after:always" />

<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;7.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_7_MANAGEMENTS_DISCUSSION_ANALYSIS_F">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">This Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations as of December 31, 2020, 2019 and 2018 should be read in conjunction with our Financial Statements, including the Notes thereto, and &#8220;Risk Factors&#8221; section included elsewhere in this Form 10-K. This Form 10-K contains forward-looking statements within the meaning of Section&#160;21E of the Securities Exchange Act of 1934, as amended, and Section&#160;27A of the Securities Act of 1933, as amended. When used in this report or elsewhere by management from time to time, the words &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;potential,&#8221; &#8220;possibility,&#8221; and similar expressions are forward-looking statements. Such forward-looking statements contained herein are based on current expectations.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Forward-looking statements made in this report include, for example, statements about:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the clinical trial plans for DUR-928&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">potential uses and benefits of DUR-928 to treat alcohol-associated hepatitis (also called alcoholic hepatitis or AH), non-alcoholic steatohepatitis (NASH), or other conditions, including acute kidney injury (AKI), and nonalcoholic fatty liver disease&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the </span><span style="Background-color:#FFFFFF;color:#000000;font-family:Times New Roman;">results and timing of clinical trials, the ability to enroll patients in clinical trials in a timely and cost-effective manner&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="Background-color:#FFFFFF;color:#000000;font-family:Times New Roman;">the likelihood of future clinical trial results of DUR-928 being similar to results from previous trials,&#160;the possible commencement of future clinical trials, enrollment rates and announcements of the findings of our clinical trials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the potential earn-out payments we may receive from Indivior related to the commercialization of PERSERIS and milestone and royalty payments we may receive from Santen or Orient Pharma&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the progress of our third-party collaborations, including estimated milestones&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">our </span><span style="Background-color:#FFFFFF;color:#000000;font-family:Times New Roman;">intention to seek, and ability to enter into and maintain strategic alliances and collaborations, including for the commercialization of POSIMIR</span><span style="font-family:Times New Roman;color:#000000;">&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">POSIMIR&#8217;s commercial prospects, differentiating product attributes, potential for reimbursement and formulary access, the timing of post-marketing commitments and timing of potential commercial launch.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the potential benefits and uses of our product candidates and technologies, including POSIMIR and our SABER and ORADUR technologies&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">responsibilities of our third-party collaborators, including the responsibility to make cost reimbursement, milestone, royalty and other payments to us, and our expectations regarding our collaborators&#8217; plans with respect to our product candidates and continued development of our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">our responsibilities to our third-party collaborators, including our responsibilities to conduct research and development, clinical trials and manufacture products or product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">market opportunities for product candidates in our product development pipeline&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="Background-color:#FFFFFF;color:#000000;font-family:Times New Roman;">potential regulatory filings for or approval of&#160;DUR-928&#160;or any of our or any third parties&#8217; other product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the progress and results of our research and development programs and our evaluation of additional development programs&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">requirements for us to purchase supplies and raw materials from third parties, and the ability of third parties to provide us with required supplies and raw materials&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="Background-color:#FFFFFF;color:#000000;font-family:Times New Roman;">conditions for obtaining regulatory approval of our product candidates&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">submission and timing of applications for regulatory approval and timing of responses to our regulatory submissions&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the impact of FDA, EMA and other government regulation on our business&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Our ability to obtain, assert and protect patents and other intellectual property rights, including intellectual property licensed to our collaborators, as well as avoiding the intellectual property rights of others&#59;</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">products and companies that will compete with the product candidates we develop and/or license to third-party collaborators&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the possibility we may commercialize our own products and build up our commercial, sales and marketing capabilities and other required infrastructure&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the possibility that we may develop additional manufacturing capabilities&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">our employees, including the number of employees and the continued services of key management, technical and scientific personnel&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">our future performance, including our anticipation that we will not derive meaningful revenues from our product candidates in development for at least the next twelve months, potential for future inventory write-offs and our expectations regarding our ability to achieve profitability&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">sufficiency of our cash resources, anticipated capital requirements and capital expenditures, our ability to comply with covenants of our term loan, and our need or desire for additional financing, including potential sales under our shelf registration statement&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">our expectations regarding research and development expenses, and selling, general and administrative expenses&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the composition of future revenues&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">accounting policies and estimates.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Forward-looking statements are not guarantees of future performance and involve risks and uncertainties. Actual events or results may differ materially from those discussed in the forward-looking statements as a result of various factors. For a more detailed discussion of such forward looking statements and the potential risks and uncertainties that may impact upon their accuracy, see the &#8220;Risk Factors&#8221; section and &#8220;Overview&#8221; section of this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations. These forward-looking statements reflect our view only as of the date of this report. We undertake no obligations to update any forward-looking statements. You should also carefully consider the factors set forth in other reports or documents that we file from time to time with the Securities and Exchange Commission.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Overview</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a biopharmaceutical company <span style="Background-color:#FFFFFF;letter-spacing:0.4pt;">advancing novel and potentially lifesaving investigational therapies derived from our Epigenetic Regulator Program.</span>&#160;&#160;DUR&#8209;928, a new chemical entity in clinical development for three different indications, is the lead candidate in our Epigenetic Regulator Program.&#160;&#160;An endogenous, orally bioavailable small molecule, DUR-928 has been shown in preclinical studies to play an important regulatory role in lipid homeostasis, inflammation, and cell survival.&#160;&#160;Alcohol-associated hepatitis (AH) is a life-threatening acute liver condition with no approved therapeutics and a 28-day historical mortality rate of 26%.&#160;&#160;After completing a Phase 2a trial where 100% of AH patients treated with DUR-928 survived the 28-day study period, we are now conducting a double-blind, placebo-controlled Phase 2b clinical trial called AHFIRM, in which we are evaluating DUR-928&#8217;s life saving potential compared to the current standard of care in patients with severe AH. If the AHFIRM trial is successful, it may support an NDA filing and we may decide to develop our own commercial, sales and marketing organization.&#160;&#160;DUR-928 is also being investigated in patients with nonalcoholic steatohepatitis (NASH).</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to our Epigenetic Regulator Program, we developed a novel and proprietary post-surgical pain product called POSIMIR that utilizes our innovative SABER platform technology to enable continuous sustained delivery of bupivacaine, a non-opioid local analgesic, over 3 days in adults. In February 2021, the U.S. Food and Drug Administration (FDA) approved POSIMIR for infiltration use in adults for administration into the subacromial space under direct arthroscopic visualization to produce post-surgical analgesia for up to 72 hours following arthroscopic subacromial decompression. The approval was based on positive data from a randomized, multicenter, assessor-blinded, placebo&#8209;controlled clinical trial in patients undergoing arthroscopic subacromial decompression surgery with an intact rotator cuff. The primary outcome measures were mean pain intensity and total opioid rescue analgesia administered, both evaluated over the first 72 hours after surgery versus placebo. POSIMIR demonstrated a statistically significant improvement in both primary outcome measures: a 1.3 point, or 20%, reduction in mean pain intensity on a 0-10 point pain scale (p&#61;0.01), and a 67% reduction in intravenous morphine-</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">equivalent rescue opioid use, from a median of 12 mg in the placebo group to 4 mg in the POSIMIR group (p&#61;0.01).&#160;&#160;</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in discussions with potential </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">licensees</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> regarding commercialization rights to POSIMIR, for which </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we hold</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> worldwide rights.</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result of the assignment of certain patent rights, DURECT also receives single digit sales-based earn-out payments from U.S. net sales of Indivior&#8217;s PERSERIS (risperidone) drug for schizophrenia, which was launched commercially in the U.S. in February 2019.&#160;&#160;In addition, in September 2020, our licensee, Orient Pharma informed us that it had launched Methydur (Methydur) for the treatment of attention deficit hyperactivity disorder (ADHD) in Taiwan.&#160;&#160;<span style="letter-spacing:0.2pt;">We receive a single digit royalty on sales of </span>Methydur by Orient Pharma.<span style="letter-spacing:0.2pt;"> &#160;We also</span> manufacture and sell osmotic pumps used in laboratory research and have several early-stage development programs with corporate collaborators on terms which typically call for our collaborator to fund all or a substantial portion of future development costs and then pay us milestone payments based on specific development or commercial achievements plus royalties on product sales. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Developments </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The COVID-19 global pandemic poses a significant life-threatening and economic risk throughout the world. The rapid spread of the disease has resulted in a pandemic with over 100 million of confirmed cases and millions of deaths worldwide. While most cases result in mild symptoms, including fever, cough and shortness of breath, some rapidly progress into Acute Respiratory Distress Syndrome (ARDS), multi-organ failure, and death.&#160;&#160;Many of these patients may experience severe systemic inflammation that leads to acute injuries in multiple organs including the liver and the kidney. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We continue to actively advance all of our research and development programs, we are assessing on an ongoing basis the impact of COVID-19 on our clinical trials, product candidate testing, expected timelines and costs. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">COVID-19 has also had a negative impact on our business.&#160;&#160;In light of recent developments relating to the COVID-19 global pandemic, the focus of healthcare providers and hospitals has been on the prioritization of healthcare resources toward fighting the virus and clinical site initiations. As a result, patient enrollment and activities that require visits to clinical sites, including data monitoring, have been and may continue to be delayed. We are also evaluating the impact of the COVID-19 on orders for our ALZET product line. In addition, in response to the spread of COVID-19, other than laboratory and manufacturing employees, many of our other employees are working from home, and, in keeping with social distancing requirements, we have limited the number of staff in our facilities. This partial disruption, although expected to be temporary, may impact our operations and overall business by delaying the progress of our research and development programs, including our planned preclinical studies and clinical trials. The impact of COVID-19 is evolving rapidly and its future effects are uncertain. Given the uncertainty of the situation, the duration of the disruption and related financial impact cannot be reasonably estimated at this time. We will continue to evaluate the impact of the COVID-19 pandemic on our business and expect to reevaluate the timing of our anticipated preclinical and clinical objectives as we learn more and the impact of COVID-19 on our industry becomes clearer.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For additional information on the various risks posed by the COVID-19 pandemic, please read Item 1A. Risk Factors included in this report.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Collaborative Research and Development and Other Revenues</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Collaborative research and development and other revenues consist of three broad categories: (a)&#160;the recognition of upfront license payments over the period of our continuing involvement with the third party, (b)&#160;the reimbursement of qualified research expenses by third parties and (c)&#160;milestone payments in connection with our collaborative agreements. During the last three years, we generated collaborative research and development revenues from collaborative agreements with Gilead, Sandoz, Santen and others.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Product Revenues</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also currently generate product revenue from the sale of two product lines:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">ALZET<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> osmotic pumps which are used for animal research&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">certain key excipients that are included in Methydur and one excipient that is included in a marketed animal health product.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2020, we completed the sale of its LACTEL Absorbable Polymers product line to Evonik Corporation. Under the terms of the Asset Purchase Agreement, Evonik paid us approximately $15&#160;million subject to certain adjustments, and also agreed to assume certain liabilities with respect to the transferred assets and assembled workforce. LACTEL product line is reflected as a discontinued operation in our statements of operations and comprehensive loss and balance sheets. Our financial information discussed in the Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations excludes the impact of LACTEL product line.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because we consider our core business to be developing and commercializing pharmaceuticals, we do not intend to significantly increase our investments in or efforts to sell or market any of our existing product lines. However, we expect that we will continue to make efforts to increase our revenues related to collaborative research and development by entering into additional research and development agreements with third-party collaborators to develop product candidates based on our drug delivery technologies.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Operating Results</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since our inception in 1998, we have generally had a history of operating losses. At December 31, 2020, we had an accumulated deficit of $489.8 million. Our net losses were $582,000, $20.6 million and $25.3 million for the years ended December 31, 2020, 2019 and 2018, respectively. These losses have resulted primarily from costs incurred to research and develop our product candidates and to a lesser extent, from selling, general and administrative costs associated with our operations and product sales. We expect our research and development expenses to increase in 2021 compared to 2020 as we experience higher research and development expenses related to DUR-928. We expect our selling, general and administrative expenses to increase in 2021 compared to 2020. We do not anticipate meaningful revenues from our products in development, should they be approved, for at least the next twelve months. Therefore, we expect to incur continuing losses and negative cash flows from operations for the foreseeable future.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Critical Accounting Policies and Estimates</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The most significant estimates and assumptions relate to inventories and purchase commitments, revenue recognition, contract research liabilities, and stock-based compensation. Actual amounts could differ significantly from these estimates.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Revenue Recognition</p>
<p style="margin-bottom:0pt;margin-top:6pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-size:11pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Product Revenues, Net</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We manufacture and sell ALZET osmotic pumps used in laboratory research, and manufacture and sell certain excipients for use as raw materials in certain products, including an animal health product and Methydur.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenues from product sales are recognized when the customer obtains control of our product, which occurs at a point in time, typically upon shipment to the customer. &#160;&#160;We expense incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that we would have recognized is one year or less. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; &#160; </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-style:italic;font-size:11pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Trade Discounts and Allowances:<span style="font-style:normal;"> &#160;We provide certain customers with discounts that are explicitly stated in our contracts and are recorded as a reduction of revenues in the period the related product revenues are recognized.&#160;&#160; </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-style:italic;font-size:11pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Product Returns:<span style="font-style:normal;"> &#160;Consistent with industry practice, we generally offer customers a limited right of return for products that have been purchased from us.&#160;&#160;We estimate the amount of our product sales that may be returned by our customers and record this estimate as a reduction of revenues in the period the related product revenues is recognized.&#160;&#160;We currently estimate product return liabilities using our own historical sales information.&#160;&#160;We expect product returns to be minimal</span><span style="color:#000000;font-style:normal;">.</span></p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-style:italic;font-size:11pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Collaborative Research and Development Revenues </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We enter into license agreements under which we license certain rights to our product candidates to third parties.&#160;&#160;The terms of these arrangements typically include payment to us of one or more of the following: non-refundable, up-front license fees&#59; reimbursement of development costs incurred by us under approved work plans&#59; development, regulatory and commercial milestone payments&#59; payments for manufacturing supply services we provide through our contract manufacturers&#59; sales-based milestones and royalties on net sales of licensed products.&#160;&#160;Each of these payments results in collaborative research and development revenues, except for revenues from royalties or earn-out payments on net sales of licensed products, which are classified as other revenues. &#160; </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In determining the appropriate amount of revenue to be recognized as we fulfill our obligations under each of our agreements, we perform the following steps: (i) identification of the promised goods or services in the contract&#59; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract&#59; (iii) measurement of the transaction price, including the constraint on variable consideration&#59; (iv) allocation of the transaction price to the performance obligations&#59; and (v) recognition of revenue when (or as) we satisfy each performance obligation.&#160;&#160;As part of the accounting for these arrangements, we must develop assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the contract.&#160;&#160;We use key assumptions to determine the stand-alone selling price, which may include forecasted revenues, development timelines, reimbursement rates for personnel costs, discount rates and probabilities of technical and regulatory success. We expect to recognize revenue for the variable consideration currently being constrained when it is probable that a significant revenue reversal will not occur<span style="color:#000000;">.  </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;color:#FF0000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Licenses of intellectual property: &#160;<span style="font-style:normal;">If the license to our intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, we recognize revenues from non-refundable, up-front fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license.&#160;&#160;For licenses that are bundled with other promises, we utilize judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, up-front fees.&#160;&#160;We evaluate the measure of progress each reporting period and, if necessary, adjust the measure of performance and related revenue recognition. </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Milestone Payments:<span style="font-style:normal;"> &#160;At the inception of each arrangement that includes development milestone payments, we evaluate whether the milestones are considered probable of being reached and estimate the amount to be included in the transaction price using the most likely amount method.&#160;&#160;If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price.&#160;&#160;Milestone payments that are not within the control of us or the licensee, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. The transaction price is then allocated to each performance obligation on a relative stand-alone selling price basis, for which we recognize revenue as or when the performance obligations under the contract are satisfied.&#160;&#160;At the end of each subsequent reporting period, we re-evaluate the probability of achievement of such development milestones and any related constraint, and if necessary, adjust our estimate of the overall transaction price.&#160;&#160;Any such adjustments are recorded on a cumulative catch-up </span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:normal;">basis, which would affect collaborative research and development revenues and net income (loss) in the period of adjustment. </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Manufacturing Supply Services: <span style="font-style:normal;">Arrangements that include a promise for future supply of drug product for either clinical development or commercial supply at the customer&#8217;s discretion are generally considered options.&#160;&#160;We assess if these options provide a material right to the customer and if so, they are accounted for as separate performance obligations.&#160;&#160;If we are entitled to additional payments when the customer exercises these options, any additional payments are recorded in collaborative research and development revenues when the customer obtains control of the goods, which is upon delivery. </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Royalties and Earn-outs:<span style="font-style:normal;"> &#160;For arrangements that include sales-based royalties or earn-outs, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, we recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty or earn-out has been allocated has been satisfied (or partially satisfied).&#160;&#160;To date, we have not recognized material royalty revenue resulting from our collaborative arrangements or material earn-out revenue from our patent purchase agreement with Indivior. &#160;&#160;&#160;&#160; </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Prepaid and Accrued Contract Research Expenses</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We incur significant costs associated with third party consultants and organizations for pre-clinical studies, clinical trials, contract manufacturing, validation, testing, regulatory advice and other research and development-related services. We are required to estimate periodically the cost of services rendered but unbilled based on management&#8217;s estimates of project status. If these good faith estimates are inaccurate, actual expenses incurred could materially differ from our estimates.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Stock-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee stock-based compensation is estimated at the date of grant based on the employee stock award&#8217;s fair value using the Black-Scholes option-pricing model and is recognized as expense ratably over the requisite period.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We estimate the volatility of our common stock at the date of grant based on the historical volatility of our common stock. We base the risk-free rate that we use in the Black-Scholes option valuation model on the implied yield in effect at the time of option grant on U.S. Treasury zero-coupon issues with equivalent remaining terms. We have never paid any cash dividends on our common stock and we do not anticipate paying any cash dividends in the foreseeable future. Consequently, we use an expected dividend yield of zero in the Black-Scholes option valuation model. We estimated forfeitures at the time of grant and revised those estimates in subsequent periods if actual forfeitures differ from those estimates. We used historical data to estimate pre-vesting option forfeitures and recorded stock-based compensation expense only for those awards that are expected to vest. Upon the adoption of ASU 2016-09, we account for forfeitures as they occur and record stock-based compensation expense only for those awards that vest. We amortize the fair value of options granted on a straight-line basis. All options are amortized over the requisite service periods of the awards, which are generally the vesting periods. We may elect to use different assumptions under the Black-Scholes option valuation model in the future, which could materially affect our net income or loss and net income or loss per share.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Results of Operations</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Comparison of years ended December 31, 2020, 2019 and 2018 </p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Collaborative research and development and other revenues</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We recognize revenues from collaborative research and development activities and service contracts. Collaborative research and development revenue primarily represents reimbursement of qualified expenses related to collaborative agreements with various third parties to research, develop and commercialize potential products using our drug delivery technologies, and revenue from the recognition of upfront fees and milestone payments in connection with our collaborative agreements.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66</p>
<hr style="page-break-after:always" />

<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We expect our collaborative research and development and other revenues to fluctuate in future periods pending our efforts to enter into potential new collaborations, our existing third-party collaborators&#8217; commitment to and progress in the research and development programs, and any royalty or earn-out revenue recognized from collaborators or counterparties. The collaborative research and development and other revenues associated with our major collaborators or counterparties are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Collaborator/Counterparty</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gilead (1)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,879</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,133</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,542</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other (2)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,062</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">996</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,665</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total collaborative research and development and other revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,941</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,129</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,207</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:81.2%;text-indent:0%;font-size:6pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</span></p></td>
<td valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Amounts related to recognition of upfront fees and milestone payments were $22.7 million, $12.3 million and zero for the twelve months ended December 31, 2020, 2019 and 2018, respectively. We signed a license agreement with Gilead on July 19, 2019 and received a nonrefundable upfront license fee and a milestone payment totaling $35.0 million in 2019 which was being recognized as revenue as our obligation was being satisfied using the cost-to-cost input method (see Note 2 Strategic Agreements - Agreement with Gilead Sciences, Inc. in the financial statements). In June 2020, we received notice that Gilead was terminating the License Agreement and a related R&#38;D agreement between Gilead and us. As a result, we recognized all our remaining deferred revenue as there were no remaining substantive performance obligations to be provided to Gilead by the Company as of the date when the termination notice was received. Amounts recognized as revenue during each of the twelve months ended December 31, 2020, 2019 and 2018 also included our reimbursable collaborative research and development services performed under our agreement with Gilead. </p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</span></p></td>
<td valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Includes: (a) amounts related to earn-out revenue from Indivior UK Limited (Indivior) with respect to PERSERIS net sales&#59; (b) feasibility programs&#59; (c) research and development activities funded by Santen Pharmaceutical Co. Ltd. (Santen) and (d) royalty revenue from OP Pharma with respect to <span style="font-size:10pt;">Methydur</span> net sales. Note that in January 2018, we were notified by Santen that due to a shift in priorities, Santen had elected to reallocate research and development resources and put our program on pause until further notice. While the main program is on pause, the parties are working together on a limited set of research and development activities funded by Santen.</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The increase in collaborative research and development revenues in 2020 compared with 2019 was primarily due to higher revenue recognized from our agreement with Gilead and higher revenue recognized from our agreements with Indivior, Santen and feasibility agreements with other companies. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The increase in collaborative research and development revenues in 2019 compared with 2018 was primarily due to higher revenue recognized from our agreement with Gilead, partially offset by lower revenue recognized from our agreements with Indivior, Santen and feasibility agreements with other companies.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We received a $25.0 million upfront fee in connection with the license agreement signed with Gilead in July 2019 and in October 2019, we also received a $10 million milestone payment from Gilead for further development of the product candidate.&#160;&#160;Through December 31, 2020, all these amounts had been recognized as revenue as there were no remaining substantive performance obligations to be provided to Gilead by the Company as of the date when the termination notice was received.&#160;&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We received a $2.0 million upfront fee in connection with the license agreement signed with Santen in December 2014. The $2.0 million upfront fee was being recognized as collaborative research and development revenue over the term of our continuing involvement with Santen. At December 31, 2020, $1.2 million of the $2.0 million upfront fee had been recognized as revenue.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March 1, 2021, we had potential milestones of up to $76.0 million that we may receive in the future under our collaborative arrangements, of which $13.0 million are development-based milestones </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and $</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.0 million are sales-based milestones. Within the category of development-based milestones, $2.0 million are related to early stage clinical testing (defined as Phase 1 or 2 activities), $3.0 million are related to late stage clinical testing (defined as Phase 3 activities), $3.0 million are related to regulatory filings, and $5.0 million are related to regulatory approvals. No payments were received between December 31, 20</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 1, 2021</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and we do not anticipate receiving any of these milestone revenues within the next twelve months, if at all</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Product revenues</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2020, we completed the sale of our LACTEL Absorbable Polymers product line to Evonik Corporation. Revenue from LACTEL product line, related cost of product revenues, associated research and development and selling, general and administrative has been reclassified to discontinued operations for all periods presented.&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A portion of our revenues is derived from product sales, which include our ALZET osmotic pump product line, and certain excipients that are included in Methydur and in a marketed animal health product. Net product revenues were $6.2 million, $6.9 million, and $7.1 million in 2020, 2019 and 2018, respectively.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The decrease in product revenues in 2020 was primarily attributable to lower revenue from our ALZET osmotic pump product line as a result of lower units sold compared to 2019. The unit sales of this product line were particularly impacted when the effects of COVID-19 noticeably impacted our customers&#8217; ability to conduct their research and development activities and therefore the demand for our osmotic pumps during the first three quarters of 2020.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The decrease in product revenues in 2019 was primarily attributable to slightly lower revenue from our ALZET osmotic pump product line as a result of lower units sold compared to 2018. </p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Cost of product revenues</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of product revenues was $1.4 million, $1.3 million and $1.6 million in 2020, 2019 and 2018, respectively. Cost of product revenues includes the cost of product revenue from our ALZET product line, and certain excipients that are included in several products in development, Methydur and a marketed animal health product.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Excluding a one-time settlement credit of $500,000 related to certain excipients that are included in Methydur and in a currently marketed animal health product in 2019, cost of product revenue in 2020 was slightly lower primarily due to lower cost of goods sold related to our ALZET product line arising from lower units sold compared to the corresponding period in 2019.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Excluding the one-time settlement credit of $500,000 related to certain excipients that are included in Methydur and in a marketed animal health product, cost of product revenue in 2019 increased primarily due to higher manufacturing costs for our ALZET product line compared to the corresponding period in 2018. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense related to cost of product revenues was $13,000, $13,000, and $13,000, in 2020, 2019, and 2018, respectively.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, 2019, and 2018, we had 9 manufacturing employees, respectively. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Research and development<span style="font-style:normal;">.&#160;&#160;&#160;&#160;Research and development expenses are primarily comprised of salaries, benefits, stock-based compensation and other compensation cost associated with research and development personnel, overhead and facility costs, preclinical and non-clinical development costs, clinical trial and related clinical manufacturing costs, contract services, and other outside costs. Research and development expenses were $27.7 million, $29.6 million, and $25.0 million in 2020, 2019, and 2018, respectively. Stock-based compensation expense recognized related to research and development personnel was $981,000, $746,000, and $1.5 million in 2020, 2019, and 2018, respectively. We expect our research and development expenses to increase in 2021 compared to 2020 as we expect to incur higher research and development expenses related to DUR-928. </span></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">de</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">creased by $</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.9</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million in 20</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> compared to 201</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. The </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">de</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">crease in 20</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">was primarily attributable to</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> lower research and development costs associated with POSIMIR and the Gilead program,</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> partially offset by </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">higher research and development costs associated with DUR-928, depot injectable and other research programs </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">compared to 201</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, as more fully discussed below.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses increased by $4.6 million in 2019 compared to 2018. The increase in 2019 was primarily attributable to higher research and development costs associated with DUR-928 and the Gilead program, partially offset by lower research and development costs associated with POSIMIR, depot injectable and other research programs compared to 2018, as more fully discussed below.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:2pt;margin-bottom:0pt;margin-left:5.24%;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses associated with our major development programs after the</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> removal of the effects of our sale of the LACTEL product line were as follows (in thousands):</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DUR-928</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,319</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,088</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,817</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">POSIMIR</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,656</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,609</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,628</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gilead program (1)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,011</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,844</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,239</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depot injectable programs</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">862</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">599</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">697</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">861</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">500</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">632</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total research and development expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,709</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,640</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,013</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</span></p></td>
<td valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">See Note 2 Strategic Agreements in the financial statements for more details about our agreements with Gilead.</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">DUR-928</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our research and development expenses for DUR-928 increased to $21.3 million in 2020 from $20.1 million in 2019, primarily due to higher contract manufacturing expenses and higher employee related costs for this drug candidate compared with 2019.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our research and development expenses for DUR-928 increased to $20.1 million in 2019 from $14.8 million in 2018, primarily due to higher clinical trial expenses incurred.</p>
<p style="margin-bottom:0pt;margin-top:4pt;text-indent:5.24%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">It is too early to assess the full impact of the COVID-19 outbreak on our business, including our ongoing DUR-928 Phase 2b trial in alcoholic hepatitis, but COVID-19 may delay enrollment and data analysis for our DUR-928 clinical trials.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">POSIMIR</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our research and development expenses for POSIMIR decreased to $3.7 million in 2020 from $4.6 million in 2019, primarily due to lower outside expenses as well as lower employee-related expenses for POSIMIR.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our research and development expenses for POSIMIR decreased to $4.6 million in 2019 from $6.6 million in 2018, primarily due to lower outside expenses as well as lower employee-related expenses for POSIMIR.<span style="font-style:italic;"> </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">It is possible that the COVID-19 pandemic will adversely impact our efforts to out-license POSIMIR commercial rights and the timing of potential commercialization of POSIMIR.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Gilead Program</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our research and development expenses for the Gilead program decreased to $1.0 million in 2020 from $3.8 million in 2019, primarily due to lower employee-related costs and outside costs devoted to the program. In 2020, Gilead terminated the Gilead Agreement and a related R&#38;D agreement between us. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our research and development expenses for the Gilead program increased to $3.8 million in 2019 from $2.2 million in 2018, primarily due to higher employee-related costs and outside costs for the program.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Depot injectable programs</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our research and development expenses for depot injectable programs increased to $862,000 in 2020 from $599,000 in 2019 primarily due to higher employee-related costs and higher outside expenses for these programs.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our research and development expenses for depot injectable programs decreased to $599,000 in 2019 from $697,000 in 2018 primarily due to lower employee-related costs and lower research supplies expenses for these programs.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Other DURECT research programs</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our research and development expenses for all other research activities increased to $871,000 in 2020 from $500,000 in 2019, primarily due to higher employee-related costs incurred for these programs.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our research and development expenses for all other research activities decreased to $500,000 in 2019 from $632,000 in 2018, primarily due to lower employee-related costs incurred for these programs.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, 2019, and 2018, we had 46, 43, and 45 research and development employees, respectively. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We cannot reasonably estimate the timing and costs of our research and development programs due to the risks and uncertainties associated with developing pharmaceuticals as outlined in the &#8220;Risk Factors&#8221; section of this report. The duration of development of our research and development programs may span as many as ten years or more, and estimation of completion dates or costs to complete would be highly speculative and subjective due to the numerous risks and uncertainties associated with developing pharmaceutical products, including significant and changing government regulation, the uncertainties of future preclinical and clinical study results, uncertainties related to the COVID-19 outbreak, the uncertainties with our collaborators&#8217; commitment to and progress in the programs and the uncertainties associated with process development and manufacturing as well as sales and marketing. In addition, with respect to our development programs subject to third-party collaborations, the timing and expenditures to complete the programs are subject to the control of our collaborators. Therefore, we cannot reasonably estimate the timing and costs of the efforts necessary to complete the research and development programs. For additional information regarding these risks and uncertainties, see &#8220;Risk Factors&#8221; above.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Selling, general and administrative<span style="font-style:normal;">.&#160;&#160;&#160;&#160;Selling, general and administrative expenses are primarily comprised of salaries, benefits and stock-based compensation associated with finance, legal, business development, sales and marketing (including sales and marketing expenses for our ALZET product line) and other administrative personnel, overhead and facility costs, and other general and administrative costs. Selling, general and administrative expenses were $13.6 million, $14.1 million, and $12.3 million in 2020, 2019, and 2018, respectively. Stock-based compensation expense recognized related to selling, general and administrative personnel was $1.1 million, $1.3 million, and $1.4 million in 2020, 2019 and 2018, respectively. We expect our selling, general and administrative expenses to increase in 2021 compared to 2020.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative expenses decreased by $504,000 in 2020 compared to 2019, primarily due to lower stock-based compensation expenses related to selling, general and administrative personnel as well as lower legal and patent expenses in 2020 compared with 2019. Selling, general and administrative expenses increased by approximately $1.9 million in 2019 compared to 2018, primarily due to higher legal and patent expenses in 2019 compared with 2018. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, 2019, and 2018, we had 26, 22, and 22 selling, general and administrative personnel, respectively.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Other income (expense)<span style="font-style:normal;">.&#160;&#160;&#160;&#160;Interest and other income was $517,000, $1.1 million, and $870,000 in 2020, 2019, and 2018, respectively. The decrease in interest and other income in 2020 compared to 2019 was primarily the result of lower interest income generated as a result of lower interest rates associated with our cash and investments in 2020 compared with 2019. The increase in interest and other income in 2019 compared to 2018 was primarily the result of higher interest income generated as a result of higher average investment balances in 2019 compared with 2018. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense was $2.2 million, $2.5 million and $2.6 million in 2020, 2019, and 2018, respectively. The decrease in interest expense in 2020 compared to 2019 was primarily due to lower interest rates associated with the term loan with Oxford Finance in 2020 compared to 2019. The decrease </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in interest expense in 2019 compared to 2018 was primarily due to lower interest rates associated with the term loan in 2019 compared to 2018</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Income taxes.<span style="font-style:normal;">&#160;&#160;As of December 31, 2020, we had net operating loss (NOL) carryforwards for federal income tax purposes of approximately $344.7 million, of which approximately $306.3 million will expire in the years 2021 through 2037, and approximately $38.5 million will not expire.&#160;&#160;As of December 31, 2020, we had federal research and development tax credits of approximately $15.6 million, which expire at various dates beginning in 2021 through 2040, if not utilized. As of December 31, 2020, we had NOL carryforwards for state income tax purposes of approximately $219.1 million, which expire in the years 2021 through 2040, and state research and development tax credits of approximately $16.7 million, which do not expire. Utilization of the net operating losses may be subject to a substantial annual limitation due to federal and state ownership change limitations. The annual limitation may result in the expiration of net operating losses and credits before utilization.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020 and 2019, we had net deferred tax assets of $114.3 million and $117.2 million, respectively. Deferred tax assets reflect the net tax effects of net operating loss and credit carryforwards and the temporary differences between the carrying amounts of assets and liabilities for financial reporting and the amounts used for income tax purposes. Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, the net deferred tax assets have been fully offset by a valuation allowance.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because realization of such tax benefits is uncertain, we provided a 100% valuation allowance as of December 31, 2020 and 2019. Utilization of the NOL and R&#38;D credits carryforwards may be subject to a substantial annual limitation due to ownership change limitations that have occurred previously or that could occur in the future provided by Sections 382 and 383 of the Internal Revenue Code of 1986, as well as similar state and foreign provisions. These ownership changes may limit the amount of NOL and R&#38;D credits carryforwards that can be utilized annually to offset future taxable income and tax, respectively. In general, an ownership change is defined as a greater than 50% change (by value) in its equity ownership over a three-year period, the corporation&#8217;s ability to use its pre-change net operating losses and other pre-change tax attributes (such as research and development credit carryforwards) to offset its post-change taxable income or taxes may be limited. Since our formation, we have raised capital through the issuance of capital stock on several occasions which, combined with the purchasing shareholders&#8217; subsequent disposition of those shares, may have resulted in a change of control, as defined by Section&#160;382, or could result in a change of control in the future upon subsequent disposition. We issued $60.0 million of convertible notes in 2003 and subsequently all of these notes had been converted as of December&#160;31, 2008 into approximately 19.0&#160;million shares of our common stock. We also issued approximately 4.4&#160;million shares of our common stock to an institutional investor in connection with an equity financing in September 2009. In December 2012, November 2013, April 2016, June 2019 and February 2021, we completed underwritten public offerings in which we sold an aggregate of approximately 14.0&#160;million, 8.2&#160;million and 13.8 million, 29.0 million and 20.4 million shares, respectively, of our common stock pursuant to effective registration statements. In 2016, 2017, 2018, 2019, 2020 and the first two months of 2021, we issued approximately 5.2&#160;million, 8.9 million, 9.6 million, 2.3 million, 5.3 million and 950,000 shares, respectively, of our common stock in the open market through Controlled Equity Offering sales agreements with Cantor Fitzgerald pursuant to effective registration statements. These transactions may also have resulted in a change of control as defined by Section&#160;382 or could result in a change of control in the future upon the subsequent disposition of the shares.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have not currently completed a study to assess whether a change in control has occurred or whether there have been multiple changes of control since our formation due to the significant complexity and cost associated with such a study and the fact that there could be additional changes in the future. If we have experienced a change of control at any time since our formation, utilization of our NOL or R&#38;D credits carryforwards would be subject to an annual limitation under Sections 382 and 383 which is determined by first multiplying the value of our stock at the time of the ownership change by the applicable long-term tax-exempt rate, and then could be subject to additional adjustments, as required. Any limitation may result in expiration of a portion of our NOL or R&#38;D credits carryforwards before utilization. Tax years 1998 to 2020 remain subject to future examination by the major tax jurisdictions in which we are subject to tax.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Liquidity and Capital Resources</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We had cash, cash equivalents, cash held in escrow and investments totaling $56.9 million and $64.8 million at December 31, 2020 and 2019, respectively. This includes $150,000 of interest-bearing marketable securities classified as restricted investments on our balance sheets as of December 31, 2020 and 2019, which primarily serve as collateral for a letter of credit securing a leased facility in California. The letter of credit for our leased facility in California will expire in February 2024. In February 2021, we raised net proceeds of $47.8 million from an underwritten public offering and other sales of equity under the Controlled Equity Offering program with Cantor Fitzgerald.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We used $38.8 million and $19.8 million of cash in operating activities in the years ended December 31, 2020 and 2018, respectively, and generated $11.1 million of cash in operating activities in the year ended December 31, 2019.&#160;&#160;The cash provided by or used for operations was primarily to fund operations as well as working capital requirements. Our cash provided by or used in operating activities differs from our net loss in part due to the timing and recognition of up-front payments under collaborative agreements. Depending on the nature of the upfront payments received upon execution of collaborative agreements, which can either be recognized as revenue upfront in full or primarily recorded as deferred revenue and generally recognized over the period using a basis that best reflects the satisfaction of our performance obligations with the third-party collaborator pursuant to the applicable agreement.&#160;&#160;The increase in cash used in operating activities in 2020 compared to 2019 was primarily due to lower payments received from collaboration partners and customers, partially offset by the changes in accounts receivable, prepaid expenses and other assets, and accrued and other liabilities. The generation of $11.1 million of cash from operating activities in 2019 was primarily due to the receipt of $35.0 million in payments from Gilead, partially offset by the changes in accounts receivable, inventories, prepaid expenses and other assets, and accrued and other liabilities compared to $19.8 million of cash used in operating activities in 2018. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We generated $24.5 million and $4.5 million of cash from investing activities in the years ended December 31, 2020 and 2018, and used $27.3 million of cash in investing activities in the year ended December 31, 2019, respectively. The increase in cash received from investing activities in 2020 was primarily due to cash received in escrow from the sale of the LACTEL product line in 2020 compared to 2019. The decrease in cash received from investing activities in 2019 was primarily due to a decrease in proceeds from maturities of available-for-sale securities in 2019 compared to 2018. We anticipate incurring capital expenditures of approximately $100,000 over the next 12 months. The amount and timing of these capital expenditures will depend on, among other things, our research and development activities and needs, and the need for equipment replacements.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We generated $15.7 million, $19.5 million, and $17.5 million of cash from financing activities in the years ended December 31, 2020, 2019 and 2018, respectively. The decrease in cash received from financing activities in 2020 was primarily due to lower net proceeds received from issuances of common stock in 2020 compared to 2019. The increase in cash received from financing activities in 2019 was primarily due to higher net proceeds received from issuances of common stock in 2019 compared to 2018. In 2020, we raised net proceeds of approximately $12.3 million from the sale of 5,308,002 shares of the Company&#8217;s common stock in the open market at a weighted average price of $2.39 per share pursuant to the October 2019 registration statement. In June 2019, we entered into a privately negotiated transaction to sell 29,000,000 shares of our common stock to certain investors in a registered offering at a price of $0.52 per share, raising total net proceeds to us of approximately $15 million. In 2019, we also raised net proceeds (net of commission) of approximately $3.5 million from the sale of 2.3 million shares of common stock at a weighted average price of $1.55 per share in the open market through our Controlled Equity Offering sales agreement with Cantor Fitzgerald.&#160;&#160; </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2015, we entered into the 2015 Sales Agreement with Cantor Fitzgerald, acting as agent. As of December 31, 2018, approximately 24.6 million registered shares of common stock were sold through the 2015 Sales Agreement for total net proceeds (net of commissions) of approximately $38.3 million.&#160; In August 2018, we filed a shelf registration statement on Form S-3 with the SEC, which upon being declared effective in October 2018 and allowed us to offer up to $175.0 million of securities from time to time in one or more public offerings, inclusive of up to $75.0 million of additional shares of common stock which we may sell, subject to certain limitations, under the 2015 Sales Agreement through </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:6pt;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cantor Fitzgerald, acting as agent</span><span style="font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Any additional sales in the public market of our common stock, under the Controlled Equity Offering program with Cantor Fitzgerald or otherwise under the October 2018 shelf registration statement, could adversely affect prevailing market prices for our common stock. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2021, we completed an underwritten public offering of 20,364,582 shares of its common stock at a price of $2.2386 per share pursuant to an underwriting agreement with Cantor Fitzgerald&#160;&#38; Co., raising total gross proceeds to us of approximately $45.6 million before deducting estimated offering expenses payable by us. Total stock issuance costs related to this financing were approximately $195,000. After deducting estimated offering expenses payable by us, the net proceeds to us were approximately $45.4 million.&#160;&#160;From January 1, 2021 to March 1, 2021, we also raised net proceeds (net of commissions) of approximately $2.4 million from the sale of 950,009 shares of our common stock in the open market at a weighted average price of $2.60 per share pursuant to the October 2018 registration statement. As of March 1, 2021, we had up to approximately $56.2 million of common stock available for sale under the Controlled Equity Offering program and approximately $45.3 million of common stock available for sale under our shelf registration statement.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July 2016, we entered into a Loan and Security Agreement (the Loan Agreement) with Oxford Finance LLC (Oxford Finance), pursuant to which Oxford Finance provided a $20.0 million secured single-draw term loan to us with an initial maturity date of August&#160;1, 2020. The term loan was fully drawn at close and the proceeds may be used for working capital and general business requirements. The term loan repayment schedule provided initially for interest only payments for the first 18 months, followed by consecutive monthly payments of principal and interest in arrears starting on March&#160;1, 2018 and continuing through the maturity date of August&#160;1, 2020. Following three amendments, we make interest only payments under the amended Loan Agreement until December 1, 2021 and the final maturity date of the loan is May 1, 2024.&#160;&#160;The Loan Agreement provides for a floating interest rate (7.95% initially and 7.95% as of December 31, 2020) based on an index rate plus a spread and an additional payment equal to 10% of the principal amount of the term loan, which is due when the term loan becomes due or upon the prepayment of the facility. If we elect to prepay the loan, there is also a prepayment fee between 0.75% and 2.5% of the principal amount of the term loan depending on the timing of prepayment.&#160;&#160;&#160;Our debt repayment obligations under the Loan Agreement, as amended, may prove a burden to the Company as they become due, particularly following the expiration of the interest-only period.</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term loan is secured by substantially all of our assets, except that the collateral does not include any intellectual property (including licensing, collaboration and similar agreements relating thereto), and certain other excluded assets. The Loan Agreement contains customary representations, warranties and covenants by us, which covenants limit our ability to convey, sell, lease, transfer, assign or otherwise dispose of certain assets&#59; engage in any business other than the businesses currently engaged in by us or reasonably related thereto&#59; liquidate or dissolve&#59; make certain management changes&#59; undergo certain change of control events&#59; create, incur, assume, or be liable with respect to certain indebtedness&#59; grant certain liens&#59; pay dividends and make certain other restricted payments&#59; make certain investments&#59; and make payments on any subordinated debt. </p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Loan Agreement also contains customary indemnification obligations and customary events of default, including, among other things, our&#160;failure to fulfill certain obligations under the 2016 Loan Agreement and the occurrence of a material adverse change which is defined as a material adverse change in our business, operations, or condition (financial or otherwise), a material impairment of the prospect of repayment of any portion of the loan, or a material impairment in the perfection or priority of lender&#8217;s lien in the collateral or in the value of such collateral.&#160;In the event of default by us under the 2016 Loan Agreement, the lender would be entitled to exercise its remedies thereunder, including the right to accelerate the debt, upon which we may be required to repay all amounts then outstanding under the Loan Agreement. As a result, that portion of the term loan that was due more than 12 months after December 31, 20</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> was classified within non-current liabilities</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash used in our operating activities is heavily influenced by the timing and structure of new corporate collaborations. While one feature of our business strategy is seeking new corporate collaborations, assuming no new collaborations and no milestone payments, we anticipate that cash used in operating activities will increase in the near term. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The COVID-19 pandemic is impacting our business in several ways.&#160;&#160;Sales of our ALZET product line were negatively impacted in 2020 by COVID-19 and the future impact on sales of our ALZET product line are uncertain.&#160;&#160;For DUR-928, we may experience delays and increased expenses in the recruitment and running of the ongoing Phase 2b clinical trial in patients with AH, and some patients who completed dosing of the Phase 1b clinical trial in NASH were not able to complete their follow up visits.&#160;&#160;These losses, delays and additional expenses will increase our expenses.&#160;&#160;Additional volatility in capital markets and/or clinical trial delays resulting from the impacts of COVID-19 may also limit our ability to raise capital on acceptable terms, if at all.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe that our existing cash, cash equivalents and investments including proceeds received from our February 2021 stock offering will be sufficient to fund our planned operations, existing debt and contractual commitments and planned capital expenditures through at least the next 12 months from the date the financial statements are filed. We may consume available resources more rapidly than currently anticipated, resulting in the need for additional funding. Additionally, we do not expect to generate significant revenues from our pharmaceutical products currently under development for at least the next twelve months, if at all. Depending on whether we enter into additional collaborative agreements in the near term and the extent to which we earn revenues from our collaborative agreements, we may decide to raise additional capital through a variety of sources, including:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">the public equity markets&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">private equity financings&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">collaborative arrangements&#59; and/or</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">public or private debt.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There can be no assurance that we will enter into additional collaborative agreements or maintain existing collaborative agreements in the near term, will earn collaborative revenues or that additional capital will be available on favorable terms, if at all. If adequate funds are not available, we may be required to significantly reduce or refocus our operations or to obtain funds through arrangements that may require us to relinquish rights to certain of our products, technologies or potential markets, either of which could have a material adverse effect on our business, financial condition and results of operations. To the extent that additional capital is raised through the sale of equity or convertible debt securities, the issuance of such securities would result in ownership dilution to our existing stockholders (assuming convertible debt securities were converted into shares).</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our cash and investments policy emphasizes liquidity and preservation of principal over other portfolio considerations. We select investments that maximize interest income to the extent possible given these two constraints. We satisfy liquidity requirements by investing excess cash in securities with different maturities to match projected cash needs and limit concentration of credit risk by diversifying our investments among a variety of high credit-quality issuers.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 20</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, there were no significant changes in our commercial commitments and contractual obligations.&#160;&#160;In aggregate, we are required to make future payments pursuant to our existing contractual obligations as follows (in thousands</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">):</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual Obligations</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.78%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term loan (1)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,941</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,208</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,563</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,712</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,424</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease obligations</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,933</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,991</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,970</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">275</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,169</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.78%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total contractual cash obligations</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,874</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,199</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,533</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,987</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,593</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:81.2%;text-indent:0%;font-size:6pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Includes principal, interest payments and final payments and assumes no acceleration of obligations.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, as part of its initiative to reduce complexity in the accounting standards, the FASB issued ASU 2019-12, <span style="font-style:italic;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span> (&#8220;ASU 2019-12&#8221;), which eliminates certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company early adopted ASU 2019-12 on January 1, 2020, and this adoption had no material impact on our financial position or results of operations. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2018, the Financial Accounting Standards Board (the FASB) issued ASU No.&#160;2018-18,&#160;<span style="font-style:italic;">Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606&#160;(ASU 2018-18)</span>. ASU 2018-18 clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under Topic 606 when the counterparty is a customer for a distinct good or service (i.e., a unit of account). For units of account that are in the scope of Topic 606, all of the guidance in Topic 606 should be applied, including the guidance on recognition, measurement, presentation and disclosure. ASU 2018-18 also adds a reference in Topic 808 to the unit of account guidance in ASC 606 and requires that it be applied only to assess whether transactions in a collaborative arrangement are in the scope of Topic 606. ASU 2018-18 will preclude entities from presenting amounts related to transactions with a counterparty in a collaborative arrangement that is not a customer as revenue from contracts with customers. ASU 2018-18 is effective for the Company for all interim and annual reporting periods beginning after December 15, 2019.  The adoption of this standard did not have a material effect on the Company&#8217;s financial statements.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2018, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;)<span style="font-size:12pt;">&#160;</span>No. <span style="color:#000000;">2018-13</span><span style="font-style:italic;color:#000000;">, Fair Value Measurement (Topic 820): Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurement</span>, <span style="color:#000000;">which eliminates certain disclosure requirements for fair value measurements for all entities, requires public entities to disclose certain new information and modifies some disclosure requirements. </span>This standard is effective for <span style="color:#000000;">fiscal years </span>beginning after December 15, 2019, including interim reporting periods within those years. The adoption of this standard did not have a material effect on the Company&#8217;s financial statements.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January 2017, the FASB issued ASU No.&#160;2017-04,&#160;<span style="font-style:italic;">Intangibles&#8212;Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,&#160;(ASU 2017-04)</span>.&#160;ASU 2017-04 eliminated Step 2 from the goodwill impairment test. Instead, under the amendments in ASU 2017-04, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value&#59; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax&#160;effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. ASU 2017-04 is effective for all interim and annual reporting periods beginning after December 15, 2019. The adoption of this standard did not have a material effect on the Company&#8217;s financial statements.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">75</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016,&#160;the FASB issued Accounting Standards Update No. 2016-13 (ASU 2016-13)&#160;&#8220;Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments.&#8221;&#160;ASU 2016-13 requires measurement and recognition of expected credit losses for financial assets. This standard is effective for fiscal years beginning after December 15, 20</span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for small reporting companies</span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, including interim reporting periods within those years and must be adopted using a modified retrospective approach, with certain exceptions. Early adoption is permitted.&#160; The Company does not expect the adoption of this standard to have a material effect on its financial statements.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:6pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Off-Balance Sheet Arrangements</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have not utilized &#8220;off-balance sheet&#8221; arrangements to fund our operations or otherwise manage our financial position.</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:10.47%;text-indent:-10.47%;font-weight:bold;;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:10.47%;text-indent:-10.47%;font-weight:bold;;font-size:3pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;7A.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_7A_QUANTITATIVE_QUALITATIVE_DISCLOS">Quantitative and Qualitative Disclosures About Market Risk.</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Interest Rate Risk</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our exposure to market risk for changes in interest rates relates primarily to our investment portfolio and to our term loan. Fixed rate securities and borrowings may have their fair market value adversely impacted due to fluctuations in interest rates, while floating rate securities may produce less income than expected if interest rates fall and floating rate borrowings may lead to additional interest expense if interest rates increase. Due in part to these factors, our future investment income may fall short of expectations due to changes in interest rates or we may suffer losses in principal if forced to sell securities which have declined in market value due to changes in interest rates. Our interest expense on the term loan may rise if the interest rates increase.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our primary investment objective is to preserve principal while at the same time maximizing yields without significantly increasing risk. Our portfolio includes money markets funds, certificates of deposit, commercial paper, corporate debt, and U.S. government agencies. The diversity of our portfolio helps us to achieve our investment objectives. As of December 31, 2020, 97.5% of our investment portfolio was composed of investments with original maturities of one year or less and approximately 48.8% of our investment portfolio matures less than 90 days from the date of purchase.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents the amounts of our cash equivalents and investments that may be subject to interest rate risk and the average interest rates as of December 31, 2020 by year of maturity (dollars in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fixed rate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">522</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Average fixed rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.01</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Variable rate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,097</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Average variable rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.20</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fixed rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,421</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Average fixed rate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.23</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term investments:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fixed rate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,000</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Average fixed rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.23</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted investments:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fixed rate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Average fixed rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.02</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total investment securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,190</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Average rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.20</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents the amounts of our cash equivalents and investments that may be subject to interest rate risk and the average interest rates as of December&#160;31, 2019 by year of maturity (dollars in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fixed rate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">524</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Average fixed rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.53</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Variable rate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,837</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Average variable rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.97</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fixed rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,750</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Average fixed rate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.97</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted investments:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fixed rate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Average fixed rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.39</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total investment securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62,261</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Average rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.93</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the fair value of our term loan was estimated to be $20.8 million. The term loan repayment schedule provides for interest only payments until December 1, 2021, followed by consecutive monthly payments of principal and interest in arrears continuing through the maturity date of the term loan of May 1, 2024. The term loan also provides for a floating interest rate (7.95% as of December 31, 2020) based on an index rate plus a spread and an additional payment equal to 9.25% of the principal amount of the term loan, which has been accrued over the life of the term loan and is due when the term loan becomes due or upon the prepayment of the facility. If the Company elects to prepay the loan, there is also a prepayment fee between 0.75% and 2.5% of the principal amount of the term loan depending on the timing of prepayment. The obligation under the term loan is subject to interest rate risk because the interest rates under the obligation may exceed current interest rates.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;8.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_8_FINANCIAL_STATEMENT_SUPPLEMENTAR"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"></span><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Financial Statement</span><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">s and Supplementary Data.</span></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">DURECT CORPORATION</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">INDEX TO FINANCIAL STATEMENTS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:88.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:4pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:7.5pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Page&#160;No.</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:88.18%;white-space:nowrap;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#REPORT_INDEPENDENT_REGISTERED_PUBLIC_ACC"><span style="text-decoration:none;">Report of Independent Registered Public Accounting Firm</span></a><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></span></p></td>
<td valign="top" style="width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5.9%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:88.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:88.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#BALANCE_SHEETS"><span style="text-decoration:none;">Balance Sheets</span></a><span style="text-decoration:none;"></span></p></td>
<td valign="top" style="width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:88.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:88.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#STATEMENTS_OPERATIONS_COMPREHENSIVE_LOSS"><span style="text-decoration:none;">Statements of Operations and Comprehensive Loss</span></a><span style="text-decoration:none;"></span></p></td>
<td valign="top" style="width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:88.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:88.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#STATEMENT_STOCKHOLDERS_EQUITY"><span style="text-decoration:none;">Statement of Stockholders&#8217; Equity</span></a><span style="text-decoration:none;"></span></p></td>
<td valign="top" style="width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:88.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:88.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#STATEMENTS_CASH_FLOWS"><span style="text-decoration:none;">Statements of Cash Flows</span></a><span style="text-decoration:none;"></span></p></td>
<td valign="top" style="width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</p></td>
</tr>
<tr style="height:1pt;">
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:88.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:88.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#NOTES_TO_FINANCIAL_STATEMENTS"><span style="text-decoration:none;">Notes to Financial Statements</span></a><span style="text-decoration:none;"></span></p></td>
<td valign="top" style="width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:5.9%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;" id="REPORT_INDEPENDENT_REGISTERED_PUBLIC_ACC">Report of Independent Registered Public Accounting Firm </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the Stockholders and the Board of Directors of DURECT Corporation </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Opinion on the Financial Statements </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have audited the accompanying balance sheets of DURECT Corporation (the Company) as of December&#160;31, 2020 and 2019, and the related statements of operations and comprehensive loss, stockholders&#8217; equity, and cash flows for each of the three years in the period ended December&#160;31, 2020, and the related notes and the financial statement schedule listed in the Index at Item&#160;15(a)(2) (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2020, in conformity with U.S. generally accepted accounting principles.&#160; </p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Basis for Opinion</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the <span style="color:#000000;">Public Company Accounting Oversight Board (United States) (</span>PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. <span style="color:#000000;">The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <span style="color:#000000;"> Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Critical audit matter<span style="Background-color:#F4F4F4;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&#160;</sup></span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that&#160;was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that&#160;are material to the financial statements and (2)&#160;involved our especially challenging, subjective, or complex judgments. The&#160;communication of the critical audit matter does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:auto;">
<tr>
<td style="width:24.66%;"></td>
<td style="width:76.3%;"></td>
</tr>
<tr>
<td colspan="2" valign="top" style="padding-left:2.25pt;padding-Right:2.25pt;padding-Top:2.25pt;padding-Bottom:2.25pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Prepaid and accrued contract research expenses</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:2.25pt;padding-Right:2.25pt;padding-Top:2.25pt;padding-Bottom:2.25pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Description of the Matter</p></td>
<td valign="top" style="padding-left:2.25pt;padding-Right:2.25pt;padding-Top:2.25pt;padding-Bottom:2.25pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2020, the Company incurred $27,709 thousand in research and development related expenses, of which $545 thousand was accrued as of December 31, 2020. The Company also has $2,829 thousand in prepaid clinical expenses as of December 31, 2020. As described in Note 1 of the financial statements, the Company records accruals for its estimated costs of research and development activities, including contract services for clinical trials and related clinical manufacturing costs. Clinical trial activities performed by third parties are recorded based upon estimates of the proportion of work completed over the life of the individual clinical trial and patient enrollment rates in accordance with agreements established with third-party consultants and organizations. Estimates are determined by reviewing contracts, vendor agreements and purchase orders, and through detailed discussions with internal clinical personnel and external service providers as to the progress or stage of completion of trials or services and then applying these estimates of completion to previously agreed-upon rates and fees to be paid for such services.</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Auditing management&#8217;s accounting estimates for both prepaid and accrued contract research expenses was especially challenging as evaluating the nature, progress, and stage of completion of the activities being performed under the Company&#8217;s research and development agreements is dependent upon the accumulation of a high volume of information from internal clinical personnel and third-party service providers.</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79</p>
<hr style="page-break-after:always" />
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:auto;">
<tr>
<td style="width:24.66%;"></td>
<td style="width:76.3%;"></td>
</tr>
<tr>
<td valign="top" style="padding-left:2.25pt;padding-Right:2.25pt;padding-Top:2.25pt;padding-Bottom:2.25pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">How We Addressed the Matter in Our Audit</span></p></td>
<td valign="top" style="padding-left:2.25pt;padding-Right:2.25pt;padding-Top:2.25pt;padding-Bottom:2.25pt;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the accounting for prepaid and accrued research and development expenses, including controls over management&#8217;s review of clinical trial progress and manufacturing activities in comparison to budgets and invoices received from third parties.&#160;&#160; </p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Among others, our audit procedures included obtaining supporting evidence of the research and development activities performed for significant clinical trials and attending internal clinical trial and project status meetings with accounting personnel and clinical project managers to corroborate the status of significant research and development activities. We also obtained and read significant agreements and agreement amendments with the Company&#8217;s third-party consultants and contract research organizations, examined the Company&#8217;s documentation of trial timelines and future projections of trial progress and compared them to the Company&#8217;s calculation of the estimated accrual or prepaid, and selected a sample of agreements and confirmed directly with the third parties the expenses incurred and the completeness of the terms of the arrangement. We also inspected invoices received after the balance sheet date to determine whether the services were performed prior to or after the balance sheet date and were properly recorded.</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ ERNST&#160;&#38; YOUNG LLP</p>
<p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have served as the Company&#8217;s auditor since 1998.</p>
<p style="margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Redwood City, California </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 5, 2021</p>
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">DURECT CORPORATION</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;" id="BALANCE_SHEETS">BALANCE SHEETS</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except per share amounts)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">A S S E T S</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current assets:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000034" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,312</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000035" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">34,924</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash held in escrow</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000036" name="us-gaap:EscrowDeposit" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">14,979</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000037" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,421</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000038" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">29,750</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable (net of allowances of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000100" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="C_0001082038_20201231" decimals="-3" scale="3">72</ix:nonFraction> at December 31, 2020</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000101" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="C_0001082038_20191231" decimals="-3" scale="3">27</ix:nonFraction> at December 31, 2019)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000039" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_0001082038_20201231" decimals="-3" scale="3">940</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000040" name="us-gaap:AccountsReceivableNetCurrent" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,516</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000041" name="us-gaap:InventoryNet" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,864</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000042" name="us-gaap:InventoryNet" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,919</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000043" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,545</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000044" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,424</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discontinued operations, current portion</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000045" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,296</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000046" name="us-gaap:AssetsCurrent" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">63,061</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000047" name="us-gaap:AssetsCurrent" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">71,829</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000048" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001082038_20201231" decimals="-3" scale="3">251</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000049" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001082038_20191231" decimals="-3" scale="3">159</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000050" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,749</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000051" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,866</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000052" name="us-gaap:Goodwill" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,169</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000053" name="us-gaap:Goodwill" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,399</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term investments</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000054" name="us-gaap:LongTermInvestments" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term restricted investments</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000055" name="us-gaap:RestrictedInvestmentsNoncurrent" contextRef="C_0001082038_20201231" decimals="-3" scale="3">150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000056" name="us-gaap:RestrictedInvestmentsNoncurrent" contextRef="C_0001082038_20191231" decimals="-3" scale="3">150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other long-term assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000057" name="us-gaap:OtherAssetsNoncurrent" contextRef="C_0001082038_20201231" decimals="-3" scale="3">261</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000058" name="us-gaap:OtherAssetsNoncurrent" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,085</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discontinued operations, non-current portion</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000059" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" contextRef="C_0001082038_20191231" decimals="-3" scale="3">532</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000060" name="us-gaap:Assets" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">75,641</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000061" name="us-gaap:Assets" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">86,020</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">L I A B I L I T I E S&#160;&#160;A N D&#160;&#160;S T O C K H O L D E R S&#8217;&#160;&#160;E Q U I T Y</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current liabilities:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000062" name="us-gaap:AccountsPayableCurrent" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,678</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000063" name="us-gaap:AccountsPayableCurrent" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,982</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000064" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,801</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000065" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,940</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contract research liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000066" name="drrx:ContractResearchLiability" contextRef="C_0001082038_20201231" decimals="-3" scale="3">545</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000067" name="drrx:ContractResearchLiability" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,653</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue, current portion</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000068" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,679</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term loan, current portion, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000069" name="us-gaap:LongTermDebtCurrent" contextRef="C_0001082038_20201231" decimals="-3" scale="3">884</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities, current portion</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000070" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,795</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000071" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,742</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discontinued operations, current portion</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000072" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" contextRef="C_0001082038_20191231" decimals="-3" scale="3">772</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000073" name="us-gaap:LiabilitiesCurrent" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,703</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000074" name="us-gaap:LiabilitiesCurrent" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">36,768</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue, non-current portion</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000075" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_0001082038_20201231" decimals="-3" scale="3">812</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000076" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" contextRef="C_0001082038_20191231" decimals="-3" scale="3">812</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities, non-current portion</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000077" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,202</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000078" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,356</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term loan, non-current portion, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000079" name="us-gaap:LongTermDebtNoncurrent" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,936</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000080" name="us-gaap:LongTermDebtNoncurrent" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,262</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other long-term liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000081" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="C_0001082038_20201231" decimals="-3" scale="3">873</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000082" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="C_0001082038_20191231" decimals="-3" scale="3">705</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discontinued operations, non-current portion</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000083" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" contextRef="C_0001082038_20191231" decimals="-3" scale="3">257</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commitments and contingencies</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000084">&#160;</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000085">&#160;</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stockholders&#8217; equity:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preferred stock, $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000102" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="C_0001082038_20201231" decimals="INF"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000103" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="C_0001082038_20191231" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction> par value: <ix:nonFraction unitRef="U_xbrlishares" id="F_000104" name="us-gaap:PreferredStockSharesAuthorized" contextRef="C_0001082038_20201231" decimals="INF" format="ixt:numdotdecimal" scale="3"><ix:nonFraction unitRef="U_xbrlishares" id="F_000105" name="us-gaap:PreferredStockSharesAuthorized" contextRef="C_0001082038_20191231" decimals="INF" format="ixt:numdotdecimal" scale="3">10,000</ix:nonFraction></ix:nonFraction> shares authorized&#59; <ix:nonFraction unitRef="U_xbrlishares" id="F_000106" name="us-gaap:PreferredStockSharesIssued" contextRef="C_0001082038_20201231" decimals="INF" format="ixt-sec:numwordsen" scale="3"><ix:nonFraction unitRef="U_xbrlishares" id="F_000108" name="us-gaap:PreferredStockSharesOutstanding" contextRef="C_0001082038_20201231" decimals="INF" format="ixt-sec:numwordsen" scale="3"><ix:nonFraction unitRef="U_xbrlishares" id="F_000107" name="us-gaap:PreferredStockSharesIssued" contextRef="C_0001082038_20191231" decimals="INF" format="ixt-sec:numwordsen" scale="3"><ix:nonFraction unitRef="U_xbrlishares" id="F_000109" name="us-gaap:PreferredStockSharesOutstanding" contextRef="C_0001082038_20191231" decimals="INF" format="ixt-sec:numwordsen" scale="3">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>ne issued</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; and outstanding</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000086">&#8212;</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000087">&#8212;</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock, $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000110" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_0001082038_20201231" decimals="INF"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000111" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_0001082038_20191231" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction> par value: <ix:nonFraction unitRef="U_xbrlishares" id="F_000112" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_0001082038_20201231" decimals="INF" format="ixt:numdotdecimal" scale="3"><ix:nonFraction unitRef="U_xbrlishares" id="F_000113" name="us-gaap:CommonStockSharesAuthorized" contextRef="C_0001082038_20191231" decimals="INF" format="ixt:numdotdecimal" scale="3">350,000</ix:nonFraction></ix:nonFraction> shares authorized&#59; <ix:nonFraction unitRef="U_xbrlishares" id="F_000114" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3"><ix:nonFraction unitRef="U_xbrlishares" id="F_000116" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">203,533</ix:nonFraction></ix:nonFraction></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; and <ix:nonFraction unitRef="U_xbrlishares" id="F_000117" name="us-gaap:CommonStockSharesOutstanding" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3"><ix:nonFraction unitRef="U_xbrlishares" id="F_000115" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">195,257</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31, 2020</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; and 2019, respectively</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000088" name="us-gaap:CommonStockValue" contextRef="C_0001082038_20201231" decimals="-3" scale="3">20</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000089" name="us-gaap:CommonStockValue" contextRef="C_0001082038_20191231" decimals="-3" scale="3">19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional paid-in capital</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000090" name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">529,884</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000091" name="us-gaap:AdditionalPaidInCapitalCommonStock" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">512,046</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated other comprehensive loss</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000092" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="C_0001082038_20201231" decimals="-3" sign="-" scale="3">5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000093" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="C_0001082038_20191231" decimals="-3" sign="-" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated deficit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000094" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_0001082038_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">489,784</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000095" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_0001082038_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">489,202</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stockholders&#8217; equity</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000096" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">40,115</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000097" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,860</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities and stockholders&#8217; equity</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000098" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">75,641</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000099" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">86,020</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these financial statements.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81</p>
<hr style="page-break-after:always" />

<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">DURECT CORPORATION</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;" id="STATEMENTS_OPERATIONS_COMPREHENSIVE_LOSS">STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except per share amounts)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Collaborative research and development and other revenue</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000118" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">23,941</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000119" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">18,129</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000120" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,207</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product revenue, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000121" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,170</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000122" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,945</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000123" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,068</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenues</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000124" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">30,111</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000125" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">25,074</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000126" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,275</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of product revenues</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000127" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,406</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000128" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,263</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000129" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,640</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000133" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">27,709</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000134" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">29,640</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000135" name="us-gaap:ResearchAndDevelopmentExpense" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">25,013</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000136" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,611</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000137" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">14,115</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000138" name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,262</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000139" name="us-gaap:CostsAndExpenses" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">42,726</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000140" name="us-gaap:CostsAndExpenses" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">45,018</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000141" name="us-gaap:CostsAndExpenses" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">38,915</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000142" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">12,615</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000143" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001082038_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">19,944</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000144" name="us-gaap:OperatingIncomeLoss" contextRef="C_0001082038_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">23,640</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income (expense):</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest and other income</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000145" name="us-gaap:OtherNonoperatingIncome" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">517</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000146" name="us-gaap:OtherNonoperatingIncome" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,074</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000147" name="us-gaap:OtherNonoperatingIncome" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">870</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000148" name="us-gaap:InterestExpense" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,237</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000149" name="us-gaap:InterestExpense" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,501</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000150" name="us-gaap:InterestExpense" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,573</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net other income (expense)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000151" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">1,720</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000152" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_0001082038_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">1,427</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000153" name="us-gaap:NonoperatingIncomeExpense" contextRef="C_0001082038_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">1,703</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from continuing operations</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000154" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">14,335</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000155" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001082038_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">21,371</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000156" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="C_0001082038_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">25,343</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income from discontinued operations (Note 10)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000157" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,753</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000158" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">793</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000159" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">21</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000160" name="us-gaap:NetIncomeLoss" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" scale="3">582</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000161" name="us-gaap:NetIncomeLoss" contextRef="C_0001082038_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">20,578</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000162" name="us-gaap:NetIncomeLoss" contextRef="C_0001082038_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">25,322</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net change in unrealized gain on available-for-sale</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; securities, net of tax</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000163" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000164" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001082038_20190101_20191231" decimals="-3" sign="-" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000165" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total comprehensive loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000166" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" scale="3">584</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000167" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_0001082038_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">20,581</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000168" name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="C_0001082038_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">25,321</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income (loss) per share</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Loss from continuing operations</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000169" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="C_0001082038_20200101_20201231" decimals="2" sign="-">0.07</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000170" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="C_0001082038_20190101_20191231" decimals="2" sign="-">0.12</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000171" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="C_0001082038_20180101_20181231" decimals="2" sign="-">0.16</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income from discontinued operations</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000172" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextRef="C_0001082038_20200101_20201231" decimals="2">0.07</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000173" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextRef="C_0001082038_20190101_20191231" decimals="2">0.00</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000174" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextRef="C_0001082038_20180101_20181231" decimals="2">0.00</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per common share, basic and diluted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000175" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" contextRef="C_0001082038_20200101_20201231" decimals="2">0.00</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000176" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" contextRef="C_0001082038_20190101_20191231" decimals="2" sign="-">0.12</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000177" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" contextRef="C_0001082038_20180101_20181231" decimals="2" sign="-">0.16</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average shares used in computing net income (loss) per share, basic and diluted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000178" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">199,457</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000179" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">178,042</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000180" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">159,834</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these financial statements<span style="font-family:Calibri;">.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">DURECT CORPORATION</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;" id="STATEMENT_STOCKHOLDERS_EQUITY">STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.9%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Common Stock</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additional</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Paid-In</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Other</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:7.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stockholders&#8217;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Capital</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Income (loss)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deficit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.96%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Equity</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2017</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000181" name="us-gaap:SharesOutstanding" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20171231" decimals="INF" format="ixt:numdotdecimal" scale="3">150,837</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000182" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20171231" decimals="-3" scale="3">15</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000183" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20171231" decimals="-3" format="ixt:numdotdecimal" scale="3">465,246</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000184" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20171231" decimals="-3" sign="-" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000185" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20171231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">443,772</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000186" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_20171231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,488</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon exercise of stock</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; options and purchases of ESPP shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000187" name="drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231" decimals="INF" format="ixt:numdotdecimal" scale="3">1,594</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000188" name="drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,725</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000189" name="drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,725</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon equity financings,</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; net of issuance costs of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000250" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">566</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000190" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231" decimals="INF" format="ixt:numdotdecimal" scale="3">9,629</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000191" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000192" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">16,779</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000193" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">16,780</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of fully vested options to settle accrued</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000194" name="drrx:AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,860</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000195" name="drrx:AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,860</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense from stock</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; options and ESPP shares</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000196" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,998</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000197" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,998</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000198" name="us-gaap:NetIncomeLoss" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">25,322</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000199" name="us-gaap:NetIncomeLoss" contextRef="C_0001082038_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">25,322</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in unrealized gain on available-for-sale</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; securities, net of tax</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000200" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000201" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustment due to changes in accounting policies</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000202" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_srtRestatementAxis_srtRevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231" decimals="-3" scale="3">470</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000203" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_srtRestatementAxis_srtRevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember_20181231" decimals="-3" scale="3">470</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2018</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000204" name="us-gaap:SharesOutstanding" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231" decimals="INF" format="ixt:numdotdecimal" scale="3">162,060</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000205" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231" decimals="-3" scale="3">16</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000206" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">488,608</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000207" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">468,624</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000208" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon exercise of stock</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; options and purchases of ESPP shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000209" name="drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal" scale="3">1,847</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000210" name="drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,979</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000211" name="drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,979</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon equity financings,</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; net of issuance costs of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000251" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">356</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000212" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal" scale="3">31,350</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000213" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000214" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">18,357</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000215" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">18,360</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of fully vested options to settle accrued</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000216" name="drrx:AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" scale="3">994</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000217" name="drrx:AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">994</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense from stock</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; options and ESPP shares</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000218" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,108</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000219" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,108</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000220" name="us-gaap:NetIncomeLoss" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">20,578</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000221" name="us-gaap:NetIncomeLoss" contextRef="C_0001082038_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">20,578</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in unrealized gain on available-for-sale</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; securities, net of tax</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000222" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231" decimals="-3" sign="-" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000223" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextRef="C_0001082038_20190101_20191231" decimals="-3" sign="-" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000224" name="us-gaap:SharesOutstanding" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231" decimals="INF" format="ixt:numdotdecimal" scale="3">195,257</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000225" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231" decimals="-3" scale="3">19</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000226" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">512,046</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000227" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231" decimals="-3" sign="-" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000228" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">489,202</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000229" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,860</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon exercise of stock</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; options and purchases of ESPP shares</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000230" name="drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal" scale="3">2,968</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000231" name="drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000232" name="drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,381</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000233" name="drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,381</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issuance of common stock upon equity financings,</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; net of issuance costs of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000252" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">380</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000234" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal" scale="3">5,308</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000235" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000236" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,282</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000237" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,283</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense from stock</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; options and ESPP shares</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000238" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,175</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000239" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,175</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000240" name="us-gaap:NetIncomeLoss" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231" decimals="-3" sign="-" scale="3">582</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000241" name="us-gaap:NetIncomeLoss" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" scale="3">582</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in unrealized loss on available-for-sale</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; securities, net of tax</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000242" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231" decimals="-3" sign="-" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000243" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000244" name="us-gaap:SharesOutstanding" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231" decimals="INF" format="ixt:numdotdecimal" scale="3">203,533</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000245" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231" decimals="-3" scale="3">20</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000246" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">529,884</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:double 2.5pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000247" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231" decimals="-3" sign="-" scale="3">5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:double 2.5pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000248" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">489,784</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:double 2.5pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.96%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000249" name="us-gaap:StockholdersEquity" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">40,115</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these financial statements.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83</p>
<hr style="page-break-after:always" />

<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">DURECT CORPORATION</p>
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;" id="STATEMENTS_CASH_FLOWS">STATEMENTS OF CASH FLOWS</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:6pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash flows from operating activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000253" name="us-gaap:ProfitLoss" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" scale="3">582</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000254" name="us-gaap:ProfitLoss" contextRef="C_0001082038_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">20,578</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000255" name="us-gaap:ProfitLoss" contextRef="C_0001082038_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">25,322</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustments to reconcile net loss to net cash used in operating</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; activities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000256" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">297</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000257" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">291</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000258" name="us-gaap:DepreciationDepletionAndAmortization" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">254</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000259" name="us-gaap:ShareBasedCompensation" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,170</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000260" name="us-gaap:ShareBasedCompensation" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,108</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000261" name="us-gaap:ShareBasedCompensation" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,998</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory write-down</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000262" name="us-gaap:InventoryWriteDown" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">194</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000263" name="us-gaap:InventoryWriteDown" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">255</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000264" name="us-gaap:InventoryWriteDown" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">291</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of debt issuance cost</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000265" name="us-gaap:AmortizationOfFinancingCosts" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">453</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000266" name="us-gaap:AmortizationOfFinancingCosts" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">369</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000267" name="us-gaap:AmortizationOfFinancingCosts" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">149</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net accretion/amortization on investments</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000268" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">313</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000269" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="C_0001082038_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">87</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000270" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" contextRef="C_0001082038_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">84</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in operating lease liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000271" name="drrx:ChangesInOperatingLeaseLiabilities" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" scale="3">61</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000272" name="drrx:ChangesInOperatingLeaseLiabilities" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">215</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on sale of LACTEL product line</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000273" name="us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,845</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in assets and liabilities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000274" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">389</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000275" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">556</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000276" name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="C_0001082038_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">619</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000277" name="us-gaap:IncreaseDecreaseInInventories" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">249</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000278" name="us-gaap:IncreaseDecreaseInInventories" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">217</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000279" name="us-gaap:IncreaseDecreaseInInventories" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">549</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000280" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,178</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000281" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_0001082038_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">786</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000282" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">15</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000283" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" scale="3">241</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000284" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">520</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000285" name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">69</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000286" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">49</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000287" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,894</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000288" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,594</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contract research liability</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000289" name="drrx:IncreaseDecreaseInContractResearchLiability" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">3,108</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000290" name="drrx:IncreaseDecreaseInContractResearchLiability" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,248</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000291" name="drrx:IncreaseDecreaseInContractResearchLiability" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">571</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000292" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">22,679</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000293" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,679</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000294" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" contextRef="C_0001082038_20180101_20181231" decimals="-3" sign="-" scale="3">493</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total adjustments</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000295" name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">38,122</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000296" name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">31,679</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000297" name="us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,572</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash (used in) provided by operating activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000298" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">38,704</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000299" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">11,101</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000300" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="C_0001082038_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">19,750</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash flows from investing activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchases of property and equipment</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000301" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">208</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000302" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">155</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000303" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">93</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchases of available-for-sale securities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000304" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">45,066</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000305" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">31,866</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000306" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,588</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceeds from maturities of available-for-sale securities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000307" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">54,706</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000308" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,697</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000309" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">14,218</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by (used in) investing activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000310" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,432</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000311" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_0001082038_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">27,324</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000312" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,537</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash flows from financing activities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payments on equipment financing obligations</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000313" name="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000314" name="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">7</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000315" name="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">9</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net proceeds from issuances of common stock upon exercise of</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; stock options, and purchases of ESPP shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000316" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,381</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000317" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,979</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000318" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,725</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net proceeds from issuances of common stock in connection with</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; equity financings</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000319" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,283</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000320" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">18,360</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000321" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">16,780</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term loan amendment cost</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000322" name="us-gaap:RepaymentsOfLongTermDebt" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">829</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000323" name="us-gaap:RepaymentsOfLongTermDebt" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,014</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by financing activities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000324" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,660</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000325" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,503</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000326" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">17,482</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net (decrease) increase in cash and cash equivalents</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000327" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">13,612</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000328" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,280</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000329" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,269</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash, cash equivalents, and restricted cash, beginning of the</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; period (1)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000330" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">35,074</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000331" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_0001082038_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">31,794</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000332" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_0001082038_20171231" decimals="-3" format="ixt:numdotdecimal" scale="3">29,525</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash, cash equivalents, and restricted cash, end of the period (1)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000333" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,462</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000334" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">35,074</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000335" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="C_0001082038_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">31,794</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Supplemental disclosure of cash flow information</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for interest</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000336" name="us-gaap:InterestPaidNet" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,678</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000337" name="us-gaap:InterestPaidNet" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,942</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000338" name="us-gaap:InterestPaidNet" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,886</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Supplementary disclosure of non-cash investing and financing information</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash held in escrow</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000339" name="us-gaap:EscrowDepositsRelatedToPropertySales" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">14,979</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fully vested options issued to settle accrued liabilities</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000340" name="us-gaap:StockIssued1" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">994</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000341" name="us-gaap:StockIssued1" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,860</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets obtained in exchange for</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; operating lease obligations (2)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000342" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,329</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td colspan="12" valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:99%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1) <ix:footnote id="FNT_000000" xml:lang="en-US">Includes restricted cash of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000343" name="us-gaap:RestrictedCash" contextRef="C_0001082038_us-gaapBalanceSheetLocationAxis_drrxLongTermRestrictedInvestmentsMember_20201231" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_iso4217USD" id="F_000344" name="us-gaap:RestrictedCash" contextRef="C_0001082038_us-gaapBalanceSheetLocationAxis_drrxLongTermRestrictedInvestmentsMember_20191231" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_iso4217USD" id="F_000345" name="us-gaap:RestrictedCash" contextRef="C_0001082038_us-gaapBalanceSheetLocationAxis_drrxLongTermRestrictedInvestmentsMember_20181231" decimals="0" format="ixt:numdotdecimal">150,000</ix:nonFraction></ix:nonFraction></ix:nonFraction> (presented as long-term restricted investments) on the balance sheets at each of December 31, 2020, 2019 and 2018.</ix:footnote></p></td>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td colspan="12" valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:99%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2) <ix:footnote id="FNT_000001" xml:lang="en-US">Amounts for the twelve months ended December 31, 2019 include the transition adjustment for the adoption of Accounting Standards Update ("ASU" No. 2016-02, Leases ("Topic 842").</ix:footnote></p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying notes are an integral part of these financial statements<span style="font-family:Calibri;">.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">DURECT CORPORATION</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;" id="NOTES_TO_FINANCIAL_STATEMENTS">NOTES TO FINANCIAL STATEMENTS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;">&#160;</p><ix:nonNumeric id="F_000346" name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000346_dcnt_784c14e2-a829-4af0-97b4-0d6f45f83d75">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">1.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="font-weight:normal;color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Summary of Significant Accounting Policies</span></p></td></tr></table></div><ix:nonNumeric id="F_000358" name="drrx:NatureOfOperationsPolicyTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Nature of Operations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DURECT Corporation (the Company) was incorporated in the state of Delaware on <ix:nonNumeric id="F_000401" name="dei:EntityIncorporationDateOfIncorporation" contextRef="C_0001082038_20200101_20201231" format="ixt:datemonthdayyearen">February&#160;6, 1998</ix:nonNumeric>. The Company is a biopharmaceutical company with research and development programs broadly falling into two categories: (i)&#160;new chemical entities derived from our Epigenetics Regulator Program, in which the Company attempts to discover and develop molecules which have not previously been approved and marketed as therapeutics, and (ii)&#160;Proprietary Pharmaceutical Programs, in which the Company applies its formulation expertise and technologies largely to active pharmaceutical ingredients whose safety and efficacy have previously been established but which the Company aims to improve in some manner through a new formulation. The Company has several products under development by itself and with third party collaborators. The Company also manufactures and sells osmotic pumps used in laboratory research, and manufactures certain excipients for certain clients for use as raw materials in their products. In addition, the Company conducts research and development of pharmaceutical products in collaboration with third party pharmaceutical and biotechnology companies.</p></ix:nonNumeric><ix:nonNumeric id="F_000359" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Basis of Presentation and Use of Estimates</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP). The preparation of the accompanying Financial Statements conforms to accounting principles generally accepted in the U.S. which requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. On an ongoing basis, management evaluates its estimates including, but not limited to, those related to revenue recognition, the period of performance, identification of deliverables and evaluation of milestones with respect to our collaborations, the amounts of revenues, recoverability of inventory, certain accrued liabilities including accrued clinical trial liability, and stock-based compensation. The Company bases its estimates on historical experience and on various other market-specific and other relevant assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.</p></ix:nonNumeric><ix:nonNumeric id="F_000360" name="drrx:DiscontinuedOperationsTextblock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Discontinued Operations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2020, the Company announced its decision to sell its LACTEL Absorbable Polymer (LACTEL) product line to Evonik, which was completed on December 31, 2020. The accompanying financial statements have been recast for all periods presented to reflect the assets, liabilities, revenue and expenses related to the Company&#8217;s LACTEL product line as discontinued operations (see Note 10).&#160;The Company believes this format provides comparability with its previously filed financial statements.</p></ix:nonNumeric><ix:nonNumeric id="F_000361" name="drrx:LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000361_dcnt_1a7da035-9727-47d3-b066-aabd853df712">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Liquidity and Need to Raise Additional Capital</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the Company has an accumulated deficit of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000402" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_0001082038_20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" scale="6">489.8</ix:nonFraction> million as well as negative cash flows from operating activities.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company generally has had negative cash flows from operating activities and expects its negative cash flows to continue.&#160;&#160;The Company will continue to require substantial funds to continue research and development, including clinical trials of its product candidates.&#160; Management&#8217;s plans in order to meet its operating cash flow requirements beyond the next 12 months from the date the financial statements are filed, may include seeking additional collaborative agreements for certain of its programs and achieving revenue from its collaboration and licensing agreements as well as financing activities such </p></ix:nonNumeric></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">85</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000346_dcnt_784c14e2-a829-4af0-97b4-0d6f45f83d75" continuedAt="F_000346_dcnt_f4119512-f205-4410-b01f-ac6709c7a9ab"><ix:continuation id="F_000361_dcnt_1a7da035-9727-47d3-b066-aabd853df712">
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">as public offerings and private placements of its common stock, preferred stock offerings, issuances of debt and convertible debt instruments.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are no assurances that such additional funding will be obtained and that the Company will succeed in its future operations. If the Company cannot successfully raise additional capital when needed and implement its strategic development plan, its liquidity, financial condition and business prospects will be materially and adversely affected.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company believes its existing cash, cash equivalents, cash held in escrow, investments and subsequent equity fund raising completed in February 2021 (see Note 11) are sufficient to fund its operating cashflow requirements for a period greater than 12 months from the date of issuance of these financial statements.</p></ix:continuation><ix:nonNumeric id="F_000362" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Cash, Cash Equivalents and Investments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers all highly liquid investments with maturities of <ix:nonNumeric id="F_000403" name="drrx:LiquidInvestmentsMaturityPeriodDescriptionMaximum" contextRef="C_0001082038_20200101_20201231">90 days or less</ix:nonNumeric> from the date of purchase to be cash equivalents. Investments with original maturities of greater than <ix:nonNumeric id="F_000405" name="drrx:ShortTermInvestmentMaturityPeriod" contextRef="C_0001082038_srtRangeAxis_srtMinimumMember_20200101_20201231" format="ixt-sec:durday">90</ix:nonNumeric> days from the date of purchase but less than <ix:nonNumeric id="F_000406" name="drrx:ShortTermInvestmentMaturityPeriod" contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_20200101_20201231" format="ixt-sec:durwordsen">one year</ix:nonNumeric> from the balance sheet date are classified as short-term investments, while investments with maturities in <ix:nonNumeric id="F_000404" name="drrx:LongTermInvestmentsMaturityPeriodDescriptionMinimum" contextRef="C_0001082038_20200101_20201231">one year or beyond</ix:nonNumeric> one year from the balance sheet date are classified as long-term investments. Management determines the appropriate classification of its cash equivalents and investment securities at the time of purchase and re-evaluates such determination as of each balance sheet date. Management has classified the Company&#8217;s cash equivalents and investments as available-for-sale securities in the accompanying financial statements. Available-for-sale securities are carried at fair value, with unrealized gains and losses reported as a component of accumulated other comprehensive loss. Realized gains and losses are included in interest income. There were <ix:nonFraction unitRef="U_iso4217USD" id="F_000407" name="us-gaap:RealizedInvestmentGainsLosses" contextRef="C_0001082038_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000408" name="us-gaap:RealizedInvestmentGainsLosses" contextRef="C_0001082038_20190101_20191231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> material realized gains or losses in the periods presented. The cost of securities sold is based on the specific identification method.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company invests in debt instruments of government agencies, corporations, and money market funds with high credit ratings. The Company has established guidelines regarding diversification of its investments and their maturities with the objectives of maintaining safety and liquidity, while maximizing yield.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash held in escrow (related to the sale of the LACTEL product line) was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000409" name="drrx:CashHeldInEscrow" contextRef="C_0001082038_srtProductOrServiceAxis_drrxLactelProductLineMember_20201231" decimals="-6" scale="6">15</ix:nonFraction> million as of December 31, 2020&#59; the $<ix:nonFraction unitRef="U_iso4217USD" id="F_000410" name="drrx:PaymentFromEscrow" contextRef="C_0001082038_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210131" decimals="-6" scale="6">15</ix:nonFraction> million which was released from escrow in January 2021.</p></ix:nonNumeric><ix:nonNumeric id="F_000363" name="us-gaap:ConcentrationRiskCreditRisk" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000363_dcnt_4878354c-dee5-4142-8c88-0c9984309dc3">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Concentrations of Credit Risk</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to credit risk consist principally of interest-bearing investments and trade receivables. The Company maintains cash, cash equivalents and investments with various major financial institutions. The Company performs periodic evaluations of the relative credit standing of these financial institutions. In addition, the Company performs periodic evaluations of the relative credit quality of its investments.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pharmaceutical companies and academic institutions account for a substantial portion of the Company&#8217;s trade receivables. The Company provides credit in the normal course of business to its customers and collateral for these receivables is generally not required. The risk associated with this concentration is limited to a certain extent due to the large number of accounts and their geographic dispersion. The Company monitors the creditworthiness of its customers to which it grants credit terms in the normal course of business. The Company maintains reserves for estimated credit losses and, to date, such losses have been immaterial in all periods presented.</p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000346_dcnt_f4119512-f205-4410-b01f-ac6709c7a9ab" continuedAt="F_000346_dcnt_1a40642c-aa07-4c37-91eb-48f40eaa6fe4"><ix:continuation id="F_000363_dcnt_4878354c-dee5-4142-8c88-0c9984309dc3">
</ix:continuation><ix:nonNumeric id="F_000364" name="us-gaap:MajorCustomersPolicyPolicyTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Customer and Product Line Concentrations (excluding the LACTEL product line)</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A portion of the Company&#8217;s revenue is derived from its ALZET osmotic pump product line, and the sale of certain excipients for Methydur and one excipient that is included in a marketed animal health product. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue from the sale of products from the ALZET product line accounted for <ix:nonFraction unitRef="U_xbrlipure" id="F_000411" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001082038_srtProductOrServiceAxis_drrxAlzetProductLineMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapProductConcentrationRiskMember_20200101_20201231" decimals="2" scale="-2">20</ix:nonFraction>%, <ix:nonFraction unitRef="U_xbrlipure" id="F_000412" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001082038_srtProductOrServiceAxis_drrxAlzetProductLineMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapProductConcentrationRiskMember_20190101_20191231" decimals="2" scale="-2">27</ix:nonFraction>% and <ix:nonFraction unitRef="U_xbrlipure" id="F_000413" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001082038_srtProductOrServiceAxis_drrxAlzetProductLineMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapProductConcentrationRiskMember_20180101_20181231" decimals="2" scale="-2">46</ix:nonFraction>% of total revenue for 2020, 2019 and 2018, respectively. &#160; &#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gilead accounted for <ix:nonFraction unitRef="U_xbrlipure" id="F_000414" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001082038_srtMajorCustomersAxis_drrxGileadMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231" decimals="2" scale="-2">76</ix:nonFraction>% and <ix:nonFraction unitRef="U_xbrlipure" id="F_000415" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001082038_srtMajorCustomersAxis_drrxGileadMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231" decimals="2" scale="-2">68</ix:nonFraction>% of the Company&#8217;s total revenue for 2020 and 2019, respectively. In 2018, Indivior and Gilead accounted for <ix:nonFraction unitRef="U_xbrlipure" id="F_000417" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001082038_srtMajorCustomersAxis_drrxIndiviorMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20180101_20181231" decimals="2" scale="-2">33</ix:nonFraction>% and <ix:nonFraction unitRef="U_xbrlipure" id="F_000416" name="us-gaap:ConcentrationRiskPercentage1" contextRef="C_0001082038_srtMajorCustomersAxis_drrxGileadMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20180101_20181231" decimals="2" scale="-2">17</ix:nonFraction>% of the Company&#8217;s total revenues, respectively. </p><ix:nonNumeric id="F_000378" name="us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue by geographic region for the years 2020, 2019 and 2018 are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000418" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtStatementGeographicalAxis_countryUS_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">26,894</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000419" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtStatementGeographicalAxis_countryUS_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,957</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000420" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtStatementGeographicalAxis_countryUS_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">7,058</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Europe</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000421" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtStatementGeographicalAxis_srtEuropeMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,386</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000422" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtStatementGeographicalAxis_srtEuropeMember_20190101_20191231" decimals="-3" scale="3">906</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000423" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtStatementGeographicalAxis_srtEuropeMember_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,476</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Japan</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000424" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtStatementGeographicalAxis_countryJP_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,174</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000425" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtStatementGeographicalAxis_countryJP_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,472</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000426" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtStatementGeographicalAxis_countryJP_20180101_20181231" decimals="-3" scale="3">975</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Others</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000427" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtStatementGeographicalAxis_drrxOtherForeignCountriesMember_20200101_20201231" decimals="-3" scale="3">657</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000428" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtStatementGeographicalAxis_drrxOtherForeignCountriesMember_20190101_20191231" decimals="-3" scale="3">739</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000429" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtStatementGeographicalAxis_drrxOtherForeignCountriesMember_20180101_20181231" decimals="-3" scale="3">766</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000430" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">30,111</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000431" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">25,074</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000432" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">15,275</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue by geography is determined by the location of the customer.</p></ix:nonNumeric><ix:nonNumeric id="F_000365" name="us-gaap:InventoryPolicyTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Inventories</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. The Company may be required to expense previously capitalized inventory costs upon a change in management&#8217;s judgment due to new information that suggests that the inventory will not be saleable. &#160;If the Company is able to subsequently sell products made with raw materials that were previously written down, the Company will report an unusually high gross profit as there will be no associated cost of goods for these materials.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:nonNumeric id="F_000379" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s inventories consisted of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Raw materials</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000433" name="us-gaap:InventoryRawMaterialsNetOfReserves" contextRef="C_0001082038_20201231" decimals="-3" scale="3">136</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000434" name="us-gaap:InventoryRawMaterialsNetOfReserves" contextRef="C_0001082038_20191231" decimals="-3" scale="3">163</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Work in-process</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000435" name="us-gaap:InventoryWorkInProcessNetOfReserves" contextRef="C_0001082038_20201231" decimals="-3" scale="3">796</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000436" name="us-gaap:InventoryWorkInProcessNetOfReserves" contextRef="C_0001082038_20191231" decimals="-3" scale="3">709</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finished goods</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000437" name="us-gaap:InventoryFinishedGoodsNetOfReserves" contextRef="C_0001082038_20201231" decimals="-3" scale="3">932</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000438" name="us-gaap:InventoryFinishedGoodsNetOfReserves" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,047</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total inventories</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000439" name="us-gaap:InventoryNet" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,864</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000440" name="us-gaap:InventoryNet" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,919</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000366" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Property and Equipment</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment are stated at cost less accumulated depreciation, which is computed using the straight-line method over the estimated useful lives of the assets, which range from <ix:nonNumeric id="F_000441" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0001082038_srtRangeAxis_srtMinimumMember_20200101_20201231" format="ixt-sec:durwordsen" continuedAt="C_12e238a0-605a-464f-99ed-882bbdcdbba0">three</ix:nonNumeric> to <ix:nonNumeric id="F_000442" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_20200101_20201231" format="ixt-sec:durwordsen">five<ix:continuation id="C_12e238a0-605a-464f-99ed-882bbdcdbba0"> years</ix:continuation></ix:nonNumeric>. Leasehold improvements are amortized using the straight-line method over the estimated useful lives of the assets, or the terms of the related leases, whichever are shorter.</p></ix:nonNumeric><ix:nonNumeric id="F_000367" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000367_dcnt_52e9ee29-e6da-4c7e-950e-14bd2de0e4b6">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Goodwill</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill is periodically assessed and evaluated for impairment. The Company operates in <ix:nonFraction unitRef="U_drrxSegment" id="F_000443" name="us-gaap:NumberOfOperatingSegments" contextRef="C_0001082038_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction> operating segment and also has only <ix:nonFraction unitRef="U_drrxSegment" id="F_000444" name="us-gaap:NumberOfReportableSegments" contextRef="C_0001082038_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction> reporting unit, which is the research, development and manufacturing of pharmaceutical products. The Company assesses the impairment of goodwill at least annually and whenever events or changes in circumstances indicate that the carrying value may not be </p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000346_dcnt_1a40642c-aa07-4c37-91eb-48f40eaa6fe4" continuedAt="F_000346_dcnt_e348ca77-fe3a-4c3f-a082-110b36d47228"><ix:continuation id="F_000367_dcnt_52e9ee29-e6da-4c7e-950e-14bd2de0e4b6">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">recoverable. Factors the Company considers important which could trigger an impairment review include the following:</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">significant decline in our stock price for a prolonged period&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">our market capitalization relative to net book value&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">new information affecting the commercial value of the asset&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">significant underperformance relative to historical or projected future operating results&#59;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">significant changes in the manner of our use of the acquired assets or the strategy for the Company&#8217;s overall business&#59; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">significant negative industry or economic trends.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the carrying value of goodwill was approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000445" name="us-gaap:Goodwill" contextRef="C_0001082038_20201231" decimals="-5" scale="6">6.2</ix:nonFraction> million compared with $<ix:nonFraction unitRef="U_iso4217USD" id="F_000446" name="us-gaap:Goodwill" contextRef="C_0001082038_20191231" decimals="-5" scale="6"><ix:nonFraction unitRef="U_iso4217USD" id="F_000447" name="us-gaap:Goodwill" contextRef="C_0001082038_20181231" decimals="-5" scale="6">6.4</ix:nonFraction></ix:nonFraction> million as of December 31, 2019 and 2018. As a result of the sale of the LACTEL product line, approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000448" name="us-gaap:Goodwill" contextRef="C_0001082038_us-gaapRelatedPartyTransactionAxis_drrxLACTELMember_20201231" decimals="0" format="ixt:numdotdecimal">229,000</ix:nonFraction> of the carry value of goodwill was allocated to the LACTEL product line upon its disposition.&#160;&#160;The Company evaluates goodwill for impairment at least annually. In 2020, 2019 and 2018, goodwill was evaluated and no indicators of impairment were identified. To date, the Company has not recorded any impairment charge related to goodwill. </p></ix:continuation><ix:nonNumeric id="F_000368" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Impairment of Long-Lived Assets</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company reviews long-lived assets, including property and equipment, intangible assets, and other long-term assets, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of the asset and its eventual disposition is less than its carrying amount. Impairment, if any, is calculated as the amount by which an asset&#8217;s carrying value exceeds its fair value, typically using discounted cash flows to determine fair value. Through December 31, 2020, there have been <ix:nonFraction unitRef="U_iso4217USD" id="F_000449" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextRef="C_0001082038_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> material impairment losses.</p></ix:nonNumeric><ix:nonNumeric id="F_000369" name="us-gaap:LesseeLeasesPolicyTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000369_dcnt_cc139ccf-3ad1-4c44-a8f0-577106801750">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Leases</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company leases administrative, manufacturing and laboratory facilities under operating leases. Lease agreements may include rent holidays, rent escalation clauses and tenant improvement allowances. Prior to the adoption of <span style="color:#000000;">Accounting Standards Update ("ASU" No. 2016-02, Leases, and the related amendments ("Topic 842")</span>, the Company recognized scheduled rent increases on a straight-line basis over the lease term beginning with the date the Company took possession of the leased space. The Company recorded tenant improvement allowances as deferred rent liabilities and amortized the deferred rent over the terms of the lease to rent expense on the statements of operations and comprehensive loss.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective January 1, 2019, the Company adopted Topic 842 using the modified retrospective transition method approach with a cumulative-effect adjustment as of January 1, 2019. Other prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under previous lease guidance, ASC Topic 840: Leases (Topic 840). The Company elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allowed the Company to carry forward the historical lease classification of those leases in place as of January 1, 2019.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The adjustments due to the adoption of Topic 842 primarily related to the recognition of an operating lease right-of-use asset and corresponding operating lease liability for the Company&#8217;s leased properties. <span style="color:#212529;">The Company&#8217;s operating lease right-of-use asset and liability were recognized at the adoption date of ASC 842 based on the present value of lease payments over the remaining lease term at the adoption date. In determining the net present value of lease payments, we used our incremental borrowing </span></p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000346_dcnt_e348ca77-fe3a-4c3f-a082-110b36d47228" continuedAt="F_000346_dcnt_78f77c6e-f0e1-4c77-973b-ecfd60c6578d"><ix:continuation id="F_000369_dcnt_cc139ccf-3ad1-4c44-a8f0-577106801750">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#212529;">rate of </span><span style="color:#212529;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000450" name="drrx:LesseeOperatingLeaseIncrementalBorrowingRate" contextRef="C_0001082038_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_20201231" decimals="3" scale="-2">13.8</ix:nonFraction></span><span style="color:#212529;">% based on the information available, including remaining lease term, at the adoption date of ASC 842. As of December 31, 20</span><span style="color:#212529;">20</span><span style="color:#212529;">, the weighted-average remaining lease term was </span><span><span style="color:#212529;"><ix:nonNumeric id="F_000451" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" contextRef="C_0001082038_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_20201231" format="ixt-sec:duryear">2.99</ix:nonNumeric></span><span style="color:#212529;"> years</span></span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for the Company&#8217;s leased properties</span><span style="color:#212529;">.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There was no effect from the adoption of Topic 842 on the Company&#8217;s Statement of cash flows.</p></ix:continuation><ix:nonNumeric id="F_000370" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Stock-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for share-based payments using a fair-value based method for costs related to all share-based payments, including stock options and stock issued under the Company&#8217;s employee stock purchase plan (ESPP). The Company estimates the fair value of share-based payment awards on the date of grant using an option-pricing model. See Note 8 for further information regarding stock-based compensation.</p></ix:nonNumeric><ix:nonNumeric id="F_000371" name="us-gaap:RevenueRecognitionPolicyTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000371_dcnt_a8ab8ecd-a016-457c-bb21-e6380040fd4f">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Revenue Recognition</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company enters into license and collaboration agreements under which the Company may receive upfront license fees, research funding and contingent milestone payments and royalties. Effective January 1, 2018, the Company adopted FASB ASC Topic 606, Revenue from Contracts with Customers, or ASC 606. In accordance with ASC 606, the Company changed certain characteristics of its revenue recognition accounting policy as described below. ASC 606 was applied using the modified retrospective method, where the cumulative effect of the initial application was recognized as an adjustment to opening retained earnings at January 1, 2018. The Company recorded a net decrease to opening accumulated deficit of&#160;$<ix:nonFraction unitRef="U_iso4217USD" id="F_000452" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="C_0001082038_srtRestatementAxis_srtRevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember_20180101" decimals="INF" format="ixt:numdotdecimal">470,000</ix:nonFraction> with an offset entry to reduce deferred revenue as of January 1, 2018 due to the cumulative impact of adopting Topic 606, with the impact relating to the Company&#8217;s deferred collaborative research and development revenues. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Product Revenue, Net</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company sells osmotic pumps used in laboratory research, and manufactures certain excipients for pharmaceutical clients for use as raw materials in their products.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenues from product sales are recognized when the customer obtains control of the Company&#8217;s product, which occurs at a point in time, typically upon shipment to the customer. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is one year or less.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade Discounts and Allowances: The Company provides certain customers with discounts that are explicitly stated in the Company&#8217;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product Returns: Consistent with industry practice, the Company generally offers customers a limited right of return for products that have been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. The Company currently estimates product return liabilities using its historical sales information. The Company expects product returns to be minimal.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Collaborative Research and Development and Other Revenue</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company enters into license agreements, under which it licenses certain rights to its product candidates to third parties. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, up-front license fees&#59; reimbursement of development costs incurred by the Company under approved work plans&#59; development, regulatory and commercial milestone payments&#59; payments for manufacturing supply services the Company provides through its contract manufacturers&#59; and royalties on net sales of licensed products. Each of these payments results in collaborative research and development revenues, except for revenues from royalties on net sales of licensed products, which are classified as other revenues.</p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000346_dcnt_78f77c6e-f0e1-4c77-973b-ecfd60c6578d" continuedAt="F_000346_dcnt_4de0b313-252d-4c6c-b184-c372cc294644"><ix:continuation id="F_000371_dcnt_a8ab8ecd-a016-457c-bb21-e6380040fd4f" continuedAt="F_000371_dcnt_0ec4e485-c1a5-4fdd-8854-7921719244b2">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In determining the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements, the Company performs the following steps: (i) identification of the promised goods or services in the contract&#59; (ii) determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract&#59; (iii) measurement of the transaction price, including the constraint on variable consideration&#59; (iv) allocation of the transaction price to the performance obligations&#59; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. As part of the accounting for these arrangements, the Company must develop assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the contract. The Company uses key assumptions to determine the standalone selling price, which may include forecasted revenues, development timelines, reimbursement rates for personnel costs, discount rates and probabilities of technical and regulatory success. The Company expects to recognize revenue for the variable consideration currently being constrained when it is probable that a significant revenue reversal will not occur.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Licenses of intellectual property: If the license to the Company&#8217;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, up-front fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are bundled with other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, up-front fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. Any such adjustments are recorded on a cumulative catch-up basis, which would affect collaborative research and development revenues and net income (loss) in the period of adjustment.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Milestone Payments: At the inception of each arrangement that includes development milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or the licensee, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. The transaction price is then allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as or when the performance obligations under the contract are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect collaborative research and development revenues and net income (loss) in the period of adjustment. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing Supply Services: Arrangements that include a promise for future supply of drug product for either clinical development or commercial supply at the customer&#8217;s discretion are generally considered as options. The Company assesses if these options provide a material right to the customer and if so, they are accounted for as separate performance obligations. If the Company is entitled to additional payments when the customer exercises these options, any additional payments are recorded in collaborative research and development revenue when the customer obtains control of the goods, which is upon delivery.</p></ix:continuation></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000346_dcnt_4de0b313-252d-4c6c-b184-c372cc294644" continuedAt="F_000346_dcnt_97358613-87de-4c2d-ba00-ab0b3e50b534"><ix:continuation id="F_000371_dcnt_0ec4e485-c1a5-4fdd-8854-7921719244b2">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Royalties and Earn-outs: For arrangements that include sales-based royalties or earn-outs, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). To date, the Company has not recognized material royalty revenue resulting from the Company&#8217;s collaborative arrangements or material earn-out revenue from the Company&#8217;s patent purchase agreement with Indivior.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company receives payments from its customers based on development cost schedules established in each contract. Up-front payments are recorded as deferred revenue upon receipt or when due, and may require deferral of revenue recognition to a future period until the Company performs its obligations under these arrangements.&#160;&#160;Amounts are recorded as accounts receivable when the Company&#8217;s right to consideration is unconditional. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised goods or services to the customer will be one year or less.</p></ix:continuation><ix:nonNumeric id="F_000372" name="drrx:PrepaidAndAccruedContractResearchExpensesPolicyTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Prepaid and Accrued Contract Research Expenses</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company incurs significant costs associated with third party consultants and organizations for pre-clinical studies, clinical trials, contract research and manufacturing, validation, testing, regulatory advice and other research and development-related services. The Company is required to estimate periodically the cost of services rendered but unbilled based on management&#8217;s estimates of project status. If these good faith estimates are inaccurate, actual expenses incurred could materially differ from these estimates.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses are primarily comprised of salaries and benefits associated with research and development personnel, overhead and facility costs, preclinical and non-clinical development costs, clinical trial and related clinical manufacturing costs, contract services, and other outside costs. Research and development costs are expensed as incurred. Research and development costs paid to third parties under sponsored research agreements are recognized as the related services are performed. In addition, reimbursements of research and development expenses incurred by the Company&#8217;s partners are recorded as collaborative research and development revenue.</p></ix:nonNumeric><ix:nonNumeric id="F_000373" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Comprehensive Loss</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Components of other comprehensive loss are comprised entirely of unrealized gains and losses on the Company&#8217;s available-for-sale securities for all periods presented. Total comprehensive loss has been disclosed in the Company&#8217;s Statements of Comprehensive Loss.</p></ix:nonNumeric><ix:nonNumeric id="F_000374" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000374_dcnt_ebbe43dc-6991-4b32-9cac-b89736738607">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Segment Reporting</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company operates in one operating segment, which is the research, development and manufacturing of pharmaceutical products.</p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000346_dcnt_97358613-87de-4c2d-ba00-ab0b3e50b534" continuedAt="F_000346_dcnt_5d5c25ed-ded1-4be4-8e21-4509fcc16cdb"><ix:continuation id="F_000374_dcnt_ebbe43dc-6991-4b32-9cac-b89736738607">
</ix:continuation><ix:nonNumeric id="F_000375" name="us-gaap:EarningsPerSharePolicyTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Net Loss Per Share</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding. Diluted net loss per share is computed using the weighted-average number of common shares outstanding and common stock equivalents (i.e., options to purchase common stock) outstanding during the period, if dilutive, using the treasury stock method for options. </p><ix:nonNumeric id="F_000380" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The numerators and denominators in the calculation of basic and diluted net loss per share were as follows (in thousands except per share amounts):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:79.04%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerators:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000453" name="us-gaap:NetIncomeLoss" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" scale="3">582</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000454" name="us-gaap:NetIncomeLoss" contextRef="C_0001082038_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">20,578</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000455" name="us-gaap:NetIncomeLoss" contextRef="C_0001082038_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">25,322</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominators:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares used to compute basic</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; net loss per share</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000456" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">199,457</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000457" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">178,042</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000458" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">159,834</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effect of dilutive securities:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dilution from stock options</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dilution from ESPP</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dilutive common shares</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares used to compute diluted</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; net loss per share</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000459" name="drrx:WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">199,457</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000460" name="drrx:WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">178,042</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000461" name="drrx:WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">159,834</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share:</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000462" name="us-gaap:EarningsPerShareBasic" contextRef="C_0001082038_20200101_20201231" decimals="2">0.00</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000463" name="us-gaap:EarningsPerShareBasic" contextRef="C_0001082038_20190101_20191231" decimals="2" sign="-">0.12</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000464" name="us-gaap:EarningsPerShareBasic" contextRef="C_0001082038_20180101_20181231" decimals="2" sign="-">0.16</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000465" name="us-gaap:EarningsPerShareDiluted" contextRef="C_0001082038_20200101_20201231" decimals="2">0.00</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000466" name="us-gaap:EarningsPerShareDiluted" contextRef="C_0001082038_20190101_20191231" decimals="2" sign="-">0.12</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000467" name="us-gaap:EarningsPerShareDiluted" contextRef="C_0001082038_20180101_20181231" decimals="2" sign="-">0.16</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The computation of diluted net loss per share for 2020, 2019 and 2018 excludes the impact of options to purchase <ix:nonFraction unitRef="U_xbrlishares" id="F_000468" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001082038_20200101_20201231" decimals="-5" scale="6">7.5</ix:nonFraction> million, <ix:nonFraction unitRef="U_xbrlishares" id="F_000469" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001082038_20190101_20191231" decimals="-5" scale="6">21.4</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="U_xbrlishares" id="F_000470" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="C_0001082038_20180101_20181231" decimals="-5" scale="6">16.6</ix:nonFraction>&#160;million shares of common stock outstanding at December 31, 2020, 2019 and 2018, respectively, as such impact would be antidilutive.</p></ix:nonNumeric><ix:nonNumeric id="F_000376" name="drrx:ShippingAndHandlingPolicyTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Shipping and Handling</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Costs related to shipping and handling are included in cost of revenues for all periods presented.</p></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p><ix:nonNumeric id="F_000377" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000377_dcnt_90f653b4-38ef-4157-88b7-8fc72e688de1">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:2.62%;font-family:Times New Roman;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, as part of its initiative to reduce complexity in the accounting standards, the FASB issued ASU 2019-12, <span style="font-style:italic;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span> (&#8220;ASU 2019-12&#8221;), which eliminates certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company early adopted ASU 2019-12 on January 1, 2020, and this adoption had no material impact on the Company&#8217;s financial position or results of operations. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2018, the Financial Accounting Standards Board (the FASB) issued ASU No.&#160;2018-18,&#160;<span style="font-style:italic;">Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606&#160;(ASU 2018-18)</span>. ASU 2018-18 clarifies that certain transactions between collaborative arrangement </p></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000346_dcnt_5d5c25ed-ded1-4be4-8e21-4509fcc16cdb"><ix:continuation id="F_000377_dcnt_90f653b4-38ef-4157-88b7-8fc72e688de1">
<p style="margin-top:6pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">participants should be accounted for as revenue under Topic 606 when the counterparty is a customer for a distinct good or service (i.e. a unit of account). For units of account that are in the scope of Topic 606, all of the guidance in Topic 606 should be applied, including the guidance on recognition, measurement, presentation and disclosure. ASU 2018-18 also adds a reference in Topic 808 to the unit of account guidance in ASC 606 and requires that it be applied only to assess whether transactions in a collaborative arrangement are in the scope of Topic 606. ASU 2018-18 will preclude entities from presenting amounts related to transactions with a counterparty in a collaborative arrangement that is not a customer as revenue from contracts with customers. ASU 2018-18 is effective for the Company for all interim and annual reporting periods beginning after December 15, 2019. </span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The adoption of this standard did not have a material effect on the Company&#8217;s financial statements</span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2018, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;)&#160;No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurement, which eliminates certain disclosure requirements for fair value measurements for all entities, requires public entities to disclose certain new information and modifies some disclosure requirements. This standard is effective for fiscal years beginning after December 15, 2019, including interim reporting periods within those years. The adoption of this standard did not have a material effect on the Company&#8217;s financial statements.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January 2017, the FASB issued ASU No.&#160;2017-04,&#160;<span style="font-style:italic;">Intangibles&#8212;Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,&#160;(ASU 2017-04)</span>.&#160;ASU 2017-04 eliminated Step 2 from the goodwill impairment test. Instead, under the amendments in ASU 2017-04, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value&#59; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax&#160;effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. ASU 2017-04 is effective for all interim and annual reporting periods beginning after December 15, 2019. The adoption of this standard did not have a material effect on the Company&#8217;s financial statements.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016,&#160;the FASB issued Accounting Standards Update No. 2016-13 (ASU 2016-13)&#160;&#8220;Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments.&#8221;&#160;ASU 2016-13 requires measurement and recognition of expected credit losses for financial assets. This standard is effective for fiscal years beginning after December 15, 2022 for small reporting companies, including interim reporting periods within those years and must be adopted using a modified retrospective approach, with certain exceptions. Early adoption is permitted.&#160; The Company does not expect the adoption of this standard to have a material effect on its financial statements.</p></ix:continuation></ix:continuation>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p><ix:nonNumeric id="F_000347" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000347_dcnt_10109f1b-50f0-4a37-ad34-cf6584aebbb9">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">2.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Strategic Agreements</p></td></tr></table></div><ix:nonNumeric id="F_000381" name="us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000381_dcnt_7a534d05-636a-4e70-a124-4ee5216feca6">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The collaborative research and development and other revenues associated with the Company&#8217;s major third-party collaborators are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Collaborator/Counterparty</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gilead (1)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000471" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,879</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000472" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">17,133</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000473" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,542</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other (2)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000474" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementsWithOtherCollaboratorsOrCounterpartiesMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,062</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000475" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementsWithOtherCollaboratorsOrCounterpartiesMember_20190101_20191231" decimals="-3" scale="3">996</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000476" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementsWithOtherCollaboratorsOrCounterpartiesMember_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,665</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total collaborative research and development and other revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000477" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">23,941</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000478" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">18,129</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000479" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,207</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000347_dcnt_10109f1b-50f0-4a37-ad34-cf6584aebbb9" continuedAt="F_000347_dcnt_20f74baf-121b-4a33-a1f0-c111690ea6e4"><ix:continuation id="F_000381_dcnt_7a534d05-636a-4e70-a124-4ee5216feca6">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:81.2%;text-indent:0%;font-size:6pt;font-family:Times New Roman;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</span></p></td>
<td valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"><ix:footnote id="FNT_000002" xml:lang="en-US">Amounts related to recognition of upfront fees and milestone payments were $<ix:nonFraction unitRef="U_iso4217USD" id="F_000480" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20200101_20201231" decimals="-5" scale="6">22.7</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000481" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20190101_20191231" decimals="-5" scale="6">12.3</ix:nonFraction> million and <ix:nonFraction unitRef="U_iso4217USD" id="F_000482" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20180101_20181231" decimals="-6" format="ixt-sec:numwordsen" scale="6">zero</ix:nonFraction> for the twelve months ended December 31, 2020, 2019 and 2018, respectively. The Company signed a license agreement with Gilead on July 19, 2019 and received a nonrefundable upfront license fee and a milestone payment totaling $<ix:nonFraction unitRef="U_iso4217USD" id="F_000483" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapLicenseMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20190101_20191231" decimals="-5" scale="6">35.0</ix:nonFraction> million in 2019 which was being recognized as revenue as its obligation was being satisfied using the cost-to-cost input method (see Note 2. Strategic Agreements - Agreement with Gilead Sciences, Inc. in the financial statements). In June 2020, the Company received notice that Gilead was terminating the License Agreement and a related R&#38;D agreement between Gilead and the Company. As a result, the Company recognized all its remaining deferred revenue as there were no remaining substantive performance obligations to be provided to Gilead by the Company as of the date when the termination notice was received.  Amounts recognized as revenue during each of the twelve months ended December 31, 2020, 2019 and 2018 also included the Company&#8217;s reimbursable collaborative research and development services performed under its agreement with Gilead.</ix:footnote></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"><ix:footnote id="FNT_000003" xml:lang="en-US">Includes: (a) amounts related to earn-out revenue from Indivior UK Limited (Indivior) with respect to PERSERIS net sales&#59; (b) feasibility programs&#59; (c) research and development activities funded by Santen Pharmaceutical Co. Ltd. (Santen)&#59; and (d) royalty revenue from OP Pharma with respect to Methydur net sales. Note that in January 2018, the Company was notified by Santen that due to a shift in priorities, Santen had elected to reallocate research and development resources and put the Company&#8217;s program on pause until further notice. While the main program is on pause, the parties are working together on a limited set of research and development activities funded by Santen.</ix:footnote> </p></td></tr></table></div></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:-5.24%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the Company had potential milestones of up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000484" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_20200101_20201231" decimals="INF" scale="6">76.0</ix:nonFraction> million that the Company may receive in the future under its collaborative arrangements, of which $<ix:nonFraction unitRef="U_iso4217USD" id="F_000485" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxDevelopmentBasedMilestonesMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210227_20210301" decimals="-5" scale="6">13.0</ix:nonFraction> million are development-based milestones and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000486" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxSalesBasedMilestonesMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210227_20210301" decimals="-5" scale="6">63.0</ix:nonFraction> million are sales-based milestones. Within the category of development-based milestones, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000487" name="drrx:DevelopmentBasedMilestones" contextRef="C_0001082038_us-gaapChangeInAccountingEstimateByTypeAxis_drrxEarlyStageClinicalTestingMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210301" decimals="-5" scale="6">2.0</ix:nonFraction> million are related to early stage clinical testing (defined as Phase 1 or 2 activities), $<ix:nonFraction unitRef="U_iso4217USD" id="F_000488" name="drrx:DevelopmentBasedMilestones" contextRef="C_0001082038_us-gaapChangeInAccountingEstimateByTypeAxis_drrxLateStageClinicalTestingMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210301" decimals="-5" scale="6">3.0</ix:nonFraction> million are related to late stage clinical testing (defined as Phase 3 activities), $<ix:nonFraction unitRef="U_iso4217USD" id="F_000489" name="drrx:DevelopmentBasedMilestones" contextRef="C_0001082038_us-gaapChangeInAccountingEstimateByTypeAxis_us-gaapRegulatoryReviewsOfFilingsMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210301" decimals="-5" scale="6">3.0</ix:nonFraction> million are related to regulatory filings, and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000490" name="drrx:DevelopmentBasedMilestones" contextRef="C_0001082038_us-gaapChangeInAccountingEstimateByTypeAxis_drrxRegulatoryApprovalsMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210301" decimals="-5" scale="6">5.0</ix:nonFraction> million are related to regulatory approvals. <span style="font-family:Calibri;">&#160;</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Agreement with Gilead Sciences, Inc.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 19, 2019, the Company entered into a license agreement (the &#8220;Gilead Agreement&#8221;) with Gilead Sciences, Inc.&#160;&#160;(&#8220;Gilead&#8221;). Pursuant to the Gilead Agreement, the Company granted Gilead the exclusive worldwide rights to develop and commercialize a long-acting injectable HIV product utilizing DURECT&#8217;s SABER<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> technology.&#160;&#160;Gilead also received exclusive access to the SABER platform for HIV and Hepatitis B Virus (HBV) and the exclusive option to license additional SABER-based products directed to HIV and HBV.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms of the Gilead Agreement, Gilead made a non-refundable upfront payment to DURECT of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000491" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20190717_20190719" decimals="-6" scale="6">25</ix:nonFraction> million, and in October 2019, the Company also received a $<ix:nonFraction unitRef="U_iso4217USD" id="F_000492" name="drrx:ContractWithCustomerLiabilityMilestonePayment" contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20191001_20191031" decimals="-6" scale="6">10</ix:nonFraction> million milestone payment from Gilead for further development of the product candidate.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the twelve months ended December 31, 2019, the upfront and milestone consideration of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000493" name="drrx:PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxUpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember_20191231" decimals="-6" scale="6">35</ix:nonFraction> million received in 2019 associated with the Primary Services was being recognized as revenue when the first performance obligation was being satisfied using the cost-to-cost input method, which the Company believes best depicts the transfer of control to the customer. Under the cost-to-cost input method, the extent of progress towards completion is measured based on the ratio of actual costs incurred to the total estimated costs. Revenue is recorded as a percentage of the transaction price based on the extent of progress towards completion. The estimate of the Company&#8217;s measure of progress, which can include additional Primary Services, if any, and the estimate of any additional consideration for those additional Primary Services, are included in the transaction price which is updated at each reporting date, and revenue is recognized on a cumulative catchup basis. As such, management applies a certain amount of judgment in estimating both the Primary Services and the corresponding timeline to through </p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000347_dcnt_20f74baf-121b-4a33-a1f0-c111690ea6e4" continuedAt="F_000347_dcnt_39a665aa-49dd-40cb-937d-6389c6b2c823">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">completion of the first performance obligation, which are key inputs when using the cost-to-cost input method.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the twelve months ended December 31, 2019, the Company recognized $<ix:nonFraction unitRef="U_iso4217USD" id="F_000494" name="drrx:AccruedAmountOfFinalPaymentOfTermLoan" contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20190101_20191231" decimals="-5" scale="6">12.3</ix:nonFraction> million of the deferred revenue within collaborative research and development and other revenues. The Company also recognized $<ix:nonFraction unitRef="U_iso4217USD" id="F_000495" name="us-gaap:DeferredRevenue" contextRef="C_0001082038_20191231" decimals="-5" scale="6">4.8</ix:nonFraction> million from Gilead during the twelve months ended December 31, 2019 from feasibility related collaborative research and development services.&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2020, Gilead terminated the Gilead Agreement and a related R&#38;D agreement between Gilead and the Company. As a result, the Company recognized $<ix:nonFraction unitRef="U_iso4217USD" id="F_000496" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20200101_20201231" decimals="-5" scale="6">22.7</ix:nonFraction> million as revenue during the year ended December 31, 2020, which represented all of the remaining upfront fee and milestone payment that had previously been deferred as there were no remaining substantive performance obligations to be provided to Gilead by the Company as of the date when the termination notice was received.</p><ix:nonNumeric id="F_000382" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents changes in the Company&#8217;s contract assets and liabilities for the twelve months ended December 31, 2020 and 2019 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">January 1,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additions</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deletions</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000497" name="us-gaap:ReceivablesNetCurrent" contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">39,812</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000498" name="us-gaap:ReceivablesNetCurrent" contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">39,318</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000499" name="us-gaap:ReceivablesNetCurrent" contextRef="C_0001082038_20191231" decimals="-3" scale="3">494</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total contract asset</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000500" name="us-gaap:ContractWithCustomerAssetNetCurrent" contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">39,812</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000501" name="us-gaap:ContractWithCustomerAssetNetCurrent" contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">39,318</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000502" name="us-gaap:ContractWithCustomerAssetNetCurrent" contextRef="C_0001082038_20191231" decimals="-3" scale="3">494</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue, current portion</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000503" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">35,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000504" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,321</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000505" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,679</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total contract liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000506" name="us-gaap:ContractWithCustomerLiability" contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">35,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000507" name="us-gaap:ContractWithCustomerLiability" contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,321</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000508" name="us-gaap:ContractWithCustomerLiability" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">22,679</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">January 1,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additions</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deletions</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000509" name="us-gaap:ReceivablesNetCurrent" contextRef="C_0001082038_20200101" decimals="-3" scale="3">494</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000510" name="us-gaap:ReceivablesNetCurrent" contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20201231" decimals="-3" scale="3">200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000511" name="us-gaap:ReceivablesNetCurrent" contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20201231" decimals="-3" scale="3">694</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total contract asset</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000512" name="us-gaap:ContractWithCustomerAssetNetCurrent" contextRef="C_0001082038_20200101" decimals="-3" scale="3">494</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000513" name="us-gaap:ContractWithCustomerAssetNetCurrent" contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20201231" decimals="-3" scale="3">200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000514" name="us-gaap:ContractWithCustomerAssetNetCurrent" contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20201231" decimals="-3" scale="3">694</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue, current portion</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000515" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0001082038_20200101" decimals="-3" format="ixt:numdotdecimal" scale="3">22,679</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000516" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,174</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000517" name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">31,853</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total contract liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000518" name="us-gaap:ContractWithCustomerLiability" contextRef="C_0001082038_20200101" decimals="-3" format="ixt:numdotdecimal" scale="3">22,679</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000519" name="us-gaap:ContractWithCustomerLiability" contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,174</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000520" name="us-gaap:ContractWithCustomerLiability" contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">31,853</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Patent Purchase Agreement with Indivior</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 26, 2017, the Company entered into a Patent Purchase Agreement (the &#8220;Indivior Agreement&#8221;) with Indivior.&#160;&#160;Pursuant to the Indivior Agreement, the Company assigned to Indivior certain patents that may provide further intellectual property protection for PERSERIS&#8482; (risperidone), Indivior&#8217;s extended-release injectable suspension for the treatment of schizophrenia in adults.&#160;&#160;In consideration for such assignment, Indivior made an upfront non-refundable payment to the Company of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000521" name="drrx:NonRefundableUpfrontPaymentReceived" contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20170925_20170926" decimals="-5" scale="6">12.5</ix:nonFraction> million.&#160;&#160;Indivior also agreed to make an additional $<ix:nonFraction unitRef="U_iso4217USD" id="F_000522" name="drrx:PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxRegulatoryBasedMilestoneMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20170926" decimals="-5" scale="6">5.0</ix:nonFraction> million payment to the Company contingent upon NDA approval of PERSERIS, as well as quarterly earn-out payments that are based on a single digit percentage of U.S. net sales for certain products covered by the assigned patent rights, including PERSERIS. The assigned patent rights include granted patents extending through at least <ix:nonNumeric id="F_000523" name="drrx:GrantedPatentsExtendingYearMinimum" contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20170925_20170926">2026</ix:nonNumeric>.&#160;&#160;The Company also received a non-exclusive right under the assigned patents to develop and </p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000347_dcnt_39a665aa-49dd-40cb-937d-6389c6b2c823" continuedAt="F_000347_dcnt_451ad2eb-7e65-43c5-a631-2c8cef20b435">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">commercialize certain risperidone-containing products and products that do not contain risperidone or buprenorphine.&#160;&#160;The Indivior Agreement contains customary representations, warranties and indemnities of the parties. The Company received the payment of $</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000524" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapRoyaltyMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20170901_20170930" decimals="-5" scale="6">12.5</ix:nonFraction></span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million from Indivior in September 2017 and recognized the $</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000525" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapRoyaltyMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20170101_20171231" decimals="-5" scale="6">12.5</ix:nonFraction></span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million as revenue from sale of intellectual property rights in 2017 as the Company did not have any continuing obligations under the purchase agreement</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. In August 2018, the Company received the payment of $</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000526" name="drrx:PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxRegulatoryBasedMilestoneMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20180831" decimals="-5" scale="6">5.0</ix:nonFraction></span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million from Indivior for the FDA approval of PERSERIS.&#160;&#160;The Company recognized the $</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000527" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxRegulatoryBasedMilestoneMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20180101_20181231" decimals="-5" scale="6">5.0</ix:nonFraction></span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million as milestone revenue in 2018 as there was no further performance obligation associated with this milestone payment. Amounts recognized to date related to earn-out revenues from PERSERIS have been immaterial</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Agreement with Santen Pharmaceutical Co., Ltd.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December&#160;11, 2014, the Company and Santen Pharmaceutical Co., Ltd. (Santen) entered into a definitive agreement (the Santen Agreement). Pursuant to the Santen Agreement, the Company granted Santen an exclusive worldwide license to the Company&#8217;s proprietary SABER formulation platform and other intellectual property to develop and commercialize a sustained release product utilizing the Company&#8217;s SABER technology to deliver an ophthalmology drug. Santen controls and funds the development and commercialization program, and the parties established a joint management committee to oversee, review and coordinate the development activities of the parties under the Santen Agreement.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Santen agreement, Santen paid the Company an upfront fee of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000528" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapLicenseMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20141210_20141211" decimals="-5" scale="6">2.0</ix:nonFraction> million in cash and agreed to make contingent cash payments to the Company of up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000529" name="drrx:PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20141211" decimals="INF" scale="6">76.0</ix:nonFraction> million upon the achievement of certain milestones, of which $<ix:nonFraction unitRef="U_iso4217USD" id="F_000530" name="drrx:PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxDevelopmentBasedMilestonesMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20141211" decimals="-5" scale="6">13.0</ix:nonFraction> million are development-based milestones and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000531" name="drrx:PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxCommercializationBasedMilestonesMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20141211" decimals="-5" scale="6">63.0</ix:nonFraction> million are commercialization-based milestones including milestones requiring the achievement of certain product sales targets (<ix:nonFraction unitRef="U_iso4217USD" id="F_000532" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxCommercializationBasedMilestonesMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen">none</ix:nonFraction> of which has been achieved as of December 31, 2020). Santen will also pay for certain Company costs incurred in the development of the licensed product. If the product is commercialized, the Company would also receive a tiered royalty on annual net product sales ranging from single-digit to the low double digits, determined on a country-by-country basis. In January 2018, the Company was notified by Santen that due to a shift in priorities, Santen elected to reallocate research and development resources and put the Company&#8217;s program on pause until further notice. While the main program is on pause, the parties are working together on a limited set of research and development activities funded by Santen. As of December 31, 2020, the cumulative aggregate payments received by the Company under this agreement were $<ix:nonFraction unitRef="U_iso4217USD" id="F_000533" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20200101_20201231" decimals="-5" scale="6">3.3</ix:nonFraction> million.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Agreement with Sandoz AG.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2017, the Company and Sandoz AG (&#8220;Sandoz&#8221;) entered into a license agreement to develop and market POSIMIR in the United States. On January 2, 2019, the Company received written notice from Sandoz that Sandoz terminated this agreement effective January 27, 2019. As a result of this termination, Sandoz returned its exclusive commercialization rights to develop and market POSIMIR in the United States.&#160;&#160;The parties are in dispute with regard to Sandoz&#8217;s obligation to pay a termination fee to the Company. The Company has initiated a formal dispute resolution process related to the termination fee. The cumulative aggregate payments received by the Company from Sandoz as of December 31, 2020 were $<ix:nonFraction unitRef="U_iso4217USD" id="F_000534" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithSandozAGMember_20200101_20201231" decimals="-5" scale="6">20.0</ix:nonFraction> million under this agreement. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;;font-size:9pt;">&#160;</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000347_dcnt_451ad2eb-7e65-43c5-a631-2c8cef20b435">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation><ix:nonNumeric id="F_000348" name="us-gaap:FairValueDisclosuresTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000348_dcnt_29707f47-1720-468b-92f5-6aed62dcea19">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">3.</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Financial Instruments</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company&#8217;s valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company follows a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value. These levels of inputs are the following:</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Level 1&#8212;Quoted prices in active markets for identical assets or liabilities.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Level 2&#8212;Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities&#59; quoted prices in markets that are not active&#59; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></span><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;">Level 3&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s financial instruments are valued using quoted prices in active markets or based upon other observable inputs. <ix:nonNumeric id="F_000383" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000383_cnt_1">The following table sets forth the fair value of the Company&#8217;s financial assets that were measured at fair value on a recurring basis as of December 31, 2020 (in thousands):</ix:nonNumeric></p><ix:continuation id="F_000383_cnt_1" continuedAt="F_000383_cnt_2">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000535" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" scale="3">522</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000542" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" scale="3">522</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificates of deposit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000537" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCertificatesOfDepositMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" scale="3">150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000543" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCertificatesOfDepositMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" scale="3">150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000538" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,213</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000544" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCommercialPaperMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,213</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal bonds</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000539" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMunicipalBondsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,305</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000545" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMunicipalBondsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,305</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Government agencies</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000540" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000546" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000536" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" scale="3">522</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000541" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">39,668</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000547" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">40,190</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation><ix:continuation id="F_000383_cnt_2">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth the fair value of our financial assets that were measured at fair value on a recurring basis as of December&#160;31, 2019 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000548" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" scale="3">524</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000555" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" scale="3">524</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificates of deposit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000550" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCertificatesOfDepositMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" scale="3">150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000556" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCertificatesOfDepositMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" scale="3">150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000551" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">47,218</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000557" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCommercialPaperMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">47,218</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Government agencies</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000552" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,501</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000558" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,501</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000553" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,868</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000559" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,868</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000549" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" scale="3">524</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000554" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">61,737</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000560" name="us-gaap:AssetsFairValueDisclosure" contextRef="C_0001082038_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">62,261</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s financial instruments are valued using quoted prices in active markets or based upon other observable inputs. Money market funds are classified as Level 1 financial assets. Certificates of deposit, commercial paper, corporate debt securities, and U.S. Government agency securities are classified as Level 2 financial assets. The fair value of the Level 2 assets is estimated using pricing models using current observable market information for similar securities. The Company&#8217;s Level 2 investments include U.S. government-backed securities and corporate securities that are valued based upon observable inputs that may include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data including market research publications. The fair value of commercial paper is based upon the time to maturity and discounted using the three-month treasury bill rate. The average remaining maturity of the Company&#8217;s </p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000348_dcnt_29707f47-1720-468b-92f5-6aed62dcea19" continuedAt="F_000348_dcnt_d6770940-38be-4775-b159-02a6bef55d2f">
<p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2 investments as of December 31, 20</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> is less than twelve months and these investments are rated by S&#38;P and Moody&#8217;s at AAA or AA- for securities and A1 or P1 for commercial paper.</span></p><ix:nonNumeric id="F_000384" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is a summary of available-for-sale securities as of December 31, 2020 and 2019 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gain</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000561" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231" decimals="-3" scale="3">522</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000583" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231" decimals="-3" scale="3">522</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificates of deposit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000562" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCertificatesOfDepositMember_20201231" decimals="-3" scale="3">150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000584" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCertificatesOfDepositMember_20201231" decimals="-3" scale="3">150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000563" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,213</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000572" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000577" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000585" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,213</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal bonds</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000564" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,310</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000578" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20201231" decimals="-3" scale="3">5</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000586" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,305</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Government agencies</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000565" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000587" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000566" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">40,195</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000573" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001082038_20201231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000579" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001082038_20201231" decimals="-3" scale="3">7</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000588" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">40,190</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reported as:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000567" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCashAndCashEquivalentsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,619</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000574" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCashAndCashEquivalentsMember_20201231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000580" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCashAndCashEquivalentsMember_20201231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000589" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCashAndCashEquivalentsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,619</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000568" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,426</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000575" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20201231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000581" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20201231" decimals="-3" scale="3">6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000590" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,421</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term investments</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000569" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapOtherLongTermInvestmentsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000591" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapOtherLongTermInvestmentsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term restricted investments</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000570" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_drrxLongTermRestrictedInvestmentsMember_20201231" decimals="-3" scale="3">150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000592" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_drrxLongTermRestrictedInvestmentsMember_20201231" decimals="-3" scale="3">150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000571" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">40,195</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000576" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001082038_20201231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000582" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001082038_20201231" decimals="-3" scale="3">7</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000593" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">40,190</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gain</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Loss</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000594" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20191231" decimals="-3" scale="3">524</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000612" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20191231" decimals="-3" scale="3">524</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificates of deposit</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000595" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCertificatesOfDepositMember_20191231" decimals="-3" scale="3">150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000613" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCertificatesOfDepositMember_20191231" decimals="-3" scale="3">150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000596" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">47,221</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000602" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20191231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000607" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20191231" decimals="-3" scale="3">4</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000614" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">47,218</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Government agencies</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000597" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,500</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000603" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_20191231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000615" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,501</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000598" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,869</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000604" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20191231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000608" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20191231" decimals="-3" scale="3">2</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000616" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,868</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000599" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">62,264</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000605" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001082038_20191231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000609" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001082038_20191231" decimals="-3" scale="3">6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000617" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">62,261</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reported as:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000600" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCashAndCashEquivalentsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,364</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000610" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCashAndCashEquivalentsMember_20191231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000618" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCashAndCashEquivalentsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">32,361</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000601" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">29,750</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000606" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20191231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000611" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20191231" decimals="-3" scale="3">3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000619" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">29,750</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric><ix:nonNumeric id="F_000385" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is a summary of the cost and estimated fair value of available-for-sale securities at December 31, 2020, by contractual maturity (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mature in one year or less</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000620" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">38,523</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000623" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">38,518</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mature after one year through five years</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000621" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000624" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,150</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000622" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">39,673</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000625" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">39,668</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were <ix:nonFraction unitRef="U_iso4217USD" id="F_000626" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" contextRef="C_0001082038_20201231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> securities that have had an unrealized loss for more than 12 months as of December 31, 2020.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, unrealized losses on available-for-sale investments are not attributed to credit risk and are considered to be temporary. The Company believes that it is more-likely-than-not that </p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000348_dcnt_d6770940-38be-4775-b159-02a6bef55d2f">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">investments in an unrealized loss position will be held until maturity or the recovery of the cost basis of the investment. To date, the Company has not recorded any impairment charges on marketable securities related to other-than-temporary declines in market value.</span></p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;">&#160;</p><ix:nonNumeric id="F_000349" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">4.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Property and Equipment</p></td></tr></table></div><ix:nonNumeric id="F_000386" name="us-gaap:PropertyPlantAndEquipmentTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment consist of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equipment</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000627" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,890</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000628" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,740</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000629" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,428</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000630" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,422</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction-in-progress</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000631" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20201231" decimals="-3" scale="3">42</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000632" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20191231" decimals="-3" scale="3">74</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000633" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,360</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000634" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,236</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less accumulated depreciation and amortization</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000635" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,109</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000636" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,077</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000637" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001082038_20201231" decimals="-3" scale="3">251</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000638" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="C_0001082038_20191231" decimals="-3" scale="3">159</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation expense was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000639" name="us-gaap:Depreciation" contextRef="C_0001082038_20200101_20201231" decimals="0" format="ixt:numdotdecimal">297,000</ix:nonFraction>, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000640" name="us-gaap:Depreciation" contextRef="C_0001082038_20190101_20191231" decimals="0" format="ixt:numdotdecimal">291,000</ix:nonFraction> and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000641" name="us-gaap:Depreciation" contextRef="C_0001082038_20180101_20181231" decimals="0" format="ixt:numdotdecimal">254,000</ix:nonFraction> in 2020, 2019 and 2018, respectively.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the Company has recorded $<ix:nonFraction unitRef="U_iso4217USD" id="F_000642" name="us-gaap:AssetRetirementObligation" contextRef="C_0001082038_20201231" decimals="0" format="ixt:numdotdecimal">482,000</ix:nonFraction> as a liability which was included in other long-term liabilities on its balance sheet for asset retirement obligations associated with the estimated restoration cost for its leased buildings.</p></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p><ix:nonNumeric id="F_000350" name="drrx:RestrictedInvestmentsDisclosureTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">5.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Restricted Investments</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020 and 2019, the Company had $<ix:nonFraction unitRef="U_iso4217USD" id="F_000643" name="us-gaap:RestrictedInvestmentsNoncurrent" contextRef="C_0001082038_srtStatementGeographicalAxis_countryCA_20201231" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_iso4217USD" id="F_000644" name="us-gaap:RestrictedInvestmentsNoncurrent" contextRef="C_0001082038_srtStatementGeographicalAxis_countryCA_20191231" decimals="0" format="ixt:numdotdecimal">150,000</ix:nonFraction></ix:nonFraction> recorded as restricted investments, which primarily served as collateral for letters of credit securing a leased facility in California.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p></ix:nonNumeric><ix:nonNumeric id="F_000351" name="us-gaap:CommitmentsDisclosureTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000351_dcnt_53a6d798-5cb3-42c7-a6be-374a4b2987a4">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">6.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Commitments</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Operating Leases</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has lease arrangements for its facilities in California and Alabama as follows. </p><ix:nonNumeric id="F_000387" name="drrx:ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:16.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Location</p></td>
<td valign="top" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Approximate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Square Feet<span style="font-weight:normal;"> </span></p></td>
<td valign="top" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.65pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:20%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operation</p></td>
<td valign="top" style="width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.65pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:45%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Expiration</p></td>
</tr>
<tr>
<td valign="top" style="width:16.98%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cupertino,&#160;CA</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_utrsqft" id="F_000645" name="us-gaap:LandSubjectToGroundLeases" contextRef="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapLeaseContractualTermAxis_drrxLeaseAmendmentMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeLaboratoryAndManufacturingMember_20201231" decimals="INF" format="ixt:numdotdecimal">30,149</ix:nonFraction> sq. ft.</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:20%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Office, Laboratory and Manufacturing</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:45%; border-top:solid 0.75pt #000000;"><ix:nonNumeric id="F_000648" name="drrx:LeaseExpirationTerm" contextRef="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapLeaseContractualTermAxis_drrxLeaseAmendmentMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeLaboratoryAndManufacturingMember_20200101_20201231"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease expires <ix:nonNumeric id="F_000651" name="drrx:LeaseExpirationYear" contextRef="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeLaboratoryAndManufacturingMember_20200101_20201231">2024</ix:nonNumeric> (with an option to renew for an additional <ix:nonNumeric id="F_000652" name="us-gaap:LesseeOperatingLeaseRenewalTerm" contextRef="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeLaboratoryAndManufacturingMember_20201231" format="ixt-sec:durwordsen">five years</ix:nonNumeric>) </p></ix:nonNumeric></td>
</tr>
<tr style="height:3.75pt;">
<td valign="middle" style="width:16.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:15%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:20%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:16.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cupertino, CA</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_utrsqft" id="F_000646" name="us-gaap:LandSubjectToGroundLeases" contextRef="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapLeaseContractualTermAxis_drrxLeaseAmendmentMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeAndLaboratoryMember_20201231" decimals="INF" format="ixt:numdotdecimal">20,100</ix:nonFraction> sq. ft.</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:20%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Office and Laboratory</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:45%;"><ix:nonNumeric id="F_000649" name="drrx:LeaseExpirationTerm" contextRef="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapLeaseContractualTermAxis_drrxLeaseAmendmentMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeAndLaboratoryMember_20200101_20201231"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease expires <ix:nonNumeric id="F_000653" name="drrx:LeaseExpirationYear" contextRef="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeAndLaboratoryMember_20200101_20201231">2024</ix:nonNumeric> (with an option to renew for an additional <ix:nonNumeric id="F_000654" name="us-gaap:LesseeOperatingLeaseRenewalTerm" contextRef="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeAndLaboratoryMember_20201231" format="ixt-sec:durwordsen">five years</ix:nonNumeric>)</p></ix:nonNumeric></td>
</tr>
<tr>
<td valign="top" style="width:16.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:20%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:16.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vacaville, CA</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_utrsqft" id="F_000647" name="us-gaap:LandSubjectToGroundLeases" contextRef="C_0001082038_srtStatementGeographicalAxis_drrxVacavilleCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapManufacturingFacilityMember_20201231" decimals="INF" format="ixt:numdotdecimal">24,634</ix:nonFraction> sq. ft.</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:20%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:45%;"><ix:nonNumeric id="F_000650" name="drrx:LeaseExpirationTerm" contextRef="C_0001082038_srtStatementGeographicalAxis_drrxVacavilleCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapManufacturingFacilityMember_20200101_20201231"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease expires <ix:nonNumeric id="F_000655" name="drrx:LeaseExpirationYear" contextRef="C_0001082038_srtStatementGeographicalAxis_drrxVacavilleCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapManufacturingFacilityMember_20200101_20201231">2023</ix:nonNumeric> (with an option to renew for an additional <ix:nonNumeric id="F_000656" name="us-gaap:LesseeOperatingLeaseRenewalTerm" contextRef="C_0001082038_srtStatementGeographicalAxis_drrxVacavilleCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapManufacturingFacilityMember_20201231" format="ixt-sec:durwordsen">five years</ix:nonNumeric>)</p></ix:nonNumeric></td>
</tr>
<tr style="height:3.75pt;">
<td valign="middle" style="width:16.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:15%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:20%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:45%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under these leases, the Company is required to pay certain maintenance expenses in addition to monthly rent. Rent expense is recognized on a straight-line basis over the lease term for leases that have scheduled rental payment increases. Rent expense under all operating leases, excluding the LACTEL product line, was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000657" name="us-gaap:OperatingLeasesRentExpenseNet" contextRef="C_0001082038_20200101_20201231" decimals="-5" scale="6">1.9</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000658" name="us-gaap:OperatingLeasesRentExpenseNet" contextRef="C_0001082038_20190101_20191231" decimals="-5" scale="6">1.9</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000659" name="us-gaap:OperatingLeasesRentExpenseNet" contextRef="C_0001082038_20180101_20181231" decimals="-5" scale="6">1.7</ix:nonFraction> million for the years ended December 31, 2020, 2019 and 2018, respectively. </p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000351_dcnt_53a6d798-5cb3-42c7-a6be-374a4b2987a4">
<ix:nonNumeric id="F_000388" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future minimum payments under these noncancelable leases are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ending December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Leases</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000660" name="us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableCurrent" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,933</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000661" name="us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,991</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000662" name="us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,970</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000663" name="us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInFourYears" contextRef="C_0001082038_20201231" decimals="-3" scale="3">275</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000664" name="us-gaap:OperatingLeasesFutureMinimumPaymentsReceivable" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">6,169</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Other Purchase Commitments </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2005, the Company entered into a supply agreement with a vendor. The remaining minimum purchase commitment under this agreement was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000665" name="us-gaap:LongTermPurchaseCommitmentAmount" contextRef="C_0001082038_20180101_20181231" decimals="0" format="ixt:numdotdecimal">500,000</ix:nonFraction> in 2018, which had been recorded as an accrued liability on the Company&#8217;s Balance Sheet at December 31, 2018, and which was charged to cost of goods sold in the Company&#8217;s Statements of Operations and Comprehensive Loss in 2017.&#160;In 2019, the Company recorded a one-time settlement credit of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000666" name="us-gaap:CostOfGoodsAndServicesSold" contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20190101_20191231" decimals="0" format="ixt:numdotdecimal">500,000</ix:nonFraction> as a reduction to cost of goods sold upon signing a settlement and release agreement with this vendor, and forgave the contractual right to receive inventory for the same amount that was previously reserved for.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p></ix:continuation><ix:nonNumeric id="F_000352" name="us-gaap:LongTermDebtTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000352_dcnt_1241c683-2664-479c-95b7-4c5d2fd2a119">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">7.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Term Loan</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July 2016, the Company entered into a $<ix:nonFraction unitRef="U_iso4217USD" id="F_000667" name="us-gaap:SecuredDebt" contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160731" decimals="-5" scale="6">20.0</ix:nonFraction> million secured single-draw term loan with Oxford Finance LLC (Oxford Finance). The Company and Oxford Finance entered into three subsequent amendments to the Loan Agreement in February 2018, November of 2018 and December 2019, for which the Company paid Oxford Finance loan modification fees of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000679" name="us-gaap:PaymentsOfDebtRestructuringCosts" contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20180201_20180228" decimals="0" format="ixt:numdotdecimal">100,000</ix:nonFraction>, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000680" name="us-gaap:PaymentsOfDebtRestructuringCosts" contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20181101_20181130" decimals="0" format="ixt:numdotdecimal">900,000</ix:nonFraction> and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000681" name="us-gaap:PaymentsOfDebtRestructuringCosts" contextRef="C_0001082038_20191201_20191231" decimals="0" format="ixt:numdotdecimal">825,000</ix:nonFraction> respectively.&#160;&#160;<ix:nonNumeric id="F_000668" name="us-gaap:DebtInstrumentPaymentTerms" contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731">As amended, the Loan Agreement provides for interest only payments for the first 18 months, followed by consecutive monthly payments of principal and interest in arrears starting on <ix:nonNumeric id="F_000669" name="us-gaap:DebtInstrumentDateOfFirstRequiredPayment1" contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731" format="ixt:datemonthdayyearen">December 1, 2021</ix:nonNumeric> and continuing through the maturity date of the term loan of <ix:nonNumeric id="F_000670" name="us-gaap:DebtInstrumentMaturityDate" contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731" format="ixt:datemonthdayyearen">May 1, 2024</ix:nonNumeric></ix:nonNumeric>. The Loan Agreement provides for a floating interest rate (<ix:nonFraction unitRef="U_xbrlipure" id="F_000671" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160731" decimals="INF" scale="-2">7.95</ix:nonFraction>% initially and <ix:nonFraction unitRef="U_xbrlipure" id="F_000672" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20201231" decimals="INF" scale="-2">7.95</ix:nonFraction>% as of December 31, 2020) based on an <ix:nonNumeric id="F_000673" name="us-gaap:DebtInstrumentDescriptionOfVariableRateBasis" contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731">index rate plus a spread</ix:nonNumeric>. In addition, a payment equal to <ix:nonFraction unitRef="U_xbrlipure" id="F_000675" name="drrx:DebtInstrumentPrincipalPaymentPercentage" contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731" decimals="INF" scale="-2">10</ix:nonFraction>% of the principal amount of the term loan is due when the term loan becomes due or upon the prepayment of the facility. If the Company elects to prepay the loan, there is also a prepayment fee of between <ix:nonFraction unitRef="U_xbrlipure" id="F_000676" name="drrx:DebtInstrumentPrepaymentFeePercentage" contextRef="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731" decimals="INF" scale="-2">0.75</ix:nonFraction>% and <ix:nonFraction unitRef="U_xbrlipure" id="F_000677" name="drrx:DebtInstrumentPrepaymentFeePercentage" contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731" decimals="INF" scale="-2">2.5</ix:nonFraction>% of the principal amount of the term loan depending on the timing of prepayment. The $<ix:nonFraction unitRef="U_iso4217USD" id="F_000674" name="us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160731" decimals="0" format="ixt:numdotdecimal">150,000</ix:nonFraction> facility fee that was paid at the original closing, the loan modification fees and other debt offering/issuance costs have been recorded as debt discount on the Company&#8217;s balance sheet and together with the final $<ix:nonFraction unitRef="U_iso4217USD" id="F_000678" name="drrx:DebtIssuanceCost" contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731" decimals="-5" scale="6">2.0</ix:nonFraction> million payment are being amortized to interest expense using the effective interest method over the revised term of the loan.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term loan is secured by substantially all of the assets of the Company, except that the collateral does not include any intellectual property (including licensing, collaboration and similar agreements relating thereto), and certain other excluded assets. The 2016 Loan Agreement contains customary representations, warranties and covenants by the Company, which covenants limit the Company&#8217;s ability to convey, sell, lease, transfer, assign or otherwise dispose of certain assets of the Company&#59; engage in any business other than the businesses currently engaged in by the Company or reasonably related thereto&#59; liquidate or dissolve&#59; make certain management changes&#59; undergo certain change of control events&#59; create, incur, assume, or be liable with respect to certain indebtedness&#59; grant certain liens&#59; pay dividends and make certain other restricted payments&#59; make certain investments&#59; and make payments on any subordinated debt.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Loan Agreement also contains customary indemnification obligations and customary events of default, including, among other things, the Company&#8217;s failure to fulfill certain obligations of the Company under the Loan Agreement and the occurrence of a material adverse change which is defined as </p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000352_dcnt_1241c683-2664-479c-95b7-4c5d2fd2a119">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a material adverse change in the Company&#8217;s business, operations, or condition (financial or otherwise), a material impairment of the prospect of repayment of any portion of the loan, or a material impairment in the perfection or priority of lender&#8217;s lien in the collateral or in the value of such collateral. In the event of default by the Company under the Loan Agreement, the lender would be entitled to exercise its remedies thereunder, including the right to accelerate the debt, upon which the Company may be required to repay all amounts then outstanding under the Loan Agreement, which could harm the Company&#8217;s financial condition. The conditionally exercisable call option related to the event of default is considered to be an embedded derivative which is required to be bifurcated and accounted for as a separate financial instrument. In the periods presented, the value of the embedded derivative is not material, but could become material in future periods if an event of default became more probable than is currently estimated.</span></p><ix:nonNumeric id="F_000389" name="us-gaap:ScheduleOfDebtTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of the term loan approximates the carrying value. Future maturities and interest payments under the term loan as of December 31, 2020, are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000682" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,941</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000683" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,208</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000684" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">8,563</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000685" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,712</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total minimum payments</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000686" name="us-gaap:DebtInstrumentFaceAmount" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">25,424</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less amount representing interest</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000687" name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,646</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross balance of term loan</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000688" name="us-gaap:DebtInstrumentCarryingAmount" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">21,778</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less unamortized debt discount</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000689" name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="C_0001082038_20201231" decimals="-3" scale="3">958</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Carrying value of term loan</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000690" name="us-gaap:LongTermDebt" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">20,820</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less term loan, current portion, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000691" name="us-gaap:LongTermDebtCurrent" contextRef="C_0001082038_20201231" decimals="-3" scale="3">884</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term loan, non-current portion, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000692" name="us-gaap:LongTermDebtNoncurrent" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,936</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:5pt;">&#160;</p><ix:nonNumeric id="F_000353" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000353_dcnt_499cf16b-1e77-4887-a5f2-c17dd371555f">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">8.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Stockholders&#8217; Equity</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Common Stock</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2015, the Company filed a shelf registration statement on Form S-3 with the SEC, which allowed the Company to offer up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000693" name="drrx:CommonStockCapitalAmountReservedForFutureIssuance" contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_20151130" decimals="INF" scale="6">125.0</ix:nonFraction> million of securities from time to time in one or more public offerings of its common stock. In addition, the Company entered into a Controlled Equity Offering sales agreement with Cantor Fitzgerald, under which the Company may sell, subject to certain limitations, up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000695" name="drrx:CommonStockCapitalAmountReservedForFutureIssuance" contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_drrxControlledEquityOfferingProgramMember_20151130" decimals="INF" scale="6">40</ix:nonFraction> million of common stock through Cantor Fitzgerald, acting as agent. In August 2018, the Company filed a new shelf registration statement on Form S-3 with the SEC, which upon being declared effective in October 2018, terminated the November 2015 registration statement and allowed the Company to offer up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000694" name="drrx:CommonStockCapitalAmountReservedForFutureIssuance" contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_20181031" decimals="INF" scale="6">175.0</ix:nonFraction> million of securities from time to time in one or more public offerings, inclusive of up to $<ix:nonFraction unitRef="U_iso4217USD" id="F_000696" name="drrx:CommonStockCapitalAmountReservedForFutureIssuance" contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_drrxControlledEquityOfferingProgramMember_20181031" decimals="INF" scale="6">75.0</ix:nonFraction> million of additional shares of common stock which the Company may sell, subject to certain limitations, under the 2015 Sales Agreement through Cantor Fitzgerald, acting as agent.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2018, the Company raised net proceeds of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000697" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapTypeOfArrangementAxis_drrxControlledEquityOfferingProgramMember_20180101_20181231" decimals="-5" scale="6">16.8</ix:nonFraction> million from the sale of approximately <ix:nonFraction unitRef="U_xbrlishares" id="F_000700" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapTypeOfArrangementAxis_drrxControlledEquityOfferingProgramMember_20180101_20181231" decimals="-5" scale="6">9.6</ix:nonFraction> million shares of common stock in the open market through the Controlled Equity Offering program with Cantor Fitzgerald at a weighted average price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000703" name="drrx:CommonStockWeightedAveragePrice" contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapTypeOfArrangementAxis_drrxControlledEquityOfferingProgramMember_20180101_20181231" decimals="2">1.80</ix:nonFraction> per share. In 2019, the Company raised net proceeds of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000698" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20190101_20191231" decimals="-5" scale="6">3.5</ix:nonFraction> million from the sale of <ix:nonFraction unitRef="U_xbrlishares" id="F_000701" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20190101_20191231" decimals="0" format="ixt:numdotdecimal">2,349,820</ix:nonFraction> shares of the Company&#8217;s common stock in the open market at a weighted average price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000704" name="drrx:CommonStockWeightedAveragePrice" contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20190101_20191231" decimals="2">1.55</ix:nonFraction> per share pursuant to the October 2018 registration statement.&#160;&#160;On June 20, 2019, the Company entered into a transaction to sell <ix:nonFraction unitRef="U_xbrlishares" id="F_000706" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="C_0001082038_20190620_20190620" decimals="INF" format="ixt:numdotdecimal">29,000,000</ix:nonFraction> shares of our common stock to certain investors in a registered offering at a price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000707" name="us-gaap:SaleOfStockPricePerShare" contextRef="C_0001082038_20190620" decimals="2">0.52</ix:nonFraction> per share, raising total gross proceeds to the Company of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000708" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="C_0001082038_20190620_20190620" decimals="-5" scale="6">15.1</ix:nonFraction> million. In 2020, the Company raised net proceeds of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000699" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20200101_20201231" decimals="-5" scale="6">12.3</ix:nonFraction> million from the sale of <ix:nonFraction unitRef="U_xbrlishares" id="F_000702" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20200101_20201231" decimals="0" format="ixt:numdotdecimal">5,308,002</ix:nonFraction> shares of the Company&#8217;s common stock in the open market at a weighted average price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000705" name="drrx:CommonStockWeightedAveragePrice" contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20200101_20201231" decimals="2">2.39</ix:nonFraction> per share pursuant to the October 2018 registration statement.</p></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000353_dcnt_499cf16b-1e77-4887-a5f2-c17dd371555f" continuedAt="F_000353_dcnt_fa9c6f29-00a6-4507-bd8d-94c7873a172c">

<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2021, the Company completed an underwritten public offering of <ix:nonFraction unitRef="U_xbrlishares" id="F_000709" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210201_20210228" decimals="INF" format="ixt:numdotdecimal">20,364,582</ix:nonFraction> shares of its common stock at a price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000710" name="us-gaap:SaleOfStockPricePerShare" contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228" decimals="4">2.2386</ix:nonFraction> per share pursuant to an underwriting agreement with Cantor Fitzgerald&#160;&#38; Co., raising total gross proceeds to the Company of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000711" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210201_20210228" decimals="-5" scale="6">45.6</ix:nonFraction> million before deducting estimated offering expenses payable by the Company. Total stock issuance costs related to this financing were approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000712" name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210201_20210228" decimals="-3" format="ixt:numdotdecimal" scale="3">195,000</ix:nonFraction>. After deducting estimated offering expenses payable by the Company, the net proceeds to the Company were approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000713" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210201_20210228" decimals="-5" scale="6">45.4</ix:nonFraction> million.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From January 1, 2021 to March 1, 2021, the Company also raised net proceeds (net of commissions) of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000714" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001082038_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20210321_20210321" decimals="-5" scale="6">2.4</ix:nonFraction> million from the sale of <ix:nonFraction unitRef="U_xbrlishares" id="F_000715" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001082038_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20210321_20210321" decimals="INF" format="ixt:numdotdecimal">950,009</ix:nonFraction> shares of the Company&#8217;s common stock in the open market at a weighted average price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000716" name="drrx:CommonStockWeightedAveragePrice" contextRef="C_0001082038_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20210321_20210321" decimals="2">2.60</ix:nonFraction> per share pursuant to the October 2018 registration statement.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Description of Stock-Based Compensation Plans</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">2000 Stock Plan (Incentive Stock Plan)</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January 2000, the Company&#8217;s Board of Directors and stockholders adopted the DURECT Corporation 2000 Stock Plan, under which incentive stock options and non-statutory stock options and stock purchase rights may be granted to employees, consultants and non-employee directors. The 2000 Stock Plan was amended by written consent of the Board of Directors in March 2000 and written consent of the stockholders in August 2000.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2005, the Board of Directors approved certain amendments to the 2000 Stock Plan. At the Company&#8217;s annual stockholders meeting in June 2005, the stockholders approved the amendments of the 2000 Stock Plan to: (i)&#160;expand the types of awards that the Company may grant to eligible service providers under the Stock Plan to include restricted stock units, stock appreciation rights and other similar types of awards (including other awards under which recipients are not required to pay any purchase or exercise price) as well as cash awards&#59; and (ii)&#160;include certain performance criteria that may be applied to awards granted under the Stock Plan.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At the Company&#8217;s annual stockholders meeting in June 2010, the stockholders approved amendments of the 2000 Stock Plan to: (i)&#160;provide that the number of shares that remain available for issuance will be reduced by two shares for each share issued pursuant to an award (other than an option or stock appreciation right) granted on or after the date of the 2010 Annual Meeting&#59; (ii)&#160;expand the types of transactions that might be considered repricings and option exchanges for which stockholder approval is required&#59; (iii)&#160;provide that shares tendered or withheld in payment of the exercise price of an option or withheld to satisfy a withholding obligation, and all shares with respect to which a stock appreciation right is exercised, will not again be available for issuance under the Stock Plan&#59; (iv)&#160;require that options and stock appreciation rights have an exercise price or base appreciation amount that is at least fair market value on the grant date, except in connection with certain corporate transactions, and that stock appreciation rights may not have longer than a <ix:nonNumeric id="F_000717" name="drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20200101_20201231" format="ixt-sec:duryear">10</ix:nonNumeric>-year term&#59; (v)&#160;add new performance goals that may be used to provide &#8220;performance-based compensation&#8221; under the 2000 Stock Plan&#59; (vi)&#160;extend the term of the 2000 Stock Plan to the date that is ten (10)&#160;years following the stockholders meeting&#59; and (vii)&#160;expand the treatment of outstanding awards in connection with certain changes of control of the Company to cover mergers in which the consideration payable to stockholders is not solely securities of the successor corporation.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At the Company&#8217;s annual stockholders meeting in June 2011, June 2014, June 2016 and June 2018, the stockholders approved amendments of the 2000 Stock Plan to increase the number of shares of the Company&#8217;s common stock available for issuance by <ix:nonFraction unitRef="U_xbrlishares" id="F_000719" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20110601_20110630" decimals="INF" format="ixt:numdotdecimal">5,500,000</ix:nonFraction> shares, <ix:nonFraction unitRef="U_xbrlishares" id="F_000720" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20140601_20140630" decimals="INF" format="ixt:numdotdecimal">4,000,000</ix:nonFraction> shares, <ix:nonFraction unitRef="U_xbrlishares" id="F_000721" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20160601_20160630" decimals="INF" format="ixt:numdotdecimal">5,000,000</ix:nonFraction> shares and <ix:nonFraction unitRef="U_xbrlishares" id="F_000722" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20180601_20180630" decimals="INF" format="ixt:numdotdecimal">7,500,000</ix:nonFraction> shares, respectively, each of which had previously been approved by the Board of Directors. </p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000353_dcnt_fa9c6f29-00a6-4507-bd8d-94c7873a172c" continuedAt="F_000353_dcnt_490ce923-b9bc-4c01-a9d4-270802dd935b">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At the Company&#8217;s annual stockholders meeting in June 2019, the stockholders approved amendments of the 2000 Stock Plan to extend the term of the 2000 Stock Plan to the date that is ten </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10)&#160;</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">years following the stockholders meeting. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A total of <ix:nonFraction unitRef="U_xbrlishares" id="F_000724" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20201231" decimals="INF" format="ixt:numdotdecimal">49,955,639</ix:nonFraction> shares of common stock have been reserved for issuance under this plan. The plan expires in <span style="-sec-ix-hidden:F_000725">June 2029</span>.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2013, the Board of Directors approved certain amendments to the 2000 Stock Plan to: (i)&#160;increase the number of stock options granted to a non-employee director on the date which such person first becomes a director from <ix:nonFraction unitRef="U_xbrlishares" id="F_000726" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_0001082038_srtTitleOfIndividualAxis_drrxNonEmployeeDirectorMember_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20000101_20000331" decimals="INF" format="ixt:numdotdecimal">30,000</ix:nonFraction> to <ix:nonFraction unitRef="U_xbrlishares" id="F_000727" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20130401_20130430" decimals="INF" format="ixt:numdotdecimal">70,000</ix:nonFraction> shares of common stock&#59; each option shall have a <span style="-sec-ix-hidden:F_000728">ten-year</span> term, become exercisable in installments of one-third of the total number of options granted on each anniversary of the grant and have a two-year period following termination of Director status in which the former director can exercise the option&#59; (ii)&#160;modify the exercise period for future option grants to a non-employee director in which a former director can exercise the option following termination of Director status from a <ix:nonNumeric id="F_000729" name="drrx:ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors" contextRef="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20130401_20130430" format="ixt-sec:durwordsen">one year</ix:nonNumeric> period to a <span style="-sec-ix-hidden:F_000730">two-year</span> period.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted under the 2000 Stock Plan expire no later than ten years from the date of grant. Options may be granted with different vesting terms from time to time not to exceed <ix:nonNumeric id="F_000731" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20200101_20201231" format="ixt-sec:durwordsen">five years</ix:nonNumeric> from the date of grant. The option price of an incentive stock option granted to an employee or of a nonstatutory stock option granted to any person who owns stock representing more than <ix:nonFraction unitRef="U_xbrlipure" id="F_000732" name="drrx:MinimumPercentageOfCombinedVotingPowerClassesOfStock" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20200101_20201231" decimals="INF" scale="-2">10</ix:nonFraction>% of the total combined voting power of all classes of stock of the Company (or any parent or subsidiary) shall be no less than <ix:nonFraction unitRef="U_xbrlipure" id="F_000733" name="drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20200101_20201231" decimals="INF" scale="-2">110</ix:nonFraction>% of the fair market value per share on the date of grant. The option price of an incentive stock option granted to any other employee shall be no less than <ix:nonFraction unitRef="U_xbrlipure" id="F_000734" name="drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20200101_20201231" decimals="INF" scale="-2">100</ix:nonFraction>% of the fair market value per share on the date of grant.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, <ix:nonFraction unitRef="U_xbrlishares" id="F_000735" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20201231" decimals="INF" format="ixt:numdotdecimal">7,599,531</ix:nonFraction> shares of common stock were available for future grant and options to purchase <ix:nonFraction unitRef="U_xbrlishares" id="F_000736" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20201231" decimals="INF" format="ixt:numdotdecimal">27,274,439</ix:nonFraction> shares of common stock were outstanding under the 2000 Stock Plan.&#160; &#160; </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;&#160; </p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">2000 Employee Stock Purchase Plan</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2000, the Company adopted the 2000 Employee Stock Purchase Plan. This purchase plan is implemented by a series of overlapping offering periods of <ix:nonNumeric id="F_000737" name="drrx:EmployeeStockPurchasePlanOfferingPeriod" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231" format="ixt-sec:durmonth">24</ix:nonNumeric> months&#8217; duration, with new offering periods, other than the first offering period, beginning on May&#160;1 and November&#160;1 of each year and ending April&#160;30 and October&#160;31, respectively, two years later. The purchase plan allows eligible employees to purchase common stock through payroll deductions at a price equal to the lower of <ix:nonFraction unitRef="U_xbrlipure" id="F_000738" name="drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231" decimals="INF" scale="-2">85</ix:nonFraction>% of the fair market value of the Company&#8217;s common stock at the beginning of each offering period or at the end of each purchase period. The initial offering period commenced on the effectiveness of the Company&#8217;s initial public offering.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2010, the Board of Directors approved certain amendments to the 2000 Employee Stock Purchase Plan. At the Company&#8217;s annual stockholders meeting in June 2010, the stockholders approved the amendments of the 2000 Employee Stock Purchase Plan to: (i)&#160;increase the number of shares of our common stock authorized for issuance under the ESPP by <ix:nonFraction unitRef="U_xbrlishares" id="F_000739" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20100401_20100430" decimals="INF" format="ixt:numdotdecimal">250,000</ix:nonFraction> shares&#59; (ii)&#160;extend the term of the ESPP to the date that is ten (10)&#160;years following the stockholders meeting&#59; (iii)&#160;provide for six-month consecutive offering periods beginning on November&#160;1, 2010&#59; (iv)&#160;revise certain provisions to reflect the final regulations issued under Section&#160;423 of the Code by the Internal Revenue Service&#59; and (v)&#160;provide for the cash-out of options outstanding under an offering period in effect prior to the consummation of certain corporate transactions as an alternative to providing for a final purchase under such offering period.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2015, the Board of Directors approved certain amendments to the 2000 Employee Stock Purchase Plan. At the Company&#8217;s annual stockholders meeting in June 2015, the stockholders approved the amendments of the 2000 Employee Stock Purchase Plan to: (i)&#160;increase the number of shares of our common stock authorized for issuance under the ESPP by <ix:nonFraction unitRef="U_xbrlishares" id="F_000741" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20150301_20150331" decimals="INF" format="ixt:numdotdecimal">350,000</ix:nonFraction> shares&#59; and (ii)&#160;extend the term of the ESPP to the date that is ten (10)&#160;years following the stockholders meeting. At each of the Company&#8217;s annual stockholders meeting in June 2017 and in June 2020, the stockholders approved amendments of </p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000353_dcnt_490ce923-b9bc-4c01-a9d4-270802dd935b" continuedAt="F_000353_dcnt_49ef55ea-5320-47e5-aca7-4a99280e1c93">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the 2000 Employee Stock Purchase Plan to increase the number of shares our common stock authorized for issuance under the ESPP by </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000742" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20170601_20170630" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_xbrlishares" id="F_000743" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200601_20200630" decimals="INF" format="ixt:numdotdecimal">350,000</ix:nonFraction></ix:nonFraction></span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shares</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, respectively,</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="color:#000000;">and to re-approve its material terms</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The plan expires in <span style="-sec-ix-hidden:F_000745">June 2030</span>. A total of <ix:nonFraction unitRef="U_xbrlishares" id="F_000746" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20201231" decimals="INF" format="ixt:numdotdecimal">2,900,000</ix:nonFraction> shares of common stock have been reserved for issuance under this plan. As of December 31, 2020, <ix:nonFraction unitRef="U_xbrlishares" id="F_000747" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20201231" decimals="INF" format="ixt:numdotdecimal">497,270</ix:nonFraction> shares of common stock were available for future grant and <ix:nonFraction unitRef="U_xbrlishares" id="F_000748" name="us-gaap:CommonStockSharesIssued" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20201231" decimals="INF" format="ixt:numdotdecimal">2,752,730</ix:nonFraction> shares of common stock have been issued under the 2000 Employee Stock Purchase Plan.</p><ix:nonNumeric id="F_000390" name="us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, shares of common stock reserved for future issuance consisted of the following:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options outstanding</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000749" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0001082038_20201231" decimals="INF" format="ixt:numdotdecimal">27,274,439</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options available for grant</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000750" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0001082038_20201231" decimals="INF" format="ixt:numdotdecimal">7,599,531</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee Stock Purchase Plan</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000751" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20201231" decimals="INF" format="ixt:numdotdecimal">497,270</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000752" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="C_0001082038_20201231" decimals="INF" format="ixt:numdotdecimal">35,371,240</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric><ix:nonNumeric id="F_000391" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of stock option activity under all stock-based compensation plans is as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price&#160;Per&#160;Share</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average&#160;Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual Term</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in Years)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in&#160;millions)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000753" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0001082038_20191231" decimals="INF" format="ixt:numdotdecimal">29,803,766</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000761" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_0001082038_20191231" decimals="2">1.41</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000769">5.17</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000773" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_0001082038_20191231" decimals="-2" scale="3">71.3</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000754" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="C_0001082038_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">2,702,860</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000762" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="C_0001082038_20200101_20201231" decimals="2">2.12</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000755" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="C_0001082038_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">2,865,835</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000763" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="C_0001082038_20200101_20201231" decimals="2">1.11</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options forfeited</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000756" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="C_0001082038_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">389,471</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000764" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="C_0001082038_20200101_20201231" decimals="2">1.45</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options expired</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_xbrlishares" id="F_000757" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="C_0001082038_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">1,976,881</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000765" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="C_0001082038_20200101_20201231" decimals="2">2.20</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000758" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="C_0001082038_20201231" decimals="INF" format="ixt:numdotdecimal">27,274,439</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000766" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="C_0001082038_20201231" decimals="2">1.45</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000770">4.98</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000774" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="C_0001082038_20201231" decimals="-2" scale="3">19.6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable at December 31, 2020</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000759" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="C_0001082038_20201231" decimals="INF" format="ixt:numdotdecimal">23,512,705</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000767" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="C_0001082038_20201231" decimals="2">1.42</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000771">4.44</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000775" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="C_0001082038_20201231" decimals="-2" scale="3">17.7</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested and expected to vest at</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; December 31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000760" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="C_0001082038_20201231" decimals="INF" format="ixt:numdotdecimal">27,274,439</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000768" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" contextRef="C_0001082038_20201231" decimals="2">1.45</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000772">4.98</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000776" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="C_0001082038_20201231" decimals="-2" scale="3">19.6</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aggregate intrinsic value in the table above represents the total intrinsic value (i.e., the difference between the Company&#8217;s closing stock price on the last trading day of 2020 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their in-the-money options on December 31, 2020. This amount changes based on the fair market value of the Company&#8217;s common stock. The total intrinsic value of options exercised was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000777" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231" decimals="-5" scale="6">3.6</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000778" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20190101_20191231" decimals="-5" scale="6">1.7</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000779" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20180101_20181231" decimals="-5" scale="6">1.6</ix:nonFraction> million for the years ended December 31, 2020, 2019 and 2018, respectively.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In lieu of providing cash bonuses to certain employees, in January 2019 and 2018, the Company granted its employees stock options to purchase <ix:nonFraction unitRef="U_xbrlishares" id="F_000780" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20191231" decimals="-5" scale="6">2.3</ix:nonFraction> million and <ix:nonFraction unitRef="U_xbrlishares" id="F_000781" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20181231" decimals="-5" scale="6">1.9</ix:nonFraction> million shares, respectively, of the Company&#8217;s common stock, which vested immediately on the grant date. The weighted-average grant-date fair value of all options granted with exercise prices equal to fair market value was $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000782" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20190101_20191231" decimals="2">0.43</ix:nonFraction> in 2019 and $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000783" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20180101_20181231" decimals="2">0.94</ix:nonFraction> in 2018 determined by the Black-Scholes option valuation method. There were <ix:nonFraction unitRef="U_iso4217USD" id="F_000784" name="drrx:OptionsGrantedWithExercisePricesLowerThanFairMarket" contextRef="C_0001082038_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> options granted with exercise prices lower than fair market value.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expenses for non-employee stock options are recorded over the vesting period of the options, which closely approximates the non-employee&#8217;s performance period, with the value determined by the Black-Scholes option valuation method and remeasured over the vesting term.</p><ix:nonNumeric id="F_000392" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000392_dcnt_8544cc71-ebf3-462a-96bf-d2ab3657d4d4"></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000353_dcnt_49ef55ea-5320-47e5-aca7-4a99280e1c93" continuedAt="F_000353_dcnt_f3e2ca63-6e05-4cc0-a2f6-2284da2861b5"><ix:continuation id="F_000392_dcnt_8544cc71-ebf3-462a-96bf-d2ab3657d4d4">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the Company had three stock-based equity compensation plans, which are described above. The employee stock-based compensation cost that has been included in the statements of operations and comprehensive loss is shown as below (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of product revenues</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000785" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20200101_20201231" decimals="-3" scale="3">13</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000786" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20190101_20191231" decimals="-3" scale="3">13</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000787" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20180101_20181231" decimals="-3" scale="3">13</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000788" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231" decimals="-3" scale="3">981</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000789" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20190101_20191231" decimals="-3" scale="3">746</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000790" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,541</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000791" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,085</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000792" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,269</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000793" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,355</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000794" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,079</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000795" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,028</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000796" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,909</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because the Company had a net operating loss carryforward as of December 31, 2020, <ix:nonFraction unitRef="U_iso4217USD" id="F_000797" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" contextRef="C_0001082038_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> excess tax benefits for the tax deductions related to stock-based compensation expense were recognized in the statement of operations. Additionally, <ix:nonFraction unitRef="U_iso4217USD" id="F_000798" name="us-gaap:DeferredTaxExpenseFromStockOptionsExercised" contextRef="C_0001082038_20200101_20201231" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction> incremental tax benefits were recognized from stock options exercised during 2020, which would have resulted in a reclassification to reduce net cash provided by operating activities with an offsetting increase in net cash provided by financing activities.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Determining Fair Value</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Valuation and Expense Recognition.<span style="font-style:normal;">&#160;&#160;&#160;&#160;The Company estimates the fair value of stock options granted using the Black-Scholes option valuation model. The Company recognizes the expense on a straight-line basis. The expense for options is recognized over the requisite service periods of the awards, which is generally the vesting period.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Expected Term.<span style="font-style:normal;">&#160;&#160;&#160;&#160;The expected term of options granted represents the period of time that the options are expected to be outstanding. The Company determines the expected life using historical options experience. This develops the expected life by taking the weighted average of the actual life of options exercised and cancelled and assumes that outstanding options are exercised uniformly from the current holding period through the end of the contractual life.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Expected Volatility.<span style="font-style:normal;">&#160;&#160;&#160;&#160;The Company estimates the volatility of its common stock at the date of grant based on the historical volatility of the Company&#8217;s common stock.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Risk-Free Rate.<span style="font-style:normal;">&#160;&#160;&#160;&#160;The Company bases the risk-free rate that it uses in the Black-Scholes option valuation model on the implied yield in effect at the time of option grant on U.S. Treasury zero-coupon issues with substantially equivalent remaining terms.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Dividends.<span style="font-style:normal;">&#160;&#160;&#160;&#160;The Company has never paid any cash dividends on its common stock and the Company does not anticipate paying any cash dividends in the foreseeable future. Consequently, the Company uses an expected dividend yield of <ix:nonFraction unitRef="U_iso4217USD" id="F_000799" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231" decimals="0" format="ixt-sec:numwordsen">zero</ix:nonFraction> in the Black-Scholes option valuation model.</span></p><ix:nonNumeric id="F_000393" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000393_dcnt_0e820370-9997-4363-8d74-006341bcde1b"></ix:nonNumeric></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000353_dcnt_f3e2ca63-6e05-4cc0-a2f6-2284da2861b5" continuedAt="F_000353_dcnt_d5ae546c-1f6b-483a-aa58-a72ea5275659"><ix:continuation id="F_000393_dcnt_0e820370-9997-4363-8d74-006341bcde1b">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company used the following assumptions to estimate the fair value of options granted (including fully vested options issued in January 2019 and 2018) and shares purchased under its stock plans and employee stock purchase plan for the years ended December 31, 2020, 2019 and 2018:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Stock Options</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free rate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000803">0.5-1.4%</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000804">1.5-2.7%</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000805">2.7-3.1%</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000806">7.0-7.3</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000807">7.5-10.0</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000808">7.0-10.0</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000812">84-87%</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000813">79-83%</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000814">78-86%</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeiture rate (1)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000818" name="drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate" contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231" decimals="INF" scale="-2">0.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000819" name="drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate" contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231" decimals="INF" scale="-2">0.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlipure" id="F_000820" name="drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate" contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231" decimals="INF" scale="-2">0.0</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"></span><span style="color:#000000;"></span><span style="font-family:Times New Roman;color:#000000;"><ix:footnote id="FNT_000004" xml:lang="en-US">Effective January 1, 2017, the Company elected to account for forfeitures as they occur.</ix:footnote></span> </p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:7.69%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Employee Stock Purchase Plan</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free rate</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.1%</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000824">1.6-2.5%</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000825">1.3-2.5%</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000826">0.5</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000827">0.5</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000828">0.5</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000829">78-124%</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000830">60-103%</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000831">60-146%</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were <ix:nonFraction unitRef="U_xbrlishares" id="F_000835" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal">102,006</ix:nonFraction>, <ix:nonFraction unitRef="U_xbrlishares" id="F_000836" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal">111,909</ix:nonFraction> and <ix:nonFraction unitRef="U_xbrlishares" id="F_000837" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20180101_20181231" decimals="INF" format="ixt:numdotdecimal">119,097</ix:nonFraction> shares purchased under the Company&#8217;s employee stock purchase plan during the years ended December 31, 2020, 2019 and 2018, respectively. Included in the statement of operations and comprehensive loss for the year ended December 31, 2020, 2019 and 2018 was $<ix:nonFraction unitRef="U_iso4217USD" id="F_000838" name="us-gaap:AdjustmentForAmortization" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231" decimals="INF" format="ixt:numdotdecimal" scale="3">86,000</ix:nonFraction>, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000839" name="us-gaap:AdjustmentForAmortization" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20190101_20191231" decimals="INF" format="ixt:numdotdecimal" scale="3">27,000</ix:nonFraction> and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000840" name="us-gaap:AdjustmentForAmortization" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20180101_20181231" decimals="INF" format="ixt:numdotdecimal" scale="3">24,000</ix:nonFraction>, respectively, in stock-based compensation expense related to the recognition of expenses related to shares purchased under the Company&#8217;s employee stock purchase plan.</p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000353_dcnt_d5ae546c-1f6b-483a-aa58-a72ea5275659">

<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000841" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20201231" decimals="-5" scale="6">3.4</ix:nonFraction> million of total unrecognized compensation costs related to nonvested stock options is expected to be recognized over the respective vesting terms of each award through 2024. The weighted average term of the unrecognized stock-based compensation expense is <ix:nonNumeric id="F_000842" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231" format="ixt-sec:duryear">2.6</ix:nonNumeric> years.</p><ix:nonNumeric id="F_000394" name="us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes information about stock options outstanding at December 31, 2020:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.72%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.52%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options Outstanding</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.56%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options Exercisable</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Range of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual&#160;Life</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In years)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercisable</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000843">$0.51 - $0.57</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000865" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20201231" decimals="INF" format="ixt:numdotdecimal">143,750</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000876">8.12</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000887" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20201231" decimals="INF">0.57</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000898" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20201231" decimals="INF" format="ixt:numdotdecimal">50,418</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000909" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20201231" decimals="2">0.56</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000844">$0.58 - $0.58</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000866" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTwoMember_20201231" decimals="INF" format="ixt:numdotdecimal">2,878,012</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000877">7.79</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000888" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTwoMember_20201231" decimals="INF">0.58</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000899" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTwoMember_20201231" decimals="INF" format="ixt:numdotdecimal">2,165,967</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000910" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTwoMember_20201231" decimals="2">0.58</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000845">$0.58 - $0.88</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000867" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeThreeMember_20201231" decimals="INF" format="ixt:numdotdecimal">3,561,267</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000878">3.65</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000889" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeThreeMember_20201231" decimals="INF">0.82</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000900" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeThreeMember_20201231" decimals="INF" format="ixt:numdotdecimal">3,549,297</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000911" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeThreeMember_20201231" decimals="2">0.82</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000846">$0.93 - $1.20</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000868" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFourMember_20201231" decimals="INF" format="ixt:numdotdecimal">2,761,642</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000879">4.92</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000890" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFourMember_20201231" decimals="INF">1.15</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000901" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFourMember_20201231" decimals="INF" format="ixt:numdotdecimal">2,706,954</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000912" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFourMember_20201231" decimals="2">1.15</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000847">$1.21 - $1.21</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000869" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFiveMember_20201231" decimals="INF" format="ixt:numdotdecimal">2,608,933</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000880">2.13</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000891" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFiveMember_20201231" decimals="INF">1.21</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000902" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFiveMember_20201231" decimals="INF" format="ixt:numdotdecimal">2,606,683</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000913" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFiveMember_20201231" decimals="2">1.21</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000848">$1.24 - $1.24</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000870" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSixMember_20201231" decimals="INF" format="ixt:numdotdecimal">2,869,328</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000881">6.84</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000892" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSixMember_20201231" decimals="INF">1.24</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000903" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSixMember_20201231" decimals="INF" format="ixt:numdotdecimal">2,457,142</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000914" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSixMember_20201231" decimals="2">1.24</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000849">$1.26 - $1.26</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000871" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSevenMember_20201231" decimals="INF" format="ixt:numdotdecimal">40,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000882">5.28</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000893" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSevenMember_20201231" decimals="INF">1.26</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000904" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSevenMember_20201231" decimals="INF" format="ixt:numdotdecimal">40,000</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000915" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSevenMember_20201231" decimals="2">1.26</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000850">$1.31 - $1.31</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000872" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeEightMember_20201231" decimals="INF" format="ixt:numdotdecimal">2,755,496</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000883">5.62</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000894" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeEightMember_20201231" decimals="INF">1.31</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000905" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeEightMember_20201231" decimals="INF" format="ixt:numdotdecimal">2,527,036</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000916" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeEightMember_20201231" decimals="2">1.31</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000851">$1.33 - $2.09</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000873" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeNineMember_20201231" decimals="INF" format="ixt:numdotdecimal">5,068,694</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000884">4.35</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000895" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeNineMember_20201231" decimals="INF">1.81</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000906" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeNineMember_20201231" decimals="INF" format="ixt:numdotdecimal">4,610,445</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000917" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeNineMember_20201231" decimals="2">1.81</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.72%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000852">$2.10 - $3.61</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000874" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTenMember_20201231" decimals="INF" format="ixt:numdotdecimal">4,587,317</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000885">4.95</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000896" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTenMember_20201231" decimals="INF">2.66</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000907" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTenMember_20201231" decimals="INF" format="ixt:numdotdecimal">2,798,763</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000918" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTenMember_20201231" decimals="2">2.95</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.72%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000853">$0.51 - $3.61</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000875" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeElevenMember_20201231" decimals="INF" format="ixt:numdotdecimal">27,274,439</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000886">4.98</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000897" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeElevenMember_20201231" decimals="INF">1.45</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_000908" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeElevenMember_20201231" decimals="INF" format="ixt:numdotdecimal">23,512,705</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_000919" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeElevenMember_20201231" decimals="2">1.42</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company received $<ix:nonFraction unitRef="U_iso4217USD" id="F_000920" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231" decimals="-5" scale="6">3.2</ix:nonFraction> million, $<ix:nonFraction unitRef="U_iso4217USD" id="F_000921" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20190101_20191231" decimals="-5" scale="6">1.9</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000922" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20180101_20181231" decimals="-5" scale="6">1.6</ix:nonFraction> million in cash from option exercises under all stock-based compensation plans for the years ended December 31, 2020, 2019 and 2018, respectively.</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p><ix:nonNumeric id="F_000354" name="us-gaap:IncomeTaxDisclosureTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000354_dcnt_24317d2e-2fb9-4ee5-b691-d9b7c3d25cd8">
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">9.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Income Taxes</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for income taxes using the liability method under ASC 740, <span style="font-style:italic;">Income Taxes</span>. Under this method, deferred tax assets and liabilities are determined based on temporary differences resulting from the different treatment of items for tax and financial reporting purposes. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to reverse. Additionally, the Company must assess the likelihood that deferred tax assets will be recovered as deductions from future taxable income. The Company has provided a full valuation allowance on the Company&#8217;s deferred tax assets because the Company believes it is more likely than not that its deferred tax assets will not be realized. The Company evaluates the realizability of its deferred tax assets on a quarterly basis. The Company recorded a deferred tax liability of $<ix:nonFraction unitRef="U_iso4217USD" id="F_000923" name="us-gaap:DeferredTaxLiabilities" contextRef="C_0001082038_20201231" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_iso4217USD" id="F_000924" name="us-gaap:DeferredTaxLiabilities" contextRef="C_0001082038_20191231" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_iso4217USD" id="F_000925" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="C_0001082038_20201231" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction unitRef="U_iso4217USD" id="F_000926" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="C_0001082038_20191231" decimals="0" format="ixt:numdotdecimal">244,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> on its balance sheet at both December 31, 2020 and 2019 that arose from tax amortization of an indefinite-lived intangible asset. The Company also recorded a deferred tax expense of <ix:nonFraction unitRef="U_iso4217USD" id="F_000927" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_0001082038_20200101_20201231" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000928" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_0001082038_20190101_20191231" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000929" name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="C_0001082038_20180101_20181231" decimals="0" format="ixt-sec:numwordsen">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction> in the years ended December 31, 2020, 2019 and 2018, respectively. The Company recorded <ix:nonFraction unitRef="U_iso4217USD" id="F_000930" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000931" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20190101_20191231" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000932" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20180101_20181231" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> tax expense in each of 2020, 2019 and 2018. </p><ix:nonNumeric id="F_000395" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000395_dcnt_d045a2c2-1e4a-43af-9f75-a7619505c018"></ix:nonNumeric></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">107</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000354_dcnt_24317d2e-2fb9-4ee5-b691-d9b7c3d25cd8" continuedAt="F_000354_dcnt_7f373dea-546d-48c7-a6c8-ccaba185ce22"><ix:continuation id="F_000395_dcnt_d045a2c2-1e4a-43af-9f75-a7619505c018">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The reconciliation of income tax expenses (benefit) at the statutory federal income tax rate of&#160;<ix:nonFraction unitRef="U_xbrlipure" id="F_000933" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_0001082038_20200101_20201231" decimals="2" scale="-2"><ix:nonFraction unitRef="U_xbrlipure" id="F_000934" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_0001082038_20190101_20191231" decimals="2" scale="-2"><ix:nonFraction unitRef="U_xbrlipure" id="F_000935" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="C_0001082038_20180101_20181231" decimals="2" scale="-2">21</ix:nonFraction></ix:nonFraction></ix:nonFraction>%, to net income tax benefit included in the statements of operations and comprehensive loss for the years ended December 31, 2020, 2019 and 2018 is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. federal taxes benefit at statutory rate</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000936" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" scale="3">122</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000937" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="C_0001082038_20190101_20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">4,321</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000938" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" contextRef="C_0001082038_20180101_20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">5,318</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State taxes</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in valuation allowance</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000939" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">2,022</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000940" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,142</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000941" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,143</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000942" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">268</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000943" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">879</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000944" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">999</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development tax credits</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000945" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,132</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000946" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,004</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000947" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">999</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax Reform change in tax rate and other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expiring net operating losses</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000948" name="drrx:IncomeTaxReconciliationExpiringNetOperatingLosses" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,991</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000949" name="drrx:IncomeTaxReconciliationExpiringNetOperatingLosses" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,252</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000950" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">17</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000951" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">52</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000952" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">175</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total income tax (benefit) provision</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2020, 2019 and 2018, total income tax provision (benefit) expense was <ix:nonFraction unitRef="U_iso4217USD" id="F_000953" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapOtherNonoperatingIncomeExpenseMember_20200101_20201231" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000954" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapOtherNonoperatingIncomeExpenseMember_20190101_20191231" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction unitRef="U_iso4217USD" id="F_000955" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapOtherNonoperatingIncomeExpenseMember_20180101_20181231" decimals="0" format="ixt-sec:numwordsen">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction>. Deferred tax assets and liabilities reflect the net tax effects of net operating loss and research and other credit carryforwards and the temporary differences between the carrying amounts of assets and liabilities for financial reporting and the amounts used for income tax purposes. <ix:nonNumeric id="F_000396" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000396_cnt_1">Significant components of the Company&#8217;s deferred tax assets and liabilities are as follows (in thousands):</ix:nonNumeric></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:continuation id="F_000396_cnt_1">
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating loss carryforwards</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000956" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">87,197</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000965" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">90,102</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and other credits</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000957" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">19,153</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000966" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">18,860</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000958" name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="C_0001082038_20201231" decimals="-3" scale="3">223</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000967" name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="C_0001082038_20191231" decimals="-3" scale="3">248</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000959" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,840</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000968" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,376</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000960" name="us-gaap:DeferredTaxAssetsOther" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,204</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000969" name="us-gaap:DeferredTaxAssetsOther" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">5,288</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000961" name="us-gaap:DeferredTaxAssetsGross" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">115,617</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000970" name="us-gaap:DeferredTaxAssetsGross" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">118,874</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance for deferred tax assets</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000962" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">114,323</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000971" name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">117,245</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities - Right of use asset</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000963" name="drrx:DeferredTaxLiabilitiesRightOfUseAssets" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,538</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000972" name="drrx:DeferredTaxLiabilitiesRightOfUseAssets" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,873</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets and liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000964" name="us-gaap:DeferredTaxLiabilities" contextRef="C_0001082038_20201231" decimals="-3" scale="3">244</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000973" name="us-gaap:DeferredTaxLiabilities" contextRef="C_0001082038_20191231" decimals="-3" scale="3">244</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes deferred tax assets to the extent that the Company believes that these assets are more likely than not to be realized. In making such a determination, all available positive and negative evidence is considered, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If it is determined that the Company would be able to realize deferred tax assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes. The recognition and measurement of tax benefits requires significant judgment. Judgments concerning the recognition and measurement of tax benefit might change as new information becomes available. Given the Company&#8217;s history of operating losses, the net deferred tax assets have been fully offset by a valuation allowance. The valuation allowance decreased by $<ix:nonFraction unitRef="U_iso4217USD" id="F_000974" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_0001082038_20200101_20201231" decimals="-5" sign="-" scale="6">2.9</ix:nonFraction> million during 2020 and increased by $<ix:nonFraction unitRef="U_iso4217USD" id="F_000975" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_0001082038_20190101_20191231" decimals="-5" scale="6">4.6</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000976" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="C_0001082038_20180101_20181231" decimals="-5" scale="6">6.3</ix:nonFraction> million during 2019 and 2018, respectively. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the Company had net operating loss carryforwards for federal income tax purposes of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000977" name="us-gaap:OperatingLossCarryforwards" contextRef="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20201231" decimals="-5" scale="6">344.7</ix:nonFraction> million, of which approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000978" name="drrx:NetOperatingLossCarryforwardsExpirationAmount" contextRef="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20201231" decimals="-5" scale="6">306.3</ix:nonFraction> million will expire in the years <ix:nonNumeric id="F_000980" name="drrx:TaxCreditCarryforwardExpiration" contextRef="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20200101_20201231">2021 through 2037</ix:nonNumeric>, and approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000979" name="drrx:NetOperatingLossCarryforwardsNonExpirationAmount" contextRef="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20201231" decimals="-5" scale="6">38.5</ix:nonFraction> million which do not expire, and federal research and </p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000354_dcnt_7f373dea-546d-48c7-a6c8-ccaba185ce22" continuedAt="F_000354_dcnt_7722437f-8a21-47b2-a20e-5fb1616a2e92">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">development tax credits of approximately $</span><ix:nonFraction unitRef="U_iso4217USD" id="F_000981" name="us-gaap:TaxCreditCarryforwardAmount" contextRef="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20201231" decimals="-5" scale="6">15.6</ix:nonFraction><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million, which expire at various dates beginning in </span><ix:nonNumeric id="F_000982" name="drrx:TaxCreditCarryforwardExpiration" contextRef="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20200101_20201231"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">202</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> through 20</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</span></ix:nonNumeric><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, if not utilized.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the Company had net operating loss carryforwards for state income tax purposes of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000983" name="us-gaap:OperatingLossCarryforwards" contextRef="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20201231" decimals="-5" scale="6">219.1</ix:nonFraction> million, which expire in the years <ix:nonNumeric id="F_000984" name="drrx:TaxCreditCarryforwardExpiration" contextRef="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231">2021 through 2040</ix:nonNumeric>, if not utilized, and state research and development tax credits of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000985" name="us-gaap:TaxCreditCarryforwardAmount" contextRef="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20201231" decimals="-5" scale="6">16.7</ix:nonFraction> million, which do not expire.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Utilization of the net operating losses may be subject to a substantial annual limitation due to federal and state ownership change limitations. The annual limitation may result in the expiration of net operating losses before utilization.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December 31, 2020 and December&#160;31, 2019, the Company had unrecognized tax benefits of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000986" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001082038_20201231" decimals="-5" scale="6">10.9</ix:nonFraction> million and $<ix:nonFraction unitRef="U_iso4217USD" id="F_000987" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001082038_20191231" decimals="-5" scale="6">9.1</ix:nonFraction> million, respectively (none of which, if recognized, would affect the Company&#8217;s effective tax rate). The Company does not believe there will be any material changes in its unrecognized tax positions over the next twelve months.</p><ix:nonNumeric id="F_000397" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at beginning of the year</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000988" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,078</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000989" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001082038_20181230" decimals="-3" format="ixt:numdotdecimal" scale="3">8,432</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increase (decrease) related to prior year tax positions</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000990" name="drrx:UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,136</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_000991" name="drrx:UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions" contextRef="C_0001082038_20190101_20191231" decimals="-3" sign="-" scale="3">73</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increase related to current year tax positions</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000992" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">674</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000993" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">719</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at end of the year</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000994" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001082038_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">10,888</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_000995" name="us-gaap:UnrecognizedTaxBenefits" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">9,078</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest and penalty costs related to unrecognized tax benefits, if any, are classified as a component of interest and other income, net in the Statements of Operations and Comprehensive Loss. The Company did not recognize any interest and penalties expenses related to unrecognized tax benefits for the years ended December 31, 2020, 2019 and 2018.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. The Company is subject to U.S. federal and state income tax examination for calendar tax years ending 1999 through 2019 due to unutilized net operating losses and research credits. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In response to the COVID-19 pandemic, the Coronavirus Aid, Relief and Economic Securities Act (CARES Act) was signed into law in the U.S. in March 2020. The CARES Act adjusted a number of provisions in the tax code, including the calculation and eligibility of certain deductions and the treatment of net operating losses and tax credits. The enactment of the CARES Act did not result in any material adjustments to the Company&#8217;s income tax provision for the year ended December 31, 2020, or to its net deferred tax assets as of December 31, 2020.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The recently enacted Consolidated Appropriations Act, 2021 has expanded, extended, and clarified selected CARES Act provisions, specifically on Paycheck Protection Program (PPP) loan and Employee Retention Tax Credit, 100% deductibility of business meals as well as other tax extenders. The Consolidated Appropriations Act is not expected to have a material impact on the Company&#8217;s tax provision.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">California Assembly Bill 85 (AB 85) was signed into law in June 2020. The legislation suspends the use of California Net Operating Loss deductions for 2020, 2021, and 2022 for certain taxpayers and imposes a limitation on the use of certain California Tax Credits for 2020, 2021, and 2022. The carryover periods for Net Operating Loss deductions disallowed by this provision will be extended. Given the Company&#8217;s loss position in the current year, the new legislation will not impact the current year </p></ix:continuation>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000354_dcnt_7722437f-8a21-47b2-a20e-5fb1616a2e92">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">provision. The Company will continue to monitor possible California net operating loss and credit limitation in future periods.</span></p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000355" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000355_dcnt_5f10ffef-23d2-4c67-95bb-87e33a0e8edc">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">10.<span style="margin-left:36pt;"></span>Discontinued Operations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 31, 2020, the Company completed the sale of its LACTEL Absorbable Polymers product line to Evonik. Under the terms of the Asset Purchase Agreement, Evonik paid DURECT approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_000999" name="drrx:AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid" contextRef="C_0001082038_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_drrxEvonikCorporationMember_20201230_20201231" decimals="-6" scale="6">15</ix:nonFraction>&#160;million subject to certain adjustments, and also agreed to assume certain liabilities with respect to the transferred assets.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result of the sale of the LACTEL product line, the operating results from our LACTEL product line have been excluded from continuing operations and presented as discontinued operations in the accompanying Statements of Operations and Comprehensive Loss for all periods presented. During the twelve months ended December 31, 2020, we recorded a gain on sale of the LACTEL product line of $<ix:nonFraction unitRef="U_iso4217USD" id="F_001000" name="us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" contextRef="C_0001082038_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_drrxEvonikCorporationMember_20200101_20201231" decimals="-5" scale="6">12.8</ix:nonFraction> million, upon the completion of sale to Evonik. The results of operations and gain from discontinued operations presented below include certain allocations that management believes fairly reflect the utilization of services provided to the LACTEL product line. The allocations do not include amounts related to general corporate administrative expenses or interest expense. Therefore, these results of operations do not necessarily reflect what the results of operations would have been had the LACTEL product line operated as a stand-alone entity.</p><ix:nonNumeric id="F_000398" name="drrx:SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:-5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of income from discontinued operations as reported in the Company&#8217;s statement of operations were as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:-5.24%;font-size:4pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product revenue, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001001" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,918</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001002" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,490</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001003" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,289</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenues</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001004" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,918</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001005" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,490</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001006" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,289</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of product revenues</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001007" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,019</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001008" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,880</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001009" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,623</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001010" name="drrx:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">476</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001011" name="drrx:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">569</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001012" name="drrx:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">488</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001013" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">515</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001014" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">248</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001015" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">157</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total costs and expenses</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001016" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">4,010</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001017" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,697</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001018" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">3,268</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income from discontinued operations</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001019" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">908</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001020" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">793</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001021" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">21</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income:</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on sale of the LACTEL product line</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001022" name="us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,845</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income from discontinued operations</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001023" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">13,753</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001024" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">793</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001025" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="C_0001082038_20180101_20181231" decimals="-3" scale="3">21</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income per share</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001026" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001082038_20200101_20201231" decimals="2">0.07</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001027" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001082038_20190101_20191231" decimals="2">0.00</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001028" name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="C_0001082038_20180101_20181231" decimals="2">0.00</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average shares used in computing net income per share basic and diluted</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001029" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">199,457</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001030" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001082038_20190101_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">178,042</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_xbrlishares" id="F_001031" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="C_0001082038_20180101_20181231" decimals="-3" format="ixt:numdotdecimal" scale="3">159,834</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric><ix:nonNumeric id="F_000399" name="drrx:SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true" continuedAt="F_000399_dcnt_be0d6fc6-7aa7-4de8-9f6b-7c728a7fac8c">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents information related to assets and liabilities reported as discontinued</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">operations in the Company&#8217;s balance sheet (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001032" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" contextRef="C_0001082038_20191231" decimals="-3" scale="3">797</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001033" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">1,465</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001034" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" contextRef="C_0001082038_20191231" decimals="-3" scale="3">34</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discontinued operations &#8211; current portion</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001035" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" contextRef="C_0001082038_20191231" decimals="-3" format="ixt:numdotdecimal" scale="3">2,296</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001036" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" contextRef="C_0001082038_20191231" decimals="-3" scale="3">310</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr></table></div></ix:nonNumeric></ix:nonNumeric>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110</p>
<hr style="page-break-after:always" /><ix:continuation id="F_000355_dcnt_5f10ffef-23d2-4c67-95bb-87e33a0e8edc"><ix:continuation id="F_000399_dcnt_be0d6fc6-7aa7-4de8-9f6b-7c728a7fac8c">
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets</span></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001037" name="drrx:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets" contextRef="C_0001082038_20191231" decimals="-3" scale="3">200</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other long-term assets</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001038" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" contextRef="C_0001082038_20191231" decimals="-3" scale="3">22</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discontinued operations &#8211; non-current portion</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001039" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" contextRef="C_0001082038_20191231" decimals="-3" scale="3">532</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001040" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" contextRef="C_0001082038_20191231" decimals="-3" scale="3">127</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001041" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" contextRef="C_0001082038_20191231" decimals="-3" scale="3">344</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities, current portion</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001042" name="drrx:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" contextRef="C_0001082038_20191231" decimals="-3" scale="3">301</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discontinued operations &#8211; current portion</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001043" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" contextRef="C_0001082038_20191231" decimals="-3" scale="3">772</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities, non-current portion</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001044" name="drrx:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent" contextRef="C_0001082038_20191231" decimals="-3" scale="3">161</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other long-term liabilities</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001045" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" contextRef="C_0001082038_20191231" decimals="-3" scale="3">96</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discontinued operations &#8211; non-current portion</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001046" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" contextRef="C_0001082038_20191231" decimals="-3" scale="3">257</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000400" name="drrx:SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents certain non-cash items related to discontinued operations, which are included in the Company&#8217;s statement of cash flows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years ended December 31,</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001047" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">198</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001048" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">241</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001049" name="drrx:DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">91</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001050" name="drrx:DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">81</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001051" name="drrx:NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">229</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss on disposal of property and equipment</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001052" name="drrx:NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">129</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001053" name="drrx:DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross" contextRef="C_0001082038_20200101_20201231" decimals="-3" scale="3">647</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001054" name="drrx:DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">322</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on sale of the LACTEL product line</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001055" name="us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" contextRef="C_0001082038_20200101_20201231" decimals="-3" format="ixt:numdotdecimal" scale="3">12,845</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-cash items, net</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001056" name="drrx:DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet" contextRef="C_0001082038_20200101_20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" scale="3">12,198</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001057" name="drrx:DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet" contextRef="C_0001082038_20190101_20191231" decimals="-3" scale="3">322</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></ix:continuation>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p><ix:nonNumeric id="F_000356" name="us-gaap:SubsequentEventsTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">11.<span style="margin-left:36pt;">Subsequent Events</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2021, the Company completed an underwritten public offering of <ix:nonFraction unitRef="U_xbrlishares" id="F_001058" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210201_20210228" decimals="INF" format="ixt:numdotdecimal">20,364,582</ix:nonFraction> shares of its common stock at a price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001059" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228" decimals="INF">2.2386</ix:nonFraction> per share pursuant to an underwriting agreement with Cantor Fitzgerald&#160;&#38; Co., raising total gross proceeds to the Company of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001060" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210201_20210228" decimals="-5" scale="6">45.6</ix:nonFraction> million before deducting estimated offering expenses payable by the Company. Total stock issuance costs related to this financing were approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001061" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210201_20210228" decimals="0" format="ixt:numdotdecimal">195,000</ix:nonFraction>. After deducting estimated offering expenses payable by the Company, the net proceeds to the Company were approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001062" name="drrx:StockIssuedDuringPeriodValueNewIssuesNet" contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210201_20210228" decimals="-5" scale="6">45.4</ix:nonFraction> million.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From January 1, 2021 to March 1, 2021, the Company also raised net proceeds (net of commissions) of approximately $<ix:nonFraction unitRef="U_iso4217USD" id="F_001063" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20210101_20210301" decimals="-5" scale="6">2.4</ix:nonFraction> million from the sale of <ix:nonFraction unitRef="U_xbrlishares" id="F_001064" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20210101_20210301" decimals="INF" format="ixt:numdotdecimal">950,009</ix:nonFraction> shares of the Company&#8217;s common stock in the open market at a weighted average price of $<ix:nonFraction unitRef="U_iso4217USD_xbrlishares" id="F_001065" name="drrx:CommonStockWeightedAveragePrice" contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20210101_20210301" decimals="INF">2.60</ix:nonFraction> per share pursuant to the October 2018 registration statement.</p></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_9_CHANGES_IN_DISAGREEMENTS_WITH_ACC">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not applicable.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9A.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_9A_CONTROLS_PROCEDURES">Controls and Procedures.</p></td></tr></table></div>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Disclosure Controls and Procedures</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As required by paragraph (b)&#160;of Exchange Act Rules 13a-15 or 15d-15, DURECT&#8217;s management, including our Chief Executive Officer and Chief Financial Officer, conducted an evaluation as of the end of the period covered by this report, of the effectiveness of DURECT&#8217;s disclosure controls and procedures as defined in Exchange Act Rule 13a-15(e) and 15d-15(e). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that DURECT&#8217;s disclosure controls and procedures were effective as of the end of the period covered by this report.</p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Management&#8217;s Report on Internal Control Over Financial Reporting</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Under the supervision of our Chief Executive Officer and Chief Financial Officer and with the participation of our management, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2020 based on the framework in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework). Based on that evaluation, our management concluded that our internal control over financial reporting was effective as of December 31, 2020.</p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Changes in Internal Control Over Financial Reporting</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d)&#160;of Exchange Act Rules 13a-15 or 15d-15 that occurred during our last fiscal quarter that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">112</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9B.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_9B_OR_INFORMATION">Other Information.</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">None</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;" id="PART_III">PART III</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-top:2pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item 10.</span></p></td>
<td valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_10___DIRECTORS_EXECUTIVE_FICERS_COR">Directors, Executive Officers and Corporate Governance</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The names of the executive officers of the Company and their ages, titles and biographies as of the date hereof are incorporated by reference from Part I, Item 1, above.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Information required by this item will be contained in our definitive proxy statement to be filed with the Securities and Exchange Commission on Schedule 14A in connection with our 2020 Annual Meeting of Stockholders (the Proxy Statement), which is expected to be filed not later than 120&#160;days after the end of our fiscal year ended December 31, 2020, under the headings&#160;&#160;&#8220;Election of Directors,&#8221; &#8220;The Board, Board Committees and Meetings,&#8221; &#8220;Code of Ethics,&#8221; and &#8220;Section&#160;16(a) Beneficial Ownership Reporting Compliance,&#8221; and is incorporated herein by reference. </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item 11.</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_11___EXECUTIVE_COMPENSATION">Executive Compensation</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Information required by this item will be contained in the Proxy Statement under the headings &#8220;Executive Compensation,&#8221; &#8220;Director Compensation,&#8221; and &#8220;Compensation Committee Report&#8221; and is incorporated herein by reference.</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item 12.</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_12___SECURITY_OWNERSHIP_CERTAIN_BEN">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Information required by this item will be contained in the Proxy Statement under the headings &#8220;Common Stock Ownership of Certain Beneficial Owners and Management&#8221; and &#8220;Equity Compensation Plan Information,&#8221; and is incorporated herein by reference.</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item 13.</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_13____CERTAIN_RELATIONSHIPS_RELATED"><span style="font-weight:normal;"></span>Certain Relationships, Related Transactions and Director Independence</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Information required by this item will be contained in the Proxy Statement under the headings &#8220;Certain Relationships,&#8221; &#8220;Other Transactions,&#8221; and &#8220;The Board, Board Committees and Meetings,&#8221; and is incorporated herein by reference. </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item 14.</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_14____PRINCIPAL_ACCOUNTANT_FEES_SER"><span style="font-weight:normal;"></span>Principal Accountant Fees and Services</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Information required by this item will be contained in the Proxy Statement under the heading &#8220;Fees Billed for Services Rendered by Principal Accountant,&#8221; and is incorporated herein by reference. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;" id="PART_IV">PART IV</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;15.</span></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_15_EXHIBITS_FINANCIAL_STATEMENT_SCH">Exhibits and Financial Statement Schedules.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">The following documents are filed as part of this report:</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"><span style="font-style:italic;">Financial Statements</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:10.47%;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Item 8 of this Form 10-K</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"><span style="font-style:italic;">Financial Statement Schedules</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:10.47%;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Schedule II&#8212;Valuation and Qualifying Accounts, immediately following Item 16 of this Form 10-K</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedules not listed above have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or notes thereto.</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">&#160;</p></td>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3)</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">The list of exhibits filed as part of this report is set forth on the Exhibit Index immediately preceding the signature page of this report and is incorporated herein by reference in this Item 5(a)(3) or is filed in accordance with Item&#160;601 of Regulation S&#8211;K.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:5pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Number</span></p></td>
<td valign="top" style="width:0.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:88.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Description</span></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-2.7pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;2.1</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000102140801501068/dex21.txt"><span style="text-decoration:none;">Agreement and Plan of Merger dated April 18, 2001, among the Company, Target and Magnolia Acquisition Corporation (incorporated by reference to Exhibit 2.1 to our Current Report on Form 8-K (File No. 000-31615) filed on May 15, 2001).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;2.2</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000119312503043968/dex22.htm"><span style="text-decoration:none;">Agreement and Plan of Merger dated August 15, 2003, among the Company, Birmingham Polymers, Inc., Absorbable Polymer Technologies, Inc. and the Principal Shareholders of Absorbable Polymer Technologies, Inc. (incorporated by reference to Exhibit 2.2 to our Registration Statement on Form S-3, as amended (File No. 333-108396), initially filed on August 29, 2003).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.1</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000101287000002254/0001012870-00-002254.txt"><span style="text-decoration:none;">Amended and Restated Certificate of Incorporation of the Company (incorporated by reference to Exhibit 3.3 to our Registration Statement on Form S-1, as amended (File No. 333-35316), initially filed on April 20, 2000).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.2</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000119312510152699/dex34.htm"><span style="text-decoration:none;">Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company (incorporated by reference to Exhibit 3.4 to our Post-Effective Amendment No. 1 to our Registration Statement on Form S-3, filed on July 1, 2010.</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:6pt;">
<td valign="top" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.3</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001082038/000156459018015889/drrx-ex31_6.htm"><span style="text-decoration:none;">Certificate of Amendment to the Amended and Restated Certificate of Incorporation of DURECT Corporation (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K, as filed with the SEC on June 20, 2018).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.4</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000119312505200984/dex33.htm"><span style="text-decoration:none;">Certificate of Designation of Rights, Preferences and Privileges of Series A Participating Preferred Stock of DURECT Corporation (incorporated by reference to Exhibit 3.3 to our Registration Statement on Form S-3 (File No. 333-128979) initially filed on October 13, 2005).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.5</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000119312510179473/dex37.htm"><span style="text-decoration:none;">Certificate of Amendment to Certificate of Designation of Rights, Preferences and Privileges of Series A Participating Preferred Stock of DURECT Corporation (incorporated by reference to Exhibit 3.7 to our Quarterly Report on Form 10-Q (File No. 000-31615) filed on August 5, 2010).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;3.6</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000119312514445383/d838545dex31.htm"><span style="text-decoration:none;">Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K (File No. 000-31615), filed on December 17, 2014).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;4.2</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000156459020008923/drrx-ex42_715.htm"><span style="text-decoration:none;">Description of Securities of the Registrant (incorporated by reference to Exhibit 4.2 to our annual report on Form 10-K (File No. 000-31615), filed on March 5, 2020).</span></a></p></td>
</tr>
<tr>
<td valign="middle" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">114</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Number</span></p></td>
<td valign="top" style="width:0.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:88.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Description</span></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.1+</span></p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000101287000002254/0001012870-00-002254.txt"><span style="text-decoration:none;">Form of Indemnification Agreement between the Company and each of its Officers and Directors (incorporated by reference to Exhibit 10.1 to our Registration Statement on Form S-1, as amended (File No. 333-35316), initially filed on April 20, 2000).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.2+</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000156459020008923/drrx-ex102_595.htm"><span style="text-decoration:none;">2000 Stock Plan, as amended (incorporated by reference to Exhibit 10.2 to our annual report on Form 10-K (File No. 000-31615), filed on March 5, 2020).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.3+</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000101287000002254/0001012870-00-002254.txt"><span style="text-decoration:none;">2000 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.4 to our Registration Statement on Form S-1, as amended (File No. 333-35316), initially filed on April 20, 2000).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.4+</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000101287000002254/0001012870-00-002254.txt"><span style="text-decoration:none;">2000 Directors&#8217; Stock Option Plan (incorporated by reference to Exhibit 10.5 to our Registration Statement on Form S-1, as amended (File No. 333-35316), initially filed on April 20, 2000).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.5</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000101287000002254/0001012870-00-002254.txt"><span style="text-decoration:none;">Modified Net Single Tenant Lease Agreement between the Company and DeAnza Enterprises, Ltd. dated as of February 18, 1999 (incorporated by reference to Exhibit 10.11 to our Registration Statement on Form S-1, as amended (File No. 333-35316), initially filed on April 20, 2000).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.6</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000101287000002254/0001012870-00-002254.txt"><span style="text-decoration:none;">Common Stock Purchase Agreement between the Company and ALZA Corporation dated April 14, 2000 (incorporated by reference to Exhibit 10.17 to our Registration Statement on Form S-1, as amended (File No. 333-35316), initially filed on April 20, 2000).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.7**</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000101287003001183/dex1034.htm"><span style="text-decoration:none;">Development and License Agreement between the Company, Southern BioSystems, Inc., an Alabama corporation and wholly-owned subsidiary of the Company (now merged into the Company), and Pain Therapeutics, Inc. dated as of December 19, 2002 (incorporated by reference to Exhibit 10.34 to our Annual Report on Form 10-K (File No. 000-31615) filed on March 14, 2003).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.8</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000119312504039240/dex1036.htm"><span style="text-decoration:none;">Lease between the Company and Renault &#38; Handley Employee Investments Co. with commencement date of January 1, 2005 (incorporated by reference to Exhibit 10.36 to our Annual Report on Form 10-K (File No. 000-31615) filed on March 11, 2004).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.9**</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000119312506055225/dex1045.htm"><span style="text-decoration:none;">Amendment dated December 21, 2005 to Development and License Agreement dated December 19, 2002 between the Company and Pain Therapeutics, Inc. (incorporated by reference to Exhibit 10.45 to our Annual Report on Form 10-K (File No. 000-31615) filed on March 16, 2006).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.10</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000119312509103189/dex1054.htm"><span style="text-decoration:none;">First Lease Extension between the Company and Renault &#38; Handley Employee Investments Co. effective March 1, 2009 (incorporated by reference to Exhibit 10.54 to our Quarterly Report on Form&#160;10-Q (File No. 000-31615) filed on May 7, 2009).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.11</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000119312509220539/dex1056.htm"><span style="text-decoration:none;">Second Amendment to Lease between De Anza Enterprises and the Company dated as of August 6, 2009 (incorporated by reference to Exhibit 10.56 to our Quarterly Report on Form 10-Q (File&#160;No.&#160;000-31615) filed on November 2, 2009).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.12</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000119312511055064/dex1062.htm"><span style="text-decoration:none;">Lease between the Company and DRA/CLP Riverchase Center Birmingham, LLC dated as of October 19, 2010 (incorporated by reference to Exhibit 10.62 to our Annual Report on Form 10-K (File No. 000-31615) filed with the SEC on March 3, 2011).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.13</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000119312511055064/dex1063.htm"><span style="text-decoration:none;">Third Amendment to Lease between De Anza Enterprises and the Company dated as of December 21, 2010 (incorporated by reference to Exhibit 10.63 to our Annual Report on Form 10-K (File&#160;No.&#160;000-31615) filed with the SEC on March 3, 2011).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.14</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000119312513427570/d588564dex1071.htm"><span style="text-decoration:none;">Fourth Amendment to Lease between De Anza Enterprises and the Company dated as of August 20, 2013 (incorporated by reference to Exhibit 10.71 to our Quarterly Report on Form 10-Q (File&#160;No.&#160;000-31615) filed with the SEC on November 5, 2013).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.15</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000119312513427570/d588564dex1072.htm"><span style="text-decoration:none;">Addendum II to Lease between the Company and Northwest Asset Management Company dated as of August 27, 2013 (incorporated by reference to Exhibit 10.72 to our Quarterly Report on Form&#160;10-Q (File No. 000-31615) filed with the SEC on November 5, 2013).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Number</span></p></td>
<td valign="top" style="width:0.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:88.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Description</span></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.1</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</span></p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000119312514076949/d657425dex1073.htm"><span style="text-decoration:none;">Second Amendment to Lease between Handley Management Corporation, as successor-by-merger to Renault &#38; Handley Employee Investments Co. and the Company dated November 11, 2013 (incorporated by reference to Exhibit 10.73 to our Annual Report on Form 10-K (File&#160;No.&#160;000-31615) filed with the SEC on February 27, 2014).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.17**</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000119312515074853/d849815dex1028.htm"><span style="text-decoration:none;">License Agreement between the Company and Santen Pharmaceutical Co., Ltd. dated December 11, 2014 (incorporated by reference to Exhibit 10.28 to our Annual Report on Form 10-K (File&#160;No.&#160;000-31615) filed with the SEC on March 3, 2015).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.18**</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000119312515074853/d849815dex1029.htm"><span style="text-decoration:none;">Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated December 5, 2012 (incorporated by reference to Exhibit 10.29 to our Annual Report on Form 10-K (File No. 000-31615) filed with the SEC on March 3, 2015).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:6pt;">
<td valign="top" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.19</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000119312516754933/d259942dex101.htm"><span style="text-decoration:none;">Loan and Security Agreement between the Company and Oxford Finance LLC dated July&#160;28, 2016. (incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q (File No. 000-31615) filed with the SEC on November 1, 2016).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="top" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.20**</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000156459017016969/drrx-ex102_388.htm"><span style="text-decoration:none;">Development and Commercialization Agreement between the Company and SANDOZ AG dated May 5, 2017. (incorporated by reference to Exhibit 10.2 to our Quarterly Report on Form 10-Q (File No. 000-31615) filed with the SEC on August 9, 2017).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:6pt;">
<td valign="top" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.21**</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000156459017021123/drrx-ex101_478.htm"><span style="text-decoration:none;">Patent purchase agreement between the Company and Indivior UK Limited dated as of September 26, 2017. (incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q (File No. 000-31615) filed with the SEC on November 2, 2017).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:6pt;">
<td valign="top" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.22</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001082038/000156459018004323/drrx-ex101_6.htm"><span style="text-decoration:none;">First Amendment to Loan and Security Agreement between the Company and Oxford Finance LLC dated February 28, 2018 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed March 5, 2018).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:6pt;">
<td valign="top" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.23</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001082038/000156459018026643/drrx-ex101_6.htm"><span style="text-decoration:none;">Second Amendment to Loan and Security Agreement between the Company and Oxford Finance LLC dated November 1, 2018 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed November 5, 2018).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:6pt;">
<td valign="top" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.24</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001082038/000156459018018845/drrx-ex101_137.htm"><span style="text-decoration:none;">Addendum III to Lease between the Company and Northwest Asset Management Company dated as of April 10, 2018 (incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q (File No. 000-31615) filed with the SEC on August 2, 2018).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:6pt;">
<td valign="top" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.25**</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001082038/000156459018018845/drrx-ex102_138.htm"><span style="text-decoration:none;">First Amendment to the Development and Commercialization Agreement between the Company and SANDOZ AG effective as of May 4, 2018 (incorporated by reference to Exhibit 10.2 to our Quarterly Report on Form 10-Q (File No. 000-31615) filed with the SEC on August 2, 2018).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:6pt;">
<td valign="top" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.26</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001082038/000156459018021965/drrx-ex101_14.htm"><span style="text-decoration:none;">Fifth Amendment to Lease between De Anza Enterprises and the Company dated as of August 15, 2018 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, as filed with the SEC on August 17, 2018).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:6pt;">
<td valign="top" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.27</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001082038/000156459018023414/drrx-ex101_7.htm"><span style="text-decoration:none;">Third Amendment to Lease between Handley Management Corporation, as successor-by-merger to Renault &#38; Handley Employee Investments Co. and the Company dated September 17, 2018 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, as filed with the SEC on September 21, 2018).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:6pt;">
<td valign="top" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.28</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001082038/000156459018028630/drrx-ex104_346.htm"><span style="text-decoration:none;">Amendment No. 1 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated July 2, 2015 (incorporated by reference to Exhibit 10.4 to our Quarterly Report on Form 10-Q (File No. 000-31615) filed with the SEC on November 8, 2018).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:6pt;">
<td valign="top" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.29</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001082038/000156459018028630/drrx-ex105_347.htm"><span style="text-decoration:none;">Amendment No. 2 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated March 6, 2018 (incorporated by reference to Exhibit 10.5 to our Quarterly Report on Form 10-Q (File No. 000-31615) filed with the SEC on November 8, 2018).</span></a></p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Number</span></p></td>
<td valign="top" style="width:0.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:88.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Description</span></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.30++</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/0001082038/000156459018028630/drrx-ex105_347.htm"><span style="text-decoration:none;">License Agreement between the Company and Gilead Sciences, Inc. dated July 19, 2019 (incorporated by reference to Exhibit 10.1 to our Quarterly Report on Form 10-Q (File No. 000-31615) filed with the SEC on November 5, 2019).</span></a></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.31</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1082038/000156459020000241/drrx-ex101_6.htm"><span style="text-decoration:none;">Third Amendment to Loan and Security Agreement between the Company and Oxford Finance LLC dated December 31, 2019 (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, as filed with the SEC on January 6, 2020).</span></a></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.32*++</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="drrx-ex1032_586.htm"><span style="text-decoration:none;">Asset purchase agreement between the Company and Evonik Corporation dated December 4, 2020.</span></a></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.33*</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="drrx-ex1033_588.htm"><span style="text-decoration:none;">Executive Change of Control Policy, as amended December 9, 2020.</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;23.1*</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="drrx-ex231_10.htm"><span style="text-decoration:none;">Consent of Independent Registered Public Accounting Firm.</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;24.1*</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#POWER_ATTORNEY"><span style="text-decoration:none;">Power of Attorney (see signature page of this Form 10-K).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;31.1*</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="drrx-ex311_11.htm"><span style="text-decoration:none;">Rule 13a-14(a) Section 302 Certification.</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;31.2*</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="drrx-ex312_12.htm"><span style="text-decoration:none;">Rule 13a-14(a) Section 302 Certification.</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;32.1***</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="drrx-ex321_13.htm"><span style="text-decoration:none;">Certificate pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;32.2***</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="drrx-ex322_14.htm"><span style="text-decoration:none;">Certificate pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.INS</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Instance Document &#8211; the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.SCH</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Schema Document</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.CAL</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr style="height:7.8pt;">
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.DEF</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Definition Linkbase Document</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.LAB</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Label Linkbase Document</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:10.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.PRE</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:10.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="top" style="width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</p></td>
</tr>
</table></div>
<p style="border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:81.2%;text-indent:0%;font-size:6pt;font-family:Times New Roman;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:2pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</span></p></td>
<td valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Filed herewith.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">**</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Confidential treatment granted with respect to certain portions of this Exhibit.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">***</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Furnished, not filed.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">+</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Indicates a management contract or compensatory plan or arrangement.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">++</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Certain portions of this exhibit (indicated by &#8220;[***]&#8221;) have been omitted in accordance with the rules of the Securities and Exchange Commission.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:-5.24%;font-size:9pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><ix:nonNumeric id="F_000357" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" contextRef="C_0001082038_20200101_20201231" escape="true">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">SCHEDULE II&#8212;VALUATION AND QUALIFYING ACCOUNTS</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31, 2020, 2019 and 2018</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">beginning</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of the year</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additions (Reductions) to allowances</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deductions</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">end of the</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">year</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for doubtful accounts</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31, 2020</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001066" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20191231" decimals="-3" scale="3">27</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001069" name="drrx:ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense" contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20200101_20201231" decimals="-3" sign="-" scale="3">46</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001072" name="us-gaap:ValuationAllowancesAndReservesDeductions" contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20200101_20201231" decimals="-3" scale="3">1</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001073" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20201231" decimals="-3" scale="3">72</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31, 2019</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001067" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20181231" decimals="-3" scale="3">83</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonFraction unitRef="U_iso4217USD" id="F_001070" name="drrx:ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense" contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20190101_20191231" decimals="-3" scale="3">56</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001074" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20191231" decimals="-3" scale="3">27</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31, 2018</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001068" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20171231" decimals="-3" scale="3">69</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001071" name="drrx:ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense" contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20180101_20181231" decimals="-3" sign="-" scale="3">14</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<ix:nonFraction unitRef="U_iso4217USD" id="F_001075" name="us-gaap:ValuationAllowancesAndReservesBalance" contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20181231" decimals="-3" scale="3">83</ix:nonFraction></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div></ix:nonNumeric>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;" id="EXHIBIT_INDEX">EXHIBIT INDEX</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="width:11.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:0.5pt;">&#160;</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:0.5pt;">&#160;</p></td>
<td valign="middle" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:0.5pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Number</span></p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:88.4%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Description</span></p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-7.2pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.32*++</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="drrx-ex1032_586.htm"><span style="text-decoration:none;">Asset purchase agreement between the Company and Evonik Corporation dated December 4, 2020.</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:11.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-7.2pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;10.33*</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="drrx-ex1033_588.htm"><span style="text-decoration:none;">Executive Change of Control Policy, as amended December 9, 2020.</span></a><span style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p></td>
</tr>
<tr>
<td valign="middle" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-7.2pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;23.1*</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="drrx-ex231_10.htm"><span style="text-decoration:none;">Consent of Independent Registered Public Accounting Firm.</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:11.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-7.2pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;24.1*</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#POWER_ATTORNEY"><span style="text-decoration:none;">Power of Attorney (see signature page of this Form 10-K).</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:11.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-7.2pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;31.1*</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="drrx-ex311_11.htm"><span style="text-decoration:none;">Rule 13a-14(a) Section 302 Certification.</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:11.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-7.2pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;31.2*</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="drrx-ex312_12.htm"><span style="text-decoration:none;">Rule 13a-14(a) Section 302 Certification.</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:11.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-7.2pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;32.1**</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="drrx-ex321_13.htm"><span style="text-decoration:none;">Certificate pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:11.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-7.2pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;32.2**</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="drrx-ex322_14.htm"><span style="text-decoration:none;">Certificate pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:11.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-7.2pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.INS</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Instance Document &#8211; the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:11.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-7.2pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.SCH</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Schema Document</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:11.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-7.2pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.CAL</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:11.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-7.2pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.DEF</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Definition Linkbase Document</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:11.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-7.2pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.LAB</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Label Linkbase Document</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle" style="width:11.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="middle" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-7.2pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101.PRE</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-7.2pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-left:7.2pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:11.18%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:-7.2pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="top" style="width:0.42%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:88.4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</p></td>
</tr>
</table></div>
<p style="border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:81.2%;text-indent:0%;font-size:6pt;font-family:Times New Roman;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</span></p></td>
<td valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Filed herewith.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">**</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Furnished, not filed.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:5.24%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">++</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Certain portions of this exhibit (indicated by &#8220;[***]&#8221;) have been omitted in accordance with the rules of the Securities and Exchange Commission.</p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:-5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10.47%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item 16.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;" id="ITEM_16____FORM_10K_SUMMARY">Form 10-K Summary<span style="font-weight:normal;">.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has elected not to include summary information.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;" id="SIGNATURES">SIGNATURES</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:right;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:42%;">
<tr>
<td colspan="2" valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DURECT CORPORATION</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:89.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.12%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:89.86%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/<span style="font-variant: small-caps;">s</span>/&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;">j</span><span style="font-variant: small-caps;">ames </span><span style="text-transform:uppercase;">e</span><span style="font-variant: small-caps;">. </span><span style="text-transform:uppercase;">b</span><span style="font-variant: small-caps;">rown</span></p></td>
</tr>
<tr>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:89.86%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">James E. Brown</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">President and Chief Executive Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: March 5, 2021</p>
<p style="text-align:center;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;" id="POWER_ATTORNEY">POWER OF ATTORNEY</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints James E. Brown, his or her attorneys-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendments to this Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his or her substitute or substitutes may do or cause to be done by virtue hereof.</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">121</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Signature</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Title</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Date</span></p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;">j</span><span style="font-variant: small-caps;">ames </span><span style="text-transform:uppercase;">e</span><span style="font-variant: small-caps;">. </span><span style="text-transform:uppercase;">b</span><span style="font-variant: small-caps;">rown</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">President,&#160;Chief&#160;Executive&#160;Officer&#160;and Director&#160;(Principal&#160;Executive&#160;Officer)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 5, 2021</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">James E. Brown</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;">m</span><span style="font-variant: small-caps;">ichael </span><span style="text-transform:uppercase;">h</span><span style="font-variant: small-caps;">. </span><span style="text-transform:uppercase;">a</span><span style="font-variant: small-caps;">renberg</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Principal Accounting Officer)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 5, 2021</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Michael H. Arenberg</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;">MOHAMMAD AZAB</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 5, 2021</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Mohammad Azab</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;">s</span><span style="font-variant: small-caps;">imon </span><span style="text-transform:uppercase;">x</span><span style="font-variant: small-caps;">. </span><span style="text-transform:uppercase;">b</span><span style="font-variant: small-caps;">enito</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 5, 2021</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Simon X. Benito</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;">t</span><span style="font-variant: small-caps;">errence </span><span style="text-transform:uppercase;">f</span><span style="font-variant: small-caps;">. </span><span style="text-transform:uppercase;">b</span><span style="font-variant: small-caps;">laschke</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 5, 2021</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Terrence F. Blaschke</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;">G</span><span style="font-variant: small-caps;">ail</span><span style="text-transform:uppercase;"> M. f</span><span style="font-variant: small-caps;">arfel</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 5, 2021</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gail M. Farfel</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;">d</span><span style="font-variant: small-caps;">avid </span><span style="text-transform:uppercase;">r</span><span style="font-variant: small-caps;">. </span><span style="text-transform:uppercase;">h</span><span style="font-variant: small-caps;">offmann</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director, Chairman of the Board</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 5, 2021</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">David R. Hoffmann</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;">GAIL J. MADERIS</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 5, 2021</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gail J. Maderis</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;">a</span><span style="font-variant: small-caps;">rmand </span><span style="text-transform:uppercase;">p</span><span style="font-variant: small-caps;">. </span><span style="text-transform:uppercase;">n</span><span style="font-variant: small-caps;">eukermans</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 5, 2021</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Armand P. Neukermans</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;">j</span><span style="font-variant: small-caps;">udith j. Robertson</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 5, 2021</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Judith J. Robertson</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/&#160;&#160;&#160;&#160;<span style="text-transform:uppercase;">j</span><span style="font-variant: small-caps;">on </span><span style="text-transform:uppercase;">s</span><span style="font-variant: small-caps;">. </span><span style="text-transform:uppercase;">s</span><span style="font-variant: small-caps;">axe</span></p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:40%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 5, 2021</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.98%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Jon S. Saxe</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.32
<SEQUENCE>2
<FILENAME>drrx-ex1032_586.htm
<DESCRIPTION>EX-10.32
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
drrx-ex1032_586.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED.</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Execution Version</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.32</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ASSET PURCHASE AGREEMENT</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">by and between</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman Bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;">DURECT CORPORATION</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">and</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman Bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;">EVONIK CORPORATION</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 4, 2020</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TABLE OF CONTENTS</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE I DEFINITIONS; CONSTRUCTION</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Definitions</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.2</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE II PURCHASE AND SALE</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">11</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.1</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agreement to Purchase and Sell</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.2</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ancillary Rights; Treatment of Acquired Books and Records</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.3</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Excluded Assets</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.4</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assumption of Acquired Liabilities</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.5</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Excluded Liabilities</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.6</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consents of Third Parties</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.7</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Wrong Pocket Provisions</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.8</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contracts and IP Not Transferred</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.9</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fully Paid; Withholding Tax</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE III PURCHASE PRICE; ALLOCATIONS; ADJUSTMENTS</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.1</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchase Price</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.2</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payment of Purchase Price</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.3</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allocation of Purchase Price</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.4</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchase Price Adjustment.</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.5</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020 EBITDAS Milestone.</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE SELLER</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.1</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Organization</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.2</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Authorization</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.3</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Absence of Restrictions and Conflicts</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.4</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title to Assets</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.5</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sufficiency of Assets</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.6</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Absence of Certain Changes</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.7</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Compliance with Law</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.8</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired Contracts</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.9</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts Receivable</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.10</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired Inventory</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.11</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intellectual Property</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.12</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Real Estate</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.13</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Environmental Matters</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.14</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Legal Proceedings</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.15</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Quality</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.16</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product Liability and Warranty Claims</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.17</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Benefit Plans</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.18</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employees</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.19</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Related Party Transactions</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.20</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Brokers, Finders Brokers, Finders and Investment Bankers</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.21</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cybersecurity and Data Protection</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;letter-spacing:0pt;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TABLE OF CONTENTS</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE V REPRESENTATIONS AND WARRANTIES OF THE PURCHASER</font></p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">29</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.1</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Organization</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.2</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Authorization</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.3</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Absence of Restrictions and Conflicts</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.4</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Brokers, Finders and Investment Bankers</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE VI CERTAIN COVENANTS AND AGREEMENTS</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">30</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.1</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conduct of Acquired Product Line by the Seller</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.2</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inspection and Access to Information</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.3</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notices of Certain Events</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.4</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reasonable Efforts; Further Assurances; Cooperation</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.5</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Public Announcements</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.6</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Transfer Taxes; Expenses</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.7</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Confidential Information</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.8</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee Matters</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.9</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Termination of Related Party Transactions</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.10</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supply Agreement</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.11</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Covenant Not to Sue</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.12</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Access and IT Activities to Be Performed by Purchaser on the Facility Prior to Closing</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE VII</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CONDITIONS TO CLOSING</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">37</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.1</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conditions to Each Party&#8217;s Obligations</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.2</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conditions to Obligations of the Purchaser</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.3</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Conditions to Obligations of the Seller</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE VIII CLOSING</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">39</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.1</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Closing</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.2</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Seller&#8217;s Closing Deliveries</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.3</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchaser Closing Deliveries</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE IX <font style="font-family:Times New Roman Bold;text-transform:uppercase;">Termination</font></p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">40</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.1</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Termination</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.2</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effect of Termination</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE X INDEMNIFICATION; LIMITATION OF LIABILITY</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">41</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indemnification Obligations of the Seller</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.2</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indemnification Obligations of the Purchaser</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.3</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indemnification Procedure</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Claims Period</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.5</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liability Limits</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.6</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exclusive Remedy</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.7</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Limitation of Liability</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.8</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warranties</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&nbsp;</p></td>
</tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;letter-spacing:0pt;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ii</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TABLE OF CONTENTS</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td colspan="2" valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ARTICLE XI MISCELLANEOUS PROVISIONS</font></p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">45</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.1</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notices</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.2</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedules and Exhibits</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.3</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assignment; Successors in Interest</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.4</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Captions</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.5</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Controlling Law; Amendment</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.6</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Legal Dispute Resolution</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.7</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Waiver of Jury Trial</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.8</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Severability</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.9</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Specific Performance</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.10</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Counterparts</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.11</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Enforcement of Certain Rights</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.12</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Waiver</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.13</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Integration</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.14</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cooperation Following the Closing</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</p></td>
</tr>
<tr>
<td valign="top"  style="width:10%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:12pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.15</p></td>
<td valign="top"  style="width:85%;">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Transaction Costs</p></td>
<td valign="bottom"  style="width:5%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;letter-spacing:0pt;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">iii</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THE FOLLOWING EXHIBITS AND SCHEDULES ATTACHED TO THE AGREEMENT HAVE BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">LIST OF EXHIBITS (***)</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 1.1.80</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of <font style="color:#000000;">Non-Competition and Non-Solicitation Agreement</font></p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 1.1.113</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Transition Services Agreement</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 2.1.8</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Proceedings, Judgments and Claims</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 3.4</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sample Pre-Closing Working Capital Statement</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 7.2.5</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease Amendment</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 8.2.2</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Bill of Sale</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 8.2.3</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Assignment and Assumption Agreement</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 8.2.4</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Trademark Assignment Agreement</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 8.2.5</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Intellectual Property Assignment Agreement</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 8.2.6</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Form of Lease Assignment Agreement</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">LIST OF SCHEDULES <font style="color:#000000;">(***)</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 1.1.7</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired Books and Records</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 1.1.8</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired Contracts</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 1.1.9</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired Copyrights</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 1.1.10</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired Customer Contracts</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 1.1.11</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired Equipment</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 1.1.13</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired Inventory</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 1.1.16</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired Product Line</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 1.1.17</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sample Calculation &#8211; Acquired Product Line 2020 EBITDAS </p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 1.1.18</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired Trademarks</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 2.2.4</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IT Transfer of Acquired Books and Records/Shared Books and Records</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 4.4</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title Exceptions; List of Assets</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 4.6</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Absence of Certain Changes</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 4.7</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Compliance with Law; Authorizations</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 4.8</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired Contracts Exceptions</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 4.11.2</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired Intellectual Property</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 4.11.3</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired Intellectual Property and Proceedings</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 4.12.1</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Real Property</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 4.18.1</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employment Matters</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 4.18.2</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">List of Business Employees</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 4.19</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Related Party Transactions</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 4.20</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Brokers and Finders and Investment Bankers</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 6.8.1</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Offered Employees; Hired Employees</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 6.8.6</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Hired Employee Amounts</p></td>
</tr>
<tr>
<td valign="top"  style="width:20%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Schedule 6.12</p></td>
<td valign="top"  style="width:80%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:6pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Access and IT Activities to Be Performed by Purchaser on the Facility Prior to Closing</p></td>
</tr>
</table></div>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ASSET PURCHASE AGREEMENT</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THIS ASSET PURCHASE AGREEMENT (this &#8220;<font style="text-decoration:underline;">Agreement</font>&#8221;), dated as of December 4, 2020, is made and entered into by and between Durect Corporation, a Delaware corporation (the &#8220;<font style="text-decoration:underline;">Seller</font>&#8221;), and Evonik Corporation, an Alabama corporation (the &#8220;<font style="text-decoration:underline;">Purchaser</font>&#8221;).&nbsp;&nbsp;The Purchaser and the Seller are sometimes individually referred to herein as a &#8220;<font style="text-decoration:underline;">Party</font>&#8221; and collectively as the &#8220;<font style="text-decoration:underline;">Parties</font>.&#8221;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">W I T N E S S E T H:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">WHEREAS, the Seller owns the Acquired Assets (as defined below) and, upon the terms and conditions set forth in this Agreement, desires to grant, sell, assign, transfer and deliver to the Purchaser, and the Purchaser desires to purchase, acquire and accept, the Acquired Assets, free and clear of all Encumbrances (other than Acquired Liabilities and Permitted Encumbrances);</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">WHEREAS, effective as of the Closing, and upon the terms and conditions set forth in this Agreement, the Purchaser and the Seller desire to enter into the Transition Services Agreement; and</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">NOW, THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants, agreements and conditions hereinafter set forth, and intending to be legally bound hereby, each Party hereby agrees as follows:</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;"><a name="_Toc514585267"></a><a name="_Toc514585482"></a><a name="_Toc515856445"></a><a name="_Toc515856550"></a><a name="_Toc69532380"></a><a name="_Toc155614565"></a><a name="_Toc155699678"></a><a name="_Toc224619043"></a><a name="_Toc12185229"></a><a name="_Toc49528501"></a><a name="_Toc47693174"></a><a name="_Toc57819101"></a><a name="_Toc45558518"></a><a name="_Toc47175065"></a>ARTICLE I<font style="font-family:Times New Roman Bold;"><br /><a name="_Toc69532380"></a><a name="_Toc155614565"></a><a name="_Toc155699678"></a><a name="_Toc224619043"></a><a name="_Toc12185229"></a><a name="_Toc49528501"></a><a name="_Toc47693174"></a><a name="_Toc57819101"></a><a name="_Toc45558518"></a><a name="_Toc47175065"></a>DEFINITIONS; CONSTRUCTION</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185230"></a><a name="_Toc49528502"></a><a name="_Toc47693175"></a><a name="_Toc57819102"></a>1.1<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Definitions</font>. The following terms, as used herein, have the following meanings: </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.1<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">AAA</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 11.6.2</font>. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.2<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Acceptance Determination Date</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 6.8.1.1</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.3<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Accounting Firm</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 3.4.4</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.4<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Accounting Methodology</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 3.4.1</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.5<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Acquired Accounts Receivable</font>&#8221; means accounts receivable, which includes any and all unbilled receivables with respect to the Acquired Contracts or Acquired Product Line accruing on or after the Closing.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.6<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Acquired Assets</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section&#160;2.1</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref_ContractCompanion_9kb9Ur026"></a><a name="_Ref55898969"></a>1.1.7<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Acquired Books and Records</font>&#8221; means all documents, books of account, sales and purchase records, cost and pricing information, customer and supplier lists and files, laboratory books, safety records, polymer research records (including records related to polymer samples provided to, or manufactured for, customers), Hired Employee employment records and electronic communication of all Business Employees whether or not Hired Employees (including, </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-align:justify;text-indent:0%;font-size:8pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:8pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">but not limited to, the e-mails of the Business Employees whether or not Hired Employees) pertaining to the Acquired Product Line, research and development reports and records, drug master files (along with all related letters of access), regulatory correspondence, purchasing materials and records, production reports and records (including batch records), quality control records, equipment logs, processes, operating guides and manuals, business reports, plans and projections, and all other documents, files, correspondence and other information that relate primarily to, or are necessary for, the continued conduct of the Acquired Product Line (whether in written, electronic or other form) other than the books, records, files and documents that are not stored at the Facility and are included within the Excluded Assets, in each case Controlled by the Seller, including such books and records set out in </font><font style="text-decoration:underline;">Schedule&#160;1.1.7</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;The Acquired Books and Records shall also include the Customer Data and Financial Information.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref_ContractCompanion_9kb9Ur029"></a><a name="_Ref_ContractCompanion_9kb9Ur02B"></a><a name="_Ref55898979"></a>1.1.8<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Acquired Contracts</font>&#8221; means those Contracts listed on <font style="text-decoration:underline;">Schedule&#160;1.1.8</font> and the Real Property Lease listed on <font style="text-decoration:underline;">Schedule 4.12.1</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref49363453"></a>1.1.9<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Acquired Copyrights</font>&#8221; means all copyrights, whether registered or unregistered, and applications, if any, Controlled by the Seller, in each case, that (a) are For the continued conduct of the Acquired Product Line, including all copyrights in any Acquired Books and Records, or (b) set forth on <font style="text-decoration:underline;">Schedule 1.1.9</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref_ContractCompanion_9kb9Ur035"></a>1.1.10<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Acquired Customer Contracts</font>&#8221; means those Contracts listed on <font style="text-decoration:underline;">Schedule&#160;1.1.10</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref47716120"></a><a name="_Ref_ContractCompanion_9kb9Ur038"></a><a name="_Ref49424422"></a><a name="_Ref55473517"></a><a name="_Ref55899013"></a><a name="_Ref_ContractCompanion_9kb9Ur03B"></a>1.1.11<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Acquired Equipment</font>&#8221; means the equipment (a) which is owned by the Seller which is ordinarily located in or about the Facility except for any Equipment listed on <font style="text-decoration:underline;">Part 1 of Schedule 1.1.11</font> and (b) which is set forth on <font style="text-decoration:underline;">Part 2 of Schedule 1.1.11</font>.<a name="_Ref_ContractCompanion_9kb9Ur03B"></a> <font style="text-decoration:underline;">Part 3 of Schedule 1.1.11</font> shall also set out all information technology equipment located at the Facility.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.12<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Acquired Intellectual Property</font>&#8221; means (a) the Acquired Copyrights, (b) the Acquired Know-How and (c) the Acquired Trademarks.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref49363366"></a>1.1.13<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Acquired Inventory</font>&#8221; means all inventory Controlled by the Seller that (a) is ordinarily stored on or about the Facility (whether or not set forth in <font style="text-decoration:underline;">Schedule&#160;1.1.13)</font>, or (b) are For the Acquired Product Line and is set forth in <font style="text-decoration:underline;">Schedule 1.1.13</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref49363305"></a><a name="_Ref55899034"></a><a name="_Ref_ContractCompanion_9kb9Ur045"></a>1.1.14<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Acquired Know-How</font>&#8221; means all technical information, know-how and data, in any tangible or intangible form and whether or not patentable, including inventions, discoveries, trade secrets, specifications, instructions, processes, formulae, methods, practices, techniques, results, formulations, algorithms, technology, test data (including biological, chemical, biochemical, toxicological and clinical test data, master files (or if applicable, drug master file) and similar documentation, analytical and quality control data and stability data and source data), studies, procedures and other technology, in each case, that are For the Acquired Product Line, including all of the foregoing with respect to the (a) Lactel Absorbable Polymers, their manufacture, development, modification, derivatization, registration, use or commercialization or methods of analyzing, assaying or testing them and (b) application and testing of devices covered with, or comprising, Lactel Absorbable Polymers.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.15<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Acquired Liabilities</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 2.4.2</font>.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">2</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref55899066"></a>1.1.16<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Acquired Product Line</font>&#8221; means the polymer product line (as conducted by the Seller at any time prior to the Closing Date or as proposed to be conducted, and including any improvements thereto or derivatives thereof) known as &#8220;Lactel Absorbable Polymers&#8221; developed and/or sold by the Seller (including the Seller&#8217;s providing manufacturing services and/or custom polymer development services to third parties) with respect to custom and standard absorbable polymers (including those polymers listed on <font style="text-decoration:underline;">Schedule 1.1.16)</font>, regardless of where manufactured, developed or maintained, except for the Excluded Assets, but in all cases including all polymers manufactured and sold (including samples) by Seller at the Facility prior to the Closing Date.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref49363273"></a>1.1.17<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Acquired Product Line 2020 EBITDAS</font>&#8221; has the meaning given to it in <font style="text-decoration:underline;">Section 3.5.1</font>.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref55472461"></a>1.1.18<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Acquired Trademarks</font>&#8221; means all of the Seller rights to those trademarks, trade names, and logos related to &#8220;Lactel Absorbable Polymers&#8221; (or &#8220;Lactel&#8221;) including all applications and registrations therefor, as set forth on <font style="text-decoration:underline;">Schedule&#160;1.1.18</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.19<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Acquisition</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 2.1</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.20<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Adjustment Shortfall</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 3.4.5.2</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.21<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Adjustment Surplus</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 3.4.5.3</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.22<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Affiliate</font>&#8221; of any specified Person means any other Person directly or indirectly Controlling or Controlled by or under direct or indirect common Control with such specified Person.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.23<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Allocation Schedule</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 3.3</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.24<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Appellate Rules</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 11.6.2</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.25<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Assignment and Assumption Agreement</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 8.2.3</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.26<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Authorization</font>&#8221; means, with respect to a Person, any order, permit, approval, certificate, clearance, consent, exemption, registration, waiver, variance, license or other authorization, in each case issued, granted, given or authorized by, or made applicable under the authority of, any Governmental Entity having jurisdiction over the Person.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.27<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Award</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 11.6.2</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.28<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Bill of Sale</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 8.2.2</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.29<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Business Day</font>&#8221; means any day except Saturday, Sunday or any other day on which banks are generally not open for business in the city of San Francisco, California, or in North-Rhine Westfalia, Germany.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.30<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Business Employee</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 4.18.2</font>.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">3</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.31<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">CFIUS</font>&#8221; means the Committee on Foreign Investment in the United States and each member agency thereof acting in such capacity.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.32<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Claims Period</font>&#8221; means the period during which a claim for indemnification may be asserted under this Agreement by an Indemnified Party.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.33<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Closing</font>&#8221; means the consummation of the transactions contemplated by this Agreement as set forth in <font style="text-decoration:underline;">Section&#160;8.1</font> (Closing) of this Agreement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.34<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Closing Date</font>&#8221; means the date on which the Closing occurs.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.35<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Code</font>&#8221; shall mean the Internal Revenue Code of 1986, as amended.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.36<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Confidential Information</font>&#8221; means, with respect to a Disclosing Party, all information of any kind whatsoever, including data, compilations, formulations, models, invention disclosures, procedures, processes, projections, protocols, results of experimentations and testing, specifications, strategies, techniques, marketing, employment, employee benefits, inventory, advertising, financial, commercial, sales or programming information and materials, and all non-public intellectual property, and all tangible and intangible embodiments thereof of any kind (including apparatus, compositions, documents, drawings, machinery, patent applications, records and reports), which is disclosed by such Disclosing Party to the Receiving Party and is marked, identified, otherwise acknowledged or known by the Receiving Party to be confidential at the time of disclosure to the Receiving Party, or is of a confidential, non-public nature. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.37<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Contract</font>&#8221; means any written or oral contract or agreement, license, lease, commitment, arrangement or understanding entered into with a third party.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.38<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Control</font>&#8221; or &#8220;<font style="text-decoration:underline;">Controlled</font>&#8221; means, when used with respect to any specified Person, the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by Contract or otherwise. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.39<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">CPR</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 11.6.1</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.40<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Customer Data</font>&#8221; shall mean material correspondence, contracts (whether or not still in effect), customer lists, invoices, purchase orders, packing lists and shipping information regarding Seller&#8217;s customers related to the Acquired Product Line,&nbsp;&nbsp;whether or not stored at the Facility.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.41<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Disclosing Party</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section&#160;6.7.1</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.42<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Disclosure Schedule</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Article IV</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.43<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Dispute Resolution Parties</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 11.6.1</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.44<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Dispute Statement</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 3.4.3.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.45<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Drug IP</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 2.3.4</font>.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">4</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.46<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">EBITDAS Dispute Statement</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 3.5.2</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.47<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">EBITDAS Milestone</font>&#8221; means an amount equal to the lesser of (a) *** times (***x) the amount obtained (if positive) by subtracting <font style="color:#000000;">***</font> dollars ($<font style="color:#000000;">***</font>) from the actual Acquired Product Line 2020 EBITDAS (as determined in accordance with <font style="text-decoration:underline;">Section 3.5.1</font>), and (b) <font style="color:#000000;">***</font> dollars ($<font style="color:#000000;">***</font>).&nbsp;&nbsp;Notwithstanding the foregoing, if the actual EBITDAS of the Acquired Product Line for the calendar year ending December 31, 2020, is <font style="color:#000000;">***</font> dollars ($<font style="color:#000000;">***</font>) or less, then the amount of the EBITDAS Milestone shall be zero ($0). </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.48<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Encumbrance</font>&#8221; means any charge, claim, community or other marital property interest, equitable interest, lien, license, option, pledge, security interest, mortgage, deed of trust, right-of-way, easement, encroachment, servitude, right of first offer or first refusal, buy/sell agreement and any other restriction or covenant with respect to, or condition governing the voting (in the case of any equity security), or receipt of income. &#8220;<font style="text-decoration:underline;">Encumbrance</font>&#8221; shall not include a Permitted Encumbrance. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.49<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Environmental Laws</font>&#8221; means any Law relating to (a) releases or threatened releases of Hazardous Substances, (b) pollution or protection of the environment or the protection of public and worker safety or health (as relates to exposure to Hazardous Substances) or (c) the manufacture, handling, transport, use, treatment, storage or disposal of Hazardous Substances.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.50<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">ERISA</font>&#8221; shall mean the Employee Retirement Income Security Act of 1974, as amended, and the rules and regulations promulgated thereunder.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.51<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">ERISA Affiliate</font>&#8221; shall mean, with respect to any entity, any other entity (whether or not incorporated) that, together with such entity, would be treated as a single employer under Section 414(b), (c), (m) or (o) of the Code or Section 4001 of ERISA.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.52<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Estimated Purchase Price</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 3.4.1</font>. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.53<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Excluded Assets</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 2.3</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.54<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Excluded Liabilities</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 2.5</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.55<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Exhibit</font>&#8221; means any exhibit attached to this Agreement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.56<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Expiration Date</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 9.1.2</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.57<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Extended Leave</font>&#8221; means long-term disability leave, short-term disability leave, medical leave, military leave, workers&#8217; compensation leave or other authorized leave of absence.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.58<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Facility</font>&#8221; means the premises leased by the Seller located at 2200 River Chase Center, Suite 501, Birmingham, Alabama 35244. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.59<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Final Purchase Price</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 3.4.5.1</font>.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">5</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.60<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Financial Information</font>&#8221; means quarterly balance sheets prepared in accordance with U.S. GAAP starting as of December 31, 2018 and quarterly income statements starting as of January 1, 2019 related to the Acquired Product Line and included in the Acquired Books and Records and Shared Books and Records not located or stored at the Facility; provided that the Financial Information shall not include financial statements relating to Seller operations that are not part of the Acquired Product Line. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.61<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">For</font>&#8221; means, with respect to particular subject matter or Intellectual Property Rights, as the case may be, that such subject matter or Intellectual Property Right (a) was used or otherwise exploited in, or developed in, the course of the conduct of the Acquired Product Line prior to the Closing, or (b) is reasonably necessary for the continued operation following the Closing of the Acquired Product Line substantially in the manner as conducted, or planned to be conducted, prior to Closing.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.62<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Fundamental Representations</font>&#8221; means the representations and warranties in <font style="text-decoration:underline;">Section 4.1</font> (Organization), <font style="text-decoration:underline;">Section&#160;4.2</font> (Authorization), <font style="text-decoration:underline;">Section&#160;4.3</font> (Absence of Restrictions and Conflicts), <font style="text-decoration:underline;">Section 4.4</font> (Title to Assets) and <font style="text-decoration:underline;">Section 4.20</font> (Brokers, Finders Brokers, Finders and Investment Bankers). </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.63<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">General Representations</font>&#8221; means any representation that is not a Fundamental or a Specified Representation. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.64<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Governmental Entity</font>&#8221; means any federal, state, local or foreign government, any political subdivision thereof, or any court, administrative or regulatory agency, department, instrumentality, body or commission or other governmental authority or agency, domestic or foreign.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.65<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Hazardous Substances</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 4.13</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.66<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Hired Employee</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 6.8.1</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.67<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Indemnified Party</font>&#8221; means a Purchaser Indemnified Party or a Seller Indemnified Party, as applicable.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.68<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Indemnifying Party</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 10.3.1</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.69<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Intellectual Property</font>&#8221; means and includes all polymers, formulation concepts and designs, formulations suitable for imparting performance-enhancing qualities to active pharmaceutical ingredients, assay components, biological materials, cell lines, preclinical and clinical data, study designs, chemical compositions or structures, databases and data collections, diagrams, formulae, gate arrays, inventions (whether or not patentable), know-how, logos, marks (including brand names, product names, logos, and slogans), methods, processes, proprietary information, protocols, sketches, designs, schematics, specifications, test results, test vectors, techniques, works of authorship, and other forms of technology (whether or not embodied in any tangible form and including all tangible embodiments of the foregoing such as instruction manuals, laboratory notebooks, prototypes, samples, studies, and summaries).</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">6</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.70</font><font style="margin-left:36pt;"></font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> &#8220;</font><font style="text-decoration:underline;">Intellectual Property Rights</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; means and include all rights of the following types, which may exist or be created under the Laws of any jurisdiction in the world: (a) rights associated with works of authorship, including exclusive exploitation rights, copyrights, moral rights, and mask works; (b) trademark and trade name rights and similar rights; (c) trade secret rights; (d) patents and industrial property rights; (e) other proprietary rights in Intellectual Property of every kind and nature; and (f) all registrations, renewals, extensions, continuations, divisions, or reissues of, and applications for, any of the rights referred to in clauses (a) through (e) above.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.71<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">IP Assignment Agreement</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 8.2.5</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.72<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Knowledge</font>&#8221; means, with respect to the Seller, the actual knowledge of (***), in each case after reasonable inquiry of their direct reports.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.73<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Law</font>&#8221; or &#8220;<font style="text-decoration:underline;">Laws</font>&#8221; means all statutes, rules, codes, regulations, restrictions, ordinances, orders, decrees, approvals, directives, judgments, injunctions, writs, awards and decrees of, or issued by, any Governmental Entity, including but not limited to CFIUS.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.74<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Lease Assignment</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 8.2.6</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.75<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Legal Dispute</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 11.6</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.76<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Liability</font>&#8221; or &#8220;<font style="text-decoration:underline;">Liabilities</font>&#8221; means debts, liabilities and obligations (including guaranties and other forms of credit support), whether accrued or fixed, absolute or contingent, known or unknown, matured or unmatured, on- or off-balance sheet, including those arising under any Law or Proceeding and those arising under any contract, agreement, arrangement, commitment or undertaking or otherwise. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="DocXTextRef214"></a><a name="DocXTextRef215"></a><a name="DocXTextRef216"></a><a name="DocXTextRef217"></a><a name="DocXTextRef219"></a><a name="DocXTextRef220"></a>1.1.77<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Material Adverse Effect</font>&#8221; means any state of facts, change, event, effect or occurrence (when taken together with all other states of fact, changes, events, effects or occurrences) that is or would be reasonably expected to be materially adverse to (a) the financial condition, results of operations, prospects, properties, assets or Liabilities of the Acquired Product Line or the Acquired Assets, when taken as a whole or (b) the ability to conduct the Acquired Product Line in the manner conducted prior to the Closing Date.&nbsp;&nbsp;A Material Adverse Effect shall also include any state of facts, change, event or occurrence that shall have occurred or been threatened that (when taken together with all other states of facts, changes, events, effects or occurrences that have occurred or been threatened) is or could be reasonably likely to prevent or materially delay the performance by the Seller of any of its material obligations under this Agreement or the consummation of the transactions contemplated hereby; <font style="font-style:italic;">provided</font>, <font style="font-style:italic;">however</font><a name="DocXTextRef214"></a>, that none of the following shall be deemed, either alone or in combination, to constitute, and none of the following shall be taken into account in determining whether there has been or will be, a Material Adverse Effect: (i)<a name="DocXTextRef215"></a>&#160;conditions generally affecting (A)<a name="DocXTextRef216"></a>&#160;any of the industries in which the Seller operates or participates, (B)<a name="DocXTextRef217"></a>&#160;the U.S. economy or financial or capital markets (including interest rates) or political conditions in the U.S., or (C)&#160;any foreign economy or financial or capital markets (including interest rates) or political conditions in any location where the Seller operates; (ii)&#160;any failure by the Seller to meet internal or other estimates, predictions, projections or forecasts, including as provided to Purchaser or any of its Representatives by the Seller or any of </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">7</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="DocXTextRef219"></a>the Seller&#8217;s Representatives; (iii)&#160;any changes arising from or attributable or relating to (A) the announcement or pendency of any of the transactions contemplated by this Agreement or any other related transaction document or the identity or involvement of Parent or any of its Affiliates (including any impact on the customers, suppliers, vendors or employees of the Seller), </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or (B)</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="DocXTextRef220"></a>&#160;any breach by Purchaser of this Agreement or any Related Agreement, or </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(C)</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;the introduction or success of any product or service that competes with any product or service of the Seller; (iv)&#160;the taking of any action by Purchaser or any of Purchaser&#8217;s Representatives, or the taking of any action or the failure to take any action by the Seller approved in writing by Purchaser or that are otherwise permitted or required under the terms of this Agreement; (v)&#160;the failure to take any action as a result of any restrictions or prohibitions set forth in </font><font style="text-decoration:underline;">Section&#160;6.1</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or elsewhere in this Agreement; (vi)&#160;any change in accounting requirements or principles or any change in applicable Law or U.S. GAAP or the interpretation thereof; (vii)&#160;acts of war, hostilities or terrorism or any escalation or material worsening of any such acts of war, hostilities or terrorism, or the occurrence or escalation of any other calamity or crisis, including any riots, violent or destructive rallies, or similar activities or events; (viii)&#160;natural disasters, act of God, or other force majeure event; (ix)&#160;epidemics and pandemics (including in respect of COVID-19); or (x)&#160;any matters set forth in the Disclosure Schedule; or, except, for purposes of clauses&#160;(i) and (vi) through (ix), to the extent, and only to the extent, that such conditions have a materially disproportionate impact on the Seller as compared to other Persons engaged in the principal business segment in which the Seller operates or participates.&nbsp;&nbsp;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="DocXTextRef222"></a><a name="DocXTextRef223"></a>1.1.78<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Net Working Capital</font><a name="DocXTextRef222"></a>&#8221; means (a)&#160;the sum of the Seller&#8217;s current assets associated with the Acquired Product Line to the extent included in the Acquired Assets except for cash accounts as of the Closing Date, <font style="font-style:italic;">minus</font><a name="DocXTextRef223"></a> (b)&#160;the sum of the Seller&#8217;s current liabilities associated with the Acquired Product Line as of the Closing Date to the extent included in the Acquired Assets, in each case, calculated in accordance with the Accounting Methodology and reflecting the exclusions set forth on the Pre-Closing Working Capital Statement. For clarity, amounts owed under the Real Property Lease in respect of periods prior to the Closing Date (but not in respect of periods from and after the Closing Date) shall be deducted as a current liability in calculating Net Working Capital to the extent not paid by Seller prior to the Closing Date. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.79<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Net Working Capital Adjustment</font>&#8221; means the amount (if any) by which the Net Working Capital is <font style="font-style:italic;">less</font> or <font style="font-style:italic;">more</font> than the Net Working Capital Target.&nbsp;&nbsp;For the avoidance of doubt, if the Net Working Capital is <font style="font-style:italic;">less</font> than the Net Working Capital Target, the Net Working Capital Adjustment amount shall be expressed as a negative number, and if the Net Working Capital is greater than the Net Working Capital Target, the Net Working Capital Adjustment shall be expressed as a positive number.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.80<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Net Working Capital Target</font>&#8221; means <font style="color:#000000;">***</font> dollars ($<font style="color:#000000;">***</font>).</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.81<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Non-Competition and Non-Solicitation Agreement</font>&#8221; means those non-competition and non-solicitation terms set forth in <font style="text-decoration:underline;">Exhibit 1.1.80</font>.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.82<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Non-Transferred Asset</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 2.8</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.83<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Offered Employee</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 6.8.1</font>.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">8</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.84<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Ordinary Course</font>&#8221; means the ordinary course of business consistent with past practice of the Seller. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.85<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Other Business Information</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 2.2</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.86<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Permitted Encumbrance</font>&#8221; means (a) statutory liens for Taxes, special assessments or other governmental charges not yet delinquent or the amount or validity of which is being contested in good faith by appropriate proceedings and for which appropriate reserves have been established; (b) mechanics&#8217;, materialmen&#8217;s, carriers&#8217;, workers&#8217;, suppliers&#8217;, landlords&#8217;, repairers&#8217; and similar statutory liens arising or incurred in the Ordinary Course which liens are not delinquent; (c) easements, rights-of-way, zoning ordinances and other similar Encumbrances affecting the Real Property, except as would be material to the Acquired Product Line, taken as a whole; (d) liens arising through or under any landlords of any leased real property; and (e) liens (other than those securing indebtedness) that do not materially detract from the value or materially interfere with any present or intended use of the property or asset to which such lien relates.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.87<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Person</font>&#8221; means any individual, corporation, partnership, joint venture, limited liability company, trust, unincorporated organization or Governmental Entity.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.88<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Pre-Closing Activities</font>&#8221; means the operation of the activities of the Acquired Product Line as it was conducted on or before the Closing Date (including any planned changes or improvements to the extent actually documented by the Seller prior to the Closing Date) on or before the Closing Date.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.89<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Polymer Patent Claim</font>&#8221; means those specific claims in any patent or patent application that directed to the composition or synthesis of any polymer developed or produced in connection with any Pre-Closing Activities.&nbsp;&nbsp;For clarity, a Polymer Patent Claim&nbsp;&nbsp;excludes any claim directed to Drug IP. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.90<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Post-Closing Working Capital Statement</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 3.4.2</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.91<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Pre-Closing Working Capital Statement</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 3.4.1</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.92<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Proceeding</font>&#8221; means any action, claim, suit, litigation, arbitration, proceeding (including any civil, criminal, administrative, investigative or appellate proceeding and any informal proceeding), prosecution, contest, hearing, inquiry, inquest, audit, examination or investigation commenced, brought, conducted or heard by or before, or otherwise involving, any Governmental Entity or any arbitrator or arbitration panel.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.93<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Purchase Price</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 3.1</font>. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.94<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Purchaser Indemnified Parties</font>&#8221; means the Purchaser and each of its Affiliates, and each of their respective officers, directors, employees, agents and Representatives and each of the heirs, executors, successors and assigns of any of the foregoing.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.95<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Purchaser Losses</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 10.1.3</font>.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">9</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.96<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Real Property</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 4.12.1</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.97<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Real Property Lease</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 4.12.1</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.98<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Receiving Party</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section&#160;6.7.1</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.99<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Related Agreements</font>&#8221; means, individually and collectively, the Non-Competition and Non-Solicitation Agreement, Transition Services Agreement, Assignment and Assumption Agreement, IP Assignment Agreement, Lease Assignment and Assumption Agreement and the Bill of Sale.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.100<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Related Party Transaction</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 4.19</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.101<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Representatives</font>&#8221; means, with respect to a Person, such Person&#8217;s officers, directors, principals, employees, advisors, auditors, attorneys, agents, bankers, and other representatives of such Person.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.102<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Resolution Period</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 3.4.5</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.103<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Review Period</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 3.4.3</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.104<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Schedule</font>&#8221; means any schedule attached to this Agreement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.105<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Seller EBITDAS Statement</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 3.5.1</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.106<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Seller Indemnified Parties</font>&#8221; means the Seller and each of its shareholders, officers, directors, managers, employees, agents and Representatives and each of the heirs, executors, successors and assigns of any of the foregoing.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.107<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Seller Losses</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 10.2</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.108<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Shared Books and Records</font>&#8221; means any of the Acquired Books and Records that, in the reasonable judgement of the Seller, relate to businesses or assets of the Seller in addition to, or other than, the Acquired Product Line.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.109<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">&#8220;Specified Representations</font>&#8221; means the representations and warranties in <font style="text-decoration:underline;">Section 4.5</font> (Sufficiency of Assets), <font style="text-decoration:underline;">Section 4.11</font> (Intellectual Property) and <font style="text-decoration:underline;">Section 4.13</font> (Environmental Matters).</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.110<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Tax Return</font>&#8221; means any report, return, declaration or other information required to be supplied to a Governmental Entity in connection with Taxes, including estimated returns, amended returns, information statements and reports of every kind with respect to Taxes.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref483277283"></a>1.1.111<font style="margin-left:36pt;"></font> &#8220;<font style="text-decoration:underline;">Taxes</font><a name="_Ref483277283"></a>&#8221; means all taxes, assessments, charges, duties, fees, levies and other governmental charges (including interest, penalties or additions associated therewith), </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">10</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">including income, franchise, capital stock, real property, personal property, unclaimed property, tangible, withholding, employment, payroll, social security, social contribution, unemployment compensation, disability, transfer, sales, use, excise, license, occupation, registration, stamp, premium, environmental, customs duties, alternative or add-on minimum, estimated, gross receipts, value-added and all other taxes of any kind for which the Seller may have any liability imposed by any Governmental Entity, whether disputed or not</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and any charges, interest or penalties imposed by any Governmental Entity.</font><font style="font-style:italic;"> </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.112<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Trademark Assignment</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 8.2.4</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.113<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Transfer Taxes</font>&#8221; has the meaning set forth in <font style="text-decoration:underline;">Section 6.6</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref55474591"></a>1.1.114<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">Transition Services Agreement</font>&#8221; means the transition services agreement to be dated as of the Closing Date by and between the Seller and the Purchaser in the form attached hereto as <font style="text-decoration:underline;">Exhibit 3</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.1.115<font style="margin-left:36pt;"></font>&#8220;<font style="text-decoration:underline;">U.S. GAAP</font>&#8221; means generally accepted accounting principles in the United States, consistently applied and as in effect from time to time. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12554019"></a><a name="_Toc12554525"></a><a name="_Toc12554637"></a><a name="_Toc12554749"></a><a name="_Toc476596434"></a><a name="_Toc476647984"></a><a name="_Toc480816325"></a><a name="_Toc512673749"></a><a name="_Toc512673837"></a><a name="_Toc523205647"></a><a name="_Toc12185231"></a><a name="_Toc49528503"></a><a name="_Toc47693176"></a><a name="_Toc57819103"></a>1.2<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Construction</font>.&nbsp;&nbsp;Unless the context of this Agreement clearly requires otherwise, (a) references to the plural include the singular, and references to the singular include the plural, (b) references to any gender include the other genders, (c) the words &#8220;include,&#8221; &#8220;includes&#8221; and &#8220;including&#8221; do not limit the preceding terms or words and shall be deemed to be followed by the words &#8220;without limitation,&#8221; (d) the terms &#8220;hereof,&#8221; &#8220;herein,&#8221; &#8220;hereunder,&#8221; &#8220;hereto&#8221; and similar terms in this Agreement refer to this Agreement as a whole and not to any particular provision of this Agreement, (e) the terms &#8220;day&#8221; and &#8220;days&#8221; mean and refer to calendar day(s), (f) the terms &#8220;year&#8221; and &#8220;years&#8221; mean and refer to calendar year(s) and (g) all references in this Agreement to &#8220;dollars&#8221; or &#8220;$&#8221; shall mean U.S. Dollars, unless expressly stated otherwise.&nbsp;&nbsp;Unless otherwise set forth herein, references in this Agreement to (i) any document, instrument or agreement (including this Agreement) (A) includes and incorporates all exhibits, schedules and other attachments thereto, (B) includes all documents, instruments or agreements issued or executed in replacement thereof and (C) means such document, instrument or agreement, or replacement or predecessor thereto, as amended, modified or supplemented from time to time in accordance with its terms and in effect at any given time, and (ii) a particular Law means such Law as amended, modified, supplemented or succeeded, from time to time and in effect at any given time.&nbsp;&nbsp;All Article, Section, Exhibit and Schedule references herein are to Articles, Sections, Exhibits and Schedules of this Agreement unless otherwise specified.&nbsp;&nbsp;This Agreement shall not be construed as if prepared by one of the Parties but rather according to its fair meaning as a whole as if all Parties had prepared it.</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;"><a name="_Toc69532386"></a><a name="_Toc155614571"></a><a name="_Toc155699684"></a><a name="_Toc224619049"></a><a name="_Toc12185232"></a><a name="_Ref47717140"></a><a name="_Toc49528504"></a><a name="_Toc47693177"></a><a name="_Toc57819104"></a><a name="_Toc45558522"></a><a name="_Toc47175069"></a>ARTICLE II<font style="font-family:Times New Roman Bold;"><br /><a name="_Toc69532386"></a><a name="_Toc155614571"></a><a name="_Toc155699684"></a><a name="_Toc224619049"></a><a name="_Toc12185232"></a><a name="_Ref47717140"></a><a name="_Toc49528504"></a><a name="_Toc47693177"></a><a name="_Toc57819104"></a><a name="_Toc45558522"></a><a name="_Toc47175069"></a>PURCHASE AND SALE</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185233"></a><a name="_Ref47716221"></a><a name="_Toc49528505"></a><a name="_Toc47693178"></a><a name="_Toc57819105"></a>2.1<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Agreement to Purchase and Sell</font>.&nbsp;&nbsp;Subject to the terms and conditions of this Agreement, at the Closing and except as otherwise specifically provided in this <font style="text-decoration:underline;">Article&#160;II</font>, the Seller, in consideration for the payment of the Purchase Price and the assumption of the Acquired Liabilities, shall grant, sell, assign, transfer and deliver to the Purchaser, and the Purchaser shall </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">11</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">purchase, acquire and accept from the Seller, all right, title and interest of the Seller in and to the Acquired Product Line, including the assets described in </font><font style="text-decoration:underline;">Sections 2.1.1</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> &#8211; </font><font style="text-decoration:underline;">2.1.9</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> immediately below (collectively such assets, the &#8220;</font><font style="text-decoration:underline;">Acquired Assets</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;), free and clear of all Encumbrances, other than Permitted Encumbrances, and the Purchaser shall assume the Acquired Liabilities but shall not acquire the Excluded Assets or assume Excluded Liabilities (the foregoing transaction, the &#8220;</font><font style="text-decoration:underline;">Acquisition</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;):</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref50539919"></a>2.1.1<font style="margin-left:36pt;"></font>the Acquired Accounts Receivable;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref49412279"></a>2.1.2<font style="margin-left:36pt;"></font>the Acquired Books and Records, including any Shared Books and Records;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.1.3<font style="margin-left:36pt;"></font>the Acquired Contracts; </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.1.4<font style="margin-left:36pt;"></font>the Acquired Customer Contracts;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.1.5<font style="margin-left:36pt;"></font>the Acquired Inventory;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.1.6<font style="margin-left:36pt;"></font>the Acquired Equipment; </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.1.7<font style="margin-left:36pt;"></font>the Acquired Intellectual Property; </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref50540022"></a>2.1.8<font style="margin-left:36pt;"></font>all rights to causes of Proceedings, judgments, claims and demands of any nature available to or being pursued by the Seller prior to the Closing Date, whether arising by way of counterclaim or otherwise in connection with the Acquired Product Line or any Acquired Assets but for clarity excluding a Proceeding, judgment, claim or demand described in <font style="text-decoration:underline;">Exhibit 2.1.8</font>; and</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref50539932"></a>2.1.9<font style="margin-left:36pt;"></font>all other property of every kind, character or description, tangible and intangible, known or unknown, owned or leased by the Seller and are For the operation of the Acquired Product Line, whether or not described in this Agreement (other than the Excluded Assets).</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding anything to the contrary, (i) the Acquired Assets shall exclude the Excluded Assets, (ii) the Seller shall have the right to redact any information from its books and records that contain the Acquired Books and Records to the extent the Seller and the Purchaser, each acting reasonably, agree that such information relates primarily to the Excluded Assets and is not necessary for the conduct of the Acquired Product Line, and (iii) with respect to the Shared Books and Records, the Seller may retain copies of such Shared Books and Records for its nonexclusive use and exploitation in connection with the conduct of the Excluded Assets but for clarity, from and after the Closing, such Shared Books and Records and the Acquired Books and Records shall be deemed to be the Confidential Information of the Purchaser and subject to <font style="text-decoration:underline;">Section 6.8</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185234"></a><a name="_Ref47715440"></a><a name="_Toc49424224"></a><a name="_Toc47693179"></a><a name="_Toc49528506"></a><a name="_Toc57819106"></a>2.2<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Ancillary Rights; Treatment of Acquired Books and Records</font>. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:1.92%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.2.1<font style="margin-left:36pt;"></font>Except to the extent constituting an Excluded Asset, the Seller shall also grant, sell, assign, transfer and deliver to the Purchaser in connection with the Acquisition the following rights of the Seller immediately preceding the Closing Date to the extent exclusively used, held for exclusive use or intended to be exclusively used in, or arising from or necessary for, the operation or conduct of the Acquired Product Line:</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">12</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:9.62%;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.2.1.1</font><font style="margin-left:36pt;"></font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">all rights in and under all express or implied guarantees, warranties, representations, covenants, indemnities and similar rights in favor of the Seller in connection with the Acquired Product Line or any Acquired Assets; and</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:9.62%;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.2.1.2<font style="margin-left:36pt;"></font>all goodwill associated with the Acquired Product Line or Acquired Assets.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:1.92%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.2.2<font style="margin-left:36pt;"></font>Upon the Closing, the Purchaser shall acquire legal title of ownership in respect of all such Acquired Assets; provided, however, that until the earlier of the expiry or termination of the Transition Services Agreement, the Seller may retain physical possession of any Acquired Books and Records that are not located at the Facility and Acquired Inventory as are reasonably necessary for the Seller to perform and satisfy its duties and obligations, and to exercise its rights, under the Transition Services Agreement.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:1.92%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.2.3<font style="margin-left:36pt;"></font> To the extent that the Seller has retained physical possession of any such Acquired Books and Records or Acquired Inventory post-Closing, (i) subject to the below provisions of this <font style="text-decoration:underline;">Section&#160;2.2,</font> the Purchaser shall, in its sole discretion, have the right to obtain the original Acquired Books and Records and provide the Seller with copies, as required and (ii) the Seller shall, at its sole cost, upon the earlier of the expiration of the Transaction Services Agreement, the termination of the Transition Services Agreement or such date as such Acquired Books and Records or Acquired Inventory is no longer necessary for the Seller to perform and satisfy its duties and obligations, and to exercise its rights, under the Transition Services Agreement, promptly deliver to the Purchaser (or an Affiliate thereof) any retained Acquired Books and Records or Acquired Inventory, including any and all copies thereof, other than Shared Books and Records.&nbsp;&nbsp;Any retained Acquired Books and Records or Acquired Inventory, including any and all copies thereof shall be deemed to be Confidential Information of the Purchaser and subject to <font style="text-decoration:underline;">Section&#160;6.7.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:1.92%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref55475079"></a>2.2.4<font style="margin-left:36pt;"></font><a name="_Ref55475079"></a> Notwithstanding anything to the contrary in this Agreement, the Acquired Books and Records shall include:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:9.62%;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.2.4.1<font style="margin-left:36pt;"></font>the Financial Information through the Closing Date;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:9.62%;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.2.4.2<font style="margin-left:36pt;"></font>Customer Data from <font style="color:#000000;">***</font> to the Closing Date; and</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:9.62%;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.2.4.3<font style="margin-left:36pt;"></font>with respect of any Acquired Books and Records and Shared Books and Records located at the Facility, such shall include the period from creation of the particular Acquired Books and Records or Shared Books and Records to the Closing Date.&nbsp;&nbsp;The Seller confirms to the Buyer that all books and records ordinarily stored at the Facility relate to the Acquired Product Line.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding the foregoing, to the extent that Acquired Books and Records comprise Shared Books and Records, the Seller shall have a reasonable opportunity to redact therefrom any information relating to any Excluded Assets (collectively, &#8220;<font style="text-decoration:underline;">Other Business Information</font>&#8221;), and shall have the right to retain copies of all such Other Business Information. However, to the extent any such Other Business Information is not redacted, such Other Business Information shall be and remain the Confidential Information of the Seller.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">13</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to the Closing, in order to ensure a smooth transition of the Acquired Product Line from the Seller to the Purchaser, the Seller shall complete those activities set out in </font><font style="text-decoration:underline;">Schedule 2.2.4</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in order to facilitate the transfer of all Acquired Books and Records and Shared Books and Records stored in electronic form to the servers or systems designated in </font><font style="text-decoration:underline;">Schedule 2.2.4</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> so that such books and records are electronically accessible and available to the Purchaser (including the Hired Employees) from and after the Closing Date (the &#8220;</font><font style="text-decoration:underline;">IT Transfer</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;).&nbsp;&nbsp; </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref10568647"></a><a name="_Toc12185235"></a><a name="_Toc49528507"></a><a name="_Toc47693180"></a><a name="_Toc57819107"></a>2.3<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Excluded Assets</font>.&nbsp;&nbsp;Notwithstanding anything to the contrary set forth in this Agreement, the Acquired Assets will exclude the following assets, properties and rights of the Seller (collectively, the &#8220;<font style="text-decoration:underline;">Excluded Assets</font>&#8221;):</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.3.1<font style="margin-left:36pt;"></font><font style="color:#000000;">any cash, cash equivalents or marketable securities and all rights to any bank accounts of the Seller;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.3.2<font style="margin-left:36pt;"></font>all ownership and other rights with respect to any employment agreement or employee benefit plan that the Seller is a party to or has liability; </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.3.3<font style="margin-left:36pt;"></font>any manufacturing, laboratory or similar equipment owned or leased by the Seller, other than the Acquired Equipment;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref53412543"></a>2.3.4<font style="margin-left:36pt;"></font>except for the Acquired Intellectual Property, all other Intellectual Property Rights, including the Intellectual Property Rights that comprise (or in the case of patents or applications therefor, claim) (i) any active pharmaceutical/biological agent (or the formulation, delivery or use thereof), or (ii) any composition that (a) incorporates any active pharmaceutical/biological agent or (b) involves noncovalent complexation intended to modify solubility, dissolution or stability of any target compound(s), including in each case&nbsp;&nbsp;(i) and (ii) any manufacture or use thereof, (such Intellectual Property Rights referred to in (i) and (ii) of this <font style="text-decoration:underline;">Section 2.3.4</font> are individually and collectively referred to as &#8220;<font style="text-decoration:underline;">Drug IP</font>&#8221;) (notwithstanding anything herein to the contrary, Acquired Intellectual Property does not include any Drug IP); </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.3.5<font style="margin-left:36pt;"></font><font style="font-size:8pt;letter-spacing:0pt;"> </font>any books and records or portions thereof that relate to the Seller assets other than the Acquired Books and Records and the Shared Books and Records; </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.3.6<font style="margin-left:36pt;"></font>any Proceeding not included under <font style="text-decoration:underline;">Section 2.1.8</font>; </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.3.7<font style="margin-left:36pt;"></font>any interest in real property other than the Real Property Lease; and </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.3.8<font style="margin-left:36pt;"></font>the rights that accrue to the Seller under this Agreement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185236"></a><a name="_Toc49528508"></a><a name="_Toc47693181"></a><a name="_Toc57819108"></a><a name="_Ref2785289"></a>2.4<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Assumption of Acquired Liabilities</font>.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref47713382"></a>2.4.1<font style="margin-left:36pt;"></font>Except as provided in <font style="text-decoration:underline;">Section&#160;2.4.2</font>, in connection with the Acquisition, the Purchaser shall not assume any liability or obligation of the Seller for, and the Seller shall retain responsibility for, any Liabilities accrued by the Seller as of the Closing Date and any Liabilities arising from the Acquired Assets and the Seller&#8217;s operations, in each case prior to or on the Closing Date, whether or not accrued and whether or not disclosed.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">14</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref3162546"></a><a name="_Ref47715540"></a>2.4.2<font style="margin-left:36pt;"></font>As the sole exception to the provisions in <font style="text-decoration:underline;">Section&#160;2.4.1</font>, effective as of the close of business on the Closing Date, the Purchaser shall assume the obligations of the Seller under each Acquired Contract to the extent such obligations are not required to be performed on or prior to the Closing Date (collectively, the &#8220;<font style="text-decoration:underline;">Acquired Liabilities</font>&#8221;) but excluding any Liability to the extent (i) relating to defaults under the Acquired Contracts occurring on or prior to the Closing Date, (ii) arising out of any breach by the Seller on or prior to the Closing Date of any representation or warranty contained therein (whether or not such breach was first discovered before, on or after the Closing Date), (iii) that the Seller was obliged to perform or discharge on or prior to the Closing Date, or (iv) resulting from goods, products or services sold or provided by the Seller on or prior to the Closing Date.&nbsp;&nbsp;For greater certainty, in the event that there is an accounts payable associated with any purported Acquired Liability (i.e., a customer made a pre-payment), then the Purchaser shall only assume the obligations of the Seller, and the obligation shall only become an Acquired Liability, to the extent that the Seller also transfers to the Purchaser the applicable cash pre-payment. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185237"></a><a name="_Toc49528509"></a><a name="_Toc47693182"></a><a name="_Toc57819109"></a>2.5<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Excluded Liabilities</font>.&nbsp;&nbsp;Specifically, and without in any way limiting the generality of <font style="text-decoration:underline;">Section&#160;2.4.1</font>, the Acquired Liabilities shall not include, and in no event shall the Purchaser  assume, agree to pay, discharge or satisfy any Liability under this Agreement or otherwise have any responsibility for, any Liability (together with all other Liabilities of the Seller that are not Acquired Liabilities, the &#8220;<font style="text-decoration:underline;">Excluded Liabilities</font>&#8221;) relating to, resulting from or arising out of:&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.5.1<font style="margin-left:36pt;"></font>any Liability owed to the Seller or any shareholder (including amounts due to the Seller under the Transition Services Agreement);</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.5.2<font style="margin-left:36pt;"></font>any indebtedness of the Seller with respect to borrowed money, including any interest or penalties accrued thereon;&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.5.3<font style="margin-left:36pt;"></font> (i) claims made in pending or future Proceedings or (ii) claims based on violations of Law, breach of contract, employment practices, or environmental, health and safety matters or any other actual or alleged failure of the Seller to perform any obligation, in each case to the extent arising out of, or relating to, (A) events that shall have occurred prior to the Closing Date, (B) services performed prior to the Closing Date, or (C) the operation of the Acquired Product Line prior to the Closing Date;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.5.4<font style="margin-left:36pt;"></font>any Contract entered into by the Seller or predecessor entities that is not an Acquired Contract;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.5.5<font style="margin-left:36pt;"></font>any former operations of the Seller or predecessor entities thereof that have been discontinued or disposed of prior to the Closing Date; </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.5.6<font style="margin-left:36pt;"></font>any Excluded Asset;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.5.7<font style="margin-left:36pt;"></font>under or relating to any employment agreement or Benefit Plan of the Seller, to the extent such liability or obligation arises on or prior to the Closing Date; </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.5.8<font style="margin-left:36pt;"></font>any Taxes owing by Seller;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">15</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.5.9<font style="margin-left:36pt;"></font><font style="color:#000000;">or relating to any product or service provided by the Seller or the Acquired Product Line prior to the Closing Date; and</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.5.10<font style="margin-left:36pt;"></font>or incurred in connection with the negotiation, preparation and execution of this Agreement and the transactions contemplated hereby and any fees and expenses of counsel, accountants, brokers, financial advisors or other experts of the Seller.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Such Excluded Liabilities shall include all Proceedings of the Seller to the extent directly relating to any or all of the foregoing listed Excluded Liabilities and all costs and expenses in connection therewith.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185238"></a><a name="_Toc49528510"></a><a name="_Toc47693183"></a><a name="_Toc57819110"></a>2.6<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Consents of Third Parties</font>.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref47715678"></a>2.6.1<font style="margin-left:36pt;"></font>Notwithstanding anything in this Agreement to the contrary, this Agreement shall not constitute an agreement to assign any Acquired Asset if an attempted assignment thereof, without the consent of a third party, would constitute a breach or other contravention of the rights of such third party, would be ineffective with respect to any party to a Contract concerning such Acquired Asset, or would in any way adversely affect the rights of the Seller or, upon transfer, the Purchaser under such Acquired Asset. If any transfer or assignment by the Seller to, or any assumption by the Purchaser of, any interest in, or liability, obligation or commitment under, any Acquired Asset requires the consent of a third party, then such assignment or assumption shall be made subject to such consent being obtained.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.6.2<font style="margin-left:36pt;"></font>If any consent referred to in <font style="text-decoration:underline;">Section&#160;2.6.1</font> is not obtained prior to the Closing, each of the Seller and the Purchaser shall cooperate (at their own expense) in any lawful and reasonable arrangement reasonably proposed by the Purchaser under which the Purchaser shall obtain the economic claims, rights and benefits under the asset with respect to which such consent has not been obtained. Such reasonable arrangement may include (i) the subcontracting, sublicensing or subleasing to the Purchaser of any and all rights of the Seller against the other party to such third-party agreement arising out of a breach or cancelation thereof by the other party, and (ii) the enforcement by the Seller of such rights.&nbsp;&nbsp;To the extent, and only to the extent, the Purchaser is able to receive the economic claims, rights and benefits under such Acquired Asset, the Purchaser shall be responsible for the Acquired Liabilities, if any, arising under such Acquired Asset.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185239"></a><a name="_Toc49528511"></a><a name="_Toc47693184"></a><a name="_Toc57819111"></a>2.7<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Wrong Pocket Provisions</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref12350432"></a>2.7.1<font style="margin-left:36pt;"></font>If, at any time following the Closing, either Party becomes aware that any Acquired Asset which should have been transferred to, or any Acquired Liability (whether arising prior to, at or following the Closing) which should have been assumed by, the Purchaser pursuant to the terms of this Agreement was not transferred to or assumed by the Purchaser as contemplated by this Agreement, then (i) the Seller shall, or shall require its Affiliate (if any), to promptly transfer such Acquired Asset or Acquired Liability to the Purchaser, and (ii) the Purchaser shall promptly accept the transfer of such Acquired Asset or assume such Acquired Liability, in each case for no additional consideration. Notwithstanding the foregoing, the Purchaser shall have to agree in writing to any Contract being deemed an Acquired Asset pursuant to the terms of this <font style="text-decoration:underline;">Section&#160;2.7.1</font>. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">16</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.7.2</font><font style="margin-left:36pt;"></font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If, at any time following the Closing, either Party becomes aware that any Excluded Asset or Excluded Liability (whether arising prior to, at or following the Closing)&nbsp;&nbsp;which should have been retained by the Seller pursuant to the terms of this Agreement was transferred to or assumed by the Purchaser, then (i) Purchaser shall promptly transfer or cause its Affiliates to transfer such Excluded Asset or Excluded Liability to the Seller, and (ii) the Seller shall promptly accept the transfer of such Excluded Asset or assume such Excluded Liability, in each case for no additional consideration.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref55476592"></a>2.7.3<font style="margin-left:36pt;"></font><a name="_Ref55476592"></a>The Seller shall not, and shall ensure its Affiliates (if any) do not, prior to or after the Closing apply for, or authorize any third party to apply for, a patent that includes a Polymer Patent Claim.&nbsp;&nbsp;For clarity, this <font style="text-decoration:underline;">Section 2.7.3</font> shall not preclude the Seller or its Affiliates (if any) from applying for or authorizing third parties to apply for any patent to the extent claiming Drug IP.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc49528512"></a><a name="_Toc57819112"></a>2.8<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Contracts and IP Not Transferred</font>2.8.1<font style="margin-left:36pt;"></font>.&nbsp;&nbsp;In the event that any Contract that is not an Acquired Contract is related to the operation of the Acquired Product Line and under which Confidential Information related to the Acquired Product Line was made available by or on behalf of the Seller, or under which Intellectual Property that is included in the Acquired Intellectual Property was created or made available (together, a &#8220;<font style="text-decoration:underline;">Non-Transferred Asset</font>&#8221;), then at the written request and reasonable expense of the Purchaser or its Affiliate, the Seller shall (or at the request of the Purchaser permit the Purchaser or its Affiliates to take such action in the name of the Seller) take reasonable efforts to enforce any and all confidentiality obligations imposed on the counterparty to such Contract as necessary to protect the confidentiality and non-use of the Confidential Information related to the Acquired Assets in accordance with <font style="text-decoration:underline;">Section 6.7.1</font> and to enforce any rights and obligations in relation to any Acquired Intellectual Property (or Intellectual Property that would, if such third party complied with its obligations thereunder to assign such rights to the Seller, be Acquired Intellectual Property) in order to permit Purchaser or its Affiliates to enjoy the rights under <font style="text-decoration:underline;">Section 2.7.1.</font>&nbsp;&nbsp; </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc57819113"></a>2.9<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Fully Paid; Withholding Tax</font>2.9.1<font style="margin-left:36pt;"></font>.&nbsp;&nbsp;No less than fifteen (15) Business Days prior to the Closing, the Seller shall have paid any Tax Liability related to the Acquired Assets, and shall have delivered evidence of such payment to the Purchaser.&nbsp;&nbsp;The Purchaser shall deduct and withhold from the Purchase Price all Taxes that the Purchaser is required to deduct and withhold under any provision of Tax Law. All such withheld amounts shall be treated as delivered to the Seller hereunder.&nbsp;&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;"><a name="_Toc12554029"></a><a name="_Toc12554535"></a><a name="_Toc12554647"></a><a name="_Toc12554759"></a><a name="_Toc12554030"></a><a name="_Toc12554536"></a><a name="_Toc12554648"></a><a name="_Toc12554760"></a><a name="_Toc69532393"></a><a name="_Toc155614578"></a><a name="_Toc155699691"></a><a name="_Toc224619056"></a><a name="_Toc12185241"></a><a name="_Ref47717259"></a><a name="_Toc49528515"></a><a name="_Toc47693185"></a><a name="_Toc57819114"></a><a name="_Toc45558528"></a><a name="_Toc47175075"></a>ARTICLE III<font style="font-family:Times New Roman Bold;"><br /><a name="_Toc69532393"></a><a name="_Toc155614578"></a><a name="_Toc155699691"></a><a name="_Toc224619056"></a><a name="_Toc12185241"></a><a name="_Ref47717259"></a><a name="_Toc49528515"></a><a name="_Toc47693185"></a><a name="_Toc57819114"></a><a name="_Toc45558528"></a><a name="_Toc47175075"></a>PURCHASE PRICE; ALLOCATIONS; ADJUSTMENTS</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185242"></a><a name="_Toc49528516"></a><a name="_Toc47693186"></a><a name="_Toc57819115"></a><a name="DocXTextRef211"></a><a name="_Toc12185243"></a>3.1<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Purchase Price</font>. The purchase price to be paid for the Acquired Assets shall be<a name="DocXTextRef211"></a> an amount, in cash, equal to the sum of (a)&#160; fifteen million dollars ($15,000,000) <font style="font-style:italic;">plus</font> (b) &#160;the Net Working Capital Adjustment (which may be positive or negative), if any, subject to adjustment pursuant to <font style="text-decoration:underline;">Section 3.4</font>, <font style="font-style:italic;">plus</font> (c) the 2020 EBITDAS Milestone, if any (the &#8220;<font style="text-decoration:underline;">Purchase Price</font><a name="_Toc12185243"></a>&#8221;).&nbsp;&nbsp;In addition to the foregoing payment, as consideration for the grant, sale, assignment, transfer and delivery of the Acquired Assets, the Purchaser shall assume and discharge the Acquired Liabilities.&nbsp;&nbsp;For clarity, in no event shall the amount of the 2020 EBITDAS Milestone exceed <font style="color:#000000;">***</font>  dollars ($<font style="color:#000000;">***</font>).</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">17</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref12983796"></a><a name="_Toc49528517"></a><a name="_Toc47693187"></a><a name="_Toc57819116"></a><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.2</font><font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Payment of Purchase Price</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;On or before the Closing Date, the </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Purchaser shall, or shall cause an Affiliate of Purchaser to, pay the Purchase Price (excluding any portion thereof related to the </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 2020 EBITDAS Milestone, which cannot be determined until after the Closing Date)</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> to </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Wilson Sonsini Goodrich &amp; Rosati, to be held in escrow on behalf of </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Seller, on customary terms confirmed in writing between the legal representatives of the Parties. All payments required under this </font><font style="text-decoration:underline;">Article&#160;III</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall be made in cash by the wire transfer of immediately available funds to such trust account of </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Wilson Sonsini Goodrich &amp; Rosati</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> as shall be designated in writing by the recipient </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or on behalf of the recipient</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top"> </sup></font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185244"></a><a name="_Ref47715782"></a><a name="_Toc49528518"></a><a name="_Toc47693188"></a><a name="_Toc57819117"></a>3.3<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Allocation of Purchase Price</font>. Within sixty (60) days of the Closing Date, the Purchaser shall deliver to the Seller a schedule (the &#8220;<font style="text-decoration:underline;">Allocation Schedule</font>&#8221;) reasonably allocating the Purchase Price (together with the Acquired Liabilities and any other items treated as consideration for the Acquired Assets for Tax purposes) among the Acquired Assets. Such allocation shall be deemed final unless the Seller shall have notified the Purchaser in writing of any disagreement with the Allocation Schedule within thirty (30) days after submission thereof by the Purchaser.&nbsp;&nbsp;In the event of such disagreement, the Purchaser and the Seller shall use reasonable efforts to reach agreement on a reasonable allocation.&nbsp;&nbsp;In the event that the Purchaser and the Seller do not reach an agreement within thirty (30) days, an independent tax accountant appointed by the Purchaser (and to which the Seller has no reasonable objection) shall make a determination as to each disputed item, which determination shall be final and binding upon the Purchaser and the Seller. The fees, costs and expenses of the independent tax accountant will be split equally between the Seller and the Purchaser. The Purchaser (or any applicable Affiliate thereof) and the Seller agree to file their respective Tax Returns in accordance with the Allocation Schedule as finally determined under this <font style="text-decoration:underline;">Section&#160;3.3</font>.&nbsp;&nbsp;The Purchaser (or any applicable Affiliate thereof) and the Seller each agrees to provide the other promptly with any other information required to complete the Allocation Schedule and their Tax Returns.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref2113037"></a><a name="_Ref18680001"></a><a name="_Toc42871084"></a><a name="_Ref47714601"></a><a name="_Toc49528519"></a><a name="_Toc57819118"></a><font style="text-decoration:none;">3.4</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;">Purchase Price Adjustment.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref18843552"></a>3.4.1<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Pre-Closing Working Capital Statement</font>.&nbsp;&nbsp;At least five (5) Business Days prior to the Closing, the Seller shall deliver to the Purchaser a statement (the &#8220;<font style="text-decoration:underline;">Pre-Closing Working Capital Statement</font>&#8221;) setting forth in reasonable detail the Seller&#8217;s good faith calculation of the estimated Net Working Capital Adjustment (including all components thereof) and the Purchase Price (&#8220;<font style="text-decoration:underline;">Estimated Purchase Price</font>&#8221;), accompanied by reasonably detailed backup documentation for such calculations and any additional information reasonably requested by the Purchaser.&nbsp;&nbsp;The Seller shall prepare the Pre-Closing Working Capital Statement using the same accounting principles, practices, procedures, policies and methods, with consistent classifications, judgments, inclusions, exclusions and valuation and estimation methodologies that were employed in the preparation of the Sample Pre-Closing Working Capital Statement attached hereto as <font style="text-decoration:underline;">Exhibit&#160;3.4</font> and otherwise in accordance with U.S. GAAP (the &#8220;<font style="text-decoration:underline;">Accounting Methodology</font>&#8221;), which calculates the Purchase Price as if each of its component parts were determined as of July 31, 2020.&nbsp;&nbsp;At least ten (10) Business Days prior to the Closing, the Seller shall deliver to the Purchaser a preliminary Pre-Closing Working Capital Statement, and the Seller shall take into consideration any good faith comments of the Purchaser thereto.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">18</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p><a name="_AEIOULastRenderedPageBreakAEIOU1"></a>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref18843553"></a><a name="_Ref438033051"></a>3.4.2<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Post-Closing Working Capital Statement</font>.&nbsp;&nbsp;As promptly as practicable, but in no event later than the sixtieth (60<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup>) day after the Closing Date, the Purchaser shall prepare and deliver, or cause to be prepared and delivered, to the Seller a statement (the &#8220;<font style="text-decoration:underline;">Post-Closing Working Capital Statement</font>&#8221;) setting forth in reasonable detail the Purchaser&#8217;s good faith calculation of the Net Working Capital Adjustment (including all components thereof), accompanied by reasonably detailed backup documentation for such calculations and any additional information reasonably requested by the Seller.&nbsp;&nbsp;The Purchaser shall prepare the Post-Closing Working Capital Statement using the Accounting Methodology.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref438033086"></a><a name="_Ref438033144"></a>3.4.3<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Review of Post-Closing Working Capital Statement</font>.&nbsp;&nbsp;The Seller shall have sixty (60) days following its receipt of the Post-Closing Working Capital Statement (the &#8220;<font style="text-decoration:underline;">Review Period</font>&#8221;) to review the Post-Closing Working Capital Statement.&nbsp;&nbsp;During the Review Period, the Purchaser will use commercially reasonable efforts to make available to the Seller, to the extent reasonably requested by the Seller, the Purchaser&#8217;s books, records, work papers, personnel and such other information as the Seller may require in order to evaluate the Post-Closing Working Capital Statement and the calculations set forth therein.&nbsp;&nbsp;On or before the expiration of the Review Period, the Seller shall deliver to the Purchaser a written statement accepting or disputing, in whole or in part, the Post-Closing Working Capital Statement.&nbsp;&nbsp;If the Seller disputes the Post-Closing Working Capital Statement, such statement shall include a detailed itemization of the Seller&#8217;s objections and the reasons therefor (such statement, a &#8220;<font style="text-decoration:underline;">Dispute Statement</font><a name="_Ref438033144"></a>&#8221;).&nbsp;&nbsp;Any component of the Post-Closing Working Capital Statement that is not disputed in a Dispute Statement shall be final and binding upon the Parties to this Agreement and the Indemnified Parties, and not subject to appeal.&nbsp;&nbsp;If the Seller does not deliver a Dispute Statement to the Purchaser within the Review Period or delivers a statement accepting the Post-Closing Working Capital Statement, the Post-Closing Working Capital Statement shall be final and binding upon the Parties to this Agreement and the Indemnified Parties, and not subject to appeal.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref55481601"></a><a name="DocXTextRef24"></a><a name="DocXTextRef20"></a><a name="DocXTextRef21"></a><a name="DocXTextRef22"></a><a name="DocXTextRef23"></a>3.4.4<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Dispute Resolution</font>.&nbsp;&nbsp;If the Seller delivers a Dispute Statement or an EBITDAS Dispute Statement (as defined below) during the Review Period, the Purchaser and the Seller shall meet and attempt in good faith to resolve their differences with respect to the disputed items set forth in the Dispute Statement or the EBITDAS Dispute Statement during the thirty (30) calendar days immediately following the Purchaser&#8217;s receipt of the Dispute Statement or the EBITDAS Dispute Statement, or such longer period as the Purchaser and the Seller may mutually agree (the &#8220;<font style="text-decoration:underline;">Resolution Period</font>&#8221;).&nbsp;&nbsp;Any such disputed items that are resolved by the Purchaser and the Seller during the Resolution Period shall be set forth in a memorandum signed by both Parties, which shall be final and binding upon the Parties to this Agreement, and the Indemnified Parties and not subject to appeal.&nbsp;&nbsp;If the Purchaser and the Seller do not resolve all such disputed items by the end of the Resolution Period, the Purchaser and the Seller shall submit all items remaining in dispute with respect to the Dispute Statement or the EBITDAS Dispute Statement to any nationally recognized independent accounting firm upon which the Purchaser and the Seller shall reasonably agree (the &#8220;<font style="text-decoration:underline;">Accounting Firm</font>&#8221;) for review and resolution.&nbsp;&nbsp;The Accounting Firm shall act as an expert and not an arbitrator.&nbsp;&nbsp;The Accounting Firm shall make all calculations in accordance with the practices used in preparation of the Sample Pre-Closing Working Capital Statement, shall determine only those items remaining in dispute between the Purchaser and the Seller and shall only be permitted or authorized to determine an amount with respect to any such disputed item that is either the amount of such disputed item as proposed by the Purchaser in the Post-Closing Working Capital Statement or the amount of such disputed item as proposed by the Seller in the Dispute Statement or the EBITDAS Dispute Statement or an amount between the </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">19</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="DocXTextRef24"></a>two amounts.&nbsp;&nbsp;Each of the Purchaser and the Seller shall </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="DocXTextRef20"></a>&#160;enter into a customary engagement letter with the Accounting Firm at the time such dispute is submitted to the Accounting Firm and otherwise cooperate with the Accounting Firm, (ii)&#160;have the opportunity to submit a written statement in support of their respective positions with respect to such disputed items, to provide supporting material to the Accounting Firm in defense of their respective positions with respect to such disputed items and to submit a written statement responding to the other Party&#8217;s position with respect to such disputed items, and (iii)&#160;subject to customary confidentiality and indemnity agreements, provide the Accounting Firm with access to their respective books, records, personnel and Representatives and such other information as the Accounting Firm may require in order to render its determination.&nbsp;&nbsp;The Accounting Firm shall be instructed to deliver to the Purchaser and the Seller a written determination (such determination to include a worksheet setting forth all material calculations used in arriving at such determination and to be based solely on information provided to the Accounting Firm by the Purchaser and the Seller) of the disputed items within thirty (30) calendar days of receipt of the disputed items, which determination shall be final and binding upon the Parties to this Agreement and not subject to appeal.&nbsp;&nbsp;The costs and expenses of the Accounting Firm shall be allocated between the Purchaser, on the one hand, and the Seller, on the other hand, based upon the percentage that the portion of the contested amount not awarded to each Party bears to the amount actually contested by such Party.&nbsp;&nbsp;For example, if the Seller claims the Purchase Price is $1,000 greater than the amount determined by the Purchaser, and the Purchaser contests only $500 of the amount claimed by the Seller, and if the Accounting Firm ultimately resolves the dispute by awarding the Purchaser $300 of the $500 contested, then the costs and expenses of the Accounting Firm shall be allocated forty percent (40%) (i.e., </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="DocXTextRef21"></a> &#247; </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">500</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="DocXTextRef22"></a>) to the Purchaser and sixty percent (60%) (i.e., </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="DocXTextRef23"></a> &#247; </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">500</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) to the Seller.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref18843554"></a><a name="_Ref534684426"></a><a name="_Ref438148865"></a>3.4.5<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Post-Closing Payments</font>.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref18843555"></a>3.4.5.1<font style="margin-left:36pt;"></font>For purposes of this Agreement, &#8220;<font style="text-decoration:underline;">Final Purchase Price</font>&#8221; means the Purchase Price and each of its components as finally determined pursuant to this <font style="text-decoration:underline;">Section 3.4</font>.&nbsp;&nbsp;For clarity, this <font style="text-decoration:underline;">Section 3.4.5</font> shall apply to the Net Working Capital Adjustment as determined pursuant to <font style="text-decoration:underline;">Section 3.4</font>, but shall not apply to the 2020 EBITDAS Milestone described in <font style="text-decoration:underline;">Section 3.5</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref534683696"></a>3.4.5.2<font style="margin-left:36pt;"></font>If the Final Purchase Price is less than the Estimated Purchase Price (the amount of such deficit, the &#8220;<font style="text-decoration:underline;">Adjustment Shortfall</font>&#8221;), then the Purchaser and the Seller shall promptly, and in any event within fifteen (15) Business Days after such final determination, pay or cause to be paid to the Purchaser the Adjustment Shortfall. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref534683702"></a>3.4.5.3<font style="margin-left:36pt;"></font>If the Final Purchase Price is greater than the Estimated Purchase Price (the amount of such surplus, the &#8220;<font style="text-decoration:underline;">Adjustment Surplus</font>&#8221;), then, promptly, and in any event within fifteen (15) Business Days after such final determination, Purchaser shall pay or cause to be paid to the Seller the Adjustment Surplus.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref18843556"></a>3.4.5.4<font style="margin-left:36pt;"></font>Notwithstanding anything in this <font style="text-decoration:underline;">Section&#160;3.4</font> to the contrary, but subject to this <font style="text-decoration:underline;">Subsection 3.4.5.4</font>, if the amount of the Adjustment Shortfall or the Adjustment Surplus, as applicable, is less than ($<font style="color:#000000;">***)</font>, Purchaser and the Seller shall have no obligation to take any further actions, and neither Purchaser nor the Seller shall have any liability to the other, and no amounts shall be payable to Purchaser or Seller pursuant to or arising out of this <font style="text-decoration:underline;">Section&#160;3.4</font>.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">20</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref18843559"></a>3.4.6<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Tax Treatment</font>.&nbsp;&nbsp;Any payment made under this <font style="text-decoration:underline;">Section&#160;3.4</font>, to the maximum extent permitted by applicable Law, shall be treated for all Tax purposes as an adjustment to the Purchase Price.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc57819119"></a><font style="text-decoration:none;">3.5</font><font style="text-decoration:none;margin-left:36pt;"></font><font style="text-decoration:underline;">2020 EBITDAS Milestone</font><font style="text-decoration:none;">.&nbsp;&nbsp;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.5.1<font style="margin-left:36pt;"></font>On or before February 26, 2021, Seller shall deliver to Purchaser a statement (the &#8220;<font style="text-decoration:underline;">Seller EBITDAS Statement</font>&#8221;) setting forth Seller&#8217;s good faith calculations of the earnings of the Acquired Product Line for the fiscal year ending December 31, 2020, as calculated in accordance with the methodology set out in <font style="text-decoration:underline;">Schedule 1.1.17</font> and otherwise in accordance with U.S. GAAP (the &#8220;<font style="text-decoration:underline;">Acquired Product Line 2020 EBITDAS</font>&#8221;).&nbsp;&nbsp;Seller shall accompany the Seller EBITDAS Statement with reasonably detailed backup documentation for such calculations, including such information related thereto as reasonably requested by Purchaser. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.5.2<font style="margin-left:36pt;"></font>Within sixty (60) days following receipt of the Seller EBITDAS Statement, Purchaser shall notify Seller whether or not Purchaser agrees with the Seller EBITDAS Statement.&nbsp;&nbsp;If Purchaser disagrees, Purchaser shall either provide Seller with a summary setting out the areas of disagreement or notify Seller that Purchaser is electing&nbsp;&nbsp;to engage a mutually agreed upon (with each Party acting reasonably) third party auditor of a nationally recognized accounting firm to review Seller&#8217;s books, records, work papers, personnel and such other information as such auditor may require in order for such auditor to evaluate the Seller EBITDAS Statement and the calculation of the 2020 Acquired Product Line EBITDAS set forth therein.&nbsp;&nbsp;In the event Purchaser elects to engage such a third party auditor to review the aforementioned, Purchaser may elect to extend such review period by thirty (30) days.&nbsp;&nbsp;The results of such audit will be shared with Purchaser and Seller. If the Purchaser notifies Seller that Purchaser agrees with the Seller EBITDAS Statement or the auditor finds no discrepancy, the Seller EBITDAS Statement shall be final and binding upon the Parties to this Agreement and the Indemnified Parties, and not subject to appeal.&nbsp;&nbsp;If the auditor determines that the Seller EBITDAS Statement is incorrect or Purchaser notifies Seller that it disagrees with the Seller EBITDAS Statement but elects not to engage an auditor (or the Parties are unable to agree on an auditor), the Parties will attempt to resolve the discrepancy in good faith. Any component of the Seller EBITDAS Statement that is found to be correct or incorrect by the auditor shall be final and binding upon the Parties to this Agreement and the Indemnified Parties, and not subject to appeal.&nbsp;&nbsp;If an auditor is not engaged and the Parties are unable to resolve any discrepancy, such discrepancy shall be described by Purchaser in a written statement delivered to the Seller setting forth a detailed itemization of the Purchaser&#8217;s objections and the reasons therefor (such statement, an &#8220;<font style="text-decoration:underline;">EBITDAS Dispute Statement</font>&#8221;) and resolved in accordance with <font style="text-decoration:underline;">Section 3.4.4</font>.&nbsp;&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;"><a name="_Toc69532401"></a><a name="_Toc155614585"></a><a name="_Toc155699699"></a><a name="_Toc224619064"></a><a name="_Toc12185245"></a><a name="_Ref47717077"></a><a name="_Ref47717330"></a><a name="_Toc49528520"></a><a name="_Toc47693189"></a><a name="_Toc57819120"></a>ARTICLE IV<font style="font-family:Times New Roman Bold;"><br /><a name="_Toc69532401"></a><a name="_Toc155614585"></a><a name="_Toc155699699"></a><a name="_Toc224619064"></a><a name="_Toc12185245"></a><a name="_Ref47717077"></a><a name="_Ref47717330"></a><a name="_Toc49528520"></a><a name="_Toc47693189"></a><a name="_Toc57819120"></a>REPRESENTATIONS AND WARRANTIES OF THE SELLER</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to such exceptions as are disclosed in the disclosure schedule dated as of the Agreement Date and delivered herewith by the Seller to Purchaser (the &#8220;<font style="text-decoration:underline;">Disclosure Schedule</font>&#8221;) corresponding to the applicable section, subsection or clause of this <font style="text-decoration:underline;">Article IV</font> (or disclosed in any other section, subsection or clause of the Disclosure Schedule if it is reasonably apparent that such disclosure is responsive to such other section, subsection or clause of this <font style="text-decoration:underline;">Article IV</font>), the Seller hereby represents and warrants to the Purchaser as follows as of the date of this Agreement:</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">21</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185246"></a><a name="_Ref49381257"></a><a name="_Toc49528521"></a><a name="_Toc47693190"></a><a name="_Toc57819121"></a><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.1</font><font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Organization</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;The Seller is a corporation duly formed, validly existing and in good standing under </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the laws of the State of Delaware.</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;The Seller has all requisite power and authority to carry on its business as now being conducted.&nbsp;&nbsp;The Seller is duly qualified or registered as a foreign corporation to transact business under the Laws of each jurisdiction where the character of its activities or the location of the properties owned or leased by it requires such qualification or registration.</font><font style="letter-spacing:0pt;"><sup style="font-size:85%;line-height:120%;vertical-align:top"> </sup></font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Seller does not have any Affiliates.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185247"></a><a name="_Ref47716348"></a><a name="_Toc49528522"></a><a name="_Toc47693191"></a><a name="_Toc57819122"></a>4.2<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Authorization</font>.&nbsp;&nbsp;The Seller has full power and authority to execute and deliver this Agreement and the Related Agreements and to perform its obligations under this Agreement and the Related Agreements and to consummate the transactions contemplated hereby and thereby.&nbsp;&nbsp;The execution and delivery of this Agreement and the Related Agreements by the Seller and the performance by the Seller of its obligations hereunder and thereunder and the consummation of the transactions provided for herein and therein have been duly and validly authorized by all necessary board action on the part of the Seller, and no other corporate action on the part of the Seller is necessary to authorize this Agreement and the Related Agreements or to consummate the transactions provided for herein and therein.&nbsp;&nbsp;This Agreement has been, and the Related Agreements shall be as of the Closing Date, duly executed and delivered by the Seller and do or shall, as the case may be, constitute the valid and binding agreements of the Seller, enforceable against the Seller in accordance with their respective terms, subject to applicable bankruptcy, insolvency and other similar Laws affecting the enforceability of creditors&#8217; rights generally, general equitable principles and the discretion of courts in granting equitable remedies.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185248"></a><a name="_Ref47716362"></a><a name="_Toc49528523"></a><a name="_Toc47693192"></a><a name="_Toc57819123"></a>4.3<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Absence of Restrictions and Conflicts</font>.&nbsp;&nbsp;The execution, delivery and performance of this Agreement and the Related Agreements, the consummation of the transactions contemplated hereby and thereby and the fulfillment of and compliance with the terms and conditions hereof and thereof do not or shall not (as the case may be), with the passing of time or the giving of notice or both, violate or conflict with, constitute a breach of or default under, result in the loss of any benefit under, permit the acceleration of any obligation under or create in any party the right to terminate, modify or cancel, (a)&#160;any term or provision of the charter documents of the Seller, (b)&#160;any Acquired Contract (except as indicated with an asterisk on <font style="text-decoration:underline;">Schedule 1.1.8</font> (Acquired Contracts)) or (c)&#160;any Law or arbitration award applicable to the Acquired Product Line or the Seller.&nbsp;&nbsp;No consent, approval, order or authorization of, or registration, declaration or filing with, any Governmental Entity is required with respect to the Seller in connection with the execution, delivery or performance of this Agreement or the Related Agreements or the consummation of the transactions contemplated hereby or thereby.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185249"></a><a name="_Ref47715981"></a><a name="_Ref47716378"></a><a name="_Toc49528524"></a><a name="_Toc47693193"></a><a name="_Toc57819124"></a>4.4<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Title to Assets</font>.&nbsp;&nbsp;Except as set forth on <font style="text-decoration:underline;">Schedule&#160;4.4</font>, the Seller has, and shall convey to the Purchaser at the Closing, good and marketable title to the Acquired Assets, free and clear of all Encumbrances other than Permitted Encumbrances. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185250"></a><a name="_Ref12218491"></a><a name="_Toc49528525"></a><a name="_Toc47693194"></a><a name="_Toc57819125"></a>4.5<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Sufficiency of Assets</font>.&nbsp;&nbsp;Other than the Equipment listed on Part 1 of <font style="text-decoration:underline;">Schedule 1.1.11</font>, selling, general and administration activities that have been performed by employees of the Seller not ordinarily working from the Facility, services to be provided by the Seller under the Transition Services Agreement, commercially available materials which are purchased by Seller as a catalogue item from Third&nbsp;&nbsp;Parties on an as-needed basis and off-the-shelf software and insurance, the Acquired Assets (a) are sufficient for the continued conduct of the Acquired Product Line substantially in the manner as it was conducted prior to Closing, (b) include all </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">22</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">rights, assets and property Controlled or purported to be Controlled by the Seller with respect directly to the Acquired Product Line and (c) to the Knowledge of the Seller, are in good operating condition and repair in all material respects&nbsp;&nbsp;and none of such Acquired Assets are in need of material maintenance or repairs except for ordinary, routine maintenance and repairs that are not material in nature or cost.&nbsp;&nbsp;All of the Acquired Assets and Acquired Inventory consists of a quality and quantity usable in the Ordinary Course.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc46941191"></a><a name="_Toc46941192"></a><a name="_Toc12185252"></a><a name="_Ref47716001"></a><a name="_Toc49528526"></a><a name="_Toc47693195"></a><a name="_Toc57819126"></a>4.6<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Absence of Certain Changes</font>.&nbsp;&nbsp;Since June 30, 2020, except for impacts of the COVID-19 pandemic, and except as set forth on <font style="text-decoration:underline;">Schedule&#160;4.6</font> there has not been (a)&#160;any Material Adverse Effect or (b)&#160;any damage, destruction, loss or casualty to property or assets of the Seller (including the Acquired Assets) with a value in excess of (<font style="font-weight:bold;">$</font>***), whether or not covered by insurance.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185254"></a><a name="_Ref49381384"></a><a name="_Toc49528527"></a><a name="_Toc47693196"></a><a name="_Toc57819127"></a>4.7<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Compliance with Law</font><font style="text-decoration:underline;color:#000000;">; Authorizations</font><font style="color:#000000;">.&nbsp;&nbsp;T</font>he Seller (a)&nbsp;&nbsp;has not been charged with, and the Seller has not received any written notice that it is under investigation with respect to, and, to the Knowledge of the Seller, the Seller is not otherwise now under investigation with respect to, any violation of any applicable Law or other requirement of a Governmental Entity relating to the Acquired Product Line or Acquired Assets, and (b) is not a party to, or bound by, any order, judgment, decree, injunction, rule or award of any Governmental Entity or arbitrator relating to the Acquired Product Line or Acquired Assets. Except as set forth on <font style="text-decoration:underline;">Schedule 4.7</font>, there are no Authorizations required by the Seller to conduct the Acquired Product Line or to operate the Acquired Assets substantially in the same manner as it was conducted in the twelve-month period prior to Closing except for those that are standard in the industry for businesses of the nature of the Acquired Product Line.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185255"></a><a name="_Ref47716057"></a><a name="_Toc49528528"></a><a name="_Toc47693197"></a><a name="_Toc57819128"></a>4.8<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Acquired Contracts</font>4.8.1<font style="margin-left:36pt;"></font>.&nbsp;&nbsp;<font style="text-decoration:underline;">Schedule 1.1.8</font> (Acquired Contracts) contains a true, correct and complete list of all material Contracts pursuant to which the Seller enjoys any right or benefit or undertakes any obligation related to the Acquired Assets or the Acquired Product Line, other than (a) licenses granted to the Seller for off-the-shelf software, (b) employment agreements and<font style="font-weight:bold;"> </font>invention assignment agreements with employees, (c) agreements with consultants and contractors that assign or grant to the Seller ownership of inventions developed in the course of providing services to the Seller by such consultants and contractors, except to the extent such invention assignment agreements relate to activities under any Acquired Contract. True, correct and accurate copies of all Acquired Contracts (including, for greater certainty, all amendments or modifications thereto) have been made available to the Purchaser and (d) the Real Property Lease.&nbsp;&nbsp;The Acquired Contracts are legal, valid, binding and enforceable in accordance with their respective terms with respect to the Seller and each other party to such Acquired Contracts, subject to applicable bankruptcy, insolvency and other similar Laws affecting the enforceability of creditors&#8217; rights generally, general equitable principles and the discretion of courts in granting equitable remedies. Except as set forth in <font style="text-decoration:underline;">Schedule&#160;4.8</font>, there exists no default or event of default or event, occurrence, condition or act, with respect to the Seller, or to the Knowledge of the Seller, with respect to the other contracting party, which, with the giving of notice, the lapse of the time or the happening of any other event or conditions, would become a default or event of default under any Acquired Contract that would allow such Contract to be terminated or otherwise have, or be expected to have, a Material Adverse Effect thereon. The Seller has not received written or, to the Knowledge of the Seller, oral notice of, and has no Knowledge of any intent to effect, the cancellation, modification or termination of any Acquired </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">23</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contract. Only those Acquired Contracts identified with an asterisk on </font><font style="text-decoration:underline;">Schedule 1.1.8</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (Acquired Contracts) require the consent of or notice to the other party thereto to avoid any breach, default or violation of such Contract in connection with the transactions contemplated hereby, including the assignment of such Acquired Contract to the Purchaser or its Affiliates. Subject to receipt on or prior to the Closing Date of any such consent disclosed on </font><font style="text-decoration:underline;">Schedule 1.1.8</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (Acquired Contracts), the</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> consummation of the transactions contemplated by this Agreement will not result in a material breach of any </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired Contract</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc46941196"></a><a name="_Toc46941197"></a><a name="_Toc46941198"></a><a name="_Toc46941199"></a><a name="_Toc12185260"></a><a name="_Toc49528529"></a><a name="_Toc47693198"></a><a name="_Toc57819129"></a>4.9<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Accounts Receivable</font>.&nbsp;&nbsp;All Acquired Accounts Receivable are (a) shown on the Acquired Books and Records; (b) actual and bona fide receivables resulting from the Ordinary Course related to the Acquired Product Line; (c) subject to customary trade terms; and (d) collectible without set-off or counterclaim. Any reserves provided for such Acquired Accounts Receivable in the Acquired Books and Records have been computed in accordance with U.S. generally accepted accounting principles applied on a consistent basis.&nbsp;&nbsp;The Financial Information provided by Seller is, in all material respects, true and complete, consistent with past practice, and fairly present the financial condition of the Acquired Product Line for the periods covered.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc49528530"></a><a name="_Toc47693199"></a><a name="_Toc57819130"></a>4.10<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Acquired Inventory</font>.&nbsp;&nbsp;The <font style="color:#auto;">Acquired Inventory is</font> being maintained at levels appropriate for the continuation of the Acquired Product Line in the Ordinary Course.&nbsp;&nbsp;<font style="text-decoration:underline;">Schedule 1.1.13</font> (Acquired Inventory) accurately sets out for all Acquired Inventory as of the date specified therein the product name, lot number, manufacturing date, manufacturer, and approximate amount remaining. To the Seller&#8217;s Knowledge, the Acquired Inventory was manufactured and has at all times been transported and stored in accordance with all applicable requirements of any Governmental Entity and applicable Laws.&nbsp;&nbsp;At least <font style="color:#000000;">***</font> percent (<font style="color:#000000;">***</font>%) of the Acquired Inventory has <font style="color:#000000;">*** </font>percent (<font style="color:#000000;">***</font>%) shelf life remaining and is less than <font style="color:#000000;">***</font>years old, both as measured on the Closing Date.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref49381269"></a><a name="_Toc49528531"></a><a name="_Toc57819131"></a>4.11<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Intellectual Property</font>. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.11.1<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Schedule 1.1.9</font> (Acquired Copyrights) lists all Acquired Copyrights that are registered, and <font style="text-decoration:underline;">Schedule 1.1.18</font> (Acquired Trademarks) lists all Acquired Trademarks that are registered.&nbsp;&nbsp;The Seller does not own, and has not applied for, any pending or issued patent that includes a Polymer Patent Claim.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.11.2<font style="margin-left:36pt;"></font>Except as set forth in <font style="text-decoration:underline;">Schedule 4.11.2</font>, the Seller has a valid, legally enforceable, and exclusive right to use and license each item of Acquired Intellectual Property free and clear of any Encumbrance and the Acquired Intellectual Property constitutes all Intellectual Property that is used by the Seller in or, to the extent material, necessary for the conduct of the Acquired Product Line by the Seller as currently conducted except for any commercially available off-the-shelf software.&nbsp;&nbsp;The Seller is not bound by, and no Acquired Intellectual Property is subject to, any Contract or order that in any way limits or restricts the ability of the Seller or the Purchaser to use, exploit, transfer, license, assert, or enforce the Acquired Intellectual Property without payment (other than legal fees and related costs incurred in asserting or enforcing any right in Acquired Intellectual Property), or that affects or may affect the validity, transferability, enforceability, or the Seller&#8217;s ownership of any Acquired Intellectual Property, other than the non-exclusive licenses or rights granted as of the date of this Agreement under the Acquired Customer Contracts. The Seller has not assigned or otherwise transferred </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">24</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ownership of, or agreed to assign or otherwise transfer ownership of, any Acquired Intellectual Property to any Person and, except as provided in the licenses or rights granted as of the date of this Agreement under the Acquired Customer Contracts, the Seller has not exclusively licensed, or agreed to exclusively license rights to, any Acquired Intellectual Property to any Person.&nbsp;&nbsp;The representations and warranties made in this </font><font style="text-decoration:underline;">Section 4.11.2</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall not be construed to expand the representations and warranties made by the Seller in </font><font style="text-decoration:underline;">Section 4.11.4</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.11.3<font style="margin-left:36pt;"></font>Except as expressly set forth in <font style="text-decoration:underline;">Schedule&#160;4.11.3</font>:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.11.3.1<font style="margin-left:36pt;"></font>All current and former directors, officers, employees, consultants and contractors of the Seller who are or were involved in, or who have contributed to, the creation or development of any Acquired Intellectual Property have executed and delivered to the Seller a written agreement regarding the protection of proprietary information and the irrevocable assignment to the Seller of any Intellectual Property Rights in the Acquired Intellectual Property arising from services performed by such Persons. To the Knowledge of the Seller, no current or former directors, officers, employee, consultant or contractor is in violation of any term of any such agreement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.11.3.2<font style="margin-left:36pt;"></font>The Seller has not received any written communication from any Person challenging or threatening to challenge, nor is the Seller a party to any pending and served Proceeding or pending but not served Proceeding or, to the Knowledge of the Seller, threatened Proceeding in which any Person is challenging, the Seller&#8217;s ownership of, and right to use and license, any Acquired Intellectual Property. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.11.3.3<font style="margin-left:36pt;"></font>The Seller's development, manufacture and sale of the polymers included in the Acquired Product Line, as conducted by the Seller at any time prior to the Closing Date and, to the Knowledge of the Seller, the sale of such polymers by the Seller's customers, has not infringed, and does not infringe (in either case directly, contributorily, by inducement, or otherwise), misappropriate, or otherwise violate any Intellectual Property Right of the Seller (other than any Acquired Intellectual Property being transferred to Purchaser on Closing) or any other Person.&nbsp;&nbsp;Without limiting the generality of the foregoing:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.11.3.4<font style="margin-left:36pt;"></font>No claim or Proceeding with respect to the infringement, misappropriation, or violation of the Intellectual Property Rights of any other Person is pending or, to the Knowledge of the Seller, threatened against the Seller with respect to the development, manufacture and sale of the polymers included in the Acquired Product Line nor alleging that the Acquired Intellectual Property is being licensed by the Seller in conflict with the terms of any Contract or otherwise in violation of any Laws. Seller has not received any written notice or other communication in writing with respect to any actual, alleged, or suspected infringement, misappropriation, or violation of the Intellectual Property Rights of any other Person by the Seller in respect of such polymers or activities, nor any letter or other written communication suggesting or offering that the Seller obtain a license to any Intellectual Property Right of another Person for the conduct of such activities or the development, manufacture or sale of such polymers).</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.11.3.5<font style="margin-left:36pt;"></font>No claim or Proceeding involving any Acquired Intellectual Property is pending or, to the Knowledge of the Seller, has been threatened, except for any such claim or Proceeding that, if adversely determined, would not materially adversely affect the conduct of the Acquired Product Line.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">25</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.11.4</font><font style="margin-left:36pt;"></font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the Knowledge of the Seller, no Person is misappropriating any Acquired Intellectual Property. The Seller has the sole and exclusive right to bring actions for misappropriation, dilution, violation or unauthorized use of the Acquired Intellectual Property without any obligation to obtain consent, joinder or to provide an accounting to any other Person.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.11.5<font style="margin-left:36pt;"></font>The Seller has taken reasonable steps to protect the rights of the Seller related to right of ownership to Acquired Intellectual Property and the Seller&#8217;s Confidential Information, in each case consistent with commercially reasonable standards. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.11.6<font style="margin-left:36pt;"></font>Seller is not subject to any outstanding order, judgment, preliminary or permanent injunction, temporary restraining order, award, citation, decree, consent decree or writ or stipulation restricting in any manner the use, transfer or licensing of the Acquired Intellectual Property by the Seller.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.11.7<font style="margin-left:36pt;"></font>No claim of indemnification has been made against the Seller, and there is no basis for any claim of indemnification against the Seller, by a licensee or customer of the Seller pursuant to any Acquired Customer Contract.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.11.8<font style="margin-left:36pt;"></font>No funding, facilities or personnel of any Governmental Entity were used, directly or indirectly, to develop or create, in whole or in part, any Acquired Intellectual Property owned by the Seller, except to the extent no rights to the Acquired Intellectual Property have been granted in connection therewith.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref49381412"></a><a name="_Toc49528532"></a><a name="_Toc57819132"></a>4.12<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Real Estate</font>(a)<font style="margin-left:36pt;"></font>. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref7778681"></a><a name="_Ref_ContractCompanion_9kb9Ur05C"></a><a name="_Ref_ContractCompanion_9kb9Ur276"></a><a name="_Ref_ContractCompanion_9kb9Ur278"></a>4.12.1<font style="margin-left:36pt;"></font>The Facility is the only<font style="text-decoration:underline;"> </font>real property currently used by the Seller primarily for the operation of the Acquired Product Line (the &#8220;<font style="text-decoration:underline;">Real Property</font>&#8221;).&nbsp;&nbsp;<font style="text-decoration:underline;">Schedule 4.12.1</font> identifies each lease, sublease, license or other occupancy agreement pursuant to which the Seller occupies or uses such Real Property, including the date of and legal name of each of the parties to such lease, sublease, license or other occupancy agreement (each, a &#8220;<font style="text-decoration:underline;">Real Property Lease</font>&#8221;). The Seller has not subleased, assigned or otherwise granted to any Person the right to use or occupy any of the Real Property or any portion thereof. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.12.2<font style="margin-left:36pt;"></font>The Seller has a valid leasehold interest in the Real Property free and clear of all Encumbrances.&nbsp;&nbsp;The Seller has delivered or made available to the Purchaser accurate and complete copies of the Real Property Lease, as amended or otherwise modified and in effect, together with extension notices and other material correspondence or documents related thereto.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.12.3<font style="margin-left:36pt;"></font>To the Seller&#8217;s Knowledge, the current use of the Real Property by the Seller is, in all material respects, in accordance with the certificates of occupancy relating thereto and the terms of any permits relating thereto. To the Seller&#8217;s Knowledge, no condemnation Proceeding is pending or threatened that would preclude or materially impair the continued use of the Real Property as it is currently used. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.12.4<font style="margin-left:36pt;"></font>To the Knowledge of the Seller, all facilities located on the Real Property Lease have received all material governmental approvals required in connection with the operation thereof and have been operated and maintained in all material respects in accordance with all applicable Laws. To the Knowledge of the Seller, all buildings, fixtures and improvements on the Real Property Lease&nbsp;&nbsp;are in good operating condition and repair, subject to normal wear and tear, and are adequate for the uses to which they are being put. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">26</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref49419663"></a><a name="_Toc49528533"></a><a name="_Toc57819133"></a><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.13</font><font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Environmental Matters</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Seller is, and for the past three (3) years has been, in compliance in all material respects with all Environmental Laws at the Facility. There has been no release or, to the Seller&#8217;s Knowledge, threatened release by the Seller at the Facility of any pollutant, petroleum or any fraction thereof, contaminant or toxic or hazardous material (including toxic mold), substance or waste (each, a &#8220;</font><font style="text-decoration:underline;">Hazardous Substance</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) on, upon, into or from any of the Real Property that would reasonably be expected to result in any material Liability.&nbsp;&nbsp;Neither the Seller, nor, to the Seller&#8217;s Knowledge, any other Person has caused or taken any action that could reasonably be expected to result in any material Liability relating to the presence of Hazardous Substances or violations of Environmental Laws at, on, above, under or about the Real Property.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185253"></a><a name="_Toc14888526"></a><a name="_Toc49528535"></a><a name="_Toc57819134"></a><a name="_Toc12185265"></a><a name="_Ref47716144"></a><a name="_Toc49528536"></a>4.14<font style="margin-left:36pt;"></font><font style="text-decoration:underline;"><a name="_Toc49528536"></a>Legal Proceedings</font>.&nbsp;&nbsp;There is no Proceeding pending or, to the Knowledge of the Seller, threatened against, relating to or involving the Acquired Product Line or the Acquired Assets before any Governmental Entity or arbitrator. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc49528537"></a><a name="_Toc57819135"></a>4.15<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Quality</font>.&nbsp;&nbsp;To the Seller&#8217;s Knowledge, there is no material deficiency with respect to the compliance of the Acquired Product Line with its quality plan or, to the extent the Seller has agreed in writing to comply with such requirements of its customers under the Acquired Customer Contracts, the quality and validation requirements of such customers as they relate to the Acquired Product Line or any products sold to such customers, and to the Knowledge of the Seller there is no material audit or investigation arising from any non-compliance or suspected non-compliance with such quality plan or quality and validation requirements. There are no outstanding or disputed claims by any customers under the Acquired Customer Contracts with respect to any products or services sold or provided by the Seller to such customers which have not been settled prior the date of this Agreement. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185264"></a><a name="_Toc14888537"></a><a name="_Ref49381432"></a><a name="_Toc49528538"></a><a name="_Toc57819136"></a>4.16<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Product Liability and Warranty Claims</font>.&nbsp;&nbsp;There are no outstanding warranty claims with respect to, or in connection with, the products or services manufactured, distributed or sold by the Seller related to any of the polymers included in the Acquired Product Line and there are no pending or, to the Knowledge of the Seller, threatened Proceedings relating to any breach of any of the product warranties, indemnities or performance guarantees given by the Seller to its customers under the Acquired Customer Contracts.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc49528540"></a><a name="_Toc57819137"></a>4.17<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Benefit Plans</font>.&nbsp;&nbsp;Neither the Seller nor any ERISA Affiliate of the Seller has any Liability with respect to, or has at any time within the last six (6) years contributed or had an obligation to contribute to any: (i) &#8220;multiemployer plan,&#8221; as defined in Section 3(37) of ERISA; (ii) pension plan subject to Title IV of ERISA, or subject to the minimum funding standards of Section 302 of ERISA; or (iii) &#8220;multiple employer plan&#8221; as defined in Section 210(a) of ERISA or Section 413(c) of the Code.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc49528541"></a><a name="_Toc57819138"></a><a name="_Ref49385626"></a>4.18<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Employees</font><a name="_Ref49385626"></a>.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref49443198"></a>4.18.1<font style="margin-left:36pt;"></font>Except as set forth in <font style="text-decoration:underline;">Schedule 4.18.1</font>: (i)&#160;there are no collective bargaining agreements which pertain to the Business Employees in their capacity as such; (ii)&#160;there is not, and since January 1, 2017, there has not been, any material labor strike, work stoppage or lockout against the Seller by the Business Employees; (iii) to the Knowledge of the Seller, no material union organizational campaign is in progress with respect to the Business Employees; (iv)&#160;there </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">27</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">are no pending Proceedings against the Seller as it relates to any Business Employees before the Equal Employment Opportunity Commission, Department of Labor or any other federal, state or local agency which deals with unlawful employment practices; (v) the Seller has not received written notice of the intent of any Governmental Entity responsible for the enforcement of labor or employment Laws to conduct any investigation relating to any of the Business Employees and, to the Knowledge of the Seller, no such investigation is in progress; (vi)&#160; all Business Employees have been properly classified as employees rather than independent contractors, and as exempt or nonexempt from overtime and other applicable wage and hour requirements under applicable Law; and (vii) there are no pending or, to the Knowledge of the Seller, threatened claims against the Seller by or in respect of any Business Employee as it relates to employment.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref49385884"></a><a name="_Ref50541137"></a>4.18.2<font style="margin-left:36pt;"></font><a name="_Ref50541137"></a> <font style="text-decoration:underline;">Schedule 4.18.2</font> contains a list of each individual employed by the Seller who primarily works on or about the Facility on the date of this Agreement (each, a &#8220;<font style="text-decoration:underline;">Business Employee</font>&#8221;).&nbsp;&nbsp;<font style="text-decoration:underline;">Schedule 4.18.2</font> sets forth the name, title or job position, FLSA classification status, base salary (or wage) rate and additional compensation (or the terms thereof, if determined pursuant to a scale or formula), if any, and any applicable employment agreement or offer letter agreement (in each case, whether written or unwritten) as in effect as of the Closing Date, with respect to each Business Employee.&nbsp;&nbsp;To the Knowledge of the Seller, no Business Employee is subject to any noncompetition, employment, consulting, or similar agreements with any Person other than the Seller relating to the present business activities of the Seller.&nbsp;&nbsp;All Business Employees are &#8220;employees at will&#8221; and are employed by the Seller.&nbsp;&nbsp;The Seller is in compliance with respect to the Business, in all material respects, with all Laws relating to employment practices, including Laws relating to workers&#8217; safety and health, sexual harassment, discrimination, equal pay, background checks, employee leaves, immigration, wages and hours (including classification of employees) or workers&#8217; compensation.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.18.3<font style="margin-left:36pt;"></font>All compensation and benefits due to the Business Employees on or prior to the date hereof have been paid in the Ordinary Course and, as of the Closing Date, there will be no other monies due to any Business Employees (whether arising out of any formal or informal arrangement).</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref49387094"></a><a name="_Toc49528542"></a><a name="_Toc57819139"></a>4.19<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Related Party Transactions</font>.&nbsp;&nbsp;Except as set forth on <font style="text-decoration:underline;">Schedule 4.19</font> or for those services to be performed by the Seller under the Transition Services Agreement, no officer, director, stockholder or employee of the Seller nor any individual in such officer&#8217;s, director&#8217;s, stockholder&#8217;s or employee&#8217;s immediate family: (a) is a party to any Acquired Contract; (b) has any material interest in any Acquired Asset; or (c) provides any services related to the Acquired Product Line (each, a &#8220;<font style="text-decoration:underline;">Related Party Transaction</font>&#8221;).</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref49414144"></a><a name="_Toc49528543"></a><a name="_Toc57819140"></a><a name="_Toc47693200"></a>4.20<font style="margin-left:36pt;"></font><font style="text-decoration:underline;"><a name="_Toc47693200"></a>Brokers, Finders Brokers, Finders and Investment Bankers</font>.&nbsp;&nbsp;Except as set forth on <font style="text-decoration:underline;">Schedule 4.20</font>, neither the Seller nor any officers, directors or employees of the Seller, nor any Affiliate of the foregoing, has employed any broker, finder or investment banker or incurred any liability for any investment banking fees, financial advisory fees, brokerage fees or finders&#8217; fees in connection with the transactions contemplated by this Agreement.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc57819141"></a>4.21<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Cybersecurity and Data Protection</font>.&nbsp;&nbsp;To the Knowledge of the Seller, the computer and other information technology systems in use as of the date of this Agreement by Seller in respect of the Acquired Product Line have not been the target of a successful attack or compromise on their security or integrity during five (5) years immediately preceding the date hereof. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">28</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;"><a name="_Toc55551778"></a><a name="_Toc69532433"></a><a name="_Toc155614617"></a><a name="_Toc155699731"></a><a name="_Toc224619096"></a><a name="_Toc12185267"></a><a name="_Ref47717357"></a><a name="_Ref47717411"></a><a name="_Toc49528544"></a><a name="_Toc47693201"></a><a name="_Toc57819142"></a><a name="_Toc45558566"></a><a name="_Toc47175113"></a><font style="font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;">ARTICLE V</font><font style="font-family:Times New Roman Bold;"><br /><a name="_Toc69532433"></a><a name="_Toc155614617"></a><a name="_Toc155699731"></a><a name="_Toc224619096"></a><a name="_Toc12185267"></a><a name="_Ref47717357"></a><a name="_Ref47717411"></a><a name="_Toc49528544"></a><a name="_Toc47693201"></a><a name="_Toc57819142"></a></font><font style="font-family:Times New Roman Bold;"><a name="_Toc45558566"></a><a name="_Toc47175113"></a>REPRESENTATIONS AND WARRANTIES OF THE PURCHASER</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Purchaser hereby represents and warrants to the Seller as follows: </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185268"></a><a name="_Toc49528545"></a><a name="_Toc47693202"></a><a name="_Toc57819143"></a>5.1<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Organization</font>.&nbsp;&nbsp;The Purchaser is a corporation duly organized, validly existing and in good standing under the laws of Alabama and has all requisite power and authority to own, lease and operate its properties and to carry on its business as now being conducted. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185269"></a><a name="_Toc49528546"></a><a name="_Toc47693203"></a><a name="_Toc57819144"></a>5.2<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Authorization</font>.&nbsp;&nbsp;The Purchaser has full power and authority to execute and deliver this Agreement and the Related Agreements, to perform its obligations hereunder and thereunder, and to consummate the transactions contemplated hereby and thereby. The execution and delivery of this Agreement and the Related Agreements by the Purchaser, the performance by the Purchaser of its obligations hereunder and thereunder, and the consummation of the transactions provided for hereby and thereby have been duly and validly authorized by all necessary action on the part of the Purchaser, and no other corporate action on the part of the Purchaser is necessary to authorize this Agreement and the Related Agreement or to consummate the transactions provided for herein and therein.&nbsp;&nbsp;This Agreement has been and, as of the Closing Date, the Related Agreements will be, duly executed and delivered by the Purchaser and do or will, as the case may be, constitute the valid and binding agreements of the Purchaser, enforceable against the Purchaser in accordance with their respective terms, subject to applicable bankruptcy insolvency and other similar Laws affecting the enforceability of creditors&#8217; rights generally, general equitable principles and the discretion of courts in granting equitable remedies.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185270"></a><a name="_Toc49528547"></a><a name="_Toc47693204"></a><a name="_Toc57819145"></a><a name="_Toc12185273"></a>5.3<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Absence of Restrictions and Conflicts</font>.&nbsp;&nbsp;The execution, delivery and performance of this Agreement and the Related Agreements, the consummation of the transactions contemplated hereby and thereby and the fulfillment of and compliance with the terms and conditions hereunder and thereunder do not or will not (as the case may be), with the passing of time or the giving of notice or both, violate or conflict with, constitute a breach of or default under, result in the loss of any benefit under, or permit the acceleration of any obligation under, (a)&#160;any term or provision of the charter documents of the Purchaser, (b)&#160;any Contract to which the Purchaser is a party, (c)&#160;any judgment, decree or order of any Governmental Entity to which the Purchaser is a party or by which the Purchaser or any of its properties is bound or (d)&#160;any Law applicable to the Purchaser unless, in each case, such violation, conflict, breach, default, loss of benefit or accelerated obligation would not, either individually or in the aggregate, have a Material Adverse Effect on the ability of the Purchaser to consummate the transactions contemplated hereby or by the Related Agreements<a name="_Toc12185273"></a>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc47693206"></a><a name="_Toc57819146"></a>5.4<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Brokers, Finders and Investment Bankers</font>.&nbsp;&nbsp;Neither the Purchaser nor any officers, directors or employees of the Purchaser, nor any Affiliate of the foregoing, has employed any broker, finder or investment banker or incurred any liability for any investment banking fees, financial advisory fees, brokerage fees or finders&#8217; fees in connection with the transactions contemplated by this Agreement.&nbsp;&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">29</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;"><a name="_Toc69532438"></a><a name="_Toc155614622"></a><a name="_Toc155699736"></a><a name="_Toc224619101"></a><a name="_Toc12185274"></a><a name="_Toc49528548"></a><a name="_Toc47693207"></a><a name="_Toc57819147"></a><a name="_Toc45558570"></a><a name="_Toc47175117"></a><font style="font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;">ARTICLE VI</font><font style="font-family:Times New Roman Bold;"><br /><a name="_Toc69532438"></a><a name="_Toc155614622"></a><a name="_Toc155699736"></a><a name="_Toc224619101"></a><a name="_Toc12185274"></a><a name="_Toc49528548"></a><a name="_Toc47693207"></a><a name="_Toc57819147"></a></font><font style="font-family:Times New Roman Bold;"><a name="_Toc45558570"></a><a name="_Toc47175117"></a>CERTAIN COVENANTS AND AGREEMENTS</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc46941210"></a><a name="_Toc46941211"></a><a name="_Toc46941212"></a><a name="_Toc46941213"></a><a name="_Toc46941214"></a><a name="_Toc46941215"></a><a name="_Toc46941216"></a><a name="_Toc46941217"></a><a name="_Toc46941218"></a><a name="_Toc46941219"></a><a name="_Toc46941220"></a><a name="_Toc46941221"></a><a name="_Toc46941222"></a><a name="_Toc46941223"></a><a name="_Toc46941224"></a><a name="_Toc46941225"></a><a name="_Toc46941226"></a><a name="_Toc46941227"></a><a name="_Toc46941228"></a><a name="_Toc46941229"></a><a name="_Toc46941230"></a><a name="_Toc46941231"></a><a name="_Toc12185275"></a><a name="_Toc14888548"></a><a name="_Toc57819148"></a><a name="_Toc49528549"></a>6.1<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Conduct of Acquired Product Line by the Seller</font>.&nbsp;&nbsp;For the period commencing on the date hereof and ending on the Closing Date, the Seller shall, except as expressly required by this Agreement and except as otherwise consented to in advance in writing by the Purchaser (such consent not to be unreasonably withheld, conditioned or delayed) with respect to the Acquired Product Line: </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.1.1<font style="margin-left:36pt;"></font>conduct the business related to the Acquired Product Line in the Ordinary Course and not enter into any agreement, transaction or activity or make any commitment with respect to the Acquired Product Line or the Acquired Assets except those in the Ordinary Course and not otherwise prohibited under this <font style="text-decoration:underline;">Section&#160;6.1</font>;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.1.2<font style="margin-left:36pt;"></font>maintain its existence and good standing in its jurisdiction of organization and in each jurisdiction in which the ownership or leasing of the Acquired Assets or the conduct of the business related to the Acquired Product Line requires such qualification;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.1.3<font style="margin-left:36pt;"></font>upon any damage, destruction or loss to any Acquired Asset, apply any and all insurance proceeds received with respect thereto to the prompt repair, replacement and restoration thereof to the condition of such Acquired Asset before such event or, if required, to such other (better) condition as may be required by applicable Law;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.1.4<font style="margin-left:36pt;"></font>not dispose of or license (other than licenses that exist under any Acquired Contract) any right to the use of any Acquired Intellectual Property;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.1.5<font style="margin-left:36pt;"></font>not (i) sell any Acquired Asset, other than polymer sold in the Ordinary Course pursuant to an Acquired Contract in effect as of the date of this Agreement, (ii)&#160;create, incur or assume any indebtedness secured by the Acquired Assets, (iii) grant, create, incur or suffer to exist any Encumbrance on the Acquired Assets that did not exist on the date hereof, (iv) incur any liability or obligation (absolute, accrued or contingent) related to the Acquired Product Line or Acquired Assets except in the Ordinary Course, or (v) enter into any Contract, amend, waive, modify or terminate any Contract or cancel, assign any rights of material value, or pay, discharge, release or settle any claim of material value arising under a Contract, in each case to the extent that such Contract is or would constitute an Acquired Asset or otherwise affects the Acquired Product Line;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.1.6<font style="margin-left:36pt;"></font>use commercially reasonable efforts to maintain supplies and inventory at levels that are in the Ordinary Course;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.1.7<font style="margin-left:36pt;"></font>maintain in full force and effect and in the same amounts policies of insurance comparable in amount and scope of coverage to that now maintained by or on behalf of the Seller;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.1.8<font style="margin-left:36pt;"></font>not (i) commence any Proceeding (other than debt collection in the Ordinary Course) or (ii) compromise or settle any Proceeding, in each case relating to the Acquired Product Line or the Acquired Assets; </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">30</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.1.9</font><font style="margin-left:36pt;"></font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">continue to maintain its books and records in </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">accordance with U.S. generally accepted accounting principles </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">applied and on a basis consistent with past practice; and</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.1.10<font style="margin-left:36pt;"></font>not authorize, or commit or agree to take, any of the prohibited actions in the foregoing.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to any restrictions under applicable laws, in connection with the continued operation of the business related to the Acquired Product Line during the period commencing on the date hereof and ending on the Closing Date, the Seller shall confer in good faith on a regular and frequent basis, during reasonable hours and under reasonable circumstances, with the Purchaser regarding operational matters and the general status of ongoing operations of the Seller.&nbsp;&nbsp;The Seller acknowledges that the Purchaser does not and shall not waive any rights it may have under this Agreement as a result of such consultations.&nbsp;&nbsp;The Seller shall not take any action that would, or that could reasonably be expected to, result in any of the representations and warranties of the Seller set forth in this Agreement to become untrue.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185276"></a><a name="_Toc14888549"></a><a name="_Toc49528550"></a><a name="_Ref57634700"></a><a name="_Toc57819149"></a>6.2<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Inspection and Access to Information</font>.&nbsp;&nbsp;During the period commencing on the date hereof and ending on the Closing Date, the Seller will (and will cause its Representatives to) provide the Purchaser and its Representatives reasonable access, during reasonable hours and under reasonable circumstances, to the business related to the Acquired Product Line and Acquired Assets.&nbsp;&nbsp;Notwithstanding the foregoing, the Seller shall not be required to disclose any information if such disclosure will contravene any applicable Law, violate a contractual obligation to any third party existing on the date hereof which cannot be addressed by virtue of suitable confidentiality terms between Seller and Purchaser (if the confidentiality terms set out herein are not already sufficient) or adversely affect the attorney client privilege between the Seller and its counsel.&nbsp;&nbsp;In addition, notwithstanding anything to the contrary herein, any access to any real property shall be subject to the Seller&#8217;s reasonable security measures.&nbsp;&nbsp;All information obtained by Purchaser pursuant to this <font style="text-decoration:underline;">Section 6.2</font> shall be kept confidential in accordance with the terms of <font style="text-decoration:underline;">Section 6.7</font> hereof.&nbsp;&nbsp;No investigation pursuant to this <font style="text-decoration:underline;">Section 6.2</font> shall affect any representation or warranty in this Agreement or the Related Agreements of any party hereto or thereto or any condition to the obligations of the parties hereto or thereto.&nbsp;&nbsp;Any access to the Facility shall be subject to the Seller&#8217;s reasonable security and worker safety measures (including the right to limit the number of Purchaser personnel at the Facility to those personnel reasonably required to fulfill Purchaser&#8217;s objectives for such access) and insurance requirements and the requirements of Seller leases, and shall not include the right to perform any &#8220;invasive&#8221; testing (which, for clarity, shall not preclude the performance by Purchaser of the activities pursuant to <font style="text-decoration:underline;">Section 6.12</font>).</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc49528551"></a><a name="_Toc57819150"></a>6.3<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Notices of Certain Events</font>.&nbsp;&nbsp;The Seller shall promptly notify the Purchaser of:&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:12.5%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.3.1<font style="margin-left:36pt;"></font>The resignation of any Business Employee or termination by the counterparty thereto of any Assumed Contract;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:12.5%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.3.2<font style="margin-left:36pt;"></font>any change or event that, individually or in the aggregate, has had or could reasonably be expected to have a Material Adverse Effect or otherwise result in any representation or warranty of the Seller under this Agreement being inaccurate in any material respect; </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">31</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:12.5%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.3.3</font><font style="margin-left:36pt;"></font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">any notice or other communication from any Person alleging that the consent of such Person is or may be required in connection with the Acquisition;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:12.5%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.3.4<font style="margin-left:36pt;"></font>any notice or other communication from any Governmental Entity in connection with the transactions contemplated by this Agreement; and</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:12.5%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.3.5<font style="margin-left:36pt;"></font>any Proceeding commenced or, to the Knowledge of the Seller, threatened against, relating to or involving or otherwise affecting the Seller, the Acquired Product Line or the Acquired Assets that, if pending on the date of this Agreement, would have been required to have been disclosed pursuant to <font style="text-decoration:underline;">Section 4.14</font> (Legal Proceedings) or that relates to the consummation of the transactions contemplated by this Agreement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Subject to the terms of this Agreement, no such notification will be deemed to prevent or cure any breach of, or otherwise disclose an exception to, or affect in any manner, the representations, warranties, covenants or agreements of the parties (or remedies with respect thereto) or the conditions to the obligations of the parties to this Agreement or the Related Agreements.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc49528552"></a><a name="_Toc12185278"></a><a name="_Toc47693208"></a><a name="_Toc57819151"></a>6.4<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Reasonable Efforts; Further Assurances; Cooperation</font>.&nbsp;&nbsp;Subject to the other provisions of this Agreement, each Party shall use its commercially reasonable efforts to perform its obligations under this Agreement and to take, or cause to be taken, and do, or cause to be done, all things necessary, proper or advisable under applicable Law to obtain all regulatory approvals and to satisfy all conditions to its respective obligations under this Agreement and to cause the transactions contemplated in this Agreement to be effected as soon as practicable, in accordance with the terms of this Agreement and will cooperate fully with each other and their respective officers, directors, managers, employees, agents, counsel, accountants and other designees in connection with any reasonable steps required to be taken as a part of their respective obligations under this Agreement, including:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.4.1<font style="margin-left:36pt;"></font>Each Party shall promptly make its filings and submissions and shall take all actions necessary, proper or advisable under applicable Laws to obtain any required approval of any Governmental Entity with jurisdiction over the transactions contemplated by this Agreement (except that the Purchaser shall have no obligation to take or consent to the taking of any action required by any such Governmental Entity that could adversely affect the Acquired Product Line, the Acquired Assets or the transactions contemplated by this Agreement or the Related Agreements).&nbsp;&nbsp;Each of the Parties will furnish all information required for any application or other filing to be made pursuant to the rules and regulations of any applicable Law in connection with the transactions contemplated by this Agreement;&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.4.2<font style="margin-left:36pt;"></font>In the event any Proceeding by any Governmental Entity or other Person is commenced that questions the validity or legality of the Acquisition or any of the other transactions contemplated by this Agreement or seeks damages in connection therewith, the Parties shall (i) cooperate and use all reasonable efforts to defend against such Proceeding, (ii) in the event an injunction or other order is issued in any Proceeding, use all reasonable efforts to have such injunction or other order lifted and (iii) cooperate reasonably regarding any other impediment to the consummation of the transactions contemplated by this Agreement;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">32</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.4.3</font><font style="margin-left:36pt;"></font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Seller shall give any notices to third parties and each Party shall use its commercially reasonable efforts (in consultation with the other) to obtain any third-party consents (i)&#160;necessary, proper or advisable to consummate the transactions contemplated by this Agreement, (ii) required to be given or obtained, including for the agreements indicated with an asterisk on </font><font style="text-decoration:underline;">Schedule&#160;1.1.8 (Acquired Contracts)</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, (iii) required to avoid a breach of or default under any Acquired Contract in connection with the consummation of the transactions contemplated by this Agreement or (iv) required to prevent a Material Adverse Effect, whether prior to or on the Closing Date; and</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.4.4<font style="margin-left:36pt;"></font>Each Party shall give prompt notice to the other Party of (i)&#160;the occurrence, or failure to occur, of any event that the occurrence or failure of which would be likely to cause any representation or warranty of the Seller or the Purchaser, as the case may be, contained in this Agreement to be materially untrue or inaccurate at any time from the date hereof to the Closing Date or that shall or may result in the failure to satisfy any of the conditions specified in <font style="text-decoration:underline;">Article&#160;VII</font> (Conditions to Closing) of this Agreement and (ii)&#160;any failure of the Seller or the Purchaser, as the case may be, to comply with or satisfy any material covenant, condition or agreement to be complied with or satisfied by any of them under this Agreement.&nbsp;&nbsp;Each Party acknowledges that the Purchaser does not and shall not waive any right it may have under this Agreement as a result of such notifications. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12554069"></a><a name="_Toc12554575"></a><a name="_Toc12554687"></a><a name="_Toc12554799"></a><a name="_Toc12185279"></a><a name="_Toc49528553"></a><a name="_Ref50544178"></a><a name="_Toc47693209"></a><a name="_Toc57819152"></a>6.5<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Public Announcements</font>.&nbsp;&nbsp;The Parties shall each make an&nbsp;&nbsp;initial public announcement of the execution of this Agreement in a form reasonably acceptable to the other Party, which shall be issued on or promptly after the date hereof and in any case within the period necessary for each Party to comply with applicable Law.&nbsp;&nbsp;After the issuance of such press release, if either Party desires to make a public announcement concerning this Agreement, such release shall be (i) subject to the prior written approval of the other Party (which approval shall not be unreasonably withheld, conditioned or delayed) or (ii) limited to the information previously approved by the other Party or included in the initial press release.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185281"></a><a name="_Toc14888554"></a><a name="_Toc49528554"></a><a name="_Toc57819153"></a>6.6<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Transfer Taxes; Expenses</font>.&nbsp;&nbsp;Any transfer, sales, use, stamp, registration or other Taxes or recording fees payable as a result of the Acquisition or any other action contemplated by this Agreement (other than any federal, provincial, local or foreign Taxes measured by or based upon income or gains imposed upon the Seller) (&#8220;<font style="text-decoration:underline;">Transfer Taxes</font>&#8221;) will be paid by the Purchaser.&nbsp;&nbsp;The Parties will cooperate in the preparation, execution and filing of all returns, questionnaires, applications or other documents regarding Transfer Taxes. The Parties shall cooperate, to the extent reasonably requested and permitted by applicable Laws in minimizing any such Transfer Taxes.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc46941234"></a><a name="_Toc46941235"></a><a name="_Toc46941236"></a><a name="_Toc46941237"></a><a name="_Toc12185282"></a><a name="_Ref47715313"></a><a name="_Ref47715488"></a><a name="_Toc49528555"></a><a name="_Toc47693210"></a><a name="_Toc57819154"></a>6.7<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Confidential Information</font>. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref47716287"></a><a name="_Ref14886964"></a><a name="_Ref_ContractCompanion_9kb9Ur049"></a><a name="_Ref_ContractCompanion_9kb9Ur04C"></a>6.7.1<font style="margin-left:36pt;"></font>Each Party (the &#8220;<font style="text-decoration:underline;">Receiving Party</font>&#8221;) shall, and shall cause its Affiliates to, for a period of ten (10) years from the Closing Date, (a)&#160;use reasonable efforts to keep confidential the other Party&#8217;s (the &#8220;<font style="text-decoration:underline;">Disclosing Party</font>&#8221;) Confidential Information (b)&#160;not use the Disclosing Party&#8217;s Confidential Information for any purpose, except (i)&#160;to the extent necessary to perform its obligations or to exercise its rights under this Agreement, the Transition Services Agreement or (ii)&#160;as required by applicable Law, and (c) not disclose the Disclosing Party&#8217;s Confidential Information to any third party other than its employees, consultants, contractors, licensees or </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">33</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">potential or actual partners or customers that have a need to know for the foregoing purposes, provided that such persons are under obligations of non-use and non-disclosure at least as protective of the Disclosing Party hereunder.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.7.2<font style="margin-left:36pt;"></font>The Acquired Assets shall, after the Closing, be deemed to be Confidential Information of Purchaser and, notwithstanding that Purchaser received such information from the Seller, for the purposes of this Agreement Purchaser shall be deemed to be the Disclosing Party and the Seller shall be deemed to be the Receiving Party with respect to such information. The terms of this Agreement shall be deemed to be the Confidential Information of both Parties.&nbsp;&nbsp;Notwithstanding anything to the contrary, either the Seller or the Purchaser may disclose this Agreement as necessary in connection with the Seller&#8217;s filings with the U.S. Securities and Exchange Commission or otherwise required by applicable Law. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref435727883"></a><a name="_Ref437852959"></a><a name="_Ref12983264"></a><a name="_Ref49444631"></a>6.7.3<font style="margin-left:36pt;"></font>The above restrictions on the use and disclosure of Confidential Information shall not apply to any information that (a)&#160;is or was already known to the Receiving Party at the time of disclosure by the Disclosing Party, as demonstrated by competent proof, (b)&#160;is or becomes generally available to the public from and after the Closing other than through any act or omission of the Receiving Party in breach of this Agreement, (c)&#160;is acquired by the Receiving Party from a third party who is not, to the Knowledge of the Receiving Party, directly or indirectly, under an obligation of confidentiality to the Disclosing Party with respect to same, or (d)&#160;is developed independently by the Receiving Party without use, direct or indirect, of information that is required to be held confidential hereunder.&nbsp;&nbsp;Notwithstanding the foregoing, with respect to the Acquired Assets after the Closing, the Seller shall not be able to rely on any of the exceptions set out in this <font style="text-decoration:underline;">Section 6.7.3</font> except for <font style="text-decoration:underline;">Section 6.7.3(b)</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref435727885"></a>6.7.4<font style="margin-left:36pt;"></font>If a Receiving Party becomes legally compelled to disclose any Confidential Information, such Receiving Party shall provide the Disclosing Party with prompt written notice of such requirement so that such Disclosing Party may seek a protective order or other remedy or waive compliance with this <font style="text-decoration:underline;">Section&#160;6.7.4</font>.&nbsp;&nbsp;If such protective order or other remedy is not obtained, or such Disclosing Party waives compliance with this <font style="text-decoration:underline;">Section&#160;6.7.4</font>, then the Receiving Party shall furnish only that portion of Confidential Information that is legally required to be provided and exercise its commercially reasonable efforts to obtain assurances that appropriate confidential treatment will be accorded to such Confidential Information. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc49528556"></a><a name="_Toc57819155"></a>6.8<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Employee Matters</font>6.8.1<font style="margin-left:36pt;"></font>. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:20.19%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.8.1<font style="margin-left:36pt;"></font>If not provided to Purchaser prior to the date of this Agreement, Seller shall deliver to Purchaser all information reasonably requested by Purchaser sufficient for Purchaser to make offers of employment to, or consulting arrangements with, all Business Employees.&nbsp;&nbsp;Within three (3) Business Days after the date of this Agreement, except as set out in <font style="text-decoration:underline;">Part 1 of Schedule 6.8.1</font>, the Purchaser shall make offers of employment with compensation and benefits comparable to the compensation and benefits provided by the Seller to similarly situated employees of Seller, with employment effective as of the Closing Date, on an at-will basis and on other terms set by the Purchaser, to the Business Employees that are set forth on <font style="text-decoration:underline;">Part 2 of Schedule 6.8.1 </font>who is not on Extended Leave (each, an &#8220;<font style="text-decoration:underline;">Offered Employee</font>&#8221;).&nbsp;&nbsp;Within fifteen (15) days after the date of this Agreement, the Purchaser shall deliver to the Seller <font style="text-decoration:underline;">Part 3 of Schedule 6.8.1</font> setting forth a list of each Offered Employee that has accepted such an offer (each, a &#8220;<font style="text-decoration:underline;">Hired Employee</font>&#8221;).&nbsp;&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">34</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:9.62%;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref55487552"></a><a name="_Ref55488461"></a><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.8.1.1</font><font style="margin-left:36pt;"></font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If within fifteen (15) days after the date of this Agreement (the &#8220;</font><font style="text-decoration:underline;">Acceptance Determination Date</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) ten (10) or less of the Business Employees (excluding Business Employees on Extended Leave) accept employment or, in the case of the individual set out in </font><font style="text-decoration:underline;">Part 1 of Schedule 6.8.1</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,&nbsp;&nbsp;a consulting engagement with the Purchaser (an &#8220;</font><font style="text-decoration:underline;">Extension Event</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref55488461"></a>&#8221;), then </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Closing Date shall be extended to a date requested in writing by Purchaser, such extension not to extend the Closing Date by more than 75 days after the Acceptance Determination Date</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;Notwithstanding anything to the contrary in this Agreement; the occurrence of an Extension Event shall not be deemed to cause a Material Adverse Effect.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:16.35%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.8.2<font style="margin-left:36pt;"></font>To the Knowledge of the Seller, there are no restrictions that would prohibit the employment of any Business Employee by the Purchaser as of the Closing Date. The Seller shall terminate, effective as of the Closing Date, all Offered Employees.&nbsp;&nbsp;Further, without the prior written consent of the Purchaser, the Seller shall not offer to employ, or promise and/or pay severance or other termination payment (except as contractually owed prior to this Agreement) to any Offered Employee who does not become a Hired Employee.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:16.35%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.8.3<font style="margin-left:36pt;"></font>Any Business Employee who is not actively at work on the Closing Date by reason of Extended Leave, who express an intention to return and accept an offer of employment from Purchaser, and who receive clearance to return from such Extended Leave within six (6) months following the Closing Date shall be eligible to commence employment with Purchaser as of the date such Business Employee returns from such Extended Leave as set forth above, rather than on the Closing Date and shall be treated as Hired Employees on the date that such Business Employee returns to work.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.8.4<font style="margin-left:36pt;"></font>Seller shall retain any financial responsibility (A) for each Business Employee on Extended Leave as of the Closing Date until the date such Business Employee becomes an employee of Purchaser, and (B) for long-term disability coverage (as and to the extent provided for in the applicable employee benefit plans maintained by the Seller) for each Business Employee who is on long-term disability leave as of the Closing Date, and each Business Employee who (1) is on short-term disability leave as of the Closing Date, (2) seeks long-term disability coverage and (3) has not returned from Extended Leave as described in <font style="text-decoration:underline;">Section 6.8.1(ii)</font>.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:21.15%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.8.5<font style="margin-left:36pt;"></font>The Seller shall retain and be solely responsible for all Liabilities in respect of any claims made by any Business Employee for severance or other termination pay or other benefits (including claims for wrongful dismissal, constructive dismissal, notice of termination of employment, pay in lieu of notice of termination, termination indemnities and any payments required to be made under any Law in respect of the termination of the Business Employee&#8217;s employment from the Seller, the failure of a Business Employee to accept an offer of employment from the Purchaser, or the non-hire of a Business Employee resulting from such Business Employee&#8217;s failure to satisfy the Purchaser&#8217;s standard background checks and drug testing policy, including payments in respect of accrued wages, vacation, overtime, bonuses and other plans, programs or obligations) arising out of the Business Employee&#8217;s employment with the Seller.&nbsp;&nbsp;The originals of all personnel records of all Business Employees shall remain with the Seller; provided that to the extent permitted by Law, the Purchaser shall be provided with full access to all such personnel records of Hired Employees to the extent authorized by the Hired Employee or reasonably necessary in order for the Purchaser or any of its Affiliates or successors to respond to a subpoena, court order, audit, investigation, or otherwise as required by Law.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">35</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:21.15%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.8.6</font><font style="margin-left:36pt;"></font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Seller shall, at the first opportunity pursuant to its standard payroll process, pay to each Hired Employee the full amount owed to such Hired Employee in respect of all accrued and unpaid salary and expense reimbursement owing to such Hired Employee as of the </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Closing Date.&nbsp;&nbsp;Purchaser shall pay to each Hired Employee the bonus amounts that such Hired Employee would have received under Seller&#8217;s 2020 bonus plan applicable to such Hired Employee for the portion of the year worked to the Closing Date, which amounts are set out in </font><font style="text-decoration:underline;">Schedule 6.8.6</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and will be reflected as a current liability associated with the Acquired Product Line as of the Closing Date in the determination of Net Working Capital</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:21.15%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.8.7<font style="margin-left:36pt;"></font>The Seller shall, at the first opportunity pursuant to its standard payroll process, pay to each Hired Employee the amount of compensation due in respect of the accrued but unused vacation time held by such Hired Employee as of the Closing Date.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:21.15%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.8.8<font style="margin-left:36pt;"></font>Nothing in this <font style="text-decoration:underline;">Section 6.8</font> shall be intended to entitle any Person other than the Parties hereto and their respective transferees and permitted assigns to any claim, cause of action, remedy or right of any kind.&nbsp;&nbsp;Nothing contained herein, express or implied, is intended to amend or modify any employee benefit plans maintained by the Seller, the Purchaser or their Affiliates.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc49528557"></a><a name="_Toc57819156"></a>6.9<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Termination of Related Party Transactions</font>6.9.1<font style="margin-left:36pt;"></font>.&nbsp;&nbsp;The Seller shall terminate all Related Party Transactions relating to or affecting the Acquired Assets (including any Acquired Contracts) or the Acquired Liabilities as of the Closing Date.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc49528558"></a><a name="_Toc57819157"></a>6.10<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Supply Agreement</font>6.10.1<font style="margin-left:36pt;"></font>.&nbsp;&nbsp;In connection with this Agreement, the Parties shall negotiate in good faith, and within ninety (90) days from the Closing Date, enter into a pre-clinical supply agreement on mutually agreeable terms.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc49528559"></a><a name="_Toc57819158"></a>6.11<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Covenant Not to Sue</font>6.11.1<font style="margin-left:36pt;"></font>.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:21.15%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.11.1<font style="margin-left:36pt;"></font>Seller (on behalf of itself, any Affiliate and its successors in title or licensees) agrees not to sue the Purchaser or the Purchaser&#8217;s Affiliates, permitted successors in title, licensees, sublicensees or customers, if any, (or third Persons acting on their behalf) (for whom the Purchaser holds such rights in trust), for such Person&#8217;s conduct of the Acquired Product Line in a manner as conducted prior to the Closing Date on the basis of infringement or misappropriation of any Excluded Asset or Intellectual Property retained by Seller as of the Closing Date or any part thereof.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:21.15%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.11.2<font style="margin-left:36pt;"></font>Seller (on behalf of itself, any Affiliate and its successors in title or licensees) agrees not to challenge or contest the validity or enforceability of any Acquired Intellectual Property.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc57819159"></a><a name="_Toc57717083"></a>6.12<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Access and IT Activities to Be Performed by Purchaser on the Facility Prior to Closing</font>6.12.1<font style="margin-left:36pt;"></font>.<a name="_Toc57717083"></a>&nbsp;&nbsp;Without limiting <font style="text-decoration:underline;">Section 6.2</font> and subject to Seller&#8217;s reasonable security and safety measures, from time-to-time from and after the date hereof as reasonably requested by Purchaser, Seller shall permit Purchaser access to the Facility to allow Purchaser to place and/or install and ready the information technology related equipment of Purchaser, and to take such other reasonable actions as are necessary, to enable Purchaser to operate the Acquired Product Line from Purchaser&#8217;s information technology systems from and after the Closing Date.&nbsp;&nbsp;<font style="text-decoration:underline;">Schedule 6.12</font> </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">36</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">sets out a high-level description of the equipment and activities to be performed by Purchaser pursuant to this </font><font style="text-decoration:underline;">Section</font><font style="text-decoration:underline;"> 6.12</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">but Seller acknowledges that Purchaser may determine once its information technology personnel attend at the Facility that additional equipment or actions may be necessary to complete such transition and Seller shall reasonably cooperate with Purchaser&#8217;s reasonable requests in that regard.</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;"><a name="_Toc45558590"></a><a name="_Toc47175135"></a><a name="_Ref_ContractCompanion_9kb9Ur05A"></a><a name="_Toc46960415"></a><a name="_Toc49528560"></a><a name="_Toc47693211"></a><a name="_Toc57819160"></a><a name="_Ref47717296"></a>ARTICLE VII</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman Bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;"><a name="_Toc49528561"></a><a name="_Toc47693212"></a><a name="_Toc57819161"></a>CONDITIONS TO CLOSING</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:bold;text-transform:uppercase;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185291"></a><a name="_Toc49528562"></a><a name="_Toc47693213"></a><a name="_Toc57819162"></a>7.1<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Conditions to Each Party&#8217;s Obligations</font>.&nbsp;&nbsp;The respective obligations of each Party to effect the transactions contemplated hereby shall be subject to the following:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.1.1<font style="margin-left:36pt;"></font>there shall be no effective injunction, writ or preliminary restraining order or any order of any nature issued by a Governmental Entity of competent jurisdiction to the effect that the Acquisition may not be consummated as provided in this Agreement, no Proceeding shall have been commenced by any Governmental Entity for the purpose of obtaining any such injunction, writ or preliminary restraining order and no written notice shall have been received from any Governmental Entity indicating an intent to restrain, prevent, materially delay or restructure the transactions contemplated by this Agreement; and</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.1.2<font style="margin-left:36pt;"></font>all consents, approvals, orders or authorizations of, or registrations, declarations or filings with, all Governmental Entities required in connection with the execution, delivery or performance of this Agreement shall have been obtained or made.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12554082"></a><a name="_Toc12554588"></a><a name="_Toc12554700"></a><a name="_Toc12554812"></a><a name="_Toc12185292"></a><a name="_Toc49528563"></a><a name="_Toc47693214"></a><a name="_Toc57819163"></a>7.2<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Conditions to Obligations of the Purchaser</font>.&nbsp;&nbsp;The obligations of the Purchaser to consummate the transactions contemplated by this Agreement shall be subject to the fulfillment at or prior to the Closing of each of the following conditions:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref47714675"></a>7.2.1<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Representations and Warranties</font>.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.2.1.1<font style="margin-left:36pt;"></font>The representations and warranties of the Seller set forth in <font style="text-decoration:underline;">Article&#160;IV</font> (Representations and Warranties of the Seller) other than the Fundamental Representations (i) shall have been true and correct in all respects as of the date of this Agreement and (ii) shall be true and correct in all material respects as of the Closing Date as though made on and as of the Closing Date, in each case, except where the failure of such representations and warranties to be so true and correct has not had, individually or in the aggregate with any other failures of such representations and warranties to be true and correct, a Material Adverse Effect;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.2.1.2<font style="margin-left:36pt;"></font>The Fundamental Representations (i) shall have been true and correct in all respects as of the date of this Agreement and (ii) shall be true and correct in all material respects as of the Closing Date as though made on and as of the Closing Date;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref47714692"></a>7.2.2<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Performance of Obligations of the Seller</font>.&nbsp;&nbsp;The Seller shall have performed in all material respects all covenants and agreements required to be performed under this Agreement on or prior to the Closing Date;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">37</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref47714708"></a>7.2.3<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">No Material Adverse Effect</font>.&nbsp;&nbsp;On or prior to the Closing Date, there shall not have occurred and be continuing (nor shall the Purchaser have become aware of) any Material Adverse Effect or any development likely to result in a Material Adverse Effect;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.2.4<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Related Agreements</font>.&nbsp;&nbsp;The Seller shall have delivered, or caused to be delivered, to the Purchaser the executed Related Agreements; </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.2.5<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Landlord Notice; Consent Letters</font>.&nbsp;&nbsp;After prior consulting with Purchaser as to the form and content, Seller shall have delivered, or caused to be delivered, to the Purchaser evidence of the notice to the landlord and/or owner of fee estate regarding the assignment of the Real Property Lease to Purchaser; </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.2.6<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">IT Transfer Activities</font>.<font style="margin-left:36pt;">&nbsp;&nbsp;The IT Transfer activities identified on Part </font><font style="text-decoration:underline;">Schedule 2.2.4</font> have been completed in all material respects on or before Closing and Seller shall have provided Purchaser with the access to the Facility and cooperation required pursuant <font style="text-decoration:underline;">Section 6.12</font>; </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.2.7<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Governmental Orders</font>. No governmental order or other legal restraint or prohibition shall be in effect that in any case would prohibit or prevent the transactions contemplated hereby.&nbsp;&nbsp;No Proceeding shall have been commenced by any Governmental Entity that seeks to prevent, prohibit or make illegal any of the transactions contemplated hereby; and</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.2.8<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Discharge of </font>Security.&nbsp;&nbsp;Confirmation that any security interests granted by Seller to third parties against the Acquired Assets have been released.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185293"></a><a name="_Toc49528564"></a><a name="_Toc47693215"></a><a name="_Toc57819164"></a>7.3<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Conditions to Obligations of the Seller</font>.&nbsp;&nbsp;The obligations of the Seller to consummate the transactions contemplated by this Agreement shall be subject to the fulfillment at or prior to the Closing of each of the following conditions:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref47714779"></a>7.3.1<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Representations and Warranties</font>.&nbsp;&nbsp;The representations and warranties of the Purchaser set forth in <font style="text-decoration:underline;">Article&#160;V</font> (Representations and Warranties of the Purchaser) (i) shall have been true and correct in all respects as of the date of this Agreement and (ii) shall be true and correct in all material respects as of the Closing Date as though made on and as of the Closing Date, in each case, except where the failure of such representations and warranties to be so true and correct would not, individually or in the aggregate with any other failures of such representations and warranties to be true and correct, prevent or materially delay or materially impair Purchaser&#8217;s ability to consummate the Acquisition or any of the other transactions contemplated hereby;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref47714794"></a>7.3.2<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Performance of Obligations by the Purchaser</font>.&nbsp;&nbsp;The Purchaser shall have performed in all material respects all covenants and agreements required to be performed by it under this Agreement on or prior to the Closing Date; and</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.3.3<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Related Agreements</font>.&nbsp;&nbsp;The Purchaser shall have delivered, or caused to be delivered, to the Seller the executed Related Agreements.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">38</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;"><a name="_Toc69279290"></a><a name="_Toc69532463"></a><a name="_Toc155614645"></a><a name="_Toc155699759"></a><a name="_Toc224619124"></a><a name="_Toc12185294"></a><a name="_Toc49528565"></a><a name="_Toc47693216"></a><a name="_Toc57819165"></a><a name="_Toc45558593"></a><a name="_Toc47175138"></a><font style="font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;">ARTICLE VIII</font><font style="font-family:Times New Roman Bold;"><br /><a name="_Toc69279290"></a><a name="_Toc69532463"></a><a name="_Toc155614645"></a><a name="_Toc155699759"></a><a name="_Toc224619124"></a><a name="_Toc12185294"></a><a name="_Toc49528565"></a><a name="_Toc47693216"></a><a name="_Toc57819165"></a></font><font style="font-family:Times New Roman Bold;"><a name="_Toc45558593"></a><a name="_Toc47175138"></a>CLOSING</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185295"></a><a name="_Ref47716263"></a><a name="_Toc49528566"></a><a name="_Toc47693217"></a><a name="_Ref57219211"></a><a name="_Toc57819166"></a>8.1<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Closing</font><font style="color:#000000;">.&nbsp;&nbsp;</font>Subject to extension pursuant to <font style="text-decoration:underline;">Section 6.8.1.1</font>, the Closing shall occur at 12:01 am Eastern Time on February 1, 2021, or the third Business Day immediately following the satisfaction or waiver of the conditions set forth in <font style="text-decoration:underline;">Article&#160;VII</font> (Conditions to Closing) that are contemplated to be satisfied prior to the Closing, whichever is later, or on such other date as the Parties may agree (the &#8220;<font style="text-decoration:underline;">Closing Time</font>&#8221;).&nbsp;&nbsp;The Closing shall take place by electronic delivery of documents no later than three (3) Business Days prior to the Closing Time,&nbsp;&nbsp;to be held in escrow by the respective legal representatives of the Parties, or at such other place or method as the Parties may agree.&nbsp;&nbsp;Upon satisfaction of the forgoing, the documents and the Purchase Price shall be released from escrow to the respective parties at the Closing Time.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185296"></a><a name="_Toc49528567"></a><a name="_Toc47693218"></a><a name="_Toc57819167"></a>8.2<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Seller&#8217;s Closing Deliveries</font>.&nbsp;&nbsp;At the Closing, the Seller shall deliver, or cause to be delivered, to the Purchaser the following:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.2.1<font style="margin-left:36pt;"></font>a certificate executed by the Chief Executive Officer of the Seller as to compliance by the Seller with the conditions set forth in <font style="text-decoration:underline;">Sections&#160;7.2.1</font>, <font style="text-decoration:underline;">7.2.2</font> and <font style="text-decoration:underline;">7.2.3</font>;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref12215607"></a>8.2.2<font style="margin-left:36pt;"></font>duly executed bills of sale, instruments of assignment, certificates of title and other conveyance documents, dated as of the Closing Date, transferring to the Purchaser and/or an Affiliate of the Purchaser all of the Seller&#8217;s right, title and interest in and to the Acquired Assets, together with possession of the Acquired Assets, including the Bill of Sale substantially in the form attached hereto as <font style="text-decoration:underline;">Exhibit 8.2.2</font> (the &#8220;<font style="text-decoration:underline;">Bill of Sale</font>&#8221;);</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref12215575"></a>8.2.3<font style="margin-left:36pt;"></font>duly executed documents evidencing the assignment of the Acquired Contracts including the Assignment and Assumption Agreement substantially in the form attached hereto as <font style="text-decoration:underline;">Exhibit 8.2.3</font> (the &#8220;<font style="text-decoration:underline;">Assignment and Assumption Agreement</font>&#8221;);</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.2.4<font style="margin-left:36pt;"></font>duly executed documents evidencing the assignment of the Acquired Trademarks substantially in the form attached hereto as <font style="text-decoration:underline;">Exhibit 8.2.4</font> (the &#8220;<font style="text-decoration:underline;">Trademark Assignment</font>&#8221;);</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref49348184"></a>8.2.5<font style="margin-left:36pt;"></font>duly executed documents evidencing the assignment of the Intellectual Property including the Intellectual Property Assignment Agreement substantially in the form attached hereto as <font style="text-decoration:underline;">Exhibit 8.2.5</font> (the &#8220;<font style="text-decoration:underline;">IP Assignment Agreement</font>&#8221;); </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.2.6<font style="margin-left:36pt;"></font>duly executed documents evidencing the assignment of the Real Property Lease including the Lease Assignment Agreement substantially in the form attached hereto as <font style="text-decoration:underline;">Exhibit 8.2.6</font> (the &#8220;<font style="text-decoration:underline;">Lease Assignment Agreement</font>&#8221;); </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.2.7<font style="margin-left:36pt;"></font>a certificate executed by an officer of the Seller, dated as of the Closing Date, as to (i) the good standing of the Seller in its jurisdiction of incorporation and in each other jurisdiction where it is qualified to do business and (ii) the effectiveness of the resolutions of the board of directors and shareholders of the Seller authorizing the execution, delivery and performance of this Agreement and the transactions contemplated hereby; </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.2.8<font style="margin-left:36pt;"></font>each of the Related Agreements, duly executed by the Seller; </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">39</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.2.9<font style="margin-left:36pt;"></font>a certificate of good standing or similar form regarding the Seller from the Secretary of State of the State of Alabama, dated within ten (10) Business Days of the Closing;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.2.10<font style="margin-left:36pt;"></font>a certificate from the Seller, dated as of the Closing Date, sworn under penalties of perjury, in a form reasonably acceptable to the Purchaser, that conforms to the requirements of Treasury Regulations &#167; 1.1445-2(b)(2), certifying that such Person is not a &#8220;foreign person&#8221; as that term is defined in Section 1445(f)(3) of the Code; </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.2.11<font style="margin-left:36pt;"></font> UCC-3 termination statements filed by the Seller to evidence release of all security interests held against the Acquired Assets, as applicable; and</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.2.12<font style="margin-left:36pt;"></font>all other documents required to be entered into by the Seller pursuant to this Agreement or reasonably requested by the Purchaser to convey the Acquired Assets to the Purchaser or to otherwise consummate the transactions contemplated by this Agreement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185297"></a><a name="_Toc49528568"></a><a name="_Toc47693219"></a><a name="_Toc57819168"></a>8.3<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Purchaser Closing Deliveries</font>.&nbsp;&nbsp;At the Closing, the Purchaser shall deliver, or cause to be delivered to the Seller, the following:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.3.1<font style="margin-left:36pt;"></font>the Purchase Price to be paid at the Closing pursuant to <font style="text-decoration:underline;">Section&#160;3.2</font> delivered to Wilson Sonsini Goodrich &amp; Rosati, to be held in escrow pursuant to <font style="text-decoration:underline;">Sections&#160;3.2</font> and<font style="text-decoration:underline;"> 8.1</font>;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.3.2<font style="margin-left:36pt;"></font>a certificate executed by an authorized officer as to compliance with the conditions set forth in <font style="text-decoration:underline;">Sections&#160;7.3.1</font> and <font style="text-decoration:underline;">7.3.2</font>; </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref12215676"></a>8.3.3<font style="margin-left:36pt;"></font>documents evidencing the assumption of the Acquired Contracts and the Acquired Liabilities, including the Assignment and Assumption Agreement executed by an authorized officer of the Purchaser;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.3.4<font style="margin-left:36pt;"></font>each of the Related Agreements, as required, duly executed by the Purchaser; and</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12554093"></a><a name="_Toc12554599"></a><a name="_Toc12554711"></a><a name="_Toc12554823"></a><a name="_Toc12554094"></a><a name="_Toc12554600"></a><a name="_Toc12554712"></a><a name="_Toc12554824"></a><a name="_Toc12554095"></a><a name="_Toc12554601"></a><a name="_Toc12554713"></a><a name="_Toc12554825"></a><a name="_Toc12185303"></a><a name="_Toc12554096"></a><a name="_Toc12554602"></a><a name="_Toc12554714"></a><a name="_Toc12554826"></a><a name="_Toc45558597"></a><a name="_Toc47175142"></a>8.3.5<font style="margin-left:36pt;"></font><a name="_Toc12554093"></a><a name="_Toc12554599"></a><a name="_Toc12554711"></a><a name="_Toc12554823"></a><a name="_Toc12554094"></a><a name="_Toc12554600"></a><a name="_Toc12554712"></a><a name="_Toc12554824"></a><a name="_Toc12554095"></a><a name="_Toc12554601"></a><a name="_Toc12554713"></a><a name="_Toc12554825"></a><a name="_Toc12185303"></a><a name="_Toc12554096"></a><a name="_Toc12554602"></a><a name="_Toc12554714"></a><a name="_Toc12554826"></a><a name="_Toc45558597"></a><a name="_Toc47175142"></a>all other documents required to be entered into or delivered by the Purchaser at or prior to the Closing.</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;"><a name="_Toc49528569"></a><a name="_Toc57819169"></a>ARTICLE IX<font style="font-family:Times New Roman Bold;"> <br /><a name="_Toc49528569"></a><a name="_Toc57819169"></a>Termination</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc49528570"></a><a name="_Toc57819170"></a>9.1<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Termination</font>.&nbsp;&nbsp;This Agreement may be terminated:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.1.1<font style="margin-left:36pt;"></font>in writing by mutual consent of the Parties; or</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref13071350"></a>9.1.2<font style="margin-left:36pt;"></font>by written notice from the Seller to the Purchaser or the Purchaser to the Seller, as the case may be, in the event the Closing has not occurred on or prior to March 31, 2021, which date shall automatically be extended by 75 days after the Acceptance Determination Date if <font style="text-decoration:underline;">Section 6.8.1.1</font> is applicable and elected by Seller (the &#8220;<font style="text-decoration:underline;">Expiration Date</font>&#8221;); <font style="font-style:italic;">provided, however</font>, that the right to terminate this Agreement under this <font style="text-decoration:underline;">Section&#160;9.1.2</font> shall not be available to any party whose action or failure to act has been a cause of or resulted in the failure of the Closing to occur on or before the Expiration Date and such action or failure to act constitutes a breach of this Agreement.&nbsp;&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">40</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185309"></a><a name="_Toc14888581"></a><a name="_Toc49528572"></a><a name="_Ref50544225"></a><a name="_Toc57819171"></a><a name="_Toc49528573"></a><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.2</font><font style="margin-left:36pt;"></font><font style="text-decoration:underline;"><a name="_Toc49528573"></a>Effect of Termination</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;In the event of termination of this Agreement pursuant to this </font><font style="text-decoration:underline;">Article IX</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, this Agreement shall forthwith become void and there shall be no liability on the part of any Party or its respective partners, officers, directors, stockholders, or managers and members, as applicable, except for rights and obligations under </font><font style="text-decoration:underline;">Section </font><font style="text-decoration:underline;">6.5</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (Public Announcements), </font><font style="text-decoration:underline;">Section </font><font style="text-decoration:underline;">11.1</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (Notices), </font><font style="text-decoration:underline;">Section </font><font style="text-decoration:underline;">11.5</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (Controlling Law; Amendment), </font><font style="text-decoration:underline;">Section 11.6</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (Legal Dispute Resolution), and </font><font style="text-decoration:underline;">Section </font><font style="text-decoration:underline;">11.15</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (Transaction Costs), and this </font><font style="text-decoration:underline;">Section </font><font style="text-decoration:underline;">9.2</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, each of which shall survive the Termination Date.&nbsp;&nbsp;Notwithstanding the foregoing, nothing contained in this Agreement will relieve any Party from liability for any breach of this Agreement.</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;"><a name="_Toc69532473"></a><a name="_Toc155614655"></a><a name="_Toc155699769"></a><a name="_Toc224619134"></a><a name="_Toc12185310"></a><a name="_Ref47715065"></a><a name="_Ref47715197"></a><a name="_Ref47717027"></a><a name="_Toc49528574"></a><a name="_Toc47693220"></a><a name="_Toc57819172"></a><a name="_Toc45558601"></a><a name="_Toc47175146"></a>ARTICLE X<font style="font-family:Times New Roman Bold;"><br /><a name="_Toc69532473"></a><a name="_Toc155614655"></a><a name="_Toc155699769"></a><a name="_Toc224619134"></a><a name="_Toc12185310"></a><a name="_Ref47715065"></a><a name="_Ref47715197"></a><a name="_Ref47717027"></a><a name="_Toc49528574"></a><a name="_Toc47693220"></a><a name="_Toc57819172"></a><a name="_Toc45558601"></a><a name="_Toc47175146"></a>INDEMNIFICATION; LIMITATION OF LIABILITY</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185311"></a><a name="_Ref47714855"></a><a name="_Toc49528575"></a><a name="_Toc47693221"></a><a name="_Toc57819173"></a>10.1<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Indemnification Obligations of the Seller</font>.&nbsp;&nbsp;The Seller will indemnify, defend and hold harmless the Purchaser Indemnified Parties from, against and in respect of any and all claims, Liabilities, obligations, losses, costs, expenses, penalties, fines, Tax assessments, awards, and judgments (at equity or at law) and damages suffered or incurred by such Purchaser Indemnified Parties whenever arising or incurred (including amounts paid in settlement, costs of investigation and reasonable fees and expenses of attorneys, accountants and other outside consultants and expert witnesses) arising out of or relating to: </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref47714826"></a>10.1.1<font style="margin-left:36pt;"></font>any breach or inaccuracy of any representation or warranty made by the Seller in this Agreement (for purposes of this <font style="text-decoration:underline;">Section&#160;10.1.1</font> and the calculation of any related Purchaser Losses, such representations and warranties shall be read without reference to materiality or Material Adverse Effect);</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref10713676"></a>10.1.2<font style="margin-left:36pt;"></font> any non-Affiliate third-party claim resulting from any breach of any covenant, agreement or undertaking made by the Seller in this Agreement or in any Related Agreement; and</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref10654409"></a>10.1.3<font style="margin-left:36pt;"></font><a name="_Ref10654409"></a>the Excluded Liabilities. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The claims, Liabilities, obligations, losses, costs, expenses, penalties, fines, Taxes, assessments, awards, and judgments and damages described in this <font style="text-decoration:underline;">Section&#160;10.1</font> as to which the Purchaser Indemnified Parties are entitled to indemnification are collectively referred to as &#8220;<font style="text-decoration:underline;">Purchaser Losses</font>.&#8221;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185312"></a><a name="_Ref47714910"></a><a name="_Toc49528576"></a><a name="_Toc47693222"></a><a name="_Toc57819174"></a>10.2<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Indemnification Obligations of the Purchaser</font>.&nbsp;&nbsp;The Purchaser shall indemnify and hold harmless the Seller Indemnified Parties from, against and in respect of any and all claims, Liabilities, obligations, losses, costs, expenses, penalties, fines, Taxes, assessments, awards, and judgments (at equity or at law) and damages suffered or incurred by such Seller Indemnified Parties whenever arising or incurred (including amounts paid in settlement, costs of investigation and reasonable fees and expenses of attorneys, accountants and other outside consultants and expert witnesses) arising out of or relating to:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref47715245"></a>10.2.1<font style="margin-left:36pt;"></font>the Purchaser&#8217;s failure to perform, discharge or satisfy the Acquired Liabilities;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">41</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref47715262"></a>10.2.2<font style="margin-left:36pt;"></font>any breach or inaccuracy of any representation or warranty made by the Purchaser in this Agreement or in any Related Agreement; and</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref47715283"></a><a name="_Ref12183781"></a>10.2.3<font style="margin-left:36pt;"></font><a name="_Ref12183781"></a>from any breach of any covenant, agreement or undertaking made by the Purchaser in this Agreement or in any Related Agreement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The claims, Liabilities, obligations, losses, costs, expenses, penalties, fines, Taxes, assessments, awards, and judgments and damages described in this <font style="text-decoration:underline;">Section&#160;10.2</font> as to which the Seller Indemnified Parties are entitled to indemnification are collectively referred to as &#8220;<font style="text-decoration:underline;">Seller Losses</font>.&#8221;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185313"></a><a name="_Toc49528577"></a><a name="_Toc47693223"></a><a name="_Toc57819175"></a>10.3<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Indemnification Procedure</font>. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref47714934"></a>10.3.1<font style="margin-left:36pt;"></font>Promptly following receipt by an Indemnified Party of notice by a third party (including any Governmental Entity) of any complaint or the commencement of any Proceeding with respect to which such Indemnified Party may be entitled to receive payment from the other Party for any Purchaser Loss or any Seller Loss (as the case may be), such Indemnified Party shall notify the Purchaser or the Seller, as the case may be (the &#8220;<font style="text-decoration:underline;">Indemnifying Party</font>&#8221;), promptly following the Indemnified Party&#8217;s receipt of such complaint or notice of the commencement of such Proceeding; provided, however, that the failure to so notify the Indemnifying Party shall relieve the Indemnifying Party from liability under this Agreement with respect to such claim only if, and only to the extent that, such failure to notify the Indemnifying Party results in the forfeiture by the Indemnifying Party of rights and defenses otherwise available to the Indemnifying Party with respect to such claim.&nbsp;&nbsp;The Indemnifying Party shall have the right, upon written notice delivered to the Indemnified Party within twenty (20) days thereafter assuming full responsibility for any Purchaser Losses or Seller Losses (as the case may be) resulting from such Proceeding, to assume the defense of such Proceeding, to the extent such Proceeding involves solely monetary damages, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of the fees and disbursements of such counsel; provided, however, that an Indemnifying Party will not be entitled to assume the defense of any Proceeding if (i) such claim could result in criminal liability of, or equitable remedies against, the Indemnified Party; or (ii) the Indemnified Party reasonably believes that the interests of the Indemnifying Party and the Indemnified Party with respect to the such claim are in conflict with one another, and as a result, the Indemnifying Party could not adequately represent the interests of the Indemnified Party in such claim.&nbsp;&nbsp;In the event, however, that the Indemnifying Party declines or fails to assume, or is not permitted to assume, the defense of the Proceeding on the terms provided above or to employ counsel reasonably satisfactory to the Indemnified Party, in either case within such 20<font style="font-weight:bold;">-</font>day period, or if the Indemnifying Party is not entitled to assume the defense of the Proceeding in accordance with the preceding sentence, then such Indemnified Party may employ counsel to represent or defend it in any such Proceeding and the Indemnifying Party shall pay the reasonable fees and disbursements of such counsel for the Indemnified Party as incurred; provided, however, that the Indemnifying Party shall not be required to pay the fees and disbursements of more than one counsel for all Indemnified Parties in any jurisdiction in any single Proceeding.&nbsp;&nbsp;In any Proceeding for which indemnification is being sought hereunder, the Indemnified Party or the Indemnifying Party, whichever is not assuming the defense of such action, shall have the right to participate in such matter and to retain its own counsel at such Party&#8217;s own expense.&nbsp;&nbsp;The Indemnifying Party or the Indemnified Party (as the case may be) shall </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">42</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">at all times use reasonable efforts to keep the Indemnifying Party or the Indemnified Party (as the case may be) reasonably apprised of the status of the defense of any matter the defense of which it is maintaining and to cooperate in good faith with each other with respect to the defense of any such matter.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.3.2<font style="margin-left:36pt;"></font>No Indemnified Party may settle or compromise any Proceeding or consent to the entry of any judgment with respect to which indemnification is being sought hereunder without the prior written consent of the Indemnifying Party, unless (i) the Indemnifying Party fails to assume, or is not permitted to assume, and maintain the defense of such claim pursuant to <font style="text-decoration:underline;">Section&#160;10.3.1</font> or (ii) such settlement, compromise or consent includes an unconditional release of the Indemnifying Party and its officers, directors, managers, employees and Affiliates from all liability arising out of such claim.&nbsp;&nbsp;An Indemnifying Party may not, without the prior written consent of the Indemnified Party, settle or compromise any claim or consent to the entry of any judgment with respect to which indemnification is being sought hereunder unless (x) such settlement, compromise or consent includes an unconditional release of the Indemnified Party and its officers, directors, managers, employees and Affiliates from all liability arising out of such claim, (y) does not contain any admission or statement suggesting any wrongdoing or liability on behalf of the Indemnified Party and (z) does not contain any equitable order, judgment or term that in any manner affects, restrains or interferes with the business of the Indemnified Party or any of the Indemnified Party&#8217;s Affiliates.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref47714959"></a>10.3.3<font style="margin-left:36pt;"></font>In the event an Indemnified Party claims a right to payment pursuant to this Agreement, such Indemnified Party shall send written notice of such claim to the appropriate Indemnifying Party.&nbsp;&nbsp;Such notice shall specify the basis for such claim.&nbsp;&nbsp;The failure by any Indemnified Party to so notify the Indemnifying Party shall not relieve the Indemnifying Party from any liability that it may have to such Indemnified Party with respect to any claim made pursuant to this <font style="text-decoration:underline;">Section&#160;10.3.3</font>, it being understood that notices for claims in respect of a breach of a representation or warranty must be delivered prior to the expiration of the survival period for each representation or warranty under <font style="text-decoration:underline;">Section&#160;10.4</font> (Claims Period).&nbsp;&nbsp;In the event the Indemnifying Party does not notify the Indemnified Party within thirty (30)<font style="font-weight:bold;"> </font>days following its receipt of such notice that the Indemnifying Party disputes its liability to the Indemnified Party under this <font style="text-decoration:underline;">Article&#160;X</font> or the amount thereof, the claim specified by the Indemnified Party in such notice shall be conclusively deemed a liability of the Indemnifying Party under this <font style="text-decoration:underline;">Article&#160;X</font> and the Indemnifying Party shall pay the amount of such liability to the Indemnified Party on demand, or, in the case of any notice in which the amount of the claim (or any portion of the claim) is estimated, on such later date when the amount of such claim (or portion of such claim) becomes finally determined.&nbsp;&nbsp;In the event the Indemnifying Party has timely disputed its liability with respect to such claim as provided above, as promptly as possible, such Indemnified Party and the appropriate Indemnifying Party will establish the merits and amount of such claim (by mutual agreement, litigation, arbitration or otherwise) and, within five Business Days following the final determination of the merits and amount of such claim, the Indemnifying Party shall pay to the Indemnified Party immediately available funds in an amount equal to such claim as determined hereunder.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185314"></a><a name="_Ref47714977"></a><a name="_Toc49528578"></a><a name="_Toc47693224"></a><a name="_Toc57819176"></a>10.4<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Claims Period</font>.&nbsp;&nbsp;The Claims Period under this Agreement shall begin on the date hereof and terminate as follows: </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">43</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref12218658"></a><font style="color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4.1</font><font style="margin-left:36pt;"></font><font style="color:#000000;">with respect to Purchaser Losses arising under </font><font style="text-decoration:underline;color:#000000;">Section 10.1</font><font style="color:#000000;">, the Claims Period for: </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4.1.1<font style="margin-left:36pt;"></font><font style="color:#000000;">General Representations shall survive the Closing and terminate on the date that is twelve (12) months after the Closing Date; </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4.1.2<font style="margin-left:36pt;"></font><font style="color:#000000;">Specified Representations shall survive the Closing and terminate on the date that is thirty-six (36) months after the Closing Date; and</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4.1.3<font style="margin-left:36pt;"></font>Fundamental Representations shall survive the Closing and terminate on the date that is ninety-six (96) months after the Closing Date.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.4.2<font style="margin-left:36pt;"></font>with respect to Seller Losses arising under <font style="text-decoration:underline;">Section 10.2</font>, the Claims Period shall survive the Closing and terminate on the date that is sixty (60) months after the Closing Date.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding the foregoing, if, prior to the close of business on the last day of the applicable Claims Period, an Indemnifying Party shall have been properly notified of a claim for indemnity hereunder and such claim shall not have been finally resolved or disposed of at such date, such claim shall continue to survive and shall remain a basis for indemnity hereunder until such claim is finally resolved or disposed of in accordance with the terms hereof.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185315"></a><a name="_Toc49528579"></a><a name="_Toc47693225"></a><a name="_Toc57819177"></a>10.5<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Liability Limits</font><font style="color:#000000;">. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.5.1<font style="margin-left:36pt;"></font>Notwithstanding anything to the contrary set forth herein, the Purchaser Indemnified Parties shall not make a claim against the Seller for indemnification under <font style="text-decoration:underline;">Section&#160;10.1.1</font> for Purchaser Losses unless and until the aggregate amount of such Purchaser Losses exceeds <font style="color:#000000;">(***)</font> dollars ($***), in which event the Purchaser Indemnified Parties may claim indemnification for all Purchaser Losses, including the initial fifty thousand dollars. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.5.2<font style="margin-left:36pt;"></font>Except for breach of this Agreement or fraud, the total aggregate amount of liability of the Seller for Purchaser Losses under <font style="text-decoration:underline;">Section 10.1.1</font>, shall be:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.5.2.1<font style="margin-left:36pt;"></font>limited to the Purchase Price, solely with respect to Fundamental Representations; </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.5.2.2<font style="margin-left:36pt;"></font>limited to (***) percent (***%) of the Purchase Price, solely with respect to the Specified Representations; and</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.5.2.3<font style="margin-left:36pt;"></font>limited to (***) percent (***%) of the Purchase Price, solely with respect to the General Representations; and&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in the aggregate shall not exceed the Purchase Price. For clarity, there shall be no limitation of Seller&#8217;s liability with respect to Excluded Liabilities.&nbsp;&nbsp;Seller&#8217;s liability for breach of its covenants under this Agreement shall be limited to the Purchase Price.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185316"></a><a name="_Toc49528580"></a><a name="_Toc47693226"></a><a name="_Toc57819178"></a>10.6<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Exclusive Remedy</font>.&nbsp;&nbsp;The Parties agree that, excluding (a) any breach of any covenant, agreement or undertaking, (b) any claim for injunctive or other equitable relief, (c) any </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">44</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">breach of </font><font style="text-decoration:underline;">Section&#160;</font><font style="text-decoration:underline;">6.7</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (Confidential Information), (d) any claim related to fraud,&nbsp;&nbsp;by the Seller in connection with the transactions related to this Agreement, the indemnification provisions of this </font><font style="text-decoration:underline;">Article&#160;X</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> are intended to provide the sole and exclusive remedy as to all claims either the Seller, on the one hand, or the Purchaser, on the other hand, may incur arising from or relating to this Agreement, the Related Agreements, and the transactions contemplated hereby and thereby. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc7513317"></a><a name="_Toc12185317"></a><a name="_Toc49528581"></a><a name="_Toc47693227"></a><a name="_Toc57819179"></a>10.7<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Limitation of Liability</font>.&nbsp;&nbsp;IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER PARTY OR ANY OTHER ENTITY FOR COSTS OF PROCUREMENT OF SUBSTITUTE GOODS, LOST PROFITS, OR ANY OTHER SPECIAL, CONSEQUENTIAL, RELIANCE OR INCIDENTAL DAMAGES, HOWEVER CAUSED AND ARISING UNDER ANY THEORY OF LIABILITY WHETHER BASED IN CONTRACT, TORT (INCLUDING NEGLIGENCE), OR OTHERWISE, <font style="text-transform:uppercase;">provided, however, that this sentence shall not limit a party&#8217;s right to recover for any such DAMAGES to the extent (x)</font> THEY RELATE TO EITHER A BREACH OF CONFIDENTIALITY OBLIGATIONS,<font style="text-transform:uppercase;"> (Y) such damages are actually awarded in connection with a Third-Party Claim OR (Z) SUCH DAMAGES RESULT FROM FRAUD.</font>&nbsp;&nbsp;THESE LIMITATIONS SHALL APPLY WHETHER OR NOT SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES AND NOTWITHSTANDING ANY FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY PROVIDED HEREIN.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185318"></a><a name="_Toc49528582"></a><a name="_Toc47693228"></a><a name="_Toc57819180"></a>10.8<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Warranties</font>.&nbsp;&nbsp;NEITHER PARTY MAKES ANY REPRESENTATION OR WARRANTY EXCEPT FOR THEIR RESPECTIVE REPRESENTATIONS AND WARRANTIES SET FORTH IN <font style="text-decoration:underline;">ARTICLES&#160;IV</font> (REPRESENTATIONS AND WARRANTIES OF THE SELLER) AND <font style="text-decoration:underline;">V</font> (REPRESENTATIONS AND WARRANTIES OF THE PURCHASER), AND EACH PARTY DISCLAIMS ALL IMPLIED WARRANTIES, INCLUDING, WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE.&nbsp;&nbsp;EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT, THE ASSETS ARE BEING TRANSFERRED TO THE PURCHASER &#8220;AS IS&#8221; AND THE SELLER MAKES NO REPRESENTATIONS OR WARRANTIES, EXPRESS OR IMPLIED, AT LAW OR IN EQUITY, IN RESPECT OF ANY OF THE ASSETS INCLUDING WITHOUT LIMITATION IN RESPECT OF INFRINGEMENT, VALIDITY, ENFORCEABILITY, MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, AND ANY SUCH REPRESENTATIONS OR WARRANTIES ARE HEREBY EXPRESSLY DISCLAIMED BY THE SELLER AND WAIVED BY THE PURCHASER.</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;"><a name="_Toc69532481"></a><a name="_Toc155614664"></a><a name="_Toc155699778"></a><a name="_Toc224619143"></a><a name="_Toc12185319"></a><a name="_Toc49528583"></a><a name="_Toc47693229"></a><a name="_Toc57819181"></a><a name="_Toc45558608"></a><a name="_Toc47175153"></a>ARTICLE XI<font style="font-family:Times New Roman Bold;"><br /><a name="_Toc69532481"></a><a name="_Toc155614664"></a><a name="_Toc155699778"></a><a name="_Toc224619143"></a><a name="_Toc12185319"></a><a name="_Toc49528583"></a><a name="_Toc47693229"></a><a name="_Toc57819181"></a><a name="_Toc45558608"></a><a name="_Toc47175153"></a>MISCELLANEOUS PROVISIONS</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185320"></a><a name="_Toc49528584"></a><a name="_Ref50544195"></a><a name="_Toc47693230"></a><a name="_Toc57819182"></a>11.1<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Notices</font>.&nbsp;&nbsp;All notices, communications and deliveries required or made hereunder must be made in writing signed by or on behalf of the Party making the same and shall be delivered personally, by e-mail transmission, with a physical copy sent by a national overnight </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">45</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">courier service or by registered, certified mail (return receipt requested) (with postage and other fees prepaid) (together, &#8220;</font><font style="text-decoration:underline;">Delivery Service</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221;) or by Delivery Service, as follows:</font></p>
<div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:92%;">
<tr>
<td style="width:32.04%;"></td>
<td style="width:59.96%;"></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the Purchaser:</p></td>
<td valign="top" >
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:-4.35pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Evonik Corporation</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:-4.35pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">299 Jefferson Road</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:-4.35pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Parsippany, NJ 07054</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Attention:&nbsp;&nbsp;<font style="font-size:11pt;">General Counsel</font></p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">gregory.mulligan@evonik.com</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">with a copy to (which shall not constitute notice):</p></td>
<td valign="top" >
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Norton Rose Fulbright Canada LLP</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1800 - 510 West Georgia Street</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vancouver, BC</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">V6B 0M3</p>
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br />Attention: Janet Grove <br />Janet.Grove@nortonrosefulbright.com</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the Seller:</p></td>
<td valign="top" >
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DURECT Corporation</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10260 Bubb Road</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cupertino, CA 95014-4166<font style="color:#000000;"><br /></font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Attention: <font style="color:#000000;">Mike Arenberg, Chief Financial Officer</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">mike.arenberg@durect.com </p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top" >
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">with a copy to (which shall not constitute notice):</p></td>
<td valign="top" >
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Wilson Sonsini Goodrich &amp; Rosati<br />650 Page Mill Road<br />Palo Alto, CA, 94303<br />Attention: Ian B. Edvalson, Esq.</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IEdvalson@wsgr.com</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:16.92%;text-indent:13.85%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:3.85%;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">or to such other representative or at such other address of a Party as such Party may furnish to the other Parties in writing.&nbsp;&nbsp;Any such notice, communication or delivery shall be deemed given or made (a) on the date of delivery, if delivered in person, or (b) upon transmission by email provided that it is transmitted on a Business Day prior to 5:00 p.m. local time in the place of delivery or receipt and receipt of such transmission is confirmed by the recipient,&nbsp;&nbsp;or (c) on the first Business Day following timely delivery to a national overnight courier service or (d) on the fifth (5<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup>) Business Day following it being mailed by registered or certified mail.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185321"></a><a name="_Toc49528585"></a><a name="_Toc47693231"></a><a name="_Toc57819183"></a>11.2<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Schedules and Exhibits</font>.&nbsp;&nbsp;The Schedules and Exhibits to this Agreement are hereby incorporated into this Agreement and are hereby made a part of this Agreement as if set out in full in this Agreement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185322"></a><a name="_Toc49528586"></a><a name="_Toc47693232"></a><a name="_Toc57819184"></a><a name="_Ref47715360"></a>11.3<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Assignment; Successors in Interest</font><a name="_Ref47715360"></a>.&nbsp;&nbsp;This Agreement and the rights and obligations hereunder shall not be assignable or transferable by the Purchaser or the Seller (other than by operation of law in connection with a merger, consolidation or sale of all or substantially all the assets or equity interests of Purchaser or of the Acquired Product Line without the prior written </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">46</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">consent of the other Party hereto, such consent not to be unreasonably withheld.&nbsp;&nbsp;Any attempted assignment in violation of this </font><font style="text-decoration:underline;">Section&#160;11.3</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall be null and void.&nbsp;&nbsp;This Agreement will be binding upon and will inure to the benefit of the Parties and their respective successors and permitted assigns, and any reference to a Party shall also be a reference to the successors and permitted assigns thereof.</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;Notwithstanding the foregoing, either Party may, without the consent of the other Party but upon prior written notice to the other Party, assign its rights and obligations hereunder, in whole or in party, and including its rights to purchase any or all of the Acquired Assets, to an Affiliate designated by such Party not less than five (5) Business Days prior to the Closing Date. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185323"></a><a name="_Toc49528587"></a><a name="_Toc47693233"></a><a name="_Toc57819185"></a>11.4<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Captions</font>.&nbsp;&nbsp;The titles, captions and table of contents contained in this Agreement are inserted in this Agreement only as a matter of convenience and for reference and in no way define, limit, extend or describe the scope of this Agreement or the intent of any provision of this Agreement.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185324"></a><a name="_Toc49528588"></a><a name="_Ref50544203"></a><a name="_Toc47693234"></a><a name="_Toc57819186"></a>11.5<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Controlling Law; Amendment</font>.&nbsp;&nbsp;This Agreement shall be governed by and construed and enforced in accordance with the Laws of the State of Delaware, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws thereof.&nbsp;&nbsp;This Agreement may not be amended, modified or supplemented except by written agreement of the Parties.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref50541633"></a><a name="_Toc57819187"></a><a name="_Toc49528590"></a>11.6<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Legal Dispute Resolution</font>.&nbsp;&nbsp;The Parties irrevocably consent and agree that any dispute (other than a dispute to be resolved by the independent accounting firm pursuant to <font style="text-decoration:underline;">Section 3.4</font>) that arises between any one or more of the Purchaser and the Purchaser Indemnified Parties, on the one hand, and any one or more of the Seller and the Seller Indemnified Parties, on the other hand, with respect to this Agreement or the transactions contemplated by this Agreement (each, a &#8220;<font style="text-decoration:underline;">Legal Dispute</font>&#8221;) shall be resolved exclusively in the manner provided in this <font style="text-decoration:underline;">Section 11.6</font>, subject only to the right of a Party to seek and obtain equitable relief as provided in <font style="text-decoration:underline;">Section 11.9</font>.&nbsp;&nbsp;For clarity, each Party agrees and covenants (on behalf of itself and its respective Indemnified Parties) to not commence any Proceeding except as expressly permitted by <font style="text-decoration:underline;">Section 11.6</font> and <font style="text-decoration:underline;">Section 11.9</font>.&nbsp;&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Ref50541753"></a>11.6.1<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Negotiation and Mediation</font>.&nbsp;&nbsp;In the event of any <font style="font-style:italic;">bona fide</font> Legal Dispute, the Purchaser may provide to the Seller, or the Seller may provide to the Purchaser, a written notice setting forth the nature of the Legal Dispute, a summary of the material facts pertaining thereto and such Party&#8217;s proposed resolution thereof.&nbsp;&nbsp;For a period of at least thirty (30) days after any such notice is given, a Representative of the Purchaser and a Representative of the Seller (together, the &#8220;<font style="text-decoration:underline;">Dispute Resolution Parties</font>&#8221;) shall attempt to resolve such Legal Dispute in good faith through negotiation between them or their respective Representatives.&nbsp;&nbsp;If the Dispute Resolution Parties are unable to resolve the Legal Dispute within such 30 day period (or such longer period as may be agreed to between the Dispute Resolution Parties), either may request mediation of the Legal Dispute by providing a notice of mediation to the other.&nbsp;&nbsp;Within ten (10) days after a notice of mediation is given, the Dispute Resolution Parties shall appoint a mutually acceptable mediator from the CPR Panels of Distinguished Neutrals.&nbsp;&nbsp;The mediation shall be held virtually under the then current Center for Public Resource&#8217;s (&#8220;<font style="text-decoration:underline;">CPR</font>&#8221;) Model Mediation Procedures for Business Disputes.&nbsp;&nbsp;All applicable statutes of limitation and defenses based upon the passage of time will be tolled for the duration of any negotiation and mediation of a Legal </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">47</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dispute under this </font><font style="text-decoration:underline;">Section </font><font style="text-decoration:underline;">11.6</font><font style="text-decoration:underline;">.1</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;All negotiations and mediations under this </font><font style="text-decoration:underline;">Section </font><font style="text-decoration:underline;">11.6</font><font style="text-decoration:underline;">.1</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shall be considered confidential and shall be treated as compromise and settlement negotiations for purposes of the applicable rules of evidence.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.6.2<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Arbitration</font>.&nbsp;&nbsp;If the Dispute Resolution Parties are unable to resolve any Legal Dispute within sixty (60) days (or such longer period as agreed to by the Dispute Resolution Parties) after notice of Legal Dispute is given pursuant to <font style="text-decoration:underline;">Section 11.6.1</font>, the Parties irrevocably consent and agree that such Legal Dispute shall be fully and finally resolved by binding arbitration in accordance with the rules and practices of the American Arbitration Association (&#8220;<font style="text-decoration:underline;">AAA</font>&#8221;) from time to time in force and effect.&nbsp;&nbsp;One arbitrator shall be used unless the damages alleged or the amount in controversy alleged are in excess of ($***), in which case three arbitrators shall be used.&nbsp;&nbsp;Such arbitration shall be administered by the AAA under its commercial arbitration rules and the Parties agree to a virtual venue online.&nbsp;&nbsp;The award of the arbitrator(s) (the &#8220;<font style="text-decoration:underline;">Award</font>&#8221;) shall be, at a minimum, a reasoned award and the arbitrator(s) shall have the power to grant any remedy or relief that it or they deem just and equitable, including injunctive and equitable relief and remedies, whether interim and/or final in nature.&nbsp;&nbsp;An Award may be appealed pursuant to the AAA&#8217;s Optional Appellate Arbitration Rules (&#8220;<font style="text-decoration:underline;">Appellate Rules</font>&#8221;).&nbsp;&nbsp;Appeals must be initiated within thirty (30) days of receipt of an Award, as defined by Rule A-3 of the Appellate Rules, by filing a Notice of Appeal with any AAA office located in the State of Illinois.&nbsp;&nbsp;An Award shall be considered final if no appeal is filed before the expiration of the time for filing the notice of appeal pursuant to the Appellate Rules.&nbsp;&nbsp;An Award that is final or, following the appeal process, the decision rendered by the appeal tribunal, may be entered in any court having jurisdiction thereof.&nbsp;&nbsp;The arbitrator(s) shall have continuing jurisdiction to implement the Award or the appellate decision.&nbsp;&nbsp;Each Dispute Resolution Party shall initially be responsible for its own costs and attorneys&#8217; fees, and shall share the expenses of the arbitration equally; provided, however, that the arbitrator(s) may award such portion of the expenses of the arbitration, costs and reasonable attorneys&#8217; fees to the substantially prevailing Dispute Resolution Party as they may deem just and equitable.&nbsp;&nbsp;The Federal Arbitration Act shall govern all proceedings brought hereunder.&nbsp;&nbsp;Except for the right of any Party to seek or obtain equitable relief as provided in <font style="text-decoration:underline;">Section 11.9</font>, this agreement to arbitrate shall be the exclusive remedy for the resolution of Legal Disputes not resolved pursuant to <font style="text-decoration:underline;">Section 11.6.1</font> and shall be specifically enforceable.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc49528591"></a><a name="_Toc57819188"></a>11.7<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Waiver of Jury Trial</font>.&nbsp;&nbsp;THE SELLER AND THE PURCHASER EACH HEREBY AGREE THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT OR THE RELATED AGREEMENTS IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES AND, THEREFORE, EACH SUCH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES ITS RESPECTIVE RIGHTS TO JURY TRIAL OF ANY DISPUTE BASED UPON OR ARISING OUT OF THIS AGREEMENT OR ANY CONVEYANCE DOCUMENT OR ANY DEALINGS BETWEEN THEM RELATING TO THE TRANSACTIONS CONTEMPLATED THEREBY. The scope of this waiver is intended to be all-encompassing of any and all actions that may be filed in any court and that relate to the subject matter of this Agreement, including contract claims, tort claims, breach of duty claims, and all other common law and statutory claims. Each Party acknowledges that this waiver is a material inducement to enter into this Agreement and that it will continue to rely on the waiver in their related future dealings. The Seller and the Purchaser further represent and warrant that each has reviewed this waiver with its legal counsel, and that each knowingly and voluntarily waives its jury trial rights following consultation with legal counsel. NOTWITHSTANDING </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">48</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ANYTHING TO THE CONTRARY HEREIN, THIS WAIVER IS IRREVOCABLE, MEANING THAT IT MAY NOT BE MODIFIED ORALLY OR IN WRITING, AND THE WAIVER WILL APPLY TO ANY AMENDMENTS, RENEWALS, SUPPLEMENTS OR MODIFICATIONS TO THIS AGREEMENT OR TO ANY OTHER DOCUMENTS OR AGREEMENTS RELATING HERETO.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185326"></a><a name="_Toc49528592"></a><a name="_Toc47693236"></a><a name="_Toc57819189"></a>11.8<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Severability</font>.&nbsp;&nbsp;Any provision of this Agreement which is prohibited or unenforceable in any jurisdiction will, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions of this Agreement, and any such prohibition or unenforceability in any jurisdiction will not invalidate or render unenforceable such provision in any other jurisdiction.&nbsp;&nbsp;To the extent permitted by Law, each Party hereby waives any provision of Law that renders any such provision prohibited or unenforceable in any respect. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc49528593"></a><a name="_Ref50541650"></a><a name="_Toc57819190"></a>11.9<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Specific Performance</font>. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.9.1<font style="margin-left:36pt;"></font>The Parties agree that irreparable damage would occur and that the Parties would not have any adequate remedy at law if any provision of this Agreement is not performed in accordance with its terms or is otherwise breached or threatened to be breached (other than an obligation to pay an amount of cash).&nbsp;&nbsp;It is accordingly agreed that the Parties shall be entitled to equitable relief, without the proof of actual damages, including in the form of an injunction or injunctions or orders for specific performance (including the remedy of rescission), in order to prevent such breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement.&nbsp;&nbsp;Such equitable relief shall be in addition to any other remedy to which the Parties hereto are entitled at law or in equity as a remedy for such nonperformance, breach or threatened breach.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:15.38%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.9.2<font style="margin-left:36pt;"></font>Each Party agrees to waive any requirement for security or the posting of any bond in connection with any such equitable remedy. Each Party further agrees that the only permitted objections that it may raise in response to any action for equitable relief are that it contests the existence of a breach or threatened breach of the provisions of this Agreement and/or that such relief is not available pursuant to the terms of this <font style="text-decoration:underline;">Section 11.9</font>.&nbsp;&nbsp;The rights and remedies of the parties shall be cumulative (and not alternative).</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185327"></a><a name="_Toc49528594"></a><a name="_Toc47693237"></a><a name="_Toc57819191"></a>11.10<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Counterparts</font>.&nbsp;&nbsp;This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, and it shall not be necessary in making proof of this Agreement or the terms of this Agreement to produce or account for more than one of such counterparts.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185328"></a><a name="_Toc49528595"></a><a name="_Toc47693238"></a><a name="_Toc57819192"></a>11.11<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Enforcement of Certain Rights</font>.&nbsp;&nbsp;Nothing expressed or implied in this Agreement is intended, or shall be construed, to confer upon or give any Person other than the Parties, and their successors or permitted assigns, any right, remedy, obligation or liability under or by reason of this Agreement, or result in such Person being deemed a third-party beneficiary of this Agreement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185329"></a><a name="_Toc49528596"></a><a name="_Toc47693239"></a><a name="_Toc57819193"></a>11.12<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Waiver</font>.&nbsp;&nbsp;Any agreement on the part of a Party to any extension or waiver of any provision of this Agreement shall be valid only if set forth in an instrument in writing signed on </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">49</font></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">behalf of such Party.&nbsp;&nbsp;A waiver by a Party of the performance of any covenant, agreement, obligation, condition, representation or warranty shall not be construed as a waiver of any other covenant, agreement, obligation, condition, representation or warranty.&nbsp;&nbsp;A waiver by any Party of the performance of any act will not constitute a waiver of the performance of any other act or an identical act required to be performed at a later time.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185330"></a><a name="_Toc49528597"></a><a name="_Toc47693240"></a><a name="_Toc57819194"></a>11.13<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Integration</font>.&nbsp;&nbsp;This Agreement and the documents executed pursuant to this Agreement (including the Related Agreements) supersede all negotiations, agreements and understandings between the Parties with respect to the subject matter of this Agreement and constitute the entire agreement between the Parties with respect thereto.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185331"></a><a name="_Toc49528598"></a><a name="_Toc47693241"></a><a name="_Toc57819195"></a>11.14<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Cooperation Following the Closing</font>.&nbsp;&nbsp;Following the Closing, each Party shall deliver to the other Party such further information and documents and shall execute and deliver to the other Party such further instruments and agreements as the other Party shall reasonably request to consummate or confirm the transactions provided for in this Agreement, to accomplish the purpose of this Agreement or to assure to the other Party the benefits of this Agreement.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:0.96%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Toc12185332"></a><a name="_Toc49528599"></a><a name="_Ref50544218"></a><a name="_Toc47693242"></a><a name="_Toc57819196"></a>11.15<font style="margin-left:36pt;"></font><font style="text-decoration:underline;">Transaction Costs</font>.&nbsp;&nbsp;Except as provided above or as otherwise expressly provided herein, (a) the Purchaser shall pay its own fees, costs and expenses incurred in connection with this Agreement and the transactions contemplated by this Agreement, including the fees, costs and expenses of its financial advisors, accountants and counsel, and (b) the Seller shall pay the fees, costs and expenses of the Seller incurred in connection with this Agreement and the transactions contemplated by this Agreement, including the fees, costs and expenses of their financial advisors, accountants and counsel.</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">[<font style="font-weight:bold;font-style:italic;">Signatures follow on next page</font>]</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;margin-left:15.38%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:12pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="letter-spacing:0pt;">50</font></a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IN WITNESS WHEREOF, the Parties have caused this Asset Purchase Agreement to be duly executed, as of the date first above written.</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:50%;">
<tr>
<td colspan="2" valign="top"  style="width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PURCHASER:</p></td>
</tr>
<tr>
<td valign="top"  style="width:13.68%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:86.32%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman Bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;">EVONIK CORPORATION</p></td>
</tr>
<tr>
<td valign="top"  style="width:13.68%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:86.32%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:13.68%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:86.32%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:13.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:86.32%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Bonnie Tully</p></td>
</tr>
<tr>
<td valign="top"  style="width:13.68%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:86.32%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Bonnie Tully</p></td>
</tr>
<tr>
<td valign="top"  style="width:13.68%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:86.32%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">President</p></td>
</tr>
<tr>
<td valign="top"  style="width:13.68%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:86.32%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:13.68%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:86.32%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:13.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:86.32%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Paul Spencer</p></td>
</tr>
<tr>
<td valign="top"  style="width:13.68%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:86.32%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Paul Spencer</p></td>
</tr>
<tr>
<td valign="top"  style="width:13.68%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:86.32%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Authorized Person</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.96%;text-indent:0%;font-style:italic;font-size:12pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">[SIGNATURES CONTINUE ON FOLLOWING PAGE]</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.96%;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.96%;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">[Signature Page to Asset Purchase Agreement]</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IN WITNESS WHEREOF, the Parties have caused this Asset Purchase Agreement to be duly executed, as of the date first above written.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:50%;">
<tr>
<td colspan="2" valign="top"  style="width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman Bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;">SELLER:</p></td>
</tr>
<tr>
<td valign="top"  style="width:13.68%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:86.32%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:100%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman Bold;text-transform:uppercase;font-size:12pt;font-style:normal;font-variant: normal;">DURECT CORPORATION</p></td>
</tr>
<tr>
<td valign="top"  style="width:13.68%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:86.32%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:13.68%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="width:86.32%;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:13.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="top"  style="width:86.32%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ James E. Brown</p></td>
</tr>
<tr>
<td valign="top"  style="width:13.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name:</p></td>
<td valign="top"  style="width:86.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">James E. Brown</p></td>
</tr>
<tr>
<td valign="top"  style="width:13.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:</p></td>
<td valign="top"  style="width:86.32%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">President and CEO</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><br />DISCLOSURE SCHEDULE</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">[Signature Page to Asset Purchase Agreement]</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Disclosure Schedule is made and given pursuant to the Asset Purchase Agreement, dated as of December 4, 2020 (the &#8220;<font style="text-decoration:underline;">Agreement</font>&#8221;), between Durect Corporation, a Delaware corporation (the &#8220;<font style="text-decoration:underline;">Seller</font>&#8221;) and Evonik Corporation, an Alabama corporation (the &#8220;<font style="text-decoration:underline;">Purchaser</font>&#8221;). All capitalized terms used but not defined herein shall have the meanings as defined in the Agreement, unless otherwise provided. The section numbers below correspond to the section numbers of the representations and warranties in the Agreement; provided<font style="font-style:italic;">, </font>however, that any information disclosed herein under any section number shall be deemed to be disclosed and incorporated into any other section number under the Agreement where such disclosure would be appropriate and such appropriateness is reasonably apparent from the face of such disclosure. </p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nothing in this Disclosure Schedule is intended to broaden the scope of any representation or warranty contained in the Agreement or to create any covenant. Inclusion of any item in this Disclosure Schedule (1) does not represent a determination that such item is material or establish a standard of materiality, (2) does not represent a determination that such item did not arise in the Ordinary Course, (3) except for those schedules which specifically contemplate consent, notice or other third party involvement, does not represent a determination that the transactions contemplated by the Agreement require the consent of third parties, and (4) shall not constitute, or be deemed to be, an admission to any third party concerning such item. </p>
<p style="margin-bottom:0pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Disclosure Schedule includes brief descriptions or summaries of certain agreements and instruments, copies of which are available upon reasonable request. Such descriptions do not purport to be comprehensive, and are qualified in their entirety by reference to the text of the documents described, true and complete copies of which have been provided to the Purchasers or their respective counsel.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-align:justify;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.33
<SEQUENCE>3
<FILENAME>drrx-ex1033_588.htm
<DESCRIPTION>EX-10.33
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
drrx-ex1033_588.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;text-transform:none;letter-spacing:0pt;font-weight:bold;letter-spacing:0.25pt;font-family:Times New Roman;font-style:normal;font-variant: normal;">Exhibit 10.33</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-weight:bold;text-transform:uppercase;letter-spacing:0.25pt;font-family:Times New Roman;font-style:normal;font-variant: normal;">DURECT CORPORATION</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-weight:bold;text-transform:uppercase;letter-spacing:0.25pt;font-family:Times New Roman;font-style:normal;font-variant: normal;">EXECUTIVE CHANGE OF CONTROL POLICY</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(As Approved by the Board of Directors on December 9, 2020)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Executive Change of Control Policy (the &#8220;Policy&#8221;) is effective as of April 7, 2004, as amended on September 25, 2008, December 12, 2013 and December 9, 2020.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-weight:bold;text-transform:uppercase;letter-spacing:0.25pt;font-family:Times New Roman;font-style:normal;font-variant: normal;">POLICY GOALS</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A.<font style="margin-left:36pt;">It is expected that the Company from time to time will consider the possibility of an acquisition by another company or other change of control transaction. The Board of Directors of the Company (the &#8220;Board&#8221;) recognizes that such consideration can be a distraction to officers of the Company and can cause these individuals to consider alternative employment opportunities. The Board has determined that it is in the best interests of the Company and its stockholders to assure that the Company will have the continued dedication and objectivity of its officers, notwithstanding the possibility, threat or occurrence of a Change of Control (as defined below) of the Company.</font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">B.<font style="margin-left:36pt;">Accordingly, the Board believes that it is in the best interests of the Company and its stockholders to provide officers with an incentive to continue their employment and to motivate such individuals to maximize the value of the Company upon a Change of Control for the benefit of its stockholders by providing them with certain benefits upon a Change of Control that provide them with enhanced financial security and incentive notwithstanding the possibility or occurrence of a Change of Control.</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:12pt;font-weight:bold;text-transform:uppercase;letter-spacing:0.25pt;font-family:Times New Roman;font-style:normal;font-variant: normal;">POLICY</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">1.</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">ELIGIBILITY</font><font style="color:#000000;">. This Policy shall be applicable to each individual who is an employee of the Company holding a position of Vice President (or equivalent position) or higher as of the effective date of a Change of Control or who held such a position with the Company within 90 days of such date but whose employment terminated under the conditions specified in Section 3 below (each, an &#8220;Officer&#8221;); provided, however, that the terms of this Policy will not apply to any Officer who is party to one or more agreements with the Company providing for specified benefits to the Officer upon or in connection with a Change of Control unless such Officer expressly consents (by executing the acknowledgment provided below) to becoming a participant eligible to receive benefits under this Policy and thereby expressly waiving and forfeiting any rights or claims he or she has or may have under any such prior agreement(s). Once acknowledged below, the terms of this Policy shall constitute the entire agreement between the Officer and the Company as to the subject matter covered by the Policy and such terms may thereafter be amended only by a written agreement signed by the Officer and, following approval by the Company&#8217;s Board or a Committee thereof, a duly authorized officer of the Company.</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">2.</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">AT-WILL EMPLOYMENT</font><font style="color:#000000;">. Unless otherwise agreed to expressly by the Company and an Officer through a separate written agreement which remains in effect after the </font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="color:#000000;">Officer becomes eligible to receive benefits under this Policy, each Officer&#8217;s employment is and shall continue to be on an at-will basis, meaning that either the Officer or the Company (or its successor) can terminate their employment relationship with each other at any time for any or no reason. Nothing in this Policy shall give an Officer any benefits whatsoever in the event the Officer&#8217;s employment terminates in a manner that is not in connection with a Change of Control.</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">3.</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">SEPARATION BENEFITS UPON INVOLUNTARY TERMINATION FOLLOWING CHANGE OF CONTROL</font><font style="color:#000000;">. If, in connection with and within 90 days prior to a Change of Control, or within twenty-four (24) months following the effective date of a Change of Control, the Officer&#8217;s employment with the Company (or its successor) is terminated by the Company or the successor without Cause or the Officer experiences a Constructive Termination (in each case as defined below), then subject to Sections 3(c), 4 and 5 below the Officer will be entitled to the following benefits:</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Vesting Acceleration</font><font style="color:#000000;">. The remaining unvested portion of any such stock options or stock awards held by the Officer as of the effective date of the employment termination shall automatically be accelerated so as to become completely vested and exercisable (and any such right of repurchase or forfeiture provision shall lapse in full) as of the effective date of such termination; and</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Cash Benefits</font><font style="color:#000000;">. The Officer will be entitled to payment of an amount equal in aggregate to 12 months of his or her then-current annual base salary, which will be paid in the form of a lump sum within 74 days, following the date of employment termination or Change of Control, whichever is later; provided however that this Section 3(b) shall be subject to Section 5(c) below; and provided further that the Company&#8217;s obligations to make any payments under this Section 3(b) is subject to Section 3(c) below. </font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(c)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Conditions to Payment of Benefits</font><font style="color:#000000;">. Notwithstanding anything else to the contrary contained herein, no Officer shall be entitled to payment of any benefits provided under this Section 3 or otherwise under this Policy unless and until (1) the Company (or its successor) shall have received from the Officer an effective release releasing the Company (or its successor) from any and all claims Officer may have against such entities related to or arising in connection with his or her employment, the terms of such employment and termination thereof that becomes effective within sixty (60) days following the termination of employment (or if later, the Change of Control) (the &#8220;Release Period&#8221;), and (2) the Officer is in compliance and continues to be in compliance with the covenants contained in Section 4 below (the &#8220;Covenants&#8221;), which Covenants shall be acknowledged and agreed to by the Officer upon his or her executing this Policy in the acknowledgment signature block below.</font><font style="color:#000000;"> The Officer further acknowledges that the benefits under this Policy are being provided to assist in the Officer&#8217;s transition to other employment.&#160; Accordingly, to the extent that the Officer begins to engage in activities in violation of the Covenants during the period of the cash severance payment specified in Section 3(b) above, the Officer shall be entitled to retain any such payments received prior to the date he commences such activities but will cease to be eligible to receive any further payments or other benefits under the terms of this Policy or otherwise, and the Officer shall have no further claims, rights or entitlements to any severance payments or benefits in any respect.&#160;  </font></p>
<p style="text-align:center;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="text-decoration:none;Background-color:#auto;">4.</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">COVENANTS</font><font style="color:#000000;">. </font><font style="color:#000000;">&#160;</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Generally</font><font style="color:#000000;">. In consideration for the benefits provided under this Policy, each Officer will agree to the covenants set forth in this Section&#160;4.</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Non-Disparagement</font><font style="color:#000000;">. The Officer will at no time following the termination of employment make any derogatory, misleading or otherwise negative statement about the actions, performance or behavior of the Company or its officers, directors, employees and agents.</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(c)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Cooperation</font><font style="color:#000000;">.&#160;The Officer will cooperate with the Company in order to ensure an orderly transfer of his or her duties and responsibilities. In addition, the Officer will at all times after termination of employment, (a)&#160;provide reasonable cooperation in connection with any action or proceeding (or any appeal from any action or proceeding) that relates to events occurring during the Officer&#8217;s employment hereunder, provided that such cooperation does not materially interfere with the Officer&#8217;s then current employment, and (b)&#160;cooperate with the Company in executing and delivering documents requested by the Company, and taking any other actions, that are necessary or requested by the Company to assist the Company in patenting, copyrighting, or registering any programs, ideas, inventions, discoveries, patented or copyrighted material, or trademarks, and to vest title thereto in the Company.</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(d)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Recoupment</font><font style="color:#000000;">.&#160;If the Officer breaches any of the covenants set forth in this Section&#160;4, the Company will have no further obligation to pay to the Officer any benefit under this Policy, and the Officer will be obligated to repay to the Company all benefits previously paid to, or on behalf of, the Officer under this Policy. </font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">5.</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">TAXES</font><font style="color:#000000;">.</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">General Withholding Tax Obligations</font><font style="color:#000000;">. The Officer shall be responsible for any income, excise or other taxes imposed on the Officer under applicable law with respect to the benefits provided hereunder, including without limitation delivering to the Company (or its successor) any amounts necessary to timely satisfy any applicable withholding tax obligations. The Officer&#8217;s receipt of any benefit hereunder is conditioned on his or her satisfaction of any applicable withholding or similar obligations that apply to such benefit, and any cash payment owed hereunder will be reduced to satisfy any such withholding or similar obligations that may apply.</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Limitation on Payments</font><font style="color:#000000;">. In the event that the benefits provided for under this Policy (x) constitute &#8220;parachute payments&#8221; within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), and (y) but for this Section 4(b) would be subject to the excise tax imposed by Section 4999 of the Code (or any corresponding provisions of state income tax law), then such benefits shall be either (1) delivered in full to the Officer, or (2) delivered as to such lesser extent as would result in no portion of such severance benefits being subject to excise tax under Code Section 4999, whichever amount, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Code Section 4999, results in the receipt by the Officer on an after-tax basis of the greater amount of benefits, notwithstanding that all or some portion of such benefits may be taxable under Code </font></p>
<p style="text-align:center;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="color:#000000;">Section 4999. Any determination required under this Section 5(b) shall be made in writing by the Company&#8217;s independent accountants, whose determination shall be conclusive and binding for all purposes on the Company and the Officer. In the event that (1) above applies, then the Officer shall be responsible for any excise taxes imposed with respect to such benefits. In the event that (2) above applies, then each benefit provided hereunder shall be reduced to the extent necessary to avoid imposition of such excise taxes</font><font style="color:#000000;"> by paying the maximum amount with respect to each category of benefits set forth below in order: </font><font style="color:#000000;">(</font><font style="color:#000000;">i</font><font style="color:#000000;">) stock options whose exercise price exceeds the fair market value of the optioned stock (&#8220;</font><font style="font-weight:bold;font-style:italic;color:#000000;">Underwater Options</font><font style="color:#000000;">&#8221;) (ii) Full Credit Payments (as defined below) that are payable in cash, (iii) non-cash Full Credit Payments that are taxable, (iv) non-cash Full Credit Payments that are not taxable, (v) Partial Credit Payments (as defined below) and (vi) non-cash employee welfare benefits.&nbsp;&nbsp;In each case, reductions shall be made in reverse chronological order such that the payment or benefit owed on the latest date following the occurrence of the event triggering the excise tax will be the first payment or benefit to be reduced (with reductions made pro-rata in the event payments or benefits are owed at the same time).&nbsp;&nbsp;&#8220;</font><font style="font-weight:bold;font-style:italic;color:#000000;">Full Credit Payment</font><font style="color:#000000;">&#8221; means a payment, distribution or benefit, whether paid or payable or distributed or distributable pursuant to the terms of this </font><font style="color:#000000;">Policy</font><font style="color:#000000;"> or otherwise, that if reduced in value by one dollar reduces the amount of the parachute payment (as defined in Section 280G of the Code) by one dollar, determined as if such payment, distribution or benefit had been paid or distributed on the date of the event triggering the excise tax.&nbsp;&nbsp;&#8220;</font><font style="font-weight:bold;font-style:italic;color:#000000;">Partial Credit Payment</font><font style="color:#000000;">&#8221; means any payment, distribution or benefit that is not a Full Credit Payment</font><font style="color:#000000;">.</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(c)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Code Section 409A</font><font style="color:#000000;">. It is the parties&#8217; intent that this Policy and the benefits payable hereunder comply with the requirements of Code Section 409A and any final regulations and guidance promulgated thereunder (collectively &#8220;Section 409A&#8221;) so that none of the severance benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply. Notwithstanding anything to the contrary in this Policy (or other agreement or arrangement referenced below in this Section 9(b)), if Officer is a &#8220;specified employee&#8221; within the meaning of Section 409A at the time of Officer&#8217;s &#8220;separation from service&#8221; (as defined in Section 409A) (other than due to death), and if the amounts payable to Officer pursuant to Section 3(b) this Policy, when considered together with other severance payments or separation benefits, if any, to which Officer may be entitled under any other agreement or arrangement, would be considered deferred compensation under Section 409A (together, the &#8220;Deferred Compensation Separation Benefits&#8221;), then only that portion of the Deferred Compensation Separation Benefits which does not exceed the Section 409A Limit (as defined below) may be made within the first six (6) months following Officer&#8217;s separation from service date in accordance with the payment schedule that otherwise applies to each payment or benefit. Any portion of the Deferred Compensation Separation Benefits in excess of the Section 409A Limit otherwise due to Officer on or within the six (6) month period following Officer&#8217;s separation from service will accrue during such six (6) month period and will become payable in a lump sum payment on the date six (6) months and one (1) day following the separation from service date. All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule otherwise applicable to each payment or benefit.  For these purposes, each severance payment provided for under this Policy is hereby designated as a separate payment and will not collectively be treated with any other payments as a single payment. Notwithstanding anything herein to the contrary, if Officer dies following his or her separation from service but prior to the six (6) month anniversary of his or her separation from service date, then any payments delayed in accordance </font></p>
<p style="text-align:center;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="color:#000000;">with this Section 5(c) will be payable in a lump sum as soon as administratively practicable after the date of Officer&#8217;s death and all other Deferred Compensation Separation Benefits will be payable in accordance with the payment schedule applicable to each payment or benefit.</font><font style="color:#000000;"> </font><font style="color:#000000;">In addition, to the extent that the Release Period spans two calendar years, such </font><font style="color:#000000;">Deferred Compensation Separation Benefits </font><font style="color:#000000;">will not commence until the second calendar year</font><font style="color:#000000;"> regardless of whether the </font><font style="color:#000000;">Officer is a &#8220;specified employee&#8221; within the meaning of Section 409A</font><font style="color:#000000;">.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For purposes of this Policy, &#8220;Section 409A Limit&#8221; will mean the lesser of two (2) times: (i) Officer&#8217;s annualized compensation based upon the annual rate of pay paid to Officer during the Company&#8217;s taxable year preceding the Company&#8217;s taxable year of Officer&#8217;s termination of employment as determined under Treasury Regulation 1.409A-1(b)(9)(iii)(A)(1) and any Internal Revenue Service guidance issued with respect thereto; or (ii) the maximum amount that may be taken into account under a qualified plan pursuant to Code Section 401(a)(17) for the year in which Officer&#8217;s separation from service occurs.&nbsp;&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding anything to the contrary contained in this Policy, to the extent that any amendment to this Policy would constitute under Section 409A a delay or acceleration in payment of a Deferred Compensation Separation Benefit, or a change in the form of payment of a Deferred Compensation Separation Benefit, then such any amendment that effects a delay in a payment or a change in the form of payment must be done in a manner that complies with Section 409A(a)(4)(C) and any amendment that effects an acceleration of payment must be done in a manner that complies with Treas. Reg. &#167;1.409A-3(j).</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">6.</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">DEFINITION OF TERMS</font><font style="color:#000000;">. The following terms referred to in this Policy shall have the following meanings:</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Change of Control</font><font style="color:#000000;">. &#8220;Change of Control&#8221; means the occurrence of any of the following events:</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:23.08%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(i)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">The closing of the sale of all or substantially all of the assets of the Company;</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:23.08%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(ii)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">The closing of a merger or consolidation of the Company with any other corporation (other than a merger effected exclusively for the purpose of changing the domicile of the Company or a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation);</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:23.08%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(iii)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">the direct or indirect acquisition (including by way of a tender or exchange offer) by any person, or persons acting as a group, of beneficial ownership or a right to acquire beneficial ownership of shares representing a majority of the voting power of the then-outstanding shares of capital stock of the Company; or</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:23.08%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(iv)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">a contested election of members of the Board (each, a &#8220;Director&#8221;), as a result of which or in connection with which the persons who were Directors before such election or their nominees cease to constitute a majority of the Board.</font></p>
<p style="text-align:center;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If required for compliance with Section 409A of the Code, in no event will a </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change of Control </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">be deemed to have occurred if such transaction is not also a &#8220;change in the ownership or effective control of&#8221; the Company or &#8220;a change in the ownership of a substantial portion of the assets of&#8221; the Company as determined under Treasury Regulation Section 1.409A-3(</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)(5) (without regard to any alternative definition thereunder).</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Cause</font><font style="color:#000000;">. For purposes of this Policy, &#8220;Cause&#8221; for an Officer&#8217;s termination will exist at any time after the happening of one or more of the following events:</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:23.08%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(i)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">The Officer&#8217;s deliberate material violation of any policy of the Company (or its successor) or deliberate refusal to comply in any material respect with the legal directives of his or her supervisor or the Board (so long as such directives are legal and consistent with the Officer&#8217;s position and duties); or</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:23.08%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(ii)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">The Officer&#8217;s commission of any act of fraud, embezzlement, dishonesty or any other willful misconduct (including conviction of a felony) that has caused or is reasonably expected to cause material injury to the Company, its business or its reputation (or to its successor or its successor&#8217;s business or reputation), or any act that constitutes fraud, or any knowing misrepresentation, involving or related to the Company&#8217;s financial statements; or</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:23.08%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(iii)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Any unauthorized use or disclosure by the Officer of any proprietary information or trade secrets of the Company (or its successor) or any other party to whom the Officer owes an obligation of nondisclosure or use (through a written agreement or otherwise) as a result of his or her relationship with the Company (or its successor); or</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:23.08%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(iv)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">The Officer&#8217;s willful, material breach of any of his or her obligations under any written agreement or covenant with the Company (or its successor); or</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:23.08%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(v)</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">The Officer&#8217;s failure to materially perform his or her duties or materially comply with the conditions applicable to his or her employment.</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:15.38%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(c)</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">Constructive Termination</font><font style="color:#000000;">. &#8220;Constructive Termination&#8221; shall be deemed to occur if there is (i)(A) a material reduction in job title or responsibilities of the Officer (provided, however, that reassignment to a position, irrespective of title, that changes the Officer&#8217;s responsibilities in a manner designed merely to reflect the fact that the Company has become a wholly-owned subsidiary or division of the counter-party to the Change of Control shall not constitute grounds for Constructive Termination); (B) a reduction of more than 20% of the Officer&#8217;s base salary unless in connection with similar decreases of other similarly-situated officers of the Company or its successor entity; or (C) the Officer&#8217;s refusal to relocate to a facility or location more than 50 miles from the Company&#8217;s location at which the Officer works as of the effective date of the Change of Control; and (ii) immediately following any of the foregoing events, the Officer provides to his or her employer within 20 business days of such event written notice of his or her intent to terminate employment as a result of Constructive Termination, which written notice specifies the events or circumstances giving rise to the Officer&#8217;s claim that Constructive Termination has occurred as well as the effective date of termination (which date shall be within 45 days of the date on which such notice is given); provided however that the Company shall have 30 days in which to cure the events or </font></p>
<p style="text-align:center;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="color:#000000;">circumstances giving rise to the Constructive Termination claim and, if the Company is able to cure such events or circumstances within such 30-day period, then the Officer shall not have a basis to terminate his or her employment for Constructive Termination.</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">7.</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">GOVERNING LAW</font><font style="color:#000000;">. This policy shall be governed by the laws of the state in which the Officer performs or most recently performed his or her primary duties to the Company, without giving effect to the principles of conflicts of laws.</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">8.</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">SEVERABILITY</font><font style="color:#000000;">. By executing this Policy below, the Officer agrees with the Company that each provision herein will be treated as a separate and independent clause, and the unenforceability of any one clause shall in no way impair the enforceability of any of the other clauses. The parties intend that the Covenants will be construed as a series of separate covenants, one for each county, city, state, nation and other political subdivision of the territories in which the Company does business. If, in any judicial proceeding, a court refuses to enforce any of the separate covenants (or any part thereof) deemed included in the Covenants, then such unenforceable separate covenant (or such part) shall be deemed eliminated from this Policy for the purpose of those proceedings to the extent necessary to permit the remaining separate covenants (or portions thereof) to be enforced by the court. The parties intend that the Covenants be enforced to the maximum degree permitted by applicable law.</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">9.</font><font style="margin-left:36pt;color:#000000;"></font><font style="text-decoration:underline;color:#000000;">GENERAL</font><font style="color:#000000;">. Any successor to the Company (whether direct or indirect, and whether by purchase, lease, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company&#8217;s business and/or assets will assume the Company&#8217;s obligations under this Policy. Without the written consent of the Company, an Officer may not assign or transfer his or her rights under the Policy to any other person or entity. Notwithstanding the foregoing, the terms of the Policy and all rights of an Officer hereunder will inure to the benefit of, and be enforceable by, his or her personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.</font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acknowledgment:</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By signing below, the Officer indicates his or her agreement to and acceptance of the terms and conditions of the Durect Corporation Change of Control Policy, which include:</p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">&#8226;</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">waiving and forfeiting in full any benefits contingent upon or related to a Change of Control provided to the Officer under any agreement or arrangement, written or otherwise, with the Company made or entered into prior to the date hereof; and</font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;text-indent:7.69%;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">&#8226;</font><font style="margin-left:36pt;color:#000000;"></font><font style="color:#000000;">agreeing to the terms and conditions of, and the restrictions imposed by, the Covenants set forth Section 4 above.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:60%;">
<tr>
<td valign="top"  style="width:28.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Signature:</p></td>
<td valign="top"  style="width:71.66%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:28.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Name (print):</p></td>
<td valign="top"  style="width:71.66%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="2" valign="top"  style="width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:28.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date Executed:</p></td>
<td valign="top"  style="width:71.66%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman Bold;font-variant: small-caps;font-style:normal;text-transform:none;">Signature Page to Executive Change of Control Policy</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>drrx-ex231_10.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
drrx-ex231_10.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 23.1</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk505868793"></a>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </p>
<p style="margin-bottom:0pt;margin-top:9pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We consent to the incorporation by reference in the following Registration Statements: </p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.53%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:4pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:4pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:4pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Registration Statements (Form S-8 Nos. 333-126990 and 333-98939) pertaining to the DURECT&#160;Corporation 2000 Directors&#8217; Stock Option Plan, </p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.53%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:4pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:4pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:4pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Registration Statements (Form S-8 Nos. 333-166700, 333-161025, 333-152968, 333-124701, 333-86110) pertaining to the DURECT&#160;Corporation 2000 Employee Stock Purchase Plan and the DURECT Corporation 2000 Stock Plan, </p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.53%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:4pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:4pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3)</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:4pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Registration Statements (Form S-8 Nos. 333-212842,333-197980, 333-176113, 333-120405, 333-108390 and 333-226524) pertaining to the DURECT&#160;Corporation 2000 Stock Plan, </p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.53%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:4pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:4pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4)</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:4pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Registration Statements (Form S-8 No.&#160;333-240326, 333-219832, 333-206084 and 333-170349) pertaining to the DURECT&#160;Corporation 2000 Employee Stock Purchase Plan, </p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.53%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:4pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:4pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5)</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:4pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Registration Statement (Form S-8 No.&#160;333-47400) pertaining to the DURECT Corporation 2000 Employee Stock Purchase Plan and the DURECT&#160;Corporation 2000 Stock Plan, </p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.53%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:4pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:4pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6)</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:4pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Registration Statement (Form S-8 No.&#160;333-61224) pertaining to the DURECT Corporation 2000 Employee Stock Purchase Plan, the DURECT Corporation 2000 Stock Plan, and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.53%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:4pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:4pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7)</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:4pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Registration Statements (Form S-3 Nos. 333-108398, 333-108396 and 333-226518) of DURECT Corporation, </p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of our report dated March&#160;5, 2021, with respect to the financial statements and schedule of DURECT Corporation included in this Annual Report (Form 10-K) of DURECT Corporation for the year ended December&#160;31, 2020. </p>
<p style="margin-top:12pt;margin-bottom:0pt;margin-right:5.56%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ E<font style="font-size:7.5pt;">RNST</font>&#160;&amp; Y<font style="font-size:7.5pt;">OUNG</font> LLP</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Redwood City, California</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 5, 2021</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>drrx-ex311_11.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
drrx-ex311_11.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 31.1</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION PURSUANT TO</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">18 U.S.C. SECTION 1350,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">AS ADOPTED PURSUANT TO</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, James E. Brown, certify that:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">I have reviewed this report on Form 10-K of DURECT Corporation;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 5, 2021</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:40%;">
<tr>
<td style="width:40%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:0.5pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/S/&#160;&#160;&#160;&#160;JAMES E. BROWN</p></td>
</tr>
<tr>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">James E. Brown</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>drrx-ex312_12.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
drrx-ex312_12.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 31.2</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION PURSUANT TO</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">18 U.S.C. SECTION 1350,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">AS ADOPTED PURSUANT TO</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I, Michael H. Arenberg, certify that:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">I have reviewed this report on Form 10-K of DURECT Corporation;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 5, 2021</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:40%;">
<tr>
<td style="width:40%;"></td>
</tr>
<tr>
<td valign="middle" >
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:0.5pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/S/ &#160;&#160;&#160;&#160;MICHAEL H. ARENBERG</p></td>
</tr>
<tr>
<td valign="bottom"  style=" border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Michael H. Arenberg</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer and Principal Accounting Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>drrx-ex321_13.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
drrx-ex321_13.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 32.1</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION PURSUANT TO</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">18 U.S.C. SECTION 1350,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">AS ADOPTED PURSUANT TO</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Annual Report of DURECT Corporation (the &#8220;Company&#8221;) on Form 10-K for the year ended December&#160;31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, James E. Brown, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that:</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 5, 2021</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:47%;">
<tr>
<td valign="bottom"  style="width:100%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/S/&#160;&#160;&#160;&#160;<font style="font-variant: small-caps;">James E. Brown</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:100%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">James E. Brown</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>drrx-ex322_14.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
drrx-ex322_14.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 32.2</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">CERTIFICATION PURSUANT TO</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">18 U.S.C. SECTION 1350,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">AS ADOPTED PURSUANT TO</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Annual Report of DURECT Corporation (the &#8220;Company&#8221;) on Form 10-K for the year ended December&#160;31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Michael H. Arenberg, Chief Financial Officer and Principal Accounting Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that:</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 5, 2021</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:47%;">
<tr>
<td valign="bottom"  style="width:100%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/S/&#160;&#160;&#160;&#160;<font style="font-variant: small-caps;">MICHAEL H. ARENBERG</font></p></td>
</tr>
<tr>
<td valign="bottom"  style="width:100%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Michael H. Arenberg</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer and Principal Accounting Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>gguopuizh44n000005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gguopuizh44n000005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ._!+\# 2(  A$! Q$!_\0
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M=_Z"-[_W_;_&C['KO_01O?\ O^W^-=]Y2?W11Y2?W10!P/V/7?\ H(WO_?\
M;_&C['KO_01O?^_[?XUWWE)_=%'E)_=% ' _8]=_Z"-[_P!_V_QH^QZ[_P!!
M&]_[_M_C7?>4G]T4>4G]T4 <#]CUW_H(WO\ W_;_ !H^QZ[_ -!&]_[_ +?X
MUWWE)_=%'E)_=% ' _8]=_Z"-[_W_;_&C['KO_01O?\ O^W^-=]Y2?W11Y2?
MW10!P/V/7?\ H(WO_?\ ;_&C['KO_01O?^_[?XUWWE)_=%'E)_=% ' _8]=_
MZ"-[_P!_V_QH^QZ[_P!!&]_[_M_C7?>4G]T4>4G]T4 <#]CUW_H(WO\ W_;_
M !H^QZ[_ -!&]_[_ +?XUWWE)_=%'E)_=% ' _8]=_Z"-[_W_;_&C['KO_01
MO?\ O^W^-=]Y2?W11Y2?W10!P/V/7?\ H(WO_?\ ;_&C['KO_01O?^_[?XUW
MWE)_=%'E)_=% ' _8]=_Z"-[_P!_V_QH^QZ[_P!!&]_[_M_C7?>4G]T4>4G]
MT4 <#]CUW_H(WO\ W_;_ !H^QZ[_ -!&]_[_ +?XUWWE)_=%'E)_=% ' _8]
M=_Z"-[_W_;_&C['KO_01O?\ O^W^-=]Y2?W11Y2?W10!P/V/7?\ H(WO_?\
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M=_Z"-[_W_;_&C['KO_01O?\ O^W^-=]Y2?W11Y2?W10!P/V/7?\ H(WO_?\
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M=_Z"-[_W_;_&C['KO_01O?\ O^W^-=]Y2?W11Y2?W10!P/V/7?\ H(WO_?\
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M=_Z"-[_W_;_&C['KO_01O?\ O^W^-=]Y2?W11Y2?W10!P/V/7?\ H(WO_?\
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M=_Z"-[_W_;_&C['KO_01O?\ O^W^-=]Y2?W11Y2?W10!P/V/7?\ H(WO_?\
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M14=SYLT_QSK]GK$<DEU(T9?!!/%?5_A35!JV@V\^[+E1FOG'3?#<>IZ7),B
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M_M:R_P">Z_G0!=HJE_:UE_SW7\Z/[6LO^>Z_G0!=HJE_:UE_SW7\Z/[6LO\
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M^,?YT >ET5YI_P +*O?^?&/\Z/\ A95[_P ^,?YT >ET5YI_PLJ]_P"?&/\
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M_P!3%]:VM#_Y!,/TK%\9_P"IB^M;6A_\@F'Z4 <3#_R-=]_U\R?^A&O0X/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'G7Q-SY]A]#3_AH/^/SZTSXF_P"O
ML/H:?\-/^7SZT >@TM-8@+D]!7.:KXWT;29#'/<*'';- '2&FNZHA=SA5&23
M7$+\4-$8_P#'PGYUSWC#XIZ?_8EQ%9S#S&7 (- %?QW\8(='GDLK,AGZ$BO)
MF^*6N/=?: 9/+SGO6/X=T:X\:>)A'*Q(D?D_C7T+;?!S2HM*^S%5+E?O8[T
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M:^@OX!CTH =10.E% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH **** $-'>EI* ."\:ZO/#NMT)"U@>%M,CU*^!G;/.>:[[Q#H$>J6S%0/,
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MNYB7GD]6-<5X/M+N/XR:],]K*L+8Q(R_*?H: .IT3X>2:-JL-\WB34[L1_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3O"&B:7/Y]G:+&YYR!6Z.F* !@#TI:D HI*,\\T +1110 444F?:@!:2EHH
MXWQWS8$5S_@.YCM[H^80OUKK?&&GR7FG'RE)85YI]DOK52RPR*0.2* /7Y]6
MM1$W[Q3QZUY1XEE%QJ!=#WXK.AU"YNI6BBE9W'4 U?M]+O;BYCW0OUY)% #+
M:;4XXQY9<+VQ5E-:U6!LF1SBO3=-TJV33XTDA7=CG(I)_#ME,.(U'X4 <%;>
M,+J-OWNXFMJW\=\#?'Q5ZY\$VTWW<"LV7P!L4E)* -*+QQ:2=1BM6W\164X!
MW@9]ZX.X\&7,0)3)(K,?2M3MCC9(0/2@#UZ.^MI5RLR_G4HGB/1U/XUXT9=2
MAZ+*IJ:'7M2MCF0M@4 >Q!E/0BEKRZW\:W2L/E)Q6JGCXC DAQ[T =WWJ*:U
MAG&)(P?PKG+7QC;3+EF K5M]>LIO^6JC\: *U[X9L;A3LA 8]\5S%YX&F3<]
MNP^E=VM_:MPLZ'Z&I5FC8<.#^- 'CMQI>H:=+E5?([BI;?7]2L7!DD8CTKUI
M[6"4?/&K9]JQM0\*V=X#M4*3[4 8EAXY0*JS#KW-=+9:_9W@&' S[UQM_P"!
M)($8Q-N'7BL![#4K GY),#H10![&LL;'B0'Z&G\UX_9^([^RDQ*6// -=19>
M.MQ59DQ[T =S169::Y9W* ^:H)[9K025)!E"#0 ^BBDH 6BD[TM !1110 44
ME+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% 'G7Q-_U]A]#3_AI_R^?6F?$W_7V'T-/^&G_+Y]
M: /0J*** "BBF22"*-G;H* 'T5R=[XS@M9B@P<&JW_">P>@H [6BN*'CR M@
M@5TFDZI'J<'F(10!HT444 %%(3BC/- "T4A-&>.30 M%)030 M%)D#J:,\]1
M0 M%)DT9YH 6BDSFC(]10 M%)FCM0 M%)1GW% "T4G:@$F@!:*3G'4$T4 +1
M29HSQ0 M%(#GN*,T +129]2!1GTH 6N!^)G_ ![6/^^:[T5P7Q,_X]K'_?-
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M<2=6%%M+@]'8TP,4M HI (RAAA@"#VK/U:"$:3='REXC/:M#O5'6/^0-=_\
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M2]62$NY?:.M %!87OM5DC!SEN*Z*/P7.Z*V#S6/X<&-;4-U!YKV:#;Y*=.E
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M[HU;U -<'\3/^/:Q_P!\T 5_AG_Q\W_T%>C5YS\,_P#CYO\ Z"O1J "BBB@
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M'PS\:XR=2?\ [Z- 'NGVRU_Y^(O^^A1]LM?^?B+_ +[%>%_\*S\:_P#02?\
M[[-'_"L_&O\ T$G_ .^S0![I]LM?^?B+_OL4?;+7_GXB_P"^Q7A?_"L_&O\
MT$G_ .^S1_PK/QK_ -!)_P#OLT >Z?;+7_GXB_[[%'VRU_Y^(O\ OL5X7_PK
M/QK_ -!)_P#OLT?\*S\:_P#02?\ [[- 'NGVRU_Y^(O^^Q1]LM?^?B+_ +[%
M>%_\*S\:_P#02?\ [[-'_"L_&O\ T$G_ .^S0![I]LM?^?B+_OL4?;+7_GXB
M_P"^Q7A?_"L_&O\ T$G_ .^S1_PK/QK_ -!)_P#OLT >Z?;+7_GXB_[[%'VR
MU_Y^(O\ OL5X7_PK/QK_ -!)_P#OLTO_  K/QK_T$G_[[- 'N?VRU_Y^(O\
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MWV*\+_X5GXU_Z"3_ /?9H_X5GXU_Z"3_ /?9H ]T^V6O_/Q%_P!]BC[9:_\
M/Q%_WV*\+_X5GXU_Z"3_ /?9H_X5GXU_Z"3_ /?9H ]T^V6O_/Q%_P!]BC[9
M:_\ /Q%_WV*\+_X5GXU_Z"3_ /?9H_X5GXU_Z"3_ /?9H ]T^V6O_/Q%_P!]
MBC[9:_\ /Q%_WV*\+_X5GXU_Z"3_ /?9H_X5GXU_Z"3_ /?9H ]T^V6O_/Q%
M_P!]BC[9:_\ /Q%_WV*\+_X5GXU_Z"3_ /?9H_X5GXU_Z"3_ /?9H ]T^V6O
M_/Q%_P!]BC[9:_\ /Q%_WV*\+_X5GXU_Z"3_ /?9H_X5GXU_Z"3_ /?9H ]T
M^V6O_/Q%_P!]BC[9:_\ /Q%_WV*\+_X5GXU_Z"3_ /?9H_X5GXU_Z"3_ /?9
MH ]T^V6O_/Q%_P!]BC[9:_\ /Q%_WV*\+_X5GXU_Z"3_ /?9H_X5GXU_Z"3_
M /?9H ]T^V6O_/Q%_P!]BC[9:_\ /Q%_WV*\+_X5GXU_Z"3_ /?9H_X5GXU_
MZ"3_ /?9H ]T^V6O_/Q%_P!]BC[9:_\ /Q%_WV*\+_X5GXU_Z"3_ /?9H_X5
MGXU_Z"3_ /?9H ]T^V6O_/Q%_P!]BC[9:_\ /Q%_WV*\+_X5GXU_Z"3_ /?9
MH_X5GXU_Z"3_ /?9H ]T^V6O_/Q%_P!]BC[9:_\ /Q%_WV*\+_X5GXU_Z"3_
M /?9H_X5GXU_Z"3_ /?9H ]T^V6O_/Q%_P!]BC[9:_\ /Q%_WV*\+_X5GXU_
MZ"3_ /?9H_X5GXU_Z"3_ /?9H ]T^V6O_/Q%_P!]BC[9:_\ /Q%_WV*\+_X5
MGXU_Z"3_ /?9H_X5GXU_Z"3_ /?9H ]T^V6O_/Q%_P!]BC[9:_\ /Q%_WV*\
M+_X5GXU_Z"3_ /?9H_X5GXU_Z"3_ /?9H ]T^V6O_/Q%_P!]BC[9:_\ /Q%_
MWV*\+_X5GXU_Z"3_ /?9H_X5GXU_Z"3_ /?9H [/XDRQRS6)CD5\ YVG-3?#
M3_E\^M<&_AO6?#@VZQ<&9IN8R3G%=Y\-/^7SZT >A4QHHV.60'\*?10!%]GA
M_P">:_E5/5+>,Z9, @SCTK1IK('4JPR#0!X5.]Q8:C)+&A!#<<5>7Q9K  P'
MP*]0N?#=E<2;S&,_2HO^$6LL_P"K'Y4 >3:AJM_J:_OU8XKO/ %K_HA:2/CW
M%;H\+6.>4'Y5JV=E#91;(5 % $GD1?W!^5.6&-3D(!^%/HH 3O65XF_Y%K4?
M^N#?RK6JKJ5D-1TVXLV<H)D*%AVS0!YE\&(%NO -W;N 5DDD4@^^:\Z7Q#=>
M D\0>$IM[37,N+4#H QKW7P1X/C\&:.VGQ7+7 9R^YAZUD^(/A=IVO\ C&T\
M0S3LCP$%H@.'(H -#T,>'_A9+:[ DCVSR/ZDD5D_ W_D3IO^N[_SKTB_L%OM
M+FL=VQ9(S'D=N,5A>"/!T?@S27L([I[A6<ON88ZT <#X''_%YO$>%SZY'2O9
M-H!R%&?I7FNH_"N\?Q1=Z[I/B*?3IKK[ZHN:GM_ GBN*XCDD\<7<B*P+(4Z^
MU %#XY?\BM;_ /7=?YUZ#X=!'AVPR,'R%_E6/XU\%IXRT./3I;QX&0@^:HY)
M'>N=A^'/BJV@2"'QS=K$B[579T% #_C=SX#<=_-7^===X/4KX2TT$8_<+_*L
M+5? %UKG@TZ%JFM37$Q;=]J*_-63;_#;Q/:6J6T'CB[2%%VJNSH* ,GXM72>
M)-;TCPSIS">=I@TY0Y\L ]Z]<L+=;/3[>V _U4:K^0KG_"O@?3O#*F?_ (^=
M1DYENY.6<UU&* $+!$+,0% R2>U>,>+=3O\ XD^)E\*:*S#286S>W"="/3->
ML:WITFK:/<6,5RUNTR[?,7J*\ST?X-ZIX>\[^R/%US;^<<N0G)- 'I>AZ+9^
M'M'@TZQB"0PK@ =SZUH]ZX?0_!WB33=6ANK[Q=<WMNA^:!UP&K2\4^'=8UIX
M6TO7YM+"??$:YW4 <#X31A\<->!!R%%>H>(-*N-8TN2SMK^6QD;I-%]X5YO;
M_!W5K359M5M_%]TE_-_K)=G+5Z1X?TV]TO2H[74-1?4+A2<SN,$T <GI_P /
M-7L[V*=_&.HSJAR8WZ-^M=S%/;M(;59XWFC'SID%A]14^*XGQ+X!FU76%U;2
M-8GTJ\88E>/G>/I0!4^,.GZ5<^!+F?4-B2P?- ^<,&]JYN6WOM7_ &?MMTKO
M<H@9,CDJ.E;D?PMN[^_@D\2^(;C5[2$[A;2#"D^]>A)8VR6(LEA46X38(\<8
MH Y+X4W\=]X!L2C*6C&QU!Z$5Q/B9D\0?&[2K&V E6R^:=EY"UOR?"R]LM0N
M9?#WB2XTJUG.XV\:Y />NA\'^!K/PK'),TAN]2F),UW(/F>@#J@   .@XK@O
MB9_Q[6/^^:[[I7 _$S_CVL?]\T 5_AG_ ,?-_P#05Z-7G/PS_P"/F_\ H*]&
MH **** "D]*6D]* .5\9_P"IB^M;6A_\@F'Z5B^,_P#4Q?6MK0_^03#]* .)
MA_Y&N^_Z^9/_ $(UZ'!_J5^E>>0_\C7??]?,G_H1KT.#_4K]* )*AN+J&UB\
MR=PBCN:E[UQ7Q,L=3U#PXT&E[O./I0!U<=]9W,#21RJ\?<@UDKJWANPN&*W%
MO'+WY%>?^$-&\267A2:WNF;SV!QDUY/J_@3QC/JD\FV=LL2"&-%]1GT5J5SX
M/UD_Z9/;R'U)%6="7PS:$0Z6\.[_ &2,U\P?\(%XRX'ES_\ ?1KM?AKX1\3Z
M=XC2:]\U80>0S&JBA'T>*6D7[H^E&*D#F?'-]>V.@2O8J6EQT%>'Z1XS\0:=
M>-<SZ9)(V>I4U]*20I*,2(&'H15<Z78$8-I"?^ "E89YOX3^(&KZY?\ D75@
M\<9[E<5W\^@Z7>XDGM(W8]R*MQ:?:0-NBMXT;U"U8Q3$>>^+_".F?94-KIZ;
M\\X%=!X0TJ"PT:/; (Y._%= T:L/F4'ZTJH%& ,"G?03WN**6D%+2&%4=7R-
M(NR.OEFKM4M8_P"0/=Y_YYF@#PSX:R.OC2[P>?,-?0&3@&OGSX;?\CI>?]=#
M7T&.@^E !FC-  %+0 F:,TM% "9HS2T4 )FC-+10 F:,TM% "9HS2T4 )FC-
M+10 F:,TM% "9HS2T4 )FC-+10 F:6BB@!,T9I:* $HS2T4 )7!^.[628AE0
MG%=[5>ZLXKM-LB@T >&F*6+YE1E-)MGFY8,U>O2>%[.0$$#\J9%X4LXCT!_"
M@#RF*QGED"K&2?I5J33[^S._RF ]<5ZO!H-I X94'Y5<N+""XB,;1KCZ4 >-
MIJ]] WR3,,=LUN6/C6]@4"4[A[UO:EX'MY TD)PWI7&7OA^]M';,1*B@#M].
M\:PW! EP*Z*'5+.< I,N3VS7B.&C<@@J14\&H7,$@9)&X]Z /<U8,,@Y%+7E
M=GXVO+8!2"5[UT^F^,K>X \Y@": .LS1FJ<&JV=QCRY5.:N @C(H ,T9HHH
M,T9HI: $S1FEHH 3-&:6B@!,T9I:* $S1FEHH 3-&:6B@!,T9I:* $S1FEHH
M 3-&:6B@!,T9I:* $S1FEHH 3-&:6B@!,T9I:* $S1FEHH 3-&:6B@!,T9I:
M* $S1FEHH 3-&:6B@!,T9I:* $S1FEHH \Z^)G^OL/H:?\-/^7SZTSXF_P"O
ML/H:?\-/^7SZT >A4444 %%%% !1110 4444 %%%% !1110 4444 %%%(3B@
M!:*3-+0 4444 %%%% !129Q2T %%%% !1110 4444 %%%% !1110 444F10
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MX;^)[[Q9X;-_J"1I,)63"#C - '84M(.*Y[QAXQL?!>E#4+^.22(L%Q&.>:
M.BHK.T36(-=T>WU*W5EAG7<H;K6AD4 +112$XH 6BDS2/(D:,[L%51DD]!0
MZBO/M1^*]A;ZG-9Z?I5]JBP\/-:KE,^E;/A;QWI?BD-'$'MKM#AK6;AQ^% '
M3GJ*0YX_6L37?%VD>'KNVMM1NE@>YSL9N@(]:X_2_B?%;?VC+X@N[:..-\6R
M1_>D&>M 'I@Q7!?$S_CVL?\ ?-=M9745[9PW4)S'*@9?H:XGXF?\>UC_ +YH
M K_#/_CYO_H*]&KSGX9_\?-_]!7HU !1110 4GI2TGI0!ROC/_4Q?6MK0_\
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MNGTWQ;:W8'F.%)]: .EHJK#J%K,?W<JG/O5KK0 4444 %%%% !1110 4444
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M!M*[N34EW-:7'@6XEL(A%;/:L8T Q@8KD_C1,MQ\/8YTY222-A^-=!:G_BV
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M;7__ #^Q_E1_PK:__P"?V/\ *@"[_P ++B_Y\F_.C_A9<7_/DWYU2_X5M?\
M_/['^5'_  K:_P#^?V/\J +O_"RXO^?)OSH_X67%_P ^3?G5+_A6U_\ \_L?
MY4?\*VO_ /G]C_*@"\/B9#_%8O\ @:7_ (69;_\ /A)^=4/^%:WW_/['^5'_
M  K6^_Y_H_RH O\ _"S+?_GPD_.C_A9EO_SX2_G5#_A6M]_S_1_E1_PK6^_Y
M_H_RH O_ /"S+;_GPD_.C_A9EO\ \^$GYU0_X5K??\_T?Y4?\*UOO^?Z/\J
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M** "BBB@ HHHH **** "BBB@ HHHH **** $//!JK<:?;72,KQ+D]\5;I.:
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M->AP?ZE?I7GD/_(UWW_7S)_Z$:]"@_U*_2@"3'-5[V]BL+9IYCA%&35BN?\
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M 5')$DJE74$'VJ2B@#G=0\)V5VK,$ 8UQ=_X2N[5V:*,L@Z&O5J8ZAUVGH:
M/&[?4M0TR4H-PQ75:/XVS\MV>G>NFO/#UE=@DQ@,1UQ7&:EX)GB9W@)(ZT =
MU9:O:7PS%(#^-7^O3&*\65[_ $J0C+J0:Z'2/&KP86Y):@#TCI1^%9.G^(;2
M_ VL ?K6JK*WW6!^E #9(HY5VNH.?:LB[\,6%UDL@!-;7>B@#S_4O _7[,,&
MN>N= U"Q&1&P([U[#4<T$<Z;74$?2@#R&UUW4;/Y06RO7-=!IOC9]P%P>>]=
M1=>&K&X0XB ;UKE[[P+(6+0'% '36GBBRNL , WO6S'-'(H9'4@^]>/WFB:A
MISA@7X]*(M=U"T ^=^.QH ]CZ]*.,UY]IOCD(@$X)KI['Q-9WN,, ?<T ;=%
M,2:-QE74_C3NM "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 (WW3]*\4TK_DJ<O^^:]K;[I^E>*:5_R5.7_?- 'ME%%% !11
M10 4GI2TGI0!ROC/_4Q?6MK0_P#D$P_2L7QG_J8OK6UH?_()A^E '$P_\C7?
M?]?,G_H1KT.#_4K]*\\A_P"1KOO^OF3_ -"->AP?ZE?I0 \UA:EK]C9W/V:^
MVK&W!+5NFN1\8^#!XGB^68Q.!P12&A#9^#+G,K"U8GG)(H&F>"\9$=I^8KY[
M\3^"_%>AZBT-L]Q-'V*DUA'2/&?3R;O]:$#1]0C3/!?:.T/Y58M8_"FGR>;;
MFUC8=P17RM_9'C/_ )XWGYFK%AX>\8WETD++=(K'!+$U1+9]6#Q5IDMP+>VN
M$E?_ &36U&WF1AL8S7E7@3X976CRQWU[=,\A&2I->K@8  Z"D,6BBB@ HHHH
M **** "BBB@ JCK'_('N_P#KF:O51UC_ ) ]W_US- 'A7PV_Y'.\_P"NAKZ"
M'W1]*^??AM_R.=Y_UT-?00^Z/I0 M%%% !1110 4444 %%%% !4$MK!/_K(P
M?PJ>DH P=0\,6=TIVQJN?:N8O? TT2L\!XKT6@\C!% 'C,NG:EI\AV;\>HJ>
MU\0:A8R#>['V->LM:02##1*?PK%U#PI:7N<*%^E &-9^.0-JS*.:Z6RUZSNU
M!\U5)[9KC-1\#/ A,&6[YK DL=2L3Q')QWH ]C2:-_NN#]#4E>16/B:^L7"L
M&9AZUTUAXY660)<+LH [:EK-M]<L;A01,H)[9J_'(D@RC B@!]%%% !1110
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M .>Z_G1_PE>E_P#/=?SH VF 88(R#67>:!97:MNC&\]ZA_X2O2_^>Z_G2?\
M"5Z7_P ]U_.@#E=1\#R([20\CTKG=NH:3,R@.N.F*]-_X2K2R<>>GYU3NM6T
M"Y4[WC+'O0!S>D^,YK<!;C)QZUV.G>)+2_P-X4UPNIV6F2,TD-PH'H#7-F^2
MSFQ%<8P>QH ]W#JPRK _2E]Z\GTKQA/:\M(9!Z5UECXUM[H@-A30!UE%8_\
MPDFGCK*H_&FGQ3IHZSK^= &U2UA_\)7I?_/=?SH_X2O2_P#GNOYT ;E%8?\
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M)7I?_/=?SH_X2O2_^>Z_G0!N45A_\)7I?_/=?SH_X2O2_P#GNOYT ;E%8?\
MPE>E_P#/=?SH_P"$KTO_ )[K^= &Y16'_P )7I?_ #W7\Z/^$KTO_GNOYT ;
ME%8?_"5Z7_SW7\Z/^$KTO_GNOYT ;E%8?_"5Z7_SW7\Z/^$KTO\ Y[K^= &T
M_P!QOI7BVE9_X6E+_OUZA_PE.ELC_P"D+P#WKR?P_>Q7OQ/EDA8%=W:@#W.B
MBB@ HHHH *3TI:3TH Y7QG_J8OK6UH?_ ""8?I6+XS_U,7UK:T/_ )!,/TH
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M]% &7%H%E$X=8QD>U:@ 50!VHI: $I:** &E5/!4'\*ISZ5:W'WXQS[5>I*
M,";PEI\N2$ /TK$O? ZMDPUW5+0!Y5+X/U*#)3)6LQ].U*P8D;Z]G(!&#5>2
MPMI?OQ@T >2PZYJ5L,&1ACM6A;>-+M' E)(KO9?#VG2]8!GZ5BWO@NWESY2@
M4 1V7CFVQB8UL6_BFPN>%?'U-<A+X'NHR3& 16/<:%J-HQ90W'I0!ZU#>PS_
M '''YU8W#U%>,1WNJVXP"ZXJY;^*=0MW'FLQ% 'K=&:X.R\<@+B49K7MO&5E
M.<$A30!TU%4;?5;6X7(E7\ZM":)ONNI_&@"2BDX/>EH **** "BBB@ HHHH
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M "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=I;7UM=1AXID8'WH L9HHZ],&EH 3-%%'&: #O2TTNB_>91]32"6/_GHOYT
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M$\BX7UJK=0ZV/.[KP#XDO(C;W&M?*>""]=E\//AG#X:_TF:032DYW9S7@?\
M;7C._=KF)KID8[@5SBO7?A/XYO9"-,U9F\[./GZTU?H)GMPZ4M(IR,CO2U(!
M1110 4444 %%%% !1110 51UC_D#W?\ US-7JHZQ_P @>[_ZYF@#PKX;?\CG
M>?\ 70U]!#[H^E?/OPV_Y'.\_P"NAKZ"'W1]* %HHHH **** "BBB@ HHHH
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M?$FYL=C79:9XP@NRJRX1O>@#JJ*@ANH)^8Y%8_6IN<T +1110 4444 %%%%
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MU6V-YIEQ;@9,B$"OD#Q1I=YX.\7M,5*YDW T ?85BB1V,*Q@;0@QBK'>O,O
MGQ,TW4=)A@NI@)E ')KK[KQCI%I$7>X7&,]: ///CE%"^F*9 -V.*\>\!>.G
M\*7FWGRR>:W/BOXY3Q+?BUL6W*#MXJSX)^$CZ[I/VFZ4JQY&10!Z=I?QATJ[
M13-(JFNDM_B)X?N /]+13[FO$]5^"FHQ,WV,OQTQ7*S_  S\66KD>7)@=P30
M!]5V_B72KD@1W2'/3FM*.XBE&4=3^-?'R:=XNT5@Q\["_6KB_$;Q1IH'F>:
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MD_A]XRB\4:0A9AYRCGFBUP.U'2EI!2T %%%% !1110 4444 %%%% !5'6/\
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MCI_Q#\3V$H,S3,H]0: /K\$'H:6OFZQ^-]U;;?M*MQ71VW[06G':LUN<^N*
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MM::%/(APVTUN8&:Y[QHN?#MPWHIJ)#CN>2^ /#":QXHDO[Z(2INS\W->R_\
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M'$V%]<UK6?QCU[3?D>-B1ZT ?5M%?-MA^T!J)G5;F !/6NQT_P"-EC,Z^<0
M>M 'L-%<5;?$[P].H+72+GKS6M9^,-$O1^YO$/XT ;]%58-0M+G_ %4Z-^-6
M01V(H 6C-)10 M%%)0 M%%% !1110 4444 %%%% !1110 4444 (!1SFEHH
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M0!ROC/\ U,7UK:T/_D$P_2L7QG_J8OK6UH?_ ""8?I0!Q,/_ "-=]_U\R?\
MH1KT*#_4K]*\]A_Y&N^_Z^9/_0C7H4'^H7Z4 B2JM_91:A:-;RC*L,&K5!(
MR>*3 \VNO@QX?NYVE9,,QSTJ'_A2'A[^[^E>E?:8!P9D_.C[5;_\]D_[ZH \
MU_X4EX=7EE^4=:70/#GA'0=<$-HZ_:@< 5Z'=7-L;:0&=!\I_BKP.Q4'XHY6
M4N-_8U<-P/H=<;1CI2TU/]6OTIU2 4444 %%%% !1110 4444 %4=8_Y ]W_
M -<S5ZJ.L?\ ('N_^N9H \*^&W_(YWG_ %T-?00^Z/I7S[\-O^1SO/\ KH:^
M@A]T?2@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M% "T4E% "T4E% !1110 M)THHH **** &LB/PR@_6J-QHFGW6?-MT;\*T**
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MI;_>H NZ;XHO;.7]\6*CUKL]-\7VUY@,0I[YKS6[O([@Y"[:K!C#@I(1GWH
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MFA92P7D@UQ#W<5CXG$4YQN;@FJOJ+H=[J$$<^EM'(H*[.E<1X4N#%K\EHG"
M\"NPU>\B@TAG\Q>5XYKE_"-J)M2>[QU/6B.[$WHCOZ***0RAJNL6>C6WVB]D
M\N/UKD]2^)7AF73+F-;T%F0@#UKHO$7AZW\1V!M+EB$]J\_OO@OHD%A/*)GR
MB$C)H X'P'XHTK3?%5U<W,@6)G)!S7LP^)WAC&?MPKPGP7X&L]9\2W%G,Y"(
MY YKU?\ X4EH?&)I/SH W_\ A9WAC_G^%'_"SO#'_/\ "L#_ (4EH?\ SVDH
M_P"%):'_ ,]I* -__A9WAC_G^%'_  L[PQ_S_"L#_A26A_\ /:2C_A26A_\
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M^?X4?\+.\,?\_P *P/\ A26A_P#/:2C_ (4EH?\ SVDH W_^%G>&/^?X4?\
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M'_"SO#'_ #_"L#_A26A_\]I*/^%):'_SVDH W_\ A9WAC_G^%'_"SO#'_/\
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M /A9WAC_ )_A1_PL[PQ_S_"L#_A26A_\]I*/^%):'_SUD_.@#?\ ^%G>&/\
MG^%'_"SO#'_/\*P/^%):'_SUDH_X4EH?_/:2@#?_ .%G>&/^?X4?\+.\,?\
M/\*P/^%):'_SVDH_X4EH?_/:2@#?_P"%G>&/^?Y:/^%G>&/^?X5@?\*2T/\
MY[24?\*2T/\ Y[24 ;__  L[PQ_S_"C_ (6=X8_Y_A6!_P *2T/_ )[24?\
M"DM#_P">TE &_P#\+-\+][X4T_$KPHW6]0_A6%_PI+0_^>TE'_"DM#_Y[24
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MY:&OH$?=&#7S]\-O^1SO/^NAKZ"7[H^E "T444 %%%% !1110 4444 %%%%
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M !0 ZBD%+0 4GI2TGI0!ROC/_4Q?6MK0_P#D$P_2L7QG_J8OK6UH?_()A^E
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@!*.:6B@!#FBEHH *8T4;_>0'ZBGT4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCS_=%24@&% ]*6@ I/2EI/2@#E?&?^IB^M;6A_\ ()A^E8OC/_4Q?6MK0_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:'_R"8?I6+XS_P!3%]:VM#_Y!,/TH XF'_D:[[_KYD_]"->AP?ZE?I7GD/\
MR-=]_P!?,G_H1KT.#_4K]* )**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ JCK'_ "![O_KF:O51UC_D#W?_ %S- 'A7PV_Y'.\_ZZ&OH(?='TKY
M]^&W_(YWG_70U]!#[H^E "T444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 C?<;Z5XII7_)4Y?]\U
M[6WW6^E>*:5_R5.7_?- 'ME%%% !1110 4GI2TGI0!ROC/\ U,7UK:T/_D$P
M_2L7QG_J8OK6UH?_ ""8?I0!Q,/_ "-=]_U\R?\ H1KT.#_4K]*\\A_Y&N^_
MZ^9/_0C7H<'^I7Z4 24444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!5'6/^0/=_\ 7,U>JCK'_('N_P#KF: /"OAM_P CG>?]=#7T$/NCZ5\^_#;_
M )'.\_ZZ&OH(?='TH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_D=+S_KH:^@UZ#Z4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGN3S:V.AHH%% Q*I:OSH]WS_ ,LS5;7[Z2RL]T0.ZN$O?$NH2:7= HV"I[4
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MR?E0!]39'K1D>M?+/_"V/$__ #SD_*C_ (6QXG_YYR?E0!]39'K1D>M?+/\
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MFR/6C(]:^6?^%L>)_P#GG)^5'_"V/$__ #SD_*@#ZFR/6C(]:^6?^%L>)_\
MGG)^5'_"V/$__/.3\J /J;(]:,CUKY9_X6QXG_YYR?E1_P +8\3_ //.3\J
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M()H'_/DGY5TM% '-?\()H'_/DGY4?\()H'_/DGY5TM% '&:OX&T)=.D(M47
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M_"C_ (030/\ GR3\JZ6B@#FO^$$T#_GR3\J/^$$T#_GR3\JZ6B@#FO\ A!-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2>E+2>E '
M*^,_]3%]:VM#_P"03#]*Q?&?^IB^M;6A_P#()A^E '$P_P#(UWW_ %\R?^A&
MO0X/]2OTKSR'_D:[[_KYD_\ 0C7H<'^I7Z4 24444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !111G'6@ HJM_:%GYOE_:8M_]W=S5F@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BJLNI64+[9;J)&]"U-&JZ>W2\A/_ Q0!<HIB2)(N48,/4&GT %%%%
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MMUKB$\.>/Q*+;S9/LX..O:O6O"6AOI6GK]HYF(YJEW$T=(.E% Z44ABT444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M44E &7K^H+IVF22E@"1@5PW@G19IM:FU23)5CD9KH?&FC7NLVJ0VI. <G%:W
MAS3WTW2(X)1AP.:8&O1112 **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@!*6BB@ I._2BF3!S"X0X;'% &;XB"OH\X+J,+W-
M<U\/0@AN")%^]TS7%^*-"\<W]],EK*_V=CV-9WASPEXXT?4D+2/Y#'YN::=T
M#5CL/B;9Z[?1[--1BHZ8KSQKWX@6&E-;-%)Y6,=#7T/8),MG&MR 9 .<BH]5
MM/M5A)"D:EF''%3:P[W/%_A?>^(FU)A.K>63\U>ZIDH,]<5R_A70YM)DF,R
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %)Z4M)Z4 <KXS_U,7UK:T/_ )!,/TK%
M\9_ZF+ZUM:'_ ,@F'Z4 <3#_ ,C7??\ 7S)_Z$:]#@_U*_2O/(?^1KOO^OF3
M_P!"->AP?ZE?I0!)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4E'>CUH 898U^](J_4XI5EC8X61
M6/H#7SO\7?%6L6>N"UL)G3_=-<OX6\>^*-%U)9KL7$T/4A@:2&U8^LN:#7GO
M@WXGVGBBX-N8_*E!P0:[Z6:*!"\KA%]2:=@ZDE%4X-5L+F3RX;J-W] :L2SQ
MP+NE<*/<TA$E'-,BFCF7=&X8>U(]Q#&VUY%4^A-,"6DYH5@PRIR*6@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ I/2EI/2@#E?&?^IB^M;6A_P#(
M)A^E8OC/_4Q?6MK0_P#D$P_2@#B8?^1KOO\ KYD_]"->AP?ZE?I7GD/_ "-=
M]_U\R?\ H1KT.#_4K]* )**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** $H/3\*6D[&@#Y[\3Q17'Q.
MCCG7<F_D&O9X_"^BS6"K]BB(9.NWVKQSQ N[XIQC(QOKW:.1+;3%DD(54CR3
MGVI+8J6Y\^>)K6/P;XQAEL%V*[]!7<:K=ZUXHL(+"V#QB1>9!7!^+KY/$OC.
M-+/]X(I.<5TFL^.M2T,6NGZ9:AI=H!..:I;(E[F-?Z!K7PXNH-3FO7FC)^8%
MJ[;7]8O/$'@Q=3LRR$+DXKRWQKXD\3ZG:Q1ZK;E(<CJ.M>R^!;:.\^'WD%00
MT>,?A1:T1K<R/A)X@N-32:"ZD)=,CDUD>+?$5X_CV.PMY2$WXP#7/1ZH/ >L
M719MH=C@5I>$;4>*O%*:N/F ;.:%KJ#W/;]+C>/3XA)G=M&<U<I%&% ]!BEI
M""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P ^Z?E0!RW_  G#_P#/JWY4?\)P_P#SZM^5=3_95C_S[I^5']E6/_/NGY4
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MW_"</_SZM^5'_"</_P ^K?E74_V58_\ /NGY4?V58_\ /NGY4 <M_P )P_\
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MGY4?V58_\^Z?E0!RW_"</_SZM^5'_"</_P ^K?E74_V58_\ /NGY4?V58_\
M/NGY4 <M_P )P_\ SZM^5'_"</\ \^K?E74_V58_\^Z?E1_95C_S[I^5 '+?
M\)P__/JWY4?\)P__ #ZM^5=3_95C_P ^Z?E1_95C_P ^Z?E0!RW_  G#_P#/
MJWY4?\)P_P#SZM^5=3_95C_S[I^5']E6/_/NGY4 <M_PG#_\^K?E1_PG#_\
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<YTB-HM,A1AR!3TTVS1MRP(#]*M  # &!0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>gguopuizh44n000006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gguopuizh44n000006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '<!Z # 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MAHLGL'M)P^-:'TK15/2M3MM8TRWO[20/#,@8$=O;\*N5!N%%&1G&:* "BD)
M&20![T @C((/TH 6L%_&?AY-;71FU*,:@S[!!L;)/IG&*WJ^>+S_ )+Y;_\
M7V/ZTTKF=2;C:Q]#T444C0YG4?B%X5TG4)K"^UB*&ZA;;)&8W)4]>PJK_P +
M3\%?]!Z'_OW)_P#$UX=XTM$U#XR7EE*2([B_BB8CKAMH/\Z]0_X47X=_Y^+G
M\S_C5V2W.=5*DF^5+0Z>W^)/A"Z?9#KD#,>Q1Q_,5TEM=V]Y$);:>.9#_$C
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M5"D><[5 S3=B8N5W<?112;ESC<,^F:10M9VL:[IGA^S%WJETMM 3MWLI//X
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M !112$@=2!]: %HHHZ4 %% ((R#FB@ HHI"RCJP'U- "T444 %%%% !1110
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M/W'!Y7^=#]Y7%']W/E>S#X\_\C!HO_7)_P":U['X8_Y%?3/^O=/Y5XY\>?\
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MT/Y5U_C+XF:!8:!=165]%>7<\9CCCB.<9&,FO/O#W@+6/B1(WB#6[SR8)?\
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MV/T('^%>G4Y;BHJT$%>>_&'0XM3\%37>T>?9$2(<<\G!'ZUZ%7+_ !%G2W\
MZM)(/E$0'YL!26XZB3B[G&_ C5'N/#MYISGBVES']&R3^M<_XE^(&KZ!\2YT
M>]G;3X'R;<,=I]L5:^ 4;>9JDF?D&T'ZURWB^T%_\7WM2NX2W"J1Z\U=ES,Y
MG)^RC8MO/\3_ ! #K-L=12!OFC$+%5P?05Z%XB\<7W@KP3IZWK"?79X\$/\
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M\5'\98--F),7G);;0?<T^57$JDO9^>Q8T_3/B;XTA_M&/4I;:WDY0/.T:GZ
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M\W<'2:5XO4XSXWS1W/@RQFB8-&\NY2.XXKBO#'BGQ1J.@V?AGPM;E)(5S-<
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M@ HHHH I:Q_R!+__ *]I/_037@?P(_Y':Z_Z\F_]"6O?=65GT:^55+,UO(
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M,RVOPFFM)D/G7T32%<<X89 KB_@=?QV7BC4;"5MDEP@VJ>^TG_&O?PBJ@15
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M (:TG4HOC,]S)I]VEOYLA\UH6"_=]<8KZ JI&%#9^I\]?%[_ )*18_\ ;/\
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MD#VKU#XL6]UJ?@"U^RVEQ+(Q1C&D19ATZ@#-#W0HWY9W1H?![_DG5C_O2?\
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M2:,H>.,X-)_"73O[1NUCL:***@Z0HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *CDMX9?]9#&_P#O*#4E% #(
MX8HO]7$B?[J@4^BB@ HHHH **** "BBB@ HHHH 0@$8(R*C6UMT;<L$2MZA
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M4 (JA5"J  .@ I:** (OLMN7WF"+=_>V#-2T44 %%%% !1110 4444 %%%%
M!1110 4444 ,DABE&)(D?_>4&E2-(UVHBJOHHP*=10 4444 %%%% !2$ C!&
M0:6B@" V=J6W&VA+>IC%3*H50%  '0 4M% !1110!&]O#*VZ2&-V'0LH-/ "
M@   #H!2T4 %%%% !1110 4R2*.48DC5QZ,N:?10 R.&*(8CC1!_LJ!3Z**
M"BBB@ HHHH **** $9%==KJ&'H1FF1P0PY\J)$SUVJ!4E% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 445GW>NZ1I\OE7FJ6=O
M)_=FG53^1- &A145M=6]Y")K6>.:)NCQL&!_$5+0 4444 %%%% !1110 445
MD^(]?M/#.B3ZI>!C%$/NJ.2?2@#6HKF?!GC6P\:Z?)=644D1C;:R/V_&NFH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHKSWXP:[J>@>$%N]*O)+6X,ZKO3&<?C0!Z%17SG:7?Q<G\/IX@BU.673_+,V
M?,CR5'7Y<9[5UW@_XW:7=:?';^(G>WU'>(QY<+,']#QTH ]>HK \0^,M%\+V
M%M>ZI/)'!<$",K$6)R,]![5F6OQ2\)7=P\*ZB49(A,3+&4&TX[GOSTH [*F2
MRQP1/+*ZI&@RS,< "N7T'XC^&/$FHFPTV_+7 Z+)&4W?3/6N@U2.VETNYCO
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%4KK5]
M-L9XX+O4+6WFD^Y'+,JLW;@$\U=!!&1R#0 4444 %%%% !15*ZU?3;&XCM[O
M4+6":3&R.6959L\# )YJZ#D9'2@ HHHH **SCKNE#5!IAO[?[:?^6/F#=],5
MHT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 45%<7,%I \]S-'#"@RTDC!57ZDTRSOK34(//LK
MJ&YBSC?"X=?S% %BBBB@ HHI"0 23@#J: %HK.CU_1YKL6D>JV3W).!"LZE\
M_3.:T: "BJ5WJ^FV$R0WFH6MO*_W4EF56;Z FBWU?3;NZ>VMM0M9KA/O11S*
MS+]0#F@"[1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% $=P9A;R& *9@IV!NA/;->3ZC;_%.:TO-7.K6^G1
MP%F6R1%;>H/4$@]1[UZY7G/Q8\;0>']"?2[=O,U*^78B+R5!ZD_R_&@#/TCX
MK2W7PVOM:FMT.H66(W0?=9CT/Z9KG?[?^(<'A=/&;ZU!)8,V\V/ECA>O7&?U
MJ73-(M/!/P?O)-?MS+)JA&(!P<D$KSV.*Y&Z\,>+-%\#6U_//]IT*;9/):"0
M_(,=#[<]J8'T5X8UG_A(?#=CJOE^6;F(.4]#3=?\5Z+X8A675KY+<-T7!9C^
M YKS_3O&OBB?1-/?PCX0BNM-$"KEI@NQQU7[W;BN&LI+SQA\9+>+Q/9BWDC/
MS6A;*H5Y"^XI 6/B5KVF^(?'?AJ\TNZ6X@_=#<."#YIZ@\BO8-4^(/ACPZ8[
M?4M42.;8,HBER..^T'%>2?%72+#2OB3H/V&UBMQ*8F=8UV@GS,=!]*W=8\6Z
M$?$5Q8:#X5BUG59%"S.\:E"0H'?I3 ]"B^('AF?19=7BU)7LX?\ 6,J,67ZK
MC/Z5IZ3K^FZWI(U33[D2V9S^\P1TZ\&OG3P!9RZCXPUS2+FV%L+J"59+93E8
MVW X'T(Q6GX4\1S>&/ WBK1;B0+<VKE(5/7)SNI >W^'_%^B^*&N!I%T;CR"
M!(?+90,Y]1STIVO^+-$\,0K)JU\EN&Z+@LQ_ <UR_P &]$&E>!+>X=<37I\X
MGOM/0?SKSZYCC\2_'UK34P7MX)"$C?H0O(&* *_Q'UW3?$/Q \-WFEW2W$!,
M(W#C!\T]0>E>U:QXRT#PS;P_VMJ$<#,HP@!9NGH.:\8^*FE6.D_$K0S86L<
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M)7.6;_ZU=)2 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_#D&J::_AS[.D;2QR36J--@9/+%.OXU[5XB\/V7B;1IM,OU)ADP<J<$$=#7
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3S6LL$G\1MI_Q5T#58=5T76K726")"FZ"&/(1PQ8C"]O\: ,N;_DN"?[R_\
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M-?4+..-)'N8E1_NL6X- %FBF>8@C\PN-F,[L\8J"'4K*XD\N&ZB=_P"ZK9-
M%JBH;BZM[50T\R1J>A8XIZ2QR1"1'#(1D,#Q0 ^BH(;VUN79(9XY&7J%;.*1
M;ZU>9H5N(S(O50W(H L45!!>6URS+!/'(R]0K9Q4] !17)>-/B#H_@RR,EU*
M)+EA^[@4\L:3P!XW3QSH\E^EJ;<(^W:6SF@#KJ*K_;[3[1Y'VB/SO[F[FK%
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MR._M)79$N(V9/O -TH L45634+.2)Y4N8FC3[S!N!1;W]I=,5@N8Y&'4*V:
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M  LP?]"]JO\ WY-'_"S!_P!"]JO_ 'Y-=WY<?]Q?RH\N/^XOY4 <)_PLP?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "L#QC_ ,B_-6_6!XQ_Y%^:@"UX;_Y %I_N"M6LKPW_ ,@"T_W!6K0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% ",-RD>HQ7GVD?"VVTGQU-XG6^D>21F
M;RB!@9.?2O0J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#.UK1;+7],EL+^(202#D&
MO)6_9]MUD?[/K]Y!$S$B-&P!^E>UT4 >>^"/A/I?@^[>],SWEX3\LTAY6O0J
M** "BBB@ HHHH **** "BBB@ IC0QM(':-2Z]&(Y%/HH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "O,/#?_)8]<_ZY?U%>GUYAX;_Y+'KG_7+^HH ]
M/HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "L#QC_P B_-6_6!XQ_P"1?FH M>&_^0!:?[@K5K*\
M-_\ ( M/]P5JT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %>8>&_^2QZY_UR_J*]/KS#PW_R6/7/
M^N7]10!Z?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %>8>&_\ DL>N?]<OZBO3Z\P\-_\ )8]<_P"N7]10!Z?1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M17!_\+3TW_H%:K_WX'^-'_"T]-_Z!6J_]^!_C0!WE%<'_P +3TW_ *!6J_\
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M)V4QQKN)(/!QF@#Z=HK@_P#A:>F_] K5?^_ _P :/^%IZ;_T"M5_[\#_ !H
M[RBN#_X6GIO_ $"M5_[\#_&C_A:>F_\ 0*U7_OP/\: .\HK@_P#A:>F_] K5
M?^_ _P :/^%IZ;_T"M5_[\#_ !H [RBN#_X6GIO_ $"M5_[\#_&C_A:>F_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P .^(O"'CI_&VGPK<P[RQP,[.<\U]"*JHH50 HX %-EACGC,<J*Z'JK#@T
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MQBF_"CPAKUYXH?QEJB"W6;+>61@MN.<BO:?[%TS_ )\8/^^!5U$6- B*%4#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *\P\-_P#)8]<_ZY?U%>GUYAX;_P"2QZY_UR_J* /3Z*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 88HVZHI^
MHIAM;8];>(_\ %344 5_L-I_SZP?]^Q43Z1ITC;FLH"?^N8J[10!0_L33/\
MGQ@_[X%87B[2-.CT&9ELX0?4(*ZRL#QC_P B_-0 SPWI.G_V':/]CA+; <E!
M6U]AL_\ GT@_[]BJ7AO_ ) %I_N"M6@"'[);#I;Q?]\"GB*->D:#Z**?10 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7F'AO_ )+'KG_7+^HKT^O,/#?_ "6/7/\ KE_44 >GT444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !6!XQ_Y%^:M^L#QC_R+\U %KPW_P @"T_W!6K65X;_ .0!:?[@
MK5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *\P\-_\ )8]<_P"N7]17I]>8>&_^2QZY_P!<OZB@
M#T^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK;4;5+FTF26%QE64YH L4444 %%%% !1110 4444 %%%% !7F'AO_DL>N?\
M7+^HKT^O,/#?_)8]<_ZY?U% 'I]%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5@>,0Y\/S".-I&[
M*HR:WZ0@$8(!^M '$Z)XJ2UT:WADL;D.BX(\LU-=_$.QL0//L;WGIMA)_I77
M>5'_ '%_*D,$3=8D/U44 <1_PM72/^?+4/\ P';_  H_X6KI'_/EJ'_@.W^%
M=M]F@_YX1_\ ? H^S0?\\(_^^!0!Q/\ PM72/^?+4/\ P';_  H_X6KI'_/E
MJ'_@.W^%=M]F@_YX1_\ ? H^S0?\\(_^^!0!Q/\ PM72/^?+4/\ P';_  H_
MX6KI'_/EJ'_@.W^%=M]F@_YX1_\ ? H^S0?\\(_^^!0!Q/\ PM72/^?+4/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
00 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>gguopuizh44n000008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gguopuizh44n000008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 8G!YX# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$;)W,QSESW]*J?$3XP:5X#NXM.BM?[3U-L--;I-Y8@0C(+-AL,>,+CIR<<9
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MS(1G!]#0!]%T45P?Q9\:ZEX$\*VNJ:7!:33RWJ6[+=(S*%*.V1M93G*#OZT
M=Y17E_P?^(^L?$#^V?[6MK&'[#Y'E_9(W7._S,YW,W]P=,=ZR_BS\6=>\">*
MK72]+M--F@ELDN&:ZC=F#%W7 VNHQA!V]: /9**^8!^T=XOSSINAX_ZX3?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%!B)RN7!&/F"]^>E>[_\(;\#/^?K0_\ P?-_\>H /^&CO!__ $#=<_[\0_\
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M'')M;J$'+,1D?NN>F1P5MXCO+;PA?^'4EG%M>7<-RP$Q"#8K@J4Z'<3&<_\
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MA^)O^PK=?^C6K[?KX@\=_P#)0_$W_85NO_1K5]?_ /"=^#_^AKT/_P &,/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-\O<8)D8K)"Q&"58?@<'*D@9!P*WZ* /"+[]FBRDNY&L/$T\%L<;(Y[02NO
MSE@Z@\Y_A']:K_\ #,H[^+O_ "F__;:]_HH \X\(?!7PMX3O+?4&6?4M1AV.
MDUT1LCD .61!P,DY&[<5P,'(S7H]%% 'B&A?L\?V)XATS5O^$I\[[#=Q7/E?
MV?MW['#;<^8<9QC.#7:?$OX:0_$6VTY6U-]/GL7<HXA$JLK@;@5RISE5P<^O
M!SQW=% 'BGAO]GJ'0O$NFZO/XE>Z2RN$N!"ED(R[(=RC<7; R!GCD9''4=7\
M3?AE_P +&_LO_B;_ -G_ &#S?^7;S=^_9_MKC&SWZUZ!10!Q_P ./ O_  K_
M ,/7&D_VC]O\Z[:Y\WR/*QE$7;C<W]S.<]ZY_P"(_P '_P#A8'B&WU;^W?L'
MDVBVWE?9/-SAW;=G>O\ ?QC':O4** .?\$^&?^$.\(6.@?;/MGV7S/W_ )7E
M[MTC/]W)QC=CKVKH*** .(^)7@"Y^(6G66GIK?\ 9UK;RF:1/L@F\U\84YW*
M5V@O]=WL*Q_AU\&K/P)KDVKS:I_:=T8C%!FU$0AS]YAEF.XCC((P"PYSQZ?1
M0 5@>-/"=GXU\+W6BWC>5YN&AG"!FAD!RK '\CC!*EAD9S6_10!XQX4^ ]SX
M4\4:?KEKXMWR6DNYH_[. \Q",.F3(<;E)&<<9R*G\;? S_A,?%]]K_\ PD?V
M/[5Y?[C[#YFW;&J?>\P9SMST[U[!10!GZ%IG]B>'M,TGSO.^PVD5MYNW;OV(
M%W8R<9QG&34FJ:78ZWI=QINI6T=S9W";)8G'##^8(."".00".15RB@#PC_AF
M[[/J/VK3O&$]KY<OF6Y^Q9DBP<K\XD7YAQR .1G KK/''PKOO'FEZ'!J7B2-
M+S34E66Y33^+@OL^;9YF%.$&<$@DG  XKTNB@#C_ (<>!?\ A7_AZXTG^T?M
M_G7;7/F^1Y6,HB[<;F_N9SGO5WQEX'T7QUI:6.L1/F)]\-Q"0LL1XSM)!&"!
M@@@@\=P".CHH \$N/V9X&N)&MO%4D<)<F-)+ .RKG@%A( 3CO@9]!48_9E'?
MQ<?_  6__;:]_HH Y3P;\.O#O@6-SI%L[74J;);RX??*Z[B<9X"CIPH&=HSD
MC-;^J:78ZWI=QINI6T=S9W";)8G'##^8(."".00".15RB@#Q36_V<-$N[CS=
M'UF[TY&=V>*:(7"@$_*J<J0!R/F+$\<\<Y?_  S+_P!3=_Y3?_MM>_T4 >.:
M!^SMX<T^19=9O[K5G5R?+4?9XF4K@ A26R#DY#CMQUSZ_!!#:V\=O;Q)#!$@
M2..-0JHH&  !P !VJ2B@#R_XC_!__A8'B&WU;^W?L'DVBVWE?9/-SAW;=G>O
M]_&,=J[#P3X9_P"$.\(6.@?;/MGV7S/W_E>7NW2,_P!W)QC=CKVKH** .8\=
M>!M+\>:$VGWZ^7<1Y:UNT7+P.>X]5.!E>^.Q (\WT+]GC^Q/$.F:M_PE/G?8
M;N*Y\K^S]N_8X;;GS#C.,9P:]OHH **** *>J:78ZWI=QINI6T=S9W";)8G'
M##^8(."".00".17D&M_LX:)=W'FZ/K-WIR,[L\4T0N% )^54Y4@#D?,6)XYX
MY]KHH \ _P"&9?\ J;O_ "F__;:W- _9V\.:?(LNLW]UJSJY/EJ/L\3*5P 0
MI+9!R<AQVXZY]CHH C@@AM;>.WMXDA@B0)''&H544#   X  [5Y'XV^!G_"8
M^+[[7_\ A(_L?VKR_P!Q]A\S;MC5/O>8,YVYZ=Z]@HH S]"TS^Q/#VF:3YWG
M?8;2*V\W;MW[$"[L9.,XSC)K0HHH **** *>J:78ZWI=QINI6T=S9W";)8G'
M##^8(."".00".17BE]^S1927DC:?XFGM[8XV1SV@E=>!G+!U!YS_  C\>M>[
MT4 >$6/[-%E'=QMJ'B:>XMAG?'!:")VX.,,78#G'\)_#K7M>EZ78Z)I=OINF
MVT=M9VZ;(HD'"C^9).22>222>35RB@ HHHH S]=TS^V_#VIZ3YWD_;K26V\W
M;NV;T*[L9&<9SC(KR_P3\#/^$.\7V.O_ /"1_;/LOF?N/L/E[MT;)][S#C&[
M/3M7L%% !6?KNF?VWX>U/2?.\G[=:2VWF[=VS>A7=C(SC.<9%:%% '@'_#,O
M_4W?^4W_ .VT?\,R_P#4W?\ E-_^VU[_ $4 > ?\,R_]3=_Y3?\ [;74:G\&
MKG4/A]H?A%/$_DVNFRRS22?8 WGNS,RG&_*[0[CJ<YSV%>KT4 >8?#KX-6?@
M37)M7FU3^T[HQ&*#-J(A#G[S#+,=Q'&01@%ASGCT^BB@# \:>$[/QKX7NM%O
M&\KS<-#.$#-#(#E6 /Y'&"5+#(SFO-_"GP'N?"GBC3]<M?%N^2TEW-'_ &<!
MYB$8=,F0XW*2,XXSD5[/10!X_P"-O@9_PF/B^^U__A(_L?VKR_W'V'S-NV-4
M^]Y@SG;GIWKU#0M,_L3P]IFD^=YWV&TBMO-V[=^Q N[&3C.,XR:T** *>J:7
M8ZWI=QINI6T=S9W";)8G'##^8(."".00".17BG_#-WV?4?M6G>,)[7RY?,MS
M]BS)%@Y7YQ(OS#CD <C.!7N]% %/2H+ZVTNW@U*]COKR--LMRD'DB4_WMF2
M<8S@XSG  X%RBB@".>"&ZMY+>XB2:"5"DD<BAE=2,$$'@@CM7D&O_L[>'-0D
M:71;^[TEV<'RV'VB)5"X( 8ALDX.2Y[\=,>QT4 > ?\ #,O_ %-W_E-_^VUT
MGA3X >'-#N!=:Q<2:W.C[HTDC\J%<%2,H"2QR#U)4AL%>]>MT4 %>>?$#X0Z
M)X[N/[0\Z33M6V!#=0H&64 C'F)QN( (!!!Y&<@ 5Z'10!X!_P ,R^GB[_RF
M_P#VVK%C^S191W<;7_B:>>V&=\<%H(G;@XPQ=@.<?PG^M>[T4 9F@>'=)\+Z
M6NFZ+91VEH'+[%))9CU)8DECT&23P .@%<%\1_@__P + \0V^K?V[]@\FT6V
M\K[)YN<.[;L[U_OXQCM7J%% '*>'O \.C?#@>#;B^>Y@:WGMY+F.,1,5E9R2
M 2P! ?'?I^%>5_\ #,O_ %-W_E-_^VU[_10!RFF^!X=+^&3^#(+YV1[&:U-T
M\8)W2AMS[01QN<D+GI@9/6N*\$_ S_A#O%]CK_\ PD?VS[+YG[C[#Y>[=&R?
M>\PXQNST[5[!10 5XYXH_9ZT36=4>^T?49-'$SL\MN(!+$"<?ZM<J4&<G&2.
M<#:!BO8Z* / /^&9?^IN_P#*;_\ ;:V/#W[.FA:=>&?6]3GU>,?<@2/[.G0@
M[L,6/4$8*].<YQ7L]% $<$$-K;QV]O$D,,2!(XXU"JB@8  '  ':O%-=_9X_
MMOQ#J>K?\)3Y/VZ[EN?*_L_=LWN6VY\P9QG&<"O;Z* / /\ AF7_ *F[_P I
MO_VVC_AF7_J;O_*;_P#;:]_HH \8U3X#W.I^']#T9O%NRUTF*58Q_9P.YY)6
M=G_UF1P47&3]S/<UU'PU^%MG\/!?3?;O[1OKO:OVAK<1^7&.=JC+'D\GG!PO
M'&3W]% !7(?$3P!9_$'0HK&:X^QW-O*);>Z$(D*=F4@X)4CJ 1R%/.,5U]%
M'E'@#X-7/@/Q.FL0>)_M,9B>&>W^P!/-0\@;B[;<,%;@?PX[FNW\;>&?^$Q\
M(7V@?;/L?VKR_P!_Y7F;=LBO]W(SG;CKWKH** /+_AQ\'_\ A7_B&XU;^W?M
M_G6C6WE?9/*QET;=G>W]S&,=Z]0HHH \?\;? S_A,?%]]K__  D?V/[5Y?[C
M[#YFW;&J?>\P9SMST[UZAH6F?V)X>TS2?.\[[#:16WF[=N_8@7=C)QG&<9-:
M%% $<\$-U;R6]Q$DT,J%)(Y%#*ZD8((/!!':O"+C]F>%KF5K;Q4\<!<F-)+
M.RKG@%A( 3CO@9]!7O=% '(?#OP!9_#[0I;&&X^V7,\IEN+HPB,OV50!DA0.
M@)/)8\9Q77T44 >/^-O@9_PF/B^^U_\ X2/[']J\O]Q]A\S;MC5/O>8,YVYZ
M=ZP/^&9?^IN_\IO_ -MKW^B@#P#_ (9E_P"IN_\ *;_]MKK_ (<?!_\ X5_X
MAN-6_MW[?YUHUMY7V3RL9=&W9WM_<QC'>O4** "BBB@ KQ_QM\#/^$Q\7WVO
M_P#"1_8_M7E_N/L/F;=L:I][S!G.W/3O7L%% &?H6F?V)X>TS2?.\[[#:16W
MF[=N_8@7=C)QG&<9-:%%% 'G'B_X*^%O%EY<:@JSZ;J,V]WFM2-DDA PSH>#
M@C)V[2V3DY.:X?\ X9E';Q=_Y3?_ +;7O]% 'A%C^S191W<;7_B:>>V&=\<%
MH(G;@XPQ=@.<?PG^M>L>$_!>A^"M.:ST6S\KS-IGF=BTDS 8!9C^)P,*"3@#
M)K?HH *Y_P ;>&?^$Q\(7V@?;/L?VKR_W_E>9MVR*_W<C.=N.O>N@HH \O\
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M! 1U4+C(&: +?CW1-.\1_M$^&M)U:W^T6,^E-YD6]DW;?M+#E2".0#P:Z_\
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M^_)\PX/3 7G/I=<QX&\<Z7X[T-;_ $]O+GCPMU:.V7@<]CZJ<'#=\=B"!T]
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M"@ J.>>&UMY+BXE2&&)"\DDC!510,DDG@ #O4E8'CK_DGOB7'_0*NO\ T4U
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9T4 %<?\1_ O_"P/#UOI/]H_8/)NUN?-\CS<X1UVXW+_ '\YSVKL** //_\
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M+_$6D>(==U;0?'/]F_VQ=M<S1?V3'-C+NRKEW/3>1D 9K0_X1+XA_P#13_\
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M'0]F&?U(.02#L44 >?\ PR^&7_"NO[4_XF_]H?;_ "O^7;RMFS?_ +;9SO\
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M9@;/RD\S(QO.YCM(R.!D9!YQ@^_44 <9\.=&\7>']&?3/$]_IMY#;I''8-:
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M* ./\7^!?^$K\0^&-6_M'[+_ &'=_:?*\C?Y_P \;;<[AM_U>,X/7VKL***
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MK,9P.GO1J/@7[?\ %#2?&G]H^7_9]HUM]C\C/F9$HW;]W'^MZ;3]WWX["B@
MKSCXB?!_2_'EW%J,5U_9>IKA9KA(?,$Z 8 9=RY8<8;/3@YXQZ/10!S_ /PC
M/_%O/^$4^V?\PK^S?M7E?],O+W[,_CC/MFN/T3X;^,O#FCP:3I/Q'^SV,&[R
MXO[#A?;N8L>68D\DGDUZA10!Y3K'PM\8Z]O74?BA?/&\1A>*&P\F-T.<ADCD
M"MG)!R.1Q79^#? ^B^!=+>QTB)R97WS7$Q#2S'G&X@ 8 .   !R>I)/1T4 >
M?^+/AUJ.O>.;#Q7I/B7^R+ZRM/LT?^@+<=Y,M\S <B0C!!]:/^$2^(?_ $4_
M_P H%O\ XUZ!10!Y_P#\(E\0_P#HI_\ Y0+?_&F>//AK?>/M4M?MWB:2VT6W
M=673H+3EC_$Q<O@N1D E<*#TY;=Z'10!3TO2['1-+M]-TVVCMK.W39%$@X4?
MS))R23R223R:Y3XA_#/2_B!9Q&:3[%J<&!#?)'O(3.2C+D;EZD<C!Y'4@]O1
M0!S%M::IX=\!7D&K>)OM%Q9VDI75VLOGB14)#NFYO,9<9_VL#()R3'\-=3U?
M6?A[I.I:X[R:A<)([N\0C++YC;#M  P4VD$#D8/>NKHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:"9A;JK,R%1@D9^8=2,' ^8T >]WU[;Z;I]S?W<GEVUM$TTS[2=J*"6.!R<
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M0!@?"#4;S1_B'XD\!Q:A]MT33_.EM3)DO$RRJI4$A?[YW#&W<I*\$EKWQ?\
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MQ-T+Q9XIO] TM+IY[)9':X8(89%1PF496)()8$''(H Y+P]_R=#XL_[!2?\
MH-K7L%>$-H'_  D?[2'BBS_M?5=+V:?%+YVF7/D2-B.W&TM@Y7G./4#TKM_^
M%6?]3[XY_P#!Q_\ 84 <_P#M'?\ )/-/_P"PK'_Z*EKH/C;_ ,DAUW_MW_\
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MH9HSO6+:F"QZ;X\DYW"( C!X^CZ "O/_ (V_\DAUW_MW_P#1\=>@5Y_\;?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<QX^\)W'C7
MPO)H<&J_V;'-*C3R?9Q-YB*<[,$C'S!3D'^''<UT]% &1X6\/V_A7POI^AVI
MW1VD00O@CS'/+O@DXW,6.,\9P*UZ** . TOX9_V+\4+WQAI^K^3;WV_[1I_V
M;=OW@%OWA<D9D ?@#^[TJ_\ #CP+_P *_P##UQI/]H_;_.NVN?-\CRL91%VX
MW-_<SG/>NPHH CG@ANK>2WN(DF@E0I)'(H974C!!!X(([5YAX>^"=CX8^(</
MB;3-5D2S@>1HM/>#<4#QLFWS=V< L2,J3@ $D\UZG10!P_C[P!<>,]1T&_L]
M;_LJZT>5YH7^R"?+DQE3@L!P8QUSG-5_^$2^(?\ T4__ ,H%O_C7H%% 'D,7
MP-?4-0MYO%OC+5=?MK?)CMY=R<DJ2-S.Y"D+@A<'IR,5ZU!!#:V\=O;Q)#!$
M@2..-0JHH&  !P !VJ2B@ HHHH X_3O OV#XH:MXT_M'S/[0M%MOL?D8\O B
M&[?NY_U73:/O>W/8444 <?J/@7[?\4-)\:?VCY?]GVC6WV/R,^9D2C=OW<?Z
MWIM/W??CL*** .?\;>&?^$Q\(7V@?;/L?VKR_P!_Y7F;=LBO]W(SG;CKWH_X
M1G_BWG_"*?;/^85_9OVKRO\ IEY>_9G\<9]LUT%% 'E^B?#?QEX<T>#2=)^(
M_P!GL8-WEQ?V'"^W<Q8\LQ)Y)/)K0_X1+XA_]%/_ /*!;_XUZ!10!S_AG2?$
M6E_:O[>\4?VYYFSR?] CMO)QG=]PG=G(Z]-OO70444 <?J/@7[?\4-)\:?VC
MY?\ 9]HUM]C\C/F9$HW;]W'^MZ;3]WWX["BB@#SCXB?!_2_'EW%J,5U_9>IK
MA9KA(?,$Z 8 9=RY8<8;/3@YXQH>(? %QK7PUL/!T&M_9([>&W@GN/L@D\](
ME QM+#;EE5N#VQSDUV]% &1X6\/V_A7POI^AVIW1VD00O@CS'/+O@DXW,6.,
M\9P*UZ** . TOX9_V+\4+WQAI^K^3;WV_P"T:?\ 9MV_> 6_>%R1F0!^ /[O
M2J?BKX.V.M>(#XAT/5[OP]K#ONEGM!E7)#!FP"I5VR,D-@\Y!))KTNB@#S#_
M (5UXY_LG^S/^%J7WV?^_P#V</.^]N_UWF>9U_VNG'3BM#P/\*=+\'ZA+K%Q
M>3ZOKLV[??70^Z6)+,B\D,P."Q8D\X(!(/?T4 >;ZG\--9D^(&I>+M#\7_V3
M=7T20LG]FI/M0*@(R[8Y,8/0>E+>^!O'U_:/;3?%&=8WQDP:/%"_!SPZ.&'3
ML?:O1Z* /-?"OP=L=%\0#Q#KFKW?B'6$?=%/=C"H0%"MM)8LZX."6P., $ U
MI_$GP!<?$'3K&P76_P"SK6WF,TB?91-YKXPISN4K@%_KN]A7;T4 5[&RM]-T
M^VL+2/R[:VB6&%-Q.U% "C)Y. !UJQ110!P'@7X9_P#"!^(=8O;'5]^F:AG;
MI_V;'E8<F/\ >%V9MJLR]LYR>@J/Q1\(](UK5'UO1[V[\/Z\SLYOK%R S-@,
M64$<D;AE2N2Q)W5Z'10!XSJWP0UK7K2"VU;QW]M$'$<T^D(\^,L=IF,GF%<L
MWREB/;@5EQ_ GQ%X8U33M5\'^)+7^T($D$LU[#L 8Y7**%<8*-@@]",@\X7W
MJB@"O8_;/[/MO[0\C[;Y2_:/L^?+\S W;,\[<YQGG%6*** /+[;X7^(M(\0Z
M[JV@^.?[-_MB[:YFB_LF.;&7=E7+N>F\C( S5V?P9\0;BWD@D^*$@21"C&/1
M(48 C'#*P*GW!!':O0Z* .$\&_#"Q\,:I)KE_J-WKFOR)L;4+TY*CD?("20=
MNU22Q.!@8!(JWXO\"_\ "5^(?#&K?VC]E_L.[^T^5Y&_S_GC;;G<-O\ J\9P
M>OM7844 1SP0W5O);W$230RH4DCD4,KJ1@@@\$$=J\IO_@7:6VJ&_P#"'B/4
MO#;NA25(&:0%?EX4[U8#*Y(+-DXQC%>M44 >6:S\,_&?B"W^SZC\3[MH"C(T
M<&FK KJPPP<1R*'&.S9ZGU-=1X-^'7AWP-'(=)MG:ZE39+>7#[Y77<3C/ 4=
M.% SM&<D9KJZ* "N/U'P+]O^*&D^-/[1\O\ L^T:V^Q^1GS,B4;M^[C_ %O3
M:?N^_'844 %</X^\ 7'C/4=!O[/6_P"RKK1Y7FA?[()\N3&5."P'!C'7.<UW
M%% 'G_\ PB7Q#_Z*?_Y0+?\ QH_X1+XA_P#13_\ R@6_^->@44 4[>R=M&BL
M=4E34'-N(;J22%56X.W#DIT ;GY>G.*\MF^!KZ?J%Q-X2\9:KH%M<8,EO%N?
MD%B!N5T)4!L -D]>3FO7J* /+-1^%WBO7+A?[9^)FI36C)Y4]O:V8MEEB).Y
M2$?;D@D9*GMG(&*[3PGX+T/P5IS6>BVGE>9M,\SL6DF8# +,?Q.!A02< 9-;
M]% ''Z=X%^P?%#5O&G]H^9_:%HMM]C\C'EX$0W;]W/\ JNFT?>]N>PHHH X_
MXC^!?^%@>'K?2?[1^P>3=K<^;Y'FYPCKMQN7^_G.>U:'C;PS_P )CX0OM ^V
M?8_M7E_O_*\S;MD5_NY&<[<=>]=!10!GZ%IG]B>'M,TGSO.^PVD5MYNW;OV(
M%W8R<9QG&35?Q-X9TOQ=H<VD:O!YMO)RK+P\3CHZ'LPS^I!R"0=BB@#S_P"&
M7PR_X5U_:G_$W_M#[?Y7_+MY6S9O_P!MLYW^W2I?''PG\.^-WDO)TDLM69 H
MOK<\MA2%WJ>' R/1L*!N %=W10!YA:_#KQS9Z?-91?%2^:&;=N:;3Q+(,C!V
MR-(77CI@C!Y&#3-"^"&D6^J-JWB?4[OQ+J!<,'O,A.-NW<I9BY&W'S,5(.-O
M%>I44 %>3^'/A3XJ\(Z=)8:'\0_LEK)*9F3^Q8I,N0 3EW)Z*/RKUBB@#S__
M (1+XA_]%/\ _*!;_P"-=+!X?>\\*'1/%%VFNM*C)<S/;K")@6)7Y%.%*C:
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M-\83ZMX=\1/;:7<./.TJ:V,JLG]W?O!R"3M;&1G!W?-N]+HH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBN#\:_%G0? FLPZ7JEIJ4T\MNMPK6L:,
MH4LRX.YU.<H>WI0!WE%>0?\ #1W@_P#Z!NN?]^(O_CM=1X.^*_A;QK=_8=/G
MGM[\[BEK>1A'D50"2I!*GJ>,[OE)Q@9H [>BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?^3CS/LEPDNS.<9VDXS@]?0U)J6K:;HUNMQJFH6EC S[%DNIEB4M@G +$#.
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M_GMHWY2?X4>7XR_Y[:-^4G^% '245S?E^,O^>VC?E)_A1Y?C+_GMHWY2?X4
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M_GMHWY2?X4>7XR_Y[:-^4G^% '245S?E^,O^>VC?E)_A1Y?C+_GMHWY2?X4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAO\ \@*Y_P"OD_\ H*UUT_\ Q[R_[A_E7(_#?_D!7/\ U\G_ -!6@#LJ***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBN#^+/
MC74O GA6UU32X+2:>6]2W9;I&90I1VR-K*<Y0=_6@#O**Y?X=^)+SQ=X$TW7
M+^.".ZNO-WI I"#;*Z# ))Z*.]=10 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7G/Q1_Y"'A3_L(_T%>C5YS\4?\ D(>%/^PC_04 >C4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 1S_\ 'O+_ +A_E7(_
M#?\ Y 5S_P!?)_\ 05KKI_\ CWE_W#_*N1^&_P#R KG_ *^3_P"@K0!V5%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_*@#TBBN/^%NMZCXC^'&DZMJUQ]HOI_.\R78J;MLSJ.%  X ' KL* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *\Y^*/_ "$/"G_81_H*]&KS
MGXH_\A#PI_V$?Z"@#T:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BD9E1&=V"JHR23@ 5YGXJ^./ACP_(]O8>9K-S'_K!:$>4G..9.G4CIF@"
M;XP?$%/!GAPVEG(/[8OT*0 =8DZ-(?IT'O\ 0UY'\$OB+_PCNN-H>JSG^S-1
MD&R1VXAF/ )/HW /O@^M>>>*?$M]XM\176LZ@V99V^5 ?EB0?=1?8#^I[UC4
M ??]%>3?!'XAGQ1HIT/4I2VK:?&-KL>9X1@!O]Y<@'Z@]S7K- !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI(+'<5!.2 :$\/:8FC7>DF"22TO$=+GS9Y)))@Z[6WR,Q=CMPH);(  & !@
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MK=% %(7MQM!_LN[&5)QNBX/I]_K^E*;V<9_XEEV?N_Q1=QS_ !]NA_3-7**
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MBQC^]]_./U]J;]MN-H/]EW>2N[&Z+@YQC[_7OZ<]:NT4 4S>3_\ 0,NCRO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO^X?Y5R/PW_Y 5S_ -?)_P#05H [*BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6=/(8,P(NDY"C+'KV )/I2'Q%H:JS-K.G!50.2;I,!3T/7H<C!]Z -.BL_\
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MNM,'B+0RJL-9TXJR&0$728*@D%NO0$$9]J +\_\ Q[R_[A_E7(_#?_D!7/\
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M<9_$@^QH ]+U#4K+2;*2\U"[AM;:,?-+,X11^)K \+>/]$\97U[;:*;N:.T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH CG_X]Y?\ </\
M*N1^&_\ R KG_KY/_H*UUT__ ![R_P"X?Y5R/PW_ .0%<_\ 7R?_ $%: .RH
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O.?BC_ ,A#
MPI_V$?Z"O1J\Y^*/_(0\*?\ 81_H* /1J*** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M".?_ (]Y?]P_RKD?AO\ \@*Y_P"OD_\ H*UUT_\ Q[R_[A_E7(_#?_D!7/\
MU\G_ -!6@#LJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ KSGXH_\A#PI_V$?Z"O1J\Y^*/_ "$/"G_81_H* /1J*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\JY'X;_\@*Y_Z^3_ .@K0!V5%%% !1110 4444 %%%% !1110 4444 %%%%
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M!S5?Q1I-E?7%E=7GA2/Q ($EC5"8F:+>4.0DS*A!V<MNW#  !#,1EQZ%J/\
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MJR4 "'@ J/G;H>O>@"[15(Z59,"##P0%/SMT'3O3CIEF7WF'YMY?.X]3U[T
M6Z*I?V38[=OD<!=OWVZ9SZ^M+_95D?\ ECW4_?/88'>@"Y15,:79C_ECT+'[
MQ_B&#WI/[*LMI7R>"NP_.W3.?7U% %VBJG]FVF_?Y/S;P^=Q^\.AZTT:59*
M!#P 5'SMT/7O0!=HJD=*LF!!AX("GYVZ#IWIW]FVF_?Y/S;R^=Q^\>IZT 6Z
M*I?V59;0OD\!=@^=NF<^OJ:4Z79G_ECU*G[Q_A&!WH N453_ +*LA_RQ[L?O
MGN,'O2?V38[=OD<%=OWVZ9SZ^M %VBJ@TRS#[Q#\V\/G<>HZ=Z:-*LE  AX
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M[(8Q#TW?Q'^(8/>@"Y15(Z59%2##P5"GYVZ#\:=_9MIOW^3\V_S,[C][UZT
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M_AUKE/ 5_:66FS6MU<1PS27!95<XR-JCKT[5#JP3Y7)7+5*;7,D['=44459
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MP./PKI:AM;6&SMDM[>,1Q(,*HJ:O9HP<*:BW>QXU::G4<DK7"BBBM3(****
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M'+&V<,I[<5A:;\//!^DD-9^&].5P<AY(!(P^C-DBNFHH :B)&@2-%1!P%48
MIU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $5S
M;6]Y;O;W4$4\#C#QRH&5OJ#P:S/^$3\-_P#0OZ5_X!1_X5L44 8__")^&_\
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MU.:?F5;BY6#R!@$95B"3R> >,5PZ'XC_  WCV-"GB[08_P"*,;+N)?<<EO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KSGXH_P#(0\*?
M]A'^@KT:O.?BC_R$/"G_ &$?Z"@#T:BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BD)"J68@ #))[5XSXE\6:M\2M:E\'>!Y3'IJ?+J>L#.S9T*J?0
M\CCENV%R2 3>+?&VJ^-=;D\$^ I,G[NHZLI^2%.A"L/RR.3T'K7>^"_!.E>!
M]%6PTZ/=(V&N+EP/,G;U/MZ#M^9,_A+PCI7@S1(],TJ':H^:65N7F?NS'U_0
M=JW: "BBB@ HHHH **** "BBB@ HHHH ***C>>&-@KRHK'H&8 T7L%KDE% (
M(R.0:* "BBFNZQHSNP5%&69C@ >IH =17(W_ ,4/ ^FMMN/$M@Q!P1 YF_\
M0 :L^)?& T'3+.]L]%U76A>#,*Z;;F3 P""WH#GC@T =+17%>&?%?BG7=8$5
M_P""9])TS82;JYNU+ANP\O:#ST]O6J^MZ-\2=2UFY&G^*-,TK2BW[GRK3S9@
MO^UN&,^X- '>U3NM6TVQD6.\U"TMW<@*LTRH23T !-8VG^%KH>$[C0]=UV\U
M=KC<)+O'D.%./E7:<@<=R>I'3BL?3O@SX$T^43?V*+J8-NWW<SRY/NI.T_E0
M!K^*_'WASP684UN^:&6=2T421,[.!UZ# _$BH?"GC^P\87L\%AI6L0Q11[_M
M5W:>7"_(&%;)YYZ$#H:ZEXHY&5GC5F0Y4D9(^E/H \ZU#5_BI<ZA<6^E>&-'
MLK99&6.YO;SS=ZYX8!"",CG!%=!+I7B35?!JV%]K46G:T_\ K;S3(R47YLX4
M/SR,#/%=+10!Y]I7PJCM-4MM3U+Q7XCU2[MY!(OG7I6,D'(^4<X]LXKIM3\'
M>&]:U)=1U/1+&\NU0())X0_RCH"#P>O>MNB@"M9Z?9:=#Y-C9V]K%UV01!%_
M("K-%% !1110 4444 %<AXK^&GAKQ<QGO;/[/?CE;ZT/ES ]B2.&_$&NOHH
M\D)^)7P\.3_Q6.A)]5O(E_4M_P"/?A76^$_B3X:\88AL;SR+\</8W0\N93W
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M ,)'HSZ=_:=_IVY@WGV$OER<=LX/![BN+_X4KI+R;Y_$WBJ<XQ^\U$'^29H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"I]DGW[O[1NL;PVW;'C']W[F<'\_>FBRN  #JEV< C)6+G/?[G;_ /7FKM%
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M !1110 4444 %><_%'_D(>%/^PC_ $%>C5YS\4?^0AX4_P"PC_04 >C4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@".?_CWE_P!P_P JY'X;_P#("N?^OD_^@K773_\ 'O+_ +A_E7(_#?\
MY 5S_P!?)_\ 05H [*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *\Y^*/\ R$/"G_81_H*]&KSGXH_\A#PI_P!A'^@H ]&HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY74]QGCU- &C169Y^N[ ?[.T[=LR1]O?&[/3/D],8.?7C'>E,^M]M/T_JO\
MR_/TQ\W_ "Q['&/7VZ4 :5%9PFUKC.GZ?U?.+Y^F/E_Y9=SU]/?I3?/US82-
M.T[=Y8('V]\%\C(SY/3&3GUXQWH TZ*SQ-K'FX-C8^7Y@&[[:^=G=L>5][VS
M@^HIBSZYM7=IVG!MK%@+]R W\(_U/(/&3V]#0!IT5F-/KFUMNG:<6VJ5!OW
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M._J* -"BLU9];PN[3]/!PV<7SG!Q\O\ RQ[G&?3WZ4AGUS:VW3M.+; 0#?N
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M_7R?_05K=N)M:^SR_P#$OL/N+_R_/W'S_P#++L>GKWV]*POAO_R KG_KY/\
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MO^X?Y5R/PW_Y 5S_ -?)_P#05H [*BBB@ HHHH **** "BBB@ HHHH ****
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M $%: .RHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O.
M?BC_ ,A#PI_V$?Z"O1J\Y^*/_(0\*?\ 81_H* /1J*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@".?_CWE_W#_*N1^&__
M " KG_KY/_H*UUT__'O+_N'^5<C\-_\ D!7/_7R?_05H [*BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *\Y^*/_ "$/"G_81_H*]&KS
MGXH_\A#PI_V$?Z"@#T:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KDY]
M&U?Q+=NNM,+/2HWPEE!)EI\'@NP[>P_3K7644U)K8=SF;_P?;HZ7F@N-*U")
M=J/$O[N0?W77H1[]?K6OH\VI3V .JVL=M=*Q5ECDW*V/XAZ ^E7Z*;DVK,+A
M1114B"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M (Y_^/>7_</\JY'X;_\ ("N?^OD_^@K773_\>\O^X?Y5R/PW_P"0%<_]?)_]
M!6@#LJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KSGX
MH_\ (0\*?]A'^@KT:O.?BC_R$/"G_81_H* /1J*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/T[_ * /B/\ \%K?XUW%% '#_P#"S]._Z /B/_P6M_C1_P +/T[_ * /B/\
M\%K?XUW%% '#_P#"S]._Z /B/_P6M_C1_P +/T[_ * /B/\ \%K?XUW%% '#
M_P#"S]._Z /B/_P6M_C1_P +/T[_ * /B/\ \%K?XUW%% '#_P#"S]._Z /B
M/_P6M_C1_P +/T[_ * /B/\ \%K?XUW%% '#_P#"S]._Z /B/_P6M_C1_P +
M/T[_ * /B/\ \%K?XUW%% '#_P#"S]._Z /B/_P6M_C1_P +/T[_ * /B/\
M\%K?XUW%% '#_P#"S]._Z /B/_P6M_C1_P +/T[_ * /B/\ \%K?XUW%% '#
M_P#"S]._Z /B/_P6M_C1_P +/T[_ * /B/\ \%K?XUW%% '#_P#"S]._Z /B
M/_P6M_C1_P +/T[_ * /B/\ \%K?XUW%% '#_P#"S]._Z /B/_P6M_C1_P +
M/T[_ * /B/\ \%K?XUW%% '#_P#"S]._Z /B/_P6M_C1_P +/T[_ * /B/\
M\%K?XUW%% '#_P#"S]._Z /B/_P6M_C1_P +/T[_ * /B/\ \%K?XUW%% '#
M_P#"S]._Z /B/_P6M_C1_P +/T[_ * /B/\ \%K?XUW%% '#_P#"S]._Z /B
M/_P6M_C1_P +/T[_ * /B/\ \%K?XUW%% '#_P#"S]._Z /B/_P6M_C1_P +
M/T[_ * /B/\ \%K?XUW%% '#_P#"S]._Z /B/_P6M_C1_P +/T[_ * /B/\
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M/_PL_3O^@#XC_P#!:W^-'_"S]._Z /B/_P %K?XUW%% '#_\+/T[_H ^(_\
MP6M_C1_PL_3O^@#XC_\ !:W^-=Q10!P__"S]._Z /B/_ ,%K?XT?\+/T[_H
M^(__  6M_C7<44 </_PL_3O^@#XC_P#!:W^-'_"S]._Z /B/_P %K?XUW%%
M'#_\+/T[_H ^(_\ P6M_C1_PL_3O^@#XC_\ !:W^-=Q10!P__"S]._Z /B/_
M ,%K?XT?\+/T[_H ^(__  6M_C7<44 </_PL_3O^@#XC_P#!:W^-'_"S]._Z
M /B/_P %K?XUW%% '#_\+/T[_H ^(_\ P6M_C1_PL_3O^@#XC_\ !:W^-=Q1
M0!P__"S]._Z /B/_ ,%K?XT?\+/T[_H ^(__  6M_C7<44 </_PL_3O^@#XC
M_P#!:W^-'_"S]._Z /B/_P %K?XUW%% '#_\+/T[_H ^(_\ P6M_C1_PL_3O
M^@#XC_\ !:W^-=Q10!P__"S]._Z /B/_ ,%K?XT?\+/T[_H ^(__  6M_C7<
M44 >>7OQ/3[18?8]"\0>5]H_TK?IK9,7EOTYZ[]GX9JW_P +/T[_ * /B/\
M\%K?XUW%% '#_P#"S]._Z /B/_P6M_C1_P +/T[_ * /B/\ \%K?XUW%% '#
M_P#"S]._Z /B/_P6M_C1_P +/T[_ * /B/\ \%K?XUW%% '#_P#"S]._Z /B
M/_P6M_C1_P +/T[_ * /B/\ \%K?XUW%% '#_P#"S]._Z /B/_P6M_C1_P +
M/T[_ * /B/\ \%K?XUW%% '#_P#"S]._Z /B/_P6M_C1_P +/T[_ * /B/\
M\%K?XUW%% '#_P#"S]._Z /B/_P6M_C1_P +/T[_ * /B/\ \%K?XUW%% '#
M_P#"S]._Z /B/_P6M_C1_P +/T[_ * /B/\ \%K?XUW%% '#_P#"S]._Z /B
M/_P6M_C1_P +/T[_ * /B/\ \%K?XUW%% '#_P#"S]._Z /B/_P6M_C1_P +
M/T[_ * /B/\ \%K?XUW%% '#_P#"S]._Z /B/_P6M_C1_P +/T[_ * /B/\
M\%K?XUW%% '#_P#"S]._Z /B/_P6M_C1_P +/T[_ * /B/\ \%K?XUW%% '#
M_P#"S]._Z /B/_P6M_C1_P +/T[_ * /B/\ \%K?XUW%% '#_P#"S]._Z /B
M/_P6M_C1_P +/T[_ * /B/\ \%K?XUW%% '#_P#"S]._Z /B/_P6M_C1_P +
M/T[_ * /B/\ \%K?XUW%% '#_P#"S]._Z /B/_P6M_C1_P +/T[_ * /B/\
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M_!:W^-=Q10!P_P#PL_3O^@#XC_\ !:W^-'_"S]._Z /B/_P6M_C7<44 </\
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M/T[_ * /B/\ \%K?XT?\+/T[_H ^(_\ P6M_C7<44 </_P +/T[_ * /B/\
M\%K?XT?\+/T[_H ^(_\ P6M_C7<44 </_P +/T[_ * /B/\ \%K?XT?\+/T[
M_H ^(_\ P6M_C7<44 </_P +/T[_ * /B/\ \%K?XT?\+/T[_H ^(_\ P6M_
MC7<44 </_P +/T[_ * /B/\ \%K?XT?\+/T[_H ^(_\ P6M_C7<44 </_P +
M/T[_ * /B/\ \%K?XT?\+/T[_H ^(_\ P6M_C7<44 </_P +/T[_ * /B/\
M\%K?XT?\+/T[_H ^(_\ P6M_C7<44 </_P +/T[_ * /B/\ \%K?XT?\+/T[
M_H ^(_\ P6M_C7<44 </_P +/T[_ * /B/\ \%K?XT?\+/T[_H ^(_\ P6M_
MC7<44 </_P +/T[_ * /B/\ \%K?XT?\+/T[_H ^(_\ P6M_C7<44 </_P +
M/T[_ * /B/\ \%K?XT?\+/T[_H ^(_\ P6M_C7<44 </_P +/T[_ * /B/\
M\%K?XT?\+/T[_H ^(_\ P6M_C7<44 </_P +/T[_ * /B/\ \%K?XT?\+/T[
M_H ^(_\ P6M_C7<44 </_P +/T[_ * /B/\ \%K?XT?\+/T[_H ^(_\ P6M_
MC7<44 </_P +/T[_ * /B/\ \%K?XT?\+/T[_H ^(_\ P6M_C7<44 </_P +
M/T[_ * /B/\ \%K?XT?\+/T[_H ^(_\ P6M_C7<44 <++\3=/>)U&A>(\LI
MSIK?XT[X6+>_\(M-)?6TL$DEY*566,HVS.%.#ST KN** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "J]\EY)9R+83P071QLDGA,J+R,Y4,I/&?XA
MZ\]*L44 <OX:@N-0\)SVMWJ=]+)_:%["]UY@69T2[E7&X ;<JNWY NT?=VD
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MC<!G#,,X)R ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M &E<O"N[.?W32%#R2>1UYZUH?V)IW]C_ -E?9_\ 1.NW>V_=NW>9OSN\S?\
M/OSNW?-G/- '/^&;F2U\0W6ES0ZK91S6B7%M9ZG.US(2CE9I!-OD7;\\ V>9
MD$$[ &RUA?[4A^(=G'=ZGYUK/I]Z\=K#%Y4:!9;;86!9B\F'8%L@8Z*N6W:F
MF^']/TJX:X@^URSE-@DN[V:Y9%)!(4RNQ4$A<A<9VKG.!BX]C;R:C#?M'FZA
MBDAC?<?E1RA88Z<F-/R]S0!EZ7/-J7B#5;LRR?8[1Q8VT:L?+=@ TLN1PQW,
M(L'.PP. 06853T/^U(O&6L6VIZG]L8:?92JL<7E0Q%I+E3L3<Q&0BY)9B3W
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M W&X+R202%(P]-N;SPWX2UC4)FOKR!)9)]+MK^4FY=&5?+A9F!?<\I8(&W.
MZ*?F!4;&O>%])\2_8_[5AGE^QR^?;^5=RP[)!T?]VR_,.Q/(R<8R:D@\/Z?!
M;Q6Y^USQQ7 N5%W>S7'[P#Y23([$@$!@IX# , & - &/?Z'-;Z79_:I/$&M7
M$2".1=/U VA:0[FDF/[Z/AFP-A=@@VA%49S<T.]O]7\%V4UMJ$#:GY2Q374]
MG)L,\9V39B/E,/G5QCY<>G:KFI>']/U6X6XG^UQ3A-ADM+V:V9U!) 8Q.I8
MEL!LXW-C&3FY8V-OIUG':VL?EPID@%BQ)))9F8Y+,222Q))))))- &'X3NF@
M\+7$^IZC),+:]OUEO+MU!V1W4R[F. H 51T   X  Q5>SL#J/AJ#5/$%_J5E
MYR/?W,/VR2T%MO 94=E*LHB0;" 55B&=EW'(W#HFG'3)M.-OFSFE>:6(NV)&
M>0R.&YY5F9LJ?E()4C:<57U[POI/B7['_:L,\OV.7S[?RKN6'9(.C_NV7YAV
M)Y&3C&30!R8LM2^R:7IDFJ:S#INIZZWD&6X9;P6@MY)A$\A_>*#+$<9/F"-@
MK%3D#H-"B.F>)=7T:*XNY[1+>VO8S=W,EP\;2F6-D#NQ.S]PK $\%WYP0!<;
MPQILFCR:7*;Z:UDE28F;4+B2175E92LC.77#(I&&'(]S4FD>'M,T)[N6P@D$
M]VZO<3SSR3RRE5VKNDD9F( & ,X'..IH U**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK/TS7='UOS?[)U6QO
M_)QYGV6X279G.,[2<9P>OH: -"BJ]]?V>F6<EY?W<%I:QXWS3R"-%R0!ECP,
MD@?C4D$\-U;Q7%O+'-!*@>.2-@RNI&001P01WH DHK+F\2Z#;:H-+GUO38M0
M+J@M'ND64LV-HV$YR<C QSD5J4 %%9%]XK\.:9=O:7_B#2K2YCQOAN+R.-UR
M,C*DY&00?QJ33?$FA:Q<-;Z7K6G7TRIO:.UNDE8+D#)"DG&2.?<4 :=%8]]X
ML\-Z9>26=_X@TJTNH\;X9[V.-UR 1E2<C((/XU /'7A ]/%6A_\ @QB_^*H
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MJ$*;Y;19E,J+QRR9R!\R\D=QZT 7**** "BBB@ HHHH **** "BBB@ HHHH
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MC3-0M;Z!7V-);3+(H; .,J2,X(X]Q5B>>&UMY;BXE2&")"\DDC!510,DDG@
M#O0!)16?IFNZ/K?F_P!DZK8W_DX\S[+<)+LSG&=I.,X/7T-:% !16)<>,_"U
MI<26]SXET>&>)RDD<E]$K(P."""V00>U7-,UW2-:\W^RM5L;_P K'F?9;A)=
MF<XSM)QG!_(T 7Z**Q[[Q9X;TR\DL[_Q!I5I=1XWPSWL<;KD C*DY&00?QH
MV**Q+?QGX6N[B.WMO$NCS3RN$CCCOHF9V)P  &R23VJ_J6K:;HUNMQJFH6EC
M S[%DNIEB4M@G +$#. >/8T 7***Q+CQGX6M+B2WN?$NCPSQ.4DCDOHE9&!P
M006R"#VH VZ*H:9KND:UYO\ 96JV-_Y6/,^RW"2[,YQG:3C.#^1JM?>+/#>F
M7DEG?^(-*M+J/&^&>]CC=<@$94G(R"#^- &Q17/_ /"=^#_^AKT/_P &,/\
M\54A\:>%5MTN&\2Z,()'9$D-_%M9E + '=@D!ER.VX>M &Y17/\ _"=^#_\
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MXY'^%5?%7BFV\):6E_=6.HWB/((Q'8P>:X)!.3R !QW-;M% 'E__  O'1_\
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MCCA=/Q7X%\7^*-!\$^$H[5+/2[*R@;4KQYHW$<RQ["NP'<2H#8VG:QD&2,9
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MHF' P5*YR0,2:W+\9]5_L^ZM-#GTO4;7<&-KJ=L;64-NR3 Q)+8*C+.P&TD
M$YJI\/\ 0?$]O\7O[7\<Z#J,NJ7-N3;ZC"$-M"P0I^\\KY 2BE1SP2,J=P8
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M'YFY [GUKW.O-]&\+:S:?'GQ#XEGL]FD7>GI#!<>:AWN%@!&T'</N-U';Z4
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M=I.%X-4O&FG?$SXC6T6AR^%--T336=9'GNKV*X974,00RY*@Y ^5,]<MM)%
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M6/%7_@ G_P <KU"BLB3R_P#X7CH__0L>*O\ P 3_ ..4?\+QT?\ Z%CQ5_X
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MJMM=2[<9P$69L9=N&"38&.NP< U[]J>A:/K?E?VMI5C?^3GR_M=NDNS.,XW
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ML]K.*[%RD@DVO$$"C.X+L3C(&  ..E 'M]%%% !1110 4444 %%%% !1110
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MMXNO[CP[\>?"-U=PWVLW-KHH286%J&FN'VW"LZQ@X')+$ \#/I7;_P#"T_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH R-/
M\+Z-I6N7^LV%G]GO=0P;IHY7"2G^\8\[-W4[L9Y;GYCG7HHH **** "BBB@
MK(U#POHVJZY8:S?V?VB]T_)M6DE<I$?[PCSLW=#NQGA>?E&->B@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
ABB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>gguopuizh44n000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gguopuizh44n000001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ,I!XP# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M ISR1T)PPQ\N2)182E5@KNS1]/45SG@/7)_$G@C2]5NEQ<2Q%93D?.R,4+<
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M>U5;OP+X;OO$:^(+C3=^J++'*)_/D'SI@*=H;;QM';M0K=12N_A.BHHK.O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGA:/3;<*"A=PW*DL0,^8[KG@8 ^I^D=,L(M*TFSTZ!G:&T@2"-I""Q5%"@G
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M'1UB? 7_ )$:]_["4G_HJ*K^R8O^,O0XCX]?\CS9?]@V/_T;+7MW_"9^%O\
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M*X)P!QC@8=J4_BWQUI=_K^NWLUOH=G&9HV,3+;M)N98XXD'#,7;87.2H^\W
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M?1-?.WA3_DXJX_["5_\ ^@S54>IA6WCZFY^T)_S+G_;S_P"TJV_%?_)NMO\
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MD_\ 1L5?1-?.WP%_Y'F]_P"P;)_Z-BKZ)J9[FF'^ ****DW/G;X]?\CS9?\
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MT'3KK4K/4;:_L[6 S3!E,,N!DMA>5("\_>!/( SC.Y\!O$5X]Y?>')G>2T2
MW4 9N(2' 90,9PQ<'K@%3QEB:YS4/CAXON[=8X6L+!@VXRV]OEB,'@^86&.<
M],\=:M_ 7_D>;W_L&R?^C8JIWMJ9Q<%47('QZ_Y'FR_[!L?_ *-EKT[XN>(K
MWPYX'DDT]WBN;R=;59XWVM$"&9F''7"%>,$;L@Y%>8_'K_D>;+_L&Q_^C9:]
M5^*'A2]\7^$?L>G.@N[>=;F.-^!,55EV9Z*2&X)XR #@'(E]#17O.QXKX)^%
M6J>,;%-1%U#8Z<96C\R2-FD;:/O(N &7<=N=PY#>F*@\7_#S7/ /V?4WNX9+
M<W.RWN;:1ED1AED)!P58A2?E)P5//3.5IGB/Q3X)NI[2SN[S3)?^6MK-'P"P
M4[C'(" Q 7G&<=\&N[M/CC->I):>)_#NGW]C*R!DA4@*H.22DFX.>A RO(Z\
MY%>]<Q7LVK/1GI?PO\67OB_PC]LU"-!=V\YMI)$X$Q55;?CHI.[D#C()& <#
MM*YCP3K7A;6-*D;PM%;6\*L&N+6& 0M&[*/O* !G QN&0=I )Q73UF]SMC\*
MUN%%%%(H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<\L/,.2/ER=@)X''2CE[L3K-JRB[FY\!(96\9ZA.(G,*:>R-(%.U6,D9 )Z
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M%+E=Q)V$D^P X)(DD]Q3G.<6E$](^$7_ "2[1O\ MO\ ^CI*\M^ O_(\WO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&_PH_P"$\\+_ /07B_[X;_"BS"YT=%<Y_P )YX7_ .@O%_WPW^%'_">>%_\
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M1_PGGA?_ *"\7_?#?X4687.CHKG/^$\\+_\ 07B_[X;_  H_X3SPO_T%XO\
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M&_PH_P"$\\+_ /07B_[X;_"BS"YT=%<Y_P )YX7_ .@O%_WPW^%'_">>%_\
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MAO\ "C_A//"__07B_P"^&_PHLPN='17.?\)YX7_Z"\7_ 'PW^%'_  GGA?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *4?>'UI*4?>'UH OZS_ ,?_ /P 5GUH:S_Q_P#_   5GT, HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** /8_A!_R ;[_KX'_H(KT6O.OA!_R ;[_KX'_H(K
MT6H>Y2"BBBD,*^>/'7_(ZZI_UV_H*^AZ^>/'7_(ZZI_UV_H*J(F<]1115$A1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 3V?_'[!_P!=!_.I
M-2_Y",WU'\A4=G_Q^P?]=!_.I-2_Y",WU'\A0!4HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "M'3?\
MCUOO^N1_D:SJT=-_X];[_KD?Y&A 9U%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 2VO_'W#_P!=
M%_G4^J_\A*;\/Y"H+7_C[A_ZZ+_.I]5_Y"4WX?R%'0"G1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !6E9?\@N\^@K-K2LO^07>?04(#-HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ I1]X?6DI1]X?6@"_K/_'__ , %9]:&L_\ '_\ \ %9]# ****
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MK816$,FW;;18VIA0#C  Y(ST[T",^BBBF 4444 %%%% !1110 4444 %%%%
M!1110 4444 3V?\ Q^P?]=!_.I-2_P"0C-]1_(5'9_\ '[!_UT'\ZDU+_D(S
M?4?R% %2BBB@ HHHH ***]7U'4=$\,>&?#DLOA?3[^2]LU9W>-%.0B$DG8<D
M[J0SRBBO1;3QEX4U"ZCM;_P?96EO*=C31;,IGC/"J0/<'-<YXU\/IX;\1R6<
M#$V\B":'<<D*<C!^A!%%P.=HHHIB"BBB@ HHKI? %K;WGC;3[>Z@BGA?S-T<
MJ!E.(V(R#QU%(#FJ*Z*>[L]$\?7T\NFP7=I;WEPHLV "$990,8( &01QVK%O
MKB.[U"YN8H%MXYI6D2%.D8))"C@<#IT% %>BBBF 45L>(]7L]:U".YLM)@TR
M-8A&88<88@D[N%7GD#IVK'I %%%%, HHKM_!%C9W?AGQ;+<VD$TD%GNA>2,,
M8SLE.5)Z'@=/04AG$4444Q!1110 5HZ;_P >M]_UR/\ (UG5HZ;_ ,>M]_UR
M/\C0@,ZBBB@ HHHH **** "BBB@ HKU?4=1T3PQX9\.2R^%]/OY+VS5G=XT4
MY"(22=AR3NK-M/&7A34+J.UO_!]E:6\IV--%LRF>,\*I ]P<TKCL>=45VFI^
M&H-!^)6G:<%$ME/<P2(D@W9C:0 JV>O((]Q5#Q_:V]GXVU"WM8(H(4\O;'$@
M51F-2< <=31<#FJ***8@HHHH **** "BBB@ HHKJ/#'@RZUT"^NF^QZ/'EI;
MN0A05'7;GKTQGH.?3%(9R]%=K\3M.LM+\16EM8VL5O"+%"5C0+D[W&3CJ< <
MFN*H ****8@HHHH **** );7_C[A_P"NB_SJ?5?^0E-^'\A4%K_Q]P_]=%_G
M4^J_\A*;\/Y"CH!3HHHH **** "BBB@ HHHH **]7U'4=$\,>&?#DLOA?3[^
M2]LU9W>-%.0B$DG8<D[JS;3QEX4U"ZCM;_P?96EO*=C31;,IGC/"J0/<'-*X
M['G5%=IJ?AJ#0?B5IVG!1+93W,$B)(-V8VD *MGKR"/<50\?VMO9^-M0M[6"
M*"%/+VQQ(%49C4G ''4T7 YJBBBF(**** "BBB@ HHHH ***]-FM?#?@'3K2
M/4],75-9N(A*\<F"B>W.0!G(S@DX-(9YE17J&F3^$O'1;2SHL>D:@RLT#VX4
M D#U &>.<$= :\VO+62QOKBSFQYL$K1/CIE3@_RH @HHHIB"BBB@ HHHH *T
MK+_D%WGT%9M:5E_R"[SZ"A 9M%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 45I>'8HY_$VDQ2QK)&]Y"KHXR&!< @CN*]"\2>)= \/Z_=:7_ ,(9
MIEQY&S]YMC3=N4-T\L^OK2&>5T5Z;IVH>#?&4RZ7<:&FD7DN1!+;[0-W89 '
M/L1C\<5P.LZ5/HFL7.G7/,D#[=PZ,.H(^HP:+@4****8@HHHH **V+C5[.;P
MO::4FDP1W<$ID>_&-\HRWRGY<X^8=S]T5CT@"BBBF 4444 %%%=UX'L+.+P_
MKVO:A9V]REM#Y<"SH'7?C/0]\[!GWI#.%HHKK]$\7Z1I>D06=UX3L;^:/=NN
M92FY\L2,Y0G@''7M0!R%%>OW>LZ!:^"K#Q%_PB&F-]KG,/V?RXQMP7&=VSG[
MGIWKA_$?B?2]:T^.VLO#5GIDBRB0S0E<L "-O"+QR#U[47 YBBMCQ'J]GK6H
M1W-EI,&F1K$(S##C#$$G=PJ\\@=.U8] @HHHI@%%;&D:O9Z=I^IVUSI,%[)>
M1>7#-)C-N<,-RY4\_,#P1]T5CT@"BBBF 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !2C[P^M)2C[P^M %_6?\ C_\ ^ "L^M#6?^/_ /X *SZ&
M 4444 %%%% !1110 4444 %%%% 'I_@[5[C0?A9JVIVJ1/-#??*LH)4Y\I3G
M!!Z'UK.;XN^(""!:Z:/<1/\ _%UD6/B.SMOA[J7A]XYS=W5R)4<*-@ ,9Y.<
MY^0]O2N8I6'<T=8US4=>O?M6HW!ED PHP J#T '2NWF\/^$?"%I;1^)!<WVI
M31B1H("0$!..,%>.HR3S@\"O-Z]&?QOX9URPME\3Z+<7%Y NWS8#C=[Y#*1G
MKCD4,#=TG4M&U'P=XF.BZ.;"WCLG5G8#,I\M^#C/3W/\5<WX _Y%/QG_ ->(
M_P#0):OP_$;0EL+W24T:6TTR6!HHQ %+$L"&+#('?U)X_+G/!7BFR\/'4;?4
MK22XL[Z,)(L>">-PQ@D9!#'O2&:GPA_Y&RZ_Z\7_ /0XZM?"L0&S\1^=%)*/
MLZ9CB.'=<2;@IR,$\=QVYK-\/^*=!\/^,K[4K2RNXM+EMO*AA4!G4_(3G<W3
M*MW/45S_ (<\0W?AK5DOK4!QC9+$W21.X]O8_P#ZJ!'4?VM\,_\ H7M3_P"_
MC?\ QVL_QOXFTKQ#%I<>EV]U$MG&T9^T 9*_+M&=Q)Q@]:UI/%'@&XN/MT_A
MFX^UGYF50/+)]QO /_?-<OXI\33^)M0CF>%;>WA3RX($.0B_X_X"@#I?B_*Y
M\36<18^6MF&5?0EWR?T'Y4WP"3_PB7C,9.!8YQ_VSEK&\=^([/Q/K<-[91SQ
MQI;+$1,H!R&8]B>/F%'ACQ'9Z+HGB"RN8YWDU&V\J$QJ"%.UQ\V2,#YATSWH
MZ!U-C2?^2*Z[_P!?R_SAK@*[/PIXKTG3- OM$UNPGNK.YE\W$.,DX7@\C'W0
M00:Y.^>VDU"Y>SC:*U:5C#&QR53)V@\GD#'<TP(****8@HHHH **** "BBB@
M HHHH ]C^$'_ " ;[_KX'_H(KT6O.OA!_P @&^_Z^!_Z"*]%J'N4@HHHI#"O
MGCQU_P CKJG_ %V_H*^AZ^>/'7_(ZZI_UV_H*J(F<]1115$A1110 4444 %%
M%% !1110 4444 =_I/\ R177?^OY?YPU;^%GV;^RO$WVT VGD1^<#W3;+N_3
M-5-)_P"2*Z[_ -?R_P X:/ '_(I^,_\ KQ'_ *!+4C+%K\57@NX[==&LX=(!
M"F&,'>J_7[OX8IOB?PE:2_$RQTNT0007T:S2)&,!!EMVT=N$)^IKSJO7?%6H
MPZ3\6]#O+E@D*VJH['HH9I5R?8;LT 4]9\?1^&M3DT31-)LOL-JWE2AP?WA'
MW@,'CG(R<YIWC>2PG^&.DSZ9"(+26]$B1#^ L)2R_@Q-8?B_P7K0\4W<UG8S
MW=O>3--')$NX L<D,1]W!)Z]JV/&&ER:+\*M&T^5@98KL>9@@@,5E8C(]"2/
MPH&9^K?\D5T+_K^;^<U:M]?V?PTTJQL[*Q@N-9N(O-FGF&=OY8.,Y  QT]:R
MM6_Y(KH7_7\W\YJT/'ND77BB#3/$>CPO>0R6PCD2$;F7!)^Z.3RS ^F* ,_4
M_%6C>+/#-U_:\,-EK<'S6TD43$2]\9&<9Z88XY!^CM!\5Q:3H=O9>&=#EN]5
MQNNII;??D^VP[B.<#.*H0^"DL?"-_K.O_:;.90%LX,A2[$<;@03U(XX. :ZO
M?JVB?#[1W\)60E:XC$EW+%%YD@<@9.WG/.1T.-H% &IH\FK^+;6YL_%/AV*W
MMWB)CF*%"&Z8"L2P/).?:N=^$.KW'VNZT79%]F\M[O=@[]^8TQG.,8]JZ+P-
M'XLN+F;4/$4\RPM%LAMY5"$DD$L5 &,8QSZFN.^$BF/Q?=HXPPLG!!]?,2D!
MF1^([SQ/X\T.]O8X(Y$N;>("%2!@2Y[D\_,:Z#4/#\7B/XQWUI<[OLT:1S3!
M3@LHCC&,]LD@?2N0T;3KW3/&FCV]]:S6TOVV A)4*DCS ,C/49!Y'I7?P:C!
MI_QNU%;AU1;J%+=68X&XQQD#\=N/J:8C,O/BA_9]^UGH^DV(TN%B@4@@R 'J
M,< 'Z&J'CK2]-GTG3O%&D0B""_.R:%?NJ^#T X!^5@?I]:R]3\!Z_8ZN]G!I
MMS<Q%R(9HTW*RYX)8<+^.*WO&T4>A>!=#\-R2HUZC_:)44YV_?S^&7('K@T
M;VK:Y9>'O!OAB]DL(;R_^QHEJ)>D>8TW-^BC\>M1>'/$47Q#BO=&UK3[83"
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M.'1+%O"?A.RU2ST.75=8U!?,5EA:18$QD=!QP1Z$DGG KEOB1_R/VI_]LO\
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M_P#1ZT,"@_Q,72+HV6B:/91Z7"Q0 YW2@'[V1TS[@U7^)5EI^='UFP@$"ZG
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MIB"BBB@ HHHH *TK+_D%WGT%9M:5E_R"[SZ"A 9M%%% !1110 4444 %%%%
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M* "E'WA]:2E'WA]: +^L_P#'_P#\ %9]:&L_\?\ _P  %9]# **** "BBB@
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M3/&8V;8K94D'&&!'4"L^B@04444P"BBB@ HHHH **** "BBB@ HHHH GL_\
MC]@_ZZ#^=2:E_P A&;ZC^0J.S_X_8/\ KH/YU)J7_(1F^H_D* *E%%% !111
M0 5H:AK>HZI:65K>7'FPV4?EVZ[%78N ,9 !/"CKGI6?12 *EM;F:SNX;JW?
M9-#(LD;8!PP.0<'CJ*BHI@6]2U*[U?4);Z^E\VYEQO?:%S@ #@ #H!4FE:WJ
M6B3M-IMY);NPPVWD-Z9!X/XU0HI ;VI>,_$6K6S6UYJDKPMPR(JQAAZ':!D>
MQK$BED@E26*1HY$.Y70X*GU!IE% SI'\?>*9+8V[:O+L(P2J(&_[Z W?CFL;
M3M3O-*U&/4+*8QW4>2LA4-C((/!!'0FJE% &A;ZWJ-KK3:Q!<;;]I'D,NQ3\
MSYW'!&.<GM4MCXDU;3=6N=4M+OR[VYW>;)Y:'=N8,>",#D#H*RJ*!!6AJ&MZ
MCJEI96MY<>;#91^7;KL5=BX QD $\*.N>E9]% &AJ^MZCKUVMUJ=QY\R1B-6
MV*N%!)QA0!U)JWI7B_7M%MOL]AJ4D4(.1&RJZK] P./PK$HH&7-3U:_UBZ-S
MJ%U)<38P"YX ] .@'TK3T[QKXBTJS6TL]3D2!!A49%?:/0;@<"L"B@#>C\:>
M(H[F>X&J2M).FR3S%5U*^@5@0.IZ#N:HZ?K>HZ7:7MK9W'E0WL?EW"[%;>N"
M,9()'#'ICK6?10 4444Q!1110 5HZ;_QZWW_ %R/\C6=6CIO_'K??]<C_(T(
M#.HHHH **** "BBB@ HHHH T-0UO4=4M+*UO+CS8;*/R[==BKL7 &,@ GA1U
MSTK/HHI 2VMS-9W<-U;OLFAD62-L X8'(.#QU%3:EJ5WJ^H2WU]+YMS+C>^T
M+G  '  '0"JE% &A%K>HP:+/H\=QML+B022Q;%.YAMYSC(^ZO0]JLZ3XLUW0
MX#!IVH20PDY\LJKJ#[!@<?A6-10,W_\ A-O$G]H+??VM,9U4H,A2H!Z_)C;Z
M=NU9*W]VFH&_CG>.Z,AD\V/Y"&/4C'3KVJM10!TS?$+Q4\)B.KOM(QD11AOS
M"Y_6N;DD>65I)'9Y')9F8Y+$]23ZTVB@#I+?Q]XHM;=8(]7E**,#S$1V_P"^
MF!/ZUB7VH7FIW375]<R7$S=7D;)QZ#T'M5:B@ HHHIB-#5];U'7KM;K4[CSY
MDC$:ML5<*"3C"@#J36?112 ****8!1110 4444 2VO\ Q]P_]=%_G4^J_P#(
M2F_#^0J"U_X^X?\ KHO\ZGU7_D)3?A_(4= *=%%% !1110 4444 %%%% &AJ
M&MZCJEI96MY<>;#91^7;KL5=BX QD $\*.N>E9]%%("6UN9K.[ANK=]DT,BR
M1M@'# Y!P>.HJ;4M2N]7U"6^OI?-N9<;WVA<X  X  Z 54HH T(M;U&#19]'
MCN-MA<2"26+8IW,-O.<9'W5Z'M5G2?%FNZ' 8-.U"2&$G/EE5=0?8,#C\*QJ
M*!F__P )MXD_M!;[^UIC.JE!D*5 /7Y,;?3MVK)6_NTU W\<[QW1D,GFQ_(0
MQZD8Z=>U5J* .F;XA>*GA,1U=]I&,B*,-^87/ZUS<DCRRM)([/(Y+,S')8GJ
M2?6FT4 =);^/O%%K;K!'J\I11@>8B.W_ 'TP)_6L2^U"\U.Z:ZOKF2XF;J\C
M9./0>@]JK44 %=4/B/XL P-5_P#):+_XFN5HH ZK_A9'BS_H+?\ DO%_\37-
M75S->7<UU</OFFD:21L 98G).!QU-144 %%%%,04444 %%%% !6E9?\ (+O/
MH*S:TK+_ )!=Y]!0@,VBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M EM;F:SNX;JW?9-#(LD;8!PP.0<'CJ*Z7_A9'BS_ *"W_DO%_P#$URM%(9MZ
MGXOU_6(#!?:G-)"?O(H"*WU"@9_&L2BB@1TEOX^\46MNL$>KRE%&!YB([?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!/9_P#'[!_UT'\ZDU+_ )",
MWU'\A4=G_P ?L'_70?SJ34O^0C-]1_(4 5**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K1TW_CUOO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]"_Y^]1_[^)_\11<+'CM%>Q?\*GT+_G[U'_OXG_Q%'_"I]"_Y^]1_P"_B?\
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M_P"_L?\ \11=!8\6HKVG_A4.@?\ /YJ?_?V/_P"(H_X5#H'_ #^:G_W]C_\
MB*+H+'BU%>T_\*AT#_G\U/\ [^Q__$4?\*AT#_G\U/\ [^Q__$4706/%J*]I
M_P"%0Z!_S^:G_P!_8_\ XBC_ (5#H'_/YJ?_ ']C_P#B*+H+'BU%>T_\*AT#
M_G\U/_O['_\ $4?\*AT#_G\U/_O['_\ $4706/%J*]I_X5#H'_/YJ?\ W]C_
M /B*/^%0Z!_S^:G_ -_8_P#XBBZ"QXM17M/_  J'0/\ G\U/_O['_P#$4?\
M"H= _P"?S4_^_L?_ ,11=!8\6HKVG_A4.@?\_FI_]_8__B*/^%0Z!_S^:G_W
M]C_^(HN@L>+45[3_ ,*AT#_G\U/_ +^Q_P#Q%'_"H= _Y_-3_P"_L?\ \11=
M!8\6HKVG_A4.@?\ /YJ?_?V/_P"(H_X5#H'_ #^:G_W]C_\ B*+H+'BU%>T_
M\*AT#_G\U/\ [^Q__$4?\*AT#_G\U/\ [^Q__$4706/%J*]I_P"%0Z!_S^:G
M_P!_8_\ XBC_ (5#H'_/YJ?_ ']C_P#B*+H+'BU%>T_\*AT#_G\U/_O['_\
M$4?\*AT#_G\U/_O['_\ $4706/&[7_C[A_ZZ+_.I]5_Y"4WX?R%>KW?PLT.Q
MLI[N*ZU$R01M*H:1,$J,C/R=.*KZ/\.=(U[2H=3NKF^2:;=N6)T"C#%1C*D]
M!ZT[Z!8\DHKVG_A4.@?\_FI_]_8__B*/^%0Z!_S^:G_W]C_^(I706/%J*]I_
MX5#H'_/YJ?\ W]C_ /B*/^%0Z!_S^:G_ -_8_P#XBBZ"QXM17M/_  J'0/\
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M*AT#_G\U/_O['_\ $4?\*AT#_G\U/_O['_\ $4706/%J*]I_X5#H'_/YJ?\
MW]C_ /B*/^%0Z!_S^:G_ -_8_P#XBBZ"QXM17M/_  J'0/\ G\U/_O['_P#$
M4?\ "H= _P"?S4_^_L?_ ,11=!8\6HKVG_A4.@?\_FI_]_8__B*/^%0Z!_S^
M:G_W]C_^(HN@L>+45[3_ ,*AT#_G\U/_ +^Q_P#Q%'_"H= _Y_-3_P"_L?\
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M ._L?_Q%%T%CQ:BO:?\ A4.@?\_FI_\ ?V/_ .(H_P"%0Z!_S^:G_P!_8_\
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M -_8_P#XBC_A4.@?\_FI_P#?V/\ ^(HN@L>+45[3_P *AT#_ )_-3_[^Q_\
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M4.@?\_FI_P#?V/\ ^(HN@L>+45[3_P *AT#_ )_-3_[^Q_\ Q%'_  J'0/\
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M'0/^?S4_^_L?_P 11=!8\6HKVG_A4.@?\_FI_P#?V/\ ^(H_X5#H'_/YJ?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5RFO\ _(XZ#]6KJZY37_\ D<=!^K4T)G5T444AA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %-?\ U;?0TZFO_JV^AH YKP'_ ,BW_P!MG_I73US'
M@/\ Y%O_ +;/_2NGIO<2V"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .8\.?\C)
MXC_Z[)_[/73US'AS_D9/$?\ UV3_ -GKIZ;W$@HHHI#"N.\(_P"MU?\ Z^S_
M %KL:X[PC_K=7_Z^S_6J6PF=-1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% %#7/^0#?_P#7N_\ Z":/"7_(K6/^X?\ T(T:Y_R ;_\
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MJ?074WJ***0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]U*SMI"NX)-.J$CIG!/3@_E7'?$F9M2\,Z6^CSK/++J4:VTEO,/FDVN!M<'
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M_P"A+74URWBO_D+^'?\ K\'_ *$M-;B9U-%%%(84444 %%%% !1110 4444
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M5@:[)\0/#6BP:I-KEM>"*0?:HA;QA5&X!>=JEE;@'&TC/']X.P'IM%>:7O\
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M[/\ 6J6PF=-1110 445Q?Q3U=M*\"W21EUEO66T5E4$ -DN#GL45QD<Y(^H
M.(\*V,?Q$\=^(-;G9[>U\EH@D9"R;98VA3((89$88GG[V,9&16G\(KZ33=4U
MOPG<*C2V\SS>;$"5+(PBD&3@XX3''][/855\)^%O'MCX?MY=#UO3;:RO56[6
M-QN/SHO7,1P< < XXK&URVU_P7XVTGQ'KU];W5U<3;Y'M%!9HT"(XVE54$HV
MT8^N0>: .T^(W_(X^!?^P@?_ $9#5KQU\0G\.WL&DZ/;PWVJS8#1DLWDDE=J
ME%Y9F!. &!'!P01FK\1O^1Q\"_\ 80/_ *,AJE9_8?\ AH/4/M7^N\@?9?O?
MZWR$STX_U?F=>/QQ0!#+\1_&&AW-E/XC\.Q0Z=/M9VBA=6PP. &+E0XP3L;!
MXP<9R.F\6_$33?#^A075FZ75Y?0+-9Q$$#8PR)''!"^W!)&.,$C<\2W.@6>E
M"?Q&MHUDD@VBYA$HWD$#:N"2V"W09QGMFO.M;ET:?XM>$9<(-->Q@:V"(RKD
MM(8,* "!NV<8QZ\9H 2Y^(7CW2[.WU'4_#5O%8.WSL;>5" &"D-ESY9). 6'
M.<@&NTOM>T_Q'\.=8U'3IO,A?3[@,IX:-O+.58=B,_J",@@UM:Z]I%X>U.2_
MB>:R2TE:XCC.&>,(=P'(Y(SW'UKS#P#C_A3OBC_MZS_X#I0!G^$/&7B-=%TW
M0/"^BI>2VRR&YEG0E S.[KR&4(, \L>3P!QSTWA#XD:EJGB2/P_KNC_9+V7<
M49$:/9A-X#QOR,@,<Y[KQWK3^%%I!;?#^SEB3:]S)++*<D[F#E,^WRHHX]*R
M]5ABB^/6AO'&B-+8L\C*H!=MDRY/J<*!GT ]* )/%_Q*GT_5TT7PS:)J6I*Q
M$X\MI0I .454(+,,$GLN,<G.VC'\2O$.A^((;/QCHT5E9R97S8(GX/!W [F5
MU&1D+R,^HVD^'GV'_A9?C#?_ ,?_ -HF\G[W^K\YO,]OO>7UY].]:OQA>T3P
M.%N8G>5[N-;9E/"288DGD<; X[\D<=P 5/C'-%<>![">"1)89+Z-TD1@RLIC
MD(((Z@CO7I5>0>/<?\*;\+XZ?Z)_Z3M7>>*[SQ7:?9/^$8TRUO=V_P"T?:&
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M))8\?+P2&Z$ ]""!T5>'^"'LY?#WQ$DL(GALGM&:".0Y9(RD^T'D\@8[GZT
M; ^)?B;7==FM/"FAV]U;1,5$DBNVX9;:[-E!&&5>%;G((R>E:O@OXB7FKZV^
MA>(=/^PZHWS0*L+H" NXJRL25; + G@CT.-T_P (?L7_  @D?V7_ %WVB3[7
M][_6\8Z\?<\OIQ^.:VWOO"L?C..S*6/_  D4@W!EMP9?N'K(%X.P="0<8[$4
M 9WA[QE/?ZEXK34UMX;/1)F"R1(V[RU,F2W)R<(.@]>*Y?1_'WCWQ+]JGT70
M-.EMHI-N7R-N>0NYI%#,!C.!W!P,BK7@F]CTS7OB)?S*[16MTTSJ@!8A6G)
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MVWYG_"@#?HK _P"$W\,_]!FV_,_X4?\ ";^&?^@S;?F?\* -^BL#_A-_#/\
MT&;;\S_A1_PF_AG_ *#-M^9_PH WZ*P/^$W\,_\ 09MOS/\ A1_PF_AG_H,V
MWYG_  H WZ*P/^$W\,_]!FV_,_X4?\)OX9_Z#-M^9_PH WZ*P/\ A-_#/_09
MMOS/^%'_  F_AG_H,VWYG_"@#?HK _X3?PS_ -!FV_,_X4?\)OX9_P"@S;?F
M?\* -^BL#_A-_#/_ $&;;\S_ (4?\)OX9_Z#-M^9_P * -^BL#_A-_#/_09M
MOS/^%'_";^&?^@S;?F?\* -^BL#_ (3?PS_T&;;\S_A1_P )OX9_Z#-M^9_P
MH WZ*P/^$W\,_P#09MOS/^%'_";^&?\ H,VWYG_"@#?KEO%?_(7\._\ 7X/_
M $):M?\ ";^&?^@S;?F?\*YWQ'XJT*[U/1)(-3@D2"Z#R$$_*,KR?R--;B9Z
M#16!_P )OX9_Z#-M^9_PH_X3?PS_ -!FV_,_X4AF_16!_P )OX9_Z#-M^9_P
MH_X3?PS_ -!FV_,_X4 ;]%8'_";^&?\ H,VWYG_"C_A-_#/_ $&;;\S_ (4
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MAG_H,VWYG_"C_A-_#/\ T&;;\S_A0!OT5@?\)OX9_P"@S;?F?\*/^$W\,_\
M09MOS/\ A0!OT5@?\)OX9_Z#-M^9_P */^$W\,_]!FV_,_X4 ;]%8'_";^&?
M^@S;?F?\*/\ A-_#/_09MOS/^% &_15/3M6L-7@:;3[N*XC5MK&,YP?0U<H
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MO+SL\^%7VYQG&1QG _*IOLMO]K^U^1%]I\OR_.V#?LSG;NZXSSB@9S]KX/\
MLUW#<?\ "1^(9?*D5_+EOMR/@YPPV\@]Q6'X=UN/P]XH\0:3KDD5@MS?/=V;
M3 @2*Y;+%_NA=JIC..21UX'H-5+W2]/U(QF_L+6Z,>=AGA5]N<9QD<9P/RH
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MZW5_^OL_UJEL)G34444 %<%XU\$ZEXK\3:3.9[1M'M=HFMY797.7S+M*KGE
MH'S#D=NM=[10 5S?CKPT_BKPQ)I\'DB[65);=YG951@<$G:#_ 7'0]?Q'244
M >='P-KDUMX,6YO+*270IB9V#, T8D0H$PG)"(!SCGN>M6/'7P\?Q'>P:MI%
MQ#8ZK#@M(0R^<05V,77E64 X(4D\#(P,=[10!Y._PV\6:[+;0>)O$JR6$"*
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MX_SIH3&4444Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1Y]*O6!,*R,7$NW=NP=HX^4D,,J<'GIDL!U]1275O%<0V\D\2339\J-G :3
MR=HZG ZXKE-1\=;?$8T+0M,.L7B*YG\N<1K$5ZC<01QT.< $@<DX&2OB";6/
MB%X<MKO2KK3;RT^U^;%-@J0R, 4;C</D/.,>A/6G8#T:BBN*'CV;4M;N=/\
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M"#\Q51EB$#=2>4CP#BBPCT&BBBD,*:_^K;Z&G4U_]6WT- '-> _^1;_[;/\
MTKIZYCP'_P BW_VV?^E=/3>XEL%%%%(85F>(=3NM&T*YO[+39=2N(MNVTASN
MDRP!QA6/ )/0]*TZ* /,AH/C_P 9?NO$M]#H>FCY);2P(+W [Y(9OE968<L1
ME1\AZUW7A[0[;PWH=OI-G)-)!;[MK3$%SN8L<X '5CVK3HH XWX@_P#,J_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!L>'/$=[X:U-;NT;*'B6$GY9%]#[^
MA[5[[H6NV7B'3$OK&3*GAT/WHV[J1ZU\U5L>'/$=[X:U-;NT;*'B6$GY9%]#
M[^A[4FAIGTA16;H6N67B'3$OK&3*'AT/WHV[J1ZUI5!04444 %%%% !1110
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MQ7B?2=>L- DU3Q'XLG9S&;?[#9_(DS-N"#JH;KN;Y,[0PYP#6OJ'_(I^ _\
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MFMMX"U/P=XLM-1\)3-)IEW,L>HV4[@[(RQ.Y2<;@H)QU8$=6#,*]*H ****
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MVLI/.TYPV".,;8KRS^*7B/4+6WNMNBV>X>9+9SJH3&<L=KEV.#C;G:3CIUH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!L^&O$M[X9U(7
M5JVZ-L":$GY9%_H?0]J]^T36[+7],COK&3=&W#*?O(W=2/6O!O"WA:\\4:B(
M( 8[="#/.1P@_J3V%>^:3I-GHFG1V-C$(X4'XL>Y)[DU+*1>HHHJ1A1110 4
M444 %<IK_P#R..@_5JZNN4U__D<=!^K4T)G5T444AA1110 4444 %%<LWQ&\
M)KLSJZG>NX;8)#@9(YPO!XZ'G&#T(JS>:[9ZMX+U74M'O?,1+6?;+'N1D=4/
M8X*D<'MU![B@#H**YZSUVSTGP5I6I:Q>&-'M8-TK[G9W9!V&2Q/)/7H3V-5U
M^(_A-Y$3^UU4NP4%X)%49..25PH]S@#O0!U-%4M3U?3]&ABFU&Y2VBEE$*NX
M.W<<D9/8<'DX K#B^(WA.:2-%U8 R,%!>"5 "?4E0 /<\"@#J:KWEA9ZC"(;
MZT@NH@VX)/&'4'IG![\G\ZJ:OXATK03"-3O%MO.5VCW*QW;!EN@Z\C ZDD 9
M-9]CX\\,ZC>PV=MJBM/,VV-6AD0$]AEE R>WJ>.M '1T5E7\EHNOZ0DU_<PW
M+^=Y%M&Q$=QA1NW@#!VCD9(Y]:K:EXT\/:1=S6E]J*PW$+*KQ^6[,-R[AP <
MC'4C@9 ."10!O45CZ-XJT37YY8=,OEGEB4.R%&0XZ9 8#(]<=,C/44FL^*M$
MT">*#4[Y8)95+J@1G.T<9(4' ],]<''0T ;-%8.F^,_#^KW<-K8ZBLMQ,S*D
M?ENK$JNX\$# QT)X."!D@ULW5S#9VDUU</LAAC:21L$X4#).!ST% $M%<1X/
M\8V6IZEJ-G-J+S75SJ$S6:-&V# %&W'&%&%)P<'.2>3SLZIXS\/Z+?M97^HK
M%<JH9D6-WV@],E00#WP><$'N*+ ;U%4=)UC3]<L1>:;<K<0%BA8 @AAU!! (
M/?D="#T-7J "BN<O?'GAG3[Z:SN=459X&V2*L,C@'N,JI!(Z'!X.1U%;=A?V
MNIV,-[93+-;3+N1U[C^8(Z$'D'@T 6**Y9OB-X379G5U.]=PVP2'')'.%X/'
M0\XP>A%;>E:Q8:Y8B\TVY6> L4W $$$=00<$'ZCH0>AH O45SD/CSPS<W-K;
MPZHKS7+*D2K%)DLS;0#\ORG/KC@@]"#4NJ>,_#^BW[65_J*Q7*J&9%C=]H/3
M)4$ ]\'G!![B@#>HJCI.L:?KEB+S3;E;B L4+ $$,.H((!![\CH0>AKEK&_O
M'\,^-)6NYVDM[R^6!S(<Q!4!4*>P';'2@#MZKO86<E]'>O:0-=QKM2=HP9%'
M/ ;J!R?S-5?#LLD_AG2999&DD>SA9W<Y+$H"23W-:5 !117->+X_$-U#966@
MEX5GFVW=W&Z!H8C\IP&P3]XME2"-G'6@#I:*\N\2Z7KG@VRMM<MO%MU<FW*+
M);7TK%)W.0V%W8((_@/( 8AL@5O?$'7+ZPMM/TC2Y/(OM7G^SI.>!&N54_,.
M5)+KR <#=C!Q3L!V=%>7:[H_B3P=IL6O0^*[J^^R,HG@NB^R3<Y7[I<@CYD&
M#SU8,#@#6\8^*;I]#T2WT9GMKKQ 46&63Y3$C[1R025;,B#(!P-V.<&BP'=T
M5Y=KNC^)/!VFQ:]#XKNK[[(RB>"Z+[)-SE?NER"/F08//5@P. /2-/O8]2TV
MUOH5=8KF%)D5P P# $ XSSS2 LU6LM/LM-A,-C:6]K$6W%((@BDX S@#K@#\
MJJZSXATKP_%%)JEXMNLS%8QM9BQ'7A03@>O3D>HJ+1O%6B:_/+#IE\L\L2AV
M0HR'!XR P&1ZXZ9&>HH V**QM9\5:)H$\4&IWRP2RJ75 C.=HXR0H.!Z9ZX.
M.AI^F>)M(UFSN;K3KLW,=M_K5CB?>.,\)C<<\XP#D@@9(H UJ*HZ5K&GZY9"
M\TVZ2X@W%2R@@@CL0>0>AY[$'O3/[=TW^W/[&6YWZALWM#'&S;%QG+$#"]OO
M$=5]1D T:*YR]\>>&=/OIK.YU15G@;9(JPR. >XRJD$CH<'@Y'45JQ:Q83Z-
M_:\5RKV'E&8S*"<( 2>.N1@Y&,@C&,T 7J*P;'QGX>U+4H=/L]16:ZF&418W
MP?EW]<8! SD9X((Z\4:IXS\/Z+?M8W^HK%<JH9D6)WV@],E00#WP><$'N* -
MZBJ.DZQI^N6(O--N5G@+%-P!!!'4$$ @]^1T(/0U>H **X?Q[JM\;[1_#NE7
M4MO=:C.#-+;MF6*,$#.T<[>6;((XC8=,XL?#K7;K6/#\D&HLQU"QE,$PE;]Z
M1U4NN 5/5><DE"2<YH ["JR:?91WTE\EI;K>2+M>X6("1AQP6QDCY1^0]*P_
MM5Q_PLW[)Y\OV;^QO,\G>=F_SL;MO3..,UTM !17->#[JXN?[>^T3RR^5K-Q
M''YCEMB#;A1GH!Z5TM !37_U;?0TZFO_ *MOH: .:\!_\BW_ -MG_I73US'@
M/_D6_P#ML_\ 2NGIO<2V"BBBD,**** "BBB@ HHHH **** "BBB@ KAO%UY!
M9?$7P/+</L1I+N(':3\SHB*./5F _&NYKGO%_A#3_&.D&SO (YX\FVNE7+0L
M?YJ<#*]\=B 0 =#7!>#-0BU+XA>.9H5=52>V@(< '=&LD;'@]"4./;'2F?\
M"#^+?[+_ +._X6'=^3_?^Q_O?O;O];YF_K_M=..G%;_@_P (:?X.T@6=F/,G
MDP;FZ9<-,P_DHR<+VSW))(!KZE?1:7I=WJ$ZNT-K"\[A "Q55+'&>^!7!R>!
M/!_Q!MH/$=J+RT^V;I)#;D1F1L[6W*P8 @J<E<9))RV<UW.E6U[::;#!J.H?
M;[M<^9<^2L6_))'RKP,# _"N)A^&5WH^H^=X8\5WVE6I9I/LCQ^?&';()P6
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\G&<?+W!!&01SQB>(/!GC7Q/*3J.JZ8L$?SP6T+.(U?Y5/\ #GIN.26()(&
MQP ;GQ&LX]1TW1K&5G6.YU:"%V0@, P<$C.>>:L>+_#FDW'@V]B6R@@%G;R3
M6[0PHIB(_>$+Q\H8J-V,9!-3ZCHFIZEIGA^.>X@DO+&[MKF[E.5$A0'>5PO4
MDY P!]*UM8LY-0T2_LHBJR7%M)$A<X +*0,^W- ' W&FV^J2?#FSN5W0&T9V
M3 (;9#&X4@@@@[<$>A-7OB9H&FOX/DO$M8H9[$1+"T4:J?+W;!&3C.P!R0HQ
MR!6M#X<O([OPG*9(-NCVSQ7 #'+%HE0;>.1D=\<5=\6Z1<:]X8O-,M7B2:;9
MM:4D*,.K'. 3T'I0!GZ]_P C]X1_[?/_ $4*HZ9I%G??$_Q%>W4*RR6BVHA5
MU5E5F13O&1PP*#!'3)K>U+2+B\\3Z'J<;Q"&P^T>:K$[CYB!1MXQU'.2*--T
MBXL_$^N:G(\1AO\ [/Y2J3N'EH5.[C'4\8)H Y_4]&L;'XH^';^UA6&2[6Z\
MY8T559E1CO.!RQ\PY))S@55\'Z+I^H>+/$NJWS17M[!J3QPQS?.UN%<E7&2<
M= JG'R^60#U%=5J6D7%YXGT/4XWB$-A]H\U6)W'S$"C;QCJ.<D5R T6Z;Q9J
M&I>"-;MHW\]EU2SNF;;YH?)&"I)5COYXQ\P5L'  +6H:;967Q=T*XM6MXY+F
M&=IK>)%5@VV0^:V.I<L1DC^ \GMW]>6V]MJMO\5]&DUZ_M;C4)4F*Q6T9"10
M[)"@W%1GDR#') 49)S7J5#&<KX(_YF/_ +#ES_[+6%\-- TJ[\/RZK>+;ZE?
M74LBS23J)7C!!4H=Q/+!F8G@L) #D8K9TC0/$&D^)KR6._M&T2ZO9+N2+:1+
MEE;Y?NGC<5S\W\ (QD@Y2>"O$GA_4+H>$]6M[?3+@%OL]V2WEN5*\95NF00<
M@G"AMP'((?H.F6FB_%;5+33IE6UFL//>TB;"PN73Y2,GGDL.!@28  Z];XDD
MDB\+:O)%(\4B64S)(C%64A#@@CD$>M8OA'PC<:/=W6L:Q>?;-;N]RRRJY**A
M(.!D#.=J]@  %  '/3W=K#?64]I<IO@GC:*1<D;E88(R.1P>U SS3P<M_8>&
M0FF^#8KZWO4_?W#:E"?M'4%2".%'(V=N<\DD[W@71]2TN_UR6[T]]/M+N5);
M>U^T)(D9^;?MV8 '*CH. HYQ6?8^%?&7AXW5EH>LV3Z6P<6R7F2\1;!W#"$!
M@<\9*G))7)Q70^$]%U?2K>ZFUS5I;^]N9-S+YA:*( G 3(&,YR< #H .,D8C
M&^&NA:</!L=W):Q337WFK,TL:L2F[88\XSL(0$J<\DU+X.TRVTCQCXMM+1=L
M(DMW5< !=ZN^T   *"Q '8 5N>$M(N-!\,6>F73Q/-#OW-$25.79AC(!Z'TH
MTW2+BS\3ZYJ<CQ&&_P#L_E*I.X>6A4[N,=3Q@F@#G?AMH.F_\(?:WDMK%///
M<&YW31JQ1T9D0J<9& "1W!9L=:J?#30-*N_#\NJWBV^I7UU+(LTDZB5XP05*
M'<3RP9F)X+"0 Y&*ZWPEI%QH/ABSTRZ>)YH=^YHB2IR[,,9 /0^E<LG@KQ)X
M?U"Z'A/5K>WTRX!;[/=DMY;E2O&5;ID$'()PH;<!R /T'3+31?BMJEIITRK:
MS6'GO:1-A87+I\I&3SR6' P),  =5T__ )%/QY_U_:A_Z *TO"/A&XT>[NM8
MUB\^V:W=[EEE5R45"0<#(&<[5[   *  .9K7PY>0:)XELFD@,FJ7-U+ 0QPH
ME7"[N.#ZXS^- &EX8_Y%/1O^O&#_ - %5?$>BZGK<UC'::S/IMI$S/<FW)$D
MO*[5!&,#&_DDC./E/;2T>SDT_1+"RE*M);VT<3E#D$JH!Q[<5=I#//X_#7CW
M2V\K3_%4%W"RL6:]4[@Y!7C<'( X8?-C/4$9STVERG1=+L;/7=7MY-2G9LO)
M(%\V1GSM0'&0"X4  =N!P*VJY[Q7X9_X2"WMI[:;[/JE@_G64S<JKY!PPY!!
M*KS@D8'7D%@<QXL\&3V%M-XEL-5O[O5[/]Z&O/*E 0$EMH*A5VY+@8(&.!DC
M%F]U=7USX?ZC?LD<EU#*6\M3M\R6*-0 .2 6<#GIGD]Z=>^'/&6OV]MIFM:G
MIB:;\HNS:*3+-M(8'YDP&W*.FT#).#@"M;Q+X/AU?P_:V-A)]CN=/"FPF!.8
M]HP%W\L <#D'.54\XP01<\874-GX.U>6X?8C6KQ X)^9QL4<>K,!^-<I]L@L
M[WX;2SOL1[1HU."<L\,:*./5F _&BZ\(^-->%M8Z_KUJVFJP-P+7Y7DP6(./
M+ )Y Y^4;5;!(YZ'Q5X3BUW18+:R9+*[LB'L98UV"(@8"@@95>!]WH54\XQ0
M!:\874-GX.U>6X?8C6KQ X)^9QL4<>K,!^-3>%SGPEHQ'_/C!_Z+6N.NO"/C
M37A;6.OZ]:MIJL#<"U^5Y,%B#CRP">0.?E&U6P2.?0X8HK>&.&&-(XHU"(B*
M JJ.  !T H&>?^-M*U]/%5IX@TC3+6_CMK3:R2QK(59&9@=APV>05*'=E2/8
MT='\2:9<>,K*?Q!X;FTSQ!*L<<5R ZB1F#)N:,X(!^Z"0_H2 N:WO%OA+5-2
MUVQU[0M0BM=2MHS#^_ **N'^9?E;YOG8$$$$$=,<QMX<\3:UXATZ\U^_L8[&
MP<3I;Z>7P\JG()#C]<G !  W$T".?T/[8GC3Q!J=GH1UF^AOIHA+)J*(;=-Q
M  1N1D#:&]%VC&&SK6&DZS-X_L=:;P]_8\(25+SRKR)UFW!B"RH 22Q&<YSA
M3QC-37W@[6M/\2RZQX4U&&V6[;S+RWNF8H[;MQ_A;())]"N3M(!P+>B:%XI_
MX21M4U_6U>&-2(;.RD81-G=PRE0,*&XZL>,M\O(!AZ+<#P3X]UK2[R9(=)NH
M9+^W58SA0,O\B*2% 42*> 6\I<8X!B\.075SX;\6^+IF>&?48;@VK;]TD**'
M^[(#D -A0,#'E ^F-SQ_X(?Q5':3V)MX[Z [6>8[5>/J 2%))#8QV&YO6NFB
MTBU30$T5]\UHMJ+1M[89TV[>2N.2.XQ0!Y[X.6_L/#(33?!L5];WJ?O[AM2A
M/VCJ"I!'"CD;.W.>22;.F:/J6EZ%XTEN]/?3[2[MGEM[7[0DB1G9)OV[, #E
M1T' 4<XJ6Q\*^,O#QNK+0]9LGTM@XMDO,EXBV#N&$(# YXR5.22N3BM32_#6
MMQ>'-9@U;6&O=2U**1 &E9H(<A@-N1D9W9.  . !QD@%CP9H.FV7AC1IDM8G
MN!#]H6>2-3(KRJ"^&QD<87UVJ <XKB?A\^I6EA-J>G>'#JUW<.RSW\FIQAR<
MY*X897/#'/+$@DD;<>H:/9R:?HEA92E6DM[:.)RAR"54 X]N*XRV\'>(O#6K
MS-X6U&T7293YAL[YF8!L$8X4G XPP()P V<9(!)X4T74[/QE>ZE)HG]CZ?<6
M@0VT=S&\7F J 0J8QP&Z@\EN><5WE<IX5T+Q#8W]UJ'B+6WO)Y%\N."*0^2!
M\OS[=J@-QCY0.YY+<=%J"74NFW4=C*L-XT+K!(PR$D(.TG@\ X[&AC/,+/6_
M[0^(-[XBETS4M0M;,M:6!TZ#SD &1NWJ5!R&9@#N_P!;U^4$RZ'JG]E?$J1D
ML;VPT[76.Y-0B\DB<9;*EB=V6)  (YE QP,]IX.\-KX7\/QV!=7G9S+<.F=K
M.<#C/8 *O;.,X!)JOXS\,7'B""QN-.N(K;5-/G$MM+*"5'()!'(ZJIR5/W<=
MS0(S-7M-1O/B:L>F:I_9TPT8,TOV=9LKYQ^7#<=2#GVK0_L'Q9_T.G_E+B_Q
MK0_LBX_X3?\ MK?%]F_LW[)MR=^_S-^<8QC'O6U0,Y#X?1S16FNQW$_GS)K-
MPLDNP+YC +EL#@9/.*Z^L7P[I%QI']K?:'B;[9J4UW'Y9)PCXP#D#GBMJDP"
MFO\ ZMOH:=37_P!6WT- '-> _P#D6_\ ML_]*Z>N8\!_\BW_ -MG_I73TWN)
M;!1112&%%%% !17(6?B<6WC'Q/::OJEM;:?9M:):_:'2)5:2)F8!CC)."<$G
MIQ716&L:9JID&G:C:7GE8\S[/.LFS.<9VDXS@_D: +M%4K_6-,THQC4=1M+/
MS<^7]HG6/?C&<;B,XR/S%/L=2L-4A:;3[VVNXE;8SV\JR*&P#@D$\X(X]Z +
M5%9EWXCT*PN7MKS6M.M[B/&^*:Z1&7(R,@G(X(/XUH0S17,$<\$J2PR*'21&
M#*RD9!!'4$=Z 'T5DOXI\/1K&TFO:6BRKOC+7D8WKDKD<\C*L,^H/I4TU];W
MVA7%W8:K;1PM#)Y=^C+)'$0"-^<[2%(.<G'!S0!H45Q7B+Q6-"T_P[ NM6,U
MQ=7=HES<,R R6[??F"YPJMM^]R &.#G!'4'6-,&F?VF=1LQI_P#S]>>OE?>V
M_?SC[W'7KQ0!=HK(B\5>'9YHX8=>TN265@D:)>1EG8G   /))[51\8ZK>Z5_
M8'V*;ROM>LV]K-\BMNB;=N7D'&<#D<T =+169OD_X2?9_;$/E_8L_P!E[$WY
MW_Z[=G=C^'&,9]ZA_P"$N\-?]#%I/_@;'_\ %4 ;-%4K#5],U7S/[.U&TO/+
MQYGV>=9-N<XSM)QG!_*J0\8>&",CQ'I&/7[='_\ %4 ;5%<GXY\5IH?@R?4-
M.O[3[7/$ILB75O-#,H+H,_/A6W=QT)R*T-2U2UU#P[=7.E>);&R565/[25HY
MHX6W+D')VY((')_B'M0!N45!=WEKI]J]U>W,-M;IC?+,X1%R<#)/ Y('XU6L
M=>T?4YS!I^JV-W,J[S';W"2,%R!G .<9(Y]Z -"BJMWJ5C8,BWE[;6[.KNHF
ME5"RH-SD9/(4<D]AUJM:>(]"O[E+:SUK3KBXDSLBAND=FP,G !R> 3^% &G1
M5*_UC3-*,8U'4;2S\W/E_:)UCWXQG&XC.,C\Q3['4K'5(6FT^]MKN)6V,]O*
MLBAL X)!/."./>@"U17F?CNRUIO%WAZ_NKZ$:0FLV<-I9Q Y+,27DD[;@5P.
MO![<[O3* "BBB@ HHHH YCPY_P C)XC_ .NR?^SUT]<QX<_Y&3Q'_P!=D_\
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M<UHW_)=_$/\ V#T_]!@K,AT6'PW\=+"#3F\BUOH'G-O%E54&.3*8SRNY-P'
M'  ^45IZ-_R7?Q#_ -@]/_08* -KQ-\1=#\+:@EC=_:+BY*[G2U56\H=MV6&
M"1R!R<<G&1D\,_$70_%.H/8VGVBWN0NY$NE5?-'.=N&.2!R1P<<C.#CR7P1>
M36<T^K'PA>^(KPS9%V2SK$X(8D?NV_>9P2Q.>F,9.;/BF/4]?O(M0T_P)JNC
MZBDF][BVCD_>');<0(U^<-SO!SZYXP >C_%+1I]2\*_;K([+W2Y!=I(@ D"
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV26LI5C^8Y#/]TD,0<'!&?J23UE% '/>&/!>D>$Q,;!)'EEX,LQ4LJ_W1@
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M[_-R2-I.25P5R>N>1TY% '345SNKZQJF@>"[C4[Z*SEU*%>5@+"'+.%4\\X
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M78E5 !RNW[Q.&(ZZ?PX\,ZKHHU74=7@M+.YU*1"+&TC1$@5-P &P[>=W09X
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M6UK2UAB%M+<._DPC:%QG#( 6+_*RYW$,,9^;:^'NH>"KGQ/?7.@7%_87=ZK
MZ7<%4B8#:VZ-5R,CYL#=D O@!:OZY9^.-*\<MK&AK_:^F74:H]A-<^6EOC8&
MVAG"AFVDA@#C<V5]8=)T+Q%J_P 1XO$VKZ1::-;V<9$<4;1RRW#-&4):1.3@
M=VZ * .6- CHO&.E7NJ_V!]BA\W[)K-O=3?.J[8EW;FY(SC(X'-=+112&%%%
M% !1110!S'AS_D9/$?\ UV3_ -GKIZYCPY_R,GB/_KLG_L]=/3>XD%%%%(85
MQWA'_6ZO_P!?9_K78UQWA'_6ZO\ ]?9_K5+83.FHHHH **** "BBB@ HHHH
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MB@"AKG_(!O\ _KW?_P!!-9WACP_HMSX<LYI](L)974EG>V1F/S'J2*T=<_Y
M-_\ ]>[_ /H)H\)?\BM8_P"X?_0C0]@ZDO\ PC&@?] /3/\ P$C_ ,*/^$8T
M#_H!Z9_X"1_X5JT5(S*_X1C0/^@'IG_@)'_A1_PC&@?] /3/_ 2/_"M6B@#*
M_P"$8T#_ * >F?\ @)'_ (4?\(QH'_0#TS_P$C_PK5HH RO^$8T#_H!Z9_X"
M1_X4?\(QH'_0#TS_ ,!(_P#"M6B@#*_X1C0/^@'IG_@)'_A1_P (QH'_ $ ]
M,_\  2/_  K5HH RO^$8T#_H!Z9_X"1_X4?\(QH'_0#TS_P$C_PK5HH RO\
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M!(_\*/\ A&- _P"@'IG_ ("1_P"%:M% &5_PC&@?] /3/_ 2/_"C_A&- _Z
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MVFE>0GFQL#.^QUP@*@GA4/U?'8$U=;T36SX8\+ZKI0<7^BVR.UH58._R)N7
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M'D*-ZY4%2<OU;"84DMSC0U3PY>Z9\(Y-$0->WB!21;QEMQ,X<A1U(&3SWQG
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M_P#(M_\ ;9_Z5T]<QX#_ .1;_P"VS_TKIZ;W$M@HHHI#"BBB@ HHHH ****
M"BBB@#&\*:#_ ,(QX:M-'^T_:?L^_P#>^7LW;G9NF3C[V.O:MFBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .8\.?\C)
MXC_Z[)_[/73US'AS_D9/$?\ UV3_ -GKIZ;W$@HHHI#"N.\(_P"MU?\ Z^S_
M %KL:X[PC_K=7_Z^S_6J6PF=-1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% %#7/^0#?_P#7N_\ Z":/"7_(K6/^X?\ T(T:Y_R ;_\
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MJ?074WJ***0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQX#_ .1;_P"VS_TKIZ;W$M@HHHI#"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F/#G_(
MR>(_^NR?^SUT]<QX<_Y&3Q'_ -=D_P#9ZZ>F]Q(****0PKCO"/\ K=7_ .OL
M_P!:[&N.\(_ZW5_^OL_UJEL)G34444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!0US_D W_\ U[O_ .@FCPE_R*UC_N'_ -"-&N?\@&__
M .O=_P#T$T>$O^16L?\ </\ Z$:'L'4VJ***D84444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<MXK_P"0OX=_
MZ_!_Z$M=37+>*_\ D+^'?^OP?^A+36XF=31112&%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!2UC_D"
M7_\ U[2?^@FL[P9_R*=E_P!M/_0VK1UC_D"7_P#U[2?^@FL[P9_R*=E_VT_]
M#:GT%U-ZBBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ KE-?_P"1QT'ZM75URFO_ /(XZ#]6IH3.
MKHHHI#"BBB@ HHHH X9O'-S#\/K/79K>W-]>2M!$N[RX5?<X#,6;A0$R>?Q
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M2,0 2N8QAAD$9!P0<<$"N 6[O=-N='\(ZFC^=I^MVSVDS[LW%ON<!NX &5
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MZ==QC)W<="O;K6WX8_Y%/1O^O&#_ - % &K1112&%-?_ %;?0TZFO_JV^AH
MYKP'_P BW_VV?^E=/7,> _\ D6_^VS_TKIZ;W$M@HHHI#"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ<L#J4=@HEC7 8=,C.>OY5L44[@%%%%( IK_ .K;Z&G4U_\ 5M]#0!S7@/\
MY%O_ +;/_2NGKF/ ?_(M_P#;9_Z5T]-[B6P4444AA1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!S'AS_D9/$?_79/_9ZZ>N8\.?\ (R>(_P#KLG_L]=/3>XD%%%%(85RG
MABVFMY=5\U-NZ[8#D'I_^NNKK$TO[^H?]?DG]*:$S0HHHI@%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!0US_D W_\ U[O_ .@FCPE_R*UC
M_N'_ -"-&N?\@&__ .O=_P#T$T>$O^16L?\ </\ Z$:'L'4VJ***D84444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %<MXK_P"0OX=_Z_!_Z$M=37+>*_\ D+^'?^OP?^A+36XF=31112&%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!2UC_D"7_\ U[2?^@FL[P9_R*=E_P!M/_0VK1UC_D"7_P#U[2?^
M@FL[P9_R*=E_VT_]#:GT%U-ZBBBD,**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KE-?_P"1QT'ZM75U
MRFO_ /(XZ#]6IH3.KHHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&U:.L?\ ($O_ /KVD_\ 036=X,_Y%.R_[:?^AM3Z"ZF]1112&%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5RFO_P#(XZ#]6KJZY37_ /D<=!^K4T)G5T444AA1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %-?_5M]#3J:_P#JV^AH YKP'_R+?_;9_P"E=/7,> _^
M1;_[;/\ TKIZ;W$M@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#,L/^0UJW^_%_
MZ+%:=9EA_P AK5O]^+_T6*TZ "BBB@ K$TO[^H?]?DG]*VZQ-+^_J'_7Y)_2
MFA&A1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"AKG_
M " ;_P#Z]W_]!-'A+_D5K'_</_H1HUS_ ) -_P#]>[_^@FCPE_R*UC_N'_T(
MT/8.IM4445(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 9EA_R&M6_WXO_ $6*TZS+#_D-:M_OQ?\ HL5IT %%%% !6)I?
MW]0_Z_)/Z5MUB:7]_4/^OR3^E-"-"BBBF 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% %#7/^0#?_P#7N_\ Z":/"7_(K6/^X?\ T(T:Y_R
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M&'(VEL%01SDX[FK7B+PSJ%WI@@\0>-K5;-I!M-S80QC?@D;6W @XST/3/;-
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M%G_06_\ )>+_ .)H_P"%D>+/^@M_Y+Q?_$URM%%@.J_X61XL_P"@M_Y+Q?\
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M*+ =5_PLCQ9_T%O_ "7B_P#B:/\ A9'BS_H+?^2\7_Q-<K118#JO^%D>+/\
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M@M755<L"&)!4\L"0<<'G(Y.=;PYX8TWPO8M:Z>CDNVZ2:4@R2>@)  P <
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT %>/> M.7QUXIUWQ'K$#F%T:!(OF"_O%*%0Z[<E(OE/&?G#<'!KJ/BWK/\
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M'O\ L'O_ .@SUZ/0 4444 %%%% !1110 4444 %%%% !1110 4444 4-<_Y
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M0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "N4U_P#Y''0?JU=77*:__P CCH/U:FA,ZNBBBD,****
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MO[73+&6]O9T@MXEW/(YX'^))X '))P*H3^)]'MM#BUFXNS%82D".22)U9\G
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MTP<UYSX.6_L/#(33?!L5];WJ?O[AM2A/VCJ"I!'"CD;.W.>224B\):[+X?\
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M+'&!@G 7!+;LC)4 %SP?=Z[HWBN[\':Q=OJ445I]NM=0E.)'0LJLI&6)&YF
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MLS4=1OD\(^ 9DO;A9;J_TY+AQ*P:96C)8.<_,">N>M5M,_Y$OXC_ /81U/\
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M(SH#\YQDG#Y()SSZUTLOQ2\%PRR1-K:EHV*DI;RNI(.."%(8>XR#VK$\3_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"&W<D.14^@>#]5;Q.WB?Q5>V]UJD2F*RCM 5B@C.[V!8_.P .<#DDG&WMZ*
M"L#PMH=SHG]M?:7A?[=JL][%Y9)PC[< Y YXYQD>];]% &!I.AW-AXN\1:M*
M\)M]2^S>2JD[E\N,JVX8P.3Q@FC^P[G_ (6#_;^^'[)_97V+9D[]_F[\XQC&
M/?.>U;]% '(6?A6^M_#WBS3WEMS+K%U>36Y#-M594PN_C@@]<9_&B\\*WUQX
M>\)Z>DMN)='NK.:X)9MK+$F&V<<DGIG'X5U]% &!JVAW-_XN\.ZM$\(M]-^T
M^<K$[F\R,*NT8P>1SDBN:U'P-KVF>*YM<\&ZI;VHO6\R^M;QF,<C[MQQ\K9#
M$MZ%<MM(#8'HE% ' ^%O VJP>(W\2^+-474=7C7R[;R6(CC7;M)QM49P6&T#
M R3R3D;_ (6T.YT3^VOM+PO]NU6>]B\LDX1]N <@<\<XR/>M^B@# _L.Y_X6
M#_;^^'[)_97V+9D[]_F[\XQC&/?.>U;]%% '(6?A6^M_#WBS3WEMS+K%U>36
MY#-M594PN_C@@]<9_&M_0K&73/#VFZ?,R-+:VL4+E"2I94 .,]LBM"B@# \+
M:'<Z)_;7VEX7^W:K/>Q>62<(^W .0.>.<9'O6EJ]A_:NBW^G>;Y7VNWD@\S;
MNV;E*YQD9QGIFKM% 'FP\'>+KOP%?^'-3U#3)#Y-M#8F,L%18Y-S;SL!SM"*
M, _='?)/I-%% '!V_P .EN_AI:>%M7G07-LSRQW%NQ98Y"[E6P<;AAR"#ZG&
M#@C-_L#XJ?V'_9G_  D.DYZ?:=[^?LV[=F_R_P =V-^>=U>G44 9^AZ;+I&B
MVMA/?W&H31*=]U<MN>1B22><\9. ,G  &3UK0HHH **** ,RP_Y#6K?[\7_H
ML5IUF6'_ "&M6_WXO_18K3H **** "L32_OZA_U^2?TK;K$TO[^H?]?DG]*:
M$:%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y?Q3XP;0=0T[3+#
M3'U35+XG9:QS!"JC^)C@X!/0D8PK$D;:W-5U6RT339=0U";R;6+;ODV,V,L%
M'"@GJ1VKS;P1)'XO^).M>))9_-CL,16*@. $?>JL 3Q\BME2,$R$X!%0_$W[
M5K7COP_X9/G&QE\N1U@SO^>0J[$<CY44D''&6SP: 'I\:9+F:Y6R\,37$<"O
M*6%S\RQ*?ON AVC&,\D#/6M[P=\3M.\4W?V":V:QOW8B"+<95E4*6)W!1@C:
M<@X[8)S@=AIVG6FDZ?#86$"06L"[8XUZ ?S))Y)/)))->:?&#0H(+2U\2V,,
MT6HQW"1S3V^1A<':[$=&#!5#<=0.?EP >JT5R6K>*+ZP^&<7B2.*W-ZUK;S%
M&5O+W2% W&<X^8XYKG?#_C7QOK]SI]S#X?M!I-Q<I!).%8D #]XX)<<</@X(
M!PN6;J >GT5Y/;_$7Q9XAUV_MO"VCV-W9V[91Y58'9G"LS,Z %L$A< XR.=I
M-/TKXE>(8?%]MHGB31HK;[1(( (HG1PS-M5P68ATR",CKU!.,$ [+Q'XK_X1
M_6="T_[%Y_\ :MQY'F>;M\KYD7.,'=]_VZ5%<^,&T_QO!X?O],>WMKL?Z)J#
M3#9,VT';C P<Y7&2<[>,,#6!\1O^1Q\"_P#80/\ Z,AJ?XN:6LWA>/68YG@O
M-*F62&1"0V'95(!!&#G8V>2-O&,F@#T"BLGPSK"Z_P"&M/U0,A:XA!EV*542
M#AP ><!@P_#J>M:U !1110 4444 %%%% !1110 4444 %%%% !1110!0US_D
M W__ %[O_P"@FOGS4_\ D(S?4?R%?0>N?\@&_P#^O=__ $$U\^:G_P A&;ZC
M^0IK83*E%%%,04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>D?#_ , F^:/6-7A_
MT4?-! X_UOHS#^[Z#O\ 3JG@#P =0,>KZO%BT'S06[#_ %O^TW^S[=_IU]@
M   & .@J6RDBGJ_&AWX'_/M)_P"@FL[P9_R*=E_VT_\ 0VK1UC_D"7__ %[2
M?^@FL[P9_P BG9?]M/\ T-J70.IO4444AA1110 4444 %%%% !1110 4444
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MDQ:OK\NGZ-;H(H+&*(NS,JD;P?F/ *C)4XZ9!>@#T.JG_$P_M;_EV_LWR/\
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M "&M6_WXO_18K3H **** "L32_OZA_U^2?TK;K$TO[^H?]?DG]*:$:%%%%,
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M],D5GW/PB\4S20W_ /;]O+J9.Z662:7=&RX"%9,%F. .2%Q@8SUH Z/XC?\
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M-'N[$:K?SZ7_ &7;WCHMO:,SET5-X^;?\W\74XR<G !%=AI.IQZOIL=[%#/
MKLZF*X3:Z%6*D,,G!RIJ[67X=TF70]#@T^>]>]EC9V>X=2&D+.S$G))S\W7/
M/6D,H^-6\01^'VF\-N5O(GWR!45W:/:V0BL""V=IQU.#C)P#PVNR#7M($5O\
M/+NWUBYGRTIM61$9B1O,BA2Q.<_/A03DYV\^MT4[@>?^(_#FMVV@^';W2W5[
M_0(5#P1;CYV%0-MQ@L/D(V\%E8CKP2Y\=>))K.WCT_P9J$=_*VUOM$3F*,[@
M%YVKD$9R24"GU%>@447 Y2_MM1E\5>$+BX@#R0QW/VN2W5C%&YB ZGH"V<9Z
MU>\9:7=:UX2O["R5&N9%0HK-M#;75L9]2!@9XSUQUK=HI >?R^-O$%QH4<-O
MX4U9-9G7RB_V8I#&Y! <%@>^TX; '.6P,FM8:9J">"?"%NUC<K-;ZS')-&86
M#1H))#N88R!@CD^M>DT4[@<UX_M;B\\$ZA;VL$L\S^7MCB0LQQ(I. .>@K3\
M1123^&=6BBC:21[.941!DL2A  '<UI44@,WP[%)!X9TF*6-HY$LX5='&"I"
M$$=C69XPM;BY_L'[/!++Y6LV\DGEH6V(-V6..@'K72T4 <U]EN/^%F_:_(E^
MS?V-Y?G;#LW^=G;NZ9QSBN3T#5=4T3Q%XCN5T>_U#2[C5)8F:U;>89%+DD1=
M3D% 6X' Y)P*]1K%\.Z1<:1_:WVAXF^V:E-=Q^62<(^, Y YXIB.4T&'Q#XH
M\:P>(M3LI=)LM.1HHK28/EV9"#@,!_>R7V@':JX."1 GAC5]2^%.EV=MYMGJ
M=G.]RD4@,3DAY, $X*-\P(/J!TSD>F447&><3>,?$>H^'I+,>$M6AU2Y4VXF
MB22)$W)CS0S+E"&/0G ')>BVM_%&G?"BQ71HY;;4K=Y'FB>$&4Q[Y,A493EN
M5.,9('&3@'T>BBX'DFNR#7M($5O\/+NWUBYGRTIM61$9B1O,BA2Q.<_/A03D
MYV\^@6$W]AVF@:)<PR/-);BW\V%<Q*\<62"QP1D*<<<X/2MNLN_TF6]US2=0
M6]>**P:5GMPI*S%TV@GG *Y.#@]2.,T :E<AXXTG4IYM*UO2]\LVD2M,]K&Q
M5YT)4L%(]E(*X.0QZ]#U]%(#SV_U?Q+XL^S:3INEZEH(<++=7\ZLGE@9W(O
M+<E<$%2<$$ 9-)KL/B#PQXTG\1:98RZK9Z@BQ36D.\%&5  2%!_NY#[3C<RX
M&03Z'13N!Q5OXI\1ZKXDM[.P\-SV>GA@T]SJ43H3'\N['0!OO #+9R#P <:&
MBVMQ%XV\47$D$J0S?9/*D9"%DQ&0=IZ'!ZXKI:*0''^,#?66O^'=7M=,N;^&
MSDG69+9=SJ)%"YP.>@8^F0 2,BL3Q)9WEQK^A>)+OPS_ &C9RV:0W5CL:62!
MCN8Y3 SC><;AC(.=I*D>ET4[@>0>(M:\4:UK5A?0^%]4CL=+N5ECMS'(&G;<
M64L,8^ZF. VPL?F.X5W7V6X_X6;]K\B7[-_8WE^=L.S?YV=N[IG'.*Z6BBX'
M->#[6XMO[>^T02Q>;K-Q)'YB%=Z';AAGJ#ZT?9;C_A9OVOR)?LW]C>7YVP[-
M_G9V[NF<<XKI:*0!1110 4444 %%%% !1110 4U_]6WT-.IK_P"K;Z&@#FO
M?_(M_P#;9_Z5T]<QX#_Y%O\ [;/_ $KIZ;W$M@HHHI#"BBB@ HHHH **** "
MBBB@ HHHH I:QIYU;0]0TT2^2;NVD@\S;NV;U*YQD9QGID5YSX6\0^(_"-N?
M#NM^&-7OXK'<D-]81/.'7(*@9P"H!."", *NT$&O4Z* /)WBU_X@^.M)O)M$
MN-%TO0YO/62]B99)OG5@ " ,L(UX&0O)+'*@^E_VA_Q.O[-^QW?_ ![_ &C[
M5Y7[C[VW9OS]_OC'3FKM% 'G'B&T\0^%O&]QXJT739M6L;ZV6.]M(Y3N#KA5
M*J!GH%P<.1F3.T$&F:OXXUS4]*_LZP\"ZS]IOH&@E-W;XBA=UVC[R%74$G.\
M*,#G@G'I5% '+:'92^!? -M:SQ7&I36:DO'80EW=GD)(121D#?UXX&<#I74T
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% &98?\AK5O]^+_P!%BM.L
MRP_Y#6K?[\7_ *+%:= !1110 5B:7]_4/^OR3^E;=8FE_?U#_K\D_I30C0HH
MHI@%%%% !1110 4444 %%%% !1110 4444 %%%% '+^*?![:_?Z?J=AJ;Z5J
MEBQV74<(<LI_A89&0#T!.,,P(.ZNHHHH **** "BBB@ HHHH *Y>Y\'MJ'C>
M#Q!?ZF]Q;6@_T33VA&R%MH&[.3DYRV< YV\X4"NHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@"AKG_(!O_\ KW?_ -!->:VWPSO-<MTU*/4(
M(DG&0C(21CC^E>E:Y_R ;_\ Z]W_ /031X2_Y%:Q_P!P_P#H1HZ >=?\*=U#
M_H*VW_?MJ/\ A3NH?]!6V_[]M7K]%*["QY!_PIW4/^@K;?\ ?MJ/^%.ZA_T%
M;;_OVU>OT4786/(/^%.ZA_T%;;_OVU'_  IW4/\ H*VW_?MJ]?HHNPL>0?\
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M_P *=U#_ *"MM_W[:M/0OA,EGJ:7&JW<5U!'\P@1" S=MV>WMWKTRBB["P@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;/(,\D\X;D\]3SC Z 5K67AW2=/T:;2+2S6*QF#B2,,Q+[AALL3N)QQG/
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MO ?_ "+?_;9_Z5T]<QX#_P"1;_[;/_2NGIO<2V"BBBD,**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** ,RP_P"0UJW^_%_Z+%:=9EA_R&M6_P!^+_T6*TZ "BBB@ K$TO[^
MH?\ 7Y)_2MNL32_OZA_U^2?TIH1H4444P"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH H:Y_R ;_ /Z]W_\ 031X2_Y%:Q_W#_Z$:-<_Y -_
M_P!>[_\ H)H\)?\ (K6/^X?_ $(T/8.IM4445(PHHHH **** "BBB@ HHHH
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M^K4T)G5T444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-?\ U;?0TZFO
M_JV^AH YKP'_ ,BW_P!MG_I73US'@/\ Y%O_ +;/_2NGIO<2V"BBBD,****
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MK[_H ZA_W\M__CM %^BJ'VZ^_P"@#J'_ '\M_P#X[1]NOO\ H ZA_P!_+?\
M^.T 7Z*H?;K[_H ZA_W\M_\ X[1]NOO^@#J'_?RW_P#CM %^BJ'VZ^_Z .H?
M]_+?_P".T?;K[_H ZA_W\M__ ([0!?HJA]NOO^@#J'_?RW_^.T?;K[_H ZA_
MW\M__CM %^BJ'VZ^_P"@#J'_ '\M_P#X[1]NOO\ H ZA_P!_+?\ ^.T 7Z*H
M?;K[_H ZA_W\M_\ X[1]NOO^@#J'_?RW_P#CM %^BJ'VZ^_Z .H?]_+?_P".
MT?;K[_H ZA_W\M__ ([0!?HJA]NOO^@#J'_?RW_^.T?;K[_H ZA_W\M__CM
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MO56TN!+('E@!(RIXQ)UXIK<3.MHK,_M2\_Z &H_]_+?_ ..T?VI>?] #4?\
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M?] #4?\ OY;_ /QVC^U+S_H :C_W\M__ ([0!IURFO\ _(XZ#]6K8_M2\_Z
M&H_]_+?_ ..UB:G'JE[K^F7\>AW@BM2=X:6#<<^G[RFA,ZZBLS^U+S_H :C_
M -_+?_X[1_:EY_T -1_[^6__ ,=I#-.BLS^U+S_H :C_ -_+?_X[1_:EY_T
M-1_[^6__ ,=H TZ*S/[4O/\ H :C_P!_+?\ ^.T?VI>?] #4?^_EO_\ ': -
M.BLS^U+S_H :C_W\M_\ X[1_:EY_T -1_P"_EO\ _': -.BLS^U+S_H :C_W
M\M__ ([1_:EY_P! #4?^_EO_ /': -.BLS^U+S_H :C_ -_+?_X[1_:EY_T
M-1_[^6__ ,=H TZ*S/[4O/\ H :C_P!_+?\ ^.T?VI>?] #4?^_EO_\ ': -
M.BLS^U+S_H :C_W\M_\ X[1_:EY_T -1_P"_EO\ _': -.BLS^U+S_H :C_W
M\M__ ([1_:EY_P! #4?^_EO_ /': -.BLS^U+S_H :C_ -_+?_X[1_:EY_T
M-1_[^6__ ,=H TZ*S/[4O/\ H :C_P!_+?\ ^.T?VI>?] #4?^_EO_\ ': -
M.BLS^U+S_H :C_W\M_\ X[1_:EY_T -1_P"_EO\ _': -.BLS^U+S_H :C_W
M\M__ ([1_:EY_P! #4?^_EO_ /': -.BLS^U+S_H :C_ -_+?_X[1_:EY_T
M-1_[^6__ ,=H TZ*S/[4O/\ H :C_P!_+?\ ^.T?VI>?] #4?^_EO_\ ': -
M.BLS^U+S_H :C_W\M_\ X[1_:EY_T -1_P"_EO\ _': -.BLS^U+S_H :C_W
M\M__ ([1_:EY_P! #4?^_EO_ /': -.BLS^U+S_H :C_ -_+?_X[1_:EY_T
M-1_[^6__ ,=H TZ*S/[4O/\ H :C_P!_+?\ ^.T?VI>?] #4?^_EO_\ ': -
M.BLS^U+S_H :C_W\M_\ X[1_:EY_T -1_P"_EO\ _': -.BLS^U+S_H :C_W
M\M__ ([1_:EY_P! #4?^_EO_ /': -.BLS^U+S_H :C_ -_+?_X[1_:EY_T
M-1_[^6__ ,=H TZ*S/[4O/\ H :C_P!_+?\ ^.T?VI>?] #4?^_EO_\ ': -
M.BLS^U+S_H :C_W\M_\ X[1_:EY_T -1_P"_EO\ _': -.BLS^U+S_H :C_W
M\M__ ([1_:EY_P! #4?^_EO_ /': -.BLS^U+S_H :C_ -_+?_X[1_:EY_T
M-1_[^6__ ,=H TZ*S/[4O/\ H :C_P!_+?\ ^.T?VI>?] #4?^_EO_\ ': -
M.BLS^U+S_H :C_W\M_\ X[1_:EY_T -1_P"_EO\ _': -.BLS^U+S_H :C_W
M\M__ ([1_:EY_P! #4?^_EO_ /': -.BLS^U+S_H :C_ -_+?_X[1_:EY_T
M-1_[^6__ ,=H TZ:_P#JV^AK._M2\_Z &H_]_+?_ ..TC:G>%2/[!U'D?\]+
M?_X[0!F> _\ D6_^VS_TKIZY/PRNIZ-I/V2XT.]:3S&;,<L!&#CUD%;/]J7G
M_0 U'_OY;_\ QVF]Q(TZ*S/[4O/^@!J/_?RW_P#CM']J7G_0 U'_ +^6_P#\
M=I#-.BLS^U+S_H :C_W\M_\ X[1_:EY_T -1_P"_EO\ _': -.BLS^U+S_H
M:C_W\M__ ([1_:EY_P! #4?^_EO_ /': -.BLS^U+S_H :C_ -_+?_X[1_:E
MY_T -1_[^6__ ,=H TZ*S/[4O/\ H :C_P!_+?\ ^.T?VI>?] #4?^_EO_\
M': -.BLS^U+S_H :C_W\M_\ X[1_:EY_T -1_P"_EO\ _': -.BLS^U+S_H
M:C_W\M__ ([1_:EY_P! #4?^_EO_ /': -.BLS^U+S_H :C_ -_+?_X[1_:E
MY_T -1_[^6__ ,=H TZ*S/[4O/\ H :C_P!_+?\ ^.T?VI>?] #4?^_EO_\
M': -.BLS^U+S_H :C_W\M_\ X[1_:EY_T -1_P"_EO\ _': -.BLS^U+S_H
M:C_W\M__ ([1_:EY_P! #4?^_EO_ /': -.BLS^U+S_H :C_ -_+?_X[1_:E
MY_T -1_[^6__ ,=H TZ*S/[4O/\ H :C_P!_+?\ ^.T?VI>?] #4?^_EO_\
M': -.BLS^U+S_H :C_W\M_\ X[1_:EY_T -1_P"_EO\ _': -.BLS^U+S_H
M:C_W\M__ ([1_:EY_P! #4?^_EO_ /': -.BLS^U+S_H :C_ -_+?_X[1_:E
MY_T -1_[^6__ ,=H TZ*S/[4O/\ H :C_P!_+?\ ^.T?VI>?] #4?^_EO_\
M': "P_Y#6K?[\7_HL5IUE:4+E[_4;B>RFM5F="BRLA)PH!^XS#M6K0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8VL2V#Q\H.">:NZIX^TS2_$)T,6>HWE\J@E+2 /R5W;0"P)(7#' (P>O!PK
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M=HS0!U=%<!H?Q>\/ZSKEEI$MEJNE7%]$);-M3MUA2X#?=V$,<[N=IZ'& <D
M\WX3\>37/Q3\2F7P_P")RE^^GV\44ED<V"A&&9AN_=(6=G&,Y!8T >QT53U7
M5;'1-+N-2U*YCMK.W3?+*YX4?S))P !R20!R:\XD^.^A0Z9%J<OA[Q.FGS-L
MBNVL4$3MSP'\S!/RMP/0^E 'J=%>2?$'Q9I.D^+_ (>>*9YG?2Q;W]PCQQDM
M(KVZ; %.#EBRCG&,\XYK<\,_%[0/%'B.'0H;/5;*^GB\V%;VW5!(-F\8VLW5
M/F!. 1WY&0#OZ*X#Q!\7O#_AS7K_ $2XLM5N+^RV%XK6W5]Z&(RLZG</E1?O
M9QC/&0"13N/C=X=CN9+>WTKQ!>3V]N9[R.WL/FL]IPZRAF!4H?O'E1GK0!Z7
M17*>#/B%HOCN2^71UNL620M*T\80$R*3M').5*L#VR."1S6IXF\3:7X1T.;5
M]7G\JWCX55Y>5ST1!W8X_0DX ) !KT5Y9-\>O#-I&&OM)\069DMUN+=;BS53
M<(S  Q_/@@C)R< A3SG .YXA^*6AZ!XB'A]+35=4U?\ CM--M#*Z?(''4KG*
MG/RYQ@YQ0!V]%>>0?&7PS=^%+SQ#:0:C/!8O&M[;K"JRVXD9E1FW,%8$K_"S
M$9&0.<=W8WMOJ6GVU_:2>9;7,2S0OM(W(P!4X/(R".M %BBN<\(>--.\;6][
M=Z3!=?8[6X-N+B9%59F R2@W%L8*GY@OWAWR!I:]J\.@Z'=ZG.-RP)D+S\[$
MX5<@'&6(&<<9S0!HT5Y]X6ELO"O@Z;Q/K+NE[JC&XG.Y29B69HPBKA<L&+8_
MVCG 'RVI/BAI%NMI)=Z;K%M!= -%--;*%9.,N/FRP (/R@]>,Y%.P';T5S?B
M#QMIOAS4[73KB"\N+JY4,D=M$&/+;5')&2Q!  R>.<9&9?#_ (OTSQ'<75K;
MK/;WELQ$EK=($DP#@G )X!X/<'J!D90&_17"_P#"UM%>.ZF@T_5I[>V8"2:.
MW78 3A2<L-H;'&[!]LUL:IXWT+2]"M]8>Z\^VN?]0L&"\G/S8!(QM[YQ@\'G
M HL!T5%<YHWC73=8U>;2O)N[&_C4-]GO8Q&[\9P!D\@8.#@X.1D XQ_^%KZ&
MT=U-#8ZK-;VS 23I NP!CA"26&T,>F[!]L\46 [NBN2U#XC:'IVB:=JLBW;P
MW^XQ(D8W+LX?=D@#:<#J<YXR.:DTKQ[INJ>(/[$^QZA9WQ4G9=PA.0N[:0&)
M!*\\@# Z\C(!U-%<GJGQ"TC3=3N;!(+V]EM8S+<-9Q*ZQ!?O;B6&-O&3T&<$
MYR!IV?BG2+WP\=<2[5+%%S*TG#1'C*L!GYN0,#.<C&<C(!LT5YQJ_P 2=)O_
M  ]<P?8M3MUO[6>.WFG@41NP4K@$,<_,0IQG!/.*[+PQ_P BGHW_ %XP?^@"
MBP&K163XGU@Z!X;OM35-\D*8C4KD;V(5<C(^7<1GG.,XKC- \!0^(+2RU_Q)
MJ%UJ-U=1^<(_,Q'Y;C<JGC<,;BV%*@$X P.0#TFBO*]3TR;X73Z?J6FZG=3:
M3+/Y-W:3D,7)&2R@;5W;4X/!!4<D$BNJU3Q[INF>(&T06>HWE\J@E+2 /R5W
M;0"020N"< C!Z\'#L!U5%>7:W\0+#78M(73;;4W\K4K>:XC6(<@,Q6/AL,S%
M0RCD''7(('HVFWW]I:?%=_9;FU\S/[FZCV2+@D<KVZ9^A%*P%NBL#Q?HVHZ_
MHHTW3[U+19I0+IV!^:'!W*,=<G'&1D @G!-<5XK^'VC>'_"K:E8W-U!>6)5T
MG>4Y=C(NW.U>&&<*5"\X+'N #U2BO*-5BNO&6N>$]&U"2X>SETM+VXEMQAO,
M:-LNW!0<JH!V\>81_%4VJ>'X/!?CCP]?:%%/'%?7/V:=79FB16*+MSUR068!
MB?F0'&%Q3L!ZC17GEA\+XKK[5>^)KZ6^U2Z#B22%]JH3@*PX!+ #@$;0#C;@
M"L#3[Z\\/>&O&VG6%^TL&G3I#:Y+ PB25D<@X4AL<\?+N!(R#DE@/8J*\J_X
M5GI7_"O_ +5]EO\ ^U/L?VKROX_,\K/D[-O3=VQNSQGM5>>:[7PEX;\="-YM
M3L'%O</YO$EN'DC&[?N.XY +#G,A..!M+"/7:*AM+J&_LH+RV??!/&LL;8(W
M*PR#@\C@]ZFI#"BBB@ HKRJVM;WQYJFN>(-,G-O);[+/2;DR;%5>?,)PN\$H
MQ(R./-XY4%;&H_"O0M.\)7;-<S?:;:%YS<N<)E8S\I15;$>1G !;MD]*8'IM
M%>5SVUWK7PLTSQ TTT^LZ27G@G+KD*DV&+!N&PJ!LGDE.^2#Z'H.KPZ]H=IJ
M< VK.F2O/R,#AER0,X8$9QSC-(#1HK*\3_\ (IZS_P!>,_\ Z :YK0O 'AB\
M\/:;=7&F;YIK2*21O/D&6* DX#8ZF@#NJ*Y9M)\->!+.[UV&R> 11;',;O(S
M!F7"@,Q&2VT9X]R!FLX?%;1 EK++8ZK#;W3$1SR0+L(4X8@ACN"GKMR1Z9H
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MP5))!&#SSG Q7@^'.APV&I6TANKB74/];=S2@S#Y@WRL /XP&.0=Q W9  H
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M9(/ /([@]",G-+2/A]I.CZQ%JL-Q?37B222&2>4,9"ZX.[Y1GJQSURQR3Q@
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M'!''?('5I6!^=@<;F(&WJ -WH,58L_AS9Z="8;'7=>M8BVXI!=A%)Z9P%ZX
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M %QR23^-,1M3Z?H^E^%KFQD@6#1X;619HTW<1;27Z?,21DD]223UK*^&V/\
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MO8*AW#9(YZ<\@ALY/;L='^'?A[1K*[M5MFNENE\N1KD@L$X.U=H&T9 ;(YR
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MLK>\V*@$%RNZ,DNH!8=P"0<<9QU'47-"T6+0-.%C#=W=S$K90W4@<HN  JX
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** .5\$?\S'_V'+G_ -EH^)'_
M "(.I_\ ;+_T:E8N@>$M#UZ[\076IV7GS)K-S&K>:ZX4$'&%('4FHO&W@GP]
MI'A"^OK'3_*N8O+V/YTC8S(H/!8CH33ZBZ'5^(?%VF^')K6WN1/<7=RP6*VM
ME#R')P#@D<$\#N3T!P<'A[Q=IOB.:ZM[83V]W;,5EMKE0D@P<$X!/ /![@]0
M,C/(C^TO^%K^(/[%_LW[=Y$6?MOF_P"KV1[MNSCKLSGGICO5Z+3-4G^(6DZA
MK5WH$=Y;Q.JP6L\@FD0I(!A'Z@$OR,=^N. "5/BIHLP;[/8:K/Y<+3RB*W4^
M4H."6^;H!@D]/F'.<@:J>.M"?PW)KHN'%M&WEF-D*R&7:&\L \,V".A(ZG.
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
B444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>gguopuizh44n000007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gguopuizh44n000007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" -]!YX# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKB".>"1)89%#I(C!E92,@@CJ"*H/XAT2*62*36-/22-BCJUR@*L#@@C/!!H
MTJ*AM;NVOK=;BTN(KB!\[987#J<'!P1QP01^%34 %%92^)M 9=RZYII7U%W'
M_C5RRU"RU&)I;&\M[J-6V,\$H<!L X)!ZX(X]Z +-%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD8)([@<_*:]S/A_13="Z.D6'V@2><)?LR;P^=V[.,[L\YZYKS#XK?\C1;?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4450_MO20<'5++_P(3_&@"_15#^V])_Z"EE_X$)_C1_;>D_]!2R_\"$_
MQHL!?HJA_;>D_P#04LO_  (3_&C^V])_Z"EE_P"!"?XT6 OT50_MO2?^@I9?
M^!"?XT?VWI/_ $%++_P(3_&BP%^BJ']MZ3_T%++_ ,"$_P :/[;TG_H*67_@
M0G^-%@+]%4/[;TG_ *"EE_X$)_C1_;>D_P#04LO_  (3_&BP%^BJ']MZ3_T%
M++_P(3_&C^V])_Z"EE_X$)_C18"_15#^V])_Z"EE_P"!"?XT?VWI/_04LO\
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M++_P(3_&C^V])_Z"EE_X$)_C18"_15#^V])_Z"EE_P"!"?XT?VWI/_04LO\
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M++_P(3_&C^V])_Z"EE_X$)_C18"_15#^V])_Z"EE_P"!"?XT?VWI/_04LO\
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MO?\ GM_XX/\ "KNH7UQ!Y'ER;=T8)^4')K&K1U7_ )=O^N0H B_M6]_Y[?\
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M **** "BBB@ HHHH **** "BBB@ HHHH *T=1_X\['_KG_05G5HZC_QYV/\
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MSJ34O^0C-]1_(5'9_P#'[!_UT'\ZDU+_ )",WU'\A0!4HHHH **** "BBB@
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MW//>3IK2R@6]N =CIE<DG;UY?^(=!^*&8]%%%,04444 %%%% !1110 4444
M%%%% !1110 4444 %:.J_P#+M_UR%9U:.J_\NW_7(4 9U%%% !1110 4444
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MX4@O;=>#/< ;F]QN5B?QQ2N,\\HKT+7-!T37_#$OB3PW UL]N?\ 2K3L .I
MZ# YXX(]Z\]H ****8@HHHH **** "BBB@ HHHH **** "BBNJ\)^'[+5]&\
M17UWYC/I]H9(55L#<4<@GN<%12&<K1113$%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110!;TO_D(P_4_R-?2&C_\ ($L/^O:/_P!!%?-^E_\ (1A^
MI_D:^D-'_P"0)8?]>T?_ *"*F6PT7:***DH*^</$W_(5;ZM_Z$:^CZ^</$W_
M "%6^K?^A&JB)F-1115$A1110 4444 %%%% !1110 4444 >D^%]-N]7^$NL
M6-C%YMS+?#8FX+G'DD\D@= :Q(/AGXJEF5'L(X5/622X0@?7:2?TK6T"ZN+/
MX.ZW<6L\L$R7R[9(G*L,F$'!'/0UQ[>)-==2KZUJ+*>H-TY'\ZD9U7Q,N+:)
MM&T2&;SI-,MMDKYSR0H /OA,_C71>,+CPQX3U&%_^$<L[NXN(0/(V)''&H)^
M;&TC<2<=.B]:\?)).3R37?\ Q>_Y&RU_Z\4_]#DHL!=M;+0/#?AZ+Q'K&F1W
M=WJ3F2WL\ QQJV6  /&,8YP<9  IT-IX>\?Z3>#3=*CTK5[6/S$2+ 1_;@ $
M<8SC(R*36]+G\5?#[P_=Z2AN9=/B\B6%/O#"JIX]04''H:?\/]'N_#*:EXAU
MB&2S@CM2B+,-K-R"?E//\( ]<T#,7P1H>F2:=J/B+6XS-8V'"PC^-\9Y'?JH
M Z$GFNG\):OX;\0>);=[714TJ_M-[P&':%F0J5(8 #G#9_#KUK'\&0?V[\/M
M>\/V[J+TRBX1"<;ON$?K'CVR*/AWX5U:U\617U]936D-J'&9EV[V*E<+GKP2
M<CCBA@5-'M;>\^,5Q;W4$4\+WUWNCE0,IP)",@\=17+^(HHX/$VK111K'&EY
M,J(@P% <@ #L*ZO0I$B^-$K.P4'4+I03ZGS !^9%5/$G@[7Y?%]^+?3+B9+F
MY>6*5%^0AF+#+=!U[D4Q%OQ;I%N=$\%QV-I;PW-[;!7=(PID<K%@L0,GECR?
M4UIZK/X5\"M%I7]A0ZM>[ UQ+/CC(]PV#WP ..]2^-#'H;>!3+()([$C<Z\A
M@GDY(_*L[XA>&-4O?$K:IIUG->VMZD;*]NN\ A0N..<84'/3FD,J:DWAK3-0
MTWQ'I<%K>6<P;S])FE4M&Y4CE3NP,\],9 QU&-[XJZO9PR'2GTF"2[GMHY$O
MSC?$/,/RCY<X^4]Q]XUQOB#P@_AO1K"YO;Q1?71YLPG,:CJ=V>>W;O[5T?Q;
MT^\?7+?4$M96LUM%1IU0E%;>W!/;[PZ^M CS>NO\,#^S/"OB#6SD2-$+&W8'
M!W2?>Q[@8-<A77>(_P#B5^#] T88$DJ-J%P,8.7X3\ER/PIL#D:[_P"$/_(V
M77_7B_\ Z''7 5W_ ,(?^1LNO^O%_P#T..A[ BO\+;&SU#Q-<Q7MI!<QBS9@
MDT8< [T&<'OR?SJ_%XF\%Z9>#3(_#,5Q9QMY;WLP5Y&YP6P021WZCZ#I4'PA
M_P"1LNO^O%__ $..N I=0.\\1^#;>/XB6FC:?^YM[Y5E"YSY:Y;=C/\ N$BM
M+5=7\&:%J#Z!_P (W'<P1?NKB[./,!QR5.-Q(SZK@CBM'Q-?0Z=\7]"N9V"Q
MBU"%CT&XRJ"?Q:N7\5^"M</BV\:TT^>YAO)VFCEC7*C<<D,>BX)QSB@9I?%&
M"&UTCPO;VTAD@B@D2-SU90L0!_*J?BW2+<Z)X+CL;2WAN;VV"NZ1A3(Y6+!8
M@9/+'D^IJW\4+7[!HWA:SWA_L]N\6X=&VK$,_I4OB6ZCL;#X=WDO^K@BCE;
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MG_H<E+\7E8>*;1\?*;)0#[AW_P 12?%[_D;+7_KQ3_T.2A". HHHJA!1110
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M2@,GE*, 8"D$#MD../:J7Q(_Y'[4_P#ME_Z*2M7Q_P#\BGX,_P"O$_\ H$5
M&OJ4/AK1/"_AS5KW2(KBX:T4+!&BH)W:-"7D..<8[YY;I1):>$O$GAA?$CZ<
M--BL92+J"V4+YF /W8Q@<EDYP#SCCJ,CQ_\ \BGX,_Z\3_Z!%1I/_)%==_Z_
ME_G#0,V="F\+^.8[W2(_#T&G3I"7AEB"[L @;MP .02.#G-<UX+T+3)M/O\
MQ!K@+Z=88 B!_P!8_'!_-0!GDFKGPA_Y&RZ_Z\7_ /0XZTOAQ=7,_A#6-,TN
MZ6#5EE\^$L >H4=&!&/E(/'&10!%IVN^$/$U^FCW/AB"P6X;RX+B$J&W=LD
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M:JJB1" 1D[5 _BQU/6K'C_\ Y%/P9_UXG_T"*@1O^'/$47Q#BO=&UK3[83"
MR1RQ*<*,A<C.2&!8=Z@^'OB.\C\&:S$(X-NCVS2VY*G+%O,<[N>1D=L<5C_"
M'_D;+K_KQ?\ ]#CJ3X<PR7/ASQ=;PH7FELU2-!U8E)0!^9H&6_!;IXK\0ZUK
MM_96MQJ44,;6]MTC+!2 ?FSC[BC/.-V:MW/C+Q#9SM%XE\*QG2^DFR L O\
MO$E#]./PKE?!_AW4;G6+N&'4)M(U>UB$D43Q%6DSV.2"!]WL>#TKJM+\1_$*
M&^CLKO0VN\-M=Y(#&"/^NB_)^.#0P/,]7DT^75KF32XY8K%WW11R@;E!ZC@G
MH<XYZ8JE78_$RUL+3Q@Z6"1INA5YTCZ"0DYX[$C:?QSWKCJ:$%%%%,04444
M%%%% !1110 4444 %%%% !1110!;TO\ Y",/U/\ (U](:/\ \@2P_P"O:/\
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M@ HHHH **** "BBB@ HHHH *T=5_Y=O^N0K.K1U7_EV_ZY"@#.HHHH ****
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M#2M8OM*UJ?3K[[-;VD&^\B\YT\U-KG&%&&X##!]:S=)TB^UR_6RT^!IIB-Q
M. H[DD]!7HNC*%7XEJHP )@!_P!_ZH^$[A]&^&6OZQ:?+>&=8!(.JCY "/IY
MA-%P*5Q\*?$<%LTRM9SL!GRHI3N/YJ!^M<SI.@ZCK6J?V=9P$W"Y+J_R^6 <
M$MGI@FC2]>U'2-674K:X<W ;+^8Q(E]0W/(-='X?OO$WB'Q'J#Z*T%E+?*&N
MWCC C08QG+!B"23T.23GMP]0+!^$?B#9N^TZ<3_=\U\_^@5AZ7I=YH_CO2K*
M_A,,\=]!E2<Y&]<$$=173P^$-"T>\^TW_C:-+B-MS"V91(K=3SN8Y_"K?C8
M?%CP[@=?LV?^_P"U*X['+?$C_D?M3_[9?^BDKE:ZKXD?\C]J?_;+_P!%)7*T
MT(****8@HHHH T=3_P!19_\ 7(?R%9U:.I_ZBS_ZY#^0K.H8!1110 4444
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MF^U"\U.Z:ZOKF2XF;J\C9./0>@]JGU#6]1U2TLK6\N/-ALH_+MUV*NQ< 8R
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M8H?]@<+^@%9=%(85UW@OQ3:Z0MUI6K1&;2+WB48SY9QC=CN,8SCG@8Z5R-%
M'HK^"_"%Q,)[7QA;PVIY\J5TWX],E@1^*U!XD\1Z-IWAW_A&/#):2!SFZNCD
M&0\9&>,DX&3TP,#VX&BBP7.WTR_LX_A%K5D]W MW)>*R0&0!V&8>0O4C@_D:
MXJ.1XI%DC=DD0AE93@J1T(--HH ])UW4=,\:>"8;^>\M+?7+$$-')*J&7&-P
M /7/!'OQZTWPB-+U#X=:EHM[K-GITEQ>;@TTB@@ 1'.TL,@[2*\XHHL%SO\
M_A - _Z'O3/RC_\ CM<AK>GV^EZO/9VM_%?PQ[=MS%C:^5!.,$C@G'7M6?10
M 4444Q!1110 4444 :-]_P @^Q_W3_2LZM&^_P"0?8_[I_I6=0P"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH TA_P @$_\
M76LVM(?\@$_]=:S: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** )[/_C]@_P"N@_G4FI?\A&;ZC^0J.S_X_8/^N@_G
M4FI?\A&;ZC^0H J4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% %O2_P#D(P_4_P C7TAH_P#R!+#_
M *]H_P#T$5\WZ7_R$8?J?Y&OI#1_^0)8?]>T?_H(J9;#1=HHHJ2@KYP\3?\
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M:/\ A5\/_/S#_P!^C_C0!Y)17K?_  J^'_GYA_[]'_&C_A5\/_/S#_WZ/^-
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M'_OR?\:/^%4Q?\_</_?D_P"-%T%F>/T5[!_PJF+_ )^X?^_)_P :/^%4Q?\
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M>/T5[!_PJF+_ )^X?^_)_P :/^%4Q?\ /W#_ -^3_C2N@LSQ^BO8/^%4Q?\
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M6A_PJF+_ )^X?^_)_P :;:%8\?HKV#_A5,7_ #]P_P#?D_XT?\*IB_Y^X?\
MOR?\:5T.S/'Z*]@_X53%_P _</\ WY/^-'_"J8O^?N'_ +\G_&BZ"S/'Z*]@
M_P"%4Q?\_</_ 'Y/^-'_  JF+_G[A_[\G_&BZ"S/'Z*]@_X53%_S]P_]^3_C
M1_PJF+_G[A_[\G_&BZ"S/'Z*]@_X53%_S]P_]^3_ (T?\*IB_P"?N'_OR?\
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MM_EG'Y9K1_X53%_S]P_]^3_C3N@L>/T5[!_PJF+_ )^X?^_)_P :/^%4Q?\
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M !HN@LSQ^BO8/^%4Q?\ /W#_ -^3_C1_PJF+_G[A_P"_)_QHN@LSQ^BO8/\
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M %%%9NO:U;>'=%N-5NTE>"#;N6$ L=S!1C) ZD=Z -*BO./^%T^'/^?+5?\
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M_C_U[_K\;^;5U-<MX1_X_P#7O^OQOYM74TWN);!1112&%%%% !1110 4444
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MG_'MJ'_7VW\A5+83.FHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KD/BC_ ,DYU7_MC_Z.2NOKD/BC_P DYU7_ +8_^CDH U_"?_(G:'_V
M#X/_ $6M>;?&NVT5$LI5,,>L2.3(D:@-+"5QOD(&3@HJKD_WL9P<6]$\ Z_>
M:!IUU#XZU*VBFM8I$@02;8E*@A1B4<#..@Z5H:#\);33=<75M2U:XU&XCG%P
MGR>6#("3N<[F+'=@]1R.<@XH S?BKJ-W?^(]%\(Q3O;6MXT332+R',DNQ<KP
M2%*DXS@DC^Z#7>:/X/T'1+ 6EKIMNV8#!+-+$K23HWW@[8^8$]1T[   "N'\
M9ZA_8GQA\.ZG/%BU-NL)FD;9&-S2(QW$8^42!B/3'3.:]4H \>^)?AZU\)S6
M'BCP^_\ 9MU]H6#RK= J;MC$,HZ#A2"N,-GIUW=_J-S)KOPXN[J.U?S;_2'D
M6W3,C9>$D(,#YCSCIS7/_&+4S9^#4LD:'??7"HR.?F\M<N649[,J GD?-[BM
MNVU:+PM\.-.U#4K>X5;6QMEEA5,2*Q")C#$8()Y!H \_^%FM>$=.L534FM+;
M6/M,C1W%R@R%*#E9=H$:XW#!;DY_O 5U6N^ =%\6O;:UH>H16%SYA?[;8 .D
MQ#$EOE8?.'S\X.>H.<#!-X/\(_$'3;?7+:":T-R2YFM@(G<AF#!U(*D[B<MC
M)('S$5Q/B/P'JW@&)O$&A:Q*8HY-LC*/+DB0N-@;G$BYVAA@ G'RXS@ ZSXT
M_P#(G6?_ &$$_P#1<E=?XL_Y$[7/^P?/_P"BVK@?B;>RZE\+M!OYPBS7,UO-
M($!"AFA<G&2>,GUKOO%G_(G:Y_V#Y_\ T6U 'A/AZ)O#6M^$->!1;>]=A)+<
M.-B?O7ADQR"H$;*V3QD]P,#VKQ[K/]A>"]1NDDV7$D?D08E\M][_ "Y4]=R@
MEL#GY3TZUY=JFCK>_ [1=3"IYNGS2Y9F(/ER3,I  X)+>6>>P//8M\7>([GQ
MCI7A#2(97%S>(KS-.BJCSES K97) W+*< =&'&>  ,\"Z0VD^/O"C2!UEO;*
M2[968$ ,LP3&.Q14.#SDGZ#L]9_Y+OX>_P"P>_\ Z#/3-3ABM_CCX;@@C2*&
M/361(T4*JJ%G   Z "GZS_R7?P]_V#W_ /09Z #XC?\ (X^!?^P@?_1D->CU
MY?\ %>RCU+7_  A83,ZQ7-T\+E" P5FB!QGOS63XL^$ L-*^V>'9;JZEARTU
MM,59W7UCV@<C^[W[<@!@"KXBE\+R?$SPTOAT6X$=U;K/]C1%MR?-4KM*CYFY
M.3R/NCJ"*Z'[-:W*S7%O91ZS?R>)+M;FVO& #F.&<1Q;F4C:J!2H.0"<97M0
M^#-MX?GBFG,2'7[=G^:20D^2P #(N  .JDC)Y.2 P%=MJ/@]I/$?]OZ3J;V&
MH2-&9UDA$\,H12H^0D%6VG;N5@0I8#&XF@#BECL8OA]XL^W01:/>6NHM>1VE
MJ6\RQFP@AP<'&YEX=/E*L=I49"^NUR \#F\\1KK.LZBMR\<\=Q%;VEJ+:/S$
M7"M(<L\A'!7<W'S#HQ%=?0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5@>"ONZM_U^-6_6!X*^[JW_7XU'0#JJ***D84444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '+>$?\ C_U[_K\;
M^;5U-<MX1_X_]>_Z_&_FU=33>XEL%%%%(84444 %%%% !1110 4444 %%%%
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M* "BBB@ HHHH **** "BBB@ HHHH **** ,[7O\ D7M1_P"O:3_T$U6\)?\
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M",Y&%& ,8+G&<\CG=^&&OZKXA\-7,NLS0SW=K>R6QEBV8< *V<I\I^\0"O!
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MHHH Y1O^2E)_UZ?XUU=<HW_)2D_Z]/\ &NKIL2"BBBD,**** "BBB@ HHHH
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M^?Y2R% [!&4 D<X^<G@CD#MD'G?"4,5M\2O&\$$210Q+IR1QQJ%5%$!   X
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MY5"^QM[/T!X(.P]#E=V 2.,_XA>-++Q5I$/A;PLQU2^U*2/>L<381!B0?,<
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MX!^91R-VX,<<*3757^FV&J0+!J%E;7D*MO6.XB610V",X8'G!//O18:;8:7
MT&GV5M:0LV]H[>)8U+8 SA0.< <^U%QJ+3WT/"?!NE^"H7N-"\<:>ECKEO.5
M#W$\L2.F-PRP?8".<'@$%,;B37<> )? LOB6]3PCI=XLL-MB2^/F^2R,5.WY
MV)#$CNHSL;''7N+[0='U2=9]0TFPNYE78)+BV21@N2<9(/&2>/>IK#3;#2H&
M@TZQMK.%FWM';Q+&I; &2% YP!S[4-DQIV?0M5Y!\*O'NC:?X.;3-7U&VM);
M%I7C5E8%X>'SGHS;G8!5Y( X[UZ_7"> ?#=K-\/-&MM>T6&2XM_/Q%?VH+Q[
MI6/1QD9&#[\4+8J5^96_K8X36Y]1^(>H^*M4T33IKG3H-.CL;:18]K2E9XI3
M@$Y9L"1@ ,XV @$@'M--^+_AJ7PU'?ZA>&*_2-1/:1PMN,N#D(.05)4X.[ R
MNX@FN[M+.UT^U2ULK:&VMTSLBAC"(N3DX X'))_&L^;PIX=N)I)I] TN665B
M\CO9QLSL3DDDCDD]Z+B4&G='G6A374/PE\1:SKN@?;8]2O9+]K(902Q2&/+C
M[S(HPS ]0%#9Z-7-SZ/\.[G0'\0Z9K]SH]_$L<BV44OFO!, I*QJP61SD\.&
M !YR "!] 5B_\(=X8QC_ (1O1\?]>,7_ ,31<3IZ6/-[S5KD?#/P+JVO3S;X
MM:MYIIID.\Q*TI5CQEOD .>2W7G-=Q>:-9^,C%JUAXGUJWMMK0K_ &9>>5$Y
M1V!;&TY.<C<." ,<<UTEW9VM_:O:WEM#<V[XWQ3('1L'(R#P>0#^%%I9VMA:
MI:V=M#;6Z9V10H$1<G)P!P.23^-%RE#N<'X[CL?#?P]@M]2TV\\2VD=RJNUY
M=,)4R682-*JY&#A >.& SS@^?:]I'@;2M(/B'PKXKO(+[S6^S00R9D&=PV!?
MDDC7_;8GY?[Q89^@)H8KF"2">))895*21NH974C!!!Z@CM67#X5\.V\\<\&@
M:7%+&P>.1+.-65@<@@@<$'O0F3*G<X3Q#K,NCWWP[\0:]'<JL4$JWTOD$&.6
M6! =R@#!SN.T#.%; .,5#\6/'.AS^$IM%T^_MKZZO&CS]GDWK&@;=NW %2<H
M!MR#\V?KZC=V=KJ%J]K>VT-S;OC?%-&'1L'(R#P>0#^%9Z>%?#L2R+'H&EHL
MJ[) MG& ZY#8/'(RH./4#THN-P=FD]S"_P":V_\ <N?^W-9WQ+O+S0=:\+^)
MHK-Y[+39IENV5=VQ)0B=,CDC=@GC=M!Z@'O_ +':_;OMOV:'[7Y?D^?L'F;,
MYV[NNW/..F:Y3Q]<^([&"QO-&L$U/3T9X]2TTQ"1KF-\* !M)P/FSCU!(8 X
M DK19B>./B1X?F\"7J:3JEM<W5_"\$4)1]VTL$DW# *':6(W8SC(R*;:?\A?
MX4?]@Z?_ -)4K'OY;G6X5TGP_P##5M&O+V 1/J5Q8K"ML6!$HW>7RI3<N[(8
M[N%S@'U+2]#M;#3=)MY8X;FXTRV6"&Y:(!UP@1BO4KN Y /YT;$I.3N<)X7\
M00^%O%_B?1/$,T.FK=ZC)?6+S@J)5D+$MYGW N$3&2.21UX%V#QOJGB27Q$_
MART\S2;+39#:7R0L9);S8&555@,XR1MVGD D_,!7:ZAH^EZMY?\ :6FV=YY6
M?+^TP+)LSC.-P.,X'Y"IK2SM=/M4M;*VAMK=,[(H8PB+DY. .!R2?QHN6HM:
M7T/!O#]M\-U\+OK?B2^NM1U2=V\^WED=9?.^9CM5&R0V1\[,5)QDJ20.Q^"F
MJ07^B:RBK##<'46N9+>",K'$LBKM"CH%RC #)P!]*[B;PIX=N9I)I] TJ665
MB\CO9QLSL3DDDCDDU=M=-L+&>XGM+*VMYKEM\\D42HTK9)RQ ^8Y)Y/J:+DQ
MIM-,Y7X3?\DRTC_MM_Z.>L3XPS<>'[*_N[RTT"ZN7&HR6T6[IM* _P#CYQST
MSM8J!7I-I9VMA:I:V=M#;6Z9V10H$1<G)P!P.23^-%W9VM_:O:WMM#<V[XWQ
M3('1L'(R#P>0#^%%];E<GN<I\]^.1X#T725TOPQ'%>ZF^R.XO#(\P5 %8LK9
MV;V(7E!@#>/ESBO3_&]Y!J%CX,O;5_,M[C7K&6)\$;E8,0<'D<'O72)X4\.1
MK(L>@:4JRKLD"V<8#KD-@\<C*J<>H![5=;3;!X+:![*V:&U97MXS$I6%E&%*
M#'RD#ICI1<E4WJ9_C#_D2=?_ .P=<?\ HMJ\CUU;749O VD>(=2O+#P]+HMN
MZO$H$9N-FW)<C P"F20VT'HH8L/<YH8KB"2">-)89%*/&ZAE92,$$'J"*JW&
MCZ9>6,-E=:;9SVD./*@E@5HTP,#:I&!@' QVH3*G#F/"-=U/P+H_BK1(?#4$
M26]MJ,5QJ%Z/-EVB-\!8V8DE<%V.T8;Y,$XKU#Q+_P E-\#_ /;_ /\ HD5N
MCPIX<6%X1H&E")V5V06<>UF4$ D8Y(#-CZGUK1EL[6:Z@NI;:&2XM]WDRN@+
MQ[AAMIZC(X..M%R5!_D>7^'?%,/@_P 9^(]#\1C^SXK[47OK*>1#M<2/C)8$
M@*0%(. !A]Q!&*6?Q79>(OC3X;M=,N8;FSL8KD&6-6_UK1R!AD\,N$0@CCD\
MGL_4M1UJS\4W=EXH\&OXDTOSGEL+NVL%G:WA;.$ VX)^5002I&"<L-M'A/3-
M3UWQ;8ZX_AU/#&E:4LHCL/)"-//(A5W V(<;=F201\@ ZMADZ_"NYR/@W2_!
M4+W&A>.-/2QURWG*A[B>6)'3&X98/L!'.#P""F-Q)KN/ $O@67Q+>IX1TN\6
M6&VQ)?'S?)9&*G;\[$AB1W49V-CCKW%]H.CZI.L^H:387<RKL$EQ;)(P7).,
MD'C)/'O4UAIMAI4#0:=8VUG"S;VCMXEC4M@#)"@<X Y]J394:=GT/#].T_X=
M>+)[A=2A?PEJ,,TOFV@N]JL,KG)E3:A#%@$7!&#QCIH^#KNZE\">.;--3O-2
MT>SLGBL;BXA* XA<,$!)(4 )A<\ @X4L17JMWX;T*_NGNKS1--N;B3&^6:U1
MW; P,DC)X 'X5:BTVP@TXZ?#96T=B59#;)$HC*MG<-H&,')SZY-%P5-W/(/&
M,W_%$> ;*_N[RTT"ZMH1J,EM%NZ1QE ?_'SCGIG:Q4"N>\<CP'HNDKI?AB.*
M]U-]D=Q>&1Y@J *Q96SLWL0O*# &\?+G%?0$NFV$^GC3YK*VDL0JH+9XE,85
M<;1M(Q@8&/3 JDGA3PY&LBQZ!I2K*NR0+9Q@.N0V#QR,JIQZ@'M1<4J39H65
MY!J%C;WMJ_F6]Q$LL3X(W*PR#@\C@]ZGID,,5O!'!!&D4,:A$C10JJH&  !T
M ':GTC8*\.US6]4TO5KB.PO[BV1Y'9EBD*@G<>:]QKY_\5_\AJ7_ 'W_ /0C
M30F,_P"$O\1_]!N^_P"_QH_X2_Q'_P!!N^_[_&L6B@#:_P"$O\1_]!N^_P"_
MQH_X2_Q'_P!!N^_[_&L6B@#:_P"$O\1_]!N^_P"_QH_X2_Q'_P!!N^_[_&L6
MB@#:_P"$O\1_]!N^_P"_QH_X2_Q'_P!!N^_[_&L6B@#:_P"$O\1_]!N^_P"_
MQH_X2_Q'_P!!N^_[_&L6B@#:_P"$O\1_]!N^_P"_QH_X2_Q'_P!!N^_[_&L6
MB@#:_P"$O\1_]!N^_P"_QH_X2_Q'_P!!N^_[_&L6B@#:_P"$O\1_]!N^_P"_
MQH_X2_Q'_P!!N^_[_&L6B@#:_P"$O\1_]!N^_P"_QH_X2_Q'_P!!N^_[_&L6
MB@#:_P"$O\1_]!N^_P"_QH_X2_Q'_P!!N^_[_&L6B@#:_P"$O\1_]!N^_P"_
MQH_X2_Q'_P!!N^_[_&L6B@#:_P"$O\1_]!N^_P"_QH_X2_Q'_P!!N^_[_&L6
MB@#4@\2:U:M*T&J7<;2MND*RD;CZFIO^$O\ $?\ T&[[_O\ &L6B@#:_X2_Q
M'_T&[[_O\:/^$O\ $?\ T&[[_O\ &L6B@#:_X2_Q'_T&[[_O\:/^$O\ $?\
MT&[[_O\ &L6B@#:_X2_Q'_T&[[_O\:/^$O\ $?\ T&[[_O\ &L6B@#:_X2_Q
M'_T&[[_O\:/^$O\ $?\ T&[[_O\ &L6B@#:_X2_Q'_T&[[_O\:/^$O\ $?\
MT&[[_O\ &L6B@#:_X2_Q'_T&[[_O\:/^$O\ $?\ T&[[_O\ &L6B@#:_X2_Q
M'_T&[[_O\:/^$O\ $?\ T&[[_O\ &L6B@#:_X2_Q'_T&[[_O\:/^$O\ $?\
MT&[[_O\ &L6B@#:_X2_Q'_T&[[_O\:/^$O\ $?\ T&[[_O\ &L6B@#:_X2_Q
M'_T&[[_O\:/^$O\ $?\ T&[[_O\ &L6B@#:_X2_Q'_T&[[_O\:/^$O\ $?\
MT&[[_O\ &L6B@#:_X2_Q'_T&[[_O\:AA\2:U;RRR0ZI=QO,VZ1EE(+GU/YFL
MNB@#:_X2_P 1_P#0;OO^_P :/^$O\1_]!N^_[_&L6B@#:_X2_P 1_P#0;OO^
M_P :/^$O\1_]!N^_[_&L6B@#:_X2_P 1_P#0;OO^_P :/^$O\1_]!N^_[_&L
M6B@#:_X2_P 1_P#0;OO^_P :/^$O\1_]!N^_[_&L6B@#:_X2_P 1_P#0;OO^
M_P :/^$O\1_]!N^_[_&L6B@#:_X2_P 1_P#0;OO^_P :/^$O\1_]!N^_[_&L
M6B@#:_X2_P 1_P#0;OO^_P :/^$O\1_]!N^_[_&L6B@#:_X2_P 1_P#0;OO^
M_P :/^$O\1_]!N^_[_&L6B@#:_X2_P 1_P#0;OO^_P :/^$O\1_]!N^_[_&L
M6B@#:_X2_P 1_P#0;OO^_P :/^$O\1_]!N^_[_&L6B@#:_X2_P 1_P#0;OO^
M_P :/^$O\1_]!N^_[_&L6B@#:_X2_P 1_P#0;OO^_P :/^$O\1_]!N^_[_&L
M6B@#4B\2:U!-+-%JEVDDQS(ZRD%C[U-_PE_B/_H-WW_?XUBT4 ;7_"7^(_\
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M2"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG:"Q)^8+7>?\(]_Q7/\ PDOVK_F&_8/L_E_]-?,W[L_AC'XUMT7&H.[N<?X
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MTO92T\I ^Z=CX5N <-M #KR1\U==X0UN_P!>T".ZU/2;G3+Y&\N:&>)HPS
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *]Q^&5SK5QX?_XF29M%P+25S\[+Z>ZCL:X[
MP%X";5WCU35(RNGJ<Q1'@SG_ .)_G7LZJJ(J(H55&  , "I;*2.5;_DI2?\
M7I_C75URC?\ )2D_Z]/\:ZNDP04444AA1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 9VO?\ (O:C_P!>TG_H)JMX2_Y%:Q_W
M#_Z$:LZ]_P B]J/_ %[2?^@FJWA+_D5K'_</_H1I]!=3:HHHI#"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@##\8?\BK??1/_ $-:OZ/_ ,@2P_Z]H_\ T$50\8?\BK??1/\ T-:OZ/\
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M_LE=I0.+NKA1110,**** "BBB@ HHHH *^?_ !7_ ,AJ7_??_P!"-?0%?/\
MXK_Y#4O^^_\ Z$::$S"HHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MVL%O$MNX."TL"C?D$8("L![L"""HK8LK.#3OC);V-K'Y=O;>%EAB3<3M1;@
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MV*V,RHIX8$=">U8'P7L)=*\-:SIUPR--::S/!(8R2I9$C4XR <9'I6C\7?\
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M27*Q*)77SGX+8R1\HXSV'I1I8=Y<R3/0:***DT,/QA_R*M]]$_\ 0UJ_H_\
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MMV["8((R#VS7J.O:?I+^$K^QOXT@TE+1ED$<8Q#&JYRBX."N 1@'! P*H?\
M"O\ P[_PB/\ PC7V/_0OO^9D>;YN,>;NQ]_WZ8^7&WBN4_X5)JLVG6^E7OCB
M^GTJ)ANM! 0"@V_*"9"  $&T$$*>0.3D"TET.8NDLY/@?X0CU"5X;%M8Q<2Q
MC+)&7GW,.#R!D]#]#7LOB2UTZ\\,ZG!JQVZ>;9S.X3<8U R7 P?F7&X<'D"N
M+^(OA_3E\->&?#]M#]ET^36K:V"0\%582 D$Y^;DG)SD\G-)J'PQU?588["^
M\<ZC<:3'*3]FDBR[H7#;7DW?.PP,,RD ] !Q3%%.+:M?8P-*_P"29?#W'_0Q
MQ?\ HZ:N@T2UTZ;XY^)YYSNU""V@:V0ID!3%&)'SCAAE%ZCAVZ\XZ34/!UG<
M:=H>GZ>4L+72+^&\CC2/<&$>[Y>HY)8DL<G.2<DU5\1^!_[6U>#6]'U2;1-8
M3"RW4";A<(,$+(N0&P57KD$#!!&,*X<C7R+5_%X7'CS2YKLI_P )(\#K9@.Y
M;RP')RH.T##/@L.><9QQJ:]:Q7WAW4[2:Y2UBGM)8GN'QMB5D(+')' SGJ.E
M8/AOP/\ V3J\^M:QJDVMZP^5BNITVB!#DE8UR0N2S=. #@ #.>GO+2#4+&XL
MKI/,M[B)HI4R1N5A@C(Y'![4C17MJ>,Z?%\2=$T18; Z7XGT$6CHJHZ7,.W)
M#(.5D<@ KM&X8.T#C TM=URUUSX(ZTUMHW]C_9+E;66Q"A5B<3QL0  /[W.0
M#G/U.G8?#77]&M;FQTCQW>6NGR[E2!K02&)26/RL7^5OF.60+D\^F-K3?AWH
M]AX&F\+2---;W/SW,P8JSR_+\X'(7!5<#D?*,[N<U=&2A*UO(ZN::*V@DGGD
M2*&-2[R.P554#)))Z #O7C7_ #;+_G_G\KH%^&NOMH]MHMQX[NVTF+"-!%:"
M-FCY!3?O)V[20 VY1QP0 *U/^$ _XME_PAO]I_\ ;WY'_3;S?N;OPZ^_M25D
M5)2ETZ,Z#1K73I/"NGVEL?M>EM8QQQ&=,^=#L &X$#JO4$#KTKQ;P]JEKI.A
MK9>']%AUS4+C7[@:1+=P!_+1%A/F'.TJQ78<C:!@L2-N#UQ^%.KQ:/+HEGXW
MNX-(:5W2V-KDA6R"K,'!*D$Y7A223MR:U-3^%>CW/A[3]-TN:;3;G3Y?.M[V
M/YI/,.W<SX(W,=J\@@@JN, 8HT!J3Z'#_$.'QHWAB2]\4ZCI<%G,T7D:=;0>
M8RS\?*'*DH0HD)8.1P5'#5U?Q&M=.O?''@:WU4_Z))<SJ5V;@[?NMB$8.59]
MJGCH3TZU5UCX2:GXBN'N-:\9W-Y,%Q#FS"I$V5R0@? !5>0NW)P23@@]5J_@
MN#6_#5AIUY>3-J5A$GV;55R)DF4 >9G.>2H)&>?7(!#N+E>OR)/&\7A>305;
MQ:4&G1SJR[G=29,$# 0[F."W SQD]LC(GM(+GXYVTLR;GM=!,L)R1M8S,F>.
MORNPY]:9;?#B\NM1LYO$_B:YUVSLT7RK*6'RXV=<[6<;B'(!.21ENY(R#TG]
M@?\ %;?\)']I_P"8=]A^S^7_ ---^_=G\,8_&D4TV[V.1U>UTZZ^/.CB_.9(
M]*\RU0IN5YE>0C/!QA=[ \8*CGL3XV6NG2^!UN+L[;N&Y1;-@F2S-]Y"<'"E
M S=1DHOL#N^,O MGXM2WN%N'L-6M65K>_A7+H <X.""1GD<@J>0>H.+:?"R2
MXUJUO_$_B*YU^&U3$-K<1%4W * 3EVR,*"1@;B 6)Y!!.+U5MR?QK81:C\1/
M D$S.JI/<S@H0#NC5)%'(Z949]L]*/BCIUGJ,'AF&[MTE677+>W<GAO+<,'4
M,.0#@9P>P]!72:EH']H^)M#UG[3Y?]E?:/W/EY\WS4"]<_+C&>AS[4>(M _M
M_P#LG_2?(_L_48;[_5[O,\O/R=1C.>O/THN-Q;3\S"^+D,4OPUU-Y(D=HFA>
M-F4$HWFJN1Z'#$9]"?6G^)?^2F^!_P#M_P#_ $2*VO%F@?\ "4>&;S1OM/V;
M[3L_?>7OV[75NF1G[N.O>C4M _M'Q-H>L_:?+_LK[1^Y\O/F^:@7KGY<8ST.
M?:A,)1;?W?F<.-8\1ZGXHURR\$^']+L+:.9[:\U6YA"LTZ[\N2I^8Y)P-K_>
M!; ; @\&0ZE;_%Z^AUK4;:^U9='/VN2W@$:JWF1E5R%7>=FP[L=]O\-;=]\.
M+M->U/4_#WB:YT8:FA^UPK#YH9R26926!4Y)((Y4EL$ X$'ACX6R^&_%%OK@
M\1W-U*%D^UH\1'VEGW<D[R<9*'!W99<YY&#0GEE=&C\._P#F:_\ L8[S_P!D
MKM*Q?#N@?V!_:W^D^?\ VAJ,U]_J]OE^9CY.ISC'7CZ5M4F:032LPHHHH*"B
MBB@ HHHH **** "O!?$MI<W&L3-!;RR@.X)1"V/F/I7O58'@K[NK?]?C4^@'
MAG]F:A_SXW/_ 'Y;_"C^S-0_Y\;G_ORW^%?3M%+F"Q\Q?V9J'_/C<_\ ?EO\
M*/[,U#_GQN?^_+?X5].T4<P6/F+^S-0_Y\;G_ORW^%']F:A_SXW/_?EO\*^G
M:*.8+'S%_9FH?\^-S_WY;_"C^S-0_P"?&Y_[\M_A7T[11S!8^8O[,U#_ )\;
MG_ORW^%']F:A_P ^-S_WY;_"OIVBCF"Q\Q?V9J'_ #XW/_?EO\*/[,U#_GQN
M?^_+?X5].T4<P6/F+^S-0_Y\;G_ORW^%']F:A_SXW/\ WY;_  KZ=HHY@L?,
M7]F:A_SXW/\ WY;_  H_LS4/^?&Y_P"_+?X5].T4<P6/F+^S-0_Y\;G_ +\M
M_A1_9FH?\^-S_P!^6_PKZ=HHY@L?,7]F:A_SXW/_ 'Y;_"C^S-0_Y\;G_ORW
M^%?3M%',%CYB_LS4/^?&Y_[\M_A1_9FH?\^-S_WY;_"OIVBCF"Q\Q?V9J'_/
MC<_]^6_PH_LS4/\ GQN?^_+?X5].T4<P6/E]+"\D+!+2=BIPP6,G!]Z?_9FH
M?\^-S_WY;_"O=/"/_'_KW_7XW\VKJ:&["L?,7]F:A_SXW/\ WY;_  H_LS4/
M^?&Y_P"_+?X5].T4<P['S%_9FH?\^-S_ -^6_P */[,U#_GQN?\ ORW^%?3M
M%',%CYB_LS4/^?&Y_P"_+?X4?V9J'_/C<_\ ?EO\*^G:*.8+'S%_9FH?\^-S
M_P!^6_PH_LS4/^?&Y_[\M_A7T[11S!8^8O[,U#_GQN?^_+?X4?V9J'_/C<_]
M^6_PKZ=HHY@L?,7]F:A_SXW/_?EO\*/[,U#_ )\;G_ORW^%?3M%',%CYB_LS
M4/\ GQN?^_+?X4?V9J'_ #XW/_?EO\*^G:*.8+'S%_9FH?\ /C<_]^6_PH_L
MS4/^?&Y_[\M_A7T[11S!8^8O[,U#_GQN?^_+?X4?V9J'_/C<_P#?EO\ "OIV
MBCF"Q\Q?V9J'_/C<_P#?EO\ "C^S-0_Y\;G_ +\M_A7T[11S!8^8O[,U#_GQ
MN?\ ORW^%']F:A_SXW/_ 'Y;_"OIVBCF"Q\Q?V9J'_/C<_\ ?EO\*8MA>.S*
MEI.S*<,!&3CZU]05RWA;_D.^(O\ KZ'\WHN*QX7_ &9J'_/C<_\ ?EO\*/[,
MU#_GQN?^_+?X5].T4<P['S%_9FH?\^-S_P!^6_PH_LS4/^?&Y_[\M_A7T[11
MS!8^8O[,U#_GQN?^_+?X4?V9J'_/C<_]^6_PKZ=HHY@L?,7]F:A_SXW/_?EO
M\*/[,U#_ )\;G_ORW^%?3M%',%CYB_LS4/\ GQN?^_+?X4?V9J'_ #XW/_?E
MO\*^G:*.8+'S%_9FH?\ /C<_]^6_PH_LS4/^?&Y_[\M_A7T[11S!8^8O[,U#
M_GQN?^_+?X4?V9J'_/C<_P#?EO\ "OIVBCF"Q\Q?V9J'_/C<_P#?EO\ "C^S
M-0_Y\;G_ +\M_A7T[11S!8^8O[,U#_GQN?\ ORW^%']F:A_SXW/_ 'Y;_"OI
MVBCF"Q\Q?V9J'_/C<_\ ?EO\*/[,U#_GQN?^_+?X5].T4<P6/F+^S-0_Y\;G
M_ORW^%']F:A_SXW/_?EO\*^G:*.8+'S%_9FH?\^-S_WY;_"C^S-0_P"?&Y_[
M\M_A7T[11S!8^7UL+QV95M)V9?O 1DD?6G_V9J'_ #XW/_?EO\*]T\.?\C1X
MA_ZZI_-JZFAL5CYB_LS4/^?&Y_[\M_A1_9FH?\^-S_WY;_"OIVBCF'8^8O[,
MU#_GQN?^_+?X4?V9J'_/C<_]^6_PKZ=HHY@L?,7]F:A_SXW/_?EO\*/[,U#_
M )\;G_ORW^%?3M%',%CYB_LS4/\ GQN?^_+?X4?V9J'_ #XW/_?EO\*^G:*.
M8+'S%_9FH?\ /C<_]^6_PH_LS4/^?&Y_[\M_A7T[11S!8^8O[,U#_GQN?^_+
M?X4?V9J'_/C<_P#?EO\ "OIVBCF"Q\Q?V9J'_/C<_P#?EO\ "C^S-0_Y\;G_
M +\M_A7T[11S!8^8O[,U#_GQN?\ ORW^%']F:A_SXW/_ 'Y;_"OIVBCF"Q\Q
M?V9J'_/C<_\ ?EO\*[GP)\/I-1E74]9A:.S0_N[=Q@S$=R.R_P _I7LE%*X6
M$50JA5 "@8  X%+112&%%%% '*-_R4I/^O3_ !KJZY1O^2E)_P!>G^-=738D
M%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% &=KW_(O:C_U[2?\ H)JMX2_Y%:Q_W#_Z$:LZ]_R+VH_]>TG_ *":K>$O
M^16L?]P_^A&GT%U-JBBBD,*\B^)G@+Q'KOBA;OP_;VOV;4+-+2^<NB'*RA]S
MY&2/ECY7+8CQC& ?7:*:=B914E9D%E9P:=86]C:Q^7;VT2PQ)N)VHH  R>3P
M.]>1>'/AMK>E?$B%IK.U_P"$8T^\N+RSW2+(!YB@( #E]XVQ<MP#&2#G!/LE
M%"=@E!2MY'F?BGPMXHTKQNWC'P<L-[=7<?V>\LKDJ%VA5 ()*_+\B' 8$$#J
M"0(+?PWXO\8^-K#5_%=K#I&GZ/+YUG:P2)(\C;PP!8%O[J;B<9P-JC)(]3HH
MN+D5SEM"TB^L_'OBW4[B#99W_P!C^S2;U/F>7$5?@'(P3W H_LB^_P"%K?VU
MY'_$O_L3[)YV]?\ 6^?OV[<Y^[SG&*ZFBBX^5'DND:!XV^'5UJ>F^'=,AUS1
MKG,UJ\T\<3PRD 9?)!; 4 @8!PI!4EA6C\.O"NM:?J'BFX\3:?;*-9:.9HT9
M9(G+^8TB;<G@&3:0>#S@L.:])HHN)4TFO(\L^%_@+5O"_B'5;G5C,T<$7V/3
MI#*A26$R,[,$!8IRJMC(^^W4](_AW\.]1\/>,]2O]1C<V-FLEMI/VATE8QM(
MQWJ0?W9QG(P,^:W3D'U>BB[!4XJWD<M_9%]_PM;^VO(_XE_]B?9/.WK_ *WS
M]^W;G/W><XQ7':1H'C;X=76IZ;X=TR'7-&N<S6KS3QQ/#*0!E\D%L!0"!@'"
MD%26%>M447!P1Y%X=^'FMW]CXRM?$L:6#:\\%RLMLZNJR;GE8 9)PKL 03SS
MAC]ZIM(N/BIX?T/^QE\-6%^;15@L[O[5&J[$./F7>I8;<!?N$8RV3FO5Z*+B
M5-+9F!X.M_$=OX?C/BF^2ZU.5C(P2-%$*D#$>4 #$8))'<D#( )J^-M(OM7_
M .$=^PP>;]CUNVNY_G5=D2;MS<D9QD<#FNIHHN4XW5CEO&VD7VK_ /"._88/
M-^QZW;7<_P ZKLB3=N;DC.,C@<UR.K0WFG_%B_U?PB;;5=7,$<.J:5</Y3QQ
M$1D/$S%0051 3\VTL,@[L#U>N/\ $OPUT/Q/K,&KS27ECJ$.#]HL9%C=RN-K
M$E3\RXX88/3G@8$R91>Z.'@EURZ^.?AN[\06UG97DMM.([*W=G>&$+/L\QN5
M9CEN5/;D+TKO]"TB^L_'OBW4[B#99W_V/[-)O4^9Y<15^ <C!/<"H_#?PYT'
MPUJ4FJ0K<WNIN[L;V^E\R0;_ +V, #)Y^;&[YF&<'%=;0V$8=6<M_9%]_P +
M6_MKR/\ B7_V)]D\[>O^M\_?MVYS]WG.,5SFF:-XRT_6O$6CQVD,&D:O?75T
MFKQ3 R6_FQMM(3<&W!O*[#!#=00P],HHN/D1Y1I4GQ-TG0[O1-0\,6VNH%DB
MBN[C4$;S0Q;)D#L3(AR,*0AVC!]NG^&OAF_\+^&'AU-H?MMY<M>310HJK"65
M1L&WY>-O\( &<#( )["BBX*%G>YRWC;2+[5_^$=^PP>;]CUNVNY_G5=D2;MS
M<D9QD<#FCXC:1?:]X"U+3-,@\^\F\KRX]ZKG$J,>6('0'O74T47&XIW\SS/Q
M3X7\4:3XW;QCX.6&]NKR+[/>65R5"[0J@$$E?E^1#@,""!U!(%JTN/B5K/BN
MT-S8VWA[0X6$DRB2*Y>91MS&2"3DD'! 3 )ZD#/H5%%Q<FNYQ=KX8N;GQ/XY
M-_$\6FZU!;00S1R+N91 R.0.<$$]Q^=<SHMG\2/!&E7?A_3-%L]8M89<Z?>O
M/'$JJS;F#(6#'.3P2,$GEABO6J*+AR+H<)\*?#&I^$O#5]INJQ)',=0DDC,<
M@99$V(H88YP2IX(!]0*TOB-I%]KW@+4M,TR#S[R;RO+CWJN<2HQY8@= >]=3
M11?6X^1<O*>0RVGQ,D\(#P>F@V$485;#^TTNDV&U"B,G826R0,EL9P3A V".
M_P!"\)V>C>"XO#$DCW=H()(9F?Y#()"Q?[O*@ECCG(&.2>:WZQ_$OAZ+Q/I)
MTZ>_O[.%FS(;*81M(NTJ4;((*D-R,<X%%Q*-M=SRCX#:!Y=_K6M[_,BC_P!!
M@FC;]W+DAW.U@'Z"(C('#'C/3V^L[0=$L_#FAVND:>'%M;*54R-N9B2223ZD
MDGC YX '%:-#=V$(\L;'FFD'QGX8OM?BM?!O]HV][J]Q>Q3_ -IPPY1R /E.
M3T7/..O2J^L6WQ+\:>=I$VGV?AS1Y]OFR_:!-*8^ R91OFSDG&U 0-I;!.?4
MZ*+B]GI:YPGBKP3<MX&TS2_"\B07>BSQ7=F'5?WKQANIP%WL6+9(P6ZX!)'+
M>,+/XF^,]$73)?#MMI]O&L<LRQWR%KF13@J,/@+\P;:W39]XG /LE%"8Y4TS
MEO[(OO\ A:W]M>1_Q+_[$^R>=O7_ %OG[]NW.?N\YQBL;QYX3UN?Q!IOB_PN
MZ2:QIZB'[)-MV2QDMG!.,'#L#DC(/!! SZ%11<;@K6/,Y[SXKZS=6%I%IEGX
M>@.W[5?"2*X((!W$*6/RGC"X)R!E\$FI]>\-^(-%\>-XQ\+VD.J2WT:VU[97
M$@C*H-GS1L2 ,B-1SG!.<,#A?1:*+BY.[//="T+Q+KGC2+Q3XIA331IRR0Z?
MIT$PD&'# NY!(SM;&1@L5!P H!7X;6'BWP_;IX=UC2K:+3+-9S%?13*YF8R*
M5 &[('S2')4<;1@$'=Z#11<%!)W"BBBD68?C#_D5;[Z)_P"AK5_1_P#D"6'_
M %[1_P#H(JAXP_Y%6^^B?^AK5_1_^0)8?]>T?_H(I]!=2[1112&%<=X,_P"/
M;4/^OMOY"NQKCO!G_'MJ'_7VW\A5+83.FHHHH ***@N[RUT^U>ZO;F&VMTQO
MEFD"(N3@9)X') _&@">BN+\9^+H8/ NK:EX<UBSFN[3R?WEM)'-Y>Z55Y'(Y
M&[J*ZV[O+73[5[J]N8;:W3&^6:0(BY.!DG@<D#\:!*2;L3T5GV.O:/JD[0:?
MJUA=S*N\QV]RDC!<@9P">,D<^]37^I6&EP+/J%[;6<+-L62XE6-2V"<98CG
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MU--[B6P4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P"O:3_T$U6\)?\ (K6/^X?_ $(T^@NIM4444AA1110 4444 %%%% !1110
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MH3^+-.U_PS>6\GB*PA'_ !+9G3,L&Y@6 )&!\[*22,@\$,!D!QT;MU,7XJ^
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M "L#P5]W5O\ K\:M^L#P5]W5O^OQJ.@'54445(PHHHH **** "BBB@ HHHH
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M?^U?%/\ T!8?^^O_ +*C^U?%/_0%A_[Z_P#LJ+!<ZBBN7_M7Q3_T!8?^^O\
M[*C^U?%/_0%A_P"^O_LJ+!<O>'= _L#^UO\ 2?/_ +0U&:^_U>WR_,Q\G4YQ
MCKQ]*VJY?^U?%/\ T!8?^^O_ +*C^U?%/_0%A_[Z_P#LJ+"5DK(ZBBN7_M7Q
M3_T!8?\ OK_[*C^U?%/_ $!8?^^O_LJ+#N=117+_ -J^*?\ H"P_]]?_ &5'
M]J^*?^@+#_WU_P#946"YU%%<O_:OBG_H"P_]]?\ V5']J^*?^@+#_P!]?_94
M6"YU%%<O_:OBG_H"P_\ ?7_V5']J^*?^@+#_ -]?_946"YU%%<O_ &KXI_Z
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M +Z_^RH_M7Q3_P! 6'_OK_[*BPE9'445R_\ :OBG_H"P_P#?7_V5']J^*?\
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M_LWQ7K'B&YO?M=U?X6/]UY?DQY^YP<-PL8R0#\GN:Z6N7_M7Q3_T!8?^^O\
M[*C^U?%/_0%A_P"^O_LJ+#N=117+_P!J^*?^@+#_ -]?_94?VKXI_P"@+#_W
MU_\ 946"YU%%<O\ VKXI_P"@+#_WU_\ 94?VKXI_Z L/_?7_ -E18+G445R_
M]J^*?^@+#_WU_P#94?VKXI_Z L/_ 'U_]E18+G45@>"ONZM_U^-5;^U?%/\
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M*3_KT_QKJZY1O^2E)_UZ?XUU=-B04444AA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 9VO?\B]J/_7M)_Z":K>$O^16L?\
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M_OK_ .RH_M?Q=_T X/\ OK_[*BP7.MHKDO[7\7?] .#_ +Z_^RH_M?Q=_P!
M.#_OK_[*BP7.MHKDO[7\7?\ 0#@_[Z_^RH_M?Q=_T X/^^O_ +*BP7.MHKDO
M[7\7?] .#_OK_P"RH_M?Q=_T X/^^O\ [*BP7.MHKDO[7\7?] .#_OK_ .RH
M_M?Q=_T X/\ OK_[*BP7.MHKDO[7\7?] .#_ +Z_^RH_M?Q=_P! .#_OK_[*
MBP7.MHKDO[7\7?\ 0#@_[Z_^RH_M?Q=_T X/^^O_ +*BP7.MHKDO[7\7?] .
M#_OK_P"RH_M?Q=_T X/^^O\ [*BP7.MHKDO[7\7?] .#_OK_ .RH_M?Q=_T
MX/\ OK_[*BP7.MHKDO[7\7?] .#_ +Z_^RH_M?Q=_P! .#_OK_[*BP7.MHKD
MO[7\7?\ 0#@_[Z_^RH_M?Q=_T X/^^O_ +*BP7-'QA_R*M]]$_\ 0UJ_H_\
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MWAS_ )&CQ#_UU3^;5U--[B04444AA1110 4444 %%%% !1110 4444 %%%%
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M:A_U]M_(5V-<=X,_X]M0_P"OMOY"J6PF=-1110 4444 %%%% !1110 4444
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M,=8\4?\ "?Z=X?\ #^I16GVJS\T":)&7<#(222C'HE']C?%7_H9=*_[]K_\
M&: /1Z*YSPI9^*[3[7_PD^IVM[NV?9_LZ@;,;MV<(O7Y?7I7$VNI>/?$7B7Q
M!::-KEK;P:=>/$$N(4X4NX4 B-B<!.] 'K-%>77UA\6[2!7@U>SO6+;3';I"
M&48//[R-1CMUSSTK:^&WC2;Q;I4T=['_ *=9!!+,H 68-G:V!T;Y3D8QT(ZX
M !V]%<5X*U[4]6\2^*[2^N?-@L+SRK9/+5=B[Y1C( )X5>N>E5/'_C?4=%U2
MR\/Z);(VI7RKMFEQM7>Q1 H)QNW#.6^48'!R< 'H%%>27*?%VVT<7QO$=QDO
M:Q10/,@&><!-K=. I).1QUQU7P\\:/XPTJX>ZCABOK60+*L(;84;)1AG.,X8
M8R?NYXR!0 [XH_\ ).=5_P"V/_HY*/BC_P DYU7_ +8_^CDKJ;JTMKZV>VN[
M>*X@?&Z*9 ZM@Y&0>#R :+JTMKZV>VN[>*X@?&Z*9 ZM@Y&0>#R : /!_&=O
MJ6C^+=<\/6-LDL/B.:"93,P,CDR%E"D$!1YI=?F'0#ZGT7P98QZ9XR\4:?"S
MM%:PZ="C.06*K 0"<8&>/2NMN-(TR[O8KVYTZTFNHMOESR0*SIM.5PQ&1@G(
M]ZFCM+:&YFN8K>))Y]OG2J@#2;1A=QZG X&>E $U%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5Y2?'-SX5OKRV@LXIUFG:0EV(QR1VKU:OG_P 5
M_P#(:E_WW_\ 0C30F=9_PN+4/^@5;?\ ?QJ/^%Q:A_T"K;_OXU>;44607/2?
M^%Q:A_T"K;_OXU'_  N+4/\ H%6W_?QJ\VHHL@N>D_\ "XM0_P"@5;?]_&H_
MX7%J'_0*MO\ OXU>;44607/2?^%Q:A_T"K;_ +^-1_PN+4/^@5;?]_&KS:BB
MR"YZ3_PN+4/^@5;?]_&H_P"%Q:A_T"K;_OXU>;44607/2?\ A<6H?] JV_[^
M-1_PN+4/^@5;?]_&KS:BBR"YZ3_PN+4/^@5;?]_&H_X7%J'_ $"K;_OXU>;4
M4607/2?^%Q:A_P! JV_[^-1_PN+4/^@5;?\ ?QJ\VHHL@N>D_P#"XM0_Z!5M
M_P!_&H_X7%J'_0*MO^_C5YM119!<])_X7%J'_0*MO^_C4?\ "XM0_P"@5;?]
M_&KS:BBR"YZ3_P +BU#_ *!5M_W\:C_A<6H?] JV_P"_C5YM119!<])_X7%J
M'_0*MO\ OXU'_"XM0_Z!5M_W\:O-J*+(+G<:7\2KS2Y[V5-/@<W4IE8,Y^4Y
M/ _.M'_A<6H?] JV_P"_C5YM118+GI/_  N+4/\ H%6W_?QJ/^%Q:A_T"K;_
M +^-7FU%%D%STG_A<6H?] JV_P"_C4?\+BU#_H%6W_?QJ\VHHL@N>D_\+BU#
M_H%6W_?QJ/\ A<6H?] JV_[^-7FU%%D%STG_ (7%J'_0*MO^_C4?\+BU#_H%
M6W_?QJ\VHHL@N>D_\+BU#_H%6W_?QJ/^%Q:A_P! JV_[^-7FU%%D%STG_A<6
MH?\ 0*MO^_C4?\+BU#_H%6W_ '\:O-J*+(+GI/\ PN+4/^@5;?\ ?QJ/^%Q:
MA_T"K;_OXU>;44607/2?^%Q:A_T"K;_OXU'_  N+4/\ H%6W_?QJ\VHHL@N>
MD_\ "XM0_P"@5;?]_&H_X7%J'_0*MO\ OXU>;44607/2?^%Q:A_T"K;_ +^-
M1_PN+4/^@5;?]_&KS:BBR"YZ3_PN+4/^@5;?]_&H_P"%Q:A_T"K;_OXU>;44
M607/2?\ A<6H?] JV_[^-6=IOQ*O--O;^Y33X':\D\Q@7/R\D\?G7#T46"YZ
M3_PN+4/^@5;?]_&H_P"%Q:A_T"K;_OXU>;44607/2?\ A<6H?] JV_[^-1_P
MN+4/^@5;?]_&KS:BBR"YZ3_PN+4/^@5;?]_&H_X7%J'_ $"K;_OXU>;44607
M/2?^%Q:A_P! JV_[^-1_PN+4/^@5;?\ ?QJ\VHHL@N>D_P#"XM0_Z!5M_P!_
M&H_X7%J'_0*MO^_C5YM119!<])_X7%J'_0*MO^_C4?\ "XM0_P"@5;?]_&KS
M:BBR"YZ3_P +BU#_ *!5M_W\:C_A<6H?] JV_P"_C5YM119!<])_X7%J'_0*
MMO\ OXU'_"XM0_Z!5M_W\:O-J*+(+GI/_"XM0_Z!5M_W\:C_ (7%J'_0*MO^
M_C5YM119!<])_P"%Q:A_T"K;_OXU'_"XM0_Z!5M_W\:O-J*+(+GI/_"XM0_Z
M!5M_W\:C_A<6H?\ 0*MO^_C5YM119!<])_X7%J'_ $"K;_OXU'_"XM0_Z!5M
M_P!_&KS:BBR"YW%A\2KRPU&_O%T^!VO&#,I<X7&>GYUH_P#"XM0_Z!5M_P!_
M&KS:BBP7/2?^%Q:A_P! JV_[^-1_PN+4/^@5;?\ ?QJ\VHHL@N>D_P#"XM0_
MZ!5M_P!_&H_X7%J'_0*MO^_C5YM119!<])_X7%J'_0*MO^_C4?\ "XM0_P"@
M5;?]_&KS:BBR"YZ3_P +BU#_ *!5M_W\:C_A<6H?] JV_P"_C5YM119!<])_
MX7%J'_0*MO\ OXU'_"XM0_Z!5M_W\:O-J*+(+GI/_"XM0_Z!5M_W\:C_ (7%
MJ'_0*MO^_C5YM119!<])_P"%Q:A_T"K;_OXU'_"XM0_Z!5M_W\:O-J*+(+GI
M/_"XM0_Z!5M_W\:C_A<6H?\ 0*MO^_C5YM119!<])_X7%J'_ $"K;_OXU'_"
MXM0_Z!5M_P!_&KS:BBR"YZ3_ ,+BU#_H%6W_ '\:C_A<6H?] JV_[^-7FU%%
MD%STG_A<6H?] JV_[^-1_P +BU#_ *!5M_W\:O-J*+(+G;GXDWA\0#5_[/@\
MP1>7Y>\XQZUI?\+BU#_H%6W_ '\:O-J*+!<])_X7%J'_ $"K;_OXU'_"XM0_
MZ!5M_P!_&KS:BBR"YZ3_ ,+BU#_H%6W_ '\:C_A<6H?] JV_[^-7FU%%D%ST
MG_A<6H?] JV_[^-1_P +BU#_ *!5M_W\:O-J*+(+GI/_  N+4/\ H%6W_?QJ
M/^%Q:A_T"K;_ +^-7FU%%D%STG_A<6H?] JV_P"_C4?\+BU#_H%6W_?QJ\VH
MHL@N>D_\+BU#_H%6W_?QJ/\ A<6H?] JV_[^-7FU%%D%STG_ (7%J'_0*MO^
M_C4?\+BU#_H%6W_?QJ\VHHL@N>D_\+BU#_H%6W_?QJ/^%Q:A_P! JV_[^-7F
MU%%D%STG_A<6H?\ 0*MO^_C4?\+BU#_H%6W_ '\:O-J*+(+GI/\ PN+4/^@5
M;?\ ?QJN:7\7C+J$4>I6$<-JYPTL3$E/?'<5Y5119!<^I8I8YX4FA=9(W4,K
MJ<A@>A!I]>'>!?'4GA^9;"_9I-,=N#U,!/<>WJ/Q'O[=%+'/"DT+K)&ZAE=3
MD,#T(-2U8I,?1112 SM>_P"1>U'_ *]I/_035;PE_P BM8_[A_\ 0C5G7O\
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M%%4;75[&\U2_TRWGWWEAY?VF/8P\OS%W)R1@Y [$TBKEZBBB@ HHHH ****
M"BBB@ HHHH P_&'_ "*M]]$_]#6K^C_\@2P_Z]H__015#QA_R*M]]$_]#6K^
MC_\ ($L/^O:/_P!!%/H+J7:***0PKCO!G_'MJ'_7VW\A78UQW@S_ (]M0_Z^
MV_D*I;"9TU%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C^+/^1.U
MS_L'S_\ HMJX3P'X\\-:+X+T_3]0U+R;J+S-\?D2-C,C,.0I'0BN[\6?\B=K
MG_8/G_\ 1;5RWPX\/:+?> M,N;O1]/N)W\W=+-;([-B5P,DC)X % '->/_B-
M9^(-.;P]H-O+="YD17G,9&_!5E6-?O%BV!R!TP <@C0^)UE+IOPNT*PG9&FM
MIK>%RA)4LL+@XSCC(KT>RT/2--G,]AI=C:S,NPR06Z(Q7(.,@=,@?E7#_&G_
M )$ZS_[""?\ HN2@ _X73X<_Y\M5_P"_4?\ \76WX8^(6D^+-3DL+"WO8Y8X
M3,3.B!=H*CLQY^85UE% 'E_Q7O8]-U_PA?S*[16UT\SA "Q56B)QGOQ5G_A=
M/AS_ )\M5_[]1_\ Q='Q&_Y''P+_ -A _P#HR&NH\6>$K#Q=I7V6['ESQY:V
MN57+0L?YJ<#*]\=B 0 >8V>I^(/B3XWTC4(M/%OIFFW"2 \F.+:R-)F3 W.<
M+A0/3@#<U=C\3/"FK>(;;3KS19/],T^1BL2OY;MN*_,KD@ J5![=^<@ \[\-
MM>F\-:W=^"M:9(ML["VD=F \PD?(NX8VO]Y?NY)[EQ6MX^\8:UX2\7:3(C9T
M2:(&6'RT8R%6(DQT8,%9".0,XZ\T 8UM\9=2L+HV>OZ J7"RCS1$6A>*,@'_
M %;@DM@DC+*#D=.M=MX5\3>&/$][/>:7#%%JIC_?K+ J7&S.!EAG</E7H3CY
M<X.!6C'JWASQ'I,[?:].O[!8UEN$E9&6-?O R*WW<;<_,!C:?2O+]$AT27XW
M6S^&HW>QB$KS-&N8D?RW5BF.D>2H!Z9/'!6@#1\;ZU;>'?B[HVJW:2O!!I_S
M+" 6.[SE&,D#J1WK2_X73X<_Y\M5_P"_4?\ \71K/_)=_#W_ &#W_P#09Z]'
MH Q/#'B>R\6:9)?V$5Q'%',82)U4-N 4]B>/F%>8:'XUTWP?XQ\7_P!H07<O
MVK4&V?9T5L;9),YRP_O"O:J\X^'/_(X^.O\ L(#_ -&34 4M4^-FG)8M_9.F
MW,ET<A3=[4C3@X8[6);!Q\O&1GD5?^%6CZW:+K.K:U \,NI3*X65-DC,I<NQ
M3 V@E^.G0\8P3F?$WP(D23>*M%WV]U"PFNHX002<C]\FWE6!Y8]."V00=W:>
M"?%D/BW04NLPI?1?)=6\;']VW.#@\X8#(Z]QDD&@#G/AS_R./CK_ +" _P#1
MDU)\0O#FOMXBT[Q5H"FXFL8PKVZ$A\(6?/!!=6!*E1R>@SDX7X<_\CCXZ_["
M _\ 1DU5]=\=ZGX7^)QL]4E_XI^6-&5!$K,B,N/,&WYN)%;(.>,X!^6@"AI_
MQJE@F6UUS1"DL;.ER]LY5D8$X B?H0< @OZGVKO/"FL>'-=ANK[08X(YI&5K
MQ5A$<H<@L/,X^8\M\V2"=V">:LW5YX9UC27N;RYTB^TV"4;I9GCEACDZ#).0
M&^8#U^;WKS7X90Z:WQ*UF?0HKDZ0EHZ0R2J?EW/&0,GD [6VAOFP.>0: /8Z
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OG_ ,5_
M\AJ7_??_ -"-?0%?/_BO_D-2_P"^_P#Z$::$S"HHHIB"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *[
M?P+XZD\/S+87[-)ICMP>I@)[CV]1^(]^(HI#/J6*6.>%)H762-U#*ZG(8'H0
M:?7AW@7QU)X?F6POV:33';@]3 3W'MZC\1[^W12QSPI-"ZR1NH974Y# ]"#4
MM6*3*.O?\B]J/_7M)_Z":K>$O^16L?\ </\ Z$:LZ]_R+VH_]>TG_H)JMX2_
MY%:Q_P!P_P#H1HZ"ZFU1112&<1_S7+_N6O\ VYKMZXC_ )KE_P!RU_[<UV]-
MD0ZGGMWXD\>ZCXKN].\/^';:VTVV8Q->ZO'(BR,-WSKM8;E)7 VANQ.-V!)X
M2\6^)[OQMJ/AGQ-IEG;S6]M]IAFM0X610X7(W$[E;<,'C&T@C.0.51;KQYXR
M\3P:OXQETS3-,DFMY--M9C#OMD+J78D[-O3<Q#=2#M&VH/AP/#FF_%N\T[0;
MCS+./37MX[F6<,UY*)$=BO ' RH"C!$>[G)-.VAGS.Z9Z;X2UZZU[^W/M4<*
M?8-7N+&+RE(S''MP6R3\W/.,#VHT?7KK4/&?B71Y8X5M]+^R^0R*=[>;&6;<
M<X/(XP!^-<Y\/=9TV"^\:64][#%<0:W>7<J2-MVPY WY/&T%3D]N,XR,G@+5
MK76_B#XZOK)]]NTMI&CY!#[$="P()!4E20>X(HMN4I?#_7<Q_#?CKXB>+].E
MO-'T;1!#;JZ223LX$LRX;8@WY4E63[WRY!)89P.FT/XB07/@.\\0ZU9S6,NF
MRFVO8%C.?.&T853R,EU&&Q@D@G W4?"+_DEVC?\ ;?\ ]'25QFHPRS_#'XCI
M#$\C#Q%.Y5%)(59868\=@ 23V )IZ7)3DHIWZ&@?&OQ)N/"\OB>UT'1XM,^>
M9(9]_G+;A2WFG+J&7 ZC!;J%P0:I>)O&MQJ%S\/_ !-I&F[[RY^VPV]I/( /
M.8+" 6XRH<Y_AR/[N>.]LO&>@0>!;?7//LK:TCME_P!%@GC/ER"+?]G7D#>!
MP%X/'05S2:W+XC\5_#;5YK![%KI=1<0.Q8A?*PIR0,A@ P..A%)!+:U^WYDT
M7C#QGHGB#1;3Q9HU@+'5F2!)M.W$P3N0 CEF(R.X'!&2I;:15KQ-XYU1?%T'
MA/PG80WFK##WDMVC>3;QD \X(/1E)/3D* S-@6/B1_S*/_8RV?\ [/7%ZM]B
M3XSZ[::OKNJ^'[>\@@E@NK:]^RQRE(E&&)4@C[^&) !4CDG@5AMM:'4VGC/Q
M#HGBJTT7QI8V$,6I,(M/O-.+,CR?+E65B6P2ZKD@8/J#N!=^,_$.M^*KO1?!
M=C831::QBU"\U$LJ))\V%55(; *,N0#D^@&XYUYHGA33/$^D66J^.=>O-1CO
MH9+:QN;[[0!,"I3>H0[,[A@G;D$X/6G_  \U>RLO'/C#0+N!+74Y]4FNH6D&
MV2YC))"C(Y"CYQSR)"0, FC3<$W>S95\&ZQK.K_&"Z7Q!I\-CJEGHAMYXH7#
M(<S)(I&"V/ED7C<>F>,X'?\ C/\ Y$;Q!_V#;G_T4U<7H.KV&L?'?59M.%L\
M,6C"(W-M(KK<MOB;>2O!(#!.I^X.>P[3QG_R(WB#_L&W/_HIJ'N./POYGG/A
M77_B/?>#K2XT+1-';3K:VBM[5;F0F6XV#RW(PZ@89&)#;>" -W4ZNJ_$Z[N/
MAJOBOPY90M)#<K!?0W@)%OD<XPR[OF:/!'9N0.<7?A_XIT.'X7V=W+/9V,6G
M6P6\B2128B&90S*HR&D*E@,9);C)ZX_PZTR+Q1\-_$EN]BEA:ZOJ%R]M&T(>
M.$,B!2@P P1AP1CE.Q' 2KV23W1TWC7QO'X?\!IX@TUX97NO)^P^?$Y27?AN
M0,$?NPQYQT_"NFTR2]ETFSDU&%(;YX$:YB0Y5)"HW*.3P#D=3]37S_X>DU+Q
M3KOA?P/J5M,L>@7,S7WF2?:(Y0C9"NGW0J[?*!)(P_'7!^BZ35BX2YM3B/\
MFN7_ '+7_MS65JOC?Q;)\0=1\*>'M+TVXDM_)D$URS*(XBB;V<;ANPTB_=Y
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M@]O(Z!MRG<25P6.W:3^[(SEACG=)U"UU4_%R\LH88[=[8JGD,&23;'.ID!
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MU#_K[;^0KL:X[P9_Q[:A_P!?;?R%4MA,Z:BBB@ HHHH **** "BBB@ HHHH
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M_87%[)+)"82)W0KM)4]E'/RBM'1?#%EH6IZM?VLMP\NIS>=,)64JK98_+@#
M^<]<]JVZ* &30Q7,$D$\22PR*4>-U#*RD8((/4$=JYCP_P" =-\,:K+?:7>Z
MA$DN1):M*K0L.< @KN^7/!SGW.3GJJ* ,31?#%EH6IZM?VLMP\NIS>=,)64J
MK98_+@# ^<]<]J=XB\+Z3XILUM]4M]YCW&&5&VO$2,94_D<'() R#@5LT4 >
M<?\ "E?#F/\ C^U7Z^;'_P#&Z['0/#FE^&K!;73;9(_E"R3%1YDQ&>7;')R3
M[#.  .*UJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ KY_\5_\AJ7_ 'W_ /0C7T!7S_XK_P"0U+_OO_Z$::$S"HHHIB"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "NZ\ >-KC1KN+2[H23V$SA4506:)B?X1W!/4?B/?B(XY)I
M4BB1GD<A551DL3T %>V>!/ D>@Q+J.HHKZFX^5>H@![#_:]3^ ]TQHZC7O\
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M9_L[[3]F_M#[(/(W=<YW9^[\VW&['\/:NPT'7[7Q#:W$UM'-#):W,EI<0SJ
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MA?>0<DY.<<GG  S@ 5OT478<JO>QQ<_PF\#W$\DSZ$@:1BS".XE102<\*K@
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M""">"*Q?$/\ R4;P9_V_?^B14?C(>&M"T^6ZET/3+G5KQF6TA-BDLEQ.W3(
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4^..2:5(HD9Y'(5549+$] !1%%)/,D
M,*-)([!511DL3T %>W>!? L?A^%;^_59-3=>!U$ /8>_J?P'NF[#0WP)X$CT
M&)=1U%%?4W'RKU$ /8?[7J?P'OW-%%049VO?\B]J/_7M)_Z":K>$O^16L?\
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M^U6\D'F;=VW<I7..,XS1I-C_ &7HUCI_F>;]EMXX/,V[=VU0N<<XSB@#S9/
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M?D?\:/\ A"/#/_0&MOR/^-',%CYVHKV?PUX5T*[O=82XTR"18;HI&&!^49/
MKHO^$(\,_P#0&MOR/^--L+'SM17T3_PA'AG_ * UM^1_QH_X0CPS_P! :V_(
M_P"-+F"Q\[45]$_\(1X9_P"@-;?D?\:/^$(\,_\ 0&MOR/\ C1S!8^=J*^B?
M^$(\,_\ 0&MOR/\ C1_PA'AG_H#6WY'_ !HY@L?.U%?1/_"$>&?^@-;?D?\
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M!K;\C_C1_P (1X9_Z UM^1_QHY@L?.U%?1/_  A'AG_H#6WY'_&C_A"/#/\
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M#6WY'_&C_A"/#/\ T!K;\C_C1S!8^=J*^B?^$(\,_P#0&MOR/^-'_"$>&?\
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M0 4444 8?C#_ )%6^^B?^AK5_1_^0)8?]>T?_H(JAXP_Y%6^^B?^AK5_1_\
MD"6'_7M'_P"@BGT%U+M%%%(85QW@S_CVU#_K[;^0KL:X[P9_Q[:A_P!?;?R%
M4MA,Z:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *P/!7W=6_P"OQJWZP/!7
MW=6_Z_&HZ =51114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** ,/QA_R*M]]$_\ 0UJ_H_\
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M)'H__00A_.BP&I167_PD>C_]!"'\Z/\ A(]'_P"@A#^=%@-2BLO_ (2/1_\
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MWAS_ )&CQ#_UU3^;5U--[B04444AA1110 4444 %%%% !1110 4444 %%%%
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MU%9/_"3Z)_T$H/S-'_"3Z)_T$H/S-%F!K45D_P#"3Z)_T$H/S-'_  D^B?\
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M@9W]@Z3_ - ZV_[]BC^P=)_Z!UM_W[%:-%%P,[^P=)_Z!UM_W[%']@Z3_P!
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <MX1_X_\
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M1_PCVC?] RU_[]BM.BB[ S/^$>T;_H&6O_?L4?\ "/:-_P! RU_[]BM.BB[
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M5O\ K\:CH!U5%%%2,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** ,/QA_R*M]]$_]#6K^C_\
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M_P!]_P#T(TT)EC_A/_%/_07E_P"_:?X4?\)_XI_Z"\O_ '[3_"N:HHL!TO\
MPG_BG_H+R_\ ?M/\*/\ A/\ Q3_T%Y?^_:?X5S5%%@.E_P"$_P#%/_07E_[]
MI_A1_P )_P"*?^@O+_W[3_"N:HHL!TO_  G_ (I_Z"\O_?M/\*/^$_\ %/\
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M_P#?M/\ "N:HHL!TO_"?^*?^@O+_ -^T_P */^$_\4_]!>7_ +]I_A7-446
MZ7_A/_%/_07E_P"_:?X4?\)_XI_Z"\O_ '[3_"N:HHL!TO\ PG_BG_H+R_\
M?M/\*/\ A/\ Q3_T%Y?^_:?X5S5%%@.E_P"$_P#%/_07E_[]I_A5:V\8:_:3
M7$T&I2))<-OE8(OS'GGI[FL.B@#I?^$_\4_]!>7_ +]I_A1_PG_BG_H+R_\
M?M/\*YJBBP'2_P#"?^*?^@O+_P!^T_PH_P"$_P#%/_07E_[]I_A7-446 Z7_
M (3_ ,4_]!>7_OVG^%'_  G_ (I_Z"\O_?M/\*YJBBP'2_\ "?\ BG_H+R_]
M^T_PH_X3_P 4_P#07E_[]I_A7-446 Z7_A/_ !3_ -!>7_OVG^%'_"?^*?\
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M +]I_A7-446 Z7_A/_%/_07E_P"_:?X4?\)_XI_Z"\O_ '[3_"N:HHL!TO\
MPG_BG_H+R_\ ?M/\*/\ A/\ Q3_T%Y?^_:?X5S5%%@.E_P"$_P#%/_07E_[]
MI_A1_P )_P"*?^@O+_W[3_"N:HHL!TO_  G_ (I_Z"\O_?M/\*/^$_\ %/\
MT%Y?^_:?X5S5%%@.E_X3_P 4_P#07E_[]I_A1_PG_BG_ *"\O_?M/\*YJBBP
M'2_\)_XI_P"@O+_W[3_"C_A/_%/_ $%Y?^_:?X5S5%%@-O\ X2_7_P"T!?\
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MX"Q_PIOQ1GI_I>?_  '6F?#2TUC4O#DD>C^*DTWR)B)K4:;#(V3R'+$[F!'
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M,]N:X?Q+_P D(A_[!]E_Z%%74^";N"]\$:++;OO1;2.(G:1\R#8PY]&4C\*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5T'A3Q9>>%K_ ,R+
M,MK(1Y]N3PP]1Z-[US]%(#Z;TK5;/6M.BOK&420R#\5/<$=B*NU\[>%/%=YX
M7U'S8LR6LA G@)X<>H]".QKWS2M5L]:TZ*^L91)#(/Q4]P1V(J6K%)D>O?\
M(O:C_P!>TG_H)JMX2_Y%:Q_W#_Z$:LZ]_P B]J/_ %[2?^@FJWA+_D5K'_</
M_H1HZ!U-JBBBD,**** "BBB@#C_ %[=7G_"4?:KF:?R?$%W#%YLA;RXQMPJY
MZ*,\ <5V%<1\-_\ F;O^QEO/_9*ZG6OL']A:A_:G_(.^S2?:OO?ZK:=_W>?N
MYZ<^E-[D0^$YF;XL^!X)Y(7UU"T;%"4MY74D''#*A!'N"0:W+#Q5HFI^'Y]=
MLK])M-MU=II51LQA!ELKC<"!SC&2"".HKRO0M9U.ZT2ZM_ 'PWMH].E<I)<7
M\@9;N++C#;RN\Y)!&]PO*]Q5CP5$D'PA\<PQFV9(Y[]5-JY>$@0*/D9B2R^A
M))(Q3LB%49Z[97D&H6-O>VLGF6]Q$LL3X(W(PR#@\C@]ZR_^$OT+_A%_^$E^
MW?\ $H_Y^/)?^_Y?W=N[[W'3]*/!G_(C>'_^P;;?^BEKRW_FUW_/_/[0D5*;
M2OY7.]_X6GX)^W?8_P"WH?-\WRMWE2>7G.,^9MV[?]K.,<YQ73:EJ5GH^FSZ
MAJ%PEO:0+ODD?H!_,DG@ <DD <UR7B7PAH=A\+=3TN+3X3!9V+SQL457,T<7
MRRDJ!ESM&3WY!X.*X[6]/M];LOA3HU_=^1IUU;*TR,Y5)2L,15>"/F;)0'.1
MYG'7!+(3E):,[O3?B;X.U;4;?3[/6D>YN&V1*\$L89NPW,H&3T SR< <FL1?
M&VG>'?B!XNCU_6'AM%:R2TA<O(%)A+/L10<#.,D#&2,\D5K^-/!7A76]&A_M
M<PZ9;V>Q5NX?*A,<8RJQ[V4@)E^%X&<5D:+H=AJ/QG\7:C>0)/-8K9"!9$5E
M1FB5MXR,AP8Q@@C&30K!+FNE_6S.P\/^*M$\4P33:+?I=+ P20!61E)&1E6
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M]ZR_B[_R2[6?^V'_ *.CI=2W=4W?L,G^&TK6\BP>-_%L<Q4B-Y-1+JK8X)4
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M /C:VUBV=M"M->N(S C.6*HT0C4$$-G<$&2?J<9H:5Q0E)15^QTW_"WO O\
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MC6.G^9YOV6WC@\S;MW;5"YQSC.*N44 <YX<\*?\ "/ZSKNH?;?/_ +5N//\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^*_^0U+_ +[_ /H1KZ KY_\ %?\ R&I?]]__ $(TT)F%1113$%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG&<''0U/X?\ %6B>*8)IM%OTNE@8)* K(RDC(RK '!YP<8.#Z&O*/#CZDGQ
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MU%X7T;Q)\1O%G]KV?VG[/]C\K]ZZ;=T//W2,_='6MC_A5W@W_H#_ /DU-_\
M%UNV>BVUCK6IZK$\IGU'RO.5B-J^6NU=O&1P><DUI4 ><>&O^2$3?]@^]_\
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M7'B6[D \^<CECZ#T45T-%%2,**** ,[7O^1>U'_KVD_]!-5O"7_(K6/^X?\
MT(U9U[_D7M1_Z]I/_035;PE_R*UC_N'_ -"-/H+J;5%%%(84444 %<[K&@W6
MH>,_#6L120K;Z7]J\]78[V\V,*NT8P>1SDC\:Z*B@35S'\4^'XO%/AF]T6:=
MX%N5 $J $JRL&4X/4949'&1GD=:X"[\(_$_5=#MM"OO$>E1V.WR;J>)I&GGC
M)'WR4&X@#'!7<"0Q.2:]7HIW$X)NYYA:?#[Q"GPCOO"%U>V#W;SAK5E9O*CC
M\Q)"I.P-G<)#T/WASCIT7Q&\(R^-/"ITZVF2*ZBG2> RL5C+#*D-A2<;6;H.
MN.V:ZVBB[%R*UCSW5_AR;WX467A6V6V2^M5BDCD>63REGSF5LX)(.Z7 (Q\P
MX&!B]!X B/PLC\&SW;H3 /,G3#[9=_FDC(&4W]N#MXR#S7:4478^2)Y1=^$?
MB?JNAVVA7WB/2H[';Y-U/$TC3SQDC[Y*#<0!C@KN!(8G)-6+3X?>(4^$=]X0
MNKVP>[><-:LK-Y4<?F)(5)V!L[A(>A^\.<=/3Z*+B]FC.\06$NJ^&]4TZ!D6
M:[M)8(V<D*&9"HSC/&3Z4>'["72O#>EZ=.R--:6D4$C(25+*@4XSCC(]*T:*
M15M;G.ZQH-UJ'C/PUK$4D*V^E_:O/5V.]O-C"KM&,'D<Y(_&C1]!NM/\9^)=
M8EDA:WU3[+Y"HQWKY495MPQ@<GC!/X5T5%.XN57N<[_8-U_PLC_A(O,A^Q_V
M1]AV;CYGF>=OSC&-N/?.>U;\T,5S!)!/$DL,JE)(Y%#*ZD8((/!!':GT4AI6
M/,-.\%>.O",ZVOACQ#87.BHSR)::HC#:6)^7*J3@<'*LH+9.T9.;6G>"/$>K
M>)[76/&^J6=W'ITIGT^UL5*K'(S \MM5MJ[5P"6)P,G@AO1:*=R>1'FVI> _
M$.E>+I]>\$ZK;6@OV\R_M+YF,<C[MQQA6X8EO0KEMI ; O>'?#?C/_A*VUKQ
M1XB22&)6$&GZ?(RP'=N^^I4 A0W&<L3C+?+SW=%%PY%>YXQX9T?Q</%'BC6/
M#&H:8D;ZW=6]W:WZ-MDV$E#N4%O^6K< KT'7.!T6@?#:Z@L=>N]>U3[7XBUJ
MVFM9KM,M'#&XQA5.W=T4]  %"K@#)[?3=(L=(^U_88/*^V7+W<_SLV^5\;FY
M)QG X'%7J&Q1II+4X'0O!NN7/A*[\->,;RSN=.-M#;6HL6*N@0L=Q)4?,/W8
M'4'8,@Y;=E:=X7^*.AZ7+I&G>(M'ELX\):37*L988U8D8^0CD8&&WA1@*1C-
M>IT47'R(\]N? FM3_"R\\.7&MOJ&KW;1RR7-[.[1HP=&**2"VT!.,CDDG S@
M=!XZT&Z\3^#+_1[*2&.XN/+V-,Q"#;(K') )Z*>U=%11<?(K6.=\=:#=>)_!
ME_H]E)#'<7'E[&F8A!MD5CD@$]%/:N<\9>"?$>K>-;7Q)X?U2SL;BSL1# TR
MEB9"[AL@JP"[)&YP3D8P,Y'HM%"8.">YYU9^!M?UGQE;^(/&E_9S+8;6L++3
MFD$22 @[CN (Y /4ECC)VJ%,>I> _$.E>+I]>\$ZK;6@OV\R_M+YF,<C[MQQ
MA6X8EO0KEMI ; ])HHN+D5CA/#OAOQG_ ,)6VM>*/$220Q*P@T_3Y&6 [MWW
MU*@$*&XSEB<9;Y>=GPEH-UH/]N?:I(7^WZO<7T7E,3B.3;@-D#YN.<9'O714
M47&HI!7CVB^ ?'NC^([KQ#)<>&]1U:XZW-\\[M'D8.P*JA<C"]. ,# R#[#1
M0G8)14C T6'Q)<P7L'BR+1)895"1QV*R,KJ0P<2"3@@C''US7#V?@?X@^&4N
M]-\,>)+ :.S$VJWP+20Y*L<?NV /!']T[F;:">/5Z*+@X)GGNF^ M7T+P!J6
MGZ7JJ#Q-J3"6YU*1B"7+#< ^TO@+OPQYW,6&TGC+\)^#?'?@S37L]*C\(DRM
MNFGF-PTLIYQN( & #@   <GJ23ZM11<7LT<MJWAFZ\7>"&TCQ(UG'J$F6\ZQ
M0M'#(&.QDW\_=P#T)!8 C-<=-X-^*&I:-'HFH>*--^P/^[N)4+M,\1V@J6\L
M%L!3W!;<P9B#QZU11<'!,HZ-I-KH6C6FEV2;;>UB$:< %L=6. !N)R2<<DDU
M/<V5K>^3]JMH9_(E6:+S8PWER#HZYZ,,G!'-3T4B[!4%M96MEYWV6VA@\^5I
MI?*C"^9(>KMCJQP,D\U/10 4444 %%%% &'XP_Y%6^^B?^AK5_1_^0)8?]>T
M?_H(JAXP_P"15OOHG_H:U?T?_D"6'_7M'_Z"*?074NT444AA7'>#/^/;4/\
MK[;^0KL:X[P9_P >VH?]?;?R%4MA,Z:BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "JU[I]EJ4*PW]G;W42MO"3Q*ZAN1G!'7D_G5FB@ HH
MHH **** "BBB@ HHHH **** "BBB@"M?:=8ZG"L-_9V]W$K;U2>)9%#8(S@C
MK@G\ZLT44 %%%% !1110 4444 %%%% !59-.L8]0DOTL[=;V5=DEPL2B1UXX
M+8R1\H_(>E6:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K \%?=U;
M_K\:M^L#P5]W5O\ K\:CH!U5%%%2,**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#EO"/_'_KW_7XW\VKJ:Y;PC_Q_P"O?]?C
M?S:NIIO<2V"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "N6\+?\AWQ%_P!?0_F]=37+>%O^0[XB_P"OH?S>FMA'4T444AA1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <MX
M<_Y&CQ#_ -=4_FU=37+>'/\ D:/$/_75/YM74TWN)!1112&%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% '*-_R4I/^O3_ !KJZY1O
M^2E)_P!>G^-=738D%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% &=KW_(O:C_U[2?\ H)JMX2_Y%:Q_W#_Z$:LZ]_R+
MVH_]>TG_ *":K>$O^16L?]P_^A&GT%U-JBBBD,**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,/QA_R*M]
M]$_]#6K^C_\ ($L/^O:/_P!!%4/&'_(JWWT3_P!#6K^C_P#($L/^O:/_ -!%
M/H+J7:***0PKCO!G_'MJ'_7VW\A78UQW@S_CVU#_ *^V_D*I;"9TU%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5@>"ONZM_U^-6_6!X*^[JW_7XU'0#JJ**
M*D84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M '+>$?\ C_U[_K\;^;5U-<MX1_X_]>_Z_&_FU=33>XEL%%%%(84444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<MX6_P"0[XB_Z^A_
M-ZZFN6\+?\AWQ%_U]#^;TUL(ZFBBBD,**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#EO#G_(T>(?^NJ?S:NIKEO#G_(T>(?^
MNJ?S:NIIO<2"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME/\ A'->_P"AB?\ []?_ %Z/^$<U[_H8G_[]?_7KJZ*+L+'*?\(YKW_0Q/\
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M<+'+?V!X@_Z&1_\ OU_]>C^P/$'_ $,C_P#?K_Z]=311<+'+?V!X@_Z&1_\
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M%%PL<M_8'B#_ *&1_P#OU_\ 7H_L#Q!_T,C_ /?K_P"O74T47"QRW]@>(/\
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M +]?_7KJ:*+A8Y;^P/$'_0R/_P!^O_KT?V!X@_Z&1_\ OU_]>NIHHN%CEO[
M\0?]#(__ 'Z_^O1_8'B#_H9'_P"_7_UZZFBBX6.6_L#Q!_T,C_\ ?K_Z]']@
M>(/^AD?_ +]?_7KJ:*+A8Y;^P/$'_0R/_P!^O_KT?V!X@_Z&1_\ OU_]>NIH
MHN%CEO[ \0?]#(__ 'Z_^O1_8'B#_H9'_P"_7_UZZFBBX6.6_L#Q!_T,C_\
M?K_Z]']@>(/^AD?_ +]?_7KJ:*+A8Y;^P/$'_0R/_P!^O_KT?V!X@_Z&1_\
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MT+!YF6 /SMP, D\]<8[UH4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP^Q$1ON;S @W;&8<KDG&0*P-5^*US\1(++0O$=S8Z)I"RQS7\UN)RUP%<Y1
MH?'RD$!@1NCSN' H ]/UH>)/''Q/U+PW8ZY?:'H>B16[W4MBZK+/*XW !AAE
MRC,/XE!C!(R0*Q+U?&WP^\9-I-IK^HZW9ZQIM[)8F]_?RQSPQ2.BH"6)<'R\
MG 5]^-N0,<WKOQ0M/#OQ/O/%7A75(-8LM6BB2\LI(IX=GEA%_B !8A3M?!QN
M8%?6/3/B9;>*?';^(_$>M1^'QI]E/!I,<,,MP(Y90RB1EVLK%5;YC\FXJG&
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MM\J'&<'@X/M1X!^*7@W1/^$H_M'6?)^W>(+N]M_]%F;?"^W:WRH<9P>#@^U
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH;(.5Y.0,'WK8HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHJAJ>M:=HRQ-?W(B\YBJ *S$X&3PH)P/7IR/44 7Z*R+'Q/H^HWJV=K>AYV
M4LJF-EW8ZX) !/?'7 )[&M>@ HHHH ***CGFCMK>2>5ML<2%W;&< #)H DHK
M!_X3/0/^?_\ \@R?_$UHZ=J^GZM&SV-U'-M^\HX9<D@94\C.#C(YQ3LP+M%0
M65[;ZA:)=6LGF0OG:VTC.#@\'GJ*);VW@N[>UDDVS7&[REVGYMHR>>@X]:0$
M]%9-[XFT?3[M[6ZN_+F3&Y?*<XR,CD#'0TRW\6:)=745M#? RRMM0&-U!/ID
MC'/;U/%.S"YLT5F:CX@TO2KA8+VZ\J1DWA?+9N,D=@?0U4_X3/0/^?\ _P#(
M,G_Q-%F%S>HJA=ZUI]CID>HW-P$M9 I1MC$MNZ84#)XYZ< $GH:H#QIX?+(O
M]H8WL%!,,@ R<<G;@#W/ [TK,#>HK,U'Q!I>E7"P7MUY4C)O"^6S<9([ ^AJ
MI_PF>@?\_P#_ .09/_B:=F%S>HJ.":.YMXYXFW1RH'1L8R",BF75Y;V2Q-<2
MA/-E6&,=2SL<  #_ " "3P#2 GHHHH **** "BBB@ HHHH ***@LKVWU"T2Z
MM9/,A?.UMI&<'!X//44 3T444 %%%% !1110 4444 %%%% !1110 4444 %%
M06UY;W;3K;RB3R)3#(1T#@ D9[XR,X[Y'4&IZ "BBB@ HHHH **** "BBB@
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MHHH ***@LKVWU"T2ZM9/,A?.UMI&<'!X//44 3T5'/-';6\D\S;8XD+NV,X
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MV,;)(MP%!61@P(!4G)(*<9X [9&2VMP+":SI^D>+-<^W7'E>;Y&SY&;.$YZ
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M;2SG,4+2A9 0Q 13UW@?>8+TZL,X )KL:P=*_P"1L\0?]NW_ * :2&9\.O\
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M:&PT]+4@RIO)8K#MWASAP",<=CG^$"F:Q;SW4OBV*VA>:4BT(1!EB  3@=^
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M6:)<W$<$5[NDE<(B^4XR2<#M5#4=3L]*\;+/>S>5&VG; VTMSYA/8'T-6_\
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MR-HP22"2PR-P-:&H_$"QCLHO[-CDGOKA0(HW3 1S@!6YRQYX"9R1C(R#1KT
MD\)V[ZGX3FTO6;=66"9K9XF;<5QM.-P)Y5B0"IXVKCIFN5NDU?3[FZ\*V]T/
M+GN%$.^Y4+L;.%8XRN[<I91CE3A6#_-T O)? _A)7NCYVI7<K2,LLP8*Q'+,
M>I  &<9RQQG!R(K;P"TGAJXCN_).K3MYBRREG*>J,V?F+?-N//+9^;:"0"[K
M%A8>'=)TF.!?+MXM2BEED(RSD Y9L=3@?D !P *T?^$ST#_G_P#_ "#)_P#$
MURB^(_.L;"RU']W<Z7J,*RN9/,,BIN#,>22RE<-UY(.><#J_^$ST#_G_ /\
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MRIP2,@Y!YZ@U9TK_ )&SQ!_V[?\ H!KEI[>ZT37['17=I+&2_BNK,_-B-=[
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M_K1H!O4445(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY 8@,R@DYSMXV8)^;%2VMWJVK^,K&[GTN[M+&W,L<8E0]=K?,> 1D%!CD9&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
-BB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>gguopuizh44n000002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gguopuizh44n000002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" -B!YX# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^>OAK>V]I^T9XJAFDVR
M7<M]# -I.]Q.'(XZ?*C'GT]<5] SSPVMO)<7$J0PQ(7DDD8*J*!DDD\  =Z\
ML^(WP>?Q1K@\2^']4_L[7!L+>8S!)'3:%<.OS1L%'8'.%X!R3CZO\._BUXIL
MTTO7_&&E/ICRHTZP*5) /7"Q)OQU"E@"0.F 0 4/V9_^9I/O:_\ M:CX6_\
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M)<AFX)Y).>3U#X:_%?Q#I<&B:YXQTV720T8E"EFD*KW)\I3(1UPS<D DYYH
MR/B1XCT7Q/\  O2;S0[%-/MH]72*2RCC"+;R^5*S*,  CYLY YW<X.0.8^+$
MU\VC> () _\ 9Z>'K=X28\*92H$F&QR=JQ9&>..F>?6_$'P=$_PJLO".B7L"
M7-I=+=M<7$>P7,F&#%BH)'#\<,0$5?>L>V^"WB#6O"PT7Q;X@@=M/V#1Y[;=
M+]F0Y\U'#*A92!&!D_+L&"!D$ Z?[#\5/[/_ +/^R^ /L7E>1]F\NZ\OR\;=
MFWIMQQCIBN9\,?#G6/A_\/\ QZ-6N;&;[;I;^5]D=VQLBFSG<J_WQZ]ZJ_\
M"M_B[_PC'_"-_P#"6Z5_9/E>1Y7F/N\O/W-_D[]N.,;L;?EZ<5V/AWX4VWA3
MP'KVB6%Y]JU+5K66&6[F!C1B4=8QM!;:HWG/4G)]@ #@_P!FB"%I_$MPT2&=
M!;HDA4;E5C(6 /4 E5R.^T>E0?#F&QE_:.\2O=E!/%<7[V>Z3:3+YNT[1GYC
MY9DXYXR>V1W7P@^'.K_#\:R-5N;&;[:8?+^RN[8V;\YW*O\ ?'3/>L_QC\(-
M4NO&?_"7>#=8@TS5&E65XI4V('P0SAE!SNXW*RG=N<D\XH I_M)0V+>%-'GD
M*?V@EZ4@!DPWE%"9,+GD96+)QQQTSSY?\4^O@G_L5['_ -GKU"#X.^)O$WB"
M+4?B)XECU"WMW#):6C-M<8PRCY4$0.U,[%RW/(/-3?%#X0ZOXQ\0Z?>:'-I5
MI96EC':+#,SQ[=KN0%54("@, /I0!Q_Q%%Q?_M':3::G#YMC]JL8;>.:$;)(
M2REAR/G4NT@.<]QVP/2OCQ#8R_"N]>[*":*>%[3=)M)EW@':,_,?+,G'/&3V
MR)/B?\*;?Q^(;^VO/L6KVT1C21P6CE3DJC#/R_,?O#. 3D-QCB]9^$_Q.\4:
M7#8:_P"+-.NH+- ;6(NY#OPN9&$8)(7=\S;CGC^(F@!EAHVC^(OV=- TO4M?
ML='N?-GN;)[RX2-))$FE&T[N2N'P2.1D'GH<?S_BIX/\,>3?:98^(O"L46R(
M31QWMNT0^=91L/F>6 N07^4#' XQZ/%\*'OO@Y8^"]6O(([VUE::.[@#2)&_
MFNV0#LW?([+SZY["N7_X5O\ %W_A&/\ A&_^$MTK^R?*\CRO,?=Y>?N;_)W[
M<<8W8V_+TXH [CX4>+_#_BK0KH:)HL&BRVTH-U8P1JJ MG:X954-D+CH"-N,
M8P3H?\*ZTC_A8O\ PF_VF^_M/&/*WIY/^J\KIMW?=Y^]U_*CX=^ +/X?:%+8
MP7'VRYN)3+<730B,OV50!DA0.@)/)8\9Q77T %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% '@OQ0_Y. \&?\ ;E_Z5/7O
M5>"_%#_DX#P9_P!N7_I4]>Y7M]::;:27=_=06MM'C?-/($1<G RQX') _&@#
MYVU/3_\ A"/VC]-_LVP@M;2[NH#;Q#E/+G'E2%0#\OS&7 X P.-N!6O\4/\
MDX#P9_VY?^E3UB6]XOQ'_:'M;[39[J33K:XCGBE>)F"10*&^[GY$>13C..9
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BO#?'?BG7M;MK=;G1]0TG1S,J"*XC*-,Y#NA?(&<+&3L7(5N23
M\A'K/A'_ )$O0O\ L'6__HM:'N!LT444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#EO^$R_Z</\ R-_]C1_PF7_3A_Y&_P#L:ZFBC0#EO^$R_P"G#_R-_P#8T?\
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M\C?_ &-'_"9?].'_ )&_^QKJ:*- .6_X3+_IP_\ (W_V-'_"9?\ 3A_Y&_\
ML:ZFBC0#EO\ A,O^G#_R-_\ 8T?\)E_TX?\ D;_[&NIHHT Y;_A,O^G#_P C
M?_8U:TWQ-_:%_%:_9/+WY^;S,XP">F/:M^BC0 HHHI %%%% !1110 4444 %
M%%% !1110!YO\:/^1;TC_L*K_P"B)JZ_PC_R)>A?]@ZW_P#1:U4\:>$_^$OT
MVSL_MOV3[/="YW^5YF[".F,9&/OYS[5L:18?V5HMCIWF>;]DMXX/,V[=VU0N
M<<XSCI0^@%RBBB@#!\2R.J6Z*[!6W;E!X.,8S5O^R/\ IO\ ^.?_ %ZI>)_^
M77_@?]*Z"@#,_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG
M_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,
M_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__
M (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG
M_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,
M_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__
M (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG
M_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,
M_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__
M (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG
M_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,
M_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__
M (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG
M_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,
M_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__
M (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG
M_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,
M_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__
M (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG
M_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,
M_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__
M (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG
M_P!>C^R/^F__ (Y_]>M.B@#,_LC_ *;_ /CG_P!>C^R/^F__ (Y_]>M.B@""
MTM_LL13?NRV<XQ4]%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5RW_,^_Y_YY5U-<M_S/O^?^>5- =31112 **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYU^+OQ=_M3S_#
M7AJX_P! YCO+V,_\?'K&A_YY^K?Q=!\OWO4?BYIWB'5/ %U;>'&<S%P;J&(X
MDGM\-O1>,DD[3@8+ $<YVGY#H *^BOA%\7?[4\CPUXEN/]/XCL[V0_\ 'QZ1
MN?\ GIZ-_%T/S?>^=:D@@FNKB.WMXGFFE<)''&I9G8G   Y))[4Q'WC169X<
MAOK?POI,&IESJ$=E"ET9)-[&4( ^6R=QSGG)S6G2&%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!S_B?_EU_X'_2N@KG_$__
M "Z_\#_I704 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7+?\S[_G_GE74URW_,^_Y_YY4T!U-%%%(
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "O%/B[\(O[4\_Q+X:M_P#3^9+RRC7_ (^/61!_ST]5_BZCYOO>UT4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<M_S
M/O\ G_GE74URW_,^_P"?^>5- =31112 **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKD?$WQ'
MT#PGX@TW1=2><7-]M(=541P(S[0\C,0 N0W3. ISCC(!UU%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW^;=-<^;Y'E8RB+C&YO[F<Y[TAG74444 %%%% !1110 4444 %%%% !1110
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M_P #_I6O_:%K_P ]?_'3_A0!9HJM_:%K_P ]?_'3_A1_:%K_ ,]?_'3_ (4
M6:*K?VA:_P#/7_QT_P"%']H6O_/7_P =/^% %FBJW]H6O_/7_P =/^%']H6O
M_/7_ ,=/^% %FBJW]H6O_/7_ ,=/^%']H6O_ #U_\=/^% %FBJW]H6O_ #U_
M\=/^%']H6O\ SU_\=/\ A0!9HJM_:%K_ ,]?_'3_ (4?VA:_\]?_ !T_X4 6
M:*K?VA:_\]?_ !T_X4?VA:_\]?\ QT_X4 6:*K?VA:_\]?\ QT_X4?VA:_\
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M?_'3_A1_:%K_ ,]?_'3_ (4 6:*K?VA:_P#/7_QT_P"%']H6O_/7_P =/^%
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MJS10!6_L^U_YY?\ CQ_QH_L^U_YY?^/'_&K-% %;^S[7_GE_X\?\:/[/M?\
MGE_X\?\ &K-% %;^S[7_ )Y?^/'_ !H_L^U_YY?^/'_&K-% %;^S[7_GE_X\
M?\:/[/M?^>7_ (\?\:LT4 5O[/M?^>7_ (\?\:/[/M?^>7_CQ_QJS10!6_L^
MU_YY?^/'_&C^S[7_ )Y?^/'_ !JS10!6_L^U_P">7_CQ_P :/[/M?^>7_CQ_
MQJS10!6_L^U_YY?^/'_&C^S[7_GE_P"/'_&K-% %;^S[7_GE_P"/'_&C^S[7
M_GE_X\?\:LT4 5O[/M?^>7_CQ_QH_L^U_P">7_CQ_P :LT4 5O[/M?\ GE_X
M\?\ &C^S[7_GE_X\?\:LT4 5O[/M?^>7_CQ_QH_L^U_YY?\ CQ_QJS10!6_L
M^U_YY?\ CQ_QH_L^U_YY?^/'_&K-% %;^S[7_GE_X\?\:/[/M?\ GE_X\?\
M&K-% %;^S[7_ )Y?^/'_ !H_L^U_YY?^/'_&K-% %;^S[7_GE_X\?\:/[/M?
M^>7_ (\?\:LT4 5O[/M?^>7_ (\?\:/[/M?^>7_CQ_QJS10!6_L^U_YY?^/'
M_&C^S[7_ )Y?^/'_ !JS10!6_L^U_P">7_CQ_P :/[/M?^>7_CQ_QJS10!6_
ML^U_YY?^/'_&C^S[7_GE_P"/'_&K-% %;^S[7_GE_P"/'_&C^S[7_GE_X\?\
M:LT4 5O[/M?^>7_CQ_QH_L^U_P">7_CQ_P :LT4 5O[/M?\ GE_X\?\ &C^S
M[7_GE_X\?\:LT4 5O[/M?^>7_CQ_QH_L^U_YY?\ CQ_QJS10!6_L^U_YY?\
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M4 %%%% !1110!S_B?_EU_P"!_P!*Z"N?\3_\NO\ P/\ I704 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH **** .?\3_ /+K_P #_I705S_B?_EU_P"!_P!*Z"@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y;
M_F??\_\ /*NIKEO^9]_S_P \J: ZFBBBD 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y_P 3_P#+K_P/^E=!7/\
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M0\6_\)#X(73IVS>Z/MMFX^]#@^4>  . 4QDGY,G[U 'IM%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% '/^)_\ EU_X'_2N@KG_ !/_ ,NO_ _Z
M5T% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!X;^T42J^'B#@A;K'_D&O2-*^&_A#1;
MY+VRT2%;A,%'E=YMA!!#*'8@,"!AAR/6N0^-6H:,D>E:?/HR:QK,I86D#2R
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M'$E[]H10((W4I\H.>"H.[&=HP5+<UZQ13N%C)\,Z%'X:\/6NDQSO.( Q:5P
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M5?3-% 'C?PO^$6K^#O$MSJ&M2Z7=6TEFT"I"SN0Y=&!PR 8PI_.O6O[,L/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S_B?_ )=?^!_TKH*Y
M_P 3_P#+K_P/^E=!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\C_&G_DK>N?\ ;#_T
M1'7UQ7C'Q+^"^H^*_%4FNZ-J%K&]TBBYBO&90K*JJI0JIR" ,@]".IS@ 'I'
M_"<^$?\ H:=$_P#!A%_\51_PG/A'_H:=$_\ !A%_\57@O_#.WB[_ *".B?\
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ML<#G QR>M;-%%2;)6"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KEO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **\4^)WQ/\06?C*#P?X37[/?K+%').Z1L9I) "D:A\J%^=<L><^@&6C\%
M?$OQ3:?$4^#/&$EK.[7$D'VIT$#*X7*;<!0R/CY<J"?,!ST% 'M]%%<5\4/'
M">"/"DD\1SJ5WN@LE#+E7VG]X0V<JG!/!Y*@XW9H [6BO(_@AXT\0>+_ .W?
M[=U#[7]E^S^3^YCCV[O,W?<49SM'7TKCO"7C+XJ_$'6+V#1];M;1(5,SF6T0
M0Q MA8PWEN<\G 8DD*>3B@#Z-HKG/!EGXILM'FC\7:E:ZAJ!N"T<MLH51%M7
M"G")SD,>G<<UT= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% '@G[0FG0QZKH^I+(XFN+:6W?)&U5C8,I'?.96SSV'3OJA[O6]5T^S
MT;X5:?I\+HIOY]6TA=L1+*&V<H'"@D]=S?W5QS4_:+_U7A__ ';K_P!I5[C5
M7T1CRWFPHHHJ38**** "BBB@ HHHH **** "BBB@ HHHH **** "N6_YGW_/
M_/*NIKEO^9]_S_SRIH#J:***0!1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0?W5W'DC)R2<< =K0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_%4?\)SX1_Z&G1/_  81?_%5\S?\*6^(/_0O_P#DY;__ !='_"EOB#_T+_\
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M^$?^AIT3_P &$7_Q5?,W_"EOB#_T+_\ Y.6__P 71_PI;X@_]"__ .3EO_\
M%T ?3/\ PG/A'_H:=$_\&$7_ ,51_P )SX1_Z&G1/_!A%_\ %5\S?\*6^(/_
M $+_ /Y.6_\ \71_PI;X@_\ 0O\ _DY;_P#Q= 'TS_PG/A'_ *&G1/\ P81?
M_%4?\)SX1_Z&G1/_  81?_%5\S?\*6^(/_0O_P#DY;__ !='_"EOB#_T+_\
MY.6__P 70!],_P#"<^$?^AIT3_P81?\ Q5'_  G/A'_H:=$_\&$7_P 57S-_
MPI;X@_\ 0O\ _DY;_P#Q='_"EOB#_P!"_P#^3EO_ /%T ?3/_"<^$?\ H:=$
M_P#!A%_\51_PG/A'_H:=$_\ !A%_\57S-_PI;X@_]"__ .3EO_\ %T?\*6^(
M/_0O_P#DY;__ != 'TS_ ,)SX1_Z&G1/_!A%_P#%4?\ "<^$?^AIT3_P81?_
M !5?,W_"EOB#_P!"_P#^3EO_ /%T?\*6^(/_ $+_ /Y.6_\ \70!],_\)SX1
M_P"AIT3_ ,&$7_Q5'_"<^$?^AIT3_P &$7_Q5?,W_"EOB#_T+_\ Y.6__P 7
M1_PI;X@_]"__ .3EO_\ %T ?3/\ PG/A'_H:=$_\&$7_ ,51_P )SX1_Z&G1
M/_!A%_\ %5\S?\*6^(/_ $+_ /Y.6_\ \71_PI;X@_\ 0O\ _DY;_P#Q= 'T
MS_PG/A'_ *&G1/\ P81?_%4?\)SX1_Z&G1/_  81?_%5\S?\*6^(/_0O_P#D
MY;__ !='_"EOB#_T+_\ Y.6__P 70!],_P#"<^$?^AIT3_P81?\ Q5'_  G/
MA'_H:=$_\&$7_P 57S-_PI;X@_\ 0O\ _DY;_P#Q='_"EOB#_P!"_P#^3EO_
M /%T ?3/_"<^$?\ H:=$_P#!A%_\51_PG/A'_H:=$_\ !A%_\57S-_PI;X@_
M]"__ .3EO_\ %T?\*6^(/_0O_P#DY;__ != 'TS_ ,)SX1_Z&G1/_!A%_P#%
M4?\ "<^$?^AIT3_P81?_ !5?,W_"EOB#_P!"_P#^3EO_ /%T?\*6^(/_ $+_
M /Y.6_\ \70!],_\)SX1_P"AIT3_ ,&$7_Q5'_"<^$?^AIT3_P &$7_Q5?,W
M_"EOB#_T+_\ Y.6__P 71_PI;X@_]"__ .3EO_\ %T ?3/\ PG/A'_H:=$_\
M&$7_ ,51_P )SX1_Z&G1/_!A%_\ %5\S?\*6^(/_ $+_ /Y.6_\ \71_PI;X
M@_\ 0O\ _DY;_P#Q= 'TS_PG/A'_ *&G1/\ P81?_%4?\)SX1_Z&G1/_  81
M?_%5\S?\*6^(/_0O_P#DY;__ !='_"EOB#_T+_\ Y.6__P 70!],_P#"<^$?
M^AIT3_P81?\ Q5'_  G/A'_H:=$_\&$7_P 57S-_PI;X@_\ 0O\ _DY;_P#Q
M='_"EOB#_P!"_P#^3EO_ /%T ?3/_"<^$?\ H:=$_P#!A%_\51_PG/A'_H:=
M$_\ !A%_\57S-_PI;X@_]"__ .3EO_\ %T?\*6^(/_0O_P#DY;__ != 'TS_
M ,)SX1_Z&G1/_!A%_P#%4?\ "<^$?^AIT3_P81?_ !5?,W_"EOB#_P!"_P#^
M3EO_ /%T?\*6^(/_ $+_ /Y.6_\ \70!],_\)SX1_P"AIT3_ ,&$7_Q5'_"<
M^$?^AIT3_P &$7_Q5?,W_"EOB#_T+_\ Y.6__P 71_PI;X@_]"__ .3EO_\
M%T ?3/\ PG/A'_H:=$_\&$7_ ,51_P )SX1_Z&G1/_!A%_\ %5\S?\*6^(/_
M $+_ /Y.6_\ \71_PI;X@_\ 0O\ _DY;_P#Q= 'TS_PG/A'_ *&G1/\ P81?
M_%4?\)SX1_Z&G1/_  81?_%5\S?\*6^(/_0O_P#DY;__ !='_"EOB#_T+_\
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M2WQ!_P"A?_\ )RW_ /BZ /IG_A.?"/\ T-.B?^#"+_XJC_A.?"/_ $-.B?\
M@PB_^*KYF_X4M\0?^A?_ /)RW_\ BZ/^%+?$'_H7_P#R<M__ (N@#Z9_X3GP
MC_T-.B?^#"+_ .*H_P"$Y\(_]#3HG_@PB_\ BJ^9O^%+?$'_ *%__P G+?\
M^+H_X4M\0?\ H7__ "<M_P#XN@#Z9_X3GPC_ -#3HG_@PB_^*H_X3GPC_P!#
M3HG_ (,(O_BJ^9O^%+?$'_H7_P#R<M__ (NC_A2WQ!_Z%_\ \G+?_P"+H ^F
M?^$Y\(_]#3HG_@PB_P#BJ/\ A.?"/_0TZ)_X,(O_ (JOF;_A2WQ!_P"A?_\
M)RW_ /BZ/^%+?$'_ *%__P G+?\ ^+H ^F?^$Y\(_P#0TZ)_X,(O_BJ/^$Y\
M(_\ 0TZ)_P"#"+_XJOF;_A2WQ!_Z%_\ \G+?_P"+H_X4M\0?^A?_ /)RW_\
MBZ /IG_A.?"/_0TZ)_X,(O\ XJC_ (3GPC_T-.B?^#"+_P"*KYF_X4M\0?\
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M"/\ T-.B?^#"+_XJC_A.?"/_ $-.B?\ @PB_^*KYF_X4M\0?^A?_ /)RW_\
MBZ/^%+?$'_H7_P#R<M__ (N@#Z9_X3GPC_T-.B?^#"+_ .*H_P"$Y\(_]#3H
MG_@PB_\ BJ^9O^%+?$'_ *%__P G+?\ ^+H_X4M\0?\ H7__ "<M_P#XN@#Z
M9_X3GPC_ -#3HG_@PB_^*H_X3GPC_P!#3HG_ (,(O_BJ^9O^%+?$'_H7_P#R
M<M__ (NC_A2WQ!_Z%_\ \G+?_P"+H ^F?^$Y\(_]#3HG_@PB_P#BJ/\ A.?"
M/_0TZ)_X,(O_ (JOF;_A2WQ!_P"A?_\ )RW_ /BZ/^%+?$'_ *%__P G+?\
M^+H ^F?^$Y\(_P#0TZ)_X,(O_BJ/^$Y\(_\ 0TZ)_P"#"+_XJOF;_A2WQ!_Z
M%_\ \G+?_P"+H_X4M\0?^A?_ /)RW_\ BZ /IG_A.?"/_0TZ)_X,(O\ XJC_
M (3GPC_T-.B?^#"+_P"*KYF_X4M\0?\ H7__ "<M_P#XNC_A2WQ!_P"A?_\
M)RW_ /BZ /IG_A.?"/\ T-.B?^#"+_XJC_A.?"/_ $-.B?\ @PB_^*KYF_X4
MM\0?^A?_ /)RW_\ BZ/^%+?$'_H7_P#R<M__ (N@#Z9_X3GPC_T-.B?^#"+_
M .*H_P"$Y\(_]#3HG_@PB_\ BJ^9O^%+?$'_ *%__P G+?\ ^+H_X4M\0?\
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MTS_6FA'?45RW_"&_]/\ _P"0?_LJ/^$-_P"G_P#\@_\ V5&@SJ:*Y;_A#?\
MI_\ _(/_ -E1_P (;_T__P#D'_[*C0#J:*Y;_A#?^G__ ,@__94?\(;_ -/_
M /Y!_P#LJ- .IHKEO^$-_P"G_P#\@_\ V5'_  AO_3__ .0?_LJ- .IHKEO^
M$-_Z?_\ R#_]E1_PAO\ T_\ _D'_ .RHT ZFBN6_X0W_ *?_ /R#_P#94?\
M"&_]/_\ Y!_^RHT ZFBN6_X0W_I__P#(/_V5'_"&_P#3_P#^0?\ [*C0#J:*
MY;_A#?\ I_\ _(/_ -E1_P (;_T__P#D'_[*C0#J:*Y;_A#?^G__ ,@__94?
M\(;_ -/_ /Y!_P#LJ- .IHKEO^$-_P"G_P#\@_\ V5'_  AO_3__ .0?_LJ-
M .IHKEO^$-_Z?_\ R#_]E1_PAO\ T_\ _D'_ .RHT ZFBN6_X0W_ *?_ /R#
M_P#94?\ "&_]/_\ Y!_^RHT ZFBN6_X0W_I__P#(/_V5'_"&_P#3_P#^0?\
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M_P"G_P#\@_\ V5'_  AO_3__ .0?_LJ- .IHKEO^$-_Z?_\ R#_]E1_PAO\
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"A=Z)I.H7
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K.GT#1KJYDN;C2+":XE(,DLELC,^  ,DC)X 'T%:-% #(88K>".""-
M(H8U")&BA550,  #H .U5K'2=.TS?_9^GVMIO #_ &>%8]P&<9P.<9./J:N4
M4 ,FBBN(9(9HTDBD4HZ.H*LIX((/4&H;+3K'38GBL+.WM8W?>ZP1*@9L 9(
MY. !GV%6:* "BBB@#G_$_P#RZ_\  _Z5T%<_XG_Y=?\ @?\ 2N@H **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "N6_YGW_/_ #RKJ:Y;_F??\_\ /*F@.IHHHI %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% '/\ B?\ Y=?^!_TKH*Y_Q/\ \NO_  /^E=!0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<M_S/
MO^?^>5=37+?\S[_G_GE30'4T444@"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#G_ !/_ ,NO
M_ _Z5T%<_P")_P#EU_X'_2N@H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@"O?7MOINGW-_=R>7;6T333/M)VHH)8X')P >E?/.J?M%:ZVI
MW!TC2].33]^(!=QNTNWU8JX&3UP.F<9.,GV_QS_R3_Q)_P!@NZ_]%-7SS\!]
M*T[6/'%[;ZG86M["NFNZQW,*R*&\R(9 8$9P3S[F@"Y_PT3XN_Z!VB?]^)?_
M ([4D'[17BA;B-KC2]'DA#@R)''*C,N>0&+D X[X./0U[M_P@WA'_H5M$_\
M!?%_\37SS\>-*T[1_'%E;Z986ME"VFH[1VT*QJ6\R49(4 9P!S["@#Z:TK48
M=8T>QU.W5UAO+>.XC60 ,%=0P!P2,X/K5NL#P-_R3_PW_P!@NU_]%+6_0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7R7\;8)HOBOJSR1.B3) \3,I =?)1<CU&589'<$=J^M
M*\^^)WPQA\?V]M<6]TEGJEHCK'(T099E(R$<CY@ W0\XW-\IS0!T6@>,] \2
MZ(=6T_48/L\<7FW*RR*KVHYSYHS\F-K<G@X)!(YKYN^,GB70_$GC)WT>T@+6
MV89M1AD)%[@+@XP!\IW*&R=PQS@"J%]\/_'WAC4+FT@TK5&\Z)H7FTQ7ECGA
M)((+)_"VW.UL'&,@5Z)\-_@CJFG:W8Z]XDD@@^R2B:.P1O,<NN[:6=3M7#!&
M&"V>AQR*8'K'@/1[[0/ NCZ7J4[S7D%N!+O.3&22WEYR00@(08.,*,8'%='1
M12 **** "BBB@ HHHH **^?;W]H:_C\5R1VMC8OX?2Z""01R-/) & +KEE 9
MAD@$#&0#G&:]^@GANK>.XMY4FAE0/')&P974C(((X(([T 24444 %%<CXM^)
M7ACP;NBU&^\V]&/]"M0))OX>HR G# _,1D9QFN5@_:%\'RW$<;VFL0([A6ED
M@C*H"?O';(3@=> 3Z T >L45F:-XBT;Q%;^?H^IVMZ@17<0RAFC##*[UZJ3@
M\, >#Z5IT %%%% !1110 4444 %%>;?%;XG3> DLK73[6UNM0O$9_P!]*<0*
MK* 608)#9< Y'*GK@BCX3_$N;QY;W]OJ:6L&J6KAUCMP55X2 ,@,S,2&!R>@
MW)ZT >DT444 %%%% !1110 445XI\7/BYJGAO6V\/>'F@BN(XE>ZNGCWO&[8
M8(H8;?NX))#9WX&"* /:Z*^.(_%/Q!UC[=?VNL>(KB.',UT]K/-Y< .3DA/E
M1>&]  #C@5UWPW^,>N:?K=CI7B#4?MFDSRB)Y[O#2P;MV&\PL/EW,I8N6PJ\
M8Q0!],T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!XQ\)+>R\3:IKFJZII]K-<2QK-M9-T:FY,IE 5B1@@;><G!(S@G,GPQ8V/Q
M)U_2K4^78J+I!$?F.(;D)'\QRW"NPZ\YYS3M%MM<^'7B?5[:S\-3WNFW"DV_
MV82. BES /,P<8W%7!&X?>&0!OU/AGX:U.+6-2\3ZQ;O:7%V95C@*F/)DEWR
ML4;+*-RJ%R<XW<$%26Q([CQ%H,'B723IMU<7$-N\BO((-@+[3N )93@;@#Q@
M_*.<9!X?XA?V3H_@RR\)6BF;4&,/V2)(@\@VN,R-@##/\ZY RS.V 1NQK:CX
MUU"Y\.74NE>&O$,%](%B@\^QVM&SJY\PCYLA-G(P1DH#][(YKPFTVEZA<:YK
MN@>(K_7)W8^:M@2D2]/ER1\Q'&<# ^50 "6-@W._\&Z7=Z-X1TVPOY7DN8HR
M7WG)CW$L(\@D$("$&#C"C&!Q6[5+2M1_M738[S['=V>\L/(O(O+E7:Q7E<G&
M<9'J"#5VD,PM3\2QZ?>-;+;-*Z?>);:.0",=<]?:N>_MG_B?_P!J?9_^V>__
M &=O7']*[ZN6_P"9]_S_ ,\J:$'_  F7_3A_Y&_^QH_X3+_IP_\ (W_V-=31
M1H,Y;_A,O^G#_P C?_8T?\)E_P!.'_D;_P"QKJ:*- .6_P"$R_Z</_(W_P!C
M1_PF7_3A_P"1O_L:ZFBC0#DI_%<-U;R6]QI:30RH4DCDD#*ZD8((*X(([5\X
M?$#P2-"O)-2TJ%QH\K\1ER[6Q/\ "3U*YZ$^P/."WUY535-+L=:TRXTW4K9+
MFSN$V2Q.."/Y@@X((Y! (Y%%T(^%:OZ-HU[KNI1V%C%OE?DD\*B]V8]@/_K#
M)(%>B^)?@3XHL-;FBT&U_M/33\\,S3Q1NH/\#AF7YAZ@8/!XY ]H^&WPVL?
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M.'_D;_[&NIHHT Y;_A,O^G#_ ,C?_8T?\)E_TX?^1O\ [&NIHHT Y;_A,O\
MIP_\C?\ V-'_  F7_3A_Y&_^QKJ:*- .6_X3+_IP_P#(W_V-'_"9?].'_D;_
M .QKJ:*- .6_X3+_ *</_(W_ -C1_P )E_TX?^1O_L:ZFBC0#EO^$R_Z</\
MR-_]C1_PF7_3A_Y&_P#L:ZFBC0#EO^$R_P"G#_R-_P#8T?\ "9?].'_D;_[&
MNIHHT Y;_A,O^G#_ ,C?_8T?\)E_TX?^1O\ [&NIHHT Y;_A,O\ IP_\C?\
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M_P#K5IT4 9G]K_\ 3#_Q_P#^M1_:_P#TP_\ '_\ ZU:=% &9_:__ $P_\?\
M_K4?VO\ ],/_ !__ .M6G10!F?VO_P!,/_'_ /ZU']K_ /3#_P ?_P#K5IT4
M 9G]K_\ 3#_Q_P#^M1_:_P#TP_\ '_\ ZU:=% &9_:__ $P_\?\ _K4?VO\
M],/_ !__ .M6G10!F?VO_P!,/_'_ /ZU']K_ /3#_P ?_P#K5IT4 9G]K_\
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M/_'_ /ZU']K_ /3#_P ?_P#K5IT4 9G]K_\ 3#_Q_P#^M1_:_P#TP_\ '_\
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MX\^#_P"Q_$\?B"TAVV6J?Z[8N%2X ^;HH WC#<DDL)#3$?0W]K_],/\ Q_\
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M2IWJ,_<;/W5 ( P<SPQH>L_$[QTC7KW5R+BX5]1OMIQ$F"3\P4JA*H50$8R
M.@I@?17P]\1ZA?\ @#1KG5(7-XT&UG=F#2*I*JYW9)+*%8G/.<]#73?VO_TP
M_P#'_P#ZU7X((;6WCM[>)(88D"1QQJ%5% P  .  .U24@,S^U_\ IA_X_P#_
M %J/[7_Z8?\ C_\ ]:M.B@#,_M?_ *8?^/\ _P!:C^U_^F'_ (__ /6K3HH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S_B?_ )=?^!_TKH*Y
M_P 3_P#+K_P/^E=!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%<%\1_BA:?#[[##]
MA_M"]NMS^0MP(_+C'&YCACR>!Q@X;GC!Z[1-8M/$&B6>K6#[K:[B$J9()7/5
M6P2 P.01G@@B@"_1110 4444 %%%% '.>/-.U;5_ NL:=HC(-0N;<QH'( =2
M1O3)& 63<H)QR1R.H^:O^%+?$'_H7_\ R<M__BZ^N** /D?_ (4M\0?^A?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[/.(4&Y%==I 8MPW.0,8[UZ98WMOJ6GVU_:2>9;7,2S0OM(W(P!4X/(R".M
M%BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "N6_P"9]_S_ ,\JZFN6_P"9]_S_ ,\J: ZFBBBD 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%5[J^M+'R?M=U
M!;^?*L$/FR!/,D;[J+GJQP< <FK% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH1DJ059FZ _O,$<5Y'!'<_"+XRQQ/,\>GQW 5I9 Y$ME(?O':!O*CG@$;X^
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P -'Y28CAFP=T?4XSC>!@#!(484TQ'O7PU\)?\ "&^"+/3I5VWLO^DWG/\
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M/<U]ET4 <;\*H-1M?AGHUOJL5U#>1)(C1W2LLB*)7" AN0 NW ],8XKLJ**
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M@I_Y,2?X4?V)K_\ T%/_ "8D_P *ZFBBX6.6_L37_P#H*?\ DQ)_A1_8FO\
M_04_\F)/\*ZFBBX6.6_L37_^@I_Y,2?X4?V)K_\ T%/_ "8D_P *ZFBBX6.6
M_L37_P#H*?\ DQ)_A1_8FO\ _04_\F)/\*ZFBBX6.6_L37_^@I_Y,2?X4?V)
MK_\ T%/_ "8D_P *ZFBBX6.6_L37_P#H*?\ DQ)_A1_8FO\ _04_\F)/\*ZF
MBBX6.6_L37_^@I_Y,2?X4?V)K_\ T%/_ "8D_P *ZFBBX6.6_L37_P#H*?\
MDQ)_A6?=1ZO::A#92:C*9)MNTK.^!DX&:[FJ%UI%O=ZA#>R/*)(=NT*1@X.1
MGBBXK&+_ &)K_P#T%/\ R8D_PH_L37_^@I_Y,2?X5U-%%QV.6_L37_\ H*?^
M3$G^%']B:_\ ]!3_ ,F)/\*ZFBBX6.6_L37_ /H*?^3$G^%']B:__P!!3_R8
MD_PKJ:*+A8Y;^Q-?_P"@I_Y,2?X4?V)K_P#T%/\ R8D_PKJ:*+A8Y;^Q-?\
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M^QWW_/S_ .1&J#;=_:_L_P!H;?Z[SCIFMJH/LL?VO[1EM_IGCIB@"G]COO\
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MUK.@DC9#G# @XIEO;I;1E$+$$YYH H_8[[_GY_\ (C4?8[[_ )^?_(C5IT4
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M;KKRKJ=[>RJ\5W%(X>,S,\*.02%QC(*<A1C:?EP1B1[31112&%%%% !1110
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M_%:(MG';M&;=&7<7\S.<L?[@Q^-=W7CWP0_X_=?_ .O>R_\ :U>PTQ!1110
M4444 %%%% !1110 4444 %%%% !1110!!=WEK86S7-Y<PVT"D!I9G"*"2 ,D
M\<D@?4UP.E?$F77/'=KI5C;1+I4S.@EE5O-?;&[;P,@*"5& 03CDX)PO9ZUH
M&F>(K:&VU6V^T10R^=&OF,F'VLN<J0>C-^=>3Z3I]KI7QX-C8PK#;03!8T!)
MP/L ZD\DGJ2>222>:.@=3T#QSXSA\(Z=&$02ZC=*_P!EC=3L&W&YW(_A7<O
M.22 ,<D<Y?>./%^AZ7IVK:OHU@MK>,R"W!>*96VL45LEMA(&[H< $$*>*/C,
MND_V/8R71D74D9_LI&=GEY3SM_;&-N.^[;CC=7/^,;/Q;:>%]&CU_;>6-M(&
M=XWS*KD8432;3AMK,@<!AD_-N8KD ]CTR_CU32K/484=(KJ!)T60 ,H90P!P
M2,\^IJU63X8OM-U'PSI]QI"2)8"(10QR [HPGR%#DG)4J1G)SC()ZUK4(&%%
M%% !1110 4444 %%%% !1110 4444 %4-:UBTT#1[C4[TOY$ &1&NYF)(55
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MV&CV<T>GP3S_ &HS!G:*Z50VWS.%.\32/P!D= NTJ/18F(^!*-GG_A&0<_\
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M^55VG<A"\]<8/%>B0PQ6\$<$$:10QJ$2-%"JJ@8  '0 =J?10 4444 %%%%
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M7V\_VU_8WV/RCC['YOF>9D8^]QMQNSWSBMRBBD 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% 'AG[10R?#HR!E+OD_]L:M_%#QA_;?@>XLQX0UZW_>QO]KU"Q\I+?##
MY@W/S'[G;ASSV,GQXT/5M:.@C2],O+WRTNA(;:!Y-F[RL9V@XS@_D:N^-O&>
MH:YX3O=*T[P+XADENU\MC?:8VR->N\!<DN" 5Z8.&[8-KH82W:N,N]:/A+X
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MO^1!\1_]@NY_]%-7@_Q*^&.HZ7XFFGT'2KV]L+Q7F06MMN$#$G=%A!PHX*Y
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!R/Q$\;_ /"
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M7K?_  KKM%N]0OM(@N=5TS^S+U]WF6GGK-Y>&('SKP<@ _CBN1_XNW_U)/\
MY-UVMC]K_L^V_M#R/MOE+]H^SY\OS,#=LSSMSG&><4 >9V?QIMYOB.WA.YT?
M[-&+^2Q%[]I+Y=69$^0)_$P4=>-V2<"NR\<>+(?!7A6XUJ6%+AXW1(K=IA$9
MF9@, X/(&YL 'A3]:^5_%NG37OC;QI<1,@2QO;BXE#$Y*FZ$>!QUS(O7' /T
MKL?B/XM?XB6WANPL;F#='I<VI7HCE98Q.D;-)&4P2&40OM)SD2#G!R0#O?\
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M!RO[2G_,L?\ ;U_[1H ['4?B'XNT.W6]UCX<74.GJ_[^:VU*.Y:) "6?8B]
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M]"9H?_?Y?_DB@#V"BO'_ /A(?CG_ -"9H?\ W^7_ .2*/^$A^.?_ $)FA_\
M?Y?_ )(H ]@HKQ__ (2'XY_]"9H?_?Y?_DBC_A(?CG_T)FA_]_E_^2* /8**
M\?\ ^$A^.?\ T)FA_P#?Y?\ Y(H_X2'XY_\ 0F:'_P!_E_\ DB@#V"BO'_\
MA(?CG_T)FA_]_E_^2*/^$A^.?_0F:'_W^7_Y(H ]@HKQ_P#X2'XY_P#0F:'_
M -_E_P#DBC_A(?CG_P!"9H?_ '^7_P"2* /8**\?_P"$A^.?_0F:'_W^7_Y(
MH_X2'XY_]"9H?_?Y?_DB@#V"BO'_ /A(?CG_ -"9H?\ W^7_ .2*/^$A^.?_
M $)FA_\ ?Y?_ )(H ]@HKQ__ (2'XY_]"9H?_?Y?_DBN<UGQ/\2QXZ\%6_B>
MVCT2"XU-$6/3KDA;I3+$'$@65PP (P#C[QZT ?0=%%% !1110 4444 %%%%
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MX\UC3KNQT]%*6MH"RR,NWAD9 H#D9<\Y^Z !C;Z_110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X_\ %_\
MY*'\,?\ L*G_ -&V]>P5X_\ %_\ Y*'\,?\ L*G_ -&V]>P4 %%%% !1110
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MMO7L%>/_ !?_ .2A_#'_ +"I_P#1MO0![!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'C_ ,7_ /DH
M?PQ_["I_]&V]>P5X_P#%_P#Y*'\,?^PJ?_1MO7L% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7C_B'_ ).A\)_]
M@I__ $&ZKV"O'_$/_)T/A/\ [!3_ /H-U0![!1110!Y/^T'_ ,B)I_\ V%8_
M_14M>7_"_P 1W'@OQ=I\U^WDZ5K$>R0M(-NSS&193\P"[9$8$MT7?@<BO4/V
M@_\ D1-/_P"PK'_Z*EKEQX.F\4_L_:'<V$#S:EIKW,L,<8):2-IW$B 9 S@*
MW0D[, ?-0!7^-^N7VN^+E\,V2.8=*MWN)4+;1(_E&5G^]@A8AQP#DN!G(K3_
M &<_O^)OI:?^UJC\&^#=0TOX>^-?$FNP746J7NFW<4:W882[-C,[MDY)=\?>
M&?DR#AJD_9S^_P")OI:?^UJ .L\6?&+3- UK^Q-+T^;6M3658I(X'VHKG(V!
M@&+2 [1M"]\9R"*S8?C@MEJT=EXG\+:AHB2(&#NQ=E!;&XHR*=G#<C)^7 !K
MROX;2^*)/$]SJOA^PLM7U9(6:3[?*I<;R-THW.K%NH+ G[Y!^\*[3QEHWQ2\
M<6-O:ZIX3TR/[/+YD<UO-$)!D$%=S3'Y3P2.Y5?2@#W#5-4LM%TRXU'4;E+:
MSMUWR2OT _F23@ #DD@#DUY9#\;KO5;JX7P]X(U/5+>';ET<[UR/XE1'"\AL
M?,<X_ 4_BK#>Z1\$O#6FS%X)HWM+:ZB5^"4@?*G!PP#(#W&5![5V?PCL[*T^
M&6D&RD283J\LTJP^66E+D,#W)4C9N[A!CC% 'BOPWU'^U_CG::IY7E?;;N\N
M?+W;MF^*5L9P,XSUQ7HNN^-]$LOBW'H4W@S3[F_:]M(1JCE/-#.(]K\QDY7<
M,?-_".17$>$?^3D9O^PKJ/\ Z#/1XN_Y.1@_["NG?^@PT >E>*?BU_8?BQO#
M6E^'+W5]1BQYB1OMSF-9!L"JY;Y2<\#&.]92_'%['6K:Q\1^$[S1HI<,\DTK
M%XT.0'\LQJ67(YQZ'&2,&/Q+\5-?O/&5QX1\&:?:RW:/+;BXF;YFD5,L4#[5
M4H5D'S;@VT=N#R/Q*L/B'!X2L;GQ?JUG<6<ETFVUB1!)%*8W(W%8P.!N!PQ&
M3WZT >W^*_%4/AOP9<>)+>%-0AC6)XUCF"K*LCJH(< C&&SG!S7G=A\=KO5B
M(=,\$WM[>+N:2&WN#)MC&T!OEC)ZD@Y  ^7DYXN^+O\ DVNV_P"P9IW_ *%#
M1^S[_P B)J'_ &%)/_145 &GX"^+FG^-=2;2Y+!]/OBC21*TZR)*JXX#?*2_
M+':%/"DYKT6O!X8(;?\ :H*01)$A=G*HH4%FLBS'CN222>Y)->\4 ?-G[07_
M "/UG_V"H_\ T;+7TG7S9^T%_P C]9_]@J/_ -&RU])T <1\4?$.G^&_#5K>
M:EH%KK4,EZL2V]R5VHQ1SO&Y6&0%(Z?Q'FO.?B'JUIKGP.\/ZC8Z5!I5M-JI
MV6<&-D>!<*<851R03T'6NE_:"_Y$33_^PI'_ .BI:X37?^3;?"O_ &%9/_0K
MF@ UW_DVWPK_ -A63_T*YKT+X?>)-,\*? [2]5U6;RX(S.JJO+RN9Y,(@[L<
M?H2< $CSW7?^3;?"O_85D_\ 0KFL;Q+/*OPC\!0"5Q"[Z@[1ACM9EGPI(Z$@
M,V#VW'UH ]+3XX:A=V]W?:=X%U"ZTVW=PUVLS;551G+E8RJG;@D;CC/4]:[7
MP+X^TWQW83RV<,]O<VNP7,$HSL+#(*L.&7(8 \'Y>0,BN"\/7WQ7TKP[I]CI
M/A30GL(8$$$B31D2KC._*S@$MG<2.I)/>G_"SP5XFT+Q[J6L:SHT.G6UU:RJ
MJ02QF-'>5&"*JL2% !QZ 4 >S4444 %>/_%__DH?PQ_["I_]&V]>P5X_\7_^
M2A_#'_L*G_T;;T >P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!X_\7_\ DH?PQ_["I_\ 1MO7L%>/
M_%__ )*'\,?^PJ?_ $;;U[!0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5X_XA_Y.A\)_P#8*?\ ]!NJ]@KQ_P 0
M_P#)T/A/_L%/_P"@W5 'L%%%% 'GOQB\,ZOXJ\)V=CHMI]JN([])G3S$3"".
M0$Y8@=6'YUK?#31K_P /_#_3-+U2W\B\@,WF1[U;;NE=ARI(Z$'K7644 9'B
MJRN-2\(:W8VD?F7-S83PQ)N W.T;!1D\#DCK7GWP6\&Z_P"$FUPZY8?9?M0M
M_)_?1ONV^9N^ZQQC<.OK7K%% 'B6L_"SQ3X<\4WGB'P%>PQ+)EDM 5C==[?-
M&%9?+:,<, V,8'!*@FY>-\:M?>.S-KI^A0NCI+/!+'C!'<[I'4\8!0 @MGW'
ML-% ')ZIX-_X2/X=VWAS6KK?>I:PJUZ!YK+<(HS("PR<D$$\$JS#(S7F?A[2
M/B_X-TR\T;2]-MKFT+,())+B)Q"3G+Q;G& 3\V&7&>=H);/O%% '@W@GX>^,
M],^*]OKNMV*-"+BYDN+R.>(K(SI(-X4$-AF8<;1C/05;\1^ /$]_\;8O$-MI
MF_2EU"RF,_GQCY(Q$'.TMNXVMV[<5[=10!XEKWP^\8^'/B')XG\%$WBW<LD\
MT<DJ)M+MN>)PQ4/&Q.1CD8[%0QS?%WA3XL>-+1)]4M;98HY_W>EP7$:!/D'[
MS[Q##J/F<L"S8 !KW^B@#SWQ'X9U>_\ @A!X=MK3?JJV-E";?S$&'C:(N-Q.
MWC:W?MQ1\'?#6K^%?"=Y8ZU:?9;B2_>9$\Q'RACC .5)'53^5>A44 >4?\(;
MK_\ PT!_PD_V#_B39_X^?.C_ .?3R_N[MWWN.GZ5ZO110!XC\8? 'B;Q5XOM
MK[1M,^TVJ:>D+/Y\:8<22$C#,#T8?G6Q_;WQH_Z%'1?^_J__ !^O5J* /$?%
MND_$SQOX4:QU7P[90W$%_!-;I:SQKO3RY@Y):5AP3'Z?>/7L:MX \3W/P2T#
MP]#IF[5;34'FF@\^,;$+3D'<6VG[Z]#W^M>W44 >(ZMX \3W/P2T#P]#IF[5
M;34'FF@\^,;$+3D'<6VG[Z]#W^M:4/PMN]9^#NEZ#J2)8:Y8/-+ SE7"LTCG
M8S+GY&4KG:>"%.#MP?7** /%M&M/C%X0M_[)M+'3]8L8$5+>2:9"J*!G"$O&
M^.<88<;0%P.O2> M(^(*:X=7\8ZHDD+V3P+9+*,H_F*58I&HCS@-\P).& ]A
MZ+10 4444 %>/_%__DH?PQ_["I_]&V]>P5X_\7_^2A_#'_L*G_T;;T >P444
M4 %%%% !1110 4444 %1SSPVMO)<7$J0PQ(7DDD8*J*!DDD\  =ZDKR/XK^(
M=0UK5[/X<>&I=NI:CAKR43*JI#M8F-NK#*C>PX.T  -OQ0!V7@3QYIWCW3+J
M\L8GMWMKAHG@E=2X7JCD \!A^H8 G&3U5?-V@&X^#GQB.E7TVW1=1^02/,"#
M S$12ORJAE888D<#S,#!!/TC0 4444 %%%>07'@;Q%XS^)TUWXQM/^*:L_.6
MRA68;)$SM0 (^]688<L>NS:<#  !Z_17A7@2^_L/XRWWAOPO=?;/"]R3,X23
MSXXOW(;>KCIAR(\DG(P#E@"(#;?\+2^-NH:;K$\R:7HWG"*T5^&6*18V (QM
MWL=Q/)Q\N> 0 >^45X59%_A=\:+?0[6:9M U<IY5IYK.(C,0BM@D#<)(P-QW
M'R^Y->U:KJ,.D:/>ZG<*[0V=O)<2+& 6*HI8@9(&<#UH MT5YG;_ !P\.7D#
MR6FEZ[<-$CRS10VBLT,2!<R-A\!/FQG/&#G'&7P?&WPU>FTBT^PUJ^O+G?\
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MH_X03P?_ -"IH?\ X+H?_B: .?\ ^%V_#S_H8?\ R2N/_C='_"[?AY_T,/\
MY)7'_P ;KH/^$$\'_P#0J:'_ ."Z'_XFC_A!/!__ $*FA_\ @NA_^)H Y_\
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M,/\ Y)7'_P ;KH/^$$\'_P#0J:'_ ."Z'_XFC_A!/!__ $*FA_\ @NA_^)H
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MN/\ XW70?\()X/\ ^A4T/_P70_\ Q-'_  @G@_\ Z%30_P#P70__ !- '/\
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MPO[/O_(B:A_V%)/_ $5%7/?M!S+>ZSX<TJU#S7ZQS/Y$<;,Q$C(J8XY),;#
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M(M6?ET1]_P F>ZC8,>F<=  /7ZY[PCX+T?P5ILEGI43EI7WS7$Q#2RGG&X@
M8 .   !R>I)/0T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9/$FNZG-KNL&4RI+-$(XT;C:VS)^9<';S@#&%!4&O0J "BBB@ HHHH ****
M"BBB@#Q_XO\ _)0_AC_V%3_Z-MZ]@KQ_XO\ _)0_AC_V%3_Z-MZ]@H ****
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M[\GI7L= !1110 4444 %%%% !1110 5X_P#%_P#Y*'\,?^PJ?_1MO7L%>/\
MQ?\ ^2A_#'_L*G_T;;T >P4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% $<\$5S;R6]Q$DL,JE)(Y%#*ZD8((/!!':N)_X4YX
M"QC^PO\ R<G_ /BZ[JB@".""*VMX[>WB2*&)0D<<:A510,  #@ #M4E%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&10!V=%8ND>+?#^NZ;-J&G:M:S6L"%YW+[#"HSS(K8*#Y6.6 R!GI6%/\7?
MEO/)"^OH6C8HQCMIG4D''#*A##W!(/:@#MZ*R?#_ (ETCQ3827VBW?VJVCE,
M+/Y;IAP 2,, >C#\ZP?BS?7>F_#/5[NQNI[6YC,&R:"0HZYFC!PPY&02/QH
M[2BO#OA=HNH>-O#5UJ6I>,?%,4T5ZUNJVVILJE0B-D[@3G+'OZ5)>:[XE^%'
MC2TM=8UB;5O"^H2L8YKR0R2QIE0Q)P7W1@J<#Y6!. &)V@'MM%?/WBCQ%KEO
M^T!%IL.LZA'8'4[!#:I=.(MK+#N&P'&#DY&.<FOH&@ HKY^^&OB+7+_P3\0+
MB\UG4+B:UTP/;R373NT+>7.<H2<J<J.1Z#TIOPGM=6\=G5QJGB_Q-#]B$'E_
M9M2=<[_,SG=N_N#T[T ?0=%>'^/[+Q'\-9-+\0Z3XLU:^L_/$,EKJETTP9RK
M'D<*R%00> 00"#DY7V'0]2_MG0--U3RO)^VVL5QY6[=LWJ&QG SC.,X% %^B
MN%^*OC6X\%^%TET]H/[2O)?(@\QAF,;26D"'[VW@>@++G/0\(/#?C"S^&$/B
MZ'QEK4^J)$FHBV^V,\/V? ;#!S\S!?F.<@X*[3U(![K17E<GQ(UO6?A7%K7A
MW27N=;EN/L5Q';0O*+5PI8R!=IW#;M(!R 7 );!!S;GPCXHTWX=P>(X/&?B!
M-:M;5=0N+:]N7,6%7>T1C.2& X^;()4@@!OE /9J*\JTCXGWLOP8O/%$MNEQ
MJFG.+27>NR.24L@5\*>FV1"0-N2& VC!KE-#T[Q'XA^'&N>,+GQWJRW<2S3Q
M6]I>,$C,>6=9%! 4L/NJN H*GD': #Z HK@?A%XIU7Q9X/FO-8F2:Z@O7@$J
MQA"ZA48;@.,C>1P!P!WR3WU !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%5[Z]M]-T^YO[N3R[:VB::9]I.U%!+' Y. #TH
MD$\+7#VZRH9D17>,,-RJQ(4D=0"5;![[3Z5)7R?X=^)EQ;?%V3Q9?'R[;4)3
M#=IP?+MVP%&0F3L"H> "VS'<U]84 %%%% !17F7QRU34-(\%V,^FW]U93-J2
M(TEM,T;%?*E."5(.,@<>PK9^$]]=ZC\,])N[ZZGNKF0S[YIY"[MB:0#+'DX
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M@'RQC&..!P .E>XT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0>7]E=VQL\S.=RK_ 'QZ]Z /.M/A/BWXE-H7Q,UFZ:ZL7-O:0H@AAG?>#MR
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M(7.&4#&X%3EOXL\\Y)]8KD/A_P##^R\!:;<0PW+W=W=,#<7#+L#!<[%5,D*
M&/<DDGG& .OH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB@ HHHH **** "BBB@ HHHH \?\ B_\ \E#^&/\ V%3_ .C;>O8*\?\ B_\
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M-SYN]8%(0;9'08!)/11WKB?VB/\ DG]A_P!A2/\ ]%2UO_!?_DDNA_\ ;?\
M]'R4 =[1110 4444 %%%% !1110 4444 %>/^(?^3H?"?_8*?_T&ZKV"O'_$
M/_)T/A/_ +!3_P#H-U0![!1110 4444 %%%% !1110 4450US4O[&\/ZEJOD
M^=]BM9;CRMVW?L0MC.#C.,9P: /+O$_Q:UV3QF_AKP-HB:G<6KM%=//"[#S
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MIS\IW$\!1WZ[0#T*BN%\*_$E-<\2W7AK5='FT;6H-Y\B6975PH4X5N"6()8
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M*T,D<Z;71Q@X."0>"IX)Z^N0-V@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_#&D7>A>';73;_59]5N8=^^]GSOERY89RS'@$#J>E?/O[1/_ "4"P_[!<?\
MZ-EKZ.U73H=8T>^TRX9UAO+>2WD:,@,%=2I(R",X/I7EW_#.WA'_ *".M_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** /'_B_P#\E#^&/_85/_HVWKV"O$_%WPY^)?B3Q5#J
M@\0:-Y&G7LEQI*R95K=2X9 <0X8@(GWBW3OSFY_PCWQS_P"AST/_ +\K_P#(
M] 'L%%>/_P#"/?'/_H<]#_[\K_\ (]'_  CWQS_Z'/0_^_*__(] 'L%%>/\
M_"/?'/\ Z'/0_P#ORO\ \CT?\(]\<_\ H<]#_P"_*_\ R/0![!17C_\ PCWQ
MS_Z'/0_^_*__ "/1_P (]\<_^AST/_ORO_R/0![!17C_ /PCWQS_ .AST/\
M[\K_ /(]'_"/?'/_ *'/0_\ ORO_ ,CT >P45X__ ,(]\<_^AST/_ORO_P C
MT?\ "/?'/_H<]#_[\K_\CT >P45X_P#\(]\<_P#H<]#_ ._*_P#R/1_PCWQS
M_P"AST/_ +\K_P#(] 'L%%>/_P#"/?'/_H<]#_[\K_\ (]'_  CWQS_Z'/0_
M^_*__(] 'L%%>/\ _"/?'/\ Z'/0_P#ORO\ \CT?\(]\<_\ H<]#_P"_*_\
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M#GH?_?E?_D>C_A'OCG_T.>A_]^5_^1Z /8**\?\ ^$>^.?\ T.>A_P#?E?\
MY'H_X1[XY_\ 0YZ'_P!^5_\ D>@#V"BO'_\ A'OCG_T.>A_]^5_^1Z/^$>^.
M?_0YZ'_WY7_Y'H ]@HKQ_P#X1[XY_P#0YZ'_ -^5_P#D>C_A'OCG_P!#GH?_
M 'Y7_P"1Z /8**\?_P"$>^.?_0YZ'_WY7_Y'H_X1[XY_]#GH?_?E?_D>@#V"
MBO'_ /A'OCG_ -#GH?\ WY7_ .1Z/^$>^.?_ $.>A_\ ?E?_ )'H ]@HKQ__
M (1[XY_]#GH?_?E?_D>C_A'OCG_T.>A_]^5_^1Z /8**\?\ ^$>^.?\ T.>A
M_P#?E?\ Y'H_X1[XY_\ 0YZ'_P!^5_\ D>@#V"BO'_\ A'OCG_T.>A_]^5_^
M1Z/^$>^.?_0YZ'_WY7_Y'H ]@HKQ_P#X1[XY_P#0YZ'_ -^5_P#D>C_A'OCG
M_P!#GH?_ 'Y7_P"1Z /8**\?_P"$>^.?_0YZ'_WY7_Y'H_X1[XY_]#GH?_?E
M?_D>@#V"O'_B_P#\E#^&/_85/_HVWH_X1[XY_P#0YZ'_ -^5_P#D>J;?#GXE
MZSXJ\.ZIXG\0:-?0:1>QW"K'E&"[T9P-L*@DA!U/;M0![91110 4444 %%%%
M !1110!F:CX<T+6+A;C4]%TZ]F5-BR7-JDC!<DX!8$XR3Q[FJ?\ P@WA'_H5
MM$_\%\7_ ,36_10!@?\ "#>$?^A6T3_P7Q?_ !-6++PKX=TV[CN[#0-+M;F/
M.R:"SC1UR"#A@,C()'XUKT4 %%%% !1110 4444 %%%% !1110 4444 8OBS
M2]1UKPO?:?I.HOIU_*JF"Y1V4JRL&QE>0#C:2.@)X/0^9VZ_%)?A_>>&KSPN
M;ZXN(I8!J%QJD3/Y<F<A@7)9@&8 [@!\O!QS[-10!R?P[\&_\(/X6737N?M%
MS+*;BX=?N"0JH(3OM 4#)Y/)XS@=9110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
>1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>gguopuizh44n000003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gguopuizh44n000003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +@ ^0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M\?\ ^&CO!_\ T#=<_P"_$/\ \=KV"N#\9^#/"MKX%\0W%OX9T:&>+3+EXY([
M")61A$Q!!"Y!![T <W_PT=X/_P"@;KG_ 'XA_P#CM>D>%O$EGXN\.6FN6$<\
M=K=;]B3J XVNR'(!(ZJ>]>2? /PUH.L^!;ZXU31--OIUU.1%DNK5)6"^5$<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/_I6]6+G]F_[6#-/XPN);Z25Y)[B6SW^9G!'!DSNSN)))SD<#!)Z#QG\%O\
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M)KR.\GOM3GB,,EPXV($W;L*@SC.%SDM]WC&2*[^@#Q_QM_PN7_A+[[_A%/\
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M<JS[F'/0CITKH'_9O\N6Z6Q\87%O:SY4Q&SW%H]P8*Y$BAL%5/0#*@X%=_\
M#OX9:5\/K.4PR?;=3GR)KYX]I*9R$5<G:O0GDY/)Z   \OO+*WO_ -K98;J/
MS(UECF W$8>.S5T/'HRJ?PYXJQ^TUT\+_P#;W_[1KO\ _A67_%WO^$]_M?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#G_$W@GP[XQ^R_P!OZ?\
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M32X+N&"*X:W9;I%5BP56R-K,,8<=_6@#I**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!Y__P W"_\ <J?^W=>@5Y__ ,W"
M_P#<J?\ MW7H% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >?_ /-PO_<J?^W=
M>@5Y_P#\W"_]RI_[=UZ!0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'G__ #<+
M_P!RI_[=UZ!7G_\ S<+_ -RI_P"W=>@4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!Y_\ \W"_]RI_[=UZ!7G_ /S<+_W*G_MW7H% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 >?_\ -PO_ '*G_MW7H%>?_P#-PO\ W*G_ +=UZ!0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% 'G_P#S<+_W*G_MW7H%>?\ _-PO_<J?^W=>@4 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!Y__P W"_\ <J?^W=>@5Y__ ,W"_P#<
MJ?\ MW7H% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 >?_ /-PO_<J?^W=>@5Y
M_P#\W"_]RI_[=UZ!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH \__ .;A?^Y4_P#;NO0*\_\
M^;A?^Y4_]NZ] H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBL_7=3_L3P]J>K>3YWV&TEN?*W;=^Q"VW.
M#C.,9P: -"BL_0M3_MOP]IFK>3Y/VZTBN?*W;MF] VW.!G&<9P*T* "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'G_ /S<+_W*G_MW7H%>?_\ -PO_ '*G_MW7H% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S_ ([_
M .2>>)O^P5=?^BFKH*R_$NFS:SX5U?2[=HUGO;*:WC:0D*&="H)P"<9/H: /
M!-"^)/Q3L?#VF6>G>"OM%C!:116\W]E73^9&J *VY6P<@ Y'!K0_X6G\7_\
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M@'_"T_B__P!"%_Y1[O\ ^+H_X6G\7_\ H0O_ "CW?_Q=>_T4 > ?\+3^+_\
MT(7_ )1[O_XNC_A:?Q?_ .A"_P#*/=__ !=>_P!% '@'_"T_B_\ ]"%_Y1[O
M_P"+H_X6G\7_ /H0O_*/=_\ Q=>_T4 > ?\ "T_B_P#]"%_Y1[O_ .+H_P"%
MI_%__H0O_*/=_P#Q=>_T4 > ?\+3^+__ $(7_E'N_P#XNC_A:?Q?_P"A"_\
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M$+_RCW?_ ,77O]% '@'_  M/XO\ _0A?^4>[_P#BZ/\ A:?Q?_Z$+_RCW?\
M\77O]% '@'_"T_B__P!"%_Y1[O\ ^+H_X6G\7_\ H0O_ "CW?_Q=>_T4 > ?
M\+3^+_\ T(7_ )1[O_XNC_A:?Q?_ .A"_P#*/=__ !=>_P!% '@'_"T_B_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%>8>,?&=SX?^*NCZ/J\D$?A'5-/:*Y^UP Q&4F0'Y\?]<E8$E0KY(&<UZ?7E
M_P 1_@__ ,+ \0V^K?V[]@\FT6V\K[)YN<.[;L[U_OXQCM0!U-EX3\"ZE:)>
M6'A_PY=6TF=DT%G Z-@X.& P<$$?A73UX!_PS+_U-W_E-_\ MM=_\,OAE_PK
MG^U/^)O_ &A]O\K_ )=O*V;-_P#MMG._VZ4 >@4444 %%%% !1110!Y__P W
M"_\ <J?^W=>@5Y__ ,W"_P#<J?\ MW7H% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !116?K.N:7X>TY[_5[^"RM
M5R-\SXW$ G:HZLV <*,DXX% %R>"&ZMY;>XBCF@E0I)'(H974C!!!X(([5X)
MK?[-?^OET'Q!_=\FWOX?INW2I^)&$]![UO\ _#1/A;_A(?L7V.^_LS[G]H;1
M][?C/E_>\O;\V?O=ME>N03PW5O%<6\L<T$J!XY(V#*ZD9!!'!!'>@#A_AS\+
MM-^'J7$T5W)?ZA<H$EN9(E0*H8G"#DJ#E=P+')4'CI7>444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFN-9P6UM?W<8C2W 6-'7S'9$7.551*F/8]\&@#V^BBB@ HHHH **** //_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!'//#:V\MQ<2I#!$A>221@JHH&223P
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M[?AY_P!##_Y)7'_QNC_A=OP\_P"AA_\ )*X_^-UZ!10!Y_\ \+M^'G_0P_\
MDE<?_&Z/^%V_#S_H8?\ R2N/_C=>@5Y_XM_Y*]\.O^XE_P"B%H /^%V_#S_H
M8?\ R2N/_C='_"[?AY_T,/\ Y)7'_P ;KT"B@#S_ /X7;\//^AA_\DKC_P"-
MT?\ "[?AY_T,/_DE<?\ QNO0** //_\ A=OP\_Z&'_R2N/\ XW1_PNWX>?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?WK28MP4P2 "NQ\DG'RG!.1GJ/V?WOM4N/&'B2ZA1$U.]1LQGY?-S([J!DD
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** .;\:Z9X4U71H8/&$EHFGK<*\9NKL
MVZ^;M8##!ER=I;C/KZ5Q^I?#?X/:-<+;ZI#IMC.R;UCNM7DB8KDC(#2@XR#S
M[&NP\:^"M-\=Z-#I>J3W<,$5PMPK6KJK%@K+@[E88PY[>E8_C7X3:#X[UF'5
M-4N]2AGBMUMU6UD15*AF;)W(QSESW]* .;_X0WX&?\_6A_\ @^;_ ./5V'@7
M1O VD?;_ /A"Y;&3S?+^U_9+\W.,;MF<NVWJ_IGGTKC_ /AG'P?_ -!+7/\
MO_#_ /&JT/@_IW@:P_MG_A"]9OM2W^1]K^UH5\O'F;,9C3KE_7H.G< ]0HHH
MH **** "BBB@#S__ )N%_P"Y4_\ ;NO0*\__ .;A?^Y4_P#;NO0* "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O'
M_P!H'Q1>:%X>TBSTV^OK*^N[MI1-:2F/]W&A#*64@\F1#CIP?05[!7F?QE^'
ME]X[T:QETEXSJ&G/(R12R;%E1E&Y1P?G+(@&2!R<GT /E3[?>?VC_:/VN?[=
MYOG_ &GS#YGF9W;]W7=GG/7-?0GA7Q!-XEU;X27MW<1SWD::I;W#*Y9MR0A0
M7R2=Y4*QSUW9Z$5Y?!\&O'DVLQ:8^A20.Z"1IY)4,"(6VY,BDC(Z[1EL<A37
MK]AX4A\&>+OA7HR",SQIJ3W4B8_>3-;J7.< D9^4$C.U5!Z4 >R4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:23:JESG@$A1P !Z 5H:3IL.C:-8Z7;M(T%E;QV\;2$%BJ*%!. !G ]!5R@
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M/_J0O'/_ ()__LZ/^%I_]2%XY_\ !/\ _9UZ!10!Y_\ \+3_ .I"\<_^"?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUM8M0AA3<3M1;90HR>3@ =:](KS_ ,6_\E>^'7_<2_\ 1"T >@4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!Y__P W"_\ <J?^W=>@5Y__ ,W"_P#<J?\ MW7H% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y_X
MM_Y*]\.O^XE_Z(6O0*\_\6_\E>^'7_<2_P#1"T >@4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y__
M ,W"_P#<J?\ MW7H%>?_ /-PO_<J?^W=>@4 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7G_BW_ )*]\.O^
MXE_Z(6O0*\_\6_\ )7OAU_W$O_1"T >@4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y_\ \W"_]RI_
M[=UZ!7G_ /S<+_W*G_MW7H% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5Y_P"+?^2O?#K_ +B7_HA:] KS
M_P 6_P#)7OAU_P!Q+_T0M 'H%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M512Q R0,X'J* .+_ .%I_P#4A>.?_!/_ /9T?\+3_P"I"\<_^"?_ .SKG_\
MAH[P?_T#=<_[\0__ !VMCPM\:_#?B[Q'::'866JQW5UOV//%&$&U&<Y(D)Z*
M>U %C_A:?_4A>.?_  3_ /V=5YOC%9V]Y;6<W@WQE'=76[[/"^F /+M&6VJ7
MRV!R<=*Z3QKXUTWP)HT.J:I!=S02W"VZK:HK,&*LV3N91C"'OZ5XYKGQK\-Z
MGX[\*:Y#9:JMKI'VS[0CQ1AV\V((NT"3!P1SDC\: /1_^%I_]2%XY_\ !/\
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M_P"A>_\ )VW_ /CE?7]% 'G<'B;Q[:V\5O;_  JCA@B0)'''KMNJHH&   N
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** //\ _FX7_N5/_;NO0*\__P";A?\
MN5/_ &[KT"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<TO[):R2B%7^T7<F7() PC$]%/Y5YQJW_"FO^$O\.?V;_P @3_2?[5_X_/\
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M?]"]_P"3MQ_\<KT"B@#S_P#X4E\//^A>_P#)VX_^.4?\*2^'G_0O?^3MQ_\
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MCM85B4M@#)"@#. .?85<HH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ).W'_QR@#T"BO/_ /A27P\_Z%[_ ,G;C_XY1_PI+X>?]"]_Y.W'_P <H ]
MHKS_ /X4E\//^A>_\G;C_P".4?\ "DOAY_T+W_D[<?\ QR@#T"BO/_\ A27P
M\_Z%[_R=N/\ XY1_PI+X>?\ 0O?^3MQ_\<H ] HKS_\ X4E\//\ H7O_ "=N
M/_CE'_"DOAY_T+W_ ).W'_QR@#T"BO/_ /A27P\_Z%[_ ,G;C_XY1_PI+X>?
M]"]_Y.W'_P <H ] HKS_ /X4E\//^A>_\G;C_P".4?\ "DOAY_T+W_D[<?\
MQR@#T"BO/_\ A27P\_Z%[_R=N/\ XY1_PI+X>?\ 0O?^3MQ_\<H ] HKS_\
MX4E\//\ H7O_ "=N/_CE'_"DOAY_T+W_ ).W'_QR@#T"BO/_ /A27P\_Z%[_
M ,G;C_XY1_PI+X>?]"]_Y.W'_P <H ] HKS_ /X4E\//^A>_\G;C_P".4?\
M"DOAY_T+W_D[<?\ QR@#T"BO/_\ A27P\_Z%[_R=N/\ XY1_PI+X>?\ 0O?^
M3MQ_\<H ] HKS_\ X4E\//\ H7O_ "=N/_CE'_"DOAY_T+W_ ).W'_QR@#T"
MBO/_ /A27P\_Z%[_ ,G;C_XY1_PI+X>?]"]_Y.W'_P <H ] HKS_ /X4E\//
M^A>_\G;C_P".4?\ "DOAY_T+W_D[<?\ QR@#T"BO/_\ A27P\_Z%[_R=N/\
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M^A>_\G;C_P".4 >@45Y__P *2^'G_0O?^3MQ_P#'*/\ A27P\_Z%[_R=N/\
MXY0!Z!17G_\ PI+X>?\ 0O?^3MQ_\<H_X4E\//\ H7O_ "=N/_CE 'H%%>?_
M /"DOAY_T+W_ ).W'_QRC_A27P\_Z%[_ ,G;C_XY0!Z!17G_ /PI+X>?]"]_
MY.W'_P <H_X4E\//^A>_\G;C_P".4 >@45Y__P *2^'G_0O?^3MQ_P#'*/\
MA27P\_Z%[_R=N/\ XY0!Z!17G_\ PI+X>?\ 0O?^3MQ_\<H_X4E\//\ H7O_
M "=N/_CE 'H%%>?_ /"DOAY_T+W_ ).W'_QRC_A27P\_Z%[_ ,G;C_XY0!Z!
M17G_ /PI+X>?]"]_Y.W'_P <H_X4E\//^A>_\G;C_P".4 >@45Y__P *2^'G
M_0O?^3MQ_P#'*/\ A27P\_Z%[_R=N/\ XY0!Z!17G_\ PI+X>?\ 0O?^3MQ_
M\<H_X4E\//\ H7O_ "=N/_CE 'H%%>?_ /"DOAY_T+W_ ).W'_QRC_A27P\_
MZ%[_ ,G;C_XY0!Z!17G_ /PI+X>?]"]_Y.W'_P <KN+"QM],TZVL+./R[6UB
M6&%-Q.U% "C)Y. !UH L4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !5/4=)TW6+=;?5-/M;Z!7WK'=0K*H;!&<,",X)Y]S5RB@"GIVDZ;H]NUOI
M>GVMC S[VCM85B4M@#.% &< <^PHL])TW3[BZN++3[2VGNWWW,D,*HTS9)RY
M RQRQY/J?6KE% &7J7AO0M8N%N-4T73KZ=4V+)=6J2L%R3@%@3C)/'N:T(((
M;6WCM[>)(8(D"1QQJ%5% P  .  .U244 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>FV G\%:K96MB0)8HK>8^=.P/[S81G: I X.W<06.X5]/T44 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %>/_&FUUC_A(?!.K:3HE]JO]F7<ES)%:0N_W7A8*2JG;G:1DCL>
MN*]@HH \(\0_$'XB>)M/DT73OAQ?6*7\4EI,]W#,_$@V ABL:IC)Y;(Z9P <
M]AX%^'=QHGPFO/#5]-Y%_JL4YNB")%@>5-@ QC.U0N1D\[L'&*]'HH ^<?"6
MN?$SX;:==>'G\%7VHPIO>W98I95AD<*1AX]R-&#DE%P=S-\P.:ZCX0^&_%$O
MC+6_&_B>UGLIM0B:.*&92&;=("<*S%T5!&JJ&'*D8.!S[-10!Y7H6DZE#^T;
MXGU273[M-/FTQ$BNVA81.VVWX5\8)^5N >Q]*P?B%X1U?PK\1],\>^%-,N[\
MRW&Z]L[2 ,0VW#8"@D"12^6VG#9.<L /<J* .(\=WGBVY\!0ZIX,6>UU(>7<
MR6TT"F<PE"6CV,&'F E25Z_*0,G /DFLZE\4?B/I>F^%+OPU=6*.Z?:KV:VE
M@29EW?-(2 JIC:Q4 Y905ZA1])44 >$_&.V\20Z'HW@?PYHFJWFDVUK"TMW!
M#)*9-F42-MB[>-H<@]25( QRGPWUO4/"TMIHEA\+-<LX;V[C2ZU&Z:1G 9L;
MW/D*-J G X Y[DD^[T4 ?//D^-/AO\6=?U:S\*3ZW8ZI++-NM;=GS'(Y=0)5
M0E&!X92,''0_*PV/@_H7BBX\?:]XR\0:5_9BWD3PF%[<VY:1G1R5C(SM 7EC
MR2>K'<1[=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOK:O'_ /@GQ%HGQD\4:_J&G^3IE]]K^SS^=&V_?<*Z_*K%AE03R!0!Y[X_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>gguopuizh44n000004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gguopuizh44n000004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ,Y!* # 2(  A$! Q$!_\0
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MI79T4 <9_P (@OI1_P (@OI79T4 <9_PB"^E'_"(+Z5V=% '&?\ "(+Z4?\
M"(+Z5V=% '&?\(@OI1_PB"^E=G10!QG_  B"^E'_  B"^E=G10!QG_"(+Z4?
M\(@OI79T4 <9_P (@OI1_P (@OI79T4 <9_PB"^E'_"(+Z5V=% '&?\ "(+Z
M4?\ "(+Z5V=% '&?\(@OI1_PB"^E=G10!QG_  B"^E'_  B"^E=G10!QG_"(
M+Z4?\(@OI79T4 <9_P (@OI1_P (@OI79T4 <9_PB"^E'_"(+Z5V=% '&?\
M"(+Z4?\ "(+Z5V=% '&?\(@OI1_PB"^E=G10!QG_  B"^E'_  B"^E=G10!Q
MG_"(+Z4?\(@OI79T4 <9_P (@OI1_P (@OI79T4 <9_PB"^E'_"(+Z5V=% '
M&?\ "(+Z4?\ "(+Z5V=% '&?\(@OI1_PB"^E=G10!QG_  B"^E'_  B"^E=G
M10!QG_"(+Z4?\(@OI79T4 <9_P (@OI1_P (@OI79T4 <9_PB"^E'_"(+Z5V
M=% '&?\ "(+Z4?\ "(+Z5V=% '&?\(@OI1_PB"^E=G10!QG_  B"^E'_  B"
M^E=G10!QG_"(+Z4?\(@OI79T4 <9_P (@OI1_P (@OI79T4 <9_PB"^E'_"(
M+Z5V=% '&?\ "(+Z4?\ "(+Z5V=% '&?\(@OI1_PB"^E=G10!QG_  B"^E'_
M  B"^E=G10!QG_"(+Z4?\(@OI79T4 <9_P (@OI1_P (@OI79T4 <9_PB"^E
M'_"(+Z5V=% '&?\ "(+Z4?\ "(+Z5V=% '&?\(@OI1_PB"^E=G10!QG_  B"
M^E'_  B"^E=G10!QG_"(+Z4?\(@OI79T4 <9_P (@OI1_P (@OI79T4 <9_P
MB"^E'_"(+Z5V=% '&?\ "(+Z4?\ "(+Z5V=% '&?\(@OI1_PB"^E=G10!QG_
M  B"^E'_  B"^E=G10!QG_"(+Z4?\(@OI79T4 <9_P (@OI1_P (@OI79T4
M<9_PB"^E'_"(+Z5V=% '&?\ "(+Z4?\ "(+Z5V=% '&?\(@OI1_PB"^E=G10
M!QG_  B"^E'_  B"^E=G10!QG_"(+Z4?\(@OI79T4 <9_P (@OI1_P (@OI7
M9T4 <9_PB"^E'_"(+Z5V=% '&?\ "(+Z4?\ "(+Z5V=% '&?\(@OI1_PB"^E
M=G10!QG_  B"^E'_  B"^E=G10!QG_"(+Z4?\(@OI79T4 <9_P (@OI1_P (
M@OI79T4 <9_PB"^E'_"(+Z5V=% '&?\ "(+Z4?\ "(+Z5V=% '&?\(@OI1_P
MB"UV=% '"7?A86T#2@<KS6AX1N6D#QM_#Q6[JW_(/D^E<[X/_P"/B;ZF@"#P
ME7;#I7$^$J[8=* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBDS0 M%%% !1
M110 4444 %%%% !1110 4444 %%%% !1129H 6BBB@ HHI,\XH 6BBDS0 M%
M%% !1110 4444 %%)FC- "T4F:6@ HHHH **** "BBB@ HHHH **3-&: %HI
M,TM !1110 4444 %%%% !1110 4444 %%%% !1110 44F:6@ HHHH **** "
MBDS1F@!:**3- "T44E "T444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M 4-6_P"0=)]*Y[P?_P ?$WU-=#JW_(.D^E<]X/\ ^/B;ZF@"#PE7;#I7$^$J
M[8=* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *2EJEJ.HPZ99O<SL BC.328%RBO%M
M4^(^O:EJ#Q>'[?SHU/45L^%?%OB&:]6'6+8Q@]\4T#T/4*6F1R"1%8=#2F1!
MU8#\: '44W<",@@TN10 M%-W*!G<,4H8$9!% "T4FX9QD9H)P* %HI,YZ$4F
MX>HH =13#(H/+#\Z7=QG(H =13!(IZ,#^-.H **;(VV-F]!7A_B?XJ:W9Z\^
MFZ=!YC!L"EU"Q[E1VKP63QWX[M8A<3V#"$<DX[?E7>>!/'T?B:$PS$+< 8(J
MK".REU6QAE$4ES&KG@*3S5L,K)N!!'K7B7C'PGXCOO&D5U:2.+4."<$^M>O:
M?')!HJQRG]XL>#^5+I<;)3JECYWDFYC\S^[GFEGU*SM0#/<(@/3)KY^N+N\'
MQ&*>>^SS.%S[UU'Q!\.Z[K-M:MILC  #.":.@/<]?BFCG0/$X=3T(J2N<\%V
M5W8:!##>DF8+@Y-=%D X)%,$.HII=1_$/SH#J>C T@'44F:-P/0B@"I/J5G;
M2".:X1&/0$U9CD21-R,&![BO _B9<W<?BZ 13LB;N@->P>%7_P")' 7D#,5'
M4T+8;-ZJUSJ%I9X%Q.D>>FXU8# C(.?I7E'Q4\.ZYK$\!TQV50V3@D4A(]5A
MGCGC$D3AT/0BG]ZYKP/87FG>'H8+YB9E'.3729'<TP0ZBF%U'5@/QI00>A!H
M 6EI*RM;UZTT2S>>XD"X&0*0&K17AMS\2/$VJWCC1+4RQ \$"M[PUXK\3-=J
MFLVQC0]\55@9Z;<W4%JFZ>58U]2:(+NWN5S!*L@]0:\V^*][))X>62UD*Y[@
MT?"26631P9Y]Q]S2Z#:T/4**:&4]&!_&G9Q0(6BF>8F>7'YTH<-T(/XT .HI
M,@=32%U'5@* '44T.IZ,#2T +13#(H/WQ^=&]?[P_.@!]%)FF^8F?O#\Z 'T
ME ((R#D44 (S!5)8X [U4CU2RED\I+A"_IGFDU?(TN<@X.TUX%X6N;M_'DJ/
M<L4\SH30AV/HK((ZT5%$Z>4OSJ3CUJ7(QGM0(6BDW ]"**0"T4FX'H1574I)
MHK&1[<9D ^44P+5%>):MXN\=65Q*RV1,*G@X_P#K5SL'Q?\ %5U>?8XK7,V<
M8Q_]:A*^@['T>S!5+,< =35.'5+&:8Q1W,;./X0:\ET_7?'&HPRQ7=FR!EP#
MS_A53P1X5\2V?BR2]OI'\ACT)- GL>XT4@X49HW#^\* Z#J*:'4]&!H+!>K
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M6\6(DOQ#0.N1YG>G+1@C5U?_ (3:6'^UK:=EM<;BOM4N@?$'4]<A_LN,M]K
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M9Q+-G&<YKV1&WHKCHPS7E&@?!J#1]52_>[,L@.>37J\:[(U0=ABJ=B2KJO\
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MKMATH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ K'UW37O;)S 2)@/EK8I* /$+BT^(
MUO-)':%_*S@=:L>'/AWJFH:HM_XAW-(#G!KV? ]**$#.0\2^!K+6-'^RJF&4
M87BO,K?P]X_T"1X-+9_LP/RCFO?*,>U 'E'AP^/?MR_VEO\ *SSG-=AXQT>Y
MUGP\UK#_ *TK73X'I1BANX(\Q^''@W4?#I?[6",GO7I4\0G@>-NC#!J2BAZH
M#P_Q)\/=<LM9;4-"#!V;/%/'A/Q7X@TR2WUHMNQA<YKVTT?A0,\\^''A"[\,
M1RQS@X;I7.Z]\/M6OO&*ZC$#Y(?->RT4/5B,.[TV:7PV;,?ZPIBO/? _@/5=
M$\2RWMR#Y;'(S7KU%.^MPZ6. ^(7A>]U^)5M03CTJUX \.WF@V/E76<UVN**
M2T!ZC)5WQ,HZD5X)XH^'GB5_$CZCI8;[V1C->_TF/:EU&F>#?8/B5)!]E?>(
MR,'KTKK/!7PY_L^3[=J:[KIN3GUKTW ]**JY/D>0>-? 6J:QXAAN;4'R48'I
M7I&BV,MEHZV\GWPF/TK7[T4N@V>,3?#W5I/&O]I 'R=^<_C6SX_\&ZCKUC!'
M; ED !Q7IU+1TL.^MSE/!&B7.BZ2D%SPP&*XSQUX#U36_$D5Y:@^6K9->O44
M"1D:!8266CQVTWW@N#7F7C7X?:G)JS:EHRXF+9XKV2DHZW!;'B5EX<\9:O:O
M::P6\K;@9S6W\/? EYX:U*268'822*]2P*6A:(.ECR;QW\/[WQ'K4<T8/E \
MUDW_ (>\:Z9$EEI!<08P<9KVZCCTHZ6"^IY9X'^']S9W?]HZL,W).>?6KOQ+
M\)WWB.*%+('Y#SBO1J*.EAIZW.3\"Z%<Z'I"07/W@,5Q_COP+JFN>((KNU!V
M*P)KUVDQ0]03L8NBZ?+9:&MM)_K F/TKRN+X<ZNOC[^U2I\C?GI7M]%#U=Q=
M+$4"&.W13U Q6!XI\(6/B:T:.X0%\<'%=)24 CP4>#_&7ABZ:/0B_D$\=:Z/
MP[IGB^\NP=:+"///6O5\>U&!3N!P7CSPG=:OHJVMB#N'6G?#KPS>^'M/\J[!
MW>]=W126@/5'D?Q*\"ZIXCU>"XLP2J'G%=._A-[CP:NGRC]^$Q7:T4!?4\!L
M?#/CSP_+-!INX0,>V>E16WPQ\0WNLKJ6H;C)NR<YKZ#Q[48%.^MP9Y=XN\%Z
MEJVAP6MN#O3&?TKH_ >@W6A:2D%T/G KKL447#I8\;\=> -5USQ7!?6H/EJP
M)(_"I_&TZV'AR/3VXN FW/OBO7*Y;QAX0B\1V3HAV38X:I'U/'] B\6Q6!:T
M:,Q=>:U- ^(&NZ?KBV>J$&/.,"K$?PM\46R>7!JI6/TR*U_#'PLN++4?M6JS
M^>0<\U2$;?BWPC:^,=,6[B3]_C*\=ZX"UT?XC:,/L]DSF%>%ZU[O#"D$0CC&
M%'05)@>@I >9>%3XV^V+_:Q?R\\YS7IJYVC/7'-&!Z447 K7\+3V4L2_>9<5
MXNGPOU)=<GU  AMQ*5[C10M!WZ'@U[X=\>:G/]CN"_V/.._2O3O!?A.+PW8!
M=O[TCYC75\>E%,1Q7Q*T^VO?#<HGP#@X->%_#?PJ]SXL+%=T*-Q^=?0OC#P]
M+XATW[-%)LS5#P9X)7PW$2[!I#WI1T&]4=;:P+;6Z1)P%%3>U%+0(H:M;/=Z
M=+"GWF&!7DFB?#O5[+Q>=0D!\G?FO:J*%H[CN5;V%IM/EB7[S(0*\AT7X>ZM
M9^,)-0D!\DMFO:**.MQ=+&'XBTZ;4/#\EI"/WC)@?E7 _#[P-J>@:I+/= [6
M8GFO6:6CK<.ECSSXD^%+[Q)9+%9@Y'I6CX$T"ZT/P^;2YXDQCFNQQ11?0#QO
M5_A_JMWXG%X@)BWYK=\3_#N/5M)C>-,7D8X('>O1Z*+Z ]3P6UTSXDZ7']GM
M6<Q+PO7I79^$?^$S^U#^V-WE]\YKT? STH_"G< &<#-+112 **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH H:M_R#I/I7/>#_\ CXF^IKH=6_Y!TGTKGO!__'Q-]30!!X2KMATK
MB?"5=L.E "T444 %%%% !1110 4444 %%%)0 M%)2T %%)52;5+*W;;+<QH?
M=J +E%0074%TNZ"59!_LG-3"@!:**0G R3@4 +17,>(/&5GH2Y;YR.P-<DWQ
MDL@W_'LVV@#U2BN7\/\ C2RUR,,IV$^M=.K!AE2"* %HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ I,4M% "8HQ2T4 %%%% !1110 E+110 4444 )12T4 )1BEHH **** "BB
MB@ HHHH **** $Q2T44 )BC%+10 4E+10 4E+10 E%+10 F*,4M% "8HI:*
M"DI:* $HQ2T4 )BC%+10 F**6B@!,4M%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWT*/-C_YZ)_WT*\1QK7K>?\ ?1_QHQK7K>?]]'_&@#V[S8_^>B?]]"CS8_\
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MUTDD^67QF@#0VGD]<U'Y-MNW.N6KT:^\#Q+IXDMR3)C)K@+S3Y()6CD!4@T
M;FD7FFVR#S;8-ZG%==82>&[U>88U)]<5Y6EO?<NBDQ+UI8-5CW^6"R..M 'M
M46A:+,,QP1M],5+_ ,(UI7_/HGY5YEI_B*\L=I23>OIFNMTSQM')@7/RT ;_
M /PC6D_\^J?E1_PC6D_\^J?E5BSU:UO1F*1?SJ\"#T(- &3_ ,(UI/\ SZI^
M5'_"-:3_ ,^J?E6O10!D?\(UI/\ SZI^5'_"-:3_ ,^J?E6O10!D?\(UI/\
MSZI^5'_"-:3_ ,^J?E6O10!D?\(UI/\ SZI^5'_"-:3_ ,^J?E6O10!D?\(U
MI/\ SZI^5'_"-:3_ ,^J?E6O10!D?\(UI/\ SZI^5'_"-:3_ ,^J?E6O10!D
M?\(UI/\ SZI^5'_"-:3_ ,^J?E6O10!D?\(UI/\ SZI^5'_"-:3_ ,^J?E6O
M10!D?\(UI/\ SZI^5'_"-:3_ ,^J?E6O10!D?\(UI/\ SZI^5'_"-:3_ ,^J
M?E6O10!D?\(UI/\ SZI^5'_"-:3_ ,^J?E6O10!D?\(UI/\ SZI^5'_"-:3_
M ,^J?E6O10!D?\(UI/\ SZI^5'_"-:3_ ,^J?E6O10!D?\(UI/\ SZI^5'_"
M-:3_ ,^J?E6O10!D?\(UI/\ SZI^5'_"-:3_ ,^J?E6O10!D?\(UI/\ SZI^
M5'_"-:3_ ,^J?E6O10!D?\(UI/\ SZI^5'_"-:3_ ,^J?E6O10!D?\(UI/\
MSZI^5'_"-:3_ ,^J?E6O10!D?\(UI/\ SZI^5'_"-:3_ ,^J?E6O10!D?\(U
MI/\ SZI^5'_"-:3_ ,^J?E6O10!D?\(UI/\ SZI^5'_"-:3_ ,^J?E6O10!D
M?\(UI/\ SZI^5'_"-:3_ ,^J?E6O10!D?\(UI/\ SZI^5'_"-:3_ ,^J?E6O
M10!D?\(UI/\ SZI^5'_"-:3_ ,^J?E6O10!D?\(UI/\ SZI^5'_"-:3_ ,^J
M?E6O10!D?\(UI/\ SZI^5'_"-:3_ ,^J?E6O10!D?\(UI/\ SZI^5'_"-:3_
M ,^J?E6O10!D?\(UI/\ SZI^5'_"-:3_ ,^J?E6O10!D?\(UI/\ SZI^5'_"
M-:3_ ,^J?E6O10!D?\(UI/\ SZI^5'_"-:3_ ,^J?E6O10!D?\(UI/\ SZI^
M5'_"-:3_ ,^J?E6O10!D?\(UI/\ SZI^5'_"-:3_ ,^J?E6O10!D?\(UI/\
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MK0D-GTGX>U^TU^S^T6:@1X]*V:X/X;/:QZ3Y%H!L48R*[P4V(6BBBD 4444
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M%Y_QZ2?[IKYYD_Y*:G_73^M?0UY_QZ2?[IKYYD_Y*:G_ %T_K0!]$0?ZB/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9SN]A2:!XEMM?@\V $#T- &Y13)9%BC+L<*!DUP6M_%33-'NC"T+R$<94$T
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M[_D/3_6NU^'G_(!/^^: .OHHHH **** *&K?\@Z3Z5SW@_\ X^)OJ:Z'5O\
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M4T_4,VTQ.#V->B:)XIM9[=1<RA&QWK!D^'2PQ[HV+/7+ZII%S9LT3[D /44
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M?\_:?G7'?\*W_P"GAOSH_P"%;_\ 3PWYT =C_P ))I7_ #]I^='_  DFE?\
M/VGYUQW_  K?_IX;\Z/^%;_]/#?G0!V/_"2:5_S]I^='_"2:5_S]I^=<=_PK
M?_IX;\Z/^%;_ /3PWYT =C_PDFE?\_:?G1_PDFE?\_:?G7'?\*W_ .GAOSH_
MX5O_ -/#?G0!V/\ PDFE?\_:?G1_PDFE?\_:?G7'?\*W_P"GAOSH_P"%;_\
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M^I-=32T4 %%%% !1110 4444 %(>AI:0]#0!XYXN_P"0]/\ 6NU^'G_(!/\
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M^+G)_P!=/ZU]#7G_ !Z2?[IKYYD_Y*:G_73^M 'T3!_J(_\ =%25%!_J(_\
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MW4=#FFT_7WLX?-;]T$!_F* /8-.\-:-I,WFV&G0P2'C<F:\QO/\ DNEKR?\
M5'O_ +M>C^'-)U32XY%U+5&OV8_*2H&/R%><7G_)<[7_ *Y'_P!EH ]DKQ+5
M=/M-3^-26]] )X?+^XQ..M>V]J\;G_Y+DG_7/^HH ZS7_AIH5]8$Z?;+8WD8
M+130D@@UF_#'Q+>W$EWX?U:4RWUDV/,)^\.E>CR8$3$_W37C7@8&X^+6MS0+
M^Z7@D'C.30![/TKG=3\':9K6IK>:@'N @P(6/R5T1J"YN8;.W>XN'6.)!EF)
MZ4 >0?%+PW8>&K>RUO1(A8W,,H7$1QN!_P#U5Z78SW^H^%(9H&6.\EA&&<<
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M%% !1110!!>?\>DG^Z:^>9/^2FI_UT_K7T->?\>DG^Z:^>9/^2FI_P!=/ZT
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M4IZ&EI#T- 'CGB[_ )#T_P!:[7X>?\@$_P"^:XKQ=_R'I_K7:_#S_D G_?-
M'7T444 %%%% %#5O^0=)]*Y[P?\ \?$WU-=#JW_(.D^E<]X/_P"/B;ZF@"#P
MEVKMATKB?"5=MVH *CEF2")I)&"J.234E>>?$V_O$L/LEG)M>08H&C:;X@Z
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MI]U<;[6$X1,=*K^+?%'B/3_B%9:7I&R5)T.8GX'4<T >J8SP:8[QQ@;Y%7/
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MNGY4 <?_ ,+*;_GT?\C1_P +*;_GT?\ (UV'_".:;_S[I^5'_".:;_S[I^5
M''_\+*;_ )]'_(T?\+*;_GT?\C78?\(YIO\ S[I^5'_".:;_ ,^Z?E0!Q_\
MPLIO^?1_R-'_  LIO^?1_P C78?\(YIO_/NGY4?\(YIO_/NGY4 <?_PLIO\
MGT?\C1_PLIO^?1_R-=A_PCFF_P#/NGY4?\(YIO\ S[I^5 ''_P#"RF_Y]'_(
MT?\ "RF_Y]'_ "-=A_PCFF_\^Z?E1_PCFF_\^Z?E0!Q__"RF_P"?1_R-'_"R
MF_Y]'_(UV'_".:;_ ,^Z?E1_PCFF_P#/NGY4 <?_ ,+*;_GT?\C1_P +*;_G
MT?\ (UV'_".:;_S[I^5'_".:;_S[I^5 ''_\+*;/_'F^/H:#\1PPPUFQ!_V:
M[#_A'--_Y]T_*C_A'--_Y]T_*@#SF^U_1]3#?:-*RY[[?_K5Y_XCT*TU-&%E
M8M&W;"U]#?\ ".:;_P ^Z?E2CP_IXZ0+^5 'R ?#NOZ4Q>WCE&#Q@&M&P\6^
M+M)F5W,_EKU!!KZO/A_3C]ZW0_453N_!VCW<95K6,9[XH \:TKX\O;1K'>1,
MS#KD5T5K\=]+FP&3:35O5/@AH]\[21G8Q]*\[\2?!6^L"3IX,@'3% 'J$7Q:
MLKA088]V?2K ^(KN,BS8CZ&OGN/2?$?AAR\UHY1?:NBT7XHFVD6&]L<+T.5H
M ]:F\<V\^?-T]B?]VL+4-?AN,^38LN?]FM31?''A"^C47 B5V[&NQLH?#VHH
M&M1"P/I0!X]]KN_-+);N/PJY')=RK\\3 ?2O9!H&G$<0I^ I6T&R*;1$H_"@
M#Q_S$"[63!JFTYB?*$CTKUFX\&64Y)^[6)?^ U0$P_-Z4 <C::[?0@%)2,=J
MZ73_ !O+  )LL:Q+GPS?VQ)$1(%9DMO-"V)$(/TH [B;XE00]8B:K_\ "THF
M.%MV/X5Q;1PLN77-+ (HFR(@?PH [<?$AB,BS<_@:#\26'6S?\C6'9:M;1L%
MEMTQ]*ZFPN]!G \V*,$^U %'_A93?\^C_D:/^%E-_P ^C_D:ZB#2]$NAF**(
MU/\ \([IG_/NGY4 <A_PLIO^?1_R-'_"RF_Y]'_(UV'_  CFF_\ /NGY4?\
M".:;_P ^Z?E0!Q__  LIO^?1_P C1_PLIO\ GT?\C78?\(YIO_/NGY4?\(YI
MO_/NGY4 <?\ \+*;_GT?\C1_PLIO^?1_R-=A_P (YIO_ #[I^5'_  CFF_\
M/NGY4 <?_P +*;_GT?\ (T?\+*;_ )]'_(UV'_".:;_S[I^5'_".:;_S[I^5
M ''_ /"RF_Y]'_(TG_"RFS_QZ/\ D:['_A'--_Y]T_*C_A'=-_Y]T_*@#S'Q
M'XC/B!H286C\OU'6I?!W_(9CK2^(%A;6+V8MXPFX<X'7K6;X._Y#24 >O$ K
M@]ZSI="T^:0R/ "QK1I: ,K_ (1[3?\ GW6J>H^%K&YM66*)5?'6NAI* /&;
MJRO/#NH%T!"@]<5?NO&LMU8B $[\8KT75M'AU.!D=1DCK7*6W@.-+W>?N9H
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M*XF_Y^!1_P *XF_Y^!0!=_X65:_\^<GYT?\ "RK7_GSD_.J7_"N)O^?@4?\
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M%I#:Q=Y( 4FM[7?""6EIY\1^Z.0*P+*]NO#U]L8$ 'O6CK/BV6_A$,/<8(%
M%;0?$$VFW*Q.Y,>>:].L=1@OH5=''(]:\HMO#U[=1&<(0#S2PSZIIC%!O&*
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M .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*ZAF4,DBG/O0!/12 @]#2T %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8=* &NZQC+L /4FL/5(]!U0A+R>%R.@+5S_Q/U6YT[1]MJ2KOP"*\TTCX?\
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MY_PNR+_H&2_E1_PNR+_H&2_E7H?_  B>B?\ 0/A_[Y%'_")Z)_T#X?\ OD4
M>>?\+LB_Z!DOY4?\+LB_Z!DOY5Z'_P (GHG_ $#X?^^11_PB>B?] ^'_ +Y%
M 'GG_"[(O^@9+^5'_"[(O^@9+^5>A_\ ")Z)_P! ^'_OD4?\(GHG_0/A_P"^
M10!YY_PNR+_H&2_E1_PNR+_H&2_E7H?_  B>B?\ 0/A_[Y%'_")Z)_T#X?\
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M)_T#X?\ OD4 >>?\+LB_Z!DOY4O_  NR'_H&2_E7H7_")Z'_ - ^'_OD4?\
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M3Q'\'M3TS)M4:0#VH ]/3X[:;-Q#:._TJ3_A=,?;2YORKQ+3H;_PPV^^TW<
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MD4 >>?\ "[(O^@9+^5'_  NR+_H&2_E7H?\ PB>B?] ^'_OD4?\ ")Z)_P!
M^'_OD4 >>?\ "[(O^@9+^5!^-D6#_P 2R7\J]#_X1/1/^@?#_P!\BD;PIH>T
M_P#$OAZ?W10!X_#XZ&OZ\N+5H\MW%>W:7SI\1]0*\RU+2=.L]>'V6W6/YNPK
MT[3/^/"+Z4 7**** "BBB@"AJW_(.D^E<]X/_P"/B;ZFNAU;_D'2?2N>\'_\
M?$WU- $'A+M7;=JXGPGVKMNU 'F?Q@,D>B>9&A9EY&!FO#[3XF^);&Q-G$L@
MCZ?<-?65[IUKJ,?EW42R)Z$5C_\ "#^'\Y_L^'G_ &:!W/E>S\=:]97C7,22
M"1CDD(:N:E\2O$NJVWV:<2E#P1M-?3G_  @WA[_H'P_]\T?\(/X?SG^SX?\
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M#7B"QG>2QD;RP<C!K+.L^,/"+"-O.(7V-?6I (P0#67?>'M,U#/VFUC?/JM
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M7HFF?\>$?TKSO6?^0\/]ZO1-,_X\(_I0!<HHHH **** *&K?\@Z3Z5SW@_\
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M/_=%2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX=Z5H]Z "BBB@"AJW_(.D^E<]X/_ ./B;ZFNAU;_ )!TGTKGO!__ !\3?4T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%SA=VUN_- '1T57AO()UW)(OYU."#T(H 6BBB@ HHHH **** "BBB@ HHHH
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MHS3"PZBEI#CO0!#>?\>DG^Z:^>9/^2FI_P!=/ZU]"W)5K:0;E^Z>]?/DJ?\
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MA=[I_P 1BTI$C^7SW/2O,VM_$?\ PE80LWVS=P>:^NKH[;60@#[IKY[E<_\
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M_9WQ+_YZO^9H_L[XE_\ /5_S->Z8'I1@>E 'A?\ 9WQ+_P">K_F:/[.^)?\
MSU?\S7NF!Z48'I0!X7_9WQ+_ .>K_F:/[.^)?_/5_P S7NF!Z48'I0!X7_9W
MQ+_YZO\ F:/[.^)?_/5_S->Z8'I1@>E 'A?]G?$O_GJ_YFC^SOB7_P ]7_,U
M[I@>E&!Z4 >%_P!G?$O_ )ZO^9H_L[XE_P#/5_S->Z8'I1@>E 'A?]G?$O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M /'Q-]30!!X2KMATKB?"5=L.E !5/58S+ILR*,L5.!5SVJ.>58(&D?[JC)H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "4A4,,, 13J*
M *<VEV<X_>0J<^U8-_X,M;G)0!:ZJDQ0!YG?^";BW!:')QZ5E&+6+(X'F +[
M5[#@'KS4,MI!,I#QJ<^U 'F=AXNO+,XFR<>M=#8^.()VVR@+6E=^$K"Y).P
M^U<[J'@9E.ZV)H [*#6;*=1MF7/IFKJ2)(-R$&O)9]%U:Q;<-P ]*?;^)-3L
M?E8M@>HH ]9HK@M.\= D"YXKI+;Q/I]R0JR#)H VJ*CCGBE&4<$?6GYST- "
MTU_N-]*=37^ZWTH \QUG_D/#_>KT33/^/"/Z5YQKDJIKX!_O5Z-I;AM/B*G/
M% %VBBB@ HHHH H:M_R#I/I7/>#_ /CXF^IKH=6_Y!TGTKGO!_\ Q\3?4T 0
M>$J[8=*XGPE7;#I0!#=1O+;.L9PY'!KA+/PUX@BU*::6[8Q,3M&XUZ#VKG/$
MGB[3] M9&N9-KXXH X'5/!/C&>^>6VU%Q&3PNXU3_P"$#\<$C.I,!_OFKGAS
MXOZ=)?S)>S$1Y^4DUM:W\5]%BT]Q93[YR/E HM8;.E\)Z9J.FZ>(M0F,LF.I
M-=%7$_#[7[S7;)YK@';VS7;4V(6BBBD 4444 %%)10 M%)1VH 6BDHH 6BBB
M@""\_P"/23_=-?/,G_)34_ZZ?UKZ&O/^/23_ '37SS)_R4U/^NG]: /HB#_4
M1_[HJ6HH/]1'_NBI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/O#G_01C_,4?\)]X<_Z",?YB@#IJ*YG_ (3[PY_T$8_S%'_"?>'/^@C'^8H
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M9_X3[PY_T$8_S%'_  GWAS_H(Q_F* .FHKF?^$^\.?\ 01C_ #%'_"?>'/\
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M",?YB@#IJ*YG_A/O#G_01C_,4?\ "?>'/^@C'^8H Z:BN9_X3[PY_P!!&/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *:_W&^E.IK_<;Z4 >8ZU_R'A_O5Z)IG_'A']*\[UK_D/#_>KT33/^/"/Z
M4 7**** "BBB@"AJW_(.D^E<]X/_ ./B;ZFNAU;_ )!TGTKGO!__ !\3?4T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M: "BBB@""\_X])/]TU\\R?\ )34_ZZ?UKZ&O/^/23_=-?/,G_)34_P"NG]:
M/HB#_41_[HJ6HH/^/>/_ '14M !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'K6Q52PO8[ZV25"/F&<5:H8"T444 %(QP,FJUUJ%K9+NN9EC'JQK,F\2Z5-
MZP7L;OC@*U# YGQAXGU L;'1 3<=.*YO1C\0OMB&\#>5GG.:S;WQO/HWB&1X
M].:9L\$*36WIOQ=GN;R.&XTQX@QQN*D5770&>E->O9:4);G_ %H7GZUY7JVM
M>,]4OG.C*WEJ>V:[/Q#J?VBSA>/E9.HK8\-01Q6 *H 6&34=0.0\(>*-4MIQ
M8:_D7!/&:]*5@R@CH1FO,_$4:MXNB?&""*]'LSFUC.?X13N4T344M5KR[2SA
M,C] *"1UY_QZ2?[IKYYD'_%SE_ZZ?UKUJ^\:PI!*NWL17@U[XH2W\=+>E. ]
M 'U1!_Q[Q_[HJ2O*T^+UHD2#RL\4?\+AM/\ GE0!ZI17E?\ PN*T_P">7Z4?
M\+BM/^>7Z4 >J45Y7_PN*T_YY?I1_P +BM/^>7Z4 >J45Y7_ ,+BM/\ GE^E
M'_"XK3_GE^E 'JE%>5_\+BM/^>7Z4?\ "XK3_GE^E 'JE%>5_P#"XK3_ )Y?
MI1_PN*T_YY?I0!ZI17E?_"XK3_GE^E'_  N*T_YY?I0!ZI17E?\ PN*T_P">
M7Z4?\+BM/^>7Z4 >J45Y7_PN*T_YY?I1_P +BM/^>7Z4 >J45Y7_ ,+BM/\
MGE^E'_"XK3_GE^E 'JE%>5_\+BM/^>7Z4?\ "XK3_GE^E 'JE%>5_P#"XK3_
M )Y?I1_PN*T_YY?I0!ZI17E?_"XK3_GE^E'_  N*T_YY?I0!ZI17E?\ PN&T
M_P">7Z4O_"X;/_GE^E 'J=%>5GXQ68&?*IH^,U@W CYH ]6HKRO_ (7%:?\
M/+]*/^%Q6G_/+]* /5**\K_X7%:?\\OTH_X7%:?\\OTH ]4HKRO_ (7%:?\
M/+]*/^%Q6G_/+]* /5**\K_X7%:?\\OTH_X7%:?\\OTH ]4HKRO_ (7%:?\
M/+]*/^%Q6G_/+]* /5**\K_X7%:?\\OTH_X7%:?\\OTH ]4HKRO_ (7%:?\
M/+]*/^%Q6G_/+]* /5**\K_X7%:?\\OTH_X7%:?\\OTH ]4HKRO_ (7%:?\
M/+]*/^%Q6G_/+]* /5**\K_X7%:?\\OTH_X7%:?\\OTH ]4HKRO_ (7%:?\
M/+]*/^%Q6G_/+]* /5**\K_X7%:?\\OTH_X7%:?\\OTH ]4HKRO_ (7%:?\
M/+]*/^%Q6G_/+]* /5**\K_X7%:?\\OTH_X7#9Y_U7Z4 >J45Y2_QFL4/S1X
MI1\8[)AD14 >JT5Y7_PN*T_YY?I1_P +BM/^>7Z4 >J45Y7_ ,+BM/\ GE^E
M'_"XK3_GE^E 'JE%>5_\+BM/^>7Z4?\ "XK3_GE^E 'JE%>5_P#"XK3_ )Y?
MI1_PN*T_YY?I0!ZI17E?_"XK3_GE^E'_  N*T_YY?I0!ZI17E?\ PN*T_P">
M7Z4?\+BM/^>7Z4 >J45Y7_PN*T_YY?I1_P +BM/^>7Z4 >J45Y7_ ,+BM/\
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M;2U?0A&5(]17'3^$GDU];\'@'- &<GPITHQ+GKBE_P"%3Z3ZUZ"HVH!Z"G4
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MHHH **** "BBB@ I*6B@!**6B@ [T444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %#
M5O\ D'2?2N>\'_\ 'Q-]370ZM_R#I/I7/>#_ /CXF^IH @\)5VPZ5Q/A*NV'
M2@!:*** $I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBD- "T5EZMKM
MEHL)ENI H%<_8?$S0M0NQ;0S?.3B@#M**9&ZR('0@J1D8IPH 6BBB@ HHHH
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MI:='):L&7%)(;->BCM2"F(6BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M444 %%%% !1110 4444 %%%% !24M% !112<T +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M24M !1110!0U;_D'2?2N>\'_ /'Q-]370ZM_R#I/I7/>#_\ CXF^IH @\)5V
MPZ5Q/A*NV'2@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDU]#* H '04WHDA=1:***D HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *&K
M?\@Z3Z5SW@__ (^)OJ:Z'5O^0=)]*Y[P?_Q\3?4T 0>$J[8=*XGPE7;#I0 M
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH
MX/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_O
MFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC
M[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)
MXE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\H
MH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE
M_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_O
MFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/
M[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN
M\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)
MXE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE
M_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH
MX/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_O
MFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC
M[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)
MXE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\H
MH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE
M_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_O
MFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/
M[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN
M\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)
MXE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE
M_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH
MX/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_OFN\HH X/[)XE_OFC[)XE_O
MFN\HH X/[)XE_OFC[)XE_OFN\HH X*33_$<\>QW^4]:W?#>D2Z:C&;[S=:Z"
$B@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>17
<FILENAME>drrx-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-03-05T18:40:51.4878585+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : 68f21b77591e4eada77a5e64a41cc482 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:drrx="http://www.durect.com/20201231" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.durect.com/20201231" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" namespace="http://xbrl.sec.gov/country/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" namespace="http://xbrl.sec.gov/currency/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2020-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd" namespace="http://xbrl.sec.gov/exch/2020-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" namespace="http://fasb.org/srt/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd" namespace="http://fasb.org/srt-roles/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" namespace="http://fasb.org/srt-types/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" namespace="http://xbrl.sec.gov/stpr/2018-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" namespace="http://fasb.org/us-gaap/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd" namespace="http://fasb.org/us-roles/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" namespace="http://fasb.org/us-types/2020-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.durect.com/20201231/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="drrx-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation Links, all" xlink:type="simple" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="drrx-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="drrx-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="drrx-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets" id="Role_StatementBalanceSheets">
        <link:definition>100010 - Statement - Balance Sheets</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheetsParenthetical" id="Role_StatementBalanceSheetsParenthetical">
        <link:definition>100020 - Statement - Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss" id="Role_StatementStatementsOfOperationsAndComprehensiveLoss">
        <link:definition>100030 - Statement - Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity" id="Role_StatementStatementsOfStockholdersEquity">
        <link:definition>100040 - Statement - Statements of Stockholders&apos; Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquityParenthetical" id="Role_StatementStatementsOfStockholdersEquityParenthetical">
        <link:definition>100050 - Statement - Statements of Stockholders&apos; Equity (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows" id="Role_StatementStatementsOfCashFlows">
        <link:definition>100060 - Statement - Statements of Cash Flows</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlowsParenthetical" id="Role_StatementStatementsOfCashFlowsParenthetical">
        <link:definition>100070 - Statement - Statements of Cash Flows (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>100080 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreements" id="Role_DisclosureStrategicAgreements">
        <link:definition>100090 - Disclosure - Strategic Agreements</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstruments" id="Role_DisclosureFinancialInstruments">
        <link:definition>100100 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipment" id="Role_DisclosurePropertyAndEquipment">
        <link:definition>100110 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureRestrictedInvestments" id="Role_DisclosureRestrictedInvestments">
        <link:definition>100120 - Disclosure - Restricted Investments</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitments" id="Role_DisclosureCommitments">
        <link:definition>100130 - Disclosure - Commitments</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoan" id="Role_DisclosureTermLoan">
        <link:definition>100140 - Disclosure - Term Loan</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity" id="Role_DisclosureStockholdersEquity">
        <link:definition>100150 - Disclosure - Stockholders&apos; Equity</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>100160 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperations" id="Role_DisclosureDiscontinuedOperations">
        <link:definition>100170 - Disclosure - Discontinued Operations</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEvents" id="Role_DisclosureSubsequentEvents">
        <link:definition>100180 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccounts" id="Role_DisclosureScheduleIIValuationAndQualifyingAccounts">
        <link:definition>100190 - Disclosure - Schedule II-Valuation and Qualifying Accounts</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100200 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>100210 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsTables" id="Role_DisclosureStrategicAgreementsTables">
        <link:definition>100220 - Disclosure - Strategic Agreements (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsTables" id="Role_DisclosureFinancialInstrumentsTables">
        <link:definition>100230 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentTables" id="Role_DisclosurePropertyAndEquipmentTables">
        <link:definition>100240 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsTables" id="Role_DisclosureCommitmentsTables">
        <link:definition>100250 - Disclosure - Commitments (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanTables" id="Role_DisclosureTermLoanTables">
        <link:definition>100260 - Disclosure - Term Loan (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityTables" id="Role_DisclosureStockholdersEquityTables">
        <link:definition>100270 - Disclosure - Stockholders&apos; Equity (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables" id="Role_DisclosureIncomeTaxesTables">
        <link:definition>100280 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsTables" id="Role_DisclosureDiscontinuedOperationsTables">
        <link:definition>100290 - Disclosure - Discontinued Operations (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
        <link:definition>100300 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfTotalRevenueByGeographicRegionDetail" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfTotalRevenueByGeographicRegionDetail">
        <link:definition>100310 - Disclosure - Summary of Significant Accounting Policies - Summary of Total Revenue by Geographic Region (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfComponentsOfInventoriesDetail" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfComponentsOfInventoriesDetail">
        <link:definition>100320 - Disclosure - Summary of Significant Accounting Policies - Summary of Components of Inventories (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail">
        <link:definition>100330 - Disclosure - Summary of Significant Accounting Policies - Summary of Numerators and Denominators in Calculation of Basic and Diluted Net Loss per Share (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail" id="Role_DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail">
        <link:definition>100340 - Disclosure - Strategic Agreements - Summary of Collaborative Research and Development and Other Revenues Associated with Company&apos;s Major Third-Party Collaborators (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail" id="Role_DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail">
        <link:definition>100350 - Disclosure - Strategic Agreements - Summary of Collaborative Research and Development and Other Revenues Associated with Company&apos;s Major Third-Party Collaborators (Parenthetical) (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail" id="Role_DisclosureStrategicAgreementsAdditionalInformationDetail">
        <link:definition>100360 - Disclosure - Strategic Agreements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail" id="Role_DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail">
        <link:definition>100370 - Disclosure - Strategic Agreements - Agreement with Gilead Sciences, Inc - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail" id="Role_DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail">
        <link:definition>100380 - Disclosure - Strategic Agreements - Summary of Changes in the Company&apos;s Contract Asset and Liabilities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail" id="Role_DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail">
        <link:definition>100390 - Disclosure - Strategic Agreements - Patent Purchase Agreement with Indivior - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail" id="Role_DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail">
        <link:definition>100400 - Disclosure - Strategic Agreements - Agreement with Santen Pharmaceutical Co., Ltd. - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSandozAGAdditionalInformationDetail" id="Role_DisclosureStrategicAgreementsAgreementWithSandozAGAdditionalInformationDetail">
        <link:definition>100410 - Disclosure - Strategic Agreements - Agreement with Sandoz AG - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail" id="Role_DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail">
        <link:definition>100420 - Disclosure - Financial Instruments - Fair Value Measurements of Assets (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail" id="Role_DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail">
        <link:definition>100430 - Disclosure - Financial Instruments - Summary of Money Market Funds and Available-for-Sale Securities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail" id="Role_DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail">
        <link:definition>100440 - Disclosure - Financial Instruments - Summary of Cost and Estimated Fair Value of Available-for-Sale Securities by Contractual Maturity (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAdditionalInformationDetail" id="Role_DisclosureFinancialInstrumentsAdditionalInformationDetail">
        <link:definition>100450 - Disclosure - Financial Instruments - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail" id="Role_DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail">
        <link:definition>100460 - Disclosure - Property and Equipment - Property and Equipment (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail" id="Role_DisclosurePropertyAndEquipmentAdditionalInformationDetail">
        <link:definition>100470 - Disclosure - Property and Equipment - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureRestrictedInvestmentsAdditionalInformationDetail" id="Role_DisclosureRestrictedInvestmentsAdditionalInformationDetail">
        <link:definition>100480 - Disclosure - Restricted Investments - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail" id="Role_DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail">
        <link:definition>100490 - Disclosure - Commitments - Summary of Lease Arrangements of Company Facilities (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsAdditionalInformationDetail" id="Role_DisclosureCommitmentsAdditionalInformationDetail">
        <link:definition>100500 - Disclosure - Commitments - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail" id="Role_DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail">
        <link:definition>100510 - Disclosure - Commitments - Schedule of Future Operating Lease Minimum Payments (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail" id="Role_DisclosureTermLoanAdditionalInformationDetail">
        <link:definition>100520 - Disclosure - Term Loan - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail" id="Role_DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail">
        <link:definition>100530 - Disclosure - Term Loan - Schedule of Future Maturities and Interest Payments under Term Loan (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail2" id="Role_DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail2">
        <link:definition>100540 - Disclosure - Term Loan - Schedule of Future Maturities and Interest Payments under Term Loan (Detail)2</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail" id="Role_DisclosureStockholdersEquityCommonStockAdditionalInformationDetail">
        <link:definition>100550 - Disclosure - Stockholders&apos; Equity - Common Stock - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail" id="Role_DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail">
        <link:definition>100560 - Disclosure - Stockholders&apos; Equity - 2000 Stock Plan (Incentive Stock Plan) - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail" id="Role_DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail">
        <link:definition>100570 - Disclosure - Stockholders&apos; Equity - 2000 Employee Stock Purchase Plan - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfSharesOfCommonStockReservedForFutureIssuanceDetail" id="Role_DisclosureStockholdersEquitySummaryOfSharesOfCommonStockReservedForFutureIssuanceDetail">
        <link:definition>100580 - Disclosure - Stockholders&apos; Equity - Summary of Shares of Common Stock Reserved for Future Issuance (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail" id="Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail">
        <link:definition>100590 - Disclosure - Stockholders&apos; Equity - Summary of Stock Option Activity under all Stock-Based Compensation Plans (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfEmployeeStockBasedCompensationCostThatHasBeenIncludedInStatementsOfOperationsAndComprehensiveLossDetail" id="Role_DisclosureStockholdersEquitySummaryOfEmployeeStockBasedCompensationCostThatHasBeenIncludedInStatementsOfOperationsAndComprehensiveLossDetail">
        <link:definition>100600 - Disclosure - Stockholders&apos; Equity - Summary of Employee Stock-Based Compensation Cost that has been Included in Statements of Operations and Comprehensive Loss (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail" id="Role_DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail">
        <link:definition>100610 - Disclosure - Stockholders&apos; Equity - Determining Fair Value - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail" id="Role_DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail">
        <link:definition>100620 - Disclosure - Stockholders&apos; Equity - Summary of Assumptions Used to Estimate Fair Value of Options Granted and Shares Purchased (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail" id="Role_DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail">
        <link:definition>100630 - Disclosure - Stockholders&apos; Equity - Summary of Stock Options Outstanding (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" id="Role_DisclosureIncomeTaxesAdditionalInformationDetail">
        <link:definition>100640 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail" id="Role_DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail">
        <link:definition>100650 - Disclosure - Income Taxes - Reconciliation of Income Tax Expenses (Benefit) (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail" id="Role_DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail">
        <link:definition>100660 - Disclosure - Income Taxes - Summary of Components of Company&apos;s Deferred Tax Assets (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetail" id="Role_DisclosureIncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetail">
        <link:definition>100670 - Disclosure - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail" id="Role_DisclosureDiscontinuedOperationsAdditionalInformationDetail">
        <link:definition>100680 - Disclosure - Discontinued Operations - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail" id="Role_DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail">
        <link:definition>100690 - Disclosure - Discontinued Operations - Summary of Discontinued Operations Reported in Statement of Operations (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail" id="Role_DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail">
        <link:definition>100700 - Disclosure - Discontinued Operations - Summary of Assets and Liabilities Reported as Discontinued Operations in Balance Sheet (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail" id="Role_DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail">
        <link:definition>100710 - Disclosure - Discontinued Operations - Summary of Non-cash Items Related to Discontinued Operations Included in Statement of Cash Flows (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" id="Role_DisclosureSubsequentEventsAdditionalInformationDetail">
        <link:definition>100720 - Disclosure - Subsequent Events - Additional Information (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccountsDetail" id="Role_DisclosureScheduleIIValuationAndQualifyingAccountsDetail">
        <link:definition>100730 - Disclosure - Schedule II-Valuation and Qualifying Accounts (Detail)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="drrx_DeferredTaxLiabilitiesRightOfUseAssets" name="DeferredTaxLiabilitiesRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="drrx_ContractResearchLiability" name="ContractResearchLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" name="CollaborativeResearchAndDevelopmentAndOtherRevenueMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares" name="IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan" name="IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="drrx_AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities" name="AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="drrx_ChangesInOperatingLeaseLiabilities" name="ChangesInOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="drrx_IncreaseDecreaseInContractResearchLiability" name="IncreaseDecreaseInContractResearchLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="drrx_LongTermRestrictedInvestmentsMember" name="LongTermRestrictedInvestmentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_RestrictedInvestmentsDisclosureTextBlock" name="RestrictedInvestmentsDisclosureTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_NatureOfOperationsPolicyTextBlock" name="NatureOfOperationsPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_DiscontinuedOperationsTextblock" name="DiscontinuedOperationsTextblock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock" name="LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_PrepaidAndAccruedContractResearchExpensesPolicyTextBlock" name="PrepaidAndAccruedContractResearchExpensesPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_ShippingAndHandlingPolicyTextBlock" name="ShippingAndHandlingPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock" name="ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock" name="SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock" name="SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock" name="SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_SummaryOfSignificantAccountingPoliciesLineItems" name="SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_SummaryOfSignificantAccountingPoliciesTable" name="SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_LactelProductLineMember" name="LactelProductLineMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_AlzetProductLineMember" name="AlzetProductLineMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_GileadMember" name="GileadMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_IndiviorMember" name="IndiviorMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_LACTELMember" name="LACTELMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_LiquidInvestmentsMaturityPeriodDescriptionMaximum" name="LiquidInvestmentsMaturityPeriodDescriptionMaximum" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_LongTermInvestmentsMaturityPeriodDescriptionMinimum" name="LongTermInvestmentsMaturityPeriodDescriptionMinimum" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_ShortTermInvestmentMaturityPeriod" name="ShortTermInvestmentMaturityPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_CashHeldInEscrow" name="CashHeldInEscrow" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="drrx_PaymentFromEscrow" name="PaymentFromEscrow" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="drrx_OtherForeignCountriesMember" name="OtherForeignCountriesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_LesseeOperatingLeaseIncrementalBorrowingRate" name="LesseeOperatingLeaseIncrementalBorrowingRate" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xsd:element id="drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities" name="WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_AgreementWithGileadMember" name="AgreementWithGileadMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_AgreementsWithOtherCollaboratorsOrCounterpartiesMember" name="AgreementsWithOtherCollaboratorsOrCounterpartiesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_DevelopmentBasedMilestones" name="DevelopmentBasedMilestones" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="drrx_DevelopmentBasedMilestonesMember" name="DevelopmentBasedMilestonesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_SalesBasedMilestonesMember" name="SalesBasedMilestonesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_EarlyStageClinicalTestingMember" name="EarlyStageClinicalTestingMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_LateStageClinicalTestingMember" name="LateStageClinicalTestingMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_RegulatoryApprovalsMember" name="RegulatoryApprovalsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_ContractWithCustomerLiabilityMilestonePayment" name="ContractWithCustomerLiabilityMilestonePayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="drrx_UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember" name="UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" name="PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="drrx_AccruedAmountOfFinalPaymentOfTermLoan" name="AccruedAmountOfFinalPaymentOfTermLoan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="drrx_AdditionsMember" name="AdditionsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_DeletionsMember" name="DeletionsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_NonRefundableUpfrontPaymentReceived" name="NonRefundableUpfrontPaymentReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="drrx_GrantedPatentsExtendingYearMinimum" name="GrantedPatentsExtendingYearMinimum" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_PatentPurchaseAgreementWithIndiviorMember" name="PatentPurchaseAgreementWithIndiviorMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_RegulatoryBasedMilestoneMember" name="RegulatoryBasedMilestoneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_AgreementWithSantenPharmaceuticalCoLtdMember" name="AgreementWithSantenPharmaceuticalCoLtdMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_CommercializationBasedMilestonesMember" name="CommercializationBasedMilestonesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_AgreementWithSandozAGMember" name="AgreementWithSandozAGMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_InvestmentHoldingsAbstract" name="InvestmentHoldingsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_RestrictedInvestmentsLineItems" name="RestrictedInvestmentsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_RestrictedInvestmentsTable" name="RestrictedInvestmentsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_LeaseExpirationTerm" name="LeaseExpirationTerm" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_CupertinoCAMember" name="CupertinoCAMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_VacavilleCAMember" name="VacavilleCAMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_OfficeLaboratoryAndManufacturingMember" name="OfficeLaboratoryAndManufacturingMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_OfficeAndLaboratoryMember" name="OfficeAndLaboratoryMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_LeaseAmendmentMember" name="LeaseAmendmentMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_LeaseExpirationYear" name="LeaseExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_CommitmentAndContingenciesLineItems" name="CommitmentAndContingenciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_CommitmentAndContingenciesTable" name="CommitmentAndContingenciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_DebtInstrumentPrincipalPaymentPercentage" name="DebtInstrumentPrincipalPaymentPercentage" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_DebtInstrumentPrepaymentFeePercentage" name="DebtInstrumentPrepaymentFeePercentage" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_DebtIssuanceCost" name="DebtIssuanceCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="drrx_OxfordFinanceLlcTermLoanMember" name="OxfordFinanceLlcTermLoanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_CommonStockCapitalAmountReservedForFutureIssuance" name="CommonStockCapitalAmountReservedForFutureIssuance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="drrx_CantorFitzgeraldCoMember" name="CantorFitzgeraldCoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_ControlledEquityOfferingProgramMember" name="ControlledEquityOfferingProgramMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_OctoberTwoThousandEighteenRegistrationStatementMember" name="OctoberTwoThousandEighteenRegistrationStatementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_CommonStockWeightedAveragePrice" name="CommonStockWeightedAveragePrice" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_EmployeesStockPurchasePlanExtendedTermPeriod" name="EmployeesStockPurchasePlanExtendedTermPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_TwoThousandStockPlanMember" name="TwoThousandStockPlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_NonEmployeeDirectorMember" name="NonEmployeeDirectorMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_EmployeeStockPurchasePlanExpirationDate" name="EmployeeStockPurchasePlanExpirationDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_StockOptionsVestingPeriod" name="StockOptionsVestingPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors" name="ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_MinimumPercentageOfCombinedVotingPowerClassesOfStock" name="MinimumPercentageOfCombinedVotingPowerClassesOfStock" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_EmployeeStockPurchasePlanOfferingPeriod" name="EmployeeStockPurchasePlanOfferingPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_TwoThousandEmployeeStockPurchasePlanMember" name="TwoThousandEmployeeStockPurchasePlanMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_OptionsGrantedWithExercisePricesLowerThanFairMarket" name="OptionsGrantedWithExercisePricesLowerThanFairMarket" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_ExercisePriceRangeOneMember" name="ExercisePriceRangeOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_ExercisePriceRangeTwoMember" name="ExercisePriceRangeTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_ExercisePriceRangeThreeMember" name="ExercisePriceRangeThreeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_ExercisePriceRangeFourMember" name="ExercisePriceRangeFourMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_ExercisePriceRangeFiveMember" name="ExercisePriceRangeFiveMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_ExercisePriceRangeSixMember" name="ExercisePriceRangeSixMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_ExercisePriceRangeSevenMember" name="ExercisePriceRangeSevenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_ExercisePriceRangeEightMember" name="ExercisePriceRangeEightMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_ExercisePriceRangeNineMember" name="ExercisePriceRangeNineMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_ExercisePriceRangeTenMember" name="ExercisePriceRangeTenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_ExercisePriceRangeElevenMember" name="ExercisePriceRangeElevenMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_IncomeTaxReconciliationExpiringNetOperatingLosses" name="IncomeTaxReconciliationExpiringNetOperatingLosses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="drrx_NetOperatingLossCarryforwardsExpirationAmount" name="NetOperatingLossCarryforwardsExpirationAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="drrx_NetOperatingLossCarryforwardsNonExpirationAmount" name="NetOperatingLossCarryforwardsNonExpirationAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="drrx_TaxCreditCarryforwardExpiration" name="TaxCreditCarryforwardExpiration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xsd:element id="drrx_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions" name="UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="drrx_AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid" name="AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="drrx_EvonikCorporationMember" name="EvonikCorporationMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" name="DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract" name="DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent" name="DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="drrx_DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense" name="DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="drrx_NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill" name="NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="drrx_NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment" name="NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross" name="DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet" name="DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xsd:element id="drrx_StockIssuedDuringPeriodValueNewIssuesNet" name="StockIssuedDuringPeriodValueNewIssuesNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xsd:element id="drrx_ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense" name="ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>18
<FILENAME>drrx-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-03-05T18:40:51.4878585+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : 68f21b77591e4eada77a5e64a41cc482 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="drrx-20201231.xsd#TemplateLink" roleURI="http://www.durect.com/20201231/role/TemplateLink" />
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets" xlink:href="drrx-20201231.xsd#Role_StatementBalanceSheets" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:type="locator" xlink:label="us-gaap_InventoryNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EscrowDeposit" xlink:type="locator" xlink:label="us-gaap_EscrowDeposit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedInvestmentsNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedInvestmentsNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments" xlink:type="locator" xlink:label="us-gaap_LongTermInvestments" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ContractResearchLiability" xlink:type="locator" xlink:label="drrx_ContractResearchLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LongTermDebtNoncurrent" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="10120.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="10130.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="10140.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="10150.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="drrx_ContractResearchLiability" order="10160.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="10170.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LongTermDebtCurrent" order="10180.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="10190.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" order="10200.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="10210.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10220.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="10230.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Goodwill" order="10240.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_LongTermInvestments" order="10250.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_RestrictedInvestmentsNoncurrent" order="10260.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="10270.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" order="10280.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10290.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_EscrowDeposit" order="10300.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="10310.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="10320.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InventoryNet" order="10330.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10340.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" order="10350.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss" xlink:href="drrx-20201231.xsd#Role_StatementStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" xlink:label="us-gaap_InterestExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncome" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_NonoperatingIncomeExpense" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncome" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestExpense" order="10080.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_CostsAndExpenses" order="10100.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10120.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="10130.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows" xlink:href="drrx-20201231.xsd#Role_StatementStatementsOfCashFlows" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_IncreaseDecreaseInContractResearchLiability" xlink:type="locator" xlink:label="drrx_IncreaseDecreaseInContractResearchLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:type="locator" xlink:label="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ChangesInOperatingLeaseLiabilities" xlink:type="locator" xlink:label="drrx_ChangesInOperatingLeaseLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown" xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermDebt" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" order="10040.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfLongTermDebt" order="10070.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="10080.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" order="10090.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" order="10120.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="10130.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="10140.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_InventoryWriteDown" order="10150.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="10160.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="10170.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="drrx_ChangesInOperatingLeaseLiabilities" order="10180.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" order="10190.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="10200.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="10210.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="10220.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="10230.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="10240.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="drrx_IncreaseDecreaseInContractResearchLiability" order="10250.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="10260.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfComponentsOfInventoriesDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfComponentsOfInventoriesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfComponentsOfInventoriesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:type="locator" xlink:label="us-gaap_InventoryNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="10030.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="locator" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements" xlink:type="locator" xlink:label="us-gaap_IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities" xlink:type="locator" xlink:label="drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" order="10040.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="10010.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="10030.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" order="10040.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail" xlink:href="drrx-20201231.xsd#Role_DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10020.00" priority="2" use="optional" weight="-1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears" order="10040.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:type="locator" xlink:label="us-gaap_LongTermDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="10020.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="10060.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail2" xlink:href="drrx-20201231.xsd#Role_DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail2" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail2">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:type="locator" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:type="locator" xlink:label="us-gaap_LongTermDebt" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtNoncurrent" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="10040.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_IncomeTaxReconciliationExpiringNetOperatingLosses" xlink:type="locator" xlink:label="drrx_IncomeTaxReconciliationExpiringNetOperatingLosses" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" order="10050.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="drrx_IncomeTaxReconciliationExpiringNetOperatingLosses" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="10080.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DeferredTaxLiabilitiesRightOfUseAssets" xlink:type="locator" xlink:label="drrx_DeferredTaxLiabilitiesRightOfUseAssets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10010.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="drrx_DeferredTaxLiabilitiesRightOfUseAssets" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="10080.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:type="locator" xlink:label="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:type="locator" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" order="10040.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" order="10070.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" order="10020.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" order="10060.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets" order="10070.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" order="10080.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" order="10090.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" order="10100.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" order="10110.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" order="10120.00" priority="2" use="optional" weight="1.00" />
  </link:calculationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail">
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment" xlink:type="locator" xlink:label="drrx_NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill" xlink:type="locator" xlink:label="drrx_NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:type="locator" xlink:label="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross" order="10010.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet" xlink:to="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" order="10020.00" priority="2" use="optional" weight="-1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" order="10030.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense" order="10040.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross" xlink:to="drrx_NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill" order="10050.00" priority="2" use="optional" weight="1.00" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross" xlink:to="drrx_NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment" order="10060.00" priority="2" use="optional" weight="-1.00" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>19
<FILENAME>drrx-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-03-05T18:40:51.4878585+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : 68f21b77591e4eada77a5e64a41cc482 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef xlink:type="simple" xlink:href="drrx-20201231.xsd#TemplateLink" roleURI="http://www.durect.com/20201231/role/TemplateLink" />
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss" xlink:href="drrx-20201231.xsd#Role_StatementStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" xlink:label="us-gaap_InterestExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncome" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:type="locator" xlink:label="us-gaap_TypeOfCostGoodOrServiceExtensibleList" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember" xlink:type="locator" xlink:label="us-gaap_ProductMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" xlink:type="locator" xlink:label="drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10140.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_2" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="10570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_TypeOfCostGoodOrServiceExtensibleList" order="10630.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="10750.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" order="10810.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="10870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="10930.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncome" order="11050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpense" order="11110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="11170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" order="11230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" order="11290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="11350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="11410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="11470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" order="11530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract" order="11650.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" order="11770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" order="11830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" order="11890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="11950.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity" xlink:href="drrx-20201231.xsd#Role_StatementStatementsOfStockholdersEquity" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities" xlink:type="locator" xlink:label="drrx_AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares" xlink:type="locator" xlink:label="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember" xlink:type="locator" xlink:label="srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain" xlink:type="locator" xlink:label="srt_RestatementDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain" xlink:type="locator" xlink:label="srt_RestatementDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis" xlink:type="locator" xlink:label="srt_RestatementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_RestatementAxis" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain_2" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares" order="10420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="10540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="drrx_AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities" order="10680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" order="10820.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="10960.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="11100.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlowsParenthetical" xlink:href="drrx-20201231.xsd#Role_StatementStatementsOfCashFlowsParenthetical" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlowsParenthetical">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCash" xlink:type="locator" xlink:label="us-gaap_RestrictedCash" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LongTermRestrictedInvestmentsMember" xlink:type="locator" xlink:label="drrx_LongTermRestrictedInvestmentsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="drrx_LongTermRestrictedInvestmentsMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RestrictedCash" order="10120.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LesseeOperatingLeaseIncrementalBorrowingRate" xlink:type="locator" xlink:label="drrx_LesseeOperatingLeaseIncrementalBorrowingRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_PaymentFromEscrow" xlink:type="locator" xlink:label="drrx_PaymentFromEscrow" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CashHeldInEscrow" xlink:type="locator" xlink:label="drrx_CashHeldInEscrow" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:type="locator" xlink:label="us-gaap_RealizedInvestmentGainsLosses" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShortTermInvestmentMaturityPeriod" xlink:type="locator" xlink:label="drrx_ShortTermInvestmentMaturityPeriod" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LongTermInvestmentsMaturityPeriodDescriptionMinimum" xlink:type="locator" xlink:label="drrx_LongTermInvestmentsMaturityPeriodDescriptionMinimum" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LiquidInvestmentsMaturityPeriodDescriptionMaximum" xlink:type="locator" xlink:label="drrx_LiquidInvestmentsMaturityPeriodDescriptionMaximum" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:type="locator" xlink:label="dei_EntityIncorporationDateOfIncorporation" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember" xlink:type="locator" xlink:label="srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain" xlink:type="locator" xlink:label="srt_RestatementDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis" xlink:type="locator" xlink:label="srt_RestatementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdate201409Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="locator" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LACTELMember" xlink:type="locator" xlink:label="drrx_LACTELMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_IndiviorMember" xlink:type="locator" xlink:label="drrx_IndiviorMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_GileadMember" xlink:type="locator" xlink:label="drrx_GileadMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:type="locator" xlink:label="srt_MajorCustomersAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductConcentrationRiskMember" xlink:type="locator" xlink:label="us-gaap_ProductConcentrationRiskMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AlzetProductLineMember" xlink:type="locator" xlink:label="drrx_AlzetProductLineMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LactelProductLineMember" xlink:type="locator" xlink:label="drrx_LactelProductLineMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="drrx_SummaryOfSignificantAccountingPoliciesTable" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="drrx_SummaryOfSignificantAccountingPoliciesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="drrx_SummaryOfSignificantAccountingPoliciesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RangeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_ProductOrServiceAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="drrx_LactelProductLineMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_2" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_2" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="drrx_AlzetProductLineMember" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="10360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain_2" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ProductConcentrationRiskMember" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_MajorCustomersAxis" order="10500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain_2" order="10510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="10530.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="drrx_GileadMember" order="10550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="drrx_IndiviorMember" order="10570.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="10630.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_2" order="10750.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="10770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="drrx_LACTELMember" order="10790.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="10800.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_2" order="10810.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="10830.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201409Member" order="10850.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RestatementAxis" order="10880.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="10910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RestatementDomain" xlink:to="srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember" order="10930.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="dei_EntityIncorporationDateOfIncorporation" order="10960.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="11010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="drrx_LiquidInvestmentsMaturityPeriodDescriptionMaximum" order="11060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="drrx_LongTermInvestmentsMaturityPeriodDescriptionMinimum" order="11100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="drrx_ShortTermInvestmentMaturityPeriod" order="11140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RealizedInvestmentGainsLosses" order="11220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="drrx_CashHeldInEscrow" order="11290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="drrx_PaymentFromEscrow" order="11310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="11360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="11600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="11690.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="11710.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_Goodwill" order="11760.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="11910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="drrx_LesseeOperatingLeaseIncrementalBorrowingRate" order="11960.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="11980.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="12080.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfTotalRevenueByGeographicRegionDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfTotalRevenueByGeographicRegionDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfTotalRevenueByGeographicRegionDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OtherForeignCountriesMember" xlink:type="locator" xlink:label="drrx_OtherForeignCountriesMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_JP" xlink:type="locator" xlink:label="country_JP" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember" xlink:type="locator" xlink:label="srt_EuropeMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:type="locator" xlink:label="country_US" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="locator" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="srt_StatementGeographicalAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_EuropeMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_JP" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="drrx_OtherForeignCountriesMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10180.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" xlink:type="locator" xlink:label="drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AgreementsWithOtherCollaboratorsOrCounterpartiesMember" xlink:type="locator" xlink:label="drrx_AgreementsWithOtherCollaboratorsOrCounterpartiesMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AgreementWithGileadMember" xlink:type="locator" xlink:label="drrx_AgreementWithGileadMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_AgreementWithGileadMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_AgreementsWithOtherCollaboratorsOrCounterpartiesMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10240.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicenseMember" xlink:type="locator" xlink:label="us-gaap_LicenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AgreementWithGileadMember" xlink:type="locator" xlink:label="drrx_AgreementWithGileadMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_AgreementWithGileadMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="10260.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStrategicAgreementsAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail">
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DevelopmentBasedMilestones" xlink:type="locator" xlink:label="drrx_DevelopmentBasedMilestones" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_RegulatoryApprovalsMember" xlink:type="locator" xlink:label="drrx_RegulatoryApprovalsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RegulatoryReviewsOfFilingsMember" xlink:type="locator" xlink:label="us-gaap_RegulatoryReviewsOfFilingsMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LateStageClinicalTestingMember" xlink:type="locator" xlink:label="drrx_LateStageClinicalTestingMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_EarlyStageClinicalTestingMember" xlink:type="locator" xlink:label="drrx_EarlyStageClinicalTestingMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:type="locator" xlink:label="us-gaap_ChangeInAccountingEstimateTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:type="locator" xlink:label="us-gaap_ChangeInAccountingEstimateTypeDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ChangeInAccountingEstimateByTypeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_SalesBasedMilestonesMember" xlink:type="locator" xlink:label="drrx_SalesBasedMilestonesMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DevelopmentBasedMilestonesMember" xlink:type="locator" xlink:label="drrx_DevelopmentBasedMilestonesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="drrx_DevelopmentBasedMilestonesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="drrx_SalesBasedMilestonesMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ChangeInAccountingEstimateByTypeAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:to="us-gaap_ChangeInAccountingEstimateTypeDomain_2" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:to="us-gaap_ChangeInAccountingEstimateTypeDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:to="drrx_EarlyStageClinicalTestingMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:to="drrx_LateStageClinicalTestingMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:to="us-gaap_RegulatoryReviewsOfFilingsMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:to="drrx_RegulatoryApprovalsMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" order="10400.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="10500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="drrx_DevelopmentBasedMilestones" order="10620.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue" xlink:type="locator" xlink:label="us-gaap_DeferredRevenue" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AccruedAmountOfFinalPaymentOfTermLoan" xlink:type="locator" xlink:label="drrx_AccruedAmountOfFinalPaymentOfTermLoan" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" xlink:type="locator" xlink:label="drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ContractWithCustomerLiabilityMilestonePayment" xlink:type="locator" xlink:label="drrx_ContractWithCustomerLiabilityMilestonePayment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" xlink:type="locator" xlink:label="drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember" xlink:type="locator" xlink:label="drrx_UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AgreementWithGileadMember" xlink:type="locator" xlink:label="drrx_AgreementWithGileadMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_AgreementWithGileadMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="drrx_UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="drrx_ContractWithCustomerLiabilityMilestonePayment" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="drrx_AccruedAmountOfFinalPaymentOfTermLoan" order="10440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredRevenue" order="10460.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityAbstract" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerAssetNetCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:type="locator" xlink:label="us-gaap_ReceivablesNetCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerAssetNetCurrentAbstract" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DeletionsMember" xlink:type="locator" xlink:label="drrx_DeletionsMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AdditionsMember" xlink:type="locator" xlink:label="drrx_AdditionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerDurationDomain" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerDurationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerDurationDomain" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerDurationDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerDurationAxis" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerDurationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ContractWithCustomerDurationAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ContractWithCustomerDurationAxis" xlink:to="us-gaap_ContractWithCustomerDurationDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ContractWithCustomerDurationAxis" xlink:to="us-gaap_ContractWithCustomerDurationDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContractWithCustomerDurationDomain" xlink:to="drrx_AdditionsMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContractWithCustomerDurationDomain" xlink:to="drrx_DeletionsMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerAssetNetCurrentAbstract" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ReceivablesNetCurrent" order="10380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerAssetNetCurrent" order="10460.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityAbstract" order="10540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="10700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiability" order="10780.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_GrantedPatentsExtendingYearMinimum" xlink:type="locator" xlink:label="drrx_GrantedPatentsExtendingYearMinimum" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" xlink:type="locator" xlink:label="drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NonRefundableUpfrontPaymentReceived" xlink:type="locator" xlink:label="drrx_NonRefundableUpfrontPaymentReceived" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyMember" xlink:type="locator" xlink:label="us-gaap_RoyaltyMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_RegulatoryBasedMilestoneMember" xlink:type="locator" xlink:label="drrx_RegulatoryBasedMilestoneMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_PatentPurchaseAgreementWithIndiviorMember" xlink:type="locator" xlink:label="drrx_PatentPurchaseAgreementWithIndiviorMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_PatentPurchaseAgreementWithIndiviorMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="drrx_RegulatoryBasedMilestoneMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="drrx_NonRefundableUpfrontPaymentReceived" order="10380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" order="10440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="drrx_GrantedPatentsExtendingYearMinimum" order="10500.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="10680.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" xlink:type="locator" xlink:label="drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicenseMember" xlink:type="locator" xlink:label="us-gaap_LicenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CommercializationBasedMilestonesMember" xlink:type="locator" xlink:label="drrx_CommercializationBasedMilestonesMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DevelopmentBasedMilestonesMember" xlink:type="locator" xlink:label="drrx_DevelopmentBasedMilestonesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AgreementWithSantenPharmaceuticalCoLtdMember" xlink:type="locator" xlink:label="drrx_AgreementWithSantenPharmaceuticalCoLtdMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_AgreementWithSantenPharmaceuticalCoLtdMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="drrx_DevelopmentBasedMilestonesMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="drrx_CommercializationBasedMilestonesMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" order="10380.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="10440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" order="10460.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSandozAGAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStrategicAgreementsAgreementWithSandozAGAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSandozAGAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AgreementWithSandozAGMember" xlink:type="locator" xlink:label="drrx_AgreementWithSandozAGMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_AgreementWithSandozAGMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" order="10120.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MunicipalBondsMember" xlink:type="locator" xlink:label="us-gaap_MunicipalBondsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember" xlink:type="locator" xlink:label="us-gaap_CommercialPaperMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember" xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CertificatesOfDepositMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CommercialPaperMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MunicipalBondsMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_2" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="10510.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="10740.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LongTermRestrictedInvestmentsMember" xlink:type="locator" xlink:label="drrx_LongTermRestrictedInvestmentsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermInvestmentsMember" xlink:type="locator" xlink:label="us-gaap_OtherLongTermInvestmentsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember" xlink:type="locator" xlink:label="us-gaap_ShortTermInvestmentsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MunicipalBondsMember" xlink:type="locator" xlink:label="us-gaap_MunicipalBondsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember" xlink:type="locator" xlink:label="us-gaap_CommercialPaperMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember" xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" order="10040.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_2" order="10080.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CertificatesOfDepositMember" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CommercialPaperMember" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MunicipalBondsMember" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CashAndCashEquivalentsMember" order="10220.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_ShortTermInvestmentsMember" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_OtherLongTermInvestmentsMember" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="drrx_LongTermRestrictedInvestmentsMember" order="10280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="10420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="10490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="10770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="11050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="11330.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail" xlink:href="drrx-20201231.xsd#Role_DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:type="locator" xlink:label="us-gaap_EquipmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10030.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10060.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_2" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10380.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureRestrictedInvestmentsAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureRestrictedInvestmentsAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureRestrictedInvestmentsAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedInvestmentsNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedInvestmentsNoncurrent" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA" xlink:type="locator" xlink:label="country_CA" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_RestrictedInvestmentsTable" xlink:type="locator" xlink:label="drrx_RestrictedInvestmentsTable" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_RestrictedInvestmentsLineItems" xlink:type="locator" xlink:label="drrx_RestrictedInvestmentsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="drrx_RestrictedInvestmentsLineItems" xlink:to="drrx_RestrictedInvestmentsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="drrx_RestrictedInvestmentsTable" xlink:to="srt_StatementGeographicalAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_CA" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_RestrictedInvestmentsLineItems" xlink:to="us-gaap_RestrictedInvestmentsNoncurrent" order="10120.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LeaseExpirationYear" xlink:type="locator" xlink:label="drrx_LeaseExpirationYear" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LeaseExpirationTerm" xlink:type="locator" xlink:label="drrx_LeaseExpirationTerm" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandSubjectToGroundLeases" xlink:type="locator" xlink:label="us-gaap_LandSubjectToGroundLeases" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LeaseAmendmentMember" xlink:type="locator" xlink:label="drrx_LeaseAmendmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ManufacturingFacilityMember" xlink:type="locator" xlink:label="us-gaap_ManufacturingFacilityMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OfficeAndLaboratoryMember" xlink:type="locator" xlink:label="drrx_OfficeAndLaboratoryMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OfficeLaboratoryAndManufacturingMember" xlink:type="locator" xlink:label="drrx_OfficeLaboratoryAndManufacturingMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_VacavilleCAMember" xlink:type="locator" xlink:label="drrx_VacavilleCAMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CupertinoCAMember" xlink:type="locator" xlink:label="drrx_CupertinoCAMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable" xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems" xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable" xlink:to="srt_StatementGeographicalAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="drrx_CupertinoCAMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="drrx_VacavilleCAMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="drrx_OfficeLaboratoryAndManufacturingMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="drrx_OfficeAndLaboratoryMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ManufacturingFacilityMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable" xlink:to="us-gaap_LeaseContractualTermAxis" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain_2" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="drrx_LeaseAmendmentMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems" xlink:to="us-gaap_LandSubjectToGroundLeases" order="10660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems" xlink:to="drrx_LeaseExpirationTerm" order="10740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems" xlink:to="drrx_LeaseExpirationYear" order="10850.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="10870.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureCommitmentsAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:type="locator" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember" xlink:type="locator" xlink:label="us-gaap_ProductMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CommitmentAndContingenciesTable" xlink:type="locator" xlink:label="drrx_CommitmentAndContingenciesTable" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CommitmentAndContingenciesLineItems" xlink:type="locator" xlink:label="drrx_CommitmentAndContingenciesLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="drrx_CommitmentAndContingenciesLineItems" xlink:to="drrx_CommitmentAndContingenciesTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="drrx_CommitmentAndContingenciesTable" xlink:to="srt_ProductOrServiceAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseNet" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="10230.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureTermLoanAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtRestructuringCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfDebtRestructuringCosts" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DebtIssuanceCost" xlink:type="locator" xlink:label="drrx_DebtIssuanceCost" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DebtInstrumentPrepaymentFeePercentage" xlink:type="locator" xlink:label="drrx_DebtInstrumentPrepaymentFeePercentage" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DebtInstrumentPrincipalPaymentPercentage" xlink:type="locator" xlink:label="drrx_DebtInstrumentPrincipalPaymentPercentage" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPaymentTerms" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebt" xlink:type="locator" xlink:label="us-gaap_SecuredDebt" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OxfordFinanceLlcTermLoanMember" xlink:type="locator" xlink:label="drrx_OxfordFinanceLlcTermLoanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="drrx_OxfordFinanceLlcTermLoanMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_SecuredDebt" order="10440.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPaymentTerms" order="10480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" order="10520.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="10560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="10600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" order="10640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" order="10680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="drrx_DebtInstrumentPrincipalPaymentPercentage" order="10720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="drrx_DebtInstrumentPrepaymentFeePercentage" order="10760.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="drrx_DebtIssuanceCost" order="10840.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_PaymentsOfDebtRestructuringCosts" order="10880.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStockholdersEquityCommonStockAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CommonStockWeightedAveragePrice" xlink:type="locator" xlink:label="drrx_CommonStockWeightedAveragePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CommonStockCapitalAmountReservedForFutureIssuance" xlink:type="locator" xlink:label="drrx_CommonStockCapitalAmountReservedForFutureIssuance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OctoberTwoThousandEighteenRegistrationStatementMember" xlink:type="locator" xlink:label="drrx_OctoberTwoThousandEighteenRegistrationStatementMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ControlledEquityOfferingProgramMember" xlink:type="locator" xlink:label="drrx_ControlledEquityOfferingProgramMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CantorFitzgeraldCoMember" xlink:type="locator" xlink:label="drrx_CantorFitzgeraldCoMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_CounterpartyNameAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="drrx_CantorFitzgeraldCoMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_ControlledEquityOfferingProgramMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_OctoberTwoThousandEighteenRegistrationStatementMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="10470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_CommonStockCapitalAmountReservedForFutureIssuance" order="10920.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="11030.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="11110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_CommonStockWeightedAveragePrice" order="11190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="11270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="11350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="11430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="11600.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower" xlink:type="locator" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower" xlink:type="locator" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_MinimumPercentageOfCombinedVotingPowerClassesOfStock" xlink:type="locator" xlink:label="drrx_MinimumPercentageOfCombinedVotingPowerClassesOfStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors" xlink:type="locator" xlink:label="drrx_ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_StockOptionsVestingPeriod" xlink:type="locator" xlink:label="drrx_StockOptionsVestingPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_EmployeeStockPurchasePlanExpirationDate" xlink:type="locator" xlink:label="drrx_EmployeeStockPurchasePlanExpirationDate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_EmployeesStockPurchasePlanExtendedTermPeriod" xlink:type="locator" xlink:label="drrx_EmployeesStockPurchasePlanExtendedTermPeriod" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm" xlink:type="locator" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NonEmployeeDirectorMember" xlink:type="locator" xlink:label="drrx_NonEmployeeDirectorMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_TwoThousandStockPlanMember" xlink:type="locator" xlink:label="drrx_TwoThousandStockPlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="drrx_TwoThousandStockPlanMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_2" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="drrx_NonEmployeeDirectorMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm" order="10740.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_EmployeesStockPurchasePlanExtendedTermPeriod" order="10760.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10810.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="11010.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_EmployeeStockPurchasePlanExpirationDate" order="11110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="11240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_StockOptionsVestingPeriod" order="11280.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors" order="11300.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="11370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_MinimumPercentageOfCombinedVotingPowerClassesOfStock" order="11390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower" order="11410.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower" order="11430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="11480.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="11500.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxExpenseFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_DeferredTaxExpenseFromStockOptionsExercised" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OptionsGrantedWithExercisePricesLowerThanFairMarket" xlink:type="locator" xlink:label="drrx_OptionsGrantedWithExercisePricesLowerThanFairMarket" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_EmployeeStockPurchasePlanExpirationDate" xlink:type="locator" xlink:label="drrx_EmployeeStockPurchasePlanExpirationDate" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_EmployeesStockPurchasePlanExtendedTermPeriod" xlink:type="locator" xlink:label="drrx_EmployeesStockPurchasePlanExtendedTermPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum" xlink:type="locator" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_EmployeeStockPurchasePlanOfferingPeriod" xlink:type="locator" xlink:label="drrx_EmployeeStockPurchasePlanOfferingPeriod" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_TwoThousandEmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="drrx_TwoThousandEmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="drrx_TwoThousandEmployeeStockPurchasePlanMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_EmployeeStockPurchasePlanOfferingPeriod" order="10560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum" order="10580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="10630.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_EmployeesStockPurchasePlanExtendedTermPeriod" order="10650.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_EmployeeStockPurchasePlanExpirationDate" order="10850.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="10870.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="10890.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="10910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="10960.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="11090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_OptionsGrantedWithExercisePricesLowerThanFairMarket" order="11130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" order="11200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_DeferredTaxExpenseFromStockOptionsExercised" order="11220.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfSharesOfCommonStockReservedForFutureIssuanceDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStockholdersEquitySummaryOfSharesOfCommonStockReservedForFutureIssuanceDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfSharesOfCommonStockReservedForFutureIssuanceDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_TwoThousandEmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="drrx_TwoThousandEmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="drrx_TwoThousandEmployeeStockPurchasePlanMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="10160.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfEmployeeStockBasedCompensationCostThatHasBeenIncludedInStatementsOfOperationsAndComprehensiveLossDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStockholdersEquitySummaryOfEmployeeStockBasedCompensationCostThatHasBeenIncludedInStatementsOfOperationsAndComprehensiveLossDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfEmployeeStockBasedCompensationCostThatHasBeenIncludedInStatementsOfOperationsAndComprehensiveLossDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:type="locator" xlink:label="us-gaap_CostOfSalesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10160.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:type="locator" xlink:label="us-gaap_AdjustmentForAmortization" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_TwoThousandEmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="drrx_TwoThousandEmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="drrx_TwoThousandEmployeeStockPurchasePlanMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AdjustmentForAmortization" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="10540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="10560.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="10610.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail">
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate" xlink:type="locator" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember" xlink:type="locator" xlink:label="us-gaap_StockCompensationPlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_StockCompensationPlanMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10260.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10330.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10340.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_2" order="10350.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10370.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="10390.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="10540.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="10600.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="10660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="10720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="10780.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="10900.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="10960.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate" order="11020.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeElevenMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeElevenMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeTenMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeTenMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeNineMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeNineMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeEightMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeEightMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeSevenMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeSevenMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeSixMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeSixMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeFiveMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeFiveMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeFourMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeFourMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeThreeMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeThreeMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeTwoMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeTwoMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeOneMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeOneMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeOneMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeTwoMember" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeThreeMember" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeFourMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeFiveMember" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeSixMember" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeSevenMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeEightMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeNineMember" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeTenMember" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeElevenMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" order="10320.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" order="10580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" order="10840.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" order="11100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" order="11360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="11620.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="11880.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_TaxCreditCarryforwardExpiration" xlink:type="locator" xlink:label="drrx_TaxCreditCarryforwardExpiration" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NetOperatingLossCarryforwardsNonExpirationAmount" xlink:type="locator" xlink:label="drrx_NetOperatingLossCarryforwardsNonExpirationAmount" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NetOperatingLossCarryforwardsExpirationAmount" xlink:type="locator" xlink:label="drrx_NetOperatingLossCarryforwardsExpirationAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:type="locator" xlink:label="us-gaap_InternalRevenueServiceIRSMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember" xlink:type="locator" xlink:label="us-gaap_ResearchMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:type="locator" xlink:label="us-gaap_IncomeTaxContingencyTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:type="locator" xlink:label="us-gaap_IncomeTaxContingencyLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_IncomeTaxContingencyTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_IncomeTaxContingencyTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_IncomeTaxContingencyTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10100.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10130.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseMember" order="10150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_IncomeTaxContingencyTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_2" order="10170.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_IncomeTaxContingencyTable" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis" order="10240.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_2" order="10250.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain" order="10270.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_InternalRevenueServiceIRSMember" order="10290.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredTaxLiabilities" order="10580.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="10640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="10700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10760.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="10850.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="11030.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="11120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="drrx_NetOperatingLossCarryforwardsExpirationAmount" order="11140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="drrx_NetOperatingLossCarryforwardsNonExpirationAmount" order="11160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="drrx_TaxCreditCarryforwardExpiration" order="11180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="11200.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="11360.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" order="11430.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureDiscontinuedOperationsAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:type="locator" xlink:label="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid" xlink:type="locator" xlink:label="drrx_AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_EvonikCorporationMember" xlink:type="locator" xlink:label="drrx_EvonikCorporationMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="locator" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="locator" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="locator" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="locator" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="drrx_EvonikCorporationMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="drrx_AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" order="10230.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:type="locator" xlink:label="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:type="locator" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember" xlink:type="locator" xlink:label="us-gaap_ProductMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="locator" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="locator" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" order="10080.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="srt_ProductOrServiceAxis" order="10110.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10140.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="10160.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" order="10190.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="10310.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" order="10430.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" order="10490.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" order="10550.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" order="10610.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" order="10670.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract" order="10730.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract" xlink:to="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" order="10850.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" order="10910.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" order="10970.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="11090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" order="11150.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="11270.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureSubsequentEventsAdditionalInformationDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail">
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CommonStockWeightedAveragePrice" xlink:type="locator" xlink:label="drrx_CommonStockWeightedAveragePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_StockIssuedDuringPeriodValueNewIssuesNet" xlink:type="locator" xlink:label="drrx_StockIssuedDuringPeriodValueNewIssuesNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OctoberTwoThousandEighteenRegistrationStatementMember" xlink:type="locator" xlink:label="drrx_OctoberTwoThousandEighteenRegistrationStatementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CantorFitzgeraldCoMember" xlink:type="locator" xlink:label="drrx_CantorFitzgeraldCoMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_CounterpartyNameAxis" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10210.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="drrx_CantorFitzgeraldCoMember" order="10230.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10420.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10450.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_OctoberTwoThousandEighteenRegistrationStatementMember" order="10470.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10640.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="10660.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="10680.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" order="10700.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="drrx_StockIssuedDuringPeriodValueNewIssuesNet" order="10720.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10770.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="drrx_CommonStockWeightedAveragePrice" order="10810.00" priority="2" use="optional" />
  </link:definitionLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccountsDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureScheduleIIValuationAndQualifyingAccountsDetail" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccountsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense" xlink:type="locator" xlink:label="drrx_ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember" xlink:type="locator" xlink:label="us-gaap_AllowanceForCreditLossMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="locator" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="locator" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureLineItems" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="srt_ValuationAndQualifyingAccountsDisclosureTable" order="10010.00" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="us-gaap_ValuationAllowancesAndReservesTypeAxis" order="10040.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="us-gaap_ValuationAllowancesAndReservesDomain_2" order="10050.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="us-gaap_ValuationAllowancesAndReservesDomain" order="10070.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="us-gaap_AllowanceForCreditLossMember" order="10090.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance" order="10120.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="drrx_ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense" order="10180.00" priority="2" use="optional" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="us-gaap_ValuationAllowancesAndReservesDeductions" order="10240.00" priority="2" use="optional" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>20
<FILENAME>drrx-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-03-05T18:40:51.4888581+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : 68f21b77591e4eada77a5e64a41cc482 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DeferredTaxLiabilitiesRightOfUseAssets" xlink:type="locator" xlink:label="drrx_DeferredTaxLiabilitiesRightOfUseAssets" />
    <link:label xml:lang="en-US" xlink:label="drrx_DeferredTaxLiabilitiesRightOfUseAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax liabilities right of use assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_DeferredTaxLiabilitiesRightOfUseAssets" xlink:to="drrx_DeferredTaxLiabilitiesRightOfUseAssets_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well Known Seasoned Issuer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFilerCategory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFilerCategory_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:type="locator" xlink:label="dei_EntityShellCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityShellCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityShellCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:type="locator" xlink:label="dei_EntitySmallBusiness" />
    <link:label xml:lang="en-US" xlink:label="dei_EntitySmallBusiness_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntitySmallBusiness_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag" xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ICFR Auditor Attestation Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Icfr Auditor Attestation Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:type="locator" xlink:label="dei_EntityPublicFloat" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityPublicFloat_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Public Float</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityPublicFloat_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:type="locator" xlink:label="dei_DocumentAnnualReport" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentAnnualReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Annual Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentAnnualReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:type="locator" xlink:label="dei_DocumentTransitionReport" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentTransitionReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentTransitionReport_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="locator" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated By Reference [Text Block]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ContractResearchLiability" xlink:type="locator" xlink:label="drrx_ContractResearchLiability" />
    <link:label xml:lang="en-US" xlink:label="drrx_ContractResearchLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to clinical and non-clinical costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include clinical trial expenses and non-clinical study expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ContractResearchLiability" xlink:to="drrx_ContractResearchLiability_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Financial Position [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">A S S E T S</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents At Carrying Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EscrowDeposit" xlink:type="locator" xlink:label="us-gaap_EscrowDeposit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EscrowDeposit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash held in escrow</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EscrowDeposit" xlink:to="us-gaap_EscrowDeposit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EscrowDeposit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Escrow Deposit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Securities Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable (net of allowances of $72 at December 31, 2020 and $27 at December 31, 2019)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable Net Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:type="locator" xlink:label="us-gaap_InventoryNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventories, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense And Other Assets Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Discontinued operations, current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Of Disposal Group Including Discontinued Operation Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Right Of Use Asset</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Goodwill_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Goodwill_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments" xlink:type="locator" xlink:label="us-gaap_LongTermInvestments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermInvestments" xlink:to="us-gaap_LongTermInvestments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedInvestmentsNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedInvestmentsNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedInvestmentsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term restricted investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedInvestmentsNoncurrent" xlink:to="us-gaap_RestrictedInvestmentsNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedInvestmentsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Investments Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other long-term assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Discontinued operations, non-current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Assets Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Assets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Assets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">L I A B I L I T I E S A N D S T O C K H O L D E R S&#8217; E Q U I T Y</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ContractResearchLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contract research liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ContractResearchLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract Research Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue, current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan, current portion, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities, current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Discontinued operations, current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Of Disposal Group Including Discontinued Operation Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue, non-current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities, non-current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liability Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan, non-current portion, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other long-term liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Discontinued operations, non-current portion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities Of Disposal Group Including Discontinued Operation Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders&#8217; equity:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, $0.0001 par value: 10,000 shares authorized; none issued and outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.0001 par value: 350,000 shares authorized; 203,533 and 195,257 shares issued and outstanding at December 31, 2020 and 2019, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income Loss Net Of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings Accumulated Deficit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Stockholders&#8217; equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders&#8217; equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities And Stockholders Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allowances for accounts receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Allowance For Doubtful Accounts Receivable Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Par Or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Par Or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Shares Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product and Service</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Product Or Service [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product and Service</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Products And Services [Domain]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" xlink:type="locator" xlink:label="drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaborative research and development and other revenue.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" xlink:to="drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Research and Development and Other Revenue [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Research And Development And Other Revenue [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember" xlink:type="locator" xlink:label="us-gaap_ProductMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProductMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product Revenue, Net [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductMember" xlink:to="us-gaap_ProductMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProductMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Product [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue From Contract With Customer Excluding Assessed Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of product revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cost Of Goods And Services Sold</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:type="locator" xlink:label="us-gaap_TypeOfCostGoodOrServiceExtensibleList" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfCostGoodOrServiceExtensibleList_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Type of cost, good or service [extensible list]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:to="us-gaap_TypeOfCostGoodOrServiceExtensibleList_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfCostGoodOrServiceExtensibleList_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Type Of Cost Good Or Service Extensible List</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling, general and administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Selling General And Administrative Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Costs And Expenses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income (expense):</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income Expense [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncome" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNonoperatingIncome_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest and other income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="us-gaap_OtherNonoperatingIncome_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNonoperatingIncome_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" xlink:label="us-gaap_InterestExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net other income (expense)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from continuing operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income from discontinued operations (Note 10)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Discontinued Operations Net Of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Income Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net change in unrealized gain on available-for-sale securities, net of tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total comprehensive loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income Net Of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net income (loss) per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic and diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Basic And Diluted [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss from continuing operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Per Basic Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income from discontinued operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Discontinued Operations Net Of Tax Per Basic Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per common share, basic and diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Loss From Continuing Operations Per Basic And Diluted Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average shares used in computing net income (loss) per share, basic and diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Share Outstanding Basic And Diluted</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares" xlink:type="locator" xlink:label="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares" />
    <link:label xml:lang="en-US" xlink:label="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock upon exercise of stock options and purchases of employee stock purchase plan shares.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares" xlink:to="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan" />
    <link:label xml:lang="en-US" xlink:label="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock upon exercise of stock options and purchases of employee stock purchase plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan" xlink:to="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities" xlink:type="locator" xlink:label="drrx_AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities" />
    <link:label xml:lang="en-US" xlink:label="drrx_AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Adjustments to additional paid-in capital stock issued to settle accrued liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities" xlink:to="drrx_AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Stockholders Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Equity Components [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-In Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid In Capital [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Income (loss) [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis" xlink:type="locator" xlink:label="srt_RestatementAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_RestatementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revision of Prior Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RestatementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restatement [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain" xlink:type="locator" xlink:label="srt_RestatementDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_RestatementDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revision of Prior Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementDomain" xlink:to="srt_RestatementDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RestatementDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restatement [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember" xlink:type="locator" xlink:label="srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember" />
    <link:label xml:lang="en-US" xlink:label="srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revision of Prior Period, Change in Accounting Principle, Adjustment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember" xlink:to="srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revision Of Prior Period Change In Accounting Principle Adjustment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options and purchases of ESPP shares</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock Upon Exercise Of Stock Options And Purchases Of Employee Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options and purchases of ESPP shares, shares</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock Upon Exercise Of Stock Options And Purchases Of Employee Stock Purchase Plan Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon equity financings, net of issuance costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value New Issues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon equity financings, net of issuance cost, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares New Issues</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of fully vested options to settle accrued liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Stock Issued To Settle Accrued Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense from stock options and ESPP shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in unrealized gain (loss) on available-for-sale securities, net of tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance, shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock issuance costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Additional Paid In Capital Stock Issued Issuance Costs</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ChangesInOperatingLeaseLiabilities" xlink:type="locator" xlink:label="drrx_ChangesInOperatingLeaseLiabilities" />
    <link:label xml:lang="en-US" xlink:label="drrx_ChangesInOperatingLeaseLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Changes in operating lease liabilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ChangesInOperatingLeaseLiabilities" xlink:to="drrx_ChangesInOperatingLeaseLiabilities_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_IncreaseDecreaseInContractResearchLiability" xlink:type="locator" xlink:label="drrx_IncreaseDecreaseInContractResearchLiability" />
    <link:label xml:lang="en-US" xlink:label="drrx_IncreaseDecreaseInContractResearchLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">The increase (decrease) during the reporting period in the aggregate amount of clinical and non-clinical expenses incurred but not yet paid.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_IncreaseDecreaseInContractResearchLiability" xlink:to="drrx_IncreaseDecreaseInContractResearchLiability_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Of Cash Flows [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProfitLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProfitLoss_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Profit Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation Depletion And Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown" xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryWriteDown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventory write-down</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryWriteDown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Write Down</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of debt issuance cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amortization Of Financing Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Net accretion/amortization on investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accretion Amortization Of Discounts And Premiums Investments</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ChangesInOperatingLeaseLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ChangesInOperatingLeaseLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Changes In Operating Lease Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:type="locator" xlink:label="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Gain on sale of LACTEL product line</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:to="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in assets and liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accounts receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Receivable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Inventories</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Inventories</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Prepaid Deferred Expense And Other Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accounts Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accrued Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_IncreaseDecreaseInContractResearchLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contract research liability</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_IncreaseDecreaseInContractResearchLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Contract Research Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Contract With Customer Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total adjustments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash (used in) provided by operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Property Plant And Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of available-for-sale securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments To Acquire Available For Sale Securities Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from maturities of available-for-sale securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by (used in) investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payments on equipment financing obligations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:to="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Repayments Of Long Term Capital Lease Obligations</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds from issuances of common stock upon exercise of stock options, and purchases of ESPP shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds from issuances of common stock in connection with equity financings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Term loan amendment cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Repayments Of Long Term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided By Used In Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net (decrease) increase in cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash, cash equivalents, and restricted cash, beginning of the period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash, cash equivalents, and restricted cash, end of the period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of cash flow information</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplementary disclosure of non-cash investing and financing information</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Investing And Financing Items [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EscrowDepositsRelatedToPropertySales" xlink:type="locator" xlink:label="us-gaap_EscrowDepositsRelatedToPropertySales" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EscrowDepositsRelatedToPropertySales_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash held in escrow</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EscrowDepositsRelatedToPropertySales" xlink:to="us-gaap_EscrowDepositsRelatedToPropertySales_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EscrowDepositsRelatedToPropertySales_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Escrow Deposits Related To Property Sales</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1" xlink:type="locator" xlink:label="us-gaap_StockIssued1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssued1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fully vested options issued to settle accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssued1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use assets obtained in exchange for operating lease obligations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Right Of Use Asset Obtained In Exchange For Operating Lease Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LongTermRestrictedInvestmentsMember" xlink:type="locator" xlink:label="drrx_LongTermRestrictedInvestmentsMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_LongTermRestrictedInvestmentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Long term restricted investments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_LongTermRestrictedInvestmentsMember" xlink:to="drrx_LongTermRestrictedInvestmentsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_LongTermRestrictedInvestmentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long Term Restricted Investments [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_LongTermRestrictedInvestmentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Restricted Investments [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCash" xlink:type="locator" xlink:label="us-gaap_RestrictedCash" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCash_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedCash_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Organization Consolidation And Presentation Of Financial Statements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Strategic Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_RestrictedInvestmentsDisclosureTextBlock" xlink:type="locator" xlink:label="drrx_RestrictedInvestmentsDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="drrx_RestrictedInvestmentsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted investments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_RestrictedInvestmentsDisclosureTextBlock" xlink:to="drrx_RestrictedInvestmentsDisclosureTextBlock_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TextBlockAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Text Block [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TextBlockAbstract" xlink:to="us-gaap_TextBlockAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_RestrictedInvestmentsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Investments</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_RestrictedInvestmentsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Investments Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsDisclosureTextBlock" xlink:to="us-gaap_CommitmentsDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommitmentsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitments Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:type="locator" xlink:label="us-gaap_LongTermDebtTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term Loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders&apos; Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Not Discontinued Operation Income Statement Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disposal Groups, Including Discontinued Operations, Disclosure</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Groups Including Discontinued Operations Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:type="locator" xlink:label="srt_ValuationAndQualifyingAccountsAbstract" />
    <link:label xml:lang="en-US" xlink:label="srt_ValuationAndQualifyingAccountsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation And Qualifying Accounts [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ValuationAndQualifyingAccountsAbstract" xlink:to="srt_ValuationAndQualifyingAccountsAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="locator" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" />
    <link:label xml:lang="en-US" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule II-Valuation and Qualifying Accounts</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Valuation And Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NatureOfOperationsPolicyTextBlock" xlink:type="locator" xlink:label="drrx_NatureOfOperationsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="drrx_NatureOfOperationsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Nature of operations.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_NatureOfOperationsPolicyTextBlock" xlink:to="drrx_NatureOfOperationsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_NatureOfOperationsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nature Of Operations Policy</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_NatureOfOperationsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Nature Of Operations Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Basis Of Accounting Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DiscontinuedOperationsTextblock" xlink:type="locator" xlink:label="drrx_DiscontinuedOperationsTextblock" />
    <link:label xml:lang="en-US" xlink:label="drrx_DiscontinuedOperationsTextblock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of discontinued operations.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_DiscontinuedOperationsTextblock" xlink:to="drrx_DiscontinuedOperationsTextblock_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_DiscontinuedOperationsTextblock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Discontinued Operations</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DiscontinuedOperationsTextblock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Discontinued Operations Textblock</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock" xlink:type="locator" xlink:label="drrx_LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="drrx_LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Liquidity and need to raise additional capital.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock" xlink:to="drrx_LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liquidity and Need to Raise Additional Capital Policy</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liquidity And Need To Raise Additional Capital Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash, Cash Equivalents and Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentrations of Credit Risk</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Credit Risk</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_MajorCustomersPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MajorCustomersPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer and Product Line Concentrations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:to="us-gaap_MajorCustomersPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MajorCustomersPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Major Customers Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventories</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill And Intangible Assets Goodwill Policy</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of Long-Lived Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Impairment Or Disposal Of Long Lived Assets Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Leases Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Compensation Related Costs Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Recognition Policy [Text Block]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_PrepaidAndAccruedContractResearchExpensesPolicyTextBlock" xlink:type="locator" xlink:label="drrx_PrepaidAndAccruedContractResearchExpensesPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="drrx_PrepaidAndAccruedContractResearchExpensesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid and Accrued Contract Research Expenses.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_PrepaidAndAccruedContractResearchExpensesPolicyTextBlock" xlink:to="drrx_PrepaidAndAccruedContractResearchExpensesPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_PrepaidAndAccruedContractResearchExpensesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid and Accrued Contract Research Expenses</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_PrepaidAndAccruedContractResearchExpensesPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid And Accrued Contract Research Expenses Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Reporting</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Policy [Text Block]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShippingAndHandlingPolicyTextBlock" xlink:type="locator" xlink:label="drrx_ShippingAndHandlingPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="drrx_ShippingAndHandlingPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Shipping and handling.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ShippingAndHandlingPolicyTextBlock" xlink:to="drrx_ShippingAndHandlingPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_ShippingAndHandlingPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shipping and Handling</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ShippingAndHandlingPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Shipping And Handling Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Pronouncements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements Policy Policy [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Total Revenue by Geographic Region</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:to="us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Components of Inventories</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Inventory Current Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Numerators and Denominators in Calculation of Basic and Diluted Net Income (Loss) per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Collaborative Research and Development and Other Revenues Associated with Company&apos;s Major Third-Party Collaborators</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Changes in the Company&apos;s Contract Asset and Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Asset And Liability Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements of Assets and Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Money Market Funds and Available-for-Sale Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Cost and Estimated Fair Value of Available-for-Sale Securities by Contractual Maturity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investments Classified By Contractual Maturity Date Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Text Block]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock" xlink:type="locator" xlink:label="drrx_ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="drrx_ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of lease arrangements of company facilities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock" xlink:to="drrx_ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Lease Arrangements of Company Facilities</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Lease Arrangements Of Company Facilities Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Operating Lease Minimum Payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Future Minimum Rental Payments For Operating Leases Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Maturities and Interest Payments under Term Loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Debt Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Shares of Common Stock Reserved for Future Issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Common Stock Outstanding Roll Forward Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Option Activity under all Stock-Based Compensation Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Employee Stock-Based Compensation Cost that has been Included in Statements of Operations and Comprehensive Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Assumptions Used to Estimate Fair Value of Options Granted and Shares Purchased</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Options Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Stock Options Roll Forward Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reconciliation of Income Tax Expenses (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Components of Company&apos;s Deferred Tax Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reconciliation of Unrecognized Tax Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Unrecognized Tax Benefits Roll Forward Table [Text Block]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock" xlink:type="locator" xlink:label="drrx_SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="drrx_SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of Discontinued Operations Reported in Statement of Operations.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock" xlink:to="drrx_SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Discontinued Operations Reported in Statement of Operations</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Discontinued Operations Reported In Statement Of Operations Table [Text Block]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock" xlink:type="locator" xlink:label="drrx_SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="drrx_SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of Assets and Liabilities Reported as Discontinued Operations in Balance Sheet.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock" xlink:to="drrx_SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Assets and Liabilities Reported as Discontinued Operations in Balance Sheet</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Assets And Liabilities Reported As Discontinued Operations In Balance Sheet Table [Text Block]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock" xlink:type="locator" xlink:label="drrx_SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock" />
    <link:label xml:lang="en-US" xlink:label="drrx_SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of Non-cash Items Related to Discontinued Operations Included in Statement of Cash Flows.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock" xlink:to="drrx_SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Non-cash Items Related to Discontinued Operations Included in Statement of Cash Flows</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Non Cash Items Related To Discontinued Operations Included In Statement Of Cash Flows Table [Text Block]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="drrx_SummaryOfSignificantAccountingPoliciesLineItems" />
    <link:label xml:lang="en-US" xlink:label="drrx_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of significant accounting policies.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="drrx_SummaryOfSignificantAccountingPoliciesLineItems_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="drrx_SummaryOfSignificantAccountingPoliciesTable" />
    <link:label xml:lang="en-US" xlink:label="drrx_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="drrx_SummaryOfSignificantAccountingPoliciesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RangeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Range [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:label xml:lang="en-US" xlink:label="srt_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_MinimumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:label xml:lang="en-US" xlink:label="srt_MaximumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_MaximumMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LactelProductLineMember" xlink:type="locator" xlink:label="drrx_LactelProductLineMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_LactelProductLineMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">LACTEL product line.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_LactelProductLineMember" xlink:to="drrx_LactelProductLineMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_LactelProductLineMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LACTEL Product Line [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_LactelProductLineMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lactel Product Line [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk Benchmark</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk By Benchmark [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk Benchmark</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales Revenue Net [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sales Revenue Net [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AlzetProductLineMember" xlink:type="locator" xlink:label="drrx_AlzetProductLineMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_AlzetProductLineMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">ALZET Product Line.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_AlzetProductLineMember" xlink:to="drrx_AlzetProductLineMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_AlzetProductLineMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ALZET Product Line [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_AlzetProductLineMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Alzet Product Line [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk By Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductConcentrationRiskMember" xlink:type="locator" xlink:label="us-gaap_ProductConcentrationRiskMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProductConcentrationRiskMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product Concentration Risk [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductConcentrationRiskMember" xlink:to="us-gaap_ProductConcentrationRiskMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProductConcentrationRiskMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:type="locator" xlink:label="srt_MajorCustomersAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_MajorCustomersAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_MajorCustomersAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Major Customers [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_NameOfMajorCustomerDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="srt_NameOfMajorCustomerDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_NameOfMajorCustomerDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Name Of Major Customer [Domain]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_GileadMember" xlink:type="locator" xlink:label="drrx_GileadMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_GileadMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Gilead.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_GileadMember" xlink:to="drrx_GileadMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_GileadMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gilead [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_GileadMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Gilead [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_IndiviorMember" xlink:type="locator" xlink:label="drrx_IndiviorMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_IndiviorMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Indivior.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_IndiviorMember" xlink:to="drrx_IndiviorMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_IndiviorMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Indivior [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_IndiviorMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Indivior [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer Concentration Risk [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LACTELMember" xlink:type="locator" xlink:label="drrx_LACTELMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_LACTELMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">LACTEL member.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_LACTELMember" xlink:to="drrx_LACTELMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_LACTELMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">L A C T E L</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_LACTELMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">L A C T E L [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="locator" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments For New Accounting Pronouncements [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Type Of Adoption [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdate201409Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountingStandardsUpdate201409Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update 2014-09</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201409Member" xlink:to="us-gaap_AccountingStandardsUpdate201409Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccountingStandardsUpdate201409Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update201409 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:type="locator" xlink:label="dei_EntityIncorporationDateOfIncorporation" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Date of incorporation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationDateOfIncorporation" xlink:to="dei_EntityIncorporationDateOfIncorporation_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation Date Of Incorporation</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated deficit</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LiquidInvestmentsMaturityPeriodDescriptionMaximum" xlink:type="locator" xlink:label="drrx_LiquidInvestmentsMaturityPeriodDescriptionMaximum" />
    <link:label xml:lang="en-US" xlink:label="drrx_LiquidInvestmentsMaturityPeriodDescriptionMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Liquid investments maturity period description maximum.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_LiquidInvestmentsMaturityPeriodDescriptionMaximum" xlink:to="drrx_LiquidInvestmentsMaturityPeriodDescriptionMaximum_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LongTermInvestmentsMaturityPeriodDescriptionMinimum" xlink:type="locator" xlink:label="drrx_LongTermInvestmentsMaturityPeriodDescriptionMinimum" />
    <link:label xml:lang="en-US" xlink:label="drrx_LongTermInvestmentsMaturityPeriodDescriptionMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Long term investments maturity period description minimum.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_LongTermInvestmentsMaturityPeriodDescriptionMinimum" xlink:to="drrx_LongTermInvestmentsMaturityPeriodDescriptionMinimum_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShortTermInvestmentMaturityPeriod" xlink:type="locator" xlink:label="drrx_ShortTermInvestmentMaturityPeriod" />
    <link:label xml:lang="en-US" xlink:label="drrx_ShortTermInvestmentMaturityPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Short-term investment maturity period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ShortTermInvestmentMaturityPeriod" xlink:to="drrx_ShortTermInvestmentMaturityPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_LiquidInvestmentsMaturityPeriodDescriptionMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Highly liquid investments maturity period</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_LiquidInvestmentsMaturityPeriodDescriptionMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Liquid Investments Maturity Period Description Maximum</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_LongTermInvestmentsMaturityPeriodDescriptionMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long term investments maturity period description minimum</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_LongTermInvestmentsMaturityPeriodDescriptionMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Investments Maturity Period Description Minimum</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ShortTermInvestmentMaturityPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short term investment maturity period</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ShortTermInvestmentMaturityPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Investment Maturity Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:type="locator" xlink:label="us-gaap_RealizedInvestmentGainsLosses" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Realized investment gains losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RealizedInvestmentGainsLosses" xlink:to="us-gaap_RealizedInvestmentGainsLosses_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Realized Investment Gains Losses</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CashHeldInEscrow" xlink:type="locator" xlink:label="drrx_CashHeldInEscrow" />
    <link:label xml:lang="en-US" xlink:label="drrx_CashHeldInEscrow_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash held in escrow.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_CashHeldInEscrow" xlink:to="drrx_CashHeldInEscrow_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_PaymentFromEscrow" xlink:type="locator" xlink:label="drrx_PaymentFromEscrow" />
    <link:label xml:lang="en-US" xlink:label="drrx_PaymentFromEscrow_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment from escrow.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_PaymentFromEscrow" xlink:to="drrx_PaymentFromEscrow_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_CashHeldInEscrow_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash held in escrow</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_CashHeldInEscrow_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash Held In Escrow</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_PaymentFromEscrow_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount released from escrow</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_PaymentFromEscrow_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payment From Escrow</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of revenue accounted in Company&apos;s total revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Percentage1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Revenues From External Customers And Long Lived Assets [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Revenues From External Customers And Long Lived Assets [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Statement Geographical [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Segment Geographical [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:type="locator" xlink:label="country_US" />
    <link:label xml:lang="en-US" xlink:label="country_US_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">UNITED STATES</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl" />
    <link:label xml:lang="en-US" xlink:label="country_US_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">UNITED STATES</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember" xlink:type="locator" xlink:label="srt_EuropeMember" />
    <link:label xml:lang="en-US" xlink:label="srt_EuropeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Europe</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EuropeMember" xlink:to="srt_EuropeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_EuropeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Europe [Member]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_JP" xlink:type="locator" xlink:label="country_JP" />
    <link:label xml:lang="en-US" xlink:label="country_JP_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">JAPAN</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_JP" xlink:to="country_JP_lbl" />
    <link:label xml:lang="en-US" xlink:label="country_JP_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">JAPAN</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OtherForeignCountriesMember" xlink:type="locator" xlink:label="drrx_OtherForeignCountriesMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_OtherForeignCountriesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Other foreign countries.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_OtherForeignCountriesMember" xlink:to="drrx_OtherForeignCountriesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_OtherForeignCountriesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Foreign Countries</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_OtherForeignCountriesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Foreign Countries [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="locator" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenues From External Customers And Long Lived Assets [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Revenues From External Customers And Long Lived Assets [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Raw materials</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Raw Materials Net Of Reserves</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Work in-process</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Work In Process Net Of Reserves</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finished goods</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Inventory Finished Goods Net Of Reserves</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_InventoryNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total inventories</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property plant and equipment useful life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of operating segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Operating Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of reportable segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Reportable Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of long lived assets held for use</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Impairment Of Long Lived Assets Held For Use</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LesseeOperatingLeaseIncrementalBorrowingRate" xlink:type="locator" xlink:label="drrx_LesseeOperatingLeaseIncrementalBorrowingRate" />
    <link:label xml:lang="en-US" xlink:label="drrx_LesseeOperatingLeaseIncrementalBorrowingRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Incremental borrowing rate used by lessee to determine present value of operating lease payments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_LesseeOperatingLeaseIncrementalBorrowingRate" xlink:to="drrx_LesseeOperatingLeaseIncrementalBorrowingRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_LesseeOperatingLeaseIncrementalBorrowingRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee operating lease incremental borrowing rate</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_LesseeOperatingLeaseIncrementalBorrowingRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Incremental Borrowing Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease weighted average remaining lease term1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Weighted Average Remaining Lease Term1</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities" xlink:type="locator" xlink:label="drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities" />
    <link:label xml:lang="en-US" xlink:label="drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Weighted average number of shares outstanding diluted net of effect of dilutive securities.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities" xlink:to="drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAbstract" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Numerators:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Income Loss [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Denominators:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Shares Outstanding Diluted Disclosure Items [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted average shares used to compute basic net loss per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Shares Outstanding Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_DilutiveSecuritiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DilutiveSecuritiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effect of dilutive securities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_DilutiveSecuritiesAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DilutiveSecuritiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Dilutive Securities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements" xlink:type="locator" xlink:label="us-gaap_IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dilution from stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements" xlink:to="us-gaap_IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Incremental Common Shares Attributable To Equity Unit Purchase Agreements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="locator" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dilution from ESPP</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Incremental Common Shares Attributable To Share Based Payment Arrangements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Dilutive common shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted average shares used to compute diluted net loss per share</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number Of Shares Outstanding Diluted Net Of Effect Of Dilutive Securities</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss per share:</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive securities excluded from computation of earnings per share amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Type Of Arrangement [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Arrangements And Nonarrangement Transactions [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AgreementWithGileadMember" xlink:type="locator" xlink:label="drrx_AgreementWithGileadMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_AgreementWithGileadMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Agreement with Gilead [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_AgreementWithGileadMember" xlink:to="drrx_AgreementWithGileadMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_AgreementWithGileadMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agreement with Gilead [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_AgreementWithGileadMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Agreement With Gilead [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AgreementsWithOtherCollaboratorsOrCounterpartiesMember" xlink:type="locator" xlink:label="drrx_AgreementsWithOtherCollaboratorsOrCounterpartiesMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_AgreementsWithOtherCollaboratorsOrCounterpartiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Agreements with other collaborators or counterparties.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_AgreementsWithOtherCollaboratorsOrCounterpartiesMember" xlink:to="drrx_AgreementsWithOtherCollaboratorsOrCounterpartiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_AgreementsWithOtherCollaboratorsOrCounterpartiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agreements With Other Collaborators or Counterparties [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_AgreementsWithOtherCollaboratorsOrCounterpartiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Agreements With Other Collaborators Or Counterparties [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total collaborative research and development and other revenue</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicenseMember" xlink:type="locator" xlink:label="us-gaap_LicenseMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LicenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License Fees [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicenseMember" xlink:to="us-gaap_LicenseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LicenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">License [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount related to the milestone payment earned</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Revenue Recognized</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DevelopmentBasedMilestones" xlink:type="locator" xlink:label="drrx_DevelopmentBasedMilestones" />
    <link:label xml:lang="en-US" xlink:label="drrx_DevelopmentBasedMilestones_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Development based milestones.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_DevelopmentBasedMilestones" xlink:to="drrx_DevelopmentBasedMilestones_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Arrangement, Contract to Perform for Others, Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Arrangement Contract To Perform For Others By Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Arrangement, Contract to Perform for Others, Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Arrangement Contract To Perform For Others Type [Domain]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DevelopmentBasedMilestonesMember" xlink:type="locator" xlink:label="drrx_DevelopmentBasedMilestonesMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_DevelopmentBasedMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Development based milestones.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_DevelopmentBasedMilestonesMember" xlink:to="drrx_DevelopmentBasedMilestonesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_DevelopmentBasedMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Development-Based Milestones [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DevelopmentBasedMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Development Based Milestones [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_SalesBasedMilestonesMember" xlink:type="locator" xlink:label="drrx_SalesBasedMilestonesMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_SalesBasedMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Sales based milestones.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_SalesBasedMilestonesMember" xlink:to="drrx_SalesBasedMilestonesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_SalesBasedMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales-Based Milestones [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_SalesBasedMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sales Based Milestones [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ChangeInAccountingEstimateByTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ChangeInAccountingEstimateByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in Accounting Estimate by Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:to="us-gaap_ChangeInAccountingEstimateByTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ChangeInAccountingEstimateByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Change In Accounting Estimate By Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:type="locator" xlink:label="us-gaap_ChangeInAccountingEstimateTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ChangeInAccountingEstimateTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in Accounting Estimate, Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:to="us-gaap_ChangeInAccountingEstimateTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ChangeInAccountingEstimateTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Change In Accounting Estimate Type [Domain]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_EarlyStageClinicalTestingMember" xlink:type="locator" xlink:label="drrx_EarlyStageClinicalTestingMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_EarlyStageClinicalTestingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Early stage clinical testing.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_EarlyStageClinicalTestingMember" xlink:to="drrx_EarlyStageClinicalTestingMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_EarlyStageClinicalTestingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Early stage clinical testing [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_EarlyStageClinicalTestingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Early Stage Clinical Testing [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LateStageClinicalTestingMember" xlink:type="locator" xlink:label="drrx_LateStageClinicalTestingMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_LateStageClinicalTestingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Late stage clinical testing.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_LateStageClinicalTestingMember" xlink:to="drrx_LateStageClinicalTestingMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_LateStageClinicalTestingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Late stage clinical testing [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_LateStageClinicalTestingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Late Stage Clinical Testing [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RegulatoryReviewsOfFilingsMember" xlink:type="locator" xlink:label="us-gaap_RegulatoryReviewsOfFilingsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RegulatoryReviewsOfFilingsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Regulatory filings [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RegulatoryReviewsOfFilingsMember" xlink:to="us-gaap_RegulatoryReviewsOfFilingsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RegulatoryReviewsOfFilingsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Regulatory Reviews Of Filings [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_RegulatoryApprovalsMember" xlink:type="locator" xlink:label="drrx_RegulatoryApprovalsMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_RegulatoryApprovalsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Regulatory approvals.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_RegulatoryApprovalsMember" xlink:to="drrx_RegulatoryApprovalsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_RegulatoryApprovalsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Regulatory approvals [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_RegulatoryApprovalsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Regulatory Approvals [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DevelopmentBasedMilestones_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Development-based milestones</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DevelopmentBasedMilestones_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Development Based Milestones</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ContractWithCustomerLiabilityMilestonePayment" xlink:type="locator" xlink:label="drrx_ContractWithCustomerLiabilityMilestonePayment" />
    <link:label xml:lang="en-US" xlink:label="drrx_ContractWithCustomerLiabilityMilestonePayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract with customer liability milestone payment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ContractWithCustomerLiabilityMilestonePayment" xlink:to="drrx_ContractWithCustomerLiabilityMilestonePayment_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember" xlink:type="locator" xlink:label="drrx_UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upfront, Development, Regulatory and Sales-Based Milestones [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember" xlink:to="drrx_UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Upfront Development Regulatory And Sales Based Milestone [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ContractWithCustomerLiabilityMilestonePayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount related to the milestone payment earned</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ContractWithCustomerLiabilityMilestonePayment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Milestone Payment</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" xlink:type="locator" xlink:label="drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" />
    <link:label xml:lang="en-US" xlink:label="drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Performance milestone payments based on successful development and approval of the four ORADUR based opioids.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" xlink:to="drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Performance milestone payments based on successful development</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Performance Milestone Payments Based On Successful Development</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AccruedAmountOfFinalPaymentOfTermLoan" xlink:type="locator" xlink:label="drrx_AccruedAmountOfFinalPaymentOfTermLoan" />
    <link:label xml:lang="en-US" xlink:label="drrx_AccruedAmountOfFinalPaymentOfTermLoan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued amount of final payment of term loan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_AccruedAmountOfFinalPaymentOfTermLoan" xlink:to="drrx_AccruedAmountOfFinalPaymentOfTermLoan_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_AccruedAmountOfFinalPaymentOfTermLoan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue recognized</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_AccruedAmountOfFinalPaymentOfTermLoan_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Amount Of Final Payment Of Term Loan</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue" xlink:type="locator" xlink:label="us-gaap_DeferredRevenue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred Revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredRevenue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Revenue</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerDurationAxis" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerDurationAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerDurationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contract with Customer, Duration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerDurationAxis" xlink:to="us-gaap_ContractWithCustomerDurationAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerDurationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Duration [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerDurationDomain" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerDurationDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerDurationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contract with Customer, Duration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerDurationDomain" xlink:to="us-gaap_ContractWithCustomerDurationDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerDurationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Duration [Domain]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AdditionsMember" xlink:type="locator" xlink:label="drrx_AdditionsMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_AdditionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Additions [Member].</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_AdditionsMember" xlink:to="drrx_AdditionsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_AdditionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additions [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_AdditionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Additions [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DeletionsMember" xlink:type="locator" xlink:label="drrx_DeletionsMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_DeletionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Deletions [Member].</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_DeletionsMember" xlink:to="drrx_DeletionsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_DeletionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deletions [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DeletionsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deletions [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerAssetNetCurrentAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerAssetNetCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerAssetNetCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerAssetNetCurrentAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerAssetNetCurrentAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Asset Net Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:type="locator" xlink:label="us-gaap_ReceivablesNetCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ReceivablesNetCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesNetCurrent" xlink:to="us-gaap_ReceivablesNetCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ReceivablesNetCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Receivables Net Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerAssetNetCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerAssetNetCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total contract asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="us-gaap_ContractWithCustomerAssetNetCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerAssetNetCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Asset Net Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityAbstract" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total contract liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NonRefundableUpfrontPaymentReceived" xlink:type="locator" xlink:label="drrx_NonRefundableUpfrontPaymentReceived" />
    <link:label xml:lang="en-US" xlink:label="drrx_NonRefundableUpfrontPaymentReceived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Non-refundable upfront payment received.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_NonRefundableUpfrontPaymentReceived" xlink:to="drrx_NonRefundableUpfrontPaymentReceived_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_GrantedPatentsExtendingYearMinimum" xlink:type="locator" xlink:label="drrx_GrantedPatentsExtendingYearMinimum" />
    <link:label xml:lang="en-US" xlink:label="drrx_GrantedPatentsExtendingYearMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Granted patents extending year, minimum.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_GrantedPatentsExtendingYearMinimum" xlink:to="drrx_GrantedPatentsExtendingYearMinimum_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_PatentPurchaseAgreementWithIndiviorMember" xlink:type="locator" xlink:label="drrx_PatentPurchaseAgreementWithIndiviorMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_PatentPurchaseAgreementWithIndiviorMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Patent Purchase Agreement with Indivior.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_PatentPurchaseAgreementWithIndiviorMember" xlink:to="drrx_PatentPurchaseAgreementWithIndiviorMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_PatentPurchaseAgreementWithIndiviorMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Patent Purchase Agreement with Indivior [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_PatentPurchaseAgreementWithIndiviorMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Patent Purchase Agreement With Indivior [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_RegulatoryBasedMilestoneMember" xlink:type="locator" xlink:label="drrx_RegulatoryBasedMilestoneMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_RegulatoryBasedMilestoneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Regulatory based milestone.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_RegulatoryBasedMilestoneMember" xlink:to="drrx_RegulatoryBasedMilestoneMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_RegulatoryBasedMilestoneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Regulatory Based Milestone [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_RegulatoryBasedMilestoneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Regulatory Based Milestone [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyMember" xlink:type="locator" xlink:label="us-gaap_RoyaltyMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RoyaltyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intellectual Property Rights [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyMember" xlink:to="us-gaap_RoyaltyMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_RoyaltyMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Royalty [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_NonRefundableUpfrontPaymentReceived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upfront non-refundable payment received</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_NonRefundableUpfrontPaymentReceived_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Non Refundable Upfront Payment Received</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_GrantedPatentsExtendingYearMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted patents extending year, minimum</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_GrantedPatentsExtendingYearMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Granted Patents Extending Year Minimum</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Revenue recognition milestone achieved</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AgreementWithSantenPharmaceuticalCoLtdMember" xlink:type="locator" xlink:label="drrx_AgreementWithSantenPharmaceuticalCoLtdMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_AgreementWithSantenPharmaceuticalCoLtdMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Agreement with Santen Pharmaceutical Co., Ltd.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_AgreementWithSantenPharmaceuticalCoLtdMember" xlink:to="drrx_AgreementWithSantenPharmaceuticalCoLtdMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_AgreementWithSantenPharmaceuticalCoLtdMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agreement with Santen Pharmaceutical Co., Ltd. [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_AgreementWithSantenPharmaceuticalCoLtdMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Agreement With Santen Pharmaceutical Co Ltd [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CommercializationBasedMilestonesMember" xlink:type="locator" xlink:label="drrx_CommercializationBasedMilestonesMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_CommercializationBasedMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Commercialization based milestones.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_CommercializationBasedMilestonesMember" xlink:to="drrx_CommercializationBasedMilestonesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_CommercializationBasedMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercialization-Based Milestones [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_CommercializationBasedMilestonesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commercialization Based Milestones [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cumulative aggregate payments received by the Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Arrangement Contract To Perform For Others Compensation Earned</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AgreementWithSandozAGMember" xlink:type="locator" xlink:label="drrx_AgreementWithSandozAGMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_AgreementWithSandozAGMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Agreement with Sandoz AG.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_AgreementWithSandozAGMember" xlink:to="drrx_AgreementWithSandozAGMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_AgreementWithSandozAGMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agreement with Sandoz AG [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_AgreementWithSandozAGMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Agreement With Sandoz A G [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Asset Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money market funds [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember" xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CertificatesOfDepositMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Certificates of deposit [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CertificatesOfDepositMember" xlink:to="us-gaap_CertificatesOfDepositMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CertificatesOfDepositMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Certificates Of Deposit [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember" xlink:type="locator" xlink:label="us-gaap_CommercialPaperMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial paper [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommercialPaperMember" xlink:to="us-gaap_CommercialPaperMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Paper [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MunicipalBondsMember" xlink:type="locator" xlink:label="us-gaap_MunicipalBondsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MunicipalBondsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Municipal bonds [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MunicipalBondsMember" xlink:to="us-gaap_MunicipalBondsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_MunicipalBondsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Municipal Bonds [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Government agencies [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">U S Government Corporations And Agencies Securities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Measurement Frequency [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement Frequency [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value on Recurring Basis [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements Recurring [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value By Fair Value Hierarchy Level [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements Fair Value Hierarchy [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 1 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level1 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 2 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Inputs Level2 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate debt [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateDebtSecuritiesMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Assets Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investments Debt And Equity Securities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Available For Sale Securities [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Available For Sale Securities [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type Categorization [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsMember" xlink:to="us-gaap_CashAndCashEquivalentsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CashAndCashEquivalentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember" xlink:type="locator" xlink:label="us-gaap_ShortTermInvestmentsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShortTermInvestmentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestmentsMember" xlink:to="us-gaap_ShortTermInvestmentsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShortTermInvestmentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Investments [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermInvestmentsMember" xlink:type="locator" xlink:label="us-gaap_OtherLongTermInvestmentsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherLongTermInvestmentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term investments [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLongTermInvestmentsMember" xlink:to="us-gaap_OtherLongTermInvestmentsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherLongTermInvestmentsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Long Term Investments [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Available-for-sale Securities [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Available For Sale Securities [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Debt Securities Amortized Cost Basis</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized Gain</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unrealized Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Securities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Mature in one year or less, Amortized Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities Within One Year Amortized Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Mature after one year through five years, Amortized Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Mature in one year or less, Estimated Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities Within One Year Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Mature after one year through five years, Estimated Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities After One Through Five Years Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Estimated Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities Single Maturity Date</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized loss of securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment By Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:type="locator" xlink:label="us-gaap_EquipmentMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EquipmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Equipment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Construction-in-progress [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Construction In Progress [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Plant And Equipment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less accumulated depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation Depletion And Amortization Property Plant And Equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property and equipment, net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Depreciation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_Depreciation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligation" xlink:type="locator" xlink:label="us-gaap_AssetRetirementObligation" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetRetirementObligation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restoration cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetRetirementObligation" xlink:to="us-gaap_AssetRetirementObligation_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetRetirementObligation_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Asset Retirement Obligation</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_InvestmentHoldingsAbstract" xlink:type="locator" xlink:label="drrx_InvestmentHoldingsAbstract" />
    <link:label xml:lang="en-US" xlink:label="drrx_InvestmentHoldingsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Investment Holdings [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_InvestmentHoldingsAbstract" xlink:to="drrx_InvestmentHoldingsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_InvestmentHoldingsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Investment Holdings [Abstract]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_RestrictedInvestmentsLineItems" xlink:type="locator" xlink:label="drrx_RestrictedInvestmentsLineItems" />
    <link:label xml:lang="en-US" xlink:label="drrx_RestrictedInvestmentsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted Investments [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_RestrictedInvestmentsLineItems" xlink:to="drrx_RestrictedInvestmentsLineItems_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_RestrictedInvestmentsTable" xlink:type="locator" xlink:label="drrx_RestrictedInvestmentsTable" />
    <link:label xml:lang="en-US" xlink:label="drrx_RestrictedInvestmentsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted investments.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_RestrictedInvestmentsTable" xlink:to="drrx_RestrictedInvestmentsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_RestrictedInvestmentsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Investments [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_RestrictedInvestmentsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Investments [Table]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA" xlink:type="locator" xlink:label="country_CA" />
    <link:label xml:lang="en-US" xlink:label="country_CA_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">California [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_CA" xlink:to="country_CA_lbl" />
    <link:label xml:lang="en-US" xlink:label="country_CA_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">CANADA</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_RestrictedInvestmentsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Investments [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_RestrictedInvestmentsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Investments [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_RestrictedInvestmentsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Restricted investments in connection with deposits on letters of credit</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LeaseExpirationTerm" xlink:type="locator" xlink:label="drrx_LeaseExpirationTerm" />
    <link:label xml:lang="en-US" xlink:label="drrx_LeaseExpirationTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease expiration term.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_LeaseExpirationTerm" xlink:to="drrx_LeaseExpirationTerm_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Leases [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable" xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Subject To Or Available For Operating Lease By Major Property Class [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Subject To Or Available For Operating Lease By Major Property Class [Table]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CupertinoCAMember" xlink:type="locator" xlink:label="drrx_CupertinoCAMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_CupertinoCAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Cupertino, CA.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_CupertinoCAMember" xlink:to="drrx_CupertinoCAMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_CupertinoCAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cupertino, CA [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_CupertinoCAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cupertino C A [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_VacavilleCAMember" xlink:type="locator" xlink:label="drrx_VacavilleCAMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_VacavilleCAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Vacaville, CA.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_VacavilleCAMember" xlink:to="drrx_VacavilleCAMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_VacavilleCAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vacaville, CA [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_VacavilleCAMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Vacaville C A [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OfficeLaboratoryAndManufacturingMember" xlink:type="locator" xlink:label="drrx_OfficeLaboratoryAndManufacturingMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_OfficeLaboratoryAndManufacturingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Office, laboratory and manufacturing.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_OfficeLaboratoryAndManufacturingMember" xlink:to="drrx_OfficeLaboratoryAndManufacturingMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_OfficeLaboratoryAndManufacturingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Office, Laboratory and Manufacturing [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_OfficeLaboratoryAndManufacturingMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Office Laboratory And Manufacturing [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OfficeAndLaboratoryMember" xlink:type="locator" xlink:label="drrx_OfficeAndLaboratoryMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_OfficeAndLaboratoryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Office and laboratory.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_OfficeAndLaboratoryMember" xlink:to="drrx_OfficeAndLaboratoryMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_OfficeAndLaboratoryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Office and Laboratory [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_OfficeAndLaboratoryMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Office And Laboratory [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ManufacturingFacilityMember" xlink:type="locator" xlink:label="us-gaap_ManufacturingFacilityMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ManufacturingFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Manufacturing [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ManufacturingFacilityMember" xlink:to="us-gaap_ManufacturingFacilityMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ManufacturingFacilityMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Manufacturing Facility [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Contractual Term [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="us-gaap_LeaseContractualTermDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Contractual Term [Domain]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LeaseAmendmentMember" xlink:type="locator" xlink:label="drrx_LeaseAmendmentMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_LeaseAmendmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease amendment.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_LeaseAmendmentMember" xlink:to="drrx_LeaseAmendmentMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_LeaseAmendmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Amendment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_LeaseAmendmentMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Amendment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems" xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Subject To Or Available For Operating Lease [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Property Subject To Or Available For Operating Lease [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandSubjectToGroundLeases" xlink:type="locator" xlink:label="us-gaap_LandSubjectToGroundLeases" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LandSubjectToGroundLeases_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Approximate Square Feet</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandSubjectToGroundLeases" xlink:to="us-gaap_LandSubjectToGroundLeases_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LandSubjectToGroundLeases_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Land Subject To Ground Leases</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_LeaseExpirationTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expiration</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_LeaseExpirationTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Term</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LeaseExpirationYear" xlink:type="locator" xlink:label="drrx_LeaseExpirationYear" />
    <link:label xml:lang="en-US" xlink:label="drrx_LeaseExpirationYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease expiration year.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_LeaseExpirationYear" xlink:to="drrx_LeaseExpirationYear_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_LeaseExpirationYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expiration year</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_LeaseExpirationYear_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease renewal term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Renewal Term</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CommitmentAndContingenciesLineItems" xlink:type="locator" xlink:label="drrx_CommitmentAndContingenciesLineItems" />
    <link:label xml:lang="en-US" xlink:label="drrx_CommitmentAndContingenciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitment and contingencies.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_CommitmentAndContingenciesLineItems" xlink:to="drrx_CommitmentAndContingenciesLineItems_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CommitmentAndContingenciesTable" xlink:type="locator" xlink:label="drrx_CommitmentAndContingenciesTable" />
    <link:label xml:lang="en-US" xlink:label="drrx_CommitmentAndContingenciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitment and contingencies.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_CommitmentAndContingenciesTable" xlink:to="drrx_CommitmentAndContingenciesTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_CommitmentAndContingenciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitment And Contingencies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_CommitmentAndContingenciesTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitment And Contingencies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_CommitmentAndContingenciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitment And Contingencies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_CommitmentAndContingenciesLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Commitment And Contingencies [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rent expenses of operating leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseNet" xlink:to="us-gaap_OperatingLeasesRentExpenseNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Rent Expense Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Receivable Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Receivable In Two Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Receivable In Three Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Receivable In Four Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating leases future minimum payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Future Minimum Payments Receivable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:type="locator" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Remaining minimum purchase commitment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentAmount" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Purchase Commitment Amount</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cost of goods sold</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DebtInstrumentPrincipalPaymentPercentage" xlink:type="locator" xlink:label="drrx_DebtInstrumentPrincipalPaymentPercentage" />
    <link:label xml:lang="en-US" xlink:label="drrx_DebtInstrumentPrincipalPaymentPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument principal payment percentage.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_DebtInstrumentPrincipalPaymentPercentage" xlink:to="drrx_DebtInstrumentPrincipalPaymentPercentage_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DebtInstrumentPrepaymentFeePercentage" xlink:type="locator" xlink:label="drrx_DebtInstrumentPrepaymentFeePercentage" />
    <link:label xml:lang="en-US" xlink:label="drrx_DebtInstrumentPrepaymentFeePercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument prepayment fee percentage.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_DebtInstrumentPrepaymentFeePercentage" xlink:to="drrx_DebtInstrumentPrepaymentFeePercentage_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DebtIssuanceCost" xlink:type="locator" xlink:label="drrx_DebtIssuanceCost" />
    <link:label xml:lang="en-US" xlink:label="drrx_DebtIssuanceCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of debt issuance costs (for example, but not limited to, legal, accounting, broker, and regulatory fees).</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_DebtIssuanceCost" xlink:to="drrx_DebtIssuanceCost_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Name [Domain]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OxfordFinanceLlcTermLoanMember" xlink:type="locator" xlink:label="drrx_OxfordFinanceLlcTermLoanMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_OxfordFinanceLlcTermLoanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Oxford Finance LLC term loan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_OxfordFinanceLlcTermLoanMember" xlink:to="drrx_OxfordFinanceLlcTermLoanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_OxfordFinanceLlcTermLoanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Oxford Finance LLC Term Loan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_OxfordFinanceLlcTermLoanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Oxford Finance Llc Term Loan [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebt" xlink:type="locator" xlink:label="us-gaap_SecuredDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SecuredDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Secured term loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredDebt" xlink:to="us-gaap_SecuredDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SecuredDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Secured Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPaymentTerms" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentPaymentTerms_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan repayment description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPaymentTerms" xlink:to="us-gaap_DebtInstrumentPaymentTerms_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentPaymentTerms_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Payment Terms</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">First principal payment date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:to="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Date Of First Required Payment1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan, maturity date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Maturity Date</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest rate on term loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Interest Rate Stated Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan, floating interest rate basis</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:to="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Description Of Variable Rate Basis</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Facility fee paid at final payment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Periodic Payment Terms Balloon Payment To Be Paid</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DebtInstrumentPrincipalPaymentPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of an additional payment equal to principal amount</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DebtInstrumentPrincipalPaymentPercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Principal Payment Percentage</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DebtInstrumentPrepaymentFeePercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of prepayment fee</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DebtInstrumentPrepaymentFeePercentage_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Prepayment Fee Percentage</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DebtIssuanceCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt offering/issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DebtIssuanceCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Issuance Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtRestructuringCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfDebtRestructuringCosts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfDebtRestructuringCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loan modification fee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtRestructuringCosts" xlink:to="us-gaap_PaymentsOfDebtRestructuringCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfDebtRestructuringCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments Of Debt Restructuring Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:type="locator" xlink:label="us-gaap_LongTermDebtByMaturityAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtByMaturityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future maturities and interest payments under the term loan:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtByMaturityAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtByMaturityAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt By Maturity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Maturities Repayments Of Principal In Next Twelve Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Maturities Repayments Of Principal In Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Maturities Repayments Of Principal In Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Maturities Repayments Of Principal In Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total minimum payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Face Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:type="locator" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less amount representing interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Interest Payable Current And Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross balance of term loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Carrying Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less unamortized debt discount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Unamortized Discount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:type="locator" xlink:label="us-gaap_LongTermDebt" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Carrying value of term loan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebt_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less term loan, current portion, net</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CommonStockCapitalAmountReservedForFutureIssuance" xlink:type="locator" xlink:label="drrx_CommonStockCapitalAmountReservedForFutureIssuance" />
    <link:label xml:lang="en-US" xlink:label="drrx_CommonStockCapitalAmountReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock capital amount reserved for future issuance.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_CommonStockCapitalAmountReservedForFutureIssuance" xlink:to="drrx_CommonStockCapitalAmountReservedForFutureIssuance_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Repurchase Agreement Counterparty Name [Domain]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CantorFitzgeraldCoMember" xlink:type="locator" xlink:label="drrx_CantorFitzgeraldCoMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_CantorFitzgeraldCoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Cantor Fitzgerald &amp; Co.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_CantorFitzgeraldCoMember" xlink:to="drrx_CantorFitzgeraldCoMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_CantorFitzgeraldCoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cantor Fitzgerald Co [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_CantorFitzgeraldCoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cantor Fitzgerald Co [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ControlledEquityOfferingProgramMember" xlink:type="locator" xlink:label="drrx_ControlledEquityOfferingProgramMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_ControlledEquityOfferingProgramMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Controlled equity offering program.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ControlledEquityOfferingProgramMember" xlink:to="drrx_ControlledEquityOfferingProgramMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_ControlledEquityOfferingProgramMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Controlled Equity Offering Program [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ControlledEquityOfferingProgramMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Controlled Equity Offering Program [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OctoberTwoThousandEighteenRegistrationStatementMember" xlink:type="locator" xlink:label="drrx_OctoberTwoThousandEighteenRegistrationStatementMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_OctoberTwoThousandEighteenRegistrationStatementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">October 2018 registration statement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_OctoberTwoThousandEighteenRegistrationStatementMember" xlink:to="drrx_OctoberTwoThousandEighteenRegistrationStatementMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_OctoberTwoThousandEighteenRegistrationStatementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">October Two Thousand Eighteen Registration Statement</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_OctoberTwoThousandEighteenRegistrationStatementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">October Two Thousand Eighteen Registration Statement [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_CommonStockCapitalAmountReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Securities offered</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_CommonStockCapitalAmountReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Capital Amount Reserved For Future Issuance</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CommonStockWeightedAveragePrice" xlink:type="locator" xlink:label="drrx_CommonStockWeightedAveragePrice" />
    <link:label xml:lang="en-US" xlink:label="drrx_CommonStockWeightedAveragePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock weighted average price.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_CommonStockWeightedAveragePrice" xlink:to="drrx_CommonStockWeightedAveragePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Proceeds from sale of common stock, net of commission</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Sale of common stock during period</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_CommonStockWeightedAveragePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock weighted average price</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_CommonStockWeightedAveragePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Weighted Average Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of stock number of shares issued in transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sale Of Stock Number Of Shares Issued In Transaction</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of stock price per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sale Of Stock Price Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross proceeds from sale of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sale Of Stock Consideration Received On Transaction</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock issuance costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Payments Of Stock Issuance Costs</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm" xlink:type="locator" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm" />
    <link:label xml:lang="en-US" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Maximum expiration term.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm" xlink:to="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_EmployeesStockPurchasePlanExtendedTermPeriod" xlink:type="locator" xlink:label="drrx_EmployeesStockPurchasePlanExtendedTermPeriod" />
    <link:label xml:lang="en-US" xlink:label="drrx_EmployeesStockPurchasePlanExtendedTermPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Employees stock purchase plan extended term period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_EmployeesStockPurchasePlanExtendedTermPeriod" xlink:to="drrx_EmployeesStockPurchasePlanExtendedTermPeriod_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_TwoThousandStockPlanMember" xlink:type="locator" xlink:label="drrx_TwoThousandStockPlanMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_TwoThousandStockPlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand stock plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_TwoThousandStockPlanMember" xlink:to="drrx_TwoThousandStockPlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_TwoThousandStockPlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2000 Stock Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_TwoThousandStockPlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Stock Plan [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title Of Individual [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title Of Individual With Relationship To Entity [Domain]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NonEmployeeDirectorMember" xlink:type="locator" xlink:label="drrx_NonEmployeeDirectorMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_NonEmployeeDirectorMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Non employee director.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_NonEmployeeDirectorMember" xlink:to="drrx_NonEmployeeDirectorMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_NonEmployeeDirectorMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-employee director [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_NonEmployeeDirectorMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Non Employee Director [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum expiration term of stock appreciation rights</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Maximum Expiration Term</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_EmployeesStockPurchasePlanExtendedTermPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Extended term of stock plan to the date</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_EmployeesStockPurchasePlanExtendedTermPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employees Stock Purchase Plan Extended Term Period</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_EmployeeStockPurchasePlanExpirationDate" xlink:type="locator" xlink:label="drrx_EmployeeStockPurchasePlanExpirationDate" />
    <link:label xml:lang="en-US" xlink:label="drrx_EmployeeStockPurchasePlanExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee stock purchase plan expiration date.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_EmployeeStockPurchasePlanExpirationDate" xlink:to="drrx_EmployeeStockPurchasePlanExpirationDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel">Issuance of common stock upon equity financing, net of issuance cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reserved common stock for issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Capital Shares Reserved For Future Issuance</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_EmployeeStockPurchasePlanExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan expiry date</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_EmployeeStockPurchasePlanExpirationDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Purchase Plan Expiration Date</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_StockOptionsVestingPeriod" xlink:type="locator" xlink:label="drrx_StockOptionsVestingPeriod" />
    <link:label xml:lang="en-US" xlink:label="drrx_StockOptionsVestingPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock and unit award vesting period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_StockOptionsVestingPeriod" xlink:to="drrx_StockOptionsVestingPeriod_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors" xlink:type="locator" xlink:label="drrx_ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercisable period from date of grant for stock option granted to non employee directors.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors" xlink:to="drrx_ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercised, shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_StockOptionsVestingPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Option plan vesting period</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_StockOptionsVestingPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Options Vesting Period</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock option exercisable period</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercisable Period From Date Of Grant For Stock Option Granted To Non Employee Directors</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_MinimumPercentageOfCombinedVotingPowerClassesOfStock" xlink:type="locator" xlink:label="drrx_MinimumPercentageOfCombinedVotingPowerClassesOfStock" />
    <link:label xml:lang="en-US" xlink:label="drrx_MinimumPercentageOfCombinedVotingPowerClassesOfStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum percentage of total combined voting power classes of stock.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_MinimumPercentageOfCombinedVotingPowerClassesOfStock" xlink:to="drrx_MinimumPercentageOfCombinedVotingPowerClassesOfStock_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower" xlink:type="locator" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower" />
    <link:label xml:lang="en-US" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum exercise price as percentage of fair market value to holder of more than ten percent voting power.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower" xlink:to="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower" xlink:type="locator" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower" />
    <link:label xml:lang="en-US" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum exercise price as percentage of fair market value to holder of ten percent or less voting power.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower" xlink:to="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options granted with different vesting terms</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_MinimumPercentageOfCombinedVotingPowerClassesOfStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum percentage of total combined voting power of stock</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_MinimumPercentageOfCombinedVotingPowerClassesOfStock_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Minimum Percentage Of Combined Voting Power Classes Of Stock</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum exercise price as percentage of fair market value to holder of more than 10% voting power</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Minimum Exercise Price As Percentage Of Fair Market Value To Holder Of More Than Ten Percent Voting Power</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum exercise price as percentage of fair market value to holder of 10% or less voting power</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Minimum Exercise Price As Percentage Of Fair Market Value To Holder Of Ten Percent Or Less Voting Power</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares available for future grant</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_EmployeeStockPurchasePlanOfferingPeriod" xlink:type="locator" xlink:label="drrx_EmployeeStockPurchasePlanOfferingPeriod" />
    <link:label xml:lang="en-US" xlink:label="drrx_EmployeeStockPurchasePlanOfferingPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee stock purchase plan offering period.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_EmployeeStockPurchasePlanOfferingPeriod" xlink:to="drrx_EmployeeStockPurchasePlanOfferingPeriod_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum" xlink:type="locator" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum" />
    <link:label xml:lang="en-US" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise price as percentage of fair market value minimum.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum" xlink:to="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_TwoThousandEmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="drrx_TwoThousandEmployeeStockPurchasePlanMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_TwoThousandEmployeeStockPurchasePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand employee stock purchase plan.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_TwoThousandEmployeeStockPurchasePlanMember" xlink:to="drrx_TwoThousandEmployeeStockPurchasePlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_TwoThousandEmployeeStockPurchasePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2000 Employee Stock Purchase Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_TwoThousandEmployeeStockPurchasePlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Employee Stock Purchase Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_EmployeeStockPurchasePlanOfferingPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee stock purchase plan</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_EmployeeStockPurchasePlanOfferingPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Purchase Plan Offering Period</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise price as percentage of fair market value minimum</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Exercise Price As Percentage Of Fair Market Value Minimum</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock option increase</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options shares reserved for issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel">Share available for future grant</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock options outstanding</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock options available for grant</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares of common stock reserved for future issuance</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, Number of Options, beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Options granted, Number of Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Options exercised, Number of Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Stock Options Exercised</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Options forfeited, Number of Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Options expired, Number of Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, Number of Options, ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable, Number of Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Vested and expected to vest, Number of Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, Number of Options, Weighted Average Exercise Price Per Share, beginning balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options granted, Weighted Average Exercise Price Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercised, Weighted Average Exercise Price Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options forfeited, Weighted Average Exercise Price Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options expired, Weighted Average Exercise Price Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, Number of Options, Weighted Average Exercise Price Per Share, ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable, Number of Options, Weighted Average Exercise Price Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest, Number of Options, Weighted Average Exercise Price Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding, Number of Options, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable, Number of Options, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest, Number of Options, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding, Number of Options, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable, Number of Options, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested and expected to vest, Number of Options, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intrinsic value of options exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OptionsGrantedWithExercisePricesLowerThanFairMarket" xlink:type="locator" xlink:label="drrx_OptionsGrantedWithExercisePricesLowerThanFairMarket" />
    <link:label xml:lang="en-US" xlink:label="drrx_OptionsGrantedWithExercisePricesLowerThanFairMarket_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Options granted with exercise prices lower than fair market.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_OptionsGrantedWithExercisePricesLowerThanFairMarket" xlink:to="drrx_OptionsGrantedWithExercisePricesLowerThanFairMarket_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveTerseLabel">Share available for future grant</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average grant-date fair value of all options granted with exercise prices</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_OptionsGrantedWithExercisePricesLowerThanFairMarket_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options granted with exercise prices lower than fair market</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_OptionsGrantedWithExercisePricesLowerThanFairMarket_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Options Granted With Exercise Prices Lower Than Fair Market</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:type="locator" xlink:label="us-gaap_CostOfSalesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfSalesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of product revenues [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CostOfSalesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cost Of Sales [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development Expense [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling, general and administrative [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Selling General And Administrative Expenses [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total employee stock-based compensation cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Allocated Share Based Compensation Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Excess tax benefits recognized for tax deductions on stock based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Tax Benefit From Compensation Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxExpenseFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_DeferredTaxExpenseFromStockOptionsExercised" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxExpenseFromStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Incremental tax benefits recognized from stock options exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxExpenseFromStockOptionsExercised" xlink:to="us-gaap_DeferredTaxExpenseFromStockOptionsExercised_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxExpenseFromStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Expense From Stock Options Exercised</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend yield in Black-Scholes option valuation model</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate" xlink:type="locator" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate" />
    <link:label xml:lang="en-US" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award fair value assumptions forfeiture interest rate.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate" xlink:to="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember" xlink:type="locator" xlink:label="us-gaap_StockCompensationPlanMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockCompensationPlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Option Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockCompensationPlanMember" xlink:to="us-gaap_StockCompensationPlanMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StockCompensationPlanMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Compensation Plan [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary Sale Of Stock [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sale Of Stock Name Of Transaction [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employees Stock Purchase Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockMember" xlink:to="us-gaap_EmployeeStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free rate, minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free rate, maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend yield</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Volatility, minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Volatility, maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeiture rate</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Interest Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares purchased under Company&apos;s employee stock purchase plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:type="locator" xlink:label="us-gaap_AdjustmentForAmortization" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentForAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recognition of expenses on shares purchased under employee stock purchase plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForAmortization" xlink:to="us-gaap_AdjustmentForAmortization_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AdjustmentForAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Adjustment For Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise Price Range</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise Price Range</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Domain]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeOneMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeOneMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise price range one.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ExercisePriceRangeOneMember" xlink:to="drrx_ExercisePriceRangeOneMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Range of Exercise Price, $0.51 - $0.57 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeOneMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Price Range One [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeTwoMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeTwoMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise price range two.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ExercisePriceRangeTwoMember" xlink:to="drrx_ExercisePriceRangeTwoMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Range of Exercise Price, $0.58 - $0.58 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeTwoMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Price Range Two [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeThreeMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeThreeMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise price range three.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ExercisePriceRangeThreeMember" xlink:to="drrx_ExercisePriceRangeThreeMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Range of Exercise Price, $0.58 - $0.88 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeThreeMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Price Range Three [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeFourMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeFourMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeFourMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise price range four.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ExercisePriceRangeFourMember" xlink:to="drrx_ExercisePriceRangeFourMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeFourMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Range of Exercise Price, $0.93 - $1.20 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeFourMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Price Range Four [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeFiveMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeFiveMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeFiveMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise price range five.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ExercisePriceRangeFiveMember" xlink:to="drrx_ExercisePriceRangeFiveMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeFiveMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Range of Exercise Price, $1.21 - $1.21 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeFiveMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Price Range Five [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeSixMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeSixMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeSixMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise price range six.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ExercisePriceRangeSixMember" xlink:to="drrx_ExercisePriceRangeSixMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeSixMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Range of Exercise Price, $1.24 - $1.24 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeSixMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Price Range Six [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeSevenMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeSevenMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeSevenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise price range seven.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ExercisePriceRangeSevenMember" xlink:to="drrx_ExercisePriceRangeSevenMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeSevenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Range of Exercise Price, $1.26 - $1.26 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeSevenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Price Range Seven [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeEightMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeEightMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeEightMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise price range eight.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ExercisePriceRangeEightMember" xlink:to="drrx_ExercisePriceRangeEightMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeEightMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Range of Exercise Price, $1.31 - $1.31 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeEightMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Price Range Eight [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeNineMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeNineMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeNineMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise price range nine.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ExercisePriceRangeNineMember" xlink:to="drrx_ExercisePriceRangeNineMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeNineMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Range of Exercise Price, $1.33 - $2.09 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeNineMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Price Range Nine [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeTenMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeTenMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeTenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise price range ten.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ExercisePriceRangeTenMember" xlink:to="drrx_ExercisePriceRangeTenMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeTenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Range of Exercise Price, $2.10 - $3.61 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeTenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Price Range Ten [Member]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeElevenMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeElevenMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeElevenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise price range eleven.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ExercisePriceRangeElevenMember" xlink:to="drrx_ExercisePriceRangeElevenMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeElevenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Range of Exercise Price, $0.51 - $3.61 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ExercisePriceRangeElevenMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Price Range Eleven [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Outstanding, Range of Exercise Price, minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Outstanding, Range of Exercise Price, maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Options Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Outstanding, Weighted-Average Remaining Contractual Life(In years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Outstanding, Weighted-Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Options Exercisable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options Exercisable, Weighted-Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from Stock Options Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Stock Options Exercised</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:type="locator" xlink:label="us-gaap_IncomeTaxContingencyTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxContingencyTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Contingency [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxContingencyTable" xlink:to="us-gaap_IncomeTaxContingencyTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxContingencyTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">State And Local Jurisdiction [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest and other income, net [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income Expense [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember" xlink:type="locator" xlink:label="us-gaap_ResearchMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchMember" xlink:to="us-gaap_ResearchMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ResearchMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Research [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority, Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:type="locator" xlink:label="us-gaap_InternalRevenueServiceIRSMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InternalRevenueServiceIRSMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InternalRevenueServiceIRSMember" xlink:to="us-gaap_InternalRevenueServiceIRSMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_InternalRevenueServiceIRSMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Internal Revenue Service I R S [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:type="locator" xlink:label="us-gaap_IncomeTaxContingencyLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxContingencyLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Contingency [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_IncomeTaxContingencyLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxContingencyLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Liabilities Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred income tax provision</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total income tax provision (benefit) expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense Benefit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statutory federal income tax rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_IncomeTaxReconciliationExpiringNetOperatingLosses" xlink:type="locator" xlink:label="drrx_IncomeTaxReconciliationExpiringNetOperatingLosses" />
    <link:label xml:lang="en-US" xlink:label="drrx_IncomeTaxReconciliationExpiringNetOperatingLosses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax reconciliation expiring net operating losses.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_IncomeTaxReconciliationExpiringNetOperatingLosses" xlink:to="drrx_IncomeTaxReconciliationExpiringNetOperatingLosses_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense Benefit Continuing Operations Income Tax Reconciliation [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. federal taxes benefit at statutory rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation State And Local Income Taxes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Research and development tax credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Tax Credits Research</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Reform change in tax rate and other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Change In Enacted Tax Rate</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_IncomeTaxReconciliationExpiringNetOperatingLosses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expiring net operating losses</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_IncomeTaxReconciliationExpiringNetOperatingLosses_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Expiring Net Operating Losses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Other Adjustments</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total income tax (benefit) provision</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="locator" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Components Of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Operating Loss Carryforwards</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and other credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Credit Carryforwards Research</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Deferred Income</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Valuation allowance for deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Valuation Allowance</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DeferredTaxLiabilitiesRightOfUseAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Deferred tax liabilities - Right of use asset</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DeferredTaxLiabilitiesRightOfUseAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities Right Of Use Assets</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Net deferred tax assets and liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase (decrease) in valuation allowance of net deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowance Deferred Tax Asset Change In Amount</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NetOperatingLossCarryforwardsExpirationAmount" xlink:type="locator" xlink:label="drrx_NetOperatingLossCarryforwardsExpirationAmount" />
    <link:label xml:lang="en-US" xlink:label="drrx_NetOperatingLossCarryforwardsExpirationAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Net operating loss carryforwards expiration amount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_NetOperatingLossCarryforwardsExpirationAmount" xlink:to="drrx_NetOperatingLossCarryforwardsExpirationAmount_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NetOperatingLossCarryforwardsNonExpirationAmount" xlink:type="locator" xlink:label="drrx_NetOperatingLossCarryforwardsNonExpirationAmount" />
    <link:label xml:lang="en-US" xlink:label="drrx_NetOperatingLossCarryforwardsNonExpirationAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Net operating loss carryforwards non-expiration amount.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_NetOperatingLossCarryforwardsNonExpirationAmount" xlink:to="drrx_NetOperatingLossCarryforwardsNonExpirationAmount_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_TaxCreditCarryforwardExpiration" xlink:type="locator" xlink:label="drrx_TaxCreditCarryforwardExpiration" />
    <link:label xml:lang="en-US" xlink:label="drrx_TaxCreditCarryforwardExpiration_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax credit carryforward expiration.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_TaxCreditCarryforwardExpiration" xlink:to="drrx_TaxCreditCarryforwardExpiration_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards for income tax purposes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_NetOperatingLossCarryforwardsExpirationAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards expiration amount</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_NetOperatingLossCarryforwardsExpirationAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Operating Loss Carryforwards Expiration Amount</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_NetOperatingLossCarryforwardsNonExpirationAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards non-expiration amount</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_NetOperatingLossCarryforwardsNonExpirationAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Net Operating Loss Carryforwards Non Expiration Amount</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_TaxCreditCarryforwardExpiration_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax carryforwards expire date</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_TaxCreditCarryforwardExpiration_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Expiration</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development tax credits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator" xlink:label="drrx_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions" />
    <link:label xml:lang="en-US" xlink:label="drrx_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Unrecognized tax benefits increase (decreases) resulting from prior period tax positions.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="drrx_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="locator" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Reconciliation Of Unrecognized Tax Benefits Excluding Amounts Pertaining To Examined Tax Returns Roll Forward</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at beginning of the year</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase (decrease) related to prior year tax positions</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Increase Decreases Resulting From Prior Period Tax Positions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase related to current year tax positions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at end of the year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest and penalty expense related to unrecognized tax benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits Income Tax Penalties And Interest Expense</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid" xlink:type="locator" xlink:label="drrx_AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid" />
    <link:label xml:lang="en-US" xlink:label="drrx_AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Asset purchase agreement subject to certain adjustments paid.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid" xlink:to="drrx_AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="locator" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disposal Group Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="locator" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disposal Group Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Groups Including Discontinued Operations Name [Domain]</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_EvonikCorporationMember" xlink:type="locator" xlink:label="drrx_EvonikCorporationMember" />
    <link:label xml:lang="en-US" xlink:label="drrx_EvonikCorporationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Evonik Corporation.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_EvonikCorporationMember" xlink:to="drrx_EvonikCorporationMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="drrx_EvonikCorporationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Evonik [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_EvonikCorporationMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Evonik Corporation [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="locator" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset purchase agreement subject to certain adjustments paid</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Asset Purchase Agreement Subject To Certain Adjustments Paid</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gain from discontinued operations</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" />
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disposal group including discontinued operation research and development.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract" />
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disposal group including discontinued operation other income.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Revenue</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of product revenues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Costs Of Goods Sold</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Research And Development</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling, general and administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation General And Administrative Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total costs and expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Operating Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:type="locator" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income from discontinued operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:to="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income:</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Other Income [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net income from discontinued operations</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic and diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Basic And Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average shares used in computing net income per share basic and diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Basic And Diluted Other Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Basic and diluted</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets" />
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disposal group including discontinued operation operating lease right-of-use assets.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disposal group including discontinued operation operating lease liabilities, current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent" />
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disposal group including discontinued operation operating lease liabilities, non current.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Inventories, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Inventory Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Prepaid And Other Assets Current</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Discontinued operations &#8211; current portion</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Property Plant And Equipment Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use assets</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Operating Lease Right Of Use Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Goodwill Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other long-term assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Other Noncurrent Assets</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Discontinued operations &#8211; non-current portion</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Accounts Payable Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Accrued Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities, current portion</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Operating Lease Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Discontinued operations &#8211; current portion</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities, non-current portion</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Operating Lease Liabilities Non Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other long-term liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Other Noncurrent Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Discontinued operations &#8211; non-current portion</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense" />
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disposal group including discontinued operation stock-based compensation expense.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill" xlink:type="locator" xlink:label="drrx_NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill" />
    <link:label xml:lang="en-US" xlink:label="drrx_NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Non-cash items related to disposal group including discontinued operation goodwill.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill" xlink:to="drrx_NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment" xlink:type="locator" xlink:label="drrx_NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment" />
    <link:label xml:lang="en-US" xlink:label="drrx_NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Non-cash items related to discontinued operation gain (loss) on property plant equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment" xlink:to="drrx_NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross" />
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disposal group including discontinued operation non-cash items, gross.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross_lbl" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet" />
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Disposal group including discontinued operation non-cash items, net.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Depreciation And Amortization</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Stock Based Compensation Expense</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Non Cash Items Related To Disposal Group Including Discontinued Operation Goodwill</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Loss on disposal of property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Non Cash Items Related To Discontinued Operation Gain Loss On Property Plant Equipment</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Non-cash items, gross</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Non Cash Items Gross</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Non-cash items, net</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Disposal Group Including Discontinued Operation Non Cash Items Net</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_StockIssuedDuringPeriodValueNewIssuesNet" xlink:type="locator" xlink:label="drrx_StockIssuedDuringPeriodValueNewIssuesNet" />
    <link:label xml:lang="en-US" xlink:label="drrx_StockIssuedDuringPeriodValueNewIssuesNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period value new Issues net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_StockIssuedDuringPeriodValueNewIssuesNet" xlink:to="drrx_StockIssuedDuringPeriodValueNewIssuesNet_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTable" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_OctoberTwoThousandEighteenRegistrationStatementMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">October 2018 Registration Statement [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_StockIssuedDuringPeriodValueNewIssuesNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds from stock issued during period value new issues, net of issuance cost</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_StockIssuedDuringPeriodValueNewIssuesNet_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value New Issues Net</link:label>
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense" xlink:type="locator" xlink:label="drrx_ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense" />
    <link:label xml:lang="en-US" xlink:label="drrx_ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation">Valuation allowances and reserves charged and reversal of charges to cost and expense.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="drrx_ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense" xlink:to="drrx_ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense_lbl" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="locator" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureTable" />
    <link:label xml:lang="en-US" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation And Qualifying Accounts Disclosure [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="srt_ValuationAndQualifyingAccountsDisclosureTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation And Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesTypeAxis" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SEC Schedule, 12-09, Valuation Allowances and Reserves Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowancesAndReservesTypeAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowances And Reserves Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesDomain" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowancesAndReservesDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SEC Schedule, 12-09, Valuation Allowances and Reserves</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="us-gaap_ValuationAllowancesAndReservesDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowancesAndReservesDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowances And Reserves [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember" xlink:type="locator" xlink:label="us-gaap_AllowanceForCreditLossMember" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllowanceForCreditLossMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allowance for doubtful accounts [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForCreditLossMember" xlink:to="us-gaap_AllowanceForCreditLossMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_AllowanceForCreditLossMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Allowance For Credit Loss [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="locator" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureLineItems" />
    <link:label xml:lang="en-US" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation And Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="srt_ValuationAndQualifyingAccountsDisclosureLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation And Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel">Balance at beginning of the year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowances And Reserves Balance</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additions (Reductions) to allowances</link:label>
    <link:label xml:lang="en-US" xlink:label="drrx_ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowances And Reserves Charged And Reversal Of Charges To Cost And Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deductions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="us-gaap_ValuationAllowancesAndReservesDeductions_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowances And Reserves Deductions</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel">Balance at end of the year</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>21
<FILENAME>drrx-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-03-05T18:40:51.4888581+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : 68f21b77591e4eada77a5e64a41cc482 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.durect.com/20201231/role/TemplateLink" xlink:href="drrx-20201231.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="drrx-20201231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="locator" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:type="locator" xlink:label="dei_DocumentTransitionReport" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:type="locator" xlink:label="dei_DocumentAnnualReport" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:type="locator" xlink:label="dei_EntityPublicFloat" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag" xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:type="locator" xlink:label="dei_EntitySmallBusiness" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:type="locator" xlink:label="dei_EntityShellCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" xlink:label="dei_EntityFilerCategory" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityVoluntaryFilers" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityPublicFloat" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentAnnualReport" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets" xlink:href="drrx-20201231.xsd#Role_StatementBalanceSheets" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" xlink:label="us-gaap_CommonStockValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ContractResearchLiability" xlink:type="locator" xlink:label="drrx_ContractResearchLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:type="locator" xlink:label="us-gaap_Assets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedInvestmentsNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedInvestmentsNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermInvestments" xlink:type="locator" xlink:label="us-gaap_LongTermInvestments" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:type="locator" xlink:label="us-gaap_InventoryNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EscrowDeposit" xlink:type="locator" xlink:label="us-gaap_EscrowDeposit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_EscrowDeposit" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Goodwill" order="10920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_LongTermInvestments" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedInvestmentsNoncurrent" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" order="11080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="11160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="11240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="11320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="11360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="drrx_ContractResearchLiability" order="11400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="11440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LongTermDebtCurrent" order="11480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="11520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" order="11560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="11600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="11640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="11680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" order="11720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="11760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" order="11800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="11840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="11880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="11960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="12000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="12040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="12080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="12120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="12160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="12200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheetsParenthetical" xlink:href="drrx-20201231.xsd#Role_StatementBalanceSheetsParenthetical" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheetsParenthetical">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss" xlink:href="drrx-20201231.xsd#Role_StatementStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:type="locator" xlink:label="us-gaap_InterestExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncome" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses" xlink:type="locator" xlink:label="us-gaap_CostsAndExpenses" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:type="locator" xlink:label="us-gaap_TypeOfCostGoodOrServiceExtensibleList" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember" xlink:type="locator" xlink:label="us-gaap_ProductMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" xlink:type="locator" xlink:label="drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_TypeOfCostGoodOrServiceExtensibleList" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="10680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense" order="10740.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="10860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="10920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncome" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpense" order="11100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="11160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" order="11220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" order="11280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="11340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="11400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="11460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" order="11520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract" order="11640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" order="11760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" order="11820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" order="11880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="11940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity" xlink:href="drrx-20201231.xsd#Role_StatementStatementsOfStockholdersEquity" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities" xlink:type="locator" xlink:label="drrx_AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares" xlink:type="locator" xlink:label="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan" xlink:type="locator" xlink:label="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember" xlink:type="locator" xlink:label="srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain" xlink:type="locator" xlink:label="srt_RestatementDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis" xlink:type="locator" xlink:label="srt_RestatementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_RestatementAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementDomain" xlink:to="srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="drrx_AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="10950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="11090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_li0l2" order="11230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_li0l2" order="11390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquityParenthetical" xlink:href="drrx-20201231.xsd#Role_StatementStatementsOfStockholdersEquityParenthetical" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquityParenthetical">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows" xlink:href="drrx-20201231.xsd#Role_StatementStatementsOfCashFlows" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1" xlink:type="locator" xlink:label="us-gaap_StockIssued1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EscrowDepositsRelatedToPropertySales" xlink:type="locator" xlink:label="us-gaap_EscrowDepositsRelatedToPropertySales" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermDebt" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:type="locator" xlink:label="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="locator" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_IncreaseDecreaseInContractResearchLiability" xlink:type="locator" xlink:label="drrx_IncreaseDecreaseInContractResearchLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:type="locator" xlink:label="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ChangesInOperatingLeaseLiabilities" xlink:type="locator" xlink:label="drrx_ChangesInOperatingLeaseLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="locator" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown" xlink:type="locator" xlink:label="us-gaap_InventoryWriteDown" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:type="locator" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss" xlink:type="locator" xlink:label="us-gaap_ProfitLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_InventoryWriteDown" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="drrx_ChangesInOperatingLeaseLiabilities" order="10870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" order="10930.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="10990.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="11110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="11170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="11230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="11290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="11350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="drrx_IncreaseDecreaseInContractResearchLiability" order="11410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="11470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities" order="11530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="11590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="11650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="11770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" order="11830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" order="11890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="11950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="12010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" order="12130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" order="12190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="12250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfLongTermDebt" order="12310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="12370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="12430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="12490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_li0l2" order="12550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="12610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="12730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="12790.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_EscrowDepositsRelatedToPropertySales" order="12910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_StockIssued1" order="12970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="13030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlowsParenthetical" xlink:href="drrx-20201231.xsd#Role_StatementStatementsOfCashFlowsParenthetical" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlowsParenthetical">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCash" xlink:type="locator" xlink:label="us-gaap_RestrictedCash" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LongTermRestrictedInvestmentsMember" xlink:type="locator" xlink:label="drrx_LongTermRestrictedInvestmentsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="drrx_LongTermRestrictedInvestmentsMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RestrictedCash" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="drrx-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreements" xlink:href="drrx-20201231.xsd#Role_DisclosureStrategicAgreements" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreements">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstruments" xlink:href="drrx-20201231.xsd#Role_DisclosureFinancialInstruments" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstruments">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipment" xlink:href="drrx-20201231.xsd#Role_DisclosurePropertyAndEquipment" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipment">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureRestrictedInvestments" xlink:href="drrx-20201231.xsd#Role_DisclosureRestrictedInvestments" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureRestrictedInvestments">
    <link:loc xlink:href="drrx-20201231.xsd#drrx_RestrictedInvestmentsDisclosureTextBlock" xlink:type="locator" xlink:label="drrx_RestrictedInvestmentsDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TextBlockAbstract" xlink:type="locator" xlink:label="us-gaap_TextBlockAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TextBlockAbstract" xlink:to="drrx_RestrictedInvestmentsDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitments" xlink:href="drrx-20201231.xsd#Role_DisclosureCommitments" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitments">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_CommitmentsDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoan" xlink:href="drrx-20201231.xsd#Role_DisclosureTermLoan" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoan">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:type="locator" xlink:label="us-gaap_LongTermDebtTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity" xlink:href="drrx-20201231.xsd#Role_DisclosureStockholdersEquity" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxes" xlink:href="drrx-20201231.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxes">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperations" xlink:href="drrx-20201231.xsd#Role_DisclosureDiscontinuedOperations" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperations">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="locator" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEvents" xlink:href="drrx-20201231.xsd#Role_DisclosureSubsequentEvents" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEvents">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccounts" xlink:href="drrx-20201231.xsd#Role_DisclosureScheduleIIValuationAndQualifyingAccounts" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccounts">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="locator" xlink:label="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:type="locator" xlink:label="srt_ValuationAndQualifyingAccountsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ValuationAndQualifyingAccountsAbstract" xlink:to="srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="drrx-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShippingAndHandlingPolicyTextBlock" xlink:type="locator" xlink:label="drrx_ShippingAndHandlingPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_PrepaidAndAccruedContractResearchExpensesPolicyTextBlock" xlink:type="locator" xlink:label="drrx_PrepaidAndAccruedContractResearchExpensesPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_MajorCustomersPolicyPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock" xlink:type="locator" xlink:label="drrx_LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DiscontinuedOperationsTextblock" xlink:type="locator" xlink:label="drrx_DiscontinuedOperationsTextblock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NatureOfOperationsPolicyTextBlock" xlink:type="locator" xlink:label="drrx_NatureOfOperationsPolicyTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="drrx_NatureOfOperationsPolicyTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="drrx_DiscontinuedOperationsTextblock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="drrx_LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MajorCustomersPolicyPolicyTextBlock" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="drrx_PrepaidAndAccruedContractResearchExpensesPolicyTextBlock" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="drrx_ShippingAndHandlingPolicyTextBlock" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:href="drrx-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsTables" xlink:href="drrx-20201231.xsd#Role_DisclosureStrategicAgreementsTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsTables">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsTables" xlink:href="drrx-20201231.xsd#Role_DisclosureFinancialInstrumentsTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsTables">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="locator" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentTables" xlink:href="drrx-20201231.xsd#Role_DisclosurePropertyAndEquipmentTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentTables">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsTables" xlink:href="drrx-20201231.xsd#Role_DisclosureCommitmentsTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsTables">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock" xlink:type="locator" xlink:label="drrx_ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="drrx_ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanTables" xlink:href="drrx-20201231.xsd#Role_DisclosureTermLoanTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanTables">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityTables" xlink:href="drrx-20201231.xsd#Role_DisclosureStockholdersEquityTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityTables">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:href="drrx-20201231.xsd#Role_DisclosureIncomeTaxesTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsTables" xlink:href="drrx-20201231.xsd#Role_DisclosureDiscontinuedOperationsTables" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsTables">
    <link:loc xlink:href="drrx-20201231.xsd#drrx_SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock" xlink:type="locator" xlink:label="drrx_SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock" xlink:type="locator" xlink:label="drrx_SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock" xlink:type="locator" xlink:label="drrx_SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="drrx_SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="drrx_SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="drrx_SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LesseeOperatingLeaseIncrementalBorrowingRate" xlink:type="locator" xlink:label="drrx_LesseeOperatingLeaseIncrementalBorrowingRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="locator" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:type="locator" xlink:label="us-gaap_Goodwill" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfReportableSegments" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:type="locator" xlink:label="us-gaap_NumberOfOperatingSegments" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_PaymentFromEscrow" xlink:type="locator" xlink:label="drrx_PaymentFromEscrow" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CashHeldInEscrow" xlink:type="locator" xlink:label="drrx_CashHeldInEscrow" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:type="locator" xlink:label="us-gaap_RealizedInvestmentGainsLosses" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShortTermInvestmentMaturityPeriod" xlink:type="locator" xlink:label="drrx_ShortTermInvestmentMaturityPeriod" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LongTermInvestmentsMaturityPeriodDescriptionMinimum" xlink:type="locator" xlink:label="drrx_LongTermInvestmentsMaturityPeriodDescriptionMinimum" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LiquidInvestmentsMaturityPeriodDescriptionMaximum" xlink:type="locator" xlink:label="drrx_LiquidInvestmentsMaturityPeriodDescriptionMaximum" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:type="locator" xlink:label="dei_EntityIncorporationDateOfIncorporation" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="locator" xlink:label="drrx_SummaryOfSignificantAccountingPoliciesLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember" xlink:type="locator" xlink:label="srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain" xlink:type="locator" xlink:label="srt_RestatementDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis" xlink:type="locator" xlink:label="srt_RestatementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member" xlink:type="locator" xlink:label="us-gaap_AccountingStandardsUpdate201409Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="locator" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LACTELMember" xlink:type="locator" xlink:label="drrx_LACTELMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:type="locator" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_IndiviorMember" xlink:type="locator" xlink:label="drrx_IndiviorMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_GileadMember" xlink:type="locator" xlink:label="drrx_GileadMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:type="locator" xlink:label="srt_NameOfMajorCustomerDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:type="locator" xlink:label="srt_MajorCustomersAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductConcentrationRiskMember" xlink:type="locator" xlink:label="us-gaap_ProductConcentrationRiskMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AlzetProductLineMember" xlink:type="locator" xlink:label="drrx_AlzetProductLineMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:type="locator" xlink:label="us-gaap_SalesRevenueNetMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="locator" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LactelProductLineMember" xlink:type="locator" xlink:label="drrx_LactelProductLineMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:type="locator" xlink:label="drrx_SummaryOfSignificantAccountingPoliciesTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="drrx_SummaryOfSignificantAccountingPoliciesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RangeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_ProductOrServiceAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="drrx_LactelProductLineMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="drrx_AlzetProductLineMember" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="10030.08" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ProductConcentrationRiskMember" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_MajorCustomersAxis" order="10030.10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="drrx_GileadMember" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="drrx_IndiviorMember" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="10030.12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="drrx_LACTELMember" order="10780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="10030.14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="10820.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201409Member" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RestatementAxis" order="10030.16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementDomain" order="10900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RestatementDomain" xlink:to="srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember" order="10920.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesTable" xlink:to="drrx_SummaryOfSignificantAccountingPoliciesLineItems" order="10940.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="dei_EntityIncorporationDateOfIncorporation" order="10950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="drrx_LiquidInvestmentsMaturityPeriodDescriptionMaximum" order="11050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="drrx_LongTermInvestmentsMaturityPeriodDescriptionMinimum" order="11090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="drrx_ShortTermInvestmentMaturityPeriod" order="11130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RealizedInvestmentGainsLosses" order="11210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="drrx_CashHeldInEscrow" order="11280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="drrx_PaymentFromEscrow" order="11300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="11350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="11590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="11680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="11700.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_Goodwill" order="11750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="11900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="drrx_LesseeOperatingLeaseIncrementalBorrowingRate" order="11950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="11970.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_li0l2" order="12020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="12070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfTotalRevenueByGeographicRegionDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfTotalRevenueByGeographicRegionDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfTotalRevenueByGeographicRegionDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="locator" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OtherForeignCountriesMember" xlink:type="locator" xlink:label="drrx_OtherForeignCountriesMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_JP" xlink:type="locator" xlink:label="country_JP" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember" xlink:type="locator" xlink:label="srt_EuropeMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US" xlink:type="locator" xlink:label="country_US" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="srt_StatementGeographicalAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_EuropeMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_JP" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="drrx_OtherForeignCountriesMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfComponentsOfInventoriesDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfComponentsOfInventoriesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfComponentsOfInventoriesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:type="locator" xlink:label="us-gaap_InventoryNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoodsNetOfReserves" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryWorkInProcessNetOfReserves" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="locator" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryWorkInProcessNetOfReserves" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryFinishedGoodsNetOfReserves" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryNet" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities" xlink:type="locator" xlink:label="drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="locator" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements" xlink:type="locator" xlink:label="us-gaap_IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_DilutiveSecuritiesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAbstract" xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NetIncomeLossAbstract" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLoss" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DilutiveSecuritiesAbstract" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DilutiveSecuritiesAbstract" xlink:to="drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerShareAbstract" order="10770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="10890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="10950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" xlink:type="locator" xlink:label="drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AgreementsWithOtherCollaboratorsOrCounterpartiesMember" xlink:type="locator" xlink:label="drrx_AgreementsWithOtherCollaboratorsOrCounterpartiesMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AgreementWithGileadMember" xlink:type="locator" xlink:label="drrx_AgreementWithGileadMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_AgreementWithGileadMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_AgreementsWithOtherCollaboratorsOrCounterpartiesMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicenseMember" xlink:type="locator" xlink:label="us-gaap_LicenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AgreementWithGileadMember" xlink:type="locator" xlink:label="drrx_AgreementWithGileadMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_AgreementWithGileadMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStrategicAgreementsAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail">
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DevelopmentBasedMilestones" xlink:type="locator" xlink:label="drrx_DevelopmentBasedMilestones" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_RegulatoryApprovalsMember" xlink:type="locator" xlink:label="drrx_RegulatoryApprovalsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RegulatoryReviewsOfFilingsMember" xlink:type="locator" xlink:label="us-gaap_RegulatoryReviewsOfFilingsMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LateStageClinicalTestingMember" xlink:type="locator" xlink:label="drrx_LateStageClinicalTestingMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_EarlyStageClinicalTestingMember" xlink:type="locator" xlink:label="drrx_EarlyStageClinicalTestingMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:type="locator" xlink:label="us-gaap_ChangeInAccountingEstimateTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ChangeInAccountingEstimateByTypeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_SalesBasedMilestonesMember" xlink:type="locator" xlink:label="drrx_SalesBasedMilestonesMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DevelopmentBasedMilestonesMember" xlink:type="locator" xlink:label="drrx_DevelopmentBasedMilestonesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="drrx_DevelopmentBasedMilestonesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="drrx_SalesBasedMilestonesMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ChangeInAccountingEstimateByTypeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:to="us-gaap_ChangeInAccountingEstimateTypeDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:to="drrx_EarlyStageClinicalTestingMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:to="drrx_LateStageClinicalTestingMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:to="us-gaap_RegulatoryReviewsOfFilingsMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:to="drrx_RegulatoryApprovalsMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="drrx_DevelopmentBasedMilestones" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue" xlink:type="locator" xlink:label="us-gaap_DeferredRevenue" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AccruedAmountOfFinalPaymentOfTermLoan" xlink:type="locator" xlink:label="drrx_AccruedAmountOfFinalPaymentOfTermLoan" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" xlink:type="locator" xlink:label="drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ContractWithCustomerLiabilityMilestonePayment" xlink:type="locator" xlink:label="drrx_ContractWithCustomerLiabilityMilestonePayment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" xlink:type="locator" xlink:label="drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember" xlink:type="locator" xlink:label="drrx_UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AgreementWithGileadMember" xlink:type="locator" xlink:label="drrx_AgreementWithGileadMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_AgreementWithGileadMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="drrx_UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="drrx_ContractWithCustomerLiabilityMilestonePayment" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="drrx_AccruedAmountOfFinalPaymentOfTermLoan" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredRevenue" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiability" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityAbstract" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerAssetNetCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:type="locator" xlink:label="us-gaap_ReceivablesNetCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrentAbstract" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerAssetNetCurrentAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DeletionsMember" xlink:type="locator" xlink:label="drrx_DeletionsMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AdditionsMember" xlink:type="locator" xlink:label="drrx_AdditionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerDurationDomain" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerDurationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerDurationAxis" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerDurationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ContractWithCustomerDurationAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContractWithCustomerDurationAxis" xlink:to="us-gaap_ContractWithCustomerDurationDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContractWithCustomerDurationDomain" xlink:to="drrx_AdditionsMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContractWithCustomerDurationDomain" xlink:to="drrx_DeletionsMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerAssetNetCurrentAbstract" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ReceivablesNetCurrent" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerAssetNetCurrent" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityAbstract" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiability" order="10770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_GrantedPatentsExtendingYearMinimum" xlink:type="locator" xlink:label="drrx_GrantedPatentsExtendingYearMinimum" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" xlink:type="locator" xlink:label="drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NonRefundableUpfrontPaymentReceived" xlink:type="locator" xlink:label="drrx_NonRefundableUpfrontPaymentReceived" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyMember" xlink:type="locator" xlink:label="us-gaap_RoyaltyMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_RegulatoryBasedMilestoneMember" xlink:type="locator" xlink:label="drrx_RegulatoryBasedMilestoneMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_PatentPurchaseAgreementWithIndiviorMember" xlink:type="locator" xlink:label="drrx_PatentPurchaseAgreementWithIndiviorMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_PatentPurchaseAgreementWithIndiviorMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="drrx_RegulatoryBasedMilestoneMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="drrx_NonRefundableUpfrontPaymentReceived" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="drrx_GrantedPatentsExtendingYearMinimum" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="locator" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" xlink:type="locator" xlink:label="drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicenseMember" xlink:type="locator" xlink:label="us-gaap_LicenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CommercializationBasedMilestonesMember" xlink:type="locator" xlink:label="drrx_CommercializationBasedMilestonesMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DevelopmentBasedMilestonesMember" xlink:type="locator" xlink:label="drrx_DevelopmentBasedMilestonesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AgreementWithSantenPharmaceuticalCoLtdMember" xlink:type="locator" xlink:label="drrx_AgreementWithSantenPharmaceuticalCoLtdMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_AgreementWithSantenPharmaceuticalCoLtdMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="drrx_DevelopmentBasedMilestonesMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="drrx_CommercializationBasedMilestonesMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSandozAGAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStrategicAgreementsAgreementWithSandozAGAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSandozAGAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="locator" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AgreementWithSandozAGMember" xlink:type="locator" xlink:label="drrx_AgreementWithSandozAGMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_AgreementWithSandozAGMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MunicipalBondsMember" xlink:type="locator" xlink:label="us-gaap_MunicipalBondsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember" xlink:type="locator" xlink:label="us-gaap_CommercialPaperMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember" xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CertificatesOfDepositMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CommercialPaperMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MunicipalBondsMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="10500.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LongTermRestrictedInvestmentsMember" xlink:type="locator" xlink:label="drrx_LongTermRestrictedInvestmentsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLongTermInvestmentsMember" xlink:type="locator" xlink:label="us-gaap_OtherLongTermInvestmentsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember" xlink:type="locator" xlink:label="us-gaap_ShortTermInvestmentsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:type="locator" xlink:label="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MunicipalBondsMember" xlink:type="locator" xlink:label="us-gaap_MunicipalBondsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember" xlink:type="locator" xlink:label="us-gaap_CommercialPaperMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember" xlink:type="locator" xlink:label="us-gaap_CertificatesOfDepositMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:type="locator" xlink:label="us-gaap_MoneyMarketFundsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_InvestmentTypeAxis" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CertificatesOfDepositMember" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CommercialPaperMember" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MunicipalBondsMember" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CashAndCashEquivalentsMember" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_ShortTermInvestmentsMember" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_OtherLongTermInvestmentsMember" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="drrx_LongTermRestrictedInvestmentsMember" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="11320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureFinancialInstrumentsAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail" xlink:href="drrx-20201231.xsd#Role_DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:type="locator" xlink:label="us-gaap_ConstructionInProgressMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:type="locator" xlink:label="us-gaap_EquipmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="10040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosurePropertyAndEquipmentAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligation" xlink:type="locator" xlink:label="us-gaap_AssetRetirementObligation" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" xlink:label="us-gaap_Depreciation" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_Depreciation" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_AssetRetirementObligation" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureRestrictedInvestmentsAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureRestrictedInvestmentsAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureRestrictedInvestmentsAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedInvestmentsNoncurrent" xlink:type="locator" xlink:label="us-gaap_RestrictedInvestmentsNoncurrent" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_RestrictedInvestmentsLineItems" xlink:type="locator" xlink:label="drrx_RestrictedInvestmentsLineItems" />
    <link:loc xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA" xlink:type="locator" xlink:label="country_CA" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_RestrictedInvestmentsTable" xlink:type="locator" xlink:label="drrx_RestrictedInvestmentsTable" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_InvestmentHoldingsAbstract" xlink:type="locator" xlink:label="drrx_InvestmentHoldingsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_InvestmentHoldingsAbstract" xlink:to="drrx_RestrictedInvestmentsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_RestrictedInvestmentsTable" xlink:to="srt_StatementGeographicalAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_CA" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_RestrictedInvestmentsTable" xlink:to="drrx_RestrictedInvestmentsLineItems" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_RestrictedInvestmentsLineItems" xlink:to="us-gaap_RestrictedInvestmentsNoncurrent" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LeaseExpirationYear" xlink:type="locator" xlink:label="drrx_LeaseExpirationYear" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LeaseExpirationTerm" xlink:type="locator" xlink:label="drrx_LeaseExpirationTerm" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandSubjectToGroundLeases" xlink:type="locator" xlink:label="us-gaap_LandSubjectToGroundLeases" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems" xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_LeaseAmendmentMember" xlink:type="locator" xlink:label="drrx_LeaseAmendmentMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:type="locator" xlink:label="us-gaap_LeaseContractualTermAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ManufacturingFacilityMember" xlink:type="locator" xlink:label="us-gaap_ManufacturingFacilityMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OfficeAndLaboratoryMember" xlink:type="locator" xlink:label="drrx_OfficeAndLaboratoryMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OfficeLaboratoryAndManufacturingMember" xlink:type="locator" xlink:label="drrx_OfficeLaboratoryAndManufacturingMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_VacavilleCAMember" xlink:type="locator" xlink:label="drrx_VacavilleCAMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CupertinoCAMember" xlink:type="locator" xlink:label="drrx_CupertinoCAMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable" xlink:type="locator" xlink:label="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable" xlink:to="srt_StatementGeographicalAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="drrx_CupertinoCAMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="drrx_VacavilleCAMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="drrx_OfficeLaboratoryAndManufacturingMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="drrx_OfficeAndLaboratoryMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ManufacturingFacilityMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable" xlink:to="us-gaap_LeaseContractualTermAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="drrx_LeaseAmendmentMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable" xlink:to="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems" xlink:to="us-gaap_LandSubjectToGroundLeases" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems" xlink:to="drrx_LeaseExpirationTerm" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems" xlink:to="drrx_LeaseExpirationYear" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="10860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureCommitmentsAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:type="locator" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CommitmentAndContingenciesLineItems" xlink:type="locator" xlink:label="drrx_CommitmentAndContingenciesLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember" xlink:type="locator" xlink:label="us-gaap_ProductMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CommitmentAndContingenciesTable" xlink:type="locator" xlink:label="drrx_CommitmentAndContingenciesTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="drrx_CommitmentAndContingenciesTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_CommitmentAndContingenciesTable" xlink:to="srt_ProductOrServiceAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_CommitmentAndContingenciesTable" xlink:to="drrx_CommitmentAndContingenciesLineItems" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeasesRentExpenseNet" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent" xlink:type="locator" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureTermLoanAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtRestructuringCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfDebtRestructuringCosts" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DebtIssuanceCost" xlink:type="locator" xlink:label="drrx_DebtIssuanceCost" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DebtInstrumentPrepaymentFeePercentage" xlink:type="locator" xlink:label="drrx_DebtInstrumentPrepaymentFeePercentage" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DebtInstrumentPrincipalPaymentPercentage" xlink:type="locator" xlink:label="drrx_DebtInstrumentPrincipalPaymentPercentage" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentPaymentTerms" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebt" xlink:type="locator" xlink:label="us-gaap_SecuredDebt" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OxfordFinanceLlcTermLoanMember" xlink:type="locator" xlink:label="drrx_OxfordFinanceLlcTermLoanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="drrx_OxfordFinanceLlcTermLoanMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_SecuredDebt" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPaymentTerms" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentDateOfFirstRequiredPayment1" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="drrx_DebtInstrumentPrincipalPaymentPercentage" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="drrx_DebtInstrumentPrepaymentFeePercentage" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="drrx_DebtIssuanceCost" order="10830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_PaymentsOfDebtRestructuringCosts" order="10870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:type="locator" xlink:label="us-gaap_LongTermDebtCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt" xlink:type="locator" xlink:label="us-gaap_LongTermDebt" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:type="locator" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="locator" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:type="locator" xlink:label="us-gaap_LongTermDebtByMaturityAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtByMaturityAbstract" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebtByMaturityAbstract" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebt" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtCurrent" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtNoncurrent" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStockholdersEquityCommonStockAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="locator" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CommonStockWeightedAveragePrice" xlink:type="locator" xlink:label="drrx_CommonStockWeightedAveragePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CommonStockCapitalAmountReservedForFutureIssuance" xlink:type="locator" xlink:label="drrx_CommonStockCapitalAmountReservedForFutureIssuance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OctoberTwoThousandEighteenRegistrationStatementMember" xlink:type="locator" xlink:label="drrx_OctoberTwoThousandEighteenRegistrationStatementMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ControlledEquityOfferingProgramMember" xlink:type="locator" xlink:label="drrx_ControlledEquityOfferingProgramMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CantorFitzgeraldCoMember" xlink:type="locator" xlink:label="drrx_CantorFitzgeraldCoMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_CounterpartyNameAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="drrx_CantorFitzgeraldCoMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_ControlledEquityOfferingProgramMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_OctoberTwoThousandEighteenRegistrationStatementMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_CommonStockCapitalAmountReservedForFutureIssuance" order="10910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="11020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="11100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_CommonStockWeightedAveragePrice" order="11180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="11260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="11340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="11420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_li0l2" order="11570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="11590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_li0l2" order="11680.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower" xlink:type="locator" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower" xlink:type="locator" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_MinimumPercentageOfCombinedVotingPowerClassesOfStock" xlink:type="locator" xlink:label="drrx_MinimumPercentageOfCombinedVotingPowerClassesOfStock" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors" xlink:type="locator" xlink:label="drrx_ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_StockOptionsVestingPeriod" xlink:type="locator" xlink:label="drrx_StockOptionsVestingPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_EmployeeStockPurchasePlanExpirationDate" xlink:type="locator" xlink:label="drrx_EmployeeStockPurchasePlanExpirationDate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_EmployeesStockPurchasePlanExtendedTermPeriod" xlink:type="locator" xlink:label="drrx_EmployeesStockPurchasePlanExtendedTermPeriod" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm" xlink:type="locator" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NonEmployeeDirectorMember" xlink:type="locator" xlink:label="drrx_NonEmployeeDirectorMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_TwoThousandStockPlanMember" xlink:type="locator" xlink:label="drrx_TwoThousandStockPlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="drrx_TwoThousandStockPlanMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="drrx_NonEmployeeDirectorMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10340.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_EmployeesStockPurchasePlanExtendedTermPeriod" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="11000.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_EmployeeStockPurchasePlanExpirationDate" order="11100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="11230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_StockOptionsVestingPeriod" order="11270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors" order="11290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="11360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_MinimumPercentageOfCombinedVotingPowerClassesOfStock" order="11380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower" order="11400.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower" order="11420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="11470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="11490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxExpenseFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_DeferredTaxExpenseFromStockOptionsExercised" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OptionsGrantedWithExercisePricesLowerThanFairMarket" xlink:type="locator" xlink:label="drrx_OptionsGrantedWithExercisePricesLowerThanFairMarket" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_EmployeeStockPurchasePlanExpirationDate" xlink:type="locator" xlink:label="drrx_EmployeeStockPurchasePlanExpirationDate" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_EmployeesStockPurchasePlanExtendedTermPeriod" xlink:type="locator" xlink:label="drrx_EmployeesStockPurchasePlanExtendedTermPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum" xlink:type="locator" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_EmployeeStockPurchasePlanOfferingPeriod" xlink:type="locator" xlink:label="drrx_EmployeeStockPurchasePlanOfferingPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_TwoThousandEmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="drrx_TwoThousandEmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="drrx_TwoThousandEmployeeStockPurchasePlanMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_EmployeeStockPurchasePlanOfferingPeriod" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_EmployeesStockPurchasePlanExtendedTermPeriod" order="10640.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_EmployeeStockPurchasePlanExpirationDate" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="10860.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="10880.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="10900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="10950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_li0l2" order="11040.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveTerseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="11080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_OptionsGrantedWithExercisePricesLowerThanFairMarket" order="11120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" order="11190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_DeferredTaxExpenseFromStockOptionsExercised" order="11210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfSharesOfCommonStockReservedForFutureIssuanceDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStockholdersEquitySummaryOfSharesOfCommonStockReservedForFutureIssuanceDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfSharesOfCommonStockReservedForFutureIssuanceDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="locator" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_TwoThousandEmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="drrx_TwoThousandEmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="drrx_TwoThousandEmployeeStockPurchasePlanMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_li0l2" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="10810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="10910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="11010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="11110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="11210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_li0l2" order="11310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="11410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="11510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="11610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="11810.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="11910.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="12010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="12210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="12310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfEmployeeStockBasedCompensationCostThatHasBeenIncludedInStatementsOfOperationsAndComprehensiveLossDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStockholdersEquitySummaryOfEmployeeStockBasedCompensationCostThatHasBeenIncludedInStatementsOfOperationsAndComprehensiveLossDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfEmployeeStockBasedCompensationCostThatHasBeenIncludedInStatementsOfOperationsAndComprehensiveLossDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="locator" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:type="locator" xlink:label="us-gaap_CostOfSalesMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_CostOfSalesMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:type="locator" xlink:label="us-gaap_AdjustmentForAmortization" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_TwoThousandEmployeeStockPurchasePlanMember" xlink:type="locator" xlink:label="drrx_TwoThousandEmployeeStockPurchasePlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:type="locator" xlink:label="us-gaap_PlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:type="locator" xlink:label="us-gaap_PlanNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="drrx_TwoThousandEmployeeStockPurchasePlanMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AdjustmentForAmortization" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="10550.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail">
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate" xlink:type="locator" xlink:label="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember" xlink:type="locator" xlink:label="us-gaap_EmployeeStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:type="locator" xlink:label="srt_MaximumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:type="locator" xlink:label="srt_MinimumMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:type="locator" xlink:label="srt_RangeMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:type="locator" xlink:label="srt_RangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember" xlink:type="locator" xlink:label="us-gaap_StockCompensationPlanMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_StockCompensationPlanMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="10320.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="10360.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="10380.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10520.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="10590.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="10770.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="10890.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="10950.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate" order="11010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeElevenMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeElevenMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeTenMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeTenMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeNineMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeNineMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeEightMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeEightMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeSevenMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeSevenMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeSixMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeSixMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeFiveMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeFiveMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeFourMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeFourMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeThreeMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeThreeMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeTwoMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeTwoMember" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ExercisePriceRangeOneMember" xlink:type="locator" xlink:label="drrx_ExercisePriceRangeOneMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" xlink:label="us-gaap_EquityAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeOneMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeTwoMember" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeThreeMember" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeFourMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeFiveMember" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeSixMember" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeSevenMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeEightMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeNineMember" order="10240.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeTenMember" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="drrx_ExercisePriceRangeElevenMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" order="10830.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" order="11090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" order="11350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="11610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="11870.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAmount" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_TaxCreditCarryforwardExpiration" xlink:type="locator" xlink:label="drrx_TaxCreditCarryforwardExpiration" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NetOperatingLossCarryforwardsNonExpirationAmount" xlink:type="locator" xlink:label="drrx_NetOperatingLossCarryforwardsNonExpirationAmount" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NetOperatingLossCarryforwardsExpirationAmount" xlink:type="locator" xlink:label="drrx_NetOperatingLossCarryforwardsExpirationAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="locator" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:type="locator" xlink:label="us-gaap_IncomeTaxContingencyLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:type="locator" xlink:label="us-gaap_InternalRevenueServiceIRSMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember" xlink:type="locator" xlink:label="us-gaap_ResearchMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:type="locator" xlink:label="us-gaap_TaxCreditCarryforwardAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxContingencyTable" xlink:type="locator" xlink:label="us-gaap_IncomeTaxContingencyTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxContingencyTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="10120.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseMember" order="10140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyTable" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis" order="10030.06" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain" order="10260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_InternalRevenueServiceIRSMember" order="10280.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyTable" xlink:to="us-gaap_IncomeTaxContingencyLineItems" order="10560.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredTaxLiabilities" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10750.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="11020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="11110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="drrx_NetOperatingLossCarryforwardsExpirationAmount" order="11130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="drrx_NetOperatingLossCarryforwardsNonExpirationAmount" order="11150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="drrx_TaxCreditCarryforwardExpiration" order="11170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="11190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="11350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" order="11420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_IncomeTaxReconciliationExpiringNetOperatingLosses" xlink:type="locator" xlink:label="drrx_IncomeTaxReconciliationExpiringNetOperatingLosses" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" order="10510.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="drrx_IncomeTaxReconciliationExpiringNetOperatingLosses" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DeferredTaxLiabilitiesRightOfUseAssets" xlink:type="locator" xlink:label="drrx_DeferredTaxLiabilitiesRightOfUseAssets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="locator" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="drrx_DeferredTaxLiabilitiesRightOfUseAssets" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxLiabilities" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureIncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="locator" xlink:label="drrx_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="locator" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="drrx_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_UnrecognizedTaxBenefits_li0l2" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureDiscontinuedOperationsAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:type="locator" xlink:label="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid" xlink:type="locator" xlink:label="drrx_AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="locator" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_EvonikCorporationMember" xlink:type="locator" xlink:label="drrx_EvonikCorporationMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="locator" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="locator" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="locator" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="drrx_EvonikCorporationMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" order="10160.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="drrx_AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="locator" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:type="locator" xlink:label="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:type="locator" xlink:label="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="locator" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember" xlink:type="locator" xlink:label="us-gaap_ProductMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="locator" xlink:label="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="srt_ProductOrServiceAxis" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductMember" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" order="10180.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="10300.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" order="10420.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment" order="10480.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense" order="10540.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" order="10600.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" order="10660.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract" order="10720.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract" xlink:to="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" order="10840.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" order="10900.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="us-gaap_EarningsPerShareAbstract" order="10960.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="11080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" order="11140.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="11260.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="locator" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="locator" xlink:label="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent" order="10530.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent" order="10570.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" order="10610.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent" order="10730.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail">
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:type="locator" xlink:label="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment" xlink:type="locator" xlink:label="drrx_NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill" xlink:type="locator" xlink:label="drrx_NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense" xlink:type="locator" xlink:label="drrx_DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" xlink:type="locator" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:type="locator" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="drrx_NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="drrx_NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract" xlink:to="drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureSubsequentEventsAdditionalInformationDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail">
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CommonStockWeightedAveragePrice" xlink:type="locator" xlink:label="drrx_CommonStockWeightedAveragePrice" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_StockIssuedDuringPeriodValueNewIssuesNet" xlink:type="locator" xlink:label="drrx_StockIssuedDuringPeriodValueNewIssuesNet" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" xlink:label="us-gaap_SubsequentEventLineItems" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_OctoberTwoThousandEighteenRegistrationStatementMember" xlink:type="locator" xlink:label="drrx_OctoberTwoThousandEighteenRegistrationStatementMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_CantorFitzgeraldCoMember" xlink:type="locator" xlink:label="drrx_CantorFitzgeraldCoMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="locator" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:type="locator" xlink:label="srt_CounterpartyNameAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" xlink:label="us-gaap_SubsequentEventTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_CounterpartyNameAxis" order="10030.02" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="10200.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="drrx_CantorFitzgeraldCoMember" order="10220.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="10030.04" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="10440.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="drrx_OctoberTwoThousandEighteenRegistrationStatementMember" order="10460.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="10620.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10630.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="10650.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="10670.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" order="10690.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="drrx_StockIssuedDuringPeriodValueNewIssuesNet" order="10710.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="10760.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_li0l2" order="10780.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="drrx_CommonStockWeightedAveragePrice" order="10800.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:roleRef roleURI="http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccountsDetail" xlink:href="drrx-20201231.xsd#Role_DisclosureScheduleIIValuationAndQualifyingAccountsDetail" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccountsDetail">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance_li0l2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesDeductions" />
    <link:loc xlink:href="drrx-20201231.xsd#drrx_ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense" xlink:type="locator" xlink:label="drrx_ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesBalance" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="locator" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForCreditLossMember" xlink:type="locator" xlink:label="us-gaap_AllowanceForCreditLossMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="locator" xlink:label="us-gaap_ValuationAllowancesAndReservesTypeAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="locator" xlink:label="srt_ValuationAndQualifyingAccountsDisclosureTable" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:type="locator" xlink:label="srt_ValuationAndQualifyingAccountsAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ValuationAndQualifyingAccountsAbstract" xlink:to="srt_ValuationAndQualifyingAccountsDisclosureTable" order="10020.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="us-gaap_ValuationAllowancesAndReservesTypeAxis" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="us-gaap_ValuationAllowancesAndReservesDomain" order="10060.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="us-gaap_AllowanceForCreditLossMember" order="10080.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="srt_ValuationAndQualifyingAccountsDisclosureLineItems" order="10100.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="drrx_ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="us-gaap_ValuationAllowancesAndReservesDeductions" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="us-gaap_ValuationAllowancesAndReservesBalance_li0l2" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>drrx-10k_20201231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:drrx="http://www.durect.com/20201231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="drrx-20201231.xsd" xlink:type="simple"/>
    <context id="C_0001082038_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="C_0001082038_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="C_0001082038_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtRestatementAxis_srtRevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_srtRestatementAxis_srtRevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapBalanceSheetLocationAxis_drrxLongTermRestrictedInvestmentsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">drrx:LongTermRestrictedInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapBalanceSheetLocationAxis_drrxLongTermRestrictedInvestmentsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">drrx:LongTermRestrictedInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapBalanceSheetLocationAxis_drrxLongTermRestrictedInvestmentsMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">drrx:LongTermRestrictedInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_srtRangeAxis_srtMinimumMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtRangeAxis_srtMaximumMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_drrxLactelProductLineMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:LactelProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_drrxAlzetProductLineMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapProductConcentrationRiskMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:AlzetProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_drrxAlzetProductLineMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapProductConcentrationRiskMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:AlzetProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_drrxAlzetProductLineMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapProductConcentrationRiskMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:AlzetProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtMajorCustomersAxis_drrxGileadMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">drrx:GileadMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtMajorCustomersAxis_drrxGileadMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">drrx:GileadMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtMajorCustomersAxis_drrxGileadMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">drrx:GileadMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtMajorCustomersAxis_drrxIndiviorMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">drrx:IndiviorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_countryUS_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_countryUS_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_countryUS_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_srtEuropeMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_srtEuropeMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_srtEuropeMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_countryJP_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_countryJP_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_countryJP_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_drrxOtherForeignCountriesMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:OtherForeignCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_drrxOtherForeignCountriesMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:OtherForeignCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_drrxOtherForeignCountriesMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:OtherForeignCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapRelatedPartyTransactionAxis_drrxLACTELMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">drrx:LACTELMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_srtRestatementAxis_srtRevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember_20180101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithGileadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithGileadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithGileadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementsWithOtherCollaboratorsOrCounterpartiesMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementsWithOtherCollaboratorsOrCounterpartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementsWithOtherCollaboratorsOrCounterpartiesMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementsWithOtherCollaboratorsOrCounterpartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementsWithOtherCollaboratorsOrCounterpartiesMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementsWithOtherCollaboratorsOrCounterpartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithGileadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithGileadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithGileadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_us-gaapLicenseMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithGileadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxDevelopmentBasedMilestonesMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210227_20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:DevelopmentBasedMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-27</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxSalesBasedMilestonesMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210227_20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:SalesBasedMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-27</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapChangeInAccountingEstimateByTypeAxis_drrxEarlyStageClinicalTestingMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">drrx:EarlyStageClinicalTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapChangeInAccountingEstimateByTypeAxis_drrxLateStageClinicalTestingMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">drrx:LateStageClinicalTestingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapChangeInAccountingEstimateByTypeAxis_us-gaapRegulatoryReviewsOfFilingsMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">us-gaap:RegulatoryReviewsOfFilingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapChangeInAccountingEstimateByTypeAxis_drrxRegulatoryApprovalsMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">drrx:RegulatoryApprovalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20190717_20190719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithGileadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-17</startDate>
            <endDate>2019-07-19</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20191001_20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithGileadMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxUpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:CollaborativeResearchAndDevelopmentAndOtherRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">drrx:AdditionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">drrx:DeletionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">drrx:AdditionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerDurationAxis">drrx:DeletionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20170925_20170926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:PatentPurchaseAgreementWithIndiviorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-25</startDate>
            <endDate>2017-09-26</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxRegulatoryBasedMilestoneMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20170926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:RegulatoryBasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:PatentPurchaseAgreementWithIndiviorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-09-26</instant>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_us-gaapRoyaltyMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20170901_20170930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:PatentPurchaseAgreementWithIndiviorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2017-09-30</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_us-gaapRoyaltyMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20170101_20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:PatentPurchaseAgreementWithIndiviorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxRegulatoryBasedMilestoneMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:RegulatoryBasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:PatentPurchaseAgreementWithIndiviorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxRegulatoryBasedMilestoneMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:RegulatoryBasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:PatentPurchaseAgreementWithIndiviorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtProductOrServiceAxis_us-gaapLicenseMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20141210_20141211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithSantenPharmaceuticalCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-12-10</startDate>
            <endDate>2014-12-11</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20141211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithSantenPharmaceuticalCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-11</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxDevelopmentBasedMilestonesMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20141211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:DevelopmentBasedMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithSantenPharmaceuticalCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-11</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxCommercializationBasedMilestonesMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20141211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:CommercializationBasedMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithSantenPharmaceuticalCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-11</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxCommercializationBasedMilestonesMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">drrx:CommercializationBasedMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithSantenPharmaceuticalCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithSantenPharmaceuticalCoLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithSandozAGMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:AgreementWithSandozAGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCertificatesOfDepositMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMunicipalBondsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCertificatesOfDepositMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCommercialPaperMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMunicipalBondsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCertificatesOfDepositMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCertificatesOfDepositMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCommercialPaperMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCertificatesOfDepositMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCashAndCashEquivalentsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapOtherLongTermInvestmentsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapInvestmentTypeAxis_drrxLongTermRestrictedInvestmentsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">drrx:LongTermRestrictedInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCertificatesOfDepositMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCashAndCashEquivalentsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_countryCA_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_countryCA_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapLeaseContractualTermAxis_drrxLeaseAmendmentMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeLaboratoryAndManufacturingMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:CupertinoCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">drrx:LeaseAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">drrx:OfficeLaboratoryAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapLeaseContractualTermAxis_drrxLeaseAmendmentMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeAndLaboratoryMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:CupertinoCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">drrx:LeaseAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">drrx:OfficeAndLaboratoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_drrxVacavilleCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapManufacturingFacilityMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:VacavilleCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapLeaseContractualTermAxis_drrxLeaseAmendmentMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeLaboratoryAndManufacturingMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:CupertinoCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">drrx:LeaseAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">drrx:OfficeLaboratoryAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapLeaseContractualTermAxis_drrxLeaseAmendmentMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeAndLaboratoryMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:CupertinoCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">drrx:LeaseAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">drrx:OfficeAndLaboratoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_drrxVacavilleCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapManufacturingFacilityMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:VacavilleCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeLaboratoryAndManufacturingMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:CupertinoCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">drrx:OfficeLaboratoryAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeLaboratoryAndManufacturingMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:CupertinoCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">drrx:OfficeLaboratoryAndManufacturingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeAndLaboratoryMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:CupertinoCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">drrx:OfficeAndLaboratoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeAndLaboratoryMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">drrx:CupertinoCAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">drrx:OfficeAndLaboratoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">drrx:OxfordFinanceLlcTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-07-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">drrx:OxfordFinanceLlcTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">drrx:OxfordFinanceLlcTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">drrx:OxfordFinanceLlcTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">drrx:OxfordFinanceLlcTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20180201_20180228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">drrx:OxfordFinanceLlcTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-01</startDate>
            <endDate>2018-02-28</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20181101_20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">drrx:OxfordFinanceLlcTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="C_0001082038_20191201_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtRangeAxis_srtMaximumMember_20151130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-11-30</instant>
        </period>
    </context>
    <context id="C_0001082038_srtRangeAxis_srtMaximumMember_20181031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-31</instant>
        </period>
    </context>
    <context id="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_drrxControlledEquityOfferingProgramMember_20151130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">drrx:CantorFitzgeraldCoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:ControlledEquityOfferingProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-11-30</instant>
        </period>
    </context>
    <context id="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_drrxControlledEquityOfferingProgramMember_20181031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">drrx:CantorFitzgeraldCoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:ControlledEquityOfferingProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-31</instant>
        </period>
    </context>
    <context id="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapTypeOfArrangementAxis_drrxControlledEquityOfferingProgramMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">drrx:CantorFitzgeraldCoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:ControlledEquityOfferingProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:OctoberTwoThousandEighteenRegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:OctoberTwoThousandEighteenRegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_20190620_20190620">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
        </entity>
        <period>
            <startDate>2019-06-20</startDate>
            <endDate>2019-06-20</endDate>
        </period>
    </context>
    <context id="C_0001082038_20190620">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
        </entity>
        <period>
            <instant>2019-06-20</instant>
        </period>
    </context>
    <context id="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210201_20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">drrx:CantorFitzgeraldCoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">drrx:CantorFitzgeraldCoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20210321_20210321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:OctoberTwoThousandEighteenRegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-21</startDate>
            <endDate>2021-03-21</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20110601_20110630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2011-06-01</startDate>
            <endDate>2011-06-30</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20140601_20140630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-06-01</startDate>
            <endDate>2014-06-30</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20160601_20160630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-06-01</startDate>
            <endDate>2016-06-30</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20180601_20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20190601_20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_srtTitleOfIndividualAxis_drrxNonEmployeeDirectorMember_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20000101_20000331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">drrx:NonEmployeeDirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2000-01-01</startDate>
            <endDate>2000-03-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20130401_20130430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-04-01</startDate>
            <endDate>2013-04-30</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20130401_20130430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-04-01</startDate>
            <endDate>2013-04-30</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20130401_20130430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-04-01</startDate>
            <endDate>2013-04-30</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20100401_20100430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-04-01</startDate>
            <endDate>2010-04-30</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20150301_20150331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-03-01</startDate>
            <endDate>2015-03-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20170601_20170630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-06-01</startDate>
            <endDate>2017-06-30</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200601_20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">drrx:TwoThousandEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTwoMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeThreeMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFourMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFiveMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSixMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSevenMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeEightMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeNineMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTenMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeTenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeElevenMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeElevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTwoMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeThreeMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFourMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFiveMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSixMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSevenMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeEightMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeNineMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTenMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeTenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeElevenMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">drrx:ExercisePriceRangeElevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapOtherNonoperatingIncomeExpenseMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapOtherNonoperatingIncomeExpenseMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapOtherNonoperatingIncomeExpenseMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_20181230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
        </entity>
        <period>
            <instant>2018-12-30</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_drrxEvonikCorporationMember_20201230_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">drrx:EvonikCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-30</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_drrxEvonikCorporationMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">drrx:EvonikCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20210101_20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">drrx:CantorFitzgeraldCoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">drrx:OctoberTwoThousandEighteenRegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20200101_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20190101_20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20180101_20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001082038</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForCreditLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <unit id="U_xbrlishares">
        <measure>shares</measure>
    </unit>
    <unit id="U_iso4217USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U_iso4217USD_xbrlishares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_xbrlipure">
        <measure>pure</measure>
    </unit>
    <unit id="U_drrxSegment">
        <measure>drrx:Segment</measure>
    </unit>
    <unit id="U_utrsqft">
        <measure>utr:sqft</measure>
    </unit>
    <dei:AmendmentFlag contextRef="C_0001082038_20200101_20201231" id="F_000001">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="C_0001082038_20200101_20201231" id="F_000004">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="C_0001082038_20200101_20201231" id="F_000007">0001082038</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="C_0001082038_20200101_20201231" id="F_000008">--12-31</dei:CurrentFiscalYearEndDate>
    <drrx:EmployeesStockPurchasePlanExtendedTermPeriod
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20200101_20201231"
      id="F_000718">P10Y</drrx:EmployeesStockPurchasePlanExtendedTermPeriod>
    <drrx:EmployeesStockPurchasePlanExtendedTermPeriod
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20190601_20190630"
      id="F_000723">P10Y</drrx:EmployeesStockPurchasePlanExtendedTermPeriod>
    <drrx:EmployeesStockPurchasePlanExtendedTermPeriod
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20100401_20100430"
      id="F_000740">P10Y</drrx:EmployeesStockPurchasePlanExtendedTermPeriod>
    <drrx:EmployeesStockPurchasePlanExtendedTermPeriod
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20150301_20150331"
      id="F_000744">P10Y</drrx:EmployeesStockPurchasePlanExtendedTermPeriod>
    <drrx:EmployeeStockPurchasePlanExpirationDate
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20200101_20201231"
      id="F_000725">2029-06-30</drrx:EmployeeStockPurchasePlanExpirationDate>
    <drrx:StockOptionsVestingPeriod
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20130401_20130430"
      id="F_000728">P10Y</drrx:StockOptionsVestingPeriod>
    <drrx:ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors
      contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20130401_20130430"
      id="F_000730">P2Y</drrx:ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors>
    <drrx:EmployeeStockPurchasePlanExpirationDate
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231"
      id="F_000745">2030-06-30</drrx:EmployeeStockPurchasePlanExpirationDate>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="C_0001082038_20200101_20201231"
      decimals="INF"
      id="F_000996"
      unitRef="U_iso4217USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="C_0001082038_20190101_20191231"
      decimals="INF"
      id="F_000997"
      unitRef="U_iso4217USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="C_0001082038_20180101_20181231"
      decimals="INF"
      id="F_000998"
      unitRef="U_iso4217USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_0001082038_20201231"
      id="F_000084"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_0001082038_20191231"
      id="F_000085"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_0001082038_20201231"
      id="F_000086"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_0001082038_20191231"
      id="F_000087"
      unitRef="U_iso4217USD"
      xsi:nil="true"/>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList contextRef="C_0001082038_20200101_20201231" id="F_000130">us-gaap:ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList contextRef="C_0001082038_20190101_20191231" id="F_000131">us-gaap:ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList contextRef="C_0001082038_20180101_20181231" id="F_000132">us-gaap:ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="C_0001082038_20190101_20191231" id="F_000769">P5Y2M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="C_0001082038_20200101_20201231" id="F_000770">P4Y11M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="C_0001082038_20200101_20201231" id="F_000771">P4Y5M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="C_0001082038_20200101_20201231" id="F_000772">P4Y11M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231"
      decimals="INF"
      id="F_000803"
      unitRef="U_xbrlipure">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231"
      decimals="INF"
      id="F_000804"
      unitRef="U_xbrlipure">0.027</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231"
      decimals="INF"
      id="F_000805"
      unitRef="U_xbrlipure">0.031</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231"
      id="F_000806">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231"
      id="F_000807">P7Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231"
      id="F_000808">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231"
      decimals="INF"
      id="F_000812"
      unitRef="U_xbrlipure">0.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231"
      decimals="INF"
      id="F_000813"
      unitRef="U_xbrlipure">0.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231"
      decimals="INF"
      id="F_000814"
      unitRef="U_xbrlipure">0.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231"
      decimals="INF"
      id="F_000800"
      unitRef="U_xbrlipure">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231"
      decimals="INF"
      id="F_000801"
      unitRef="U_xbrlipure">0.015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231"
      decimals="INF"
      id="F_000802"
      unitRef="U_xbrlipure">0.027</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231"
      id="F_000809">P7Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231"
      id="F_000810">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231"
      id="F_000811">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231"
      decimals="INF"
      id="F_000815"
      unitRef="U_xbrlipure">0.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231"
      decimals="INF"
      id="F_000816"
      unitRef="U_xbrlipure">0.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231"
      decimals="INF"
      id="F_000817"
      unitRef="U_xbrlipure">0.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20190101_20191231"
      decimals="INF"
      id="F_000824"
      unitRef="U_xbrlipure">0.025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20180101_20181231"
      decimals="INF"
      id="F_000825"
      unitRef="U_xbrlipure">0.025</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20201231"
      id="F_000826">P6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20190101_20191231"
      id="F_000827">P6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20180101_20181231"
      id="F_000828">P6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20201231"
      decimals="INF"
      id="F_000829"
      unitRef="U_xbrlipure">0.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20190101_20191231"
      decimals="INF"
      id="F_000830"
      unitRef="U_xbrlipure">0.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20180101_20181231"
      decimals="INF"
      id="F_000831"
      unitRef="U_xbrlipure">0.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20201231"
      decimals="INF"
      id="F_000821"
      unitRef="U_xbrlipure">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20190101_20191231"
      decimals="INF"
      id="F_000822"
      unitRef="U_xbrlipure">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20180101_20181231"
      decimals="INF"
      id="F_000823"
      unitRef="U_xbrlipure">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20201231"
      decimals="INF"
      id="F_000832"
      unitRef="U_xbrlipure">1.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20190101_20191231"
      decimals="INF"
      id="F_000833"
      unitRef="U_xbrlipure">1.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_0001082038_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20180101_20181231"
      decimals="INF"
      id="F_000834"
      unitRef="U_xbrlipure">1.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20200101_20201231"
      decimals="INF"
      id="F_000843"
      unitRef="U_iso4217USD_xbrlishares">0.51</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20200101_20201231"
      id="F_000876">P8Y1M13D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTwoMember_20200101_20201231"
      decimals="INF"
      id="F_000844"
      unitRef="U_iso4217USD_xbrlishares">0.58</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTwoMember_20200101_20201231"
      id="F_000877">P7Y9M14D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeThreeMember_20200101_20201231"
      decimals="INF"
      id="F_000845"
      unitRef="U_iso4217USD_xbrlishares">0.58</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeThreeMember_20200101_20201231"
      id="F_000878">P3Y7M24D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFourMember_20200101_20201231"
      decimals="INF"
      id="F_000846"
      unitRef="U_iso4217USD_xbrlishares">0.93</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFourMember_20200101_20201231"
      id="F_000879">P4Y11M1D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFiveMember_20200101_20201231"
      decimals="INF"
      id="F_000847"
      unitRef="U_iso4217USD_xbrlishares">1.21</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFiveMember_20200101_20201231"
      id="F_000880">P2Y1M17D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSixMember_20200101_20201231"
      decimals="INF"
      id="F_000848"
      unitRef="U_iso4217USD_xbrlishares">1.24</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSixMember_20200101_20201231"
      id="F_000881">P6Y10M2D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSevenMember_20200101_20201231"
      decimals="INF"
      id="F_000849"
      unitRef="U_iso4217USD_xbrlishares">1.26</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSevenMember_20200101_20201231"
      id="F_000882">P5Y3M10D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeEightMember_20200101_20201231"
      decimals="INF"
      id="F_000850"
      unitRef="U_iso4217USD_xbrlishares">1.31</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeEightMember_20200101_20201231"
      id="F_000883">P5Y7M13D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeNineMember_20200101_20201231"
      decimals="INF"
      id="F_000851"
      unitRef="U_iso4217USD_xbrlishares">1.33</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeNineMember_20200101_20201231"
      id="F_000884">P4Y4M6D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTenMember_20200101_20201231"
      decimals="INF"
      id="F_000852"
      unitRef="U_iso4217USD_xbrlishares">2.10</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTenMember_20200101_20201231"
      id="F_000885">P4Y11M12D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeElevenMember_20200101_20201231"
      decimals="INF"
      id="F_000853"
      unitRef="U_iso4217USD_xbrlishares">0.51</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeElevenMember_20200101_20201231"
      id="F_000886">P4Y11M23D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20200101_20201231"
      decimals="INF"
      id="F_000854"
      unitRef="U_iso4217USD_xbrlishares">0.57</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTwoMember_20200101_20201231"
      decimals="INF"
      id="F_000855"
      unitRef="U_iso4217USD_xbrlishares">0.58</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeThreeMember_20200101_20201231"
      decimals="INF"
      id="F_000856"
      unitRef="U_iso4217USD_xbrlishares">0.88</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFourMember_20200101_20201231"
      decimals="INF"
      id="F_000857"
      unitRef="U_iso4217USD_xbrlishares">1.20</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFiveMember_20200101_20201231"
      decimals="INF"
      id="F_000858"
      unitRef="U_iso4217USD_xbrlishares">1.21</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSixMember_20200101_20201231"
      decimals="INF"
      id="F_000859"
      unitRef="U_iso4217USD_xbrlishares">1.24</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSevenMember_20200101_20201231"
      decimals="INF"
      id="F_000860"
      unitRef="U_iso4217USD_xbrlishares">1.26</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeEightMember_20200101_20201231"
      decimals="INF"
      id="F_000861"
      unitRef="U_iso4217USD_xbrlishares">1.31</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeNineMember_20200101_20201231"
      decimals="INF"
      id="F_000862"
      unitRef="U_iso4217USD_xbrlishares">2.09</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTenMember_20200101_20201231"
      decimals="INF"
      id="F_000863"
      unitRef="U_iso4217USD_xbrlishares">3.61</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeElevenMember_20200101_20201231"
      decimals="INF"
      id="F_000864"
      unitRef="U_iso4217USD_xbrlishares">3.61</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <dei:DocumentType contextRef="C_0001082038_20200101_20201231" id="F_000000">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="C_0001082038_20200101_20201231" id="F_000031">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="C_0001082038_20200101_20201231" id="F_000002">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="C_0001082038_20200101_20201231" id="F_000003">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="C_0001082038_20200101_20201231" id="F_000032">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="C_0001082038_20200101_20201231" id="F_000022">000-31615</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="C_0001082038_20200101_20201231" id="F_000006">DURECT CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0001082038_20200101_20201231" id="F_000023">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="C_0001082038_20200101_20201231" id="F_000024">94-3297098</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0001082038_20200101_20201231" id="F_000025">10260 Bubb Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="C_0001082038_20200101_20201231" id="F_000026">Cupertino</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0001082038_20200101_20201231" id="F_000027">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0001082038_20200101_20201231" id="F_000028">95014</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0001082038_20200101_20201231" id="F_000029">408</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0001082038_20200101_20201231" id="F_000030">777-1417</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="C_0001082038_20200101_20201231" id="F_000020">Common Stock $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0001082038_20200101_20201231" id="F_000005">DRRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0001082038_20200101_20201231" id="F_000021">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="C_0001082038_20200101_20201231" id="F_000009">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="C_0001082038_20200101_20201231" id="F_000011">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="C_0001082038_20200101_20201231" id="F_000010">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="C_0001082038_20200101_20201231" id="F_000019">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="C_0001082038_20200101_20201231" id="F_000012">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="C_0001082038_20200101_20201231" id="F_000014">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="C_0001082038_20200101_20201231" id="F_000015">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="C_0001082038_20200101_20201231" id="F_000016">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany contextRef="C_0001082038_20200101_20201231" id="F_000013">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_0001082038_20200630"
      decimals="0"
      id="F_000018"
      unitRef="U_iso4217USD">169632305</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_0001082038_20210301"
      decimals="INF"
      id="F_000017"
      unitRef="U_xbrlishares">227201863</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000033">Part III incorporates information by reference from the definitive Proxy Statement for the 2020 annual meeting of stockholders, which is expected to be filed not later than 120 days after the Registrant&#x2019;s fiscal year ended December 31, 2020.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000034"
      unitRef="U_iso4217USD">21312000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000035"
      unitRef="U_iso4217USD">34924000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:EscrowDeposit
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000036"
      unitRef="U_iso4217USD">14979000</us-gaap:EscrowDeposit>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000037"
      unitRef="U_iso4217USD">19421000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000038"
      unitRef="U_iso4217USD">29750000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000100"
      unitRef="U_iso4217USD">72000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000101"
      unitRef="U_iso4217USD">27000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000039"
      unitRef="U_iso4217USD">940000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000040"
      unitRef="U_iso4217USD">1516000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000041"
      unitRef="U_iso4217USD">1864000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000042"
      unitRef="U_iso4217USD">1919000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000043"
      unitRef="U_iso4217USD">4545000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000044"
      unitRef="U_iso4217USD">1424000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000045"
      unitRef="U_iso4217USD">2296000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000046"
      unitRef="U_iso4217USD">63061000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000047"
      unitRef="U_iso4217USD">71829000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000048"
      unitRef="U_iso4217USD">251000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000049"
      unitRef="U_iso4217USD">159000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000050"
      unitRef="U_iso4217USD">4749000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000051"
      unitRef="U_iso4217USD">5866000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000052"
      unitRef="U_iso4217USD">6169000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000053"
      unitRef="U_iso4217USD">6399000</us-gaap:Goodwill>
    <us-gaap:LongTermInvestments
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000054"
      unitRef="U_iso4217USD">1000000</us-gaap:LongTermInvestments>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000055"
      unitRef="U_iso4217USD">150000</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000056"
      unitRef="U_iso4217USD">150000</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000057"
      unitRef="U_iso4217USD">261000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000058"
      unitRef="U_iso4217USD">1085000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000059"
      unitRef="U_iso4217USD">532000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000060"
      unitRef="U_iso4217USD">75641000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000061"
      unitRef="U_iso4217USD">86020000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000062"
      unitRef="U_iso4217USD">1678000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000063"
      unitRef="U_iso4217USD">1982000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000064"
      unitRef="U_iso4217USD">5801000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000065"
      unitRef="U_iso4217USD">5940000</us-gaap:AccruedLiabilitiesCurrent>
    <drrx:ContractResearchLiability
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000066"
      unitRef="U_iso4217USD">545000</drrx:ContractResearchLiability>
    <drrx:ContractResearchLiability
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000067"
      unitRef="U_iso4217USD">3653000</drrx:ContractResearchLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000068"
      unitRef="U_iso4217USD">22679000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000069"
      unitRef="U_iso4217USD">884000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000070"
      unitRef="U_iso4217USD">1795000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000071"
      unitRef="U_iso4217USD">1742000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000072"
      unitRef="U_iso4217USD">772000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000073"
      unitRef="U_iso4217USD">10703000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000074"
      unitRef="U_iso4217USD">36768000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000075"
      unitRef="U_iso4217USD">812000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000076"
      unitRef="U_iso4217USD">812000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000077"
      unitRef="U_iso4217USD">3202000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000078"
      unitRef="U_iso4217USD">4356000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000079"
      unitRef="U_iso4217USD">19936000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000080"
      unitRef="U_iso4217USD">20262000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000081"
      unitRef="U_iso4217USD">873000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000082"
      unitRef="U_iso4217USD">705000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000083"
      unitRef="U_iso4217USD">257000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_0001082038_20201231"
      decimals="INF"
      id="F_000102"
      unitRef="U_iso4217USD_xbrlishares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_0001082038_20191231"
      decimals="INF"
      id="F_000103"
      unitRef="U_iso4217USD_xbrlishares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_0001082038_20201231"
      decimals="INF"
      id="F_000104"
      unitRef="U_xbrlishares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_0001082038_20191231"
      decimals="INF"
      id="F_000105"
      unitRef="U_xbrlishares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_0001082038_20201231"
      decimals="INF"
      id="F_000106"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0001082038_20201231"
      decimals="INF"
      id="F_000108"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_0001082038_20191231"
      decimals="INF"
      id="F_000107"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_0001082038_20191231"
      decimals="INF"
      id="F_000109"
      unitRef="U_xbrlishares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0001082038_20201231"
      decimals="INF"
      id="F_000110"
      unitRef="U_iso4217USD_xbrlishares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0001082038_20191231"
      decimals="INF"
      id="F_000111"
      unitRef="U_iso4217USD_xbrlishares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0001082038_20201231"
      decimals="INF"
      id="F_000112"
      unitRef="U_xbrlishares">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_0001082038_20191231"
      decimals="INF"
      id="F_000113"
      unitRef="U_xbrlishares">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000114"
      unitRef="U_xbrlishares">203533000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000116"
      unitRef="U_xbrlishares">203533000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000117"
      unitRef="U_xbrlishares">195257000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000115"
      unitRef="U_xbrlishares">195257000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000088"
      unitRef="U_iso4217USD">20000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000089"
      unitRef="U_iso4217USD">19000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000090"
      unitRef="U_iso4217USD">529884000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000091"
      unitRef="U_iso4217USD">512046000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000092"
      unitRef="U_iso4217USD">-5000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000093"
      unitRef="U_iso4217USD">-3000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000094"
      unitRef="U_iso4217USD">-489784000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000095"
      unitRef="U_iso4217USD">-489202000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000096"
      unitRef="U_iso4217USD">40115000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000097"
      unitRef="U_iso4217USD">22860000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000098"
      unitRef="U_iso4217USD">75641000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000099"
      unitRef="U_iso4217USD">86020000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20200101_20201231"
      decimals="-3"
      id="F_000118"
      unitRef="U_iso4217USD">23941000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20190101_20191231"
      decimals="-3"
      id="F_000119"
      unitRef="U_iso4217USD">18129000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20180101_20181231"
      decimals="-3"
      id="F_000120"
      unitRef="U_iso4217USD">8207000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20200101_20201231"
      decimals="-3"
      id="F_000121"
      unitRef="U_iso4217USD">6170000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20190101_20191231"
      decimals="-3"
      id="F_000122"
      unitRef="U_iso4217USD">6945000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20180101_20181231"
      decimals="-3"
      id="F_000123"
      unitRef="U_iso4217USD">7068000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000124"
      unitRef="U_iso4217USD">30111000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000125"
      unitRef="U_iso4217USD">25074000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000126"
      unitRef="U_iso4217USD">15275000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000127"
      unitRef="U_iso4217USD">1406000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000128"
      unitRef="U_iso4217USD">1263000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000129"
      unitRef="U_iso4217USD">1640000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000133"
      unitRef="U_iso4217USD">27709000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000134"
      unitRef="U_iso4217USD">29640000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000135"
      unitRef="U_iso4217USD">25013000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000136"
      unitRef="U_iso4217USD">13611000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000137"
      unitRef="U_iso4217USD">14115000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000138"
      unitRef="U_iso4217USD">12262000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000139"
      unitRef="U_iso4217USD">42726000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000140"
      unitRef="U_iso4217USD">45018000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000141"
      unitRef="U_iso4217USD">38915000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000142"
      unitRef="U_iso4217USD">-12615000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000143"
      unitRef="U_iso4217USD">-19944000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000144"
      unitRef="U_iso4217USD">-23640000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncome
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000145"
      unitRef="U_iso4217USD">517000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000146"
      unitRef="U_iso4217USD">1074000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000147"
      unitRef="U_iso4217USD">870000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:InterestExpense
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000148"
      unitRef="U_iso4217USD">2237000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000149"
      unitRef="U_iso4217USD">2501000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000150"
      unitRef="U_iso4217USD">2573000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000151"
      unitRef="U_iso4217USD">-1720000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000152"
      unitRef="U_iso4217USD">-1427000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000153"
      unitRef="U_iso4217USD">-1703000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000154"
      unitRef="U_iso4217USD">-14335000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000155"
      unitRef="U_iso4217USD">-21371000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000156"
      unitRef="U_iso4217USD">-25343000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000157"
      unitRef="U_iso4217USD">13753000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000158"
      unitRef="U_iso4217USD">793000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000159"
      unitRef="U_iso4217USD">21000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000160"
      unitRef="U_iso4217USD">-582000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000161"
      unitRef="U_iso4217USD">-20578000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000162"
      unitRef="U_iso4217USD">-25322000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000163"
      unitRef="U_iso4217USD">-2000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000164"
      unitRef="U_iso4217USD">-3000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000165"
      unitRef="U_iso4217USD">1000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000166"
      unitRef="U_iso4217USD">-584000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000167"
      unitRef="U_iso4217USD">-20581000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000168"
      unitRef="U_iso4217USD">-25321000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="C_0001082038_20200101_20201231"
      decimals="2"
      id="F_000169"
      unitRef="U_iso4217USD_xbrlishares">-0.07</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="C_0001082038_20190101_20191231"
      decimals="2"
      id="F_000170"
      unitRef="U_iso4217USD_xbrlishares">-0.12</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="C_0001082038_20180101_20181231"
      decimals="2"
      id="F_000171"
      unitRef="U_iso4217USD_xbrlishares">-0.16</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="C_0001082038_20200101_20201231"
      decimals="2"
      id="F_000172"
      unitRef="U_iso4217USD_xbrlishares">0.07</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="C_0001082038_20190101_20191231"
      decimals="2"
      id="F_000173"
      unitRef="U_iso4217USD_xbrlishares">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="C_0001082038_20180101_20181231"
      decimals="2"
      id="F_000174"
      unitRef="U_iso4217USD_xbrlishares">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="C_0001082038_20200101_20201231"
      decimals="2"
      id="F_000175"
      unitRef="U_iso4217USD_xbrlishares">0.00</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="C_0001082038_20190101_20191231"
      decimals="2"
      id="F_000176"
      unitRef="U_iso4217USD_xbrlishares">-0.12</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
      contextRef="C_0001082038_20180101_20181231"
      decimals="2"
      id="F_000177"
      unitRef="U_iso4217USD_xbrlishares">-0.16</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000178"
      unitRef="U_xbrlishares">199457000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000179"
      unitRef="U_xbrlishares">178042000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000180"
      unitRef="U_xbrlishares">159834000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:SharesOutstanding
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20171231"
      decimals="INF"
      id="F_000181"
      unitRef="U_xbrlishares">150837000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20171231"
      decimals="-3"
      id="F_000182"
      unitRef="U_iso4217USD">15000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20171231"
      decimals="-3"
      id="F_000183"
      unitRef="U_iso4217USD">465246000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20171231"
      decimals="-3"
      id="F_000184"
      unitRef="U_iso4217USD">-1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20171231"
      decimals="-3"
      id="F_000185"
      unitRef="U_iso4217USD">-443772000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_20171231"
      decimals="-3"
      id="F_000186"
      unitRef="U_iso4217USD">21488000</us-gaap:StockholdersEquity>
    <drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231"
      decimals="INF"
      id="F_000187"
      unitRef="U_xbrlishares">1594000</drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares>
    <drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231"
      decimals="-3"
      id="F_000188"
      unitRef="U_iso4217USD">1725000</drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan>
    <drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000189"
      unitRef="U_iso4217USD">1725000</drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000250"
      unitRef="U_iso4217USD">566000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231"
      decimals="INF"
      id="F_000190"
      unitRef="U_xbrlishares">9629000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20180101_20181231"
      decimals="-3"
      id="F_000191"
      unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231"
      decimals="-3"
      id="F_000192"
      unitRef="U_iso4217USD">16779000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000193"
      unitRef="U_iso4217USD">16780000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <drrx:AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231"
      decimals="-3"
      id="F_000194"
      unitRef="U_iso4217USD">1860000</drrx:AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities>
    <drrx:AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000195"
      unitRef="U_iso4217USD">1860000</drrx:AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20180101_20181231"
      decimals="-3"
      id="F_000196"
      unitRef="U_iso4217USD">2998000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000197"
      unitRef="U_iso4217USD">2998000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20180101_20181231"
      decimals="-3"
      id="F_000198"
      unitRef="U_iso4217USD">-25322000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000199"
      unitRef="U_iso4217USD">-25322000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20180101_20181231"
      decimals="-3"
      id="F_000200"
      unitRef="U_iso4217USD">1000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000201"
      unitRef="U_iso4217USD">1000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_srtRestatementAxis_srtRevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231"
      decimals="-3"
      id="F_000202"
      unitRef="U_iso4217USD">470000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_srtRestatementAxis_srtRevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember_20181231"
      decimals="-3"
      id="F_000203"
      unitRef="U_iso4217USD">470000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231"
      decimals="INF"
      id="F_000204"
      unitRef="U_xbrlishares">162060000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20181231"
      decimals="-3"
      id="F_000205"
      unitRef="U_iso4217USD">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20181231"
      decimals="-3"
      id="F_000206"
      unitRef="U_iso4217USD">488608000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20181231"
      decimals="-3"
      id="F_000207"
      unitRef="U_iso4217USD">-468624000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_20181231"
      decimals="-3"
      id="F_000208"
      unitRef="U_iso4217USD">20000000</us-gaap:StockholdersEquity>
    <drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="INF"
      id="F_000209"
      unitRef="U_xbrlishares">1847000</drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares>
    <drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000210"
      unitRef="U_iso4217USD">1979000</drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan>
    <drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000211"
      unitRef="U_iso4217USD">1979000</drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000251"
      unitRef="U_iso4217USD">356000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="INF"
      id="F_000212"
      unitRef="U_xbrlishares">31350000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20190101_20191231"
      decimals="-3"
      id="F_000213"
      unitRef="U_iso4217USD">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000214"
      unitRef="U_iso4217USD">18357000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000215"
      unitRef="U_iso4217USD">18360000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <drrx:AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000216"
      unitRef="U_iso4217USD">994000</drrx:AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities>
    <drrx:AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000217"
      unitRef="U_iso4217USD">994000</drrx:AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20190101_20191231"
      decimals="-3"
      id="F_000218"
      unitRef="U_iso4217USD">2108000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000219"
      unitRef="U_iso4217USD">2108000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20190101_20191231"
      decimals="-3"
      id="F_000220"
      unitRef="U_iso4217USD">-20578000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000221"
      unitRef="U_iso4217USD">-20578000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20190101_20191231"
      decimals="-3"
      id="F_000222"
      unitRef="U_iso4217USD">-3000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000223"
      unitRef="U_iso4217USD">-3000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231"
      decimals="INF"
      id="F_000224"
      unitRef="U_xbrlishares">195257000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191231"
      decimals="-3"
      id="F_000225"
      unitRef="U_iso4217USD">19000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20191231"
      decimals="-3"
      id="F_000226"
      unitRef="U_iso4217USD">512046000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20191231"
      decimals="-3"
      id="F_000227"
      unitRef="U_iso4217USD">-3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20191231"
      decimals="-3"
      id="F_000228"
      unitRef="U_iso4217USD">-489202000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000229"
      unitRef="U_iso4217USD">22860000</us-gaap:StockholdersEquity>
    <drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="INF"
      id="F_000230"
      unitRef="U_xbrlishares">2968000</drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares>
    <drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000231"
      unitRef="U_iso4217USD">0</drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan>
    <drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000232"
      unitRef="U_iso4217USD">3381000</drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan>
    <drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000233"
      unitRef="U_iso4217USD">3381000</drrx:IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000252"
      unitRef="U_iso4217USD">380000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="INF"
      id="F_000234"
      unitRef="U_xbrlishares">5308000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200101_20201231"
      decimals="-3"
      id="F_000235"
      unitRef="U_iso4217USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000236"
      unitRef="U_iso4217USD">12282000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000237"
      unitRef="U_iso4217USD">12283000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20200101_20201231"
      decimals="-3"
      id="F_000238"
      unitRef="U_iso4217USD">2175000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000239"
      unitRef="U_iso4217USD">2175000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20200101_20201231"
      decimals="-3"
      id="F_000240"
      unitRef="U_iso4217USD">-582000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000241"
      unitRef="U_iso4217USD">-582000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20200101_20201231"
      decimals="-3"
      id="F_000242"
      unitRef="U_iso4217USD">-2000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000243"
      unitRef="U_iso4217USD">-2000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231"
      decimals="INF"
      id="F_000244"
      unitRef="U_xbrlishares">203533000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20201231"
      decimals="-3"
      id="F_000245"
      unitRef="U_iso4217USD">20000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAdditionalPaidInCapitalMember_20201231"
      decimals="-3"
      id="F_000246"
      unitRef="U_iso4217USD">529884000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedOtherComprehensiveIncomeMember_20201231"
      decimals="-3"
      id="F_000247"
      unitRef="U_iso4217USD">-5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_us-gaapStatementEquityComponentsAxis_us-gaapRetainedEarningsMember_20201231"
      decimals="-3"
      id="F_000248"
      unitRef="U_iso4217USD">-489784000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000249"
      unitRef="U_iso4217USD">40115000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000253"
      unitRef="U_iso4217USD">-582000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000254"
      unitRef="U_iso4217USD">-20578000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000255"
      unitRef="U_iso4217USD">-25322000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000256"
      unitRef="U_iso4217USD">297000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000257"
      unitRef="U_iso4217USD">291000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000258"
      unitRef="U_iso4217USD">254000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000259"
      unitRef="U_iso4217USD">2170000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000260"
      unitRef="U_iso4217USD">2108000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000261"
      unitRef="U_iso4217USD">2998000</us-gaap:ShareBasedCompensation>
    <us-gaap:InventoryWriteDown
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000262"
      unitRef="U_iso4217USD">194000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000263"
      unitRef="U_iso4217USD">255000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000264"
      unitRef="U_iso4217USD">291000</us-gaap:InventoryWriteDown>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000265"
      unitRef="U_iso4217USD">453000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000266"
      unitRef="U_iso4217USD">369000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000267"
      unitRef="U_iso4217USD">149000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000268"
      unitRef="U_iso4217USD">313000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000269"
      unitRef="U_iso4217USD">-87000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000270"
      unitRef="U_iso4217USD">-84000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <drrx:ChangesInOperatingLeaseLiabilities
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000271"
      unitRef="U_iso4217USD">-61000</drrx:ChangesInOperatingLeaseLiabilities>
    <drrx:ChangesInOperatingLeaseLiabilities
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000272"
      unitRef="U_iso4217USD">215000</drrx:ChangesInOperatingLeaseLiabilities>
    <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000273"
      unitRef="U_iso4217USD">12845000</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000274"
      unitRef="U_iso4217USD">-389000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000275"
      unitRef="U_iso4217USD">556000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000276"
      unitRef="U_iso4217USD">-619000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000277"
      unitRef="U_iso4217USD">249000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000278"
      unitRef="U_iso4217USD">217000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000279"
      unitRef="U_iso4217USD">549000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000280"
      unitRef="U_iso4217USD">2178000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000281"
      unitRef="U_iso4217USD">-786000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000282"
      unitRef="U_iso4217USD">15000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000283"
      unitRef="U_iso4217USD">-241000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000284"
      unitRef="U_iso4217USD">520000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000285"
      unitRef="U_iso4217USD">69000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000286"
      unitRef="U_iso4217USD">49000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000287"
      unitRef="U_iso4217USD">2894000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000288"
      unitRef="U_iso4217USD">1594000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <drrx:IncreaseDecreaseInContractResearchLiability
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000289"
      unitRef="U_iso4217USD">-3108000</drrx:IncreaseDecreaseInContractResearchLiability>
    <drrx:IncreaseDecreaseInContractResearchLiability
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000290"
      unitRef="U_iso4217USD">2248000</drrx:IncreaseDecreaseInContractResearchLiability>
    <drrx:IncreaseDecreaseInContractResearchLiability
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000291"
      unitRef="U_iso4217USD">571000</drrx:IncreaseDecreaseInContractResearchLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000292"
      unitRef="U_iso4217USD">-22679000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000293"
      unitRef="U_iso4217USD">22679000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000294"
      unitRef="U_iso4217USD">-493000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000295"
      unitRef="U_iso4217USD">-38122000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000296"
      unitRef="U_iso4217USD">31679000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000297"
      unitRef="U_iso4217USD">5572000</us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000298"
      unitRef="U_iso4217USD">-38704000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000299"
      unitRef="U_iso4217USD">11101000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000300"
      unitRef="U_iso4217USD">-19750000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000301"
      unitRef="U_iso4217USD">208000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000302"
      unitRef="U_iso4217USD">155000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000303"
      unitRef="U_iso4217USD">93000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000304"
      unitRef="U_iso4217USD">45066000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000305"
      unitRef="U_iso4217USD">31866000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000306"
      unitRef="U_iso4217USD">9588000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000307"
      unitRef="U_iso4217USD">54706000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000308"
      unitRef="U_iso4217USD">4697000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000309"
      unitRef="U_iso4217USD">14218000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000310"
      unitRef="U_iso4217USD">9432000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000311"
      unitRef="U_iso4217USD">-27324000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000312"
      unitRef="U_iso4217USD">4537000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000313"
      unitRef="U_iso4217USD">4000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000314"
      unitRef="U_iso4217USD">7000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000315"
      unitRef="U_iso4217USD">9000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000316"
      unitRef="U_iso4217USD">3381000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000317"
      unitRef="U_iso4217USD">1979000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000318"
      unitRef="U_iso4217USD">1725000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000319"
      unitRef="U_iso4217USD">12283000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000320"
      unitRef="U_iso4217USD">18360000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000321"
      unitRef="U_iso4217USD">16780000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000322"
      unitRef="U_iso4217USD">829000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000323"
      unitRef="U_iso4217USD">1014000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000324"
      unitRef="U_iso4217USD">15660000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000325"
      unitRef="U_iso4217USD">19503000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000326"
      unitRef="U_iso4217USD">17482000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000327"
      unitRef="U_iso4217USD">-13612000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000328"
      unitRef="U_iso4217USD">3280000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000329"
      unitRef="U_iso4217USD">2269000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000330"
      unitRef="U_iso4217USD">35074000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_0001082038_20181231"
      decimals="-3"
      id="F_000331"
      unitRef="U_iso4217USD">31794000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_0001082038_20171231"
      decimals="-3"
      id="F_000332"
      unitRef="U_iso4217USD">29525000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000333"
      unitRef="U_iso4217USD">21462000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000334"
      unitRef="U_iso4217USD">35074000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_0001082038_20181231"
      decimals="-3"
      id="F_000335"
      unitRef="U_iso4217USD">31794000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000336"
      unitRef="U_iso4217USD">1678000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000337"
      unitRef="U_iso4217USD">1942000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000338"
      unitRef="U_iso4217USD">1886000</us-gaap:InterestPaidNet>
    <us-gaap:EscrowDepositsRelatedToPropertySales
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000339"
      unitRef="U_iso4217USD">14979000</us-gaap:EscrowDepositsRelatedToPropertySales>
    <us-gaap:StockIssued1
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000340"
      unitRef="U_iso4217USD">994000</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000341"
      unitRef="U_iso4217USD">1860000</us-gaap:StockIssued1>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000342"
      unitRef="U_iso4217USD">7329000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RestrictedCash
      contextRef="C_0001082038_us-gaapBalanceSheetLocationAxis_drrxLongTermRestrictedInvestmentsMember_20201231"
      decimals="0"
      id="F_000343"
      unitRef="U_iso4217USD">150000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="C_0001082038_us-gaapBalanceSheetLocationAxis_drrxLongTermRestrictedInvestmentsMember_20191231"
      decimals="0"
      id="F_000344"
      unitRef="U_iso4217USD">150000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="C_0001082038_us-gaapBalanceSheetLocationAxis_drrxLongTermRestrictedInvestmentsMember_20181231"
      decimals="0"
      id="F_000345"
      unitRef="U_iso4217USD">150000</us-gaap:RestrictedCash>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000346">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;1.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="font-weight:normal;color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;color:#000000;"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Nature of Operations&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;DURECT Corporation (the Company) was incorporated in the state of Delaware on February&#160;6, 1998. The Company is a biopharmaceutical company with research and development programs broadly falling into two categories: (i)&#160;new chemical entities derived from our Epigenetics Regulator Program, in which the Company attempts to discover and develop molecules which have not previously been approved and marketed as therapeutics, and (ii)&#160;Proprietary Pharmaceutical Programs, in which the Company applies its formulation expertise and technologies largely to active pharmaceutical ingredients whose safety and efficacy have previously been established but which the Company aims to improve in some manner through a new formulation. The Company has several products under development by itself and with third party collaborators. The Company also manufactures and sells osmotic pumps used in laboratory research, and manufactures certain excipients for certain clients for use as raw materials in their products. In addition, the Company conducts research and development of pharmaceutical products in collaboration with third party pharmaceutical and biotechnology companies.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Basis of Presentation and Use of Estimates&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP). The preparation of the accompanying Financial Statements conforms to accounting principles generally accepted in the U.S. which requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. On an ongoing basis, management evaluates its estimates including, but not limited to, those related to revenue recognition, the period of performance, identification of deliverables and evaluation of milestones with respect to our collaborations, the amounts of revenues, recoverability of inventory, certain accrued liabilities including accrued clinical trial liability, and stock-based compensation. The Company bases its estimates on historical experience and on various other market-specific and other relevant assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Discontinued Operations&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In December 2020, the Company announced its decision to sell its LACTEL Absorbable Polymer (LACTEL) product line to Evonik, which was completed on December 31, 2020. The accompanying financial statements have been recast for all periods presented to reflect the assets, liabilities, revenue and expenses related to the Company&#x2019;s LACTEL product line as discontinued operations (see Note 10).&#160;The Company believes this format provides comparability with its previously filed financial statements.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Liquidity and Need to Raise Additional Capital&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020, the Company has an accumulated deficit of $489.8 million as well as negative cash flows from operating activities.&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company generally has had negative cash flows from operating activities and expects its negative cash flows to continue.&#160;&#160;The Company will continue to require substantial funds to continue research and development, including clinical trials of its product candidates.&#160; Management&#x2019;s plans in order to meet its operating cash flow requirements beyond the next 12 months from the date the financial statements are filed, may include seeking additional collaborative agreements for certain of its programs and achieving revenue from its collaboration and licensing agreements as well as financing activities such &lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;as public offerings and private placements of its common stock, preferred stock offerings, issuances of debt and convertible debt instruments.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;There are no assurances that such additional funding will be obtained and that the Company will succeed in its future operations. If the Company cannot successfully raise additional capital when needed and implement its strategic development plan, its liquidity, financial condition and business prospects will be materially and adversely affected.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company believes its existing cash, cash equivalents, cash held in escrow, investments and subsequent equity fund raising completed in February 2021 (see Note 11) are sufficient to fund its operating cashflow requirements for a period greater than 12 months from the date of issuance of these financial statements.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Cash, Cash Equivalents and Investments&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company considers all highly liquid investments with maturities of 90 days or less from the date of purchase to be cash equivalents. Investments with original maturities of greater than 90 days from the date of purchase but less than one year from the balance sheet date are classified as short-term investments, while investments with maturities in one year or beyond one year from the balance sheet date are classified as long-term investments. Management determines the appropriate classification of its cash equivalents and investment securities at the time of purchase and re-evaluates such determination as of each balance sheet date. Management has classified the Company&#x2019;s cash equivalents and investments as available-for-sale securities in the accompanying financial statements. Available-for-sale securities are carried at fair value, with unrealized gains and losses reported as a component of accumulated other comprehensive loss. Realized gains and losses are included in interest income. There were no material realized gains or losses in the periods presented. The cost of securities sold is based on the specific identification method.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company invests in debt instruments of government agencies, corporations, and money market funds with high credit ratings. The Company has established guidelines regarding diversification of its investments and their maturities with the objectives of maintaining safety and liquidity, while maximizing yield.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash held in escrow (related to the sale of the LACTEL product line) was $15 million as of December 31, 2020; the $15 million which was released from escrow in January 2021.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Concentrations of Credit Risk&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial instruments that potentially subject the Company to credit risk consist principally of interest-bearing investments and trade receivables. The Company maintains cash, cash equivalents and investments with various major financial institutions. The Company performs periodic evaluations of the relative credit standing of these financial institutions. In addition, the Company performs periodic evaluations of the relative credit quality of its investments.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Pharmaceutical companies and academic institutions account for a substantial portion of the Company&#x2019;s trade receivables. The Company provides credit in the normal course of business to its customers and collateral for these receivables is generally not required. The risk associated with this concentration is limited to a certain extent due to the large number of accounts and their geographic dispersion. The Company monitors the creditworthiness of its customers to which it grants credit terms in the normal course of business. The Company maintains reserves for estimated credit losses and, to date, such losses have been immaterial in all periods presented.&lt;/p&gt;

&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Customer and Product Line Concentrations (excluding the LACTEL product line)&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A portion of the Company&#x2019;s revenue is derived from its ALZET osmotic pump product line, and the sale of certain excipients for Methydur and one excipient that is included in a marketed animal health product. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue from the sale of products from the ALZET product line accounted for 20%, 27% and 46% of total revenue for 2020, 2019 and 2018, respectively. &#160; &#160;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gilead accounted for 76% and 68% of the Company&#x2019;s total revenue for 2020 and 2019, respectively. In 2018, Indivior and Gilead accounted for 33% and 17% of the Company&#x2019;s total revenues, respectively. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total revenue by geographic region for the years 2020, 2019 and 2018 are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;United States&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;26,894&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,957&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,058&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Europe&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,386&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;906&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,476&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Japan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,174&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,472&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;975&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Others&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;657&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;739&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;766&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,111&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,074&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,275&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue by geography is determined by the location of the customer.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Inventories&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. The Company may be required to expense previously capitalized inventory costs upon a change in management&#x2019;s judgment due to new information that suggests that the inventory will not be saleable. &#160;If the Company is able to subsequently sell products made with raw materials that were previously written down, the Company will report an unusually high gross profit as there will be no associated cost of goods for these materials.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s inventories consisted of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Raw materials&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;136&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;163&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Work in-process&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;796&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;709&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Finished goods&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;932&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,047&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total inventories&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,864&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,919&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Property and Equipment&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment are stated at cost less accumulated depreciation, which is computed using the straight-line method over the estimated useful lives of the assets, which range from three to five years. Leasehold improvements are amortized using the straight-line method over the estimated useful lives of the assets, or the terms of the related leases, whichever are shorter.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Goodwill&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Goodwill is periodically assessed and evaluated for impairment. The Company operates in one operating segment and also has only one reporting unit, which is the research, development and manufacturing of pharmaceutical products. The Company assesses the impairment of goodwill at least annually and whenever events or changes in circumstances indicate that the carrying value may not be &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;recoverable. Factors the Company considers important which could trigger an impairment review include the following:&lt;/span&gt;&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.85%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:11pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;color:#000000;"&gt;significant decline in our stock price for a prolonged period;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.85%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:11pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;color:#000000;"&gt;our market capitalization relative to net book value;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.85%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:11pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;color:#000000;"&gt;new information affecting the commercial value of the asset;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.85%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:11pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;color:#000000;"&gt;significant underperformance relative to historical or projected future operating results;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.85%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:11pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;color:#000000;"&gt;significant changes in the manner of our use of the acquired assets or the strategy for the Company&#x2019;s overall business; and&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.85%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:11pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;color:#000000;"&gt;significant negative industry or economic trends.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020, the carrying value of goodwill was approximately $6.2 million compared with $6.4 million as of December 31, 2019 and 2018. As a result of the sale of the LACTEL product line, approximately $229,000 of the carry value of goodwill was allocated to the LACTEL product line upon its disposition.&#160;&#160;The Company evaluates goodwill for impairment at least annually. In 2020, 2019 and 2018, goodwill was evaluated and no indicators of impairment were identified. To date, the Company has not recorded any impairment charge related to goodwill. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Impairment of Long-Lived Assets&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company reviews long-lived assets, including property and equipment, intangible assets, and other long-term assets, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of the asset and its eventual disposition is less than its carrying amount. Impairment, if any, is calculated as the amount by which an asset&#x2019;s carrying value exceeds its fair value, typically using discounted cash flows to determine fair value. Through December 31, 2020, there have been no material impairment losses.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Leases&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company leases administrative, manufacturing and laboratory facilities under operating leases. Lease agreements may include rent holidays, rent escalation clauses and tenant improvement allowances. Prior to the adoption of &lt;span style="color:#000000;"&gt;Accounting Standards Update ("ASU" No. 2016-02, Leases, and the related amendments ("Topic 842")&lt;/span&gt;, the Company recognized scheduled rent increases on a straight-line basis over the lease term beginning with the date the Company took possession of the leased space. The Company recorded tenant improvement allowances as deferred rent liabilities and amortized the deferred rent over the terms of the lease to rent expense on the statements of operations and comprehensive loss.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Effective January 1, 2019, the Company adopted Topic 842 using the modified retrospective transition method approach with a cumulative-effect adjustment as of January 1, 2019. Other prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under previous lease guidance, ASC Topic 840: Leases (Topic 840). The Company elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allowed the Company to carry forward the historical lease classification of those leases in place as of January 1, 2019.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The adjustments due to the adoption of Topic 842 primarily related to the recognition of an operating lease right-of-use asset and corresponding operating lease liability for the Company&#x2019;s leased properties. &lt;span style="color:#212529;"&gt;The Company&#x2019;s operating lease right-of-use asset and liability were recognized at the adoption date of ASC 842 based on the present value of lease payments over the remaining lease term at the adoption date. In determining the net present value of lease payments, we used our incremental borrowing &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#212529;"&gt;rate of &lt;/span&gt;&lt;span style="color:#212529;"&gt;13.8&lt;/span&gt;&lt;span style="color:#212529;"&gt;% based on the information available, including remaining lease term, at the adoption date of ASC 842. As of December 31, 20&lt;/span&gt;&lt;span style="color:#212529;"&gt;20&lt;/span&gt;&lt;span style="color:#212529;"&gt;, the weighted-average remaining lease term was &lt;/span&gt;&lt;span&gt;&lt;span style="color:#212529;"&gt;2.99&lt;/span&gt;&lt;span style="color:#212529;"&gt; years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; for the Company&#x2019;s leased properties&lt;/span&gt;&lt;span style="color:#212529;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;There was no effect from the adoption of Topic 842 on the Company&#x2019;s Statement of cash flows.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Stock-Based Compensation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company accounts for share-based payments using a fair-value based method for costs related to all share-based payments, including stock options and stock issued under the Company&#x2019;s employee stock purchase plan (ESPP). The Company estimates the fair value of share-based payment awards on the date of grant using an option-pricing model. See Note 8 for further information regarding stock-based compensation.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Revenue Recognition&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company enters into license and collaboration agreements under which the Company may receive upfront license fees, research funding and contingent milestone payments and royalties. Effective January 1, 2018, the Company adopted FASB ASC Topic 606, Revenue from Contracts with Customers, or ASC 606. In accordance with ASC 606, the Company changed certain characteristics of its revenue recognition accounting policy as described below. ASC 606 was applied using the modified retrospective method, where the cumulative effect of the initial application was recognized as an adjustment to opening retained earnings at January 1, 2018. The Company recorded a net decrease to opening accumulated deficit of&#160;$470,000 with an offset entry to reduce deferred revenue as of January 1, 2018 due to the cumulative impact of adopting Topic 606, with the impact relating to the Company&#x2019;s deferred collaborative research and development revenues. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Product Revenue, Net&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company sells osmotic pumps used in laboratory research, and manufactures certain excipients for pharmaceutical clients for use as raw materials in their products.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenues from product sales are recognized when the customer obtains control of the Company&#x2019;s product, which occurs at a point in time, typically upon shipment to the customer. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is one year or less.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Trade Discounts and Allowances: The Company provides certain customers with discounts that are explicitly stated in the Company&#x2019;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Product Returns: Consistent with industry practice, the Company generally offers customers a limited right of return for products that have been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. The Company currently estimates product return liabilities using its historical sales information. The Company expects product returns to be minimal.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Collaborative Research and Development and Other Revenue&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company enters into license agreements, under which it licenses certain rights to its product candidates to third parties. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, up-front license fees; reimbursement of development costs incurred by the Company under approved work plans; development, regulatory and commercial milestone payments; payments for manufacturing supply services the Company provides through its contract manufacturers; and royalties on net sales of licensed products. Each of these payments results in collaborative research and development revenues, except for revenues from royalties on net sales of licensed products, which are classified as other revenues.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In determining the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements, the Company performs the following steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. As part of the accounting for these arrangements, the Company must develop assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the contract. The Company uses key assumptions to determine the standalone selling price, which may include forecasted revenues, development timelines, reimbursement rates for personnel costs, discount rates and probabilities of technical and regulatory success. The Company expects to recognize revenue for the variable consideration currently being constrained when it is probable that a significant revenue reversal will not occur.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Licenses of intellectual property: If the license to the Company&#x2019;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, up-front fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are bundled with other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, up-front fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. Any such adjustments are recorded on a cumulative catch-up basis, which would affect collaborative research and development revenues and net income (loss) in the period of adjustment.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Milestone Payments: At the inception of each arrangement that includes development milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or the licensee, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. The transaction price is then allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as or when the performance obligations under the contract are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect collaborative research and development revenues and net income (loss) in the period of adjustment. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Manufacturing Supply Services: Arrangements that include a promise for future supply of drug product for either clinical development or commercial supply at the customer&#x2019;s discretion are generally considered as options. The Company assesses if these options provide a material right to the customer and if so, they are accounted for as separate performance obligations. If the Company is entitled to additional payments when the customer exercises these options, any additional payments are recorded in collaborative research and development revenue when the customer obtains control of the goods, which is upon delivery.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Royalties and Earn-outs: For arrangements that include sales-based royalties or earn-outs, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). To date, the Company has not recognized material royalty revenue resulting from the Company&#x2019;s collaborative arrangements or material earn-out revenue from the Company&#x2019;s patent purchase agreement with Indivior.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company receives payments from its customers based on development cost schedules established in each contract. Up-front payments are recorded as deferred revenue upon receipt or when due, and may require deferral of revenue recognition to a future period until the Company performs its obligations under these arrangements.&#160;&#160;Amounts are recorded as accounts receivable when the Company&#x2019;s right to consideration is unconditional. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised goods or services to the customer will be one year or less.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Prepaid and Accrued Contract Research Expenses&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company incurs significant costs associated with third party consultants and organizations for pre-clinical studies, clinical trials, contract research and manufacturing, validation, testing, regulatory advice and other research and development-related services. The Company is required to estimate periodically the cost of services rendered but unbilled based on management&#x2019;s estimates of project status. If these good faith estimates are inaccurate, actual expenses incurred could materially differ from these estimates.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development expenses are primarily comprised of salaries and benefits associated with research and development personnel, overhead and facility costs, preclinical and non-clinical development costs, clinical trial and related clinical manufacturing costs, contract services, and other outside costs. Research and development costs are expensed as incurred. Research and development costs paid to third parties under sponsored research agreements are recognized as the related services are performed. In addition, reimbursements of research and development expenses incurred by the Company&#x2019;s partners are recorded as collaborative research and development revenue.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Comprehensive Loss&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Components of other comprehensive loss are comprised entirely of unrealized gains and losses on the Company&#x2019;s available-for-sale securities for all periods presented. Total comprehensive loss has been disclosed in the Company&#x2019;s Statements of Comprehensive Loss.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Segment Reporting&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company operates in one operating segment, which is the research, development and manufacturing of pharmaceutical products.&lt;/p&gt;

&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Net Loss Per Share&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding. Diluted net loss per share is computed using the weighted-average number of common shares outstanding and common stock equivalents (i.e., options to purchase common stock) outstanding during the period, if dilutive, using the treasury stock method for options. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The numerators and denominators in the calculation of basic and diluted net loss per share were as follows (in thousands except per share amounts):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:79.04%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Numerators:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(582&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20,578&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(25,322&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Denominators:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average shares used to compute basic&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; net loss per share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;199,457&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;178,042&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;159,834&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Effect of dilutive securities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dilution from stock options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dilution from ESPP&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dilutive common shares&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average shares used to compute diluted&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; net loss per share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;199,457&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;178,042&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;159,834&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss per share:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.00&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.12&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.16&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.00&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.12&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.16&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The computation of diluted net loss per share for 2020, 2019 and 2018 excludes the impact of options to purchase 7.5 million, 21.4&#160;million and 16.6&#160;million shares of common stock outstanding at December 31, 2020, 2019 and 2018, respectively, as such impact would be antidilutive.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Shipping and Handling&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Costs related to shipping and handling are included in cost of revenues for all periods presented.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Recent Accounting Pronouncements&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:2.62%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In December 2019, as part of its initiative to reduce complexity in the accounting standards, the FASB issued ASU 2019-12, &lt;span style="font-style:italic;"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt; (&#x201c;ASU 2019-12&#x201d;), which eliminates certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company early adopted ASU 2019-12 on January 1, 2020, and this adoption had no material impact on the Company&#x2019;s financial position or results of operations. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In November 2018, the Financial Accounting Standards Board (the FASB) issued ASU No.&#160;2018-18,&#160;&lt;span style="font-style:italic;"&gt;Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606&#160;(ASU 2018-18)&lt;/span&gt;. ASU 2018-18 clarifies that certain transactions between collaborative arrangement &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;participants should be accounted for as revenue under Topic 606 when the counterparty is a customer for a distinct good or service (i.e. a unit of account). For units of account that are in the scope of Topic 606, all of the guidance in Topic 606 should be applied, including the guidance on recognition, measurement, presentation and disclosure. ASU 2018-18 also adds a reference in Topic 808 to the unit of account guidance in ASC 606 and requires that it be applied only to assess whether transactions in a collaborative arrangement are in the scope of Topic 606. ASU 2018-18 will preclude entities from presenting amounts related to transactions with a counterparty in a collaborative arrangement that is not a customer as revenue from contracts with customers. ASU 2018-18 is effective for the Company for all interim and annual reporting periods beginning after December 15, 2019. &lt;/span&gt;&lt;span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The adoption of this standard did not have a material effect on the Company&#x2019;s financial statements&lt;/span&gt;&lt;span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In August 2018, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;)&#160;No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework &#x2013; Changes to the Disclosure Requirements for Fair Value Measurement, which eliminates certain disclosure requirements for fair value measurements for all entities, requires public entities to disclose certain new information and modifies some disclosure requirements. This standard is effective for fiscal years beginning after December 15, 2019, including interim reporting periods within those years. The adoption of this standard did not have a material effect on the Company&#x2019;s financial statements.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In January 2017, the FASB issued ASU No.&#160;2017-04,&#160;&lt;span style="font-style:italic;"&gt;Intangibles&#x2014;Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,&#160;(ASU 2017-04)&lt;/span&gt;.&#160;ASU 2017-04 eliminated Step 2 from the goodwill impairment test. Instead, under the amendments in ASU 2017-04, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#x2019;s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax&#160;effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. ASU 2017-04 is effective for all interim and annual reporting periods beginning after December 15, 2019. The adoption of this standard did not have a material effect on the Company&#x2019;s financial statements.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In June 2016,&#160;the FASB issued Accounting Standards Update No. 2016-13 (ASU 2016-13)&#160;&#x201c;Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments.&#x201d;&#160;ASU 2016-13 requires measurement and recognition of expected credit losses for financial assets. This standard is effective for fiscal years beginning after December 15, 2022 for small reporting companies, including interim reporting periods within those years and must be adopted using a modified retrospective approach, with certain exceptions. Early adoption is permitted.&#160; The Company does not expect the adoption of this standard to have a material effect on its financial statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <drrx:NatureOfOperationsPolicyTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000358">
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Nature of Operations&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;DURECT Corporation (the Company) was incorporated in the state of Delaware on February&#160;6, 1998. The Company is a biopharmaceutical company with research and development programs broadly falling into two categories: (i)&#160;new chemical entities derived from our Epigenetics Regulator Program, in which the Company attempts to discover and develop molecules which have not previously been approved and marketed as therapeutics, and (ii)&#160;Proprietary Pharmaceutical Programs, in which the Company applies its formulation expertise and technologies largely to active pharmaceutical ingredients whose safety and efficacy have previously been established but which the Company aims to improve in some manner through a new formulation. The Company has several products under development by itself and with third party collaborators. The Company also manufactures and sells osmotic pumps used in laboratory research, and manufactures certain excipients for certain clients for use as raw materials in their products. In addition, the Company conducts research and development of pharmaceutical products in collaboration with third party pharmaceutical and biotechnology companies.&lt;/p&gt;</drrx:NatureOfOperationsPolicyTextBlock>
    <dei:EntityIncorporationDateOfIncorporation contextRef="C_0001082038_20200101_20201231" id="F_000401">1998-02-06</dei:EntityIncorporationDateOfIncorporation>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000359">
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Basis of Presentation and Use of Estimates&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP). The preparation of the accompanying Financial Statements conforms to accounting principles generally accepted in the U.S. which requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. On an ongoing basis, management evaluates its estimates including, but not limited to, those related to revenue recognition, the period of performance, identification of deliverables and evaluation of milestones with respect to our collaborations, the amounts of revenues, recoverability of inventory, certain accrued liabilities including accrued clinical trial liability, and stock-based compensation. The Company bases its estimates on historical experience and on various other market-specific and other relevant assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <drrx:DiscontinuedOperationsTextblock contextRef="C_0001082038_20200101_20201231" id="F_000360">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Discontinued Operations&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In December 2020, the Company announced its decision to sell its LACTEL Absorbable Polymer (LACTEL) product line to Evonik, which was completed on December 31, 2020. The accompanying financial statements have been recast for all periods presented to reflect the assets, liabilities, revenue and expenses related to the Company&#x2019;s LACTEL product line as discontinued operations (see Note 10).&#160;The Company believes this format provides comparability with its previously filed financial statements.&lt;/p&gt;</drrx:DiscontinuedOperationsTextblock>
    <drrx:LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000361">
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Liquidity and Need to Raise Additional Capital&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020, the Company has an accumulated deficit of $489.8 million as well as negative cash flows from operating activities.&lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company generally has had negative cash flows from operating activities and expects its negative cash flows to continue.&#160;&#160;The Company will continue to require substantial funds to continue research and development, including clinical trials of its product candidates.&#160; Management&#x2019;s plans in order to meet its operating cash flow requirements beyond the next 12 months from the date the financial statements are filed, may include seeking additional collaborative agreements for certain of its programs and achieving revenue from its collaboration and licensing agreements as well as financing activities such &lt;/p&gt;
&lt;p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;as public offerings and private placements of its common stock, preferred stock offerings, issuances of debt and convertible debt instruments.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;There are no assurances that such additional funding will be obtained and that the Company will succeed in its future operations. If the Company cannot successfully raise additional capital when needed and implement its strategic development plan, its liquidity, financial condition and business prospects will be materially and adversely affected.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company believes its existing cash, cash equivalents, cash held in escrow, investments and subsequent equity fund raising completed in February 2021 (see Note 11) are sufficient to fund its operating cashflow requirements for a period greater than 12 months from the date of issuance of these financial statements.&lt;/p&gt;</drrx:LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0001082038_20201231"
      decimals="-5"
      id="F_000402"
      unitRef="U_iso4217USD">-489800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000362">
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Cash, Cash Equivalents and Investments&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company considers all highly liquid investments with maturities of 90 days or less from the date of purchase to be cash equivalents. Investments with original maturities of greater than 90 days from the date of purchase but less than one year from the balance sheet date are classified as short-term investments, while investments with maturities in one year or beyond one year from the balance sheet date are classified as long-term investments. Management determines the appropriate classification of its cash equivalents and investment securities at the time of purchase and re-evaluates such determination as of each balance sheet date. Management has classified the Company&#x2019;s cash equivalents and investments as available-for-sale securities in the accompanying financial statements. Available-for-sale securities are carried at fair value, with unrealized gains and losses reported as a component of accumulated other comprehensive loss. Realized gains and losses are included in interest income. There were no material realized gains or losses in the periods presented. The cost of securities sold is based on the specific identification method.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company invests in debt instruments of government agencies, corporations, and money market funds with high credit ratings. The Company has established guidelines regarding diversification of its investments and their maturities with the objectives of maintaining safety and liquidity, while maximizing yield.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total cash held in escrow (related to the sale of the LACTEL product line) was $15 million as of December 31, 2020; the $15 million which was released from escrow in January 2021.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <drrx:LiquidInvestmentsMaturityPeriodDescriptionMaximum contextRef="C_0001082038_20200101_20201231" id="F_000403">90 days or less</drrx:LiquidInvestmentsMaturityPeriodDescriptionMaximum>
    <drrx:ShortTermInvestmentMaturityPeriod
      contextRef="C_0001082038_srtRangeAxis_srtMinimumMember_20200101_20201231"
      id="F_000405">P90D</drrx:ShortTermInvestmentMaturityPeriod>
    <drrx:ShortTermInvestmentMaturityPeriod
      contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_20200101_20201231"
      id="F_000406">P1Y</drrx:ShortTermInvestmentMaturityPeriod>
    <drrx:LongTermInvestmentsMaturityPeriodDescriptionMinimum contextRef="C_0001082038_20200101_20201231" id="F_000404">one year or beyond</drrx:LongTermInvestmentsMaturityPeriodDescriptionMinimum>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="C_0001082038_20200101_20201231"
      decimals="INF"
      id="F_000407"
      unitRef="U_iso4217USD">0</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="C_0001082038_20190101_20191231"
      decimals="INF"
      id="F_000408"
      unitRef="U_iso4217USD">0</us-gaap:RealizedInvestmentGainsLosses>
    <drrx:CashHeldInEscrow
      contextRef="C_0001082038_srtProductOrServiceAxis_drrxLactelProductLineMember_20201231"
      decimals="-6"
      id="F_000409"
      unitRef="U_iso4217USD">15000000</drrx:CashHeldInEscrow>
    <drrx:PaymentFromEscrow
      contextRef="C_0001082038_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210131"
      decimals="-6"
      id="F_000410"
      unitRef="U_iso4217USD">15000000</drrx:PaymentFromEscrow>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="C_0001082038_20200101_20201231" id="F_000363">
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Concentrations of Credit Risk&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Financial instruments that potentially subject the Company to credit risk consist principally of interest-bearing investments and trade receivables. The Company maintains cash, cash equivalents and investments with various major financial institutions. The Company performs periodic evaluations of the relative credit standing of these financial institutions. In addition, the Company performs periodic evaluations of the relative credit quality of its investments.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Pharmaceutical companies and academic institutions account for a substantial portion of the Company&#x2019;s trade receivables. The Company provides credit in the normal course of business to its customers and collateral for these receivables is generally not required. The risk associated with this concentration is limited to a certain extent due to the large number of accounts and their geographic dispersion. The Company monitors the creditworthiness of its customers to which it grants credit terms in the normal course of business. The Company maintains reserves for estimated credit losses and, to date, such losses have been immaterial in all periods presented.&lt;/p&gt;
</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:MajorCustomersPolicyPolicyTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000364">
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Customer and Product Line Concentrations (excluding the LACTEL product line)&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A portion of the Company&#x2019;s revenue is derived from its ALZET osmotic pump product line, and the sale of certain excipients for Methydur and one excipient that is included in a marketed animal health product. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue from the sale of products from the ALZET product line accounted for 20%, 27% and 46% of total revenue for 2020, 2019 and 2018, respectively. &#160; &#160;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gilead accounted for 76% and 68% of the Company&#x2019;s total revenue for 2020 and 2019, respectively. In 2018, Indivior and Gilead accounted for 33% and 17% of the Company&#x2019;s total revenues, respectively. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total revenue by geographic region for the years 2020, 2019 and 2018 are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;United States&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;26,894&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,957&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,058&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Europe&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,386&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;906&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,476&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Japan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,174&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,472&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;975&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Others&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;657&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;739&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;766&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,111&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,074&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,275&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenue by geography is determined by the location of the customer.&lt;/p&gt;</us-gaap:MajorCustomersPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001082038_srtProductOrServiceAxis_drrxAlzetProductLineMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapProductConcentrationRiskMember_20200101_20201231"
      decimals="2"
      id="F_000411"
      unitRef="U_xbrlipure">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001082038_srtProductOrServiceAxis_drrxAlzetProductLineMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapProductConcentrationRiskMember_20190101_20191231"
      decimals="2"
      id="F_000412"
      unitRef="U_xbrlipure">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001082038_srtProductOrServiceAxis_drrxAlzetProductLineMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapProductConcentrationRiskMember_20180101_20181231"
      decimals="2"
      id="F_000413"
      unitRef="U_xbrlipure">0.46</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001082038_srtMajorCustomersAxis_drrxGileadMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20200101_20201231"
      decimals="2"
      id="F_000414"
      unitRef="U_xbrlipure">0.76</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001082038_srtMajorCustomersAxis_drrxGileadMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20190101_20191231"
      decimals="2"
      id="F_000415"
      unitRef="U_xbrlipure">0.68</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001082038_srtMajorCustomersAxis_drrxIndiviorMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20180101_20181231"
      decimals="2"
      id="F_000417"
      unitRef="U_xbrlipure">0.33</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_0001082038_srtMajorCustomersAxis_drrxGileadMember_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapCustomerConcentrationRiskMember_20180101_20181231"
      decimals="2"
      id="F_000416"
      unitRef="U_xbrlipure">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000378">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total revenue by geographic region for the years 2020, 2019 and 2018 are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;United States&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;26,894&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,957&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,058&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Europe&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,386&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;906&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,476&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Japan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,174&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,472&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;975&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Others&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;657&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;739&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;766&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,111&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,074&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;15,275&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtStatementGeographicalAxis_countryUS_20200101_20201231"
      decimals="-3"
      id="F_000418"
      unitRef="U_iso4217USD">26894000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtStatementGeographicalAxis_countryUS_20190101_20191231"
      decimals="-3"
      id="F_000419"
      unitRef="U_iso4217USD">21957000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtStatementGeographicalAxis_countryUS_20180101_20181231"
      decimals="-3"
      id="F_000420"
      unitRef="U_iso4217USD">7058000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtStatementGeographicalAxis_srtEuropeMember_20200101_20201231"
      decimals="-3"
      id="F_000421"
      unitRef="U_iso4217USD">1386000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtStatementGeographicalAxis_srtEuropeMember_20190101_20191231"
      decimals="-3"
      id="F_000422"
      unitRef="U_iso4217USD">906000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtStatementGeographicalAxis_srtEuropeMember_20180101_20181231"
      decimals="-3"
      id="F_000423"
      unitRef="U_iso4217USD">6476000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtStatementGeographicalAxis_countryJP_20200101_20201231"
      decimals="-3"
      id="F_000424"
      unitRef="U_iso4217USD">1174000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtStatementGeographicalAxis_countryJP_20190101_20191231"
      decimals="-3"
      id="F_000425"
      unitRef="U_iso4217USD">1472000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtStatementGeographicalAxis_countryJP_20180101_20181231"
      decimals="-3"
      id="F_000426"
      unitRef="U_iso4217USD">975000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtStatementGeographicalAxis_drrxOtherForeignCountriesMember_20200101_20201231"
      decimals="-3"
      id="F_000427"
      unitRef="U_iso4217USD">657000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtStatementGeographicalAxis_drrxOtherForeignCountriesMember_20190101_20191231"
      decimals="-3"
      id="F_000428"
      unitRef="U_iso4217USD">739000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtStatementGeographicalAxis_drrxOtherForeignCountriesMember_20180101_20181231"
      decimals="-3"
      id="F_000429"
      unitRef="U_iso4217USD">766000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000430"
      unitRef="U_iso4217USD">30111000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000431"
      unitRef="U_iso4217USD">25074000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000432"
      unitRef="U_iso4217USD">15275000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InventoryPolicyTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000365">
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Inventories&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. The Company may be required to expense previously capitalized inventory costs upon a change in management&#x2019;s judgment due to new information that suggests that the inventory will not be saleable. &#160;If the Company is able to subsequently sell products made with raw materials that were previously written down, the Company will report an unusually high gross profit as there will be no associated cost of goods for these materials.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s inventories consisted of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Raw materials&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;136&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;163&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Work in-process&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;796&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;709&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Finished goods&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;932&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,047&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total inventories&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,864&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,919&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000379">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s inventories consisted of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Raw materials&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;136&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;163&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Work in-process&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;796&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;709&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Finished goods&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;932&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,047&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total inventories&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,864&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,919&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000433"
      unitRef="U_iso4217USD">136000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000434"
      unitRef="U_iso4217USD">163000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000435"
      unitRef="U_iso4217USD">796000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000436"
      unitRef="U_iso4217USD">709000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000437"
      unitRef="U_iso4217USD">932000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000438"
      unitRef="U_iso4217USD">1047000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000439"
      unitRef="U_iso4217USD">1864000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000440"
      unitRef="U_iso4217USD">1919000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000366">
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Property and Equipment&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment are stated at cost less accumulated depreciation, which is computed using the straight-line method over the estimated useful lives of the assets, which range from three to five years. Leasehold improvements are amortized using the straight-line method over the estimated useful lives of the assets, or the terms of the related leases, whichever are shorter.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0001082038_srtRangeAxis_srtMinimumMember_20200101_20201231"
      id="F_000441">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_20200101_20201231"
      id="F_000442">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="C_0001082038_20200101_20201231" id="F_000367">
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Goodwill&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Goodwill is periodically assessed and evaluated for impairment. The Company operates in one operating segment and also has only one reporting unit, which is the research, development and manufacturing of pharmaceutical products. The Company assesses the impairment of goodwill at least annually and whenever events or changes in circumstances indicate that the carrying value may not be &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;recoverable. Factors the Company considers important which could trigger an impairment review include the following:&lt;/span&gt;&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.85%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:11pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;color:#000000;"&gt;significant decline in our stock price for a prolonged period;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.85%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:11pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;color:#000000;"&gt;our market capitalization relative to net book value;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.85%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:11pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;color:#000000;"&gt;new information affecting the commercial value of the asset;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.85%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:11pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;color:#000000;"&gt;significant underperformance relative to historical or projected future operating results;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.85%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:11pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;color:#000000;"&gt;significant changes in the manner of our use of the acquired assets or the strategy for the Company&#x2019;s overall business; and&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.85%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:11pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;color:#000000;"&gt;significant negative industry or economic trends.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020, the carrying value of goodwill was approximately $6.2 million compared with $6.4 million as of December 31, 2019 and 2018. As a result of the sale of the LACTEL product line, approximately $229,000 of the carry value of goodwill was allocated to the LACTEL product line upon its disposition.&#160;&#160;The Company evaluates goodwill for impairment at least annually. In 2020, 2019 and 2018, goodwill was evaluated and no indicators of impairment were identified. To date, the Company has not recorded any impairment charge related to goodwill. &lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_0001082038_20200101_20201231"
      decimals="INF"
      id="F_000443"
      unitRef="U_drrxSegment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="C_0001082038_20200101_20201231"
      decimals="INF"
      id="F_000444"
      unitRef="U_drrxSegment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:Goodwill
      contextRef="C_0001082038_20201231"
      decimals="-5"
      id="F_000445"
      unitRef="U_iso4217USD">6200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="C_0001082038_20191231"
      decimals="-5"
      id="F_000446"
      unitRef="U_iso4217USD">6400000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="C_0001082038_20181231"
      decimals="-5"
      id="F_000447"
      unitRef="U_iso4217USD">6400000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="C_0001082038_us-gaapRelatedPartyTransactionAxis_drrxLACTELMember_20201231"
      decimals="0"
      id="F_000448"
      unitRef="U_iso4217USD">229000</us-gaap:Goodwill>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000368">
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Impairment of Long-Lived Assets&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company reviews long-lived assets, including property and equipment, intangible assets, and other long-term assets, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of the asset and its eventual disposition is less than its carrying amount. Impairment, if any, is calculated as the amount by which an asset&#x2019;s carrying value exceeds its fair value, typically using discounted cash flows to determine fair value. Through December 31, 2020, there have been no material impairment losses.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_0001082038_20200101_20201231"
      decimals="INF"
      id="F_000449"
      unitRef="U_iso4217USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000369">
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Leases&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company leases administrative, manufacturing and laboratory facilities under operating leases. Lease agreements may include rent holidays, rent escalation clauses and tenant improvement allowances. Prior to the adoption of &lt;span style="color:#000000;"&gt;Accounting Standards Update ("ASU" No. 2016-02, Leases, and the related amendments ("Topic 842")&lt;/span&gt;, the Company recognized scheduled rent increases on a straight-line basis over the lease term beginning with the date the Company took possession of the leased space. The Company recorded tenant improvement allowances as deferred rent liabilities and amortized the deferred rent over the terms of the lease to rent expense on the statements of operations and comprehensive loss.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Effective January 1, 2019, the Company adopted Topic 842 using the modified retrospective transition method approach with a cumulative-effect adjustment as of January 1, 2019. Other prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under previous lease guidance, ASC Topic 840: Leases (Topic 840). The Company elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allowed the Company to carry forward the historical lease classification of those leases in place as of January 1, 2019.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The adjustments due to the adoption of Topic 842 primarily related to the recognition of an operating lease right-of-use asset and corresponding operating lease liability for the Company&#x2019;s leased properties. &lt;span style="color:#212529;"&gt;The Company&#x2019;s operating lease right-of-use asset and liability were recognized at the adoption date of ASC 842 based on the present value of lease payments over the remaining lease term at the adoption date. In determining the net present value of lease payments, we used our incremental borrowing &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#212529;"&gt;rate of &lt;/span&gt;&lt;span style="color:#212529;"&gt;13.8&lt;/span&gt;&lt;span style="color:#212529;"&gt;% based on the information available, including remaining lease term, at the adoption date of ASC 842. As of December 31, 20&lt;/span&gt;&lt;span style="color:#212529;"&gt;20&lt;/span&gt;&lt;span style="color:#212529;"&gt;, the weighted-average remaining lease term was &lt;/span&gt;&lt;span&gt;&lt;span style="color:#212529;"&gt;2.99&lt;/span&gt;&lt;span style="color:#212529;"&gt; years&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; for the Company&#x2019;s leased properties&lt;/span&gt;&lt;span style="color:#212529;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;There was no effect from the adoption of Topic 842 on the Company&#x2019;s Statement of cash flows.&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <drrx:LesseeOperatingLeaseIncrementalBorrowingRate
      contextRef="C_0001082038_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_20201231"
      decimals="3"
      id="F_000450"
      unitRef="U_xbrlipure">0.138</drrx:LesseeOperatingLeaseIncrementalBorrowingRate>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_0001082038_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_20201231"
      id="F_000451">P2Y11M26D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000370">
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Stock-Based Compensation&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company accounts for share-based payments using a fair-value based method for costs related to all share-based payments, including stock options and stock issued under the Company&#x2019;s employee stock purchase plan (ESPP). The Company estimates the fair value of share-based payment awards on the date of grant using an option-pricing model. See Note 8 for further information regarding stock-based compensation.&lt;/p&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000371">
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Revenue Recognition&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company enters into license and collaboration agreements under which the Company may receive upfront license fees, research funding and contingent milestone payments and royalties. Effective January 1, 2018, the Company adopted FASB ASC Topic 606, Revenue from Contracts with Customers, or ASC 606. In accordance with ASC 606, the Company changed certain characteristics of its revenue recognition accounting policy as described below. ASC 606 was applied using the modified retrospective method, where the cumulative effect of the initial application was recognized as an adjustment to opening retained earnings at January 1, 2018. The Company recorded a net decrease to opening accumulated deficit of&#160;$470,000 with an offset entry to reduce deferred revenue as of January 1, 2018 due to the cumulative impact of adopting Topic 606, with the impact relating to the Company&#x2019;s deferred collaborative research and development revenues. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Product Revenue, Net&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company sells osmotic pumps used in laboratory research, and manufactures certain excipients for pharmaceutical clients for use as raw materials in their products.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Revenues from product sales are recognized when the customer obtains control of the Company&#x2019;s product, which occurs at a point in time, typically upon shipment to the customer. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is one year or less.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Trade Discounts and Allowances: The Company provides certain customers with discounts that are explicitly stated in the Company&#x2019;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Product Returns: Consistent with industry practice, the Company generally offers customers a limited right of return for products that have been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. The Company currently estimates product return liabilities using its historical sales information. The Company expects product returns to be minimal.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Collaborative Research and Development and Other Revenue&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company enters into license agreements, under which it licenses certain rights to its product candidates to third parties. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, up-front license fees; reimbursement of development costs incurred by the Company under approved work plans; development, regulatory and commercial milestone payments; payments for manufacturing supply services the Company provides through its contract manufacturers; and royalties on net sales of licensed products. Each of these payments results in collaborative research and development revenues, except for revenues from royalties on net sales of licensed products, which are classified as other revenues.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In determining the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements, the Company performs the following steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. As part of the accounting for these arrangements, the Company must develop assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the contract. The Company uses key assumptions to determine the standalone selling price, which may include forecasted revenues, development timelines, reimbursement rates for personnel costs, discount rates and probabilities of technical and regulatory success. The Company expects to recognize revenue for the variable consideration currently being constrained when it is probable that a significant revenue reversal will not occur.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Licenses of intellectual property: If the license to the Company&#x2019;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, up-front fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are bundled with other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, up-front fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. Any such adjustments are recorded on a cumulative catch-up basis, which would affect collaborative research and development revenues and net income (loss) in the period of adjustment.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Milestone Payments: At the inception of each arrangement that includes development milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or the licensee, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. The transaction price is then allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as or when the performance obligations under the contract are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect collaborative research and development revenues and net income (loss) in the period of adjustment. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Manufacturing Supply Services: Arrangements that include a promise for future supply of drug product for either clinical development or commercial supply at the customer&#x2019;s discretion are generally considered as options. The Company assesses if these options provide a material right to the customer and if so, they are accounted for as separate performance obligations. If the Company is entitled to additional payments when the customer exercises these options, any additional payments are recorded in collaborative research and development revenue when the customer obtains control of the goods, which is upon delivery.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Royalties and Earn-outs: For arrangements that include sales-based royalties or earn-outs, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). To date, the Company has not recognized material royalty revenue resulting from the Company&#x2019;s collaborative arrangements or material earn-out revenue from the Company&#x2019;s patent purchase agreement with Indivior.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company receives payments from its customers based on development cost schedules established in each contract. Up-front payments are recorded as deferred revenue upon receipt or when due, and may require deferral of revenue recognition to a future period until the Company performs its obligations under these arrangements.&#160;&#160;Amounts are recorded as accounts receivable when the Company&#x2019;s right to consideration is unconditional. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised goods or services to the customer will be one year or less.&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_0001082038_srtRestatementAxis_srtRevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember_20180101"
      decimals="INF"
      id="F_000452"
      unitRef="U_iso4217USD">470000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <drrx:PrepaidAndAccruedContractResearchExpensesPolicyTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000372">
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Prepaid and Accrued Contract Research Expenses&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company incurs significant costs associated with third party consultants and organizations for pre-clinical studies, clinical trials, contract research and manufacturing, validation, testing, regulatory advice and other research and development-related services. The Company is required to estimate periodically the cost of services rendered but unbilled based on management&#x2019;s estimates of project status. If these good faith estimates are inaccurate, actual expenses incurred could materially differ from these estimates.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development expenses are primarily comprised of salaries and benefits associated with research and development personnel, overhead and facility costs, preclinical and non-clinical development costs, clinical trial and related clinical manufacturing costs, contract services, and other outside costs. Research and development costs are expensed as incurred. Research and development costs paid to third parties under sponsored research agreements are recognized as the related services are performed. In addition, reimbursements of research and development expenses incurred by the Company&#x2019;s partners are recorded as collaborative research and development revenue.&lt;/p&gt;</drrx:PrepaidAndAccruedContractResearchExpensesPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000373">
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Comprehensive Loss&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Components of other comprehensive loss are comprised entirely of unrealized gains and losses on the Company&#x2019;s available-for-sale securities for all periods presented. Total comprehensive loss has been disclosed in the Company&#x2019;s Statements of Comprehensive Loss.&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000374">
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Segment Reporting&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company operates in one operating segment, which is the research, development and manufacturing of pharmaceutical products.&lt;/p&gt;
</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000375">
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Net Loss Per Share&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding. Diluted net loss per share is computed using the weighted-average number of common shares outstanding and common stock equivalents (i.e., options to purchase common stock) outstanding during the period, if dilutive, using the treasury stock method for options. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The numerators and denominators in the calculation of basic and diluted net loss per share were as follows (in thousands except per share amounts):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:79.04%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Numerators:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(582&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20,578&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(25,322&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Denominators:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average shares used to compute basic&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; net loss per share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;199,457&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;178,042&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;159,834&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Effect of dilutive securities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dilution from stock options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dilution from ESPP&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dilutive common shares&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average shares used to compute diluted&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; net loss per share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;199,457&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;178,042&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;159,834&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss per share:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.00&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.12&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.16&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.00&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.12&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.16&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The computation of diluted net loss per share for 2020, 2019 and 2018 excludes the impact of options to purchase 7.5 million, 21.4&#160;million and 16.6&#160;million shares of common stock outstanding at December 31, 2020, 2019 and 2018, respectively, as such impact would be antidilutive.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000380">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The numerators and denominators in the calculation of basic and diluted net loss per share were as follows (in thousands except per share amounts):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:79.04%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Numerators:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(582&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(20,578&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(25,322&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Denominators:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average shares used to compute basic&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; net loss per share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;199,457&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;178,042&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;159,834&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Effect of dilutive securities:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dilution from stock options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dilution from ESPP&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Dilutive common shares&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted average shares used to compute diluted&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; net loss per share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;199,457&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;178,042&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;159,834&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net loss per share:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.00&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.12&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.16&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.00&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.12&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(0.16&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000453"
      unitRef="U_iso4217USD">-582000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000454"
      unitRef="U_iso4217USD">-20578000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000455"
      unitRef="U_iso4217USD">-25322000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000456"
      unitRef="U_xbrlishares">199457000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000457"
      unitRef="U_xbrlishares">178042000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000458"
      unitRef="U_xbrlishares">159834000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <drrx:WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000459"
      unitRef="U_xbrlishares">199457000</drrx:WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities>
    <drrx:WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000460"
      unitRef="U_xbrlishares">178042000</drrx:WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities>
    <drrx:WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000461"
      unitRef="U_xbrlishares">159834000</drrx:WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_0001082038_20200101_20201231"
      decimals="2"
      id="F_000462"
      unitRef="U_iso4217USD_xbrlishares">0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_0001082038_20190101_20191231"
      decimals="2"
      id="F_000463"
      unitRef="U_iso4217USD_xbrlishares">-0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_0001082038_20180101_20181231"
      decimals="2"
      id="F_000464"
      unitRef="U_iso4217USD_xbrlishares">-0.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_0001082038_20200101_20201231"
      decimals="2"
      id="F_000465"
      unitRef="U_iso4217USD_xbrlishares">0.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_0001082038_20190101_20191231"
      decimals="2"
      id="F_000466"
      unitRef="U_iso4217USD_xbrlishares">-0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_0001082038_20180101_20181231"
      decimals="2"
      id="F_000467"
      unitRef="U_iso4217USD_xbrlishares">-0.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001082038_20200101_20201231"
      decimals="-5"
      id="F_000468"
      unitRef="U_xbrlishares">7500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001082038_20190101_20191231"
      decimals="-5"
      id="F_000469"
      unitRef="U_xbrlishares">21400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0001082038_20180101_20181231"
      decimals="-5"
      id="F_000470"
      unitRef="U_xbrlishares">16600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <drrx:ShippingAndHandlingPolicyTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000376">
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Shipping and Handling&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Costs related to shipping and handling are included in cost of revenues for all periods presented.&lt;/p&gt;</drrx:ShippingAndHandlingPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000377">
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Recent Accounting Pronouncements&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:2.62%;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In December 2019, as part of its initiative to reduce complexity in the accounting standards, the FASB issued ASU 2019-12, &lt;span style="font-style:italic;"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt; (&#x201c;ASU 2019-12&#x201d;), which eliminates certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company early adopted ASU 2019-12 on January 1, 2020, and this adoption had no material impact on the Company&#x2019;s financial position or results of operations. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In November 2018, the Financial Accounting Standards Board (the FASB) issued ASU No.&#160;2018-18,&#160;&lt;span style="font-style:italic;"&gt;Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606&#160;(ASU 2018-18)&lt;/span&gt;. ASU 2018-18 clarifies that certain transactions between collaborative arrangement &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;participants should be accounted for as revenue under Topic 606 when the counterparty is a customer for a distinct good or service (i.e. a unit of account). For units of account that are in the scope of Topic 606, all of the guidance in Topic 606 should be applied, including the guidance on recognition, measurement, presentation and disclosure. ASU 2018-18 also adds a reference in Topic 808 to the unit of account guidance in ASC 606 and requires that it be applied only to assess whether transactions in a collaborative arrangement are in the scope of Topic 606. ASU 2018-18 will preclude entities from presenting amounts related to transactions with a counterparty in a collaborative arrangement that is not a customer as revenue from contracts with customers. ASU 2018-18 is effective for the Company for all interim and annual reporting periods beginning after December 15, 2019. &lt;/span&gt;&lt;span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The adoption of this standard did not have a material effect on the Company&#x2019;s financial statements&lt;/span&gt;&lt;span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In August 2018, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;)&#160;No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework &#x2013; Changes to the Disclosure Requirements for Fair Value Measurement, which eliminates certain disclosure requirements for fair value measurements for all entities, requires public entities to disclose certain new information and modifies some disclosure requirements. This standard is effective for fiscal years beginning after December 15, 2019, including interim reporting periods within those years. The adoption of this standard did not have a material effect on the Company&#x2019;s financial statements.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In January 2017, the FASB issued ASU No.&#160;2017-04,&#160;&lt;span style="font-style:italic;"&gt;Intangibles&#x2014;Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,&#160;(ASU 2017-04)&lt;/span&gt;.&#160;ASU 2017-04 eliminated Step 2 from the goodwill impairment test. Instead, under the amendments in ASU 2017-04, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#x2019;s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax&#160;effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. ASU 2017-04 is effective for all interim and annual reporting periods beginning after December 15, 2019. The adoption of this standard did not have a material effect on the Company&#x2019;s financial statements.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In June 2016,&#160;the FASB issued Accounting Standards Update No. 2016-13 (ASU 2016-13)&#160;&#x201c;Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments.&#x201d;&#160;ASU 2016-13 requires measurement and recognition of expected credit losses for financial assets. This standard is effective for fiscal years beginning after December 15, 2022 for small reporting companies, including interim reporting periods within those years and must be adopted using a modified retrospective approach, with certain exceptions. Early adoption is permitted.&#160; The Company does not expect the adoption of this standard to have a material effect on its financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000347">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"&gt;Strategic Agreements&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The collaborative research and development and other revenues associated with the Company&#x2019;s major third-party collaborators are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Collaborator/Counterparty&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gilead (1)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,879&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,133&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,542&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other (2)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,062&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;996&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,665&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total collaborative research and development and other revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,941&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,129&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,207&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:81.2%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"&gt;Amounts related to recognition of upfront fees and milestone payments were $22.7 million, $12.3 million and zero for the twelve months ended December 31, 2020, 2019 and 2018, respectively. The Company signed a license agreement with Gilead on July 19, 2019 and received a nonrefundable upfront license fee and a milestone payment totaling $35.0 million in 2019 which was being recognized as revenue as its obligation was being satisfied using the cost-to-cost input method (see Note 2. Strategic Agreements - Agreement with Gilead Sciences, Inc. in the financial statements). In June 2020, the Company received notice that Gilead was terminating the License Agreement and a related R&amp;amp;D agreement between Gilead and the Company. As a result, the Company recognized all its remaining deferred revenue as there were no remaining substantive performance obligations to be provided to Gilead by the Company as of the date when the termination notice was received.  Amounts recognized as revenue during each of the twelve months ended December 31, 2020, 2019 and 2018 also included the Company&#x2019;s reimbursable collaborative research and development services performed under its agreement with Gilead.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"&gt;Includes: (a) amounts related to earn-out revenue from Indivior UK Limited (Indivior) with respect to PERSERIS net sales; (b) feasibility programs; (c) research and development activities funded by Santen Pharmaceutical Co. Ltd. (Santen); and (d) royalty revenue from OP Pharma with respect to Methydur net sales. Note that in January 2018, the Company was notified by Santen that due to a shift in priorities, Santen had elected to reallocate research and development resources and put the Company&#x2019;s program on pause until further notice. While the main program is on pause, the parties are working together on a limited set of research and development activities funded by Santen. &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:-5.24%;font-size:6pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020, the Company had potential milestones of up to $76.0 million that the Company may receive in the future under its collaborative arrangements, of which $13.0 million are development-based milestones and $63.0 million are sales-based milestones. Within the category of development-based milestones, $2.0 million are related to early stage clinical testing (defined as Phase 1 or 2 activities), $3.0 million are related to late stage clinical testing (defined as Phase 3 activities), $3.0 million are related to regulatory filings, and $5.0 million are related to regulatory approvals. &lt;span style="font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Agreement with Gilead Sciences, Inc.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On July 19, 2019, the Company entered into a license agreement (the &#x201c;Gilead Agreement&#x201d;) with Gilead Sciences, Inc.&#160;&#160;(&#x201c;Gilead&#x201d;). Pursuant to the Gilead Agreement, the Company granted Gilead the exclusive worldwide rights to develop and commercialize a long-acting injectable HIV product utilizing DURECT&#x2019;s SABER&lt;sup style="font-size:85%;line-height:120%;vertical-align:top"&gt;&#xae;&lt;/sup&gt; technology.&#160;&#160;Gilead also received exclusive access to the SABER platform for HIV and Hepatitis B Virus (HBV) and the exclusive option to license additional SABER-based products directed to HIV and HBV.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Under the terms of the Gilead Agreement, Gilead made a non-refundable upfront payment to DURECT of $25 million, and in October 2019, the Company also received a $10 million milestone payment from Gilead for further development of the product candidate.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During the twelve months ended December 31, 2019, the upfront and milestone consideration of $35 million received in 2019 associated with the Primary Services was being recognized as revenue when the first performance obligation was being satisfied using the cost-to-cost input method, which the Company believes best depicts the transfer of control to the customer. Under the cost-to-cost input method, the extent of progress towards completion is measured based on the ratio of actual costs incurred to the total estimated costs. Revenue is recorded as a percentage of the transaction price based on the extent of progress towards completion. The estimate of the Company&#x2019;s measure of progress, which can include additional Primary Services, if any, and the estimate of any additional consideration for those additional Primary Services, are included in the transaction price which is updated at each reporting date, and revenue is recognized on a cumulative catchup basis. As such, management applies a certain amount of judgment in estimating both the Primary Services and the corresponding timeline to through &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;completion of the first performance obligation, which are key inputs when using the cost-to-cost input method.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;During the twelve months ended December 31, 2019, the Company recognized $12.3 million of the deferred revenue within collaborative research and development and other revenues. The Company also recognized $4.8 million from Gilead during the twelve months ended December 31, 2019 from feasibility related collaborative research and development services.&#160;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In June 2020, Gilead terminated the Gilead Agreement and a related R&amp;amp;D agreement between Gilead and the Company. As a result, the Company recognized $22.7 million as revenue during the year ended December 31, 2020, which represented all of the remaining upfront fee and milestone payment that had previously been deferred as there were no remaining substantive performance obligations to be provided to Gilead by the Company as of the date when the termination notice was received.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table presents changes in the Company&#x2019;s contract assets and liabilities for the twelve months ended December 31, 2020 and 2019 (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;January 1,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deletions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance Sheet&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts receivable&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,812&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(39,318&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;494&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total contract asset&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,812&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(39,318&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;494&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred revenue, current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;35,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(12,321&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,679&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total contract liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;35,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(12,321&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,679&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;January 1,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deletions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance Sheet&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts receivable&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;494&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(694&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total contract asset&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;494&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(694&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred revenue, current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,679&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,174&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(31,853&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total contract liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,679&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,174&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(31,853&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Patent Purchase Agreement with Indivior&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On September 26, 2017, the Company entered into a Patent Purchase Agreement (the &#x201c;Indivior Agreement&#x201d;) with Indivior.&#160;&#160;Pursuant to the Indivior Agreement, the Company assigned to Indivior certain patents that may provide further intellectual property protection for PERSERIS&#x2122; (risperidone), Indivior&#x2019;s extended-release injectable suspension for the treatment of schizophrenia in adults.&#160;&#160;In consideration for such assignment, Indivior made an upfront non-refundable payment to the Company of $12.5 million.&#160;&#160;Indivior also agreed to make an additional $5.0 million payment to the Company contingent upon NDA approval of PERSERIS, as well as quarterly earn-out payments that are based on a single digit percentage of U.S. net sales for certain products covered by the assigned patent rights, including PERSERIS. The assigned patent rights include granted patents extending through at least 2026.&#160;&#160;The Company also received a non-exclusive right under the assigned patents to develop and &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;commercialize certain risperidone-containing products and products that do not contain risperidone or buprenorphine.&#160;&#160;The Indivior Agreement contains customary representations, warranties and indemnities of the parties. The Company received the payment of $&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12.5&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million from Indivior in September 2017 and recognized the $&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12.5&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million as revenue from sale of intellectual property rights in 2017 as the Company did not have any continuing obligations under the purchase agreement&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;. In August 2018, the Company received the payment of $&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.0&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million from Indivior for the FDA approval of PERSERIS.&#160;&#160;The Company recognized the $&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.0&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million as milestone revenue in 2018 as there was no further performance obligation associated with this milestone payment. Amounts recognized to date related to earn-out revenues from PERSERIS have been immaterial&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Agreement with Santen Pharmaceutical Co., Ltd.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On December&#160;11, 2014, the Company and Santen Pharmaceutical Co., Ltd. (Santen) entered into a definitive agreement (the Santen Agreement). Pursuant to the Santen Agreement, the Company granted Santen an exclusive worldwide license to the Company&#x2019;s proprietary SABER formulation platform and other intellectual property to develop and commercialize a sustained release product utilizing the Company&#x2019;s SABER technology to deliver an ophthalmology drug. Santen controls and funds the development and commercialization program, and the parties established a joint management committee to oversee, review and coordinate the development activities of the parties under the Santen Agreement.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In connection with the Santen agreement, Santen paid the Company an upfront fee of $2.0 million in cash and agreed to make contingent cash payments to the Company of up to $76.0 million upon the achievement of certain milestones, of which $13.0 million are development-based milestones and $63.0 million are commercialization-based milestones including milestones requiring the achievement of certain product sales targets (none of which has been achieved as of December 31, 2020). Santen will also pay for certain Company costs incurred in the development of the licensed product. If the product is commercialized, the Company would also receive a tiered royalty on annual net product sales ranging from single-digit to the low double digits, determined on a country-by-country basis. In January 2018, the Company was notified by Santen that due to a shift in priorities, Santen elected to reallocate research and development resources and put the Company&#x2019;s program on pause until further notice. While the main program is on pause, the parties are working together on a limited set of research and development activities funded by Santen. As of December 31, 2020, the cumulative aggregate payments received by the Company under this agreement were $3.3 million.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Agreement with Sandoz AG.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In May 2017, the Company and Sandoz AG (&#x201c;Sandoz&#x201d;) entered into a license agreement to develop and market POSIMIR in the United States. On January 2, 2019, the Company received written notice from Sandoz that Sandoz terminated this agreement effective January 27, 2019. As a result of this termination, Sandoz returned its exclusive commercialization rights to develop and market POSIMIR in the United States.&#160;&#160;The parties are in dispute with regard to Sandoz&#x2019;s obligation to pay a termination fee to the Company. The Company has initiated a formal dispute resolution process related to the termination fee. The cumulative aggregate payments received by the Company from Sandoz as of December 31, 2020 were $20.0 million under this agreement. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;;font-size:9pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000381">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The collaborative research and development and other revenues associated with the Company&#x2019;s major third-party collaborators are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Collaborator/Counterparty&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gilead (1)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,879&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17,133&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,542&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other (2)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,062&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;996&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,665&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total collaborative research and development and other revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,941&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,129&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,207&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:81.2%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"&gt;&#160;&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"&gt;Amounts related to recognition of upfront fees and milestone payments were $22.7 million, $12.3 million and zero for the twelve months ended December 31, 2020, 2019 and 2018, respectively. The Company signed a license agreement with Gilead on July 19, 2019 and received a nonrefundable upfront license fee and a milestone payment totaling $35.0 million in 2019 which was being recognized as revenue as its obligation was being satisfied using the cost-to-cost input method (see Note 2. Strategic Agreements - Agreement with Gilead Sciences, Inc. in the financial statements). In June 2020, the Company received notice that Gilead was terminating the License Agreement and a related R&amp;amp;D agreement between Gilead and the Company. As a result, the Company recognized all its remaining deferred revenue as there were no remaining substantive performance obligations to be provided to Gilead by the Company as of the date when the termination notice was received.  Amounts recognized as revenue during each of the twelve months ended December 31, 2020, 2019 and 2018 also included the Company&#x2019;s reimbursable collaborative research and development services performed under its agreement with Gilead.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"&gt;Includes: (a) amounts related to earn-out revenue from Indivior UK Limited (Indivior) with respect to PERSERIS net sales; (b) feasibility programs; (c) research and development activities funded by Santen Pharmaceutical Co. Ltd. (Santen); and (d) royalty revenue from OP Pharma with respect to Methydur net sales. Note that in January 2018, the Company was notified by Santen that due to a shift in priorities, Santen had elected to reallocate research and development resources and put the Company&#x2019;s program on pause until further notice. While the main program is on pause, the parties are working together on a limited set of research and development activities funded by Santen. &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20200101_20201231"
      decimals="-3"
      id="F_000471"
      unitRef="U_iso4217USD">22879000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20190101_20191231"
      decimals="-3"
      id="F_000472"
      unitRef="U_iso4217USD">17133000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20180101_20181231"
      decimals="-3"
      id="F_000473"
      unitRef="U_iso4217USD">2542000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementsWithOtherCollaboratorsOrCounterpartiesMember_20200101_20201231"
      decimals="-3"
      id="F_000474"
      unitRef="U_iso4217USD">1062000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementsWithOtherCollaboratorsOrCounterpartiesMember_20190101_20191231"
      decimals="-3"
      id="F_000475"
      unitRef="U_iso4217USD">996000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementsWithOtherCollaboratorsOrCounterpartiesMember_20180101_20181231"
      decimals="-3"
      id="F_000476"
      unitRef="U_iso4217USD">5665000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20200101_20201231"
      decimals="-3"
      id="F_000477"
      unitRef="U_iso4217USD">23941000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20190101_20191231"
      decimals="-3"
      id="F_000478"
      unitRef="U_iso4217USD">18129000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20180101_20181231"
      decimals="-3"
      id="F_000479"
      unitRef="U_iso4217USD">8207000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20200101_20201231"
      decimals="-5"
      id="F_000480"
      unitRef="U_iso4217USD">22700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20190101_20191231"
      decimals="-5"
      id="F_000481"
      unitRef="U_iso4217USD">12300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20180101_20181231"
      decimals="-6"
      id="F_000482"
      unitRef="U_iso4217USD">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapLicenseMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20190101_20191231"
      decimals="-5"
      id="F_000483"
      unitRef="U_iso4217USD">35000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_20200101_20201231"
      decimals="INF"
      id="F_000484"
      unitRef="U_iso4217USD">76000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxDevelopmentBasedMilestonesMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210227_20210301"
      decimals="-5"
      id="F_000485"
      unitRef="U_iso4217USD">13000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxSalesBasedMilestonesMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210227_20210301"
      decimals="-5"
      id="F_000486"
      unitRef="U_iso4217USD">63000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <drrx:DevelopmentBasedMilestones
      contextRef="C_0001082038_us-gaapChangeInAccountingEstimateByTypeAxis_drrxEarlyStageClinicalTestingMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210301"
      decimals="-5"
      id="F_000487"
      unitRef="U_iso4217USD">2000000.0</drrx:DevelopmentBasedMilestones>
    <drrx:DevelopmentBasedMilestones
      contextRef="C_0001082038_us-gaapChangeInAccountingEstimateByTypeAxis_drrxLateStageClinicalTestingMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210301"
      decimals="-5"
      id="F_000488"
      unitRef="U_iso4217USD">3000000.0</drrx:DevelopmentBasedMilestones>
    <drrx:DevelopmentBasedMilestones
      contextRef="C_0001082038_us-gaapChangeInAccountingEstimateByTypeAxis_us-gaapRegulatoryReviewsOfFilingsMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210301"
      decimals="-5"
      id="F_000489"
      unitRef="U_iso4217USD">3000000.0</drrx:DevelopmentBasedMilestones>
    <drrx:DevelopmentBasedMilestones
      contextRef="C_0001082038_us-gaapChangeInAccountingEstimateByTypeAxis_drrxRegulatoryApprovalsMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210301"
      decimals="-5"
      id="F_000490"
      unitRef="U_iso4217USD">5000000.0</drrx:DevelopmentBasedMilestones>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20190717_20190719"
      decimals="-6"
      id="F_000491"
      unitRef="U_iso4217USD">25000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <drrx:ContractWithCustomerLiabilityMilestonePayment
      contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20191001_20191031"
      decimals="-6"
      id="F_000492"
      unitRef="U_iso4217USD">10000000</drrx:ContractWithCustomerLiabilityMilestonePayment>
    <drrx:PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment
      contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxUpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember_20191231"
      decimals="-6"
      id="F_000493"
      unitRef="U_iso4217USD">35000000</drrx:PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment>
    <drrx:AccruedAmountOfFinalPaymentOfTermLoan
      contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_20190101_20191231"
      decimals="-5"
      id="F_000494"
      unitRef="U_iso4217USD">12300000</drrx:AccruedAmountOfFinalPaymentOfTermLoan>
    <us-gaap:DeferredRevenue
      contextRef="C_0001082038_20191231"
      decimals="-5"
      id="F_000495"
      unitRef="U_iso4217USD">4800000</us-gaap:DeferredRevenue>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20200101_20201231"
      decimals="-5"
      id="F_000496"
      unitRef="U_iso4217USD">22700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000382">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table presents changes in the Company&#x2019;s contract assets and liabilities for the twelve months ended December 31, 2020 and 2019 (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;January 1,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deletions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance Sheet&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts receivable&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,812&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(39,318&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;494&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total contract asset&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,812&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(39,318&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;494&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred revenue, current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;35,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(12,321&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,679&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total contract liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;35,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(12,321&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,679&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;January 1,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deletions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance Sheet&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts receivable&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;494&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(694&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total contract asset&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;494&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(694&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred revenue, current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,679&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,174&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(31,853&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total contract liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22,679&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,174&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(31,853&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ReceivablesNetCurrent
      contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20191231"
      decimals="-3"
      id="F_000497"
      unitRef="U_iso4217USD">39812000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20191231"
      decimals="-3"
      id="F_000498"
      unitRef="U_iso4217USD">39318000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000499"
      unitRef="U_iso4217USD">494000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20191231"
      decimals="-3"
      id="F_000500"
      unitRef="U_iso4217USD">39812000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20191231"
      decimals="-3"
      id="F_000501"
      unitRef="U_iso4217USD">39318000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000502"
      unitRef="U_iso4217USD">494000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20191231"
      decimals="-3"
      id="F_000503"
      unitRef="U_iso4217USD">35000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20191231"
      decimals="-3"
      id="F_000504"
      unitRef="U_iso4217USD">12321000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000505"
      unitRef="U_iso4217USD">22679000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20191231"
      decimals="-3"
      id="F_000506"
      unitRef="U_iso4217USD">35000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20191231"
      decimals="-3"
      id="F_000507"
      unitRef="U_iso4217USD">12321000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000508"
      unitRef="U_iso4217USD">22679000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ReceivablesNetCurrent
      contextRef="C_0001082038_20200101"
      decimals="-3"
      id="F_000509"
      unitRef="U_iso4217USD">494000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20201231"
      decimals="-3"
      id="F_000510"
      unitRef="U_iso4217USD">200000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20201231"
      decimals="-3"
      id="F_000511"
      unitRef="U_iso4217USD">694000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="C_0001082038_20200101"
      decimals="-3"
      id="F_000512"
      unitRef="U_iso4217USD">494000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20201231"
      decimals="-3"
      id="F_000513"
      unitRef="U_iso4217USD">200000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20201231"
      decimals="-3"
      id="F_000514"
      unitRef="U_iso4217USD">694000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0001082038_20200101"
      decimals="-3"
      id="F_000515"
      unitRef="U_iso4217USD">22679000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20201231"
      decimals="-3"
      id="F_000516"
      unitRef="U_iso4217USD">9174000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20201231"
      decimals="-3"
      id="F_000517"
      unitRef="U_iso4217USD">31853000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_0001082038_20200101"
      decimals="-3"
      id="F_000518"
      unitRef="U_iso4217USD">22679000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxAdditionsMember_20201231"
      decimals="-3"
      id="F_000519"
      unitRef="U_iso4217USD">9174000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="C_0001082038_us-gaapContractWithCustomerDurationAxis_drrxDeletionsMember_20201231"
      decimals="-3"
      id="F_000520"
      unitRef="U_iso4217USD">31853000</us-gaap:ContractWithCustomerLiability>
    <drrx:NonRefundableUpfrontPaymentReceived
      contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20170925_20170926"
      decimals="-5"
      id="F_000521"
      unitRef="U_iso4217USD">12500000</drrx:NonRefundableUpfrontPaymentReceived>
    <drrx:PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment
      contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxRegulatoryBasedMilestoneMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20170926"
      decimals="-5"
      id="F_000522"
      unitRef="U_iso4217USD">5000000.0</drrx:PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment>
    <drrx:GrantedPatentsExtendingYearMinimum
      contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20170925_20170926"
      id="F_000523">2026</drrx:GrantedPatentsExtendingYearMinimum>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapRoyaltyMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20170901_20170930"
      decimals="-5"
      id="F_000524"
      unitRef="U_iso4217USD">12500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapRoyaltyMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20170101_20171231"
      decimals="-5"
      id="F_000525"
      unitRef="U_iso4217USD">12500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <drrx:PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment
      contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxRegulatoryBasedMilestoneMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20180831"
      decimals="-5"
      id="F_000526"
      unitRef="U_iso4217USD">5000000.0</drrx:PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxRegulatoryBasedMilestoneMember_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20180101_20181231"
      decimals="-5"
      id="F_000527"
      unitRef="U_iso4217USD">5000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapLicenseMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20141210_20141211"
      decimals="-5"
      id="F_000528"
      unitRef="U_iso4217USD">2000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <drrx:PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment
      contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20141211"
      decimals="INF"
      id="F_000529"
      unitRef="U_iso4217USD">76000000.0</drrx:PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment>
    <drrx:PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment
      contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxDevelopmentBasedMilestonesMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20141211"
      decimals="-5"
      id="F_000530"
      unitRef="U_iso4217USD">13000000.0</drrx:PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment>
    <drrx:PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment
      contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxCommercializationBasedMilestonesMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20141211"
      decimals="-5"
      id="F_000531"
      unitRef="U_iso4217USD">63000000.0</drrx:PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_0001082038_us-gaapResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_drrxCommercializationBasedMilestonesMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20200101_20201231"
      decimals="INF"
      id="F_000532"
      unitRef="U_iso4217USD">0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
      contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20200101_20201231"
      decimals="-5"
      id="F_000533"
      unitRef="U_iso4217USD">3300000</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
      contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithSandozAGMember_20200101_20201231"
      decimals="-5"
      id="F_000534"
      unitRef="U_iso4217USD">20000000.0</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000348">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;3.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"&gt;Financial Instruments&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company&#x2019;s valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company follows a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value. These levels of inputs are the following:&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.85%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:11pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;color:#000000;"&gt;Level 1&#x2014;Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.85%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:11pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;color:#000000;"&gt;Level 2&#x2014;Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:3.85%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/&gt;&lt;span style="font-size:11pt;font-family:'Times New Roman'"&gt;&#x2022;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;color:#000000;"&gt;Level 3&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s financial instruments are valued using quoted prices in active markets or based upon other observable inputs. The following table sets forth the fair value of the Company&#x2019;s financial assets that were measured at fair value on a recurring basis as of December 31, 2020 (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;522&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;522&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Certificates of deposit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Municipal bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,305&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,305&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. Government agencies&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;522&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,668&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40,190&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table sets forth the fair value of our financial assets that were measured at fair value on a recurring basis as of December&#160;31, 2019 (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;524&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;524&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Certificates of deposit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;47,218&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;47,218&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. Government agencies&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,501&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,501&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,868&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,868&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;524&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;61,737&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;62,261&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company&#x2019;s financial instruments are valued using quoted prices in active markets or based upon other observable inputs. Money market funds are classified as Level 1 financial assets. Certificates of deposit, commercial paper, corporate debt securities, and U.S. Government agency securities are classified as Level 2 financial assets. The fair value of the Level 2 assets is estimated using pricing models using current observable market information for similar securities. The Company&#x2019;s Level 2 investments include U.S. government-backed securities and corporate securities that are valued based upon observable inputs that may include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data including market research publications. The fair value of commercial paper is based upon the time to maturity and discounted using the three-month treasury bill rate. The average remaining maturity of the Company&#x2019;s &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2 investments as of December 31, 20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; is less than twelve months and these investments are rated by S&amp;amp;P and Moody&#x2019;s at AAA or AA- for securities and A1 or P1 for commercial paper.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following is a summary of available-for-sale securities as of December 31, 2020 and 2019 (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gain&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;522&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;522&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Certificates of deposit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Municipal bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,310&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,305&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. Government agencies&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40,195&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40,190&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Reported as:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,619&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,619&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Short-term investments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,426&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,421&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Long-term investments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Long-term restricted investments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40,195&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40,190&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gain&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;524&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;524&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Certificates of deposit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;47,221&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;47,218&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. Government agencies&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,500&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,501&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,869&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,868&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;62,264&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;62,261&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Reported as:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,364&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,361&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Short-term investments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29,750&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29,750&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following is a summary of the cost and estimated fair value of available-for-sale securities at December 31, 2020, by contractual maturity (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Mature in one year or less&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,523&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,518&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Mature after one year through five years&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,673&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,668&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;There were no securities that have had an unrealized loss for more than 12 months as of December 31, 2020.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020, unrealized losses on available-for-sale investments are not attributed to credit risk and are considered to be temporary. The Company believes that it is more-likely-than-not that &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;investments in an unrealized loss position will be held until maturity or the recovery of the cost basis of the investment. To date, the Company has not recorded any impairment charges on marketable securities related to other-than-temporary declines in market value.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000383">The following table sets forth the fair value of the Company&#x2019;s financial assets that were measured at fair value on a recurring basis as of December 31, 2020 (in thousands):
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;522&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;522&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Certificates of deposit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Municipal bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,305&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,305&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. Government agencies&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;522&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,668&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40,190&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table sets forth the fair value of our financial assets that were measured at fair value on a recurring basis as of December&#160;31, 2019 (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Level 3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;524&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;524&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Certificates of deposit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;47,218&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;47,218&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. Government agencies&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,501&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,501&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,868&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,868&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;524&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;61,737&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;62,261&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000535"
      unitRef="U_iso4217USD">522000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000542"
      unitRef="U_iso4217USD">522000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCertificatesOfDepositMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000537"
      unitRef="U_iso4217USD">150000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCertificatesOfDepositMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000543"
      unitRef="U_iso4217USD">150000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000538"
      unitRef="U_iso4217USD">32213000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCommercialPaperMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000544"
      unitRef="U_iso4217USD">32213000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMunicipalBondsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000539"
      unitRef="U_iso4217USD">6305000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMunicipalBondsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000545"
      unitRef="U_iso4217USD">6305000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000540"
      unitRef="U_iso4217USD">1000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000546"
      unitRef="U_iso4217USD">1000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000536"
      unitRef="U_iso4217USD">522000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000541"
      unitRef="U_iso4217USD">39668000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231"
      decimals="-3"
      id="F_000547"
      unitRef="U_iso4217USD">40190000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000548"
      unitRef="U_iso4217USD">524000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapMoneyMarketFundsMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000555"
      unitRef="U_iso4217USD">524000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCertificatesOfDepositMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000550"
      unitRef="U_iso4217USD">150000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCertificatesOfDepositMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000556"
      unitRef="U_iso4217USD">150000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCommercialPaperMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000551"
      unitRef="U_iso4217USD">47218000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCommercialPaperMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000557"
      unitRef="U_iso4217USD">47218000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000552"
      unitRef="U_iso4217USD">4501000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000558"
      unitRef="U_iso4217USD">4501000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000553"
      unitRef="U_iso4217USD">9868000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByAssetClassAxis_us-gaapCorporateDebtSecuritiesMember_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000559"
      unitRef="U_iso4217USD">9868000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel1Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000549"
      unitRef="U_iso4217USD">524000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000554"
      unitRef="U_iso4217USD">61737000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0001082038_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231"
      decimals="-3"
      id="F_000560"
      unitRef="U_iso4217USD">62261000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000384">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following is a summary of available-for-sale securities as of December 31, 2020 and 2019 (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gain&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;522&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;522&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Certificates of deposit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,213&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Municipal bonds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,310&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,305&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. Government agencies&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40,195&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40,190&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Reported as:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,619&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,619&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Short-term investments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,426&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,421&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Long-term investments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Long-term restricted investments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40,195&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40,190&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gain&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Unrealized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Loss&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Money market funds&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;524&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;524&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Certificates of deposit&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Commercial paper&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;47,221&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;47,218&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. Government agencies&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,500&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,501&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Corporate debt&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,869&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,868&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;62,264&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;62,261&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Reported as:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cash and cash equivalents&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,364&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;32,361&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Short-term investments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29,750&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29,750&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231"
      decimals="-3"
      id="F_000561"
      unitRef="U_iso4217USD">522000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20201231"
      decimals="-3"
      id="F_000583"
      unitRef="U_iso4217USD">522000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCertificatesOfDepositMember_20201231"
      decimals="-3"
      id="F_000562"
      unitRef="U_iso4217USD">150000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCertificatesOfDepositMember_20201231"
      decimals="-3"
      id="F_000584"
      unitRef="U_iso4217USD">150000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231"
      decimals="-3"
      id="F_000563"
      unitRef="U_iso4217USD">32213000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231"
      decimals="-3"
      id="F_000572"
      unitRef="U_iso4217USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231"
      decimals="-3"
      id="F_000577"
      unitRef="U_iso4217USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20201231"
      decimals="-3"
      id="F_000585"
      unitRef="U_iso4217USD">32213000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20201231"
      decimals="-3"
      id="F_000564"
      unitRef="U_iso4217USD">6310000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20201231"
      decimals="-3"
      id="F_000578"
      unitRef="U_iso4217USD">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMunicipalBondsMember_20201231"
      decimals="-3"
      id="F_000586"
      unitRef="U_iso4217USD">6305000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_20201231"
      decimals="-3"
      id="F_000565"
      unitRef="U_iso4217USD">1000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_20201231"
      decimals="-3"
      id="F_000587"
      unitRef="U_iso4217USD">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000566"
      unitRef="U_iso4217USD">40195000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000573"
      unitRef="U_iso4217USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000579"
      unitRef="U_iso4217USD">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000588"
      unitRef="U_iso4217USD">40190000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCashAndCashEquivalentsMember_20201231"
      decimals="-3"
      id="F_000567"
      unitRef="U_iso4217USD">19619000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCashAndCashEquivalentsMember_20201231"
      decimals="-3"
      id="F_000574"
      unitRef="U_iso4217USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCashAndCashEquivalentsMember_20201231"
      decimals="-3"
      id="F_000580"
      unitRef="U_iso4217USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCashAndCashEquivalentsMember_20201231"
      decimals="-3"
      id="F_000589"
      unitRef="U_iso4217USD">19619000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20201231"
      decimals="-3"
      id="F_000568"
      unitRef="U_iso4217USD">19426000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20201231"
      decimals="-3"
      id="F_000575"
      unitRef="U_iso4217USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20201231"
      decimals="-3"
      id="F_000581"
      unitRef="U_iso4217USD">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20201231"
      decimals="-3"
      id="F_000590"
      unitRef="U_iso4217USD">19421000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapOtherLongTermInvestmentsMember_20201231"
      decimals="-3"
      id="F_000569"
      unitRef="U_iso4217USD">1000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapOtherLongTermInvestmentsMember_20201231"
      decimals="-3"
      id="F_000591"
      unitRef="U_iso4217USD">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_drrxLongTermRestrictedInvestmentsMember_20201231"
      decimals="-3"
      id="F_000570"
      unitRef="U_iso4217USD">150000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_drrxLongTermRestrictedInvestmentsMember_20201231"
      decimals="-3"
      id="F_000592"
      unitRef="U_iso4217USD">150000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000571"
      unitRef="U_iso4217USD">40195000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000576"
      unitRef="U_iso4217USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000582"
      unitRef="U_iso4217USD">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000593"
      unitRef="U_iso4217USD">40190000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20191231"
      decimals="-3"
      id="F_000594"
      unitRef="U_iso4217USD">524000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapMoneyMarketFundsMember_20191231"
      decimals="-3"
      id="F_000612"
      unitRef="U_iso4217USD">524000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCertificatesOfDepositMember_20191231"
      decimals="-3"
      id="F_000595"
      unitRef="U_iso4217USD">150000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCertificatesOfDepositMember_20191231"
      decimals="-3"
      id="F_000613"
      unitRef="U_iso4217USD">150000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20191231"
      decimals="-3"
      id="F_000596"
      unitRef="U_iso4217USD">47221000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20191231"
      decimals="-3"
      id="F_000602"
      unitRef="U_iso4217USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20191231"
      decimals="-3"
      id="F_000607"
      unitRef="U_iso4217USD">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCommercialPaperMember_20191231"
      decimals="-3"
      id="F_000614"
      unitRef="U_iso4217USD">47218000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_20191231"
      decimals="-3"
      id="F_000597"
      unitRef="U_iso4217USD">4500000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_20191231"
      decimals="-3"
      id="F_000603"
      unitRef="U_iso4217USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapUSGovernmentCorporationsAndAgenciesSecuritiesMember_20191231"
      decimals="-3"
      id="F_000615"
      unitRef="U_iso4217USD">4501000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20191231"
      decimals="-3"
      id="F_000598"
      unitRef="U_iso4217USD">9869000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20191231"
      decimals="-3"
      id="F_000604"
      unitRef="U_iso4217USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20191231"
      decimals="-3"
      id="F_000608"
      unitRef="U_iso4217USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCorporateDebtSecuritiesMember_20191231"
      decimals="-3"
      id="F_000616"
      unitRef="U_iso4217USD">9868000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000599"
      unitRef="U_iso4217USD">62264000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000605"
      unitRef="U_iso4217USD">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000609"
      unitRef="U_iso4217USD">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000617"
      unitRef="U_iso4217USD">62261000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCashAndCashEquivalentsMember_20191231"
      decimals="-3"
      id="F_000600"
      unitRef="U_iso4217USD">32364000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCashAndCashEquivalentsMember_20191231"
      decimals="-3"
      id="F_000610"
      unitRef="U_iso4217USD">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapCashAndCashEquivalentsMember_20191231"
      decimals="-3"
      id="F_000618"
      unitRef="U_iso4217USD">32361000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20191231"
      decimals="-3"
      id="F_000601"
      unitRef="U_iso4217USD">29750000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20191231"
      decimals="-3"
      id="F_000606"
      unitRef="U_iso4217USD">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20191231"
      decimals="-3"
      id="F_000611"
      unitRef="U_iso4217USD">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0001082038_us-gaapInvestmentTypeAxis_us-gaapShortTermInvestmentsMember_20191231"
      decimals="-3"
      id="F_000619"
      unitRef="U_iso4217USD">29750000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000385">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following is a summary of the cost and estimated fair value of available-for-sale securities at December 31, 2020, by contractual maturity (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Amortized&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Estimated&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Fair&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Mature in one year or less&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,523&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;38,518&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Mature after one year through five years&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,150&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,673&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;39,668&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000620"
      unitRef="U_iso4217USD">38523000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000623"
      unitRef="U_iso4217USD">38518000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000621"
      unitRef="U_iso4217USD">1150000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000624"
      unitRef="U_iso4217USD">1150000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000622"
      unitRef="U_iso4217USD">39673000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000625"
      unitRef="U_iso4217USD">39668000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_0001082038_20201231"
      decimals="INF"
      id="F_000626"
      unitRef="U_iso4217USD">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000349">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;4.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"&gt;Property and Equipment&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment consist of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,890&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,740&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,428&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,422&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Construction-in-progress&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;74&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,360&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,236&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less accumulated depreciation and amortization&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19,109&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19,077&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;251&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;159&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Depreciation expense was $297,000, $291,000 and $254,000 in 2020, 2019 and 2018, respectively.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020, the Company has recorded $482,000 as a liability which was included in other long-term liabilities on its balance sheet for asset retirement obligations associated with the estimated restoration cost for its leased buildings.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000386">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment consist of the following (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,890&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,740&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leasehold improvements&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,428&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,422&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Construction-in-progress&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;42&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;74&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,360&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,236&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less accumulated depreciation and amortization&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19,109&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(19,077&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;251&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;159&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20201231"
      decimals="-3"
      id="F_000627"
      unitRef="U_iso4217USD">10890000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapEquipmentMember_20191231"
      decimals="-3"
      id="F_000628"
      unitRef="U_iso4217USD">10740000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20201231"
      decimals="-3"
      id="F_000629"
      unitRef="U_iso4217USD">8428000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapLeaseholdImprovementsMember_20191231"
      decimals="-3"
      id="F_000630"
      unitRef="U_iso4217USD">8422000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20201231"
      decimals="-3"
      id="F_000631"
      unitRef="U_iso4217USD">42000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001082038_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapConstructionInProgressMember_20191231"
      decimals="-3"
      id="F_000632"
      unitRef="U_iso4217USD">74000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000633"
      unitRef="U_iso4217USD">19360000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000634"
      unitRef="U_iso4217USD">19236000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000635"
      unitRef="U_iso4217USD">19109000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000636"
      unitRef="U_iso4217USD">19077000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000637"
      unitRef="U_iso4217USD">251000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000638"
      unitRef="U_iso4217USD">159000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="C_0001082038_20200101_20201231"
      decimals="0"
      id="F_000639"
      unitRef="U_iso4217USD">297000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_0001082038_20190101_20191231"
      decimals="0"
      id="F_000640"
      unitRef="U_iso4217USD">291000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_0001082038_20180101_20181231"
      decimals="0"
      id="F_000641"
      unitRef="U_iso4217USD">254000</us-gaap:Depreciation>
    <us-gaap:AssetRetirementObligation
      contextRef="C_0001082038_20201231"
      decimals="0"
      id="F_000642"
      unitRef="U_iso4217USD">482000</us-gaap:AssetRetirementObligation>
    <drrx:RestrictedInvestmentsDisclosureTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000350">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;5.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"&gt;Restricted Investments&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020 and 2019, the Company had $150,000 recorded as restricted investments, which primarily served as collateral for letters of credit securing a leased facility in California.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;"&gt;&#160;&lt;/p&gt;</drrx:RestrictedInvestmentsDisclosureTextBlock>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="C_0001082038_srtStatementGeographicalAxis_countryCA_20201231"
      decimals="0"
      id="F_000643"
      unitRef="U_iso4217USD">150000</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:RestrictedInvestmentsNoncurrent
      contextRef="C_0001082038_srtStatementGeographicalAxis_countryCA_20191231"
      decimals="0"
      id="F_000644"
      unitRef="U_iso4217USD">150000</us-gaap:RestrictedInvestmentsNoncurrent>
    <us-gaap:CommitmentsDisclosureTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000351">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;6.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"&gt;Commitments&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Operating Leases&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company has lease arrangements for its facilities in California and Alabama as follows. &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:16.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Location&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Approximate&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Square Feet&lt;span style="font-weight:normal;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.65pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:20%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operation&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.65pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:45%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expiration&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width:16.98%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cupertino,&#160;CA&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,149 sq. ft.&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:20%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Office, Laboratory and Manufacturing&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:45%; border-top:solid 0.75pt #000000;" valign="top"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lease expires 2024 (with an option to renew for an additional five years) &lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height:3.75pt;"&gt;
&lt;td style="width:16.98%;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:15%;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:20%;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:45%;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width:16.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cupertino, CA&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,100 sq. ft.&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:20%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Office and Laboratory&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:45%;" valign="top"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lease expires 2024 (with an option to renew for an additional five years)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width:16.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:20%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:45%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width:16.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vacaville, CA&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,634 sq. ft.&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:20%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Manufacturing&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:45%;" valign="top"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lease expires 2023 (with an option to renew for an additional five years)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height:3.75pt;"&gt;
&lt;td style="width:16.98%;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:15%;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:20%;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:45%;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Under these leases, the Company is required to pay certain maintenance expenses in addition to monthly rent. Rent expense is recognized on a straight-line basis over the lease term for leases that have scheduled rental payment increases. Rent expense under all operating leases, excluding the LACTEL product line, was $1.9 million, $1.9 million and $1.7 million for the years ended December 31, 2020, 2019 and 2018, respectively. &lt;/p&gt;

&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Future minimum payments under these noncancelable leases are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ending December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leases&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,933&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,991&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,970&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;275&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,169&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Other Purchase Commitments &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In 2005, the Company entered into a supply agreement with a vendor. The remaining minimum purchase commitment under this agreement was $500,000 in 2018, which had been recorded as an accrued liability on the Company&#x2019;s Balance Sheet at December 31, 2018, and which was charged to cost of goods sold in the Company&#x2019;s Statements of Operations and Comprehensive Loss in 2017.&#160;In 2019, the Company recorded a one-time settlement credit of $500,000 as a reduction to cost of goods sold upon signing a settlement and release agreement with this vendor, and forgave the contractual right to receive inventory for the same amount that was previously reserved for.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:3pt;"&gt;&#160;&lt;/p&gt;</us-gaap:CommitmentsDisclosureTextBlock>
    <drrx:ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000387">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:16.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Location&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Approximate&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Square Feet&lt;span style="font-weight:normal;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.65pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:20%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operation&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.65pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:45%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expiration&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width:16.98%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cupertino,&#160;CA&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;30,149 sq. ft.&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:20%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Office, Laboratory and Manufacturing&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:45%; border-top:solid 0.75pt #000000;" valign="top"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lease expires 2024 (with an option to renew for an additional five years) &lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height:3.75pt;"&gt;
&lt;td style="width:16.98%;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:15%;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:20%;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:45%;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width:16.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cupertino, CA&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,100 sq. ft.&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:20%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Office and Laboratory&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:45%;" valign="top"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lease expires 2024 (with an option to renew for an additional five years)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width:16.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:20%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:45%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="width:16.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vacaville, CA&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%;white-space:nowrap;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;24,634 sq. ft.&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:20%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Manufacturing&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:45%;" valign="top"&gt;&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Lease expires 2023 (with an option to renew for an additional five years)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="height:3.75pt;"&gt;
&lt;td style="width:16.98%;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:15%;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:20%;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:1%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:45%;" valign="middle"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</drrx:ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock>
    <us-gaap:LandSubjectToGroundLeases
      contextRef="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapLeaseContractualTermAxis_drrxLeaseAmendmentMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeLaboratoryAndManufacturingMember_20201231"
      decimals="INF"
      id="F_000645"
      unitRef="U_utrsqft">30149</us-gaap:LandSubjectToGroundLeases>
    <drrx:LeaseExpirationTerm
      contextRef="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapLeaseContractualTermAxis_drrxLeaseAmendmentMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeLaboratoryAndManufacturingMember_20200101_20201231"
      id="F_000648">Lease expires 2024 (with an option to renew for an additional five years) </drrx:LeaseExpirationTerm>
    <drrx:LeaseExpirationYear
      contextRef="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeLaboratoryAndManufacturingMember_20200101_20201231"
      id="F_000651">2024</drrx:LeaseExpirationYear>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeLaboratoryAndManufacturingMember_20201231"
      id="F_000652">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LandSubjectToGroundLeases
      contextRef="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapLeaseContractualTermAxis_drrxLeaseAmendmentMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeAndLaboratoryMember_20201231"
      decimals="INF"
      id="F_000646"
      unitRef="U_utrsqft">20100</us-gaap:LandSubjectToGroundLeases>
    <drrx:LeaseExpirationTerm
      contextRef="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapLeaseContractualTermAxis_drrxLeaseAmendmentMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeAndLaboratoryMember_20200101_20201231"
      id="F_000649">Lease expires 2024 (with an option to renew for an additional five years)</drrx:LeaseExpirationTerm>
    <drrx:LeaseExpirationYear
      contextRef="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeAndLaboratoryMember_20200101_20201231"
      id="F_000653">2024</drrx:LeaseExpirationYear>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeAndLaboratoryMember_20201231"
      id="F_000654">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LandSubjectToGroundLeases
      contextRef="C_0001082038_srtStatementGeographicalAxis_drrxVacavilleCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapManufacturingFacilityMember_20201231"
      decimals="INF"
      id="F_000647"
      unitRef="U_utrsqft">24634</us-gaap:LandSubjectToGroundLeases>
    <drrx:LeaseExpirationTerm
      contextRef="C_0001082038_srtStatementGeographicalAxis_drrxVacavilleCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapManufacturingFacilityMember_20200101_20201231"
      id="F_000650">Lease expires 2023 (with an option to renew for an additional five years)</drrx:LeaseExpirationTerm>
    <drrx:LeaseExpirationYear
      contextRef="C_0001082038_srtStatementGeographicalAxis_drrxVacavilleCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapManufacturingFacilityMember_20200101_20201231"
      id="F_000655">2023</drrx:LeaseExpirationYear>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_0001082038_srtStatementGeographicalAxis_drrxVacavilleCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_us-gaapManufacturingFacilityMember_20201231"
      id="F_000656">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="C_0001082038_20200101_20201231"
      decimals="-5"
      id="F_000657"
      unitRef="U_iso4217USD">1900000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="C_0001082038_20190101_20191231"
      decimals="-5"
      id="F_000658"
      unitRef="U_iso4217USD">1900000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="C_0001082038_20180101_20181231"
      decimals="-5"
      id="F_000659"
      unitRef="U_iso4217USD">1700000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000388">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Future minimum payments under these noncancelable leases are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ending December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Leases&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,933&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,991&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,970&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;275&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;6,169&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableCurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000660"
      unitRef="U_iso4217USD">1933000</us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000661"
      unitRef="U_iso4217USD">1991000</us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000662"
      unitRef="U_iso4217USD">1970000</us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInFourYears
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000663"
      unitRef="U_iso4217USD">275000</us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsReceivable
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000664"
      unitRef="U_iso4217USD">6169000</us-gaap:OperatingLeasesFutureMinimumPaymentsReceivable>
    <us-gaap:LongTermPurchaseCommitmentAmount
      contextRef="C_0001082038_20180101_20181231"
      decimals="0"
      id="F_000665"
      unitRef="U_iso4217USD">500000</us-gaap:LongTermPurchaseCommitmentAmount>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20190101_20191231"
      decimals="0"
      id="F_000666"
      unitRef="U_iso4217USD">500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:LongTermDebtTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000352">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;7.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"&gt;Term Loan&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In July 2016, the Company entered into a $20.0 million secured single-draw term loan with Oxford Finance LLC (Oxford Finance). The Company and Oxford Finance entered into three subsequent amendments to the Loan Agreement in February 2018, November of 2018 and December 2019, for which the Company paid Oxford Finance loan modification fees of $100,000, $900,000 and $825,000 respectively.&#160;&#160;As amended, the Loan Agreement provides for interest only payments for the first 18 months, followed by consecutive monthly payments of principal and interest in arrears starting on December 1, 2021 and continuing through the maturity date of the term loan of May 1, 2024. The Loan Agreement provides for a floating interest rate (7.95% initially and 7.95% as of December 31, 2020) based on an index rate plus a spread. In addition, a payment equal to 10% of the principal amount of the term loan is due when the term loan becomes due or upon the prepayment of the facility. If the Company elects to prepay the loan, there is also a prepayment fee of between 0.75% and 2.5% of the principal amount of the term loan depending on the timing of prepayment. The $150,000 facility fee that was paid at the original closing, the loan modification fees and other debt offering/issuance costs have been recorded as debt discount on the Company&#x2019;s balance sheet and together with the final $2.0 million payment are being amortized to interest expense using the effective interest method over the revised term of the loan.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The term loan is secured by substantially all of the assets of the Company, except that the collateral does not include any intellectual property (including licensing, collaboration and similar agreements relating thereto), and certain other excluded assets. The 2016 Loan Agreement contains customary representations, warranties and covenants by the Company, which covenants limit the Company&#x2019;s ability to convey, sell, lease, transfer, assign or otherwise dispose of certain assets of the Company; engage in any business other than the businesses currently engaged in by the Company or reasonably related thereto; liquidate or dissolve; make certain management changes; undergo certain change of control events; create, incur, assume, or be liable with respect to certain indebtedness; grant certain liens; pay dividends and make certain other restricted payments; make certain investments; and make payments on any subordinated debt.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Loan Agreement also contains customary indemnification obligations and customary events of default, including, among other things, the Company&#x2019;s failure to fulfill certain obligations of the Company under the Loan Agreement and the occurrence of a material adverse change which is defined as &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;a material adverse change in the Company&#x2019;s business, operations, or condition (financial or otherwise), a material impairment of the prospect of repayment of any portion of the loan, or a material impairment in the perfection or priority of lender&#x2019;s lien in the collateral or in the value of such collateral. In the event of default by the Company under the Loan Agreement, the lender would be entitled to exercise its remedies thereunder, including the right to accelerate the debt, upon which the Company may be required to repay all amounts then outstanding under the Loan Agreement, which could harm the Company&#x2019;s financial condition. The conditionally exercisable call option related to the event of default is considered to be an embedded derivative which is required to be bifurcated and accounted for as a separate financial instrument. In the periods presented, the value of the embedded derivative is not material, but could become material in future periods if an event of default became more probable than is currently estimated.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The fair value of the term loan approximates the carrying value. Future maturities and interest payments under the term loan as of December 31, 2020, are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,941&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,208&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,563&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,712&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total minimum payments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,424&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less amount representing interest&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,646&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross balance of term loan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,778&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less unamortized debt discount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(958&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Carrying value of term loan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,820&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less term loan, current portion, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(884&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Term loan, non-current portion, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,936&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:SecuredDebt
      contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160731"
      decimals="-5"
      id="F_000667"
      unitRef="U_iso4217USD">20000000.0</us-gaap:SecuredDebt>
    <us-gaap:PaymentsOfDebtRestructuringCosts
      contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20180201_20180228"
      decimals="0"
      id="F_000679"
      unitRef="U_iso4217USD">100000</us-gaap:PaymentsOfDebtRestructuringCosts>
    <us-gaap:PaymentsOfDebtRestructuringCosts
      contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20181101_20181130"
      decimals="0"
      id="F_000680"
      unitRef="U_iso4217USD">900000</us-gaap:PaymentsOfDebtRestructuringCosts>
    <us-gaap:PaymentsOfDebtRestructuringCosts
      contextRef="C_0001082038_20191201_20191231"
      decimals="0"
      id="F_000681"
      unitRef="U_iso4217USD">825000</us-gaap:PaymentsOfDebtRestructuringCosts>
    <us-gaap:DebtInstrumentPaymentTerms
      contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731"
      id="F_000668">As amended, the Loan Agreement provides for interest only payments for the first 18 months, followed by consecutive monthly payments of principal and interest in arrears starting on December 1, 2021 and continuing through the maturity date of the term loan of May 1, 2024</us-gaap:DebtInstrumentPaymentTerms>
    <us-gaap:DebtInstrumentDateOfFirstRequiredPayment1
      contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731"
      id="F_000669">2021-12-01</us-gaap:DebtInstrumentDateOfFirstRequiredPayment1>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731"
      id="F_000670">2024-05-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160731"
      decimals="INF"
      id="F_000671"
      unitRef="U_xbrlipure">0.0795</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20201231"
      decimals="INF"
      id="F_000672"
      unitRef="U_xbrlipure">0.0795</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis
      contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731"
      id="F_000673">index rate plus a spread</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <drrx:DebtInstrumentPrincipalPaymentPercentage
      contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731"
      decimals="INF"
      id="F_000675"
      unitRef="U_xbrlipure">0.10</drrx:DebtInstrumentPrincipalPaymentPercentage>
    <drrx:DebtInstrumentPrepaymentFeePercentage
      contextRef="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731"
      decimals="INF"
      id="F_000676"
      unitRef="U_xbrlipure">0.0075</drrx:DebtInstrumentPrepaymentFeePercentage>
    <drrx:DebtInstrumentPrepaymentFeePercentage
      contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731"
      decimals="INF"
      id="F_000677"
      unitRef="U_xbrlipure">0.025</drrx:DebtInstrumentPrepaymentFeePercentage>
    <us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid
      contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160731"
      decimals="0"
      id="F_000674"
      unitRef="U_iso4217USD">150000</us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid>
    <drrx:DebtIssuanceCost
      contextRef="C_0001082038_us-gaapDebtInstrumentAxis_drrxOxfordFinanceLlcTermLoanMember_20160701_20160731"
      decimals="-5"
      id="F_000678"
      unitRef="U_iso4217USD">2000000.0</drrx:DebtIssuanceCost>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000389">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The fair value of the term loan approximates the carrying value. Future maturities and interest payments under the term loan as of December 31, 2020, are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2021&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,941&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,208&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2023&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,563&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2024&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,712&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total minimum payments&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;25,424&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less amount representing interest&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(3,646&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gross balance of term loan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21,778&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less unamortized debt discount&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(958&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Carrying value of term loan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;20,820&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Less term loan, current portion, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(884&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Term loan, non-current portion, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,936&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000682"
      unitRef="U_iso4217USD">2941000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000683"
      unitRef="U_iso4217USD">9208000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000684"
      unitRef="U_iso4217USD">8563000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000685"
      unitRef="U_iso4217USD">4712000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000686"
      unitRef="U_iso4217USD">25424000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000687"
      unitRef="U_iso4217USD">3646000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000688"
      unitRef="U_iso4217USD">21778000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000689"
      unitRef="U_iso4217USD">958000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000690"
      unitRef="U_iso4217USD">20820000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000691"
      unitRef="U_iso4217USD">884000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000692"
      unitRef="U_iso4217USD">19936000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000353">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;8.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"&gt;Stockholders&#x2019; Equity&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;Common Stock&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In November 2015, the Company filed a shelf registration statement on Form S-3 with the SEC, which allowed the Company to offer up to $125.0 million of securities from time to time in one or more public offerings of its common stock. In addition, the Company entered into a Controlled Equity Offering sales agreement with Cantor Fitzgerald, under which the Company may sell, subject to certain limitations, up to $40 million of common stock through Cantor Fitzgerald, acting as agent. In August 2018, the Company filed a new shelf registration statement on Form S-3 with the SEC, which upon being declared effective in October 2018, terminated the November 2015 registration statement and allowed the Company to offer up to $175.0 million of securities from time to time in one or more public offerings, inclusive of up to $75.0 million of additional shares of common stock which the Company may sell, subject to certain limitations, under the 2015 Sales Agreement through Cantor Fitzgerald, acting as agent.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In 2018, the Company raised net proceeds of approximately $16.8 million from the sale of approximately 9.6 million shares of common stock in the open market through the Controlled Equity Offering program with Cantor Fitzgerald at a weighted average price of $1.80 per share. In 2019, the Company raised net proceeds of approximately $3.5 million from the sale of 2,349,820 shares of the Company&#x2019;s common stock in the open market at a weighted average price of $1.55 per share pursuant to the October 2018 registration statement.&#160;&#160;On June 20, 2019, the Company entered into a transaction to sell 29,000,000 shares of our common stock to certain investors in a registered offering at a price of $0.52 per share, raising total gross proceeds to the Company of approximately $15.1 million. In 2020, the Company raised net proceeds of approximately $12.3 million from the sale of 5,308,002 shares of the Company&#x2019;s common stock in the open market at a weighted average price of $2.39 per share pursuant to the October 2018 registration statement.&lt;/p&gt;

&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In February 2021, the Company completed an underwritten public offering of 20,364,582 shares of its common stock at a price of $2.2386 per share pursuant to an underwriting agreement with Cantor Fitzgerald&#160;&amp;amp; Co., raising total gross proceeds to the Company of approximately $45.6 million before deducting estimated offering expenses payable by the Company. Total stock issuance costs related to this financing were approximately $195,000. After deducting estimated offering expenses payable by the Company, the net proceeds to the Company were approximately $45.4 million.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;From January 1, 2021 to March 1, 2021, the Company also raised net proceeds (net of commissions) of approximately $2.4 million from the sale of 950,009 shares of the Company&#x2019;s common stock in the open market at a weighted average price of $2.60 per share pursuant to the October 2018 registration statement.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Description of Stock-Based Compensation Plans&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;2000 Stock Plan (Incentive Stock Plan)&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In January 2000, the Company&#x2019;s Board of Directors and stockholders adopted the DURECT Corporation 2000 Stock Plan, under which incentive stock options and non-statutory stock options and stock purchase rights may be granted to employees, consultants and non-employee directors. The 2000 Stock Plan was amended by written consent of the Board of Directors in March 2000 and written consent of the stockholders in August 2000.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In April 2005, the Board of Directors approved certain amendments to the 2000 Stock Plan. At the Company&#x2019;s annual stockholders meeting in June 2005, the stockholders approved the amendments of the 2000 Stock Plan to: (i)&#160;expand the types of awards that the Company may grant to eligible service providers under the Stock Plan to include restricted stock units, stock appreciation rights and other similar types of awards (including other awards under which recipients are not required to pay any purchase or exercise price) as well as cash awards; and (ii)&#160;include certain performance criteria that may be applied to awards granted under the Stock Plan.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At the Company&#x2019;s annual stockholders meeting in June 2010, the stockholders approved amendments of the 2000 Stock Plan to: (i)&#160;provide that the number of shares that remain available for issuance will be reduced by two shares for each share issued pursuant to an award (other than an option or stock appreciation right) granted on or after the date of the 2010 Annual Meeting; (ii)&#160;expand the types of transactions that might be considered repricings and option exchanges for which stockholder approval is required; (iii)&#160;provide that shares tendered or withheld in payment of the exercise price of an option or withheld to satisfy a withholding obligation, and all shares with respect to which a stock appreciation right is exercised, will not again be available for issuance under the Stock Plan; (iv)&#160;require that options and stock appreciation rights have an exercise price or base appreciation amount that is at least fair market value on the grant date, except in connection with certain corporate transactions, and that stock appreciation rights may not have longer than a 10-year term; (v)&#160;add new performance goals that may be used to provide &#x201c;performance-based compensation&#x201d; under the 2000 Stock Plan; (vi)&#160;extend the term of the 2000 Stock Plan to the date that is ten (10)&#160;years following the stockholders meeting; and (vii)&#160;expand the treatment of outstanding awards in connection with certain changes of control of the Company to cover mergers in which the consideration payable to stockholders is not solely securities of the successor corporation.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At the Company&#x2019;s annual stockholders meeting in June 2011, June 2014, June 2016 and June 2018, the stockholders approved amendments of the 2000 Stock Plan to increase the number of shares of the Company&#x2019;s common stock available for issuance by 5,500,000 shares, 4,000,000 shares, 5,000,000 shares and 7,500,000 shares, respectively, each of which had previously been approved by the Board of Directors. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At the Company&#x2019;s annual stockholders meeting in June 2019, the stockholders approved amendments of the 2000 Stock Plan to extend the term of the 2000 Stock Plan to the date that is ten &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(10)&#160;&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;years following the stockholders meeting. &lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A total of 49,955,639 shares of common stock have been reserved for issuance under this plan. The plan expires in &lt;span style="-sec-ix-hidden:F_000725"&gt;June 2029&lt;/span&gt;.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In April 2013, the Board of Directors approved certain amendments to the 2000 Stock Plan to: (i)&#160;increase the number of stock options granted to a non-employee director on the date which such person first becomes a director from 30,000 to 70,000 shares of common stock; each option shall have a &lt;span style="-sec-ix-hidden:F_000728"&gt;ten-year&lt;/span&gt; term, become exercisable in installments of one-third of the total number of options granted on each anniversary of the grant and have a two-year period following termination of Director status in which the former director can exercise the option; (ii)&#160;modify the exercise period for future option grants to a non-employee director in which a former director can exercise the option following termination of Director status from a one year period to a &lt;span style="-sec-ix-hidden:F_000730"&gt;two-year&lt;/span&gt; period.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options granted under the 2000 Stock Plan expire no later than ten years from the date of grant. Options may be granted with different vesting terms from time to time not to exceed five years from the date of grant. The option price of an incentive stock option granted to an employee or of a nonstatutory stock option granted to any person who owns stock representing more than 10% of the total combined voting power of all classes of stock of the Company (or any parent or subsidiary) shall be no less than 110% of the fair market value per share on the date of grant. The option price of an incentive stock option granted to any other employee shall be no less than 100% of the fair market value per share on the date of grant.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020, 7,599,531 shares of common stock were available for future grant and options to purchase 27,274,439 shares of common stock were outstanding under the 2000 Stock Plan.&#160; &#160; &lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160;&#160;&#160;&#160;&#160; &lt;/p&gt;
&lt;p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;"&gt;2000 Employee Stock Purchase Plan&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In August 2000, the Company adopted the 2000 Employee Stock Purchase Plan. This purchase plan is implemented by a series of overlapping offering periods of 24 months&#x2019; duration, with new offering periods, other than the first offering period, beginning on May&#160;1 and November&#160;1 of each year and ending April&#160;30 and October&#160;31, respectively, two years later. The purchase plan allows eligible employees to purchase common stock through payroll deductions at a price equal to the lower of 85% of the fair market value of the Company&#x2019;s common stock at the beginning of each offering period or at the end of each purchase period. The initial offering period commenced on the effectiveness of the Company&#x2019;s initial public offering.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In April 2010, the Board of Directors approved certain amendments to the 2000 Employee Stock Purchase Plan. At the Company&#x2019;s annual stockholders meeting in June 2010, the stockholders approved the amendments of the 2000 Employee Stock Purchase Plan to: (i)&#160;increase the number of shares of our common stock authorized for issuance under the ESPP by 250,000 shares; (ii)&#160;extend the term of the ESPP to the date that is ten (10)&#160;years following the stockholders meeting; (iii)&#160;provide for six-month consecutive offering periods beginning on November&#160;1, 2010; (iv)&#160;revise certain provisions to reflect the final regulations issued under Section&#160;423 of the Code by the Internal Revenue Service; and (v)&#160;provide for the cash-out of options outstanding under an offering period in effect prior to the consummation of certain corporate transactions as an alternative to providing for a final purchase under such offering period.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In March 2015, the Board of Directors approved certain amendments to the 2000 Employee Stock Purchase Plan. At the Company&#x2019;s annual stockholders meeting in June 2015, the stockholders approved the amendments of the 2000 Employee Stock Purchase Plan to: (i)&#160;increase the number of shares of our common stock authorized for issuance under the ESPP by 350,000 shares; and (ii)&#160;extend the term of the ESPP to the date that is ten (10)&#160;years following the stockholders meeting. At each of the Company&#x2019;s annual stockholders meeting in June 2017 and in June 2020, the stockholders approved amendments of &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;the 2000 Employee Stock Purchase Plan to increase the number of shares our common stock authorized for issuance under the ESPP by &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;350,000&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; shares&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, respectively,&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; &lt;/span&gt;&lt;span style="color:#000000;"&gt;and to re-approve its material terms&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The plan expires in &lt;span style="-sec-ix-hidden:F_000745"&gt;June 2030&lt;/span&gt;. A total of 2,900,000 shares of common stock have been reserved for issuance under this plan. As of December 31, 2020, 497,270 shares of common stock were available for future grant and 2,752,730 shares of common stock have been issued under the 2000 Employee Stock Purchase Plan.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020, shares of common stock reserved for future issuance consisted of the following:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock options outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,274,439&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock options available for grant&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,599,531&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee Stock Purchase Plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;497,270&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;35,371,240&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A summary of stock option activity under all stock-based compensation plans is as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&#160;of&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Price&#160;Per&#160;Share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&#160;Remaining&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual Term&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in Years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intrinsic&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in&#160;millions)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29,803,766&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.41&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000769"&gt;5.17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;71.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,702,860&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.12&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,865,835&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.11&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options forfeited&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(389,471&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.45&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options expired&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,976,881&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.20&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,274,439&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.45&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000770"&gt;4.98&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercisable at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,512,705&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.42&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000771"&gt;4.44&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested and expected to vest at&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,274,439&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.45&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000772"&gt;4.98&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The aggregate intrinsic value in the table above represents the total intrinsic value (i.e., the difference between the Company&#x2019;s closing stock price on the last trading day of 2020 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their in-the-money options on December 31, 2020. This amount changes based on the fair market value of the Company&#x2019;s common stock. The total intrinsic value of options exercised was $3.6 million, $1.7 million and $1.6 million for the years ended December 31, 2020, 2019 and 2018, respectively.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In lieu of providing cash bonuses to certain employees, in January 2019 and 2018, the Company granted its employees stock options to purchase 2.3 million and 1.9 million shares, respectively, of the Company&#x2019;s common stock, which vested immediately on the grant date. The weighted-average grant-date fair value of all options granted with exercise prices equal to fair market value was $0.43 in 2019 and $0.94 in 2018 determined by the Black-Scholes option valuation method. There were no options granted with exercise prices lower than fair market value.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expenses for non-employee stock options are recorded over the vesting period of the options, which closely approximates the non-employee&#x2019;s performance period, with the value determined by the Black-Scholes option valuation method and remeasured over the vesting term.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020, the Company had three stock-based equity compensation plans, which are described above. The employee stock-based compensation cost that has been included in the statements of operations and comprehensive loss is shown as below (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost of product revenues&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;981&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;746&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,541&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Selling, general and administrative&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,085&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,269&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,355&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,079&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,028&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,909&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Because the Company had a net operating loss carryforward as of December 31, 2020, no excess tax benefits for the tax deductions related to stock-based compensation expense were recognized in the statement of operations. Additionally, no incremental tax benefits were recognized from stock options exercised during 2020, which would have resulted in a reclassification to reduce net cash provided by operating activities with an offsetting increase in net cash provided by financing activities.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Determining Fair Value&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Valuation and Expense Recognition.&lt;span style="font-style:normal;"&gt;&#160;&#160;&#160;&#160;The Company estimates the fair value of stock options granted using the Black-Scholes option valuation model. The Company recognizes the expense on a straight-line basis. The expense for options is recognized over the requisite service periods of the awards, which is generally the vesting period.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Expected Term.&lt;span style="font-style:normal;"&gt;&#160;&#160;&#160;&#160;The expected term of options granted represents the period of time that the options are expected to be outstanding. The Company determines the expected life using historical options experience. This develops the expected life by taking the weighted average of the actual life of options exercised and cancelled and assumes that outstanding options are exercised uniformly from the current holding period through the end of the contractual life.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Expected Volatility.&lt;span style="font-style:normal;"&gt;&#160;&#160;&#160;&#160;The Company estimates the volatility of its common stock at the date of grant based on the historical volatility of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Risk-Free Rate.&lt;span style="font-style:normal;"&gt;&#160;&#160;&#160;&#160;The Company bases the risk-free rate that it uses in the Black-Scholes option valuation model on the implied yield in effect at the time of option grant on U.S. Treasury zero-coupon issues with substantially equivalent remaining terms.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;"&gt;Dividends.&lt;span style="font-style:normal;"&gt;&#160;&#160;&#160;&#160;The Company has never paid any cash dividends on its common stock and the Company does not anticipate paying any cash dividends in the foreseeable future. Consequently, the Company uses an expected dividend yield of zero in the Black-Scholes option valuation model.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company used the following assumptions to estimate the fair value of options granted (including fully vested options issued in January 2019 and 2018) and shares purchased under its stock plans and employee stock purchase plan for the years ended December 31, 2020, 2019 and 2018:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock Options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000803"&gt;0.5-1.4%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000804"&gt;1.5-2.7%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000805"&gt;2.7-3.1%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected dividend yield&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected term (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000806"&gt;7.0-7.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000807"&gt;7.5-10.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000808"&gt;7.0-10.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000812"&gt;84-87%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000813"&gt;79-83%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000814"&gt;78-86%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeiture rate (1)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:3.85%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;color:#000000;"&gt;Effective January 1, 2017, the Company elected to account for forfeitures as they occur.&lt;/span&gt; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:7.69%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee Stock Purchase Plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.1%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000824"&gt;1.6-2.5%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000825"&gt;1.3-2.5%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected dividend yield&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected term (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000826"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000827"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000828"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000829"&gt;78-124%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000830"&gt;60-103%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000831"&gt;60-146%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;There were 102,006, 111,909 and 119,097 shares purchased under the Company&#x2019;s employee stock purchase plan during the years ended December 31, 2020, 2019 and 2018, respectively. Included in the statement of operations and comprehensive loss for the year ended December 31, 2020, 2019 and 2018 was $86,000, $27,000 and $24,000, respectively, in stock-based compensation expense related to the recognition of expenses related to shares purchased under the Company&#x2019;s employee stock purchase plan.&lt;/p&gt;

&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020, $3.4 million of total unrecognized compensation costs related to nonvested stock options is expected to be recognized over the respective vesting terms of each award through 2024. The weighted average term of the unrecognized stock-based compensation expense is 2.6 years.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes information about stock options outstanding at December 31, 2020:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.52%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options Outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options Exercisable&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Range of&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number of&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remaining&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual&#160;Life&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(In years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number of&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercisable&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000843"&gt;$0.51 - $0.57&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;143,750&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000876"&gt;8.12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.57&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;50,418&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.56&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000844"&gt;$0.58 - $0.58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,878,012&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000877"&gt;7.79&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.58&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,165,967&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.58&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000845"&gt;$0.58 - $0.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,561,267&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000878"&gt;3.65&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.82&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,549,297&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.82&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000846"&gt;$0.93 - $1.20&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,761,642&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000879"&gt;4.92&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.15&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,706,954&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.15&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000847"&gt;$1.21 - $1.21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,608,933&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000880"&gt;2.13&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,606,683&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000848"&gt;$1.24 - $1.24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,869,328&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000881"&gt;6.84&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.24&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,457,142&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.24&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000849"&gt;$1.26 - $1.26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000882"&gt;5.28&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.26&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.26&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000850"&gt;$1.31 - $1.31&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,755,496&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000883"&gt;5.62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.31&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,527,036&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.31&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000851"&gt;$1.33 - $2.09&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,068,694&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000884"&gt;4.35&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.81&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,610,445&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.81&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.72%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000852"&gt;$2.10 - $3.61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,587,317&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000885"&gt;4.95&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.66&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,798,763&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.95&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.72%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000853"&gt;$0.51 - $3.61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,274,439&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000886"&gt;4.98&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.45&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,512,705&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.42&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company received $3.2 million, $1.9 million and $1.6 million in cash from option exercises under all stock-based compensation plans for the years ended December 31, 2020, 2019 and 2018, respectively.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <drrx:CommonStockCapitalAmountReservedForFutureIssuance
      contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_20151130"
      decimals="INF"
      id="F_000693"
      unitRef="U_iso4217USD">125000000.0</drrx:CommonStockCapitalAmountReservedForFutureIssuance>
    <drrx:CommonStockCapitalAmountReservedForFutureIssuance
      contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_drrxControlledEquityOfferingProgramMember_20151130"
      decimals="INF"
      id="F_000695"
      unitRef="U_iso4217USD">40000000</drrx:CommonStockCapitalAmountReservedForFutureIssuance>
    <drrx:CommonStockCapitalAmountReservedForFutureIssuance
      contextRef="C_0001082038_srtRangeAxis_srtMaximumMember_20181031"
      decimals="INF"
      id="F_000694"
      unitRef="U_iso4217USD">175000000.0</drrx:CommonStockCapitalAmountReservedForFutureIssuance>
    <drrx:CommonStockCapitalAmountReservedForFutureIssuance
      contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_srtRangeAxis_srtMaximumMember_us-gaapTypeOfArrangementAxis_drrxControlledEquityOfferingProgramMember_20181031"
      decimals="INF"
      id="F_000696"
      unitRef="U_iso4217USD">75000000.0</drrx:CommonStockCapitalAmountReservedForFutureIssuance>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapTypeOfArrangementAxis_drrxControlledEquityOfferingProgramMember_20180101_20181231"
      decimals="-5"
      id="F_000697"
      unitRef="U_iso4217USD">16800000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapTypeOfArrangementAxis_drrxControlledEquityOfferingProgramMember_20180101_20181231"
      decimals="-5"
      id="F_000700"
      unitRef="U_xbrlishares">9600000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <drrx:CommonStockWeightedAveragePrice
      contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapTypeOfArrangementAxis_drrxControlledEquityOfferingProgramMember_20180101_20181231"
      decimals="2"
      id="F_000703"
      unitRef="U_iso4217USD_xbrlishares">1.80</drrx:CommonStockWeightedAveragePrice>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20190101_20191231"
      decimals="-5"
      id="F_000698"
      unitRef="U_iso4217USD">3500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20190101_20191231"
      decimals="0"
      id="F_000701"
      unitRef="U_xbrlishares">2349820</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <drrx:CommonStockWeightedAveragePrice
      contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20190101_20191231"
      decimals="2"
      id="F_000704"
      unitRef="U_iso4217USD_xbrlishares">1.55</drrx:CommonStockWeightedAveragePrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_0001082038_20190620_20190620"
      decimals="INF"
      id="F_000706"
      unitRef="U_xbrlishares">29000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_0001082038_20190620"
      decimals="2"
      id="F_000707"
      unitRef="U_iso4217USD_xbrlishares">0.52</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="C_0001082038_20190620_20190620"
      decimals="-5"
      id="F_000708"
      unitRef="U_iso4217USD">15100000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20200101_20201231"
      decimals="-5"
      id="F_000699"
      unitRef="U_iso4217USD">12300000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20200101_20201231"
      decimals="0"
      id="F_000702"
      unitRef="U_xbrlishares">5308002</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <drrx:CommonStockWeightedAveragePrice
      contextRef="C_0001082038_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20200101_20201231"
      decimals="2"
      id="F_000705"
      unitRef="U_iso4217USD_xbrlishares">2.39</drrx:CommonStockWeightedAveragePrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210201_20210228"
      decimals="INF"
      id="F_000709"
      unitRef="U_xbrlishares">20364582</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228"
      decimals="4"
      id="F_000710"
      unitRef="U_iso4217USD_xbrlishares">2.2386</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210201_20210228"
      decimals="-5"
      id="F_000711"
      unitRef="U_iso4217USD">45600000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210201_20210228"
      decimals="-3"
      id="F_000712"
      unitRef="U_iso4217USD">195000000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210201_20210228"
      decimals="-5"
      id="F_000713"
      unitRef="U_iso4217USD">45400000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001082038_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20210321_20210321"
      decimals="-5"
      id="F_000714"
      unitRef="U_iso4217USD">2400000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001082038_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20210321_20210321"
      decimals="INF"
      id="F_000715"
      unitRef="U_xbrlishares">950009</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <drrx:CommonStockWeightedAveragePrice
      contextRef="C_0001082038_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20210321_20210321"
      decimals="2"
      id="F_000716"
      unitRef="U_iso4217USD_xbrlishares">2.60</drrx:CommonStockWeightedAveragePrice>
    <drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20200101_20201231"
      id="F_000717">P10Y</drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20110601_20110630"
      decimals="INF"
      id="F_000719"
      unitRef="U_xbrlishares">5500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20140601_20140630"
      decimals="INF"
      id="F_000720"
      unitRef="U_xbrlishares">4000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20160601_20160630"
      decimals="INF"
      id="F_000721"
      unitRef="U_xbrlishares">5000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20180601_20180630"
      decimals="INF"
      id="F_000722"
      unitRef="U_xbrlishares">7500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20201231"
      decimals="INF"
      id="F_000724"
      unitRef="U_xbrlishares">49955639</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0001082038_srtTitleOfIndividualAxis_drrxNonEmployeeDirectorMember_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20000101_20000331"
      decimals="INF"
      id="F_000726"
      unitRef="U_xbrlishares">30000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20130401_20130430"
      decimals="INF"
      id="F_000727"
      unitRef="U_xbrlishares">70000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <drrx:ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors
      contextRef="C_0001082038_srtRangeAxis_srtMinimumMember_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20130401_20130430"
      id="F_000729">P1Y</drrx:ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20200101_20201231"
      id="F_000731">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <drrx:MinimumPercentageOfCombinedVotingPowerClassesOfStock
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20200101_20201231"
      decimals="INF"
      id="F_000732"
      unitRef="U_xbrlipure">0.10</drrx:MinimumPercentageOfCombinedVotingPowerClassesOfStock>
    <drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20200101_20201231"
      decimals="INF"
      id="F_000733"
      unitRef="U_xbrlipure">1.10</drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower>
    <drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20200101_20201231"
      decimals="INF"
      id="F_000734"
      unitRef="U_xbrlipure">1</drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20201231"
      decimals="INF"
      id="F_000735"
      unitRef="U_xbrlishares">7599531</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20201231"
      decimals="INF"
      id="F_000736"
      unitRef="U_xbrlishares">27274439</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <drrx:EmployeeStockPurchasePlanOfferingPeriod
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231"
      id="F_000737">P24M</drrx:EmployeeStockPurchasePlanOfferingPeriod>
    <drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231"
      decimals="INF"
      id="F_000738"
      unitRef="U_xbrlipure">0.85</drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20100401_20100430"
      decimals="INF"
      id="F_000739"
      unitRef="U_xbrlishares">250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20150301_20150331"
      decimals="INF"
      id="F_000741"
      unitRef="U_xbrlishares">350000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20170601_20170630"
      decimals="INF"
      id="F_000742"
      unitRef="U_xbrlishares">350000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200601_20200630"
      decimals="INF"
      id="F_000743"
      unitRef="U_xbrlishares">350000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20201231"
      decimals="INF"
      id="F_000746"
      unitRef="U_xbrlishares">2900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20201231"
      decimals="INF"
      id="F_000747"
      unitRef="U_xbrlishares">497270</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20201231"
      decimals="INF"
      id="F_000748"
      unitRef="U_xbrlishares">2752730</us-gaap:CommonStockSharesIssued>
    <us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000390">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020, shares of common stock reserved for future issuance consisted of the following:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December&#160;31,&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock options outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,274,439&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock options available for grant&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;7,599,531&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee Stock Purchase Plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;497,270&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;35,371,240&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0001082038_20201231"
      decimals="INF"
      id="F_000749"
      unitRef="U_xbrlishares">27274439</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0001082038_20201231"
      decimals="INF"
      id="F_000750"
      unitRef="U_xbrlishares">7599531</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20201231"
      decimals="INF"
      id="F_000751"
      unitRef="U_xbrlishares">497270</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0001082038_20201231"
      decimals="INF"
      id="F_000752"
      unitRef="U_xbrlishares">35371240</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000391">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A summary of stock option activity under all stock-based compensation plans is as follows:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number&#160;of&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Price&#160;Per&#160;Share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&#160;Remaining&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual Term&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in Years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Aggregate&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Intrinsic&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Value&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in&#160;millions)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;29,803,766&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.41&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000769"&gt;5.17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;71.3&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options granted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,702,860&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.12&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options exercised&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,865,835&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.11&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options forfeited&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(389,471&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.45&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options expired&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,976,881&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.20&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,274,439&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.45&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000770"&gt;4.98&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercisable at December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,512,705&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.42&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000771"&gt;4.44&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17.7&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Vested and expected to vest at&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&#160; December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,274,439&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.45&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000772"&gt;4.98&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19.6&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0001082038_20191231"
      decimals="INF"
      id="F_000753"
      unitRef="U_xbrlishares">29803766</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0001082038_20191231"
      decimals="2"
      id="F_000761"
      unitRef="U_iso4217USD_xbrlishares">1.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0001082038_20191231"
      decimals="-2"
      id="F_000773"
      unitRef="U_iso4217USD">71300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0001082038_20200101_20201231"
      decimals="INF"
      id="F_000754"
      unitRef="U_xbrlishares">2702860</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_0001082038_20200101_20201231"
      decimals="2"
      id="F_000762"
      unitRef="U_iso4217USD_xbrlishares">2.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0001082038_20200101_20201231"
      decimals="INF"
      id="F_000755"
      unitRef="U_xbrlishares">2865835</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_0001082038_20200101_20201231"
      decimals="2"
      id="F_000763"
      unitRef="U_iso4217USD_xbrlishares">1.11</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_0001082038_20200101_20201231"
      decimals="INF"
      id="F_000756"
      unitRef="U_xbrlishares">389471</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_0001082038_20200101_20201231"
      decimals="2"
      id="F_000764"
      unitRef="U_iso4217USD_xbrlishares">1.45</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="C_0001082038_20200101_20201231"
      decimals="INF"
      id="F_000757"
      unitRef="U_xbrlishares">1976881</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="C_0001082038_20200101_20201231"
      decimals="2"
      id="F_000765"
      unitRef="U_iso4217USD_xbrlishares">2.20</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_0001082038_20201231"
      decimals="INF"
      id="F_000758"
      unitRef="U_xbrlishares">27274439</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_0001082038_20201231"
      decimals="2"
      id="F_000766"
      unitRef="U_iso4217USD_xbrlishares">1.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_0001082038_20201231"
      decimals="-2"
      id="F_000774"
      unitRef="U_iso4217USD">19600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_0001082038_20201231"
      decimals="INF"
      id="F_000759"
      unitRef="U_xbrlishares">23512705</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_0001082038_20201231"
      decimals="2"
      id="F_000767"
      unitRef="U_iso4217USD_xbrlishares">1.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_0001082038_20201231"
      decimals="-2"
      id="F_000775"
      unitRef="U_iso4217USD">17700</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_0001082038_20201231"
      decimals="INF"
      id="F_000760"
      unitRef="U_xbrlishares">27274439</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="C_0001082038_20201231"
      decimals="2"
      id="F_000768"
      unitRef="U_iso4217USD_xbrlishares">1.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_0001082038_20201231"
      decimals="-2"
      id="F_000776"
      unitRef="U_iso4217USD">19600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231"
      decimals="-5"
      id="F_000777"
      unitRef="U_iso4217USD">3600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20190101_20191231"
      decimals="-5"
      id="F_000778"
      unitRef="U_iso4217USD">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20180101_20181231"
      decimals="-5"
      id="F_000779"
      unitRef="U_iso4217USD">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20191231"
      decimals="-5"
      id="F_000780"
      unitRef="U_xbrlishares">2300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20181231"
      decimals="-5"
      id="F_000781"
      unitRef="U_xbrlishares">1900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20190101_20191231"
      decimals="2"
      id="F_000782"
      unitRef="U_iso4217USD_xbrlishares">0.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20180101_20181231"
      decimals="2"
      id="F_000783"
      unitRef="U_iso4217USD_xbrlishares">0.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <drrx:OptionsGrantedWithExercisePricesLowerThanFairMarket
      contextRef="C_0001082038_20200101_20201231"
      decimals="INF"
      id="F_000784"
      unitRef="U_iso4217USD">0</drrx:OptionsGrantedWithExercisePricesLowerThanFairMarket>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000392">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020, the Company had three stock-based equity compensation plans, which are described above. The employee stock-based compensation cost that has been included in the statements of operations and comprehensive loss is shown as below (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost of product revenues&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;981&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;746&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,541&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Selling, general and administrative&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,085&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,269&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,355&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,079&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,028&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,909&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20200101_20201231"
      decimals="-3"
      id="F_000785"
      unitRef="U_iso4217USD">13000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20190101_20191231"
      decimals="-3"
      id="F_000786"
      unitRef="U_iso4217USD">13000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20180101_20181231"
      decimals="-3"
      id="F_000787"
      unitRef="U_iso4217USD">13000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20200101_20201231"
      decimals="-3"
      id="F_000788"
      unitRef="U_iso4217USD">981000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20190101_20191231"
      decimals="-3"
      id="F_000789"
      unitRef="U_iso4217USD">746000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapResearchAndDevelopmentExpenseMember_20180101_20181231"
      decimals="-3"
      id="F_000790"
      unitRef="U_iso4217USD">1541000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20200101_20201231"
      decimals="-3"
      id="F_000791"
      unitRef="U_iso4217USD">1085000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20190101_20191231"
      decimals="-3"
      id="F_000792"
      unitRef="U_iso4217USD">1269000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapSellingGeneralAndAdministrativeExpensesMember_20180101_20181231"
      decimals="-3"
      id="F_000793"
      unitRef="U_iso4217USD">1355000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000794"
      unitRef="U_iso4217USD">2079000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000795"
      unitRef="U_iso4217USD">2028000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000796"
      unitRef="U_iso4217USD">2909000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="C_0001082038_20200101_20201231"
      decimals="INF"
      id="F_000797"
      unitRef="U_iso4217USD">0</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:DeferredTaxExpenseFromStockOptionsExercised
      contextRef="C_0001082038_20200101_20201231"
      decimals="INF"
      id="F_000798"
      unitRef="U_iso4217USD">0</us-gaap:DeferredTaxExpenseFromStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231"
      decimals="0"
      id="F_000799"
      unitRef="U_iso4217USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000393">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company used the following assumptions to estimate the fair value of options granted (including fully vested options issued in January 2019 and 2018) and shares purchased under its stock plans and employee stock purchase plan for the years ended December 31, 2020, 2019 and 2018:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock Options&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000803"&gt;0.5-1.4%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000804"&gt;1.5-2.7%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000805"&gt;2.7-3.1%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected dividend yield&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected term (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000806"&gt;7.0-7.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000807"&gt;7.5-10.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000808"&gt;7.0-10.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000812"&gt;84-87%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000813"&gt;79-83%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000814"&gt;78-86%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Forfeiture rate (1)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.0&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;%&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:3.85%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;&lt;span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"&gt;&lt;span style="Background-color:#auto;text-decoration:none;"/&gt;&lt;span style="color:#000000;"/&gt;&lt;span style="font-family:Times New Roman;color:#000000;"&gt;Effective January 1, 2017, the Company elected to account for forfeitures as they occur.&lt;/span&gt; &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:0pt;margin-bottom:0pt;margin-left:7.69%;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Employee Stock Purchase Plan&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Risk-free rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.1%&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000824"&gt;1.6-2.5%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000825"&gt;1.3-2.5%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected dividend yield&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expected term (in years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000826"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000827"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000828"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Volatility&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000829"&gt;78-124%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000830"&gt;60-103%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000831"&gt;60-146%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate
      contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231"
      decimals="INF"
      id="F_000818"
      unitRef="U_xbrlipure">0.000</drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate>
    <drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate
      contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20190101_20191231"
      decimals="INF"
      id="F_000819"
      unitRef="U_xbrlipure">0.000</drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate>
    <drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate
      contextRef="C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20180101_20181231"
      decimals="INF"
      id="F_000820"
      unitRef="U_xbrlipure">0.000</drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231"
      decimals="INF"
      id="F_000835"
      unitRef="U_xbrlishares">102006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20190101_20191231"
      decimals="INF"
      id="F_000836"
      unitRef="U_xbrlishares">111909</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20180101_20181231"
      decimals="INF"
      id="F_000837"
      unitRef="U_xbrlishares">119097</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:AdjustmentForAmortization
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231"
      decimals="INF"
      id="F_000838"
      unitRef="U_iso4217USD">86000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20190101_20191231"
      decimals="INF"
      id="F_000839"
      unitRef="U_iso4217USD">27000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20180101_20181231"
      decimals="INF"
      id="F_000840"
      unitRef="U_iso4217USD">24000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20201231"
      decimals="-5"
      id="F_000841"
      unitRef="U_iso4217USD">3400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231"
      id="F_000842">P2Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000394">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table summarizes information about stock options outstanding at December 31, 2020:&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.52%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options Outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options Exercisable&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Range of&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number of&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Outstanding&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Remaining&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Contractual&#160;Life&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;(In years)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Number of&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Options&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercisable&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Average&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Exercise&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Price&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%; border-top:solid 0.75pt #000000;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000843"&gt;$0.51 - $0.57&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;143,750&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000876"&gt;8.12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.57&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;50,418&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.56&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000844"&gt;$0.58 - $0.58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,878,012&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000877"&gt;7.79&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.58&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,165,967&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.58&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000845"&gt;$0.58 - $0.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,561,267&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000878"&gt;3.65&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.82&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,549,297&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.82&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000846"&gt;$0.93 - $1.20&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,761,642&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000879"&gt;4.92&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.15&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,706,954&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.15&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000847"&gt;$1.21 - $1.21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,608,933&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000880"&gt;2.13&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,606,683&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000848"&gt;$1.24 - $1.24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,869,328&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000881"&gt;6.84&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.24&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,457,142&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.24&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000849"&gt;$1.26 - $1.26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000882"&gt;5.28&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.26&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40,000&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.26&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000850"&gt;$1.31 - $1.31&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,755,496&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000883"&gt;5.62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.31&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,527,036&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.31&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000851"&gt;$1.33 - $2.09&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,068,694&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000884"&gt;4.35&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.81&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,610,445&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.81&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.72%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000852"&gt;$2.10 - $3.61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,587,317&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000885"&gt;4.95&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.66&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,798,763&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2.95&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.72%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000853"&gt;$0.51 - $3.61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;27,274,439&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="-sec-ix-hidden:F_000886"&gt;4.98&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.45&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;23,512,705&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1.42&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20201231"
      decimals="INF"
      id="F_000865"
      unitRef="U_xbrlishares">143750</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20201231"
      decimals="INF"
      id="F_000887"
      unitRef="U_iso4217USD_xbrlishares">0.57</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20201231"
      decimals="INF"
      id="F_000898"
      unitRef="U_xbrlishares">50418</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20201231"
      decimals="2"
      id="F_000909"
      unitRef="U_iso4217USD_xbrlishares">0.56</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTwoMember_20201231"
      decimals="INF"
      id="F_000866"
      unitRef="U_xbrlishares">2878012</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTwoMember_20201231"
      decimals="INF"
      id="F_000888"
      unitRef="U_iso4217USD_xbrlishares">0.58</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTwoMember_20201231"
      decimals="INF"
      id="F_000899"
      unitRef="U_xbrlishares">2165967</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTwoMember_20201231"
      decimals="2"
      id="F_000910"
      unitRef="U_iso4217USD_xbrlishares">0.58</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeThreeMember_20201231"
      decimals="INF"
      id="F_000867"
      unitRef="U_xbrlishares">3561267</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeThreeMember_20201231"
      decimals="INF"
      id="F_000889"
      unitRef="U_iso4217USD_xbrlishares">0.82</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeThreeMember_20201231"
      decimals="INF"
      id="F_000900"
      unitRef="U_xbrlishares">3549297</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeThreeMember_20201231"
      decimals="2"
      id="F_000911"
      unitRef="U_iso4217USD_xbrlishares">0.82</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFourMember_20201231"
      decimals="INF"
      id="F_000868"
      unitRef="U_xbrlishares">2761642</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFourMember_20201231"
      decimals="INF"
      id="F_000890"
      unitRef="U_iso4217USD_xbrlishares">1.15</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFourMember_20201231"
      decimals="INF"
      id="F_000901"
      unitRef="U_xbrlishares">2706954</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFourMember_20201231"
      decimals="2"
      id="F_000912"
      unitRef="U_iso4217USD_xbrlishares">1.15</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFiveMember_20201231"
      decimals="INF"
      id="F_000869"
      unitRef="U_xbrlishares">2608933</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFiveMember_20201231"
      decimals="INF"
      id="F_000891"
      unitRef="U_iso4217USD_xbrlishares">1.21</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFiveMember_20201231"
      decimals="INF"
      id="F_000902"
      unitRef="U_xbrlishares">2606683</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeFiveMember_20201231"
      decimals="2"
      id="F_000913"
      unitRef="U_iso4217USD_xbrlishares">1.21</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSixMember_20201231"
      decimals="INF"
      id="F_000870"
      unitRef="U_xbrlishares">2869328</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSixMember_20201231"
      decimals="INF"
      id="F_000892"
      unitRef="U_iso4217USD_xbrlishares">1.24</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSixMember_20201231"
      decimals="INF"
      id="F_000903"
      unitRef="U_xbrlishares">2457142</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSixMember_20201231"
      decimals="2"
      id="F_000914"
      unitRef="U_iso4217USD_xbrlishares">1.24</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSevenMember_20201231"
      decimals="INF"
      id="F_000871"
      unitRef="U_xbrlishares">40000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSevenMember_20201231"
      decimals="INF"
      id="F_000893"
      unitRef="U_iso4217USD_xbrlishares">1.26</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSevenMember_20201231"
      decimals="INF"
      id="F_000904"
      unitRef="U_xbrlishares">40000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeSevenMember_20201231"
      decimals="2"
      id="F_000915"
      unitRef="U_iso4217USD_xbrlishares">1.26</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeEightMember_20201231"
      decimals="INF"
      id="F_000872"
      unitRef="U_xbrlishares">2755496</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeEightMember_20201231"
      decimals="INF"
      id="F_000894"
      unitRef="U_iso4217USD_xbrlishares">1.31</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeEightMember_20201231"
      decimals="INF"
      id="F_000905"
      unitRef="U_xbrlishares">2527036</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeEightMember_20201231"
      decimals="2"
      id="F_000916"
      unitRef="U_iso4217USD_xbrlishares">1.31</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeNineMember_20201231"
      decimals="INF"
      id="F_000873"
      unitRef="U_xbrlishares">5068694</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeNineMember_20201231"
      decimals="INF"
      id="F_000895"
      unitRef="U_iso4217USD_xbrlishares">1.81</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeNineMember_20201231"
      decimals="INF"
      id="F_000906"
      unitRef="U_xbrlishares">4610445</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeNineMember_20201231"
      decimals="2"
      id="F_000917"
      unitRef="U_iso4217USD_xbrlishares">1.81</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTenMember_20201231"
      decimals="INF"
      id="F_000874"
      unitRef="U_xbrlishares">4587317</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTenMember_20201231"
      decimals="INF"
      id="F_000896"
      unitRef="U_iso4217USD_xbrlishares">2.66</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTenMember_20201231"
      decimals="INF"
      id="F_000907"
      unitRef="U_xbrlishares">2798763</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeTenMember_20201231"
      decimals="2"
      id="F_000918"
      unitRef="U_iso4217USD_xbrlishares">2.95</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeElevenMember_20201231"
      decimals="INF"
      id="F_000875"
      unitRef="U_xbrlishares">27274439</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeElevenMember_20201231"
      decimals="INF"
      id="F_000897"
      unitRef="U_iso4217USD_xbrlishares">1.45</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeElevenMember_20201231"
      decimals="INF"
      id="F_000908"
      unitRef="U_xbrlishares">23512705</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
      contextRef="C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeElevenMember_20201231"
      decimals="2"
      id="F_000919"
      unitRef="U_iso4217USD_xbrlishares">1.42</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231"
      decimals="-5"
      id="F_000920"
      unitRef="U_iso4217USD">3200000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20190101_20191231"
      decimals="-5"
      id="F_000921"
      unitRef="U_iso4217USD">1900000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20180101_20181231"
      decimals="-5"
      id="F_000922"
      unitRef="U_iso4217USD">1600000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000354">
&lt;div style="align:left;"&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"&gt;
&lt;tr&gt;
&lt;td style="width:5.24%;white-space:nowrap" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;9.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;"&gt;Income Taxes&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company accounts for income taxes using the liability method under ASC 740, &lt;span style="font-style:italic;"&gt;Income Taxes&lt;/span&gt;. Under this method, deferred tax assets and liabilities are determined based on temporary differences resulting from the different treatment of items for tax and financial reporting purposes. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to reverse. Additionally, the Company must assess the likelihood that deferred tax assets will be recovered as deductions from future taxable income. The Company has provided a full valuation allowance on the Company&#x2019;s deferred tax assets because the Company believes it is more likely than not that its deferred tax assets will not be realized. The Company evaluates the realizability of its deferred tax assets on a quarterly basis. The Company recorded a deferred tax liability of $244,000 on its balance sheet at both December 31, 2020 and 2019 that arose from tax amortization of an indefinite-lived intangible asset. The Company also recorded a deferred tax expense of zero in the years ended December 31, 2020, 2019 and 2018, respectively. The Company recorded no tax expense in each of 2020, 2019 and 2018. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The reconciliation of income tax expenses (benefit) at the statutory federal income tax rate of&#160;21%, to net income tax benefit included in the statements of operations and comprehensive loss for the years ended December 31, 2020, 2019 and 2018 is as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. federal taxes benefit at statutory rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(122&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4,321&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5,318&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,142&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,143&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-based compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;268&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;879&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;999&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development tax credits&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,132&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,004&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(999&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax Reform change in tax rate and other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expiring net operating losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,991&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,252&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;52&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;175&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total income tax (benefit) provision&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In 2020, 2019 and 2018, total income tax provision (benefit) expense was zero. Deferred tax assets and liabilities reflect the net tax effects of net operating loss and research and other credit carryforwards and the temporary differences between the carrying amounts of assets and liabilities for financial reporting and the amounts used for income tax purposes. Significant components of the Company&#x2019;s deferred tax assets and liabilities are as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax assets:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net operating loss carryforwards&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;87,197&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;90,102&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and other credits&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,153&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,860&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;223&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;248&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-based compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,840&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,376&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,204&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,288&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;115,617&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;118,874&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Valuation allowance for deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(114,323&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(117,245&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax liabilities - Right of use asset&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,538&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,873&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net deferred tax assets and liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(244&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(244&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company recognizes deferred tax assets to the extent that the Company believes that these assets are more likely than not to be realized. In making such a determination, all available positive and negative evidence is considered, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If it is determined that the Company would be able to realize deferred tax assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes. The recognition and measurement of tax benefits requires significant judgment. Judgments concerning the recognition and measurement of tax benefit might change as new information becomes available. Given the Company&#x2019;s history of operating losses, the net deferred tax assets have been fully offset by a valuation allowance. The valuation allowance decreased by $2.9 million during 2020 and increased by $4.6 million and $6.3 million during 2019 and 2018, respectively. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020, the Company had net operating loss carryforwards for federal income tax purposes of approximately $344.7 million, of which approximately $306.3 million will expire in the years 2021 through 2037, and approximately $38.5 million which do not expire, and federal research and &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;development tax credits of approximately $&lt;/span&gt;15.6&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; million, which expire at various dates beginning in &lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;202&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt; through 20&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;40&lt;/span&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;, if not utilized.&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As of December 31, 2020, the Company had net operating loss carryforwards for state income tax purposes of approximately $219.1 million, which expire in the years 2021 through 2040, if not utilized, and state research and development tax credits of approximately $16.7 million, which do not expire.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Utilization of the net operating losses may be subject to a substantial annual limitation due to federal and state ownership change limitations. The annual limitation may result in the expiration of net operating losses before utilization.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;At December 31, 2020 and December&#160;31, 2019, the Company had unrecognized tax benefits of approximately $10.9 million and $9.1 million, respectively (none of which, if recognized, would affect the Company&#x2019;s effective tax rate). The Company does not believe there will be any material changes in its unrecognized tax positions over the next twelve months.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at beginning of the year&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,078&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,432&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increase (decrease) related to prior year tax positions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,136&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(73&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increase related to current year tax positions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;674&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;719&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at end of the year&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,888&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,078&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Interest and penalty costs related to unrecognized tax benefits, if any, are classified as a component of interest and other income, net in the Statements of Operations and Comprehensive Loss. The Company did not recognize any interest and penalties expenses related to unrecognized tax benefits for the years ended December 31, 2020, 2019 and 2018.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. The Company is subject to U.S. federal and state income tax examination for calendar tax years ending 1999 through 2019 due to unutilized net operating losses and research credits. &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In response to the COVID-19 pandemic, the Coronavirus Aid, Relief and Economic Securities Act (CARES Act) was signed into law in the U.S. in March 2020. The CARES Act adjusted a number of provisions in the tax code, including the calculation and eligibility of certain deductions and the treatment of net operating losses and tax credits. The enactment of the CARES Act did not result in any material adjustments to the Company&#x2019;s income tax provision for the year ended December 31, 2020, or to its net deferred tax assets as of December 31, 2020.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The recently enacted Consolidated Appropriations Act, 2021 has expanded, extended, and clarified selected CARES Act provisions, specifically on Paycheck Protection Program (PPP) loan and Employee Retention Tax Credit, 100% deductibility of business meals as well as other tax extenders. The Consolidated Appropriations Act is not expected to have a material impact on the Company&#x2019;s tax provision.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;California Assembly Bill 85 (AB 85) was signed into law in June 2020. The legislation suspends the use of California Net Operating Loss deductions for 2020, 2021, and 2022 for certain taxpayers and imposes a limitation on the use of certain California Tax Credits for 2020, 2021, and 2022. The carryover periods for Net Operating Loss deductions disallowed by this provision will be extended. Given the Company&#x2019;s loss position in the current year, the new legislation will not impact the current year &lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;provision. The Company will continue to monitor possible California net operating loss and credit limitation in future periods.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:DeferredTaxLiabilities
      contextRef="C_0001082038_20201231"
      decimals="0"
      id="F_000923"
      unitRef="U_iso4217USD">244000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="C_0001082038_20191231"
      decimals="0"
      id="F_000924"
      unitRef="U_iso4217USD">244000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_0001082038_20201231"
      decimals="0"
      id="F_000925"
      unitRef="U_iso4217USD">244000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_0001082038_20191231"
      decimals="0"
      id="F_000926"
      unitRef="U_iso4217USD">244000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_0001082038_20200101_20201231"
      decimals="0"
      id="F_000927"
      unitRef="U_iso4217USD">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_0001082038_20190101_20191231"
      decimals="0"
      id="F_000928"
      unitRef="U_iso4217USD">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_0001082038_20180101_20181231"
      decimals="0"
      id="F_000929"
      unitRef="U_iso4217USD">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231"
      decimals="0"
      id="F_000930"
      unitRef="U_iso4217USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20190101_20191231"
      decimals="0"
      id="F_000931"
      unitRef="U_iso4217USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20180101_20181231"
      decimals="0"
      id="F_000932"
      unitRef="U_iso4217USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000395">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The reconciliation of income tax expenses (benefit) at the statutory federal income tax rate of&#160;21%, to net income tax benefit included in the statements of operations and comprehensive loss for the years ended December 31, 2020, 2019 and 2018 is as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;U.S. federal taxes benefit at statutory rate&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(122&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(4,321&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(5,318&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;State taxes&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Change in valuation allowance&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(2,022&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,142&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,143&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-based compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;268&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;879&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;999&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development tax credits&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,132&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,004&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(999&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Tax Reform change in tax rate and other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Expiring net operating losses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,991&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,252&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;17&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;52&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;175&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total income tax (benefit) provision&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_0001082038_20200101_20201231"
      decimals="2"
      id="F_000933"
      unitRef="U_xbrlipure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_0001082038_20190101_20191231"
      decimals="2"
      id="F_000934"
      unitRef="U_xbrlipure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_0001082038_20180101_20181231"
      decimals="2"
      id="F_000935"
      unitRef="U_xbrlipure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000936"
      unitRef="U_iso4217USD">-122000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000937"
      unitRef="U_iso4217USD">-4321000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000938"
      unitRef="U_iso4217USD">-5318000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000939"
      unitRef="U_iso4217USD">-2022000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000940"
      unitRef="U_iso4217USD">3142000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000941"
      unitRef="U_iso4217USD">5143000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000942"
      unitRef="U_iso4217USD">268000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000943"
      unitRef="U_iso4217USD">879000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000944"
      unitRef="U_iso4217USD">999000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000945"
      unitRef="U_iso4217USD">1132000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000946"
      unitRef="U_iso4217USD">1004000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000947"
      unitRef="U_iso4217USD">999000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <drrx:IncomeTaxReconciliationExpiringNetOperatingLosses
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000948"
      unitRef="U_iso4217USD">2991000</drrx:IncomeTaxReconciliationExpiringNetOperatingLosses>
    <drrx:IncomeTaxReconciliationExpiringNetOperatingLosses
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000949"
      unitRef="U_iso4217USD">1252000</drrx:IncomeTaxReconciliationExpiringNetOperatingLosses>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000950"
      unitRef="U_iso4217USD">17000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000951"
      unitRef="U_iso4217USD">52000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_000952"
      unitRef="U_iso4217USD">175000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapOtherNonoperatingIncomeExpenseMember_20200101_20201231"
      decimals="0"
      id="F_000953"
      unitRef="U_iso4217USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapOtherNonoperatingIncomeExpenseMember_20190101_20191231"
      decimals="0"
      id="F_000954"
      unitRef="U_iso4217USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_0001082038_us-gaapIncomeStatementLocationAxis_us-gaapOtherNonoperatingIncomeExpenseMember_20180101_20181231"
      decimals="0"
      id="F_000955"
      unitRef="U_iso4217USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000396">Significant components of the Company&#x2019;s deferred tax assets and liabilities are as follows (in thousands):
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax assets:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net operating loss carryforwards&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;87,197&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;90,102&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and other credits&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;19,153&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;18,860&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred revenue&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;223&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;248&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-based compensation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,840&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,376&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,204&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;5,288&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;115,617&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;118,874&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Valuation allowance for deferred tax assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(114,323&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(117,245&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deferred tax liabilities - Right of use asset&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,538&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(1,873&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net deferred tax assets and liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(244&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(244&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000956"
      unitRef="U_iso4217USD">87197000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000965"
      unitRef="U_iso4217USD">90102000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000957"
      unitRef="U_iso4217USD">19153000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000966"
      unitRef="U_iso4217USD">18860000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000958"
      unitRef="U_iso4217USD">223000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000967"
      unitRef="U_iso4217USD">248000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000959"
      unitRef="U_iso4217USD">3840000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000968"
      unitRef="U_iso4217USD">4376000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000960"
      unitRef="U_iso4217USD">5204000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000969"
      unitRef="U_iso4217USD">5288000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000961"
      unitRef="U_iso4217USD">115617000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000970"
      unitRef="U_iso4217USD">118874000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000962"
      unitRef="U_iso4217USD">114323000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000971"
      unitRef="U_iso4217USD">117245000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <drrx:DeferredTaxLiabilitiesRightOfUseAssets
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000963"
      unitRef="U_iso4217USD">1538000</drrx:DeferredTaxLiabilitiesRightOfUseAssets>
    <drrx:DeferredTaxLiabilitiesRightOfUseAssets
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000972"
      unitRef="U_iso4217USD">1873000</drrx:DeferredTaxLiabilitiesRightOfUseAssets>
    <us-gaap:DeferredTaxLiabilities
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000964"
      unitRef="U_iso4217USD">244000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000973"
      unitRef="U_iso4217USD">244000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_0001082038_20200101_20201231"
      decimals="-5"
      id="F_000974"
      unitRef="U_iso4217USD">-2900000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_0001082038_20190101_20191231"
      decimals="-5"
      id="F_000975"
      unitRef="U_iso4217USD">4600000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_0001082038_20180101_20181231"
      decimals="-5"
      id="F_000976"
      unitRef="U_iso4217USD">6300000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20201231"
      decimals="-5"
      id="F_000977"
      unitRef="U_iso4217USD">344700000</us-gaap:OperatingLossCarryforwards>
    <drrx:NetOperatingLossCarryforwardsExpirationAmount
      contextRef="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20201231"
      decimals="-5"
      id="F_000978"
      unitRef="U_iso4217USD">306300000</drrx:NetOperatingLossCarryforwardsExpirationAmount>
    <drrx:TaxCreditCarryforwardExpiration
      contextRef="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20200101_20201231"
      id="F_000980">2021 through 2037</drrx:TaxCreditCarryforwardExpiration>
    <drrx:NetOperatingLossCarryforwardsNonExpirationAmount
      contextRef="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_20201231"
      decimals="-5"
      id="F_000979"
      unitRef="U_iso4217USD">38500000</drrx:NetOperatingLossCarryforwardsNonExpirationAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20201231"
      decimals="-5"
      id="F_000981"
      unitRef="U_iso4217USD">15600000</us-gaap:TaxCreditCarryforwardAmount>
    <drrx:TaxCreditCarryforwardExpiration
      contextRef="C_0001082038_us-gaapIncomeTaxAuthorityNameAxis_us-gaapInternalRevenueServiceIRSMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20200101_20201231"
      id="F_000982">2021 through 2040</drrx:TaxCreditCarryforwardExpiration>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20201231"
      decimals="-5"
      id="F_000983"
      unitRef="U_iso4217USD">219100000</us-gaap:OperatingLossCarryforwards>
    <drrx:TaxCreditCarryforwardExpiration
      contextRef="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_20200101_20201231"
      id="F_000984">2021 through 2040</drrx:TaxCreditCarryforwardExpiration>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_0001082038_us-gaapIncomeTaxAuthorityAxis_us-gaapStateAndLocalJurisdictionMember_us-gaapTaxCreditCarryforwardAxis_us-gaapResearchMember_20201231"
      decimals="-5"
      id="F_000985"
      unitRef="U_iso4217USD">16700000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001082038_20201231"
      decimals="-5"
      id="F_000986"
      unitRef="U_iso4217USD">10900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001082038_20191231"
      decimals="-5"
      id="F_000987"
      unitRef="U_iso4217USD">9100000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000397">
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at beginning of the year&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,078&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;8,432&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increase (decrease) related to prior year tax positions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,136&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(73&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Increase related to current year tax positions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;674&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;719&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at end of the year&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;10,888&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;9,078&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000988"
      unitRef="U_iso4217USD">9078000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001082038_20181230"
      decimals="-3"
      id="F_000989"
      unitRef="U_iso4217USD">8432000</us-gaap:UnrecognizedTaxBenefits>
    <drrx:UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000990"
      unitRef="U_iso4217USD">1136000</drrx:UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions>
    <drrx:UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000991"
      unitRef="U_iso4217USD">-73000</drrx:UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_000992"
      unitRef="U_iso4217USD">674000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_000993"
      unitRef="U_iso4217USD">719000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001082038_20201231"
      decimals="-3"
      id="F_000994"
      unitRef="U_iso4217USD">10888000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_000995"
      unitRef="U_iso4217USD">9078000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000355">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;10.&lt;span style="margin-left:36pt;"/&gt;Discontinued Operations&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;On December 31, 2020, the Company completed the sale of its LACTEL Absorbable Polymers product line to Evonik. Under the terms of the Asset Purchase Agreement, Evonik paid DURECT approximately $15&#160;million subject to certain adjustments, and also agreed to assume certain liabilities with respect to the transferred assets.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;As a result of the sale of the LACTEL product line, the operating results from our LACTEL product line have been excluded from continuing operations and presented as discontinued operations in the accompanying Statements of Operations and Comprehensive Loss for all periods presented. During the twelve months ended December 31, 2020, we recorded a gain on sale of the LACTEL product line of $12.8 million, upon the completion of sale to Evonik. The results of operations and gain from discontinued operations presented below include certain allocations that management believes fairly reflect the utilization of services provided to the LACTEL product line. The allocations do not include amounts related to general corporate administrative expenses or interest expense. Therefore, these results of operations do not necessarily reflect what the results of operations would have been had the LACTEL product line operated as a stand-alone entity.&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:-5.24%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The components of income from discontinued operations as reported in the Company&#x2019;s statement of operations were as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:-5.24%;font-size:4pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Product revenue, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,918&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,490&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,289&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total revenues&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,918&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,490&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,289&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating expenses:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost of product revenues&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,880&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,623&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;476&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;569&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;488&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Selling, general and administrative&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;515&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;248&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;157&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total costs and expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,010&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,697&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,268&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income from discontinued operations&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;908&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;793&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other income:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gain on sale of the LACTEL product line&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,845&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net income from discontinued operations&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,753&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;793&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net income per share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.07&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.00&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.00&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average shares used in computing net income per share basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;199,457&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;178,042&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;159,834&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table presents information related to assets and liabilities reported as discontinued&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;operations in the Company&#x2019;s balance sheet (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts receivable&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;797&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inventories, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,465&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid expenses and other current assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Discontinued operations &#x2013; current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,296&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;310&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Goodwill&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other long-term assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Discontinued operations &#x2013; non-current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;532&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts payable&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;127&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;344&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease liabilities, current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;301&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Discontinued operations &#x2013; current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;772&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease liabilities, non-current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;161&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other long-term liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;96&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Discontinued operations &#x2013; non-current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;257&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table presents certain non-cash items related to discontinued operations, which are included in the Company&#x2019;s statement of cash flows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Depreciation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;198&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;241&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-based compensation expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;91&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;81&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Goodwill&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;229&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Loss on disposal of property and equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;129&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;647&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;322&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gain on sale of the LACTEL product line&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,845&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-cash items, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(12,198&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;322&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <drrx:AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid
      contextRef="C_0001082038_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_drrxEvonikCorporationMember_20201230_20201231"
      decimals="-6"
      id="F_000999"
      unitRef="U_iso4217USD">15000000</drrx:AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid>
    <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
      contextRef="C_0001082038_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_drrxEvonikCorporationMember_20200101_20201231"
      decimals="-5"
      id="F_001000"
      unitRef="U_iso4217USD">12800000</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
    <drrx:SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000398">
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:-5.24%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The components of income from discontinued operations as reported in the Company&#x2019;s statement of operations were as follows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:-5.24%;font-size:4pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.76%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Product revenue, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,918&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,490&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,289&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total revenues&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,918&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,490&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,289&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating expenses:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Cost of product revenues&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,880&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,623&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Research and development&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;476&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;569&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;488&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Selling, general and administrative&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;515&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;248&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;157&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Total costs and expenses&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;4,010&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,697&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;3,268&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Income from discontinued operations&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;908&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;793&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other income:&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gain on sale of the LACTEL product line&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,845&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net income from discontinued operations&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;13,753&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;793&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;21&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Net income per share&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.07&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.00&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;0.00&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Weighted-average shares used in computing net income per share basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Basic and diluted&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;199,457&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;178,042&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;159,834&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</drrx:SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20200101_20201231"
      decimals="-3"
      id="F_001001"
      unitRef="U_iso4217USD">4918000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20190101_20191231"
      decimals="-3"
      id="F_001002"
      unitRef="U_iso4217USD">4490000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="C_0001082038_srtProductOrServiceAxis_us-gaapProductMember_20180101_20181231"
      decimals="-3"
      id="F_001003"
      unitRef="U_iso4217USD">3289000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_001004"
      unitRef="U_iso4217USD">4918000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_001005"
      unitRef="U_iso4217USD">4490000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_001006"
      unitRef="U_iso4217USD">3289000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_001007"
      unitRef="U_iso4217USD">3019000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_001008"
      unitRef="U_iso4217USD">2880000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_001009"
      unitRef="U_iso4217USD">2623000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold>
    <drrx:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_001010"
      unitRef="U_iso4217USD">476000</drrx:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment>
    <drrx:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_001011"
      unitRef="U_iso4217USD">569000</drrx:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment>
    <drrx:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_001012"
      unitRef="U_iso4217USD">488000</drrx:DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_001013"
      unitRef="U_iso4217USD">515000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_001014"
      unitRef="U_iso4217USD">248000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_001015"
      unitRef="U_iso4217USD">157000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_001016"
      unitRef="U_iso4217USD">4010000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_001017"
      unitRef="U_iso4217USD">3697000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_001018"
      unitRef="U_iso4217USD">3268000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_001019"
      unitRef="U_iso4217USD">908000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_001020"
      unitRef="U_iso4217USD">793000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_001021"
      unitRef="U_iso4217USD">21000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
    <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_001022"
      unitRef="U_iso4217USD">12845000</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_001023"
      unitRef="U_iso4217USD">13753000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_001024"
      unitRef="U_iso4217USD">793000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_001025"
      unitRef="U_iso4217USD">21000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001082038_20200101_20201231"
      decimals="2"
      id="F_001026"
      unitRef="U_iso4217USD_xbrlishares">0.07</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001082038_20190101_20191231"
      decimals="2"
      id="F_001027"
      unitRef="U_iso4217USD_xbrlishares">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0001082038_20180101_20181231"
      decimals="2"
      id="F_001028"
      unitRef="U_iso4217USD_xbrlishares">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_001029"
      unitRef="U_xbrlishares">199457000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_001030"
      unitRef="U_xbrlishares">178042000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0001082038_20180101_20181231"
      decimals="-3"
      id="F_001031"
      unitRef="U_xbrlishares">159834000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <drrx:SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000399">
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table presents information related to assets and liabilities reported as discontinued&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;operations in the Company&#x2019;s balance sheet (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts receivable&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;797&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Inventories, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1,465&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Prepaid expenses and other current assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;34&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Discontinued operations &#x2013; current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;2,296&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Property and equipment, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;310&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&lt;span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;200&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Goodwill&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other long-term assets&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;22&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Discontinued operations &#x2013; non-current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;532&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accounts payable&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;127&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Accrued liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;344&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease liabilities, current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;301&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Discontinued operations &#x2013; current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;772&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Operating lease liabilities, non-current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;161&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Other long-term liabilities&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;96&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Discontinued operations &#x2013; non-current portion&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;257&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</drrx:SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_001032"
      unitRef="U_iso4217USD">797000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_001033"
      unitRef="U_iso4217USD">1465000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_001034"
      unitRef="U_iso4217USD">34000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_001035"
      unitRef="U_iso4217USD">2296000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_001036"
      unitRef="U_iso4217USD">310000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent>
    <drrx:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_001037"
      unitRef="U_iso4217USD">200000</drrx:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_001038"
      unitRef="U_iso4217USD">22000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_001039"
      unitRef="U_iso4217USD">532000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_001040"
      unitRef="U_iso4217USD">127000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_001041"
      unitRef="U_iso4217USD">344000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent>
    <drrx:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_001042"
      unitRef="U_iso4217USD">301000</drrx:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_001043"
      unitRef="U_iso4217USD">772000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <drrx:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_001044"
      unitRef="U_iso4217USD">161000</drrx:DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_001045"
      unitRef="U_iso4217USD">96000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
      contextRef="C_0001082038_20191231"
      decimals="-3"
      id="F_001046"
      unitRef="U_iso4217USD">257000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent>
    <drrx:SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000400">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;The following table presents certain non-cash items related to discontinued operations, which are included in the Company&#x2019;s statement of cash flows (in thousands):&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Years ended December 31,&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Depreciation&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;198&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;241&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Stock-based compensation expense&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;91&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;81&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Goodwill&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;229&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Loss on disposal of property and equipment&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;129&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;647&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;322&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Gain on sale of the LACTEL product line&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;12,845&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Non-cash items, net&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(12,198&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;322&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</drrx:SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_001047"
      unitRef="U_iso4217USD">198000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_001048"
      unitRef="U_iso4217USD">241000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization>
    <drrx:DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_001049"
      unitRef="U_iso4217USD">91000</drrx:DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense>
    <drrx:DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_001050"
      unitRef="U_iso4217USD">81000</drrx:DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense>
    <drrx:NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_001051"
      unitRef="U_iso4217USD">229000</drrx:NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill>
    <drrx:NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_001052"
      unitRef="U_iso4217USD">-129000</drrx:NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment>
    <drrx:DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_001053"
      unitRef="U_iso4217USD">647000</drrx:DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross>
    <drrx:DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_001054"
      unitRef="U_iso4217USD">322000</drrx:DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross>
    <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_001055"
      unitRef="U_iso4217USD">12845000</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
    <drrx:DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet
      contextRef="C_0001082038_20200101_20201231"
      decimals="-3"
      id="F_001056"
      unitRef="U_iso4217USD">-12198000</drrx:DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet>
    <drrx:DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet
      contextRef="C_0001082038_20190101_20191231"
      decimals="-3"
      id="F_001057"
      unitRef="U_iso4217USD">322000</drrx:DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet>
    <us-gaap:SubsequentEventsTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000356">
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;11.&lt;span style="margin-left:36pt;"&gt;Subsequent Events&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;In February 2021, the Company completed an underwritten public offering of 20,364,582 shares of its common stock at a price of $2.2386 per share pursuant to an underwriting agreement with Cantor Fitzgerald&#160;&amp;amp; Co., raising total gross proceeds to the Company of approximately $45.6 million before deducting estimated offering expenses payable by the Company. Total stock issuance costs related to this financing were approximately $195,000. After deducting estimated offering expenses payable by the Company, the net proceeds to the Company were approximately $45.4 million.&lt;/p&gt;
&lt;p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;From January 1, 2021 to March 1, 2021, the Company also raised net proceeds (net of commissions) of approximately $2.4 million from the sale of 950,009 shares of the Company&#x2019;s common stock in the open market at a weighted average price of $2.60 per share pursuant to the October 2018 registration statement.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210201_20210228"
      decimals="INF"
      id="F_001058"
      unitRef="U_xbrlishares">20364582</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228"
      decimals="INF"
      id="F_001059"
      unitRef="U_iso4217USD_xbrlishares">2.2386</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210201_20210228"
      decimals="-5"
      id="F_001060"
      unitRef="U_iso4217USD">45600000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210201_20210228"
      decimals="0"
      id="F_001061"
      unitRef="U_iso4217USD">195000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <drrx:StockIssuedDuringPeriodValueNewIssuesNet
      contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210201_20210228"
      decimals="-5"
      id="F_001062"
      unitRef="U_iso4217USD">45400000</drrx:StockIssuedDuringPeriodValueNewIssuesNet>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20210101_20210301"
      decimals="-5"
      id="F_001063"
      unitRef="U_iso4217USD">2400000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20210101_20210301"
      decimals="INF"
      id="F_001064"
      unitRef="U_xbrlishares">950009</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <drrx:CommonStockWeightedAveragePrice
      contextRef="C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_us-gaapTypeOfArrangementAxis_drrxOctoberTwoThousandEighteenRegistrationStatementMember_20210101_20210301"
      decimals="INF"
      id="F_001065"
      unitRef="U_iso4217USD_xbrlishares">2.60</drrx:CommonStockWeightedAveragePrice>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock contextRef="C_0001082038_20200101_20201231" id="F_000357">
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;SCHEDULE II&#x2014;VALUATION AND QUALIFYING ACCOUNTS&lt;/p&gt;
&lt;p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year Ended December 31, 2020, 2019 and 2018&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"&gt;(in thousands)&lt;/p&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"&gt;&#160;&lt;/p&gt;
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;beginning&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;of the year&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Additions (Reductions) to allowances&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Deductions&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;Balance at&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;end of the&lt;/p&gt;
&lt;p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;year&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Allowance for doubtful accounts&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31, 2020&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(27&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(46&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;1&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(72&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31, 2019&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(83&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;56&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(27&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;Year ended December 31, 2018&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(69&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(14&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;$&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;(83&lt;/p&gt;&lt;/td&gt;
&lt;td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"&gt;
&lt;p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"&gt;)&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20191231"
      decimals="-3"
      id="F_001066"
      unitRef="U_iso4217USD">27000</us-gaap:ValuationAllowancesAndReservesBalance>
    <drrx:ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense
      contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20200101_20201231"
      decimals="-3"
      id="F_001069"
      unitRef="U_iso4217USD">-46000</drrx:ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20200101_20201231"
      decimals="-3"
      id="F_001072"
      unitRef="U_iso4217USD">1000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20201231"
      decimals="-3"
      id="F_001073"
      unitRef="U_iso4217USD">72000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20181231"
      decimals="-3"
      id="F_001067"
      unitRef="U_iso4217USD">83000</us-gaap:ValuationAllowancesAndReservesBalance>
    <drrx:ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense
      contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20190101_20191231"
      decimals="-3"
      id="F_001070"
      unitRef="U_iso4217USD">56000</drrx:ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20191231"
      decimals="-3"
      id="F_001074"
      unitRef="U_iso4217USD">27000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20171231"
      decimals="-3"
      id="F_001068"
      unitRef="U_iso4217USD">69000</us-gaap:ValuationAllowancesAndReservesBalance>
    <drrx:ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense
      contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20180101_20181231"
      decimals="-3"
      id="F_001071"
      unitRef="U_iso4217USD">-14000</drrx:ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20181231"
      decimals="-3"
      id="F_001075"
      unitRef="U_iso4217USD">83000</us-gaap:ValuationAllowancesAndReservesBalance>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#F_000342"
          xlink:label="F_000342"
          xlink:type="locator"/>
        <link:footnote id="FNT_000001" xlink:label="FNT_000001" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts for the twelve months ended December 31, 2019 include the transition adjustment for the adoption of Accounting Standards Update ("ASU" No. 2016-02, Leases ("Topic 842").</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000342"
          xlink:to="FNT_000001"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_000474"
          xlink:label="F_000474"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000475"
          xlink:label="F_000475"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000476"
          xlink:label="F_000476"
          xlink:type="locator"/>
        <link:footnote id="FNT_000003" xlink:label="FNT_000003" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes: (a) amounts related to earn-out revenue from Indivior UK Limited (Indivior) with respect to PERSERIS net sales; (b) feasibility programs; (c) research and development activities funded by Santen Pharmaceutical Co. Ltd. (Santen); and (d) royalty revenue from OP Pharma with respect to Methydur net sales. Note that in January 2018, the Company was notified by Santen that due to a shift in priorities, Santen had elected to reallocate research and development resources and put the Company&#x2019;s program on pause until further notice. While the main program is on pause, the parties are working together on a limited set of research and development activities funded by Santen.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000474"
          xlink:to="FNT_000003"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000475"
          xlink:to="FNT_000003"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000476"
          xlink:to="FNT_000003"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_000819"
          xlink:label="F_000819"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000818"
          xlink:label="F_000818"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000820"
          xlink:label="F_000820"
          xlink:type="locator"/>
        <link:footnote id="FNT_000004" xlink:label="FNT_000004" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Effective January 1, 2017, the Company elected to account for forfeitures as they occur.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000819"
          xlink:to="FNT_000004"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000818"
          xlink:to="FNT_000004"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000820"
          xlink:to="FNT_000004"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_000471"
          xlink:label="F_000471"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000472"
          xlink:label="F_000472"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000473"
          xlink:label="F_000473"
          xlink:type="locator"/>
        <link:footnote id="FNT_000002" xlink:label="FNT_000002" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts related to recognition of upfront fees and milestone payments were $22.7 million, $12.3 million and zero for the twelve months ended December 31, 2020, 2019 and 2018, respectively. The Company signed a license agreement with Gilead on July 19, 2019 and received a nonrefundable upfront license fee and a milestone payment totaling $35.0 million in 2019 which was being recognized as revenue as its obligation was being satisfied using the cost-to-cost input method (see Note 2. Strategic Agreements - Agreement with Gilead Sciences, Inc. in the financial statements). In June 2020, the Company received notice that Gilead was terminating the License Agreement and a related R&amp;D agreement between Gilead and the Company. As a result, the Company recognized all its remaining deferred revenue as there were no remaining substantive performance obligations to be provided to Gilead by the Company as of the date when the termination notice was received.  Amounts recognized as revenue during each of the twelve months ended December 31, 2020, 2019 and 2018 also included the Company&#x2019;s reimbursable collaborative research and development services performed under its agreement with Gilead.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000471"
          xlink:to="FNT_000002"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000472"
          xlink:to="FNT_000002"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000473"
          xlink:to="FNT_000002"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_000330"
          xlink:label="F_000330"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000331"
          xlink:label="F_000331"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000332"
          xlink:label="F_000332"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_000333"
          xlink:label="F_000333"
          xlink:type="locator"/>
        <link:footnote id="FNT_000000" xlink:label="FNT_000000" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes restricted cash of $150,000 (presented as long-term restricted investments) on the balance sheets at each of December 31, 2020, 2019 and 2018.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000330"
          xlink:to="FNT_000000"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000331"
          xlink:to="FNT_000000"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000332"
          xlink:to="FNT_000000"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_000333"
          xlink:to="FNT_000000"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167750685224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 01, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DRRX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DURECT CORP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001082038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227,201,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 169,632,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-31615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3297098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10260 Bubb Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cupertino<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">95014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">777-1417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Part III incorporates information by reference from the definitive Proxy Statement for the 2020 annual meeting of stockholders, which is expected to be filed not later than 120 days after the Registrant&#8217;s fiscal year ended December 31, 2020.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167750853576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 21,312<span></span>
</td>
<td class="nump">$ 34,924<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EscrowDeposit', window );">Cash held in escrow</a></td>
<td class="nump">14,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="nump">19,421<span></span>
</td>
<td class="nump">29,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable (net of allowances of $72 at December 31, 2020 and $27 at December 31, 2019)</a></td>
<td class="nump">940<span></span>
</td>
<td class="nump">1,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">1,864<span></span>
</td>
<td class="nump">1,919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">4,545<span></span>
</td>
<td class="nump">1,424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations, current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,296<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">63,061<span></span>
</td>
<td class="nump">71,829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">251<span></span>
</td>
<td class="nump">159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">4,749<span></span>
</td>
<td class="nump">5,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">6,169<span></span>
</td>
<td class="nump">6,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedInvestmentsNoncurrent', window );">Long-term restricted investments</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">261<span></span>
</td>
<td class="nump">1,085<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent', window );">Discontinued operations, non-current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">75,641<span></span>
</td>
<td class="nump">86,020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,678<span></span>
</td>
<td class="nump">1,982<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">5,801<span></span>
</td>
<td class="nump">5,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_ContractResearchLiability', window );">Contract research liabilities</a></td>
<td class="nump">545<span></span>
</td>
<td class="nump">3,653<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue, current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Term loan, current portion, net</a></td>
<td class="nump">884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current portion</a></td>
<td class="nump">1,795<span></span>
</td>
<td class="nump">1,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations, current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">772<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">10,703<span></span>
</td>
<td class="nump">36,768<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, non-current portion</a></td>
<td class="nump">812<span></span>
</td>
<td class="nump">812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current portion</a></td>
<td class="nump">3,202<span></span>
</td>
<td class="nump">4,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Term loan, non-current portion, net</a></td>
<td class="nump">19,936<span></span>
</td>
<td class="nump">20,262<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">873<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent', window );">Discontinued operations, non-current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value: 10,000 shares authorized; none issued and outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value: 350,000 shares authorized; 203,533 and 195,257 shares issued and outstanding at December 31, 2020 and 2019, respectively</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">529,884<span></span>
</td>
<td class="nump">512,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(489,784)<span></span>
</td>
<td class="num">(489,202)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders&#8217; equity</a></td>
<td class="nump">40,115<span></span>
</td>
<td class="nump">22,860<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 75,641<span></span>
</td>
<td class="nump">$ 86,020<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_ContractResearchLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to clinical and non-clinical costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include clinical trial expenses and non-clinical study expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_ContractResearchLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2510-110228<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2510-110228<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedInvestmentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the noncurrent portion of investments which are not defined as or included in marketable (debt, equity, or other) securities that are pledged or subject to withdrawal restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedInvestmentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167833419768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement Of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowances for accounts receivable</a></td>
<td class="nump">$ 72<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">350,000,000<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">203,533,000<span></span>
</td>
<td class="nump">195,257,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">203,533,000<span></span>
</td>
<td class="nump">195,257,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167750615368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Operations and Comprehensive Loss - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 30,111,000<span></span>
</td>
<td class="nump">$ 25,074,000<span></span>
</td>
<td class="nump">$ 15,275,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of product revenues</a></td>
<td class="nump">$ 1,406,000<span></span>
</td>
<td class="nump">$ 1,263,000<span></span>
</td>
<td class="nump">$ 1,640,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList', window );">Type of cost, good or service [extensible list]</a></td>
<td class="text">us-gaap:ProductMember<span></span>
</td>
<td class="text">us-gaap:ProductMember<span></span>
</td>
<td class="text">us-gaap:ProductMember<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 27,709,000<span></span>
</td>
<td class="nump">$ 29,640,000<span></span>
</td>
<td class="nump">$ 25,013,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">13,611,000<span></span>
</td>
<td class="nump">14,115,000<span></span>
</td>
<td class="nump">12,262,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">42,726,000<span></span>
</td>
<td class="nump">45,018,000<span></span>
</td>
<td class="nump">38,915,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(12,615,000)<span></span>
</td>
<td class="num">(19,944,000)<span></span>
</td>
<td class="num">(23,640,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncome', window );">Interest and other income</a></td>
<td class="nump">517,000<span></span>
</td>
<td class="nump">1,074,000<span></span>
</td>
<td class="nump">870,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(2,237,000)<span></span>
</td>
<td class="num">(2,501,000)<span></span>
</td>
<td class="num">(2,573,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Net other income (expense)</a></td>
<td class="num">(1,720,000)<span></span>
</td>
<td class="num">(1,427,000)<span></span>
</td>
<td class="num">(1,703,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Loss from continuing operations</a></td>
<td class="num">(14,335,000)<span></span>
</td>
<td class="num">(21,371,000)<span></span>
</td>
<td class="num">(25,343,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Income from discontinued operations (Note 10)</a></td>
<td class="nump">13,753,000<span></span>
</td>
<td class="nump">793,000<span></span>
</td>
<td class="nump">21,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(582,000)<span></span>
</td>
<td class="num">(20,578,000)<span></span>
</td>
<td class="num">(25,322,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net change in unrealized gain on available-for-sale securities, net of tax</a></td>
<td class="num">(2,000)<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="num">$ (584,000)<span></span>
</td>
<td class="num">$ (20,581,000)<span></span>
</td>
<td class="num">$ (25,321,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Basic and diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Loss from continuing operations</a></td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Income from discontinued operations</a></td>
<td class="nump">0.07<span></span>
</td>
<td class="nump">0.00<span></span>
</td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare', window );">Net loss per common share, basic and diluted</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average shares used in computing net income (loss) per share, basic and diluted</a></td>
<td class="nump">199,457<span></span>
</td>
<td class="nump">178,042<span></span>
</td>
<td class="nump">159,834<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember', window );">Collaborative Research and Development and Other Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 23,941,000<span></span>
</td>
<td class="nump">$ 18,129,000<span></span>
</td>
<td class="nump">$ 8,207,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product Revenue, Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 6,170,000<span></span>
</td>
<td class="nump">6,945,000<span></span>
</td>
<td class="nump">$ 7,068,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of product revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868656-224227<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates type of cost from product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121551570&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfCostGoodOrServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167747386344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Statements of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Revision of Prior Period, Change in Accounting Principle, Adjustment</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-In Capital [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (loss) [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th">
<div>Accumulated Deficit [Member] </div>
<div>Revision of Prior Period, Change in Accounting Principle, Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2017</a></td>
<td class="nump">$ 21,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 465,246<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (443,772)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,837,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan', window );">Issuance of common stock upon exercise of stock options and purchases of ESPP shares</a></td>
<td class="nump">1,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares', window );">Issuance of common stock upon exercise of stock options and purchases of ESPP shares, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,594,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock upon equity financings, net of issuance costs</a></td>
<td class="nump">16,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">16,779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon equity financings, net of issuance cost, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,629,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities', window );">Issuance of fully vested options to settle accrued liabilities</a></td>
<td class="nump">1,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Stock-based compensation expense from stock options and ESPP shares</a></td>
<td class="nump">2,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(25,322)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,322)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Change in unrealized gain (loss) on available-for-sale securities, net of tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2018</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">$ 470<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">488,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(468,624)<span></span>
</td>
<td class="nump">$ 470<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,060,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan', window );">Issuance of common stock upon exercise of stock options and purchases of ESPP shares</a></td>
<td class="nump">1,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares', window );">Issuance of common stock upon exercise of stock options and purchases of ESPP shares, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,847,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock upon equity financings, net of issuance costs</a></td>
<td class="nump">18,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">18,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon equity financings, net of issuance cost, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities', window );">Issuance of fully vested options to settle accrued liabilities</a></td>
<td class="nump">994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Stock-based compensation expense from stock options and ESPP shares</a></td>
<td class="nump">2,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(20,578)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,578)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Change in unrealized gain (loss) on available-for-sale securities, net of tax</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="nump">22,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">512,046<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(489,202)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,257,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan', window );">Issuance of common stock upon exercise of stock options and purchases of ESPP shares</a></td>
<td class="nump">3,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">3,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares', window );">Issuance of common stock upon exercise of stock options and purchases of ESPP shares, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,968,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock upon equity financings, net of issuance costs</a></td>
<td class="nump">12,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">12,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon equity financings, net of issuance cost, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,308,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Stock-based compensation expense from stock options and ESPP shares</a></td>
<td class="nump">2,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(582)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(582)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Change in unrealized gain (loss) on available-for-sale securities, net of tax</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 40,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 529,884<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
<td class="num">$ (489,784)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203,533,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid-in capital stock issued to settle accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock upon exercise of stock options and purchases of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock upon exercise of stock options and purchases of employee stock purchase plan shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167744360184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Stockholders' Equity (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement Of Stockholders Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="nump">$ 380<span></span>
</td>
<td class="nump">$ 356<span></span>
</td>
<td class="nump">$ 566<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167750760760">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (582)<span></span>
</td>
<td class="num">$ (20,578)<span></span>
</td>
<td class="num">$ (25,322)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">297<span></span>
</td>
<td class="nump">291<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,170<span></span>
</td>
<td class="nump">2,108<span></span>
</td>
<td class="nump">2,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">194<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="nump">291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">453<span></span>
</td>
<td class="nump">369<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Net accretion/amortization on investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(313)<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_ChangesInOperatingLeaseLiabilities', window );">Changes in operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(61)<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax', window );">Gain on sale of LACTEL product line</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12,845)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">389<span></span>
</td>
<td class="num">(556)<span></span>
</td>
<td class="nump">619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(249)<span></span>
</td>
<td class="num">(217)<span></span>
</td>
<td class="num">(549)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,178)<span></span>
</td>
<td class="nump">786<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(241)<span></span>
</td>
<td class="nump">520<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">49<span></span>
</td>
<td class="nump">2,894<span></span>
</td>
<td class="nump">1,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_IncreaseDecreaseInContractResearchLiability', window );">Contract research liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,108)<span></span>
</td>
<td class="nump">2,248<span></span>
</td>
<td class="nump">571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(22,679)<span></span>
</td>
<td class="nump">22,679<span></span>
</td>
<td class="num">(493)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities', window );">Total adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(38,122)<span></span>
</td>
<td class="nump">31,679<span></span>
</td>
<td class="nump">5,572<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in) provided by operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(38,704)<span></span>
</td>
<td class="nump">11,101<span></span>
</td>
<td class="num">(19,750)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(208)<span></span>
</td>
<td class="num">(155)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of available-for-sale securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(45,066)<span></span>
</td>
<td class="num">(31,866)<span></span>
</td>
<td class="num">(9,588)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from maturities of available-for-sale securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">54,706<span></span>
</td>
<td class="nump">4,697<span></span>
</td>
<td class="nump">14,218<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,432<span></span>
</td>
<td class="num">(27,324)<span></span>
</td>
<td class="nump">4,537<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations', window );">Payments on equipment financing obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Net proceeds from issuances of common stock upon exercise of stock options, and purchases of ESPP shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,381<span></span>
</td>
<td class="nump">1,979<span></span>
</td>
<td class="nump">1,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuances of common stock in connection with equity financings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,283<span></span>
</td>
<td class="nump">18,360<span></span>
</td>
<td class="nump">16,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Term loan amendment cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(829)<span></span>
</td>
<td class="num">(1,014)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,660<span></span>
</td>
<td class="nump">19,503<span></span>
</td>
<td class="nump">17,482<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net (decrease) increase in cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(13,612)<span></span>
</td>
<td class="nump">3,280<span></span>
</td>
<td class="nump">2,269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash, beginning of the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">35,074<span></span>
</td>
<td class="nump">31,794<span></span>
</td>
<td class="nump">29,525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash, end of the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">21,462<span></span>
</td>
<td class="nump">35,074<span></span>
</td>
<td class="nump">31,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,678<span></span>
</td>
<td class="nump">1,942<span></span>
</td>
<td class="nump">1,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplementary disclosure of non-cash investing and financing information</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EscrowDepositsRelatedToPropertySales', window );">Cash held in escrow</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 14,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Fully vested options issued to settle accrued liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">994<span></span>
</td>
<td class="nump">$ 1,860<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating lease right-of-use assets obtained in exchange for operating lease obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes restricted cash of $150,000 (presented as long-term restricted investments) on the balance sheets at each of December 31, 2020, 2019 and 2018.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Amounts for the twelve months ended December 31, 2019 include the transition adjustment for the adoption of Accounting Standards Update ("ASU" No. 2016-02, Leases ("Topic 842").</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_ChangesInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Changes in operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_ChangesInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_IncreaseDecreaseInContractResearchLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of clinical and non-clinical expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_IncreaseDecreaseInContractResearchLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDepositsRelatedToPropertySales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Escrow deposits related to property sales in noncash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDepositsRelatedToPropertySales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167746066280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Statements of Cash Flows (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=drrx_LongTermRestrictedInvestmentsMember', window );">Long Term Restricted Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=drrx_LongTermRestrictedInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=drrx_LongTermRestrictedInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167859556696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:bold;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">1.</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="font-weight:normal;color:#000000;"/><span style="font-family:Times New Roman;color:#000000;">Summary of Significant Accounting Policies</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Nature of Operations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DURECT Corporation (the Company) was incorporated in the state of Delaware on February&#160;6, 1998. The Company is a biopharmaceutical company with research and development programs broadly falling into two categories: (i)&#160;new chemical entities derived from our Epigenetics Regulator Program, in which the Company attempts to discover and develop molecules which have not previously been approved and marketed as therapeutics, and (ii)&#160;Proprietary Pharmaceutical Programs, in which the Company applies its formulation expertise and technologies largely to active pharmaceutical ingredients whose safety and efficacy have previously been established but which the Company aims to improve in some manner through a new formulation. The Company has several products under development by itself and with third party collaborators. The Company also manufactures and sells osmotic pumps used in laboratory research, and manufactures certain excipients for certain clients for use as raw materials in their products. In addition, the Company conducts research and development of pharmaceutical products in collaboration with third party pharmaceutical and biotechnology companies.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Basis of Presentation and Use of Estimates</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP). The preparation of the accompanying Financial Statements conforms to accounting principles generally accepted in the U.S. which requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. On an ongoing basis, management evaluates its estimates including, but not limited to, those related to revenue recognition, the period of performance, identification of deliverables and evaluation of milestones with respect to our collaborations, the amounts of revenues, recoverability of inventory, certain accrued liabilities including accrued clinical trial liability, and stock-based compensation. The Company bases its estimates on historical experience and on various other market-specific and other relevant assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Discontinued Operations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2020, the Company announced its decision to sell its LACTEL Absorbable Polymer (LACTEL) product line to Evonik, which was completed on December 31, 2020. The accompanying financial statements have been recast for all periods presented to reflect the assets, liabilities, revenue and expenses related to the Company&#8217;s LACTEL product line as discontinued operations (see Note 10).&#160;The Company believes this format provides comparability with its previously filed financial statements.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Liquidity and Need to Raise Additional Capital</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the Company has an accumulated deficit of $489.8 million as well as negative cash flows from operating activities.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company generally has had negative cash flows from operating activities and expects its negative cash flows to continue.&#160;&#160;The Company will continue to require substantial funds to continue research and development, including clinical trials of its product candidates.&#160; Management&#8217;s plans in order to meet its operating cash flow requirements beyond the next 12 months from the date the financial statements are filed, may include seeking additional collaborative agreements for certain of its programs and achieving revenue from its collaboration and licensing agreements as well as financing activities such </p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">as public offerings and private placements of its common stock, preferred stock offerings, issuances of debt and convertible debt instruments.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are no assurances that such additional funding will be obtained and that the Company will succeed in its future operations. If the Company cannot successfully raise additional capital when needed and implement its strategic development plan, its liquidity, financial condition and business prospects will be materially and adversely affected.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company believes its existing cash, cash equivalents, cash held in escrow, investments and subsequent equity fund raising completed in February 2021 (see Note 11) are sufficient to fund its operating cashflow requirements for a period greater than 12 months from the date of issuance of these financial statements.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Cash, Cash Equivalents and Investments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers all highly liquid investments with maturities of 90 days or less from the date of purchase to be cash equivalents. Investments with original maturities of greater than 90 days from the date of purchase but less than one year from the balance sheet date are classified as short-term investments, while investments with maturities in one year or beyond one year from the balance sheet date are classified as long-term investments. Management determines the appropriate classification of its cash equivalents and investment securities at the time of purchase and re-evaluates such determination as of each balance sheet date. Management has classified the Company&#8217;s cash equivalents and investments as available-for-sale securities in the accompanying financial statements. Available-for-sale securities are carried at fair value, with unrealized gains and losses reported as a component of accumulated other comprehensive loss. Realized gains and losses are included in interest income. There were no material realized gains or losses in the periods presented. The cost of securities sold is based on the specific identification method.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company invests in debt instruments of government agencies, corporations, and money market funds with high credit ratings. The Company has established guidelines regarding diversification of its investments and their maturities with the objectives of maintaining safety and liquidity, while maximizing yield.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash held in escrow (related to the sale of the LACTEL product line) was $15 million as of December 31, 2020; the $15 million which was released from escrow in January 2021.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Concentrations of Credit Risk</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to credit risk consist principally of interest-bearing investments and trade receivables. The Company maintains cash, cash equivalents and investments with various major financial institutions. The Company performs periodic evaluations of the relative credit standing of these financial institutions. In addition, the Company performs periodic evaluations of the relative credit quality of its investments.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pharmaceutical companies and academic institutions account for a substantial portion of the Company&#8217;s trade receivables. The Company provides credit in the normal course of business to its customers and collateral for these receivables is generally not required. The risk associated with this concentration is limited to a certain extent due to the large number of accounts and their geographic dispersion. The Company monitors the creditworthiness of its customers to which it grants credit terms in the normal course of business. The Company maintains reserves for estimated credit losses and, to date, such losses have been immaterial in all periods presented.</p>

<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Customer and Product Line Concentrations (excluding the LACTEL product line)</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A portion of the Company&#8217;s revenue is derived from its ALZET osmotic pump product line, and the sale of certain excipients for Methydur and one excipient that is included in a marketed animal health product. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue from the sale of products from the ALZET product line accounted for 20%, 27% and 46% of total revenue for 2020, 2019 and 2018, respectively. &#160; &#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gilead accounted for 76% and 68% of the Company&#8217;s total revenue for 2020 and 2019, respectively. In 2018, Indivior and Gilead accounted for 33% and 17% of the Company&#8217;s total revenues, respectively. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue by geographic region for the years 2020, 2019 and 2018 are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,894</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,957</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,058</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Europe</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,386</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">906</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,476</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Japan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,174</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,472</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">975</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Others</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">657</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">739</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">766</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,111</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,074</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,275</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue by geography is determined by the location of the customer.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Inventories</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. The Company may be required to expense previously capitalized inventory costs upon a change in management&#8217;s judgment due to new information that suggests that the inventory will not be saleable. &#160;If the Company is able to subsequently sell products made with raw materials that were previously written down, the Company will report an unusually high gross profit as there will be no associated cost of goods for these materials.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s inventories consisted of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Raw materials</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">163</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Work in-process</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">796</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">709</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finished goods</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">932</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,047</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total inventories</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,864</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,919</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Property and Equipment</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment are stated at cost less accumulated depreciation, which is computed using the straight-line method over the estimated useful lives of the assets, which range from three to five years. Leasehold improvements are amortized using the straight-line method over the estimated useful lives of the assets, or the terms of the related leases, whichever are shorter.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Goodwill</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill is periodically assessed and evaluated for impairment. The Company operates in one operating segment and also has only one reporting unit, which is the research, development and manufacturing of pharmaceutical products. The Company assesses the impairment of goodwill at least annually and whenever events or changes in circumstances indicate that the carrying value may not be </p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">recoverable. Factors the Company considers important which could trigger an impairment review include the following:</span></p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td style="width:3.85%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-family:Times New Roman;color:#000000;">significant decline in our stock price for a prolonged period;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td style="width:3.85%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-family:Times New Roman;color:#000000;">our market capitalization relative to net book value;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td style="width:3.85%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-family:Times New Roman;color:#000000;">new information affecting the commercial value of the asset;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td style="width:3.85%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-family:Times New Roman;color:#000000;">significant underperformance relative to historical or projected future operating results;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td style="width:3.85%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-family:Times New Roman;color:#000000;">significant changes in the manner of our use of the acquired assets or the strategy for the Company&#8217;s overall business; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td style="width:3.85%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-family:Times New Roman;color:#000000;">significant negative industry or economic trends.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the carrying value of goodwill was approximately $6.2 million compared with $6.4 million as of December 31, 2019 and 2018. As a result of the sale of the LACTEL product line, approximately $229,000 of the carry value of goodwill was allocated to the LACTEL product line upon its disposition.&#160;&#160;The Company evaluates goodwill for impairment at least annually. In 2020, 2019 and 2018, goodwill was evaluated and no indicators of impairment were identified. To date, the Company has not recorded any impairment charge related to goodwill. </p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Impairment of Long-Lived Assets</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company reviews long-lived assets, including property and equipment, intangible assets, and other long-term assets, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of the asset and its eventual disposition is less than its carrying amount. Impairment, if any, is calculated as the amount by which an asset&#8217;s carrying value exceeds its fair value, typically using discounted cash flows to determine fair value. Through December 31, 2020, there have been no material impairment losses.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Leases</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company leases administrative, manufacturing and laboratory facilities under operating leases. Lease agreements may include rent holidays, rent escalation clauses and tenant improvement allowances. Prior to the adoption of <span style="color:#000000;">Accounting Standards Update ("ASU" No. 2016-02, Leases, and the related amendments ("Topic 842")</span>, the Company recognized scheduled rent increases on a straight-line basis over the lease term beginning with the date the Company took possession of the leased space. The Company recorded tenant improvement allowances as deferred rent liabilities and amortized the deferred rent over the terms of the lease to rent expense on the statements of operations and comprehensive loss.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective January 1, 2019, the Company adopted Topic 842 using the modified retrospective transition method approach with a cumulative-effect adjustment as of January 1, 2019. Other prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under previous lease guidance, ASC Topic 840: Leases (Topic 840). The Company elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allowed the Company to carry forward the historical lease classification of those leases in place as of January 1, 2019.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The adjustments due to the adoption of Topic 842 primarily related to the recognition of an operating lease right-of-use asset and corresponding operating lease liability for the Company&#8217;s leased properties. <span style="color:#212529;">The Company&#8217;s operating lease right-of-use asset and liability were recognized at the adoption date of ASC 842 based on the present value of lease payments over the remaining lease term at the adoption date. In determining the net present value of lease payments, we used our incremental borrowing </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#212529;">rate of </span><span style="color:#212529;">13.8</span><span style="color:#212529;">% based on the information available, including remaining lease term, at the adoption date of ASC 842. As of December 31, 20</span><span style="color:#212529;">20</span><span style="color:#212529;">, the weighted-average remaining lease term was </span><span><span style="color:#212529;">2.99</span><span style="color:#212529;"> years</span></span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for the Company&#8217;s leased properties</span><span style="color:#212529;">.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There was no effect from the adoption of Topic 842 on the Company&#8217;s Statement of cash flows.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Stock-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for share-based payments using a fair-value based method for costs related to all share-based payments, including stock options and stock issued under the Company&#8217;s employee stock purchase plan (ESPP). The Company estimates the fair value of share-based payment awards on the date of grant using an option-pricing model. See Note 8 for further information regarding stock-based compensation.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Revenue Recognition</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company enters into license and collaboration agreements under which the Company may receive upfront license fees, research funding and contingent milestone payments and royalties. Effective January 1, 2018, the Company adopted FASB ASC Topic 606, Revenue from Contracts with Customers, or ASC 606. In accordance with ASC 606, the Company changed certain characteristics of its revenue recognition accounting policy as described below. ASC 606 was applied using the modified retrospective method, where the cumulative effect of the initial application was recognized as an adjustment to opening retained earnings at January 1, 2018. The Company recorded a net decrease to opening accumulated deficit of&#160;$470,000 with an offset entry to reduce deferred revenue as of January 1, 2018 due to the cumulative impact of adopting Topic 606, with the impact relating to the Company&#8217;s deferred collaborative research and development revenues. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Product Revenue, Net</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company sells osmotic pumps used in laboratory research, and manufactures certain excipients for pharmaceutical clients for use as raw materials in their products.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenues from product sales are recognized when the customer obtains control of the Company&#8217;s product, which occurs at a point in time, typically upon shipment to the customer. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is one year or less.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade Discounts and Allowances: The Company provides certain customers with discounts that are explicitly stated in the Company&#8217;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product Returns: Consistent with industry practice, the Company generally offers customers a limited right of return for products that have been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. The Company currently estimates product return liabilities using its historical sales information. The Company expects product returns to be minimal.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Collaborative Research and Development and Other Revenue</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company enters into license agreements, under which it licenses certain rights to its product candidates to third parties. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, up-front license fees; reimbursement of development costs incurred by the Company under approved work plans; development, regulatory and commercial milestone payments; payments for manufacturing supply services the Company provides through its contract manufacturers; and royalties on net sales of licensed products. Each of these payments results in collaborative research and development revenues, except for revenues from royalties on net sales of licensed products, which are classified as other revenues.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In determining the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements, the Company performs the following steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. As part of the accounting for these arrangements, the Company must develop assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the contract. The Company uses key assumptions to determine the standalone selling price, which may include forecasted revenues, development timelines, reimbursement rates for personnel costs, discount rates and probabilities of technical and regulatory success. The Company expects to recognize revenue for the variable consideration currently being constrained when it is probable that a significant revenue reversal will not occur.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Licenses of intellectual property: If the license to the Company&#8217;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, up-front fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are bundled with other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, up-front fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. Any such adjustments are recorded on a cumulative catch-up basis, which would affect collaborative research and development revenues and net income (loss) in the period of adjustment.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Milestone Payments: At the inception of each arrangement that includes development milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or the licensee, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. The transaction price is then allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as or when the performance obligations under the contract are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect collaborative research and development revenues and net income (loss) in the period of adjustment. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing Supply Services: Arrangements that include a promise for future supply of drug product for either clinical development or commercial supply at the customer&#8217;s discretion are generally considered as options. The Company assesses if these options provide a material right to the customer and if so, they are accounted for as separate performance obligations. If the Company is entitled to additional payments when the customer exercises these options, any additional payments are recorded in collaborative research and development revenue when the customer obtains control of the goods, which is upon delivery.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Royalties and Earn-outs: For arrangements that include sales-based royalties or earn-outs, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). To date, the Company has not recognized material royalty revenue resulting from the Company&#8217;s collaborative arrangements or material earn-out revenue from the Company&#8217;s patent purchase agreement with Indivior.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company receives payments from its customers based on development cost schedules established in each contract. Up-front payments are recorded as deferred revenue upon receipt or when due, and may require deferral of revenue recognition to a future period until the Company performs its obligations under these arrangements.&#160;&#160;Amounts are recorded as accounts receivable when the Company&#8217;s right to consideration is unconditional. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised goods or services to the customer will be one year or less.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Prepaid and Accrued Contract Research Expenses</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company incurs significant costs associated with third party consultants and organizations for pre-clinical studies, clinical trials, contract research and manufacturing, validation, testing, regulatory advice and other research and development-related services. The Company is required to estimate periodically the cost of services rendered but unbilled based on management&#8217;s estimates of project status. If these good faith estimates are inaccurate, actual expenses incurred could materially differ from these estimates.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses are primarily comprised of salaries and benefits associated with research and development personnel, overhead and facility costs, preclinical and non-clinical development costs, clinical trial and related clinical manufacturing costs, contract services, and other outside costs. Research and development costs are expensed as incurred. Research and development costs paid to third parties under sponsored research agreements are recognized as the related services are performed. In addition, reimbursements of research and development expenses incurred by the Company&#8217;s partners are recorded as collaborative research and development revenue.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Comprehensive Loss</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Components of other comprehensive loss are comprised entirely of unrealized gains and losses on the Company&#8217;s available-for-sale securities for all periods presented. Total comprehensive loss has been disclosed in the Company&#8217;s Statements of Comprehensive Loss.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Segment Reporting</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company operates in one operating segment, which is the research, development and manufacturing of pharmaceutical products.</p>

<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Net Loss Per Share</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding. Diluted net loss per share is computed using the weighted-average number of common shares outstanding and common stock equivalents (i.e., options to purchase common stock) outstanding during the period, if dilutive, using the treasury stock method for options. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The numerators and denominators in the calculation of basic and diluted net loss per share were as follows (in thousands except per share amounts):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:79.04%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerators:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(582</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,578</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25,322</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominators:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares used to compute basic</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; net loss per share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">199,457</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">178,042</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">159,834</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effect of dilutive securities:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dilution from stock options</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dilution from ESPP</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dilutive common shares</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares used to compute diluted</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; net loss per share</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">199,457</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">178,042</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">159,834</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.00</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.12</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.16</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.00</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.12</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.16</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The computation of diluted net loss per share for 2020, 2019 and 2018 excludes the impact of options to purchase 7.5 million, 21.4&#160;million and 16.6&#160;million shares of common stock outstanding at December 31, 2020, 2019 and 2018, respectively, as such impact would be antidilutive.</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Shipping and Handling</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Costs related to shipping and handling are included in cost of revenues for all periods presented.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:2.62%;font-family:Times New Roman;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, as part of its initiative to reduce complexity in the accounting standards, the FASB issued ASU 2019-12, <span style="font-style:italic;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span> (&#8220;ASU 2019-12&#8221;), which eliminates certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company early adopted ASU 2019-12 on January 1, 2020, and this adoption had no material impact on the Company&#8217;s financial position or results of operations. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2018, the Financial Accounting Standards Board (the FASB) issued ASU No.&#160;2018-18,&#160;<span style="font-style:italic;">Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606&#160;(ASU 2018-18)</span>. ASU 2018-18 clarifies that certain transactions between collaborative arrangement </p>
<p style="margin-top:6pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">participants should be accounted for as revenue under Topic 606 when the counterparty is a customer for a distinct good or service (i.e. a unit of account). For units of account that are in the scope of Topic 606, all of the guidance in Topic 606 should be applied, including the guidance on recognition, measurement, presentation and disclosure. ASU 2018-18 also adds a reference in Topic 808 to the unit of account guidance in ASC 606 and requires that it be applied only to assess whether transactions in a collaborative arrangement are in the scope of Topic 606. ASU 2018-18 will preclude entities from presenting amounts related to transactions with a counterparty in a collaborative arrangement that is not a customer as revenue from contracts with customers. ASU 2018-18 is effective for the Company for all interim and annual reporting periods beginning after December 15, 2019. </span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The adoption of this standard did not have a material effect on the Company&#8217;s financial statements</span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2018, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;)&#160;No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurement, which eliminates certain disclosure requirements for fair value measurements for all entities, requires public entities to disclose certain new information and modifies some disclosure requirements. This standard is effective for fiscal years beginning after December 15, 2019, including interim reporting periods within those years. The adoption of this standard did not have a material effect on the Company&#8217;s financial statements.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January 2017, the FASB issued ASU No.&#160;2017-04,&#160;<span style="font-style:italic;">Intangibles&#8212;Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,&#160;(ASU 2017-04)</span>.&#160;ASU 2017-04 eliminated Step 2 from the goodwill impairment test. Instead, under the amendments in ASU 2017-04, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax&#160;effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. ASU 2017-04 is effective for all interim and annual reporting periods beginning after December 15, 2019. The adoption of this standard did not have a material effect on the Company&#8217;s financial statements.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016,&#160;the FASB issued Accounting Standards Update No. 2016-13 (ASU 2016-13)&#160;&#8220;Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments.&#8221;&#160;ASU 2016-13 requires measurement and recognition of expected credit losses for financial assets. This standard is effective for fiscal years beginning after December 15, 2022 for small reporting companies, including interim reporting periods within those years and must be adopted using a modified retrospective approach, with certain exceptions. Early adoption is permitted.&#160; The Company does not expect the adoption of this standard to have a material effect on its financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167849501992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Strategic Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Strategic Agreements</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">2.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Strategic Agreements</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The collaborative research and development and other revenues associated with the Company&#8217;s major third-party collaborators are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Collaborator/Counterparty</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gilead (1)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,879</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,133</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,542</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other (2)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,062</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">996</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,665</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total collaborative research and development and other revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,941</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,129</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,207</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:81.2%;text-indent:0%;font-size:6pt;font-family:Times New Roman;">&#160;</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</span></p></td>
<td valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Amounts related to recognition of upfront fees and milestone payments were $22.7 million, $12.3 million and zero for the twelve months ended December 31, 2020, 2019 and 2018, respectively. The Company signed a license agreement with Gilead on July 19, 2019 and received a nonrefundable upfront license fee and a milestone payment totaling $35.0 million in 2019 which was being recognized as revenue as its obligation was being satisfied using the cost-to-cost input method (see Note 2. Strategic Agreements - Agreement with Gilead Sciences, Inc. in the financial statements). In June 2020, the Company received notice that Gilead was terminating the License Agreement and a related R&amp;D agreement between Gilead and the Company. As a result, the Company recognized all its remaining deferred revenue as there were no remaining substantive performance obligations to be provided to Gilead by the Company as of the date when the termination notice was received.  Amounts recognized as revenue during each of the twelve months ended December 31, 2020, 2019 and 2018 also included the Company&#8217;s reimbursable collaborative research and development services performed under its agreement with Gilead.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Includes: (a) amounts related to earn-out revenue from Indivior UK Limited (Indivior) with respect to PERSERIS net sales; (b) feasibility programs; (c) research and development activities funded by Santen Pharmaceutical Co. Ltd. (Santen); and (d) royalty revenue from OP Pharma with respect to Methydur net sales. Note that in January 2018, the Company was notified by Santen that due to a shift in priorities, Santen had elected to reallocate research and development resources and put the Company&#8217;s program on pause until further notice. While the main program is on pause, the parties are working together on a limited set of research and development activities funded by Santen. </p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:-5.24%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the Company had potential milestones of up to $76.0 million that the Company may receive in the future under its collaborative arrangements, of which $13.0 million are development-based milestones and $63.0 million are sales-based milestones. Within the category of development-based milestones, $2.0 million are related to early stage clinical testing (defined as Phase 1 or 2 activities), $3.0 million are related to late stage clinical testing (defined as Phase 3 activities), $3.0 million are related to regulatory filings, and $5.0 million are related to regulatory approvals. <span style="font-family:Calibri;">&#160;</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Agreement with Gilead Sciences, Inc.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 19, 2019, the Company entered into a license agreement (the &#8220;Gilead Agreement&#8221;) with Gilead Sciences, Inc.&#160;&#160;(&#8220;Gilead&#8221;). Pursuant to the Gilead Agreement, the Company granted Gilead the exclusive worldwide rights to develop and commercialize a long-acting injectable HIV product utilizing DURECT&#8217;s SABER<sup style="font-size:85%;line-height:120%;vertical-align:top">&#174;</sup> technology.&#160;&#160;Gilead also received exclusive access to the SABER platform for HIV and Hepatitis B Virus (HBV) and the exclusive option to license additional SABER-based products directed to HIV and HBV.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms of the Gilead Agreement, Gilead made a non-refundable upfront payment to DURECT of $25 million, and in October 2019, the Company also received a $10 million milestone payment from Gilead for further development of the product candidate.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the twelve months ended December 31, 2019, the upfront and milestone consideration of $35 million received in 2019 associated with the Primary Services was being recognized as revenue when the first performance obligation was being satisfied using the cost-to-cost input method, which the Company believes best depicts the transfer of control to the customer. Under the cost-to-cost input method, the extent of progress towards completion is measured based on the ratio of actual costs incurred to the total estimated costs. Revenue is recorded as a percentage of the transaction price based on the extent of progress towards completion. The estimate of the Company&#8217;s measure of progress, which can include additional Primary Services, if any, and the estimate of any additional consideration for those additional Primary Services, are included in the transaction price which is updated at each reporting date, and revenue is recognized on a cumulative catchup basis. As such, management applies a certain amount of judgment in estimating both the Primary Services and the corresponding timeline to through </p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">completion of the first performance obligation, which are key inputs when using the cost-to-cost input method.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the twelve months ended December 31, 2019, the Company recognized $12.3 million of the deferred revenue within collaborative research and development and other revenues. The Company also recognized $4.8 million from Gilead during the twelve months ended December 31, 2019 from feasibility related collaborative research and development services.&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2020, Gilead terminated the Gilead Agreement and a related R&amp;D agreement between Gilead and the Company. As a result, the Company recognized $22.7 million as revenue during the year ended December 31, 2020, which represented all of the remaining upfront fee and milestone payment that had previously been deferred as there were no remaining substantive performance obligations to be provided to Gilead by the Company as of the date when the termination notice was received.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents changes in the Company&#8217;s contract assets and liabilities for the twelve months ended December 31, 2020 and 2019 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">January 1,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deletions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,812</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(39,318</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">494</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total contract asset</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,812</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(39,318</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">494</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue, current portion</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,321</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,679</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total contract liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,321</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,679</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">January 1,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deletions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">494</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(694</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total contract asset</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">494</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(694</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue, current portion</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,679</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,174</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(31,853</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total contract liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,679</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,174</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(31,853</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Patent Purchase Agreement with Indivior</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 26, 2017, the Company entered into a Patent Purchase Agreement (the &#8220;Indivior Agreement&#8221;) with Indivior.&#160;&#160;Pursuant to the Indivior Agreement, the Company assigned to Indivior certain patents that may provide further intellectual property protection for PERSERIS&#8482; (risperidone), Indivior&#8217;s extended-release injectable suspension for the treatment of schizophrenia in adults.&#160;&#160;In consideration for such assignment, Indivior made an upfront non-refundable payment to the Company of $12.5 million.&#160;&#160;Indivior also agreed to make an additional $5.0 million payment to the Company contingent upon NDA approval of PERSERIS, as well as quarterly earn-out payments that are based on a single digit percentage of U.S. net sales for certain products covered by the assigned patent rights, including PERSERIS. The assigned patent rights include granted patents extending through at least 2026.&#160;&#160;The Company also received a non-exclusive right under the assigned patents to develop and </p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">commercialize certain risperidone-containing products and products that do not contain risperidone or buprenorphine.&#160;&#160;The Indivior Agreement contains customary representations, warranties and indemnities of the parties. The Company received the payment of $</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.5</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million from Indivior in September 2017 and recognized the $</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.5</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million as revenue from sale of intellectual property rights in 2017 as the Company did not have any continuing obligations under the purchase agreement</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. In August 2018, the Company received the payment of $</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.0</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million from Indivior for the FDA approval of PERSERIS.&#160;&#160;The Company recognized the $</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.0</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million as milestone revenue in 2018 as there was no further performance obligation associated with this milestone payment. Amounts recognized to date related to earn-out revenues from PERSERIS have been immaterial</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Agreement with Santen Pharmaceutical Co., Ltd.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December&#160;11, 2014, the Company and Santen Pharmaceutical Co., Ltd. (Santen) entered into a definitive agreement (the Santen Agreement). Pursuant to the Santen Agreement, the Company granted Santen an exclusive worldwide license to the Company&#8217;s proprietary SABER formulation platform and other intellectual property to develop and commercialize a sustained release product utilizing the Company&#8217;s SABER technology to deliver an ophthalmology drug. Santen controls and funds the development and commercialization program, and the parties established a joint management committee to oversee, review and coordinate the development activities of the parties under the Santen Agreement.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Santen agreement, Santen paid the Company an upfront fee of $2.0 million in cash and agreed to make contingent cash payments to the Company of up to $76.0 million upon the achievement of certain milestones, of which $13.0 million are development-based milestones and $63.0 million are commercialization-based milestones including milestones requiring the achievement of certain product sales targets (none of which has been achieved as of December 31, 2020). Santen will also pay for certain Company costs incurred in the development of the licensed product. If the product is commercialized, the Company would also receive a tiered royalty on annual net product sales ranging from single-digit to the low double digits, determined on a country-by-country basis. In January 2018, the Company was notified by Santen that due to a shift in priorities, Santen elected to reallocate research and development resources and put the Company&#8217;s program on pause until further notice. While the main program is on pause, the parties are working together on a limited set of research and development activities funded by Santen. As of December 31, 2020, the cumulative aggregate payments received by the Company under this agreement were $3.3 million.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Agreement with Sandoz AG.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In May 2017, the Company and Sandoz AG (&#8220;Sandoz&#8221;) entered into a license agreement to develop and market POSIMIR in the United States. On January 2, 2019, the Company received written notice from Sandoz that Sandoz terminated this agreement effective January 27, 2019. As a result of this termination, Sandoz returned its exclusive commercialization rights to develop and market POSIMIR in the United States.&#160;&#160;The parties are in dispute with regard to Sandoz&#8217;s obligation to pay a termination fee to the Company. The Company has initiated a formal dispute resolution process related to the termination fee. The cumulative aggregate payments received by the Company from Sandoz as of December 31, 2020 were $20.0 million under this agreement. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;;font-size:9pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167844143464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Financial Instruments</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">3.</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Financial Instruments</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company&#8217;s valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company follows a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value. These levels of inputs are the following:</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td style="width:3.85%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-family:Times New Roman;color:#000000;">Level 1&#8212;Quoted prices in active markets for identical assets or liabilities.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td style="width:3.85%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-family:Times New Roman;color:#000000;">Level 2&#8212;Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td style="width:3.85%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-family:Times New Roman;color:#000000;">Level 3&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s financial instruments are valued using quoted prices in active markets or based upon other observable inputs. The following table sets forth the fair value of the Company&#8217;s financial assets that were measured at fair value on a recurring basis as of December 31, 2020 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">522</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">522</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificates of deposit</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,213</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,213</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal bonds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,305</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,305</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Government agencies</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">522</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,668</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,190</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth the fair value of our financial assets that were measured at fair value on a recurring basis as of December&#160;31, 2019 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">524</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">524</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificates of deposit</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,218</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,218</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Government agencies</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,501</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,501</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,868</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,868</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">524</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61,737</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62,261</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s financial instruments are valued using quoted prices in active markets or based upon other observable inputs. Money market funds are classified as Level 1 financial assets. Certificates of deposit, commercial paper, corporate debt securities, and U.S. Government agency securities are classified as Level 2 financial assets. The fair value of the Level 2 assets is estimated using pricing models using current observable market information for similar securities. The Company&#8217;s Level 2 investments include U.S. government-backed securities and corporate securities that are valued based upon observable inputs that may include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data including market research publications. The fair value of commercial paper is based upon the time to maturity and discounted using the three-month treasury bill rate. The average remaining maturity of the Company&#8217;s </p>
<p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2 investments as of December 31, 20</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> is less than twelve months and these investments are rated by S&amp;P and Moody&#8217;s at AAA or AA- for securities and A1 or P1 for commercial paper.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is a summary of available-for-sale securities as of December 31, 2020 and 2019 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gain</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">522</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">522</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificates of deposit</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,213</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,213</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal bonds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,310</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,305</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Government agencies</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,195</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,190</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reported as:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,619</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,619</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,426</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,421</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term investments</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term restricted investments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,195</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,190</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gain</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">524</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">524</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificates of deposit</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,221</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,218</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Government agencies</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,500</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,501</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,869</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,868</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62,264</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62,261</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reported as:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,364</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,361</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,750</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,750</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is a summary of the cost and estimated fair value of available-for-sale securities at December 31, 2020, by contractual maturity (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mature in one year or less</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,523</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,518</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mature after one year through five years</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,673</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,668</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were no securities that have had an unrealized loss for more than 12 months as of December 31, 2020.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, unrealized losses on available-for-sale investments are not attributed to credit risk and are considered to be temporary. The Company believes that it is more-likely-than-not that </p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">investments in an unrealized loss position will be held until maturity or the recovery of the cost basis of the investment. To date, the Company has not recorded any impairment charges on marketable securities related to other-than-temporary declines in market value.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167855245832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property Plant And Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">4.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Property and Equipment</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment consist of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,890</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,740</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,428</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,422</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction-in-progress</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,360</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,236</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less accumulated depreciation and amortization</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,109</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,077</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">251</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">159</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation expense was $297,000, $291,000 and $254,000 in 2020, 2019 and 2018, respectively.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the Company has recorded $482,000 as a liability which was included in other long-term liabilities on its balance sheet for asset retirement obligations associated with the estimated restoration cost for its leased buildings.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167748510472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restricted Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_RestrictedInvestmentsDisclosureTextBlock', window );">Restricted Investments</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">5.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Restricted Investments</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020 and 2019, the Company had $150,000 recorded as restricted investments, which primarily served as collateral for letters of credit securing a leased facility in California.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:6pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_RestrictedInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restricted investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_RestrictedInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167754282488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">Commitments</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">6.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Commitments</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Operating Leases</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has lease arrangements for its facilities in California and Alabama as follows. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="width:16.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Location</p></td>
<td style="width:1%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Approximate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Square Feet<span style="font-weight:normal;"> </span></p></td>
<td style="width:1%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.65pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:20%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operation</p></td>
<td style="width:1%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.65pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:45%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Expiration</p></td>
</tr>
<tr>
<td style="width:16.98%; border-top:solid 0.75pt #000000;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cupertino,&#160;CA</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,149 sq. ft.</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:20%; border-top:solid 0.75pt #000000;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Office, Laboratory and Manufacturing</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:45%; border-top:solid 0.75pt #000000;" valign="top"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease expires 2024 (with an option to renew for an additional five years) </p></td>
</tr>
<tr style="height:3.75pt;">
<td style="width:16.98%;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:15%;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:20%;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:45%;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td style="width:16.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cupertino, CA</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,100 sq. ft.</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:20%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Office and Laboratory</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:45%;" valign="top"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease expires 2024 (with an option to renew for an additional five years)</p></td>
</tr>
<tr>
<td style="width:16.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:20%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:45%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td style="width:16.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vacaville, CA</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,634 sq. ft.</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:20%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:45%;" valign="top"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease expires 2023 (with an option to renew for an additional five years)</p></td>
</tr>
<tr style="height:3.75pt;">
<td style="width:16.98%;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:15%;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:20%;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:45%;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under these leases, the Company is required to pay certain maintenance expenses in addition to monthly rent. Rent expense is recognized on a straight-line basis over the lease term for leases that have scheduled rental payment increases. Rent expense under all operating leases, excluding the LACTEL product line, was $1.9 million, $1.9 million and $1.7 million for the years ended December 31, 2020, 2019 and 2018, respectively. </p>

<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future minimum payments under these noncancelable leases are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ending December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Leases</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%; border-top:solid 0.75pt #000000;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,933</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,991</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,970</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">275</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,169</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Other Purchase Commitments </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2005, the Company entered into a supply agreement with a vendor. The remaining minimum purchase commitment under this agreement was $500,000 in 2018, which had been recorded as an accrued liability on the Company&#8217;s Balance Sheet at December 31, 2018, and which was charged to cost of goods sold in the Company&#8217;s Statements of Operations and Comprehensive Loss in 2017.&#160;In 2019, the Company recorded a one-time settlement credit of $500,000 as a reduction to cost of goods sold upon signing a settlement and release agreement with this vendor, and forgave the contractual right to receive inventory for the same amount that was previously reserved for.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:3pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167848487720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Term Loan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Term Loan</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">7.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Term Loan</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July 2016, the Company entered into a $20.0 million secured single-draw term loan with Oxford Finance LLC (Oxford Finance). The Company and Oxford Finance entered into three subsequent amendments to the Loan Agreement in February 2018, November of 2018 and December 2019, for which the Company paid Oxford Finance loan modification fees of $100,000, $900,000 and $825,000 respectively.&#160;&#160;As amended, the Loan Agreement provides for interest only payments for the first 18 months, followed by consecutive monthly payments of principal and interest in arrears starting on December 1, 2021 and continuing through the maturity date of the term loan of May 1, 2024. The Loan Agreement provides for a floating interest rate (7.95% initially and 7.95% as of December 31, 2020) based on an index rate plus a spread. In addition, a payment equal to 10% of the principal amount of the term loan is due when the term loan becomes due or upon the prepayment of the facility. If the Company elects to prepay the loan, there is also a prepayment fee of between 0.75% and 2.5% of the principal amount of the term loan depending on the timing of prepayment. The $150,000 facility fee that was paid at the original closing, the loan modification fees and other debt offering/issuance costs have been recorded as debt discount on the Company&#8217;s balance sheet and together with the final $2.0 million payment are being amortized to interest expense using the effective interest method over the revised term of the loan.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term loan is secured by substantially all of the assets of the Company, except that the collateral does not include any intellectual property (including licensing, collaboration and similar agreements relating thereto), and certain other excluded assets. The 2016 Loan Agreement contains customary representations, warranties and covenants by the Company, which covenants limit the Company&#8217;s ability to convey, sell, lease, transfer, assign or otherwise dispose of certain assets of the Company; engage in any business other than the businesses currently engaged in by the Company or reasonably related thereto; liquidate or dissolve; make certain management changes; undergo certain change of control events; create, incur, assume, or be liable with respect to certain indebtedness; grant certain liens; pay dividends and make certain other restricted payments; make certain investments; and make payments on any subordinated debt.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Loan Agreement also contains customary indemnification obligations and customary events of default, including, among other things, the Company&#8217;s failure to fulfill certain obligations of the Company under the Loan Agreement and the occurrence of a material adverse change which is defined as </p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a material adverse change in the Company&#8217;s business, operations, or condition (financial or otherwise), a material impairment of the prospect of repayment of any portion of the loan, or a material impairment in the perfection or priority of lender&#8217;s lien in the collateral or in the value of such collateral. In the event of default by the Company under the Loan Agreement, the lender would be entitled to exercise its remedies thereunder, including the right to accelerate the debt, upon which the Company may be required to repay all amounts then outstanding under the Loan Agreement, which could harm the Company&#8217;s financial condition. The conditionally exercisable call option related to the event of default is considered to be an embedded derivative which is required to be bifurcated and accounted for as a separate financial instrument. In the periods presented, the value of the embedded derivative is not material, but could become material in future periods if an event of default became more probable than is currently estimated.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of the term loan approximates the carrying value. Future maturities and interest payments under the term loan as of December 31, 2020, are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,941</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,208</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,563</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,712</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total minimum payments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,424</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less amount representing interest</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,646</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross balance of term loan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,778</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less unamortized debt discount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(958</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Carrying value of term loan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,820</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less term loan, current portion, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(884</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term loan, non-current portion, net</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,936</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167956232760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">8.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Stockholders&#8217; Equity</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Common Stock</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2015, the Company filed a shelf registration statement on Form S-3 with the SEC, which allowed the Company to offer up to $125.0 million of securities from time to time in one or more public offerings of its common stock. In addition, the Company entered into a Controlled Equity Offering sales agreement with Cantor Fitzgerald, under which the Company may sell, subject to certain limitations, up to $40 million of common stock through Cantor Fitzgerald, acting as agent. In August 2018, the Company filed a new shelf registration statement on Form S-3 with the SEC, which upon being declared effective in October 2018, terminated the November 2015 registration statement and allowed the Company to offer up to $175.0 million of securities from time to time in one or more public offerings, inclusive of up to $75.0 million of additional shares of common stock which the Company may sell, subject to certain limitations, under the 2015 Sales Agreement through Cantor Fitzgerald, acting as agent.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2018, the Company raised net proceeds of approximately $16.8 million from the sale of approximately 9.6 million shares of common stock in the open market through the Controlled Equity Offering program with Cantor Fitzgerald at a weighted average price of $1.80 per share. In 2019, the Company raised net proceeds of approximately $3.5 million from the sale of 2,349,820 shares of the Company&#8217;s common stock in the open market at a weighted average price of $1.55 per share pursuant to the October 2018 registration statement.&#160;&#160;On June 20, 2019, the Company entered into a transaction to sell 29,000,000 shares of our common stock to certain investors in a registered offering at a price of $0.52 per share, raising total gross proceeds to the Company of approximately $15.1 million. In 2020, the Company raised net proceeds of approximately $12.3 million from the sale of 5,308,002 shares of the Company&#8217;s common stock in the open market at a weighted average price of $2.39 per share pursuant to the October 2018 registration statement.</p>

<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2021, the Company completed an underwritten public offering of 20,364,582 shares of its common stock at a price of $2.2386 per share pursuant to an underwriting agreement with Cantor Fitzgerald&#160;&amp; Co., raising total gross proceeds to the Company of approximately $45.6 million before deducting estimated offering expenses payable by the Company. Total stock issuance costs related to this financing were approximately $195,000. After deducting estimated offering expenses payable by the Company, the net proceeds to the Company were approximately $45.4 million.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From January 1, 2021 to March 1, 2021, the Company also raised net proceeds (net of commissions) of approximately $2.4 million from the sale of 950,009 shares of the Company&#8217;s common stock in the open market at a weighted average price of $2.60 per share pursuant to the October 2018 registration statement.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Description of Stock-Based Compensation Plans</p>
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">2000 Stock Plan (Incentive Stock Plan)</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January 2000, the Company&#8217;s Board of Directors and stockholders adopted the DURECT Corporation 2000 Stock Plan, under which incentive stock options and non-statutory stock options and stock purchase rights may be granted to employees, consultants and non-employee directors. The 2000 Stock Plan was amended by written consent of the Board of Directors in March 2000 and written consent of the stockholders in August 2000.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2005, the Board of Directors approved certain amendments to the 2000 Stock Plan. At the Company&#8217;s annual stockholders meeting in June 2005, the stockholders approved the amendments of the 2000 Stock Plan to: (i)&#160;expand the types of awards that the Company may grant to eligible service providers under the Stock Plan to include restricted stock units, stock appreciation rights and other similar types of awards (including other awards under which recipients are not required to pay any purchase or exercise price) as well as cash awards; and (ii)&#160;include certain performance criteria that may be applied to awards granted under the Stock Plan.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At the Company&#8217;s annual stockholders meeting in June 2010, the stockholders approved amendments of the 2000 Stock Plan to: (i)&#160;provide that the number of shares that remain available for issuance will be reduced by two shares for each share issued pursuant to an award (other than an option or stock appreciation right) granted on or after the date of the 2010 Annual Meeting; (ii)&#160;expand the types of transactions that might be considered repricings and option exchanges for which stockholder approval is required; (iii)&#160;provide that shares tendered or withheld in payment of the exercise price of an option or withheld to satisfy a withholding obligation, and all shares with respect to which a stock appreciation right is exercised, will not again be available for issuance under the Stock Plan; (iv)&#160;require that options and stock appreciation rights have an exercise price or base appreciation amount that is at least fair market value on the grant date, except in connection with certain corporate transactions, and that stock appreciation rights may not have longer than a 10-year term; (v)&#160;add new performance goals that may be used to provide &#8220;performance-based compensation&#8221; under the 2000 Stock Plan; (vi)&#160;extend the term of the 2000 Stock Plan to the date that is ten (10)&#160;years following the stockholders meeting; and (vii)&#160;expand the treatment of outstanding awards in connection with certain changes of control of the Company to cover mergers in which the consideration payable to stockholders is not solely securities of the successor corporation.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At the Company&#8217;s annual stockholders meeting in June 2011, June 2014, June 2016 and June 2018, the stockholders approved amendments of the 2000 Stock Plan to increase the number of shares of the Company&#8217;s common stock available for issuance by 5,500,000 shares, 4,000,000 shares, 5,000,000 shares and 7,500,000 shares, respectively, each of which had previously been approved by the Board of Directors. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At the Company&#8217;s annual stockholders meeting in June 2019, the stockholders approved amendments of the 2000 Stock Plan to extend the term of the 2000 Stock Plan to the date that is ten </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10)&#160;</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">years following the stockholders meeting. </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A total of 49,955,639 shares of common stock have been reserved for issuance under this plan. The plan expires in <span style="-sec-ix-hidden:F_000725">June 2029</span>.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2013, the Board of Directors approved certain amendments to the 2000 Stock Plan to: (i)&#160;increase the number of stock options granted to a non-employee director on the date which such person first becomes a director from 30,000 to 70,000 shares of common stock; each option shall have a <span style="-sec-ix-hidden:F_000728">ten-year</span> term, become exercisable in installments of one-third of the total number of options granted on each anniversary of the grant and have a two-year period following termination of Director status in which the former director can exercise the option; (ii)&#160;modify the exercise period for future option grants to a non-employee director in which a former director can exercise the option following termination of Director status from a one year period to a <span style="-sec-ix-hidden:F_000730">two-year</span> period.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted under the 2000 Stock Plan expire no later than ten years from the date of grant. Options may be granted with different vesting terms from time to time not to exceed five years from the date of grant. The option price of an incentive stock option granted to an employee or of a nonstatutory stock option granted to any person who owns stock representing more than 10% of the total combined voting power of all classes of stock of the Company (or any parent or subsidiary) shall be no less than 110% of the fair market value per share on the date of grant. The option price of an incentive stock option granted to any other employee shall be no less than 100% of the fair market value per share on the date of grant.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, 7,599,531 shares of common stock were available for future grant and options to purchase 27,274,439 shares of common stock were outstanding under the 2000 Stock Plan.&#160; &#160; </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;&#160;&#160;&#160;&#160; </p>
<p style="margin-top:3pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">2000 Employee Stock Purchase Plan</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2000, the Company adopted the 2000 Employee Stock Purchase Plan. This purchase plan is implemented by a series of overlapping offering periods of 24 months&#8217; duration, with new offering periods, other than the first offering period, beginning on May&#160;1 and November&#160;1 of each year and ending April&#160;30 and October&#160;31, respectively, two years later. The purchase plan allows eligible employees to purchase common stock through payroll deductions at a price equal to the lower of 85% of the fair market value of the Company&#8217;s common stock at the beginning of each offering period or at the end of each purchase period. The initial offering period commenced on the effectiveness of the Company&#8217;s initial public offering.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In April 2010, the Board of Directors approved certain amendments to the 2000 Employee Stock Purchase Plan. At the Company&#8217;s annual stockholders meeting in June 2010, the stockholders approved the amendments of the 2000 Employee Stock Purchase Plan to: (i)&#160;increase the number of shares of our common stock authorized for issuance under the ESPP by 250,000 shares; (ii)&#160;extend the term of the ESPP to the date that is ten (10)&#160;years following the stockholders meeting; (iii)&#160;provide for six-month consecutive offering periods beginning on November&#160;1, 2010; (iv)&#160;revise certain provisions to reflect the final regulations issued under Section&#160;423 of the Code by the Internal Revenue Service; and (v)&#160;provide for the cash-out of options outstanding under an offering period in effect prior to the consummation of certain corporate transactions as an alternative to providing for a final purchase under such offering period.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2015, the Board of Directors approved certain amendments to the 2000 Employee Stock Purchase Plan. At the Company&#8217;s annual stockholders meeting in June 2015, the stockholders approved the amendments of the 2000 Employee Stock Purchase Plan to: (i)&#160;increase the number of shares of our common stock authorized for issuance under the ESPP by 350,000 shares; and (ii)&#160;extend the term of the ESPP to the date that is ten (10)&#160;years following the stockholders meeting. At each of the Company&#8217;s annual stockholders meeting in June 2017 and in June 2020, the stockholders approved amendments of </p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the 2000 Employee Stock Purchase Plan to increase the number of shares our common stock authorized for issuance under the ESPP by </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">350,000</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> shares</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, respectively,</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="color:#000000;">and to re-approve its material terms</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The plan expires in <span style="-sec-ix-hidden:F_000745">June 2030</span>. A total of 2,900,000 shares of common stock have been reserved for issuance under this plan. As of December 31, 2020, 497,270 shares of common stock were available for future grant and 2,752,730 shares of common stock have been issued under the 2000 Employee Stock Purchase Plan.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, shares of common stock reserved for future issuance consisted of the following:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options outstanding</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,274,439</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options available for grant</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,599,531</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee Stock Purchase Plan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">497,270</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,371,240</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of stock option activity under all stock-based compensation plans is as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price&#160;Per&#160;Share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average&#160;Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual Term</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in Years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in&#160;millions)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,803,766</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.41</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000769">5.17</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71.3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,702,860</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.12</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,865,835</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.11</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options forfeited</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(389,471</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.45</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options expired</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,976,881</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.20</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,274,439</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.45</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000770">4.98</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,512,705</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.42</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000771">4.44</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested and expected to vest at</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,274,439</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.45</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000772">4.98</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aggregate intrinsic value in the table above represents the total intrinsic value (i.e., the difference between the Company&#8217;s closing stock price on the last trading day of 2020 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their in-the-money options on December 31, 2020. This amount changes based on the fair market value of the Company&#8217;s common stock. The total intrinsic value of options exercised was $3.6 million, $1.7 million and $1.6 million for the years ended December 31, 2020, 2019 and 2018, respectively.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In lieu of providing cash bonuses to certain employees, in January 2019 and 2018, the Company granted its employees stock options to purchase 2.3 million and 1.9 million shares, respectively, of the Company&#8217;s common stock, which vested immediately on the grant date. The weighted-average grant-date fair value of all options granted with exercise prices equal to fair market value was $0.43 in 2019 and $0.94 in 2018 determined by the Black-Scholes option valuation method. There were no options granted with exercise prices lower than fair market value.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expenses for non-employee stock options are recorded over the vesting period of the options, which closely approximates the non-employee&#8217;s performance period, with the value determined by the Black-Scholes option valuation method and remeasured over the vesting term.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the Company had three stock-based equity compensation plans, which are described above. The employee stock-based compensation cost that has been included in the statements of operations and comprehensive loss is shown as below (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of product revenues</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">981</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">746</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,541</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,085</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,269</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,355</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,079</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,028</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,909</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because the Company had a net operating loss carryforward as of December 31, 2020, no excess tax benefits for the tax deductions related to stock-based compensation expense were recognized in the statement of operations. Additionally, no incremental tax benefits were recognized from stock options exercised during 2020, which would have resulted in a reclassification to reduce net cash provided by operating activities with an offsetting increase in net cash provided by financing activities.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Determining Fair Value</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Valuation and Expense Recognition.<span style="font-style:normal;">&#160;&#160;&#160;&#160;The Company estimates the fair value of stock options granted using the Black-Scholes option valuation model. The Company recognizes the expense on a straight-line basis. The expense for options is recognized over the requisite service periods of the awards, which is generally the vesting period.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Expected Term.<span style="font-style:normal;">&#160;&#160;&#160;&#160;The expected term of options granted represents the period of time that the options are expected to be outstanding. The Company determines the expected life using historical options experience. This develops the expected life by taking the weighted average of the actual life of options exercised and cancelled and assumes that outstanding options are exercised uniformly from the current holding period through the end of the contractual life.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Expected Volatility.<span style="font-style:normal;">&#160;&#160;&#160;&#160;The Company estimates the volatility of its common stock at the date of grant based on the historical volatility of the Company&#8217;s common stock.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Risk-Free Rate.<span style="font-style:normal;">&#160;&#160;&#160;&#160;The Company bases the risk-free rate that it uses in the Black-Scholes option valuation model on the implied yield in effect at the time of option grant on U.S. Treasury zero-coupon issues with substantially equivalent remaining terms.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Dividends.<span style="font-style:normal;">&#160;&#160;&#160;&#160;The Company has never paid any cash dividends on its common stock and the Company does not anticipate paying any cash dividends in the foreseeable future. Consequently, the Company uses an expected dividend yield of zero in the Black-Scholes option valuation model.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company used the following assumptions to estimate the fair value of options granted (including fully vested options issued in January 2019 and 2018) and shares purchased under its stock plans and employee stock purchase plan for the years ended December 31, 2020, 2019 and 2018:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Stock Options</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free rate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000803">0.5-1.4%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000804">1.5-2.7%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000805">2.7-3.1%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000806">7.0-7.3</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000807">7.5-10.0</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000808">7.0-10.0</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000812">84-87%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000813">79-83%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000814">78-86%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeiture rate (1)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.85%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-family:Times New Roman;color:#000000;">Effective January 1, 2017, the Company elected to account for forfeitures as they occur.</span> </p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:7.69%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Employee Stock Purchase Plan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free rate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.1%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000824">1.6-2.5%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000825">1.3-2.5%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000826">0.5</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000827">0.5</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000828">0.5</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000829">78-124%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000830">60-103%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000831">60-146%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were 102,006, 111,909 and 119,097 shares purchased under the Company&#8217;s employee stock purchase plan during the years ended December 31, 2020, 2019 and 2018, respectively. Included in the statement of operations and comprehensive loss for the year ended December 31, 2020, 2019 and 2018 was $86,000, $27,000 and $24,000, respectively, in stock-based compensation expense related to the recognition of expenses related to shares purchased under the Company&#8217;s employee stock purchase plan.</p>

<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, $3.4 million of total unrecognized compensation costs related to nonvested stock options is expected to be recognized over the respective vesting terms of each award through 2024. The weighted average term of the unrecognized stock-based compensation expense is 2.6 years.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes information about stock options outstanding at December 31, 2020:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.52%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options Outstanding</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.56%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options Exercisable</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Range of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual&#160;Life</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercisable</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%; border-top:solid 0.75pt #000000;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000843">$0.51 - $0.57</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">143,750</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000876">8.12</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.57</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,418</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.56</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000844">$0.58 - $0.58</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,878,012</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000877">7.79</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.58</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,165,967</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.58</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000845">$0.58 - $0.88</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,561,267</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000878">3.65</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.82</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,549,297</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.82</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000846">$0.93 - $1.20</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,761,642</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000879">4.92</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.15</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,706,954</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.15</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000847">$1.21 - $1.21</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,608,933</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000880">2.13</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.21</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,606,683</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.21</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000848">$1.24 - $1.24</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,869,328</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000881">6.84</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.24</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,457,142</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.24</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000849">$1.26 - $1.26</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000882">5.28</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.26</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.26</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000850">$1.31 - $1.31</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,755,496</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000883">5.62</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.31</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,527,036</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.31</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000851">$1.33 - $2.09</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,068,694</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000884">4.35</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.81</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,610,445</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.81</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.72%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000852">$2.10 - $3.61</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,587,317</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000885">4.95</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.66</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,798,763</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.95</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.72%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000853">$0.51 - $3.61</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,274,439</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000886">4.98</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.45</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,512,705</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.42</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company received $3.2 million, $1.9 million and $1.6 million in cash from option exercises under all stock-based compensation plans for the years ended December 31, 2020, 2019 and 2018, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167750319256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">9.</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Income Taxes</p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for income taxes using the liability method under ASC 740, <span style="font-style:italic;">Income Taxes</span>. Under this method, deferred tax assets and liabilities are determined based on temporary differences resulting from the different treatment of items for tax and financial reporting purposes. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to reverse. Additionally, the Company must assess the likelihood that deferred tax assets will be recovered as deductions from future taxable income. The Company has provided a full valuation allowance on the Company&#8217;s deferred tax assets because the Company believes it is more likely than not that its deferred tax assets will not be realized. The Company evaluates the realizability of its deferred tax assets on a quarterly basis. The Company recorded a deferred tax liability of $244,000 on its balance sheet at both December 31, 2020 and 2019 that arose from tax amortization of an indefinite-lived intangible asset. The Company also recorded a deferred tax expense of zero in the years ended December 31, 2020, 2019 and 2018, respectively. The Company recorded no tax expense in each of 2020, 2019 and 2018. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The reconciliation of income tax expenses (benefit) at the statutory federal income tax rate of&#160;21%, to net income tax benefit included in the statements of operations and comprehensive loss for the years ended December 31, 2020, 2019 and 2018 is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. federal taxes benefit at statutory rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(122</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,321</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,318</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State taxes</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in valuation allowance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,142</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,143</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">268</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">879</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">999</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development tax credits</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,132</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,004</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(999</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax Reform change in tax rate and other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expiring net operating losses</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,991</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,252</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">175</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total income tax (benefit) provision</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2020, 2019 and 2018, total income tax provision (benefit) expense was zero. Deferred tax assets and liabilities reflect the net tax effects of net operating loss and research and other credit carryforwards and the temporary differences between the carrying amounts of assets and liabilities for financial reporting and the amounts used for income tax purposes. Significant components of the Company&#8217;s deferred tax assets and liabilities are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating loss carryforwards</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87,197</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90,102</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and other credits</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,153</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,860</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">223</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">248</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,840</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,376</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,204</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,288</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115,617</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,874</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance for deferred tax assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(114,323</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(117,245</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities - Right of use asset</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,538</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,873</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets and liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(244</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(244</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes deferred tax assets to the extent that the Company believes that these assets are more likely than not to be realized. In making such a determination, all available positive and negative evidence is considered, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If it is determined that the Company would be able to realize deferred tax assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes. The recognition and measurement of tax benefits requires significant judgment. Judgments concerning the recognition and measurement of tax benefit might change as new information becomes available. Given the Company&#8217;s history of operating losses, the net deferred tax assets have been fully offset by a valuation allowance. The valuation allowance decreased by $2.9 million during 2020 and increased by $4.6 million and $6.3 million during 2019 and 2018, respectively. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the Company had net operating loss carryforwards for federal income tax purposes of approximately $344.7 million, of which approximately $306.3 million will expire in the years 2021 through 2037, and approximately $38.5 million which do not expire, and federal research and </p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">development tax credits of approximately $</span>15.6<span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million, which expire at various dates beginning in </span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">202</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> through 20</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, if not utilized.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the Company had net operating loss carryforwards for state income tax purposes of approximately $219.1 million, which expire in the years 2021 through 2040, if not utilized, and state research and development tax credits of approximately $16.7 million, which do not expire.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Utilization of the net operating losses may be subject to a substantial annual limitation due to federal and state ownership change limitations. The annual limitation may result in the expiration of net operating losses before utilization.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December 31, 2020 and December&#160;31, 2019, the Company had unrecognized tax benefits of approximately $10.9 million and $9.1 million, respectively (none of which, if recognized, would affect the Company&#8217;s effective tax rate). The Company does not believe there will be any material changes in its unrecognized tax positions over the next twelve months.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at beginning of the year</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,078</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,432</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increase (decrease) related to prior year tax positions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,136</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(73</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increase related to current year tax positions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">674</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">719</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at end of the year</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,888</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,078</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest and penalty costs related to unrecognized tax benefits, if any, are classified as a component of interest and other income, net in the Statements of Operations and Comprehensive Loss. The Company did not recognize any interest and penalties expenses related to unrecognized tax benefits for the years ended December 31, 2020, 2019 and 2018.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. The Company is subject to U.S. federal and state income tax examination for calendar tax years ending 1999 through 2019 due to unutilized net operating losses and research credits. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In response to the COVID-19 pandemic, the Coronavirus Aid, Relief and Economic Securities Act (CARES Act) was signed into law in the U.S. in March 2020. The CARES Act adjusted a number of provisions in the tax code, including the calculation and eligibility of certain deductions and the treatment of net operating losses and tax credits. The enactment of the CARES Act did not result in any material adjustments to the Company&#8217;s income tax provision for the year ended December 31, 2020, or to its net deferred tax assets as of December 31, 2020.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The recently enacted Consolidated Appropriations Act, 2021 has expanded, extended, and clarified selected CARES Act provisions, specifically on Paycheck Protection Program (PPP) loan and Employee Retention Tax Credit, 100% deductibility of business meals as well as other tax extenders. The Consolidated Appropriations Act is not expected to have a material impact on the Company&#8217;s tax provision.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">California Assembly Bill 85 (AB 85) was signed into law in June 2020. The legislation suspends the use of California Net Operating Loss deductions for 2020, 2021, and 2022 for certain taxpayers and imposes a limitation on the use of certain California Tax Credits for 2020, 2021, and 2022. The carryover periods for Net Operating Loss deductions disallowed by this provision will be extended. Given the Company&#8217;s loss position in the current year, the new legislation will not impact the current year </p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">provision. The Company will continue to monitor possible California net operating loss and credit limitation in future periods.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167848487720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract', window );"><strong>Disposal Group Not Discontinued Operation Income Statement Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Disposal Groups, Including Discontinued Operations, Disclosure</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">10.<span style="margin-left:36pt;"/>Discontinued Operations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 31, 2020, the Company completed the sale of its LACTEL Absorbable Polymers product line to Evonik. Under the terms of the Asset Purchase Agreement, Evonik paid DURECT approximately $15&#160;million subject to certain adjustments, and also agreed to assume certain liabilities with respect to the transferred assets.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As a result of the sale of the LACTEL product line, the operating results from our LACTEL product line have been excluded from continuing operations and presented as discontinued operations in the accompanying Statements of Operations and Comprehensive Loss for all periods presented. During the twelve months ended December 31, 2020, we recorded a gain on sale of the LACTEL product line of $12.8 million, upon the completion of sale to Evonik. The results of operations and gain from discontinued operations presented below include certain allocations that management believes fairly reflect the utilization of services provided to the LACTEL product line. The allocations do not include amounts related to general corporate administrative expenses or interest expense. Therefore, these results of operations do not necessarily reflect what the results of operations would have been had the LACTEL product line operated as a stand-alone entity.</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:-5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of income from discontinued operations as reported in the Company&#8217;s statement of operations were as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:-5.24%;font-size:4pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.76%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product revenue, net</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,918</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,490</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,289</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenues</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,918</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,490</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,289</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of product revenues</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,880</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,623</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">476</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">569</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">488</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">515</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">248</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">157</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total costs and expenses</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,010</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,697</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,268</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income from discontinued operations</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">908</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">793</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on sale of the LACTEL product line</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,845</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income from discontinued operations</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,753</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">793</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income per share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.07</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.00</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.00</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average shares used in computing net income per share basic and diluted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">199,457</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">178,042</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">159,834</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents information related to assets and liabilities reported as discontinued</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">operations in the Company&#8217;s balance sheet (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">797</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,465</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discontinued operations &#8211; current portion</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,296</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">310</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr></table></div>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other long-term assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discontinued operations &#8211; non-current portion</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">532</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">127</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">344</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities, current portion</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">301</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discontinued operations &#8211; current portion</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">772</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities, non-current portion</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">161</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other long-term liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discontinued operations &#8211; non-current portion</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">257</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents certain non-cash items related to discontinued operations, which are included in the Company&#8217;s statement of cash flows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">198</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">241</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">229</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss on disposal of property and equipment</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">647</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">322</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on sale of the LACTEL product line</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,845</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-cash items, net</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,198</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">322</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167848703576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">11.<span style="margin-left:36pt;">Subsequent Events</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2021, the Company completed an underwritten public offering of 20,364,582 shares of its common stock at a price of $2.2386 per share pursuant to an underwriting agreement with Cantor Fitzgerald&#160;&amp; Co., raising total gross proceeds to the Company of approximately $45.6 million before deducting estimated offering expenses payable by the Company. Total stock issuance costs related to this financing were approximately $195,000. After deducting estimated offering expenses payable by the Company, the net proceeds to the Company were approximately $45.4 million.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From January 1, 2021 to March 1, 2021, the Company also raised net proceeds (net of commissions) of approximately $2.4 million from the sale of 950,009 shares of the Company&#8217;s common stock in the open market at a weighted average price of $2.60 per share pursuant to the October 2018 registration statement.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167752267656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II-Valuation and Qualifying Accounts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>Valuation And Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Schedule II-Valuation and Qualifying Accounts</a></td>
<td class="text">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">SCHEDULE II&#8212;VALUATION AND QUALIFYING ACCOUNTS</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31, 2020, 2019 and 2018</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">beginning</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of the year</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additions (Reductions) to allowances</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deductions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">end of the</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">year</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for doubtful accounts</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(46</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(72</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31, 2019</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(83</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31, 2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(69</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(83</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167848183944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_NatureOfOperationsPolicyTextBlock', window );">Nature Of Operations Policy</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Nature of Operations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DURECT Corporation (the Company) was incorporated in the state of Delaware on February&#160;6, 1998. The Company is a biopharmaceutical company with research and development programs broadly falling into two categories: (i)&#160;new chemical entities derived from our Epigenetics Regulator Program, in which the Company attempts to discover and develop molecules which have not previously been approved and marketed as therapeutics, and (ii)&#160;Proprietary Pharmaceutical Programs, in which the Company applies its formulation expertise and technologies largely to active pharmaceutical ingredients whose safety and efficacy have previously been established but which the Company aims to improve in some manner through a new formulation. The Company has several products under development by itself and with third party collaborators. The Company also manufactures and sells osmotic pumps used in laboratory research, and manufactures certain excipients for certain clients for use as raw materials in their products. In addition, the Company conducts research and development of pharmaceutical products in collaboration with third party pharmaceutical and biotechnology companies.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Basis of Presentation and Use of Estimates</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s financial statements have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP). The preparation of the accompanying Financial Statements conforms to accounting principles generally accepted in the U.S. which requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. On an ongoing basis, management evaluates its estimates including, but not limited to, those related to revenue recognition, the period of performance, identification of deliverables and evaluation of milestones with respect to our collaborations, the amounts of revenues, recoverability of inventory, certain accrued liabilities including accrued clinical trial liability, and stock-based compensation. The Company bases its estimates on historical experience and on various other market-specific and other relevant assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_DiscontinuedOperationsTextblock', window );">Discontinued Operations</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Discontinued Operations</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2020, the Company announced its decision to sell its LACTEL Absorbable Polymer (LACTEL) product line to Evonik, which was completed on December 31, 2020. The accompanying financial statements have been recast for all periods presented to reflect the assets, liabilities, revenue and expenses related to the Company&#8217;s LACTEL product line as discontinued operations (see Note 10).&#160;The Company believes this format provides comparability with its previously filed financial statements.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock', window );">Liquidity and Need to Raise Additional Capital Policy</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Liquidity and Need to Raise Additional Capital</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the Company has an accumulated deficit of $489.8 million as well as negative cash flows from operating activities.</p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company generally has had negative cash flows from operating activities and expects its negative cash flows to continue.&#160;&#160;The Company will continue to require substantial funds to continue research and development, including clinical trials of its product candidates.&#160; Management&#8217;s plans in order to meet its operating cash flow requirements beyond the next 12 months from the date the financial statements are filed, may include seeking additional collaborative agreements for certain of its programs and achieving revenue from its collaboration and licensing agreements as well as financing activities such </p>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">as public offerings and private placements of its common stock, preferred stock offerings, issuances of debt and convertible debt instruments.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are no assurances that such additional funding will be obtained and that the Company will succeed in its future operations. If the Company cannot successfully raise additional capital when needed and implement its strategic development plan, its liquidity, financial condition and business prospects will be materially and adversely affected.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company believes its existing cash, cash equivalents, cash held in escrow, investments and subsequent equity fund raising completed in February 2021 (see Note 11) are sufficient to fund its operating cashflow requirements for a period greater than 12 months from the date of issuance of these financial statements.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash, Cash Equivalents and Investments</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Cash, Cash Equivalents and Investments</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers all highly liquid investments with maturities of 90 days or less from the date of purchase to be cash equivalents. Investments with original maturities of greater than 90 days from the date of purchase but less than one year from the balance sheet date are classified as short-term investments, while investments with maturities in one year or beyond one year from the balance sheet date are classified as long-term investments. Management determines the appropriate classification of its cash equivalents and investment securities at the time of purchase and re-evaluates such determination as of each balance sheet date. Management has classified the Company&#8217;s cash equivalents and investments as available-for-sale securities in the accompanying financial statements. Available-for-sale securities are carried at fair value, with unrealized gains and losses reported as a component of accumulated other comprehensive loss. Realized gains and losses are included in interest income. There were no material realized gains or losses in the periods presented. The cost of securities sold is based on the specific identification method.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company invests in debt instruments of government agencies, corporations, and money market funds with high credit ratings. The Company has established guidelines regarding diversification of its investments and their maturities with the objectives of maintaining safety and liquidity, while maximizing yield.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash held in escrow (related to the sale of the LACTEL product line) was $15 million as of December 31, 2020; the $15 million which was released from escrow in January 2021.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Concentrations of Credit Risk</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to credit risk consist principally of interest-bearing investments and trade receivables. The Company maintains cash, cash equivalents and investments with various major financial institutions. The Company performs periodic evaluations of the relative credit standing of these financial institutions. In addition, the Company performs periodic evaluations of the relative credit quality of its investments.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pharmaceutical companies and academic institutions account for a substantial portion of the Company&#8217;s trade receivables. The Company provides credit in the normal course of business to its customers and collateral for these receivables is generally not required. The risk associated with this concentration is limited to a certain extent due to the large number of accounts and their geographic dispersion. The Company monitors the creditworthiness of its customers to which it grants credit terms in the normal course of business. The Company maintains reserves for estimated credit losses and, to date, such losses have been immaterial in all periods presented.</p>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorCustomersPolicyPolicyTextBlock', window );">Customer and Product Line Concentrations</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Customer and Product Line Concentrations (excluding the LACTEL product line)</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A portion of the Company&#8217;s revenue is derived from its ALZET osmotic pump product line, and the sale of certain excipients for Methydur and one excipient that is included in a marketed animal health product. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue from the sale of products from the ALZET product line accounted for 20%, 27% and 46% of total revenue for 2020, 2019 and 2018, respectively. &#160; &#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gilead accounted for 76% and 68% of the Company&#8217;s total revenue for 2020 and 2019, respectively. In 2018, Indivior and Gilead accounted for 33% and 17% of the Company&#8217;s total revenues, respectively. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue by geographic region for the years 2020, 2019 and 2018 are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,894</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,957</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,058</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Europe</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,386</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">906</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,476</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Japan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,174</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,472</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">975</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Others</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">657</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">739</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">766</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,111</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,074</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,275</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue by geography is determined by the location of the customer.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Inventories</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out basis. The Company may be required to expense previously capitalized inventory costs upon a change in management&#8217;s judgment due to new information that suggests that the inventory will not be saleable. &#160;If the Company is able to subsequently sell products made with raw materials that were previously written down, the Company will report an unusually high gross profit as there will be no associated cost of goods for these materials.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s inventories consisted of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Raw materials</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">163</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Work in-process</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">796</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">709</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finished goods</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">932</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,047</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total inventories</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,864</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,919</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Property and Equipment</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment are stated at cost less accumulated depreciation, which is computed using the straight-line method over the estimated useful lives of the assets, which range from three to five years. Leasehold improvements are amortized using the straight-line method over the estimated useful lives of the assets, or the terms of the related leases, whichever are shorter.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Goodwill</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill is periodically assessed and evaluated for impairment. The Company operates in one operating segment and also has only one reporting unit, which is the research, development and manufacturing of pharmaceutical products. The Company assesses the impairment of goodwill at least annually and whenever events or changes in circumstances indicate that the carrying value may not be </p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">recoverable. Factors the Company considers important which could trigger an impairment review include the following:</span></p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td style="width:3.85%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-family:Times New Roman;color:#000000;">significant decline in our stock price for a prolonged period;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td style="width:3.85%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-family:Times New Roman;color:#000000;">our market capitalization relative to net book value;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td style="width:3.85%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-family:Times New Roman;color:#000000;">new information affecting the commercial value of the asset;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td style="width:3.85%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-family:Times New Roman;color:#000000;">significant underperformance relative to historical or projected future operating results;</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td style="width:3.85%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-family:Times New Roman;color:#000000;">significant changes in the manner of our use of the acquired assets or the strategy for the Company&#8217;s overall business; and</span></p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td style="width:3.85%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:11pt;font-family:'Times New Roman'">&#8226;</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-family:Times New Roman;color:#000000;">significant negative industry or economic trends.</span></p></td></tr></table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the carrying value of goodwill was approximately $6.2 million compared with $6.4 million as of December 31, 2019 and 2018. As a result of the sale of the LACTEL product line, approximately $229,000 of the carry value of goodwill was allocated to the LACTEL product line upon its disposition.&#160;&#160;The Company evaluates goodwill for impairment at least annually. In 2020, 2019 and 2018, goodwill was evaluated and no indicators of impairment were identified. To date, the Company has not recorded any impairment charge related to goodwill. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Impairment of Long-Lived Assets</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company reviews long-lived assets, including property and equipment, intangible assets, and other long-term assets, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of the asset and its eventual disposition is less than its carrying amount. Impairment, if any, is calculated as the amount by which an asset&#8217;s carrying value exceeds its fair value, typically using discounted cash flows to determine fair value. Through December 31, 2020, there have been no material impairment losses.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Leases</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company leases administrative, manufacturing and laboratory facilities under operating leases. Lease agreements may include rent holidays, rent escalation clauses and tenant improvement allowances. Prior to the adoption of <span style="color:#000000;">Accounting Standards Update ("ASU" No. 2016-02, Leases, and the related amendments ("Topic 842")</span>, the Company recognized scheduled rent increases on a straight-line basis over the lease term beginning with the date the Company took possession of the leased space. The Company recorded tenant improvement allowances as deferred rent liabilities and amortized the deferred rent over the terms of the lease to rent expense on the statements of operations and comprehensive loss.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effective January 1, 2019, the Company adopted Topic 842 using the modified retrospective transition method approach with a cumulative-effect adjustment as of January 1, 2019. Other prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under previous lease guidance, ASC Topic 840: Leases (Topic 840). The Company elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allowed the Company to carry forward the historical lease classification of those leases in place as of January 1, 2019.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The adjustments due to the adoption of Topic 842 primarily related to the recognition of an operating lease right-of-use asset and corresponding operating lease liability for the Company&#8217;s leased properties. <span style="color:#212529;">The Company&#8217;s operating lease right-of-use asset and liability were recognized at the adoption date of ASC 842 based on the present value of lease payments over the remaining lease term at the adoption date. In determining the net present value of lease payments, we used our incremental borrowing </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#212529;">rate of </span><span style="color:#212529;">13.8</span><span style="color:#212529;">% based on the information available, including remaining lease term, at the adoption date of ASC 842. As of December 31, 20</span><span style="color:#212529;">20</span><span style="color:#212529;">, the weighted-average remaining lease term was </span><span><span style="color:#212529;">2.99</span><span style="color:#212529;"> years</span></span><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> for the Company&#8217;s leased properties</span><span style="color:#212529;">.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There was no effect from the adoption of Topic 842 on the Company&#8217;s Statement of cash flows.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Stock-Based Compensation</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for share-based payments using a fair-value based method for costs related to all share-based payments, including stock options and stock issued under the Company&#8217;s employee stock purchase plan (ESPP). The Company estimates the fair value of share-based payment awards on the date of grant using an option-pricing model. See Note 8 for further information regarding stock-based compensation.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Revenue Recognition</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company enters into license and collaboration agreements under which the Company may receive upfront license fees, research funding and contingent milestone payments and royalties. Effective January 1, 2018, the Company adopted FASB ASC Topic 606, Revenue from Contracts with Customers, or ASC 606. In accordance with ASC 606, the Company changed certain characteristics of its revenue recognition accounting policy as described below. ASC 606 was applied using the modified retrospective method, where the cumulative effect of the initial application was recognized as an adjustment to opening retained earnings at January 1, 2018. The Company recorded a net decrease to opening accumulated deficit of&#160;$470,000 with an offset entry to reduce deferred revenue as of January 1, 2018 due to the cumulative impact of adopting Topic 606, with the impact relating to the Company&#8217;s deferred collaborative research and development revenues. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Product Revenue, Net</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company sells osmotic pumps used in laboratory research, and manufactures certain excipients for pharmaceutical clients for use as raw materials in their products.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenues from product sales are recognized when the customer obtains control of the Company&#8217;s product, which occurs at a point in time, typically upon shipment to the customer. The Company expenses incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that the Company would have recognized is one year or less.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade Discounts and Allowances: The Company provides certain customers with discounts that are explicitly stated in the Company&#8217;s contracts and are recorded as a reduction of revenue in the period the related product revenue is recognized.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product Returns: Consistent with industry practice, the Company generally offers customers a limited right of return for products that have been purchased from the Company. The Company estimates the amount of its product sales that may be returned by its customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. The Company currently estimates product return liabilities using its historical sales information. The Company expects product returns to be minimal.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">Collaborative Research and Development and Other Revenue</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company enters into license agreements, under which it licenses certain rights to its product candidates to third parties. The terms of these arrangements typically include payment to the Company of one or more of the following: non-refundable, up-front license fees; reimbursement of development costs incurred by the Company under approved work plans; development, regulatory and commercial milestone payments; payments for manufacturing supply services the Company provides through its contract manufacturers; and royalties on net sales of licensed products. Each of these payments results in collaborative research and development revenues, except for revenues from royalties on net sales of licensed products, which are classified as other revenues.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In determining the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements, the Company performs the following steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. As part of the accounting for these arrangements, the Company must develop assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the contract. The Company uses key assumptions to determine the standalone selling price, which may include forecasted revenues, development timelines, reimbursement rates for personnel costs, discount rates and probabilities of technical and regulatory success. The Company expects to recognize revenue for the variable consideration currently being constrained when it is probable that a significant revenue reversal will not occur.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Licenses of intellectual property: If the license to the Company&#8217;s intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, up-front fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are bundled with other promises, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, up-front fees. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. Any such adjustments are recorded on a cumulative catch-up basis, which would affect collaborative research and development revenues and net income (loss) in the period of adjustment.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Milestone Payments: At the inception of each arrangement that includes development milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or the licensee, such as regulatory approvals, are not considered probable of being achieved until those approvals are received. The transaction price is then allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company recognizes revenue as or when the performance obligations under the contract are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such development milestones and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect collaborative research and development revenues and net income (loss) in the period of adjustment. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing Supply Services: Arrangements that include a promise for future supply of drug product for either clinical development or commercial supply at the customer&#8217;s discretion are generally considered as options. The Company assesses if these options provide a material right to the customer and if so, they are accounted for as separate performance obligations. If the Company is entitled to additional payments when the customer exercises these options, any additional payments are recorded in collaborative research and development revenue when the customer obtains control of the goods, which is upon delivery.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Royalties and Earn-outs: For arrangements that include sales-based royalties or earn-outs, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). To date, the Company has not recognized material royalty revenue resulting from the Company&#8217;s collaborative arrangements or material earn-out revenue from the Company&#8217;s patent purchase agreement with Indivior.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company receives payments from its customers based on development cost schedules established in each contract. Up-front payments are recorded as deferred revenue upon receipt or when due, and may require deferral of revenue recognition to a future period until the Company performs its obligations under these arrangements.&#160;&#160;Amounts are recorded as accounts receivable when the Company&#8217;s right to consideration is unconditional. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the customer and the transfer of the promised goods or services to the customer will be one year or less.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_PrepaidAndAccruedContractResearchExpensesPolicyTextBlock', window );">Prepaid and Accrued Contract Research Expenses</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Prepaid and Accrued Contract Research Expenses</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company incurs significant costs associated with third party consultants and organizations for pre-clinical studies, clinical trials, contract research and manufacturing, validation, testing, regulatory advice and other research and development-related services. The Company is required to estimate periodically the cost of services rendered but unbilled based on management&#8217;s estimates of project status. If these good faith estimates are inaccurate, actual expenses incurred could materially differ from these estimates.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses are primarily comprised of salaries and benefits associated with research and development personnel, overhead and facility costs, preclinical and non-clinical development costs, clinical trial and related clinical manufacturing costs, contract services, and other outside costs. Research and development costs are expensed as incurred. Research and development costs paid to third parties under sponsored research agreements are recognized as the related services are performed. In addition, reimbursements of research and development expenses incurred by the Company&#8217;s partners are recorded as collaborative research and development revenue.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Comprehensive Loss</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Components of other comprehensive loss are comprised entirely of unrealized gains and losses on the Company&#8217;s available-for-sale securities for all periods presented. Total comprehensive loss has been disclosed in the Company&#8217;s Statements of Comprehensive Loss.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Segment Reporting</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company operates in one operating segment, which is the research, development and manufacturing of pharmaceutical products.</p>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Net Loss Per Share</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per share is calculated by dividing the net loss by the weighted-average number of common shares outstanding. Diluted net loss per share is computed using the weighted-average number of common shares outstanding and common stock equivalents (i.e., options to purchase common stock) outstanding during the period, if dilutive, using the treasury stock method for options. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The numerators and denominators in the calculation of basic and diluted net loss per share were as follows (in thousands except per share amounts):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:79.04%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerators:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(582</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,578</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25,322</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominators:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares used to compute basic</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; net loss per share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">199,457</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">178,042</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">159,834</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effect of dilutive securities:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dilution from stock options</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dilution from ESPP</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dilutive common shares</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares used to compute diluted</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; net loss per share</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">199,457</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">178,042</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">159,834</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.00</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.12</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.16</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.00</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.12</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.16</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The computation of diluted net loss per share for 2020, 2019 and 2018 excludes the impact of options to purchase 7.5 million, 21.4&#160;million and 16.6&#160;million shares of common stock outstanding at December 31, 2020, 2019 and 2018, respectively, as such impact would be antidilutive.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_ShippingAndHandlingPolicyTextBlock', window );">Shipping and Handling</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Shipping and Handling</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Costs related to shipping and handling are included in cost of revenues for all periods presented.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:2.62%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:11pt;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:2.62%;font-family:Times New Roman;">&#160;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, as part of its initiative to reduce complexity in the accounting standards, the FASB issued ASU 2019-12, <span style="font-style:italic;">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span> (&#8220;ASU 2019-12&#8221;), which eliminates certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company early adopted ASU 2019-12 on January 1, 2020, and this adoption had no material impact on the Company&#8217;s financial position or results of operations. </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2018, the Financial Accounting Standards Board (the FASB) issued ASU No.&#160;2018-18,&#160;<span style="font-style:italic;">Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606&#160;(ASU 2018-18)</span>. ASU 2018-18 clarifies that certain transactions between collaborative arrangement </p>
<p style="margin-top:6pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">participants should be accounted for as revenue under Topic 606 when the counterparty is a customer for a distinct good or service (i.e. a unit of account). For units of account that are in the scope of Topic 606, all of the guidance in Topic 606 should be applied, including the guidance on recognition, measurement, presentation and disclosure. ASU 2018-18 also adds a reference in Topic 808 to the unit of account guidance in ASC 606 and requires that it be applied only to assess whether transactions in a collaborative arrangement are in the scope of Topic 606. ASU 2018-18 will preclude entities from presenting amounts related to transactions with a counterparty in a collaborative arrangement that is not a customer as revenue from contracts with customers. ASU 2018-18 is effective for the Company for all interim and annual reporting periods beginning after December 15, 2019. </span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The adoption of this standard did not have a material effect on the Company&#8217;s financial statements</span><span style="color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2018, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;)&#160;No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurement, which eliminates certain disclosure requirements for fair value measurements for all entities, requires public entities to disclose certain new information and modifies some disclosure requirements. This standard is effective for fiscal years beginning after December 15, 2019, including interim reporting periods within those years. The adoption of this standard did not have a material effect on the Company&#8217;s financial statements.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January 2017, the FASB issued ASU No.&#160;2017-04,&#160;<span style="font-style:italic;">Intangibles&#8212;Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,&#160;(ASU 2017-04)</span>.&#160;ASU 2017-04 eliminated Step 2 from the goodwill impairment test. Instead, under the amendments in ASU 2017-04, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax&#160;effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. ASU 2017-04 is effective for all interim and annual reporting periods beginning after December 15, 2019. The adoption of this standard did not have a material effect on the Company&#8217;s financial statements.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016,&#160;the FASB issued Accounting Standards Update No. 2016-13 (ASU 2016-13)&#160;&#8220;Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments.&#8221;&#160;ASU 2016-13 requires measurement and recognition of expected credit losses for financial assets. This standard is effective for fiscal years beginning after December 15, 2022 for small reporting companies, including interim reporting periods within those years and must be adopted using a modified retrospective approach, with certain exceptions. Early adoption is permitted.&#160; The Company does not expect the adoption of this standard to have a material effect on its financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_DiscontinuedOperationsTextblock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_DiscontinuedOperationsTextblock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liquidity and need to raise additional capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_NatureOfOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nature of operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_NatureOfOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_PrepaidAndAccruedContractResearchExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid and Accrued Contract Research Expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_PrepaidAndAccruedContractResearchExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_ShippingAndHandlingPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shipping and handling.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_ShippingAndHandlingPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167745858408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock', window );">Summary of Total Revenue by Geographic Region</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue by geographic region for the years 2020, 2019 and 2018 are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:59.3%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,894</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,957</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,058</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Europe</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,386</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">906</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,476</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.64%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Japan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,174</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,472</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">975</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Others</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">657</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">739</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">766</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:37.64%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,111</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,074</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.72%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,275</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Summary of Components of Inventories</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s inventories consisted of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Raw materials</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">163</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Work in-process</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">796</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">709</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finished goods</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">932</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,047</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total inventories</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,864</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,919</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Summary of Numerators and Denominators in Calculation of Basic and Diluted Net Income (Loss) per Share</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The numerators and denominators in the calculation of basic and diluted net loss per share were as follows (in thousands except per share amounts):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:79.04%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.28%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerators:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(582</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,578</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25,322</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominators:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares used to compute basic</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; net loss per share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">199,457</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">178,042</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">159,834</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effect of dilutive securities:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dilution from stock options</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dilution from ESPP</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dilutive common shares</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares used to compute diluted</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; net loss per share</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">199,457</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">178,042</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">159,834</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share:</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.00</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.12</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.16</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.00</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.52%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.12</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.02%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.58%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.16</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167746517128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Strategic Agreements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization Consolidation And Presentation Of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock', window );">Summary of Collaborative Research and Development and Other Revenues Associated with Company's Major Third-Party Collaborators</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The collaborative research and development and other revenues associated with the Company&#8217;s major third-party collaborators are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Collaborator/Counterparty</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gilead (1)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,879</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,133</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,542</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other (2)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,062</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">996</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,665</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total collaborative research and development and other revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,941</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,129</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,207</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:81.2%;text-indent:0%;font-size:6pt;font-family:Times New Roman;">&#160;</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</span></p></td>
<td valign="top">
<p style="margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Amounts related to recognition of upfront fees and milestone payments were $22.7 million, $12.3 million and zero for the twelve months ended December 31, 2020, 2019 and 2018, respectively. The Company signed a license agreement with Gilead on July 19, 2019 and received a nonrefundable upfront license fee and a milestone payment totaling $35.0 million in 2019 which was being recognized as revenue as its obligation was being satisfied using the cost-to-cost input method (see Note 2. Strategic Agreements - Agreement with Gilead Sciences, Inc. in the financial statements). In June 2020, the Company received notice that Gilead was terminating the License Agreement and a related R&amp;D agreement between Gilead and the Company. As a result, the Company recognized all its remaining deferred revenue as there were no remaining substantive performance obligations to be provided to Gilead by the Company as of the date when the termination notice was received.  Amounts recognized as revenue during each of the twelve months ended December 31, 2020, 2019 and 2018 also included the Company&#8217;s reimbursable collaborative research and development services performed under its agreement with Gilead.</p></td></tr></table></div>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</span></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">Includes: (a) amounts related to earn-out revenue from Indivior UK Limited (Indivior) with respect to PERSERIS net sales; (b) feasibility programs; (c) research and development activities funded by Santen Pharmaceutical Co. Ltd. (Santen); and (d) royalty revenue from OP Pharma with respect to Methydur net sales. Note that in January 2018, the Company was notified by Santen that due to a shift in priorities, Santen had elected to reallocate research and development resources and put the Company&#8217;s program on pause until further notice. While the main program is on pause, the parties are working together on a limited set of research and development activities funded by Santen. </p></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Summary of Changes in the Company's Contract Asset and Liabilities</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents changes in the Company&#8217;s contract assets and liabilities for the twelve months ended December 31, 2020 and 2019 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">January 1,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deletions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,812</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(39,318</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">494</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total contract asset</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,812</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(39,318</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">494</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue, current portion</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,321</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,679</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total contract liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,321</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,679</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">January 1,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.68%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Deletions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.16%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">494</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(694</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total contract asset</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">494</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(694</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue, current portion</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,679</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,174</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(31,853</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:45.16%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total contract liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,679</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,174</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(31,853</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.16%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.68%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.16%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167744317128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value Measurements of Assets and Liabilities</a></td>
<td class="text">The following table sets forth the fair value of the Company&#8217;s financial assets that were measured at fair value on a recurring basis as of December 31, 2020 (in thousands):
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">522</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">522</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificates of deposit</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,213</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,213</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal bonds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,305</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,305</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Government agencies</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">522</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,668</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,190</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth the fair value of our financial assets that were measured at fair value on a recurring basis as of December&#160;31, 2019 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">524</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">524</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificates of deposit</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,218</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,218</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Government agencies</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,501</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,501</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,868</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,868</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">524</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61,737</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62,261</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Summary of Money Market Funds and Available-for-Sale Securities</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is a summary of available-for-sale securities as of December 31, 2020 and 2019 (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gain</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">522</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">522</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificates of deposit</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,213</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,213</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Municipal bonds</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,310</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,305</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Government agencies</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,195</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,190</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reported as:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,619</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,619</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,426</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,421</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term investments</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,000</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term restricted investments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,195</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,190</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gain</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Loss</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">524</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">524</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certificates of deposit</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,221</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,218</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. Government agencies</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,500</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,501</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate debt</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,869</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,868</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62,264</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62,261</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reported as:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and cash equivalents</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,364</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,361</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term investments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,750</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,750</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Summary of Cost and Estimated Fair Value of Available-for-Sale Securities by Contractual Maturity</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is a summary of the cost and estimated fair value of available-for-sale securities at December 31, 2020, by contractual maturity (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Estimated</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mature in one year or less</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,523</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,518</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mature after one year through five years</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,150</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,673</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,668</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167752193016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property Plant And Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property and Equipment</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment consist of the following (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equipment</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,890</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,740</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,428</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,422</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction-in-progress</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,360</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,236</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less accumulated depreciation and amortization</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,109</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,077</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">251</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">159</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167747658024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments And Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock', window );">Summary of Lease Arrangements of Company Facilities</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="width:16.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Location</p></td>
<td style="width:1%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Approximate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Square Feet<span style="font-weight:normal;"> </span></p></td>
<td style="width:1%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.65pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:20%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operation</p></td>
<td style="width:1%;" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:8.65pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;">&#160;</p></td>
<td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:45%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Expiration</p></td>
</tr>
<tr>
<td style="width:16.98%; border-top:solid 0.75pt #000000;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cupertino,&#160;CA</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,149 sq. ft.</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:20%; border-top:solid 0.75pt #000000;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Office, Laboratory and Manufacturing</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:45%; border-top:solid 0.75pt #000000;" valign="top"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease expires 2024 (with an option to renew for an additional five years) </p></td>
</tr>
<tr style="height:3.75pt;">
<td style="width:16.98%;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:15%;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:20%;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:45%;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td style="width:16.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cupertino, CA</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,100 sq. ft.</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:20%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Office and Laboratory</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:45%;" valign="top"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease expires 2024 (with an option to renew for an additional five years)</p></td>
</tr>
<tr>
<td style="width:16.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:20%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:45%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td style="width:16.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vacaville, CA</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="padding-left:0pt;padding-Right:0pt;padding-Top:0pt;padding-Bottom:0pt;width:15%;white-space:nowrap;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,634 sq. ft.</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:20%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:15.85pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td style="width:45%;" valign="top"><p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease expires 2023 (with an option to renew for an additional five years)</p></td>
</tr>
<tr style="height:3.75pt;">
<td style="width:16.98%;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:15%;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:20%;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:1%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td style="width:45%;" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Operating Lease Minimum Payments</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Future minimum payments under these noncancelable leases are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ending December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Leases</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%; border-top:solid 0.75pt #000000;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,933</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,991</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,970</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">275</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,169</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of lease arrangements of company facilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167845491976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Term Loan (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Future Maturities and Interest Payments under Term Loan</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of the term loan approximates the carrying value. Future maturities and interest payments under the term loan as of December 31, 2020, are as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,941</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,208</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,563</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,712</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total minimum payments</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,424</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less amount representing interest</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,646</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross balance of term loan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,778</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less unamortized debt discount</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(958</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Carrying value of term loan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,820</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less term loan, current portion, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(884</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term loan, non-current portion, net</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,936</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167742052760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock', window );">Summary of Shares of Common Stock Reserved for Future Issuance</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, shares of common stock reserved for future issuance consisted of the following:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options outstanding</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,274,439</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options available for grant</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,599,531</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee Stock Purchase Plan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">497,270</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,371,240</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity under all Stock-Based Compensation Plans</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of stock option activity under all stock-based compensation plans is as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price&#160;Per&#160;Share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average&#160;Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual Term</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in Years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in&#160;millions)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,803,766</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.41</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000769">5.17</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71.3</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,702,860</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.12</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,865,835</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.11</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options forfeited</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(389,471</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.45</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options expired</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,976,881</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.20</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,274,439</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.45</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000770">4.98</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable at December 31, 2020</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,512,705</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.42</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000771">4.44</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.7</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested and expected to vest at</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; December 31, 2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,274,439</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.45</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000772">4.98</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.6</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Employee Stock-Based Compensation Cost that has been Included in Statements of Operations and Comprehensive Loss</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the Company had three stock-based equity compensation plans, which are described above. The employee stock-based compensation cost that has been included in the statements of operations and comprehensive loss is shown as below (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of product revenues</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">981</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">746</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,541</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,085</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,269</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,355</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,079</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,028</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,909</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Assumptions Used to Estimate Fair Value of Options Granted and Shares Purchased</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company used the following assumptions to estimate the fair value of options granted (including fully vested options issued in January 2019 and 2018) and shares purchased under its stock plans and employee stock purchase plan for the years ended December 31, 2020, 2019 and 2018:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Stock Options</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free rate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000803">0.5-1.4%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000804">1.5-2.7%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000805">2.7-3.1%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000806">7.0-7.3</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000807">7.5-10.0</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000808">7.0-10.0</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000812">84-87%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000813">79-83%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000814">78-86%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeiture rate (1)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.0</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:3.85%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;">&#160;</p></td>
<td style="width:5.24%;white-space:nowrap" valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</span></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Calibri;font-size:11pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/><span style="font-family:Times New Roman;color:#000000;">Effective January 1, 2017, the Company elected to account for forfeitures as they occur.</span> </p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:7.69%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Employee Stock Purchase Plan</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free rate</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.1%</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000824">1.6-2.5%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000825">1.3-2.5%</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000826">0.5</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000827">0.5</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000828">0.5</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000829">78-124%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000830">60-103%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000831">60-146%</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock', window );">Summary of Stock Options Outstanding</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes information about stock options outstanding at December 31, 2020:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.72%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.52%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options Outstanding</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.56%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options Exercisable</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Range of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual&#160;Life</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(In years)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercisable</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.46%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%; border-top:solid 0.75pt #000000;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000843">$0.51 - $0.57</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">143,750</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000876">8.12</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.57</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,418</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.56</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000844">$0.58 - $0.58</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,878,012</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000877">7.79</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.58</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,165,967</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.58</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000845">$0.58 - $0.88</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,561,267</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000878">3.65</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.82</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,549,297</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.82</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000846">$0.93 - $1.20</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,761,642</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000879">4.92</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.15</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,706,954</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.15</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000847">$1.21 - $1.21</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,608,933</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000880">2.13</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.21</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,606,683</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.21</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000848">$1.24 - $1.24</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,869,328</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000881">6.84</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.24</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,457,142</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.24</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000849">$1.26 - $1.26</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000882">5.28</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.26</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,000</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.26</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000850">$1.31 - $1.31</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,755,496</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000883">5.62</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.31</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,527,036</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.31</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.72%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000851">$1.33 - $2.09</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,068,694</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000884">4.35</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.81</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,610,445</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.81</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.72%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000852">$2.10 - $3.61</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,587,317</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000885">4.95</span></p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.66</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,798,763</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.95</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:19.72%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000853">$0.51 - $3.61</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,274,439</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000886">4.98</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.45</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,512,705</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.46%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.42</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167745951912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of Income Tax Expenses (Benefit)</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The reconciliation of income tax expenses (benefit) at the statutory federal income tax rate of&#160;21%, to net income tax benefit included in the statements of operations and comprehensive loss for the years ended December 31, 2020, 2019 and 2018 is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. federal taxes benefit at statutory rate</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(122</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,321</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,318</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State taxes</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in valuation allowance</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,022</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,142</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,143</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">268</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">879</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">999</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development tax credits</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,132</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,004</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(999</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax Reform change in tax rate and other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expiring net operating losses</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,991</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,252</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">175</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total income tax (benefit) provision</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Summary of Components of Company's Deferred Tax Assets</a></td>
<td class="text">Significant components of the Company&#8217;s deferred tax assets and liabilities are as follows (in thousands):
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating loss carryforwards</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87,197</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90,102</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and other credits</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,153</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,860</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">223</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">248</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,840</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,376</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,204</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,288</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115,617</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,874</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance for deferred tax assets</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(114,323</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(117,245</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities - Right of use asset</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,538</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,873</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets and liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(244</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(244</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Reconciliation of Unrecognized Tax Benefits</a></td>
<td class="text">
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at beginning of the year</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,078</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,432</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increase (decrease) related to prior year tax positions</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,136</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(73</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increase related to current year tax positions</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">674</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">719</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at end of the year</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,888</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,078</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=121610041&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167751312856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract', window );"><strong>Disposal Group Not Discontinued Operation Income Statement Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock', window );">Summary of Discontinued Operations Reported in Statement of Operations</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:-5.24%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of income from discontinued operations as reported in the Company&#8217;s statement of operations were as follows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:-5.24%;font-size:4pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.76%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-top:solid 0.75pt #000000;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product revenue, net</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,918</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,490</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,289</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenues</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,918</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,490</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,289</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of product revenues</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,880</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,623</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">476</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">569</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">488</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">515</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">248</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">157</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total costs and expenses</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,010</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,697</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,268</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income from discontinued operations</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">908</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">793</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other income:</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on sale of the LACTEL product line</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,845</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income from discontinued operations</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,753</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">793</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income per share</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.07</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.00</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.00</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average shares used in computing net income per share basic and diluted</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:70.5%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic and diluted</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">199,457</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">178,042</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">159,834</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:70.5%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock', window );">Summary of Assets and Liabilities Reported as Discontinued Operations in Balance Sheet</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:5.24%;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents information related to assets and liabilities reported as discontinued</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">operations in the Company&#8217;s balance sheet (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">797</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,465</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discontinued operations &#8211; current portion</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,296</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">310</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr></table></div>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease right-of-use assets</span></p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">200</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other long-term assets</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discontinued operations &#8211; non-current portion</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">532</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">127</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">344</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities, current portion</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">301</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discontinued operations &#8211; current portion</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">772</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities, non-current portion</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">161</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other long-term liabilities</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discontinued operations &#8211; non-current portion</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">257</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock', window );">Summary of Non-cash Items Related to Discontinued Operations Included in Statement of Cash Flows</a></td>
<td class="text">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents certain non-cash items related to discontinued operations, which are included in the Company&#8217;s statement of cash flows (in thousands):</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;">
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years ended December 31,</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">198</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">241</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">229</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss on disposal of property and equipment</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">647</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">322</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on sale of the LACTEL product line</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,845</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-cash items, net</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,198</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">322</p></td>
<td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
</table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of Assets and Liabilities Reported as Discontinued Operations in Balance Sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of Discontinued Operations Reported in Statement of Operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of Non-cash Items Related to Discontinued Operations Included in Statement of Cash Flows.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167849125256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Detail)<br> shares in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Segment </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationDateOfIncorporation', window );">Date of incorporation</a></td>
<td class="text">Feb.  06,  1998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 489,784,000<span></span>
</td>
<td class="nump">$ 489,202,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_LiquidInvestmentsMaturityPeriodDescriptionMaximum', window );">Highly liquid investments maturity period</a></td>
<td class="text">90 days or less<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_LongTermInvestmentsMaturityPeriodDescriptionMinimum', window );">Long term investments maturity period description minimum</a></td>
<td class="text">one year or beyond<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Realized investment gains losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | Segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 6,169,000<span></span>
</td>
<td class="nump">6,399,000<span></span>
</td>
<td class="nump">$ 6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long lived assets held for use</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">$ (489,784,000)<span></span>
</td>
<td class="num">$ (489,202,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share amount | shares</a></td>
<td class="nump">7.5<span></span>
</td>
<td class="nump">21.4<span></span>
</td>
<td class="nump">16.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember', window );">Revision of Prior Period, Change in Accounting Principle, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (470,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 470,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member', window );">Accounting Standards Update 2014-09</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_LesseeOperatingLeaseIncrementalBorrowingRate', window );">Lessee operating lease incremental borrowing rate</a></td>
<td class="nump">13.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease weighted average remaining lease term1</a></td>
<td class="text">2 years 11 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=drrx_LACTELMember', window );">L A C T E L</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 229,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Sales Revenue Net [Member] | Customer Concentration Risk [Member] | Gilead [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue accounted in Company's total revenue</a></td>
<td class="nump">76.00%<span></span>
</td>
<td class="nump">68.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Sales Revenue Net [Member] | Customer Concentration Risk [Member] | Indivior [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue accounted in Company's total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_PaymentFromEscrow', window );">Amount released from escrow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=drrx_LactelProductLineMember', window );">LACTEL Product Line [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_CashHeldInEscrow', window );">Cash held in escrow</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=drrx_AlzetProductLineMember', window );">ALZET Product Line [Member] | Sales Revenue Net [Member] | Product Concentration Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue accounted in Company's total revenue</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_ShortTermInvestmentMaturityPeriod', window );">Short term investment maturity period</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property plant and equipment useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_ShortTermInvestmentMaturityPeriod', window );">Short term investment maturity period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property plant and equipment useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationDateOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when an entity was incorporated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationDateOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_CashHeldInEscrow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash held in escrow.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_CashHeldInEscrow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_LesseeOperatingLeaseIncrementalBorrowingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Incremental borrowing rate used by lessee to determine present value of operating lease payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_LesseeOperatingLeaseIncrementalBorrowingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_LiquidInvestmentsMaturityPeriodDescriptionMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liquid investments maturity period description maximum.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_LiquidInvestmentsMaturityPeriodDescriptionMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_LongTermInvestmentsMaturityPeriodDescriptionMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long term investments maturity period description minimum.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_LongTermInvestmentsMaturityPeriodDescriptionMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_PaymentFromEscrow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment from escrow.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_PaymentFromEscrow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_ShortTermInvestmentMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short-term investment maturity period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_ShortTermInvestmentMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=drrx_LACTELMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=drrx_LACTELMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=drrx_GileadMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=drrx_GileadMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=drrx_IndiviorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=drrx_IndiviorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=drrx_LactelProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=drrx_LactelProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=drrx_AlzetProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=drrx_AlzetProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167833526168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Total Revenue by Geographic Region (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues From External Customers And Long Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 30,111<span></span>
</td>
<td class="nump">$ 25,074<span></span>
</td>
<td class="nump">$ 15,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues From External Customers And Long Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">26,894<span></span>
</td>
<td class="nump">21,957<span></span>
</td>
<td class="nump">7,058<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues From External Customers And Long Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">1,386<span></span>
</td>
<td class="nump">906<span></span>
</td>
<td class="nump">6,476<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_JP', window );">JAPAN</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues From External Customers And Long Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">1,174<span></span>
</td>
<td class="nump">1,472<span></span>
</td>
<td class="nump">975<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=drrx_OtherForeignCountriesMember', window );">Other Foreign Countries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues From External Customers And Long Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 657<span></span>
</td>
<td class="nump">$ 739<span></span>
</td>
<td class="nump">$ 766<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=drrx_OtherForeignCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=drrx_OtherForeignCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167746533448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Components of Inventories (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 136<span></span>
</td>
<td class="nump">$ 163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in-process</a></td>
<td class="nump">796<span></span>
</td>
<td class="nump">709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">932<span></span>
</td>
<td class="nump">1,047<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 1,864<span></span>
</td>
<td class="nump">$ 1,919<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167751465400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Numerators and Denominators in Calculation of Basic and Diluted Net Loss per Share (Detail) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerators:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (582)<span></span>
</td>
<td class="num">$ (20,578)<span></span>
</td>
<td class="num">$ (25,322)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominators:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares used to compute basic net loss per share</a></td>
<td class="nump">199,457<span></span>
</td>
<td class="nump">178,042<span></span>
</td>
<td class="nump">159,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities', window );">Weighted average shares used to compute diluted net loss per share</a></td>
<td class="nump">199,457<span></span>
</td>
<td class="nump">178,042<span></span>
</td>
<td class="nump">159,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.16)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average number of shares outstanding diluted net of effect of dilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167833476488">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Strategic Agreements - Summary of Collaborative Research and Development and Other Revenues Associated with Company's Major Third-Party Collaborators (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 19, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaborative research and development and other revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,111<span></span>
</td>
<td class="nump">$ 25,074<span></span>
</td>
<td class="nump">$ 15,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember', window );">Collaborative Research and Development and Other Revenue [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaborative research and development and other revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,941<span></span>
</td>
<td class="nump">18,129<span></span>
</td>
<td class="nump">8,207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=drrx_AgreementWithGileadMember', window );">Agreement with Gilead [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaborative research and development and other revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">22,700<span></span>
</td>
<td class="nump">12,300<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=drrx_AgreementWithGileadMember', window );">Agreement with Gilead [Member] | Collaborative Research and Development and Other Revenue [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaborative research and development and other revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,879<span></span>
</td>
<td class="nump">17,133<span></span>
</td>
<td class="nump">2,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=drrx_AgreementsWithOtherCollaboratorsOrCounterpartiesMember', window );">Agreements With Other Collaborators or Counterparties [Member] | Collaborative Research and Development and Other Revenue [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaborative research and development and other revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,062<span></span>
</td>
<td class="nump">$ 996<span></span>
</td>
<td class="nump">$ 5,665<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amounts related to recognition of upfront fees and milestone payments were $22.7 million, $12.3 million and zero for the twelve months ended December 31, 2020, 2019 and 2018, respectively. The Company signed a license agreement with Gilead on July 19, 2019 and received a nonrefundable upfront license fee and a milestone payment totaling $35.0 million in 2019 which was being recognized as revenue as its obligation was being satisfied using the cost-to-cost input method (see Note 2. Strategic Agreements - Agreement with Gilead Sciences, Inc. in the financial statements). In June 2020, the Company received notice that Gilead was terminating the License Agreement and a related R&amp;D agreement between Gilead and the Company. As a result, the Company recognized all its remaining deferred revenue as there were no remaining substantive performance obligations to be provided to Gilead by the Company as of the date when the termination notice was received.  Amounts recognized as revenue during each of the twelve months ended December 31, 2020, 2019 and 2018 also included the Company&#8217;s reimbursable collaborative research and development services performed under its agreement with Gilead.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes: (a) amounts related to earn-out revenue from Indivior UK Limited (Indivior) with respect to PERSERIS net sales; (b) feasibility programs; (c) research and development activities funded by Santen Pharmaceutical Co. Ltd. (Santen); and (d) royalty revenue from OP Pharma with respect to Methydur net sales. Note that in January 2018, the Company was notified by Santen that due to a shift in priorities, Santen had elected to reallocate research and development resources and put the Company&#8217;s program on pause until further notice. While the main program is on pause, the parties are working together on a limited set of research and development activities funded by Santen.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=drrx_AgreementWithGileadMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=drrx_AgreementWithGileadMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=drrx_AgreementsWithOtherCollaboratorsOrCounterpartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=drrx_AgreementsWithOtherCollaboratorsOrCounterpartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167747444648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Strategic Agreements - Summary of Collaborative Research and Development and Other Revenues Associated with Company's Major Third-Party Collaborators (Parenthetical) (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 19, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,111<span></span>
</td>
<td class="nump">$ 25,074<span></span>
</td>
<td class="nump">$ 15,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=drrx_AgreementWithGileadMember', window );">Agreement with Gilead [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 22,700<span></span>
</td>
<td class="nump">12,300<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=drrx_AgreementWithGileadMember', window );">Agreement with Gilead [Member] | License Fees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Amount related to the milestone payment earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=drrx_AgreementWithGileadMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=drrx_AgreementWithGileadMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167751672840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Strategic Agreements - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Amount related to the milestone payment earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=drrx_EarlyStageClinicalTestingMember', window );">Early stage clinical testing [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_DevelopmentBasedMilestones', window );">Development-based milestones</a></td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=drrx_LateStageClinicalTestingMember', window );">Late stage clinical testing [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_DevelopmentBasedMilestones', window );">Development-based milestones</a></td>
<td class="nump">3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=us-gaap_RegulatoryReviewsOfFilingsMember', window );">Regulatory filings [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_DevelopmentBasedMilestones', window );">Development-based milestones</a></td>
<td class="nump">3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=drrx_RegulatoryApprovalsMember', window );">Regulatory approvals [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_DevelopmentBasedMilestones', window );">Development-based milestones</a></td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=drrx_DevelopmentBasedMilestonesMember', window );">Development-Based Milestones [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Amount related to the milestone payment earned</a></td>
<td class="nump">13,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=drrx_SalesBasedMilestonesMember', window );">Sales-Based Milestones [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Amount related to the milestone payment earned</a></td>
<td class="nump">$ 63,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_DevelopmentBasedMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Development based milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_DevelopmentBasedMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=drrx_EarlyStageClinicalTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=drrx_EarlyStageClinicalTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=drrx_LateStageClinicalTestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=drrx_LateStageClinicalTestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=us-gaap_RegulatoryReviewsOfFilingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=us-gaap_RegulatoryReviewsOfFilingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=drrx_RegulatoryApprovalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=drrx_RegulatoryApprovalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=drrx_DevelopmentBasedMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=drrx_DevelopmentBasedMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=drrx_SalesBasedMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=drrx_SalesBasedMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167751736872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Strategic Agreements - Agreement with Gilead Sciences, Inc - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 19, 2019</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,111<span></span>
</td>
<td class="nump">$ 25,074<span></span>
</td>
<td class="nump">$ 15,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=drrx_UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember', window );">Upfront, Development, Regulatory and Sales-Based Milestones [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment', window );">Performance milestone payments based on successful development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember', window );">Collaborative Research and Development and Other Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_AccruedAmountOfFinalPaymentOfTermLoan', window );">Deferred revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=drrx_AgreementWithGileadMember', window );">Agreement with Gilead [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,700<span></span>
</td>
<td class="nump">$ 12,300<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_ContractWithCustomerLiabilityMilestonePayment', window );">Amount related to the milestone payment earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_AccruedAmountOfFinalPaymentOfTermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued amount of final payment of term loan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_AccruedAmountOfFinalPaymentOfTermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_ContractWithCustomerLiabilityMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract with customer liability milestone payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_ContractWithCustomerLiabilityMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Performance milestone payments based on successful development and approval of the four ORADUR based opioids.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=drrx_UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=drrx_UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=drrx_AgreementWithGileadMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=drrx_AgreementWithGileadMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167859523544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Strategic Agreements - Summary of Changes in the Company's Contract Asset and Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 494<span></span>
</td>
<td class="nump">$ 494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Total contract asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">494<span></span>
</td>
<td class="nump">494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue, current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,679<span></span>
</td>
<td class="nump">22,679<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Total contract liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,679<span></span>
</td>
<td class="nump">22,679<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerDurationAxis=drrx_AdditionsMember', window );">Additions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Total contract asset</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue, current portion</a></td>
<td class="nump">9,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Total contract liabilities</a></td>
<td class="nump">9,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerDurationAxis=drrx_DeletionsMember', window );">Deletions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrentAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Total contract asset</a></td>
<td class="nump">694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue, current portion</a></td>
<td class="nump">31,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Total contract liabilities</a></td>
<td class="nump">$ 31,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,321<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerDurationAxis=drrx_AdditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerDurationAxis=drrx_AdditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerDurationAxis=drrx_DeletionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerDurationAxis=drrx_DeletionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167833646984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Strategic Agreements - Patent Purchase Agreement with Indivior - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 26, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,111<span></span>
</td>
<td class="nump">$ 25,074<span></span>
</td>
<td class="nump">$ 15,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=drrx_PatentPurchaseAgreementWithIndiviorMember', window );">Patent Purchase Agreement with Indivior [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_NonRefundableUpfrontPaymentReceived', window );">Upfront non-refundable payment received</a></td>
<td class="nump">$ 12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_GrantedPatentsExtendingYearMinimum', window );">Granted patents extending year, minimum</a></td>
<td class="text">2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=drrx_PatentPurchaseAgreementWithIndiviorMember', window );">Patent Purchase Agreement with Indivior [Member] | Intellectual Property Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=drrx_PatentPurchaseAgreementWithIndiviorMember', window );">Patent Purchase Agreement with Indivior [Member] | Regulatory Based Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment', window );">Performance milestone payments based on successful development</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognition milestone achieved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_GrantedPatentsExtendingYearMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Granted patents extending year, minimum.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_GrantedPatentsExtendingYearMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_NonRefundableUpfrontPaymentReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-refundable upfront payment received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_NonRefundableUpfrontPaymentReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Performance milestone payments based on successful development and approval of the four ORADUR based opioids.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=drrx_PatentPurchaseAgreementWithIndiviorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=drrx_PatentPurchaseAgreementWithIndiviorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=drrx_RegulatoryBasedMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=drrx_RegulatoryBasedMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167748433624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Strategic Agreements - Agreement with Santen Pharmaceutical Co., Ltd. - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 11, 2014</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,111,000<span></span>
</td>
<td class="nump">$ 25,074,000<span></span>
</td>
<td class="nump">$ 15,275,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Amount related to the milestone payment earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=drrx_AgreementWithSantenPharmaceuticalCoLtdMember', window );">Agreement with Santen Pharmaceutical Co., Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned', window );">Cumulative aggregate payments received by the Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=drrx_AgreementWithSantenPharmaceuticalCoLtdMember', window );">Agreement with Santen Pharmaceutical Co., Ltd. [Member] | License Fees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=drrx_AgreementWithSantenPharmaceuticalCoLtdMember', window );">Agreement with Santen Pharmaceutical Co., Ltd. [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment', window );">Performance milestone payments based on successful development</a></td>
<td class="nump">76,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=drrx_AgreementWithSantenPharmaceuticalCoLtdMember', window );">Agreement with Santen Pharmaceutical Co., Ltd. [Member] | Development-Based Milestones [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment', window );">Performance milestone payments based on successful development</a></td>
<td class="nump">13,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=drrx_AgreementWithSantenPharmaceuticalCoLtdMember', window );">Agreement with Santen Pharmaceutical Co., Ltd. [Member] | Commercialization-Based Milestones [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment', window );">Performance milestone payments based on successful development</a></td>
<td class="nump">$ 63,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Amount related to the milestone payment earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Performance milestone payments based on successful development and approval of the four ORADUR based opioids.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23221-108380<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23199-108380<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=drrx_AgreementWithSantenPharmaceuticalCoLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=drrx_AgreementWithSantenPharmaceuticalCoLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=drrx_DevelopmentBasedMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=drrx_DevelopmentBasedMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=drrx_CommercializationBasedMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=drrx_CommercializationBasedMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167746045544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Strategic Agreements - Agreement with Sandoz AG - Additional Information (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=drrx_AgreementWithSandozAGMember', window );">Agreement with Sandoz AG [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned', window );">Cumulative aggregate payments received by the Company</a></td>
<td class="nump">$ 20.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23221-108380<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23199-108380<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=drrx_AgreementWithSandozAGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=drrx_AgreementWithSandozAGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167751029496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Fair Value Measurements of Assets (Detail) - Fair Value on Recurring Basis [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">$ 40,190<span></span>
</td>
<td class="nump">$ 62,261<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">522<span></span>
</td>
<td class="nump">524<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">39,668<span></span>
</td>
<td class="nump">61,737<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">522<span></span>
</td>
<td class="nump">524<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">522<span></span>
</td>
<td class="nump">524<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember', window );">Commercial paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">32,213<span></span>
</td>
<td class="nump">47,218<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember', window );">Commercial paper [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">32,213<span></span>
</td>
<td class="nump">47,218<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MunicipalBondsMember', window );">Municipal bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">6,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MunicipalBondsMember', window );">Municipal bonds [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">6,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. Government agencies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">4,501<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. Government agencies [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">4,501<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,868<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,868<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167750782216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Summary of Money Market Funds and Available-for-Sale Securities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 40,195<span></span>
</td>
<td class="nump">$ 62,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">40,190<span></span>
</td>
<td class="nump">62,261<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">522<span></span>
</td>
<td class="nump">524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">522<span></span>
</td>
<td class="nump">524<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">32,213<span></span>
</td>
<td class="nump">47,221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">32,213<span></span>
</td>
<td class="nump">47,218<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember', window );">Municipal bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">6,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">6,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. Government agencies [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">4,501<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">19,619<span></span>
</td>
<td class="nump">32,364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">19,619<span></span>
</td>
<td class="nump">32,361<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">19,426<span></span>
</td>
<td class="nump">29,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">19,421<span></span>
</td>
<td class="nump">29,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember', window );">Long-term investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=drrx_LongTermRestrictedInvestmentsMember', window );">Long Term Restricted Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,868<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=drrx_LongTermRestrictedInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=drrx_LongTermRestrictedInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167752390952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Summary of Cost and Estimated Fair Value of Available-for-Sale Securities by Contractual Maturity (Detail)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments Debt And Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Mature in one year or less, Amortized Cost</a></td>
<td class="nump">$ 38,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Mature after one year through five years, Amortized Cost</a></td>
<td class="nump">1,150<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">39,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Mature in one year or less, Estimated Fair Value</a></td>
<td class="nump">38,518<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Mature after one year through five years, Estimated Fair Value</a></td>
<td class="nump">1,150<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate', window );">Estimated Fair Value</a></td>
<td class="nump">$ 39,668<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167861700792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Additional Information (Detail)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments Debt And Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Unrealized loss of securities</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167750775016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment - Property and Equipment (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 19,360<span></span>
</td>
<td class="nump">$ 19,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(19,109)<span></span>
</td>
<td class="num">(19,077)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">251<span></span>
</td>
<td class="nump">159<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">10,890<span></span>
</td>
<td class="nump">10,740<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">8,428<span></span>
</td>
<td class="nump">8,422<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction-in-progress [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167742432728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property Plant And Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 297,000<span></span>
</td>
<td class="nump">$ 291,000<span></span>
</td>
<td class="nump">$ 254,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligation', window );">Restoration cost</a></td>
<td class="nump">$ 482,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167744325736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Restricted Investments - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_RestrictedInvestmentsLineItems', window );"><strong>Restricted Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedInvestmentsNoncurrent', window );">Restricted investments in connection with deposits on letters of credit</a></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">California [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_RestrictedInvestmentsLineItems', window );"><strong>Restricted Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedInvestmentsNoncurrent', window );">Restricted investments in connection with deposits on letters of credit</a></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_RestrictedInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restricted Investments [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_RestrictedInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedInvestmentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the noncurrent portion of investments which are not defined as or included in marketable (debt, equity, or other) securities that are pledged or subject to withdrawal restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedInvestmentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167751358040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments - Summary of Lease Arrangements of Company Facilities (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>ft&#178;</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=drrx_CupertinoCAMember', window );">Cupertino, CA [Member] | Office, Laboratory and Manufacturing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems', window );"><strong>Property Subject To Or Available For Operating Lease [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_LeaseExpirationYear', window );">Lease expiration year</a></td>
<td class="text">2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease renewal term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=drrx_CupertinoCAMember', window );">Cupertino, CA [Member] | Office, Laboratory and Manufacturing [Member] | Lease Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems', window );"><strong>Property Subject To Or Available For Operating Lease [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LandSubjectToGroundLeases', window );">Approximate Square Feet</a></td>
<td class="nump">30,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_LeaseExpirationTerm', window );">Expiration</a></td>
<td class="text">Lease expires 2024 (with an option to renew for an additional five years) <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=drrx_CupertinoCAMember', window );">Cupertino, CA [Member] | Office and Laboratory [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems', window );"><strong>Property Subject To Or Available For Operating Lease [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_LeaseExpirationYear', window );">Lease expiration year</a></td>
<td class="text">2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease renewal term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=drrx_CupertinoCAMember', window );">Cupertino, CA [Member] | Office and Laboratory [Member] | Lease Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems', window );"><strong>Property Subject To Or Available For Operating Lease [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LandSubjectToGroundLeases', window );">Approximate Square Feet</a></td>
<td class="nump">20,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_LeaseExpirationTerm', window );">Expiration</a></td>
<td class="text">Lease expires 2024 (with an option to renew for an additional five years)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=drrx_VacavilleCAMember', window );">Vacaville, CA [Member] | Manufacturing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems', window );"><strong>Property Subject To Or Available For Operating Lease [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LandSubjectToGroundLeases', window );">Approximate Square Feet</a></td>
<td class="nump">24,634<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_LeaseExpirationTerm', window );">Expiration</a></td>
<td class="text">Lease expires 2023 (with an option to renew for an additional five years)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_LeaseExpirationYear', window );">Lease expiration year</a></td>
<td class="text">2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease renewal term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_LeaseExpirationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease expiration term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_LeaseExpirationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_LeaseExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease expiration year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_LeaseExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LandSubjectToGroundLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of land subject to a ground lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LandSubjectToGroundLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=drrx_CupertinoCAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=drrx_CupertinoCAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=drrx_OfficeLaboratoryAndManufacturingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=drrx_OfficeLaboratoryAndManufacturingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=drrx_LeaseAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=drrx_LeaseAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=drrx_OfficeAndLaboratoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=drrx_OfficeAndLaboratoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=drrx_VacavilleCAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=drrx_VacavilleCAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ManufacturingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ManufacturingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167752249704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_CommitmentAndContingenciesLineItems', window );"><strong>Commitment And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expenses of operating leases</a></td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Remaining minimum purchase commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="nump">$ 1,406,000<span></span>
</td>
<td class="nump">1,263,000<span></span>
</td>
<td class="nump">$ 1,640,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product Revenue, Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_CommitmentAndContingenciesLineItems', window );"><strong>Commitment And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_CommitmentAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commitment and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_CommitmentAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum amount the entity agreed to spend under the long-term purchase commitment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167742050296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments - Schedule of Future Operating Lease Minimum Payments (Detail)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent', window );">2021</a></td>
<td class="nump">$ 1,933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears', window );">2022</a></td>
<td class="nump">1,991<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears', window );">2023</a></td>
<td class="nump">1,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears', window );">2024</a></td>
<td class="nump">275<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable', window );">Total operating leases future minimum payments</a></td>
<td class="nump">$ 6,169<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future minimum rental payments in aggregate as of the balance sheet date under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121578510&amp;loc=d3e41551-112718<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future rental payments receivable within one year of the balance sheet date under an operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121578510&amp;loc=d3e41551-112718<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future rental payments receivable within the fourth year from the balance sheet date under an operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121578510&amp;loc=d3e41551-112718<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future rental payments receivable within the third year from the balance sheet date under an operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121578510&amp;loc=d3e41551-112718<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future rental payments receivable within the second year from the balance sheet date under an operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121578510&amp;loc=d3e41551-112718<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167747385864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Term Loan - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>Feb. 28, 2018</div></th>
<th class="th"><div>Jul. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtRestructuringCosts', window );">Loan modification fee</a></td>
<td class="nump">$ 825,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=drrx_OxfordFinanceLlcTermLoanMember', window );">Oxford Finance LLC Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPaymentTerms', window );">Term loan repayment description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">As amended, the Loan Agreement provides for interest only payments for the first 18 months, followed by consecutive monthly payments of principal and interest in arrears starting on December 1, 2021 and continuing through the maturity date of the term loan of May 1, 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1', window );">First principal payment date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec.  01,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Term loan, maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May  01,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.95%<span></span>
</td>
<td class="nump">7.95%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Term loan, floating interest rate basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">index rate plus a spread<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid', window );">Facility fee paid at final payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_DebtInstrumentPrincipalPaymentPercentage', window );">Percentage of an additional payment equal to principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_DebtIssuanceCost', window );">Debt offering/issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtRestructuringCosts', window );">Loan modification fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=drrx_OxfordFinanceLlcTermLoanMember', window );">Oxford Finance LLC Term Loan [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_DebtInstrumentPrepaymentFeePercentage', window );">Percentage of prepayment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=drrx_OxfordFinanceLlcTermLoanMember', window );">Oxford Finance LLC Term Loan [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_DebtInstrumentPrepaymentFeePercentage', window );">Percentage of prepayment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_DebtInstrumentPrepaymentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument prepayment fee percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_DebtInstrumentPrepaymentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_DebtInstrumentPrincipalPaymentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument principal payment percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_DebtInstrumentPrincipalPaymentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_DebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt issuance costs (for example, but not limited to, legal, accounting, broker, and regulatory fees).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_DebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDateOfFirstRequiredPayment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the debt agreement requires the first payment to be made, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDateOfFirstRequiredPayment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The reference rate for the variable rate of the debt instrument, such as LIBOR or the US Treasury rate and the maturity of the reference rate used, such as three months or six months LIBOR.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescriptionOfVariableRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred in the modification of term of existing debt agreement in order for the entity to achieve some advantage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=drrx_OxfordFinanceLlcTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=drrx_OxfordFinanceLlcTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167748291848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Term Loan - Schedule of Future Maturities and Interest Payments under Term Loan (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Future maturities and interest payments under the term loan:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 2,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2022</a></td>
<td class="nump">9,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2023</a></td>
<td class="nump">8,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2024</a></td>
<td class="nump">4,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total minimum payments</a></td>
<td class="nump">25,424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Less amount representing interest</a></td>
<td class="num">(3,646)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross balance of term loan</a></td>
<td class="nump">21,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Less unamortized debt discount</a></td>
<td class="num">(958)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value of term loan</a></td>
<td class="nump">20,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less term loan, current portion, net</a></td>
<td class="num">(884)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Term loan, non-current portion, net</a></td>
<td class="nump">$ 19,936<span></span>
</td>
<td class="nump">$ 20,262<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167849139960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Common Stock - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 21, 2021</div></th>
<th class="th"><div>Jun. 20, 2019</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Mar. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Oct. 31, 2018</div></th>
<th class="th"><div>Nov. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock, net of commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,283,000<span></span>
</td>
<td class="nump">$ 18,360,000<span></span>
</td>
<td class="nump">$ 16,780,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross proceeds from sale of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuances of common stock in connection with equity financings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,283,000<span></span>
</td>
<td class="nump">18,360,000<span></span>
</td>
<td class="nump">16,780,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=drrx_OctoberTwoThousandEighteenRegistrationStatementMember', window );">October Two Thousand Eighteen Registration Statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock, net of commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,300,000<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,308,002<span></span>
</td>
<td class="nump">2,349,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_CommonStockWeightedAveragePrice', window );">Common stock weighted average price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.39<span></span>
</td>
<td class="nump">$ 1.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuances of common stock in connection with equity financings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,300,000<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon equity financings, net of issuance cost, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,308,002<span></span>
</td>
<td class="nump">2,349,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=drrx_OctoberTwoThousandEighteenRegistrationStatementMember', window );">October Two Thousand Eighteen Registration Statement | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock, net of commission</a></td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock during period</a></td>
<td class="nump">950,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_CommonStockWeightedAveragePrice', window );">Common stock weighted average price</a></td>
<td class="nump">$ 2.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuances of common stock in connection with equity financings</a></td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon equity financings, net of issuance cost, shares</a></td>
<td class="nump">950,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_CommonStockCapitalAmountReservedForFutureIssuance', window );">Securities offered</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175,000,000.0<span></span>
</td>
<td class="nump">$ 125,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=drrx_CantorFitzgeraldCoMember', window );">Cantor Fitzgerald Co [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock, net of commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,364,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock number of shares issued in transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,364,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.2386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross proceeds from sale of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuances of common stock in connection with equity financings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Common stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 195,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon equity financings, net of issuance cost, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,364,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=drrx_CantorFitzgeraldCoMember', window );">Cantor Fitzgerald Co [Member] | Controlled Equity Offering Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock, net of commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_CommonStockWeightedAveragePrice', window );">Common stock weighted average price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuances of common stock in connection with equity financings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon equity financings, net of issuance cost, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=drrx_CantorFitzgeraldCoMember', window );">Cantor Fitzgerald Co [Member] | October Two Thousand Eighteen Registration Statement | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock, net of commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">950,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_CommonStockWeightedAveragePrice', window );">Common stock weighted average price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuances of common stock in connection with equity financings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon equity financings, net of issuance cost, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">950,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=drrx_CantorFitzgeraldCoMember', window );">Cantor Fitzgerald Co [Member] | Maximum [Member] | Controlled Equity Offering Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_CommonStockCapitalAmountReservedForFutureIssuance', window );">Securities offered</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000.0<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_CommonStockCapitalAmountReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock capital amount reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_CommonStockCapitalAmountReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_CommonStockWeightedAveragePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock weighted average price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_CommonStockWeightedAveragePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=drrx_OctoberTwoThousandEighteenRegistrationStatementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=drrx_OctoberTwoThousandEighteenRegistrationStatementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=drrx_CantorFitzgeraldCoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=drrx_CantorFitzgeraldCoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=drrx_ControlledEquityOfferingProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=drrx_ControlledEquityOfferingProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167751928632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - 2000 Stock Plan (Incentive Stock Plan) - Additional Information (Detail) - shares<br></strong></div></th>
<th class="th" colspan="6">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2014</div></th>
<th class="th"><div>Apr. 30, 2013</div></th>
<th class="th"><div>Jun. 30, 2011</div></th>
<th class="th"><div>Mar. 31, 2000</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Reserved common stock for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,371,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options exercised, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,702,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,599,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Common stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,274,439<span></span>
</td>
<td class="nump">29,803,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=drrx_TwoThousandStockPlanMember', window );">2000 Stock Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm', window );">Maximum expiration term of stock appreciation rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_EmployeesStockPurchasePlanExtendedTermPeriod', window );">Extended term of stock plan to the date</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon equity financing, net of issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Reserved common stock for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,955,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_EmployeeStockPurchasePlanExpirationDate', window );">Plan expiry date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 30,  2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options exercised, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_StockOptionsVestingPeriod', window );">Option plan vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Options granted with different vesting terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_MinimumPercentageOfCombinedVotingPowerClassesOfStock', window );">Minimum percentage of total combined voting power of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower', window );">Minimum exercise price as percentage of fair market value to holder of more than 10% voting power</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower', window );">Minimum exercise price as percentage of fair market value to holder of 10% or less voting power</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,599,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Common stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,274,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=drrx_TwoThousandStockPlanMember', window );">2000 Stock Plan [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors', window );">Stock option exercisable period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=drrx_TwoThousandStockPlanMember', window );">2000 Stock Plan [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors', window );">Stock option exercisable period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=drrx_TwoThousandStockPlanMember', window );">2000 Stock Plan [Member] | Non-employee director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options exercised, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_EmployeeStockPurchasePlanExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee stock purchase plan expiration date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_EmployeeStockPurchasePlanExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_EmployeesStockPurchasePlanExtendedTermPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employees stock purchase plan extended term period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_EmployeesStockPurchasePlanExtendedTermPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercisable period from date of grant for stock option granted to non employee directors.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_MinimumPercentageOfCombinedVotingPowerClassesOfStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of total combined voting power classes of stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_MinimumPercentageOfCombinedVotingPowerClassesOfStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum expiration term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum exercise price as percentage of fair market value to holder of more than ten percent voting power.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum exercise price as percentage of fair market value to holder of ten percent or less voting power.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_StockOptionsVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock and unit award vesting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_StockOptionsVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=drrx_TwoThousandStockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=drrx_TwoThousandStockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=drrx_NonEmployeeDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=drrx_NonEmployeeDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167747766168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - 2000 Employee Stock Purchase Plan - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Mar. 31, 2015</div></th>
<th class="th"><div>Apr. 30, 2010</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share available for future grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,599,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203,533,000<span></span>
</td>
<td class="nump">195,257,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share available for future grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,599,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_OptionsGrantedWithExercisePricesLowerThanFairMarket', window );">Options granted with exercise prices lower than fair market</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Excess tax benefits recognized for tax deductions on stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxExpenseFromStockOptionsExercised', window );">Incremental tax benefits recognized from stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=drrx_TwoThousandEmployeeStockPurchasePlanMember', window );">2000 Employee Stock Purchase Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_EmployeeStockPurchasePlanOfferingPeriod', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum', window );">Exercise price as percentage of fair market value minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Stock option increase</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_EmployeesStockPurchasePlanExtendedTermPeriod', window );">Extended term of stock plan to the date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_EmployeeStockPurchasePlanExpirationDate', window );">Plan expiry date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 30,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Options shares reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share available for future grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">497,270<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,752,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600,000<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share available for future grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">497,270<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant-date fair value of all options granted with exercise prices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.43<span></span>
</td>
<td class="nump">$ 0.94<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_EmployeeStockPurchasePlanExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee stock purchase plan expiration date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_EmployeeStockPurchasePlanExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_EmployeeStockPurchasePlanOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee stock purchase plan offering period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_EmployeeStockPurchasePlanOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_EmployeesStockPurchasePlanExtendedTermPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employees stock purchase plan extended term period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_EmployeesStockPurchasePlanExtendedTermPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_OptionsGrantedWithExercisePricesLowerThanFairMarket">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Options granted with exercise prices lower than fair market.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_OptionsGrantedWithExercisePricesLowerThanFairMarket</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price as percentage of fair market value minimum.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxExpenseFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax expense from write-off of the deferred tax asset related to deductible stock options at exercise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxExpenseFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=drrx_TwoThousandEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=drrx_TwoThousandEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167848183512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Shares of Common Stock Reserved for Future Issuance (Detail) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding</a></td>
<td class="nump">27,274,439<span></span>
</td>
<td class="nump">29,803,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Stock options available for grant</a></td>
<td class="nump">7,599,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved for future issuance</a></td>
<td class="nump">35,371,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=drrx_TwoThousandEmployeeStockPurchasePlanMember', window );">2000 Employee Stock Purchase Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Stock options available for grant</a></td>
<td class="nump">497,270<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved for future issuance</a></td>
<td class="nump">497,270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=drrx_TwoThousandEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=drrx_TwoThousandEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167750902056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Stock Option Activity under all Stock-Based Compensation Plans (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, Number of Options, beginning balance</a></td>
<td class="nump">29,803,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted, Number of Options</a></td>
<td class="nump">2,702,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised, Number of Options</a></td>
<td class="num">(2,865,835)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options forfeited, Number of Options</a></td>
<td class="num">(389,471)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Options expired, Number of Options</a></td>
<td class="num">(1,976,881)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, Number of Options, ending balance</a></td>
<td class="nump">27,274,439<span></span>
</td>
<td class="nump">29,803,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable, Number of Options</a></td>
<td class="nump">23,512,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest, Number of Options</a></td>
<td class="nump">27,274,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, Number of Options, Weighted Average Exercise Price Per Share, beginning balance</a></td>
<td class="nump">$ 1.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">2.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">1.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options forfeited, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">1.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Options expired, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">2.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding, Number of Options, Weighted Average Exercise Price Per Share, ending balance</a></td>
<td class="nump">1.45<span></span>
</td>
<td class="nump">$ 1.41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable, Number of Options, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">1.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest, Number of Options, Weighted Average Exercise Price Per Share</a></td>
<td class="nump">$ 1.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding, Number of Options, Weighted Average Remaining Contractual Term</a></td>
<td class="text">4 years 11 months 23 days<span></span>
</td>
<td class="text">5 years 2 months 1 day<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable, Number of Options, Weighted Average Remaining Contractual Term</a></td>
<td class="text">4 years 5 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest, Number of Options, Weighted Average Remaining Contractual Term</a></td>
<td class="text">4 years 11 months 23 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding, Number of Options, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 19,600<span></span>
</td>
<td class="nump">$ 71,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable, Number of Options, Aggregate Intrinsic Value</a></td>
<td class="nump">17,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest, Number of Options, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 19,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167751088280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Employee Stock-Based Compensation Cost that has been Included in Statements of Operations and Comprehensive Loss (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total employee stock-based compensation cost</a></td>
<td class="nump">$ 2,079<span></span>
</td>
<td class="nump">$ 2,028<span></span>
</td>
<td class="nump">$ 2,909<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of product revenues [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total employee stock-based compensation cost</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total employee stock-based compensation cost</a></td>
<td class="nump">981<span></span>
</td>
<td class="nump">746<span></span>
</td>
<td class="nump">1,541<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total employee stock-based compensation cost</a></td>
<td class="nump">$ 1,085<span></span>
</td>
<td class="nump">$ 1,269<span></span>
</td>
<td class="nump">$ 1,355<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167752071800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Determining Fair Value - Additional Information (Detail) - 2000 Employee Stock Purchase Plan [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments', window );">Expected dividend yield in Black-Scholes option valuation model</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Shares purchased under Company's employee stock purchase plan</a></td>
<td class="nump">102,006<span></span>
</td>
<td class="nump">111,909<span></span>
</td>
<td class="nump">119,097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Recognition of expenses on shares purchased under employee stock purchase plan</a></td>
<td class="nump">$ 86,000,000<span></span>
</td>
<td class="nump">$ 27,000,000<span></span>
</td>
<td class="nump">$ 24,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</a></td>
<td class="nump">$ 3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from Stock Options Exercised</a></td>
<td class="nump">$ 3,200,000<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated amount of dividends to be paid to holders of the underlying shares (expected dividends) over the option's term. Dividends are taken into account because payment of dividends to shareholders reduces the fair value of the underlying shares, and option holders generally do not receive dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares purchased for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=drrx_TwoThousandEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=drrx_TwoThousandEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167743087656">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Assumptions Used to Estimate Fair Value of Options Granted and Shares Purchased (Detail)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember', window );">Employees Stock Purchase Plan [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free rate, minimum</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free rate, maximum</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Volatility, minimum</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">78.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Volatility, maximum</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">124.00%<span></span>
</td>
<td class="nump">103.00%<span></span>
</td>
<td class="nump">146.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember', window );">Stock Option Plan [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free rate, minimum</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free rate, maximum</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Volatility, minimum</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">84.00%<span></span>
</td>
<td class="nump">79.00%<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Volatility, maximum</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">87.00%<span></span>
</td>
<td class="nump">83.00%<span></span>
</td>
<td class="nump">86.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate', window );">Forfeiture rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember', window );">Stock Option Plan [Member] | Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember', window );">Stock Option Plan [Member] | Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">7 years 3 months 18 days<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Effective January 1, 2017, the Company elected to account for forfeitures as they occur.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award fair value assumptions forfeiture interest rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167849040200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Stock Options Outstanding (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeOneMember', window );">Range of Exercise Price, $0.51 - $0.57 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options Outstanding, Range of Exercise Price, minimum</a></td>
<td class="nump">$ 0.51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options Outstanding, Range of Exercise Price, maximum</a></td>
<td class="nump">$ 0.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding | shares</a></td>
<td class="nump">143,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted-Average Remaining Contractual Life(In years)</a></td>
<td class="text">8 years 1 month 13 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 0.57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Options Exercisable | shares</a></td>
<td class="nump">50,418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 0.56<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeTwoMember', window );">Range of Exercise Price, $0.58 - $0.58 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options Outstanding, Range of Exercise Price, minimum</a></td>
<td class="nump">0.58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options Outstanding, Range of Exercise Price, maximum</a></td>
<td class="nump">$ 0.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding | shares</a></td>
<td class="nump">2,878,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted-Average Remaining Contractual Life(In years)</a></td>
<td class="text">7 years 9 months 14 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 0.58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Options Exercisable | shares</a></td>
<td class="nump">2,165,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 0.58<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeThreeMember', window );">Range of Exercise Price, $0.58 - $0.88 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options Outstanding, Range of Exercise Price, minimum</a></td>
<td class="nump">0.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options Outstanding, Range of Exercise Price, maximum</a></td>
<td class="nump">$ 0.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding | shares</a></td>
<td class="nump">3,561,267<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted-Average Remaining Contractual Life(In years)</a></td>
<td class="text">3 years 7 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 0.82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Options Exercisable | shares</a></td>
<td class="nump">3,549,297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 0.82<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeFourMember', window );">Range of Exercise Price, $0.93 - $1.20 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options Outstanding, Range of Exercise Price, minimum</a></td>
<td class="nump">0.93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options Outstanding, Range of Exercise Price, maximum</a></td>
<td class="nump">$ 1.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding | shares</a></td>
<td class="nump">2,761,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted-Average Remaining Contractual Life(In years)</a></td>
<td class="text">4 years 11 months 1 day<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 1.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Options Exercisable | shares</a></td>
<td class="nump">2,706,954<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 1.15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeFiveMember', window );">Range of Exercise Price, $1.21 - $1.21 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options Outstanding, Range of Exercise Price, minimum</a></td>
<td class="nump">1.21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options Outstanding, Range of Exercise Price, maximum</a></td>
<td class="nump">$ 1.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding | shares</a></td>
<td class="nump">2,608,933<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted-Average Remaining Contractual Life(In years)</a></td>
<td class="text">2 years 1 month 17 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 1.21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Options Exercisable | shares</a></td>
<td class="nump">2,606,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 1.21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeSixMember', window );">Range of Exercise Price, $1.24 - $1.24 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options Outstanding, Range of Exercise Price, minimum</a></td>
<td class="nump">1.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options Outstanding, Range of Exercise Price, maximum</a></td>
<td class="nump">$ 1.24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding | shares</a></td>
<td class="nump">2,869,328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted-Average Remaining Contractual Life(In years)</a></td>
<td class="text">6 years 10 months 2 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 1.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Options Exercisable | shares</a></td>
<td class="nump">2,457,142<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 1.24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeSevenMember', window );">Range of Exercise Price, $1.26 - $1.26 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options Outstanding, Range of Exercise Price, minimum</a></td>
<td class="nump">1.26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options Outstanding, Range of Exercise Price, maximum</a></td>
<td class="nump">$ 1.26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding | shares</a></td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted-Average Remaining Contractual Life(In years)</a></td>
<td class="text">5 years 3 months 10 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 1.26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Options Exercisable | shares</a></td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 1.26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeEightMember', window );">Range of Exercise Price, $1.31 - $1.31 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options Outstanding, Range of Exercise Price, minimum</a></td>
<td class="nump">1.31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options Outstanding, Range of Exercise Price, maximum</a></td>
<td class="nump">$ 1.31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding | shares</a></td>
<td class="nump">2,755,496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted-Average Remaining Contractual Life(In years)</a></td>
<td class="text">5 years 7 months 13 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 1.31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Options Exercisable | shares</a></td>
<td class="nump">2,527,036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 1.31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeNineMember', window );">Range of Exercise Price, $1.33 - $2.09 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options Outstanding, Range of Exercise Price, minimum</a></td>
<td class="nump">1.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options Outstanding, Range of Exercise Price, maximum</a></td>
<td class="nump">$ 2.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding | shares</a></td>
<td class="nump">5,068,694<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted-Average Remaining Contractual Life(In years)</a></td>
<td class="text">4 years 4 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 1.81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Options Exercisable | shares</a></td>
<td class="nump">4,610,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 1.81<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeTenMember', window );">Range of Exercise Price, $2.10 - $3.61 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options Outstanding, Range of Exercise Price, minimum</a></td>
<td class="nump">2.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options Outstanding, Range of Exercise Price, maximum</a></td>
<td class="nump">$ 3.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding | shares</a></td>
<td class="nump">4,587,317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted-Average Remaining Contractual Life(In years)</a></td>
<td class="text">4 years 11 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 2.66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Options Exercisable | shares</a></td>
<td class="nump">2,798,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 2.95<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeElevenMember', window );">Range of Exercise Price, $0.51 - $3.61 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options Outstanding, Range of Exercise Price, minimum</a></td>
<td class="nump">0.51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options Outstanding, Range of Exercise Price, maximum</a></td>
<td class="nump">$ 3.61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number of Options Outstanding | shares</a></td>
<td class="nump">27,274,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Weighted-Average Remaining Contractual Life(In years)</a></td>
<td class="text">4 years 11 months 23 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 1.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Number of Options Exercisable | shares</a></td>
<td class="nump">23,512,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted-Average Exercise Price</a></td>
<td class="nump">$ 1.42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeTenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeTenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeElevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=drrx_ExercisePriceRangeElevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167750783080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="nump">$ 244,000<span></span>
</td>
<td class="nump">$ 244,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred tax assets</a></td>
<td class="nump">244,000<span></span>
</td>
<td class="nump">244,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax provision</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory federal income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase (decrease) in valuation allowance of net deferred tax assets</a></td>
<td class="num">$ (2,900,000)<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="nump">$ 6,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">10,888,000<span></span>
</td>
<td class="nump">9,078,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,432,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Interest and penalty expense related to unrecognized tax benefits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Federal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards for income tax purposes</a></td>
<td class="nump">344,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_NetOperatingLossCarryforwardsExpirationAmount', window );">Net operating loss carryforwards expiration amount</a></td>
<td class="nump">306,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_NetOperatingLossCarryforwardsNonExpirationAmount', window );">Net operating loss carryforwards non-expiration amount</a></td>
<td class="nump">$ 38,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_TaxCreditCarryforwardExpiration', window );">Tax carryforwards expire date</a></td>
<td class="text">2021 through 2037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Research [Member] | Federal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_TaxCreditCarryforwardExpiration', window );">Tax carryforwards expire date</a></td>
<td class="text">2021 through 2040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Research and development tax credits</a></td>
<td class="nump">$ 15,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Interest and other income, net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax provision (benefit) expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax provision (benefit) expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards for income tax purposes</a></td>
<td class="nump">$ 219,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_TaxCreditCarryforwardExpiration', window );">Tax carryforwards expire date</a></td>
<td class="text">2021 through 2040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State [Member] | Research [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Research and development tax credits</a></td>
<td class="nump">$ 16,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_NetOperatingLossCarryforwardsExpirationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carryforwards expiration amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_NetOperatingLossCarryforwardsExpirationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_NetOperatingLossCarryforwardsNonExpirationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carryforwards non-expiration amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_NetOperatingLossCarryforwardsNonExpirationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_TaxCreditCarryforwardExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax credit carryforward expiration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_TaxCreditCarryforwardExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167750987592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Income Tax Expenses (Benefit) (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Amount [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">U.S. federal taxes benefit at statutory rate</a></td>
<td class="num">$ (122)<span></span>
</td>
<td class="num">$ (4,321)<span></span>
</td>
<td class="num">$ (5,318)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(2,022)<span></span>
</td>
<td class="nump">3,142<span></span>
</td>
<td class="nump">5,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">268<span></span>
</td>
<td class="nump">879<span></span>
</td>
<td class="nump">999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development tax credits</a></td>
<td class="num">(1,132)<span></span>
</td>
<td class="num">(1,004)<span></span>
</td>
<td class="num">(999)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_IncomeTaxReconciliationExpiringNetOperatingLosses', window );">Expiring net operating losses</a></td>
<td class="nump">2,991<span></span>
</td>
<td class="nump">1,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 52<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_IncomeTaxReconciliationExpiringNetOperatingLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation expiring net operating losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_IncomeTaxReconciliationExpiringNetOperatingLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167849086824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Summary of Components of Company's Deferred Tax Assets (Detail) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 87,197,000<span></span>
</td>
<td class="nump">$ 90,102,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and other credits</a></td>
<td class="nump">19,153,000<span></span>
</td>
<td class="nump">18,860,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred revenue</a></td>
<td class="nump">223,000<span></span>
</td>
<td class="nump">248,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">3,840,000<span></span>
</td>
<td class="nump">4,376,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">5,204,000<span></span>
</td>
<td class="nump">5,288,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">115,617,000<span></span>
</td>
<td class="nump">118,874,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance for deferred tax assets</a></td>
<td class="num">(114,323,000)<span></span>
</td>
<td class="num">(117,245,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_DeferredTaxLiabilitiesRightOfUseAssets', window );">Deferred tax liabilities - Right of use asset</a></td>
<td class="num">(1,538,000)<span></span>
</td>
<td class="num">(1,873,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax assets and liabilities</a></td>
<td class="num">$ (244,000)<span></span>
</td>
<td class="num">$ (244,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_DeferredTaxLiabilitiesRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities right of use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_DeferredTaxLiabilitiesRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167742028872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Unrecognized Tax Benefits (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at beginning of the year</a></td>
<td class="nump">$ 9,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions', window );">Increase (decrease) related to prior year tax positions</a></td>
<td class="nump">1,136<span></span>
</td>
<td class="num">$ (73)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase related to current year tax positions</a></td>
<td class="nump">674<span></span>
</td>
<td class="nump">719<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at end of the year</a></td>
<td class="nump">$ 10,888<span></span>
</td>
<td class="nump">$ 9,078<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized tax benefits increase (decreases) resulting from prior period tax positions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167744509288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax', window );">Gain from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,845<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=drrx_EvonikCorporationMember', window );">Evonik [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid', window );">Asset purchase agreement subject to certain adjustments paid</a></td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax', window );">Gain from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset purchase agreement subject to certain adjustments paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=drrx_EvonikCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=drrx_EvonikCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167751683576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations - Summary of Discontinued Operations Reported in Statement of Operations (Detail) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Total revenues</a></td>
<td class="nump">$ 4,918<span></span>
</td>
<td class="nump">$ 4,490<span></span>
</td>
<td class="nump">$ 3,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold', window );">Cost of product revenues</a></td>
<td class="nump">3,019<span></span>
</td>
<td class="nump">2,880<span></span>
</td>
<td class="nump">2,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment', window );">Research and development</a></td>
<td class="nump">476<span></span>
</td>
<td class="nump">569<span></span>
</td>
<td class="nump">488<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">515<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Total costs and expenses</a></td>
<td class="nump">4,010<span></span>
</td>
<td class="nump">3,697<span></span>
</td>
<td class="nump">3,268<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax', window );">Income from discontinued operations</a></td>
<td class="nump">908<span></span>
</td>
<td class="nump">793<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract', window );"><strong>Other income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax', window );">Gain from discontinued operations</a></td>
<td class="nump">12,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net income from discontinued operations</a></td>
<td class="nump">$ 13,753<span></span>
</td>
<td class="nump">$ 793<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income (loss) per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted</a></td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Weighted-average shares used in computing net income per share basic and diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted</a></td>
<td class="nump">199,457<span></span>
</td>
<td class="nump">178,042<span></span>
</td>
<td class="nump">159,834<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product Revenue, Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Total revenues</a></td>
<td class="nump">$ 4,918<span></span>
</td>
<td class="nump">$ 4,490<span></span>
</td>
<td class="nump">$ 3,289<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal group including discontinued operation other income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal group including discontinued operation research and development.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167748472696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Discontinued Operations - Summary of Assets and Liabilities Reported as Discontinued Operations in Balance Sheet (Detail)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract', window );"><strong>Disposal Group Not Discontinued Operation Income Statement Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Accounts receivable</a></td>
<td class="nump">$ 797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Inventories, net</a></td>
<td class="nump">1,465<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations &#8211; current portion</a></td>
<td class="nump">2,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent', window );">Property and equipment, net</a></td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent', window );">Discontinued operations &#8211; non-current portion</a></td>
<td class="nump">532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent', window );">Operating lease liabilities, current portion</a></td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Discontinued operations &#8211; current portion</a></td>
<td class="nump">772<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent', window );">Operating lease liabilities, non-current portion</a></td>
<td class="nump">161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent', window );">Discontinued operations &#8211; non-current portion</a></td>
<td class="nump">$ 257<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal group including discontinued operation operating lease liabilities, current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal group including discontinued operation operating lease liabilities, non current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal group including discontinued operation operating lease right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2510-110228<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2510-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2510-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2510-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2510-110228<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167745975608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations - Summary of Non-cash Items Related to Discontinued Operations Included in Statement of Cash Flows (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract', window );"><strong>Disposal Group Not Discontinued Operation Income Statement Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization', window );">Depreciation</a></td>
<td class="nump">$ 198<span></span>
</td>
<td class="nump">$ 241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill', window );">Goodwill</a></td>
<td class="nump">229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment', window );">Loss on disposal of property and equipment</a></td>
<td class="nump">129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross', window );">Non-cash items, gross</a></td>
<td class="nump">647<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax', window );">Gain from discontinued operations</a></td>
<td class="nump">12,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet', window );">Non-cash items, net</a></td>
<td class="num">$ (12,198)<span></span>
</td>
<td class="nump">$ 322<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal group including discontinued operation non-cash items, gross.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal group including discontinued operation non-cash items, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal group including discontinued operation stock-based compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash items related to discontinued operation gain (loss) on property plant equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-cash items related to disposal group including discontinued operation goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of depreciation and amortization expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167747379976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 21, 2021</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Mar. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock upon equity financings, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,283,000<span></span>
</td>
<td class="nump">$ 18,360,000<span></span>
</td>
<td class="nump">$ 16,780,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">380,000<span></span>
</td>
<td class="nump">356,000<span></span>
</td>
<td class="nump">566,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock, net of commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,283,000<span></span>
</td>
<td class="nump">$ 18,360,000<span></span>
</td>
<td class="nump">$ 16,780,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=drrx_OctoberTwoThousandEighteenRegistrationStatementMember', window );">October 2018 Registration Statement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon equity financings, net of issuance cost, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,308,002<span></span>
</td>
<td class="nump">2,349,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock, net of commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,300,000<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,308,002<span></span>
</td>
<td class="nump">2,349,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_CommonStockWeightedAveragePrice', window );">Common stock weighted average price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.39<span></span>
</td>
<td class="nump">$ 1.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | October 2018 Registration Statement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon equity financings, net of issuance cost, shares</a></td>
<td class="nump">950,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock, net of commission</a></td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock during period</a></td>
<td class="nump">950,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_CommonStockWeightedAveragePrice', window );">Common stock weighted average price</a></td>
<td class="nump">$ 2.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Cantor Fitzgerald Co [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon equity financings, net of issuance cost, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,364,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.2386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock upon equity financings, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_StockIssuedDuringPeriodValueNewIssuesNet', window );">Net proceeds from stock issued during period value new issues, net of issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock, net of commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,364,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Cantor Fitzgerald Co [Member] | October 2018 Registration Statement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon equity financings, net of issuance cost, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">950,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock, net of commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Sale of common stock during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">950,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_CommonStockWeightedAveragePrice', window );">Common stock weighted average price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_CommonStockWeightedAveragePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock weighted average price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_CommonStockWeightedAveragePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_StockIssuedDuringPeriodValueNewIssuesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value new Issues net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_StockIssuedDuringPeriodValueNewIssuesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=drrx_OctoberTwoThousandEighteenRegistrationStatementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=drrx_OctoberTwoThousandEighteenRegistrationStatementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=drrx_CantorFitzgeraldCoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=drrx_CantorFitzgeraldCoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140167742077016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II-Valuation and Qualifying Accounts (Detail) - Allowance for doubtful accounts [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>Valuation And Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of the year</a></td>
<td class="num">$ (27)<span></span>
</td>
<td class="num">$ (83)<span></span>
</td>
<td class="num">$ (69)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_drrx_ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense', window );">Additions (Reductions) to allowances</a></td>
<td class="num">(46)<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of the year</a></td>
<td class="num">$ (72)<span></span>
</td>
<td class="num">$ (27)<span></span>
</td>
<td class="num">$ (83)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_drrx_ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation allowances and reserves charged and reversal of charges to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">drrx_ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>drrx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForCreditLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>96
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ,%]95('04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #!?652N";3G^\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9++
M:L,P$$5_I6AOCQ]-%\+Q)B6K% H-M'0GI$DB:CV0IMCY^\IJXE#:#RAHHYFK
M,V= G?1<NH#/P7D,I#'>36:PD4N_9B<BSP&B/*$1L4P)FYH'%XR@= U'\$)^
MB"-"4U4/8)"$$B1@!A9^(;*^4Y++@()<N."57/#^,PP9IB3@@ 8M1:C+&E@_
M3_3G:>C@!IAAA,'$[P*JA9BK?V)S!]@E.46]I,9Q+,<VY](.-;P][5[RNH6V
MD825F%Y%S>GL<<VNDU_;S>-^R_JF:NJB:HMJM:]7_#Z=]GUV_>%W$S9.Z8/^
MQ\97P;Z#7_^B_P)02P,$%     @ P7UE4IE<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" #!?652WOEA?&0&  "U&0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;)5946_;-A!^WGX%X15#"\2Q1#FVTR4!'#O9O+:I9Z?MNF$/M$1;0B32(ZDX
M_O<[2K+D%O))>TDD6??QXQWYW?%TM9/J28><&_*2Q$)?=T)CMF][/>V'/&'Z
M7&ZY@%_64B7,P*W:]/16<19D1DG<HXXSZ"4L$IV;J^S97-U<R=3$D>!S172:
M)$SM;WDL=]<=MW-XL(@VH;$/>C=76[;A2VX^;><*[GHE2A E7.A("J+X^KHS
M=M].O:$UR-[X'/&=/KHF=BHK*9_LS2RX[CB6$8^Y;RP$@W_/?,+CV"(!CW\+
MT$XYIC4\OCZ@WV>3A\FLF.83&7^) A->=T8=$O U2V.SD+O?>#&A"XOGRUAG
M?\DN?[??[Q _U48FA3$P2"*1_V<OA2..#$;."0-:&-#O#-Q3(WB%@=?6H%\8
M]#//Y%/)_#!EAMU<*;DCRKX-:/8B<V9F#=./A(W[TBCX-0([<S.5?@IA-(2)
M@-P)$YD]F8E\/=FX=,FGY92\?O7FJF=@.&O4\POHVQR:GH!V*?D@A0DUX 8\
M^!:@!SQ+LO1 ]I:BB%/NGQ///2/4H4X-H0EN_H&I<^+DYFZ-^10W_ST5,+I3
M-_HWL_%*UWL9GG<";R*?N2)_CU?:*%C^_R"0_1*RGT'VFZ+YN-_RNHCAYJ[3
M?8>PN"A97* P8Z 09#3N8[:IHX';KUFL.<)C4/(8M//&G*M(VN4=$-@DM8YI
M0"H6WH\__- 0_&');=B.VWVD?1:3KYPI<@\/=1T['*N!TJBD-/I?E JOG22%
MH]U_12A=EI0N49!'Q8)(;,ARGZQD7$<"MY\N%G\B-%RG4DD'!2J4<<$WD=VM
MX*0'EM0NI :@Z:?%W>213#XNYABQ(_EVVQ";0-P4Q&P&2OM"WO%]+34<RG$<
MUQE1QQMAS&C%C*)PDU2I[Q<XM@,;X+I=EW8]%Z-6":_KM7':%Z@VND]"[@19
M<J:EX &9:9UR5<L/QWR0&+5*P%U<@@_Q+)RWX%NI3+8%##/U^[ !\2O7&+-*
MU%U<E0MFGV6<"@,E(@0VYJJ>$8Z$NZI2=Q<7Y8)01H-,8%5MI*I?]SC.@Q1=
MYOM0BBH "7) C&&E\2XNS 7#90@+C4QDLF6BGB .TY0/W4KA75R4#X02!H1N
M4PT_Z_H(XCA&I2BA2M]=7* +0G<)5QN[RG\%!!.BOL(!FWQ%*\FGN%+/)O<+
M,DZ#R$A%QL9P;?*2^%11TX#7R*S2?-I.\V62 )VED?[3&2PRIK@F'U,#/(7-
MFK4%<HY\D2';,^'S#:5#ZKBC@7?5>ZZC50D^Q16ZH#5/5W'D@Y<D,[5%=HXR
M.*+@#BX''O6<BQ,4*F&GK81])@Q7^8G2IAMVD-/:J.&(N'K22M<IKL*/D8DY
MD6OBTM>K-Y!O_%0!U5I&.-)QV,DKY]RF;;*%Y/K,XI23+8BAMFL!HUV)/L6E
M^L"3W+WX(1,;?K+N:0!Z&"^GXS\P3I7NT]:Z3Q[29%6?KAM P&M030S<"XQ2
M)?2TE=#/A"\5).Q,)\ZRE TQA^0D(64JNV.#>M\UG!7N,)*5^--6XO_(7L@L
M@-T0K2,_5S3$BSCD9;_KT<NA<XF5C+3*!K15-A@' 4B9/CM<D/?P'ODHZGV'
M0[H.'3B0ZE8KLI ,:T)X56;P6AT&2IH3>P=A?H1*LHYB ]PDA3T+-1Y6%7E5
M<O!:)8>27+D(YTH^1\*O=6(#YF2,4:L2A-<J0934YA)254S^BK8G=T8#XN6%
MX_8Q;D>]&%SGLQB.%6>GJ>  ?0?; UZ5*#Q<WM_+[.P=PFD$V9<-(,/AL.OV
MW2'&J,H!'B[=95]@+$0*W/(S22TK'*BA:O2J#."U;.P\PE%<1YF&(:QPL*:Z
MS*NR@->NIZ./$@&<)U:V;[#F4("<V'PXZIPI0V:S&8DJ4 TW58\6!E"' <A:
MR828D-OF=R2BK :"K?^RSY4@<QN89J_8QA%A>503SK-S)I0HVI86H8P#.-Z=
MD5T8^2&)-.$O6^[;"1E)5C 0Y-^ "&E(#+@6D FH;AP2L+TF;)T_XT<]DY]_
M&E%W^(L&TZPEL+<M 6Y[PV3*?6[7>MG=/:^+2.^HSVU/#-GW DU\FU[SEG?Y
MM/PF,<XZ\;WJ]?R#Q@=F#QR:Q'P-IL[Y$):NRK\1Y#=&;K.N^4H:(Y/L,N0,
M7&)?@-_74IK#C1V@_%)S\Q]02P,$%     @ P7UE4D6,Y.//!@  TAT  !@
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M%Y2+7W])$4S>]UM8^>(]6AR4"_N5ZYZ_\I?0/9V#L^!"[7V@JN@XV)"ZHY<
M!N?J$Q EX?JLI),EX]5_M'BOIP,%E1!ZFO1G*)T44CVH4;&.AQ?+SXS'VQT=
MYFL02^P72ST'6>M)%HZ<V4(!/H\P[C,%L^A<+8E7,WL.W6> ^KSO7!>,:]I?
M3]0OUGQ;-FK3S:3%QG6\A@<!QWX!_U 4E>8&I>+ZH&U>M2 GZTJINA6F94^&
MLG%9MH-JL8,H"%UR,F@X]FNXVB5T35<3O4'?'0.R1LV<4M\B;90^,F'G%U.=
MY].BS6;CJ,+Q(.#8+^!CP 5=57EEUSM3?>=AFB5F9NV&8ST_O!(8E#KT*[6;
MOZQW Z;RA@&$TYQ:S!!2.V4'V$&@0[] ;^O.D2SW:TW\7 C0N%NQ;?4M9K:M
M_F)TX:9O._\F_*EJA:K;5JI=<)&H'/#M!>+V1;)U?P?WR*1D3?]84J*@:P/U
M^XHQ^?JBK_7VU[C+_P%02P,$%     @ P7UE4H4@XC?Q @  _0D  !@   !X
M;"]W;W)K<VAE971S+W-H965T,RYX;6R=EM]OVC 0Q_\5*]I#*W7D5T.@ J26
MJMH>IJ&R;@_3'DPXB%7'9K8#W?[ZV4Z:)25 * _$=NZ^][GCC#W:<?$L4P"%
M7C+*Y-A)E=K<N*Y,4LBP[/$-,/UFQ46&E9Z*M2LW O#2.F74#3RO[V:8,&<R
MLFLS,1GQ7%'"8":0S+,,BS]W0/EN[/C.Z\(C6:?*++B3T0:O80[J:3,3>N96
M*DN2 9.$,R1@-79N_9NI;QVLQ7<".UD;(Y/*@O-G,_F\'#N>(0(*B3(26#^V
M, 5*C9+F^%V*.E5,XU@?OZH_V.1U,@LL8<KI#[)4Z=@9.&@)*YQ3]<AWGZ!,
M*#)Z":?2?J-=81OU'93D4O&L=-8$&6'%$[^4A:@Y^-<''(+2(>CJ$)8.H4VT
M(+-IW6.%)R/!=T@8:ZUF!K8VUEMG0YCY&>=*Z+=$^ZG)'::8)8#F1D&BBQD6
MP%0*BB287J*/Z&E^CRX^7*(/B##T+>6YQ&PI1Z[2P8V$FY2![HI P8% ]Y#T
M4.A?H< +O!;W:6=W?]AT=W7*5=Y!E7=@]<(#>G.%%>AV5.CK"CT0IHM ,$4S
M+HEMKY^W"ZF$;K)?1X*%5;#0!KL^$.R6ZMUBRBR1WGBZ=1.>,UUM 0F0+5Y0
M:*MGH=FWFF8W;B=Q,'*W]9KMFP1Q9=) O:Y0KX^BSO0N B%@B73K)<]7:(,%
MVF*:MR(66G$MOM?S/,]_@WG2K($:5:C1>:@RU<TK$<Y5R@7Y"\LVY$(SJK'X
M7O%Y ]W!L('=K[#[[\(F4N;MR/T]DK>LQRP:D'$%&;\+4A\$4ND_ ,+6;:3Q
M2=)C%@W2044Z.$HZY5FF]VN7;AUTZ]:39@W.8<4Y/(.S4ZL.]VH51NV]VL6R
M0>U[_\\'[WSNP[U:JM51 B^,PG ?NL74'T9!%!^FKIUJ_OG4)YJWE.R$OF]Z
M"-VMG<WF8O0%BS5A$E%8:5^O%VL14=PUBHGB&WM<+[C2A[\=IOI^!L(8Z/<K
MSM7KQ-P JAO?Y!]02P,$%     @ P7UE4F+B1[PO!@  #!H  !@   !X;"]W
M;W)K<VAE971S+W-H965T-"YX;6RM65UOVS84_2N$L8<6B&.1DBPK2 PT]H85
M6+L@:=>'H@^,1-O")-$3*2?=K]^EI%AV>$6[6/O06/:Y5SKG\GZ0NGZ2U=]J
M(X0FST5>JIO11NOMU62BDHTHN+J46U'"+RM9%5S#9;6>J&TE>-H8%?F$>=YT
M4O"L',VOF^_NJOFUK'6>E>*N(JHN"EY]OQ6Y?+H9T='+%_?9>J/-%Y/Y]9:O
MQ8/0G[=W%5Q-]E[2K!"ERF1)*K&Z&;VC5TO?,P8-XJ],/*F#S\10>93R;W/Q
M/KT9>>:)1"X2;5QP^+,3"Y'GQA,\QS^=T]'^GL;P\/.+]]\:\D#FD2NQD/F7
M+-6;F]%L1%*QXG6N[^73[Z(C%!I_B<Q5\S]YZK#>B"2UTK+HC.$)BJQL__+G
M3H@# \8&#%AGP,XU\#L#_UR#H#,(&F5:*HT.2Z[Y_+J23Z0R:/!F/C1B-M9
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M3$(&   U(   &    'AL+W=O<FMS:&5E=',O<VAE970U+GAM;,V:2V_;.!"
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M>8-N77%>U=F2JR?9U2VOZ[;:RD-R3\J$\OKN[C+;JI*43A<IV%9ELI'=K]X
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M<@*G=\.#+4C IT$2T$()\4&?:7)Y1*H;9 L3\&G1!+3@1.3U8Q]L>0(^%E!
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M):42D/=7C(F'$_41=?^? K/_ 5!+ P04    " #!?6529-IY9%<"  "^!0
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M\G$6$-V?N#ZPJO4]N%$6.]H/:[RD0+L$7*^4LH? M?5X[65_ 5!+ P04
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M(+$-,6[.RO^[\ZOKR16D7<'ZF*0="(C^7YI5RK8AW1AQ&_GXC5*_H(D%$SW
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M4&+?1%(7P8#D@<7RW)6+0?5SZC/0ZR77@J@7)Y(G*#>0<@1;H,(,XGS=4+@
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M/6MLLKR5EM5,9A6 Q![K'')&Q3&@AT^,U)ZFV6^=IA-%"_6 FB0<$X!Q Q-
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M1G:\JN^9PAA1S5PX'](Z+D_MCT\[ZQ VG9T>4<&1=_4C*/8OUJ>PQ6T,QM'
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MT]')T:#AT&V"K>);;&T#7G9Q6> I+1T)X/O&VM!MR$'_.%_\!U!+ P04
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MO26-(V-U#\%N^'M79@-Z+_]<XP52.3J _=+:T#W0!?T'T(<_ %!+ P04
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M@-[PZ3#5Z3H$MUCD=[TZW*563KL2ZYR:%^1F\!Y!)39MSC< 5#^*&74CZ\+
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M18^R$CC!1<-3(<*A(8B1:"S+5 B9IP+42#,;BO][J&D*;P:B>U32%D(1Y 0
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M@N[8URZ/AL-=AXIG*/8;#8=Z;EA>PC]$WJ;[I]W6J.F; $G/#0;<*DF])$M
M2K1]#B7\WTL-"XNBDP"_E.F:5H_$S]45HR)1-J^;N6_? [, !6-5AI$1<PQ
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MREI5N+^9X'B3(P&LKY2R[0TYZ+XB7?X?4$L#!!0    ( ,%]95)9!%VY<P,
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M1RY:K\#RVAC:;[R#PQ!?_PM02P,$%     @ P7UE4C2ZN5J_ @  -@8  !D
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M5Y>XUG-L^6+)M1MA5?HV6Q[$A38R7X,I@SP3Y<R>UW78 K3K.P#A&A"ZO,M
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MH*DM*"'_PBS)Z9XYHT*O(ZW-<Q TX+!P.-"LP T^AEW7(1[(W,SU7M1DP9Z
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MA\5/85D6E>>"B9]A_<"0_ZD-7 ];"/,\:22@"S9Y@6HP< 5(U#\15XW ]\$
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MQ S_4<N1HOB1!7&D?G4&[0>Q$:_5C:T@1WM/5"@A,^!HIGP1\R8"9]=&CCG
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MJ("6()3G)]G8&PH8B:/802L4'R0KHL%P(6F4?CBH(X#8E.[,3"64>O"S>FS
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MU\C_D=0#448A%I*\=E;L*+-:R&)1:^,RYYWEBNX 6&1:]BBX@4<[G^S,X%%
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M])O;CD>Q2"QU=&Y&2[Z "=A/RX\:I4YE928RD$8HR33,KYNW_M5=1/I.X;.
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M:.> ]Z52=K]Q"?KYN_@+4$L#!!0    ( ,%]95)<BEIV1 ,  (H'   9
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MPRW^ 8!V#FA?*V6[B=N@_TM9_ =02P,$%     @ P7UE4EMSH%FR!P  U!,
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MM?;*OO1Q>(M T L$QF]KR'CY ]/LZD**)RJ1&[3APFS52(-S58N'\J E/*U
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M*#N/^_(X2<+..#"=QG"27_T#U_C@FN%"]W:#>V*_8^+18S:ADE57U\^F7>#
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MRPUG,'.1 9ZOA-###1H8/^1=_0]02P,$%     @ P7UE4JVDOK$.!0  4PP
M !D   !X;"]W;W)K<VAE971S+W-H965T,CDN>&ULE5?;<MLV$'W'5V#4FSW#
M6 0H2I1C:\:7=)J'M!G;2:?3Z0-$KB1,2$(!(,ONUW<7I&BIEI3VA5J0V+.W
MLPOH8FWL%[< \/RI*FMWV5MXOSSO]UV^@$JY,[.$&K_,C*V4QZ6=]]W2@BJ"
M4E7V91P/^Y72=6]R$=Y]M),+L_*EKN&CY6Y55<H^7T-IUI<]T=N\N-/SA:<7
M_<G%4LWA'ORGY4>+JWZ'4N@*:J=-S2W,+GM7XOQZ2/O#AL\:UFY+YA3)U)@O
MM'A?7/9B<@A*R#TA*/QYA!LH2P)"-[ZVF+W.)"ENRQOTGT/L&,M4.;@QY>^Z
M\(O+7M;C!<S4JO1W9OT+M/&DA)>;TH4G7S=[T[3'\Y7SIFJ5T8-*U\VO>FKS
ML*60Q0<49*L@@]^-H>#EK?)J<F'-FEO:C6@DA%"#-CJG:RK*O;?X5:.>G[RO
M<U,!?U!/X/C)@YJ6X$XO^AZA:4,_;V&N&QAY $9(_L'4?N'XN[J 8A>@CSYU
MCLF-8]?R*.(MY&<\$1&7L8R/X"5=H$G 2[X9*+_5+B^-6UG@?UY-G;=(C;^.
MF!AT)@;!Q." B3O(39WK4JM .#/C6T;?/6$?.4KR-=0PTWYOEH\;>%@ -L*_
MC>C&B$<CT!F9MD:X\MRCFO/*K[RQSWP&!5A5;JM9Y8&0I/@AXM[P&H?!UN<6
MBUZ5*ZPN"ATF8(-Z1\HX)VSPR7%5%QRU<4HLJ'T?@6.Z'<<1$O2>05G'@8C"
ML<Q03<%VI::G& <(%#*N$8Y42QP?&%<P;58.O[O3<_8'0C64VT%BA,0(B!X9
M^W1V?]8%[@/7-T%A?EYR0XE@W[,3(24[)6$0)5(T8AHEB'3*[BGJ!H3]^%TF
MA7S[ZO=FH>HY4)X>5;EJ*J4H E7GP$YD% <#220&DJ7X3!#6Y%_>T(!I<H>)
M"WI,#C.6C<9L/!ZS.W 8<+X(Z2G@$6?JD@H0RI1;*+1WZ'TD$H)'(8X'))#N
M*2,:W@$-<IYW#G;U)TB#Y;$'HT(*:ZOK>>!'6VY<46TQ%S(:CP43D4QEI_%;
MP!,CAN_$*&4/QN\R[X6G2VL>-8UZS/5&?8]TI$W3KDW3HUUTWYP_Q-D;3+2I
M-PRFE:J??W+(I1E83&?HW"L,S[M]W7K4#AVGYVZI<KCL82<XL(_0F]SK>:UG
M.E=8M'S'.G5&ZT&(=?36T?'2^$&Y4L&/4"?L_BF. *^1R K'V)$..= 6MZ^1
MS]FOK^K*<V7M,U)FK6SAD(>1&(^P&N,X$K'<Y6,@3\=",8Y$FC"11=DP?C%G
MD;3U"IB4"9.#[##MDR@;Q S[;S1L:91&$MF,SRQKB;0G/4R(-!HBXP19'@W8
MY]<-& ;1/MT3(:CAD] [8A3)08KB3JJV,_^&ASL,%6_EH &AIDN3K.F^;$10
ME-7_4$B:,7(P:(9-$/@1L@\[L@__YYGTJ:8C!%GX=\OO]CS:R_#CX%=[3B.B
M\13FNJZ)0Q0C#OH@5F95-\G:]F#K@''?&/8'J'RMRE!5G.0OAEM/Z*@AND;Q
M*,/?+!K@9,13&>^O6+&3 AKI% ,I<0@6=/HMK49^D&9P;FF<#L<:H[DZ9">A
MJ!W&EF*^PA)CB'M4A\C$T:ZO0"VSXZ6(HRS+-N[N*WY_ZZ)7@9V'ZRPV*66V
MN?-U;[L;\U5S47S9WERW/RB+N7*\A!FJQF<C'&:VN<(V"V^6X=HX-1XOH4%<
MX*T?+&W [S-C_&9!!KK_$9-_ %!+ P04    " #!?652:_SP[8 %   &#P
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M*#8_L6I ?>,O%JFR?]&F:AMT4%PH+;+*&!!D/"]_Z9<J$#6#,#I@0"H#LF-
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MI>T" B[2A>3Z&:V9Y")IPN]W/0Y00I\5$A*E3"E/6(=;L$.OQSL!N:29S'Q
M(> JEGQM&0R(E6=%U@3>WY6 -'UF5!KT<_8L<A]AC;;X1UZGCXRF_/^L'F>T
M!)&@4"J4:N2%J]'>S._F1MFBW]CB%<SQ%N;8"_/G(ILS:=85Z!RSIB#JJN)5
M]!>J*+8)['@/"FZ&@@-7QH*68"2#%:[I/&4MT52>V\"I557LA?->B&0#-;"Q
M/[PW5P,\&.^OYJIA'=@@'.\WG#9Y-.QP:-5CXL9!O..XS=:42YN!$-K4+*P4
ME&""*"0B!';%T@2!$D"%8HUC)6VS#KLR@L.OP9J5EWI0WA[BS0-M?<R)7?'!
M_K)Q"<4MX6EA)#2D9&Q8R!0Y]B5."Y X:"%%AF*1K0M="BH(-7!*#@M*&;8J
M=16BF:F3D,L'U<%5A<1D]'8@PVY_=[0-K0CN1KM9U= ,#[J# _%P10_[J]XC
M>^*J&N8#4+%$#Y:1WZ#)BN9+9O1C711(*-M\G;(WH#__+$H^]+ L=C4-#TXL
M2+ K4=A?.-HE\4WEY75B#CTKV]48["\R;0'L%Q9O_ZYX8'_UJ$5YIFF>4)DH
M]'&=&*D&NC-Z&XQ]VM\5!A*<>)*)JP+$7P7N0,\P5BN/*8--L)&ADIDLAGW4
M7$AP:]Y!DT8*/=('#KNCX#\^N([LB9_L?]G!N;';<D/V3_ "%B:@!AGB&AB-
MA1LQ^SLB5C,IA#'*RKT>&5@1Z!N&JP_$7Q_NT"6:H _H&MWY_#G^)M&I,\AQ
M)?%SI4]'D'VU3\CXX-(DCA>)7Y'/* AQ!#3-\H*AGYE&O]\S(Z_^@.(SL6<2
M4)0F(H\AA\O-%'KDZE.]V7L.*9)LG_B"X3B3#$\]$8XNB9\NH429T9I58#5F
M&1M:=FVE.@0$Q%+^_+U"6IBE735JG#I_9\-!-]A=T]6QA-]P,#I@.#UBB(?[
MAJ\CY8B=^(G]:V3/;9[P)Z,,6N1/Z$I!>.I2$+I2$/II^JOFS_1(9V%X9#9#
M5Q-"/U7/BKEBGPNS ;A^,G_;S$CM1.C41T*AH_7PB"POY;1DMI95*MR<"8A-
MT\%;Y:W.MK@?>#99H2/YT$_R=Y>3#]=W('1%4L0:V8&V";,C]/#40C=TI!WZ
MA>Z$JE6Y3804/QC>JW!?Z!X)KZ/N\(C2O?O?]8?FZ)J# 1]=O1AYV,H7),>9
MX?C41Z..%2/_R<G7K6Q'.B/!H<IVS+"A0)5<>,0P:JBEKR/E.#SRT^I]>4K8
M9NHC1[ 1.?74._J-_$IYMA)2[YZ4MCG1/>*W.M+U8:P=W?MI&I8@X#!H4A,7
MV"DBJ$=\;:$6BBV*%*5\T9R,?M=AN0WQP70<'ODY_)Y^:9T;CK>C4_-VY'@[
M\O/V/\\-OU]L@^Z#Z(@].J+)_TUJ^%WW#Z=&K_:Q%93LTGX65\A.2?E1<OMT
M^^G]TGYPWGE^A=]-RP_HSDWY/?^>RJ4][F<+<!ETAY![LOQ$7MYHL;:?=.="
M@YRVERO8;C%I&L#[A1#ZY<9TL/U'A8N_ 5!+ P04    " #!?652NCH.4F\#
M  !O#   &0   'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6S%5]%NHS@4_94K
M- \STF[!$" 9)9'2D-GMJC,;->G.PV@?*#A@#=A9VVDZ?[^VH802@BKUH2\!
MFWL.]]P3+I?ID?&?(L=8PE-94#&S<BGWGVU;)#DN8W'%]IBJ*SO&RUBJ)<]L
ML><X3@VH+&S7<0*[C FUYE.SM^;S*3O(@E"\YB .91GS7]>X8,>9A:SGC3N2
MY5)OV//I/L[P!LO[_9JKE=VPI*3$5!!&@>/=S%J@SQ$*-,!$_$/P4;3.04MY
M8.RG7MRD,\O1&>$")U)3Q.KPB)>X*#23RN._FM1J[JF![?-G]B]&O!+S$ N\
M9,5WDLI\9HTM2/$N/A3RCAW_Q+4@7_,EK!#F%XYUK&-!<A"2E35895 26AWC
MI[H0+8 2V@]P:X#;!8PN +P:X+T6,*H!(U.92HJI0Q3+>#[E[ A<1RLV?6**
M:=!*/J':]XWDZBI1.#G?5'X#V\&&9)3L2!)3"8LD80<J"<U@S0J2$"S@=V@%
M;YF,"[C#CY@>,#S\@C\PRWB\STFB=C-MZ<<(RY@4GQ3P?A/!QP^?X ,0"MN<
M'41,4S&UI5*@\["3.MOK*EOW0K;(A:^,RES BJ8X?4E@*^F-?O=9_[4[R!CA
MY H\]!NXCNOT)+1\-1Q->N#1Z^'C 35>XZ9G^+P+?+4? KYP5L+J26).E4U+
M\S_"7,""IG#+E*NWZFE+82$$E@)^W"H>N)&X%/\.9#%JLAB9+$87LJC^&[S.
MI<_E"A\8O.Y,CW//00A-[<=VZ<^C7-\)1R^CHO,HY+NAWT2]D. W$OQ!"???
M;K:K"#;;Q7:U&2A)T/ %[VA,V&01OM&8"N^W2QZ,)YV2+WNBT,0/.\:<1X6.
M/^[W9=PH& \J6!VX>N4-E&+2$$W>T1#DG-JO\T9+:H)V'9$W#CJ6]$1-G$Y0
MU!,4C,*@WQ+4>H6@00U_+=:+;T/5<$],[GNZ<FJCR'NK*]ZY*ZC;FY9]4:/0
M[=IR'C6YU,#0J0FCX2[\M\PQ!S4<J=&'PE*_SCGIBGG)?>J.R']/GTY=%05O
M]2DX>ST$W4ZU[ D*O4G7I9Z@H/OLV*U)3!4B,Q.M #-,54-)L]M,S0LS*W;V
MK_4T;2:\$TTUBG^->4:H@ +O%*5S%2JK>#7=5@O)]F;>>V!2N6%.<_5%@+D.
M4-=WC,GGA;Y!\XTQ_Q]02P,$%     @ P7UE4D<H_>MY @  :P8  !D   !X
M;"]W;W)K<VAE971S+W-H965T,S,N>&ULC55-3^,P$/TK5L0!I*7Y:@-%:21H
MA9;#2A6%Y;#:@YLXB87CR=IN _]^;2=$H:05E\1COS?S9B:>Q V(5UD2HM!;
MQ;A<.*52]8WKRK0D%983J G7)SF("BMMBL*5M2 XLZ2*N8'G16Z%*7>2V.ZM
M11+#3C'*R5H@N:LJ+-[O"(-FX?C.Q\8C+4IE-MPDKG%!-D0]UVNA+;?WDM&*
M<$F!(T'RA7/KWRPC@[> WY0T<K!&)I,MP*LQ'K*%XQE!A)%4&0]8O_9D21@S
MCK2,?YU/IP]IB,/UA_=[F[O.98LE60)[H9DJ%\ZU@S*2XQU3C]#\)%T^,^,O
M!2;M$S4=UG-0NI,*JHZL%524MV_\UM5A0/"G1PA!1PB^2P@[0F@3;979M%98
MX206T"!AT-J;6=C:6+;.AG+3Q8T2^I1JGDHV;?<0Y&A#"TYSFF*NT&V:PHXK
MR@NT!D932B2Z1 /P$JH:..%*&NN![_42A(&=KXC"E%UH_/-FA<[/+M 9HAP]
ME;"3F&<R=I46;L*[:2?RKA49'!&Y(ND$A?X/%'B!-T)??IONSS_375VNOF9!
M7[/ ^@N/^!LKSI_;K51"?Y1_3P0(^P"A#3 ]$N 1-[K'B@B*V6BY6GIDZ>:>
M[A,_C&)W/ZS)""8*>\PG7=->U_2DKA=](W4K+VL!*9&CREH'LT'4J_FALA&,
M-Q]7-NN5S4XJNZ><ZDN0H0)@_ N;?0DZ#X,#85\QOC>]&E<6]<JBD\J>0&&F
MB]9?D#%QT==>74?3 W4CH+E_6#=W, K,&/Z%14&Y1(SDFN9-KG1VHAUMK:&@
MMM-A"TK/&KLL]=^ " /0YSF ^C#,P.G_+\E_4$L#!!0    ( ,%]95(\]6_5
M6P,  )8*   9    >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;*U636_;.!#]
M*P,AAQ9HHP]+MAS8!N*HBUU@6P3U9GMF),HB2I%>DHK;?[]#2E845];ZL!=;
M',Y[G'DDA[,Z2O5=5Y0:^%%SH==>9<SASO=U7M&:Z%MYH )G2JEJ8G"H]KX^
M*$H*!ZJY'P7!W*\)$]YFY6R/:K.2C>%,T$<%NJEKHGYN*9?'M1=Z)\-7MJ^,
M-?B;U8'LZ8Z:I\.CPI'?LQ2LID(S*4#1<NW=AW=9Z #.XV]&CWKP#3:59RF_
MV\$?Q=H+;$24T]Q8"H)_+_2!<FZ9,(Y_.E*O7],"A]\G]M]<\IC,,]'T0?)O
MK##5VDL]*&A)&FZ^RN/OM$LHL7RYY-K]PK'S#3S(&VUDW8$Q@IJ)]I_\Z(08
M ,+Y!4#4 :)S0'P!,.L LVL!<0>(G3)M*DZ'C!BR62EY!&6]D<U^.#$=&M-G
MPN[[SBB<98@SFUV[WR!+V+&]8"7+B3!PG^>R$8:)/3Q*SG)&-7R$@?.7IJ:*
M&*DT$%% 1H7$Z%H#$_! >-YPXK86O;=$L[QU9+PQM( O>*3_E%K#@2K85411
M>)=10QA_CPL][3)X=_,>;L ';2<=Z9-@1G\8&/ZJ9*.1%8TW;\8KWZ V-D,_
M[W38MCI$%W0((_@LA:DT?!(%+=X2^"AJKVQT4G8;33)F-+^%6?@!HB *1@)Z
MN!H>+D?@V?7P="*;67].9HYO=H'O=;_O)MCBGBUV;/$E-MQ]CKL_MD\M<NZ0
MMFJ];#XF:;3R7X;:C3A%0;)(W[IE8V[)+'IE>Q-]TD>?3&HQ/.Q3:LQ[OOFD
M&M]<<<)+05Y0XST]G?!&H\U(R&5]P$MCZQO>(M%IYVZ.\QQ3L5TQ&60>+I=Q
MLCC3<<1MD0;QF=S9B%NR3&?QN(Z+/N_%I(Z?RA*KOZT/A:T*6/]!T[Q1S&"Y
MF1(V[1=(_Q=ABZXH72=M>IVT(VYCTHZX34B[[#-?3E_77S*9TC,,7E^+8%)1
M5\A'JVOPRU4+S@3I7-+A;0QNPW-!+KC-QP4)!P]=.!EZ]_*,!A_^=_#A=<&/
MNYT'[P\>;*RK>]?X:'!O;OO"]-:^N;IW+<69?6N;+M<(O-*T'=MGHO9,:."T
M1,K@=H%'3+5-4#LP\N#:@F=IL,EPGQ4VCE19!YPOI32G@5V@;T4W_P)02P,$
M%     @ P7UE4H@ME#D2!P  CA@  !D   !X;"]W;W)K<VAE971S+W-H965T
M,S4N>&ULS5E;;]LX%OXKA#>838#$EN1[FP3(=3>S[4R0M-.'8AYHZ=CF5A(U
M)!6/!_OCYR,ERS?9-;) T(?6DGCNYSN'/,SY3*IO>DIDV)])G.J+QM28[%VK
MI<,I)5PW948I5L92)=S@54U:.E/$(\>4Q*W \WJMA(NT<7GNOCVJRW.9FUBD
M]*B8SI.$J_DUQ7)VT? ;BP]/8C(U]D/K\CSC$WHF\SE[5'AK55(BD5"JA4R9
MHO%%X\I_=^\/+(.C^$W03*\\,^O*2,IO]N4ANFAXUB***316!,?/"]U0'%M)
ML../4FBCTFD95Y\7TN^=\W!FQ#7=R/B+B,STHC%HL(C&/(_-DYS]FTJ'NE9>
M*&/M_F>SDM9KL##71B8E,RQ(1%K\\C_+0!S"$)0,P0:#W]G!T"X9VH<R=$J&
MSJ$,W9*A>RA#KV3HN=@7P7*1ON6&7YXK.6/*4D.:?7#I<MP(L$@MLIZ-PJH
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M9Y82 L31;-ZSX]$).A#78B1B8>863Q/%$[L2GNS9)VV_%.XH8AL;.=0] [$
MU^.4 ZXAY< 42OM&-MD' SP=%^LG[YVTXPCBY9S'9K[NU*^/I80M^S^B"\T!
MNZ7]S:(;N3: GO(S3W-[@U;T]=4BL,BV('>M;FFJ8XR@&=(YTU,Q=G(RA?@Y
M[TX7E%,4EKN:7>QG*' 9VH+:&2,LR%R%Y0YGVV@=N,N VTTDXSEZ%5(O8D15
MN6-(49E-]F4*D#H!MD=47$)7C(7#BP,BMWU%JF^N$\H).6%VS\2^4P!%(XBH
MV]>DN+946BL7H@FIB;NZUJA7.%1<S51?J^OQ:W>+O/6]]^[.[]6LX."!E7[M
MR@ K[JZ]M51>W-1_Y&HBT#!C&L,0K]G'Z4D5E]_%BY&9NZP=26-DXAZG: BD
M+ '6QQ(@*U^L@NI/$)=_ U!+ P04    " #!?652S/!HP2D#  "U"0  &0
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M5^/0(@N'%29UQK-=1O9 QBNNCTA$7Q,6,;HG_+P_? [)$8EWX=&?X2'6WBP
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M2[:5;>"1N-1&YA48&>1,[/_I4W401P ,M!D058"H*Z!7 7I= ?T*T.\*&%2
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MX8<7*&N ]]=2FN<+.^76GW*S?P%02P,$%     @ P7UE4L!2^+S4 P  #!$
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MN086@S0&>'\IA#YTS.MJ^0?(^%]02P,$%     @ P7UE4MWLV\AG @  1P4
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M-#Z ]C=:N[WC"8:W,_\+4$L#!!0    ( ,%]95+I<=>W@@0  -L:   9
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MOHW ] /6!Z2;<*D'36Y$PK)R;Q*-3W#GI=9T#OR<C*\\^P-02P,$%     @
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MY)SW('NB[&G*B>*Y:0MF7$&3888Q](%4: /8GW.NUA/=:=2=Y>@O4$L#!!0
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M46^$H2D_H_S&R,9U[5(:G %N6>%8!V4-\'XEI=EMK(/NCR+["U!+ P04
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M1KTKJJ9I+JS&0%WY,[_22#>('Q9TQX-Q#K2^UAKWAKM&NK]&^@=02P,$%
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M#7/\#@!E#?#]4DKS,K$.FB^+X1]02P,$%     @ P7UE4NC%&.%- @  M@4
M !D   !X;"]W;W)K<VAE971S+W-H965T-3(N>&ULA53;;MHP&'X5*^I%*VWD
M!,FH0J0"JC9IU5!IMXMI%X;\(59]R&RGM&\_VPD174.YB8_?*?[M;"_DDZH
M-'IAE*N95VE=7_N^VE; L!J)&KA9*85D6)NAW/FJEH +!V+4CX(@\1DFW,LS
M-[>2>28:30F'E42J80S+USE0L9]YH7>8N">[2ML)/\]JO(,UZ,=Z)<W([UD*
MPH K(CB24,Z\F_!ZGMK];L-/ GMUU$<VR4:()SOX5LR\P!H""EMM&;!IGF$!
ME%HB8^-OQ^GUDA9XW#^PW[KL)LL&*U@(^HL4NIIY7SQ40(D;JN_%_BMT>2:6
M;RNH<E^T[_8&'MHV2@O6@8T#1GC;XI?N/QP!HO $(.H D?/="CF72ZQQGDFQ
M1]+N-FRVXZ(ZM#%'N#V4M99FE1B<SA>",:+-7]8*?49K<^9%0P&)$MTVNI&
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M7&HC\QH,&N1<5+_TN7;$#@!XN@&D!I"7@,$!0+\&](\%#&K X 5@'!T #&O
M\%@)HQHP<KZOG.4\?4,-G4Z47"-E5P.;?7#A<FAP,!<VLYZ,@ED..#/]Q%2.
M[B45Z%=TF23<AIMFZ$Y426N#__Z&&<JS#[#B\],->O_SATEH0+0E".-:S%4E
MAAP0@]&#%&:IT:U(6+*/#T'E1F^RU?N*> EO6-Q#?7R"2(3/.O2Y]L/_D"N
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MTN)P2<F,<E5 _CYG3-R<J*]JMI^G'?P/4$L#!!0    ( ,%]95*U/!N!P04
M *T9   9    >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;,U9VV[;.!!][GX%
M8:#8%DABD?*U2 SDVKK8[ 8I=O>AV ?:HFTBDJB2M!T#^_$[I&3)=FA*+;I
M7FQ=>(9GR)DY(^E\+>236C"FT7,2I^JBM= Z^]!NJ^F")52=B8RE<&<F9$(U
MG,IY6V62T<B"DKA-@J#73BA/6Z-S>^U!CL[%4L<\90\2J6624+FY8K%87[1P
M:WOAD<\7VEQHC\XS.F=?F/XS>Y!PUBZM1#QAJ>(B19+-+EJ7^,/GT +LB+\X
M6ZN=8V1<F0CQ9$[&T44K,(Q8S*;:F*#PMV+7+(Z-)>#QK3#:*N<TP-WCK?4[
MZSPX,Z&*78OX;Q[IQ45KT$(1F]%EK!_%^A,K'.H:>U,1*_N+UL78H(6F2Z5%
M4H"!0<+3_)\^%PNQ P [;@ I .00T#D"" M V!30*0"=IH!N >@V!?0*0*\I
MH%\ ^DU7:5  !H> WA' L  ,FU+"P7;G AM!^9;;>+FAFH[.I5@C:<:#/7-@
M@\[B(4QX:O+CBY9PEP-.C[YH,7U:B#AB4OV*;K\MN=Z@4P3I%2![#SW$-$7O
MQNF4I2:4=ZZ^AX&74<1-H-,8C=,\74W8O[MAFO+8C% +*IDZ;VM@:^9L3PMF
M5SDS<H091O<BU0N%;M.(10[\)S\^K,./:^8G'@-M6.9RK<EVK:^(U^+G97J&
MPN $5A</'82NF\,'#OA-<WC/ ;]M#N\XX'=^^&4F2WCH@']L/CMVQ8(??D_-
M[/C$QK4K%/SP&S;=PHD+_KDQ_'#?]^(H+',VM/;"8SEK,NK4J$*$KD4"4JGR
MK+N4DJ9S!O*ET62#=L<]T(V]?+FF,D)??P.3:*Q9HO[Q$.J4A#J64.<(H4>F
MF%S!+%.1),!#V1(!U0!QI9842H=KS7.;76O3R/AJ%';#/B8=6.*5@TVW9-/U
MLODC,XNA$'MF<LK!^9/C-6C<?4&"] ,RZ!WAT"LY]+P<[-(K1%=0!.DD9G8Q
M9DN]E S-89.TBTOO!9=^=SCLAMC-I5]RZ7NY7.]N"K1(2M,TXNG<1:'O6 [2
M[W3"8<DACWC'P.$@"/N]GIOLH"0[\)(]%)ZO]RR9,.F+TF%I>O@ZT@8'E?@&
M7F_OZ3-/E@F$:L9E3D8SF2 Q*[:+9M#U3GE^2YI>SQG%-=/@ &T8E<K'>:=A
MP%YCM\^:&4$\8)J9W=("Z05#$=6NC+^JL>RF67CX(]!]#TGE(?$:&Q=%RSBW
M5]&6&1RRO$>:\13&0!J=H!0>8V#HMM8!1KGR^[J8=C_!@\!*TFYRW3@&YN,.
M!MXZ!G9< S^Z+!Y,O;]8E1;A\'^H_871/>)0ZKJ]G4*S3ZC2(NP7(ULV;$)M
MC@7BN,;$MMOXY<T;4'R?9.-*E/#/4Z4[_%*6^I[-JE0)^V4I)Y'GZHHI#>&+
M,B:Y</7'=S7&FN1<I5'8+U+;Y;'B"-&TYGJ!(CZ;,6GJ[Y:LJ3GN^N WWZVG
M6BD4]DO4/4]MT8:%,\]$=&X+A18:GH$@"28P/$(KD2^N6#-9%DDG<?]D.#@+
M@K<^WI7\X6$CWML(1)GD4*VH.O!D1KF$9TSY!&5M1>,E,V4]?T0TMQ,!/8Q>
M0 3AX.V>GT[W_)QPK7^D$E-2(Z8_QS_C%52OF"E5ZUT-(QS4>E?)+O$KW ]U
ME(7-QBTEJ322^#7R>YI*\E)\7G25^S0J]2%^]3G6+J)_T38<&G20I!(7TGD=
M/22IA(7XA27W7N25O8A]&R#'"WN-16R+I8]<)3C$KQ&^_2EZWR;[4\D(Z;^2
M_:GD@O@K^(_L3\TS4JV8D4H4B+\ >S;H=Y&>LB2+Q89!2\_A.41#R6FP76%5
MLL/@=6Q76-79T%]GOZ=/^Q2^K*^AHT]K[[R?39B<V^\!"IJ%9:KSUX?EU?*;
MPZ5]TWYP_0I_^)A_.:C,Y!\R[JF<<Z =LQF8#,[ZP$GFWP;R$RTR^Q9X(K06
MB3U<, J:9P; _9D0>GMB)BB_T(S^ U!+ P04    " #!?652DOKK^#X%  "&
M%   &0   'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6S-6-]OVS80?N[^"L+8
ML!9H8I&R+#MP#"2QTV18L:!!UX=B#[1$VT(D424I_]A?OZ,D2W),TV[1AP5(
M8E'W';\['N^C.5IS\2*7C"FT2>)47G>62F57W:X,EBRA\I)G+(4W<RX2JN!1
M++HR$XR&!2B)N\1Q^MV$1FEG/"K&GL1XQ',51RE[$DCF24+%]I;%?'W=P9W=
MP*=HL51ZH#L>973!GIGZG#T)>.K67L(H8:F,>(H$FU]W;O#5 R$:4%C\';&U
M;'U&.I09YR_ZX3&\[CB:$8M9H+0+"O]6[([%L?8$/+Y53COUG!K8_KSS?E\$
M#\',J&1W//X2A6IYW1ET4,CF-(_5)[Y^8%5 GO87\%@6?]&ZLG4Z*,BEXDD%
M!@9)E);_Z:9*1 L ?LP 4@'(:T#O","M .ZY@%X%Z)T+\"J ]QK0/P+H5X#^
MN3/X%< _%S"H (-B=<OE*-9R0A4=CP1?(Z&MP9O^4!1$@88EC%)=N\]*P-L(
M<&K\K'CPLN1QR(3\'4V_Y9':H@L$I>^@:9+%?,L8*HS04RZ")90)>HII"C8W
M81CI^J,Q>DS+7:2K\>V$*1K%[\#B\_,$O?WUW:BK@*F>KQM4K&Y+5N0(*XP^
M\E0M)9JF(0L-^/L3>&)QT(44U7DBNSS=$JO'/_+T$KG.>\@,<0R$[LZ&8]\
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MN%(\*3XN&0V9T ;P?LZYVCWH">JKQ_%_4$L#!!0    ( ,%]95*)W*I4\0(
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M+E/Y#]+".%,K:>O2T3TAWVI?X-ZKN/?^+^Y3U$)QH.L=#M11%\ME2A%Y9MI
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MI '@]UP(_3XQ&[3OM\5/4$L#!!0    ( ,%]95(\B9L;- ,  !T*   9
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MYB[23+38NW9^+[2Y'+CASMS?0%H#\WXCA'Z9V!M"=R-<_ %02P,$%     @
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MNMK=)CQMA:>'U@#*_%^WGVYD+HX&@\$'F9M16VHD7.ML)>JY;_@&,O=WJ)M
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MOIG30X7:3:#QM5+V-7"UL'WZDM]02P,$%     @ P7UE4I8/UY:E!   _!
M !D   !X;"]W;W)K<VAE971S+W-H965T-CDN>&ULU5A+;^,V$/XKA+&'!,A&
MHAZ6%#@&XKC=!MBT0;SI'A8],!)M"RN)*DG9V7_?(25+LEZ;]M8<8I&>&<[W
MS6AFZ,61\>]B3ZE$;VF2B=O97LK\QC!$N*<I$=<LIQE\LV4\)1*6?&>(G%,2
M::4T,2S3G!LIB;/9<J'WGOARP0J9Q!E]XD@4:4KXCQ5-V/%VAF>GC>=XMY=J
MPU@N<K*C&RI?\B<.*Z.V$L4IS43,,L3I]G9VAV_6EJD4M,2?,3V*UC-24%X9
M^ZX6#]'MS%0>T82&4ID@\'&@]S1)E"7PX^_*Z*P^4RFVGT_6?]7@ <PK$?2>
M)5_C2.YO9_X,171+BD0^L^-OM +D*GLA2X3^CXZ5K#E#82$D2RME\""-L_*3
MO%5$M!3P?$3!JA2LKH(SHF!7"O9[%9Q*P=',E% T#VLBR7+!V1%Q)0W6U(,F
M4VL#_#A3<=](#M_&H">7ZUB$+)-Q5M (_9%33E0X!/J(-F4F(+9%8T+/-&=<
MPEZ<H8TDDD)"2*70DKE84TGBY!(LOFS6Z.+#)?J #"3VA%.A%%^R6(JKUL:7
M/2L$R2+8_'"V7A@2$"N_C;!"MRK162/HL(4>P?&]0+]D$8W.#1A 5<V7=>)K
M94U:7-/P&MGX"EFF90XX=/]N=1P,J*_?K^Y/H+'KZ-O:GCUB[R$+64I;L5N1
MA&0A[.B:<Y=%Z"Z*8A5)DN@T2)@H5)Q6/]0R9P+V/W%6Y *!L:2(XFPWFB_?
M/L/YZ '.$G]->._4WCO:>V?$^R],PNF<'B@<-)@=I?Y<ZZL*>%@Z@2+NT([8
M@) 3F.="Z[Z0;?E!+73FOUO[[TZR7S$#A-$WJ.."BIL)5N:UU?DD*_=,Z'<P
MYRPJ0CG)3VG);:/2>7G&3U_(\OTN/P-"<\L>YL>KD7B32)ZIH(2'>P0O/]3R
M S2I7&7I$!*O=[[CS3M ^C+NO -V/6#']X=A^#4,?Q+&!IH:!/D*[6@& 4\T
M'!)!,8^%5 EPH$.(_+ZWV.T@ZLM83B>]UWT9['K#B((:4?".%R^$1!,:S"E]
MAV $?4)-W,F>^[Z0/0^\#I !(6L^$AML-OW/G,12E< M9RF*VG6+U75KL.^8
M/6\"LUM9!H2\P.[ &A"R\ BJ5E?'TZ5%[BF'YJFP3145;#46K4F>/L$,^>]9
MLOK)9_F..P*O:5O8GG3F=VA.\7\,G-VKY-CV7+L;NK[80.CZ0J.A:YH:=B9#
MU\)V =U67"+ 4XY'4X%LF@YV)[E;$1&'94F-DT)VIZ**I=*&WT)F7IN>>?:'
MNYRY/3JZ;6)2Y!Q0T^_P?)*PKWJVI]%'<H# [^AIE"Q$.9D"E7FAVVS64%MS
MJFX-4WR<.]6T+CS=N]['<K_;X"!P7*]+[("<YYN.U65W0,X-?-L9H;CI8'BZ
MA3U5L\1S.4M<(96DWQYI^DKYU"2'FXZ"@__A)&HU;<2:;B,_GT4K S\91H>D
M^M/H@-3 .&JTKH4IY3M]O1;P/A29+&\\]6Y]A;_3%]?._@JN]N5%O#%3_B[P
M2/@N!CX3N@63YK4'N<?+JW:YD"S7E\]7)N$JJQ_WE$24*P'X?LN8/"W4 ?4/
M'LM_ %!+ P04    " #!?652CU[]I(<#  #_"P  &0   'AL+W=O<FMS:&5E
M=',O<VAE970W,"YX;6RMEFUOTS 0Q[^*%1 ":5WB]"$MM)4V)F 2#]/*PPO$
M"S>]MA:.'6RGW;X]MI,EW1IGD^!-&\>^NY_/=_]XNA?RM]H":'23,:YFP5;K
M_'48JG0+&5&G(@=N9M9"9D2;H=R$*I= 5LXH8V$<1:,P(Y0'\ZE[=R7G4U%H
M1CE<2:2*+"/R]AR8V,\"'-R]N*:;K;8OPODT)QM8@/Z67TDS"FLO*YH!5U1P
M)&$]"\[PZW.<6 .WXCN%O3IX1G8K2R%^V\'E:A9$E@@8I-JZ(.9O!V^!,>O)
M</RIG 9U3&MX^'SG_9W;O-G,DBAX*]@/NM+;63 .T K6I&#Z6NP_0+6AH?67
M"J;<+]I7:Z, I872(JN,#4%&>?E/;JI$'!C$V&,05P:QXRX#.<H+HLE\*L4>
M2;O:>+,/;JO.VL!1;D]EH:69I<9.SR^H2@77E!>P0E]RD,0F2Z$>6I3GA,0:
MG2D%6B'"5^@C)4O*J*:@T#7D0FIC1Q3R^:$<G1-&> IHX:KLY05H0MDK]-S.
M?=V*0AF_:AIJLQO+%*85^7E)'OO((3U%?7R"X@A/OBTNT,OGK^Y["4TNZH3$
M=4)BY[;O3T@N%&'HO11%CCX+[=D;NN2IR,RV--%@ZK1<QX0JI,G-S[.ETM+4
MW*\.IG[-U'=, P_369J*@IL3D) "W9$E@[9\E4Y&SHGMQMT\F233<-<2>5!'
M'G1&ON0[LS,AS7&?( ZZ+6SI87@0%@]&P_:XPSKNL#/NE82<T!6"&R,_"LK:
M$WH+TC2%E#;;Q!5E&]#P"*@_:,<9U3BC3IQ[%2":ZG[Q;!QC_*9FLOU@)MJ@
M1D=0<3P9M6,E-5;R2)8LB[YUV8$_!<UM'7H/*CG."X[:"<8UP;B3H.H&OD$,
MC#8B:46P)]:]P@S\)S0^3D;D(9G4))-N$E<<3/!-3X/,.H)/6DZB/3:.&A6-
M_JE N."])Q1)%>60;=CWP1U(/'Z:?.3DUJ<=E8M[71Q[Q ,W6HKCQR)+FQ'6
M?#5:@\<M'>MI6=R()NY6S8>U>0!Q\I2.K=S?HXJPAZH15-RMJ/]!2O"QXB:)
MKTH:Q<7=DMN9KJ?6[['TXI$O98WXXF[U?=C:CU73L=3ZA!8W2HN[I?9_-7AR
M](V.AP_;+#RXSMFK\2<B-]3$8K V5M%I8K8FR]MF.= B=S>\I=#FON@>M^:&
M#M(N,/-K(?3=P%X:ZSO__"]02P,$%     @ P7UE4C0FL4XY P  $@D  !D
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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M2N\B4>*8,IOC3KE*?+:REZ50DIBR6V)+7I!-83;*#5-F.2Q,;BLE[N0WU6M
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MXA_X"0_[<UGFUTXT?[IE>$G:++!9UF5Y#ON^&*ARBLWZ^,W:_M.?4$L#!!0
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M%?56 KT5]58"O17U5@*]#?4V KT-]38"O0WU-@*]#?4V KUM\K*;0&]#O8U
M;T.]C4!O0[V-0&]#O8U ;T.]C4!O1[V=0&]'O9U ;T>]G4!O1[V=0&]'O9U
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ P7UE4IE<G",0!@  G"<  !,
M             ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M" #!?652WOEA?&0&  "U&0  &               @($."   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ P7UE4D6,Y.//!@  TAT  !@
M             ("!J X  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4
M Q0    ( ,%]95*%(.(W\0(  /T)   8              " @:T5  !X;"]W
M;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #!?6528N)'O"\&   ,
M&@  &               @('4&   >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL
M4$L! A0#%     @ P7UE4OZ]X$Q"!@  -2   !@              ("!.1\
M 'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( ,%]95)DVGED
M5P(  +X%   8              " @;$E  !X;"]W;W)K<VAE971S+W-H965T
M-BYX;6Q02P$"% ,4    " #!?652'3)A*4@)  !+)@  &
M@($^*   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ P7UE
M4@+E+FL. @   @4  !@              ("!O#$  'AL+W=O<FMS:&5E=',O
M<VAE970X+GAM;%!+ 0(4 Q0    ( ,%]95)+_V:CF24  +%V   8
M      " @0 T  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,%]95(]'M5N.04  *@+   9              "
M@9%X  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ P7UE
M4O]W]!S "   #!4  !D              ("! 7X  'AL+W=O<FMS:&5E=',O
M<VAE970Q-2YX;6Q02P$"% ,4    " #!?652,K]Z65T6  !I2@  &0
M        @('XA@  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0
M   ( ,%]95+RUV;-7PL  /T>   9              " @8R=  !X;"]W;W)K
M<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ P7UE4L/@/@$.!P  41(
M !D              ("!(JD  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q0
M2P$"% ,4    " #!?652601=N7,#  #0!P  &0              @(%GL
M>&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( ,%]95(TNKE:
MOP(  #8&   9              " @1&T  !X;"]W;W)K<VAE971S+W-H965T
M,C N>&UL4$L! A0#%     @ P7UE4K9,/4GU)@  .8$  !D
M ("!![<  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " #!
M?652XV:#GF $  "2"@  &0              @($SW@  >&PO=V]R:W-H965T
M<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( ,%]95)2YN)=$P<   L2   9
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M970R-RYX;6Q02P$"% ,4    " #!?6526W.@6;('  #4$P  &0
M    @('/^   >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    (
M ,%]95*MI+ZQ#@4  %,,   9              " @;@  0!X;"]W;W)K<VAE
M971S+W-H965T,CDN>&UL4$L! A0#%     @ P7UE4FO\\.V !0  !@\  !D
M             ("!_04! 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"
M% ,4    " #!?652%@8FL1H'  "T(   &0              @(&T"P$ >&PO
M=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( ,%]95*Z.@Y2;P,
M &\,   9              " @043 0!X;"]W;W)K<VAE971S+W-H965T,S(N
M>&UL4$L! A0#%     @ P7UE4D<H_>MY @  :P8  !D              ("!
MJQ8! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " #!?652
M//5OU5L#  "6"@  &0              @(%;&0$ >&PO=V]R:W-H965T<R]S
M:&5E=#,T+GAM;%!+ 0(4 Q0    ( ,%]95*(+90Y$@<  (X8   9
M      " @>T< 0!X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%
M  @ P7UE4LSP:,$I P  M0D  !D              ("!-B0! 'AL+W=O<FMS
M:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " #!?652DGD,V5(#  #Q#@
M&0              @(&6)P$ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+
M 0(4 Q0    ( ,%]95)^)>OZI@,  +$,   9              " @1\K 0!X
M;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ P7UE4@U- 9^*
M P  > X  !D              ("!_"X! 'AL+W=O<FMS:&5E=',O<VAE970S
M.2YX;6Q02P$"% ,4    " #!?652>:-BWKL#  #6#0  &0
M@(&],@$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( ,%]
M95+ 4OB\U ,   P1   9              " @:\V 0!X;"]W;W)K<VAE971S
M+W-H965T-#$N>&UL4$L! A0#%     @ P7UE4MWLV\AG @  1P4  !D
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M=#0V+GAM;%!+ 0(4 Q0    ( ,%]95)AZ*SM]P(  &4*   9
M  " @1%- 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @
MP7UE4I5>((5J @  - 8  !D              ("!/U ! 'AL+W=O<FMS:&5E
M=',O<VAE970T."YX;6Q02P$"% ,4    " #!?652K"M0"D "  !!!@  &0
M            @('@4@$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4
M Q0    ( ,%]95)HH\%)V@,  $@0   9              " @5=5 0!X;"]W
M;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ P7UE4C-K97S; @
M90@  !D              ("!:%D! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX
M;6Q02P$"% ,4    " #!?652Z,48X4T"  "V!0  &0              @(%Z
M7 $ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( ,%]95(S
M('BJM 0  $H1   9              " @?Y> 0!X;"]W;W)K<VAE971S+W-H
M965T-3,N>&UL4$L! A0#%     @ P7UE4NL*C4HJ P  KPD  !D
M     ("!Z6,! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,%]95)A^%J=DP0  "\4   9              "
M@:=\ 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ P7UE
M4C5Z!2V% P  * P  !D              ("!<8$! 'AL+W=O<FMS:&5E=',O
M<VAE970V,"YX;6Q02P$"% ,4    " #!?652I1HRF;$#  "'"@  &0
M        @($MA0$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0
M   ( ,%]95)M:6/\L 0  )06   9              " @16) 0!X;"]W;W)K
M<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ P7UE4G5ROSJA"   94
M !D              ("!_(T! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6Q0
M2P$"% ,4    " #!?652>M3>_/L$  ""%@  &0              @('4E@$
M>&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( ,%]95(=0*:Q
M7@,  ,L)   9              " @0:< 0!X;"]W;W)K<VAE971S+W-H965T
M-C4N>&UL4$L! A0#%     @ P7UE4CR)FQLT P  '0H  !D
M ("!FY\! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4    " #!
M?652B5'U/^4"  "-!P  &0              @($&HP$ >&PO=V]R:W-H965T
M<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( ,%]95)BZ2&*F (   8'   9
M          " @2*F 0!X;"]W;W)K<VAE971S+W-H965T-C@N>&UL4$L! A0#
M%     @ P7UE4I8/UY:E!   _!   !D              ("!\:@! 'AL+W=O
M<FMS:&5E=',O<VAE970V.2YX;6Q02P$"% ,4    " #!?652CU[]I(<#  #_
M"P  &0              @('-K0$ >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM
M;%!+ 0(4 Q0    ( ,%]95(T)K%..0,  !()   9              " @8NQ
M 0!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ P7UE4LZ?
MB 3E!   '!D  !D              ("!^[0! 'AL+W=O<FMS:&5E=',O<VAE
M970W,BYX;6Q02P$"% ,4    " #!?652[+>"1><"   1"   &0
M    @($7N@$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    (
M ,%]95)SXS_#2 (  & +   -              "  36] 0!X;"]S='EL97,N
M>&UL4$L! A0#%     @ P7UE4I>*NQS     $P(   L              ( !
MJ+\! %]R96QS+RYR96QS4$L! A0#%     @ P7UE4H+ES0='!0  7S    \
M             ( !D< ! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( ,%]
M95*WQP,P0@(  $(K   :              "  07& 0!X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( ,%]95+XPP(=!@(  $\J   3
M          "  7_( 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !1 %$
*+A8  +;* 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>278</ContextCount>
  <ElementCount>464</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>101</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets</Role>
      <ShortName>Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020 - Statement - Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheetsParenthetical</Role>
      <ShortName>Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030 - Statement - Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040 - Statement - Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity</Role>
      <ShortName>Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050 - Statement - Statements of Stockholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquityParenthetical</Role>
      <ShortName>Statements of Stockholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060 - Statement - Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows</Role>
      <ShortName>Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070 - Statement - Statements of Cash Flows (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlowsParenthetical</Role>
      <ShortName>Statements of Cash Flows (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100080 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100090 - Disclosure - Strategic Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreements</Role>
      <ShortName>Strategic Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100100 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100110 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100120 - Disclosure - Restricted Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureRestrictedInvestments</Role>
      <ShortName>Restricted Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100130 - Disclosure - Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureCommitments</Role>
      <ShortName>Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100140 - Disclosure - Term Loan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoan</Role>
      <ShortName>Term Loan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100150 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100160 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100170 - Disclosure - Discontinued Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperations</Role>
      <ShortName>Discontinued Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100180 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100190 - Disclosure - Schedule II-Valuation and Qualifying Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccounts</Role>
      <ShortName>Schedule II-Valuation and Qualifying Accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100200 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100210 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100220 - Disclosure - Strategic Agreements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsTables</Role>
      <ShortName>Strategic Agreements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreements</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100230 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstruments</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100240 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipment</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100250 - Disclosure - Commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsTables</Role>
      <ShortName>Commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.durect.com/20201231/taxonomy/role/DisclosureCommitments</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100260 - Disclosure - Term Loan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanTables</Role>
      <ShortName>Term Loan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoan</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100270 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100280 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxes</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100290 - Disclosure - Discontinued Operations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsTables</Role>
      <ShortName>Discontinued Operations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperations</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100300 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100310 - Disclosure - Summary of Significant Accounting Policies - Summary of Total Revenue by Geographic Region (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfTotalRevenueByGeographicRegionDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Total Revenue by Geographic Region (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100320 - Disclosure - Summary of Significant Accounting Policies - Summary of Components of Inventories (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfComponentsOfInventoriesDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Components of Inventories (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100330 - Disclosure - Summary of Significant Accounting Policies - Summary of Numerators and Denominators in Calculation of Basic and Diluted Net Loss per Share (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Numerators and Denominators in Calculation of Basic and Diluted Net Loss per Share (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>100340 - Disclosure - Strategic Agreements - Summary of Collaborative Research and Development and Other Revenues Associated with Company's Major Third-Party Collaborators (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail</Role>
      <ShortName>Strategic Agreements - Summary of Collaborative Research and Development and Other Revenues Associated with Company's Major Third-Party Collaborators (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>100350 - Disclosure - Strategic Agreements - Summary of Collaborative Research and Development and Other Revenues Associated with Company's Major Third-Party Collaborators (Parenthetical) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail</Role>
      <ShortName>Strategic Agreements - Summary of Collaborative Research and Development and Other Revenues Associated with Company's Major Third-Party Collaborators (Parenthetical) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>100360 - Disclosure - Strategic Agreements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail</Role>
      <ShortName>Strategic Agreements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>100370 - Disclosure - Strategic Agreements - Agreement with Gilead Sciences, Inc - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail</Role>
      <ShortName>Strategic Agreements - Agreement with Gilead Sciences, Inc - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>100380 - Disclosure - Strategic Agreements - Summary of Changes in the Company's Contract Asset and Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail</Role>
      <ShortName>Strategic Agreements - Summary of Changes in the Company's Contract Asset and Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>100390 - Disclosure - Strategic Agreements - Patent Purchase Agreement with Indivior - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail</Role>
      <ShortName>Strategic Agreements - Patent Purchase Agreement with Indivior - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>100400 - Disclosure - Strategic Agreements - Agreement with Santen Pharmaceutical Co., Ltd. - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail</Role>
      <ShortName>Strategic Agreements - Agreement with Santen Pharmaceutical Co., Ltd. - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>100410 - Disclosure - Strategic Agreements - Agreement with Sandoz AG - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSandozAGAdditionalInformationDetail</Role>
      <ShortName>Strategic Agreements - Agreement with Sandoz AG - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>100420 - Disclosure - Financial Instruments - Fair Value Measurements of Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail</Role>
      <ShortName>Financial Instruments - Fair Value Measurements of Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>100430 - Disclosure - Financial Instruments - Summary of Money Market Funds and Available-for-Sale Securities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail</Role>
      <ShortName>Financial Instruments - Summary of Money Market Funds and Available-for-Sale Securities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>100440 - Disclosure - Financial Instruments - Summary of Cost and Estimated Fair Value of Available-for-Sale Securities by Contractual Maturity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail</Role>
      <ShortName>Financial Instruments - Summary of Cost and Estimated Fair Value of Available-for-Sale Securities by Contractual Maturity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>100450 - Disclosure - Financial Instruments - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAdditionalInformationDetail</Role>
      <ShortName>Financial Instruments - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>100460 - Disclosure - Property and Equipment - Property and Equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail</Role>
      <ShortName>Property and Equipment - Property and Equipment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>100470 - Disclosure - Property and Equipment - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail</Role>
      <ShortName>Property and Equipment - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>100480 - Disclosure - Restricted Investments - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureRestrictedInvestmentsAdditionalInformationDetail</Role>
      <ShortName>Restricted Investments - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>100490 - Disclosure - Commitments - Summary of Lease Arrangements of Company Facilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail</Role>
      <ShortName>Commitments - Summary of Lease Arrangements of Company Facilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>100500 - Disclosure - Commitments - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsAdditionalInformationDetail</Role>
      <ShortName>Commitments - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>100510 - Disclosure - Commitments - Schedule of Future Operating Lease Minimum Payments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail</Role>
      <ShortName>Commitments - Schedule of Future Operating Lease Minimum Payments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>100520 - Disclosure - Term Loan - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail</Role>
      <ShortName>Term Loan - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>100530 - Disclosure - Term Loan - Schedule of Future Maturities and Interest Payments under Term Loan (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail</Role>
      <ShortName>Term Loan - Schedule of Future Maturities and Interest Payments under Term Loan (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>100550 - Disclosure - Stockholders' Equity - Common Stock - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail</Role>
      <ShortName>Stockholders' Equity - Common Stock - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>100560 - Disclosure - Stockholders' Equity - 2000 Stock Plan (Incentive Stock Plan) - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail</Role>
      <ShortName>Stockholders' Equity - 2000 Stock Plan (Incentive Stock Plan) - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>100570 - Disclosure - Stockholders' Equity - 2000 Employee Stock Purchase Plan - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail</Role>
      <ShortName>Stockholders' Equity - 2000 Employee Stock Purchase Plan - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>100580 - Disclosure - Stockholders' Equity - Summary of Shares of Common Stock Reserved for Future Issuance (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfSharesOfCommonStockReservedForFutureIssuanceDetail</Role>
      <ShortName>Stockholders' Equity - Summary of Shares of Common Stock Reserved for Future Issuance (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>100590 - Disclosure - Stockholders' Equity - Summary of Stock Option Activity under all Stock-Based Compensation Plans (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail</Role>
      <ShortName>Stockholders' Equity - Summary of Stock Option Activity under all Stock-Based Compensation Plans (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>100600 - Disclosure - Stockholders' Equity - Summary of Employee Stock-Based Compensation Cost that has been Included in Statements of Operations and Comprehensive Loss (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfEmployeeStockBasedCompensationCostThatHasBeenIncludedInStatementsOfOperationsAndComprehensiveLossDetail</Role>
      <ShortName>Stockholders' Equity - Summary of Employee Stock-Based Compensation Cost that has been Included in Statements of Operations and Comprehensive Loss (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>100610 - Disclosure - Stockholders' Equity - Determining Fair Value - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail</Role>
      <ShortName>Stockholders' Equity - Determining Fair Value - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>100620 - Disclosure - Stockholders' Equity - Summary of Assumptions Used to Estimate Fair Value of Options Granted and Shares Purchased (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail</Role>
      <ShortName>Stockholders' Equity - Summary of Assumptions Used to Estimate Fair Value of Options Granted and Shares Purchased (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>100630 - Disclosure - Stockholders' Equity - Summary of Stock Options Outstanding (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail</Role>
      <ShortName>Stockholders' Equity - Summary of Stock Options Outstanding (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>100640 - Disclosure - Income Taxes - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail</Role>
      <ShortName>Income Taxes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>100650 - Disclosure - Income Taxes - Reconciliation of Income Tax Expenses (Benefit) (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail</Role>
      <ShortName>Income Taxes - Reconciliation of Income Tax Expenses (Benefit) (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>100660 - Disclosure - Income Taxes - Summary of Components of Company's Deferred Tax Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail</Role>
      <ShortName>Income Taxes - Summary of Components of Company's Deferred Tax Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>100670 - Disclosure - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetail</Role>
      <ShortName>Income Taxes - Reconciliation of Unrecognized Tax Benefits (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>100680 - Disclosure - Discontinued Operations - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail</Role>
      <ShortName>Discontinued Operations - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>100690 - Disclosure - Discontinued Operations - Summary of Discontinued Operations Reported in Statement of Operations (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail</Role>
      <ShortName>Discontinued Operations - Summary of Discontinued Operations Reported in Statement of Operations (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>100700 - Disclosure - Discontinued Operations - Summary of Assets and Liabilities Reported as Discontinued Operations in Balance Sheet (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail</Role>
      <ShortName>Discontinued Operations - Summary of Assets and Liabilities Reported as Discontinued Operations in Balance Sheet (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>100710 - Disclosure - Discontinued Operations - Summary of Non-cash Items Related to Discontinued Operations Included in Statement of Cash Flows (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail</Role>
      <ShortName>Discontinued Operations - Summary of Non-cash Items Related to Discontinued Operations Included in Statement of Cash Flows (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>100720 - Disclosure - Subsequent Events - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail</Role>
      <ShortName>Subsequent Events - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="drrx-10k_20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>100730 - Disclosure - Schedule II-Valuation and Qualifying Accounts (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccountsDetail</Role>
      <ShortName>Schedule II-Valuation and Qualifying Accounts (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccounts</ParentRole>
      <Position>73</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="drrx-10k_20201231.htm">drrx-10k_20201231.htm</File>
    <File>drrx-20201231.xsd</File>
    <File>drrx-20201231_cal.xml</File>
    <File>drrx-20201231_def.xml</File>
    <File>drrx-20201231_lab.xml</File>
    <File>drrx-20201231_pre.xml</File>
    <File>drrx-ex1032_586.htm</File>
    <File>drrx-ex1033_588.htm</File>
    <File>drrx-ex231_10.htm</File>
    <File>drrx-ex311_11.htm</File>
    <File>drrx-ex312_12.htm</File>
    <File>drrx-ex321_13.htm</File>
    <File>drrx-ex322_14.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>gguopuizh44n000001.jpg</File>
    <File>gguopuizh44n000002.jpg</File>
    <File>gguopuizh44n000003.jpg</File>
    <File>gguopuizh44n000004.jpg</File>
    <File>gguopuizh44n000005.jpg</File>
    <File>gguopuizh44n000006.jpg</File>
    <File>gguopuizh44n000007.jpg</File>
    <File>gguopuizh44n000008.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>102
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "drrx-10k_20201231.htm": {
   "axisCustom": 0,
   "axisStandard": 35,
   "contextCount": 278,
   "dts": {
    "calculationLink": {
     "local": [
      "drrx-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "drrx-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "drrx-10k_20201231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "drrx-20201231_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "drrx-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "drrx-20201231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 654,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 79,
    "http://www.durect.com/20201231": 8,
    "http://xbrl.sec.gov/dei/2020-01-31": 4,
    "total": 91
   },
   "keyCustom": 66,
   "keyStandard": 398,
   "memberCustom": 47,
   "memberStandard": 46,
   "nsprefix": "drrx",
   "nsuri": "http://www.durect.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100090 - Disclosure - Strategic Agreements",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreements",
     "shortName": "Strategic Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100100 - Disclosure - Financial Instruments",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstruments",
     "shortName": "Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100110 - Disclosure - Property and Equipment",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipment",
     "shortName": "Property and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "drrx:RestrictedInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100120 - Disclosure - Restricted Investments",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureRestrictedInvestments",
     "shortName": "Restricted Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "drrx:RestrictedInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100130 - Disclosure - Commitments",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitments",
     "shortName": "Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100140 - Disclosure - Term Loan",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoan",
     "shortName": "Term Loan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100150 - Disclosure - Stockholders' Equity",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100160 - Disclosure - Income Taxes",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100170 - Disclosure - Discontinued Operations",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperations",
     "shortName": "Discontinued Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100180 - Disclosure - Subsequent Events",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010 - Statement - Balance Sheets",
     "role": "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets",
     "shortName": "Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100190 - Disclosure - Schedule II-Valuation and Qualifying Accounts",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccounts",
     "shortName": "Schedule II-Valuation and Qualifying Accounts",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "drrx:NatureOfOperationsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100200 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "drrx:NatureOfOperationsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:MajorCustomersPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100210 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:MajorCustomersPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100220 - Disclosure - Strategic Agreements (Tables)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsTables",
     "shortName": "Strategic Agreements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100230 - Disclosure - Financial Instruments (Tables)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsTables",
     "shortName": "Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100240 - Disclosure - Property and Equipment (Tables)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "drrx:ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100250 - Disclosure - Commitments (Tables)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsTables",
     "shortName": "Commitments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "drrx:ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100260 - Disclosure - Term Loan (Tables)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanTables",
     "shortName": "Term Loan (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100270 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100280 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020 - Statement - Balance Sheets (Parenthetical)",
     "role": "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheetsParenthetical",
     "shortName": "Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "drrx:SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100290 - Disclosure - Discontinued Operations (Tables)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsTables",
     "shortName": "Discontinued Operations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "drrx:SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "drrx:NatureOfOperationsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityIncorporationDateOfIncorporation",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100300 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "drrx:NatureOfOperationsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityIncorporationDateOfIncorporation",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100310 - Disclosure - Summary of Significant Accounting Policies - Summary of Total Revenue by Geographic Region (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfTotalRevenueByGeographicRegionDetail",
     "shortName": "Summary of Significant Accounting Policies - Summary of Total Revenue by Geographic Region (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "us-gaap:MajorCustomersPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_srtStatementGeographicalAxis_countryUS_20200101_20201231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100320 - Disclosure - Summary of Significant Accounting Policies - Summary of Components of Inventories (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfComponentsOfInventoriesDetail",
     "shortName": "Summary of Significant Accounting Policies - Summary of Components of Inventories (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100330 - Disclosure - Summary of Significant Accounting Policies - Summary of Numerators and Denominators in Calculation of Basic and Diluted Net Loss per Share (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail",
     "shortName": "Summary of Significant Accounting Policies - Summary of Numerators and Denominators in Calculation of Basic and Diluted Net Loss per Share (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100340 - Disclosure - Strategic Agreements - Summary of Collaborative Research and Development and Other Revenues Associated with Company's Major Third-Party Collaborators (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail",
     "shortName": "Strategic Agreements - Summary of Collaborative Research and Development and Other Revenues Associated with Company's Major Third-Party Collaborators (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_srtProductOrServiceAxis_drrxCollaborativeResearchAndDevelopmentAndOtherRevenueMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20200101_20201231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100350 - Disclosure - Strategic Agreements - Summary of Collaborative Research and Development and Other Revenues Associated with Company's Major Third-Party Collaborators (Parenthetical) (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail",
     "shortName": "Strategic Agreements - Summary of Collaborative Research and Development and Other Revenues Associated with Company's Major Third-Party Collaborators (Parenthetical) (Detail)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "link:footnote",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_srtProductOrServiceAxis_us-gaapLicenseMember_us-gaapTypeOfArrangementAxis_drrxAgreementWithGileadMember_20190101_20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_srtRangeAxis_srtMaximumMember_20200101_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100360 - Disclosure - Strategic Agreements - Additional Information (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail",
     "shortName": "Strategic Agreements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapChangeInAccountingEstimateByTypeAxis_drrxEarlyStageClinicalTestingMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210301",
      "decimals": "-5",
      "lang": null,
      "name": "drrx:DevelopmentBasedMilestones",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100370 - Disclosure - Strategic Agreements - Agreement with Gilead Sciences, Inc - Additional Information (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail",
     "shortName": "Strategic Agreements - Agreement with Gilead Sciences, Inc - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20191231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:DeferredRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100380 - Disclosure - Strategic Agreements - Summary of Changes in the Company's Contract Asset and Liabilities (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail",
     "shortName": "Strategic Agreements - Summary of Changes in the Company's Contract Asset and Liabilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030 - Statement - Statements of Operations and Comprehensive Loss",
     "role": "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss",
     "shortName": "Statements of Operations and Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100390 - Disclosure - Strategic Agreements - Patent Purchase Agreement with Indivior - Additional Information (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail",
     "shortName": "Strategic Agreements - Patent Purchase Agreement with Indivior - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapTypeOfArrangementAxis_drrxPatentPurchaseAgreementWithIndiviorMember_20170925_20170926",
      "decimals": "-5",
      "lang": null,
      "name": "drrx:NonRefundableUpfrontPaymentReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100400 - Disclosure - Strategic Agreements - Agreement with Santen Pharmaceutical Co., Ltd. - Additional Information (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail",
     "shortName": "Strategic Agreements - Agreement with Santen Pharmaceutical Co., Ltd. - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithSantenPharmaceuticalCoLtdMember_20200101_20201231",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithSandozAGMember_20200101_20201231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100410 - Disclosure - Strategic Agreements - Agreement with Sandoz AG - Additional Information (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSandozAGAdditionalInformationDetail",
     "shortName": "Strategic Agreements - Agreement with Sandoz AG - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapTypeOfArrangementAxis_drrxAgreementWithSandozAGMember_20200101_20201231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100420 - Disclosure - Financial Instruments - Fair Value Measurements of Assets (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail",
     "shortName": "Financial Instruments - Fair Value Measurements of Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100430 - Disclosure - Financial Instruments - Summary of Money Market Funds and Available-for-Sale Securities (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail",
     "shortName": "Financial Instruments - Summary of Money Market Funds and Available-for-Sale Securities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100440 - Disclosure - Financial Instruments - Summary of Cost and Estimated Fair Value of Available-for-Sale Securities by Contractual Maturity (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail",
     "shortName": "Financial Instruments - Summary of Cost and Estimated Fair Value of Available-for-Sale Securities by Contractual Maturity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100450 - Disclosure - Financial Instruments - Additional Information (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAdditionalInformationDetail",
     "shortName": "Financial Instruments - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100460 - Disclosure - Property and Equipment - Property and Equipment (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail",
     "shortName": "Property and Equipment - Property and Equipment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100470 - Disclosure - Property and Equipment - Additional Information (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail",
     "shortName": "Property and Equipment - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestrictedInvestmentsNoncurrent",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100480 - Disclosure - Restricted Investments - Additional Information (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureRestrictedInvestmentsAdditionalInformationDetail",
     "shortName": "Restricted Investments - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "drrx:RestrictedInvestmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_srtStatementGeographicalAxis_countryCA_20201231",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:RestrictedInvestmentsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20171231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040 - Statement - Statements of Stockholders' Equity",
     "role": "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity",
     "shortName": "Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20171231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "drrx:LeaseExpirationTerm",
       "td",
       "tr",
       "table",
       "div",
       "drrx:ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock",
       "us-gaap:CommitmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeLaboratoryAndManufacturingMember_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "drrx:LeaseExpirationYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100490 - Disclosure - Commitments - Summary of Lease Arrangements of Company Facilities (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail",
     "shortName": "Commitments - Summary of Lease Arrangements of Company Facilities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "drrx:LeaseExpirationTerm",
       "td",
       "tr",
       "table",
       "div",
       "drrx:ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock",
       "us-gaap:CommitmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_srtStatementGeographicalAxis_drrxCupertinoCAMember_us-gaapPropertyPlantAndEquipmentByTypeAxis_drrxOfficeLaboratoryAndManufacturingMember_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "drrx:LeaseExpirationYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CommitmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesRentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100500 - Disclosure - Commitments - Additional Information (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsAdditionalInformationDetail",
     "shortName": "Commitments - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:CommitmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesRentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100510 - Disclosure - Commitments - Schedule of Future Operating Lease Minimum Payments (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail",
     "shortName": "Commitments - Schedule of Future Operating Lease Minimum Payments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20191201_20191231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsOfDebtRestructuringCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100520 - Disclosure - Term Loan - Additional Information (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail",
     "shortName": "Term Loan - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20191201_20191231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsOfDebtRestructuringCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100530 - Disclosure - Term Loan - Schedule of Future Maturities and Interest Payments under Term Loan (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail",
     "shortName": "Term Loan - Schedule of Future Maturities and Interest Payments under Term Loan (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100550 - Disclosure - Stockholders' Equity - Common Stock - Additional Information (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
     "shortName": "Stockholders' Equity - Common Stock - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20190620_20190620",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100560 - Disclosure - Stockholders' Equity - 2000 Stock Plan (Incentive Stock Plan) - Additional Information (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail",
     "shortName": "Stockholders' Equity - 2000 Stock Plan (Incentive Stock Plan) - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandStockPlanMember_20200101_20201231",
      "decimals": null,
      "lang": "en-US",
      "name": "drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100570 - Disclosure - Stockholders' Equity - 2000 Employee Stock Purchase Plan - Additional Information (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail",
     "shortName": "Stockholders' Equity - 2000 Employee Stock Purchase Plan - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "INF",
      "lang": null,
      "name": "drrx:OptionsGrantedWithExercisePricesLowerThanFairMarket",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100580 - Disclosure - Stockholders' Equity - Summary of Shares of Common Stock Reserved for Future Issuance (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfSharesOfCommonStockReservedForFutureIssuanceDetail",
     "shortName": "Stockholders' Equity - Summary of Shares of Common Stock Reserved for Future Issuance (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20201231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20191231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100590 - Disclosure - Stockholders' Equity - Summary of Stock Option Activity under all Stock-Based Compensation Plans (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail",
     "shortName": "Stockholders' Equity - Summary of Stock Option Activity under all Stock-Based Compensation Plans (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050 - Statement - Statements of Stockholders' Equity (Parenthetical)",
     "role": "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquityParenthetical",
     "shortName": "Statements of Stockholders' Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100600 - Disclosure - Stockholders' Equity - Summary of Employee Stock-Based Compensation Cost that has been Included in Statements of Operations and Comprehensive Loss (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfEmployeeStockBasedCompensationCostThatHasBeenIncludedInStatementsOfOperationsAndComprehensiveLossDetail",
     "shortName": "Stockholders' Equity - Summary of Employee Stock-Based Compensation Cost that has been Included in Statements of Operations and Comprehensive Loss (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100610 - Disclosure - Stockholders' Equity - Determining Fair Value - Additional Information (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail",
     "shortName": "Stockholders' Equity - Determining Fair Value - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapPlanNameAxis_drrxTwoThousandEmployeeStockPurchasePlanMember_20200101_20201231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100620 - Disclosure - Stockholders' Equity - Summary of Assumptions Used to Estimate Fair Value of Options Granted and Shares Purchased (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail",
     "shortName": "Stockholders' Equity - Summary of Assumptions Used to Estimate Fair Value of Options Granted and Shares Purchased (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapAwardTypeAxis_us-gaapStockCompensationPlanMember_20200101_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "drrx:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlipure",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100630 - Disclosure - Stockholders' Equity - Summary of Stock Options Outstanding (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail",
     "shortName": "Stockholders' Equity - Summary of Stock Options Outstanding (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_drrxExercisePriceRangeOneMember_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxLiabilities",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100640 - Disclosure - Income Taxes - Additional Information (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
     "shortName": "Income Taxes - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DeferredTaxLiabilities",
       "us-gaap:DeferredTaxLiabilities",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsLiabilitiesNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100650 - Disclosure - Income Taxes - Reconciliation of Income Tax Expenses (Benefit) (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail",
     "shortName": "Income Taxes - Reconciliation of Income Tax Expenses (Benefit) (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100660 - Disclosure - Income Taxes - Summary of Components of Company's Deferred Tax Assets (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail",
     "shortName": "Income Taxes - Summary of Components of Company's Deferred Tax Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100670 - Disclosure - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetail",
     "shortName": "Income Taxes - Reconciliation of Unrecognized Tax Benefits (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "lang": null,
      "name": "drrx:UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100680 - Disclosure - Discontinued Operations - Additional Information (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail",
     "shortName": "Discontinued Operations - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_drrxEvonikCorporationMember_20201230_20201231",
      "decimals": "-6",
      "lang": null,
      "name": "drrx:AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "drrx:SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100690 - Disclosure - Discontinued Operations - Summary of Discontinued Operations Reported in Statement of Operations (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail",
     "shortName": "Discontinued Operations - Summary of Discontinued Operations Reported in Statement of Operations (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "drrx:SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060 - Statement - Statements of Cash Flows",
     "role": "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows",
     "shortName": "Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "drrx:SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100700 - Disclosure - Discontinued Operations - Summary of Assets and Liabilities Reported as Discontinued Operations in Balance Sheet (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail",
     "shortName": "Discontinued Operations - Summary of Assets and Liabilities Reported as Discontinued Operations in Balance Sheet (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "drrx:SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "drrx:SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100710 - Disclosure - Discontinued Operations - Summary of Non-cash Items Related to Discontinued Operations Included in Statement of Cash Flows (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail",
     "shortName": "Discontinued Operations - Summary of Non-cash Items Related to Discontinued Operations Included in Statement of Cash Flows (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "drrx:SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20201231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "U_iso4217USD_xbrlishares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100720 - Disclosure - Subsequent Events - Additional Information (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
     "shortName": "Subsequent Events - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_srtCounterpartyNameAxis_drrxCantorFitzgeraldCoMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210228",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD_xbrlishares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20191231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100730 - Disclosure - Schedule II-Valuation and Qualifying Accounts (Detail)",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccountsDetail",
     "shortName": "Schedule II-Valuation and Qualifying Accounts (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapValuationAllowancesAndReservesTypeAxis_us-gaapAllowanceForCreditLossMember_20171231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "link:footnote",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapBalanceSheetLocationAxis_drrxLongTermRestrictedInvestmentsMember_20201231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestrictedCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070 - Statement - Statements of Cash Flows (Parenthetical)",
     "role": "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlowsParenthetical",
     "shortName": "Statements of Cash Flows (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "link:footnote",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_us-gaapBalanceSheetLocationAxis_drrxLongTermRestrictedInvestmentsMember_20201231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RestrictedCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_iso4217USD",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100080 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "drrx-10k_20201231.htm",
      "contextRef": "C_0001082038_20200101_20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 101,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "California [Member]"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureRestrictedInvestmentsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "country_JP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "JAPAN",
        "terseLabel": "JAPAN"
       }
      }
     },
     "localname": "JP",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfTotalRevenueByGeographicRegionDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfTotalRevenueByGeographicRegionDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r566",
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated By Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "verboseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when an entity was incorporated",
        "label": "Entity Incorporation Date Of Incorporation",
        "terseLabel": "Date of incorporation"
       }
      }
     },
     "localname": "EntityIncorporationDateOfIncorporation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well Known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r566",
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Icfr Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "drrx_AccruedAmountOfFinalPaymentOfTermLoan": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued amount of final payment of term loan.",
        "label": "Accrued Amount Of Final Payment Of Term Loan",
        "terseLabel": "Deferred revenue recognized"
       }
      }
     },
     "localname": "AccruedAmountOfFinalPaymentOfTermLoan",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_AdditionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions [Member].",
        "label": "Additions [Member]",
        "terseLabel": "Additions [Member]"
       }
      }
     },
     "localname": "AdditionsMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to additional paid-in capital stock issued to settle accrued liabilities.",
        "label": "Adjustments To Additional Paid In Capital Stock Issued To Settle Accrued Liabilities",
        "terseLabel": "Issuance of fully vested options to settle accrued liabilities"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedToSettleAccruedLiabilities",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_AgreementWithGileadMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement with Gilead [Member]",
        "label": "Agreement With Gilead [Member]",
        "terseLabel": "Agreement with Gilead [Member]"
       }
      }
     },
     "localname": "AgreementWithGileadMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_AgreementWithSandozAGMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement with Sandoz AG.",
        "label": "Agreement With Sandoz A G [Member]",
        "terseLabel": "Agreement with Sandoz AG [Member]"
       }
      }
     },
     "localname": "AgreementWithSandozAGMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSandozAGAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_AgreementWithSantenPharmaceuticalCoLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement with Santen Pharmaceutical Co., Ltd.",
        "label": "Agreement With Santen Pharmaceutical Co Ltd [Member]",
        "terseLabel": "Agreement with Santen Pharmaceutical Co., Ltd. [Member]"
       }
      }
     },
     "localname": "AgreementWithSantenPharmaceuticalCoLtdMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_AgreementsWithOtherCollaboratorsOrCounterpartiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreements with other collaborators or counterparties.",
        "label": "Agreements With Other Collaborators Or Counterparties [Member]",
        "terseLabel": "Agreements With Other Collaborators or Counterparties [Member]"
       }
      }
     },
     "localname": "AgreementsWithOtherCollaboratorsOrCounterpartiesMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_AlzetProductLineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ALZET Product Line.",
        "label": "Alzet Product Line [Member]",
        "terseLabel": "ALZET Product Line [Member]"
       }
      }
     },
     "localname": "AlzetProductLineMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset purchase agreement subject to certain adjustments paid.",
        "label": "Asset Purchase Agreement Subject To Certain Adjustments Paid",
        "terseLabel": "Asset purchase agreement subject to certain adjustments paid"
       }
      }
     },
     "localname": "AssetPurchaseAgreementSubjectToCertainAdjustmentsPaid",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_CantorFitzgeraldCoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cantor Fitzgerald &amp; Co.",
        "label": "Cantor Fitzgerald Co [Member]",
        "terseLabel": "Cantor Fitzgerald Co [Member]"
       }
      }
     },
     "localname": "CantorFitzgeraldCoMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_CashHeldInEscrow": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash held in escrow.",
        "label": "Cash Held In Escrow",
        "terseLabel": "Cash held in escrow"
       }
      }
     },
     "localname": "CashHeldInEscrow",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_ChangesInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10180.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Changes in operating lease liabilities.",
        "label": "Changes In Operating Lease Liabilities",
        "terseLabel": "Changes in operating lease liabilities"
       }
      }
     },
     "localname": "ChangesInOperatingLeaseLiabilities",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_CollaborativeResearchAndDevelopmentAndOtherRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative research and development and other revenue.",
        "label": "Collaborative Research And Development And Other Revenue [Member]",
        "terseLabel": "Collaborative Research and Development and Other Revenue [Member]"
       }
      }
     },
     "localname": "CollaborativeResearchAndDevelopmentAndOtherRevenueMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_CommercializationBasedMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercialization based milestones.",
        "label": "Commercialization Based Milestones [Member]",
        "terseLabel": "Commercialization-Based Milestones [Member]"
       }
      }
     },
     "localname": "CommercializationBasedMilestonesMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_CommitmentAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitment and contingencies.",
        "label": "Commitment And Contingencies [Line Items]",
        "terseLabel": "Commitment And Contingencies [Line Items]"
       }
      }
     },
     "localname": "CommitmentAndContingenciesLineItems",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "drrx_CommitmentAndContingenciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitment and contingencies.",
        "label": "Commitment And Contingencies [Table]",
        "terseLabel": "Commitment And Contingencies [Table]"
       }
      }
     },
     "localname": "CommitmentAndContingenciesTable",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "drrx_CommonStockCapitalAmountReservedForFutureIssuance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock capital amount reserved for future issuance.",
        "label": "Common Stock Capital Amount Reserved For Future Issuance",
        "terseLabel": "Securities offered"
       }
      }
     },
     "localname": "CommonStockCapitalAmountReservedForFutureIssuance",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_CommonStockWeightedAveragePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock weighted average price.",
        "label": "Common Stock Weighted Average Price",
        "terseLabel": "Common stock weighted average price"
       }
      }
     },
     "localname": "CommonStockWeightedAveragePrice",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "drrx_ContractResearchLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10160.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to clinical and non-clinical costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include clinical trial expenses and non-clinical study expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Contract Research Liability",
        "terseLabel": "Contract research liabilities"
       }
      }
     },
     "localname": "ContractResearchLiability",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_ContractWithCustomerLiabilityMilestonePayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer liability milestone payment.",
        "label": "Contract With Customer Liability Milestone Payment",
        "terseLabel": "Amount related to the milestone payment earned"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityMilestonePayment",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_ControlledEquityOfferingProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Controlled equity offering program.",
        "label": "Controlled Equity Offering Program [Member]",
        "terseLabel": "Controlled Equity Offering Program [Member]"
       }
      }
     },
     "localname": "ControlledEquityOfferingProgramMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_CupertinoCAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cupertino, CA.",
        "label": "Cupertino C A [Member]",
        "terseLabel": "Cupertino, CA [Member]"
       }
      }
     },
     "localname": "CupertinoCAMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_DebtInstrumentPrepaymentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument prepayment fee percentage.",
        "label": "Debt Instrument Prepayment Fee Percentage",
        "terseLabel": "Percentage of prepayment fee"
       }
      }
     },
     "localname": "DebtInstrumentPrepaymentFeePercentage",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "drrx_DebtInstrumentPrincipalPaymentPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument principal payment percentage.",
        "label": "Debt Instrument Principal Payment Percentage",
        "terseLabel": "Percentage of an additional payment equal to principal amount"
       }
      }
     },
     "localname": "DebtInstrumentPrincipalPaymentPercentage",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "drrx_DebtIssuanceCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt issuance costs (for example, but not limited to, legal, accounting, broker, and regulatory fees).",
        "label": "Debt Issuance Cost",
        "terseLabel": "Debt offering/issuance costs"
       }
      }
     },
     "localname": "DebtIssuanceCost",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_DeferredTaxLiabilitiesRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities right of use assets.",
        "label": "Deferred Tax Liabilities Right Of Use Assets",
        "negatedLabel": "Deferred tax liabilities - Right of use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesRightOfUseAssets",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_DeletionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deletions [Member].",
        "label": "Deletions [Member]",
        "terseLabel": "Deletions [Member]"
       }
      }
     },
     "localname": "DeletionsMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_DevelopmentBasedMilestones": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development based milestones.",
        "label": "Development Based Milestones",
        "terseLabel": "Development-based milestones"
       }
      }
     },
     "localname": "DevelopmentBasedMilestones",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_DevelopmentBasedMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development based milestones.",
        "label": "Development Based Milestones [Member]",
        "terseLabel": "Development-Based Milestones [Member]"
       }
      }
     },
     "localname": "DevelopmentBasedMilestonesMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_DiscontinuedOperationsTextblock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of discontinued operations.",
        "label": "Discontinued Operations Textblock",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "DiscontinuedOperationsTextblock",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail": {
       "order": 10010.0,
       "parentTag": "drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group including discontinued operation non-cash items, gross.",
        "label": "Disposal Group Including Discontinued Operation Non Cash Items Gross",
        "totalLabel": "Non-cash items, gross"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group including discontinued operation non-cash items, net.",
        "label": "Disposal Group Including Discontinued Operation Non Cash Items Net",
        "totalLabel": "Non-cash items, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group including discontinued operation operating lease liabilities, current.",
        "label": "Disposal Group Including Discontinued Operation Operating Lease Liabilities Current",
        "terseLabel": "Operating lease liabilities, current portion"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group including discontinued operation operating lease liabilities, non current.",
        "label": "Disposal Group Including Discontinued Operation Operating Lease Liabilities Non Current",
        "terseLabel": "Operating lease liabilities, non-current portion"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNonCurrent",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group including discontinued operation operating lease right-of-use assets.",
        "label": "Disposal Group Including Discontinued Operation Operating Lease Right Of Use Assets",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group including discontinued operation other income.",
        "label": "Disposal Group Including Discontinued Operation Other Income [Abstract]",
        "terseLabel": "Other income:"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherIncomeAbstract",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "drrx_DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group including discontinued operation research and development.",
        "label": "Disposal Group Including Discontinued Operation Research And Development",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationResearchAndDevelopment",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail": {
       "order": 10040.0,
       "parentTag": "drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group including discontinued operation stock-based compensation expense.",
        "label": "Disposal Group Including Discontinued Operation Stock Based Compensation Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationStockBasedCompensationExpense",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_EarlyStageClinicalTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Early stage clinical testing.",
        "label": "Early Stage Clinical Testing [Member]",
        "terseLabel": "Early stage clinical testing [Member]"
       }
      }
     },
     "localname": "EarlyStageClinicalTestingMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_EmployeeStockPurchasePlanExpirationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee stock purchase plan expiration date.",
        "label": "Employee Stock Purchase Plan Expiration Date",
        "terseLabel": "Plan expiry date"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanExpirationDate",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "drrx_EmployeeStockPurchasePlanOfferingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee stock purchase plan offering period.",
        "label": "Employee Stock Purchase Plan Offering Period",
        "terseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanOfferingPeriod",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "drrx_EmployeesStockPurchasePlanExtendedTermPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees stock purchase plan extended term period.",
        "label": "Employees Stock Purchase Plan Extended Term Period",
        "terseLabel": "Extended term of stock plan to the date"
       }
      }
     },
     "localname": "EmployeesStockPurchasePlanExtendedTermPeriod",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "drrx_EvonikCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Evonik Corporation.",
        "label": "Evonik Corporation [Member]",
        "terseLabel": "Evonik [Member]"
       }
      }
     },
     "localname": "EvonikCorporationMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercisable period from date of grant for stock option granted to non employee directors.",
        "label": "Exercisable Period From Date Of Grant For Stock Option Granted To Non Employee Directors",
        "terseLabel": "Stock option exercisable period"
       }
      }
     },
     "localname": "ExercisablePeriodFromDateOfGrantForStockOptionGrantedToNonEmployeeDirectors",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "drrx_ExercisePriceRangeEightMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price range eight.",
        "label": "Exercise Price Range Eight [Member]",
        "terseLabel": "Range of Exercise Price, $1.31 - $1.31 [Member]"
       }
      }
     },
     "localname": "ExercisePriceRangeEightMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_ExercisePriceRangeElevenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price range eleven.",
        "label": "Exercise Price Range Eleven [Member]",
        "terseLabel": "Range of Exercise Price, $0.51 - $3.61 [Member]"
       }
      }
     },
     "localname": "ExercisePriceRangeElevenMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_ExercisePriceRangeFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price range five.",
        "label": "Exercise Price Range Five [Member]",
        "terseLabel": "Range of Exercise Price, $1.21 - $1.21 [Member]"
       }
      }
     },
     "localname": "ExercisePriceRangeFiveMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_ExercisePriceRangeFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price range four.",
        "label": "Exercise Price Range Four [Member]",
        "terseLabel": "Range of Exercise Price, $0.93 - $1.20 [Member]"
       }
      }
     },
     "localname": "ExercisePriceRangeFourMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_ExercisePriceRangeNineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price range nine.",
        "label": "Exercise Price Range Nine [Member]",
        "terseLabel": "Range of Exercise Price, $1.33 - $2.09 [Member]"
       }
      }
     },
     "localname": "ExercisePriceRangeNineMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_ExercisePriceRangeOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price range one.",
        "label": "Exercise Price Range One [Member]",
        "terseLabel": "Range of Exercise Price, $0.51 - $0.57 [Member]"
       }
      }
     },
     "localname": "ExercisePriceRangeOneMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_ExercisePriceRangeSevenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price range seven.",
        "label": "Exercise Price Range Seven [Member]",
        "terseLabel": "Range of Exercise Price, $1.26 - $1.26 [Member]"
       }
      }
     },
     "localname": "ExercisePriceRangeSevenMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_ExercisePriceRangeSixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price range six.",
        "label": "Exercise Price Range Six [Member]",
        "terseLabel": "Range of Exercise Price, $1.24 - $1.24 [Member]"
       }
      }
     },
     "localname": "ExercisePriceRangeSixMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_ExercisePriceRangeTenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price range ten.",
        "label": "Exercise Price Range Ten [Member]",
        "terseLabel": "Range of Exercise Price, $2.10 - $3.61 [Member]"
       }
      }
     },
     "localname": "ExercisePriceRangeTenMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_ExercisePriceRangeThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price range three.",
        "label": "Exercise Price Range Three [Member]",
        "terseLabel": "Range of Exercise Price, $0.58 - $0.88 [Member]"
       }
      }
     },
     "localname": "ExercisePriceRangeThreeMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_ExercisePriceRangeTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price range two.",
        "label": "Exercise Price Range Two [Member]",
        "terseLabel": "Range of Exercise Price, $0.58 - $0.58 [Member]"
       }
      }
     },
     "localname": "ExercisePriceRangeTwoMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_GileadMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gilead.",
        "label": "Gilead [Member]",
        "terseLabel": "Gilead [Member]"
       }
      }
     },
     "localname": "GileadMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_GrantedPatentsExtendingYearMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Granted patents extending year, minimum.",
        "label": "Granted Patents Extending Year Minimum",
        "terseLabel": "Granted patents extending year, minimum"
       }
      }
     },
     "localname": "GrantedPatentsExtendingYearMinimum",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail"
     ],
     "xbrltype": "gYearItemType"
    },
    "drrx_IncomeTaxReconciliationExpiringNetOperatingLosses": {
     "auth_ref": [],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation expiring net operating losses.",
        "label": "Income Tax Reconciliation Expiring Net Operating Losses",
        "terseLabel": "Expiring net operating losses"
       }
      }
     },
     "localname": "IncomeTaxReconciliationExpiringNetOperatingLosses",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_IncreaseDecreaseInContractResearchLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10250.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of clinical and non-clinical expenses incurred but not yet paid.",
        "label": "Increase Decrease In Contract Research Liability",
        "terseLabel": "Contract research liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractResearchLiability",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_IndiviorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indivior.",
        "label": "Indivior [Member]",
        "terseLabel": "Indivior [Member]"
       }
      }
     },
     "localname": "IndiviorMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_InvestmentHoldingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Holdings [Abstract]",
        "label": "Investment Holdings [Abstract]"
       }
      }
     },
     "localname": "InvestmentHoldingsAbstract",
     "nsuri": "http://www.durect.com/20201231",
     "xbrltype": "stringItemType"
    },
    "drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock upon exercise of stock options and purchases of employee stock purchase plan.",
        "label": "Issuance Of Common Stock Upon Exercise Of Stock Options And Purchases Of Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock upon exercise of stock options and purchases of ESPP shares"
       }
      }
     },
     "localname": "IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlan",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock upon exercise of stock options and purchases of employee stock purchase plan shares.",
        "label": "Issuance Of Common Stock Upon Exercise Of Stock Options And Purchases Of Employee Stock Purchase Plan Shares",
        "terseLabel": "Issuance of common stock upon exercise of stock options and purchases of ESPP shares, shares"
       }
      }
     },
     "localname": "IssuanceOfCommonStockUponExerciseOfStockOptionsAndPurchasesOfEmployeeStockPurchasePlanShares",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "drrx_LACTELMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "LACTEL member.",
        "label": "L A C T E L [Member]",
        "terseLabel": "L A C T E L"
       }
      }
     },
     "localname": "LACTELMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_LactelProductLineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "LACTEL product line.",
        "label": "Lactel Product Line [Member]",
        "terseLabel": "LACTEL Product Line [Member]"
       }
      }
     },
     "localname": "LactelProductLineMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_LateStageClinicalTestingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Late stage clinical testing.",
        "label": "Late Stage Clinical Testing [Member]",
        "terseLabel": "Late stage clinical testing [Member]"
       }
      }
     },
     "localname": "LateStageClinicalTestingMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_LeaseAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease amendment.",
        "label": "Lease Amendment [Member]",
        "terseLabel": "Lease Amendment [Member]"
       }
      }
     },
     "localname": "LeaseAmendmentMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_LeaseExpirationTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease expiration term.",
        "label": "Lease Expiration Term",
        "terseLabel": "Expiration"
       }
      }
     },
     "localname": "LeaseExpirationTerm",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "drrx_LeaseExpirationYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease expiration year.",
        "label": "Lease Expiration Year",
        "terseLabel": "Lease expiration year"
       }
      }
     },
     "localname": "LeaseExpirationYear",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail"
     ],
     "xbrltype": "gYearItemType"
    },
    "drrx_LesseeOperatingLeaseIncrementalBorrowingRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental borrowing rate used by lessee to determine present value of operating lease payments.",
        "label": "Lessee Operating Lease Incremental Borrowing Rate",
        "terseLabel": "Lessee operating lease incremental borrowing rate"
       }
      }
     },
     "localname": "LesseeOperatingLeaseIncrementalBorrowingRate",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "drrx_LiquidInvestmentsMaturityPeriodDescriptionMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liquid investments maturity period description maximum.",
        "label": "Liquid Investments Maturity Period Description Maximum",
        "terseLabel": "Highly liquid investments maturity period"
       }
      }
     },
     "localname": "LiquidInvestmentsMaturityPeriodDescriptionMaximum",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "drrx_LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liquidity and need to raise additional capital.",
        "label": "Liquidity And Need To Raise Additional Capital Policy [Text Block]",
        "terseLabel": "Liquidity and Need to Raise Additional Capital Policy"
       }
      }
     },
     "localname": "LiquidityAndNeedToRaiseAdditionalCapitalPolicyTextBlock",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "drrx_LongTermInvestmentsMaturityPeriodDescriptionMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term investments maturity period description minimum.",
        "label": "Long Term Investments Maturity Period Description Minimum",
        "terseLabel": "Long term investments maturity period description minimum"
       }
      }
     },
     "localname": "LongTermInvestmentsMaturityPeriodDescriptionMinimum",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "drrx_LongTermRestrictedInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term restricted investments.",
        "label": "Long Term Restricted Investments [Member]",
        "terseLabel": "Long Term Restricted Investments [Member]"
       }
      }
     },
     "localname": "LongTermRestrictedInvestmentsMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlowsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_MinimumPercentageOfCombinedVotingPowerClassesOfStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of total combined voting power classes of stock.",
        "label": "Minimum Percentage Of Combined Voting Power Classes Of Stock",
        "terseLabel": "Minimum percentage of total combined voting power of stock"
       }
      }
     },
     "localname": "MinimumPercentageOfCombinedVotingPowerClassesOfStock",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "drrx_NatureOfOperationsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature of operations.",
        "label": "Nature Of Operations Policy [Text Block]",
        "terseLabel": "Nature Of Operations Policy"
       }
      }
     },
     "localname": "NatureOfOperationsPolicyTextBlock",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "drrx_NetOperatingLossCarryforwardsExpirationAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net operating loss carryforwards expiration amount.",
        "label": "Net Operating Loss Carryforwards Expiration Amount",
        "terseLabel": "Net operating loss carryforwards expiration amount"
       }
      }
     },
     "localname": "NetOperatingLossCarryforwardsExpirationAmount",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_NetOperatingLossCarryforwardsNonExpirationAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net operating loss carryforwards non-expiration amount.",
        "label": "Net Operating Loss Carryforwards Non Expiration Amount",
        "terseLabel": "Net operating loss carryforwards non-expiration amount"
       }
      }
     },
     "localname": "NetOperatingLossCarryforwardsNonExpirationAmount",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail": {
       "order": 10060.0,
       "parentTag": "drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-cash items related to discontinued operation gain (loss) on property plant equipment",
        "label": "Non Cash Items Related To Discontinued Operation Gain Loss On Property Plant Equipment",
        "negatedLabel": "Loss on disposal of property and equipment"
       }
      }
     },
     "localname": "NonCashItemsRelatedToDiscontinuedOperationGainLossOnPropertyPlantEquipment",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail": {
       "order": 10050.0,
       "parentTag": "drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-cash items related to disposal group including discontinued operation goodwill.",
        "label": "Non Cash Items Related To Disposal Group Including Discontinued Operation Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "NonCashItemsRelatedToDisposalGroupIncludingDiscontinuedOperationGoodwill",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_NonEmployeeDirectorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non employee director.",
        "label": "Non Employee Director [Member]",
        "terseLabel": "Non-employee director [Member]"
       }
      }
     },
     "localname": "NonEmployeeDirectorMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_NonRefundableUpfrontPaymentReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-refundable upfront payment received.",
        "label": "Non Refundable Upfront Payment Received",
        "terseLabel": "Upfront non-refundable payment received"
       }
      }
     },
     "localname": "NonRefundableUpfrontPaymentReceived",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_OctoberTwoThousandEighteenRegistrationStatementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2018 registration statement [Member]",
        "label": "October Two Thousand Eighteen Registration Statement [Member]",
        "terseLabel": "October Two Thousand Eighteen Registration Statement",
        "verboseLabel": "October 2018 Registration Statement [Member]"
       }
      }
     },
     "localname": "OctoberTwoThousandEighteenRegistrationStatementMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_OfficeAndLaboratoryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office and laboratory.",
        "label": "Office And Laboratory [Member]",
        "terseLabel": "Office and Laboratory [Member]"
       }
      }
     },
     "localname": "OfficeAndLaboratoryMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_OfficeLaboratoryAndManufacturingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office, laboratory and manufacturing.",
        "label": "Office Laboratory And Manufacturing [Member]",
        "terseLabel": "Office, Laboratory and Manufacturing [Member]"
       }
      }
     },
     "localname": "OfficeLaboratoryAndManufacturingMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_OptionsGrantedWithExercisePricesLowerThanFairMarket": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options granted with exercise prices lower than fair market.",
        "label": "Options Granted With Exercise Prices Lower Than Fair Market",
        "terseLabel": "Options granted with exercise prices lower than fair market"
       }
      }
     },
     "localname": "OptionsGrantedWithExercisePricesLowerThanFairMarket",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_OtherForeignCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other foreign countries.",
        "label": "Other Foreign Countries [Member]",
        "terseLabel": "Other Foreign Countries"
       }
      }
     },
     "localname": "OtherForeignCountriesMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfTotalRevenueByGeographicRegionDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_OxfordFinanceLlcTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oxford Finance LLC term loan.",
        "label": "Oxford Finance Llc Term Loan [Member]",
        "terseLabel": "Oxford Finance LLC Term Loan [Member]"
       }
      }
     },
     "localname": "OxfordFinanceLlcTermLoanMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_PatentPurchaseAgreementWithIndiviorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patent Purchase Agreement with Indivior.",
        "label": "Patent Purchase Agreement With Indivior [Member]",
        "terseLabel": "Patent Purchase Agreement with Indivior [Member]"
       }
      }
     },
     "localname": "PatentPurchaseAgreementWithIndiviorMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_PaymentFromEscrow": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment from escrow.",
        "label": "Payment From Escrow",
        "terseLabel": "Amount released from escrow"
       }
      }
     },
     "localname": "PaymentFromEscrow",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance milestone payments based on successful development and approval of the four ORADUR based opioids.",
        "label": "Performance Milestone Payments Based On Successful Development",
        "terseLabel": "Performance milestone payments based on successful development"
       }
      }
     },
     "localname": "PerformanceMilestonePaymentsBasedOnSuccessfulDevelopment",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_PrepaidAndAccruedContractResearchExpensesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid and Accrued Contract Research Expenses.",
        "label": "Prepaid And Accrued Contract Research Expenses Policy [Text Block]",
        "terseLabel": "Prepaid and Accrued Contract Research Expenses"
       }
      }
     },
     "localname": "PrepaidAndAccruedContractResearchExpensesPolicyTextBlock",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "drrx_RegulatoryApprovalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory approvals.",
        "label": "Regulatory Approvals [Member]",
        "terseLabel": "Regulatory approvals [Member]"
       }
      }
     },
     "localname": "RegulatoryApprovalsMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_RegulatoryBasedMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory based milestone.",
        "label": "Regulatory Based Milestone [Member]",
        "terseLabel": "Regulatory Based Milestone [Member]"
       }
      }
     },
     "localname": "RegulatoryBasedMilestoneMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_RestrictedInvestmentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted investments.",
        "label": "Restricted Investments Disclosure [Text Block]",
        "terseLabel": "Restricted Investments"
       }
      }
     },
     "localname": "RestrictedInvestmentsDisclosureTextBlock",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureRestrictedInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "drrx_RestrictedInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Investments [Line Items]",
        "label": "Restricted Investments [Line Items]",
        "terseLabel": "Restricted Investments [Line Items]"
       }
      }
     },
     "localname": "RestrictedInvestmentsLineItems",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureRestrictedInvestmentsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "drrx_RestrictedInvestmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted investments.",
        "label": "Restricted Investments [Table]",
        "terseLabel": "Restricted Investments [Table]"
       }
      }
     },
     "localname": "RestrictedInvestmentsTable",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureRestrictedInvestmentsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "drrx_SalesBasedMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales based milestones.",
        "label": "Sales Based Milestones [Member]",
        "terseLabel": "Sales-Based Milestones [Member]"
       }
      }
     },
     "localname": "SalesBasedMilestonesMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of lease arrangements of company facilities.",
        "label": "Schedule Of Lease Arrangements Of Company Facilities Table [Text Block]",
        "terseLabel": "Summary of Lease Arrangements of Company Facilities"
       }
      }
     },
     "localname": "ScheduleOfLeaseArrangementsOfCompanyFacilitiesTableTextBlock",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price as percentage of fair market value minimum.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Exercise Price As Percentage Of Fair Market Value Minimum",
        "terseLabel": "Exercise price as percentage of fair market value minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsPercentageOfFairMarketValueMinimum",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award fair value assumptions forfeiture interest rate.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Interest Rate",
        "terseLabel": "Forfeiture rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureInterestRate",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum expiration term.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Maximum Expiration Term",
        "terseLabel": "Maximum expiration term of stock appreciation rights"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumExpirationTerm",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum exercise price as percentage of fair market value to holder of more than ten percent voting power.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Minimum Exercise Price As Percentage Of Fair Market Value To Holder Of More Than Ten Percent Voting Power",
        "terseLabel": "Minimum exercise price as percentage of fair market value to holder of more than 10% voting power"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfMoreThanTenPercentVotingPower",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "drrx_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum exercise price as percentage of fair market value to holder of ten percent or less voting power.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Minimum Exercise Price As Percentage Of Fair Market Value To Holder Of Ten Percent Or Less Voting Power",
        "terseLabel": "Minimum exercise price as percentage of fair market value to holder of 10% or less voting power"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceAsPercentageOfFairMarketValueToHolderOfTenPercentOrLessVotingPower",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "drrx_ShippingAndHandlingPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shipping and handling.",
        "label": "Shipping And Handling Policy [Text Block]",
        "terseLabel": "Shipping and Handling"
       }
      }
     },
     "localname": "ShippingAndHandlingPolicyTextBlock",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "drrx_ShortTermInvestmentMaturityPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term investment maturity period.",
        "label": "Short Term Investment Maturity Period",
        "terseLabel": "Short term investment maturity period"
       }
      }
     },
     "localname": "ShortTermInvestmentMaturityPeriod",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "drrx_StockIssuedDuringPeriodValueNewIssuesNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period value new Issues net",
        "label": "Stock Issued During Period Value New Issues Net",
        "terseLabel": "Net proceeds from stock issued during period value new issues, net of issuance cost"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssuesNet",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_StockOptionsVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock and unit award vesting period.",
        "label": "Stock Options Vesting Period",
        "terseLabel": "Option plan vesting period"
       }
      }
     },
     "localname": "StockOptionsVestingPeriod",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "drrx_SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of Assets and Liabilities Reported as Discontinued Operations in Balance Sheet.",
        "label": "Summary Of Assets And Liabilities Reported As Discontinued Operations In Balance Sheet Table [Text Block]",
        "terseLabel": "Summary of Assets and Liabilities Reported as Discontinued Operations in Balance Sheet"
       }
      }
     },
     "localname": "SummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetTableTextBlock",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "drrx_SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of Discontinued Operations Reported in Statement of Operations.",
        "label": "Summary Of Discontinued Operations Reported In Statement Of Operations Table [Text Block]",
        "terseLabel": "Summary of Discontinued Operations Reported in Statement of Operations"
       }
      }
     },
     "localname": "SummaryOfDiscontinuedOperationsReportedInStatementOfOperationsTableTextBlock",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "drrx_SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of Non-cash Items Related to Discontinued Operations Included in Statement of Cash Flows.",
        "label": "Summary Of Non Cash Items Related To Discontinued Operations Included In Statement Of Cash Flows Table [Text Block]",
        "terseLabel": "Summary of Non-cash Items Related to Discontinued Operations Included in Statement of Cash Flows"
       }
      }
     },
     "localname": "SummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsTableTextBlock",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "drrx_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of significant accounting policies.",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "drrx_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Significant Accounting Policies [Table]",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "drrx_TaxCreditCarryforwardExpiration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax credit carryforward expiration.",
        "label": "Tax Credit Carryforward Expiration",
        "terseLabel": "Tax carryforwards expire date"
       }
      }
     },
     "localname": "TaxCreditCarryforwardExpiration",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "drrx_TwoThousandEmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand employee stock purchase plan.",
        "label": "Two Thousand Employee Stock Purchase Plan [Member]",
        "terseLabel": "2000 Employee Stock Purchase Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandEmployeeStockPurchasePlanMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfSharesOfCommonStockReservedForFutureIssuanceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_TwoThousandStockPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand stock plan.",
        "label": "Two Thousand Stock Plan [Member]",
        "terseLabel": "2000 Stock Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandStockPlanMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized tax benefits increase (decreases) resulting from prior period tax positions.",
        "label": "Unrecognized Tax Benefits Increase Decreases Resulting From Prior Period Tax Positions",
        "terseLabel": "Increase (decrease) related to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreaseDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Upfront Development Regulatory And Sales Based Milestone [Member]",
        "terseLabel": "Upfront, Development, Regulatory and Sales-Based Milestones [Member]"
       }
      }
     },
     "localname": "UpfrontDevelopmentRegulatoryAndSalesBasedMilestoneMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_VacavilleCAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vacaville, CA.",
        "label": "Vacaville C A [Member]",
        "terseLabel": "Vacaville, CA [Member]"
       }
      }
     },
     "localname": "VacavilleCAMember",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "drrx_ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowances and reserves charged and reversal of charges to cost and expense.",
        "label": "Valuation Allowances And Reserves Charged And Reversal Of Charges To Cost And Expense",
        "terseLabel": "Additions (Reductions) to allowances"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedAndReversalOfChargesToCostAndExpense",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccountsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average number of shares outstanding diluted net of effect of dilutive securities.",
        "label": "Weighted Average Number Of Shares Outstanding Diluted Net Of Effect Of Dilutive Securities",
        "totalLabel": "Weighted average shares used to compute diluted net loss per share"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities",
     "nsuri": "http://www.durect.com/20201231",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r75",
      "r131",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Continent of Europe.",
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfTotalRevenueByGeographicRegionDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r208",
      "r286",
      "r291",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Major Customers [Axis]",
        "terseLabel": "Customer"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r305",
      "r307",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r514",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r305",
      "r307",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r514",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r208",
      "r286",
      "r291",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Name Of Major Customer [Domain]",
        "terseLabel": "Customer"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r204",
      "r286",
      "r289",
      "r463",
      "r513",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product Or Service [Axis]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r204",
      "r286",
      "r289",
      "r463",
      "r513",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Products And Services [Domain]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r294",
      "r305",
      "r307",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r514",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Range [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r294",
      "r305",
      "r307",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r514",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Range [Member]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Repurchase Agreement Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r150",
      "r151",
      "r152",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r171",
      "r236",
      "r237",
      "r346",
      "r380",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.",
        "label": "Restatement [Axis]",
        "terseLabel": "Revision of Prior Period"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r147",
      "r150",
      "r151",
      "r152",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r171",
      "r236",
      "r237",
      "r346",
      "r380",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.",
        "label": "Restatement [Domain]",
        "terseLabel": "Revision of Prior Period"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember": {
     "auth_ref": [
      "r146",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative increase (decrease) to previously issued financial statements for change in accounting principle. Excludes adjustment for amendment to accounting standards.",
        "label": "Revision Of Prior Period Change In Accounting Principle Adjustment [Member]",
        "terseLabel": "Revision of Prior Period, Change in Accounting Principle, Adjustment"
       }
      }
     },
     "localname": "RevisionOfPriorPeriodChangeInAccountingPrincipleAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "auth_ref": [
      "r140",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.",
        "label": "Schedule Of Valuation And Qualifying Accounts Disclosure [Text Block]",
        "terseLabel": "Schedule II-Valuation and Qualifying Accounts"
       }
      }
     },
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r205",
      "r206",
      "r286",
      "r290",
      "r516",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Segment Geographical [Domain]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureRestrictedInvestmentsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfTotalRevenueByGeographicRegionDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r205",
      "r206",
      "r286",
      "r290",
      "r516",
      "r549",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r572",
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Statement Geographical [Axis]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureRestrictedInvestmentsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfTotalRevenueByGeographicRegionDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r209",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title Of Individual [Axis]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals.",
        "label": "Title Of Individual With Relationship To Entity [Domain]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation And Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Valuation And Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "Valuation And Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r140",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "Valuation And Qualifying Accounts Disclosure [Table]",
        "terseLabel": "Valuation And Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201409Member": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
        "label": "Accounting Standards Update201409 [Member]",
        "terseLabel": "Accounting Standards Update 2014-09"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201409Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10140.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r24",
      "r36",
      "r210",
      "r211"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10320.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable Net Current",
        "terseLabel": "Accounts receivable (net of allowances of $72 at December 31, 2020 and $27 at December 31, 2019)"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10170.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion Amortization Of Discounts And Premiums Investments",
        "negatedLabel": "Net accretion/amortization on investments"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10150.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities Current",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r58",
      "r257"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation Depletion And Amortization Property Plant And Equipment",
        "negatedLabel": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r39",
      "r79",
      "r80",
      "r81",
      "r498",
      "r526",
      "r530"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10120.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income Loss Net Of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r78",
      "r81",
      "r82",
      "r142",
      "r143",
      "r145",
      "r402",
      "r521",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (loss) [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10110.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid In Capital Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r142",
      "r143",
      "r145",
      "r343",
      "r344",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid In Capital [Member]",
        "terseLabel": "Additional Paid-In Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r115",
      "r250"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Adjustment For Amortization",
        "terseLabel": "Recognition of expenses on shares purchased under employee stock purchase plan"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r149",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r377",
      "r378",
      "r379",
      "r380",
      "r464",
      "r465",
      "r466",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Adjustments For New Accounting Pronouncements [Axis]",
        "terseLabel": "Accounting Standards Update"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement.",
        "label": "Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options",
        "terseLabel": "Stock-based compensation expense from stock options and ESPP shares"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r274",
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Adjustments To Additional Paid In Capital Stock Issued Issuance Costs",
        "terseLabel": "Stock issuance costs"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10120.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method.",
        "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities",
        "totalLabel": "Total adjustments"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r309",
      "r335",
      "r348"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Allocated Share Based Compensation Expense",
        "terseLabel": "Total employee stock-based compensation cost"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfEmployeeStockBasedCompensationCostThatHasBeenIncludedInStatementsOfOperationsAndComprehensiveLossDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForCreditLossMember": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for credit loss from right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Allowance For Credit Loss [Member]",
        "terseLabel": "Allowance for doubtful accounts [Member]"
       }
      }
     },
     "localname": "AllowanceForCreditLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r43",
      "r212",
      "r238"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Allowance For Doubtful Accounts Receivable Current",
        "terseLabel": "Allowances for accounts receivable"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r96",
      "r115",
      "r432"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10160.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization Of Financing Costs",
        "terseLabel": "Amortization of debt issuance cost"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Arrangements And Nonarrangement Transactions [Member]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSandozAGAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetRetirementObligation": {
     "auth_ref": [
      "r266"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.",
        "label": "Asset Retirement Obligation",
        "terseLabel": "Restoration cost"
       }
      }
     },
     "localname": "AssetRetirementObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r129",
      "r188",
      "r197",
      "r202",
      "r231",
      "r398",
      "r403",
      "r420",
      "r469",
      "r495"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "A S S E T S"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r25",
      "r26",
      "r74",
      "r129",
      "r231",
      "r398",
      "r403",
      "r420"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10210.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r409"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets Fair Value Disclosure",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r14",
      "r16",
      "r20",
      "r254",
      "r261"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10350.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Assets Of Disposal Group Including Discontinued Operation Current",
        "terseLabel": "Discontinued operations, current portion",
        "totalLabel": "Discontinued operations \u2013 current portion"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r219"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax",
        "terseLabel": "Unrealized Gain"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r220"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax",
        "negatedLabel": "Unrealized Loss"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r217",
      "r239"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Debt Securities Amortized Cost Basis",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r224"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost",
        "terseLabel": "Mature after one year through five years, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r221",
      "r224",
      "r488"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Available For Sale Securities Debt Maturities After One Through Five Years Fair Value",
        "terseLabel": "Mature after one year through five years, Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "auth_ref": [
      "r221",
      "r225",
      "r489"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.",
        "label": "Available For Sale Securities Debt Maturities Single Maturity Date",
        "totalLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis": {
     "auth_ref": [
      "r221",
      "r225",
      "r486"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.",
        "label": "Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r223"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Available For Sale Securities Debt Maturities Within One Year Amortized Cost",
        "terseLabel": "Mature in one year or less, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r221",
      "r223",
      "r487"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Available For Sale Securities Debt Maturities Within One Year Fair Value",
        "terseLabel": "Mature in one year or less, Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCostAndEstimatedFairValueOfAvailableForSaleSecuritiesByContractualMaturityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r214",
      "r218",
      "r239",
      "r473"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available For Sale Securities Debt Securities",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r216",
      "r239"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10310.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Available For Sale Securities Debt Securities Current",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r310",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlowsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r407",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlowsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis Of Accounting Policy Policy [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r22",
      "r54",
      "r117"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10290.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash And Cash Equivalents At Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash And Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents [Member]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r28",
      "r118",
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash And Cash Equivalents Policy [Text Block]",
        "terseLabel": "Cash, Cash Equivalents and Investments"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r111",
      "r117",
      "r123"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash, end of the period",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash, beginning of the period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r111",
      "r421"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates Of Deposit [Member]",
        "terseLabel": "Certificates of deposit [Member]"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInAccountingEstimateByTypeAxis": {
     "auth_ref": [
      "r153",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of change in accounting estimate.",
        "label": "Change In Accounting Estimate By Type [Axis]",
        "terseLabel": "Change in Accounting Estimate by Type"
       }
      }
     },
     "localname": "ChangeInAccountingEstimateByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ChangeInAccountingEstimateTypeDomain": {
     "auth_ref": [
      "r153",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the accounting estimate that was changed that had the effect of adjusting the carrying amount of an existing asset or liability, or that will alter the subsequent accounting for existing or future assets or liabilities.",
        "label": "Change In Accounting Estimate Type [Domain]",
        "terseLabel": "Change in Accounting Estimate, Type"
       }
      }
     },
     "localname": "ChangeInAccountingEstimateTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r393",
      "r394",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Strategic Agreements"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]",
        "terseLabel": "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSandozAGAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper [Member]"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r69",
      "r268",
      "r476",
      "r503"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10070.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments And Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments And Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsDisclosureTextBlock": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.",
        "label": "Commitments Disclosure [Text Block]",
        "terseLabel": "Commitments"
       }
      }
     },
     "localname": "CommitmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock Capital Shares Reserved For Future Issuance",
        "terseLabel": "Reserved common stock for issuance",
        "verboseLabel": "Shares of common stock reserved for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfSharesOfCommonStockReservedForFutureIssuanceDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r142",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock Par Or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock Shares Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r35",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock Shares Outstanding",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10100.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock Value",
        "terseLabel": "Common stock, $0.0001 par value: 350,000 shares authorized; 203,533 and 195,257 shares issued and outstanding at December 31, 2020 and 2019, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r124",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs Policy [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components Of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r84",
      "r86",
      "r87",
      "r93",
      "r480",
      "r509"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income Net Of Tax",
        "totalLabel": "Total comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income Policy Policy [Text Block]",
        "terseLabel": "Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r180",
      "r181",
      "r208",
      "r418",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r180",
      "r181",
      "r208",
      "r418",
      "r419",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk By Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r180",
      "r181",
      "r208",
      "r418",
      "r419",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk By Type [Axis]",
        "terseLabel": "Concentration Risk Type"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r176",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk Credit Risk",
        "terseLabel": "Concentrations of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r180",
      "r181",
      "r208",
      "r418",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk Percentage1",
        "terseLabel": "Percentage of revenue accounted in Company's total revenue"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r180",
      "r181",
      "r208",
      "r418",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction In Progress [Member]",
        "terseLabel": "Construction-in-progress [Member]"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract With Customer Asset And Liability Table [Text Block]",
        "terseLabel": "Summary of Changes in the Company's Contract Asset and Liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r281",
      "r283",
      "r287"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract With Customer Asset Net Current",
        "terseLabel": "Total contract asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract With Customer Asset Net Current [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerDurationAxis": {
     "auth_ref": [
      "r286",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts.",
        "label": "Contract With Customer Duration [Axis]",
        "terseLabel": "Contract with Customer, Duration"
       }
      }
     },
     "localname": "ContractWithCustomerDurationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerDurationDomain": {
     "auth_ref": [
      "r286",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Duration of contract with customer. Includes, but is not limited to, short-term and long-term contracts.",
        "label": "Contract With Customer Duration [Domain]",
        "terseLabel": "Contract with Customer, Duration"
       }
      }
     },
     "localname": "ContractWithCustomerDurationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r281",
      "r282",
      "r287"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract With Customer Liability",
        "terseLabel": "Total contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract With Customer Liability [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r281",
      "r282",
      "r287"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10170.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract With Customer Liability Current",
        "terseLabel": "Deferred revenue, current portion"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r281",
      "r282",
      "r287"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10020.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract With Customer Liability Noncurrent",
        "terseLabel": "Deferred revenue, non-current portion"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r288"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract With Customer Liability Revenue Recognized",
        "terseLabel": "Amount related to the milestone payment earned",
        "verboseLabel": "Revenue recognition milestone achieved"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r295",
      "r303",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt [Member]"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r99",
      "r463"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10110.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost Of Goods And Services Sold",
        "terseLabel": "Cost of product revenues",
        "verboseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost Of Sales [Member]",
        "terseLabel": "Cost of product revenues [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfEmployeeStockBasedCompensationCostThatHasBeenIncludedInStatementsOfOperationsAndComprehensiveLossDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10100.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs And Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r178",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk [Member]"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r31",
      "r32",
      "r33",
      "r470",
      "r471",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r33",
      "r271",
      "r471",
      "r494"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail2": {
       "order": 10040.0,
       "parentTag": "us-gaap_DebtInstrumentFaceAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Debt Instrument Carrying Amount",
        "terseLabel": "Gross balance of term loan"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentDateOfFirstRequiredPayment1": {
     "auth_ref": [
      "r67",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the debt agreement requires the first payment to be made, in CCYY-MM-DD format.",
        "label": "Debt Instrument Date Of First Required Payment1",
        "terseLabel": "First principal payment date"
       }
      }
     },
     "localname": "DebtInstrumentDateOfFirstRequiredPayment1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentDescriptionOfVariableRateBasis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The reference rate for the variable rate of the debt instrument, such as LIBOR or the US Treasury rate and the maturity of the reference rate used, such as three months or six months LIBOR.",
        "label": "Debt Instrument Description Of Variable Rate Basis",
        "terseLabel": "Term loan, floating interest rate basis"
       }
      }
     },
     "localname": "DebtInstrumentDescriptionOfVariableRateBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r431",
      "r433"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument Face Amount",
        "totalLabel": "Total minimum payments"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument Interest Rate Stated Percentage",
        "terseLabel": "Interest rate on term loan"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r65",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.",
        "label": "Debt Instrument Maturity Date",
        "terseLabel": "Term loan, maturity date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument Name [Domain]",
        "terseLabel": "Debt Instrument, Name"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPaymentTerms": {
     "auth_ref": [
      "r66",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.",
        "label": "Debt Instrument Payment Terms",
        "terseLabel": "Term loan repayment description"
       }
      }
     },
     "localname": "DebtInstrumentPaymentTerms",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt.",
        "label": "Debt Instrument Periodic Payment Terms Balloon Payment To Be Paid",
        "terseLabel": "Facility fee paid at final payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r67",
      "r132",
      "r275",
      "r276",
      "r277",
      "r278",
      "r430",
      "r431",
      "r433",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Debt Instrument [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r430",
      "r433"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument Unamortized Discount",
        "negatedLabel": "Less unamortized debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r227",
      "r240",
      "r241"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer",
        "terseLabel": "Unrealized loss of securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities Available For Sale Table [Text Block]",
        "terseLabel": "Summary of Money Market Funds and Available-for-Sale Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r115",
      "r130",
      "r375",
      "r383",
      "r384",
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense Benefit",
        "terseLabel": "Deferred income tax provision"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenue": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Revenue",
        "terseLabel": "Deferred Revenue"
       }
      }
     },
     "localname": "DeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r373",
      "r374"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred Tax Assets Deferred Income",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r367"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r369"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets Liabilities Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r373",
      "r374"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r373",
      "r374"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail": {
       "order": 10080.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r371",
      "r373",
      "r374"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets Tax Credit Carryforwards Research",
        "terseLabel": "Research and other credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r373",
      "r374"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets Valuation Allowance",
        "negatedLabel": "Valuation allowance for deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxExpenseFromStockOptionsExercised": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax expense from write-off of the deferred tax asset related to deductible stock options at exercise.",
        "label": "Deferred Tax Expense From Stock Options Exercised",
        "terseLabel": "Incremental tax benefits recognized from stock options exercised"
       }
      }
     },
     "localname": "DeferredTaxExpenseFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r355",
      "r369"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities",
        "negatedTotalLabel": "Net deferred tax assets and liabilities",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfComponentsOfCompanySDeferredTaxAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r115",
      "r255"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r115",
      "r186"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10130.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation Depletion And Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Securities [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "DilutiveSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax": {
     "auth_ref": [
      "r2",
      "r4",
      "r6",
      "r17"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": 1.0
      },
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail": {
       "order": 10020.0,
       "parentTag": "drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsNet",
       "weight": -1.0
      },
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10190.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.",
        "label": "Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax",
        "negatedLabel": "Gain on sale of LACTEL product line",
        "terseLabel": "Gain from discontinued operations"
       }
      }
     },
     "localname": "DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax": {
     "auth_ref": [
      "r2",
      "r3",
      "r17"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until disposal.",
        "label": "Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax",
        "totalLabel": "Income from discontinued operations"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r0",
      "r1",
      "r14",
      "r261"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail": {
       "order": 10100.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r14",
      "r254",
      "r261"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group Including Discontinued Operation Accounts Payable Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r14",
      "r254",
      "r261"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group Including Discontinued Operation Accrued Liabilities Current",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r14",
      "r16",
      "r20",
      "r252",
      "r261"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10280.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group Including Discontinued Operation Assets Noncurrent",
        "terseLabel": "Discontinued operations, non-current portion",
        "totalLabel": "Discontinued operations \u2013 non-current portion"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": {
     "auth_ref": [
      "r13",
      "r20"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group Including Discontinued Operation Costs Of Goods Sold",
        "terseLabel": "Cost of product revenues"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail": {
       "order": 10030.0,
       "parentTag": "drrx_DisposalGroupIncludingDiscontinuedOperationNonCashItemsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of depreciation and amortization expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group Including Discontinued Operation Depreciation And Amortization",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfNonCashItemsRelatedToDiscontinuedOperationsIncludedInStatementOfCashFlowsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail": {
       "order": 10070.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group Including Discontinued Operation General And Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r14",
      "r252",
      "r261"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail": {
       "order": 10080.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group Including Discontinued Operation Goodwill Noncurrent",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r14",
      "r254",
      "r261"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail": {
       "order": 10110.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group Including Discontinued Operation Inventory Current",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group Including Discontinued Operation Operating Expense",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r14",
      "r252",
      "r261"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail": {
       "order": 10090.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group Including Discontinued Operation Other Noncurrent Assets",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r14",
      "r252",
      "r261"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.",
        "label": "Disposal Group Including Discontinued Operation Other Noncurrent Liabilities",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r14",
      "r254",
      "r261"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail": {
       "order": 10120.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group Including Discontinued Operation Prepaid And Other Assets Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r14",
      "r252",
      "r261"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group Including Discontinued Operation Property Plant And Equipment Noncurrent",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "auth_ref": [
      "r13",
      "r20"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group Including Discontinued Operation Revenue",
        "terseLabel": "Total revenues"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal Group Not Discontinued Operation Income Statement Disclosures [Abstract]"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r21",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups Including Discontinued Operations Disclosure [Text Block]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations, Disclosure"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r304",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Groups Including Discontinued Operations Name [Domain]",
        "terseLabel": "Disposal Group Name"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income (loss) per share",
        "verboseLabel": "Net loss per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r94",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r159",
      "r160",
      "r166",
      "r167",
      "r168",
      "r171",
      "r172",
      "r481",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share Basic",
        "terseLabel": "Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share Basic And Diluted",
        "terseLabel": "Basic and diluted"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Basic And Diluted [Abstract]",
        "terseLabel": "Basic and diluted"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Basic And Diluted Other Disclosures [Abstract]",
        "terseLabel": "Weighted-average shares used in computing net income per share basic and diluted"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r94",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r160",
      "r166",
      "r167",
      "r168",
      "r171",
      "r172",
      "r481",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share Diluted",
        "terseLabel": "Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r125",
      "r169",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share Policy [Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r357",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate",
        "terseLabel": "Statutory federal income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]",
        "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfEmployeeStockBasedCompensationCostThatHasBeenIncludedInStatementsOfOperationsAndComprehensiveLossDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r336"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized",
        "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1",
        "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r335"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Employee Service Share Based Compensation Tax Benefit From Compensation Expense",
        "terseLabel": "Excess tax benefits recognized for tax deductions on stock based compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employees Stock Purchase Plan [Member]"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Equipment [Member]"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r142",
      "r143",
      "r145",
      "r147",
      "r155",
      "r158",
      "r175",
      "r235",
      "r274",
      "r279",
      "r343",
      "r344",
      "r345",
      "r379",
      "r380",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r521",
      "r522",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EscrowDeposit": {
     "auth_ref": [
      "r474"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10300.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.",
        "label": "Escrow Deposit",
        "terseLabel": "Cash held in escrow"
       }
      }
     },
     "localname": "EscrowDeposit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EscrowDepositsRelatedToPropertySales": {
     "auth_ref": [
      "r120",
      "r121",
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Escrow deposits related to property sales in noncash investing and financing activities.",
        "label": "Escrow Deposits Related To Property Sales",
        "terseLabel": "Cash held in escrow"
       }
      }
     },
     "localname": "EscrowDepositsRelatedToPropertySales",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r409",
      "r410",
      "r411",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r409",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Fair Value By Asset Class [Axis]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r410",
      "r453",
      "r454",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value By Fair Value Hierarchy Level [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r409",
      "r410",
      "r412",
      "r413",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Fair Value By Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r295",
      "r296",
      "r301",
      "r303",
      "r410",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value Inputs Level1 [Member]",
        "terseLabel": "Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r295",
      "r296",
      "r301",
      "r303",
      "r410",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value Inputs Level2 [Member]",
        "terseLabel": "Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Fair Value Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r453",
      "r454",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Measurements Fair Value Hierarchy [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r415",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value Measurements Recurring [Member]",
        "terseLabel": "Fair Value on Recurring Basis [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r247",
      "r248",
      "r468"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10240.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r125",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill And Intangible Assets Goodwill Policy",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r115",
      "r253",
      "r259"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment Of Long Lived Assets Held For Use",
        "terseLabel": "Impairment of long lived assets held for use"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r125",
      "r251",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment Or Disposal Of Long Lived Assets Policy [Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r129",
      "r146",
      "r188",
      "r196",
      "r198",
      "r201",
      "r203",
      "r231",
      "r397",
      "r420"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10030.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest",
        "totalLabel": "Loss from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.",
        "label": "Income Loss From Continuing Operations Per Basic And Diluted Share",
        "terseLabel": "Net loss per common share, basic and diluted"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicAndDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r88",
      "r94",
      "r146",
      "r150",
      "r151",
      "r152",
      "r153",
      "r160",
      "r166",
      "r167",
      "r477",
      "r478",
      "r481",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income Loss From Continuing Operations Per Basic Share",
        "terseLabel": "Loss from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r17",
      "r20",
      "r389",
      "r506"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10040.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income Loss From Discontinued Operations Net Of Tax",
        "terseLabel": "Income from discontinued operations (Note 10)",
        "totalLabel": "Net income from discontinued operations"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r91",
      "r94",
      "r164",
      "r166",
      "r167",
      "r481",
      "r506",
      "r508",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income Loss From Discontinued Operations Net Of Tax Per Basic Share",
        "terseLabel": "Income from discontinued operations"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r304",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Axis]",
        "terseLabel": "Disposal Group Name"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r15",
      "r18",
      "r19",
      "r20",
      "r262",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Table]",
        "terseLabel": "Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfEmployeeStockBasedCompensationCostThatHasBeenIncludedInStatementsOfOperationsAndComprehensiveLossDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfEmployeeStockBasedCompensationCostThatHasBeenIncludedInStatementsOfOperationsAndComprehensiveLossDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority Name [Axis]",
        "terseLabel": "Income Tax Authority, Name"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority Name [Domain]",
        "terseLabel": "Income Tax Authority, Name"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r361",
      "r364",
      "r366",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r358",
      "r365",
      "r370",
      "r381",
      "r387",
      "r390",
      "r391",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r130",
      "r157",
      "r158",
      "r187",
      "r356",
      "r382",
      "r388",
      "r511"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense Benefit",
        "terseLabel": "Total income tax provision (benefit) expense",
        "totalLabel": "Total income tax (benefit) provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense Benefit Continuing Operations Income Tax Reconciliation [Abstract]",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Amount [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r357"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r354",
      "r357"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.",
        "label": "Income Tax Reconciliation Change In Enacted Tax Rate",
        "terseLabel": "Tax Reform change in tax rate and other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r357"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate",
        "terseLabel": "U.S. federal taxes benefit at statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r357"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r357"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail": {
       "order": 10080.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Income Tax Reconciliation Other Adjustments",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r357"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Income Tax Reconciliation State And Local Income Taxes",
        "terseLabel": "State taxes"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r357"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Income Tax Reconciliation Tax Credits Research",
        "negatedLabel": "Research and development tax credits"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxExpensesBenefitDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10230.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase Decrease In Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10200.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase Decrease In Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10240.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase Decrease In Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10260.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase Decrease In Contract With Customer Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10210.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase Decrease In Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Decrease In Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10220.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase Decrease In Prepaid Deferred Expense And Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements": {
     "auth_ref": [
      "r161",
      "r162",
      "r168"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of equity unit purchase agreements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable To Equity Unit Purchase Agreements",
        "terseLabel": "Dilution from stock options"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r168"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable To Share Based Payment Arrangements",
        "terseLabel": "Dilution from ESPP"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r89",
      "r185",
      "r429",
      "r432",
      "r482"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10080.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r109",
      "r112",
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid Net",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r475",
      "r504"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail2": {
       "order": 10030.0,
       "parentTag": "us-gaap_DebtInstrumentFaceAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.",
        "label": "Interest Payable Current And Noncurrent",
        "negatedLabel": "Less amount representing interest"
       }
      }
     },
     "localname": "InterestPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service I R S [Member]",
        "terseLabel": "Federal [Member]"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r46",
      "r245"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfComponentsOfInventoriesDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory Finished Goods Net Of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfComponentsOfInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r23",
      "r72"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfComponentsOfInventoriesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10330.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory Net",
        "terseLabel": "Inventories, net",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfComponentsOfInventoriesDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r27",
      "r73",
      "r125",
      "r174",
      "r242",
      "r244",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory Policy [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r48",
      "r245"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfComponentsOfInventoriesDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory Raw Materials Net Of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfComponentsOfInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r47",
      "r245"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfComponentsOfInventoriesDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory Work In Process Net Of Reserves",
        "terseLabel": "Work in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfComponentsOfInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r243"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10150.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write Down",
        "terseLabel": "Inventory write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investment Type Categorization [Member]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified By Contractual Maturity Date Table [Text Block]",
        "terseLabel": "Summary of Cost and Estimated Fair Value of Available-for-Sale Securities by Contractual Maturity"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments Debt And Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LandSubjectToGroundLeases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of land subject to a ground lease.",
        "label": "Land Subject To Ground Leases",
        "terseLabel": "Approximate Square Feet"
       }
      }
     },
     "localname": "LandSubjectToGroundLeases",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail"
     ],
     "xbrltype": "areaItemType"
    },
    "us-gaap_LeaseContractualTermAxis": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Axis]",
        "terseLabel": "Lease Contractual Term"
       }
      }
     },
     "localname": "LeaseContractualTermAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermDomain": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Domain]",
        "terseLabel": "Lease Contractual Term"
       }
      }
     },
     "localname": "LeaseContractualTermDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee Leases Policy [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee Operating Lease Renewal Term",
        "terseLabel": "Lease renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r42",
      "r129",
      "r231",
      "r420",
      "r472",
      "r500"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities And Stockholders Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities And Stockholders Equity [Abstract]",
        "terseLabel": "L I A B I L I T I E S A N D S T O C K H O L D E R S\u2019 E Q U I T Y"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r63",
      "r129",
      "r231",
      "r399",
      "r403",
      "r404",
      "r420"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10010.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r14",
      "r16",
      "r20",
      "r254",
      "r261"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10200.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Liabilities Of Disposal Group Including Discontinued Operation Current",
        "terseLabel": "Discontinued operations, current portion",
        "totalLabel": "Discontinued operations \u2013 current portion"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r14",
      "r16",
      "r20",
      "r252",
      "r261"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10060.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.",
        "label": "Liabilities Of Disposal Group Including Discontinued Operation Noncurrent",
        "terseLabel": "Discontinued operations, non-current portion",
        "totalLabel": "Discontinued operations \u2013 non-current portion"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfAssetsAndLiabilitiesReportedAsDiscontinuedOperationsInBalanceSheetDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicenseMember": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.",
        "label": "License [Member]",
        "terseLabel": "License Fees [Member]"
       }
      }
     },
     "localname": "LicenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r33",
      "r272",
      "r471",
      "r496"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long Term Debt",
        "totalLabel": "Carrying value of term loan"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtByMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt By Maturity [Abstract]",
        "terseLabel": "Future maturities and interest payments under the term loan:"
       }
      }
     },
     "localname": "LongTermDebtByMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail2": {
       "order": 10010.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10180.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long Term Debt Current",
        "negatedLabel": "Less term loan, current portion, net",
        "terseLabel": "Term loan, current portion, net"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r133",
      "r270"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_DebtInstrumentFaceAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long Term Debt Maturities Repayments Of Principal In Next Twelve Months",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r133",
      "r270"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail": {
       "order": 10060.0,
       "parentTag": "us-gaap_DebtInstrumentFaceAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long Term Debt Maturities Repayments Of Principal In Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r133",
      "r270"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail": {
       "order": 10050.0,
       "parentTag": "us-gaap_DebtInstrumentFaceAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long Term Debt Maturities Repayments Of Principal In Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r133",
      "r270"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_DebtInstrumentFaceAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long Term Debt Maturities Repayments Of Principal In Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail2": {
       "order": 10020.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10040.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long Term Debt Noncurrent",
        "terseLabel": "Term loan, non-current portion, net"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanScheduleOfFutureMaturitiesAndInterestPaymentsUnderTermLoanDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long Term Debt [Text Block]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10250.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long Term Investments",
        "terseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment.",
        "label": "Long Term Purchase Commitment Amount",
        "verboseLabel": "Remaining minimum purchase commitment"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MajorCustomersPolicyPolicyTextBlock": {
     "auth_ref": [
      "r177",
      "r180",
      "r181",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity.",
        "label": "Major Customers Policy Policy [Text Block]",
        "terseLabel": "Customer and Product Line Concentrations"
       }
      }
     },
     "localname": "MajorCustomersPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ManufacturingFacilityMember": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure used in the manufacturing of goods.",
        "label": "Manufacturing Facility [Member]",
        "terseLabel": "Manufacturing [Member]"
       }
      }
     },
     "localname": "ManufacturingFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds [Member]"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MunicipalBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.",
        "label": "Municipal Bonds [Member]",
        "terseLabel": "Municipal bonds [Member]"
       }
      }
     },
     "localname": "MunicipalBondsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10030.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided By Used In Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10020.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided By Used In Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r111",
      "r113",
      "r116"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10010.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided By Used In Operating Activities",
        "totalLabel": "Net cash (used in) provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r20",
      "r83",
      "r85",
      "r92",
      "r116",
      "r129",
      "r146",
      "r150",
      "r151",
      "r152",
      "r153",
      "r157",
      "r158",
      "r165",
      "r188",
      "r196",
      "r198",
      "r201",
      "r203",
      "r231",
      "r420",
      "r479",
      "r507"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10010.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income Loss",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income Loss [Abstract]",
        "terseLabel": "Numerators:"
       }
      }
     },
     "localname": "NetIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements Policy Policy [Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing And Financing Items [Abstract]",
        "terseLabel": "Supplementary disclosure of non-cash investing and financing information"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10060.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income Expense",
        "totalLabel": "Net other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income Expense [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number Of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number Of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r188",
      "r196",
      "r198",
      "r201",
      "r203"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10050.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income Loss",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10190.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease Liability Current",
        "terseLabel": "Operating lease liabilities, current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10030.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease Liability Noncurrent",
        "terseLabel": "Operating lease liabilities, non-current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10230.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease Right Of Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r444",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease Weighted Average Remaining Lease Term1",
        "terseLabel": "Operating lease weighted average remaining lease term1"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable": {
     "auth_ref": [
      "r437"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future minimum rental payments in aggregate as of the balance sheet date under operating leases.",
        "label": "Operating Leases Future Minimum Payments Receivable",
        "totalLabel": "Total operating leases future minimum payments"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableCurrent": {
     "auth_ref": [
      "r437"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future rental payments receivable within one year of the balance sheet date under an operating lease.",
        "label": "Operating Leases Future Minimum Payments Receivable Current",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInFourYears": {
     "auth_ref": [
      "r437"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail": {
       "order": 10040.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future rental payments receivable within the fourth year from the balance sheet date under an operating lease.",
        "label": "Operating Leases Future Minimum Payments Receivable In Four Years",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsReceivableInFourYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears": {
     "auth_ref": [
      "r437"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail": {
       "order": 10030.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future rental payments receivable within the third year from the balance sheet date under an operating lease.",
        "label": "Operating Leases Future Minimum Payments Receivable In Three Years",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears": {
     "auth_ref": [
      "r437"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail": {
       "order": 10020.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsReceivable",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future rental payments receivable within the second year from the balance sheet date under an operating lease.",
        "label": "Operating Leases Future Minimum Payments Receivable In Two Years",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsScheduleOfFutureOperatingLeaseMinimumPaymentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "auth_ref": [
      "r434"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.",
        "label": "Operating Leases Rent Expense Net",
        "terseLabel": "Rent expenses of operating leases"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r371"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards for income tax purposes"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10270.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r76",
      "r77",
      "r79"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10020.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax",
        "terseLabel": "Net change in unrealized gain on available-for-sale securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r76",
      "r79"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax",
        "terseLabel": "Change in unrealized gain (loss) on available-for-sale securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10050.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermInvestmentsMember": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term investments classified as other.",
        "label": "Other Long Term Investments [Member]",
        "terseLabel": "Long-term investments [Member]"
       }
      }
     },
     "localname": "OtherLongTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncome": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10070.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income",
        "terseLabel": "Interest and other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income Expense [Member]",
        "terseLabel": "Interest and other income, net [Member]"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsOfDebtRestructuringCosts": {
     "auth_ref": [
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred in the modification of term of existing debt agreement in order for the entity to achieve some advantage.",
        "label": "Payments Of Debt Restructuring Costs",
        "terseLabel": "Loan modification fee"
       }
      }
     },
     "localname": "PaymentsOfDebtRestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments Of Stock Issuance Costs",
        "terseLabel": "Common stock issuance costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r102",
      "r104",
      "r215"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10090.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments To Acquire Available For Sale Securities Debt",
        "negatedLabel": "Purchases of available-for-sale securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10080.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments To Acquire Property Plant And Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r310",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfSharesOfCommonStockReservedForFutureIssuanceDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfSharesOfCommonStockReservedForFutureIssuanceDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock Par Or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock Shares Issued",
        "terseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10090.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock Value",
        "terseLabel": "Preferred stock, $0.0001 par value: 10,000 shares authorized; none issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r25",
      "r52",
      "r53"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10340.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense And Other Assets Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10060.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds From Issuance Of Common Stock",
        "terseLabel": "Net proceeds from issuances of common stock in connection with equity financings",
        "verboseLabel": "Proceeds from sale of common stock, net of commission"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r106",
      "r338"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10050.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options",
        "terseLabel": "Net proceeds from issuances of common stock upon exercise of stock options, and purchases of ESPP shares"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r102",
      "r103",
      "r215"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10100.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities",
        "terseLabel": "Proceeds from maturities of available-for-sale securities"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r106",
      "r338"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds From Stock Options Exercised",
        "terseLabel": "Proceeds from Stock Options Exercised"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk [Member]"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product Revenue, Net [Member]"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r20",
      "r83",
      "r85",
      "r110",
      "r129",
      "r146",
      "r157",
      "r158",
      "r188",
      "r196",
      "r198",
      "r201",
      "r203",
      "r231",
      "r397",
      "r400",
      "r401",
      "r405",
      "r406",
      "r420",
      "r483"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10110.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Profit Loss",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property Plant And Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r58",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property Plant And Equipment By Type [Axis]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r265",
      "r550",
      "r551",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property Plant And Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r57",
      "r256"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail": {
       "order": 10010.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property Plant And Equipment Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property Plant And Equipment [Line Items]",
        "terseLabel": "Property Plant And Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r29",
      "r30",
      "r258",
      "r502"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10220.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property Plant And Equipment Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r56",
      "r125",
      "r258",
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property Plant And Equipment Policy [Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r29",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property Plant And Equipment [Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r29",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property Plant And Equipment Type [Domain]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property Plant And Equipment Useful Life",
        "terseLabel": "Property plant and equipment useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A listing by major property class of the amount of lessor property under a leasing agreement, and available for lease (not currently under lease), at cost, between the lessor and the lessee as of the balance sheet date.",
        "label": "Property Subject To Or Available For Operating Lease By Major Property Class [Table]",
        "terseLabel": "Property Subject To Or Available For Operating Lease By Major Property Class [Table]"
       }
      }
     },
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseByMajorPropertyClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property Subject To Or Available For Operating Lease [Line Items]",
        "terseLabel": "Property Subject To Or Available For Operating Lease [Line Items]"
       }
      }
     },
     "localname": "PropertySubjectToOrAvailableForOperatingLeaseLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsSummaryOfLeaseArrangementsOfCompanyFacilitiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r512"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Realized Investment Gains Losses",
        "terseLabel": "Realized investment gains losses"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r36",
      "r44",
      "r501",
      "r533"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables Net Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation Of Unrecognized Tax Benefits Excluding Amounts Pertaining To Examined Tax Returns Roll Forward",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RegulatoryReviewsOfFilingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revisions in estimates based on preliminary indications by regulators of findings that are favorable or unfavorable to the entity based upon the regulator's review of required filings, excluding tax returns. Examples of such filings are cost reports upon which retrospective reimbursements or prospective rates from third-party payers (Medicare and Medicaid) are based, and state environmental department permitting filings in which height, angle, width and length, and closure and post-closure activities of landfills are granted.",
        "label": "Regulatory Reviews Of Filings [Member]",
        "terseLabel": "Regulatory filings [Member]"
       }
      }
     },
     "localname": "RegulatoryReviewsOfFilingsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r302",
      "r446",
      "r447",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermCapitalLeaseObligations": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10040.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).",
        "label": "Repayments Of Long Term Capital Lease Obligations",
        "negatedLabel": "Payments on equipment financing obligations"
       }
      }
     },
     "localname": "RepaymentsOfLongTermCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10070.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments Of Long Term Debt",
        "negatedLabel": "Term loan amendment cost"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": {
     "auth_ref": [
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by form of arrangement related to research and development.",
        "label": "Research And Development Arrangement Contract To Perform For Others By Type [Axis]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned": {
     "auth_ref": [
      "r350",
      "r352"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others.",
        "label": "Research And Development Arrangement Contract To Perform For Others Compensation Earned",
        "terseLabel": "Cumulative aggregate payments received by the Company"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSandozAGAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": {
     "auth_ref": [
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others.",
        "label": "Research And Development Arrangement Contract To Perform For Others Type [Domain]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r349",
      "r562"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10120.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research And Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research And Development Expense [Member]",
        "terseLabel": "Research and development [Member]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfEmployeeStockBasedCompensationCostThatHasBeenIncludedInStatementsOfOperationsAndComprehensiveLossDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research [Member]",
        "terseLabel": "Research [Member]"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r123",
      "r467",
      "r497"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlowsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedInvestmentsNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10260.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the noncurrent portion of investments which are not defined as or included in marketable (debt, equity, or other) securities that are pledged or subject to withdrawal restrictions.",
        "label": "Restricted Investments Noncurrent",
        "terseLabel": "Long-term restricted investments",
        "verboseLabel": "Restricted investments in connection with deposits on letters of credit"
       }
      }
     },
     "localname": "RestrictedInvestmentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureRestrictedInvestmentsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r38",
      "r279",
      "r346",
      "r499",
      "r525",
      "r530"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10130.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings Accumulated Deficit",
        "negatedLabel": "Accumulated deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r142",
      "r143",
      "r145",
      "r147",
      "r155",
      "r158",
      "r235",
      "r343",
      "r344",
      "r345",
      "r379",
      "r380",
      "r521",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r183",
      "r184",
      "r195",
      "r199",
      "r200",
      "r204",
      "r205",
      "r208",
      "r285",
      "r286",
      "r463"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10090.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue From Contract With Customer Excluding Assessed Tax",
        "terseLabel": "Total revenues",
        "verboseLabel": "Total collaborative research and development and other revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfTotalRevenueByGeographicRegionDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r126",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue Recognition Policy [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues From External Customers And Long Lived Assets [Line Items]",
        "terseLabel": "Revenues From External Customers And Long Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfTotalRevenueByGeographicRegionDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r443",
      "r445"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right Of Use Asset Obtained In Exchange For Operating Lease Liability",
        "terseLabel": "Operating lease right-of-use assets obtained in exchange for operating lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyMember": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money for usage-based right to asset.",
        "label": "Royalty [Member]",
        "terseLabel": "Intellectual Property Rights [Member]"
       }
      }
     },
     "localname": "RoyaltyMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale Of Stock Consideration Received On Transaction",
        "terseLabel": "Gross proceeds from sale of common stock"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale Of Stock Name Of Transaction [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale Of Stock Number Of Shares Issued In Transaction",
        "terseLabel": "Sale of stock number of shares issued in transaction"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale Of Stock Price Per Share",
        "terseLabel": "Sale of stock price per share"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r180",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Sales Revenue Net [Member]",
        "terseLabel": "Sales Revenue Net [Member]"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule Of Available For Sale Securities [Line Items]",
        "terseLabel": "Schedule of Available-for-sale Securities [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r222",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r485",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule Of Available For Sale Securities [Table]",
        "terseLabel": "Schedule Of Available For Sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]",
        "terseLabel": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSandozAGAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfChangesInCompanySContractAssetAndLiabilitiesDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions Table [Text Block]",
        "terseLabel": "Summary of Collaborative Research and Development and Other Revenues Associated with Company's Major Third-Party Collaborators"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in common stock outstanding.",
        "label": "Schedule Of Common Stock Outstanding Roll Forward Table [Text Block]",
        "terseLabel": "Summary of Shares of Common Stock Reserved for Future Issuance"
       }
      }
     },
     "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule Of Debt Table [Text Block]",
        "terseLabel": "Schedule of Future Maturities and Interest Payments under Term Loan"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]",
        "terseLabel": "Summary of Components of Company's Deferred Tax Assets"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]",
        "terseLabel": "Summary of Numerators and Denominators in Calculation of Basic and Diluted Net Income (Loss) per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]",
        "terseLabel": "Reconciliation of Income Tax Expenses (Benefit)"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r309",
      "r334",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]",
        "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfEmployeeStockBasedCompensationCostThatHasBeenIncludedInStatementsOfOperationsAndComprehensiveLossDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r309",
      "r334",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]",
        "terseLabel": "Summary of Employee Stock-Based Compensation Cost that has been Included in Statements of Operations and Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r409",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block]",
        "terseLabel": "Fair Value Measurements of Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule Of Future Minimum Rental Payments For Operating Leases Table [Text Block]",
        "terseLabel": "Schedule of Future Operating Lease Minimum Payments"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r27",
      "r49",
      "r50",
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule Of Inventory Current Table [Text Block]",
        "terseLabel": "Summary of Components of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r58",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Schedule Of Property Plant And Equipment [Table]",
        "terseLabel": "Schedule Of Property Plant And Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": {
     "auth_ref": [
      "r98",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule Of Revenue From External Customers Attributed To Foreign Countries By Geographic Area [Text Block]",
        "terseLabel": "Summary of Total Revenue by Geographic Region"
       }
      }
     },
     "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r90",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule Of Revenues From External Customers And Long Lived Assets [Table]",
        "terseLabel": "Schedule Of Revenues From External Customers And Long Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfTotalRevenueByGeographicRegionDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r310",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfSharesOfCommonStockReservedForFutureIssuanceDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r315",
      "r323",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]",
        "terseLabel": "Summary of Stock Option Activity under all Stock-Based Compensation Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]",
        "terseLabel": "Summary of Assumptions Used to Estimate Fair Value of Options Granted and Shares Purchased"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in stock options.",
        "label": "Schedule Of Stock Options Roll Forward Table [Text Block]",
        "terseLabel": "Summary of Stock Options Outstanding"
       }
      }
     },
     "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r364",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule Of Unrecognized Tax Benefits Roll Forward Table [Text Block]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebt": {
     "auth_ref": [
      "r33",
      "r471",
      "r496"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.",
        "label": "Secured Debt",
        "terseLabel": "Secured term loan"
       }
      }
     },
     "localname": "SecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureTermLoanAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r125",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting Policy Policy [Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss": {
       "order": 10130.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling General And Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling General And Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative [Member]"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfEmployeeStockBasedCompensationCostThatHasBeenIncludedInStatementsOfOperationsAndComprehensiveLossDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows": {
       "order": 10140.0,
       "parentTag": "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share Based Compensation",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1",
        "terseLabel": "Options granted with different vesting terms"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments": {
     "auth_ref": [
      "r331"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated amount of dividends to be paid to holders of the underlying shares (expected dividends) over the option's term. Dividends are taken into account because payment of dividends to shareholders reduces the fair value of the underlying shares, and option holders generally do not receive dividends.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments",
        "terseLabel": "Expected dividend yield in Black-Scholes option valuation model"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum",
        "terseLabel": "Volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum",
        "terseLabel": "Volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate",
        "terseLabel": "Risk-free rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum",
        "terseLabel": "Risk-free rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum",
        "terseLabel": "Risk-free rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfSharesOfCommonStockReservedForFutureIssuanceDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized",
        "terseLabel": "Stock option increase"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized",
        "terseLabel": "Options shares reserved for issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant",
        "positiveLabel": "Share available for future grant",
        "positiveTerseLabel": "Share available for future grant",
        "terseLabel": "Shares available for future grant",
        "verboseLabel": "Stock options available for grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfSharesOfCommonStockReservedForFutureIssuanceDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number",
        "terseLabel": "Exercisable, Number of Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price",
        "terseLabel": "Exercisable, Number of Options, Weighted Average Exercise Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r325"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value",
        "terseLabel": "Intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period",
        "negatedLabel": "Options expired, Number of Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period",
        "negatedLabel": "Options forfeited, Number of Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross",
        "terseLabel": "Options exercised, shares",
        "verboseLabel": "Options granted, Number of Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant-date fair value of all options granted with exercise prices"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000EmployeeStockPurchasePlanAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r337"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value",
        "terseLabel": "Outstanding, Number of Options, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r317",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number",
        "periodEndLabel": "Outstanding, Number of Options, ending balance",
        "periodStartLabel": "Outstanding, Number of Options, beginning balance",
        "terseLabel": "Common stock outstanding",
        "verboseLabel": "Stock options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfSharesOfCommonStockReservedForFutureIssuanceDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding, Number of Options, Weighted Average Exercise Price Per Share, ending balance",
        "periodStartLabel": "Outstanding, Number of Options, Weighted Average Exercise Price Per Share, beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r326"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value",
        "terseLabel": "Vested and expected to vest, Number of Options, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number",
        "verboseLabel": "Vested and expected to vest, Number of Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price",
        "terseLabel": "Vested and expected to vest, Number of Options, Weighted Average Exercise Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": {
     "auth_ref": [
      "r308",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares purchased for issuance under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award",
        "terseLabel": "Shares purchased under Company's employee stock purchase plan"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityDeterminingFairValueAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r308",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price",
        "terseLabel": "Options exercised, Weighted Average Exercise Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price",
        "terseLabel": "Options expired, Weighted Average Exercise Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price",
        "terseLabel": "Options forfeited, Weighted Average Exercise Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price",
        "terseLabel": "Options granted, Weighted Average Exercise Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Axis]",
        "terseLabel": "Exercise Price Range"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Domain]",
        "terseLabel": "Exercise Price Range"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit",
        "terseLabel": "Options Outstanding, Range of Exercise Price, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options",
        "terseLabel": "Number of Options Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options",
        "terseLabel": "Number of Options Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit",
        "terseLabel": "Options Outstanding, Range of Exercise Price, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r330",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r337"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1",
        "terseLabel": "Exercisable, Number of Options, Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1",
        "terseLabel": "Exercisable, Number of Options, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2",
        "terseLabel": "Outstanding, Number of Options, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1",
        "terseLabel": "Vested and expected to vest, Number of Options, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.",
        "label": "Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1",
        "terseLabel": "Options Exercisable, Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.",
        "label": "Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1",
        "terseLabel": "Options Outstanding, Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2",
        "terseLabel": "Options Outstanding, Weighted-Average Remaining Contractual Life(In years)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionsOutstandingDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r545",
      "r546",
      "r547",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short Term Investments [Member]",
        "terseLabel": "Short-term investments [Member]"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State And Local Jurisdiction [Member]",
        "terseLabel": "State [Member]"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r71",
      "r142",
      "r143",
      "r145",
      "r147",
      "r155",
      "r158",
      "r175",
      "r235",
      "r274",
      "r279",
      "r343",
      "r344",
      "r345",
      "r379",
      "r380",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r521",
      "r522",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Statement Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlowsParenthetical",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Of Stockholders Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r142",
      "r143",
      "r145",
      "r175",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlowsParenthetical",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Stock Compensation Plan [Member]",
        "terseLabel": "Stock Option Plan [Member]"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r120",
      "r121",
      "r122"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued1",
        "terseLabel": "Fully vested options issued to settle accrued liabilities"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r34",
      "r35",
      "r274",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period Shares New Issues",
        "positiveLabel": "Issuance of common stock upon equity financing, net of issuance cost",
        "terseLabel": "Issuance of common stock upon equity financings, net of issuance cost, shares",
        "verboseLabel": "Sale of common stock during period"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity2000StockPlanIncentiveStockPlanAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r34",
      "r35",
      "r274",
      "r279",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Stock Issued During Period Shares Stock Options Exercised",
        "negatedLabel": "Options exercised, Number of Options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionActivityUnderAllStockBasedCompensationPlansDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r34",
      "r35",
      "r274",
      "r279"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period Value New Issues",
        "terseLabel": "Issuance of common stock upon equity financings, net of issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r35",
      "r40",
      "r41",
      "r129",
      "r213",
      "r231",
      "r420"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets": {
       "order": 10080.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders Equity",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders Equity [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r128",
      "r279",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r428",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r428",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r428",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r428",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r450",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Subsidiary Sale Of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquitySummaryOfAssumptionsUsedToEstimateFairValueOfOptionsGrantedAndSharesPurchasedDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r371"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward Amount",
        "terseLabel": "Research and development tax credits"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Text Block [Abstract]"
       }
      }
     },
     "localname": "TextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r149",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r377",
      "r378",
      "r379",
      "r380",
      "r464",
      "r465",
      "r466",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Type Of Adoption [Member]",
        "terseLabel": "Accounting Standards Update"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Type Of Arrangement [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStockholdersEquityCommonStockAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithGileadSciencesIncAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSandozAGAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsAgreementWithSantenPharmaceuticalCoLtdAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsPatentPurchaseAgreementWithIndiviorAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureStrategicAgreementsSummaryOfCollaborativeResearchAndDevelopmentAndOtherRevenuesAssociatedWithCompanySMajorThirdPartyCollaboratorsParentheticalDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfCostGoodOrServiceExtensibleList": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates type of cost from product sold and service rendered.",
        "label": "Type Of Cost Good Or Service Extensible List",
        "terseLabel": "Type of cost, good or service [extensible list]"
       }
      }
     },
     "localname": "TypeOfCostGoodOrServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "U S Government Corporations And Agencies Securities [Member]",
        "terseLabel": "U.S. Government agencies [Member]"
       }
      }
     },
     "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsFairValueMeasurementsOfAssetsDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfMoneyMarketFundsAndAvailableForSaleSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r353",
      "r362"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at end of the year",
        "periodStartLabel": "Balance at beginning of the year",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail",
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r359"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits Income Tax Penalties And Interest Expense",
        "terseLabel": "Interest and penalty expense related to unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions",
        "terseLabel": "Increase related to current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance Deferred Tax Asset Change In Amount",
        "terseLabel": "Increase (decrease) in valuation allowance of net deferred tax assets"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r134",
      "r138"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "Valuation Allowances And Reserves Balance",
        "negatedPeriodEndLabel": "Balance at end of the year",
        "negatedPeriodStartLabel": "Balance at beginning of the year"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccountsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r137"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "Valuation Allowances And Reserves Deductions",
        "terseLabel": "Deductions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccountsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "Valuation Allowances And Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "Valuation Allowances And Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureScheduleIIValuationAndQualifyingAccountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r168"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail": {
       "order": 10020.0,
       "parentTag": "drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "totalLabel": "Dilutive common shares"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number Of Share Outstanding Basic And Diluted",
        "terseLabel": "Weighted-average shares used in computing net income (loss) per share, basic and diluted",
        "verboseLabel": "Basic and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfDiscontinuedOperationsReportedInStatementOfOperationsDetail",
      "http://www.durect.com/20201231/taxonomy/role/StatementStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r159",
      "r168"
     ],
     "calculation": {
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail": {
       "order": 10010.0,
       "parentTag": "drrx_WeightedAverageNumberOfSharesOutstandingDilutedNetOfEffectOfDilutiveSecurities",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number Of Shares Outstanding Basic",
        "verboseLabel": "Weighted average shares used to compute basic net loss per share"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number Of Shares Outstanding Diluted Disclosure Items [Abstract]",
        "terseLabel": "Denominators:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.durect.com/20201231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetail"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(ColumnA))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e22044-107793"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e777-108305"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26626-111562"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27337-111563"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27340-111563"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922890-210455"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2510-110228"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2473-110228"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32059-109318"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "http://asc.fasb.org/topic&trid=5833765"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41499-112717"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121578510&loc=d3e41551-112718"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121578510&loc=d3e41551-112718"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62586-112803"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r563": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r564": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r565": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r566": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r567": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r568": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r569": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r571": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r572": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r573": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r574": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r575": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(m)",
   "Publisher": "SEC",
   "Section": "4",
   "Subparagraph": "(1)(iii)",
   "Subsection": "08"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868656-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>103
<FILENAME>0001564590-21-011240-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-21-011240-xbrl.zip
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M@( II&!GP$. = %2NM$!5L283(Y;(TH<< L^ F_08X:"P8-9='#0@O7 VQI
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M5\5@>Q2K^%V\8I7-UXO*M6%!X/ "('?5'ZP.1)!T5AF&-GW\L;RZ-0@CCJM
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M5?$&Z@.JN9#$=.[4?F@X80GJVS8\'O=Q5<).M!V>]6=!NF\%"=:PZ<#K+6W
MYH+%# +3'L4!F+/ UV_U## N7/U8I$F<GV#S,8SL]TWQP-/A$^W6?P';T%R\
MH0/1+EYJX!2SA[E1B[Y'1 CO"E61Y3G_\@WMY_0:@?0@_U\$+)N#)21%=0SX
M-)CM%S+EL[3!BC$8#-MWXI4JHY5;PE>UA V$6V"D4/ "EI,*Q48KT7P\/@Z-
M]UA=6/7'I/M'K\+1 T-O^J@]+EGOE3>+O#&@'[3=7N]MC47>IA%-L(#U7O:T
MR,N&R9CU7G:WD!P!9<?5'S>-I[N@;"GN(ME/G#4#X'6[A[3@%%#KMTR::\&;
MX5/?)!IMV3GTXV@O\ HC2LI/9V.XYYN>D>.1HC("Z"BTF(<<<D\8?&,X-"%!
M VODV!]&#^X VU<J%$82?L,4GL*G<IG>N"P$<PP6AK0#KN7TP#2!B0GM7.3)
M:O3)E&C=*^58/5$>N3#XA.Q8$=9Q\Z$6Q"(],@CFB5G7?)<3,>IU!R86.UJ&
M"Y+"$C R4L!S&E3F('MRJ!<QRQZ/DSI Q 8NT"%BG?!:M>/B22BF8U9T)'Y@
M<50I\B.K0SK)AV>H!7Z'3\Z!Y0,NA1[MN/'["6<XD1% YBE$<(RMQ?J5=Y"8
M<X+A'3(GE2<282#0)2J-W\4S^*]EQ6 =&; DK.L9P-*04K(@Y^]Q-@WL"D8$
M#*SM>S"$-(SNWO'.%A?M):_JY'P./"PCNL@?9O._:%3.4YZQR_K1H8:!C36M
MR7J'#:.6+O*>P6@+"ADTAV=N@T+3.&,]%4EE%!F+FX]%MAA) <\TBU"8E0:*
MO#!JG^7BD#'4@;\/K$E>^8,RR0YA72[DS@J*!KK,V >OMW0-/$X\* R ^Z'3
M3:1'T**Z#X26-ZGJNQX&"R3ECII;'95WWHWBF>@0=QB(Y$@<8%B,VP!DNZ ,
M,)!]I#6!2X_PQ]'8D=L<>"!CB;&WX@5=2DS0_H@/9Y7/2!' W.*8G$ZUPW2*
M)18W$Q<,+"YJR3%M$]85665@7_6(@3T5(2VF8H)0_S?L#=/_GN]BXL8!"W!W
M(H0QY.N\C\5R3O0BF+E0S\/^O=FF#Q %G*/:,Z%A\(2OJ> WV4ZK7ZR95I^N
M4WOLU'@]]7[:(53@!,':1OI,7;!JW"4RY(O9*3"<0#MX\=-XE,[G+L'$!O%\
M5).Y\8?!0GUS>ZQX%F').9D+P28Z"5&5#C2AD&O;)A:A=[K!MZ"*=H=[4=Z>
M_%A2*3<QJ20N%W&698?A91@%A_FDD4R10[F-XAX *^F'A<I$81RL#W8B8AT,
M"_24K\,KC)FF6'F[2+Q$N +X];O<J&5@+A>3W1;X?I_%AJP"^;@RM'@1>W"J
M%/%C.*+#5286X &=,A,I1$RLT6'M'+=XRK G>>5^@J"4*8)BV9E 6J=,QM&0
M2G< RL-WX?/91433_!ZFL]$M&-84;+"'VRUHS%M (^!5F"G@D:#PY6PEC6$%
M$]/XW=#GH!^ NX@6>20Z*5" R8,[Z@*X:,:HG&&U?1;A\^%GC8L8[5 *+/L7
M=,&R)T!O<BI3$.XQU>*I-&P7<,&P$:@'8XJ9CZ["3R_=J(:NGV6 F?-C$1,1
M(\P&8#B$DZB!3GLP^IXC/#?!E(K!ZC @.#0Q[1-E+O#JZ(";@S&WK7 ,AFGK
M87)R).[B1*!GZ.1OVR0]C$Y8!R!P(2V;)XY; Z7VYV.I6HY,O-A6L& DD@:B
MUM\#%/UHC5Y 1WG^&B@*[J S25;CQ>SI@@+H*^.08THK$-**:N/8F*&=B46W
M(%EBX(#_-'0+@JBPQ!&",2 92HF7\RD:,%D0<'"92#0KQ[7?KD].^/('L<I$
M<,DA\([O:DV(.8+?8:CAP:>L[A.^=+E] .>F4R?P4MC7T1:A-0C+6B;P7 @Q
MK)Q)6M2<S6$Q1GE'&ZUIU.4QC]T%=$%#>3J-8!5.&*<.E]L $''E"_J0\%>U
MR&+?@!.SS.<H\N,4>#+[#=_(V\)<GL&T"I>+C(P9R)P]OJ2 9'E,SI=;!0V;
M]) S=EOXH/#^6?6KL^:MPH*@F)EGTV&_H8<GH-[(UUO4>Z>4.^E1C(7@BS6+
M53_5FMQ/\9 :5TIR07$:YG+# "T-41]9]M>'BZ@EB-!O_)U_4/H3E]XQ%6@"
MH[HV:,?>S/3M>H4H6YO:7=D^+6&-:@^_-ZYSZJ7RZ-@=&',.T$:$*03;8&^G
MUYL4_>629<B[KK-O&CCU^AZD YA>0[PRDHB)9Q!&#(<8K=-P[>L;L%##HJ'B
M!?-'O+0P'%WF<5JHQBRGB3R.Y>0<_)811-HW[0$Z8]LQ]7=#C]?%/T<X= ?$
M9+GQ;%JL=1'_1C&@0%(=F=Q43'@UQ&A]=(0NEC1:G: ]P\4LPZDB]C26!$#G
M%!,6,,P:QA9B?<NIF&.+]%8QC1[+95D^FXZ,KD*FIM$Q<',0MDB63WMA^MG"
M3$HP&2,L*9_%%6T1RXV]Z&0V%<E8@W/6+)D(P1QNV2J*:S&(,7OQP EH-4I
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MNP^,^\M4E.X><5$T(GT@9;*4!6LNFW;03NE@H*S)1;L'D?IV<UY3VVC*?DN
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MJ[6^?'BT\MX9+"PHV5#HG@;':9/D(4R89DE+6#>:+W@C586/BZ0<0\ASN1/
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M2O]Y\OO+./J%_O+R\='MEB?]JO/T.+JS][U>3,TVW-,?3 Q^U$;[<),9]$V
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MHZ=#LC?))WES^);2\X ) *DV/5#^*(W/7G_.^F'=])?)$^E4TA%K?<2/'F#
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M]HA@.)'0 G[3!@')'"I4T%N1G8F+V63/.:C!3XCJ?Y0 *!#3B=X&:E,D0*7
MA351;.M:(--.H<R\C6'0)5P(Z4]O,; K3BN&M1#F8OXH;'NV,#@&9$4.NB+*
MGQ7HUKBG/?'$HGUNZ>G:2N.K:S*SN/F,&T4:TD^T'UH"L*(G\N :T'3L6!TE
M94PZ<#O:4DT4#K?FJMJD:.BV\H1LR@K_1V:,'I7H^Q[A.;(RKC41*5*L)0F!
M_V?KF2'VN_CLA/L7\])YB>BYL>R\1,4.L92L.$3/<=>.K<U.!>"G;O'BI0;&
MY5BQNV9^6]B?%A Y.IH&?R /\7SQ=7V#8B,)46"A679"T,'_!K^676:VULUT
M0/P2QF>KD4"M9\K%*Y@4[8.;'-.41A=S)O%Z9+70<_? W#TP=P^<4/> NG P
MH=DUU01>/0S4A. ,*Z_5EA0?/DLO@4E$ZE]#>6*T^8_/& U/[\C.0GX6\K.0
M/R$AKXQ>B'KDL?L>R7BDZH.,MYI:"0=XIP'>*X2^57\'\NY9S#^]0SN+^5G,
MSV+^A,1\W*D3IY6B[!E+;0W/!.D?132/D*_,HOU)'=19M,^B?1;M)R3:+6<9
MVKDUZ==VHS0.)^LF\CBS(']ZQW(6Y+,@GP7Y"0ER+[Z%D;=QX\[4I*9D1K9_
MHN=PEMRSY)XE]PE);FV?<][P1M+T&O717&(MX B(CD=AF%5))CGZ?F<)_O3.
MXRS!9PD^2_ 3DN!CH<U-T W7TPID7L9EO P@@'_L2*2K6$?A]T:;J:61@Q81
MRP,0*X$NS(L'!5E.M4OY=P_L4IX5WB.YOK/"FQ7>K/!^L,)[R%;?OI\_ISKD
M[G).%C 675ZB(>B6SA]T=%8 E/15_MJ;(U $>3<N+D+? !H9G.)7!:0Q#T]V
MXPQE*U0;)> \T+CH'.T%0VY.4Y_"]9D5SJQP9H5STAZ6[USE9H&D)765[T5W
M&$PV>6,>J#-+8#NSD!%)>UT7?P/:GCSB:$_JK!J>WD&?5<.L&F;5<%*J@3G>
M >KC5MN*_GKIY;D"%D=%2[/,?H(G<);9L\R>9?8)R6R5RPK4HN"2/SR"D\TA
MG),[P;/,GV7^+/-/2.8+$(_'XV40M(/'"(P0 A5*F+'""W!/]5'OL $^%56
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M,N.B4"T^S1:7@C#J^[X\?CD-(N.2QG&CZJU))VEZV/9--\"<IH]RE7D"/VV
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M"?-@-!:DC]P$:=*^;ML"8FVJ3#U>O:_D0NSJ1JIJ0WG5R!!P@IM-9[U>5$Z
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MN(KY5^R:JD$ZS78T,/QPP'$BIV1+;51%@0_)W)A 8$CC,8,_".>,3ZR=5U8
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MR51XR8NG'KI$,8%."#4NOJ-B $+D';(XID:+TV:JZBW,*8DAKF#24I9/5AJ
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M:=K19X6:1B8,-BLTGZ7:=M\W+<@8+(IPS"H*J3%?WS0^[+[FA:])I@I18TX
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M*N('HA%TC%TU6=+@,T':K-7="=(F2)L@;39(VG !GK18(*B4/+Z,T&<#A\)
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M^'O7_(@(TB9PZ+6DM\"A X<.''J#.+27+.PG8@@ R!34<0S>DQLK\.OUH[[
MKP._#OQZ@_@U:M1*(Q/-],2RZE1-.>77)+Y1G$=2.='#WQ12^D]AB7BL!#'
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M#VPYH ],9=@5\]^.$FNAI-^^)RR[KH 53&HN;;&EAT2^+?&,V8^BU+7<+ ;
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MJ<4$7,4R^;A1NM][USD1>V^ ["?4<K#P-.CQH!CS%T13N'@G\]:;2>.Z_VQ
M\*O*A%L8QJY?0R76R+N#_FB4\^(/<+DQ A&[T!?/_M*&/U'7T4IQ>U&QCG_#
M[(&<DFH8OX^Z*\!V;DF?!;+RJ.&FS2!R!V=FK2=TDZ4G984#&C@4;5@PQ=W'
M-G_+ =T,B=01NAP7HAF<?J3\9CR$!(8 >,;G@9=ET#; +(4@ER-8:/1*<*\8
M9ZIRATR;7^2P6EQ-:3^4\4"0SC'3,/='1#\L:L?(DL17:RU1R2.Q!O*&!].>
M!F2^+S>/OH29488 ;)."NC,,46J 6D<Y/ R )/<$'6APJ?K;?RS/RA3\91\L
MDY(_E\1\G+Z.?(!4&N(OYI-1![W*S%6<6&:Z"Y?9#F+L!T]U-?$ +]8S43Z4
MU37I'L@GFU;WO;S48L$R!#E[+$7Q+>"X; \6;ANSB4APQ]19 B.O)@R#<%Q)
MN[=VFN6--0)8)Z;'<-<_2T@_'^Z_?.AF4!1 XO ;-:3C9(C(ZL2<2]E4B'?L
MQX9;R)#4?)Z<(UHW+;*E)F=6GG(C,5%T[.C8R$,@^T$2(NAQQO"/:"BC;Y]=
MX2S-14_W1W(J.(.K8_B4WHL)@K9=+/>5_;HSHZ"(M<<*;?Q^$OM$?S W3R:K
M'?62XNIU9)9>)2S0>ML(D85KH5%>'\4;#YISU#1VMW=>T F.LYP:/.B)R@DX
MR.N'B+8PLY,"DT>GT>G64]/%7I%[G=O>Y#!E+0X./G_&*_YNY_E>-,6$>LD;
M=%O(J=7H(T8K+J,^(2VGD7BM:3AFV>3\UZ)0R0N>[PVW_3?TGFEK7WCO/$<I
M'0 2Q*#5)EP\95X/KH'G483MVXM."4+YP%B<ML?8(5PL6,:;K/[K''DFH@!R
MNT+T]Y_#3]%BYM\:MBKV'BS4=I7"IAJ<_DEHA=0Y<'?'$#@_CL?>.Q<ZI86)
M1&DC";*9:2E&1, ./KST*2&@6G1IV+WOGK\</C-[#'M46IPHLW'TB-OX[U[N
M#??MH?"><819G)U7D9H5>^3/0>(4/^R-Z=/H_<[4-]#>/G%82FQY4# ?P/\5
M;:KP-R%(4Z"QR"H&WEIO<2:4BBUIDH;8/4J[>MT>-.U@65  O=]QECO-W._$
MUEU$)R<AI@OT6B6*+(:G3(3;\+_/![O/GPV>/7UY%?.\9.><;H@KDFFD/J%.
MQ2DUPF%G$@!I:@I,N8YASA 6UQ)6O&B"Z8U8\B&]"GBO'5AZ^@#E[@R?[3G.
M.8B>#_9>OASL/=VY"9]0E%B(R9>22.$(2M@X+0P5A"MF:UI8M>_4LY>X?=OW
M^^[=[>WMZ @4PG*N%'M/H@\FI_0#S 7/UH@,,IPEJ\NH-%+NHMR%Z5P'F6WE
M@%GM-.37\A/0$?!SXJ2<+)Y3:99YU"<"RESQCE[(X0YM;%99N7QOB8/)D]O8
M,6.)I2G;HC*%!L14*?9DF^YVHRR503@>S<Z/%$05LU?8WW>Q3N,_V<7@Y;Y:
M1XGG;!& <6)N^9Q+/BB=.Q?FCN9'/?=EM]&P\@R^2KWRE181VP8778:$AL78
MX0SBM$V..<][O9U=QZY?)68QX^UH';6?Q4!]+KGU)O[;\EFKG4E/H#2ZA+W'
MG'B@" H7N O+>X:YY&5%&3*-)%J/%"?84/XZ&'C2ULKQQT5V36T_L1T.L$Y@
M)DA?3[?))67:89LP7AK/C?>;KWQ1@N(*^F\E07R3\.)3[N(LO.8ZUU&S<#KY
MXZV'O7V":1O#Z(BBM-E42AZ1AYYGB)@<F^ZIL.:=%]LT=\?L4N')9.GZNRL!
M7E1*$^[:A2F<58QC;*6(J,^C<E_,F%IPM',S>*X6R-DLJ=51:$3A59/2<K-S
MDBOCMF9$9D&ND).XH[,?[2P_PV&T[NW"3"64!*G/N62E<Q0FA(>!FH0CIVAS
M\ EVK^?8IVM"^>]2]_S>:!N'D$,\%'.;2?MJ<H_V]O:V'\=/'N\^,1[QM"1Q
MT4^*B^LW1.SMP\"\S90+9^.YY2:T)4X&F)HQSV1B5D[]!=\7F&2$R4CG\_[[
M85IF<M-[PR8O;5.DTC6!I!0ICHPR^6L8I.:@HV_#P>*P9WSGTIF6?=)=S$R3
M,CZ\]6 X,/I9Q:Q^?X@+E0^CUVPM23,VQ7[QA.)S5RF]"WD1')J\ZK0W(@J/
MC;1'R$2QW9'4$QE;D>C%MI[J,DK.Z/2X(MX7>TL67#)7;20(4?.@+Q[MH7!=
M$7/S"W&5IFH<8Z#?Z=)Y"=^/XX15)YKC^T_8A'" S=&RFJPI_L0@!>32K@%#
M1:!,F0:U/";1NAFO[9$6/] P^M7]LG4K2)Q9;<I/^O?"]K*%IC++1O<7%C.@
M[:.O_5QP<55CZ^#XHJQLU8EWQSC5T<(2T!BDTB^;7HVIJZU%NA():J9J*[\I
MB0HE%A!).]S&#TGU ';1JK67'<##^F?N)?3TMJ/SM&%V<OIN=>.#L>X57/Z&
M1Z^>A>C5%XQ>B1/3&E76M%ZPJ@9R$=L5HEY>IU>#[SR_3KBTQ3/I!'RQT>D
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MT"A\J!E@W-A''GFZK3:Z D[._$;J]]H-YM$[P5 [(Y5S3-2)$32[\$U6/!C
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M?6Z;(0T?1F53MR"O$7(6<?=,SWH.>F153VHK]YN&'Y5%H6X3X0@"8$7(.0B
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M WVQ95RER/U=O1,9P;J.S\%T@%]@RDU@XVM(E(&-!S8>V/@&L?%*&1>8;F;
ME>,_0)6O6_IV=%%23*DN(S4>8]]V]":AURU&7#/VBTHK]QOZF0+K7S]"#JP_
ML/[ ^C>(]:L\X[QW\=N8UE>8_> [\K'/;ISG$<*+818\EKC",[K[P]!"96__
MEBU4NM&F?NJ^^R*W.YP[R-/5X0Y!G@9Y&N3I!LG3655.LE$F< _.?')!C$LP
MK3 S"\/BE-"$Y0A@%05+:*WH,'#NP+D#Y]X@SJTT,M!,3Y!UQ^D%1:^+LL8T
M7':0"2P_ACJ*TE0+\]\*NPM3"A0G8?=$/^!78^XR/"LUOF.**:R5R56+,5<7
MQ01F=R]$NZ-V8I4UO^Z]%F+5LP0E18T#3XKWCI&QFPH3YJ/#"1Y<-3?%!:>U
MN"%M/APF-R.PZJ<D;S!=&8]%DLD\%+Y\CLW0*,N^0?35D:HO*0=?VX1C_X#:
M:>YH5-<+OY',9&MCH[MTQ#Y4+\'SCR;-R,1VT[*3H B::WIMB6O00AA4TUE>
MSI5:\W3&+W_<F&8"!Y-=,!Z[Z&A\21.E*+!I\M_Q3JI)G(]MU0HGD0YH%'DT
MUAI]W\A ,!::3?'':/ACWB^F\H^SM('#A?FF#7I9+C%2.N>)R&':L[1(C_9
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MW$0D2(6Y*]E?G!<)C/_#T<GIT<GQ*8D)F)+2-:R._JK*>9R#>7/ERTYCS)Q
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M36V/S#NB_=XC\HOKF&]Z)X3.IBQY==4*^NBN?>*WJ*][4U:78(QLY67Y$??
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M2D7?[>X.G^.W.3PYB+[;V1T^-7_2@]17G#M/JZB^5/F%BJ8P].2FG70'&+C
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MR "50Y,F@#3'HS1%!I2@RSQU_EYX!9X!.TSP!TQZ+#6S#O>A@R9';@(J(:K
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M83%!/8YAP;\;L(JH)L=QZ'APHXE+X\9H ?#O?>_6Q[\3.GV9 9&,]E@N*!#
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M8"9W^Z;1[8@?NKT5]),+&9IXS9PAN< K/W37X@^&.0D/H E9SO< FAX-%D;
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M>9[\96XWK(HU![7Q@Z,C3!NX=E0(V"^LTXHX_1.#5Y^5#'YXZ"[-<SW -GB
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M(W]]A29V/)_*=2ITR,9-SN/ 652J2<M@I,K??H[L)]>ETQCV=%B7%3F&_UD
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MLZ)4M?#U%&\*TU=-<J.VLE%SG>R@28$S"&=^[-IP5R*,L%@H7Q:JJ7OFQ<P
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MS)ZGO 1/DV0_)@SH,XD#=  7;FL<^?&G@V<>?PI8D5PH%@'13P!GU<,HGSJ
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M@ ;B>=DD%7563AW;9\*NLES\R&T8<*6M1U5=)89&.4I%UG?L288T?9CY+A/
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M]^N* I'#WAU".JW6Z@+?;3#C/E:S^'S&76$_<;7>]R-99/B'YR  ?V>VBXN
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M!2('(@==8-#20(@<2/?KB@*1PZ?W>Y=&]%JKI1'?>'#CFMZ<?_5$57N/OO.
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M72K/:[MFBML]XC7]5(?JA'5 X1L/#&::OFP%\S>6RQN[ANT^\>@H./V65B@
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M,&XP!6C)7& C)VIP$4HP&PT17-0*]HDP<3")>%"C"M);^27>&QQ"HFK+R!F
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M<;_=:4X[K7ZSUVNW((1H3YO,' Q;8W/(QFSR;MM(RL<BY7WI$1'<>0WVP.,
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MB[VN\K/O;;A5_-+)G6#R&!5U;KTC.K5L3ZGLJZ:+6YF;+>5/+$SWNF:0'1&
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M]69GU^48K*M@CE@CF_M1C_D_P*,2+(SJ=2NX/IIQ[>ZJ/9][#B8 E2CYX4<
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M]Y%KFVG/W<(==6.?E< ^3OX.F[F'>KZ2:K$NQ3JRZQ>1_ +*8#EB 9X/F[S
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MIWS64^YS?)>R2%TEY=<ZYHIMD+0ZK\@:26< K-?B9&['B0"Z[[M VT@QPME
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MEY>0'#0(-YR90NQZ(+,2/#YS/>&XXONU*(4I@T4T T30R0BG.&W1O3/TP)B
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M[G!3S-ET0^Q=IC6JPYWWHB%[MCN="O6\"1EU<V6V'G3?!!ZY/6K N&/-@H-
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M(F\E ^7$V\3;Q-OGP=NTZ:U(J)VX[!Q"[=2Y\M+RO:B*B@*U^,DS4!6GO'M
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M>+E #=!^B<2\:Q'0G8BYW:H-NFUBYK-05.JEJ00,1,IG Y5ZI$Q;T=1+\Q+
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ME(-HF&'ZXBBEF/_RVO3M?RXX5T]=QEU7G$O<?L8W^=';N;C*C:W[?KKXFC#
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MYQ#5$]4K@!-1_5G"5G(Q0&(7Q<T<L0NQBP(X$;N<)6S$+JK@H*:9(W8A=E$
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MHZTK(?KHRCA/1S!^?'YYM0<$//G<MD!#Y0?H-)H6KI<=4ZI#YEFD4-&VP+H
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M,7)G!3U)N;(5]P1!A@$ZFN)VZQ\J=J'P>28ZN*PKC72B)HGN2 \O>2F<V4@
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MJYMN:S3\^\_X5H8GDF2D('8,3X1HP7+"3N!YDRJ7$YAV_ ;[MRK*[_A]]*+
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MBH1-Q@J,%=CE$&6W NNTKV[Z[:;>[K "(T(T5F!TCIT5&'D%IBL%UNVS MM
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MB009&$N8^PD'U!E&J ;4AZ/CW@&_I(JUW1[BC8H-L@=(2T"HP@>C-G-_?<G
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MJ3\/3<_^\#!S_6<AY*,_SP-K"NH%/Y"2?7B>OE8)-'L@T9:)U.I?W71:J^I
M UJX\$.CR%GHY,Y"'\5GH8^VGX7>6BT12LY"@Z\J<AP&O>,8)L<QW'4<JS?N
M%\?A>)IEAE-M MO0?+D%3<1;".%<0)MKINN"7H!U-"4XP[Z6^*?-$.#04]4B
MD,)G80:A)N!CMO8>)!'7JG7TAH8<C/_J(TD!7'4#9#6<"5C0HW"?6TI#PCKQ
MV!QO+A]_N!Z,U<S8=^TW*3W4*4OY[?D]?\^H^26'=7HKG1 _>G#0XM[\\=X)
M+=</YX&XAR]^ZP(EMC#7&J4A@!EF:(P&<Z$^"><+AE"T_/(_;<N+_C2Z'7U@
M&Z)I3,:C9E>(7G/<'^E->S0>6!W;Z%GV4 (U0%9R6LJX12!6&"Y1+38$_G$%
M*M42KHM0#T;#XO?8B)"_)V:),AT MEUS%HKKY(<W6FQ>M-OQJ("MEPW4FQ4D
MK9H9>UH9*Y3=%^1**3&I;!6CUO8"%CSW,@ZTV/KV.(6K&R5,&DB3"!>[D998
MU@Y;LQM<>W^VSG,C:P29E@7V?:3TLJ.V'N'6M7D(8B=5M>N88\=UHF?M08#W
M8L?*_O;K.VW0!5V]RH)J94X$U+=6CE3R24N3_@\\WPGCQS8 ER8B"  08 6:
M&88"UH48D"S @66!6P#OBT3PX'CP3H4S@"Z1>)CY@1D\:[8S@<<(SX)W V[,
MW0@W(F$+=Y/\&?T,848/^),_T4#^'V)TPB^';YTXGNE9CNG"4^#1\BFS>3#S
M >]:@%GYUOH@3-3'=GR>P@-<C3\5F!&\2?Q 9,.7?,V<S=QG_ '^+)5C3!'
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ML'%2I.BZNS*,>(-U B^\4XHO48Z'Q)YS9<KUAM[A C)R3,8EU:QR:\GX5,G
MR%<(^?*V\=\3^<HHG=8;[7:7D8\:DS'RL<JM)>-3)0,C7R'DR]MY?U_DJR+J
MS#+.O7S/__!!TC00*?A5LQ:=/C#8C#/W9!3:CZ8BH)>:8?N#,V+U)0/;']RC
MBPX=:,H((P1S?WW)P C!"$&'#C1EA!&"N;^^9&"$8(2@0P>N/*V6 A]^S)P
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M_CR$]X6OKQ/6BL_JYB!<*@Z%?W\!QQF:)6<#ZT+L1FL+B1%;/U+&+.&Z:-\
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MT29&P]DWH5&I%,YAZ M*SY!J%Q[@7<J6)&<Q;^4$W8U>9WN*;#0_WPY@XJ7
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MR-&0F63_BSH7) ]J>;&BPY-G6B!?$7 ZK L?\JII42SW /$A:9P3::7GA'9
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M_$CPZ31E:!<0\3)]>)D[1KS, 5Z.T?&Q?B.</PZ93?FJ?O6&$B9JDH()9JE
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M:*L4%?[,JGEERWV-RRH!=KFM<=QQ.J=LQ6P[6\C_C5IB [Y(P*G9!5*+UU1
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MJ8Y=GQ1$NO&0?NIS.=&GD(_6PA,A\M3F<J+70CR9.=7IM=1A4:Q$G@:^C97
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M#P]*456IQ8ZMCX0">U[?A#_^/U!+ P04    " #!?652,W,C9ZH9  ">*P$
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M.TGF#%6?>XQ.4%/WT>U=[&_WR1YG&[I3-]VI<0JB&0L3!(M)^Q((#IF%K:)
M_N+NYHOC$FP_0.3H602"6:L+C+2NP(0@W0*"'D'RC\C]1$(@*86X8W[ V:L-
MW@OLS;GMY=@VIAZ06P&,$H0/A]<.?G1<)S"D$;JMPH0US997\X 9B<&G5C!X
MY4<]*1,20HEA4Q%K@%TWL)O  R^8A!"I8)]D?-&59SM/#F4=^+@-:S&!K]YQ
M8KZ?1,B!I"!YQR=E&9S=:PZJ#]@#JTP6&!K9(J$(8L?T.K"['EQ;563 WCO-
MLE"M0382!F6E :>W_S,"B?8'"+XR!&WZ_>S+%A!GY&L"F&9%J"[ H&YT]F6
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MUSE=4@],P-;<LW.I]Y /G3AP@I"+]H71<"5)'2#90]%O\/0.M:>"D>/Q=8@
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M;EQPES8VY.4?8\;6,\IXF.RGN?1H:3]96FA6J"_+_ILVQRWU6K6(MMP.-0J
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MI3F='_<W6S+[;-AZD1B"Z9-'_'M'VX\>E8@C2RX"+P23^2JA.XD843XC+D#
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MEF*,4\AFKZ\G=.GC-N06_&8D\"$-N44MMX/4/6UK?*#$9>3Q&6&\/4'LL1U
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M\]$!_:^4^7@_,(4@0/^!/O?X+N"44*C83LL0PSYCP[-FK&)38-@#;)*\-IZ
M&D;<WFLT0_;3[G[#U<:CYNY9S=>O95CW)U6C0R +:XS3QG0;.%9O5>[$L&O-
M$(X&KS4+(S3GX^,:("KN^*XK$+I8I2D",0C6948K\]9?6[+UW30TKG?G=F-6
MBG8^C2 =8_@PHR1^FEVC)?Q_".CV]#1G7"HS[L*2J!*9Y]\@S&3F@K8.4!VW
M/J$R8?Y[ #<CG$T0L[97,[Y]0JIJR&_6$YOS+,>T3QAMC?I6@:GBU"<T=L>X
MG9G41_-1 R-I0W+_J'#RK*!;*"56GE?EWQC9()L.V8*AX/010E\ EC15W3EB
M2#N;Y)N:E'VFY4+J$>^!#Z@HN)V+"M(XD4Q3 B--C<WQM-1<MYR]B*NIZ+V/
M4J?:*.8IU]/I?F&7TI/(OQNGC3-5,,Q-4"WK:]C)CL7/_5%2=#7Q9M"/ SB>
M7L=LAX;;Y?;?$$;S>)XVJ=+:P<PPZ\&.UE 1"RO>MAAA(EM!FJPN_09?DY@*
MVTME.6S Q,:JKRH>,T,A;!V$/)=>HO!,VL=@PZ-_"%S&E"J:=IH,^J=[>TKW
MP2#0Q((T?M%.FU&V4<NO#DZ'L3H +K>U.!V@L@]=SC1Q)]S$^PO?$H"+-F@N
MPH;]&QQ!"L,HU5HTP$Z?U#+C3;/M@4%O3"4+6WJ^LW0F7[[W]!U%V$,+GG0A
M3EO8V%;9V349V#!GE$432V*KRJ\Y]%/[9]*N[IQ^[S3_SI:&AV<8+.$W@J.9
MDB?3D)&=FT(?HRR;ZAIX_%0F5O-8JFG8U^ '!NEY3]HF4U^54F+V=;H$E*YX
M_4W#-U.D8WNNZ4Z=/AB1I7H06:2=]MG45"^=,\UCV%T"L'>-),:6?*<=K=9P
MVE@'C;VIUPM/8C@Z?9M0JP E;D7C^X2<<\=/.O+'3[9W^U?AD)_8\,A?C^V7
M0S07P690?R?84S\8D2+WN\^D:I7KO8PJ"K:EUSA@*WW\=U_(G$-0"O"K=H&J
M9H/31TXJYIC4VOQFG!O98$#?CX227MD/X(5;UDD+;;3N[;?YT_H>@/ "8CA%
M>LG(C?GTP,;4U\%.K[]$@H)HXN:&K%.ZFC4F25*KEUL%=08@8F[=$V^5M3F3
M)6&HT*Y-@[*E;HQE8B77%=W@+QCP^[+YWQ7+RQ0)=Z@K^^"20A^)&\/%900&
M]"PCVJ&.;#MD"T[L18CMDNOEH/P:/M6"94,,>S#6TQMFV!>26V5X&5JRV0<!
M>>:W1!N< %+<.D1E$O%**>S?,B6#W"9C ()JTAWJ6]PLUWOE>70-F=D$ BYT
MS%ME9\^;61%U&5O%:ELV+:V+)+HWK?=I1UI[=TX[I<UAJUX G'9<FP.CM#DX
M[=8VQTK5PG#Z#*\Y7&4&J=:I76^.Q\U-MZ(STOBTKN>PZ#JD&2X*]_LZA(MR
MC"$#1//&WBY":J7W??&? 5Y-=G:>IH&U)MSZ%5[3TL3*L6"!M1BG:H>"Y13L
M'&H6>+,?"G>]YO=R9C6N)VYH)G[1#O].D$L_2,9L(Q"*I+H:"8G)(DXRIH0^
M ^IK!>F427>B[]9^NR58L\E<0U8K2)[CD+O_]I[O;N/ICQ"F=S)+1L9ER77R
M3IK% 'L3Y-L11+D#2A4%R])O7;BL)?T6A>[-TCVZD?UOP.U^V@WTKP^*.!A
MVH^%TH+I=(!HSXI5-R[J-CRGHT -,-EG\#B>P*V-2]'0=3KTTVQ\-/=ZG(X/
M-5EP$G?9G6B0J)#BEZS&T%^OE@1G 8[R/]_#!:$1GRKB_(:'P,;3[,]:@:+V
M!>E!#*E%)6T8WRA<D! $;#K$"[9,!G%R=V")T%_9&D%!P'O,^7-^HW3$/U^F
MIS-*!KM!KGI.KKP Z2XJ;B5>PH!(M]4TQ<F*$R8O)M\-PO%47"8^(8'?THO?
M9=,S'#:&:+L38)=-SW"X9V,5J_7IUZ%N2>N2%0@@S'V-,4[%KEC5Q56KBI>N
MF>+8&3J):<VEO68&5^E7KF)^Y'C'KS@=Q]$=9':3;PRKQOSM95K5"AGJ(*)&
MMWLK7 L'TO8(> 7Y6H8AU5B W [-M;FRD6;[GMMQOOX!NVM/:44-^Q-B-V"Q
MZB&Y:Z&['6<T Z0IK\_M6&5G@W)OO*!Q&+,O<;PD.LD3K7/'1.NXTGE8_O -
MO@ !/TN;S"#4*ZNT+%7_(WS&-.Z76W]'X0(@G^F59$8*+34:(QACV;.PQPUF
M!AJO_F@7DUTV/</AW!/MV,+O)!(=;WACFUS?8L7K:PPSMG*A8W)*-%6QG-2'
M3!,N/1LQ8G)G+1SD$\K,\>H9(MR$?D9!H-<UIR&CM@]0MON<ZR<2FN/8L[=?
M?0M4V\-!BG//T$I>8NO0[+*Q.T]RQJ3";F&>9]_>ON=1]KL>.F;Y]0\980YM
M-TMJV?8J,K/2\"Q[%VT;78U9]6R,%*PAW71K,PP[6T^_*XV%5MCV>9YHMFXT
MP*W[N*5!S#1"P5)#Q^G32K/X&EZ0G#["-+4KZL%:90\X?7C9.:15EJ?390X&
M437O[;R5 \Q*)UIOK$K%$=[*@68=MJ8C66[79'0V7LO"H(WK.]XFE!4!]@S-
M3^ZA:>!$IYD957>DM4&68?L[LOK'J!F.#OI1G>%8?T2?8:KI0?4EMX8[W""<
MW; 7P.8?DP3Z#Z0JE8/C52CEX@]?!^2YE;JYEH3K?Z:-:<5U I#R,F1)U%OF
M\<8VE@X^FF2I%72M$D#5W&JLL3K#MH/,DXAX/W<*IA4JP@PS[-F!PQ5<L-F?
M--CC*9G))8[BUY9.'&HY_EY#IE]#UGRNY&>U=(<B TQLZB69[M:817<FJ"ET
M-*(A)>_6R=,0@Q#VHHRK\UH8<RN1GE=4N^DX>09B%%'#-HZ3QQ_F 35G)#MY
MZF$/4!T_2^NP8R@5"EG_@?_GD<V1O_X74$L#!!0    ( ,%]95)5XXV'HCH
M ,]X!  5    9')R>"TR,#(P,3(S,5]D968N>&UL[7U;D]LXDN[[B3C_H8[G
M93?VV*XJWSNF=T-U\]2&;-4IE7MVGCI8)%1BFR+4(%FV^M<?@*0(2B*)"T$
MI#@Q,>.2Q$1F$D@D,K],_/V_?JZ"DV> (A^&O[XX>W7ZX@2$+O3\\.G7%TGT
MTHE<WW_Q7__YO__7W__/RY<G5S>W7T\F;NP_@RL_<@,8)0C\V_S+OY_\S\7]
M]&3JA]\?G0B<7$$W68$P/GEYLHSC]2^O7__X\>.5M_##" 9)C >+7KEP]?KD
MY<LMZ4L$'/+%R943@Y/T/[^<G)^>G[T\??/R]-W#V<=?WI[^\N[LU=N/'SZ^
M^_CN/TY/?SD]+1'X+9/BI/2?7T[>O3I]=?;JW8>ST@_O'/>[\P1.;J]*/WS_
M<7%^]OCAP[M/9^ M<#SGPP?G'7C_UGE[YKIO/YZ7.87K#?*?EO')O[G_GK*(
MY0U#$ 1@<W+CAT[H^DYP,M]*^G]/;D/WU<DD"$[NR6/1R3V( 'H&WJN<:H#U
M]DNP51Y^)6&4_OGKBY+V?CZBX!5$3Z_/3T_?O-[^^D7^<_*M%Q</E'_\[G7V
M9?'3 ](_WJ2_/?OTZ=/K]-OBIY%?]4-,].SU_WR9SMTE6#DO\5N-L="$E\C_
M)4H_G$(W?9T<(IS4_H+\]7+[LY?DHY=GYR_?G+WZ&7DOL.).3C+5.<A%, #W
M8'&2LO]+O%F#7U]$_FH=$*[2SY8(+&JYV>J(#/*.D/^;$P0O3G+"W^YO#S7K
MA_%KSU^]SG_S.GW@=<=<X0%!2*;Y2P\LG"2(Q7BL>%PCQW#E^*$TP_G3G?.;
MCO-R!5:/  DRN_MHUYPN,0GD)H_@9:$E,7XK"92YYF790^@GYNO\].P\6YQ_
M>P#X5]B03U-CLL]1NAG@G<.-TUU@^^3KE*O=1ZO8X247.S]A"%>;C.X\QD3)
MIE3\(YHM9E@#J9V*)J%W"5=K!)9$$\]@"J.()>4]IOM["[J[&BV+BI>G'_J$
M %'#SL_!SQB$'O"V1(AP&E21,K=E+X!NU9Q-9]K"B1[3Z8;=AR?'6:=,O 9!
M'&T_297X\O0LM^1_RS_^_9^ ;(_ FV"'!&_07Q.RCF:+^=)!8);$9),ACLF%
M$_DNYO'*QQLLU4.FG8#L.Q!M/PR<1Q"DGDRK$5YKD!X["7"5ZOH&P=4E#&,_
M3# S]+W< ;3'6<JXB ):#*)?!\3%S#@$'F7P*XAGBP?GYY;1ECH0&L2N>=#A
MV]<H[[6#0LP#&3H==6_V31ZC&#EN+"(G-TD3\JD02*\$.YM!-H>VZT-$B$8R
M.N28Q4N *K@@"V+R[/B8WP#<0#1W C ';H+P!@RBB?='$L5DDY016MV8.C2$
M1Z/LB8BY]Z!M>T57VX,M.P+^19 0S^4.(O+!)(Z1_YC$9'(]P*\P)#)@UP^S
M]G0;Q@"!2,C^=,6!ECF-'=^,33(RD>/ZYQHO1:&=LX&(GAF0:4R"\X-'M5G:
M0YT)&\XJ$D;GC,SFS4%,RSO9Y4'4PE<^KL?[B&)R),V5)L3TX;,Z.)Z#U,Q]
M!B%668"'GW@K?)HG+YM$SB46,2]%'=*1X+6#W"7QI\$S".":^"D20C$(Z9#E
M ;,Y6Y!9\AE";X;F #W[+M9G3'PUO'5-?;&-DI.@KG4S6Q VR K(&8GF,!"*
MF#11T6JUMDM8Q@(W$-&S8IX!]A^WKA,9^)]^O+S$+CZVI.CZ9^XZ32+,6@0\
M08=5BKP.N>\0]!(W_I+'P_DEVGNPF=?#L"SY!$_< %.%F8&L-C7XK]3+R!7(
MSV?+ 21T'Z&XI'?\U[[.\4=;M947ZE6>-6'+Q"#0/YY_/^^<Z\*^3W[Z7'Y)
M_;-:_))MM/^!G,J$_(^])[5R._5#<(O_*>3Y53V]RS5-L4R0NT,9+^0MU3Q5
MQIG]S9Y98$/<S$@^&*Q7,$0>0+^^.#L]>WOZZO3TQ<D:^1#Y\>;7%WA:)Q'F
M"*X)[PX9-DT,_D).V.!G?!VDA/!D T_D'_3[ &+K_^N+&"4'KU"M,BH3BXW*
MV9V1L&FE4-5\8*NF2RDKDNEE&9EV G(8,"KL1VN$W3'/BF0M27I^:EC2W2Q^
MC9@-&Q9L[2!079SW7Q<U3AV5D</"&9)1S(9+^>%4#::MF2HU-!RV"F'?OK->
M6/;!$_*=D@NAW]G_AH6$YHQU%/*_?S,L^1GQ*RKWIV')S1N,+!3P88"K?3>J
M7(CZ\<QZ406M>#G<3\6TWY3QB<F1FRF$_F2__>+/6Y5?=5VF;2LYWKJ&*?E!
M;K20^,S^=2PE<4,>F\H^E,7=%6JAT-2Y_19!1E,LS N5WW[/AG,;V(4O%0*^
ML=_P<6[GRF!HA6[>VF\B^733B$NDX@[%*M9C20M9W]EOUYBHV@:):^' A0+>
MV[_N16'30OOB'@R\T,L'^Q>!,KT(%084&OHXK*73HEZ$JL1^+T%$);(U1(4^
M/G$;E[^_WE,'-NS?NRV(F\?0_;Z$ >8UNOXSP>QM=2!>!%=/RZK"MPHV#18C
M? L1< +_+^#] [-$XFQX\I(%. M+CAGR(_S5%?X3GUT GDB>RN*$]CR,Q0J[
MO%)/.GJ $\_SLX5^Y_C>;7CIK/W8"5(+0BK=T^I+_#Y2 YO&&0%R_0CD4W66
M6@DAB3L97@J6Q<4)&>8VBO#&^P#G((X#,'%=A/^<^LZC'Z33CQNGI7!$/;"7
M@I7RTDK?#O8^?J1?"4)A^"@:E.XW)TB 2N'V"4K-5?(PZ6M!DERK%0S3L;ZM
M85B](O!2N4N0N\1+".\JUWAO@QL TE]L/[\+G##3._?T[98)B_1B6".:YG^J
M]Y*;*#37#Q_6MF8;W#B.!;KW=%>PS'OP[!.,TFQQ1WSKS!1<+IWP"3LVV*##
MA)Q?GO"7H>MCUY-N#?S87S7C=*>!:.O9BL%H*QZTG\<N(;ZEP430O0>/Z2DP
MB+$V@+<]QHHC[NLH:/&-73=9):3EBU=W(!$72("H'O^_TN^4D*N9D*9V -M=
M5YS_BH>U-&%(=QXR"6 H9'<8!/K+NZ3ME(?Q[W$1\5I53D)C <580%%50''*
MD:8<8@$%Y[*A>C(-PVZNIA S)Y##^%')32?[&DLKU I>%KL'N;S&G0\V>A54
MSAZDGWCE9'A_M%JH!UE(;IGY/7DJO^DEK5#^NJ.9-75PBJK]#D[.-M:^U17Z
MU44+#F6KJNTS;:&8M7VBXI7KFNR%B34'HZ"J6!]5A?U6F=?9/HSI4BG?#T7*
MPW [%=*T26HK9*>9%%KG9V\MKW$U;5-P5%GV%OM*F =V3I861IH^>G8L^$&F
MG4K>=UNI&F%!BR;[;F [A=[00KRAV(R:"HS33WU?(=UC[6CA%O=N:P!8>NE$
MRYL _HCN\%P/L3)BWW6*D*\XN+29GE4 TQI6]?1JC)'OQMBP8![$$L*[3TH!
MA:8P?'H :$6)W8;/(+>&@NW6N&CI2*M<. %Q!N=+ .+M+4?B.;DF*D.00E=Z
ML8H#T<QB/8TQJ3@F%<>DXJ%BZE=,W_*)3/O!D+JW^40U@O<KG\BQZ4$1=Z-/
M.4;>'F:[;A_-47 ?-+L]6]!K1^?):N6@#3X:^T^AO\ N=1B7XO$P\-VTA'U[
MXKX-%Q"MLG=.4FI\9X\.QC-U-E$IB@[()&;&(\63^*A,3\)9%SW@9>6HJW42
MIVS-%@<EG"LBCA"T4LV 6KNB3X$3@;V*U'M C,'V2V+$SD34($Y;[FQ(>B""
MW<%N0Q>E-LH)+B!"\ ?^XAZ;+?Y#HA!1+3>WK-:.C\CPLP794Z9X<GFD V0<
M_0,$W@U$WP3O<^$CJ$,VTO;OAQ\$(NS39[24B.;%V?=@#5':U6>>N=]B]:(-
M5'1*4<SK-D)4$-%T%P >.-Z0S!=I>TO2QFF_1#Q;%TDP]1="JX"+G!XP/'8H
MPSAKAG#O1]_Q=D ^P+92R.HVTY&RL'?.AFB$;%S7$?83?W";T8HGY>Y@P#XD
M,4JWH2 #AP_J*:/) O'4TR>Q^(@$X\6*4AF$I'0Y7V+;0S9<2O2+$Q,G99,E
M!+B5RT&I5;2W?%#:H7L%\,OTT^/"%^Q$K)*5</17B+:<%#XV)1[7.,Y/,1G$
M*9LH'BOA+:_P><3UA9QH'FILJ:*M6!%P7SW!Y]<>\#.)\#_V!<$?_7Z-??=X
M0S)J: TS(WJ%QYPM=C[B>E4"U,8Z5OMK1,<*T1Q$G;_,.0&S.<B+OJT]S,8Y
MN6'DDU1])0]!?9>X3;PL$"4N2O7S?>5<5^*MA&O!9\ZOX$?97L 0_]/-\M^B
MV3A!PG*;_.3RX7HJFH'>>4C/UIQNG'<./ND\(">,'%<N3\L@-!Q9=,W^&B9$
MYWHC&2W'U_QRDH/CIT1E-XN47*^9T/.?L6\BN%;W'Y,:^[,? ,<3''GWH:Y\
MCZ_."EO^+\X?$&WU+N8G-1#H'\]=]@'9&8Y[,ZM[4E.HC5RTI&!)LR@9"; 1
MIT=\UV@D,PPY=.U]!RQ<; @3HGM?(QFYWH+!7R#.Y^S4#T4O=*U[7 NLR@E
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M:""BY;00+P'"IRRX]?>S19H[%N(KA8^>/IM%/-<T-CDE;/LR5W8Q"!F41<X
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M9DQ-$' ] :H5]2'"['L:=L/GI.^W%?'^A%%$5F,7O^[C_*"S0RPIT$*5\"$
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MQ40RA63!N/=V;B)'[F!_*F'9A1$I%:D4'Y0*S!:N-F^7*!TYLHKKQ^T:2[T
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MROC]4YQ&)S<!O;-70Y&^T+>^S)U/=_9WCISD%?MO1[_9]%U155[@JJ6L^!=
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M'>=>,K[>N,CR>,LR*<*P0"<50[T W8T6V@#*1OC1.UAQ*FR3Q"4[4-&;"(J
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MQBC.%4);2HQ^"F) K(OJN>I#PU2Y)AF:L(+=/*8$=;%1 LU:@(#6F*.)['V
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M<%NK.:!NM1?D8M*M>UCVN=<+3A](9YR5R9^8K@(40Y)H8L,<*&9JO=>:*O<
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MF3WG"OB-ICA8*POU59!"]RCH]%4\B1UM(;<2Q8<<*Z6*1X?2]WDC0YLW2$:
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M$806>H'8UY;O.=XJF"W0X8YPG07["J 'G$,5_,A"3<6L"N/.PS7PL>O!!VN
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ME+H7 4_O8O:,X+6IXDKKTAT-9%2O,0*=N2IH7N4$+W--\-AE"'[F:N RW1$
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MTD%@F/T O,4:O1__$+"Y*[0&VN$Y'P*V^0$M)?LK>@G GQ%BY'K']#CN(#
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M:WX_2 G_(>NA=T+_.&Z*MB TLA+FSE8LG6H5V$_B;^R*@!I-$#06"5:PCI-
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MZ)_8G714O WCX6^# )V<M#Q>7!8O+JN"CLUK_$],V99T%']SG1/W3%D#E 4
M=EQ]"X^."VO,EP7X6:9'08S+PM, VR^6&X$<-1;K,SU!)1E[I&'T,R0G$C>/
MOD5R>NL@ 5K@.$,VKK7+E+/7:YP!3UQY700<N$."*N96. 8/EC_WX[L]X>0A
MK?'$,C,J<CI+246S*U^8=SQ=LYII<$G#^2*$+\!_?H7/:Q@%EF=?QS<D\![!
M*BUE#(E+D+ZW51_J2N2D[UO>*AX6YZXA)=8B/WE&?PJ06HP=H^SMO)A)JYCO
M,V)\OBRP1MM)JX, UZZ[M'"6VHT3_K5">IAK7T+&C=5,0%8CLD>PC?P%+FD\
M6_D@!N 2Q\X"'SW2POV]M0%LS=08",J:T^%X+,W5ZK\=0(JRG\\& @/PCL\4
M_:ZA(#+0'%AE22.)(?AG[:17__T G',Y#)MI#&[+ZIP>[%H$XJ#3LVPYU19N
M02D_9P0HO?,*NF15.U:5KFXG>A>J[KZ=FO&J='C3O#YUUQ%LUI'*9^],.X0Z
M-4O(K  3;XZ>G;3X'ABP\S%$<#/W8<L;MGPBS[6%J=T& 'M8,$C"J-Z%]'FM
M1K"?08S JZ2V_A&<Y&8S*,F#FI3,JQJ3(;L1G& WJ6=!*W94OI&II$$*V'2'
M[C("G=Z1.BS0]7.N3B43E 911@\]R=[4.ZZ893-2!&(0V":FGPBX=;, '8*A
M<,/)$6)(%[A%^B0JL LHC#1<K($=N>#V%HNH+!?E/R/+=99[M(^RLCU\P89<
MQ$<1;\C&N0*'#.'#=>$K%HSX58@;;?L[$*2MI5B\,U0$58;TM3-TA=8C>>^*
MFV21)E=P03OY2R1]5\".?X)D21Q+GOP,J5I8@<*U*AES. 6../R:RMJU\L(8
M.J1!+C^J%TU'C ,'826A2QG*-]"_1/>9$^+D"(XXI58ZP^]$]L@(.GK#SXPG
M9H*6XM"GC#J>@H/H,'-C";-@H3:HNXEQRI!KO72/Q^ _%Y#]8$\E9H-1=%(C
M.;5H#J;+%=*J!;K'=_0ZTIQ*(\G;UC>\@5])IS[@^4-#1G6(<AY\:LD++3\\
M>G!%/V%U;SFC:#<7[2 R"PM,"-(#^YF,[B-U8N+:LRD-R>F_X/_W8@7@7_\_
M4$L#!!0    ( ,%]95);PXG*L/4   3#!P 3    9')R>"UE>#$P,S)?-3@V
M+FAT;>R]:W/;2)(N_'TB]C_@>"YA=="R2(FZV#T=04MTF[.RI%>2IV?CQ(D-
M$"B*:(, !Q?)G%__YJ6J4+CQ(HL2W<1LK%LD@4*A*K,J*_/))W_^/V>7I[?_
M<]6W/MU^/K>NOGPX'YQ:K]Z\??O;_NG;MV>W9_S#P>Y>V[J-["#V$B\,;/_M
MV_[%*^O5.$FF[]Z^?7AXV'W8WPVCN[>WUV_'R<0_>.N'82QVW<1]]<M__>EG
M_([^*VP7_YMXB2_@#S>*OKT1W]I[^YW_[1X?[L)U\.M;]?//;]4-_^?-&^OB
M5^LT#.Y%E(C(NN_N[NUV=KM[UILW>,$P=&?PWS_]/+7B9.:+O[]*Q+?DC>U[
M=\&[R+L;)^\G=G3G!6^&89*$DW=[4_U-$D[I(]WA!:X(DG=[?WT_"H/DS<B>
M>/[LW:TW$;%U(1ZLZW!B!_Q;[/U'O&OCG:]^^5LPC*?O?WX[_65CN_![&B?>
M:%;H1+OS5+UH/T,OLB<M[-2#P"%_%X31Q/;EW=@;]0TUGZ!0C^ +^#80?-6]
M'7DV/-.2%[[ZY;1_?=L;7%B#L_[%[>#CH']F#2X^7EY_[MT.+B^L3[T;ZT._
M?V'U_W5Z_N4,?OUX??G9NOTTN(&O/@T^#&[A]]/>EYN^!7_"MQ>7MQ;<W+\>
M],ZMWL69]=OEE_,SZWSPW_WS_['XRM/+SU?]V\'MX)^@GKUK:.\2FNQ;U_U?
M!S>WU[T+:.FCU%FXZ6QP<WI^>=,_V[7^[T\__?3_H(=G@U-XQ@W<U;NM[O!U
M_ZQW>@OWK$5PY0P,0]\UQ]]+H&7'G,_.@OE<8:KZWX23XB)E_5-$,?QWHU7R
MB0;7"?TP>O?G/?K?*@/[75K1_S;VAEYBM?=V]SM_U&%NNO"477"@41$]<NU_
M>8GOW=ST;V')O3Z%%;1O]7Z][O<_PY;PAWWAX<RR ]<:BN1!B#E+Z3I?L_J]
MK ]X>>%5TNE41(X=B\H!R@U"S0N??;GNG]["WGM]=7E-F^4?=FYA8K=@0OO_
MO+P8_/=W3.@FK)!-'S:G#X<_BG[W8BL<66?"$9,A')@/6E9GK[-7>-MG&E\\
M^D?JF5/[3KP91L+^^L8>P0"_L_T'>Q:_?_#<9 SWPF->K7M9>JY)N.U]..];
MEQ]A ;JX!4OAYF7&OWHT?3%Z1GO0]>[AW\0>^L(:AI$KHK^_VGME.<+WXZGM
M>,&=_CRU75=]IJ[^_17/_"OU%MS &] LWY[&XIWZX[U5D*(DPG]<"RZ IT!#
MG5?6O6P3WO"5I5KD^XZ[]<*WW'#)CW@Q?<Z/'W[Q8L+8N[X=G((X#JRS_L?!
MQ0!WPYOW*)HWM]=?3M7F^//;Q.5!4P/%;UL<JSE#M>118X/'JFV,Q%L6HA]
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M^9W[SC0\>S_Z5#?J]O)S\%SJ=GIY<39@.H_;2^OT_/)F</'KQL_T<XW._H_
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M+KQ$6-V]=LOZX&'4X6YL3UI6S[>']L2V]KN=@X,MLC_7!0O&@MW^<Y\?NLN
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M,Q.U,!+EAQX7@&YQ"1]5&\:3R69.F$8<AY5L%R1*<Z$55;5;=&E2#^79CL/
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ML2<]\5CM6Y'OX<W%XMTF5Y])SB==:3JCBKV,=BS->4>2$@<IR9=O#U'?\ @
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MNE*)SA$B;>P4:]\?#K=N?UA7W.M<W(&R2,ZGM5,T;MVTK2O@I7+VBK[;Q^P
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M6CC"NW^6\CDJB?5H"^=O;2D2I=3[2KN]9<2_?,X/4A5A[H4_DQCZE>"^+8O
MH'SI#>>:Q^;/!E<WM@0?T\FTV$8-IW?+*K*XUK8AV1"%]0&9E\"ZO[&WJ+(6
M&'5K.M0KP>*R9K<9$<BZE_>3;5L<VGMK<RX7#L_+L:[;,MVXQ3@%_J#3)"N/
M[CH1N7",=^^]F"X@GR#_!7,5!6*F3_DM:\@UA<W"2E'AU ]Z;71FBT1C766^
MKP4QVJ+.75%BY=I##%M71J&]MRZ'Z[6X]Z#KSS1Q6U<9MKVW+FYZ14]13ZHK
M+\!ETL:_&0E@DJILT32L"Q@M\33]#X/;L][-LX59N]MW\&GOK8MTOJ;&[KS
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M>)<-K[,!F-\0YN)3/TA8ZA7"4@ONA0HG8EW ";<D$2]RSSRC2&\0(KR[?%4
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MC D<1ZAB$6V?=+"(59(*F-8C53R^9?V>NG?D7I0E 6+^FIS\L1ZI>]M/#>Y
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M>#1T9W,?LW<VEL?<B^NL??1)<J@G:PO^)F4?(OZ9=@!9%X9V?X-8:DC5,JU
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MJ^DKYF#^P8-15:"/C!=/HZ2 #Q)X&.ZGT>.QG/P^D,J<W"A5#GOM\@PL@?R
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M;%!PCDH'*,*-Z^$6#L@E?]1%4DZ2L0IZVE IFJ\(@W+.A<0KJ4*#AK 8011
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M%"42,V<VY*U]RN$2!Q(J*FTJ(LPMW2,*J8DMV0=I4R5V6SX?NM2Z#U)8S:+
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M[;W>W>^>C,=EZ[::J!5.QN NSY+/P6E>S.74/AJW^P&^>N?X./A'C!R&8*?
M*Z-F(=L/^=5@PY7)?!YE8):=_R/8.@03>,7?O>"P/_[-.]VVPY\XKN\CA$X0
M?HN4I%/3UZ$-MVEF5&7@*2,:^]V]'VZFL" P+QY>S^H46:VR?XM)9+T&!ZC;
MP,1/>=.>BC]KYS:MWF>A8I]-\[*X>N3A89VL<._HE"'"159)55>QN+>;?57R
MG[7BWZMML:A('95Q\+Y.1YPT/8VR:!(%9V<?O]%V_TYUUT=;6\&K8'][*_@-
M7)/@YSB'T4;!557$<?5#?_JO408>':76WY[^V%]Z\#;8^K"[U#?^Y?P+CEH;
M!1_\(\IBV- %<HKPC_27U_27?\OHU!=PZ*?JS"O=]J)&/'X;5ZZMIX9X]^D2
M,X'=WMJ/];G;6SL'6\';>C3R^6@_UK>>UD@QGV1Y&)R>!,?[6]M[K_:V#PX6
M-K-*@NRQO,^JIN?9B )+N"Z<GP_)YS@X*>)L%!<W,+&W23P-WB<9*%RL:+Y@
M</%O-G_?<<9F,!.O(YF)?T.^TS&IF059E1<?ZAGM^+^4#_5L9NVW),4 WQ72
M/F9)\'.>3PJ<M_\9S>9OT-$"'<HR]&!_*_B(&9 /B -+VH;^_C%*\^ DK4@L
MA\'QWN[6;LO &V+)PNM@,(%)+C&Y.2C_:T%=RP\WS4/UY?]V7]X47NOU[Y03
M@;]-DKNERD+M:=@^>(TI$'LBMG=?'^T_B^PD#^3Y))@9WHC*F3FC9V.R<T^@
M@@7BWZ/)I! VB,B0XAG.-.KZF-9%1OC(N=448E'3235!@QKEP88!;]0N,"6@
MI-NL8@("!;^!/V>ZB &[(VV8*QBINA-1G:P*!!@)%R%00POV1A++K%V"0)4)
ME!W5"-.* @#A[/A*(M!!$GD'G]F@1^W_M+45S%_/7@=ICE4,"'2M\+[G:31V
MQLC],9R!Q41K$P[>&5U"+3#3I)@9@'6X(9DGV$MC3R]^X%A/#-Q15NYH+3!I
MP>%6 \+V(%^IA2?!C/U>^A534$8;^_^[K.?M8#6> LSYOKKEO;R] ^?@#FU;
MF" Y8:B$_K6Z_=]_AR?\ZV;7:#7C :X2SX+)<1//C)/E7M,NZ1UO+1D7/BVH
M;O+=)=5-N[JZZ4EXDPL[),>W\:1.A:]G\.4V&1F\J%:OM/_J=FL9]6E(CUB2
MC<4[)C'@N1:ATLWU)%BX7<4#)(.LH%,"6D+6(,1J1R9I)H2PKEO7K>?M+^"M
MY^W=YZWGNTNV7A=.^O[NP9;>E7VQ.?K7])=8_(8+^2:XJL=C$$5Y0>IL*$3'
MZHG=XVILWM:6JQ2)*6_F?)0*2T!IU>8Y1+(1C4KHGU@Y3.."2TL>&MA4N=W5
M&6SDTN<9D99C6D)ILDNC>W\'TPP<0PQ!HR>1I\E$*^<R2IFW H9&'#XCA";#
MEF!LBDH%I:N$0U)J3NT'ER+:&:A4%)Z,I43Q8Y%/ZG$5G,%B+.!)6[OROX.7
M\K^7\C]_^9_#&&AL<(;C1%]52*_Y.I0GH =!I-29Q8B*1^TV3B<M6QUY1V=S
MU)^1%HPH,^Z2/+7(1Y[09>\" FYK=JOG,K,6>A#J>134=WDR623;B3<&;A@E
MC-9(?@;>2#\D&7*:B;,TBK-XFE1V274BM@W\.RD4!A%Z9Z510_B[8?/D)9&N
M>>R@+6*D]<,F7++F;>!9],E)D[@7,7/7XN<KPJ?7SVR%G';!Q3"_@G:@?5>7
MA'/!(1K!);2,K@)2;%U-S_<AE$ECCJ]'=+R 3.:LU=%/E4<@X:5&AK2>A' /
M"@V*R!@95[*I14]( 8=,1V<(&<'7(RNB8O_)\N:I61N=+C(3B(-H8W^SP4/D
MP"0[B-'KBK\@EJ^W[8<M7R\  UN^OKO$\MW7YNWJ67NB.6W"+C>K2JJ46DKD
M.I9(;'A.&8@CJTK%3,K1%8\#EL"!*BKOSWG&9%V18M;FY][%64)""5\XI>B(
M$E-\'!#$#4P;I"F&%X<,+A R0 "#2<?EN$A&@H0R!DO7CP;*J#&5''AB5%.8
M,>T;OC$6_K/<W[XF.MG?K08UU4VUL]7=#+?;35BE7$78^BM'ICZ%ZXH\35%L
MG47W;X(36. )+K+_,/C!^6XH,L82%#<F)5N*&K4EXNX@+M*8][T/S1S>JREV
MKRJ)6[Z+4\23B)&F]R8J)JG%PYOB#12+G%$T3M/&R4 $2M "HP<QG8V3.49*
M^&1-X1=VO>1AK,P7?*PP59.Y,".@H3"8Y1-!J4>W#UY'E\8$-808O*,'K1PM
M8#K'NEFOR(B<A.V#19*^&Z#GV,0X5HY/> ;;+ W>,0-C<(F _#47D/B5@H[I
M%T5\EX_)8U V$YF>&K^0Q*E0.SJAATC_E;T/S0(@X0M<OWE,BT@'!S&_$4HJ
M*;Z.@C[8U2RQFS+"(D$$YU%<W2-= IE1&1E@,[ 7FR"MA0[8+ 3_]H!G*9O<
M\W )S:@GRS\7/M8"W&H#Q?HT7#> %LVX<\L&@MS!B'4_UY,VDH*O4=U36F3J
MM=:H9.F#2HP(4;E.NRA[87EH;3PG&EB['OU!A,=H:XC%RA6T5D(+,V)Q_%G,
M<R):;T)B.IRC\/M31G7L.U4.6"U!#$J2#=>D%,6BT&(WG Y<< ?BE'D1F4=8
M^XF>#;2)7\DU ;.9&%,/&&5#&%T\8"*](T3,QY1@"1-F'$#8*E^S$#3(E<W9
M.J#?M]7'X;Y)P1S\"2WFX"%7"4=R<+4^$,UKARYP*'[%=O8$ ^C;X1R!W8$0
MFGD6!8@<J3:%(S2:/!6SZ,$@&MI%GF$CKNVYT,(IC)J>.CC$K%"((P.O!C^X
M-B*Y,:@(1,ALAL0:BEL7B92)FR%"8PKK\T!@2*0!XVR&FN>C@W:&-#]$<5-H
M->LUP5 B1(H[G6EZTC@B&@Y--QX0CSC3-D5N(AUSQ)0@Q[%?-K+[/I76=95*
M&Y@F7_SKLHJA;5LHB>37$A)F9%0XTA;\<:ZE A+X!JGNIQ';TT5>W\ $6%M8
M:748\TPVC!M+<S_:A?(>\@QTCYU<VYK3,-9(6_M'D3G3)^QN$6N4K.P&F<_(
MS)UG-ZCX^,\1TX>@P8T:8,)6DOZ6!6/:U,$M?( T<P<S=8R]^QOE.I\=XI11
M6P@N-??9H2UGEG[C;\.SM;'=V)/>)YF=^<CLRE:8S_,$K4#AT\9HP1B5%$T[
M/Y8X/?(91Z(^7L(3LC@E%P<>C^>\3LI;F,7SN :YFY8MB]:,3ELI&/X.[N"L
M\3L51#LM;Q:,:[!]852GE%\24I 12#CZ$#A9L3[Q&\L>%OB"YJGXD$_BU AC
MUMA8J<F<6R8PQ[-9MK!!+(>PA+V.US#)B0;99)20:9R1-1RAB.*Z&,RV166)
M!7"X>;"*106V*W"?8P[/4.%-;7*)Q&3?4";.+HQD#ZY=[N[P)7?WDKOS=G"(
M*+38()Z81%OZ/LM([WV/GT_Y.\Y?&Q#)R)_2%4#ERR1_=1H4(SY@;6.":6QC
MP3O 3Q6(,TX=HLL)1L8L*04;"H0C!PW==4)E,J\+-))UU-/27D4MD<P83?V,
M"%"^4;+I^[N#Y/.MO/#NI!@E5='MY3W1#$8+P&\&&^99,A:[;6#+^'UXS.X5
MF]-8G U?0:S.KXL>BM-M,_(N$0SUN##ZH&#Q(&<06L2H\.VJ@B R2]654BAT
M4>2\P'C?V!RCDQG,[!A3P-9C3LHR'XM9MK2I>G)RTC15V1!'*Q%=!JEYIBP(
M9T2F4VPOLC?811;K#\L+,R4UV:"9)*)C@[P-1N<-9QY(.#!E'Q>N5=@W6Y0/
M^B+./E)<B[,H+3Y'1/1$YS&V1U&ZPW IGG 9[970ET:369*I(F39LC!%HFR8
M\VD&BT =9O83S*(YU1^\=;!T0QR1 '9PC5%EG/^6%T,HY%IFZF_9*!&DZPE>
M^PD^KRN,&V)( IPR^.!9/0NID 3KAW#.:1SJ:]R!6+3'Y%GD]S$5$=P@]K,4
MK1!#!1-&8-!5E=[S>C]0_7^ 0ITWE(K1VNR9%K^1<XV.XU*)/9H#&%2_OZ70
M!M<E(N-I-OD[NI1X$"G33*&A1BU40+.CW?3Y/([0%[+%BRR_]@0OYE)-?P)7
MIQA]=T[B)6V"Y<^@?A@]H+%>[JAIE*7&>62"4=3/(II;P2783%8K0B1?39!G
MG'BG?8XO#DY>[6I!XPZ)D!ZQZ(2B"^=:0O-PI,@45AZ/2DY]E]0RH>L%K-SH
M$/.U>5+Z%\-GF\@J3K%>@%>)V:>I:R#&FB A%I@GA1,B(=DUI7V0JA(BHUWD
M4:WE=K_</TQ%P<Y#RXO0;L.XC?6ST<DO2U8SL/A<DE!@5LR2+W)Q520CT,%I
MJ'8D.<^2>2:>L+H@6G!\R1]UD9239-P9?;Q>=&Z%$KS]H#Q(9I((YLE@>53H
M<?+,J$]Q ;XQZ=&AWE7-FO#AI@^219KC*N.I)DHSS&G?HQ(HI<8J CNOR.*'
M4@X@X1:&EGT*_]>L/@<^&L(31P#" ]_Y)NBFNVA.%BX!"T%2^?.\L#?6@I>%
MUO!U.6;L_Q)3KF<77<_!"HEXPW;.9E2R()U%G<*TM1O>QQ,"F'),A[$JA)#B
M _S/N4XFE<&((K*5J7!SE]RP];H).4Q).2DYK S_\S-R(;N#IEP!-:]\KF6I
M\1(V^)3T1YBY;IJ@)27>M%6W.CO4];A*)F4=TVZ0^A-:T;6JMC!U$PN:F8YT
M)FWE[$6_1=A%AWO@'W7Q$%QCKLA;3N$"X;N,!,3-($CZ1&T OY]<$PP_\?I<
M_#JXO$+:ER%<]^'D=R()&@A%D$N($# )AA#EO#,_(-M!<#;\]\'9[TB),#S_
M]>+LUP$\'WD+3OE:&-B[X?OW2 EP#9=??6)V&")9N!R\O[@<A#Q6BW%F>'DY
M^/7B].3M&;,]?#J'(;\;(E_ R1ERU2#D/[S\^LJAY1C^_ O\!0;RCT^7,*!+
MY)819H1WPZN/2+O$W$:?/C+;A^)%0FX$XDYH?K7,UJ^#WXEQZ=W%Z2?[IW>#
MDS.X'^EQKG]#AASXI@\\3<08P2P11!QQ<LIL!SCW Y@>FIQK7I_7P76KRO">
M]T!2.OQL:"RFZ:LXPW@(%@>#I!:A1TH+@_52IL%U7JS.V6!QE#D;V%$EE'B6
M/J!B!U-.V21;,W8R>4SP.F&!PQ+APOS#L!U.ZNI!_UD-DXM0T*,!B82]0R2'
M*+N0%^KRU\' *F<8?\[R>_@0=.,,5929J,@D5D&FU&,MASG-TM6SISP$RDN(
M>2*QB/1!U<RHMV0Z"\CU+].:$K\3L*)0:?%*-DIR3*YT"C/O=$QS03]SU_!
M:-+@:KCF+HGOJ7G8?"59NVBLI*0<Q@S8&)KOH-MQGF T$A*X YV252#NL#4#
M'U/2$_Y T5+1;$E!N+$CT0*N4\GMT#N=][UN43NM71[FZ"4/\Y*'\2((G?\.
M:L0(?^;0 W7$[&4A*QE28)>H/8VJ&R"]SLDYW8N:>GA-:AF.&I(0?K@ +8K<
M2!>7I *9"NBWR^$U,2HI_2\/_FVH>=U@'*BJ3D!OO2.=C0R"YX/?3L[@OZX^
MP36BRN&)_))3(>:A+VC9 1<61:'2AW2S915H#8@??7WQ[:+LS\N(E)+W;K;Q
MXVX>M=UNMO&C8VUZKIQ'[0I=TP5LF2>+.QPD*IJ07T5=]1QJK3/+F5"&B./_
MH_8-A5F6_%[[UY#C31S^1<?))714.!?JG=)?;+V4OD>W:249@A9-A$^6'*^9
M%&!Y&'\MVT>5X?9Z6]=7DB>GAQ!SK))BO.XLJ9?(7,OCV&ZR'^JZ!,[$.,67
M9]&]4QXJ. 5B$K1:5^!R92#BX$KGP^6R'HLLY5*O%Y@(/^;AEQ/>JM?7I?S[
MW3Q 5KW^\<I/N+CXP<>X(-[M3'-F?(M%>A9YT./>M:]VQX*5C,-\W3QBS 3.
M+ 7W>9W",1@3>;4RQ^V$#%^ AY\"H>2S33 ^6!EB[8IA%![M)$,)BT^:\QKZ
M>X0(T@0D *$GP VFW8=],Y4%HRQ[IAU,_:/3<I%97:?4.HI1RDSES[ Y*"IO
MW83!D(;)HQ)W1%*RS:G1\2>L JA2'DHS6A<V,!S^?WO7UM2V$87_BH8GF'&X
MIPUMFAEBG)26P0PFS4,G#[*D$$UMR2/9)/S[[KGL3=(*? &+6&_86-K;.;MG
MS^7[TA13V(E&5\;W[#B.QY6[8XX_R,@.[=CZ$\X0<J10"H%T@\GYQ3G=UF_F
M,P,C31#CR ,"5Z+((+Z(V-0INQEW39[6BG.%Q"65_C;;"8?!!%Q$BLJZCZ=R
MF+'D[U3S#-(2AK%<3'VP\*C$=W22FZLD<Y,S8YU88JGBF!$ZL![3<&UR9G%B
M3*9V#U@"2%\^@[.Q(;O08[,Q>J6B#E@@/^9MA$G94)9PPB.Q"<%*L%\92)@,
M3]$P3:K)IN4!;\H-K*+EAI$^#-D1J<M8'J,-CA3]2-H3%9,S*O-A_XD3&8&)
MI/B1VPJ[7W;39Y%Z"58?092#S!R(ER<<5*N3*1DNJ5,@&;K5Z1;</F^V/L1&
MJ"RR$+CC75:"5RP11BB%3HRR?QES5F,I[I[!;#P;40+^-CR G1Z)SB7XY<[&
M>?'Y E93&%E9CDP7L*JGV#P[T#2-^ZNO+)Z!QPP6UU%87RJOA8/SA]!Y&?/^
MGJHBP<!X&UO_0GI,D%>-B0AGO!"W& /!5!)F T>)W2+*<RAD$:TP9:,ZAQV5
M@Y9FG)K1L0G",Q%>)!5IHO:/*:@.G4DB=;4SQ[&I8NSF8Z]C&W7SL9\8;*,K
MKP7KD3$C*[>[5./D7>-V5LG1GD(2R:TL'23C%%("XDKD!R,P@M5<5O8&UM C
M9 DDE\+->D(FWZT\,J^(H<NP< U+1_K3P=%OX-FD635<SCUMTAT^+3NFI2R>
M&<72(T"97))4T<^K+/L.^0/ _>[)JA_N+&%62F7%=)OPU82091 !*(A5D5D+
M(GA429/,^E(#(N@F5S[1Q9,'*\^CI9BOR^5FH" DZNPOU!^#(*+?)V?!^Z["
MR _=)I7RH%.*3#F&IZ0:1W3F !"+T"R)VE7@]TTW$$GOI(T"M5&@JG[H"GM=
MQ6LKM=1.)*4F'99FO>%S8-V5Y?L=O1&8IPQB:])MOF.A<<M] ./+][8Q9V#-
MP'W=WBQD='X5S;K'K5*UW".'] +E-#>X",P..QYE\/$ ;5'8O;#&!,"TX3M%
M9$Y.+^U(P\1D".YGF,2YV;&K2JYZ/D/=<&3'-9[M8WV&KAQN%T!U;]VU* [P
MW# -\$S+]27*OM_;\":V%_":\T#4#R#;%1AWA &+N3I6?9*A2'2EQ]Y+G$&-
M(V.YC4L(+0]GZ6@P*=(6])4(X<\BPY)XN#%R^&VH^5@)9,ZB7WD3(]%W9PR>
M:"2^@]5#\:4:C/F#E0_.X(K5P#$5/[1BA'1B,*Q_!4(E'6_2)1@GN ?KBG"E
M63K)E'6,*\8?^UYI=^:Z*HH_YN5'L1T#CU;B&-!U$+$X*.S*/ CDJ# ACE12
M\-<T*]\]"0LS@!2\$5)6?(MDT:'#$9+"==$ ;#6["Y\9P+7*J;^ARN<&@#\I
M7= 43.!!C5ZZL>%/-$S@P<IQ F^T6'E=R,ZOTL.>PDU2@N</4Z92,>-V!JR2
M_"'LT;&POX#"Q$XV)#V .)VL;J 2!ETDH&H)Q)D&D!2548'*C,FY(,',F!P&
MY%S=($ JK&PA'C4_%%?6-(-SDSR$OMP"K,Q'H&$QX&;TP!]JS7BH.5- ?J<Y
M)J%FC[#OW7/>)=>S&_Q;OL/QVX?I*#3?K5"A!@A$S( F<*2!,R(137IP#V>-
M^_(@GWGCK]<<M7S*COV<CIK7^^H6Y_\LSIKGE]]RB^Z9J.K$V@T-2)@]O[GL
M#0;>9\A,[7^PJ_"I0-''TG':OP'[7!VI=O@*XF8SJ)+B2R,F+_*9@GE]1)A%
M!SD#R!5WZF5G]&4)4AC?>4P6B0$34"J*\P\Q9>:/K?TM+Q#',2NO^CR!7!7^
MS)VF)UX%8KOW)WGTF_SC=X^T]C4KK>3W%/\7;Q4M'V[9C)7RA2YE7V2)+'M[
MXJ0N-8^UY2@7%U4(52UF<GK6$*,6)NMH]Y<WSS=="S.]UH_BS2^[1X<O8!3V
MLKQ >:X>N?<>?EZ0V=ED$F4 K5&I"9:T.R2[]T__\OQOK]N_ONI?8SU#*^%-
M'T6[+(T<Q;S+PJ>Y' 1ROGG[N[^^!DA64/$)T(5/GV/@C2$R?G]?QYI=*1=U
MTZB)Z#=G"O?R/7%6)$D<>3< =]7LC:,QTW;ICZ.%90_&N_&"UPK=W%-V \4!
M<TO=)LW051;EF)#0;(EJ[9]V61HZBM8L;<W2!DPAF*57_FSD#290B)0U>^-H
MS+2U9NG2%D0K=*U9NNH9.IU-OZ69:#KDHI.29.UAQ$9\%\9W3Q5%>H9 U;R1
M<'>C]<E5*C)N9BPLM\#SY%(,SC]>GMY\NNX1\-SYY:>>U[_T/O0O+OJ? :#G
MZO1CKY@9\623T+CE7N>X'+D5CBWE^7(^YDT2<@CV_A,+MDSY$<;7+>95NF+U
M7]I\CS;?H['Y'DNNH1ER?3;!J6FT3?%H;DB<D(+;3(_&CZ+-])A'K,^$==N]
M:3,]7JZ$M\O2D%&T+O76I=Z *027^E\^M-';]=YGZ?>R%ZJ5T>8YWULQMF>Y
M%>'&N?);&5XT307K#;N]_EKB 8UT=:S<DUJN<GSZ I"WP\S;>W=V/NA>] ?B
M(N4-NG_VSCY=]%J?=>NS7L^"K4\75E"M6REMZSD@P9]]%N?!*$7DB0% >@/3
MIOAZ[(<$P%$F-4;F18=4=M#/';+?^RP*HO$PRKSCCG>X?[B_($NL?'F!>;2C
MX&G.1.^#J==-LTDJ>0Y]T?H(.!(!QDI]OU@/J/Z_2%0+L].[2Y/XOT++B7<Z
M\H?^V%^^90754&1=]8!_/O GN$-!+)Y05#%.,9Q-$0M+$J@2_D.1&7<<^0DB
M"AE4JPR';BPGTR-K? F)*L&$9(R!D,Q@G0&="$KKQ5 (NSE4:$2%WW%0Q$8$
MRTVJ*Z2\+G1'4V16@+B9&_;6NX[',V93:0+HEPE!$Y+TZTDB_$V$N;:Z7$+"
MY7"/>A[!<!.YX#B7%FIZX774CC4ZH G.F-,CU%I)G !$ 9REDPSX= DL!VFB
M]9<)+%2<F[ VXK]H]S-I-J!*^(%&S-6MK(;6H3E;FT2*E< \CEW.XLW+4K'G
MD<0IGCV"3G>BY0&BAU^I.8SI$R#&N 70M^N=)TCN23";*)'3:%S;U>V#'2],
M%<.G8H83P@AZ'R?,N:!0R>F-N6:[ \ST'.QP0"/R/<038S)O^9MX>M_QM@\7
M:2F,&4D\8^AVF(L^4#H VFPW%:=')-Y]M(,\Z8J3%="0<AYC+A&G368# S%%
M<MYW%$=RIJ!Y8S$0 KF-DSM@/^6CZ)'C> 10B[FR# N(WW*G&)2)NZ'@@;>/
M=PQ 10VVA@"^A:T$SPW@=T>6" G6:HY-/!]$&5(0J9DOZ>VR ?FF6B0(C1,!
MXR^@[8N_@BR>*%X.!.S*&/<^8!SI HZ>@1 &L#H3_C5)'9@)&KL?H: ->F1&
M!]OUD#+#:CQ,B60%L+TRF00 L%]9] U@=N\BIH02#0#/LQ!MM5O$&2/N 3HS
M[#-?Q?X/Z)2*,N#'5*4/*)PT:GZ(X-79+&*4'^#%1B6QQX6G_1!L)(4&Q2]7
MED7...S(6(FH?O%=Y,(-6N,E[^W>, WOX<JS]VTZ'HD__@=02P,$%     @
MP7UE4@UE<8S=(P  ;<,  !,   !D<G)X+65X,3 S,U\U.#@N:'1M[3W9;MM(
MMN\7N/_ \: '$B#O<18G'<!QG(P!MQTD3O?TTT6)+$G5H4@-B[2L^?I[EMJX
MR*$S23M.N]&(;8FLY=39MWKQM]<7QY>_OSN)_GGYRUGT[N.KL]/C:&-S>_NW
M_>/M[=>7K_F+1UL[N]%E(3*M2I5G(MW>/CG?B#9F9;DXW-Y>+I=;R_VMO)AN
M7[[?GI7S]-%VFN=:;B5ELO'R?__G!7Y&/Z5(\&>IRE3"+TE17&_*Z]V=_?W_
M.WCZ= N>@V^W[=<OMNT+?]O<C,[?1L=Y=B6+4A;1U<'6SM;>UL%.M+F)#XSS
M9 4__^?%(M+E*I4_;\Q%,579YC@ORWQ^N+,HGYM/RGQ!?Y;RNMQ462*S\G#G
MI^>3/"LW)V*NTM7AI9I+'9W+9?0^GXN,O]/J/_)P%]_<>/F/;*P7SU]L+UX&
M,]* (E73[+!0TYF;\'9+X&GV[+<E@GV2%_/#+,_D\U26L/U-O1"QRJ8T"+VU
ME#CCX3A/D]8S6WL']K$;]X>[@%F*N4CYDRM1* %+B\R'&R]/KF=JK,IH=V=K
M?[^Q_3L%> R#RN*_A7@+E(TCJ!8+6<1"M\_A*\+X]<?W)\>7T?'%^W<7[X\N
M3R_.^V[;;K(-A7NP[9-_G1Q_O#S]]20Z_N?1^=N3Z.(-P.#\\OT%<*8+8$R_
MWP8,M*]^< @WW@68WAOKHM<UFQT<Z>AHL2CR*YE$XU54SF3T*A=%$N63Z+4J
M9%SFA8[R+'HM8SD? \=[-HKV=O9VAG=.=;>:\<G6XV?=^';3&LR1A CSI9"^
MG"D=G5S+N"K5E8R.9R*;2H0RR)*RR-/H79ZJ>!4-\ C^\?>G>WL[S_DC^F/W
M^3"" >1D D>" PB-+Q\M"I5&3_!(=AZ-\$,QE[#C!(_L@UR4?&9[!_3$TY$_
MQMT]_&AW/Q)9TCK<K?^.P7FI\7V3.I-S]/;BZ.Q#-W+U).$[QZZCK1?X36/U
MJ9R4A_N/B81.2\*?ZP7@#Z!'.1,E4?MQ/E^(;!5-BGP>E;#,J,SYYU*E:13G
MH&PE@!GX["+7&L1NJLH5(I_((A'_NU*LC2'[$%D.SQ7P%@^:%Y'YP*%[;-"=
M]B5B?',KNES#=B:U)8:D04\[RH 7\FD&D->\,5W%,[=T0:N+8;5C()LH41KF
MIHEQJ_EDHF+9G@S) M^)1:4E?@/_PFFK*Y54(M7XJH.-2 %#,T%T*>>+-%\!
M$991OECD15EE !ZIPTW.@$X3">_,56;/0M'YJ(P6,98:_D1"@U\ZEZ;@8UWF
M\:<9$ \N']8CM*X*V3Y:.LB9N*)MT &HK()Y@4VHF*&#0^;C/XBWF--5-#$#
M9P285BY5.=,E/ EDV$2'$7Q02)@73SR.JZ*064SG+3I8W8#V/Z'-CV6:+X>-
M+0+_071^>;^)\M5GB?(HCO,"X9D2!"U^ $R4O++(_!4P P4\8*I'=CQ+I%^5
M(3]'O&5\)LS (5418C*."P_,<WA4E)+IJT$-<W&MY@!G6M"52"O97%VU0$SK
MP > I-E<!EA16NRK[0*X"^_"8-^<]P"[*87*[*MZ_20$2PL(/X#,X,D8$!'0
M$7Y1(HTT".D"J8# Z2#T&1+HA?IK$/N'EJ_K]XJD<,N=!D3].4J-\S0O#O\N
MJC*_#1?H3> =)O#&RQK%OQ+QIVF15UFR&2Z&9DA 9+%HXBDV7NXZY+B1:YB1
M=N@_G+'CI>8,L )9I,!O6V^?G)V^/7UU>G9Z^7O70,W'48H!,S*ZJIX)D"PH
M51<+^$",4^(C4M2X0[2<Y<C!@-TP2Y$MSH!$CB0ED*!8FX G?@5>%;T#1J?P
MZ*,!$)@$=0-X"_YIGQPBX<T %5 0.X[H%>4$&=8:001OXN)F,DV8IP4+(.Y0
M%Z/E##C-LQT8<D43T2LT_K@J<21=D_\LX 6J6W0 5OPF- 'P-]#%U$1)9#*@
MK+-*LL\2,1H@%$<(-*/Q7##OMCK/<\O+DA& ;PGBHAAYT8]3&UCXXR(] +@8
M'=>*- ;8EAG7GM)"%"5]!TB)\)GGH%*(:2$E[DFWP>*Y,K)QOR?'D5&?A.?M
M/,2@X4G8,\ B,]MF@=1Q1%662JT9U'8(T&(!*S3L 54P6M8 Y(-DZ\JP9J"]
M+%^F,IG285AH684#5C4& ID;M(-=JUC!ALH(A.]4&50&Q5(B$GGQ8@[20Y5D
M(R"?I!78A2T%8#\.#=\"7"92E?SG*B*?G$80Q*E0<$PS K2&'Z@8(LS%BO4U
MG@U?HOV#L0??NL,8Z.%6=('"QN_5;G"T'@V8:A%RI2JKD@4VRKCPH&&4<BEE
M5CLZLU6O;KC#U14IC[!RY(DP.*"C]R@$D*)]\+)PEP0X,<%WD(TXVQ4@B.9$
MM 0Y7,(J_+HT" X_<K"R$< YA9T3F,FE :S'/&86C+2S^^2YMK9&@1B7S^<X
MA^2UY),1V@@5+ !X]2PO0&8D5F_JIZ4^"+@U F[O+@3<T>7F;Z=G9]')+^_.
M+G[_Y>3\LI^<^\A\A\S7I=*&-$@-]E1>1R]"<&#8%BG!),JK*;(U+8'!H)QH
MX_-RIH B"CD'+9:T?)9<$1,%COXU;*$O=[AAM*2PDR[$5&Z.@6(_;=+Z#D6Z
M!%GX?*F2<@;OPC0;WXTKOB?QW1-2:V*H13(28C#I[:36B)6T0*<@OA@H+Z2P
M)5Y8&,L0I69$#H-( -A0HQ@+K?0HFDN1L>P%'03$W<R@KUVHL?&<,P=5@)($
M>PS$E!=#<K<XG:EMA!8R)6+7,[4PMAON@1U,HB0Q28XKU$.,]RE#8 B-/J;S
M'-6W*1O236DX)9=J%LB3E8?>$G:D<]2PK!4.OV=EN+LN"+JM$%D+D'>@[13&
MIM>DB/73@1[DS.WDS/Y=R)D/)^^..$H6O3HY/WES>ODA^O@._CH]__7B[./Y
MY='[WZ/+D_>_G)[S4V\NSLXN?CO%:'(SSM1/0IV"JM*%0$"U#5.%]4;4]]O(
M-2(CB)\'C2\K5YN3O"JBP=ZC(2C_63G3@6+5V[0:?8XZ6G9$!T, *@ELJ(:P
M-?S$/4XCYF"''9/'-J]S'W1\%PH],YJ4/E!^BXIW<6FF0 @.4  C5T'72-1R
M4]*N,J?M D2-V::C_4$,7S\B\!\8&RY< +-*5K3+E!4)_-[#UO*;PV]![KL'
M6_M/?U!Z'XCA'1#\KU*327<$^)>:*$-?%XHT"A^^7V57,!(@! 8+C.?#67SD
M HWR!>,86HGT@5B"_:+9;]&TA&YP@="G;0&%D[(81"B#":=B^&-%%IG='*Q/
MY\;@8Y6#@CQPE!*>-#M W <CO(B5)E_0@!5BLQ>R>W$9A5Q413P33*7&.L;(
M!=GHVB\G%0N*ND23*DV'-V[-V95F0\]Q,0^$=$M"&M\%(1T+/8M>&>;7GX)N
M8JP+82)P'*2< P!*]!V*E%2Q*5A?4](Q\VAWSTHY>!CU0O0FLNJ:;;(W'U7+
M#-\=(\IJD8H"%&@VW.SL"Z$2JQWBJ;%83*LYH%TUMP+VR2,2R*.&1+5(O(8V
M844=\I7F9Z54 Z5@T, [N8Q'T#H$X0GG7X1#]H[;MB2+#D"0L?PB&O)C3JK"
M*/7U^**3[OD8B(I5= X(?9)$_>8T:F9(;3E*=RUDWRUD:XT-_$#):RDYOA-*
M]KYM.,=WG@AO1]WGC4 ;X!";;C+5TNI-E$< A$B_"-+1T'^G,HQ5.^;@$'TM
M=PCL/(?I77CJ<AG(&=1V QL_-5(,,!N51H/=X>?T6UX=>7J-R9Z8/(R::S,0
M=V #2V1"_-/RCQNFH.&<;PI->?8YV]&=JUE,T0%E4B<(6@I0F6QNAAH:U872
MQH1N6AT!Y_1<K.&$YJ$;4>6 SQD'+#,8Y]=P>S<\5*OK$K;Z>&?(QDV=E=;X
M9HVC$G FS"EY82VF.JREF+PWL'X'AD/N<DU&M.S!WK!V2!R@)XU("?+(8_J(
M\9H8I:GQA#. T%F>">2/'I6#@- C&Q *EG9L7_&K8G'DO@AB<V%L@+# .3(;
MJB-%9L*##.(I'M&-D&N$5] M+TB)&Z>HH3+?[D/O-6%N94RP:.T%SDU1&)Q9
MXEH=%7-&C*)\B4YKM'29Y(3?91UYM_[Q]]W'.\^C>HX&,Q_@B.P $C4O$*Q@
MJICYR6PJIG3D@G-J%+N!KE2>.NQDVK4GEE2%2RL@E+./Q*@@:93GA#B6?76'
M#U&>BC$,6K/ NQEA(2EWPL>7K*!VW,AY#IR:0@@[G[,ES3%3OT$*@U+:&%$.
MHWV79Y(RSLQ9NUE=MECKG-=$LD*6/'+1J?J6B;F!1+"S,?\;!5$X Q%>@PF*
MMJ!-3[IU&: 5$L_ 8<KGM90U^<$H3#=GK(+L?G'B])^4U;3W8EN\_$M$!NZM
MN[13*5RC0&Z\?'07[M+CBU]/SH_.+S_T4PG[/,54^& IW ?GV5O@I 4ZF7JZ
MNK-&-F\C8[!;=^\*=;%X(A7(6Q).9Y(ECES.7)#(B%5&K4??)!#S0R/7G3B4
MSO-L\[72&'*?DEC_0J<2*'=9;D.*_8P,Y_. M>534>;H*9HK#98$F;(U(S)#
M)Q1J0V#IEIP- )I;51K]F@SI$>J">&JDC) . AH-*F6-%#IC^OF,[<2FT8]<
MVITV^C_J,P^X?$]<*OGB-L$%YE0M5([-,+(==U/H8"2>B58+51 (\Q$F"1*D
M.?4I, V3BO1]1"=4@I$W4Q8T%3H MQ8).X+J1HBE*M3+2SI7D^6RCIY&$8@G
MWI+-W.9P/H478@^;[D#HRE 1KAK>C\'L12(<F/P L5A(D08NDHZ'AVSDL1^$
M+;LK-@<HU1N'"^RV&^*=Z-N@8QX%%FI0J^*WDN22LP/FZ*I0%(JAC'\XAN#\
M6M8L1B:MPSH$(?DKQ@:,-R."M_CQI00L-S"#:(]Y7%G3\-\51WOJ\5AC?XE/
M-LW1Y&58-D9[12L=SDAJC9X[ /2ZT0+CO;'$A4#3&R89 = 6*S+CZ"\:;0IO
M\(I-:NJT$&CM ;@%_LCP\'A!B=*4I@@H.S*C2LH)=,/"G_8(:'B@A40"O7_2
M(UL1@8&OB,Q']E[!1\;9\"US!']H-IO<!9M]#P]5B]ZZ M/2Z:3N_"E0T22N
MN'*NF]ZZY:B1:][ANO#Q%>/%;J96!][L+CVXZ2"QL2LSKO4)!0.[Q$9ZT*G:
M$A20"O,?*>I5YD0=6 $(NDDZB3"'MN97;"[EV\1S[I6)?CNB.+@+$_WRZ%\G
M_<SS!QYWCVSNZ#<0_+;@YE)<1Q<^;'M[0\GYE9T:F/H$3)5A# ?LC^M8<;('
M*P6EN$9O^'R1:ZY4;W.+H*(H%4M65HR[U3*GMNT?Z%@P=5K1%FU:6*KFJC0:
MEE=L&HRN(X)&_(\R"'2@NY@B:>"!&L;4DY75*.VJEP&48;]A<+P&0:>_D6M\
MT8Q*^CUAC,D5#S'8 H6<5V$UV,E-J\$L(H!%*HIZQ)X4-%L91%JI6<,HLGD\
M%(EPX=-E"'(G30J95#'+DA T-&#?96!4DI;RP%KNA<?ES-,6_&\"_SVYR6D]
MI;H9ZO/I)WF')A$-KH=A*9.)CZ+K)Y[A!S9\8P*E+M,5IK )ZT M-GJV]W3G
MK57=3C,JZD^C][BT"GD$55!'N\^>/JZUVJA'9A/9"!6OAA078Y=ED%+P"$-U
MR[S"'+Y:)@Y'&(EE(N>P?!(L)/?JLV?/O ,(EF5-6C@K9L2)"X5J3AV<L)?)
M\&0:&!BKSVCUY![$CDT:/Z8R&)[)T4;,QVLHGZ0#8EC</\C9@C0TYD901)GB
MIO %[QO66J44GP4U-\A_Y-Q'%X-S"^,(;P"J $R,&P2-$$QAHA2S\9&U4L&H
MSC'#D;+#R.?F&>9$HJ\9[#Z&&AYDFL>4/V;A9_P?ZT^K8RV\85?-;WE^(Q!O
MZBO0-[*)8U*%A3WO*?99<)O!3RUXNKHT&&\+,EM<=A/&#K+(<<>T ]I^ ,R_
M1%!S_R\3U+PG4J]57A&0T59T1![VT&V(CB15=.=N'=12'N<BH;P,+,6CM/ON
M$E$\I86DH[(\ NWXD2GSKL_N!@=1!'JGYA0'8 (J<Y71^,2B*I [:*OSAH6#
M 0/H$HK(@RFO@[F4U(9S=R9Y="GCGD<%NG=3KZXQA<YE['4O@V)L5F=M*^3A
MTIQZ&&32U!1K<95C,NT\[ 7 N6/!%GJE%HTI^=1Z9ZE#236WG+.Y=U/W4<II
M7JQ"OAKX;C@5R[K,#WO%I0=]'E)]'AHVZ@%,QP'.N,?T>6R8 $"2,M&<B2P4
MIO@5GV #M98L/ (F]=.  Z.]="TB9!A!;SIB%Z#T@<!LJ8,?\<B7)*4N%KT-
M2]?-::#4,'J#*L8Q8 O@DU4HNQH'.;\R'#2)+HP$@)DRPF%@'&!"FV2V= [H
MWC:"#]^ZZOT2.NG]B_#>.VPC('JMFU3#JW"!KCG&4J83SF<S=,BLG_\]#0J4
M1DQ-IIM$D\$5J/, 6L2S(L\ UE,LZS"Q'BZ7L,JVL^A<BA,;=X9+4>BCY/2O
M>B"TWN\F8!6%FDZE"XL$ZI&U$@D[50'#=DS.>6.64PP,H;J=T@:!QVR"72+J
M)9F=V5H(2]J/V:X6J,"![!K6(/MU:: #<VY!!&2<:&I,8:(XU+9,@2%A0E3.
M-E_.I$FC4Q2^L'0 O[IW.+#A_J3O01;I"OM=&$Y<S[#KLU8VP7HQXGJF'I?
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MDS>GYZ?49O3B#74=[5EG?SFKA7@I)%A8LK'%3<WFN>YJ(?^F468>>EG>C]*
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MBZONX%0MAN/3_CD\T&>E&K4'8KB&Y^ZM;7XI76G6OU+D"X&0LU2-!20'.2%
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MW[$L&(P)7%H#1!V8)K2<DQRP@D1$4DJY0EY)&W-K:J J<_M@=90H) @ YQ3
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M9_X>/("COVY@HOR?#D["\K]4^ =02P,$%     @ P7UE4O([VKPT!   )1
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M 87'[N19.0$T_R9=I^\VN!P!G%(6LC2XI*D)[_E@1C7[Y,*9]HWGW2\2;JM
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M!!\=_394N/UUM\T:;K3(AX+*/K;,T3C?7?_\]W;-=K1-+Y$AU 17BXC@%$<
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M,H+2JTRVG@H*=CCCH9()^98ZYY#@]95?@C?2U332F5STDD#TM%SM%GP%CT(
M,W5W4R7J.*"!'@/0[',$$G?*IA9:N5HPYV6S3IX:AX!1IR2);DMO\YTL>18D
M,WGV1X:CTTXR!G_WU4Z?LY4L-,Q0%!0S=?^IP:17^ _-(R^' R1QX]^^;48
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M4'0W$'G'?RKZERZ6C\?-HP](9/\M61%)77:0U 5&_^?S]J N*00P.88 /B.
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MG8 B6AD]@WJQS_W4UHC>,[].F*:0R^+5;$#?; *7>-_R'65BM6TDOU\Y7T$
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MNM/08HSZFE 47(7][",VP!*-.E1V_@DKV<2T@TNM#,XT1)Y4DXTM*P+X6R*
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M)=T &<.+=0JMKV0Q>Z2&8B[)/OIX(5P,?>.P?6T"DMD=7CWGNG-Z_;DBY6+
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M>[B\HNL)_)I6Q?R;E/*%/70P29B^_H#D<<[+[MR-! 4D&C5/4 =0EIL)NQ$
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MR<YJ&/VK]G\=\V^'_)=VR"IL.Q2[?2J+^12%_H9=/>:&/Q^_6"'_9^\J N!
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M.,.EG#R7]Y;][F'AS?]G?<93XR)L.N&S'^3L*^[5Z T( ;3?LYP.K4(F%00
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M]4$J7O0H5P@97 75EE0P];V@:-#:4G&+;MF<0$J9;M^,V#4ZOUL9L9YIG3J
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M-7G9?#&.0P:*3(DF&LAIW>MQQG]1EX'>HOG@P[)OE76S29*C Y>,-$&5H!"
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M?N1*@TY5*BY4T9A,NZ$*RF!99TK<V?):COKO7C4/7,789IYN8=0RHKK-(@%
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M>J[C+5^B\ &EKT7HN]R5TXX^Y;5LLEFHKHJ(KCV]-::L PT!!]%Z#IAK7G(
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MC/RSF=!99Q[VCE\\5E04G"!#&Q?)W +/D":L>5:OR58]^2AU: L:T:Q4QEO
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M]@Y]B(8FE37'-P<DNN^]#CA-( ?[J-TSSF]9X%>[U+ZN<=4U9T'8,F^%PS7
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MIE2Z1++[Q)?ODQM9>D0$,7_8]?\'U@'HDHQM4ORFN$#3;/+-PK#^3G.V;$#
M8.Z A+Q '!@-F04@4Y/_$^#0F_;K=Y[W+FQ5$]4Z:1CY\8'Z#+/0?/'RL8:1
M&@T^,B*(TH1?K0P T@'>Q-G.^$C35)H*,THV\WANI38Q\*M8F\:ZM;M-X3#
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M8DL^!)([7YVI^3MC@D8UFM88)IQ-#KF=+A=_7-V"Q+C D,0IR\QUVV#H7N"
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MN-),:^M1ZW'^Y42?Z\'IRIIPW)6?!IQ\+46;)S2L+))#^BQYO'B=T,X@YV9
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MZ\]8J >A'+$@6"H<-ECV52OY67RWV2,*PZ C+[4%C^H+CZ+#U7"GG603GF%
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MO=X"]4J6\4U'*=S6UAWH X9DYPI!4/<*VQE![<9+ZXV**=V! 40[?#CK9'P
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M=()5 '#):I,<47B#-X8 >\%NELJ4HPLCP['C:ZQ04JEQ''C9-IBRHQUGT52
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M3.?CP8Z08(&66!-%D]*I-4@)5)E5E=C!=))[Z4=B8-@F/F/B)HT2LSN,5OB
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M(H[]]YHH(*C]5:U7_Y-*YN,BQ'I_'9NLOXX+?J$X8.3];ZY*/)C_K<3_I4J
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MGE=+78@?QPA&V&=\>/4(7&A7.Q*U29Z=ZQ*ZFH8RUB"3&'[?@7B0-8/,*ZJ
MQ51^,FL\%VOIYK,K_ZM0V2=@0=CT7NT$[)JJ+5.9L4ET%.&V</:[N'O'SQ'5
M79TFU>3\JA>'P" 8+QEF5%1%X)-U4?43@+%_U6 T_,!E)U=)4W'LB/-*>\U^
MC/6R#XB*$@&W=B%;.IQ@[388Y\)?W+BMC&O2NYN@H.93%7H^O%*ALJ$4$B6^
M+;GA8L9(PT-=13^(,,,[S4N33&6O7[0 (QA<X/?(+<]U>BQJX=MWN96&Z,>\
MGWHQOM4T854,NV)&3WYUH4'Z^L7Y(/QM?++!*U$0%2]S#KIUCR;[[B-VFK3?
MC-1.77U]K86-"@7_VX@88=_/4KL%LH!;,;X2ZHFP0F/5/>.0M_'\_1Y5E]TQ
M\2WI3?G8'4FME+YV8#P$?0?Z8&9AD[2>R"^UI1T5RU)&194:V'#WLTI+ZVL3
M9",TF#+V1=)AJC+T"\-WJ'_5)8^@K0A1"]SI2@Q!1J$>30Z3I:-6J+OS!<46
M% !Z;%P,^OM_-M[];**PL(7\;K[Z2A,Z/&-%'3'TMG'LJ!/M%^),@Z8E]K8N
MS*EL2V[6G(7S-2&Y@YH,8WJX+@[/4LH7_#7")2GR.<JXH:L[^-X( 8T"G8.8
M 8YEIJ,CB/Z7 +4W3P"+0#1;AC,8UAD-NQ:4?PI?W)WFYW#OGD?C9WC!+?D&
M7S^!".H_*J8]]VP9_=N%&*:H0V7K9SA25.UM'Z$E'^!:M+:)87PL[<-N]+Y_
M\D'BT*&];R<7J!P_//Z1)CZ-O4I(*H.,C6P)Z1WNN/!!^L3R?DO,=OWK@_R9
MI&;@C9S#HF-MHGBX0L'$H8AOT,=8-FBXI #TPEXTJ(N<[BR;_.748?9$T>6E
M:495O"O3T!<<$,SOP_@%]FHU1+B0VEF2JX S=H5IB(/[_3";-RWQ#-&ROS_)
MPP B_+?\'3BT6!H9D A&\]C/4^'0R\)E&*B;<:X]?LIT4Y#=:VJ8J6-JORZ*
M=<J+P$4=S+]2@N%N_'M6&":W8C[4CU^FO'&L>P+>JR'84="?)\-V,?&,#-4.
MV<&4Z^>9/^*>(52;.6?HZ<[IZDA[PO>DH;ZWVSE.]4\'VXB2=<("G/^CKMWL
M=S.U1^+6NN;G<6QA5-BO9=KC7*2(@X4AGDMG*Q-FFBA!F-YE0[1>MPBS5SW[
M-5)>8$;HYMF4:!L"EX"!A:@7[S1FI\ZO[\,C])WS_:C2#%5#8F^/%W[]S%:M
M$\N*V*?*-WZXVZ)EL+GPM2:",& ;&"M&\HZ==<@4COE>B:@)6LS"0'KO%G[0
MFR\(U/C]_%KIGUA]Z+W;^6A3?MRXC>R/K XD7DT@,Y&Z<UW-)Z]%(S*X&13;
M/>*<7F6V@,_>=3[[O23)Z.@I,?S6I*KB,-#D<W6[+L.M-30UZ37/]U<G4H$]
M%Y*-D\-A5:S6=:IZ'&$#3GZ(1"K"JE1EU#!"U-Y]_L^8<I'Y-TGLP+XPNJ7!
MJ6#WKT'MG(HRTL4$VDB9!%BK:/9P)#KGX?[^$:FU7X_"U75-IW(9UA9PE4./
MNG,;;X=L7\;X\.[2RW<I2@L'.IIFAF5''?Y4?D?,\!X+(!L&;-R$.]UE33HV
MG@#EIOIXU2E*:?')(:/SQEQM@ENG0#3Y#Z_)S)&J!75'UPF""6+HDP8'8PRA
M>CLHNB(%4#G"XP+_.8<>&/*@];EL_TZ^#TH]XWUQ-H594/P7 &5X3YWI W.A
MN3>*PR"]-=?HQ\J48R5>F.!!Q!@ UR_L A8SCXP]$HCW1H9 ..39/S0W03[/
M?QB70LGLIT1YZ]O3'LLO=YCO$3T'FSW-*=-LL98<?ST49D^I<!A:Q;7HD[XY
MY8/<2SP"["GJW/1V-\0%7R$)T#W;:>U\WY*W[X/)WX8=Q,)+#_ZRI,6+7MH4
M4S[=/DXX#9?%!NFN4"J)-QG5XO+8X3E2&EZL$K?MB1!PI 7>&34)665?$SH[
M<V72;YOU2QLR5;#OP%36BR!2^?;U4V^["'?6A*UA'O'+E!XVO_^);)"DN"37
MUY7K#.]7.O!]B452^V?SFZ:<CE'MUE/&6?_%MW6U];YDW5VWZEOT?#PJEI]B
MXGMY;D5'B(Z MKC9-H*[=VZ0[(6XK'P=C_)E42O1</EOP,O//OF\'0_#_:1!
M"(V>,"DM*/W-\U=[U^]167D4# %/ ("9 ^C).)N-%SLB=Q<H_$JK[A>_#['+
M@G'>1=4O^(E;&I;K;3B12L'%M7,6KG^M)KCYF+=W3:(S7=W%HMV)9R?1_G/I
M1SN*B*!V">]]:P +69YW7^Z:\-WCY!-P"5+4<9$1:[I)XBSNCKLQGM0\%[_0
M-C;@0C4$7PKRN:LL'I#VGH[Z;6A)+\BX#Q*DP)FPPK\E*CM$]+C,N0DY^#@N
M8$]0;I&ILZ\@_:.Z[)Z'#@-<-P+3-C(>S8<CX;01B3Y&7"4<S/<S@I['7XG"
MNH9M1,B8.A[%OY[F-\9+XKZ?A6;"9Q\]-*8XA7\IFMK^CB7,:L1]N1U$6>*Q
MP2)ZG^SXXR8-_F=J@W6P0^TY,X0LW2QZ63O D8=!BO+5K0^< 9NM_ZSU^E7(
M H7_T8M$BC<_/98^M'*)6C<@63>\A8,S\,.<\G'$WW;#]#_RD-Z(P-+9[Q>(
M4VWX-@CWV9*JD=TU ?03#@:[CXJ'S#;DU_OS9=HG0/=T-K0ZGV:L6J;XY=V5
M,?D[IFX-]<C=9I9V'^I-)P3D.7$DU$3C!->UT:]."SI?ONQJUD4KXB7?6N5)
MHX[8L:2Q@@L!.S6J[Q/,3?S%*TL6NMS3!!;]@7U%FR&?(E\)%0C3P)U*4U?:
M3NTJW/AW/7+Z=VFF0!-EXU+#\%1CK&GF(_U]VKS=::Z@1RKM[2]+?&TW,&&6
M93*6]P@7:I*:!M&7DZVVE?W;=$7Z0:]CVQGLYHD_R9P^/I)ZX^B::LIESB[@
M+'KF+ T4_Y2X_\:RK0;$&?@@[;K05*:MI0'J%BU@'1G5.%<2HVA2E7"K%R)S
M2S!@%L\=<.EP-#)MPPG*02K5+/-QSE25\B3'W*REV9NZ[_WG3X +^N!U_0*?
M#WM@?A.,A:W)6HK0RC[RIP2!X?&! '5C"2K*B[$)4/+I[%500+&'04YQQRAY
M%$6:873*0&.TI/;:ZRVX)00$9X,2>>[L"$0]31W=FT+-Z .UEMN4"5[)^9NV
M'D*TSO#TO#;@D^%UE!DA=\,3$/;),7J%\>T*DGZ=:?#'[QK2NDEE\I0D76/5
MJS@NF@,ZF(JG*QEYGL$ZD&-([)8&?^9Q.ZFK,,NV",A8-!WM-T-[T8U\UX+V
M9)C8A_$L]CU[G/U]+IDRW("1,:"=")$JJI:LUL]!EE_F]%?*=$IK+.=1-HXV
MUQ7DJ/*_ =O1ZM8S\N9U,B_(Q_=:G'$+AA4URK;\'B48VP)IZR ?.>0>I%')
M?VP) Q$3Y',6M!]PJEH2&6>YW!^"EB2&KWG^EHRZ5'Z"0Y9?M,I"AVVU+V"+
MC>W$>! +P:XKU4<-*U$BBZY=+)<1^@1 4+0.#P,,V^J8O#Z..$%]IZY&+,I/
M'TOMB^;Z;1U_:)N55,!A:\,2MXA3GR.2A@+N1Z/$;40D_TPXE<MIO:NY(Q'C
M+?WK-:]V[U]9J#G7.'-_8]+]"YH%:]/K/P6!6=<+92F.A,WNA9Z E5MW;BLG
MJP2>^[F#A1K3_QQMXW]M4J/_$_+W64\BD+W[B@T>UY^ L3"2G0<?ZV=-EI]-
M)*[DE]8MU3^5K9];2025.7+E989$_6OY<_]-L5NA?P(B6X.\#TZ]=V5T9/_^
MMZP5K2/'OYJQZC_P.M41M[!ZSZ]3E7:'7'2"\&SFC9XG7OB2JYCL7S^"^.CV
M3V5:_]4 XW]32C[J_<G5(WI7[>CXWW.@Y'P9*?G+0T&$'9KB/?[KH8)L>QNN
M&:OUF=3Y@Y5HAJ"Q.]5IY4E'>ED]^9"['CVN!>U#SQ_V?J)K/F[^JKO_W$<^
MP@\S^SR=N4ZF@R3!5#<(E?%9[!84'/$>J/T[.L5_1M0J6JJGBE7W1XP2$8Q5
MHOA85=_8[K-A"F*:>TX/<3G%Z&@+]>D_0Z<R.3RT&-]141&<<66'% /Y68:6
M^9QEFB[2$ (%4=4_V3/(@Z+&_,="/*]^F.7\3CJRN_4V2X%LW$HO4YF ?'O%
M^C?^,'TT1X,YTC!O*1;BO4TNKEV]&YV7:XGOT^]"^H5Q!*@1O*N]SS7U'FE]
M2#=&T?1NLI0G/\6Y&XT5;^%JOW5VK1"F] WW-UM T@\;<FTKJ2DTN[YJ^/&%
M>^:_Y?X0"HJ4?(M)Z8<N6;!_YQ5L=#7\?IMQ;0F+'5:&=1< QTR=S>$N^#"-
MJQQ:'SGR$Y5:YDH?;>OTOR3'O/D;VZ^]$ ]05+_K#7&0A37-F#J90392VO<E
M'EE)>"':=CFJ#7;@_#RK/5EJE5Y36[?*<17J3G*HWT# @QXM*"_7,@63(6[2
M6[PWL:"W3-.C7Q8M=:QEX'6416P+-5QS,RY>6.IT-4.?;CP)-)V16H0SDNKC
M$;CD@&'\Z]I]=@"F:\<F\_]6V</GOV*R_K/ROTW2_\]-4J U>*GS]&Y4)W%E
M:57W_=B[QJ8ZE6L>M.ZD !@VUP>1+>J[DW".N,EC3C*,B?,)@^#U28.HG2#H
MVD.72>F'_!YN-'_M6T]\(0S336V9&=^2Y'>6(;>AE*[RI.$37('@G=+2E\TK
MOL+^E\8S#X*;KUHZ9M$^?P7WOJ L 93Z&=)>@?,H7M-9K1!%?"Z1[TJEF3KB
MO"=#%*NNCGM<AQNZMB)@)9=:LX+_VFX C<1;([=MSER1SMO5]+S,@(OG&A]:
M1R!D2$\V$;#7IH@H%F#-O\F<Z51IJ"^?(A\Z;%SRF\?=>?WS1#!!*X>]D7C/
M%VUEPK$4ERXX27K6X>L0FP0)Z0'24@<&\HN$X .H$Z5O.QKZ)]G\@[A5G%^+
MZ+ C,^Y):9725$LU!#P3G$HV2'0)>*?2;;OVW5*;,P+(&SJ$,GHX-+^*MR([
M++=5!R3K<@>R(T/86,30HJ!8.0W#B(^2)X3>BVF/(1Q(_K+/  JR,7?)C#6G
MQ;R0Q6AF;T@Z^+E PY?!=<V@'!&,U3:M=4)TH!D4G#W^\#I7S(Z1J-?5UJ$(
MF]1I\D'&!TGH1YF3'R&=I.Z?ZNL=PE>W3T!F@(&+F,;DY0F!2\S[%O6B4I.I
M5"G#I"T+GY&WZ7W$^\027M8LD7R)@(P>V**?YBJJ8,]VP6(0I*TA$<F1SZ/,
M]!%EASK@$Q$7>]2TS4*<%R>A,$;.&5Z:2<@^T3())^T[C?8%']\^M/=@<M]>
MGI^5M#,.O^TW6KXV*'4[U42^-VFNO6U')]67@0DKC!J1&OIB8Y\JY/Z:L?I@
M%#9+NSCYKHN-0=6P3 HE9?'[0]<74ZV?:##0U'E*\J#,FWEK#Y#]!FI:95*H
M2J0,3@P.,>(KGQK73^-0Z/E*DZKC;#AG&'];HO-7JR-&38O"LF+$;V<P&!09
M#')R0X%[@6#RW,@S:N<KS:OJ]>_'1H@:4VN)N&R0 /]*\ENJ'9>>;?"MI""K
MKN_&H+JE91.]B642I;]Z50CGDMRT0AM:JCRH&3 RUZ4]6PG($2LP3Y2+O5+8
M/$+%Q3H+6Q<1YB6V/%5SXO>=:%Q$[?M%QC=S1^,8_C_R#9T,*YT)/X2XC?YV
M&7T"TDD$6)^ EZEAS^X2B_<NK&]B]=#-:E<M.?[XT<G16@AD5@8<_(+J=75P
M.QGFX"SBKD5.B4QO6;<M@B_<6799?[%65L\^L8;4)U'$/*IJ:@3:_(TT<E,2
M2$U6_NZ=?JT9UTADT#(1(L"*T>[L9/T=@[T?^-$;TN340@YQ$Z3ZH$7W4FH2
MDR$4%7WPQ<+F&Q@@%5-)&4/B">B*N,5R%+Y_-C%92M4>\G]4K'Q6D?W92B)\
MAWKJ==UUN+A+-XP[2#.55O-L1C)-4JO>^T63!:Z>?,*MLI&F(N*YFPU^L%]?
M1-5Y^P3(3/RH<=(3I,0A",T=Z+5%D:=D64J_VP*IZ4U;,WHPKQVQK:K(OD&]
M-^VZ_E+Q?5I)P&.PCX);D ^MHF2_[:PF.--4D>RNN*=P@_A*DC?.YH.Z"NU;
M@-H07D75*B(JI0IF3\$E9,_#TW']H(]QH];"J*XB?JAS@(4;S7!KQSL#EKT=
MD1.A=<-B$9-@UXT\"0]7VF6Q1$F</YHA(D&+TL1\P+;_5I*,/6$S5X8T#?.F
MH[^I[\@8F2-NK"A0RYEXY#')ME["9:@)RZUS#?,F3T"FY*;I\<C8NT(,:2T
M!D/;_@*BWL#%IA7^#68WM@L3YR9"\PPCRV#]7H>5T1+<R5 [(D,,TWZK6 NX
M]A+QR_/>2EKKBG,'-7%O>!/L2__8CW?3+84_,[@*@Y92,C>U@1#[#!GDO+1/
M$?71CA_HBLT7JJN'-%>B& ..JI+4;XT^?\.Q48BVA]K[/:,5'@(!FL(EBQ6B
MRJGC:.I$R'T<Y5LH_ZL>:4'$8KM'E*EJ+6N"U1OS:XU0%;\91,=XAA$H-<C,
MH)_'2T+]-8SH6DC]Z:Q*F35L1YI%L&:7E)4SU^HK0A,T^P=^UU$YS(PV*OM_
M@[A<(M.Y0G^6&T+%;G9%(J!Z9LQ+E]PR2=G>!E.+&1M?#L9-%2'1Q9R"_-(C
MNJDYGCH.R*X5M_0C_=Q  (>#1&.'F8$OL^Y4GDOWY6=-U!$C;76T!NU0 8E4
MFY*Q?CN @!J35L=["-!-_!_LO658G-V6)OQ  85;T%!(@ 02W-U"L! T!(=
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M=21=S7D*6FT"S. "I/0FLBWDD!,>%B(DXH)R7N=(^'16MV&849B](A$V4LR
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M")YT*R<;5^LJDK(.8;;DTA>+GQ<6%L(%0X"X?[Y)_I_'=N1QU$</QYKF0^\
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M>3=S&_OK-KGJSI]==MTL2<<#HN4[=/IL07,/$F2'G RP842DOFI JJH:(#*
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MWY&1QB:6M!O%]=3]74BLQV*.L;'XPI0TF"YD9JZBH+Z#7*=W]I'XC"G_9;A
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MQZ6'X3%%9VXYL8YO,9\ "@6K6  *L=ZB_3/#,;<Q[?(G@/;CI&?5T<K>[ \
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MJ'%YP"_]WAOA^3UE2G27$1H:>\R'0Y0; QX00&TG"^IEXY(_-,ZQ_MKSX0F
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MY1#W/9B'EQFD4ZI8=?J>8TC0T*TM%CJK#N&_7L83[1926;5"I1(3JB2>S$\
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MG(8=+GO<I"?HFL8V9IB2!J>X'.]4.*RMLQ @1G6AA8N^UVQ(7-2" EMN.$\
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M[-,Y==^M,_D>U_UV <M+2)X?=<C+2Z!R85 5-D(?WL5; "0?., M9X,G#H^
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ME1L%HWG^[S]2N$O?"^U"7JCW7C'47>@/57\ZZ5@PZ:]YWN,"A<P)'3^$FXS
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MM!+;O"N0U7W%Q.M;*5+GK1:U:AR1,(QD CDR,?]8/(IVJ[Z#]1OOMJ00LT]
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M@7.=J+>SQLN@>9T9:P*/9F=F?]I2P"$;=,N2S(C I6\XD7\*E*2,\1W?Y&O
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M1R:'J#OD3T-I?.!KG5N>.U*2ZU\"R@,_))VDY_&5H*K<@W^&GO_62.4G 4M
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M\BSI<$@$ \3'ZY-"QC5UT+SY&Q>+TXJ /Q,VA;&1LI,3Q:AP);GXZN.1'QH
MX*HJ4[;#$@:^;@8/:'YYWLPQ^[.T8\"JYK&$C@QA8C?_.;&@85M$=SI5>Y&'
MN+"Q)(]<BT2SVE-]-5$OIF5K3DY.Z;5O67_WR+JA.3% FBF2Y6=ER-5JH,
MPU4HDG,]^?_%EOJ%?X/KTI$L!L@Y6S=6_TM2'>OKA")ET#\O+M7$0N&O_%F:
M$W9#3/%KMHM;0&V$CC8C_GBM=$P/T'1C4ORZ6YP@UO3_5!3GCR; _-L0##"Q
MJ#H(TX*MI/KZ<8RNGJ:%DT/QR,Y18T!&AB.A$%G'7@?C6F8\L@5R+ 596V Y
M<F8Y%<8 >U,!+G(L-\?!O7:&/KR\MQ"9?_YXHUE'$<21Y T0'V^!L5JMJW;0
MK%^%C9]H9Z/G?E1XQGNPJ[*)NQOA<DJI.$8TTO9I!+CU@P\U4:H8X'E+U27E
MU#*TI@'UAA #7. ,8H!\\UR2HC]J1)3KR@-[=XK" ./W=NS^FK8A+HJZ4_#/
MLDIP_';G L0TFZ MR</U]9%%[TZ2ZRC)^T')020/D<6]S*R-",W(XQN.ZYZ#
M7G>=W^$-R_%')N!ZEFAGNL5DV\UC !LP]66\2AV\KB;PY)1&S,@]S'"-,1[F
M,2:/[>,/GSJJ$& Q\F=#1*!NM>.'[@DY?2T7</!H^C0>?*CBVANWOM-/]QRY
M;;SG'P^/[F.!1WHODM2.UJA#>^N^;705:0[>',9A,"QC7%%;K0AP43'['Q@!
M/# ,<N:! 8(QP,,MKAP$&-6, 3HP0*'[ORY:>\AXU&V'@*E%1SZF-4<(_/G+
MR.9!CFP U!8@A0$(QE]!MFPGP' S&@Q 9:*\"@Z:;:^"M5P^4?Q:'CCJQV74
M;-)25A#7\Y%!*Z1) B]T3*)/@P0EU! -W6)_#UDZ@R"G #^\&'^K%;\J$#)D
M<:DG77I2K6B>PZ4_@$*H.C8(P!WD.*EBN<R"KN6:8H 97LU+!BH6^-@B+P;(
MC8O$ )!U#+"JLXBZ@]0N0S+TT*17E@58\+U[Z9 ?];7%FK=<E;LLQAY$*S&X
M'2<GXQIU)_?:'P:'+:9D2&@?\YTI-OC>959EQ@LF[2/&UTAN=H>Y9\DWC=;\
M/^0WL<@6=X_3O:3O73\)JTQ!3]7R=GX4X]?[SE;?67.G5TE^C7]YN9H>]/E.
M.1_M;HVW4U=:<T6KP*BT(;EP0D)+UA26^%J0H?BJ>)^2F\E+Z2>K7$XXSY#I
MZIYWV=,O?NPZW6IE;2Y]KN9<L)X8_'33=B$QM&Z&UT^&2DT%*ED9;5;RMC7?
MRXD1_<QA3NR.O35(?-Q(9U;N7VN/?4@O*K5XOYU&GUKHFOK-<[M=WPB>?Y:D
M 8"25$#)NKM"/9(WXB-_$K8Q:.N)-JA0H>IGA^2)RDE*6)E=Q=?(>@%_6U@\
MJ9%W<<]Y>(-KBV7+F\9'H>NYM \&0%)/[US-4$V11)-C#$ TC0&>.*&?0"\<
M6."CD&-1#+!^->?K)\F6ZXXWN\"4HS H8#!O3&,W+":J1RZK^7: ,F*0(TDG
MC>/88=Z":A/Z^U;312@IN#**59:E\0NT-G!I8T%D/&/-Y]D0VRI#QL6[,;\O
M=/\0=:U'P=G+0[C7X'E2?QZV,\>E,CG;4\6@U+C *A4\0] ' _8)L"G*5BNT
M;!;QI@[$QAG.<&G7@E:^J.+'TC+&F&4RQBF)5QHN=RE?!I<]9)/G.XEX8W1G
M7ML\YD/R%F$UJ'YU5XZI,AC&!.YI=FF;S%:@;TAC&Z3359XM?WK"@<L8HIPG
M4F8B Y]$W\( Y!ZCMR=//:^GW6&[F%=P)@>_76_4,YO./$H_YG%31W__+,+#
M-WH8.&?' \UH\!S=T1,?&!/*M-1>PQ/@ZV7"-UF8,S1<6JSX)!PO4OX0\7::
MH0#/60I+?%Z.J4\>^\ ;TG.N%UF1;2RZZM;;,!8V;9](38<5L2$H2/ 82UQD
M#8V-8%RDBC".V2:$$-W,.N .7Z83+&M^9#%P4S^EQ2J.>+4!LESWAOK<L5#0
M5)G[AWFX6D"!M#QH[\6XUER<0.)AMEM"/K9O[)71QX@!KD3-^C0:[Y(KMQ+2
M@P$.=S$ ")U2=9EGAP%D((A)-"76BZB*WV4A-@97:M04Y8X!P@#]]V6_S[/,
M4D./KJ87$WA%CMKFP])?L\HG856HJ\G7KXG4PDF_U_#7K/8O4K](_2+UQR15
MI"CL5FHSYXQ'URO[3X^524.6,_F*%G=]'594JLRC\--)!-0<(POU!4('=*VP
MXR28W^<C[64G$)JFK0V7Q_D!3:DPOG1!CF9=S;<N1X#*,;!:Z"E9U<V#IS.U
M+\(V[9DTCWOT>&I*^WNPGCV5]*?J&W'$&DIJ%-4K5=>WLZEJDF[(,&7K+G ?
M)E@FT\T2 $1WQ % ,KL@:8:='6;ZVAI^-3II/S[W<J0=74:[?Z"S((KKK4]0
M<'X%> ]BKQ&Q@+]),U%%=-D%O)"Y?^K>M;AC: ^3'JW#(OPJ&:'=F)Q0\-PZ
M7JL:[E%8G^%5O/22/KO:P?UU7'/6>%9L$VMIQ[WOK&MN*8_Y%2VKNO8X?Z1^
M<WN9WMM;V!JBV)"ZXM]ZE//F3I]K1TKG61S^>YBH/\4'#.#@#=9HHTXPN%9!
M&H+U>G+8,WZ=*6U]@*DF)O-%PPZAE(KP!8,?E^5=)R?Z7O)4GKJGSXDRDSMV
M7OHJ\->)38^N\KQZ6;][^HQRV%DHJW]:-F4<TC-W 4&_-X63[&. );!GR\XZ
M=",  X"/AM+-29!EX/$4991.SN9095$4K]"53Q55@SI["NG51_M_V+%YO^RZ
MA-"%Y-R+_U--8W5*(V)#]+WQHW7M*RO:^NRPK/1]=/#PGZN#8>480%;'0UC;
M6<+I;YZ,Q_/G^B5_)J#S=4*Q8QWZYP8L?Z+0G'ZGD;'A3PWR_T1![XDB#>CO
M[]!8(!?*X)N_  Q9ZX!KJ)5:2CEM8HGS+G,]YD&V**5 9B6)-/^:WD>;]-[B
MU\)J,@:=IX;&/;<>)3S<_%!/@!4\P"Y-JDA#%OV_=+?O_[B1^-6A?W"'/GS+
MN'(D2>9@%UXH/S?HI6E>OX8OK&'K_3+EW^Q)"*)4"[.<N@U2TTM!JBZ.VS39
M@M&W996D&<WJ,X,38Z*.G,(6.;[4\@CI?9RZ[7>WMWN13))JF8V=E<F_X\F;
M/@UO/#SF%OW)+7J1J9$T,7K%5]/D"9:I:I8O_ %<53IIX+<?K-A=\<SP@<#4
MG_0FRWVK/V6SBA,ZPK.U(I=EB'EUCT:\D]N7BJV%A%2=)4KZ5MD,TN]I7?;V
M'B+:ASW-V6E9>L4K:(#VYZ!,67XX;<5R'#Z[2E[L?0Z;/)VG1+]]#+ZG4^Z>
M)?5HZ3*G>';6"0!_7WEVBI5I#<JT7-VQ,>X>.,H)E^7\['Y 8%PQ.D*=I"RD
M>=-6C2'L'O].>Z-QBQ[G&A[=RS&DGLTIL]B4B)T:7JC:825[S)[.,__!Q-5H
M8/4FWDU7&M"4VXX>/6ZLE]NMT;%D,^%#4A-]GL1W'P$Z#DLX@+KW4UL9^RZ1
M0(&+4IXVF?,'O"O9?5WRF73_Q._C>G48H&8/LIF&EH;T?9+^781/%SU^599M
MBD1@ 'KP7^J43\A10?^2B_]Q87IVY9?'LR#*A+5PG/Z:S;^0G4;[0%;[42]'
M*;$,_Y*S^?UC:Q1_D?E%YA>9?PX9$%NX.&6Y72U%IK7P^;\X)-;D=)8#&4<=
M5A;]>ZHHZ$KE1,G]EW8)$V'QI(9(PV[Z\ ;WEOS:UXV/$C<DQ!\,X#&\+1D3
M'].DJC(AN)!'=J-E_&]9BQ6.HOLP -0E4VQJZ./5F%EJX84OF<R_- @;O9S/
MMAH=J1 >K[TQUI,JSDB4Y*O7@ (0GWH.D;+G>K?U;&M1X<^)OWQ1SEQ1PEWF
MQ_5:6POR9RM_MCAOVQQ6=UF0;3Q:6R;,5\M464 E+LU(*CE)=NI E;@"N>I?
M<3=]8,/+%HN6UQ*/DM<;Q=T'05+/^,<D^I2IJOY' LO_%P:F__#0^^MQW-\=
MS7WZF4F=4EOEO[04&A>>K)B&BE1HK#[^6IO6U-H8<#AT6K.6<W$ 8 4!RP"P
MK&>E"#B;P@O;62"?H1@@.8T%9<SR'[->M5JXRA'^ OE(3<VD[@<U%SRU2>_>
M24_[-P$4J1P_M<]TV_Y_MF5N.#VKA:,C?<I,V^?L5&*J0K#LW74&@6IQP#I)
MKBJU]2Y"2+L&F4,3*1)=G,10;,.;\NZ=>4/B*=6C?:L'YK3WC@Y7FRHW3T(1
M$2A?Y,,Q)[6,RU@,$+@J[E268H8!I >J<(K8#PRX1MKQO1O0Y"S8O%E2+TZ5
MY^SG [:<_?,[ .?K%ARH=V#?-M&$KG^R."+^7:#OL][O5\&__K#!'Q65AFCK
MI:.K%UM6^I=D::YD^O_FA.9_"UK?CJ,U2;;2TNLN]NIK7P\A6:G[%8T2""F"
M<'TXKD-- A 9\M_\%98)>&IU?*S"5SBS%T5O%D<J6,FQ^(?HU)_.]6E@ 6=V
MAM]X4?(5BR^G#YHW]I]P+2?1R%"YJE['!>B6@7MA3AB@ZP;LX)RJ#HJB&<8
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MSU>KVH1?>0GKXJ%N?6,YZMM$GYFB[\4CU<K!F['CEX=0E ZUA=A6.<GO[[#
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M;GTP,U&LJ;9HQM8N3NY/"SLN3:#?$PW@MS$ 'K^)*&O9$.C&2"5P\1ZO)'^
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MV%K<<@RV<N'D8YNJL\34YQ4";\RB] PSKSCIWN(#S*4F5DT$],<V,HFX%I%
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M6 G*%"3:2#K]".VC:)@WC9*LI<'5GJ%BP0R.^PQXJK<9NLJ5#U]H9=GIE=M
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MH7@4G[IN0T!$S!(W(."]=>?/[N1<W=)<OCICDJQ+C2+*([ZAT<2\6TB H/B
MP^P\.-:WH:!7=/:0@YK)9_RKH_TQCS04,:(N %UC3:&"*JR8X*4R*L@Q6*-W
MDNL(+L]33</9VI+%BYN%V_W71@1"@@<>)1(&\360>=%C1#OAXL1=^.^W][DW
M$7T4#6=(F!>UQ$J-S#%WP@O0&C2(;\1+A5LH2QX:&B@[.W-]%BHU4@:9]G]5
M4P8=*$MMB9M*!\$QEI\G#3<P>#IS2ZR7N7S"N";FV;*0A/DQNA:K#HOF5!Q^
MK^MD676,![(#.MBUSWW\SB]SQXVYL'5A(7"\:0"F\[)YD1OF\*;D]44MK^GE
M5D@+&0?[N8)Z7ZV:@&ND5<H=D;\W%OV?2@7KZ5S6H'2O!^RF#PZ46; >:0@H
MLP4 >T;..?#ISB;VVC'6H8H(X0\!E"]GWV.S89 F$9'W>"\XU0+5MUL8D^5=
MC##VL^#=JF]6PD5+2TZ\(FA,2XL;1'L6R.CM^TBK$SX_FZB.M3D1H:I6+Y^;
MNY&D U7[HAGO)"9)-(8F1;&>8ASA^WC)^IAK!U]]%"NJ(N1:^$9UZ@J[?2UA
MM7./Y*("3,!)U19^LZN]8\?5PL/FA.?>%[EXRJ>.#-0A,@([#GBQ[KM&RI*
MV]B_#B/$-WF_ZDH6'/)>,DX<U(O1T9^#8\Q*Q3)FH6ON@>D.*>$:;&+SY7_1
M?7(R07FJ;%6DQU+L(B279,%RC3[F-3!++#HSS_$9>*:'$WE$3+;Q0GOTF%IZ
MD-[(_E/?]??0:->UR(O7T)ETHBN8T79K>Y'IK$,7RLML?HPCZ.-3H?8*-%>H
M:O"#(]$.TC[1L3EUBZ(7&/O*[)^&"N._51(JT6S82*%Z>U\G26P1%(3/!JN:
MV7E*;\:LD^4K F<ILH'.1C<N*3,'?XT/R_Z@<$A?MPM]/+9CP*= S9/^@C[<
MQ+L[X,AG!Z.E3CJY4.W02,X!LW[@OGG\G)&+'"ZN7' D>Q<.Q?#P3Z8#U_KT
M/)06(4/1RU 2%0'WXPVZ@NDB="!+C;Z=I$$3JH1)8(Z1:MEX=F6QKOH/4"4:
MDBX*K8ECD4&X"T$20YBOOD?<ZK LS8<94<,<-BKI]FX=F5WBC5VY@6#,9F8C
M(.Y74'!.636Y?.?+Q-/AW)A7ABX18F,>)%!PY;S[Z?,%MX6K&X2 =R?%FVS/
M"(5]BN:,["WWZ@)2PPZ!4.MV@M+CK9P%6 LC<:[-3R !7M6=CF&CGE>X2YZ=
MZ^N7W-ZG00)^'!UXQ9F4<D%W+%K$Z NW@]CAZON\CHSZ\]-;-G;8A;:+XQ).
M6D9D0 ]!?T<H#EOF3'H%VJ;0GP0/&W'LNRZM%2XVVC=(+:X%<;U<TJFK\SQM
M<)@T":>V/Z\!Q4[-!P:Q8T W(-$L^^H=#&8[$R=UW2]+65X(&DH5'WHY823$
M7UV57VP$@.5 0X]V<*3W6D;)Y*81\YC_5,X@>]AZ?;L*]LZD(]^';QX"2;SZ
M> UFY&A'GW]O'1M%C/RP^+F^#FA>;=%6BE_Q!%G71WOS6=JW"1ROL$P5<.F\
M>EM91-D$?/G-S/;9C$=*U)--LS8Q%==$0U= 8/X^I])VB-BZT [EM '<;<G/
M"#K8_G!NLQI/M7GJ>30ZARMPR.<<U6E 6N.W&(M]J1[J3SNV-"Y\\^HVY9Z-
ML[N%[@*G66^\X4&90A_[3!$5F^AL*Y;R4Z5=2?G,UB5#T&:U#A7)=$/X >XM
M]'.UA2L6HG0!DB87V:GFC$Q+5"=J,0M]-Z_H<;S5,".>NJX4W'.KIC\J@&_P
ML%2V3[ *C:ZLI  ^H5$+6QVKTPEMN(-U%&@:/%@&'?[X/H,OYNVU6RY\"O<P
M3LO%(%<JH$;OG$OMZG!>0HY[9V-2JC!S5$97>YGXZ:TP,%8U -:H8-=FF$.R
M1[:GHNJ'YL25VG !8Z_>&&=NEAX02<!S:M&V2!-G_4J5>V/@RF>3>]+='E8-
M'PYN7C]8-2S62>SM<H[;PA5VC^WG4>\HVSR->EKUF2M_CK4J6I:%P74"6KNW
MDP'/0 *V?AF(J3TD8.5H +ZW]_X'[!DY)' E^5(4O.*(Z(J!WV_>;$<"+. 3
MX;%AA6 QQS\^$ *W62 !-:9O=$B@K#0O7.A[;M;G?8A4F0.4&FFF>''#^&@1
M"<0UG]-N66?+BG%<Z*"4Y*136CU5@H('2BNQ G5Q0;A<0;@[QJ*^LC"E(0AH
MK*+ P/J@F329=[P#Q874O?5WTBV'0?-&6JH/5<K&*_JB1!Y4J;R5>#[%K2;*
M\BV(")<E5I8E3GXH)L06$95MM%WWRIV2WS'Q&PA6T#@58R)SU@X*-(I8,@Z4
M9O\POA8A5XD8'54?)/@LJ5D7?$%$D[S&F&D"\UPAMH;;PZ#=+=Y//#A<BV>8
MJ71,G'",>24/2)@Z7_9NH =8>H(FX4SM<9N4VC'\O!8U:6NM20\ GL@G"@!
M%$"4#SH"P]Z 1U\@%% *O5UA5L2[U.H?WE]F40 )Y!-?1"&!R8F'\K1H?3_V
M73;BZLTS)R30,W\9Y2:DF4G_3VI:6.A[NWJD8CKB_#W/AY:0Z5.4,,26I6$+
MD(CGJH!@7F9>/$$"C$UD']^.K*$&##Q?,T"WM:H+'A1@'U(,M_/NG'\I7/]9
M[_+48/:3A2_9[?6L4N5KLBT8D@"6#TZKX\M#W2F9D#T69;.7-$^]<&5!'_/
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M_NZ'!^56)7S2Q5GEDG_K9'SS7Y5,[W>C'W)[CTW\]^='0PRJY)I*OTG.-SG
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MG:MC'O45(CYOKL)KW)U]]=8YM??%Z0R%F&:F%([&L2PZ8;8J]!L1GVIAX5T
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MC]E>71!_$-JIG2)H%?VC>-G$)&Q^A6NHR:-8<T.XC9(K_CIK)C\#S[T]C=(
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M9,XZSQ42E_?$+Z#=KPQ" L&)N4K&VK,W,K;8.PVYZ7=+,* AT&EK$7E:TKH
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M0$^^IB]B//V4 S(_@Q@K<_O'EV3]1TC=T0,P&Q* OI:R0C!\&9"APKEX.E_
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MBRZU0Q0:!IQ9U$]QP][;*?C:Z M"2SS7*P4:O/SO9V57MG. VVF&?]*H4&
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M_AS/17WZ *-6!> HOU2EPX# ,9W"8/F'ML[2[)+6^E!MR\L(Y6P!$FZ)QX"
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MQOJOVV@<[.YLUO$K'+]4IJ/K(^_IG3Z-,L!?/>QC2H$N_T@U7S9^TC7]_-V
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ME>3J)6HFVO$:_0-?55>^E> 4RJ>.#1)"QA')<=GX^SOIPUKV..O^AQMO^>
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M:&L (! (L"3_ *0QX#) 1T-#2T--1TM+2T]/Q\#$=HR)D9&)^_@),!L_#T2
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MEOW9L/]CURC 1 DB3QXE*P #]@_/O ED^+?\_8(E 3B[35H2\%7!E 2@6$@
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MTK;[GXRO0^O.6Z1[5\<)!RJ TK&I.RH*L^AP9U6(0E2QV89E1/0)D_-?LNP
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M;S\;3(W3MI_MFK"]%=)TV)[V;E5 S5MW_.2KV6,A%=%Z@5S%&AIN]:YHY]\
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MF.X$PFCM-PDEE6%$6XF"@V2"(V21Z;W8_R[F;C&2^VMUDIN2TPT&UTP-K65
MP/$^UK-7#Y=3A.M[DK^ #\CBK_,,NUEK30&,^$&>>SN'1&>E!"7%J1UE%>YJ
MKQ,T9_UULC:B*AYZZKXSU%\89Z(>-;[.Y&7 ]R!0);.48&3EFH]3,/U8%O>E
MIF9@*8QMG&;);OA,Y[1UPF#EF6QFV(Q3Q'N<^TQ[TMO501)@VQ#2LWUJL@3Y
MI*<E65B #LI3/5/;RSZ^=G'=7'! 0D(6YR2_HM_<6(YU0KPB>C:-"JEPYL\-
MO'T3"*49:\QB)?*NI=:9TX1-Z0_(T05J%PL(8EDSWH8]/)I]6+W [*;Y<(/(
MX@>MQIP.=Y?,D=_0T]^:G&43? OR<E33G'1^.;^S?M'Z4.4?SWRM<.%MQIRA
MXH-KIM^F/\4T3+OI= :#1D/$A\=E EW3,\^UU^:3@ =PW]O?Z[*4U^43QP],
M*C>'0RN7:+G;94(LF"PL)A]Y)9I;3/1Z>9Q6Z(:&:3X&:.YMN0"04,!_R@IA
MFS^"]K[O13U1^&I$]C@]ZT<MQ?M-350![ \:[(XRZK2][6>C4&!O]VXK?]:L
M>?TNYU/@!N_F#^#GZ<=-NMAWZO_E*^(WKYQ%@0O8C-YPXKGE0]4285:<YIV!
M4;&LBD8F#7UKVB7TD9L!53+#@:"MW,KN @E@)8+)N+@1>ZRAZ*AV#WRZS[&N
MY)-W=4NM4\\ND7@A]AOHVPA<K[$F^8WY/3BB)<6@W];ZJU'C\K"BHN5Y%W5(
MZ)-=<A[[@MI50"PHD(#*(02F:R:%():UH8=+(P%V_JC/)"#%6<RFFP1L5+JC
MQG(!GW]J9<EV[>)BRLR&TN:N+TZ\R%#(KS>FE<+S_6IWH$N.\%R0&J=H,.\'
M;\<?IV+M1"XE:IX*,]0_KTX;3+=A3E]$[$:L+7SU4S^:.CU)A+S;Z,^;U3CQ
MU9>\[@BR>J&HF9-XSN%-5)GJTEY8WSYR3M5B<FN/,(*?J#0L5H<J&&!-3;KX
MOEX+FDN49RI^:\VB2<4Z&:B("(<QED^%Y[O*&KI9K'*>.6[RZM0=AM<1S<S7
M0I+'&?F2:6.3)W\'CO.;'6P6QN=G5$P"'JT0J;X.=?D;"TMW?*+VKD/;#0K>
MH,@7Z^Q50E,JU]?4B<YYI#R3E>*V:U#M?S/EF-?&)[G:C4<>5VH-M#QP@CBI
M+PGS65M39M4>I?NITSR3=-R-$LO0]>(LN_OP$HW+\=O?8SG#[O)EPCLWB33P
MI3M8IW#_^Q^R5)>N;24XC7S:%OK13@(,>,'=4T+08#V8%_Z:$3^37$KX#YKB
ML:!8>_5@U2K'ED7$S.<-\[Q,:0]58)GG>VQ*H<-A<Q5Q%)X;^N[!P^>26]:/
MM\.DXK4[YW<$X\%6_S3NC>D=-798Z"NG$SJ.L*UO+5%B7?#[?I=UH;1IM'_:
M-M-G+LZ]$,:.T]'"9D8_J;?A%@Z$O>+5/*D1JUOXNEU1F ;*HOE>%H19\'?&
M2&_>J<-96'N<?#G[0JOPK51U)K4B]_S<L7I@CB&J70EJ#2NS%IO5MQT2]J>U
M.D\7Y(2TWK@>?QNP3$$+LY;;"HVOBSON=%\<;>Z!20X.BI!3SHUO-RFB,V\
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M'F0^TN(Z;T\C0A2*5FP'5MH\() Z*6_GN5>[70Z\*X^='$^^6%W[+,&D3_&
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M]2(5^,F!)%8+LRF<:/3T\>N7B6[HI#4S@>3<>\NI9@UI[\8T'6V=TDY%T#+
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M-MWR+*Q2G,M\M32^!C/ZNH-B6>F]_V%8W??1B/+IZQO"K-5Z=Q^?".,2@O(
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MT#Y*_'W'GC_'H-G>B-'GHR6M4ZRF-TH_Y*Z-!08&54I-G)W/O);=V^#SI""
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M=FX,=L\#E"Z/PBP'CY2'N7KX:N/02<5:.987/HJD9ED[72#6IISQ?1B='EG
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M3W.63)@7CJ-A]ZINA,PP#,C2:N=^4+T0QQBFI/Y <308:P<:T?,F$B87K64
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M ;ZR+5'=,PR/HMM.6H-7I"/L/&696:E(UIJUP?DYU+0W:8=B)@G<[\XNO7Q
MD,>LXHK[W["V?SV1T)CB%(<"(6DH&#9 <U]L8&UFYTS"JMEA"!Z81[H49)!#
M><P_KIII/2^JXN#_C;'^^PGR"A.69^8@QY8FX^;&@(+ "Q'T$QD_9*@Y.Q-8
MY1Q0$E&(9O?^,[EVV#*V=XX34!ED-&W' $6FW9C6UL*C=TA+P*Z1]Y/58F?4
M3'M6_=U )BT $V==4?_(?,:#U8ZG8"M-$&U>'5HQI,;V\LCQ:^,@TOS)%YAC
M4<Z3ZHM4L>A"V%FXLYCL.;+T)Y/ EZ+&<YB'OH4K.OUG/@X6T=8Q#U5K7\-H
M(1G'$@IAC]80EQX]&B>7@JNB7\#%TE]H[A>T0.+,[J:@[D(T=65^;$=]"X,F
MKP5=Z!2L9Q^ *YL9R/ \@<ZHH,->0K6<#[QB6N\'[?O)13N5VOL1]^?W-1K<
M5,1"7F*D&"ZIL?-/:YGL;WHP#98JX.9P^FH_R-'])#[]]T8"G,3>M(=FGE'
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MD%AF)JWJ8*PX>SQDBANH*N\MXLDTX$LPV41!VIJZ7/O'$G ,EF$@Y )L1G]
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MNM7E?)'X:D\4-)\F1&!U>WC 9#.($]9-3+"A'"/0WMBPO&.$(VH7I\!WNJO
M$?AOWO7F/';ZLJILZY@@*JW_[=VWZ0I0'R8221N&E95XX[V8M-TL]DQ.U$>_
MBHCO% 7ILT4I(Z(\-8K":BY?A-+K"^+85\?ZN"TL"M_V3_&54-"DJV'\+2L0
M&[C!1QFJL>H_2FGG/HUWY1PQ!3_6B8K8)A&_:)<5H<"@HPS\;5(DV)"<\; Z
MQ^5W\@L?\DX]<)5[8LM8/S7<*CR-H-'')Z?O#Q\/D V>A>7'G@[JCFC_^CU
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MRC2A3K.&M[[: ..+5*Z/V^LYC!&7!<%MLX()FF'+-&7=<'?-:*[(-ZDO< 4
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M[CCZ=I:RY&&1_7&XU4-?FA:+3#;)#*K:;%'7B%S?(OMQ_ZO3%DI@B:DSW_L
M<]ZH$8(MV+*<$S%H(],RSYB($T#M.1OL^RLTSX;P (^7(T2,JTP.$@HT%G\X
MG+T[C[%YG/S1$W+12Y!FQ'HVZN7N+BM0F2RB_&C:\?AN*M\;WWS39CPPY=V2
M02-]9TRS*7Q/IG:,+=!P3(UYSL RP:2A7"J#I(\EPT!F\VZ79I3L_HCABA\+
M&TL&U;MLL7>V2$$V[;>*M@6F?1=77AZ)Y2I0)9OD>A=\_U[',S6I_>ET8#-J
M-./K&LM=Q04Z!=J</HY"J8<QY,EJJ3H,#SYQO@;QVO79\$5"Y7;($4850G?%
MPV7&:JY^9;E](>H9/^@'4=2N/GS?25Z#TF7;JIIFN/?QH_@VXV'/FS/W&U[,
MPJ=W)@@+M???<Y[_$M[TV<AI/)AR>7^;?%5ZI6_#YY",L19RY"I"X#&/ZB%=
MZ4S+E0U)=ZKUN"0%9'0?7G;P29C[\,;6&>&GO-,!59(4IMQ5Q40BIWAW-\)E
MOL:]#\AX/X9+^5!::2?D#+TY^$Z*WPQA.]?'US(.M=VL?C79ZU\M.KK%783Q
MA%LXUO$G[]]3BT4REW[[)&H[S#DC_:@?<AHQS&'?\ZM#X!^\,$Y$U8_92S@=
MMH02V"6/F/QZWCX\$RX_/Z1UJ!FPRX=]_?,W5=+'@N5>AIS>@FU%)&;]]OV/
M+V*_CHG:B<EX&>HTL;..$G07CL:RNH'MR/R+BLC/+C0^63+?QRB^7=Y,'A^M
M>.L)(;3[S,YN]'9-VG,LW,]<D3+O&3_X.ZA?JD_0C9,%+6S>^?'N=]=U\R<7
M7RAVBP(5?Q&S<''56+HIS&/3 <PX2=E\V.$XI$T6XH.8+=SP3^5:@'PC>6+!
M.5HI2*L=*+[FOL-^5C/0-+]64^X16%+)DG.]O'[F; [Q)JDS3!K8EQ&O3=.2
M9OY.V*J@K<"[=DV^;*_([AAE^UAJ?#(G&GVNWJO]8'Z\ZFZ*7=O;\^D. ,IP
MM*283\\S=/F5XX!'/^V/]63=*=.GNV<@W7*B$[F)GR.]QAN>T'AS4=3[YK5D
M\[Q9;,T^(R4*^N0^>WISPOV63Z&:;[%]R:=KH0=PW:J1#7C2]6_QX!7[H=6Q
MA&><C%+;$<#NR376/GJ2SV;PFA+/L3U-O<5W#/2;1I6T9#^FEN]3F&UN/WM4
MK7O?S755X7QI@&#>=(&C,9W::I^UN8\A;N3\RV4.\L)HEY)[X@Q?0HO&T@0_
M5QX)O7[O%P'DGLDM6MVL2 (%*I;TR7>1"C,M\WX(:?=[E+VC25G$N:"K.7=*
MT%B67W@:;O"#,\K1!M'3P'V*?;%/'.VZI3HC.+'%ZB"6^JK L:A[M$H&H4OP
MO-M4[Z[S@Q&[G78_F>Y$9^;#FZYC=?ZT]#_,.UER* -7P%X1SR U?'C Z()\
MM-9_\5+S%]9K[2.!4](9("L=OC-8T.+)%7VY_:6IBYFKA5%I:N#^^1/)A/L$
M03 *Q30M9^$\D^ 6Q=(/HMFSG[#?1R3.MS?MC66E>FY?.^6#)<V(@LY-63A(
MQ!3VFLH6XH$#E?SS4GY:9(4<=F3[RV+K']A@$!XCY@Q:YEVX0.D\]<89WSZ_
MTJ=^G^Q7'KQQCS79Q0-,EP1W?>_;0JW+-SMKM -3>G]L*G".+G?@ =GSNWE%
M15%%X#TQY&* .FRYQ!M'>@([>)SN,M7DS99/="T\#\<OJ_H^: ,/<%O(H$X_
MH%Q>BJXG0-AD;SVV7@Y6@UMATO' )<YL/&#6OR.V?,AZ_B"OI48HDVS3,.*!
M"H=/'^!O]88)?(/[OOD/>$J]UP[FL\Z(F!6D)#>2)-*^F8\;ZU@'X\B9H;KD
MPR51?NT50YHW+,[X>.N%J/QS$#L(VGO9/<;M=L:9874O@I%APGR.]@>M?*@;
MC"+@1K;#-&?RLO9P5LWKWAGH.]ZZ!CZ<FLDR+I!VIY1J+CUL?TI5*=E)WM)?
M,F#L=$ !]C:#]OYPO5BVO8AO%:O']=L^D^_@-^KQ0/RJ(X'MZ/OC@<\6L02V
MIC\T'^<IJ /_$?M5_6ELM]%["]@7]TH"!U+% P\).A7\W*C'B:;6O*[IC )?
M6,])U%UI1-4!G"T=IQ$/0\BO\8.+$3A6.Z,QXM6#'AM?9D&&@7ARL1145WMU
M]3ES#,SP=4_@@^^[%"=MN7[0MW0WY*?$YBU(2>>18]6B5">YLZ]\OFD"_O+J
MRY[R9/;)8Q^JDX/]@T.(F.1Y/%0R:FM??)O:$N*P"2<U#E]5X%1$:[1Y<;)6
MEX_MW0Z-[A4.;5=E>XH']HURO_?#\C&Z+!D/8W;NJ;!T ?,EOH&3B'3& ',&
M<72%'TTD=@</]*N0X8%BQQ\ELQJF=K.*.RJ9JG,*7/(^NZW2+^+'6--*"C4\
M_7F:08JM_,NY_M_B\,"%2#-"MQL6+N@B''0/?HSA&FO@TG!*YOG$Z7H6JDVR
M]2:IU.[C^ICU&-+X''3AR):MH2BU#I.4-S[UQ7G\459O=,6;E_=QE8,FTS"G
M55)_2_$?.9:ON^OA<PKL21%8BKD4%TJS.F-EE\LW%FV)7W1S.-"&)H]N3),E
M^X_Y,OUXJ\I]J*V%,;"D]V%K]TY^W"_>P+-AOWOZ-E][UCWJZ5U4V,N,,2QC
M@?W'[Y%LD:)VTXS[+"RG_.!K+8G@KNE+(V).+A+B'[MUR9FQV5RX0BT.^P$,
MF^70OCF-7 ][.4GR97F(9PGMLRC2-X$L@/2W'_+A.9AQQ:$]3//I_)T;_;(K
MX!$GWO-,<7?.>.>+75EQE+FI$JGT2?6D]4;R(.%82?V-Y[X&?A[6[0<K\6JB
ME5\@@A%.,V+P7WDKV^O7T)_-G[Y\AGVV[X]+WBV?O%VJ1RXWX\ZAG28FC\*7
MZ;OGQ5:-QEPM32N$2_6CC.+6N:@]6PID.^."!CJ[9)1T60BGD]+QEL[SVH><
MP3_-?Q>52=KQF=UB>8Q1HR0>R/@$F]&'M3:@NTY))G#'A37%?CPOAP(8K2](
M #&IOB6G$GHA^B'?@A<U?3E346WMPFL4O 5!#\/OWA:T^/S!?M"^*IQ8":1"
MP_;4Z[\3#_2/$F-JD;V.@V$?&__4=V2%O<P V:LUOX=CX?X-BI2TQ$;F<W!Z
MGJ\"]%5L>6(##LD/I)]3EV9[2<*%1_9Z4EGWOG!Z+5\*EGURMOFLS^;=4IDV
M"S[3-Z:^_Q][[QT659/M"V]$ 4%LLF04D(Q(%B092))!:#(HHN0@.39!0+)(
M4A":G)N6G)H<!<E)R3F';DE-_AK?<.;.O&=FWG/.?/>[]YL_]M/U[%Y5M?>J
MVJO6JEKKMWHH[?@-7(T[J53(@+6_4"F8DB6%<"./&T(.3>:"WFSMBGOMR?5M
MO.J1.H#GK?/H]%DY=6GY_2"WD[T< J B 4_CTK(B!26UCF]W^2P+AB7XS8B^
MRXV4X,1<Q[&,0=UH<*ZJ,7=<?6/ACJ4] @7*6&/<*B39Q!;V4JXS:-?7HS &
M,B]^B:T-I[N*_Q2CW_>7Y==HJ!JZ/;+?>-.:)],$T[; 13%BG;-BK+*M/U)1
M%?=+*&2>!P=U,YY@/6'5D2%"&/4D-Y?3I KN5=\G,"E'[& 5"573MZE!1DL/
M/;,M>5@DLDL&;#+-;?GF7)']Q EUW[3:L^1^>+=/,0Q4Z[F7YWEM:.-C=DG5
M/5H?PM<_*L).!(5:S+^3]E$#1\.;L[%V'1E:XM,!!39?;@.]9:X20:A$C0'
M0)F=ALX%VS RQ=-T0/!Y+@N3R9H9]B-5)"^54'OR<(!00($.7<-G@E7#:'/X
M:GS(-; ][?X$!THN6SFDTPR[<P9U)_79#[FK[3"SYCE.3E1H"Y"P>4> AB!
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MBT6Y>R3:$JV\_MYR^Y/"CUM;9MC?<"<,EX)ZVC@/BAK@(M7(<R#,QG%D*-K
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M6NVVI;<>W(H8VD;+"DP?'JAT^MS##+6.TCD@$7E(+3EK*GQR)+E@^?D<>..
MN0EU/,GYBR)VY"_-K6":2S^CT(#TII_)U(!^:RORWXW^]QK-N7/B76%7RJ?#
MVS&S63A]1MPM?.8U^"/%U4&)X<<6-!9PG:E)T(N+?69VV#%7G<A +Y%H13*K
MX-OJO(.V:=,.X7J2<=#J=O!63.C(,S-.'+4L@)5]#A#PN+!;+'@1,B"+Q\\\
MIW\(&C4[F!?,T7Q0=5X VR3@Q',$:1/Y;TK11IYP96$>2O8D'$.:>.;%\$/P
M&Z1)!'.OM_H"$>>W$E;[.=#4:7NX"^GHQS3/7K^,^6$R"#IA2K ].?X)5/5+
M08H6\N\F_T>;[#UQJY,(]$?1WFW6*<(]3=B0G*4=A"Q/2G+\7@!V$C<ALD/-
M7NE/NI*/(4?#RV=,?3!!@6>FS_LKK+B]"#%*S5(B9G*N'JI'@E;G,P@.57$[
M<)NKSV):-^=CC%$^EC+-K75W!EZ"'23C:A_@U,$E& 8CIRH>[9$K;S>.B4^8
MZH[P)J-30-0#=6*UI99T"XI?11? TI:H:85$K&AS0=NGZ%OIT_?EJ;ZU#R"V
M6Z!7; NNBKKR80V28:T1>^H65ZH^BW3VXFA AVSQ<7V+3(4GSP]XRLX&\0BF
MQQA9K)0:A;",20?NMQ/T+9IACV2ANA&'.X[[K*=C34.":!O^A6_%RZ<)0_V>
M]K,$*T/Z>+'C185MG0P@"S;JH8<-1ZJXD5Z%V]U<<5N2^%6T\:_AO:18N_ 7
MU#B?9(FR9]CU'A2SESY.1Z: &':([HPH4F<-?H"RR>W"=2J1IC$+T!KM^#/L
MIY>;=]Q5<9G,"Z<?8LG+M5NL.IX#-%W ):NB @7HM>EQDL>/?77>CW<3/']\
M\Y0-NS)Q[BG1WML$.&8(G[#<TW.6#+"WIN6J<NKFNL26R'@3@@]LMK<$,C%V
M]\Z829)H.Y5 .D;HXF#6-%?B)GEW"[.:MA]\ @FQ-4H,8<G^)EDB?Y<A:S<'
M=A52/Z2]'3H'D!&KT)T+6?#ZMXDE /EU HT^^X^A5?N/HBHNPW_,+-G?YZ4S
M S+"O/ZBJ=\+@#VF_7]EHU!,01)U(>H*VW^3;NEGQ)._B#D0+XKA;>];:I)G
M9B?U:B.9%QLP)C">MQ04(SPON>>O5CKXCL)>_O3RDJ)'2''Z3Y5D]I4>9O")
M 44P:EV@$R-6/2[$JE.>>V1 @8VUSO-@3=1(-?43 )68S]E[?>U*'U'*7JM1
M-:J@0HL14#YY7GM#JW]V:.:%$Q43['7<%'8XCPNT*@%8WF6X/F$QRN@6O\@J
M%K*K[2F<+4N2__ J=K0NA;.:SL.BMA1CS82_Z# _SOFN=JJ"(U[V)_P2:<!^
MFA1C:.!19,BW;_7^$%28S3R#,O@5C%CF:QJ#KJTGEWU?$[4NS#>YG;3P4(Z9
MTE1\/=XH8(KBP9N2J!O]K^PDDP [W7,@%H)R48I_</\[S>FM.2I]CZCV3 -T
M&F2N%#GV'FL']X?@:H)PH&/2)<8$KS39Z/?M2[9?=Q1R76T5AN'<6]O6<3JP
M'I/G*IUFV"'H!BFDF)ODCW[)#S"VMY@%1^W3.=#U\1SHL\P9+E62U"NFB$=>
M?7:9+B/AG;F6B<)9#S&H>.-[B7CUA<O'K9MHDGE<='*.)Y/QU$T4#MX<1C_D
M-_R8::;K'/IBQ)EBCHWR_5/2J8^9: >%_NQD2YIG9-'EJWBLT5*4]2162W5(
MB71:?)TW+V:NER4B!UNH35Q9)NG7V*8FR!U= /_HL5JL* /\8K]L/[QU_4]0
MPA.^@TB'?9+"S2H_N0;275PRK&5WH7S+?$^+RH3AX+ [?#+\W8;H"@A%XIPU
MSIJQHKGPS6L)NXFV^&;E[B'3X]_:Z3H+^]97U=<,Z0;V/#[8\,!(S&^)/)S,
MN93OFBWKA:\PZX47V<EJ>0\W6Q&,C8P;\ C7T!D)4XP;)2&FGPT+2[;\7(FV
MG<U/#$Q08.D2FDO3(H!FV1L(9B;5AA?KC3\N:O''>OK<1RRRH4!RUMS21.0P
MKZ>R^>R&5@P?_R)TB;.?"R&<N7H4,Q905ISYM?W.3++Y(-I#L7*$<=BT7 OQ
M]AGSEXX4?$/!^<9JZ$WOA;T3SAXQNCG_6=M Y$3S*^Z%XJK'<H%N\&>($K^S
M'@6]-Z!KH64Q!^0:BGV.DXS=UER;:K<TWF6\8D@"W)YJ29*(6=E[V56+O_-J
MN-D<N[MNT!8T8RW9;#]AT/2B<HB:_V.F"//,J)$,&\;HI*L-.Q,9WG(:N*$N
MCQ<V00M4W6NSL U]MPH22K+//'P%-I=I+Q<1]YA'PN6&3TA3+<&,<UM?W9K1
M_2&DA\2* R<$*>8WC,S+2[ZFI\MMH$^^I! :W%04"%4II>U:O+-=R+%'B9V2
M>0%Z(E :E)H"HOVK<P]]\$\'P"',C8/_$H[/9'XP$OK@XB!D7DQM7B/U:Q$S
MU\*G%QHV""?"B+#X"HJ-EK!Y\E28!3U=1?P9BPQW\_'P1^'@$QHQ"<7BAOZ(
MEC[^9$GJTJT1$N^GH'!1\YN05U^B-W7KQR2 L\TR;#4DC@S%6 +Q$-JVA=AR
MW\@LA(F2*156I./.7/TBKF'5][+1QDBV.^6%8Q\6.]TC=HVI),S7/A;?[(6K
M66T9^D%8;A*E:8S6F!UW&WGZ9DLCRF"2#'LHGS#FKDZHIM&D;QB8.]=3L$]0
MY.M@\P[I6(TH&S;I0V1;TNR*9PT;4EP.EG<!EI_Y-[AH__GQR@?)^2G) VF)
M]-]<!$E"?FWB'Q1^;C#E592K&4KU5_M':>6D@#A&2Z^6=OD+W SH>4 .FX62
MS<#*NAP&$S;A7',(W_2H!QUP?A1NT/+@G6M][..?%E1Q<V49.WW[_ A%$<?-
M$NS?NJSME'&I!*?;&14H'44TI*ZGQ84 3]C-4B[_,X6+D OVBT**CRN30*DJ
MCM-9J$E.F_K<%6.O_+#A,^*5&QW=9%C,$GZU).]])*Q')'#6WBD.?!,9$P4+
M"ACR(3TV9.+-CD9'EA,RG3*^&4+:6XLEO*0!S^64$],1@7V"/,Y8.@?#J'1/
MBW[!&]I)Y2+KT;I'!TVG-\#!L3?EOAWA[WAIS(B5IV850Y,;J($# G$/Y;IP
M0YJ,^T&*(R'5E9V?)9\<4B\_0B7[.CY6NL]!S_M):RD1Y:'?=ZG5B^#]O?N^
M*:!L>N8HYV(_0M,)M'O3\OUYJB-P$MIA7BLIER.T0&9RQV O*-312Y9>>HS$
MPR;E&L;VQ&YG\>[AU5_<?L,#>VV?L.<8Q:R??@F4FMJO[]E)"+B^&!$F*J>C
MB;1X$_^H[0'<!OJD) G/#,Q:QWGIH%'HX'+,+?D4D'C)B"TW[M8B$_U>G_F9
M4&6P3Z55B$WJ3$VBG2<\X3-+__9-23$NWFDRK%4A0[[BJEL*@*4[S;C;$)\<
MXG@T\ 3UI4<S0,]?$U%AK/7RZ*6/.(+(#9<Q#M'6WC9*T<"5\KD0JHSR@HV(
MM1% =8'5G+S/%D(5#&N+&NCAO%\.\P5*?\+"G0,C.EZ2;54&H*=*+(<V]'PS
M[N L=&@SKZM/TXN/Z;R.K0[O3^Z92E97=QRD$$@BBZTARSTJ/1AE1ZM^9YEU
M^6G]K'[O.2 )8)0-_#G;0S09ELL9A2;\Y/#+12@/ 0O&ALDX68L_X0RN7YZY
M(%J"_$94<7(H_SO1PB]$Y\ O5'.0OVF*8_1WJE^;^H/^_DWT?SD1R_]"I.I-
M^Q7K') CP^JRU VQJ'X3STXE-1GN#FJ>/L1B..BV<]&E'4GP*8]JXP\+V<54
M-U?(-%>@KK)N=[D 0OGG/=?':FQG?SV5P^IP]6^@H+\5\\6!R0]2;0G%*&B<
MZ1$E7RY [G>/%L1<YER09[&W N1CXQ=;L45ZT1KN%/;[Y;W'Y\"INRN:-\V/
M9I/$_JP?3AG9ZLT3;Q A^W[VN=L]VGGRK>J MG2,)OH&;-_9)/7Q7NJ5B.SF
MHROE_N8+>B*F=%^ZK5P*&69'8 ZYVO+[\5SKZP8-62W<9&IR?W1&CL?S-R[J
M=8%_ZP8 '#&"]HC/@6H.W9#?"G_*)^B1JL&8M N!+(<?7CZ9*FZ<:U!SR>J@
M !*[1(0R?XH2I?"XR_KUA..7PJ.E,<X<79&G1++N.T;$: LEB9>5%9?OO.:5
MHD\BR^5ZUN^KT7WOKOAURR\%8CI.KVR>O7LOU9!_I!*6I?"9E?69^ KVP$I>
M.;C(L(DY;%G0XD\G B<)N\AYP\(_@EG!X-RQI0W!-V5Z\T(6RJ"!"?2?6S-\
MGV)T%1@9ULP9,YH^+^SH:8"*,:=_=*,$#W*<:MY<SNBAY;IHB*59H6I&43[[
M7@HHSLJ; YTH^_%9=<1#LID%</H*A&:#^:D"QF"*U-UV F&9B?K8\G4+TZ/)
MEZH/&M[:9)ISO?BQTX</[$XRM1T)%6+YS8I@YEM&OQS?>T[L%<M% XT&>C9D
M$4N/O#9H:RE]$#.7NO'5]AOY96I=7OI(%'%DY^#D]YI>:7HV;]2)T)-![UG?
MDBN<&YN\*K@JJA(I8*!^V[1:FK7HF12I ?IAVPS)#4+]X7/ CT4_T=N+L\^X
MIJ*:*E#3?L/"'4"%UH.F=2\97#WA%+:*HB7JM)Q8+ ^T#R:B_HI 3H9WTCY.
MC?14Q8WYOA:O%?Y#;CK)5@<]L,5ZR226/--C1N:Y[HU6A_@IZMI2UL67V&,^
M]VMXJ'244^2<BV!=U@^G%DR9C7H06@IN<R)FD_:;&GIK+L[M!Z\_M]<"'LX/
M5J3)EZA=PK:L*Q.Y#22@\_?URO'11C# B2& 6S-(M>S3I?>YO;4ZEXG?7:2"
MOOV?NUG^T]?H<?ANMH;1EO" CUB7+O-ZU]F>.SW&HJ+G/>7LV8,?@D '^?T"
MO6ADY*K4C3^10*KFE\1$=X;'\0'.;F^6@OY#C4/O%PI=U\"9FO=/1:?5?%,K
MI3I=%U0%7&';X9Y\(T*H1$?Y=$I6:YWAL]OF&JZ.YONO',,J ;!\P<G-?I[T
MEP%"<FYY8[A-4)#Y^Y=+TFXE#2QO_:TJD%E3S[(0 [FJ)V&CZ0=YY4)"1UZ5
M(9.74FB?P_YE4'?_]!53JGJ)_M,H^3RAU0-2J1N,-28#51!25U>+N_QM$L^Z
M ;MJBG=CK5-R6/*P39>FJ^;FRRW>*POX#<6UU<B]_;;+@,=(1,G<=]M9HN8)
M8U\I\E(&(J6LB0+EA?9DR\$")TJ>5+ L;:3NCU!;D.'DXU=X4F(#S1*Y6;P/
M$,]]Q$.91GZJ/F"[NWH^RN*6Z66HLHQ,K0>E"<#:2I[642:L"4<'#'4O+X0=
M:/_C<_J_=Q'+VUYK)I$I$&]];C$%&G#2_LA<%BY/)U7H%P*@:DUFM!+OF5L;
M6>X!X,1UAFMB2AD];:V++PP3E;S <FIZVVR2:E(,;+JN):UU1%BOY#^ U R@
M0=XB7YA#$L(\<%];?BN3O+JJ6_RYJOQ1\K'EF]&S:^;"[RJ^#6+4>EI57/G,
M$\4^0<:\"HY"#U(#S=J]L@'<D!?&7M1U9O5H0;BYNL#^:Q&"CD;!T'/@*B@,
M(6*_2"PQ=&]9 &NO5ZU=8"1$^+@#- 3NK0:U7X61FPS-6S<72KL+!:'T'H_<
MO9P7YD$J16<Z%6SNF"%@P;_""44@!:NTS!*A3U9A>PJ<&83D7ZVAC\!8$WQX
MC#YBR0=-PI])3-2;BED_5Y>*O!<VRO3PQJ+U?5KHF*^0>ORML;<,<-VL/1TN
MP9$WBFBKV#BQ=,$A;P./5(=NX^IT@F)JE!S WGC5;^/"%KW8L#,_H\(S.L26
M\)5L]-;B*B37%C2@[C\(8!Q;PY_[R\5SN;?A7%5:3D=]N.4V=&\SX5R#B&=N
M!+XB7&6#8ZXC \])'I3E8!>DY3W(&=>_^2+6[2"?HW,23^!_\9/^4Y?E:=N1
M1B[\@&95BMX$!NEPA=0:!F=!VM] GNS46IX]:CY=VU7B/Q-C.E*]TOGG\&\"
M?D.W+7S46L=E"_I"S;'LUNKTO1![3CC0UJG+U)+X>'A5JC^]P!6ZX4UQ[#S#
M[-BQA/F$6^CO0'6LE7E$8,,[TY2%;0QXKN7[KM:V6P_';S6J-V>Z2^]'99O7
MD0F9&>^$&">+#CZRJIJ1))6?([Q-;1_\U'C42)^A.8F[P)J9Z\&$!]AM*MA&
M[I^ ^OX?]!C\0[<)1LR"O%RV3?@@3S96%;[&2?H$^;#1D3G^759--=LE-EA:
MR"UJ-OPKTG>2S(5<FC*.YF".:3XB^=NX8P8D3Z\(]ABY4IL]+>72H^,<8%MO
M),.:WS3)U]Z5O[>M58#0@+P8?W%Y?J3VB8)KACX?-M2BO099%M[/G'*Y#X<[
M,D)=YNH]?(]166OX-WW?X!@&Q5'V'#0-<Z)&F!9A>U#9?9X/G-=<<'S$7XJ\
M5XLQGG[R'A$X;3#,E6@^(70TLI4T'XAKW7&R@MUGSJ\M5,?UN>K6(Q_+YYPY
M+U6_,'XZ[KM\@03^2.&_+&[PGMYMI,(IWCJ1S)Q:[BV3P5B16N_Z<#^XALY,
M11?PNFH^-UGA["FK]SM*C@AG2>+DI1,:'2@=R&M^!QKQD7@<@+"<_7Y0W&-B
MI&J9/^ M,OV-K]&#@-9.'IZR+9#(^2W,02\5]S1AKLSH#35.>E7+ _TC56P!
M4*B[4#;UX0Z7E9<R9VGQ:.FD%*A$/WVY;]37-6@F+O5R9FF[U75?)0?";'1[
M8W>MYQ*!%(,>=M0[!UE#//@'1Z.PZL681D&\B12Q!7"VN22U@-[GX/MOWF&^
MW8PN4UOAZ6"56>V#,XJ2FIYA@H2R;'2HTM \X95.A[-A\_STR%A_+T+ [73;
M5Y>KE$O)(9[ZRFE!T &7U-85#YY9)3,3^T IATTI>O;]_'&9AE</[U./#YX\
M<S.#WIO<$YPT0-NT;;Q'A24LES%@9UVMD P ] <1EE=Z+K?PS!M<IJZ-;;OL
MP,Y:;OG51HS=RX(*42RU6_ MHZXH,7Q%&O PN[DK4+8H=':WOL)4Y_I3L)KI
MO)X&27 /M8_H&J?$(+@, ;0S[FR#_?,=C2%_<B41/)OW8A^Z4$120+PC]0MB
MDE/PQX.2\TV2F6Y39>? K5F,3L)RH9,0G[)=6OQS'L?'8&*,8*E1Q=*'AB-T
MQ7BS2]*V8B)CP#J&FBCM@+B):@K]_F?I[4ZV-*Y-^YO+C[CLBPZENE^JY*/K
M-'58+/T^KCD8GMX.3!0.@&W%]7M+?YG[S.-I/:N1TOUR9.T.F36M2S;#V]=#
MJ]XD!I,&*UB%\ERX(G 9\J7ZJXL[7+<=U9E8?0UCE?7>8XP1=2PY91P5"UW+
M\$Y9&/#2P#7T24ET5S**N/9J+M=>[7U5Z_(*^5O[@FVNH;.Q=56NHSRNJ.@>
MK$(39>3)%/DHQ7V:<BBW'W\"$?^8//#:7<MT^JUCOO!W>S=JX51!(]6AVT$R
M$Q.*789.#,W?$9H"\6 799]D0*#:=VU?-S8KE?Y8)TYZ#P<&CEH5.I# 'YD?
M3/^8$1"I85A"<!C%Z1XV2/-HU2S-E^AOM2 O0I?N7VY)069?L3+\^"M7PY^_
M_S.X_(KOF:/LUO"R^Z6HHE>T2/VKR7L+.9/KD6(:[Y\=6I:D^8@5'S>!R_5;
MW\MFJMV@;H4>-.CN7\J;=L76S!Z$9:O3W\*LKF[[T'F%4/O@F$_NHX^>S2OH
M98TMW,HV=+W3,Q.'C5/5=0Y<F7QX6/[EDH_X)3KE 6,AQ0RH>VD!Y0O:T7?R
MI@7:0IN%O&!K,;V<,<)"$-V%?X^\ODW2O/8+AE4JG(K-O76:3U;O7ASWX622
MM43IFVHSM$'_ZQ&IZHB!C>U!ZQ;\F:.0&CE^*5HM.++KX=!SX[B.,%E5SJ].
M$)^2J\F65'+M-\%]CLXIH/>VNY*4: N#=U2=N6M78=8T<X7UJ4!UF#H1Z';^
M:G"!]:MS0.^2Y!"8!^XIVN]4=FMS^.HN&5;'BB2MP.9#Z8AEXB+XH\^HEY$0
MZ@_;3%\V$WY8OYI1Y'W\P[SGT?XEQ-E\PQ1?WQ9!XU*,Q@4J5H%)+(M!1V/,
M 0[4B%/'4QDE&?2":%*6M6OTYFBJJ\N\$ZPS9^C!HXD$8!\L'677S)C3F_:M
M-PE9J.*II?5Q'D;Z='Q!OU#%:E2:MK\S-:H9>\4,^]V0&(AL0Y'5VF$L\LV=
M3=(%&I1AEL-8@J;1-IL UCQ;=?C;&;D/^6.0$%M8)KT)!7:1X!KIZL@HGF::
MH5?^I?E&BM<EHD@EX&D9:DBY\_V=:?=5Z[+$^V^;K\9C)%AO&0C'4)I=:$W[
M>FRT@VGNMVO5U?,#/N+O1=0?Q!B;[RW$2; .<?413H!T5QQ[::_2<O>284WT
MZQ"Y1JI\\BD.@[H/RY-(7RO D]@%COY;VI 9P^9_1W;]C)88JWDVX$.]5116
M XC+%XBKB^,^O<7#&M"Q0@"61$EJ5@V6>I5GY-<#(3M*3+/GP%O!\#M*.F7L
M9*<S->&<1<EEL'5JW*#2EQ'@L.:* !R$UO<3[CDCLBO^Q+G>#E/YYLF4(YYZ
M^771'G9S]\9MY 7K\T_HZ6\4GPU65-V?6X8]E;CI3C^9:JZEJ_G&_CO;]XH<
MF.Y,'>4ZZ9J[B/P7%@D^R]HT!?6+M"BW/AT$BRF*2=J8FE$K7O>KJL6="W.?
M2N.F:'K,/,\,=G/*'INZ,_Y6Z\%*4VY[RFK<XVY;4^H.D<ML*=>-6H]DW^Z1
MGP/!BIN4S[Z-\J;I&:%E-DU'M;N9DK,3RN9XZ%RARD/)!$J"R3?M\!A.+7H'
MMYVVJ2R(6W._"ZCE]LAE$S;)FL]1&:F6!BY-S DUPGJODXNZ^SRXZ1"B$'Z3
MQ<^:B8$/WF6HQO,6 9[-S[U54>R6UDM+'5-F(FI$3$[/%:Q]0+Y2#D&M,ARG
M(>J;A:BS@_>N#.W)*7)EWV.LU1+X3@U/:;U/6#2<"+/HRM I:PRKP['C5$Y-
M'J.)^<Z'J_&M3W[A $HUK\)W*ZM3A>D>G!U"C3U_*_?T8]V^\UQ=7#6R/'A!
MKOO9C8<.I6#_+UGF\W,/&[A'OTP?V&]+T2$@U'/:P\J)=Z3.-N^?W7AAM'LM
M_@=<*JBI^E8 :-]3+'(K!'+"Z,YZBHT9X#IIP&WYY$Y'_0H5SZ+L;P7#H',
M[R)AGQ0:LATE^V_J?U/_F_I_'[7".4!0S'"$HW (3H4TL::> WT2#,<+%XXG
MR4&_5I6B=YRFW%C4E\\4.8*]G/*4'UA2!\MYM9^&[$'0CW<ECW";SP'/$".T
MM("4PRD4=/J##;NA\,1\^8E8DJ@FU=FFT>#>>M4'RME8T$!M@ZN)#!W7K8O'
M>))P_2/5(=<<@S09UI+6T5F^56IH#4\6IWM7^_-[YX!W1O+>R,2*$'_;TX?Y
MN^2]!JX4+!/]$N(YV!+'<V7A'S +D(N5AY:"I_WG'HK.A]XQ"9%^BS*2U3NX
M T4ROM:F=PX+R.;A75(T)O-/E3I7BZ-V,R2IY^D<O]1SZ(D_DBY7A6>U0688
MJVE$/-F=?6IC.*:W,$:LY*RS-.:]OT X_J.T.=M_PBLA5J/G -V7UJ,GZ^OH
M&/R5D=M_S/:L7WGGBV%[ L,_&J3?J*/^*>K_<R;7OZG_A=2_SI,KOU![K$9[
M/PU')0^H!0W0^J^5K4"1P2N075#0V2$9YKM.@_S\K%5Q(RT,^9!+.519?3WS
M9ZUN%<'>W:[MQ_<5XWC'"8PT(4WLOU)JM <*&-_[?%$="Y44;3GF$5@1,6L_
MZ&]@^!%%T%JM'_*2E#(H!YY3/TL](+G<AJFBJ;>-LU+QF7*L\W:O'<;^R7^"
MWK.]QA&/HIN'DU^XQ1Y+]Q(E*-G.&$*].!5LYO@\\'=4B$_HAW:_)CXU!_93
M0"HJ$6-6$X_,MG=S)6<=V\<5$G_ 2093ZY'-MG6#+H 'S'GL1BL=WM?/T^9J
M.:OOTWSNVZ(-['9%]:=CI7G:"#BC@AV#)#5AUO>-D/09>8^UUMJ+U RD"X-G
M\X<(K\!J_%<P3U5X#LRQ)'+)?ADPLC\'GE?!T0J+<9!XE:BGT*W1/I.FZIMB
MYLAS8)HQ64PP/2+N[D711^QYT]K2/ FC7-"J7A3:7[VT@5^H_]MH+DMX=MO=
MN*+(M!&;S%D]A8U-J:!OJCA7@B+>J&'994;"I"$HP[:N@FO3#Q0@,VZWPC[H
M.;T>E:!.<G';K_'9#@'Z)6FY^ -*7GO'U".KTVRKLA0A^,O&@P+KEF%=9IF^
M6YP9I4.EVD+IJT4FHV8I.)"F]3"G0983#'><'_TBFE:M:9KBY0ATFF 3Y.2Y
M.)A7C?JPL=E[<ED5E_!"M/-<B':UWTM@C(!O8O]/I+S;/U4AZ\]6^'W6_IT*
MOTW0_S%Z56\A:?]S@ 3#HEU)S"*E\NLB)8/,"BH]!UKJZ*&39%CS2/2*Y=&/
MN>'T+A?RS3$C44_9(?P=;@7YP8*]V7T]I\BE#<[!TEXT,O3/GBE9CU5"K^X7
MCF-L?&@;-K,[ZT=J"M,%XY<(B<$YVV K*Z5/"C<CLR<$]V*WDBQSVA<G'Q>S
MII)'8EY',F@'NH'&O,E+WXE#P]YVW;W8>?V6]U<I%]X%%EH8D2 4\L:]$NS9
M'S72*'F)8"H(!]6O,(!.=V1/;IXQ]$!*+J2"F7+3*W:D-:W9E86'!<UB(;M3
M>UKMRF6#:3\VGVN/]N&7*2MO7$D+80?4J779+E&4^48L!5S=8XR]&<@4$PR>
MP+_P$ J&I3C$!8"&G@Y]F/.ACLHPP?.5_9S=_P?9U+)Y_B";6OT?9U/[5R=,
MQ'["OH:5!Q8U@(VXM(GLY^]^2+ENN-T8I^YG0LE2E0^_8MCT=61Y$:Z<T0JX
MKNNM)3RMZD*!K4^>>=E(O6ZY7D6^6J*CUWM6?%LRX,446K=S@:XH+WI3BBI.
M0KC\!;VSPU1%P5[7_:]N-B('A0]W&E[?60I\%/FD,?K)L,#R+;&OH"? WLQ:
M,T?#F<#:CWM.I\J-[1\1.7N%@8/MZ?C%K>@^7#=I$QW7B,[-!SOD\AN6RO=S
M3'_"/ ()/P_]V=G^-*H'>SBUY+2T;4YVOQ3E&#30L5N++YZBX[4XYYOA.OR5
M"MZ:\<(O($5PGOIS'PG#80E"5[\VE_=M,C\:.QH+2@K0S4U<3+;W O8%]W*!
M,")"TVE7#\4A_OU$[6F)?"EZTMGM\ /5=]5I0K@Y@JNZDJTP@J<<=<8R$EEY
MKD$S9U%YMX[%+(DE_!#CFFBF7'./[.*DGBDI=3/LE5 #]1X4=JLH$62,W.ZN
M.![3M]$.)9YP3W%[WWV_$"^4@6$XJD1UP*\U1^JKK'X(<*3@WRI[&Z&>"Y9Z
ML \711ZTGC*!QUB<WD(U#&JSZK,,YSMJPH,W" &-&F1F0#]S"J%^3_9,L LD
MW9%\Q3B0"E>@%&L^WIT^]?GU13$7<L-!U9IBV]@)XC7.[YEE%Z?BPD-:FMN!
M!3:JF\&:D2DIU^E[VUR*[I$4F18F#[:-V*2:=MBZ?T$@F<(0/&BPL%O*U%@5
MCI#Q?5\I>KAYONYDH;KT\E1AH/H]8P@UZG953<F,0+!N'#U';=FS)?Z[F*D.
M&P 3OYHOC?+K_% 8,6I87*5VW'#U((50E^/><HA:C!V$^OT_L1/SZK]Q+G41
M-/9;X+G&BZCGX4D1Y+(":[TC\VX"'T?X SG,L#\-2;"X0I0JS5Y6THSFX.1&
MAM;1L%ZRJ=M;3J9%;H4ZS7'"-W-';T=@E[F8-!KB=C#*26X7*=VJO=XK/6HM
MV&4KT5]<ECM5["A^7WEP\[&[O0;#,:M@ 9MS9<"%-/F#.'^L*W^38_&O\LU>
M'&E+,3Q^<)8F>2"MH/;K[_^K*<2N*IF9V.2 9E72?/AXQ"1-W9+Z?:$6#75(
M 9JK;SX=@:TOL$K: \HXU9]P$HD^SV^'Y)E'=GB+6XYVYE\CX@AOBWSE\%-D
M ';EWO>J9"X9.Q^/*IG/'5/%N$5@>UG4I<YTF0\=WF0OM-EN!,?-E%JI9+%A
M]UN7$5BF?EC00 \71+0A'"$6JS ?YOD!^'=T]='WHGNV;3[BZB$+W&+VEC<U
MH^PL4\J&-^_$<W)$MOGP]"OJ$)^M8Z,'<S#RXL_#O%[.N'FWD2I;38JL4""?
MLY13L%K(*__MR!GQBGL-_P<_WE5?PV!IP',5?D)<7:)ES3O.E,7Y3NE&FP1Y
M3%=P9VZO^]&"C[NOILWNNEY'IPK^78DAK!V,8IBM/[BD#5<+R6WL=G\9C$J4
MK0[V'KTI*Y%5(2@9*(J34N#]-?_6UA6WN'HDAW-LQN BQWW #'ML=YK4W#V-
M4T\_'6>UVS)0B_:NX _K[2!/@UFFM]0O-5?+"U>@9 CIC"<X*>]C&*9P?"2R
M5A5=GWM38?66N5&$H[H4JTU#9H6*YEEJ08HHF^A<&>K[.;[BH:K8VPA^4X^D
M#JS]0DLUI$0KMY6\>("+?2]9,V\';%?P-N"ZV!MDNUG<2VJ_J=.:'8!4R"7?
M(GE$FW[=YXP\UFFVAL9'/@PG!21<C*+;^]!4=>\ =@RB[933\T4/EH&P[PNM
M7.?\5(_<6XQ:$K)RQP=V+6W)M94!/F!:=S1PC6J4MU)P=I'E[=;8FK2!OUY=
M!0-S>Z0[L/_IB%KV.'P7+CCH:2X@N?YC.%4X8OA=P*..E&M)YL.>4EB2K8;A
M6;3?9".?H&K6YUT\;>1$< 6'5NOXA?J8;;*Q0X!==\[[3X9-AF:G8M.G_FN)
M6UZMOT:(2C=G&V25<A2F$^AK*Y&<+NGCXT0F.T)Q)]#U+<**!^$XH^(TY",@
MOP-\&<&/=I+C@N'"_F+F6>L.^JL16D)689J]Q9Z*$WA);T\@;0E7M]RA@0*X
M?5:/">T&9IQ8!6OUE]]$:RN)$1H$QY/WAU#^'RTC?K]N<Y,!ZD1XC0OJ_5+D
M"T45[^CZV7O+GD^CE7NV[ZEF'%RJYF##[H$C\/K9S>B"CT9H$PSAIDGYK'2-
M@AN"-*VT_M=2EGS$T@9;W&/]+[_C;8<Y4B2+332RJHHK.8(-:3Y7?S%K4W*H
M#O*-*MFW8<-.+T/10^W2#SHI1V+ O(I\$81NINT!>YRWJIZB)C1=G:R-5+RJ
M,'3?S. BGU&(C@;]G3W,^M.Z?^.>P;A>O< %_L$LPL]IXCW/LH8?Z.%_0<'X
MS6D<)AY>UL=HIG:65E5K.WL67B#581U%>4!@8$V&-4M=WR 'N!4L&S>_PQ)<
M/CC#1SD'BPA->3 FWU7RLE7[<DW]FIA%\X0J;A>U;0N$U/755;=K070N8(_9
M[8AW!AU%TS<CAT;3+<ZP^P7?*[46+QSA[VP3>8**W[-:"UB;#/B(@U104P$Y
M>8<NP97[W8Z\*N1-N!'2IN*-\-C"LQOH[(?ONFTPXF N-:B]C@>YFW\Y^>70
M/1&,K"C-R?!C]S[".0I!@4 GKP.8G@Z3!>X)KKCSM%B#=+$[*U55GIMA/S\'
MFN-<<F0:,H[PEVP]<?(('K:,VI-/(N9YOX:!4G-K7OJ(61Q+U99P*;XRWM84
M2'1P<EMDT*?>@Q.QB2K6WU'F[-S-C1O5X).4,L.N]F_4@N,7B47I5P3O.@X@
MB5 )FS,HS9"FE/*[XI81*.=<BI3OH0G JN<U!Y.$]?50),6L66. L^-/B!K5
MX?H%.M:!JFW<<Z"]95K#X/I?I7 %_"_6^-@6]).+(Q>*E)I*/3T=%IL0?@V7
M5M619^:[7Z(@-5+T&K 3O?J(+4MQT<9,)V:<2R4"D2')C.6)U!&)-X,3<PUC
M;65&'7D(URHX\YM2/T90Q6C%OY6XB7ZXH_">0#-"_L,SN_20#/Z^$_%"V4)M
M[J9K)"+D15.(]5G[CP7T,I=E)G+@TMOR_Y&O\*^N/SR>_2.4^L>_@M.7_><H
M]?^[KA%IIV8VIJE<A?3OBM=7;K#6<9R28748H5FF9D.E PK=CQM'G7T07,JB
MSVL?OO.1P</Q$7.5*#'M85;E5&YN VNU7(UY+[I42VU)XS:4WU8?^VP2+=JT
M&&I"N"E%;H6PM;4[?H%%Z'C78L0AAY/OS*G)@AXO07C2&MI4?'M@+Q0;P7F%
M/M!'W(T93*6%NZH,9RU#*:>;-K_"'JG8W:9M9[GR9<P,NRJMF!LA_>PUSA<9
M)0OF7,9%;6K B^P?Y?[^&S0FC#"[*G.176 Q@,6@,#6HLD#O',!=J?:K2#*E
M8JWC= \!4-O$GL2?AX(]^!AM&L!0BVG\BVR0IALL46\QLCLG-Y):[NX:S1H;
M]D(B Q&ZO?F ZI,^Y=!.PN8N-)+[JC:/,1/NY83][D?-"2_3"60%2ST/QCA]
MANOP5N(#%MY8.?1>\A&0G#4UJTY^]_6E]//:JW#V>M3K[KQ2"O8E"C'K B/J
M$Y&AD[O49DEG/>+=2D@7Y<#CEB>#/FCQ%>S*HL$]O1H5\30[^W><B<-[Z]W4
MUO%V?#GB<O!,DA&\/L:65%DK<.S)BWYNUH%K->24UU-4<>J;Z=RGM3ZS\/$;
M!AL)>9(BWH^KOY\0X:RN>Z\1BSOT,UGL/X?9\(L+Z<7J"G 0?!\8Z9'/.,[C
ML_#>D]5^,V&NT>;/]71&%>]'K89BO_=->7%8Z8,[3Z,J-2'XGL212O7F>Q0D
M.2)J"4O6\:V&%*-;-EP;!OW?HEIM>5H8J-]C#4"G%[,004S?-P36K86P"$N?
M$>%73%5-7[5(",S.#A;$NZ9NDEH8$LC\BQLY.\8$)3!^@;P"5GHX(.^9D400
M.7N-7T>"::B[',IE1_M5YAZ<%9E4F'T.7-68F-#O> "I5.*,:*\A]4T>?N)E
MI%)N76(@$]3W.6^L];!T4"=^.W8.@4"#5%&F+?$:1@J7EGTH^YA&-^'<VZ1>
MB'S&H]QN;3ACW\A.8T*3>>3]GC#WZ(2]'*CGDZET@:;FG,R,>]M21%-_*PL(
M7FO",FCBMY+W=A8PMVZ(NS% "KU6L%=<?_%"XZ#4\7Q#$S1)MZ;4=3I[V(>=
MDS%1/\601!-_W+R3<B4M^O4YX.KM:&.T#>K!Z+\_B?JK( A)44"779CG(&A9
M9O$,>;*"9?;O>O_WU,,FIRU'*=888.'\Y=UKH5#"U0-\![S+HX)>,^H]NA.^
M!DL7M5>%X9B&I.A57&8G%52L._0BGX30F6@52_*+8!?AU)J/4$F<->_E@74U
MPSO?F8212M$Z0^?A7-:5ZBKN*P6>>J9N/M<'MRQ%UQLIBHO,%C19IS[#Q:C<
M+,9A"QW[ EBKQ(8/V#KELE&YOAT=2XCHSN'=^<J.;W0END+) E45MYB!>3B&
MRA',\VR>P+Q]6T[WN[]62>7Q^UQ)7:!>6H OZIWLLD*E>^3O'!CXA1]TTBP_
M7_[G.P+<9(D7KYG^"\> 4O6?1.$_/XM+_?(_F?:38Q?X=__J>@//P__B0454
MWHKR6]+3)%..\I3.U5D@VW*%?1 :H1FW'ADO@$>[BV+RR6_N+2%&V^KQK<1D
MMAU(,U[O4:80AM^?TPKWR":(YLMMLT_X 0J!$L^.RG[C$EFFHEO_,'2"6[":
M$/DM->FDV-YG>(6>&,WQ_A!<L:7P0HBF%E!"2C9K2),:3K2!69D8:T<I6S4&
M'<>]^(:Y9Z3RTFGQJS#O\\\&!3T;J(3^1.Q+P1>%C>M\%PL1N50Y2= ZY;3;
MY2::8:%R>=3)X=*$%.KNY;NMK@?!WJ1K&KWBD^&KJM_O8V7Y['(+M[K3PUR8
MB;LH=N^),):+;0I+>H,&ZEXCEYM!)/H6_*#2+SB@:=8+:!X6%*4QI-P(?I#S
M^?L&2H"KZDTNP\:07]4Y@+\2KWO[K=^: __\-JG!%98+U#Z@"84;##N1Q(IS
MY,+-?%UN=$.@:Q61,V/WO5UPTLA<RSW$JBK P(OPE?3,YG6<:;H8BRG,HD;X
MX6RPSB,W2WM6S*>MY&9<)P_I9H3K_M:&Q73PR55(KLU9;\W=._> .<3<X"PT
M^-:H:ME@K-87J[V,,V;PHQ$$>$G GE)9HXH</KM!)V[GX1"2YQBLT5SW^ VB
M,\GR:V2XX#E ,/'%1F"551$5(#"RD,3S5HZ>*]0E!_ZXY!R(U+X(/5BLH_-7
M0SGG5&<N< ,:21G/:PV9B5MR[E]3%6H?$7YK4O^^-<"74=\^Y'M&BFS U.HY
M0!SZY''DXL[$+IS?$D)\#C1I$95XE;C@)ARMK6R6O?.1P!B'BPZ8KL7ESX%D
MZ(B/(*DR.D9-+@H5J:%\UH../0?$C78$MXAFQE/;D2'1V'VJN 'GP*N+=,/)
M\,,$R9*ZV^= +_BDVR,+-Y.2/@9K%O)]FN0<6,X_>QFYL1T,V1F^B+%?]5V5
MP<T$7(WV75KJ#]?.@8_IQ_?GC$[V(%]'JXW=U7Q7I>AOG":A>,[<ZY?,,!W'
M_]KQ!_H88_=_]_GO/O_=Y_]?^MS]JSXY_UZ?3S!]1AXFN!:CW^,0%)TH>43\
MTN5,/#T].L 9S]G&NTP+!* 'NR>92)-K+5<,Q=E.V+#;-Q#DA<PF/3T> UTF
M>>;J+VSG:B'('-,R/\A>5"Z&H&-+3*F 6>]YK#_^TK:GRCSA=[^7DL%PZQKD
M8FP341%']#1YSR2:[$?_W2-5W 3=Z1.INK8OVJ\F1M(NI&[2ZXIK#EN6K^?E
MAAV73K^_QCV0YA.'@#\_J_?N'V7TX55.1+'1NF%XI?([.PS*X)$10 (#FIB\
M7QN=T+;YX)4FZXB/&/18\I=QZ+]@/\,ZA@&;10;C7R7DR4X)5=#X ++^]S9D
M?^<DW+%A-QU[P$>,Y[=A[/]M]"PG[XJS->RF@ A^9ZD Y/?!.U $/<'\C]UT
M#OP^C R_CU[M(/9 &,80^O]TG] _Z#/VMSY/G@!G>[_./KEO>,KW57%[13WI
M;X<::>3Y>=LX&!YF[F2WCB^2+X]-!)3-0K?!*:M0U#S#@,^=WW95_PQ8L4%^
M^:;4%;(R67"5I9*0N:IG9T8(4%2'USL5KN+M%[])!.E]>K*^W&'4.L4U>H>I
MJ,9L7H8I%Z8VHT*W134T#AQ!4=G/2B8T8P,U?>F'UI9.F++6W)V3F8:R^.0C
MLJHE=A.(?DML=9ME&/>^C)>]<D;F$';.4JH'I\YUPRD6B<PK2M)WJ6AY'_X_
M[7UW7)-;\O=#ER92@@("2H<("-);4(PTD:9$@H "5TI >@=#4=!($:1HQ-"E
M" &$(+U7D1Z*B$B1+AVDB.$%]>[N+;M[=>]][][?^L<\'_(PSYGS2>:9,^?,
MS'?$#ML$?HQ 14;&?&T9TR=DCC_Y>/@_(!JKSI*D^/3,@VCAU.'-,=U54"H4
M<.RKV%?X Q^7\_2EGO8;KM3N?(KUJHDY%R8ES/$Z%.&I;4]2U3L7%;40<(^!
M>3YB5YEU[):O2-?D RX*I9X[Z1Y*;2-(-W\M0#@^Y%@J=.40,<+FC3ZNF*0E
M6GOL$FV?/]9\T,PVK"?2#F<L]AQ+V%7OOEK!*:BP)S0-Y4JM+J8TJCB;@EO"
MTX!^N.3=0?&#IF$A^G7J<W*&]/9R4W7S>_,R$!5ENG]5'?:X<M ^50Z] SA6
M1!%-R/5M!P=_Z)E"6VY[J*[FR/^TC@:X]&/+MJ"?'7I.N?XT%;V#E(/A'X"V
M+R@:G!!Y*"[0 I(!.0\D8RX$D$<09D+0P.8RX^@"+6*=H;^_],P[[=?9$6/M
MNSK;S<8YWW<2NVW4M3K-&P!&2ET8FP\TE.-O,/*^$R[RONH,Y>:Y:FW=IE51
MRAFOF-3+O/@K8NIA-V"GP1"U'F&<$13SBDUM"GPJZ#/ ]J]4U)[\Q6'GSU,D
MXO^<%(D_DHA9;\]=CEVH2UO,2$^@ 2_0&)H@@4OKH+8W'@>X8OR;5[%;,7X*
M07:,!D_;JM[NOY\&GQW H*MDKBDB>N$2CD$ZJEWYU\H@YNZ/ED+B;8!QVVV7
M#S5M"3!-Q*B=DL,)\2#%_(O/"!3^U<OD8$S)8NA'#%PA;E<MT^I=:6H%AB>'
M4EL]B4UGMKQM-X/>P'MRE[+QY\B:%'0H4O7ZQ*S'Y%D64W-[2LD3[1W\8Z"3
M0W["NFHLVJ=HA?]YK7DC?->*+NX 7N6,9W<-T3Y"]*17^S^J< )UU)?GOO+@
MGNI38+XX6BXZ>W\<_II9-*OXC),L2P(=\^)<3M"1GOESN/'-U##I"",3+B5R
M+2%]BHC)L;<#JG!MUNWCN%[NR-&V*:@C'MC BM;$[Q.UJ+3LR0F."O8SS99X
MW>#%7S,]I$D)M$=O2TX]F@6K=&9+&$D&=),IOT7U)/[#J;V>SC]"]O^U0G%_
M %&JG3]>"T#E4$":5*RES,>W0LYS%Z4)-+CB9F7FDLRS.A0/WFSPC0XR!_-S
M1$>9]1X+H[A/_ &6.\Q1AA<?."E^=RECK[#K4?"=G&-M?,V-V2Y22C(!;J\$
MJ.&PZPRYQ3SO@ \P^70/EJCY0CX_>0')AX)XNP?.T^B22)Y IP.(9LM.5P3S
MH#2@*/B>P(-_=]U V']&@*37"DM];JF#AQH#3BE<4HIW.I45R.<GE9X^AA$\
MHUO-";_NW-%!W+VGLH^TD"5O-( 5]I^DDL#B$)&9B&'.!5BR]34V[5L9[4Q$
M;E^R :A8?^H7(!)_ILC*!SPT/I^4P&SE=$BE=<L*V_+B9 ^SCAS;EAS=AQ-\
M'#,7<O9<9U%?PGNL<QU&I'N5VI!U0BLG3(#$OT>!<8QE 6-D!ZVS6"P-U=\!
M;M UDH;,G*7X,('U<!XE/.+=;O86HY\<Y^GM?;9D"KVC[?B#TF;3IG)2+YN<
M*>4T.NQAVBT<9<A3\PS)3ACCX@?3LCY;#,+/[7VK&[[_[T%E=2@@S!3EED"6
M%(GZU";B_U\!]%^$B&6YPG1Q>'K#/B7.W"(]5E#S^VRX ,FM\D4AC;JJ4^C)
M' 71](MY%CQC7>5FZ*;P]2C.;,"3U"LLV\P!KDQF=]%C0@W0]%/'3DQJXHI/
MT6BVXRZ_]N#K-3,\_MB//W?)]]'8Y5Q]?9LA[H*"@JOJ) PR6&G]Q=">V':B
MW;>E37-B<Y;IW2#'R01*4<MXG3+$#3TG)W#R8A_*(O^ND;%8XSD$LG;  #/@
M]G[@(FIL6\O:#N$%)V?+'_!3-!F:D$^_$7'\"/[U;/LVO;?+#E!J5^\\5 Y\
M6YP&'+ND&O!.0=UVUK'6/- 8:HEXJLE\3QY:2S:KS*&?Z,/<;581C;VZ_\'F
M>=;IOA%(\)$KW")B'\<N]05NP]@+2QTDC183Q*K,C45#%$Q36I/4"M$!GG4^
MI?!TRRLIUKUR=NE!32+5'P<Z<V0V#-T]G<T%BR/B.$NTO"3YLCX#_J#?"D5Z
M4;E"9?B8=S<&,EK(44Q\HHEDP5V)D/TR3.B#]6R*3E/*,9%\WA$789:UNGM[
M@T)FA7G",9AQ,B1PO(CD[ ?(0T(34]7,@(L14B9.Y,2E_<5+1MJ=6#1G?EF1
M#"_4A8.OE/D]1J.PHY8$%)ZP =$L\4\K>V;X:'/SYA&);=$Q30A#?8GD<O@Z
MO,311-?W"D?X:/H];5,AX5HA,'[NH6^9W4R2?X$F%$36,RCER,+O<$ONGG+
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MLB+I2<\![^X+ZJUW (5*#<B((QS9+MJU5Z.^7+EQR2!^I64UF7 0E+:]_%&
MI$?@._,N,RT&V?/Y6XZJ;$ P020\4CD/O;MO 57F>/+7T(S_#NZ8W9<X_Q,S
M_R<5G=QB!=8TP,]-QX0#./291I90K;%<HAT=%)FZ)K#=)X/:"9Z$*.2/$@"O
M5- X\HL8U2\2='YD_BSF?XIYSW,"MR"_:&W@4E#[E8]]]AI +)P441L^FJ.R
MZT4U0%(]0DQD@DWZ\$)S+;!GUG']IU5=F8B<OBIMY%I/W88F;G>[#HB?7C&S
M:-=%K4 8^F?19.NO).XN9\A>0:\2R!PJ))<&33C]1^E9V(..DX%#FLN7C&;D
M-!H&38D",&N-VM)W4E0.>YD5F=?>9,FZ V$2GG]<]TI!7^WZ*:C[ '^(Z*IL
M#*T!0V?SNA%[YMP5=DCMK+'&F[-M*5E/,8TX-]\97/2J]/M9B6-4N:V&"WI5
M>]DALCL _<8/"B>OF45>#:'?YBO6DA\YRWJANDBSV4+1+49RVD6'(D(S:UIN
M?R'L0N&IA#%G 8DY_3J.PTND$;6IIX+L7E\ L+.&B]?"L5+V1VB&<#"-#=]$
M:\;-WL)^QZ'[KD=B-2T6ERL&GXHX7F2%U85*:X@BTL5"HX8=3>YW))\V R]'
MA,# Z=LRBX0TV1AOVSQ9F10Z_4AC98^TNKS7UL.X(FY^T,S[Z?&JVU-)3U>U
M::T'2$V,0^3);*G(^R\8O>(I#S?'"+WF)9:]O<UFR6,7K[',KEGUWFFC^C*/
MG;#I*?IH;CR,'7(#H^5K7SU\N(/<R4>P*T034[37HUH[9:LO(7W SXO*=0]
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MPI8IINH@UF,V-R5>)W<PT]J3&7D':78$75W1.B>!9;0S>)+M1<6#.LZCS;!
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M6_G2L:_^K-N4DJ2TIPX:)H$%7NMKJ2FIN*P,R/5*GJ=]8HHUNS?\KIT :6&
M>O"0H>:5H^Q6O4[22:\&XH=7VCOV/O\JZ"W(2 O59I8JYR@[-$D6X"QQ>/RT
M>5 5R5DDZD +J7"JUN1=9G;IG5J>;69'_.@K?W,;0)IO([6,E"LQ7_1/YB(,
MHC9GF31$.F.^#L.5GZUDVS@=?-HUIQS;$6S"/RHT_>#3M-+BBA0,:U*0ON-"
M?N7!(PF I\P;Y>."F*G$ M*;O:(?#LZ@+'U347.\7U?=I.QO;])^LV>VZM&Z
M0>A=.?@" A/SU3*N0$')]QISV\U=S,Y+R^;KDT1#IZ^P!00DK;8(G%@@(@0G
MV_;.'B=]OU9\#253/+>A+=&4D!+P U;R4FP12M"Z.(-)V K)S!>F71VPH$6K
M?C3R",JLJG.5]^(IO2 V=Z5?G+WVJ=8+"G?H)? 39#\QO1GZE?G,0N1E];@[
MM59/J3F458U5C4SK9;3 *"A216=H9Z+7Q.#:-WQ5B[OK4Z\94I-,V]H3>CS*
M6%$#"[QW\CF64\AH0H75(O33VS6434K F8D**T)1&E?N:]AZ18YW&)NH2H<L
MWTDZ@?7*WAY':\#91ZH,GG1N<U!X[X;RSZXJUT5)[W"_(/0IM"L8G"]C_.+B
M#;KQ=+X\IY8RY!&&#IGWRLG1]5BW+S+P2YSY^@*D<*?*=FJ>^BK32D65(,.:
M^?5/(:[#GA^)^R"%>+S>SL,%)$0>>5UOZ"=$!;; *KKV)&Z\4B&3X*YGL_ZP
M()\[J'1?F:4I@<22%6?AZEX/74=ZNZDMD2_,G<J]_(VB;UD-4N"%GXL-%3D_
M"V3K,X<;O/=(AT<TZ 5.9T%S&Q:9]\WY_3 BX\]S6B\X7TSMI._AWB YN\"N
MRD890:^EP.UN.%;YEL:-LTE\(:0KN9!9U$']^L/;)\6C38YN[+(T:7"BJ6EG
MD@P^5W4G,I45OC #F*B*"WDO==]'WTB?,D<D:]<EXX$\8^*$+]0QY@F(%M_G
MW"L-XYU9 >E)J57$S=$6L;8+"GMU2LP#=R@+GSIQ]I5:O3P@:N*%4T6+F=FO
M: @JD'_-)W[ZPM@!%N'#7Z!2:,:'T7Y6]]A)37)'9+,?4G=7H)>42+74JIV%
M5^OR.J_3<"^!'A8 S_A&=\)TB=I)G.Z^KI6&P6VZ.<K#-$0TI$H9(PI7FNYO
MM@B]W"=X]^AR&JCT5=N4B4=<KZ/,T#Z;D:3X1$M*>.>4FD+A$5T=W5G51"C+
M:BQ:$JE?[9[UPV1#Z!Z)8K"E40MQ<^.[7H,;W]1VUY..PL]O]$RKU>_QCXB4
MGP];")6%"?A(P*?C[.@]Z?L 4@$#Q8V\UNK0C\Z:8:N?Q&RN+C*]FFU1FG";
MNS)0(% BK,7$[0[ZQCLKR^ QV:2>IQR+!3[JO$KB4U$<^MQ[6*3QT6[SFJ+[
M1<NQYZ4&<,[:(CLO*Y4\^9%[FQ$!(RTN#9^077&?7WY^D9$ZH\D#MMJB2>#0
M6&N//R9Z7WNQ*<VX+[?W&2S,1PBY/7W7-55%]@6S<?T<M0=.TB'F(I\(54H*
M+=A]ISXPA4U,?*6UBZ$[(!@KVMB@OW?#B]J""Y7<E783MFJF]#B)^^*3BR1E
M^BB=Q<GJ\*?EC1*Q<O%Q\A\V$S1]]7LFCS1<&,0SQ0(6R\!49+;;+A&)Q.!]
M_7Q?^"[UC#H42.^S2IA.BW\_(ENI8:494Y/[XWYON7U]G<-,F@QD,9K2%!4D
MK>+ ^$56,;(MSGP2OAOZ8#WIOCYMMMMBWDW)E9#J[K%#HO&#@[@OD+I7-G0S
M!N!7%&V!^9E@Y-91R^VDI0U" > ;\G,/[Y3?%1_Y= .E4<&>23BCIEUNAL@$
M'3HR6NUDT[P%9PT&Q7\J3LT]M6X)>JY]^KC%$A52="M\L:SZKOC-YX1:NHF]
MPT>U;TWLAAC?)%S0.8XT5[WTD(J1Z,%0V(FB&9(U'*U$[FS2*:SP2D(;,BQ[
M"2U?7S^=LW'W)-0IL:@FQU4FRZ3@FEQSC,&&W?KU>^)L1"Q937'P[6^9EG@S
M1HTDI[&\62BSDDB#3MNG[UR_P#AC)Y9E*"<@C1XDE]4*M.XG998.<!TQ=R7F
MNVR?.)F+(+V[W'G*C(TGO_:[^RLD'0Y>N,"!&"^;DGW<)Y)$6S1_(&N)I*V$
MKU4;E1_?"(BZ2<E+(6T M^/8&]EYZ81F$SN<K<VVL[E?YUX5_;+SV]3)63OM
M2V>T:A+/(_UPSS:VV7AO@L:W'E0/D<^F#GCETH8^G=2^,G\%C^0R3#:OOCDG
M:ON=3]R@N#W'[FA)^M:GS"T%V!L?^7&!+.38Q4X>/4HB0KW#2RK5MF]5(;D]
ML2TKI,(]I;U.-!_U)<#OW8 )ZP]L6*!#DOF;2?\FRF#PG05UM18EJF;E-ED_
M?1^9X@\[6U\.L?./ET*74ZD'Y34,R4F7J*.-3]BZ&+! A!COX7B:!#R(<L'?
MR4P@'?G.I&[4K]/!?F^@]KE\#MM:[A@_BR.'C2+7\9V5C]8M=U]UL=P8EE9D
MR?7A-)S9TZN,,*C:2*?)J$5LZ=Z]TY!P$Y!9\P:M[6TDWI3]+&"E?\"O;Y7
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M.?J)WT[>$K3)%O^'WZ\O=4+G'D?7&..4?Y?%\?<RG  ->KIH<?K+0,LM&'G
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M-'Y-#R'R<J^XBR9A:=7K6.N"9J1$0(+KO'KR/OE+7F9A\/M;3O8KWVI;QLX
MF^U:M1V7%[2"XMP2>LN!I(X[._/Q'2W7Z\:VKTN&5H>0:#;[7-:?9G]1J?_0
MZ/D$:S=-!H7Z@@;6<Q:O@O.SX>V*4:;GD"N+UIJ7_!P1)0ZPA*<M=I/>I$8_
M_'B;*T?YK5"'+_F%BPT&EISHE@EF&YA!&+K!3Q6]0BJ.^UPOA4QZ9&PR* H
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M^B EM$3*?.43PO!*Z/)(3&3U</$98)WT$WVG\Y;$;<4;[PM8F_E82#@+^BM
M;7'R>U\ *6VE0+J+@-4+?!@)5S'OTV=E.2=TGL*_!/9ZD437@R@W$'97Q"NV
M*3YHQ]CL%=8_V[;&=7KPEJ!@ H$PWHHL>3A6S_/M]O7R#.\IF80?R&"L<_[:
M+&==T_L8?F4VR- 4*%*XE?(>'<**+3HY@^*Y6U80XN_OO"N,Q&E]@9*M/8KS
M/BA<RZ!PW&D[2&*+"[V)J/?7;--5ZIA>7FKV,0&MIP#HY+VO:NTK#DL.QE5H
MD^VW).H,D$)C WFWT"=R@23MC:C0R(+.:V2V!)+WT4TNEMM2$%6G,@/CI;XW
MKCO&U'/!.]?C4BCCIBJL:D>KZRL5\,'VP(&[>3M+,+E$4^)TIV%"H9GH_5)W
MNL"HTDE0FL\0R'(_MV13VAJ!LA8'R>S[W;IY/>BW<.\W6BH,*7B@S'\)V@*?
MJW0QF:2!(-U^500,,IP)<SLR&H)HJ\HQ*?LNO)H6?]M56COZ4-1P["#^NLF7
MMAW3C^B25_ WEZ!@+10\:K&*L)T.Z$%(01DFC%Z#FMWU&A+@\TSW@ZIV3%T+
MO)1^?'T[G:=3F=6 ZW--&$\$<.!HN])THH*ND5'/QJ1L\<(;);>\=2C\UPCN
MZ2#PP0HIA@#GIB(5'E4B6JW15$3\H$1]D,3 Y/4SO(.RX/AU.2;70@S[$FT(
M>Z,>88-2MK7@)SE%7X'= FMXF/N->R"<D\%1C:;>C_D\H"1)M[8WQ^#TK"IB
MMA&5&]JEKT3@SY,P*G5%0MSWF2;.A?>8O?ZA#N#M:QP1R:4JY/Q\"=KU7;A9
M73-69EQ'FKNS_*4(SP/U-$DM4/FNXK,II^A+00?Q^V6O1SJNBCWQ=A3_I1$L
M&FY]_L!R,K+VOSL.>/3?TW.]\A+. /8'9H=??(W^U&K( #_]_=%_1XRL4U>2
MKI%MF44/[^TX4X,,#%ACK+3<G71EE[V-Y8II7^E$E,+]%.9%;N?]\E3VL2;%
M!6F+@PFC/EX*%5.NFSM4,7<QNI:,H=M;VD_NY41#05HJR,5@8<U&00^1S^LR
MXDBWM]\][!".[Z1"]\M>+8R'%FT&W#B='&5UHZ\*H\Z:N7^X%CB:?Y*5KI)M
M'[2NKG4CNC#P@%0OGO;.8I.K\4B3I6_ <6K.#_8"R9J0J>9*VQMU)I495H=%
MR$JC2;O73I\ZJ"*UWC*$!S59BUB92/C]S+L>QE$M959@4DV>/['\8 DOW'Y9
MBMPZOQ,)N=W]8O(E(:0(7D(NEC+,Y3PSIO;1RRIGEAOEF"/@[IVFKN>X&G%@
M C)\93+R^OOU4/N5 /8O4-%(WCGRZU)\MGZR<*@FN3(]_YR:\ =&R'B$Y,-K
M5:]\Q=E/-U)BI5H76SLH,R>D4W/>UDL]@[:5N#6[=DN$K9-%:]ZU/P.BR]B1
M?B[#0I=S4;(2QY(+AV%/JV/ TPUW\ZRUXR, %#0]..5K<VV*O)0-39D]4FN\
MB;RHQ"@5OT83T3)H198C$=R2L"Q+T\1LP_&2/Y]*K2S[/0FPB<5;G&A2SNK8
M9A&R3(-6K)OQ8*\BIQ^@\8+MG,&9(GLAF'<:"OV;1T-$7ZAQ<^6B:=)OI1)/
M+S<+_*J52/]&CQG+[F/VJV(A1FVO]5?)0D=M_4!4PGK@KQ**"SP(G.8_+Z)8
MKXB;5Y\@N6? >2W ,^#Y>7GY\[*%1-_^1UI/>+!T']XPF$PC7G(&_-X\\^]-
M X4%7C(#7CVA^/'&S<A@1X=V0?R/;F6#Y^_+;OYJJ)03-9(G4XVW8B3"*'@7
MO^?V"'6FU6+CM*KR>_WRS+)Q$Z@<SOQ1V4P=+=TS:GJ;IWA,!R"KT<W5[_3D
M(Y$*=D73)F4Z\D?(.-,I(Z,RO34&MY6B]A)5 @OZ^.[,#+ ZVK2)M[1&GF76
MG]P:H]OA,F/L+2;PVL>ZSJ8N73MIQ<,CWZC/.=^4-YR5"";=<TF9"OYYO86_
M-H6XXSD^$5@$QXJ+C#'>D-T,\@@>^M/+#G?<DP,E-#%JPG._&.F@K9^.2K"S
M+-D\0@3^@7,$+A'M?^3>\!\YET'^F0?\._>4?Q\7F!AGB>Q?,V\FZ\,9\(?!
M^7^M_P.MV\$>!PN26\W:7H783V?3#_J$_]ZDZI]\B@*BC9)ZL<TF%:.VZK%!
M=[\_0V(ICV<D<($;T=N=EIZJVS!639H@.2O8W0RX^FA&KM3B.0HZ;YI$IRZJ
MJV/)%S2>-:0F)K,*Q\YP,L&0HDZO!YXJ.D<R=<&D9R0^?/X@JV;F\\.?I^O*
MU \$+2C7/5%&I+:!191J"&2@:(F3+]7\Z,H"K%U^IX3MI@1.ZN#J_Z0PYG:^
MO\9Z^(+<TA2CT[5 _^2Q_FCK[PUH_D'&72 !H#11ZU<)>R6T)>Z,@D\+GH%R
M?6S.6:L@L;NCK5JV)K2LRF:S*<= 7?O2G12"]VI[)V5]2\H5G'CUD?A^@0CS
M%D_3\[AK,W0K B5\."\7XB;ZTY9@]"F\3[V#K))SL+"4.H[Y?$/%E$KD^M,3
MO27 K:W47[*SZN[282[L, -LGEMV=;J[YUGES24CO5F>JE07?7 73.PHM\0)
MH^J&'K?"KO^!"[7_T=W#U/^K%=[_/:U7GP'.+0F+4WJ!"W;JIS]]PK'L$D:L
M9T". '!8?A/U<PO2>N7;ZZL7/#TRP*[_1N.%V)'_1DUDKU"H_,SX/4%;NJ;M
M;R5"JG,P>UF:26,S6UV%IYW&(3WEM"BF@A8P\OLUPX8[O,YU" WC8EO?\@.*
MI!C,CU>G1]2.LXC9,8^VRUW25!!<+TC5V\UV,:VI9H@F]RSH-1G%TL]5:9/Y
M-BX/WNIHB=-FP>C97M)=<\&/7FE:ZO!)6&D._)GTQ/7J=WV(\E)<@6@(M]W'
M9'USBR8%#28IQ$V[JY-?7_:PZ6P(S6(E,[NS];,<F)R9;Q=+=!5>3;9B*_EX
MAX%D-QVTF7:K:11_(U:P<T-1!Y/JL B=[@FL')Z2PG[4YGE)EV+ZSG<QRG(;
M*?>""D7N8WR)O9J'RAX_R$QF8N,,N"2\Z4RF%WV[6VV_]<(<]%HB]U2)%=M.
MBITDWC@^^:-1<S%1P0Z)!!'[H"^ G^OBF -S=TX=Z]/DU4TS+0R];H@.:JRJ
MG<6:1(P,F8PUQW@<3N]#1?I#XH-,'R]HOJ K?WY3=,#,XOTE6X(M,D@RUA+)
MY^ G(/)*A;"2(KF,8W6INL_NS<DRY.VFX4'Y4JD^/^,K)B"#PN/3J8G$E@;I
M)==12*F7V<.JL2P%;_\/AWT0C87T8%&((:&+&;:6OWZEWNDREGYTZXG3UKB'
MEA>)+<$P;]/M''L64G]5@QCS_?.3N)Y;/4VR0>7IBND13>P"*??FN08$H=F(
M%C&HATY7?#$5""2,MSF'*FE=7S\_'#9P/@.8'8Y&Z9B[^)A^4)T\;#/>+UNZ
MCV9Z5\P)A3Y_>C($8CQO%2<>(P$X+5YY!N3G83>'VT"91!' ;@Q&3_DTX/SD
MFCKN#$@_OW,&T,G2_7_C3LX9$(I3]IH:1\B< .$ 8;Q59E1)#/:GV*J:#.V'
M=8^Y5!^Q)>4E.:9G 30A?2:WL5!28]13B>OD*]]>[)=;6GB\=^_T]HPT7(1B
M[UADYP(05-0;ESFN)'K_34A7@T.3ME,([4&9WM2/C9&?AK<."_E%)/MRI[DK
MCH<NT#O=?J'_PS#5TR[ )TFM/J>3I37RQ:"9VO[UK*E90^65##+E7, KQ,!4
M#%OK*+WQ)2^9+>>B(S$6.N8H16G#H?:>KKT)=;\P_B('[+:#% ]45&S.\O2"
MX<MY'H/ L3F;TPL&.PM?U/ #(*P38\8;B>#8)X#O$$@>-Y3]8NJ5@72:&#W9
MO8.Y5*MI3*UV>*/SIF%-BU3]#&%?)W =<\X3A_.%GZ3O-&UZMRQXL$O4Y0PH
M>:J70[<?U3WS)L -KQ.G-<\G0\VOTV.KW[B8I2SE4O:H#6M_?PCT#O= Q5\^
MD#V,&0*]QTTCV=V]N=3?N6T:@_E_O_\3OQ,LQ#'_P/WK(_MK=KKB!FKHL-%I
M ,=RDIK+DW8ORU6PMEA; A@S!6*6]9MJO/'V:OC.TSR'B@J"NO+'>:J$.H44
ML-4IF!31]RE4CRLKF<<7,X0;>Q/K]C4KU],Q'X_L!5+UILJH4F/<N(7N/%WF
M8)G&S4>35PNC8A<;>! !49JR9/[\T[LEZAHV6HAO//6G80W--[L6S1)W8GR
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M3NDKVD'W#[FC?:^8A$;#'Q?$['F/[>[(75NW$\=R=OYSM;;O'0RK'L;2)48
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M4/_B=OU :G:5Q]G].>O^E5)_KH&ZYQ<^7)0,5,V)),D<9SLJ:]*C_]PUYE@
M@Y/U:( ]/R&#FWV0:IL!C_?9@0]/IN>=! A['!&ZF/Z'Y?R)3T7;SS C@:XW
M%RS3GAXWT)=SJ> P@'WH=;$YFSG$_=BG'O7F)5-"Y:[5N?V="3\IB]IJ^NY+
M.%GGF:L%P2 Y3QG<F7(J&?1[&9[#*,Y'H6;6)X=FEI,&],', _B?J'';A\/@
M3"+I8<&0CY:@'5IW- 7:$778O]\5M+J[OB)_A_,-&8]LCABS.^HR1X:4>[<
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MOA'[XXBE_QIBHC\0"_L%8C/[(/W5]'V:1P< 7!N7E[O?6H0ON>!R?BP0QA\
M#Z<.@)FN&AY5["VV?1_]U<+L79[F?9^>U?3OGRE4^C_0.'3-C>/1^VIXYJ&O
M\Z$SPS(\,M\_@:F:<3'H]H9#:\0W2M\H?:/TC=)_@!+3:F'Z/U ZI3G V?_!
MD:_(@-6]<$8A+*WG[ UF?U45D78FIW=^>SR=P#$"?S#;P>?_!U!+ P04
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M=@:XL@TU14:HW8XA>>9LT8.$8J(S'*^#"H_+WBMM>VE6'X;G1C]@-)-TP4]
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MU?]2$)J:;)H<%GC#E5< T#TCY>;<Q,,@WIS%E9),CM[ (_R_ .Q_V ETS''
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M^FIMLY NL*6K[E'EZM.-L;9=.BBRPJP%7;%&+KAE]+P2!\@#D#T;$Q0(SIX
MOR(/TE5D\KH='I9(T>*Q@/Q1?J[N91#=_+KXL%;VH&PK(F^&H+OJB<.K;4 &
MJ]YLIT_OOP#GK?)R76N(S<H7.OXM\Y3J;UK@C,_J(,E4"(7E;(\'S[0G5[#>
MJD!_LP"\3&<MHL[O5? +:[9*GJ>^T")0,D_=PWQH4W#ZV+*_"SP^LLSF0C)*
MV(!X*U;X^4A#C\ OM"7J!J+[V=#+XOVKX/J^UXC 2\1QL7=%##O]5&I_0_H!
M6P_CTT?-5S-*.=LV##4B)=NU*>'YMT/&*"F#LM\$.4>2EBQ3J4#1\2A.?\W[
MX6$N4@4/UPG'16<SULKDY5 Z71ZQJKN)\R7@OD2K:O]+X'&Y<["7?A*\Z[*\
M>N1^C-_;!>6C"Z755^,M;\%OD>^ 6R)/V$!C>- XW9_N\N*O7=_W,/ ?[(%1
MU;PYP#QE/Q[7*_UCR3UE/E._TQC&_"/KYEE59(3][7RS&+ *^O.:"#W:QI+%
MH4'Z9:CJ"/$CI:W,Z:VV,G6="G+K^8&-UA&/3^T*=$6@/QFZ3IX[PQ,;>MMG
M%O9]]A]5;4KSJ0:@:DJC 6[A2!?]T&=)!M,%5U9E]SQ(.3BW8&4>[-(1<I"8
ME$<=T0DY80^+V@AY6Z,JLL%!..#^SXEK-"R]Y+-KYM1+QF[+AE-6V]VDZS&;
M>ZASK*(W[%P?#]"?KPTAC0)=BHHXH'<X%;N#K<YI\,$!$0,6-DT(=Z;G"SO+
MS,0#P^/W8S<IS7BHC@@NC0,_@K61=Q>NFB[<RDQ^SZ;GZ_=*[BW?&%L; [,5
MMM.XBMQ)&/&TA.Y9,K=DRD8D^+G(DL1IIM&#M,'SB<72+'7%GU?=&1?0@ZI7
M5DX;(TSD$L^')["L9OJV"ABV^B0==&A  1-I>)Z/P.Y &]6>K;)A8I5$@?2#
MI7#P''*^9\4(_3GXM0^COX-EV N-(F<\5?N@\?ARWQ"Q!\(.Z<F)/<08//@U
M&4('5NH;F;.&W>+BNX1H7\KI3@J=62N2+SPG[!0C-E2X,A-"<;>/H:LZA[D-
M_NZ]L[G;:VN V1L.N>/??QJKKG_;.<Y0RO/7$<BC?0.21;5L1@?Q4S2KHHH'
M'3]Z SO#6]J,F4KT*ZQ:L#BV9>+"+ [\__0*-A*9TXG^_4B1WV5EUN96XX/9
M[/4 442%/"W:3!0IK21UJ;!9*8LY=ZWT6B*1P?27FR'T6JX+X9^\_3=ND"N=
MT/A3!FX=T^_(DL0VL^1N2UEX6PP5F7.1QR(JC-3*:(R__EPZE:_%Z""OX$?9
M[\NJD]S88^+;01_XCBOR[B7S?93)D]&B$X,^"Z!?A3'ZQ%/Y1\P/G.M,NFXU
MA>W[J!-]Q3.AN,T'9&J7AC72VT#[JEQP)!$'Z*]=BZK6UN](_("'PC<_>)2C
M1<-S4U.FE:1&95X0,%Z[C&"9P'J5R,W4Z]A2GBB:AC<;)L/BLS.M=TC;F8CK
MW:DQ_,BC3_<3UY6GZ_3[_?4(%//]\C-JTHW"&AK6&EI^X.'PLLVVTKGVN!)[
M9S$::CGJ/4)K3JZK+"I!$ J4+9I%[T)OU'RV&RK8I;:B'$ ,7GNZ4$BZLV(>
MM\0*Q^P0O^-.%:*]YC\NCTDUU='JNA10']V7(!?Y[31Z\6S+=R7PX@3N50JY
M.[<8;I)R0VO_4<UA-B5*M^ZS-^,9.22Y=U BX"IVY]JE'?NP_2\TVFLAJ6[H
MC9%BN@F=AH=9'5?E(0H]TZG,0V)1O4J%*(1TN*Y!+RDL("L^FSM(&F(U]X/"
M=<=KO*:T2<72L7*<,D.N\'PR4_#F7""CXC@>W0L7XC!!9KXS=WYDI<UG:"K5
MW^T.IL?GQRW(WAHL<28=?;X69D,Y.O%,5ZV<7)/6Z:D/QF5"$6_9^L)@9\B5
M?J<FSVU5UBS;H,KM&@VS<2')(3%KQ0ORA<'874KQ4.B.65&1;)UHL]Q:L$C'
M]/C"CH>$Q\!"FKACQJP#:4':*D&B[NV!3]:?R/)XLCN:C> B73.PA&:%M1]B
M$I&#B?X70M@!>(;N[_L/)J+^H&MW08P8JV@6UN80.\L(@QDG^6N!F58>?T]$
M%SM)RO"4CE5WK:K!5.U?C O+FE\G%*W!R5S^(WVRP#:9% <8@WHQ D%PAIB)
M]L8[6?0VQYZ&1 KBBU@F>MT]^]>,\Y1&NP'G'?&LLV^DC-[(KD-?>7])6[8A
M&<6:S* 'X0X?7GZW5GL=3+^QB$I#Q'%GVK_B;;[J7+XQK<BCN<PY?22?AK<3
MILK'B(51TQ084EU'0"4H9T5\!%CF^N(YNQ6J>[SXJ3$S0XB<@[!9+LA5\F^3
M#XL&*^K"X)!QZ>2&_H[-F(TNL@E^?[C8=YEC^F/9^I-2_9B[W!_S\0HAW+L.
M!]#+"_U8&7GMY?-PB/#K.^YMI?8C(YX%R8('ZN1&U15RZ)E_O*7[Y<7GBTD$
M@BJTOW<!_T PR'5@ 2IB5V E?'.3YJGA"#F_8GH.;]K6@WHY,5@;Y(*F' ?L
MG<%.Z2L,*X30>$/ 9;)R'5*'_5BS:UQ0OP,FM:\L'9/7$XLK, \,M157A2*C
MP"],PN"/#_O)1UW?KII-))^8Q20=0!C_O,M^.A:GH&%1Q 27>GI.Q8*NI2)]
M(P)>U9)C^]4-;5Y9L]%Y@0-H,! 6F[D5R8)O- 0T:5^N;OM4O$"!PB3BZ=5H
M=HNY!64>&OQ%@,)?]\*/B-$Z^I$Z\29UMYQ;S6/M;W>R5R=-*!?>W3B2XQX\
MTR6'.X:Y+CR3+9U8Z#T!);\;!MAF/;H#23IP -L(@DUV<QX'.*]84J4GQ0Y
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M?U7!4@G%4^O[E\%,:NU<C>=956P^*I'$XG3DD[1L)H2B.HMKN./P>;F=K?1
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M:OG,JJ_< #Z5YQ5OVC'O-(U[@B=KB7@$SC29QE4I0VWW<XH*&?U&'A<Q),&
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M:=X\-X !U:K+/DRO%XDQ 0JL,FF+?:PW9//!24BF+S&*VHPQ:E4K:$,7K;X
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MJQ;47.77T_!3/.OJ!2SM1;RY>K6W'W<L?> -NWYJ17/(-YY0+7FG#8(*QB2
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M>+[X'!LC73P)?&ZP9.T-J+WBR>VIXE?@SY'_Z;@+&")SY%I)<%$([D1<<.J
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M7F-_=)0BC6'*;<SZW"D7GP?;U:"MI(TFP5CJ)F1PD.GXX5:0E78H'[7S$;B
M:N+UDQ=*CYX]>>9,O4WV>1SW&SH?'NY#O*WUKN.J5K+WZ4.^)XJ%-P#IW?K.
M=H)%5X]N.S=7PL65F(W[G=I,@HBAK^>W Y R*W -V'/8:_J4:&Q^>DRUI+N
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M4P[],PTW>5ZT0A3HROY@MO<K/GQ_CR;94UCLM84S/,+[+<[!I.[3U1462ZQ
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M=:)1J:&]';9KLC]TO'*J!O@%_ <?GOU/)8\AW02UHY+ ?]"4<1)GXM0!56?
M<R.X[3\9JS]?D_]6^:-*^ 7XAH6> =_*MS+W^X\C@;WC?T<Z\G\J$4!.9CO:
M<IY$A2_KS;^C7!,A<./\AE[7L8B<]JCK %YOC=-!'?7UW=,%$+^CGR,KT4%.
MJA^ARDV/9C>2GZLO=FS_I)L,4KR0\-[ -IQT//5G)6J1S2K(?C*PSS^\!32:
M9Q666I6)W4>G3:ML*NF"D@ ?(9A=L(@7Y:G-N1P7>VUP8]$,76D_0;)7#3,Z
M1K 4*;.[VNHQ: H.M63_8E?]1I\P#B=(D-1+A^]!;C<_1,H2OA?#X&IGP$6C
MB#- A1UV\MT("J-3$+_4MM&.31C:+SP#VDA0S<?D(J<'B\O*#/W++A>89Z9Z
M8/.KG_#@92':';7DFV6M'L-&QQ!IY1COLDQ.\H]\QR-\P1(7]9TW1BX%5I%H
MMQ-X1W*&X8;[%$ROJ%^AD3E8WIC;;9M&N5P+21K[I3LX906)"Q=2@PD7%I?O
M)Z+60FU9760"&40)522?Z[XDKU$5S7#E$3]*8'&Z>:[^9=,;TD?U>'', LC+
M"2M=W'<&+!OFXQQMX_:<^]\%QCJ0?C8VOF)$ON[H/&2.FBP*DUK@;XRZ2DY^
M; ##1..^M*S.FI\8R6L"A+<DZ^/&&:?-:-I,3MNQTA_6EJ@FMS4MK@[_65"*
M/F9_,V.;@8$,\+O*U&,"U<2<+C]+7IKI/9U^>:'.V4+]RX'HP>'MGL*Z3UE4
M$O_.1P[_K85IE9/]#'C370:;$MD4'-L:4"#ZLM_B'IT!95;CNN2%(_^1-US\
M:W(_58]:Y/KYD"O7O,IXK2*./1]6V6M/7-2/#E<'I0,^$L;D1*@/UCD#LHQ^
M87ARW,C_41XF]U5[#L-4[2T>DQ&1^1(LANN/!<#G[?^\XC_A*U30B$N9-(Y"
ML .-SX8G?>G*I7&T>!W,6K@>LWQ'I/=2Y_56II@RJ,;HSIYYO=$H$K2@;L <
M]#@0N=LX$.-2=&]RA_M)+(6,!,GA&\TW9>OS%@$&J^E6'! W=&$$5*DG8;X!
M$SS@ZF'Y<TDD<@A=^V9F63N#G_TE-Z)?F3-=[2^WT[ *%/7R5H)0OXUZG %<
MCLILXT8:^!LS8/QI/A<FT1'T\^ M"4+-!M:FDW<&#,WH$:VL5.(9 "+6W/NG
MFCRX0K4('VT8H_-F5Y#4S5(0[GZ#/-$4^[N=K!,_^V)*&&Q=Q.4,"& #YG(^
MG0$H,<S.*=EV\TZN!I[7\BIQ3AIK3O<<2%]$MI\!K_O;F_=8JL^ )N*<OH?X
M$%X=+!Z.9-'T"=(1+HO0G@'#EK.$8V($:XM:/*::A2VJ!TG_"5WR7P1L/E!V
M_+%Q2?045!^&'C3T%*'J)\1"/M>#49SC)*.XX.XZ]=?WN<%5\S!JT9B.U#5]
M7>Q49'# &\91%ZO<>R1/06;K4-DE(3X5%4&-@Y+VP[6TU1L$23 Z$ [+P8&_
MC/'N\CH:DKX<YA@FTW8+&;G?+U5>/#\_.)$RX)*9[%Q0@0D-><S2,_:8&A2>
MQ5LK#Z:$Q*Z.\J=UB8=Z42OK=6\]&)5,U[^#?<MYI;%!+G).W9:%6M08P94/
M^'&K)Q09J!E>!5@+C:7+(+/WAU<NU0UY2 4Z;(^Y6\&ULW#U#Z9V/QW%@S/W
MQ<NFE'!9-,>";S_C0K+-%Q>^5E6PUX,;*:S>-R7YJ&!=TQ&O/OG&#X!6HK>0
MV*U(8"&G%F[?=6P9\T+HO5UMBHQ7C46G4L.4?"ZD8MD(ERT4@UQ*>7 BA67E
M\JK=4N:,4WMQ/!5;U<BVI%+A7PN*<(F7&D)(G( X'*7]=#H)MN'*]7FA:NTO
MB6_><"@3Q=\?3EU8\-=S]^)H+^5/S]SQ,'(C7'-(?IZ7H) 2/?]PVD?LU(&T
M.*<\>ZK42X?!O]_\57'YFS-@(6Y3T3E]#.IH7XAS%9Q\<ZBO]9LM@P;K+3GW
MZ&%R'[7G]%#SX97QIY].>+-J'L8S2X7;;TW6P<T[F-DDXS_7OZ 2_A9.7>]/
MHLQ69<R3C[\[ZB58[HJQF&$^07BP&O*-P5]DB.$BW/,A6_<_56LG/&._7%P
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M\HW@M4BU\Q>ZY3ZVMK;B8YRG7JXO7*P<;G!-\>.*7 I[X-VK%O\#]!U=39#
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MKK5O!P90=5ST3,ZOSOF0%)>!W(OD5G])?Z=HB62F!%Q@,M=CDSK*S[%O9^E
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M/K4W!,X%%@0IUJ/=PI%65#A*JGFE?<NU%R4/@.N-6^'#>!<L2Y><#<^]&OJ
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MGWFCYU<I3\"<>HH Z*X>SS^M#],8SWNO7_TK5<AEC0MS7&1X7-:\VMT"K8)
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M(K>I!S8>> <:AR$ W,NNY3,\!# 8 ;GZ7&C.^6+RJB2[IBC&OHBI&C#*>\'
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MW]ZXIKGF7P6OP@NLBXC)MC">528<"Y?:QQ$P6-*X#8@:"T#JVY@0P BM @+
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MIFM8C([#\.$J\*,K7!$?NM*:YBCCW9)S0L.PB@#6F25N9BA+8(\2A\-NR0Y
M+/+/<H^'UVXC[B49NC&8HL1DGRB5?YU1;#=!HR7;W&^;?I(YI<^T9"R4))O
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M5YA!E5S*TF/R)G9,9*VZJ>@RL6RM$, 9H8GP#N2$,&P7$E^1+P"Y1M6%S-1
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M<TWK,7%]\[! (Q[FCWV_'CE^Y8@ F"\^(@![R-G+Z8JP]HU:%>1XSF1]?0Z
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MN/$9Z==T%6,NG1.5S-JK2C51#O9I] G8?G&U@QM/W0Q/R:,<<1E0>%:*L]S
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MUZ)ADW<N] 5&>0:/RV\,SJ"1--=Z]*"=08)1^+F8^JSK@3KJ$\-G-<G 2H(
M<1.E>_G^L$36HO8.LP=%=KX=>]<;JA!T=+(D=^>+EV6SJB:LQ5-4@KAV@I)U
M@^5YD/YN03=\G5GM<(OK#ETF:<>A1^2$\_/>[5GX>CY_SC+]W42JWQBZ,QWL
M+)V>CSNC%&2&,4K^E323XR(^@@#>>,&;R2XJ7;A^LYUC7J%O$-<\^M-)>L?%
MAPAT/GS7O+L%YOEIW+# /6X=!J<G(I_&=#!V+#+#Q/\EV/[2^'XSCL4Z[6E'
MG.XA\+K<8ZL=R\:.@#"&+VQ_,J6+\L'NXHD,PC:DK>KI.2)6(]T3D=VQ:^O"
MG+]TF[_=2D#_%HCQ0O#:$DN1DP=J#72W '5E]%7(S^^NFO_S/LY+K/S*?]-9
MUD@A_]PPYKFWPR5T#C/!6]8:)_]_]C!W6$^VXN=D_^82[%E'0<VOO:PH3\^6
M>M28WPXF_QE&43L$LG1+G@HXQ1%1"!FL2^R? 7VO[0CKCA7=PG%V5D2S"X&8
ME4$GXRT=/]$'#!)_>158&0_0T 3V0!@17(22\%R^O;-.J:(>I-N;4%VKUO^\
M^R*_I>]'MQ$2"&R<>ZT&W</)T<)@?;,2V.O_+8:]^SV&"8O:42-@J!%A&*%1
MHB0*4OARS3=5N6"+X]:5V'<DV2.7H?J^+H-7LKNG0!H=$U><VUZ&:SNY*M$&
M8LFC;;-R$+#!06:(K"%$;()?0W[/H168Z&- Z7HJ^ 1&U)HX*I8N0[@0$7M7
MQ[J+)@XU@KU'3)T1S?7S1[(HM,?-T.KH!J?\+Z!'%A4#_((] >S1I-S#:/BZ
MY<].C5N8 S@"]S@5T>_"\-JFDM,"G6]HQ,J/?7L=0#T-P]Q=9751NL<1_E-<
MX^?!D]:'.%95";U-'GL;89P]9$GO_=C=R9-'$?N %=/==04O&&9!6F%G]_3]
M$'9?5':\WM)[24G[F4-=A?:TD,O%F)6M4V:CSGVCZJ#9QUJKAJ/W'EABRG1-
M&L^]Y]OSB0H#5BJ9T55JSLNSK!UT;,<@>[-/S(X);(SH5FT=?2]/*+;&*RCD
M5U<&(R&=-O7RU>46V9^^*56^2XRL[;W:'78KGD3<H<$Z?<>S.M3[B9NQS4;K
M:X^-^>:/A65N'4X!8H),SD,O]RTR_00+-:%N[TX,*&^!-JEE=]\1.P?Z3T)U
M@V6?I=EIB'@9-VGQ4QX,VRC[O"2R-(R2"ETV5^SBH?IZGY_B2T2TD52C\)_G
MTDPHK09NZHB]U@6Y;(%J+$P@2'[>%KJ:!(%JQ%_CY#2W .7ECQM?'@2R6"=
MHZ_!NP@\7?H/2C[-\%=PZS</04_N-TC,J<(?'_D+WL=_ #0Y E*R.D1.)T00
M#HQN=8C(F@4,[\9%X3\0^LY?(.'H#$M'RG'P1I&NNKIU,OA+9?!4[OF4AMQ?
MNLG?&+EK(P+8SA T6'\4O/6XT%T6+F%-^0,/_M9J\)_U6)X0J5C]1:S]GVTH
M>%V41XQ+/@]N 7'MYM^^GJT("[D.JUYZ@?@]6;+U6R1%(;TN\6\V:K6!Y!8
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MI,W]?2E^,OH7+>28C9!S(AFHSKE'16X=]6&'ME5/N30Q"O%[$WM<S3+Z*@4
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MA'GOS2R^%:[W**29;M A[3TY;E*7@O;6M=1R)&NGJ^N99X,"5Q''!5RY1U$
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M"9,C=GY#'A'8NH9RKN[IKM%>]C0<Y)^=V5=/BV5.C%N+$]A-PX@K)'J2N<S
MG:PG+ZL[673-!POK.E9EM3/WRKJ)$D@P6"CZ[&"75(_4I6#3)X_.E;JJ0+)U
MV1S:P)2Y[6:_* .JM!,<;5N/9Q-5Q.6N\F[O$;1IW>W.7MJN(OV"A99A:N.!
M674:M4(7(VX8L>R_B7I\J&8(70RRCB[?2G[#&T,'TBM@H>"HK*%TM^45DE2
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M*H99BG6MV'4DZG-&_6Z!U4WRD\%)QCN><MFID* "[9DY<1O;I!D"!GPB>GK
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MK/O(9UL_'XP.HL:4KB<&8?, 7 \X XXGCG8JN9/[V]E.^HHL_>WRP'J[0MK
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M:@%\N=4,NAE^M7?&5;.BH_\-NY8U2(8IT"@1#P49@T:&7K>V$?ZM#%XQL;0
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M],9Z4.5;"C>T7\]$7$G!"\\U3:-R7?!ON=73Q1#E.W9LI"] ^VY1D.8""+T
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MM;6CAX6SK(2R+8A1[-5J!<U*^<1G/["]$?6\12AI%P);&9X=6%;'OR /O?V
MKYOG]0)KXGC[? T>P_F,!/:R%2+O N#K1BT7G5>EM]#MJGJX_L97SPG-8PJ[
M*R^Y8?7R2M !'2XR\4G J HL8HN[UX*J*X'ZDAO*B283#-W(E!5ZBIQMJ[];
MW5 %5XS/ZD[7M@[CY+OR_(@P!_-CSG.-6P$"@$@<YIS%!=!K?P%465X UI8$
M<R,U69/(QQO2U9J.6Y+RT5I<A#;3-;?MC3U\PAILE][7D EV$KOZ6I]5;*O
MH4%\+#7(B,)IK1:;C]HZ#XTKINOO\=Y\G&'KM6;6#R3C\[B-S!0M;FE(#GHP
M%^I-CL/"/DKA#%$H^TUVKE+9OV^-;3*L, ?5, J]"'>1&^)P>H:PW_U,;ECA
M_C)WB=LHQLHA-_(&(-+)=0&@K[N-/K.;'T* FA1 BKNBDRF;KYG+,<Q>\+1>
M>UYQ/68WI@-76MJ\6*I&2_S2X"U>G"7E\O-@$\^ZR51E<F-2YO96$:-IH0A
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MJ0%NGS&"=X?A_N&:!TO)"F9#I9K3'$_^,\%+/D,UWWVI&C^42BELK]RY NV
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M!P9_G-3>YK9MY$FNPZ&/>"IE.T,%?LCE[W5GL)PJ15Q!8"M.]D&GFFS@YZM
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M#-F%,/F:&N!C>K2<&%#$,+#I(6"8ROG.:4Z)<*;F159US)-)M@KLY>?'4G-
MZOY&4K23AW!"!NAJK:1E;L@7COGJX"']QI<QG3?"&N[T4W!,+:8*HGN+F(LJ
MS2,-C*JWWX:5ZUCJM>.37WDV^@'SYCI.NF8E(=)-/E'!>E9!0Q5R0'J5R2(S
M@*#'.;+%IQ^AP3Q/%YA,$]/D#/;,;G,1.ZAUZ+TW5=#?]T'6*@L#B]FNAOI$
M@X?#>!"%C\Q[$KV\C?6_V'OKL+J6)6]XX>[N!$^PX&XA6 @!$MP3'(+;1C<2
M(+@%2' )P36XN[L[;""X;#0X[\Z],W?.F;GWSLSWSLP[,]_Y8ST\58NU>E=7
M=577ZNY?!179Q"S0OC4-SMHX0-Q8GTP"SO<.9'M>!II-<MH<T)G-EOX#0"YS
M"=SZ?.'\9=CSIGI%:R5SY=K:.!&ZT!VJ!01F@#(-3B+0@08_Z@/[N;[X4>=W
M*Y+7;*;T$\4Y<*Y4<S%!:C!E2<.[1J*^T>LZZ?%>6T*^ID%:M."2+M1M_2Y\
MI2C(3:S758:U\ECHM<-HW,DJ0NUQ[D<^90Q0@,QDTM;]XYVO-V(;XCJWX8[2
MAVU.;>R!-"<#9%>%M27&:XR?ZH-]^4!O332U/G36T=I$),CNK* ['(6.0SLK
M1B!BY-I?W4T]2<DV7-D&N_D88CWB]B3)*_^58SQ$IP] Z .PP<=Y<_0 9))?
M_[.T7 GMLYJJ#->_]9S7_XI+7' C22V4P3RF5UV=C$U9$@E/AN&4X6FV GV9
MNLR?&)YN?EX8-,$0W9MS;3X! Q150"RX)?\6I=ZV0]H+;57^C#11=5+5\(W#
M2>FO6S<&N5#JNR%"-<*_=S3^;]U)EW+AS_LW8OD\L?+PTJF.<_\V/%RVU J5
M5_%MTW^18H*70O.B9^+V$20*ENCIXNS?/#(J1W!CG*=W;T.S.?F.24F9!C*8
M)6H1/=;5[1,]^:K2F;,1*XN>EV$2JPS +3=6K&LV7C:)=8?D2%[X$ 79<[HP
MTXB-OB[*)X\YB95U[T.P%!SNMOC"V_3*32Z^<L2WF;5V FF0__LN=G6I8UBS
MHMO33J?N\1>'K^6>80L1[7AP=BPA#[3SS[-?1.4.'L!C]. =<K\D#++?L.WE
MN%%&DG:(C%=<0PX@RFUG5U88*QIG];3 &R>D17H>HS^LL '1#A&-2_LZM42R
M1AS@"<'PMKK1FH"X^&&MH?%_WGRB2/O,S>23=W9L&VA$Q^X=7:RK=Z0;I-/C
M1WH'&-<2]T6L59+^TH_4] 02BQ@5//]6>-%NXX3SK4A6>D5H0@[D*%2<9-)E
M2/G@>CB?_72QGK([\U$[4B]*-G4KG"\RLK(BU$-Q801]E[QI_S'%;E+1S[ ?
MZ9^"YBD0&/R:](Q.>]8U;I4? $:Y5O!/6,@=HPO;54JD\TG_$G_,S\+I9;RJ
M)'Z]-5"6=BV;P!S>1UGT32RT;_20X9NRY,;9D-7MRW%>_DNG/(H%B[>1_0LV
MR3WHAWX5F7CB;ZJT_1]W"Y[MXGR\3@]Z/:,\ZJ6$.(1=_%C>/,J(>#!'+DG_
MXUS-((J@J"TB7C0(A_K2K3V-!AK]Z=+_5+/AAILCSM(3O/G5H<YPN;O\H/V#
MM/^K#E]44702J8%7QK->/.[BF1 EZHM=9>ZUM6XR4R^XNCDX9@2_O@,]GT":
M]..1+@'NE4U%75+:H*D%ANX]BG*]-"(M1Z#;9(1LJPS:E=.=#A&C[M^5X-A<
M[D;->1E0-070TP?TBK%B'W4X[:S@%8NJYNBX#WA3:.\6;F+UUQIRJ&%*KF8%
MM8G"!3(SQ=B(T*<V+!S#:T)S@]X&#;1=.,+E&>IV%L0)VMRKUW:+7Y"64=\]
M96C*Z;DPC/*8[P)OYBQ'QXW "^ )?QZ3!MQMLNT9X!'3K@1:(*H@DGM?\)6
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MP"CYPHG$^J_BCO.A,&_Y6][M(VHRF,?DJ]D =_\J[EA%=*;\6U[4Y3-1G@=
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M[Q*.22U DY=M[>7#Y/5\++#3P#0^/DG1A;SF,"P0B[D7YK5,3,,C%=11!#<
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MYV9837N(!W_S_JZ2)B$6\'P</OUI>P%N5_-KA7T4K^, [V/ZKF7RJ:*U8_Y
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M:[?,KIJ :/,>,;0)RFAC)$3RNSY!WC3MWC^GI>Z EZ?\5KKA; BM$B6X.*H
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M7*R2'!N:N6]!VS5QO$+L 97X[J)1F4@O_#T]6&H%OX&FRZ%':QQ-A5)%*Z"
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M]=I3,JW'X40JD=@*B![4\O34?I)$I5445-Q$2?<GR^-,-J&G_>7Y[PG"XV:
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M)-B!C]>WS)1^/;?)82KTZ,R>F?TPO](V8C[ YB7-=BZ+<*S,CP0IU(!U@K5
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M:UZ///4F0UJJ[QQM=.FO/0B>B'%%4*L,X,BL\U]+D%RC7>?G+"2\SH@:L![
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M/M^A=9ZF!;+R,#9*A9$ZL6QCN:T1,\C+%=Y>,,.3!ZPPJY0'BI75%$'F%,?
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MOA\M,.="/GPB#D'L</!B"YG]&76'P4QZM)!!O:7&8!N)3"%BQVUAX6:=2!Z
M"KRUIX@PE67-)_8KT4MMSL]*=728F,Q"?8I3V_G4')U5Q0J5OC;6]JH=9"[+
M*Z4MR]OY^;B>1KKQFWK4T5Y&N5ON2Z[GC)]85\4TO*_:P D*:DC>>1@DRB,<
M^@%ZR=\L2.M.33"%PU96%O(_L'U,6$^*!I.DSINL;1TI^.I5VX<0CGW'%Q\7
MNNJ105XEO .R=!)&'1Y$9[_PUZR-5SUX40&1?^HW*1W5%Y!0^D,$V;+71P*9
MNL8+8#ZW.3W>)*-2'C>H4WG/A-">3!'E^<WBXNNB\NH '#+1EN@PAYFFNI+U
MXJR@K-^2!%6@1""$WO%%*_."_AXA0O)2$^XN@>@!8NGV(XVI=ERN2LL*)2&'
M[M (CHL&1=F^J@U.+TR >@,I@J\WYUQ @B@1"E4RU(N0\+61^,[[GQI3.R)9
M6@R3?@FMA]-"FU:.6&'?6D*N#_D,B]5?CQ?8FZMV^MO=O"0)H(IX\8QVIF0F
M&[W5.[)*!\?S"R /QXX6GVNG_5A$()OZ6J[IK3R+;4+Z(==U;Q@!W1"V=9*$
MNCER&\$M2<B&F;*UY I6&?3UG)8>7&7AJA5KJR'A(3(R?V+:QAQ%I:8N73QA
MFM]I_^GW+LQIED/11JZ>[T0QI$A#<$T(E8379GIIW9GMV1F?<TMYHJW7$'7:
M?/4H6A_TP#6A%7M7Z8P^V V^KDE<_[2W?@=H=-L4V@CHYI5# +@$(\ Z08F>
MMV0,ZEHOUG;&B?6TRF\"P>9)=X\%+:##*O8V//2;76%TKW!-<7SK9X(^2?:$
M&6ZKEV6%3@LX7#C(I"QQF?=:T!.SH#\X.(-KPM\5UDUUP1)A55NJ'(0>!3Q0
M6:P9&4)+PAC;8\*_''$=A##D94?9^J"E$@(^<%VP" D:>F=NA.S X$$8 ]>V
MU6:-#3R]-[5!5:2%XP?XZ(4<P/'#8C&B]OZ660=)P$FW+#CT*L]>\68(83UJ
M.R$(/0%@M1$G$J :X2"ZEC+)@9HHU7RB T)>Q_HA$04@X" _"<'J@^NF]([,
ML6,MAT7:+G69[X!?>=J_MT7__#J4(ES@51)(CP?P@^<7DZDO6=1D,YB]Z805
MJ>^<'8FMED]+, ,SRR (O[NO =2$[$EH6W3<)S6&S*@:F?+FQSDB06%$/7DZ
MU:(=B]TL05X LN6K4-72\1,4HU&AXNJZ:/WD?LW>>TV.VL6M@?Z U7:'F=?T
M<.K$7+)E'K0Z:L__<F-#BP(RFYTQRM9.VM2AP.Z_0N5/@AU^U=7!JS>6MSX?
MI,6]+QAT30YRT2J--*UT1..HB2=ZQ9L<-<3W_"'S*S+G*21>75$F/P]*4T@R
M84<Z_Q7$]^3+]'$O!].3+\\?]^I_3D@O85X-]+[JV!R@O -\O9WO +3:*[,K
M,<4[X!/3U:LK/L\DC_8U9P$MV]I>6.U9[(##]52_S>5$ZD*L .HF+T=T ?RY
M3X^<PQ;[)MZ*,^H1)2M>9P^1Z$[BW)LK/6E^[<5C[0>K^RW;QO:Y[W9WU%H,
MG_[P@Z*2*.P^8&CR#DI:P<9(?NPF.O[AEB51%.U,&VWCK-@D)I!,&%]#\-L@
M-H^C_+-61,HSL\F@Y$=UMKGJ;DI^VV]J)TB$A\C&.>Q+HX(0ZT;Z".G,NY$-
MR8D,Z*#5_ 2R^V\]$4[,B<^4O,'"KB]J17CM@@[J])VM QXLKSUL=1"=YZD_
MRMZ_4CEWS[IFFV!/M%07MY<R)V7DFNI_#@'POG@]+'D7"T?(HR/XB1B8/2\Z
M@%?YTL'IN?_%E&3'CD^E@F3PJ9'*VA%5J'$D.D))V- "HU-X]79(:+L69?6!
M8RB8<G$0W31&TN@I8W9NMQE="T89HH&27=OG-Q87TL.Q>GO"9*K[HW+[4J&?
MKJ7,EC35T,QVU9A*7U*-9B2T>-M0H7_W#,J%A?>]<6<1;"''<U)NYG6 %&PY
MUIY,!J26E1YFD@P+?;"45;"T2@\_W!E\)436>'!O;&B4[)_ZWP$HJS.GEPF7
M,]BO5B7*^@PE.-.-5FE5&%^Y9=?;)#T;<E/?'VAI;;<Z'U2=I"BI"C+%=WSW
M"!1>%D6%Y !@R['X440T!>D8N+T]CT\Y;VV&(J@I%9PR:'*@N>;&Z+?NO!:]
MBN]#X?I@""J4Z!#*QU!>JAAL$Z<O9WHT,[41][(7-'FD'M"K@6C[52CUX#!,
M2$=TXZC*ZCG\Z$GJD@S(36:LCDNO4-O8A2P KW964G>K=) NN F)T*"'#6M)
M5@\A*(P.Y\3-?/^J0RH#:G89 C'*-X&4JL3/S_>"]MLITU*H ZS<ZA(0W<]A
M82S]VXVX#&"^ X&C=BV\<8H)^@KC-,G>%T^32)-41&XIX'1Q=]U %CK*$_QL
M2P:00#>'6\H#L@IR_XYD S#Q6ZM6AJ80U5?/PV/,Z/"4+D*[J[Y;>PD!N8N[
M-IVJH\N0AO.BI0)*%1,]Q#WHJP^OT/%(]+E;/7O%] DI5[?$2DS5?(^U>,_-
M3./&8L(T87/QL2GFX=IX$/E2W'?E/AXZ//!@Y<^S;HI^VY(-Y1-U3(LWGLKA
M<8*[U>:G1'H+#Q2>"CCXX'F_1)ICQ70LE\$_EVR%^K=^1OXLOX?QB />TY8T
M8ZND?#,*8+5X7QVX@CE-880+-[3A@ORESG))$'_O(*DL<Y/7H\01,0>2$#&"
MXZ'AC_!4E[+\P$^G5N)9[CE3:Q+XP&K\@[T,:*O2H09OYO11OPD+ WB9[XO
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MQXO46](DEZ]3EY1L.BJ-5F0I72>U$@>2SK>;CSDX<^]Q1-LV>?:4B2<P!65
MG=1)5AJY2%HL)U.'_7D^][5>B@1MYTW&9VGIS4?AHDC.A@!F8K^4ZY(YN4RM
MJWI>(Z-^Q^IAPC(E91C+T&@96MR8$M;O61B2<_Y1<J00'PU61"LJM>A6:<$J
MIN..@?_>5CJPA8QU".W['6 ,J/KX#'/#"V0$P>TYX14P[-81.)R62E2:!<_)
M[PIR#D<."G<6T#'3I)5Q,&%OJHFT*9U-ZO+HR_=X$PWPZN\BPX]R#V#R$OM-
MMJM1K_; 6G-HODT]I%(2:@L#$+T0(D21WXE\(V'_#ZZOLII:L.D+0>-(HT3:
M5O(>:8UCD/OS!R[_@!9?'/V1%1<V<+7,4:,>ST_29THL* ]:6-AWWKIO_'E^
ML%C;)6<D7[.K2TDW\0][E/YR^W5C;NYU4A>7(:3ZWS'S-)6XKK.!O?BP)%M)
MDRQOA.O#[_;J+&9&-@9/Z3I$O+[JJ%3U!.E1"IRGH'W]]UE)NEHBSM;G1YC'
M+3M^K97I+]<_&K+>%GK\EU!^PGB[=6>.^"7=-6;N#::[@HR+X8.O.C-_E8C"
M?Q_WC[1@@X[69J#X+ ALK7#T<(\(= QVD?UW>:%DF+Z$P?2F2H7)HBZ7B,OW
M<+JJF]3[F .Q\0L[7UY506H#DJJZ*3Q)#LTHE8Y1I4L"9OE.$S3MNZE:8E*X
MR6G>YB<Y"Q3,D;;((0".9M)[Z/$0<1\9^_[MBO8NNJ5.RC=]0'\Y$@*X)B&[
M*,&[!.9YYD WH^=-ZAQ"L)LE/T][T61980HTRJA%0Y?H:E4L='2'W_J\IA;O
M"0]O7KF?.\ZP2NY2/[XDI1/$\M1J29"YF8+D,Q6F<B'R8H=+8.CO=# ?<W6]
MB*'8$@:C)JNF"&.9R>,=9W#EP@&,Z/8)K%[AWN@?;%WP[+P#;H4C[X" M#Y&
M2SG%?'LTJ3?S@Z55(4[G"*FKTG#-I,+-(#+GS/J&RM$"LKT]&4:$CK5F[F[
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M6[D.(L,\2/=<A%'VJ!Y*6<*J^5<FU'=!;V4S%E#C+$U&@)9)C<?LB7QS9^H
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M(JM@KQ]2G6+*>UG9/NW3I=Y%2,-U:N-,J[T':.@Z:GN:9WYU&)QXXGSFJF
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M6G9&P;3:YTMD=P.+=>.2+;[5JEB:<[3:0*8[@N6\*$!0LXG-.RUJY$$W(GP
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M+]+(V^]I8Q(YCR2>_OJN^YQ#48R5;*\MY,1Z/D!TV]2JO*IK;II1DA4U<I7
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M%QXE]F]1&QNVQ$KRG&;HR3,EN[!"Y/ENNLJ;8[;WQ82LW8H<:H=MZQ+2N/,
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MIZ"@%[K*?%7H__K -0'4),1<X P0P37@ C4!B)H UP9  8" B."W _CC(+@
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MF'SQK(W#5#JC"@P&6-)I]A0/M]@7)&XMVE PW?,?0YJYL9H5B:_<9)!?@;7
M6,N-L8Q2[6?[TQ#LJ1H.Z+0$K1WS=DA#3^37].J7ZD->WT1\74YZ?K$LR86H
M2X(OC7Y4O'.FPX.-?+1TD$ 1WHP#*%B0D&/B5<3A@CU6RK"SI3B"L3.R[NFM
MV,^MN?I*MJRZLOU%T1QAO;N1_<Z[B>(@V"U/D!SK@*)3)O6ICEB -+77YXG4
M1QY,2HGHJ967$?T$](277+?%P1C550IWXU,1MPC8*M-O1FO$; '>,$4'!&F=
M3;[[3DNEWH=\HASA=L^#]8J//;D*[&;;+R1Z,[ )O:=/,:7%[I?;M6N,DJP^
M]!%6J#KTO6(J);ZUX5<^8DHBY3D(_JKYNT=:L7XUT#-,*@Z(&CJ?S +VV"X$
M!_APX@!D&<'^&<UR)H4LOZ[[6G^J%YG5\3";>:"LUB+148KT+HF$%*4*\]*7
ML7VIC4EO,8WJQMKXWO**T _)!_'E5RYU@N)](?> $D5XM^.)BGMND;F-+:]2
MU(7%CCAEWJ]%[D0!O@^DYBP&=8K@W)C7.(!*A#>?_YD_Q8.>A_&=@$D0$R>S
M7;]P,'WW2362[2$8H4@S#Z66O8V);Y&5&BF3NLC'HZ9OS&LZ<"6H?S6V7R6&
M\K/70W#MT'\Q+1SPNY.,L5)R4(TA(WD4$AE4&59.7V;K.4$!TTIZ?3UT(%XJ
MSL%7])ZH8$1\U4J,"C$.Z("\/NYLQ0&;]INI-@P-TRM'F3:1DTS2=:8V_(<#
M!@?O( _?5\$"9VZ/U+G-ZQ<^>NP_S+!0[_5*_[&Y5A;U5S=AYJ4!Q+U\]&4D
M<<*<5%79:B&B[)=HJ[I=O,=S0G:VTF=?.B-N23HY=LC)L(8=^6*'9OBW/OPQ
M3NV;""LH=:<;DS6C:(+,EW[,UFE7&LHQ^&:3<_0\+$0/.#8*6Y:F0*;S=Z;0
M-WZ?[,V0YON176$$EHG^E,8L!G=E\\M:L+]LY4,]N/SCE\=I@3OFB9&1C@PU
MV%7\C%0<B"$H5H2O%6*'/<.G; ==>'5-=)XU'$THQ3KOIG]\?+7#26C:$]U_
M'H+A.."/&$3\'H/PHW<^PUI'X=#7^R+<!O&R:8LTAG40ONXIYY$=9M8TY^UC
MHP+3PC77X\149Y:^]!;[L,?2 EB3@!CY12KYQ8=$/;P=V)NG3T?K2!<*#/G5
MRKZ_\-?GJ'I1$SD>0/>J:6)=,)"EWLJ'X=3>^,JZA3*:63M1;$^<UJF)X?D;
M'# @7!4'E9%HM6!FM@,.)+F+TZ5OH_?:]0;"RB)O(36&$B].CMDN6LZ_$=!Q
MR(GH4G+PI@"\Z12O/"10-'-/;9LP#G21*/<V0O#,R-+H)"4,W)6?CH(I/  X
MW(TJ3U37^1TKY0<+G_D9!I^L6#$J#O2X9CT,8>CJ?;71R095_ >0_1Y?2?CX
M^KGL=Z*JMGS3AWUP,,OI_K%SS!-7E'0EE^/ HSH'3\<N\*#+$QG^)R4_]VN]
MU=2KHY;[Y\7:>5CI$0+R76R[)&R[O.VRU^ V:*Y N%N^I2NMWN/$B@;MSHP;
M%].'V--BV5AT\5'F]K[!! <$1Z%#SD NL!.T& Y@R<9#5P=TGV(0!^RTS9ZZ
M^LIF_@NQN,,-O,_.<+>U7:RJ2K@:S,'/$2?P1!'$$><.4/[:NWJ676><(3(-
M@?YJ^2-5_I90H[6G4FC.E? ZT@\;2>AFEA^CJ?5L6E2V"8,FES04659!']^'
MH0=",ZGJO.<H[JNRIF<;K%92*A:.5R;Q>!XY/;\/!C4J@=BK'D),W]=ESRNW
MCZ+KIW\F%7)&?OA8%??#9.J]2_,4\-S'O,/GD&W_2+7XT;\-U_]/P]TGX*39
M"ZX]4=QPW*B,775E?)SR_)[6A.I"0L9=9C!,".EF8&(JOL)0_'CXUPY]*VI%
M&PT-O;D_J8_YG%M3_C6,X<H[E?&0]"0N#K_=""K)M+@KH-I_T<Y_OZOX_>GM
M?/7/&!V5'[=H;V<<]#"%T@HH!+N0RW5S,<A^\+W-_>EPM.+8+M,9X<:59&-[
M65UXB\N:FS,*S 6P)NR9=VY=74BL3B@L*V04OQC/J,I<U%,]1TM)(+[CERDO
M!U4?,@"W1+^.1H,4:N(.Z-E&-G-)I1V(232_:G9L(L6?16369@@1N>T#FD;4
M>+0Q#I5F1]:KW?GR=3BGO'RW0AJM8K =RKP8"JQWECOA -30C  .>/<;U%__
M!]3O@?^:ZY[@UN@HVAF>D>=#Y1N6(F?WC-A2N&3O;ZNV ./<8QU"#Y 9\FQ4
M$./W8?BHRE]/*8P*S9VRUDOXYOK3=:WAJ0$J^RCN 0"*4P'%&U$78X>UDAEA
ME):65.+7O!6[;]9ZL.I1EZUDS;BS2,R!5B5YER$8RQTZ'# H=@<'-%[" >B)
M56G!$V61RIA)]U15?^Z<)(B'V3=";F7"#C?:YO4[+M(7E$C C4.:S=)BVF@#
M_9YX>1YPE,J84$ULC#PSE;+G$;+5&"K]Y#.F0&5X6^2,P:2^/GA&*8KA#I$;
MF<JW0 OPX"!XR$73 -J>R;AN1(@J+,K/;;82V9W)K>4;%N;6BAIG>OK *:"Q
M$'![HY-T"L5$?X;+8<>Q/RM*0C9EE9,.5*:=&[_UNPDC'%PZ/7LQI6@+(Q17
M6*%+_:WOZBFD+^/F4];%7I ;CH)L/G90N?YZ!S'#QPZTS"U\KS\U"XFM4L>+
M#INU*J[@]1FI< \M2W,Y=#<3L8Z6$ F[/\F.W"5-8W&;V3+HZTUIQ?SQM9\U
M+.V1]5,E^GU+75@SZT5>NTLFBX"3^.T2U,ZYSPV1]6)W&K\.9Y?7[+G54:LP
MVX9.F223K&>7 U[U-+VG=_%Y&P@GS;=)I&[F_%&<4,*E]7 [@6KQ D1)9B,
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M"4%5\+7Y:(AUAA3:190J>3ECW5YT>RGDK:G"K'21*D.'<_=BC&2L'-1>YR]
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MBDH[H60[=1ZYJP[61AR1_"(C">;5ZK!P_Q-9VXP75^:)'50XT@#Q8C6\'7%
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M!>!+7'R2Y_\!1Y4BD/')UA1X^*U2Q*L"R6I9O>C2MAX=@"JG0KZ[RW$RJOI
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M/Q1KU5ISS>=YQIASC&?><7R8>&]5K*HT5/6)QX5!,D95;AA; *3$@;U)+R)
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M4K^M/4;!;9FX<D[32&FK'^:P>RR4 3D-MR4 PX9#%&H$@$H'L7Y*O7"LX$X
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MO20F[=B<@K.'OE*ZL31 :,)JQCL<#>I&#13#[0[WOU7)*!LT4KWE''C 7?Y
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M#EB0X 16N(!>U'I'0D2]\;Z%V:QV>:>I4(87L,5,DDP2Z=!'<X/._]5N='&
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M4 OAT['S(M@Y(LUF;B_^#9GJK[H?7"S2RL9<&[]==5M[N5CI!CG@1P"B:D]
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MW],L6#'74#.!&JXL06..US,*ZC)8:^KVM'(_&9G.F7LO]S'?-PD9I?BH"ZC
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MNGD<Q(US;H91:.;0/I@7K=E[&8KHHFWN@2L_[_^L['9[54/^*V#=A*58=#S
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M2"JU42=#TR?#OABU,]#XR4-/"B+R+%6477.=H68A'5B7\<:O/:K=YNXT@4R
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M]K6P0%1PD.P2"_HHX"G\5QT(]/^)D7=@ <9U+% ,>>$H>Q(+3!UUP@+&;%A
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MDN8I'\PH%CCL"C]Q)U?B3PKI[O4_ED>XUO1SU_L(=KTFMN^1_9W8P(4!UYS
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M63A @-0MIFE/RZ.*V-X+^15V?ZF1XGD/P@M2-SA>)HVJ@8-*$_R]Z(@LU$@
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M%BA:O&$7-=C,7^<OP1++RLP9,K[DYP0;G>\O4+.Q;C)B*4YR9SU=EWY;Y5[
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M\+J_P)/SG;5Y#.;J1.]964<O'HD&;"M.,)O_TWIY^+$-EQ;B +!>E+4'DFM
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M&J97^N!L+&ZX+.=:E.!BPR]8/!='%UX^?0=J+/DD$9>PM^(;OANE[4D*QTQ
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MVK<HEFJ JY)87X6X+ P>$9A3:1T/3C[+)C6>BH&M)3"EF_NUOTMFJX*/=VZ
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MKT5?]R0,EKJ;[%XXT-'EPFYK+["&7ZB"!<84FO?@E"6])@/0G<B)L_Z9AEC
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M-MG\O%G_7$.P;>Q;GN(@<3;I@IT&YY,ONNTB](-D*NH2_Y=>__$E^R/][(B
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M,9'DP=>J?@QEZ1MM:=E; UP$U">#7^@P+JF@6&[UQ)$G]E3)VU!-NZH#IX!
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MF_DQ3FYU+TC02G=,OSF?X707:-,L:X653YT"@P&VA;$U6QOLB0)18Q0<AJ<
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MNA_]C;T;_[ W8_>?<)7!XNO"P=_X$ NBMK;+C%\ _S*?3GWH^?O-+2(G7:<
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MM92BBRV#[K:Q1UR.'@9;^0D)O9"\VO$+$1;9O"W-";MXG$%QPFW+:=^S1-^
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M$9F._2_5DW,V0VB7E.$-IB=^[A='V<N^MC,8TO<K&>A0(:K'"IZ1O()6EXP
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M]Q#+U5]CR-QZJ*-*#"[JP6F8C/@B;."_80-%<##\WO3DNN0\+IK8T0[>U$5
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M;A5Y0?""H.QDX K %)2Y I)Q07>UJS8+U6SY.>;GF/_6,=^E^1:<'!5<ZY[
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MJ8QNKE*PZF#:?A*$<=\7)7:=RHM4W2%W:R&(Z)Y0:!O)^Y=R+ "R![#U$CK
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M$A*)E+@UL5F3#[W=(4::2EK-=$5ID'@^^<R2/H5!O,:KLNW>^;(;2'-T-UB
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M[,&_6X9:M+('-AL04T9GV<'9=TNFF^V.9NX/+"<J8Y!9S3[KWI0! "X)VA+
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M7OJ5'78-D6?\\'_@B5"N+3R8.',DK\8C)P^PV[Y*M-IO??TP>4IP-U1SI#P
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ML)6(\=_\<6[84?)@GY^C+N89PYIOKBRB"=LW2/%T+0/![ 4M$_'3#/>7NYA
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M_A[3B,IF<9?Z>EX&'36!E;T^-DE$7),"@QD%/W+A*[(Q ->NPA0K..Y9]/7
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M>#$P,S-?-3@X+FAT;5!+ 0(4 Q0    ( ,%]95)/GL=MQ00  &HG   1
M          "  7L]!@!D<G)X+65X,C,Q7S$P+FAT;5!+ 0(4 Q0    ( ,%]
M95+PKY6<$@@  ))!   1              "  6]"!@!D<G)X+65X,S$Q7S$Q
M+FAT;5!+ 0(4 Q0    ( ,%]95*U$D:_)P@  ,-!   1              "
M ;!*!@!D<G)X+65X,S$R7S$R+FAT;5!+ 0(4 Q0    ( ,%]95+R.]J\- 0
M "40   1              "  093!@!D<G)X+65X,S(Q7S$S+FAT;5!+ 0(4
M Q0    ( ,%]95(B\(@/4@0  '80   1              "  6E7!@!D<G)X
M+65X,S(R7S$T+FAT;5!+ 0(4 Q0    ( ,%]95(=1:ND%<4! #)7 @ 6
M          "  >I;!@!G9W5O<'5I>F@T-&XP,# P,#$N:G!G4$L! A0#%
M  @ P7UE4A%I.7H+$P$ #<0! !8              ( !,R$( &=G=6]P=6EZ
M:#0T;C P,# P,BYJ<&=02P$"% ,4    " #!?652"JYR(HA9  "ZD0  %@
M            @ %R- D 9V=U;W!U:7IH-#1N,# P,# S+FIP9U!+ 0(4 Q0
M   ( ,%]95(_&3L\WZ$  )$( 0 6              "  2Z."0!G9W5O<'5I
M>F@T-&XP,# P,#0N:G!G4$L! A0#%     @ P7UE4M^YKN IM0  _BL! !8
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G=6EZ:#0T;C P,# P."YJ<&=02P4&     !4 %0!K!0  A.\.

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
